data_2le1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2le1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.927 0.394 . . . . 70.109999999999999 111.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -103.97 109.13 20.78 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.415 1.086 . . . . 74.319999999999993 109.793 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.39 140.64 29.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.782 0.833 . . . . 73.420000000000002 109.793 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -146.24 123.21 11.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.154 0.582 . . . . 74.400000000000006 109.867 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 130' ' ' PHE . 45.4 mtp85 -128.75 150.34 50.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 74.400000000000006 110.097 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -139.49 145.02 38.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.684 0.794 . . . . 54.149999999999999 110.519 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.7 p -136.23 144.91 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 122.558 0.343 . . . . 51.310000000000002 111.323 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.25 109.19 20.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.658 0.783 . . . . 72.120000000000005 110.489 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.9 t -101.19 127.17 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.984 0.914 . . . . 73.120000000000005 110.407 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 65.59 4.73 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.431 0.692 . . . . 74.209999999999994 111.491 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.0 155.13 3.62 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 124.002 0.921 . . . . 70.120000000000005 111.225 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.13 139.12 85.01 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.082 2.521 . . . . 70.310000000000002 113.865 167.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.47 64.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.258 1.577 . . . . 74.400000000000006 115.258 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.16 98.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.4 0.68 . . . . 64.319999999999993 112.426 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.22 -36.16 77.06 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.748 0.819 . . . . 72.540000000000006 112.34 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.467 HG22 ' SG ' ' A' ' 103' ' ' CYS . 41.3 t -73.57 -35.7 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.103 0.561 . . . . 72.140000000000001 111.345 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.62 -34.34 78.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.627 0.371 . . . . 74.349999999999994 111.309 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -58.84 -23.94 61.36 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.708 0.803 . . . . 65.219999999999999 111.604 171.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.8 tp -95.04 -58.47 2.14 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.067 0.947 . . . . 73.519999999999996 112.866 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.03 -34.14 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 123.607 0.763 . . . . 74.310000000000002 112.996 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.66 -45.27 94.95 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 115.216 0.846 . . . . 63.350000000000001 115.216 -166.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.78 -31.21 1.93 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.305 1.594 . . . . 74.349999999999994 115.305 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.4 t80 73.88 -59.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.03 1.332 . . . . 74.540000000000006 111.254 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -59.62 -38.16 80.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.926 0.89 . . . . 70.140000000000001 112.54 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . . . -99.58 27.21 5.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.631 0.772 . . . . 75.510000000000005 111.598 -166.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.522 HG12 HG23 ' A' ' 34' ' ' VAL . 19.0 tt -62.72 -22.98 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.286 1.034 . . . . 72.5 112.382 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -68.84 -3.73 13.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.163 0.801 . . . . 74.239999999999995 113.163 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.477 ' HD3' ' HB2' ' A' ' 26' ' ' ALA . 48.0 mtp180 -76.61 -24.37 53.41 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.826 0.85 . . . . 73.239999999999995 112.445 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -129.6 -37.56 1.57 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.255 0.835 . . . . 75.409999999999997 113.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -90.06 108.52 26.62 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.965 0.506 . . . . 73.310000000000002 109.798 -171.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.41 -23.59 32.21 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.154 2.57 . . . . 74.129999999999995 114.708 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -80.82 -15.65 55.81 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.989 0.516 . . . . 63.229999999999997 112.068 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.621 HG22 ' HE2' ' A' ' 53' ' ' PHE . 94.8 t -68.27 106.72 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.11 0.481 . . . . 75.549999999999997 111.37 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -89.11 54.92 3.13 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.491 0.716 . . . . 74.329999999999998 110.681 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.09 105.17 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 125.449 1.499 . . . . 72.030000000000001 113.429 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.646 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 64.4 Cg_endo -90.35 148.76 4.42 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.861 2.374 . . . . 74.310000000000002 113.149 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -101.02 115.14 29.77 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.127 0.571 . . . . 72.540000000000006 110.111 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.8 tm? -89.37 112.32 23.4 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 109.096 -0.705 . . . . 73.239999999999995 109.096 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -102.48 123.09 45.6 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.918 0.887 . . . . 70.040000000000006 110.856 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.32 -178.6 0.01 OUTLIER Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.716 2.247 . . . . 72.519999999999996 118.716 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 70.11 -31.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.86 1.8 . . . . 72.409999999999997 115.86 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m 83.13 137.64 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 126.202 1.801 . . . . 74.230000000000004 111.009 -167.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.14 -14.31 40.35 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.243 2.629 . . . . 73.510000000000005 115.244 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -92.21 -14.31 29.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 111.541 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.3 m -95.55 123.98 54.53 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.006 0.922 . . . . 73.099999999999994 110.905 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.412 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.6 Cg_exo -48.5 98.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.735 2.957 . . . . 64.299999999999997 114.254 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.68 -39.19 0.47 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 113.922 0.329 . . . . 50.539999999999999 113.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.65 139.08 45.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.595 1.331 . . . . 74.140000000000001 114.595 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 4.2 mp0 -103.35 149.23 24.96 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.089 0.555 . . . . 74.120000000000005 110.857 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 34.4 ptt180 -127.04 119.78 27.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.48 0.582 . . . . 72.219999999999999 110.575 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.24 102.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.647 0.779 . . . . 74.219999999999999 110.795 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HE2' HG22 ' A' ' 34' ' ' VAL . 6.0 m-85 -64.0 123.03 17.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.438 1.095 . . . . 73.239999999999995 111.354 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.06 -66.27 3.89 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-O 120.143 -0.254 . . . . 73.400000000000006 112.783 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.61 35.06 20.05 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.415 1.086 . . . . 74.510000000000005 113.456 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.82 37.78 0.05 OUTLIER Glycine 0 N--CA 1.476 1.301 0 CA-C-N 115.781 -0.645 . . . . 45.43 112.198 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -147.16 162.42 38.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.338 1.055 . . . . 74.239999999999995 110.901 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.57 -23.39 65.4 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.379 0.672 . . . . 64.519999999999996 112.496 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -122.06 90.22 3.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.011 0.524 . . . . 72.25 111.355 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.34 171.15 7.49 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.457 0.646 . . . . 63.049999999999997 111.321 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.516 HD13 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -136.72 114.15 10.91 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.661 0.784 . . . . 74.120000000000005 109.17 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 44.0 t -99.23 113.79 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.524 -0.546 . . . . 73.219999999999999 109.524 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 58.0 mt-10 -107.21 167.22 10.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.431 1.093 . . . . 72.340000000000003 110.627 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -151.07 125.23 9.32 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 63.310000000000002 110.548 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 39.5 tp -69.09 116.36 9.44 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.87 1.268 . . . . 72.340000000000003 111.245 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -82.19 -51.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 122.924 0.49 . . . . 74.019999999999996 110.98 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.5 pt-20 -156.4 152.67 27.8 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.485 0.714 . . . . 75.239999999999995 110.032 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -142.48 131.72 23.41 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.264 0.554 . . . . 74.299999999999997 111.715 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.8 m-20 -119.09 102.58 8.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.913 1.285 . . . . 71.030000000000001 110.068 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.69 -52.73 55.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.866 0.866 . . . . 74.329999999999998 112.124 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -71.49 -33.42 69.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.102 0.561 . . . . 75.150000000000006 112.182 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -83.29 -10.36 58.56 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 112.75 0.648 . . . . 64.120000000000005 112.75 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 61.16 34.37 18.96 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.927 0.891 . . . . 74.430000000000007 111.65 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -119.06 112.23 19.29 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.877 0.871 . . . . 73.420000000000002 110.432 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -118.34 108.66 15.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.478 1.111 . . . . 74.540000000000006 111.631 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.542 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.8 t -108.48 127.78 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.693 -0.629 . . . . 71.519999999999996 111.685 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -135.89 -179.26 5.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.817 0.847 . . . . 64.120000000000005 111.203 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -146.01 164.29 32.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.608 1.163 . . . . 74.219999999999999 109.839 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 61' ' ' LEU . 73.6 mtm -103.52 97.07 9.67 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 122.988 0.515 . . . . 74.129999999999995 110.013 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.07 -13.42 31.36 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.155 2.57 . . . . 63.530000000000001 112.96 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 14.6 t70 -140.57 79.36 20.17 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 109.022 -0.733 . . . . 71.530000000000001 109.022 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -90.2 136.69 2.46 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.208 2.605 . . . . 74.239999999999995 113.747 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.54 -10.9 20.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.368 2.046 . . . . 74.219999999999999 113.231 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -94.02 131.53 31.5 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.713 0.805 . . . . 74.340000000000003 110.239 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 117' ' ' THR . 37.5 Cg_endo -63.92 88.86 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.973 2.448 . . . . 74.120000000000005 113.465 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 113' ' ' CYS . 22.0 pt -134.87 165.19 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 124.998 1.319 . . . . 75.219999999999999 109.762 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.0 m -100.75 -76.9 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.898 0.479 . . . . 74.010000000000005 110.947 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.77 110.32 22.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.013 0.435 . . . . 64.540000000000006 111.073 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -89.21 147.26 24.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.03 0.532 . . . . 73.409999999999997 111.165 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -153.28 125.57 8.05 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.219 1.008 . . . . 74.420000000000002 108.869 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.61 146.86 44.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.725 0.693 . . . . 71.030000000000001 112.056 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.92 145.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.796 0.838 . . . . 75.140000000000001 110.955 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 108.78 15.9 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.572 1.149 . . . . 63.020000000000003 108.062 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.99 112.71 17.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.682 0.393 . . . . 73.239999999999995 110.533 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.605 HG13 HG23 ' A' ' 105' ' ' VAL . 21.6 t -90.54 108.12 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.819 -0.808 . . . . 75.230000000000004 108.819 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.6 t -99.39 108.92 52.87 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.398 1.079 . . . . 75.510000000000005 110.153 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.94 124.79 11.35 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.102 1.868 . . . . 71.219999999999999 113.018 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -93.81 -56.46 2.88 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.375 -0.972 . . . . 64.299999999999997 108.375 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -118.75 -169.35 1.71 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.724 1.209 . . . . 73.0 110.068 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.52 -27.25 46.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.131 0.572 . . . . 73.040000000000006 111.475 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -109.56 2.03 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.839 0.856 . . . . 75.010000000000005 112.634 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -136.93 125.24 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.873 0.469 . . . . 73.530000000000001 109.771 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' HG22 ' A' ' 17' ' ' VAL . 31.6 p -137.29 132.82 34.25 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.023 0.44 . . . . 64.430000000000007 110.657 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.2 m -91.66 109.82 21.14 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.931 -0.577 . . . . 64.409999999999997 110.828 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.605 HG23 HG13 ' A' ' 95' ' ' VAL . 27.1 t -88.34 111.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.585 -0.524 . . . . 74.230000000000004 109.585 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.09 114.75 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.562 0.745 . . . . 74.340000000000003 110.667 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -103.84 118.69 37.28 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.439 0.696 . . . . 72.450000000000003 109.178 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.5 m -112.47 139.48 48.02 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.359 1.064 . . . . 62.0 109.817 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.61 108.89 4.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.214 0.605 . . . . 63.210000000000001 111.505 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.36 135.4 54.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.308 1.043 . . . . 72.109999999999999 110.375 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.28 145.07 26.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.624 0.77 . . . . 74.409999999999997 111.274 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.42 79.6 9.51 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.849 0.833 . . . . 72.439999999999998 109.914 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.645 ' HB2' HG23 ' A' ' 86' ' ' ILE . 49.1 t -108.94 164.58 12.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.734 -1.121 . . . . 64.109999999999999 111.317 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.5 t -83.01 137.57 43.19 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.574 -0.727 . . . . 73.230000000000004 110.169 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -44.56 -49.05 9.61 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 124.617 3.545 . . . . 73.239999999999995 116.165 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.78 -32.17 73.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.836 0.68 . . . . 72.150000000000006 112.836 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' PRO . 55.0 m -82.79 -33.51 27.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.825 0.45 . . . . 74.099999999999994 110.857 174.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.48 86.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.483 0.713 . . . . 73.239999999999995 111.76 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.18 -36.47 79.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.181 0.593 . . . . 61.530000000000001 111.88 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.32 -42.04 79.95 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.099999999999994 110.79 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.94 -24.49 64.28 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 71.140000000000001 112.016 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.59 -41.63 97.7 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.851 0.461 . . . . 62.200000000000003 111.826 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -76.94 -45.54 27.38 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.021 0.748 . . . . 72.299999999999997 113.021 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.6 -54.74 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 112.535 0.569 . . . . 44.439999999999998 112.535 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.95 -49.05 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.297 0.639 . . . . 75.310000000000002 110.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.03 -79.39 0.43 Allowed Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.251 -0.431 . . . . 61.329999999999998 113.592 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.59 -7.41 26.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.496 0.924 . . . . 65.010000000000005 113.496 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.23 -83.51 1.72 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 112.098 -0.401 . . . . 51.509999999999998 112.098 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.2 t -58.2 -46.66 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.048 0.939 . . . . 74.510000000000005 113.331 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.41 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 4.4 m-30 -77.57 -49.39 14.73 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.847 0.459 . . . . 73.129999999999995 111.21 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.55 -17.14 59.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.07 0.767 . . . . 73.230000000000004 113.07 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -85.2 -55.46 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 122.843 0.457 . . . . 74.420000000000002 111.376 166.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.72 -53.62 36.87 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 114.518 0.567 . . . . 71.340000000000003 114.518 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.86 -41.6 78.24 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.323 1.049 . . . . 70.040000000000006 112.138 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.31 -39.4 62.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.349 -0.842 . . . . 72.510000000000005 111.953 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.41 75.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.408 0.683 . . . . 73.019999999999996 111.0 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 17' ' ' VAL . 9.7 tt -65.63 -43.27 90.0 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.785 0.834 . . . . 74.340000000000003 110.585 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.37 68.88 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 122.884 0.474 . . . . 72.340000000000003 111.839 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.11 -39.94 60.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.95 0.9 . . . . 74.439999999999998 112.512 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -73.83 -22.99 59.58 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.723 0.638 . . . . 73.109999999999999 112.723 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -90.09 -2.5 58.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.076 -0.39 . . . . 74.150000000000006 111.242 168.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-N 116.285 -0.416 . . . . 74.530000000000001 114.031 173.337 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 121.991 0.901 . . . . 63.520000000000003 110.306 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -142.39 131.18 22.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.06 -0.973 . . . . 75.430000000000007 110.746 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.53 121.08 44.39 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.033 1.333 . . . . 75.310000000000002 109.133 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -120.35 120.53 36.28 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.248 0.547 . . . . 73.140000000000001 110.111 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.43 147.29 46.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.542 1.137 . . . . 74.200000000000003 109.616 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.6 p -151.0 150.47 30.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.314 0.646 . . . . 61.329999999999998 111.018 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.3 p -146.82 138.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.175 0.59 . . . . 73.299999999999997 111.645 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.53 108.9 19.26 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.289 0.566 . . . . 72.25 110.036 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -101.62 131.36 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.71 1.204 . . . . 74.439999999999998 110.303 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.34 73.95 3.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.875 0.47 . . . . 75.230000000000004 111.133 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 155.81 7.51 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.393 0.677 . . . . 74.200000000000003 111.481 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.74 138.55 38.15 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.901 2.4 . . . . 73.219999999999999 111.905 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.35 -32.32 48.61 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.95 1.093 . . . . 74.219999999999999 113.95 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -50.26 66.81 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.952 0.501 . . . . 65.140000000000001 111.885 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.24 -39.23 82.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.467 0.707 . . . . 70.129999999999995 112.595 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.537 ' HA ' ' HH ' ' A' ' 141' ' ' TYR . 21.5 t -70.95 -34.37 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.491 0.316 . . . . 72.409999999999997 110.654 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.686 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 69.4 t-105 -67.31 -28.94 68.41 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.834 0.454 . . . . 71.25 111.316 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -64.17 -21.24 66.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.124 0.57 . . . . 73.439999999999998 111.579 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 tp -90.32 -43.13 10.55 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 124.465 1.106 . . . . 72.129999999999995 112.916 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -107.13 13.72 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 113.778 1.029 . . . . 75.230000000000004 113.778 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.06 -17.22 75.02 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 114.169 0.428 . . . . 75.450000000000003 114.169 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.9 m-20 -102.78 137.88 40.41 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.359 0.664 . . . . 73.400000000000006 110.307 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.67 -23.79 67.52 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.96 0.904 . . . . 73.200000000000003 111.008 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.7 p -89.21 -22.37 22.8 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.823 0.849 . . . . 60.439999999999998 112.803 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -81.92 4.17 23.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.159 0.429 . . . . 64.299999999999997 112.159 -166.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.635 HG23 HG13 ' A' ' 34' ' ' VAL . 19.4 tt -66.91 -25.29 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.131 0.572 . . . . 74.150000000000006 111.761 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -74.71 -7.06 52.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 122.08 -0.387 . . . . 75.409999999999997 111.987 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.77 -31.9 25.68 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.127 0.571 . . . . 73.319999999999993 111.752 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.7 p-90 -118.48 -29.05 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.673 0.62 . . . . 75.219999999999999 112.673 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.4 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 38.8 t-80 -94.16 107.62 30.02 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 109.741 -0.466 . . . . 72.409999999999997 109.741 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.05 -7.24 20.98 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.916 2.41 . . . . 72.239999999999995 114.96 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -87.63 -28.6 21.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.693 0.397 . . . . 75.319999999999993 111.269 172.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.635 HG13 HG23 ' A' ' 27' ' ' ILE . 46.4 t -80.97 107.45 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 109.902 -0.407 . . . . 73.129999999999995 109.902 174.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -72.75 -71.37 0.3 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.976 0.51 . . . . 74.319999999999993 110.951 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.62 104.38 0.46 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 123.986 0.915 . . . . 73.030000000000001 110.399 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 58.9 Cg_endo -84.97 166.6 11.27 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.985 2.457 . . . . 70.420000000000002 114.343 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -100.93 114.9 29.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.673 1.189 . . . . 73.420000000000002 110.122 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 4.2 mm? -90.85 134.73 34.22 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.727 0.411 . . . . 74.420000000000002 111.419 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -108.95 121.32 44.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.526 0.73 . . . . 75.530000000000001 111.322 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.02 -169.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 117.837 1.895 . . . . 65.129999999999995 117.837 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 56.63 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.635 1.174 . . . . 74.340000000000003 113.714 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.3 t 168.4 148.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 125.591 1.557 . . . . 71.040000000000006 108.766 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.17 -14.08 31.8 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.476 2.117 . . . . 73.129999999999995 112.792 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -95.82 -20.5 18.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.172 0.989 . . . . 64.25 112.789 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.8 m -99.78 123.37 47.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 122.692 0.397 . . . . 74.299999999999997 111.568 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.3 Cg_endo -57.16 126.9 23.6 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.056 2.504 . . . . 70.109999999999999 113.325 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.62 -24.75 4.58 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.918 -0.583 . . . . 44.210000000000001 112.331 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 138.75 55.67 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.155 0.582 . . . . 72.319999999999993 111.597 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 39.9 mt-10 -113.22 134.35 54.63 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.492 0.717 . . . . 70.310000000000002 110.603 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 25.1 ptt180 -108.41 118.98 38.2 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.301 0.572 . . . . 75.150000000000006 110.164 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 62' ' ' VAL . 42.3 t -116.5 114.28 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.424 0.69 . . . . 75.420000000000002 110.611 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.56 ' HB2' ' H ' ' A' ' 61' ' ' LEU . 1.7 m-85 -71.77 90.83 1.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.919 0.887 . . . . 75.140000000000001 111.897 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.26 3.72 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 119.941 -0.366 . . . . 74.120000000000005 113.251 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.89 96.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.743 1.217 . . . . 75.310000000000002 112.195 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.49 4.65 Favored Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.112 -0.367 . . . . 74.129999999999995 113.855 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.7 p -104.59 -81.63 0.52 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.611 0.764 . . . . 73.129999999999995 110.793 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.014 0.926 . . . . 70.420000000000002 110.367 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -132.36 39.23 3.4 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.136 0.97 . . . . 75.200000000000003 109.572 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 122.56 16.09 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.112 -0.949 . . . . 73.349999999999994 111.291 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' H ' ' HB2' ' A' ' 53' ' ' PHE . 57.7 tp -97.23 116.87 30.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.573 0.749 . . . . 72.439999999999998 110.611 -174.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.544 HG23 HG12 ' A' ' 52' ' ' VAL . 48.6 t -98.55 114.92 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.7 -0.481 . . . . 74.040000000000006 109.7 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 79' ' ' MET . 41.7 mt-10 -118.24 164.06 15.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.219 1.008 . . . . 73.019999999999996 110.392 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -148.3 130.38 15.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.575 0.75 . . . . 73.409999999999997 110.944 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 28.7 tp -73.3 112.1 9.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.115 0.966 . . . . 70.5 110.817 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.14 -47.91 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.439 0.695 . . . . 74.200000000000003 110.84 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.324 1.05 . . . . 73.319999999999993 109.535 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -139.91 108.67 5.95 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.68 -0.638 . . . . 74.310000000000002 109.856 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 3.2 m-20 -91.3 71.26 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.708 0.803 . . . . 72.319999999999993 109.934 -175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.686 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 44.1 tt0 -63.73 -31.96 73.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.019 -0.537 . . . . 75.299999999999997 111.631 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -66.8 -14.66 62.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.8 0.84 . . . . 71.409999999999997 112.568 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.22 4.99 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.769 0.828 . . . . 71.510000000000005 112.604 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 55.89 60.46 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.264 1.025 . . . . 73.340000000000003 112.46 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 42.5 ttm180 -143.0 147.33 34.95 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.195 0.998 . . . . 73.420000000000002 110.357 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.8 tp -137.49 108.45 6.72 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.366 1.066 . . . . 75.340000000000003 110.181 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.22 127.57 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.604 0.762 . . . . 72.450000000000003 111.1 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.2 177.69 10.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.045 0.538 . . . . 74.340000000000003 112.319 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -142.92 157.6 44.42 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.092 0.957 . . . . 75.239999999999995 110.781 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.61 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 18.0 ptt? -111.53 98.49 40.78 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 117.993 0.36 . . . . 73.540000000000006 110.231 163.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.47 -22.41 74.01 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.258 2.639 . . . . 73.230000000000004 112.726 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.491 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 3.9 m-20 -118.33 83.61 21.06 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.692 0.797 . . . . 73.420000000000002 109.909 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.74 144.51 3.02 Favored 'Trans proline' 0 CA--C 1.566 2.075 0 C-N-CA 122.806 2.337 . . . . 74.409999999999997 113.14 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.6 4.58 6.55 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.648 2.232 . . . . 74.030000000000001 112.921 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -105.36 153.64 39.55 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 124.061 0.945 . . . . 64.5 111.201 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.15 71.61 3.56 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.185 2.59 . . . . 73.420000000000002 113.12 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.728 HG21 ' HB2' ' A' ' 113' ' ' CYS . 21.4 pt -139.61 153.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.247 1.019 . . . . 73.140000000000001 110.65 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 15.9 m -95.36 -91.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.27 -0.395 . . . . 72.409999999999997 110.887 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -85.42 121.83 28.69 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-N 119.19 0.905 . . . . 74.230000000000004 109.654 175.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.417 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 52.7 t-80 -109.06 121.16 44.56 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.075 0.55 . . . . 74.430000000000007 111.875 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 146.53 28.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.296 1.038 . . . . 74.239999999999995 109.179 167.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.79 132.37 19.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.867 0.867 . . . . 74.540000000000006 109.747 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.2 p -133.82 129.9 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.159 0.584 . . . . 74.150000000000006 112.194 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.44 123.72 48.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.247 1.419 . . . . 75.129999999999995 108.618 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.05 149.25 50.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 110.503 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.537 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 13.6 m -125.56 109.78 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.86 0.838 . . . . 65.510000000000005 109.419 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 125.59 76.34 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.024 0.929 . . . . 71.040000000000006 110.504 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.78 72.65 1.93 Allowed 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.722 2.281 . . . . 73.219999999999999 111.912 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -71.31 -35.19 71.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.733 0.813 . . . . 73.329999999999998 110.006 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 27.3 t70 -163.78 163.08 24.11 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.173 1.389 . . . . 74.209999999999994 108.655 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.81 -8.42 52.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.735 -0.603 . . . . 65.230000000000004 112.21 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -126.0 -2.86 7.07 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.489 1.116 . . . . 72.430000000000007 111.935 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 39.6 m170 -135.97 127.6 28.92 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 110.453 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 39.7 t -129.88 134.22 47.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.526 0.73 . . . . 64.150000000000006 110.404 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 90.1 m -98.24 111.63 23.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.283 -0.266 . . . . 73.219999999999999 110.283 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG22 HG11 ' A' ' 95' ' ' VAL . 34.3 t -86.73 106.11 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.063 -0.717 . . . . 73.25 109.063 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.11 117.42 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.536 0.735 . . . . 74.319999999999993 110.189 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -118.82 121.42 39.99 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.166 -0.679 . . . . 73.540000000000006 109.166 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.567 HG23 ' SD ' ' A' ' 110' ' ' MET . 56.4 m -129.98 130.18 44.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.238 0.615 . . . . 72.409999999999997 110.791 -172.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.28 115.78 24.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 70.129999999999995 110.915 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.567 ' SD ' HG23 ' A' ' 108' ' ' THR . 3.5 mpp? -99.28 140.57 33.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.437 -0.949 . . . . 74.409999999999997 108.437 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.19 151.66 23.35 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.022 0.749 . . . . 74.530000000000001 113.022 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 20.2 t70 -83.7 85.29 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.146 -0.934 . . . . 74.409999999999997 109.42 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.728 ' HB2' HG21 ' A' ' 86' ' ' ILE . 43.7 t -128.83 163.58 24.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.986 -0.552 . . . . 73.400000000000006 112.406 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.4 p -75.19 141.4 74.11 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.587 -0.733 . . . . 54.43 111.47 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -48.37 -39.75 35.8 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.561 2.84 . . . . 71.239999999999995 113.866 170.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.57 -42.27 87.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.783 0.833 . . . . 64.340000000000003 112.572 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.543 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 27.0 m -82.47 -26.23 32.82 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.597 0.359 . . . . 72.109999999999999 111.424 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.89 76.42 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.544 0.738 . . . . 50.219999999999999 112.507 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -60.37 -33.56 72.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.974 0.51 . . . . 73.109999999999999 111.858 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -44.0 57.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.314 0.646 . . . . 74.519999999999996 110.601 174.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -34.65 77.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.076 0.398 . . . . 74.239999999999995 112.076 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.35 -43.8 97.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.886 0.474 . . . . 74.439999999999998 111.017 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.6 m -69.64 -56.41 7.35 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.223 0.609 . . . . 61.109999999999999 112.64 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.47 -49.65 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 124.644 1.177 . . . . 75.109999999999999 112.685 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.72 -48.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 122.604 0.361 . . . . 74.019999999999996 110.977 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.45 -75.53 0.6 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 114.126 0.411 . . . . 74.329999999999998 114.126 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.19 -26.7 68.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.181 0.592 . . . . 73.209999999999994 111.695 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.86 -89.54 0.55 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.281 -0.418 . . . . 75.329999999999998 112.777 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.21 -49.47 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.887 0.875 . . . . 74.310000000000002 113.175 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -73.36 -53.73 10.05 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.647 0.779 . . . . 73.099999999999994 112.111 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.34 73.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.677 0.391 . . . . 72.439999999999998 111.968 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.74 -49.87 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 74.329999999999998 111.329 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.34 87.21 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 116.476 -0.329 . . . . 72.540000000000006 113.602 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 mt -69.27 -38.22 78.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 74.439999999999998 112.152 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.9 m-20 -67.04 -43.11 83.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.728 0.411 . . . . 71.400000000000006 110.23 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.02 81.83 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.301 0.64 . . . . 74.230000000000004 111.737 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.446 HD23 HG13 ' A' ' 17' ' ' VAL . 7.4 tt -65.87 -41.96 90.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.359 0.664 . . . . 74.329999999999998 110.234 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.94 79.44 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 116.389 -0.369 . . . . 73.129999999999995 111.245 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 41.6 mt-10 -64.53 -41.52 96.31 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.53 0.937 . . . . 74.439999999999998 113.53 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -64.05 -32.26 73.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.164 0.431 . . . . 75.420000000000002 112.164 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HH ' ' HA ' ' A' ' 17' ' ' VAL . 75.2 m-85 -88.8 -23.12 22.94 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.311 0.856 . . . . 73.439999999999998 113.311 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.995 0 N-CA-C 115.314 0.885 . . . . 73.430000000000007 115.314 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.382 0 CA-C-O 121.016 0.436 . . . . 61.149999999999999 111.45 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 110' ' ' MET . 89.8 m -117.15 112.21 20.55 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.672 0.789 . . . . 71.120000000000005 109.922 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.42 126.32 45.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.933 1.293 . . . . 73.340000000000003 110.117 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -118.29 119.72 35.49 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.757 0.423 . . . . 75.200000000000003 109.879 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -127.64 139.29 52.82 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.594 0.757 . . . . 73.010000000000005 109.879 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 p -144.87 155.33 43.4 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.343 0.657 . . . . 75.310000000000002 111.382 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 104' ' ' THR . 13.7 p -150.31 147.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.219999999999999 110.641 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.86 109.09 21.86 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 110.289 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.2 t -95.07 137.81 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.386 1.474 . . . . 74.530000000000001 110.834 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.61 67.68 5.44 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.484 0.714 . . . . 73.030000000000001 112.305 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB3' ' CD1' ' A' ' 141' ' ' TYR . . . -163.29 150.31 10.64 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.441 0.696 . . . . 74.409999999999997 111.449 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.82 144.24 76.6 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.711 2.274 . . . . 70.140000000000001 111.296 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -48.11 -41.22 25.82 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.234 1.568 . . . . 74.400000000000006 115.234 -172.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.31 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.967 0.507 . . . . 73.219999999999999 112.087 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.63 -41.99 87.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.858 0.863 . . . . 64.340000000000003 112.511 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -70.88 -36.27 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.042 0.449 . . . . 73.340000000000003 110.647 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -68.29 -27.61 66.46 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.246 0.618 . . . . 74.120000000000005 111.628 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m -62.11 -31.5 71.96 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.268 0.556 . . . . 74.439999999999998 110.886 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.0 tp -83.15 -58.29 2.91 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.479 1.112 . . . . 75.540000000000006 112.35 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.95 -20.16 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.068 0.766 . . . . 73.310000000000002 113.068 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.83 12.4 16.95 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.346 0.898 . . . . 74.129999999999995 115.346 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 11.1 t70 -120.61 120.6 36.23 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.072 0.949 . . . . 71.040000000000006 108.486 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.5 -31.38 72.42 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.92 0.888 . . . . 74.239999999999995 112.124 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.8 t -82.3 -22.81 35.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.432 0.693 . . . . 74.439999999999998 112.074 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.55 22.52 6.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.832 0.679 . . . . 51.5 112.832 -163.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.679 HG23 HG13 ' A' ' 34' ' ' VAL . 20.1 tt -69.02 -22.53 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 123.389 0.676 . . . . 74.25 111.605 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -62.1 -14.62 38.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.752 1.019 . . . . 73.310000000000002 113.752 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -78.97 -46.46 18.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.934 0.493 . . . . 73.349999999999994 111.945 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.418 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.9 p-90 -103.79 -30.89 10.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.684 0.393 . . . . 75.299999999999997 111.706 -171.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -91.34 107.85 24.57 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 122.98 0.512 . . . . 72.430000000000007 110.107 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.34 -19.42 61.73 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.072 2.515 . . . . 74.400000000000006 114.787 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.32 -23.6 30.16 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.608 0.363 . . . . 71.430000000000007 111.858 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 27' ' ' ILE . 84.8 t -76.21 118.8 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 120.843 0.354 . . . . 72.140000000000001 111.397 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.1 m -73.26 -74.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.965 0.906 . . . . 74.439999999999998 110.554 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -167.51 103.32 0.6 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.588 0.755 . . . . 72.439999999999998 110.72 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.35 150.3 17.26 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.762 2.308 . . . . 73.329999999999998 113.529 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.7 m -100.26 123.49 44.55 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.093 0.957 . . . . 72.140000000000001 108.853 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.8 128.54 40.1 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.242 -0.651 . . . . 63.340000000000003 109.242 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -124.93 148.59 48.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.195 0.998 . . . . 74.129999999999995 110.312 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.37 132.5 0.0 OUTLIER Glycine 0 CA--C 1.554 2.515 0 N-CA-C 117.584 1.794 . . . . 60.210000000000001 117.584 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 67.31 -90.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.146 1.378 . . . . 72.340000000000003 113.392 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t 179.77 150.11 0.51 Allowed Pre-proline 0 N--CA 1.492 1.645 0 C-N-CA 124.08 0.952 . . . . 74.140000000000001 110.52 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.19 -6.55 14.97 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.459 2.106 . . . . 64.299999999999997 113.343 173.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -109.6 -7.58 15.1 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.639 0.776 . . . . 63.32 111.877 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 m -103.73 121.85 46.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 122.8 0.44 . . . . 75.010000000000005 111.401 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.8 121.19 8.81 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.297 2.664 . . . . 75.239999999999995 113.104 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.29 -6.5 8.68 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 122.865 0.269 . . . . 54.119999999999997 113.379 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.12 172.82 11.68 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.578 0.751 . . . . 71.109999999999999 112.957 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.35 152.64 45.95 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.178 0.991 . . . . 62.340000000000003 111.12 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -130.94 132.0 44.8 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.496 0.718 . . . . 72.25 110.31 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.51 110.85 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.602 0.761 . . . . 75.519999999999996 110.139 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 78.4 m-85 -71.66 97.39 1.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.451 0.908 . . . . 74.450000000000003 113.451 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.85 -59.31 0.67 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.496 -0.642 . . . . 62.219999999999999 111.496 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.03 108.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.746 1.219 . . . . 75.409999999999997 112.616 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.79 54.41 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 116.515 -0.311 . . . . 70.030000000000001 113.268 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.9 p -116.27 -79.98 0.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.613 0.765 . . . . 71.409999999999997 111.087 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 177.42 -54.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.61 1.164 . . . . 72.25 107.913 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.1 14.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.792 1.237 . . . . 73.540000000000006 113.605 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.4 pt-20 -71.05 96.08 1.28 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.266 1.031 . . . . 74.310000000000002 112.59 -172.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -87.72 131.53 34.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.425 -1.261 . . . . 73.510000000000005 108.918 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -102.43 115.59 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.283 -0.636 . . . . 73.319999999999993 109.283 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.604 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 44.8 mt-10 -121.0 133.96 55.28 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 73.040000000000006 110.749 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.35 120.83 43.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.065 0.946 . . . . 73.109999999999999 110.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.71 119.59 11.46 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.645 1.178 . . . . 73.540000000000006 112.045 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.97 -51.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.508 0.723 . . . . 65.230000000000004 111.048 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 13.0 pt-20 -160.21 165.02 32.31 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 74.209999999999994 111.131 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.2 ttp85 -156.81 128.59 7.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.314 0.646 . . . . 75.140000000000001 109.917 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.39 123.88 38.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.747 0.819 . . . . 72.349999999999994 109.949 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.23 -46.64 49.0 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.823 0.849 . . . . 72.510000000000005 111.05 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.8 t -65.54 -25.14 67.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.136 0.974 . . . . 71.239999999999995 112.72 -170.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.54 -7.58 15.7 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.817 0.847 . . . . 74.299999999999997 112.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 11.6 mtm-85 58.93 45.62 14.84 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.93 0.892 . . . . 73.439999999999998 112.296 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -114.72 124.62 52.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.237 1.015 . . . . 73.120000000000005 111.054 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.4 tp -122.43 107.95 12.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.749 0.82 . . . . 73.409999999999997 110.043 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.621 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 39.4 t -111.06 136.08 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.555 0.616 . . . . 74.409999999999997 110.711 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -150.14 -179.91 7.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.047 0.939 . . . . 73.430000000000007 110.902 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 t -142.43 164.12 30.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.877 0.871 . . . . 73.099999999999994 110.593 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mtp -109.3 88.35 5.87 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 123.661 0.784 . . . . 74.030000000000001 110.305 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.604 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 34.9 Cg_endo -62.28 -34.27 78.33 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.558 2.839 . . . . 74.230000000000004 113.637 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -125.28 81.95 63.03 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.006 0.522 . . . . 74.409999999999997 109.736 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -94.39 147.38 1.86 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 123.072 2.515 . . . . 75.439999999999998 113.869 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.72 -2.2 11.72 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.412 2.075 . . . . 72.219999999999999 112.774 170.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -99.83 135.4 20.5 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.228 1.011 . . . . 73.329999999999998 109.449 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.92 82.01 0.6 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.923 2.416 . . . . 74.219999999999999 112.666 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.751 HG21 ' HB2' ' A' ' 113' ' ' CYS . 14.6 pt -135.09 141.6 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 124.229 1.012 . . . . 75.310000000000002 110.308 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.3 m -83.94 -75.65 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.173 -0.33 . . . . 74.230000000000004 110.875 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -107.92 111.02 22.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.19 0.519 . . . . 72.219999999999999 110.448 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -92.91 151.68 19.81 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.731 0.813 . . . . 75.239999999999995 111.775 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -150.19 126.49 10.72 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 74.019999999999996 109.702 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.86 143.23 49.39 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.882 0.765 . . . . 75.439999999999998 112.003 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 8.9 p -137.6 142.24 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 113.14 0.793 . . . . 64.319999999999993 113.14 -176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -108.42 117.11 33.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.869 1.268 . . . . 73.450000000000003 109.05 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 46.5 mt-10 -127.37 113.91 16.86 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.757 0.423 . . . . 71.109999999999999 111.345 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.06 111.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.081 0.467 . . . . 74.099999999999994 109.755 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.36 110.16 59.15 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.136 0.974 . . . . 73.310000000000002 110.261 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HA ' ' SG ' ' A' ' 103' ' ' CYS . 51.8 Cg_endo -66.16 114.43 3.02 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.703 2.269 . . . . 74.299999999999997 114.655 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.4 11.91 22.31 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.162 0.985 . . . . 75.439999999999998 111.304 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 67.85 175.28 0.26 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.475 1.51 . . . . 75.219999999999999 113.287 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 60.26 -86.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.277 1.431 . . . . 74.349999999999994 112.397 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -153.09 43.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.785 0.802 . . . . 74.230000000000004 109.98 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -142.65 139.5 31.26 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.408 0.683 . . . . 75.519999999999996 109.545 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 97' ' ' PRO . 75.5 m -153.63 138.97 17.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.507 0.723 . . . . 75.329999999999998 111.141 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 25.3 m -90.93 111.27 22.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.988 0.515 . . . . 73.209999999999994 111.163 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.34 118.88 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.897 0.479 . . . . 73.420000000000002 109.938 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.29 112.55 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.782 0.833 . . . . 74.209999999999994 109.965 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -107.49 112.03 24.6 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 108.812 -0.81 . . . . 73.120000000000005 108.812 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.7 m -123.83 127.2 47.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.59 0.756 . . . . 71.549999999999997 110.152 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.3 118.44 22.3 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.225 0.61 . . . . 75.129999999999995 111.362 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.612 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -118.8 128.83 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.588 1.155 . . . . 71.409999999999997 109.09 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -145.26 156.5 43.87 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.719 0.808 . . . . 74.109999999999999 111.498 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 25.3 t70 -89.86 85.15 6.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.372 0.606 . . . . 74.439999999999998 109.861 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.751 ' HB2' HG21 ' A' ' 86' ' ' ILE . 53.6 t -122.72 148.47 45.29 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.434 -0.803 . . . . 60.310000000000002 111.809 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 t -62.82 125.08 85.71 Favored Pre-proline 0 N--CA 1.485 1.298 0 CA-C-O 118.678 -0.677 . . . . 73.510000000000005 109.847 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HA ' ' HB1' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -52.07 -22.29 14.44 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.523 2.815 . . . . 74.439999999999998 115.695 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.02 -50.23 67.06 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 122.796 0.439 . . . . 74.329999999999998 112.018 170.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.518 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 34.4 m -71.13 -36.85 72.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.912 0.485 . . . . 60.109999999999999 110.594 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 115' ' ' PRO . . . -69.61 -38.49 77.3 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.749 0.819 . . . . 74.340000000000003 112.542 -171.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -64.8 -34.11 77.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.288 0.566 . . . . 73.540000000000006 110.916 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.11 -34.12 74.58 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.416 -0.811 . . . . 73.340000000000003 110.275 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 117' ' ' THR . 77.8 mt -75.01 -25.62 58.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.433 0.693 . . . . 62.350000000000001 111.483 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.87 -32.7 74.14 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.496 0.589 . . . . 74.450000000000003 110.607 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 55.6 m -70.08 -58.12 4.18 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.556 0.576 . . . . 73.540000000000006 112.556 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.13 -55.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 122.968 0.507 . . . . 55.25 112.198 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.7 mt -74.32 -49.68 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.71 0.404 . . . . 72.0 110.39 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.96 -55.38 19.66 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.789 0.676 . . . . 72.439999999999998 114.789 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.69 -52.99 5.42 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.891 0.845 . . . . 73.549999999999997 111.59 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.51 -36.94 92.19 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 115.083 0.793 . . . . 72.450000000000003 115.083 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.66 -56.89 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 122.474 -0.427 . . . . 72.010000000000005 110.966 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -75.71 -61.97 1.74 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.727 0.64 . . . . 74.239999999999995 112.727 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.26 70.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.775 0.43 . . . . 73.120000000000005 111.11 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 t -65.58 -50.93 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.223 0.609 . . . . 73.219999999999999 111.823 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.32 95.77 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-O 120.97 0.206 . . . . 73.319999999999993 113.372 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.66 -39.44 70.32 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.448 1.099 . . . . 74.129999999999995 111.732 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 8.1 m-80 -69.77 -38.55 76.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.404 0.282 . . . . 65.209999999999994 110.402 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.71 76.65 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.679 0.792 . . . . 75.140000000000001 111.564 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.52 -36.37 82.54 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.878 0.871 . . . . 74.219999999999999 109.568 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.04 62.46 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.189 0.595 . . . . 70.5 112.295 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 10.8 mm-40 -72.56 -42.53 64.56 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 122.949 0.5 . . . . 71.209999999999994 111.828 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.47 -41.29 96.59 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 120.718 0.294 . . . . 75.010000000000005 111.54 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 71.5 m-85 -81.79 -2.94 52.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.501 0.321 . . . . 73.120000000000005 111.059 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.578 0 CA-C-N 116.569 -0.287 . . . . 74.349999999999994 113.159 168.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 112.54 0.57 . . . . 70.299999999999997 112.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -79.67 110.18 14.76 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.424 0.631 . . . . 74.040000000000006 111.677 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.74 121.71 36.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.933 1.293 . . . . 75.340000000000003 109.143 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -130.69 137.89 49.76 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.185 0.517 . . . . 71.030000000000001 111.357 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -132.12 152.46 51.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.521 1.128 . . . . 72.439999999999998 109.441 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.0 p -149.45 149.62 31.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.452 0.701 . . . . 75.430000000000007 110.201 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.7 p -144.1 138.31 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.157 0.583 . . . . 74.120000000000005 111.852 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.96 108.5 16.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.31 -0.626 . . . . 74.439999999999998 109.31 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.89 130.83 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.441 1.096 . . . . 74.049999999999997 110.976 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.3 71.8 3.02 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.066 0.546 . . . . 73.230000000000004 111.203 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.08 141.71 0.83 Allowed Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.625 1.17 . . . . 74.450000000000003 110.664 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.44 141.25 95.06 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.866 2.377 . . . . 74.329999999999998 113.255 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.5 -42.66 23.54 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.296 1.591 . . . . 70.25 115.296 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.6 85.24 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.128 0.571 . . . . 75.329999999999998 112.153 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.49 -34.94 78.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.603 0.761 . . . . 71.329999999999998 112.278 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.33 -35.55 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.847 0.459 . . . . 71.420000000000002 110.716 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.661 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 60.4 t-105 -72.38 -25.89 61.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.036 0.534 . . . . 74.340000000000003 111.342 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.1 m -58.37 -29.5 66.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 75.109999999999999 110.654 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.578 HD22 HH11 ' A' ' 140' ' ' ARG . 62.1 tp -84.97 -59.68 2.27 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.748 1.219 . . . . 75.019999999999996 111.706 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.8 14.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 113.441 0.904 . . . . 74.230000000000004 113.441 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.16 33.28 5.52 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 112.356 -0.298 . . . . 72.219999999999999 112.356 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -154.82 148.17 25.03 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.94 0.896 . . . . 75.319999999999993 110.044 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -84.97 -25.66 27.63 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.465 0.706 . . . . 74.430000000000007 111.625 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -92.87 -21.39 19.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.495 0.718 . . . . 73.319999999999993 112.384 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.21 8.14 9.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.486 0.55 . . . . 72.129999999999995 112.486 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.617 HG22 ' NH1' ' A' ' 51' ' ' ARG . 20.5 tt -68.46 -23.92 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 C-N-CA 124.153 0.981 . . . . 75.319999999999993 112.611 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -74.51 0.42 14.83 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.835 0.68 . . . . 74.140000000000001 112.835 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -97.36 -15.54 20.66 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.795 . . . . 74.400000000000006 112.313 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.549 ' HB3' HD23 ' A' ' 20' ' ' LEU . 37.5 p-90 -128.68 -38.12 1.72 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.637 0.606 . . . . 75.230000000000004 112.637 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 64.2 t-80 -89.64 115.28 63.44 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 122.86 0.464 . . . . 74.040000000000006 110.365 -173.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 13.6 Cg_exo -69.97 -23.68 29.54 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.197 2.598 . . . . 53.420000000000002 114.885 -169.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.48 -15.36 52.77 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.215 0.45 . . . . 74.230000000000004 112.215 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.581 HG21 HG12 ' A' ' 27' ' ' ILE . 98.5 t -70.89 120.74 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 122.89 0.476 . . . . 61.109999999999999 112.211 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -93.37 20.5 7.07 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.034 0.934 . . . . 60.109999999999999 112.394 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 70.28 110.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.638 1.575 . . . . 54.219999999999999 112.186 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -86.05 168.79 9.08 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.193 2.595 . . . . 74.540000000000006 114.241 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.5 m -101.91 127.75 48.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.693 1.197 . . . . 73.420000000000002 110.171 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.61 125.29 37.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.071 0.938 . . . . 62.32 113.033 -171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 41.5 mmt180 -92.8 -174.46 3.62 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.695 1.998 . . . . 73.409999999999997 110.808 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.74 -128.79 0.44 Allowed Glycine 0 CA--C 1.547 2.081 0 N-CA-C 116.993 1.557 . . . . 71.409999999999997 116.993 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.97 -79.97 0.45 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.018 0.927 . . . . 75.140000000000001 112.393 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -121.99 141.0 33.21 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.8 0.84 . . . . 73.450000000000003 111.153 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.87 -8.33 13.42 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 123.249 2.633 . . . . 71.430000000000007 114.084 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -88.2 -25.53 22.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.916 0.486 . . . . 74.439999999999998 111.366 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.7 m -77.72 123.03 86.55 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 124.011 0.925 . . . . 75.340000000000003 112.527 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.603 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.0 Cg_endo -56.48 103.4 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.115 2.543 . . . . 75.129999999999995 112.058 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.72 -36.05 1.56 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.916 -0.584 . . . . 63.020000000000003 112.18 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 148.15 50.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.298 0.639 . . . . 50.020000000000003 111.587 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 32.2 mt-10 -124.69 140.3 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.894 0.478 . . . . 74.329999999999998 111.141 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.617 ' NH1' HG22 ' A' ' 27' ' ' ILE . 15.5 ptt180 -105.25 112.97 26.28 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.706 0.765 . . . . 74.120000000000005 109.68 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.579 HG13 HG21 ' A' ' 62' ' ' VAL . 45.1 t -111.33 100.03 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 55.210000000000001 109.833 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 38.4 m-85 -59.47 134.28 56.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.149 0.58 . . . . 74.329999999999998 110.097 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.8 -67.94 1.05 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 114.803 0.681 . . . . 73.099999999999994 114.803 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.73 95.68 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.403 1.481 . . . . 74.209999999999994 111.153 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.64 23.71 66.75 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-N 115.742 -0.663 . . . . 63.539999999999999 113.467 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 p -123.29 172.72 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.559 0.744 . . . . 63.140000000000001 111.323 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.7 -39.38 80.51 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.667 0.787 . . . . 73.230000000000004 111.708 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -90.12 64.58 6.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.875 0.845 . . . . 74.239999999999995 109.774 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.4 tt0 -108.28 137.3 46.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.754 -0.657 . . . . 73.340000000000003 112.276 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.516 HD13 ' HE3' ' A' ' 79' ' ' MET . 31.0 tp -144.21 113.19 6.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.824 0.85 . . . . 73.200000000000003 109.235 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 40.0 t -98.93 115.23 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.692 -0.485 . . . . 65.120000000000005 109.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.554 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 68.9 mt-10 -123.35 148.51 45.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.944 0.898 . . . . 74.129999999999995 110.079 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -124.22 132.34 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.133 0.573 . . . . 73.519999999999996 111.027 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -74.33 114.91 13.24 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.361 0.664 . . . . 75.439999999999998 110.535 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.36 -51.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 122.801 0.441 . . . . 61.310000000000002 110.916 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.671 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 10.1 pt-20 -153.86 155.49 35.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.433 0.693 . . . . 75.420000000000002 110.124 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttp85 -144.26 145.87 32.3 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.359 -0.608 . . . . 75.439999999999998 109.359 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -146.46 134.56 21.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.399 0.679 . . . . 73.25 109.746 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.661 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 46.7 mt-10 -90.16 -50.87 5.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.233 0.613 . . . . 75.329999999999998 112.332 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.7 p -70.84 -34.6 71.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.243 0.617 . . . . 75.150000000000006 111.969 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.14 -9.71 54.59 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.332 0.653 . . . . 74.019999999999996 112.094 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 61.62 43.33 10.05 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.884 0.873 . . . . 73.329999999999998 112.211 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -114.58 115.58 27.4 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.728 0.811 . . . . 75.510000000000005 111.947 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -113.67 108.45 17.14 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.766 0.827 . . . . 74.439999999999998 108.777 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.671 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 27.0 t -117.63 130.3 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.634 0.652 . . . . 70.310000000000002 110.822 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.76 178.95 7.29 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.689 0.796 . . . . 73.109999999999999 111.257 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.403 HG22 ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -135.98 159.34 42.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.351 1.06 . . . . 73.409999999999997 109.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.516 ' HE3' HD13 ' A' ' 61' ' ' LEU . 80.1 mtp -112.44 83.94 5.8 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.538 0.735 . . . . 72.129999999999995 109.046 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 81.2 Cg_endo -72.03 -16.6 28.84 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.253 2.635 . . . . 63.439999999999998 113.511 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 9.7 t70 -134.06 82.06 49.45 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 108.72 -0.845 . . . . 64.409999999999997 108.72 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -91.41 150.02 3.59 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.167 2.578 . . . . 71.409999999999997 113.34 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HD3' HD11 ' A' ' 61' ' ' LEU . 72.7 Cg_endo -81.07 -0.68 10.73 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.739 2.292 . . . . 75.409999999999997 113.12 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -105.25 154.69 38.73 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.673 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 70.67 3.96 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.832 2.355 . . . . 73.530000000000001 113.075 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.52 133.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.588 1.155 . . . . 71.219999999999999 109.525 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 22.4 m -77.14 -79.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.941 -0.474 . . . . 71.519999999999996 111.894 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -108.88 104.69 13.99 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.928 0.491 . . . . 75.129999999999995 111.03 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.539 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 65.4 t-80 -93.38 146.26 23.87 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.742 0.817 . . . . 75.329999999999998 111.356 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -146.56 111.31 5.27 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.997 0.919 . . . . 74.230000000000004 110.094 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HB1' ' HE1' ' A' ' 89' ' ' HIS . . . -124.11 149.06 46.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.075 0.768 . . . . 73.349999999999994 113.075 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.12 139.29 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 124.095 0.958 . . . . 73.239999999999995 111.668 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 110.6 22.97 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.202 1.001 . . . . 75.310000000000002 108.422 162.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -127.04 119.06 25.69 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.755 -0.832 . . . . 71.109999999999999 108.755 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 ' SG ' ' A' ' 103' ' ' CYS . 96.4 t -101.71 109.97 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.241 0.616 . . . . 75.409999999999997 110.858 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.32 113.02 55.95 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 124.8 1.24 . . . . 72.420000000000002 111.065 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.25 95.28 1.07 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.945 2.43 . . . . 72.530000000000001 113.156 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -79.26 -37.38 38.03 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.243 0.46 . . . . 75.140000000000001 112.243 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 35.0 t70 -157.07 162.58 39.48 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.28 0.632 . . . . 73.120000000000005 111.282 -169.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.66 -21.15 65.49 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.824 1.249 . . . . 72.099999999999994 113.075 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.06 0.83 5.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.474 0.71 . . . . 74.430000000000007 112.252 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 32.8 m80 -134.7 123.06 23.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.662 0.664 . . . . 74.120000000000005 109.901 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' HG11 ' A' ' 95' ' ' VAL . 38.2 t -142.95 137.63 29.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.425 0.29 . . . . 75.239999999999995 111.341 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.2 m -92.42 111.75 23.44 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.887 0.475 . . . . 74.450000000000003 111.3 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.1 112.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.141 -0.688 . . . . 75.519999999999996 109.141 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.34 119.15 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.356 0.662 . . . . 72.209999999999994 110.075 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -107.47 113.3 26.55 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.658 -0.867 . . . . 75.319999999999993 108.658 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -108.89 149.93 28.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.087 0.955 . . . . 74.439999999999998 109.502 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.14 145.31 27.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.477 1.111 . . . . 74.319999999999993 108.633 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -154.25 133.83 12.82 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.217 0.607 . . . . 70.319999999999993 110.104 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.53 153.36 48.73 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.647 -0.706 . . . . 75.099999999999994 111.305 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 34.2 t70 -77.14 87.13 3.61 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.231 -0.441 . . . . 75.439999999999998 110.055 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.9 t -156.1 169.8 23.67 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.616 -0.72 . . . . 73.510000000000005 111.883 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 m -76.52 148.28 79.84 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.457 1.103 . . . . 64.129999999999995 112.802 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.73 -34.91 92.3 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.821 3.014 . . . . 75.209999999999994 114.796 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.89 -31.09 67.63 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.294 0.638 . . . . 74.329999999999998 112.25 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 95.2 m -76.76 -38.08 54.79 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.02 0.438 . . . . 74.120000000000005 110.027 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -31.48 71.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.968 . . . . 71.329999999999998 112.881 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -75.74 -33.33 60.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.939 0.496 . . . . 74.409999999999997 111.43 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -42.21 83.49 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 75.040000000000006 110.225 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.99 -24.93 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.338 -0.846 . . . . 74.450000000000003 111.318 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -60.16 -36.11 76.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.013 0.525 . . . . 73.150000000000006 110.908 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -72.57 -53.56 11.58 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.951 -0.568 . . . . 74.209999999999994 111.856 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.76 -57.31 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 113.148 0.795 . . . . 75.400000000000006 113.148 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -77.83 -57.99 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.804 0.842 . . . . 75.219999999999999 110.942 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.53 -51.04 61.17 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 114.263 0.465 . . . . 64.439999999999998 114.263 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -95.22 -39.82 9.89 Favored 'General case' 0 CA--C 1.556 1.193 0 O-C-N 121.998 -0.707 . . . . 64.420000000000002 112.024 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.49 73.27 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.88 0.712 . . . . 73.129999999999995 114.88 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.93 -52.41 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 117.656 0.728 . . . . 72.209999999999994 111.024 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 2.8 m-30 -77.72 -53.58 7.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.102 0.408 . . . . 73.030000000000001 112.102 -172.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.32 -15.63 62.74 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.11 0.411 . . . . 62.149999999999999 112.11 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.6 t -80.86 -51.81 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 123.929 0.892 . . . . 74.5 110.985 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.33 -51.93 44.82 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.09 -0.505 . . . . 70.209999999999994 114.258 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.6 mt -58.52 -36.18 73.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.842 0.857 . . . . 74.409999999999997 112.776 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 6.3 m-20 -67.83 -46.06 72.9 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.669 -0.493 . . . . 73.209999999999994 109.669 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.0 74.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.6 0.76 . . . . 72.310000000000002 112.267 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.72 -49.24 78.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.312 1.045 . . . . 71.510000000000005 110.121 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -24.03 62.07 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.42 -0.809 . . . . 73.219999999999999 111.924 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 6.2 mm-40 -67.57 -50.73 57.05 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.589 0.756 . . . . 74.129999999999995 110.585 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.578 HH11 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.95 -15.83 62.09 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.737 0.643 . . . . 75.420000000000002 112.737 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -87.02 -22.62 25.38 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.803 0.668 . . . . 74.329999999999998 112.803 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 1.792 0 N-CA-C 116.227 1.251 . . . . 64.329999999999998 116.227 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 122.074 0.94 . . . . 64.549999999999997 110.408 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -144.48 119.33 9.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.279 -0.873 . . . . 75.219999999999999 110.38 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.17 147.54 23.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 74.219999999999999 109.226 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -149.53 129.96 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.138 0.575 . . . . 65.439999999999998 109.832 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -130.78 151.62 51.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.932 0.893 . . . . 75.239999999999995 108.751 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 96.3 p -146.85 163.34 36.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.991 0.516 . . . . 73.530000000000001 110.895 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.69 149.19 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.87 0.468 . . . . 74.140000000000001 111.057 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.56 109.22 19.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.029 0.532 . . . . 71.349999999999994 110.231 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 105' ' ' VAL . 85.8 t -96.49 129.9 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.312 1.045 . . . . 75.319999999999993 109.601 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.23 26.24 0.78 Allowed 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.563 0.949 . . . . 73.049999999999997 113.563 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.411 ' H ' HG11 ' A' ' 10' ' ' VAL . . . -131.55 150.57 76.72 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.583 0.753 . . . . 74.219999999999999 110.317 174.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.85 151.05 50.84 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.184 2.589 . . . . 72.109999999999999 112.984 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.02 -28.81 10.87 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.789 1.236 . . . . 73.230000000000004 114.27 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -50.9 64.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.774 0.657 . . . . 75.109999999999999 112.774 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -44.94 64.7 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.704 0.801 . . . . 71.329999999999998 111.901 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 HG13 HD23 ' A' ' 137' ' ' LEU . 15.0 t -73.36 -34.51 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 114.896 -1.047 . . . . 75.030000000000001 111.62 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.619 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 65.5 t-105 -73.48 -28.99 62.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.233 0.613 . . . . 72.129999999999995 111.505 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 m -60.65 -26.96 67.45 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.629 0.728 . . . . 74.25 110.838 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD21 HH11 ' A' ' 140' ' ' ARG . 54.4 tp -91.41 -44.03 9.38 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.361 1.064 . . . . 64.430000000000007 113.091 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.62 -21.72 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 113.588 0.959 . . . . 73.219999999999999 113.588 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.68 73.89 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 114.281 0.472 . . . . 75.040000000000006 114.281 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.436 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 3.6 m-20 -86.73 122.59 30.84 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.638 -1.245 . . . . 75.239999999999995 107.638 171.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 4.0 t80 -61.1 -27.84 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.992 0.517 . . . . 71.349999999999994 110.635 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -77.5 -23.51 50.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.024 0.93 . . . . 74.219999999999999 113.426 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -83.15 9.28 10.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 112.529 0.566 . . . . 60.140000000000001 112.529 -161.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.538 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 13.7 tt -62.64 -25.11 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 123.221 0.608 . . . . 73.540000000000006 111.52 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.622 ' HA ' HG13 ' A' ' 34' ' ' VAL . 26.4 p-80 -71.84 0.17 9.73 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.632 0.605 . . . . 74.239999999999995 112.632 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -102.92 -18.18 15.16 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.721 0.808 . . . . 62.43 112.754 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 33.0 p-90 -126.99 -42.24 1.75 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.433 1.271 . . . . 74.420000000000002 114.433 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.519 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.3 t-80 -72.73 119.86 77.6 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 117.985 0.357 . . . . 72.109999999999999 110.273 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 -22.33 73.86 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.373 2.048 . . . . 71.129999999999995 115.002 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.97 -4.19 22.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.041 0.756 . . . . 71.030000000000001 113.041 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 28' ' ' HIS . 11.2 p -63.81 148.13 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 CA-C-N 118.228 0.467 . . . . 74.420000000000002 111.157 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -113.22 28.4 8.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.293 0.637 . . . . 72.439999999999998 111.402 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.41 85.97 0.18 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 123.781 0.832 . . . . 74.340000000000003 111.163 -173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.99 173.32 13.67 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.888 2.392 . . . . 73.450000000000003 114.077 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.7 m -112.97 130.51 56.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.33 1.052 . . . . 73.230000000000004 110.178 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.69 137.18 42.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.7 0.8 . . . . 73.430000000000007 110.07 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 50' ' ' GLU . 11.1 ptm180 -150.82 162.04 41.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.904 0.882 . . . . 74.310000000000002 111.012 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.74 143.89 0.0 OUTLIER Glycine 0 CA--C 1.557 2.68 0 N-CA-C 117.25 1.66 . . . . 71.549999999999997 117.25 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 57.97 -104.46 0.22 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.403 1.081 . . . . 64.129999999999995 112.165 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 m -170.73 151.19 3.37 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 125.204 1.402 . . . . 61.219999999999999 109.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.58 0.58 1.8 Allowed 'Trans proline' 0 N--CA 1.513 2.639 0 C-N-CA 123.453 2.769 . . . . 74.030000000000001 115.29 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -119.69 -18.38 8.37 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.534 0.734 . . . . 74.129999999999995 111.408 168.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 m -87.88 123.34 69.2 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 123.251 0.62 . . . . 75.420000000000002 111.22 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.522 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 71.2 Cg_exo -45.99 119.06 2.66 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.727 2.951 . . . . 74.140000000000001 114.22 171.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.43 -20.62 4.39 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.507 0.575 . . . . 61.25 112.726 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.34 141.54 54.2 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.26 0.837 . . . . 74.400000000000006 113.26 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 28.9 mt-10 -107.71 126.94 53.21 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.906 0.882 . . . . 75.150000000000006 110.698 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 24' ' ' PHE . 58.1 ttp180 -102.38 108.72 20.15 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.073 0.949 . . . . 74.329999999999998 109.869 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.467 HG12 HG22 ' A' ' 62' ' ' VAL . 41.8 t -112.11 112.98 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.844 0.858 . . . . 73.540000000000006 110.931 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.45 -58.1 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.959 0.725 . . . . 71.420000000000002 112.959 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.42 -50.27 39.26 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-N 116.436 -0.347 . . . . 63.25 112.776 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 51.07 24.66 1.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.938 1.295 . . . . 65.409999999999997 114.118 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.73 24.28 0.02 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 113.037 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.535 ' HG1' ' HB3' ' A' ' 60' ' ' GLU . 72.7 p -129.02 142.2 50.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 109.779 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.18 -30.31 70.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.779 0.659 . . . . 74.439999999999998 112.779 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.04 75.38 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.731 0.776 . . . . 73.340000000000003 110.579 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.535 ' HB3' ' HG1' ' A' ' 57' ' ' THR . 14.0 pt-20 -109.16 164.51 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.648 1.179 . . . . 74.319999999999993 111.758 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.0 tp -103.21 124.11 47.99 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.999 0.52 . . . . 71.450000000000003 109.692 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG22 HG12 ' A' ' 52' ' ' VAL . 61.7 t -120.18 128.1 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.537 0.735 . . . . 64.230000000000004 109.688 173.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 35.2 mt-10 -117.45 149.42 40.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.47 1.108 . . . . 74.319999999999993 110.335 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.669 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 96.2 mtt180 -126.03 129.83 49.95 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.005 0.522 . . . . 75.519999999999996 111.378 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 14.5 tp -67.63 115.82 7.64 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.009 0.924 . . . . 74.319999999999993 111.034 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.443 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 98.0 t -84.98 -51.75 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.509 0.724 . . . . 72.530000000000001 111.297 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 6.3 pt-20 -158.15 140.49 14.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.527 0.731 . . . . 75.209999999999994 110.197 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.23 124.15 28.37 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.099 0.56 . . . . 74.319999999999993 110.224 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.57 100.45 8.29 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.525 -0.917 . . . . 71.420000000000002 108.525 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 25.5 tt0 -80.02 -31.08 39.65 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 112.374 0.509 . . . . 70.510000000000005 112.374 -172.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -69.86 -43.59 71.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.16 0.584 . . . . 74.329999999999998 111.71 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.8 -10.12 59.75 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 75.219999999999999 111.913 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 61.21 55.62 2.93 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.557 1.143 . . . . 61.420000000000002 112.005 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -132.38 135.05 45.87 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.278 -1.328 . . . . 74.209999999999994 110.139 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -124.39 132.23 53.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.167 1.387 . . . . 72.200000000000003 108.862 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 41.3 t -133.63 130.52 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 118.338 0.517 . . . . 63.149999999999999 111.078 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.443 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 54.9 p90 -141.26 -179.45 6.12 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.342 1.057 . . . . 75.439999999999998 110.573 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.482 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.3 t -130.44 162.76 28.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.649 1.18 . . . . 43.149999999999999 110.367 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.415 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.5 mtp -109.8 85.58 4.09 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.825 0.85 . . . . 73.299999999999997 109.278 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 71.8 Cg_endo -71.36 -24.5 22.74 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.48 2.787 . . . . 74.329999999999998 113.095 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.88 76.43 70.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 109.441 -0.577 . . . . 74.219999999999999 109.441 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -95.55 150.78 1.5 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.097 2.531 . . . . 75.200000000000003 113.456 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 -6.88 17.97 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.176 1.917 . . . . 74.25 112.21 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -92.32 143.28 27.14 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.477 1.111 . . . . 72.409999999999997 110.771 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HG2' HG23 ' A' ' 117' ' ' THR . 90.5 Cg_endo -78.72 72.99 6.15 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.741 2.294 . . . . 74.329999999999998 112.689 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 113' ' ' CYS . 19.1 pt -127.87 145.52 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.356 1.062 . . . . 73.510000000000005 110.575 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.3 m -82.78 -78.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.616 0.366 . . . . 75.329999999999998 111.812 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.72 106.66 14.76 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.29 0.566 . . . . 75.099999999999994 109.944 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.607 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 56.1 t-80 -91.65 159.38 15.9 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.445 0.698 . . . . 74.230000000000004 111.673 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -165.47 103.25 0.72 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.104 0.962 . . . . 74.239999999999995 110.254 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.607 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -98.65 153.5 18.64 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.58 0.752 . . . . 70.310000000000002 112.544 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.49 132.56 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.883 0.873 . . . . 74.219999999999999 111.48 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -109.08 107.58 17.95 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.748 1.219 . . . . 75.030000000000001 109.268 166.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.92 130.71 48.92 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 122.002 -0.436 . . . . 72.120000000000005 110.434 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.6 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 27.8 m -99.67 111.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.672 0.749 . . . . 72.540000000000006 109.852 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.8 t -83.32 107.67 10.58 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.571 1.149 . . . . 74.439999999999998 109.448 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.25 108.23 2.62 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.789 2.326 . . . . 71.299999999999997 111.911 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -84.4 -60.44 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.186 0.594 . . . . 74.109999999999999 110.495 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.49 175.37 9.21 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.031 0.932 . . . . 75.230000000000004 110.366 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.69 -4.58 43.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.82 0.448 . . . . 52.200000000000003 110.578 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -23.96 11.68 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.823 1.249 . . . . 63.310000000000002 112.344 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.499 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 37.1 m80 -136.01 150.96 49.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.354 0.524 . . . . 74.120000000000005 112.014 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.6 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 45.5 t -143.56 173.6 11.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.358 1.063 . . . . 54.210000000000001 110.175 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.6 m -135.94 119.24 16.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.18 0.592 . . . . 73.019999999999996 110.835 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 10' ' ' VAL . 26.0 t -91.27 113.06 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 122.144 -0.347 . . . . 73.519999999999996 110.199 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.54 109.91 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.473 1.109 . . . . 73.099999999999994 109.725 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -106.69 111.65 24.28 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 109.163 -0.68 . . . . 74.219999999999999 109.163 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.9 m -109.63 147.13 33.6 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.187 0.995 . . . . 73.319999999999993 109.964 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.78 111.27 11.49 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.956 0.903 . . . . 75.25 111.122 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.9 mtt -98.86 131.14 45.19 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.857 0.863 . . . . 75.409999999999997 108.978 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -156.96 144.68 19.12 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.413 0.523 . . . . 75.439999999999998 112.413 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.57 87.83 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.6 0.714 . . . . 71.209999999999994 110.676 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 53.5 t -134.28 169.09 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.643 -1.162 . . . . 71.439999999999998 111.411 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.2 m -68.44 146.93 98.09 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 62.009999999999998 112.222 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 -41.33 72.96 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.436 2.757 . . . . 73.540000000000006 114.29 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.77 -43.77 97.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.493 0.717 . . . . 62.439999999999998 111.813 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 21.3 m -71.81 -36.93 70.41 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.307 -0.406 . . . . 74.040000000000006 110.756 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.04 85.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.652 0.781 . . . . 71.239999999999995 112.322 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -28.54 63.49 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.484 0.314 . . . . 74.010000000000005 111.587 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.07 -42.04 89.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.223 0.535 . . . . 74.409999999999997 110.049 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.95 -22.88 62.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.904 0.882 . . . . 75.450000000000003 112.199 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -58.04 -43.37 86.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.299 0.5 . . . . 74.310000000000002 110.683 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -72.12 -49.79 33.31 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.6 0.593 . . . . 74.540000000000006 112.6 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.09 -54.61 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.207 0.527 . . . . 75.519999999999996 112.287 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.02 -56.45 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.78 0.832 . . . . 73.530000000000001 111.536 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.53 96.36 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 114.659 0.624 . . . . 73.219999999999999 114.659 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -88.72 -60.18 2.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.955 0.502 . . . . 74.519999999999996 110.634 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.84 -29.6 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 115.834 1.094 . . . . 73.340000000000003 115.834 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -105.16 -53.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 117.317 0.558 . . . . 72.010000000000005 110.873 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -75.43 -65.47 0.89 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.804 -0.634 . . . . 74.450000000000003 111.793 -170.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.06 66.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.856 0.462 . . . . 71.439999999999998 111.554 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.56 -53.73 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.986 0.914 . . . . 75.310000000000002 112.26 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.42 -35.17 81.32 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 116.402 -0.363 . . . . 75.129999999999995 113.395 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -44.83 61.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.3 1.04 . . . . 74.239999999999995 112.027 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -65.7 -38.19 88.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.376 0.27 . . . . 72.239999999999995 110.895 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.76 88.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.946 0.498 . . . . 74.140000000000001 111.611 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.531 HD23 HG13 ' A' ' 17' ' ' VAL . 7.0 tt -64.75 -42.5 95.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.693 0.797 . . . . 75.319999999999993 110.151 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.38 80.23 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.875 -0.602 . . . . 65.310000000000002 112.06 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.08 -33.12 61.62 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.754 0.822 . . . . 74.310000000000002 112.741 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.557 HH11 HD21 ' A' ' 20' ' ' LEU . 2.2 ptm180 -73.27 -24.72 60.47 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.773 0.32 . . . . 75.400000000000006 111.06 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 54.4 m-85 -100.75 4.14 42.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.432 0.693 . . . . 74.120000000000005 111.559 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.997 0 N-CA-C 115.156 0.823 . . . . 75.430000000000007 115.156 -179.698 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 111' ' ' PHE . . . . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 120.869 0.366 . . . . 71.329999999999998 111.221 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -108.13 112.62 25.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.156 0.982 . . . . 71.530000000000001 108.969 172.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.3 mp -97.14 121.76 39.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.774 1.23 . . . . 74.329999999999998 109.936 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -117.6 113.64 22.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.789 -0.449 . . . . 74.150000000000006 109.789 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -120.95 135.49 55.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.005 0.922 . . . . 75.200000000000003 109.818 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -138.1 159.93 40.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.688 0.795 . . . . 63.43 111.301 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.1 p -155.6 150.89 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.611 0.364 . . . . 74.530000000000001 111.874 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -92.34 119.09 31.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.959 0.504 . . . . 72.409999999999997 110.025 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.23 124.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.607 1.163 . . . . 70.349999999999994 109.82 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.76 71.68 4.25 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.569 0.7 . . . . 70.430000000000007 111.241 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.77 155.89 8.36 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.013 0.925 . . . . 75.420000000000002 110.909 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.39 137.84 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.777 2.318 . . . . 75.209999999999994 112.261 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.59 -46.69 10.15 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.233 1.568 . . . . 73.129999999999995 115.233 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.58 92.02 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 112.421 0.526 . . . . 54.340000000000003 112.421 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.16 -39.36 86.12 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.674 0.789 . . . . 61.240000000000002 112.051 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 103' ' ' CYS . 44.3 t -73.9 -34.35 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.501 0.72 . . . . 71.510000000000005 111.15 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.511 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 75.8 t-105 -67.66 -29.67 69.02 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.713 0.405 . . . . 74.319999999999993 111.558 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 m -60.24 -30.86 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 110.737 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -83.5 -52.09 6.79 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.269 1.428 . . . . 75.219999999999999 112.143 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.31 -38.34 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.33 0.863 . . . . 62.100000000000001 113.33 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.58 -8.48 63.24 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.121 0.808 . . . . 74.450000000000003 115.121 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.99 113.92 26.34 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.612 -0.885 . . . . 74.129999999999995 108.612 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.15 -25.81 65.81 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.806 1.242 . . . . 74.120000000000005 113.303 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -96.7 -17.88 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.467 0.543 . . . . 73.299999999999997 112.467 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.77 15.42 4.8 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.196 0.598 . . . . 73.439999999999998 111.571 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 34' ' ' VAL . 20.2 tt -67.06 -24.9 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 C-N-CA 123.97 0.908 . . . . 72.400000000000006 111.88 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -64.55 -12.74 48.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.239 0.829 . . . . 74.120000000000005 113.239 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.35 -28.99 26.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.771 0.656 . . . . 75.329999999999998 112.771 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.455 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 48.0 p-90 -118.64 -35.49 3.71 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.034 0.534 . . . . 73.049999999999997 111.883 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -90.88 107.8 23.33 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.596 0.758 . . . . 74.219999999999999 109.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.29 -19.06 62.05 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.293 2.662 . . . . 75.409999999999997 114.715 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -96.77 0.67 49.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.02 0.748 . . . . 75.109999999999999 113.02 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 27' ' ' ILE . 60.7 t -78.56 117.71 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 120.817 0.342 . . . . 74.540000000000006 111.12 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -90.89 51.33 1.94 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.547 0.739 . . . . 55.009999999999998 111.915 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 58.9 99.81 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 124.953 1.301 . . . . 64.319999999999993 113.147 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 97.9 Cg_endo -77.46 147.26 25.27 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.821 2.347 . . . . 62.25 114.779 -172.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.6 m -105.47 120.93 42.85 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.625 1.17 . . . . 74.140000000000001 109.152 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.86 127.64 38.44 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.269 0.557 . . . . 73.340000000000003 112.187 -170.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.601 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -115.33 123.36 48.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.077 0.951 . . . . 73.409999999999997 110.659 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.68 178.35 0.01 OUTLIER Glycine 0 CA--C 1.546 1.981 0 N-CA-C 117.308 1.683 . . . . 60.439999999999998 117.308 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.26 -118.69 1.37 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 124.837 1.255 . . . . 72.25 112.967 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -175.24 162.3 2.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 124.122 0.969 . . . . 74.430000000000007 109.421 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.47 -5.29 4.08 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.798 2.332 . . . . 63.549999999999997 115.077 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.0 -10.43 9.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.729 -0.607 . . . . 75.030000000000001 112.195 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.8 m -98.73 122.0 54.45 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 123.097 0.559 . . . . 74.510000000000005 111.357 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 Cg_endo -55.87 113.67 1.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.308 2.672 . . . . 74.239999999999995 112.909 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.05 -22.76 2.1 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.132 -0.485 . . . . 72.120000000000005 113.172 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 141.49 57.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.51 0.724 . . . . 61.240000000000002 112.725 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 38.8 mt-10 -114.5 115.97 28.08 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.195 0.598 . . . . 74.129999999999995 109.938 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 29.3 ptt180 -93.36 123.78 36.89 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.441 0.696 . . . . 73.109999999999999 110.099 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -119.04 108.28 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.238 0.615 . . . . 74.540000000000006 110.209 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -66.63 101.75 0.83 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.623 0.769 . . . . 73.140000000000001 112.374 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.53 -71.18 2.3 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.339 -0.391 . . . . 63.219999999999999 112.306 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 68.37 136.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.166 1.386 . . . . 73.099999999999994 112.926 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.13 19.67 64.43 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-O 121.437 0.465 . . . . 63.409999999999997 112.191 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.3 p -117.84 -160.21 0.77 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.545 1.538 . . . . 73.150000000000006 110.132 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.87 5.6 15.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.803 0.841 . . . . 71.049999999999997 110.527 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.92 9.97 6.96 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.823 0.849 . . . . 75.540000000000006 113.233 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.28 144.31 44.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.016 0.747 . . . . 64.120000000000005 113.016 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.7 tp -120.71 126.11 49.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.375 1.07 . . . . 75.430000000000007 109.453 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.39 115.33 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.975 0.51 . . . . 64.409999999999997 109.854 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.62 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 43.6 mt-10 -120.0 137.72 53.92 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.024 0.93 . . . . 73.409999999999997 110.162 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -118.4 133.65 55.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.297 0.639 . . . . 73.120000000000005 112.102 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 23.0 tp -75.67 120.74 21.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.736 1.215 . . . . 73.519999999999996 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.72 -41.53 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.284 0.634 . . . . 73.209999999999994 111.256 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 10.7 tp10 -152.99 147.03 25.45 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.092 0.957 . . . . 73.409999999999997 110.145 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -146.67 123.44 11.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.687 0.395 . . . . 74.409999999999997 110.629 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -106.63 -177.66 3.43 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.967 0.907 . . . . 60.530000000000001 110.812 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 41.1 tt0 -147.95 -47.11 0.16 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.866 0.466 . . . . 71.209999999999994 110.706 172.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.8 p -64.31 -43.47 94.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.269 0.628 . . . . 62.149999999999999 111.186 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.09 -26.54 59.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.349 0.66 . . . . 62.140000000000001 112.512 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 60.28 59.45 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.853 0.861 . . . . 71.409999999999997 111.426 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -139.31 122.75 17.22 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.766 0.826 . . . . 74.549999999999997 110.117 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 66.1 tp -124.27 109.01 12.84 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.21 1.004 . . . . 71.010000000000005 111.459 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 56.4 t -106.4 132.0 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.014 0.825 . . . . 75.129999999999995 111.28 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -152.84 179.73 8.39 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.103 0.561 . . . . 75.439999999999998 111.865 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.2 t -144.66 166.02 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.529 1.132 . . . . 73.230000000000004 111.054 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.62 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.7 mtm -99.84 99.38 8.91 Favored Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 123.373 0.669 . . . . 74.450000000000003 110.492 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 22.5 Cg_endo -62.13 -20.34 69.53 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 123.517 2.812 . . . . 65.239999999999995 112.748 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.75 81.18 69.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.972 0.509 . . . . 74.420000000000002 110.436 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.32 123.35 1.02 Allowed 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.787 2.325 . . . . 73.340000000000003 112.774 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.98 27.11 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.641 2.228 . . . . 71.25 113.156 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.44 147.27 61.58 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.391 1.077 . . . . 73.25 109.87 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 76.69 0.94 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.099 2.533 . . . . 74.510000000000005 113.23 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.732 HG23 ' HB2' ' A' ' 113' ' ' CYS . 22.1 pt -132.75 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 124.47 1.108 . . . . 75.209999999999994 109.953 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 23.8 m -103.27 -78.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.406 0.282 . . . . 70.140000000000001 111.41 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -105.02 100.37 9.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.998 0.519 . . . . 74.140000000000001 111.171 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -88.61 144.74 26.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 75.200000000000003 112.826 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -137.33 158.04 45.29 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 72.439999999999998 109.592 168.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 107' ' ' TRP . . . -158.62 119.91 3.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.516 1.126 . . . . 71.310000000000002 109.111 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 31.9 t -125.74 132.23 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.13 0.572 . . . . 75.310000000000002 112.449 -168.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.42 119.33 38.68 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.648 0.779 . . . . 73.530000000000001 109.3 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -130.45 114.03 15.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.961 0.504 . . . . 72.400000000000006 110.567 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.46 116.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.298 0.639 . . . . 74.140000000000001 110.36 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 104' ' ' THR . 4.9 m -113.42 123.04 34.01 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 123.902 0.881 . . . . 72.299999999999997 110.904 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 124.97 11.79 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.835 2.357 . . . . 70.200000000000003 113.483 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -109.24 -9.43 15.0 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.221 1.008 . . . . 61.229999999999997 112.143 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 34.9 t70 -175.87 167.9 3.05 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.157 1.383 . . . . 61.109999999999999 109.212 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.27 -39.3 66.74 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.045 0.938 . . . . 72.25 112.23 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -131.81 38.95 3.51 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.435 0.636 . . . . 71.120000000000005 110.377 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.68 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 77.9 m80 -148.95 135.6 19.61 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.293 1.037 . . . . 65.329999999999998 109.974 166.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 17' ' ' VAL . 32.0 p -148.98 144.95 27.1 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.395 0.678 . . . . 72.420000000000002 110.681 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 78.7 m -93.35 116.96 29.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.151 0.58 . . . . 70.549999999999997 110.681 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.79 118.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.04 0.536 . . . . 74.099999999999994 109.669 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.8 117.37 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 123.605 0.762 . . . . 73.530000000000001 110.45 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.507 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 5.2 t90 -105.3 116.4 31.89 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.974 -0.75 . . . . 74.140000000000001 108.974 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -124.46 123.82 40.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.586 0.754 . . . . 75.549999999999997 111.371 -170.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -106.93 141.03 38.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.871 0.868 . . . . 74.319999999999993 111.076 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -128.59 124.58 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.869 -0.789 . . . . 70.310000000000002 108.869 168.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.439 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 5.2 p90 -148.02 147.91 30.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.886 0.328 . . . . 72.219999999999999 111.886 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.618 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -84.18 86.83 7.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.365 0.602 . . . . 71.209999999999994 109.966 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.732 ' HB2' HG23 ' A' ' 86' ' ' ILE . 50.7 t -125.64 144.01 50.78 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.151 -0.931 . . . . 71.120000000000005 111.782 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.0 m -59.44 140.08 88.64 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.939 0.896 . . . . 74.510000000000005 111.516 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -56.83 -31.62 89.27 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.143 2.562 . . . . 74.200000000000003 114.171 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.09 -40.98 95.78 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.958 0.903 . . . . 72.420000000000002 112.013 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.536 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 24.3 m -88.11 -31.43 19.21 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.521 -0.763 . . . . 64.549999999999997 110.997 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.17 86.67 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.737 0.815 . . . . 73.5 111.64 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -61.63 -33.64 74.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.427 0.691 . . . . 75.120000000000005 111.185 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 -36.19 63.12 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.562 1.145 . . . . 61.100000000000001 110.411 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 117' ' ' THR . 86.9 mt -74.42 -24.08 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 72.319999999999993 111.746 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.23 -35.11 79.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 120.96 0.41 . . . . 75.140000000000001 110.703 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 m -72.37 -56.64 5.12 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.271 0.628 . . . . 73.340000000000003 112.098 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.69 -54.45 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 112.432 0.531 . . . . 74.329999999999998 112.432 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.8 mt -78.68 -51.07 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.033 0.533 . . . . 63.420000000000002 110.789 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.99 -49.13 69.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.68 0.632 . . . . 71.439999999999998 114.68 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.82 -52.68 4.62 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 121.85 -0.794 . . . . 74.230000000000004 111.212 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.54 -28.71 73.88 Favored Glycine 0 N--CA 1.476 1.362 0 N-CA-C 115.404 0.922 . . . . 61.350000000000001 115.404 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.8 t -105.55 -58.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.57 0.685 . . . . 75.420000000000002 110.543 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 3.5 m-30 -71.27 -64.96 0.81 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.07 0.548 . . . . 73.510000000000005 112.386 -170.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.44 69.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.993 0.517 . . . . 73.230000000000004 112.079 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -58.03 -54.41 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.563 0.745 . . . . 72.400000000000006 111.93 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.68 -41.07 94.07 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.304 0.377 . . . . 74.230000000000004 113.025 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.01 -43.3 88.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.081 0.953 . . . . 74.209999999999994 112.084 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.67 -38.0 76.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 119.47 -0.3 . . . . 72.219999999999999 111.107 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.84 81.6 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.136 0.493 . . . . 72.230000000000004 111.095 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 17' ' ' VAL . 4.2 tt -66.58 -41.43 88.53 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 115.266 -0.879 . . . . 65.040000000000006 109.849 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.78 76.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.125 0.57 . . . . 71.329999999999998 112.352 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.24 -45.47 60.06 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.468 0.707 . . . . 75.209999999999994 111.574 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.38 -26.65 68.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 111.99 0.367 . . . . 70.409999999999997 111.99 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.84 -22.81 15.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.176 0.59 . . . . 73.010000000000005 112.316 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 O-C-N 122.157 -0.339 . . . . 74.439999999999998 113.821 179.572 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 112.145 0.424 . . . . 64.329999999999998 112.145 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 m -106.02 116.34 31.77 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.985 -0.746 . . . . 72.540000000000006 108.985 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 136.18 39.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.84 1.256 . . . . 75.120000000000005 109.298 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -133.9 130.33 37.64 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.201 0.524 . . . . 73.230000000000004 110.751 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.2 mmt-85 -138.07 153.68 49.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.501 1.12 . . . . 72.230000000000004 109.118 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 p -152.43 158.66 42.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.216 0.531 . . . . 64.129999999999995 111.443 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.9 p -149.82 152.49 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 72.530000000000001 109.398 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.96 123.47 48.22 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.705 0.684 . . . . 74.430000000000007 110.486 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.12 136.35 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 125.344 1.458 . . . . 75.239999999999995 110.372 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.77 66.51 4.27 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.359 0.599 . . . . 75.099999999999994 111.199 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.38 157.05 5.62 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.327 1.051 . . . . 72.310000000000002 111.023 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.92 140.96 68.87 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.95 2.433 . . . . 74.019999999999996 112.199 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.52 23.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.604 1.335 . . . . 61.329999999999998 114.604 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.51 82.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.483 0.713 . . . . 73.409999999999997 112.3 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 -37.51 86.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.387 0.675 . . . . 62.310000000000002 112.358 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG13 HD23 ' A' ' 137' ' ' LEU . 25.8 t -70.49 -36.76 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.528 -0.76 . . . . 74.109999999999999 110.645 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -70.89 -28.32 64.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.786 0.834 . . . . 72.310000000000002 111.408 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -63.61 -29.76 70.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.157 0.503 . . . . 75.310000000000002 111.028 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.09 -51.06 9.47 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.007 0.923 . . . . 74.140000000000001 112.047 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.49 -18.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 113.647 0.981 . . . . 62.399999999999999 113.647 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.23 -35.05 91.48 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 123.248 0.451 . . . . 74.420000000000002 113.221 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.15 97.96 8.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.321 -0.992 . . . . 60.43 108.321 165.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -75.61 -7.1 53.39 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.274 0.559 . . . . 74.430000000000007 112.311 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -70.4 -33.64 71.61 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.409 0.623 . . . . 71.209999999999994 110.628 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . . . -87.5 16.39 5.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.26 1.024 . . . . 74.109999999999999 111.722 -167.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 34' ' ' VAL . 19.9 tt -64.89 -22.63 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 C-N-CA 123.798 0.839 . . . . 72.230000000000004 111.667 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -69.87 -9.19 53.95 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.032 0.753 . . . . 75.519999999999996 113.032 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' NE ' ' HB2' ' A' ' 26' ' ' ALA . 75.7 mtm180 -88.92 -37.45 15.26 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.108 0.563 . . . . 74.200000000000003 111.919 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.435 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 58.5 p-90 -109.52 -39.13 5.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.613 0.597 . . . . 75.540000000000006 112.613 -171.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 60.8 t-80 -86.74 115.79 63.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.789 -0.819 . . . . 75.439999999999998 108.789 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -70.05 -19.79 34.28 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.882 2.388 . . . . 73.030000000000001 114.412 -165.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -98.81 -4.93 32.12 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.621 0.971 . . . . 75.340000000000003 113.621 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 27' ' ' ILE . 63.0 t -67.14 128.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 111.906 0.335 . . . . 75.230000000000004 111.906 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -83.52 27.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.25 1.02 . . . . 74.219999999999999 112.881 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.87 107.82 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 125.011 1.324 . . . . 63.109999999999999 112.054 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 45.1 Cg_endo -85.7 154.05 10.23 Favored 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 122.295 1.997 . . . . 71.120000000000005 114.489 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.8 m -112.47 124.95 53.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.58 0.752 . . . . 64.200000000000003 109.984 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 49' ' ' ALA . 4.2 mm? -91.2 138.49 31.55 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.385 0.674 . . . . 74.209999999999994 112.345 -168.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.42 123.11 44.43 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.335 1.054 . . . . 75.150000000000006 109.022 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.05 176.95 0.01 OUTLIER Glycine 0 CA--C 1.547 2.091 0 N-CA-C 117.363 1.705 . . . . 74.109999999999999 117.363 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.82 -122.43 1.99 Allowed 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.341 1.056 . . . . 53.43 113.085 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p -168.95 164.0 7.48 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 123.848 0.859 . . . . 61.140000000000001 109.578 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.91 -24.18 30.6 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.032 2.488 . . . . 74.310000000000002 114.415 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.12 -44.99 7.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.194 0.597 . . . . 74.430000000000007 110.892 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -67.72 119.05 63.39 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.683 0.793 . . . . 75.150000000000006 112.644 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.88 113.75 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.428 2.752 . . . . 74.25 113.14 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.28 -26.22 2.46 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.878 -0.601 . . . . 75.540000000000006 112.594 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.482 ' HB3' HD13 ' A' ' 39' ' ' LEU . . . -65.42 137.31 57.38 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.637 0.606 . . . . 74.299999999999997 112.637 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 51.3 mt-10 -118.13 118.92 33.19 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.086 0.555 . . . . 72.120000000000005 110.671 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -106.98 134.28 50.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.084 0.468 . . . . 72.420000000000002 110.909 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.448 ' HB ' ' HB1' ' A' ' 55' ' ' ALA . 20.4 t -115.27 103.35 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.593 0.757 . . . . 74.200000000000003 110.581 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.76 99.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.476 1.11 . . . . 74.239999999999995 111.649 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.68 53.7 6.36 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 123.224 0.327 . . . . 55.25 112.892 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' A' ' 52' ' ' VAL . . . -65.43 90.44 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.065 0.459 . . . . 54.5 111.762 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.19 38.4 0.06 OUTLIER Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.819 -0.628 . . . . 62.549999999999997 112.25 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 59' ' ' GLU . 15.0 t -138.36 -162.53 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.173 0.989 . . . . 70.400000000000006 110.172 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.9 15.71 20.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.345 0.658 . . . . 75.400000000000006 112.263 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 57' ' ' THR . 11.0 pt-20 -168.51 40.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.3 0.852 . . . . 72.329999999999998 113.3 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.37 156.4 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.22 0.608 . . . . 71.439999999999998 112.163 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -107.95 120.92 43.66 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.724 0.809 . . . . 74.140000000000001 110.625 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.75 121.95 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.841 0.456 . . . . 74.439999999999998 110.202 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 47.5 mt-10 -118.26 139.01 51.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.788 0.835 . . . . 73.349999999999994 110.776 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -103.85 130.7 51.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.962 0.905 . . . . 71.439999999999998 109.69 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.73 120.88 26.92 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.038 0.535 . . . . 73.019999999999996 110.151 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.25 -45.88 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.28 0.632 . . . . 72.349999999999994 112.296 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 35.4 tt0 -159.69 157.48 29.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.221 0.609 . . . . 72.239999999999995 110.858 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -148.04 131.88 17.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.237 0.615 . . . . 74.219999999999999 109.968 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -124.4 116.4 22.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.69 0.796 . . . . 63.149999999999999 109.868 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.08 13.47 33.98 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.244 0.617 . . . . 60.0 112.495 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -94.31 -46.6 6.98 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.22 0.533 . . . . 65.109999999999999 110.159 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.24 8.56 25.81 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.64 0.776 . . . . 62.409999999999997 111.834 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 56.63 67.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.088 0.955 . . . . 72.120000000000005 112.136 175.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -135.96 110.29 8.44 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.852 0.861 . . . . 74.430000000000007 111.328 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.5 tp -107.19 108.76 20.35 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.757 1.223 . . . . 72.209999999999994 110.844 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 38.3 t -104.2 130.24 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.381 0.672 . . . . 74.310000000000002 111.069 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.47 -178.9 6.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.431 0.692 . . . . 74.010000000000005 111.573 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.499 ' HB ' ' NH1' ' A' ' 90' ' ' ARG . 6.0 t -149.88 162.44 40.32 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.327 1.051 . . . . 74.450000000000003 110.741 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.8 mtp -111.55 93.17 18.62 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.077 0.951 . . . . 74.230000000000004 109.862 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 56.0 Cg_endo -67.82 -20.92 45.19 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.442 2.761 . . . . 72.230000000000004 112.732 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.87 77.79 57.64 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.734 0.814 . . . . 71.430000000000007 109.944 172.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 63.9 Cg_endo -88.72 143.55 5.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.892 2.394 . . . . 75.200000000000003 113.296 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 6.7 Cg_exo -77.13 1.53 8.6 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.878 2.385 . . . . 74.329999999999998 113.159 173.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.0 147.44 44.45 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 123.787 0.835 . . . . 72.349999999999994 111.05 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.491 ' HG2' HG23 ' A' ' 117' ' ' THR . 73.9 Cg_endo -73.1 80.95 1.77 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.695 2.263 . . . . 64.049999999999997 112.81 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.687 HG21 ' HB2' ' A' ' 113' ' ' CYS . 20.1 pt -133.41 133.03 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.263 1.025 . . . . 73.040000000000006 110.301 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m -74.55 -78.08 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.798 0.439 . . . . 74.019999999999996 111.253 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -105.76 108.62 20.23 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.978 -0.451 . . . . 64.219999999999999 110.342 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -87.98 142.82 27.49 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.344 0.658 . . . . 72.5 111.356 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.499 ' NH1' ' HB ' ' A' ' 78' ' ' THR . 6.0 tpp180 -149.39 114.25 5.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.473 0.709 . . . . 74.299999999999997 109.433 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.42 50.98 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.355 0.525 . . . . 73.319999999999993 112.006 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 49.6 t -136.65 141.22 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.224 1.01 . . . . 63.130000000000003 111.261 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 3.4 mm? -98.1 140.26 32.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.282 -1.007 . . . . 74.109999999999999 108.282 165.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 35.0 tt0 -142.89 110.13 5.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.503 0.592 . . . . 71.319999999999993 110.716 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 t -94.03 108.95 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 72.540000000000006 108.872 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.4 119.93 54.74 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.644 0.778 . . . . 74.140000000000001 109.931 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.83 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.441 2.094 . . . . 71.120000000000005 112.249 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -68.22 -32.4 72.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.811 0.844 . . . . 75.430000000000007 110.202 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.7 t70 -147.92 165.25 31.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.11 1.364 . . . . 74.450000000000003 109.461 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.64 -47.0 85.88 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.279 1.032 . . . . 73.530000000000001 111.901 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -113.3 10.94 18.52 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.722 0.809 . . . . 74.219999999999999 112.205 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 37.2 m80 -137.59 118.63 14.37 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 118.984 0.811 . . . . 65.109999999999999 110.206 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m -136.08 133.83 37.75 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.843 0.457 . . . . 60.32 111.313 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.9 m -92.54 114.81 27.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.142 0.577 . . . . 75.219999999999999 111.88 -172.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -92.3 109.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.251 0.621 . . . . 74.430000000000007 109.552 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.18 113.1 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.873 0.869 . . . . 75.109999999999999 109.647 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -102.63 120.27 40.27 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.857 -0.794 . . . . 72.010000000000005 108.857 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.7 m -123.48 141.58 51.86 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.037 0.935 . . . . 63.439999999999998 110.426 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.63 110.18 5.76 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.303 0.573 . . . . 72.349999999999994 111.508 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -109.54 125.78 52.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.528 1.131 . . . . 73.519999999999996 109.161 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -139.35 154.23 47.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.714 0.806 . . . . 72.430000000000007 110.596 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 32.7 t70 -86.73 83.76 7.51 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.385 0.612 . . . . 64.530000000000001 110.093 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.687 ' HB2' HG21 ' A' ' 86' ' ' ILE . 50.1 t -125.37 156.33 38.92 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.641 -0.709 . . . . 64.030000000000001 111.754 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -65.36 132.92 95.29 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.487 0.715 . . . . 74.439999999999998 111.158 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.23 -38.97 20.68 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.83 3.02 . . . . 75.420000000000002 115.472 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.347 0.659 . . . . 74.230000000000004 112.127 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 85' ' ' PRO . 29.5 m -87.49 -29.07 21.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.824 0.45 . . . . 73.340000000000003 110.779 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.41 70.99 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.321 0.648 . . . . 71.120000000000005 111.931 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -66.92 -28.08 68.01 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.453 0.701 . . . . 74.310000000000002 111.94 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.78 -45.43 61.63 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.567 0.747 . . . . 72.310000000000002 110.028 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 117' ' ' THR . 78.3 mt -74.41 -31.63 62.39 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.47 -0.786 . . . . 74.549999999999997 113.045 -171.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.96 -34.56 78.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.159 0.436 . . . . 73.040000000000006 111.304 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.6 t -70.6 -59.87 2.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.104 0.562 . . . . 65.420000000000002 112.117 171.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.11 -55.55 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.266 0.626 . . . . 74.530000000000001 112.421 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.2 mt -76.64 -47.97 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 72.329999999999998 110.666 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -61.3 -66.19 2.81 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.765 0.666 . . . . 74.299999999999997 114.765 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.59 -41.22 12.12 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.834 -0.804 . . . . 63.130000000000003 111.461 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.32 79.02 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.228 0.851 . . . . 60.039999999999999 115.228 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.73 -55.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.683 0.742 . . . . 74.230000000000004 111.358 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 13.2 m-30 -70.31 -56.37 6.88 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.226 0.454 . . . . 74.349999999999994 112.226 -173.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.56 68.52 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.385 0.428 . . . . 71.409999999999997 111.525 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.9 t -59.06 -51.18 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 C-N-CA 123.951 0.901 . . . . 73.430000000000007 112.263 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.88 73.95 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 116.607 -0.269 . . . . 64.310000000000002 113.633 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.25 -41.65 73.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.128 0.971 . . . . 63.32 111.554 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.64 -40.65 84.58 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.348 -0.387 . . . . 75.099999999999994 110.112 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.73 76.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.766 0.827 . . . . 64.430000000000007 111.706 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.445 ' HA ' HH11 ' A' ' 140' ' ' ARG . 5.4 tt -65.13 -39.02 92.47 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 115.419 -0.809 . . . . 75.439999999999998 110.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.26 -28.83 64.43 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.055 0.542 . . . . 70.140000000000001 112.289 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -67.7 -45.65 74.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.998 0.919 . . . . 74.219999999999999 112.099 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.445 HH11 ' HA ' ' A' ' 137' ' ' LEU . 8.8 ptp85 -71.33 -25.52 62.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.098 0.559 . . . . 75.219999999999999 112.498 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -93.94 -5.44 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.961 0.505 . . . . 72.430000000000007 111.009 170.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.435 0 C-N-CA 122.847 0.261 . . . . 71.120000000000005 113.749 176.098 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.902 0.382 . . . . 74.519999999999996 111.133 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.512 HG23 ' HB3' ' A' ' 110' ' ' MET . 23.5 m -107.55 110.15 21.99 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.765 0.826 . . . . 72.409999999999997 109.177 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -94.82 134.52 37.35 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.042 0.937 . . . . 74.040000000000006 109.022 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -136.81 137.24 39.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.811 0.444 . . . . 73.230000000000004 110.35 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.71 HH11 ' HB2' ' A' ' 131' ' ' ALA . 10.5 ttm180 -147.86 152.1 37.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.201 0.6 . . . . 72.299999999999997 109.944 175.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.6 p -141.22 166.38 24.94 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.091 0.472 . . . . 74.409999999999997 111.907 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.9 p -152.15 148.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.717 0.807 . . . . 70.140000000000001 110.425 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.83 112.08 23.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.236 0.541 . . . . 73.299999999999997 109.722 168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -91.02 127.9 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.429 1.092 . . . . 74.329999999999998 109.762 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 71.16 3.3 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 121.618 0.723 . . . . 71.319999999999993 111.541 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.34 151.63 4.62 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.474 1.109 . . . . 72.310000000000002 110.247 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.42 140.73 58.9 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.323 2.015 . . . . 51.539999999999999 112.257 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.06 -35.49 11.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.505 1.668 . . . . 74.200000000000003 115.505 -172.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.19 -48.25 80.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.537 0.569 . . . . 73.109999999999999 112.537 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.39 -36.24 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.583 0.753 . . . . 72.409999999999997 112.05 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 137' ' ' LEU . 36.2 t -72.84 -36.65 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.518 0.727 . . . . 71.010000000000005 110.631 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.538 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 61.3 t-105 -69.03 -33.5 73.72 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.618 0.767 . . . . 75.109999999999999 112.032 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -65.03 -20.1 66.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.563 0.697 . . . . 74.530000000000001 111.317 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 30' ' ' TRP . 54.2 tp -89.9 -52.67 4.86 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.001 0.921 . . . . 75.540000000000006 112.06 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.08 -48.45 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 112.867 0.692 . . . . 73.299999999999997 112.867 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.06 65.7 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 115.172 0.829 . . . . 74.310000000000002 115.172 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.44 -18.1 60.69 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.065 0.546 . . . . 72.239999999999995 111.477 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 t80 73.64 -66.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.785 1.634 . . . . 73.120000000000005 112.105 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.3 p -67.7 -14.34 62.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.994 0.918 . . . . 52.420000000000002 113.182 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.17 9.77 18.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.67 0.788 . . . . 72.109999999999999 111.674 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.622 HG23 HG11 ' A' ' 34' ' ' VAL . 19.9 tt -61.23 -31.15 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 N-CA-C 112.76 0.652 . . . . 74.209999999999994 112.76 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -70.47 -5.78 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.075 0.768 . . . . 73.019999999999996 113.075 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -91.45 -19.86 22.38 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.453 0.701 . . . . 74.310000000000002 112.495 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.514 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 60.0 p-90 -121.31 -30.6 4.25 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.037 0.535 . . . . 73.230000000000004 111.719 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -93.63 103.75 10.85 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.384 0.674 . . . . 75.439999999999998 109.815 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.14 -15.92 52.56 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.238 2.626 . . . . 72.329999999999998 115.21 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -85.07 -28.66 25.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.885 0.474 . . . . 74.219999999999999 111.446 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.622 HG11 HG23 ' A' ' 27' ' ' ILE . 49.1 t -78.7 113.57 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 110.218 -0.29 . . . . 74.310000000000002 110.218 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -73.58 -62.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.285 0.634 . . . . 62.439999999999998 110.399 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.62 116.01 0.59 Allowed Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 124.386 1.075 . . . . 75.439999999999998 110.189 173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.39 144.71 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.463 2.109 . . . . 73.329999999999998 113.381 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -95.91 126.7 41.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.193 0.997 . . . . 75.430000000000007 109.804 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 9.5 mp -110.03 145.75 36.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.648 0.737 . . . . 73.319999999999993 111.42 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -149.85 147.04 27.48 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.486 -1.234 . . . . 72.319999999999993 110.246 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.5 153.38 0.0 OUTLIER Glycine 0 CA--C 1.555 2.585 0 N-CA-C 117.687 1.835 . . . . 64.319999999999993 117.687 -167.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 72.9 -50.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.837 1.655 . . . . 65.329999999999998 115.312 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m 102.12 147.51 0.02 OUTLIER Pre-proline 0 N--CA 1.516 2.863 0 C-N-CA 127.709 2.404 . . . . 63.409999999999997 111.869 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.69 -38.53 46.27 Favored 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 124.427 3.418 . . . . 73.129999999999995 115.549 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -90.99 10.53 26.22 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.351 0.5 . . . . 73.299999999999997 112.351 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -123.75 119.13 26.99 Favored Pre-proline 0 N--CA 1.487 1.382 0 C-N-CA 123.833 0.853 . . . . 74.120000000000005 110.536 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.3 Cg_exo -52.52 129.22 31.08 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.335 2.69 . . . . 74.150000000000006 113.807 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.02 -10.5 13.59 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.392 0.52 . . . . 71.540000000000006 112.96 -175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.07 154.69 40.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.376 0.67 . . . . 71.530000000000001 111.95 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 50.6 mt-10 -112.79 128.81 56.54 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.938 0.495 . . . . 74.150000000000006 111.602 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -107.41 102.86 12.11 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.651 0.78 . . . . 75.129999999999995 109.554 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.1 t -106.7 104.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.313 0.577 . . . . 63.32 111.353 -170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HD1' HG12 ' A' ' 34' ' ' VAL . 66.0 m-85 -75.34 82.68 2.45 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.307 1.043 . . . . 71.230000000000004 111.264 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.05 -63.11 0.58 Allowed Glycine 0 N--CA 1.478 1.449 0 CA-C-N 116.042 -0.526 . . . . 63.539999999999999 112.3 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.77 -53.23 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.079 1.751 . . . . 73.319999999999993 115.318 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.83 37.56 3.32 Favored Glycine 0 N--CA 1.487 2.065 0 CA-C-O 121.234 0.352 . . . . 75.040000000000006 112.932 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -120.63 -165.75 1.24 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.274 1.029 . . . . 71.099999999999994 110.62 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -122.77 27.41 7.77 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.952 0.901 . . . . 72.519999999999996 109.701 167.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.17 9.54 1.11 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.205 1.002 . . . . 74.319999999999993 111.913 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 152.21 39.4 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.367 0.604 . . . . 71.239999999999995 112.498 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.529 HD13 ' SD ' ' A' ' 79' ' ' MET . 29.2 tp -107.22 119.92 40.71 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.102 0.961 . . . . 73.150000000000006 109.224 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 94.5 t -95.99 114.34 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.283 0.563 . . . . 73.25 109.482 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 17.1 tt0 -115.24 167.88 10.45 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.445 1.098 . . . . 55.240000000000002 109.898 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 30.3 ttm-85 -150.82 128.88 11.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.126 0.97 . . . . 74.439999999999998 111.736 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 27.0 tp -67.79 129.2 39.19 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.951 0.9 . . . . 64.319999999999993 111.123 171.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HH11 ' A' ' 90' ' ' ARG . 79.0 t -101.29 -51.13 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.772 0.829 . . . . 75.239999999999995 111.384 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -149.72 148.73 29.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.372 1.069 . . . . 70.150000000000006 109.136 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -140.02 119.6 13.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.966 -0.383 . . . . 75.329999999999998 109.966 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 24.5 m-20 -101.09 102.45 13.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.525 1.13 . . . . 72.239999999999995 109.773 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.538 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 31.4 tt0 -75.74 -41.14 54.13 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.26 -0.275 . . . . 74.409999999999997 111.008 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.9 m -68.76 -50.05 53.71 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.36 0.664 . . . . 63.43 111.146 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 69' ' ' ASP . . . -78.49 -6.14 54.55 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.983 0.734 . . . . 64.340000000000003 112.983 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 63.43 45.2 4.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.74 1.216 . . . . 74.530000000000001 111.945 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.1 ttm105 -129.39 135.36 48.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.913 1.285 . . . . 75.120000000000005 110.455 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 tp -125.43 106.15 9.59 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.043 0.537 . . . . 72.150000000000006 110.745 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -105.7 126.11 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.693 0.797 . . . . 75.299999999999997 110.519 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -146.57 179.51 7.5 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.426 0.69 . . . . 72.120000000000005 112.043 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 m -156.56 142.24 17.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.955 1.302 . . . . 71.530000000000001 109.74 -169.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.529 ' SD ' HD13 ' A' ' 61' ' ' LEU . 57.3 mtm -95.87 98.79 4.19 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 118.234 0.47 . . . . 73.450000000000003 109.79 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.82 -25.03 17.31 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.375 2.717 . . . . 75.150000000000006 112.901 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.749 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.7 t70 -129.59 80.04 72.55 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.464 0.706 . . . . 74.109999999999999 109.489 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -93.36 133.47 0.94 Allowed 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 122.964 2.443 . . . . 73.340000000000003 112.761 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' A' ' 61' ' ' LEU . 71.7 Cg_endo -72.27 -2.03 11.05 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.203 1.935 . . . . 71.420000000000002 112.073 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.84 140.77 50.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 124.454 1.102 . . . . 75.450000000000003 109.924 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 77.76 2.77 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.476 2.117 . . . . 73.239999999999995 112.889 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 89' ' ' HIS . 7.4 pt -138.94 143.99 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.661 1.184 . . . . 72.310000000000002 110.412 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -72.17 -47.45 50.78 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.344 0.868 . . . . 75.25 113.344 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -131.97 -49.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.266 0.469 . . . . 73.099999999999994 112.266 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB2' HD11 ' A' ' 86' ' ' ILE . 47.9 t-80 65.35 145.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 125.417 1.487 . . . . 75.040000000000006 113.736 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.541 HH11 HG21 ' A' ' 66' ' ' VAL . 21.4 tpp180 -147.08 149.01 32.2 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.732 1.213 . . . . 74.129999999999995 108.347 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.7 146.44 20.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.968 0.507 . . . . 74.099999999999994 111.74 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.5 p -137.23 140.28 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.376 0 N-CA-C 113.106 0.78 . . . . 74.239999999999995 113.106 -174.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -107.62 108.48 19.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.504 1.121 . . . . 72.439999999999998 108.691 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -121.0 111.65 17.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.089 -0.708 . . . . 74.040000000000006 109.089 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.32 110.79 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.709 -0.849 . . . . 73.319999999999993 108.709 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.39 123.8 61.22 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.15 0.98 . . . . 75.310000000000002 109.928 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.64 137.31 41.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.448 2.099 . . . . 74.439999999999998 111.974 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.582 HH11 ' HB2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -138.05 -34.52 0.66 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.162 0.585 . . . . 71.420000000000002 111.403 -172.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.4 t70 -163.65 159.47 21.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.178 0.991 . . . . 75.450000000000003 110.01 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.5 -31.16 55.42 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.897 1.279 . . . . 75.310000000000002 113.092 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -140.18 26.69 2.19 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.167 0.587 . . . . 75.310000000000002 110.373 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.9 m80 -147.94 111.18 4.9 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.045 0.938 . . . . 73.409999999999997 109.32 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -133.76 137.02 44.95 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.241 0.616 . . . . 70.5 110.824 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.8 m -94.71 114.09 25.96 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.102 0.561 . . . . 74.019999999999996 112.231 -170.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.78 122.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.742 -0.466 . . . . 71.120000000000005 109.742 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.83 115.31 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.168 -0.678 . . . . 72.340000000000003 109.168 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.9 123.31 49.38 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.764 -0.828 . . . . 73.140000000000001 108.764 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.449 HG21 ' SD ' ' A' ' 110' ' ' MET . 91.8 m -130.58 135.37 47.83 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 74.299999999999997 110.382 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.504 ' HB1' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.75 115.13 15.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.84 0.856 . . . . 65.549999999999997 110.761 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.512 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -121.56 132.89 54.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.714 1.206 . . . . 73.200000000000003 109.871 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -145.46 147.81 32.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.31 0.644 . . . . 74.230000000000004 111.878 -171.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.86 87.57 5.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.235 -0.654 . . . . 72.349999999999994 109.235 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.522 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 42.0 t -143.5 167.5 22.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.808 0.67 . . . . 63.530000000000001 112.808 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.41 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.7 m -70.13 142.23 89.91 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.316 1.046 . . . . 71.420000000000002 112.435 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.47 -40.3 54.15 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.473 2.782 . . . . 73.340000000000003 114.724 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.74 -31.56 69.75 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.063 0.945 . . . . 74.310000000000002 112.764 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.522 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -89.9 -29.93 18.22 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.41 0.684 . . . . 52.130000000000003 111.113 176.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.13 77.27 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.622 0.769 . . . . 75.140000000000001 112.198 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -68.33 -36.56 79.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.031 0.932 . . . . 75.400000000000006 111.988 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.58 -49.17 72.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.402 0.681 . . . . 74.299999999999997 109.895 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -71.97 -23.67 61.47 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.931 -1.031 . . . . 74.329999999999998 111.352 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.19 -48.66 79.63 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.582 0.753 . . . . 75.200000000000003 110.817 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.7 m -69.23 -53.25 20.86 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.593 -0.731 . . . . 72.219999999999999 112.665 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.7 -53.85 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.53 0.567 . . . . 74.409999999999997 112.53 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.4 -48.18 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.131 0.572 . . . . 74.439999999999998 111.125 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.52 -52.39 35.27 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 114.629 0.611 . . . . 40.340000000000003 114.629 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.31 -44.63 10.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 122.062 -0.67 . . . . 74.400000000000006 112.033 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.89 -47.51 54.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 116.071 -0.513 . . . . 72.230000000000004 113.876 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.44 -53.24 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.96 0.504 . . . . 73.230000000000004 111.631 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.504 ' HZ ' ' HB1' ' A' ' 109' ' ' ALA . 4.1 m-30 -75.65 -56.92 4.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.321 0.489 . . . . 74.239999999999995 112.321 -171.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.71 ' HB2' HH11 ' A' ' 6' ' ' ARG . . . -55.93 -38.55 70.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.768 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 t -65.78 -54.45 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 123.455 0.702 . . . . 70.239999999999995 112.347 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.98 71.81 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 113.851 0.3 . . . . 64.409999999999997 113.851 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.57 -42.89 99.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.361 1.065 . . . . 75.510000000000005 112.473 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 92.4 m-20 -70.01 -39.72 75.67 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 119.726 -0.178 . . . . 65.030000000000001 110.931 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.94 79.82 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.103 0.561 . . . . 75.5 111.234 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 17' ' ' VAL . 4.8 tt -65.49 -38.25 89.21 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.454 0.702 . . . . 74.409999999999997 110.324 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.69 68.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.939 0.496 . . . . 53.240000000000002 111.918 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 18.7 mm-40 -69.39 -42.88 74.53 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.446 0.699 . . . . 72.129999999999995 111.724 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.13 -28.92 67.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.601 0.36 . . . . 74.439999999999998 111.936 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -97.53 6.64 47.81 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.809 0.444 . . . . 75.109999999999999 111.828 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 116.434 1.334 . . . . 72.219999999999999 116.434 -177.593 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.359 0.6 . . . . 74.540000000000006 109.811 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 110' ' ' MET . 58.1 m -131.7 121.25 23.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.649 0.779 . . . . 75.109999999999999 110.01 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.75 111.47 23.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.622 1.169 . . . . 73.420000000000002 110.027 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -104.74 120.54 41.62 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.827 -0.805 . . . . 73.239999999999995 108.827 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.24 135.82 46.55 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.741 -0.466 . . . . 74.329999999999998 109.741 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.6 p -141.42 159.59 41.91 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.02 0.528 . . . . 74.120000000000005 112.294 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.9 p -147.27 141.28 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.777 0.831 . . . . 73.400000000000006 110.62 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.1 111.03 23.53 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.609 0.719 . . . . 75.019999999999996 110.276 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 137' ' ' LEU . 66.1 t -102.44 145.45 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 125.573 1.549 . . . . 75.430000000000007 112.1 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -79.66 59.74 3.13 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.031 0.932 . . . . 65.230000000000004 112.391 173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 141.64 6.55 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.349 0.659 . . . . 73.099999999999994 111.15 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.15 138.11 65.22 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.972 2.448 . . . . 71.239999999999995 113.382 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.4 -46.46 13.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.8 1.778 . . . . 70.109999999999999 115.8 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.02 90.82 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.521 0.563 . . . . 72.200000000000003 112.521 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.82 -30.44 68.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.474 0.546 . . . . 65.040000000000006 112.474 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.542 HG22 ' SG ' ' A' ' 103' ' ' CYS . 83.5 t -70.66 -35.44 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.783 0.433 . . . . 64.319999999999993 110.679 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -67.37 -27.6 67.25 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.778 0.431 . . . . 74.400000000000006 111.295 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.3 m -63.85 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.316 0.579 . . . . 73.049999999999997 111.529 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.6 tp -84.16 -56.83 3.45 Favored 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.486 1.114 . . . . 73.340000000000003 112.47 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.47 -21.61 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.727 1.01 . . . . 74.530000000000001 113.727 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.48 -50.37 59.73 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.526 0.516 . . . . 71.540000000000006 114.111 -170.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.67 127.79 34.32 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.209 -0.663 . . . . 73.439999999999998 109.209 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.68 -30.04 71.09 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.357 1.063 . . . . 74.120000000000005 112.491 -169.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -99.27 0.84 43.92 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.487 0.715 . . . . 71.010000000000005 112.476 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB2' HH11 ' A' ' 29' ' ' ARG . . . -89.94 8.88 30.07 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.199 0.6 . . . . 72.530000000000001 111.837 -174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.671 HG22 ' NH2' ' A' ' 51' ' ' ARG . 19.9 tt -65.8 -30.83 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.597 1.159 . . . . 75.099999999999994 113.208 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -66.11 -9.48 31.63 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.701 0.63 . . . . 73.319999999999993 112.701 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.455 HH11 ' HB2' ' A' ' 26' ' ' ALA . 69.8 mtp180 -83.87 -14.88 50.07 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.936 0.895 . . . . 74.120000000000005 112.354 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.431 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 51.7 p-90 -130.28 -40.83 1.27 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 112.77 0.656 . . . . 72.319999999999993 112.77 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.451 ' ND1' HG21 ' A' ' 34' ' ' VAL . 32.7 t-80 -85.79 113.17 49.92 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.073 0.549 . . . . 74.150000000000006 110.519 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -18.89 31.08 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.212 2.608 . . . . 53.340000000000003 114.525 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 4.2 mt-30 -94.69 -13.04 26.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.81 0.67 . . . . 71.099999999999994 112.81 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.451 HG21 ' ND1' ' A' ' 31' ' ' HIS . 90.9 t -73.12 114.38 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 121.072 0.463 . . . . 74.150000000000006 110.26 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -92.93 35.95 1.04 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.395 1.078 . . . . 63.310000000000002 111.64 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.03 115.32 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 C-N-CA 125.603 1.561 . . . . 62.219999999999999 112.483 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HG3' ' HE ' ' A' ' 51' ' ' ARG . 26.3 Cg_endo -95.71 177.99 0.7 Allowed 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.381 2.721 . . . . 72.140000000000001 114.703 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.1 m -119.42 132.34 55.8 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.322 1.049 . . . . 52.43 110.451 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.2 136.34 37.86 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.454 0.645 . . . . 75.420000000000002 111.416 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -121.74 145.05 48.42 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.512 1.125 . . . . 73.040000000000006 110.294 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 119.71 0.0 OUTLIER Glycine 0 CA--C 1.556 2.611 0 N-CA-C 117.613 1.805 . . . . 64.430000000000007 117.613 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.57 -96.41 0.05 OUTLIER 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 125.614 1.566 . . . . 72.319999999999993 113.644 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -158.71 150.76 17.35 Favored Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 123.29 0.636 . . . . 73.230000000000004 111.78 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.12 -12.58 33.13 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.11 2.54 . . . . 75.099999999999994 114.155 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 80.1 m-70 -97.06 -5.72 36.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.827 -0.545 . . . . 74.299999999999997 111.657 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.6 m -96.89 113.78 63.49 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.788 0.835 . . . . 72.409999999999997 110.758 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.2 Cg_endo -55.97 114.84 2.08 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.253 2.635 . . . . 65.510000000000005 112.87 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.36 -23.79 4.02 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-N 115.915 -0.584 . . . . 73.329999999999998 112.558 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.69 133.74 55.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.417 0.687 . . . . 74.239999999999995 112.254 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 43.4 mt-10 -103.26 138.57 39.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.966 0.506 . . . . 65.140000000000001 110.754 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.671 ' NH2' HG22 ' A' ' 27' ' ' ILE . 32.5 ttt-85 -125.15 106.01 9.58 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.176 0.99 . . . . 75.109999999999999 110.745 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 t -110.55 109.31 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.338 0.655 . . . . 74.230000000000004 111.4 -169.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HE2' HG22 ' A' ' 34' ' ' VAL . 46.2 m-85 -62.32 118.61 7.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.334 1.054 . . . . 74.040000000000006 111.326 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.84 -71.91 2.88 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 112.451 -0.26 . . . . 71.109999999999999 112.451 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.74 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.881 1.272 . . . . 74.219999999999999 113.468 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 25.52 3.98 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 116.348 -0.387 . . . . 60.439999999999998 113.948 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.5 -172.32 2.49 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.301 1.04 . . . . 70.140000000000001 110.205 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.4 0.96 54.7 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.808 0.443 . . . . 73.299999999999997 111.746 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.1 88.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.568 0.747 . . . . 63.450000000000003 110.034 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.38 139.6 49.35 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.376 0.671 . . . . 72.230000000000004 110.414 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -95.2 117.46 30.28 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.517 0.727 . . . . 73.310000000000002 109.902 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 43.6 t -96.17 115.97 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.735 -0.469 . . . . 75.030000000000001 109.735 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 23.3 tt0 -112.69 166.65 11.16 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.211 1.005 . . . . 72.109999999999999 109.837 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -151.6 124.98 8.84 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.926 0.49 . . . . 65.239999999999995 111.918 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 34.4 tp -68.2 120.07 13.78 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.833 1.253 . . . . 75.109999999999999 111.353 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -85.21 -52.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.246 0.618 . . . . 55.109999999999999 110.647 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 8.5 pt-20 -155.83 139.72 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.156 0.583 . . . . 73.040000000000006 110.456 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 70' ' ' GLU . 41.4 tpt85 -131.94 106.85 8.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.608 0.763 . . . . 74.540000000000006 109.641 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.92 116.63 23.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.603 0.761 . . . . 50.329999999999998 111.355 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.686 ' HB3' HH12 ' A' ' 68' ' ' ARG . 13.1 pt-20 -84.6 -39.19 19.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.284 0.634 . . . . 75.310000000000002 112.63 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.7 m -71.83 -25.34 61.94 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.311 0.644 . . . . 53.450000000000003 111.262 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.9 -17.86 32.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.468 0.707 . . . . 72.329999999999998 111.784 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 55.49 43.75 28.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.985 0.914 . . . . 75.209999999999994 111.226 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -133.45 116.07 15.56 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 114.471 -1.241 . . . . 71.549999999999997 109.887 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.652 HD13 ' HD3' ' A' ' 68' ' ' ARG . 23.9 tp -119.03 109.67 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.867 1.267 . . . . 74.120000000000005 110.923 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.526 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 75.9 t -110.34 137.44 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.829 -0.545 . . . . 71.519999999999996 111.392 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -145.14 179.21 7.51 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.67 1.188 . . . . 73.0 110.507 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -163.32 152.79 14.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.463 1.105 . . . . 73.140000000000001 109.243 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.0 mpp? -91.03 109.72 37.17 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 118.024 0.375 . . . . 75.340000000000003 110.386 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.08 -21.19 63.32 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.664 2.242 . . . . 73.420000000000002 111.851 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 29.7 t70 -122.94 80.6 50.34 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.919 0.888 . . . . 62.399999999999999 109.558 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -94.88 137.29 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.069 2.513 . . . . 74.209999999999994 113.057 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.51 12.05 3.17 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.855 2.37 . . . . 73.519999999999996 113.447 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -108.43 144.97 30.57 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 124.005 0.922 . . . . 73.010000000000005 109.971 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.26 65.47 7.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.83 2.353 . . . . 72.120000000000005 112.289 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 22.2 pt -122.76 131.62 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.18 0.992 . . . . 74.430000000000007 110.955 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 26.4 m -78.44 134.51 37.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 110.069 -0.345 . . . . 75.310000000000002 110.069 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 56.1 -67.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 128.132 2.573 . . . . 63.009999999999998 114.721 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 109' ' ' ALA . 58.9 t-80 69.11 148.06 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.343 1.457 . . . . 74.040000000000006 111.516 -174.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.423 ' CZ ' HG13 ' A' ' 76' ' ' VAL . 64.8 ttt-85 -164.66 107.86 0.89 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 109.532 -0.544 . . . . 75.230000000000004 109.532 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.37 146.31 33.22 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.197 0.599 . . . . 64.439999999999998 112.016 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.6 p -138.09 144.43 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 113.501 0.926 . . . . 75.239999999999995 113.501 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.35 112.07 24.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.17 1.388 . . . . 72.200000000000003 109.297 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -119.06 113.69 21.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.197 0.999 . . . . 72.209999999999994 110.139 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 t -93.06 112.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.988 -0.445 . . . . 74.310000000000002 110.208 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.33 119.28 58.11 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.377 1.071 . . . . 63.439999999999998 110.961 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.5 107.68 2.05 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.504 2.136 . . . . 65.129999999999995 112.825 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -86.61 -42.66 13.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.984 0.914 . . . . 74.450000000000003 111.061 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.3 t70 -140.49 178.92 6.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.44 1.096 . . . . 74.109999999999999 109.058 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.09 -48.62 28.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.056 0.542 . . . . 73.299999999999997 111.031 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.404 ' O ' ' HD3' ' A' ' 101' ' ' ARG . 3.9 tmt_? -95.96 -1.52 48.93 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.89 0.876 . . . . 73.129999999999995 111.03 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.522 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -135.77 158.54 44.15 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.391 -0.818 . . . . 74.200000000000003 110.73 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.542 ' SG ' HG22 ' A' ' 17' ' ' VAL . 22.4 p -156.61 178.23 10.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.786 0.434 . . . . 73.329999999999998 111.514 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.4 m -119.43 127.35 53.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.888 0.875 . . . . 62.25 110.782 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t -95.26 110.35 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.959 -0.756 . . . . 74.209999999999994 108.959 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.2 t -99.68 108.83 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.382 0.673 . . . . 64.319999999999993 110.04 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -106.8 119.27 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.048 -0.723 . . . . 75.430000000000007 109.048 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.4 m -126.4 150.54 48.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.0 0.92 . . . . 74.120000000000005 109.943 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.456 ' HB2' ' HE2' ' A' ' 89' ' ' HIS . . . -147.61 120.03 8.46 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.236 0.614 . . . . 74.219999999999999 111.244 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.517 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -117.12 128.6 55.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.117 0.967 . . . . 74.230000000000004 110.211 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.42 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 19.2 p90 -146.91 143.01 28.2 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.205 1.402 . . . . 74.109999999999999 108.462 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.693 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 15.8 t70 -89.88 78.39 6.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.733 0.778 . . . . 74.510000000000005 109.659 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 52.6 t -117.82 163.1 17.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.203 0.601 . . . . 72.430000000000007 111.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.1 p -64.38 138.76 97.53 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.672 0.789 . . . . 74.340000000000003 112.018 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.55 -36.43 18.47 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.943 3.095 . . . . 61.109999999999999 115.169 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -61.06 -53.75 53.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.54 0.736 . . . . 73.530000000000001 111.352 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.435 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 48.7 m -72.84 -27.29 61.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.986 0.515 . . . . 75.040000000000006 111.517 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.42 -43.3 81.55 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.914 0.885 . . . . 73.340000000000003 112.57 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -68.51 -29.14 67.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.365 0.666 . . . . 73.219999999999999 111.484 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.49 -43.93 68.72 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.361 0.665 . . . . 64.219999999999999 110.498 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.06 -23.25 59.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.89 0.876 . . . . 73.439999999999998 111.536 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -57.54 -44.78 85.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.851 0.46 . . . . 72.219999999999999 110.18 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.8 t -71.61 -52.32 18.63 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 112.738 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.91 -54.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 123.447 0.699 . . . . 70.430000000000007 112.705 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.89 -50.58 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.135 0.574 . . . . 74.230000000000004 111.115 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.18 -49.31 58.4 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 114.652 0.621 . . . . 62.200000000000003 114.652 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.08 -48.99 7.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.126 -0.631 . . . . 75.230000000000004 111.56 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.51 -29.8 65.34 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 115.496 0.959 . . . . 73.450000000000003 115.496 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.93 -53.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 117.784 0.792 . . . . 73.120000000000005 110.96 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -73.25 -60.46 2.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.444 0.698 . . . . 75.209999999999994 112.287 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.81 66.98 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 123.497 0.498 . . . . 73.310000000000002 111.488 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -55.94 -54.82 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 123.666 0.786 . . . . 74.25 112.295 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.75 80.72 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 113.69 0.236 . . . . 74.519999999999996 113.69 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.58 -42.21 71.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.057 0.943 . . . . 73.299999999999997 111.884 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.68 -41.39 83.78 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.519 0.328 . . . . 71.120000000000005 110.289 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.34 80.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.802 0.841 . . . . 55.350000000000001 111.969 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 7.8 tt -65.26 -43.22 91.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.715 0.806 . . . . 73.439999999999998 110.228 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.94 74.59 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 116.136 -0.484 . . . . 73.439999999999998 111.275 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.58 -48.13 61.27 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.865 0.866 . . . . 72.140000000000001 112.794 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -19.9 65.37 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.49 0.552 . . . . 72.299999999999997 112.49 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -91.34 -44.3 9.26 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.882 0.473 . . . . 74.040000000000006 111.864 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 114.323 0.489 . . . . 74.329999999999998 114.323 -174.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.26 0.552 . . . . 53.240000000000002 110.964 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 m -121.92 111.28 16.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.811 0.844 . . . . 72.400000000000006 110.318 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 6.8 mp -96.08 109.59 21.99 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 62.119999999999997 110.039 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.53 123.71 39.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.898 0.479 . . . . 73.319999999999993 110.946 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.435 HH22 ' HG2' ' A' ' 122' ' ' GLU . 1.2 mmp_? -122.28 160.39 25.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.333 1.053 . . . . 74.530000000000001 108.817 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -153.31 146.81 24.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.11 0.564 . . . . 73.439999999999998 111.244 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.0 p -138.73 145.58 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.156 0.583 . . . . 75.109999999999999 111.314 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.94 110.88 22.72 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.495 0.718 . . . . 75.319999999999993 110.426 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 65.9 t -101.41 139.93 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.562 1.145 . . . . 73.150000000000006 111.578 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.72 40.78 0.61 Allowed 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 113.766 1.025 . . . . 71.319999999999993 113.766 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.54 32.27 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.205 0.602 . . . . 63.140000000000001 111.654 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.08 145.28 78.67 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.984 2.456 . . . . 74.329999999999998 113.265 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.31 -35.31 37.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.345 1.458 . . . . 72.319999999999993 114.72 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.69 -51.55 61.87 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.595 0.591 . . . . 72.420000000000002 112.595 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.77 -44.78 90.73 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.282 0.633 . . . . 63.450000000000003 111.162 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG21 ' SG ' ' A' ' 103' ' ' CYS . 49.2 t -68.72 -34.07 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.605 0.762 . . . . 72.319999999999993 111.08 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 55.8 t-105 -59.55 -40.99 89.07 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.458 0.303 . . . . 72.129999999999995 111.219 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -61.37 -24.99 66.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.796 0.438 . . . . 75.219999999999999 111.564 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 30' ' ' TRP . 29.5 tp -83.67 -44.29 14.66 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 112.736 0.643 . . . . 70.299999999999997 112.736 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.62 -26.26 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 114.098 1.147 . . . . 75.540000000000006 114.098 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.71 35.42 3.22 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 115.876 1.11 . . . . 51.119999999999997 115.876 -165.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.26 -162.07 0.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.806 0.842 . . . . 53.329999999999998 111.158 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.14 25.2 1.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.302 0.641 . . . . 75.109999999999999 110.195 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -152.15 -42.83 0.11 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.498 0.719 . . . . 74.109999999999999 111.763 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.4 3.12 48.34 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.221 1.008 . . . . 61.229999999999997 111.199 -170.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.66 HG23 HG13 ' A' ' 34' ' ' VAL . 14.3 tt -55.92 -19.76 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 C-N-CA 125.853 1.661 . . . . 72.209999999999994 113.108 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.37 -14.36 55.96 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.409 0.892 . . . . 73.409999999999997 113.409 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -71.85 -20.18 61.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.533 0.733 . . . . 74.299999999999997 112.374 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.465 ' HB3' HD21 ' A' ' 20' ' ' LEU . 31.5 p-90 -127.71 -35.08 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.008 0.523 . . . . 74.25 111.912 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -89.77 112.37 51.59 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 122.819 0.447 . . . . 74.340000000000003 110.337 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.68 -16.27 37.8 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.275 2.65 . . . . 70.319999999999993 114.083 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -93.15 -20.69 20.24 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.724 0.81 . . . . 73.510000000000005 112.12 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 27' ' ' ILE . 72.9 t -69.32 111.79 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 120.919 0.39 . . . . 71.510000000000005 110.894 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -92.33 27.46 2.23 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.429 1.092 . . . . 62.229999999999997 111.9 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.03 98.1 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.577 1.151 . . . . 72.430000000000007 111.27 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.11 173.14 8.12 Favored 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 123.116 2.544 . . . . 75.530000000000001 114.693 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -99.96 123.02 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.0 0.92 . . . . 73.430000000000007 109.758 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.71 127.32 39.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.237 0.615 . . . . 73.010000000000005 111.204 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -104.64 123.23 47.22 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.719 -0.673 . . . . 74.530000000000001 109.612 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.33 -175.41 0.01 OUTLIER Glycine 0 CA--C 1.55 2.241 0 N-CA-C 117.543 1.777 . . . . 63.219999999999999 117.543 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 46.75 -121.31 1.14 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.839 1.256 . . . . 75.530000000000001 113.315 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -162.8 155.9 16.78 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 124.375 1.07 . . . . 75.349999999999994 108.985 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.42 -15.52 45.82 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.502 2.135 . . . . 72.0 114.859 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -111.41 0.77 16.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.66 -0.65 . . . . 74.129999999999995 111.546 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -110.77 127.69 26.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 123.732 0.813 . . . . 73.209999999999994 110.928 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.708 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 85.5 Cg_exo -50.15 138.68 36.21 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.68 2.92 . . . . 73.420000000000002 114.149 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.97 19.6 21.24 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 116.272 -0.422 . . . . 70.109999999999999 113.564 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.78 134.74 51.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.71 0.804 . . . . 74.409999999999997 110.737 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.35 118.44 35.85 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.952 0.501 . . . . 74.209999999999994 110.965 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -93.63 126.26 38.69 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.888 0.375 . . . . 73.400000000000006 110.042 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 62' ' ' VAL . 20.6 t -122.42 122.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 122.902 0.481 . . . . 74.450000000000003 111.238 -171.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' HE2' HG11 ' A' ' 34' ' ' VAL . 48.6 m-85 -95.56 85.31 4.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.216 1.006 . . . . 73.530000000000001 111.118 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.25 -43.41 1.61 Allowed Glycine 0 N--CA 1.478 1.488 0 N-CA-C 112.722 -0.151 . . . . 74.230000000000004 112.722 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 17.7 4.12 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.949 1.463 . . . . 73.319999999999993 114.949 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.31 57.8 0.03 OUTLIER Glycine 0 N--CA 1.472 1.064 0 N-CA-C 112.595 -0.202 . . . . 73.239999999999995 112.595 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -105.87 -69.1 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.982 0.913 . . . . 72.0 109.729 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 176.64 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.527 1.531 . . . . 72.310000000000002 109.252 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.75 82.21 2.07 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.871 0.843 . . . . 74.319999999999993 108.818 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.72 -179.77 3.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.15 0.98 . . . . 74.120000000000005 110.601 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.455 HD13 ' SD ' ' A' ' 79' ' ' MET . 55.0 tp -141.14 123.53 15.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.799 0.44 . . . . 72.209999999999994 110.896 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.0 t -104.7 115.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.162 -0.681 . . . . 75.519999999999996 109.162 170.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -104.73 149.67 25.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.872 0.869 . . . . 71.319999999999993 109.889 171.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -127.5 127.39 43.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.068 1.347 . . . . 74.400000000000006 109.867 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.17 108.99 9.47 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.932 0.893 . . . . 73.120000000000005 110.662 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -73.26 -50.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.363 0.665 . . . . 74.439999999999998 110.555 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.708 ' HA ' ' HG3' ' A' ' 47' ' ' PRO . 8.6 pt-20 -166.81 155.46 10.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.541 0.736 . . . . 75.109999999999999 111.095 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -141.69 123.04 14.87 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.37 0.668 . . . . 70.209999999999994 110.497 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.35 -178.37 4.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.045 0.938 . . . . 74.239999999999995 111.826 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.537 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 55.4 mt-10 -138.92 -63.72 0.52 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.228 1.011 . . . . 75.219999999999999 109.955 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -69.57 -38.25 77.33 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.414 0.686 . . . . 62.350000000000001 111.439 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.67 -19.83 60.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.431 0.692 . . . . 75.209999999999994 112.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 55.74 45.0 25.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 75.230000000000004 112.253 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.418 HH11 HG23 ' A' ' 76' ' ' VAL . 9.0 tmm_? -130.7 130.99 44.55 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 115.031 -0.986 . . . . 74.349999999999994 110.475 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 46.2 tp -120.36 123.63 43.56 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.363 1.065 . . . . 74.400000000000006 110.212 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.5 t -114.38 132.35 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 118.958 0.799 . . . . 74.239999999999995 111.072 174.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -147.61 175.18 11.07 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 75.019999999999996 111.349 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.6 t -150.15 145.26 26.19 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.402 1.081 . . . . 73.239999999999995 109.55 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.455 ' SD ' HD13 ' A' ' 61' ' ' LEU . 20.3 ptt? -95.96 101.06 7.46 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 118.787 0.721 . . . . 74.430000000000007 110.7 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.47 -17.37 30.38 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 123.178 2.586 . . . . 63.109999999999999 113.229 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 34.9 t70 -132.8 79.18 64.49 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 123.427 0.691 . . . . 74.230000000000004 109.859 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -96.34 154.93 1.32 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.42 2.747 . . . . 75.319999999999993 114.033 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.94 -17.43 22.45 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.119 1.879 . . . . 74.150000000000006 112.554 168.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -80.33 142.2 54.25 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 123.812 0.845 . . . . 75.209999999999994 112.047 -175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.07 77.4 3.49 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.717 2.278 . . . . 72.439999999999998 113.21 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.62 HG23 ' HB2' ' A' ' 113' ' ' CYS . 27.1 pt -133.54 154.7 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.285 1.034 . . . . 71.319999999999993 110.774 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 35.9 m -90.76 -79.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.985 -0.447 . . . . 64.150000000000006 110.757 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -106.37 107.82 19.03 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.358 0.599 . . . . 73.319999999999993 110.924 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -84.94 149.72 25.44 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.772 0.829 . . . . 64.329999999999998 111.06 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -153.31 106.89 3.01 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.492 0.717 . . . . 75.319999999999993 109.952 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -117.0 142.38 47.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.981 0.512 . . . . 63.299999999999997 111.926 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 92.8 t -133.6 134.83 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.25 1.02 . . . . 72.319999999999993 111.061 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 mm? -94.46 147.02 23.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.745 -0.835 . . . . 72.420000000000002 108.745 166.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.27 117.65 4.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.677 0.391 . . . . 75.430000000000007 110.179 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.05 112.46 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.784 -0.451 . . . . 62.409999999999997 109.784 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.84 120.7 67.02 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.737 0.815 . . . . 71.450000000000003 110.581 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.18 87.56 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.325 2.017 . . . . 64.129999999999995 112.123 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -76.17 -32.16 58.9 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.098 0.959 . . . . 74.340000000000003 111.148 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 16.6 t70 -158.73 170.9 21.1 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.65 1.58 . . . . 64.239999999999995 108.42 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -54.29 -52.86 60.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 61.240000000000002 112.475 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -119.85 23.25 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.533 0.682 . . . . 73.109999999999999 110.845 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.4 m80 -132.62 121.36 23.08 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.534 -0.729 . . . . 74.420000000000002 109.38 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.523 ' SG ' HG21 ' A' ' 17' ' ' VAL . 30.1 p -128.28 138.33 52.37 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.986 0.514 . . . . 75.140000000000001 109.647 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.9 m -96.05 109.7 22.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.834 -0.432 . . . . 74.439999999999998 109.834 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 108.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.134 -0.691 . . . . 74.239999999999995 109.134 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.89 112.5 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.261 1.024 . . . . 74.349999999999994 109.087 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -104.51 118.71 37.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.776 -0.824 . . . . 73.510000000000005 108.776 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -120.11 149.37 42.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.186 0.995 . . . . 75.420000000000002 110.023 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -146.08 157.96 43.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.557 1.143 . . . . 43.119999999999997 109.206 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -161.46 134.64 6.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.748 0.819 . . . . 75.030000000000001 109.783 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -145.51 152.98 40.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.146 0.578 . . . . 70.209999999999994 111.81 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.487 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 22.2 t70 -75.35 88.91 2.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.935 -0.575 . . . . 44.520000000000003 109.815 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.62 ' HB2' HG23 ' A' ' 86' ' ' ILE . 34.0 t -147.76 166.27 28.02 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.354 -0.839 . . . . 74.109999999999999 111.205 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.4 p -67.21 145.68 98.72 Favored Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 123.254 0.622 . . . . 72.030000000000001 111.445 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.49 -29.22 68.16 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.85 2.367 . . . . 72.030000000000001 112.963 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.08 -52.3 59.93 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.344 1.058 . . . . 71.120000000000005 112.001 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.496 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.2 m -72.46 -32.01 65.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.134 0.492 . . . . 75.340000000000003 110.82 177.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.41 -32.95 74.19 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.633 0.773 . . . . 73.099999999999994 112.055 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -69.08 -35.63 76.7 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.983 0.513 . . . . 71.010000000000005 110.952 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.95 -48.59 73.55 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.378 0.671 . . . . 72.450000000000003 110.077 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.05 -24.75 62.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.193 -0.912 . . . . 75.299999999999997 111.341 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.483 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 1.2 tm-20 -57.08 -42.05 79.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.795 0.838 . . . . 55.399999999999999 110.507 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.5 t -76.75 -49.81 15.09 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.527 0.565 . . . . 74.439999999999998 112.527 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.2 -56.75 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.925 0.713 . . . . 65.209999999999994 112.925 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.44 -42.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.184 0.593 . . . . 75.530000000000001 110.681 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.95 -66.2 2.83 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 116.398 -0.365 . . . . 72.140000000000001 113.787 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -80.97 -50.76 9.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.026 0.913 . . . . 73.5 112.025 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.28 -26.41 69.37 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 115.287 0.875 . . . . 64.310000000000002 115.287 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.09 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.759 0.779 . . . . 74.310000000000002 111.204 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 8.5 m-30 -71.72 -63.1 1.19 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.907 0.336 . . . . 71.019999999999996 111.907 -170.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.19 -28.53 69.21 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.47 0.481 . . . . 62.409999999999997 112.183 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.96 -53.47 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.439 0.696 . . . . 71.230000000000004 111.316 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.85 93.45 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 116.343 -0.39 . . . . 72.319999999999993 113.233 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.88 -40.28 91.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.069 0.948 . . . . 75.409999999999997 111.866 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.425 -0.352 . . . . 62.420000000000002 110.294 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.47 70.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.645 0.778 . . . . 71.540000000000006 112.246 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 tt -67.25 -48.45 67.73 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.958 0.903 . . . . 74.099999999999994 110.403 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.42 63.21 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.073 0.549 . . . . 61.409999999999997 111.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.23 -49.8 66.0 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.582 0.753 . . . . 73.340000000000003 111.422 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -14.41 61.64 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.305 0.483 . . . . 73.530000000000001 112.305 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -94.82 -30.58 14.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.186 0.81 . . . . 75.030000000000001 113.186 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 115.947 1.139 . . . . 31.120000000000001 115.947 -177.653 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.413 0 N-CA-C 113.155 0.798 . . . . 61.149999999999999 113.155 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.2 m -91.33 117.95 30.09 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.26 0.624 . . . . 63.219999999999999 110.529 173.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.66 128.02 42.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.948 1.299 . . . . 74.530000000000001 108.155 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -133.87 127.75 33.19 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.165 0.439 . . . . 74.430000000000007 110.216 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.79 140.57 50.3 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.665 -0.865 . . . . 73.420000000000002 108.665 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 p -141.66 156.23 45.65 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.658 0.783 . . . . 73.400000000000006 110.575 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.39 148.37 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 N-CA-C 111.976 0.361 . . . . 73.209999999999994 111.976 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.68 113.5 18.93 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.289 0.635 . . . . 73.129999999999995 110.567 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 105' ' ' VAL . 43.1 t -106.57 124.11 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.309 0.644 . . . . 75.319999999999993 110.466 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.1 66.13 8.53 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.809 0.844 . . . . 71.310000000000002 112.185 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.41 152.88 3.41 Favored Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 123.959 0.904 . . . . 73.109999999999999 110.797 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 134.95 64.09 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.06 2.507 . . . . 65.319999999999993 113.143 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.77 50.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.381 1.622 . . . . 72.099999999999994 115.381 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.43 78.98 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.942 0.497 . . . . 72.519999999999996 111.926 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.21 -34.82 79.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 75.099999999999994 112.326 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.58 HG22 ' SG ' ' A' ' 103' ' ' CYS . 59.3 t -70.36 -36.69 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.221 0.608 . . . . 62.109999999999999 110.886 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -64.14 -28.84 70.04 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.982 -0.554 . . . . 74.329999999999998 110.661 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -59.54 -28.22 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.072 0.549 . . . . 73.140000000000001 111.432 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -76.48 -41.78 45.9 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.806 0.842 . . . . 73.209999999999994 111.666 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.37 13.96 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 123.943 0.897 . . . . 72.439999999999998 112.833 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.31 7.04 80.88 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 114.449 0.539 . . . . 74.329999999999998 114.449 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.501 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 1.3 m-20 -124.98 135.36 52.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 63.329999999999998 109.311 166.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.68 -24.77 67.92 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.986 0.914 . . . . 74.049999999999997 111.286 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.9 p -89.78 -16.43 30.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.317 1.047 . . . . 73.430000000000007 112.822 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -82.22 3.54 26.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.867 -0.52 . . . . 71.510000000000005 112.238 -168.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 34' ' ' VAL . 21.1 tt -63.79 -23.24 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.142 0.977 . . . . 75.040000000000006 112.766 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.48 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 57.0 p-80 -64.47 -23.23 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.801 0.667 . . . . 72.219999999999999 112.801 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -74.29 -39.04 63.19 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.512 0.56 . . . . 73.030000000000001 112.512 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.49 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 p-90 -107.57 -30.16 8.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.597 0.359 . . . . 72.409999999999997 111.334 -174.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -100.16 102.03 16.59 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 123.453 0.701 . . . . 75.450000000000003 109.842 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.512 ' HD2' HE22 ' A' ' 33' ' ' GLN . 32.5 Cg_exo -62.21 -13.3 31.32 Favored 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 123.537 2.825 . . . . 63.329999999999998 116.035 -171.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' HD2' ' A' ' 32' ' ' PRO . 2.2 mp0 -83.8 -25.79 30.11 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.355 0.662 . . . . 74.519999999999996 111.697 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 27' ' ' ILE . 85.4 t -72.37 115.89 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 122.877 0.471 . . . . 74.349999999999994 111.465 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -95.25 30.32 2.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.974 0.91 . . . . 74.430000000000007 111.797 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.76 98.58 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 125.326 1.45 . . . . 70.430000000000007 112.643 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.9 -171.39 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.321 2.681 . . . . 75.409999999999997 114.252 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.8 m -115.52 124.53 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.785 0.834 . . . . 72.109999999999999 110.686 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.78 126.65 36.08 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.501 0.667 . . . . 74.099999999999994 111.313 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.552 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 mmt180 -111.65 148.25 33.77 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.535 1.134 . . . . 75.099999999999994 109.929 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.69 121.05 0.0 OUTLIER Glycine 0 CA--C 1.56 2.906 0 N-CA-C 117.715 1.846 . . . . 72.040000000000006 117.715 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.45 -98.35 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.421 1.488 . . . . 74.219999999999999 114.096 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -168.66 146.72 3.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 123.227 0.611 . . . . 70.030000000000001 111.68 -166.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.59 -1.2 2.39 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.675 2.917 . . . . 74.030000000000001 115.145 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -101.5 -24.8 14.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.538 0.735 . . . . 71.439999999999998 111.271 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -93.12 124.24 58.61 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.641 0.776 . . . . 61.299999999999997 111.731 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.62 118.91 4.86 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.221 2.614 . . . . 72.25 112.874 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.15 -9.46 7.89 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 112.484 -0.246 . . . . 74.010000000000005 112.484 -170.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.27 130.75 40.89 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.487 0.715 . . . . 74.219999999999999 111.05 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.599 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 36.2 mt-10 -118.88 115.16 23.82 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 122.099 -0.376 . . . . 72.530000000000001 110.558 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -93.73 119.11 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.337 0.589 . . . . 74.519999999999996 109.826 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 t -115.93 107.78 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 123.805 0.842 . . . . 73.129999999999995 110.227 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -76.85 73.64 3.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.041 0.936 . . . . 74.319999999999993 111.479 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.89 -62.44 0.48 Allowed Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.124 -0.489 . . . . 63.439999999999998 111.899 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.63 27.08 16.62 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.605 1.162 . . . . 75.239999999999995 113.663 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.27 41.48 0.03 OUTLIER Glycine 0 N--CA 1.471 1.005 0 CA-C-N 116.392 -0.367 . . . . 64.5 112.739 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -146.78 160.83 41.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.599 0.759 . . . . 74.420000000000002 110.767 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.08 -19.48 60.59 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.253 0.621 . . . . 74.519999999999996 111.858 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.12 85.98 2.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.735 0.814 . . . . 71.400000000000006 110.641 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.26 162.77 30.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 75.230000000000004 111.871 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.445 HD11 ' SD ' ' A' ' 79' ' ' MET . 51.1 tp -121.95 121.71 37.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.772 0.829 . . . . 74.109999999999999 109.89 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.54 130.09 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.066 -0.716 . . . . 73.310000000000002 109.066 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 40.1 mt-10 -130.25 128.87 42.5 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.413 0.685 . . . . 72.400000000000006 110.317 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.599 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 57.8 mtp180 -104.04 131.76 50.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.193 0.597 . . . . 74.120000000000005 111.204 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.403 HD13 ' HG2' ' A' ' 68' ' ' ARG . 16.3 tp -73.04 111.46 8.17 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.015 0.926 . . . . 75.420000000000002 110.161 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.72 -51.91 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.528 0.731 . . . . 62.210000000000001 111.731 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.584 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.8 pt-20 -153.18 151.81 30.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 71.219999999999999 110.579 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.578 HH21 HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -133.78 113.48 12.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.189 0.596 . . . . 74.010000000000005 110.557 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.711 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.5 m-20 -115.68 72.18 0.8 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.816 0.847 . . . . 71.420000000000002 109.036 176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 68' ' ' ARG . 53.3 mt-10 -67.38 -32.85 74.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.735 0.814 . . . . 74.219999999999999 113.109 -173.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -73.07 -18.56 61.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.171 0.589 . . . . 71.040000000000006 111.733 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.57 -1.82 22.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.69 0.796 . . . . 63.530000000000001 112.133 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 13.1 mtm105 62.71 42.82 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.433 1.093 . . . . 75.219999999999999 112.993 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.711 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 23.9 ttm180 -119.34 133.17 55.87 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.368 1.067 . . . . 75.5 110.781 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.578 HD23 HH21 ' A' ' 68' ' ' ARG . 13.6 tp -131.74 107.93 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.636 1.174 . . . . 64.409999999999997 110.037 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 52.0 t -113.12 132.99 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 118.491 0.587 . . . . 75.109999999999999 110.601 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -148.14 167.77 24.17 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.746 0.818 . . . . 73.219999999999999 111.339 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.0 t -134.82 158.25 44.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.12 0.968 . . . . 74.0 110.578 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.633 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 73.4 mtm -102.82 98.13 10.69 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.019 0.527 . . . . 71.120000000000005 110.309 170.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 56.8 Cg_endo -66.05 -28.21 49.4 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.371 2.714 . . . . 70.329999999999998 112.612 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.28 79.42 35.87 Favored Pre-proline 0 CA--C 1.555 1.164 0 N-CA-C 108.624 -0.88 . . . . 74.319999999999993 108.624 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.68 147.4 19.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.465 2.11 . . . . 73.120000000000005 113.12 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.38 -0.83 9.57 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.95 2.434 . . . . 64.140000000000001 112.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.18 150.38 63.35 Favored Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 74.420000000000002 111.513 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.38 80.57 1.05 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.107 2.538 . . . . 73.099999999999994 112.956 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 113' ' ' CYS . 23.5 pt -135.59 146.51 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.547 1.139 . . . . 74.349999999999994 110.383 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -89.87 -72.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.883 0.373 . . . . 54.43 110.921 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 9.1 m-20 -90.71 123.95 34.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.412 -0.959 . . . . 72.349999999999994 108.412 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -114.87 131.21 56.93 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.352 0.978 . . . . 75.439999999999998 113.237 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.529 ' HB2' ' HB2' ' A' ' 110' ' ' MET . 3.6 mpt_? -129.64 143.58 50.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.181 1.392 . . . . 75.209999999999994 109.02 165.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.81 125.6 15.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.068 0.947 . . . . 73.310000000000002 108.739 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.548 HG21 ' HG3' ' A' ' 94' ' ' GLU . 7.5 p -134.5 134.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.678 0.992 . . . . 74.340000000000003 113.678 -169.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -101.91 112.46 25.1 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.247 1.019 . . . . 75.150000000000006 109.156 171.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 92' ' ' VAL . 44.3 mt-10 -122.22 111.26 16.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.618 0.767 . . . . 73.209999999999994 109.921 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -92.59 109.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.101 -0.703 . . . . 71.439999999999998 109.101 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.406 HG22 ' HB ' ' A' ' 104' ' ' THR . 4.4 m -100.7 114.03 65.72 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 123.856 0.863 . . . . 74.400000000000006 110.624 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.76 107.09 2.12 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.543 2.162 . . . . 72.109999999999999 113.04 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -63.47 -29.52 70.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.71 0.804 . . . . 73.310000000000002 111.144 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.2 t70 -154.63 173.13 16.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.396 1.478 . . . . 74.239999999999995 108.526 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.37 -44.19 92.77 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.979 0.512 . . . . 64.349999999999994 111.423 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.8 tmm_? -106.98 1.92 24.8 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.65 0.78 . . . . 73.150000000000006 111.468 -174.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 42.5 m80 -128.58 141.52 51.34 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.406 -0.809 . . . . 74.230000000000004 110.307 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 17' ' ' VAL . 16.8 p -143.72 174.91 10.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.474 0.654 . . . . 75.219999999999999 112.407 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 96' ' ' VAL . 99.4 m -138.58 118.95 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 64.200000000000003 109.65 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 10' ' ' VAL . 47.9 t -91.77 124.8 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 109.771 -0.455 . . . . 73.519999999999996 109.771 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.75 128.35 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 74.120000000000005 109.357 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 6.4 t90 -121.2 122.91 40.99 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.79 -0.818 . . . . 73.510000000000005 108.79 174.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -127.39 124.13 37.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.454 0.702 . . . . 72.140000000000001 111.491 -170.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.3 107.81 18.99 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 62.350000000000001 110.39 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 90' ' ' ARG . 41.8 mtt -97.62 130.35 44.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.888 -0.782 . . . . 74.319999999999993 108.888 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 88' ' ' ASN . 20.4 p90 -157.28 153.21 27.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.978 0.732 . . . . 75.340000000000003 112.978 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.65 84.25 2.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.237 -0.892 . . . . 73.409999999999997 109.427 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.572 ' HB2' HG21 ' A' ' 86' ' ' ILE . 42.2 t -119.28 155.78 31.18 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.324 -1.307 . . . . 74.219999999999999 110.711 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -58.61 138.45 86.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.933 0.893 . . . . 73.120000000000005 111.427 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.59 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 123.473 2.782 . . . . 72.219999999999999 114.857 -168.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.02 -37.98 89.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.104 0.561 . . . . 75.209999999999994 111.421 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.517 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 9.0 m -79.23 -27.25 42.46 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.015 0.526 . . . . 62.119999999999997 111.071 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.995 0.918 . . . . 73.319999999999993 111.896 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -74.8 -28.1 60.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.696 0.799 . . . . 75.010000000000005 111.586 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.32 -45.63 79.65 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.146 0.498 . . . . 74.030000000000001 110.161 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.22 -24.8 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.721 0.808 . . . . 75.040000000000006 111.275 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -58.18 -45.58 87.27 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.522 0.729 . . . . 73.549999999999997 110.519 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 m -69.99 -53.19 18.77 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.523 -0.762 . . . . 74.420000000000002 112.394 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.69 -55.25 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 C-N-CA 123.479 0.712 . . . . 75.129999999999995 112.595 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.6 mt -81.49 -57.32 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.836 0.854 . . . . 72.129999999999995 111.251 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.3 -63.33 3.3 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 114.349 0.5 . . . . 63.229999999999997 114.349 -173.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.45 -16.5 58.74 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 122.871 0.468 . . . . 72.450000000000003 111.441 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.19 -88.75 1.66 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.86 -0.411 . . . . 71.319999999999993 112.463 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.7 t -52.6 -46.78 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 124.935 1.294 . . . . 75.5 113.03 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -75.98 -47.85 23.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.443 0.697 . . . . 74.420000000000002 111.558 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.36 -41.85 85.65 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.226 0.329 . . . . 73.319999999999993 111.751 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.51 -54.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 123.955 0.902 . . . . 74.0 112.107 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.91 -46.21 76.05 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.423 0.452 . . . . 52.329999999999998 113.675 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.62 -41.48 96.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.561 0.745 . . . . 73.129999999999995 112.199 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.68 -41.64 92.19 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 119.73 -0.176 . . . . 72.230000000000004 110.675 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.91 90.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.94 0.496 . . . . 64.129999999999995 111.541 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.64 -40.12 96.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.603 0.761 . . . . 74.329999999999998 110.164 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.51 -33.19 68.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.859 0.463 . . . . 71.109999999999999 111.981 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.026 0.931 . . . . 75.319999999999993 113.042 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -66.77 -32.32 73.53 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 117.922 0.328 . . . . 74.530000000000001 111.289 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.98 -11.25 36.6 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.227 0.611 . . . . 74.239999999999995 110.661 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.447 0 N-CA-C 114.569 0.588 . . . . 72.099999999999994 114.569 -177.901 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.421 0.629 . . . . 74.439999999999998 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.6 m -119.72 124.5 46.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.901 0.88 . . . . 74.409999999999997 109.972 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.94 141.07 32.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 75.439999999999998 109.097 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -145.62 132.63 20.28 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.611 -0.515 . . . . 74.150000000000006 109.611 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.468 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 5.7 tpt180 -133.7 147.35 51.37 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.346 -0.613 . . . . 72.400000000000006 109.346 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.0 p -142.76 150.36 39.94 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.24 0.616 . . . . 61.210000000000001 111.246 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.92 149.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.156 0.582 . . . . 73.430000000000007 111.173 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.18 123.7 29.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.551 -0.537 . . . . 73.519999999999996 109.551 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.519 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 95.4 t -120.51 121.56 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.814 0.845 . . . . 72.329999999999998 110.017 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -76.26 71.3 2.96 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.084 0.553 . . . . 73.409999999999997 111.191 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.91 6.6 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 123.844 0.858 . . . . 72.040000000000006 111.392 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.69 144.62 78.8 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.778 2.318 . . . . 65.420000000000002 112.299 167.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.1 -31.5 30.89 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.027 1.121 . . . . 64.129999999999995 114.027 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.58 -49.22 72.02 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.439 0.696 . . . . 74.129999999999995 112.446 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.353 0.661 . . . . 72.209999999999994 111.916 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' SG ' ' A' ' 103' ' ' CYS . 25.0 t -71.76 -34.64 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.714 -0.675 . . . . 64.420000000000002 111.43 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -67.4 -31.19 71.25 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 122.58 0.352 . . . . 74.129999999999995 111.391 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -67.57 -21.66 65.43 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-O 121.382 0.61 . . . . 61.43 111.293 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.09 -50.03 6.65 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.061 0.944 . . . . 73.230000000000004 112.838 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.2 m -93.98 -26.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.703 1.001 . . . . 72.319999999999993 113.703 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.64 -11.85 66.19 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.384 1.313 . . . . 60.229999999999997 116.384 -165.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 4.6 m-20 -79.65 -14.03 59.08 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.939 0.496 . . . . 70.310000000000002 111.862 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 72.31 -59.05 0.57 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.163 1.385 . . . . 74.409999999999997 111.257 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -62.51 -18.34 61.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.295 1.038 . . . . 51.450000000000003 113.248 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -79.94 7.36 9.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.92 0.888 . . . . 74.319999999999993 112.722 -167.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.52 HG23 HG21 ' A' ' 34' ' ' VAL . 14.1 tt -61.7 -23.49 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 123.575 0.75 . . . . 64.439999999999998 112.082 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.565 ' HA ' HG13 ' A' ' 34' ' ' VAL . 39.5 p-80 -70.67 -3.9 20.81 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 113.154 0.798 . . . . 72.140000000000001 113.154 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HD3' ' HB2' ' A' ' 26' ' ' ALA . 58.6 mtp180 -92.76 -25.51 18.15 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.02 0.928 . . . . 75.120000000000005 112.724 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.514 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.0 p-90 -127.14 -34.48 2.32 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.246 1.202 . . . . 75.019999999999996 114.246 -171.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 33.6 t-80 -78.68 139.08 58.23 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 117.969 0.35 . . . . 71.019999999999996 110.932 -170.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.57 -37.75 3.87 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.136 1.891 . . . . 64.0 113.965 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.547 ' N ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.21 -22.82 47.94 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.522 0.564 . . . . 63.25 112.522 -172.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' A' ' 28' ' ' HIS . 9.4 p -61.71 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.352 0.596 . . . . 74.25 112.549 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -115.92 28.36 8.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.026 0.93 . . . . 74.230000000000004 111.673 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.4 96.83 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.071 0.948 . . . . 62.130000000000003 110.677 -170.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.23 158.46 15.09 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.594 2.196 . . . . 74.230000000000004 114.175 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -104.87 127.3 52.64 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.31 1.044 . . . . 72.340000000000003 109.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 49' ' ' ALA . 4.3 mm? -99.76 115.96 30.74 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.466 0.707 . . . . 75.239999999999995 110.689 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HE ' HG23 ' A' ' 52' ' ' VAL . 31.4 mmt180 -83.85 119.23 24.61 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.886 -0.413 . . . . 75.400000000000006 109.886 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.8 -167.47 0.01 OUTLIER Glycine 0 CA--C 1.545 1.939 0 N-CA-C 117.85 1.9 . . . . 64.209999999999994 117.85 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 76.07 -47.16 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 125.714 1.606 . . . . 63.439999999999998 115.141 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m 91.74 144.25 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 C-N-CA 126.825 2.05 . . . . 72.450000000000003 109.983 -162.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.95 -37.86 93.24 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.842 3.028 . . . . 61.210000000000001 116.244 -167.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -85.25 -13.91 48.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.371 0.508 . . . . 74.230000000000004 112.371 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -80.72 123.51 82.44 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.446 0.698 . . . . 74.219999999999999 111.46 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -48.84 98.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.632 2.888 . . . . 55.329999999999998 113.568 171.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.87 -14.71 2.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.089 -0.505 . . . . 53.130000000000003 112.992 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB3' HD11 ' A' ' 39' ' ' LEU . . . -67.09 122.37 17.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.53 0.732 . . . . 75.340000000000003 111.211 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.6 mt-10 -102.65 117.59 34.99 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.71 0.404 . . . . 74.040000000000006 111.484 -172.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 46.7 ttp180 -92.94 103.19 15.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.559 0.744 . . . . 72.430000000000007 110.763 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 62' ' ' VAL . 20.6 t -112.6 99.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.755 . . . . 75.400000000000006 110.242 -171.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -63.18 -48.97 76.13 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.708 1.003 . . . . 74.120000000000005 113.708 -168.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.01 52.91 0.61 Allowed Glycine 0 N--CA 1.478 1.466 0 N-CA-C 112.374 -0.291 . . . . 32.5 112.374 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.746 0.818 . . . . 74.319999999999993 112.994 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.53 33.36 3.63 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 115.965 -0.561 . . . . 75.430000000000007 113.529 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -120.61 177.69 4.97 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 123.577 0.751 . . . . 74.25 110.73 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.82 -55.27 13.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.811 0.444 . . . . 73.0 111.291 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -115.74 89.9 3.21 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.446 0.698 . . . . 73.420000000000002 110.997 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.17 163.55 12.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.975 0.91 . . . . 74.120000000000005 111.268 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' HE1' ' A' ' 79' ' ' MET . 49.9 tp -116.8 119.43 35.41 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.351 0.661 . . . . 71.540000000000006 110.122 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 48.9 t -104.51 114.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.42 0.688 . . . . 73.439999999999998 110.194 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 83.3 mt-10 -101.22 169.7 8.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.6 1.16 . . . . 74.530000000000001 110.578 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 67.1 ttt180 -151.02 126.34 10.01 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.422 0.689 . . . . 75.439999999999998 110.801 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.52 127.4 32.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.975 0.91 . . . . 71.530000000000001 111.144 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.92 -40.35 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.301 0.64 . . . . 73.430000000000007 111.345 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -167.28 153.59 8.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.961 0.905 . . . . 71.040000000000006 109.835 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 153.08 35.87 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.203 0.601 . . . . 74.540000000000006 110.598 170.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.87 135.18 35.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 75.219999999999999 110.639 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.57 -57.65 3.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.608 0.763 . . . . 73.120000000000005 112.501 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.6 m -76.43 -14.83 60.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.937 0.717 . . . . 75.239999999999995 112.937 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.87 30.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.182 0.593 . . . . 64.129999999999995 111.165 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.48 36.92 18.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.868 1.267 . . . . 72.510000000000005 111.271 -176.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -110.23 97.02 6.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.14 0.976 . . . . 74.400000000000006 111.889 -166.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 14.6 tp -98.67 108.03 20.62 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.8 1.24 . . . . 71.299999999999997 110.215 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.9 t -108.97 121.68 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.055 0.942 . . . . 72.439999999999998 111.527 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -135.98 179.72 6.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.514 0.673 . . . . 73.319999999999993 112.209 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 t -133.6 163.15 30.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.117 1.367 . . . . 74.409999999999997 109.598 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.506 ' HE2' ' HB3' ' A' ' 82' ' ' PRO . 70.2 mtp -112.39 88.38 10.76 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 123.447 0.699 . . . . 75.120000000000005 109.377 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.51 -24.57 56.26 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.603 2.869 . . . . 75.299999999999997 113.62 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.661 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 22.1 t70 -135.44 78.4 51.02 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 122.786 0.434 . . . . 74.109999999999999 110.447 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.506 ' HB3' ' HE2' ' A' ' 79' ' ' MET . 61.4 Cg_endo -95.99 143.22 1.05 Allowed 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.133 2.555 . . . . 74.129999999999995 113.864 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.61 28.16 0.52 Allowed 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.943 2.428 . . . . 73.439999999999998 112.907 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.17 152.83 51.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.645 1.178 . . . . 71.120000000000005 110.008 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.31 41.11 0.74 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.629 2.886 . . . . 64.219999999999999 114.236 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -109.85 124.37 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 124.178 0.991 . . . . 70.450000000000003 110.743 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 8.9 m -68.25 -68.44 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.976 0.51 . . . . 75.120000000000005 112.156 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.71 110.08 16.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.255 0.55 . . . . 74.099999999999994 109.627 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 109' ' ' ALA . 58.7 t-80 -85.67 150.2 24.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.026 0.531 . . . . 72.409999999999997 111.334 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -152.62 117.36 5.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.842 0.857 . . . . 73.129999999999995 110.081 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.447 ' HB1' ' HE1' ' A' ' 89' ' ' HIS . . . -118.48 149.75 40.75 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.609 0.596 . . . . 74.099999999999994 112.609 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' A' ' 94' ' ' GLU . 61.4 t -135.02 137.26 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.353 1.061 . . . . 72.420000000000002 109.492 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -114.52 108.88 17.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.032 1.333 . . . . 74.030000000000001 107.46 -178.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG3' HG11 ' A' ' 92' ' ' VAL . 40.3 mt-10 -124.4 114.39 19.44 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.241 0.928 . . . . 62.450000000000003 111.875 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -89.09 109.06 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.745 -0.835 . . . . 75.140000000000001 108.745 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.9 117.9 66.79 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.117 0.967 . . . . 61.109999999999999 110.329 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 88.17 0.99 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.449 2.099 . . . . 73.010000000000005 111.902 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -34.54 78.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.059 0.943 . . . . 64.409999999999997 110.414 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.8 t70 -149.42 165.53 31.81 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.995 1.318 . . . . 54.350000000000001 109.042 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.13 -43.97 97.66 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.521 0.728 . . . . 75.329999999999998 111.897 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -91.87 -19.93 21.97 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.548 0.739 . . . . 64.129999999999995 110.835 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 39.3 m80 -127.34 138.43 53.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 72.120000000000005 111.833 -170.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -126.43 174.94 8.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.57 0.748 . . . . 73.430000000000007 110.517 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -137.01 111.01 8.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.518 0.727 . . . . 64.010000000000005 109.964 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -87.97 115.37 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.252 0.549 . . . . 73.349999999999994 110.222 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -105.81 111.84 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.826 1.25 . . . . 74.430000000000007 110.553 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -103.62 113.9 27.76 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 109.24 -0.652 . . . . 74.310000000000002 109.24 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.5 m -114.21 141.32 47.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.631 1.172 . . . . 54.100000000000001 110.054 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.49 ' HB3' ' HE2' ' A' ' 89' ' ' HIS . . . -150.65 112.18 4.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.066 0.546 . . . . 61.509999999999998 112.142 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -118.56 142.53 47.52 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.456 1.102 . . . . 75.540000000000006 110.299 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.66 153.1 33.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.532 0.733 . . . . 75.349999999999994 111.761 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 31.3 t70 -80.71 86.39 5.94 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.144 0.497 . . . . 72.430000000000007 110.021 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.421 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 36.5 t -151.39 157.77 42.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.457 -0.792 . . . . 73.109999999999999 111.979 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m -61.9 146.49 91.24 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 123.835 0.854 . . . . 73.420000000000002 112.351 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -60.98 -28.96 87.09 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.051 2.501 . . . . 75.209999999999994 113.867 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.14 -35.26 77.81 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.902 0.481 . . . . 73.420000000000002 112.074 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.421 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 19.0 m -74.8 -40.63 61.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.216 0.532 . . . . 74.239999999999995 110.071 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.97 81.98 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.135 -0.939 . . . . 63.439999999999998 112.826 -174.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.9 -33.82 72.7 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.922 0.489 . . . . 75.519999999999996 111.24 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.96 -41.52 97.54 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.056 -0.52 . . . . 63.229999999999997 109.735 171.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.53 -26.79 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.359 0.664 . . . . 73.200000000000003 112.313 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 118.615 0.643 . . . . 63.420000000000002 110.428 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 m -69.23 -59.68 2.86 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 115.691 -0.686 . . . . 71.310000000000002 111.896 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.0 -56.97 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.651 0.78 . . . . 65.5 112.483 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.2 -48.44 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.647 0.379 . . . . 74.230000000000004 110.581 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.6 -48.07 81.11 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 114.509 0.564 . . . . 72.439999999999998 114.509 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -101.23 -53.61 2.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.989 -0.712 . . . . 63.020000000000003 111.646 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.28 -22.75 69.49 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 115.399 0.92 . . . . 71.049999999999997 115.399 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -111.92 -54.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 117.548 0.674 . . . . 74.25 111.196 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 10.7 m-30 -72.8 -59.92 2.48 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.292 0.637 . . . . 65.219999999999999 112.092 -173.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HB1' ' HG2' ' A' ' 6' ' ' ARG . . . -57.84 -36.31 72.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 123.39 0.431 . . . . 72.430000000000007 111.484 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.69 -50.4 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 124.221 1.008 . . . . 73.540000000000006 111.956 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.84 97.75 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.178 -0.465 . . . . 70.219999999999999 113.103 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.49 -36.09 81.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.371 1.069 . . . . 73.230000000000004 111.946 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.91 -43.9 74.26 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.694 0.397 . . . . 74.530000000000001 110.47 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.4 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.219 0.608 . . . . 72.219999999999999 111.599 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.98 -42.58 97.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.641 0.776 . . . . 73.329999999999998 110.397 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.76 -29.59 64.67 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.325 0.491 . . . . 73.519999999999996 112.325 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.2 -41.32 73.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.459 0.703 . . . . 64.239999999999995 112.453 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.472 0.545 . . . . 74.200000000000003 112.472 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -87.16 -34.41 19.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.762 0.425 . . . . 75.140000000000001 112.133 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 115.181 0.832 . . . . 74.299999999999997 115.181 179.546 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.59 0.233 . . . . 73.430000000000007 111.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.433 HG23 ' HB3' ' A' ' 110' ' ' MET . 66.8 m -113.92 111.13 21.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.059 0.943 . . . . 75.450000000000003 109.442 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.24 137.32 36.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.21 1.004 . . . . 75.329999999999998 109.366 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -142.76 131.95 23.27 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 120.815 0.341 . . . . 74.219999999999999 110.218 168.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -125.38 157.42 36.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.547 1.139 . . . . 74.150000000000006 109.54 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.3 p -150.29 151.96 33.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.33 0.652 . . . . 75.219999999999999 110.697 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.7 p -148.38 145.2 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.75 0.42 . . . . 64.340000000000003 110.998 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -92.29 109.48 20.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.956 0.502 . . . . 70.430000000000007 110.996 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.423 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 61.0 t -95.14 139.01 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.566 1.146 . . . . 73.540000000000006 111.702 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 33.38 0.13 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.0 1.111 . . . . 71.450000000000003 114.0 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.06 149.23 34.81 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 123.582 0.753 . . . . 63.25 111.301 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 100' ' ' ASP . 13.8 Cg_endo -57.12 148.67 67.93 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.484 2.789 . . . . 75.120000000000005 114.176 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.56 -43.43 56.3 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.899 1.444 . . . . 74.209999999999994 114.899 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.22 76.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.223 0.609 . . . . 62.530000000000001 112.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.68 -47.04 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.402 1.081 . . . . 75.409999999999997 111.636 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.438 HG21 ' SG ' ' A' ' 103' ' ' CYS . 92.9 t -72.97 -34.91 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.998 0.919 . . . . 73.010000000000005 111.75 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.05 -28.5 69.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.819 0.447 . . . . 74.439999999999998 111.586 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 m -68.97 -30.78 69.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.168 0.587 . . . . 74.25 111.271 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.3 tp -77.76 -48.97 15.34 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.975 0.91 . . . . 73.239999999999995 111.848 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.3 -34.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 113.385 0.883 . . . . 73.400000000000006 113.385 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.29 -24.9 74.86 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 114.32 0.488 . . . . 62.200000000000003 114.32 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.77 111.31 21.22 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.073 -1.084 . . . . 74.519999999999996 108.073 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -6.44 47.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.762 1.023 . . . . 74.239999999999995 113.762 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -95.84 -8.17 34.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.822 0.449 . . . . 74.040000000000006 110.497 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.97 -2.87 36.31 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.751 . . . . 73.319999999999993 111.236 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 34' ' ' VAL . 20.4 tt -64.16 -26.63 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 123.052 0.541 . . . . 75.340000000000003 112.104 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.08 -9.05 57.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 112.822 0.675 . . . . 73.400000000000006 112.822 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.91 -28.22 30.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.52 0.728 . . . . 71.420000000000002 111.91 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.434 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.5 p-90 -116.24 -35.1 4.44 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.739 0.644 . . . . 75.239999999999995 112.739 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -84.82 112.65 44.39 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.488 -0.291 . . . . 75.019999999999996 110.762 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.428 ' HD2' ' HA2' ' A' ' 133' ' ' GLY . 38.9 Cg_endo -64.34 -16.39 54.81 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.371 2.714 . . . . 74.329999999999998 114.832 -175.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.441 ' N ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -88.54 -37.66 15.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.041 -0.412 . . . . 74.230000000000004 110.693 174.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 27' ' ' ILE . 61.6 t -78.2 102.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 120.829 0.347 . . . . 74.519999999999996 110.742 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -86.25 -49.88 7.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.203 0.601 . . . . 74.150000000000006 111.206 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.36 105.81 0.47 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 123.698 0.799 . . . . 61.229999999999997 111.489 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 68.6 Cg_endo -85.53 160.91 10.94 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.0 2.467 . . . . 72.129999999999995 113.842 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.4 m -103.95 120.98 42.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.848 0.859 . . . . 64.010000000000005 110.638 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.09 120.23 29.24 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.282 0.633 . . . . 73.239999999999995 110.929 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -108.24 120.63 42.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.896 0.879 . . . . 74.420000000000002 109.681 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.74 173.66 0.01 OUTLIER Glycine 0 CA--C 1.558 2.754 0 N-CA-C 119.045 2.378 . . . . 75.120000000000005 119.045 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 74.61 -39.29 0.41 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.94 1.829 . . . . 73.25 115.94 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m 87.11 135.48 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.843 0 C-N-CA 126.343 1.857 . . . . 71.109999999999999 111.555 -171.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.11 -25.37 45.26 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 124.473 3.449 . . . . 72.010000000000005 116.835 -166.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -85.32 -28.2 25.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.075 0.398 . . . . 75.239999999999995 112.075 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.7 m -81.38 123.83 80.92 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 123.834 0.853 . . . . 74.239999999999995 112.084 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 109.75 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 124.151 3.234 . . . . 71.120000000000005 114.206 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.24 -21.64 3.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 112.953 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 125.57 24.75 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.321 0.86 . . . . 71.109999999999999 113.321 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 37.3 mt-10 -104.61 137.43 42.45 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.224 0.61 . . . . 72.340000000000003 109.398 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -127.26 133.29 50.2 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.585 1.084 . . . . 72.140000000000001 111.122 167.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.51 107.66 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.553 -0.749 . . . . 71.140000000000001 109.877 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -70.77 79.87 0.61 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.406 1.082 . . . . 62.43 110.632 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.74 -65.68 0.59 Allowed Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.907 -0.588 . . . . 63.420000000000002 111.93 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.39 101.97 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.052 1.341 . . . . 55.119999999999997 113.349 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.13 66.5 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-O 121.27 0.372 . . . . 42.329999999999998 113.57 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -116.41 -162.1 0.83 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.5 1.12 . . . . 74.549999999999997 111.304 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.6 -52.33 6.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.475 0.71 . . . . 73.439999999999998 111.28 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 85.77 2.44 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.245 0.618 . . . . 75.439999999999998 111.138 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -112.19 155.72 23.5 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.189 0.518 . . . . 73.299999999999997 111.12 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD13 ' SD ' ' A' ' 79' ' ' MET . 57.4 tp -120.48 122.55 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.793 -0.817 . . . . 74.329999999999998 108.793 172.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 55.3 t -95.33 117.72 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.426 -0.953 . . . . 75.530000000000001 108.426 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -114.22 162.73 16.17 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.446 0.698 . . . . 71.540000000000006 110.011 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 4.6 tmt_? -151.45 125.12 9.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.408 0.683 . . . . 73.510000000000005 110.193 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.9 tp -82.23 127.74 33.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.802 0.841 . . . . 72.340000000000003 110.575 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG23 ' NH1' ' A' ' 90' ' ' ARG . 95.1 t -95.92 -44.46 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.313 0.645 . . . . 73.319999999999993 111.188 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -160.63 148.15 15.9 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.974 0.91 . . . . 72.519999999999996 110.163 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HG3' HD13 ' A' ' 75' ' ' LEU . 20.8 ttp85 -124.3 109.65 13.62 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.421 -0.585 . . . . 73.409999999999997 109.421 173.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.56 125.59 41.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.193 0.997 . . . . 74.219999999999999 109.125 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.18 -15.76 14.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.043 -0.41 . . . . 71.540000000000006 111.887 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 m -65.94 -39.66 90.69 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.374 0.669 . . . . 61.329999999999998 111.899 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.4 4.02 18.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.259 1.023 . . . . 73.439999999999998 111.415 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 53.23 64.03 2.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.505 1.122 . . . . 71.150000000000006 111.11 -173.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -129.11 111.55 13.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.072 0.949 . . . . 74.230000000000004 111.029 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 19.8 tp -104.23 105.63 15.85 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.482 0.713 . . . . 75.439999999999998 110.961 -173.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.1 t -101.07 124.32 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 123.852 0.861 . . . . 74.540000000000006 111.711 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -153.0 -178.01 6.65 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.484 0.659 . . . . 74.129999999999995 112.597 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 t -153.11 159.85 42.83 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.737 1.215 . . . . 70.030000000000001 110.348 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.423 ' SD ' HD13 ' A' ' 61' ' ' LEU . 20.6 ptt? -109.96 103.23 53.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.08 0.552 . . . . 75.430000000000007 109.758 171.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.59 -29.39 78.08 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.443 2.762 . . . . 75.209999999999994 113.726 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.1 m-20 -123.09 83.58 51.14 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 122.995 0.518 . . . . 54.43 110.659 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -88.98 147.08 5.59 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 123.154 2.569 . . . . 75.120000000000005 113.214 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -81.85 0.12 10.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.515 2.143 . . . . 75.019999999999996 112.671 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.83 141.75 23.36 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.196 0.999 . . . . 74.310000000000002 110.535 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HG2' HG23 ' A' ' 117' ' ' THR . 63.2 Cg_endo -71.1 81.99 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.647 2.231 . . . . 74.340000000000003 113.165 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.644 HG23 ' HB2' ' A' ' 113' ' ' CYS . 27.8 pt -133.04 151.85 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.428 1.091 . . . . 74.109999999999999 110.031 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 20.8 m -91.66 -85.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.517 0.327 . . . . 75.519999999999996 111.164 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.65 111.82 24.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.938 -0.477 . . . . 61.509999999999998 110.369 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -92.57 143.75 26.03 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.585 0.754 . . . . 74.430000000000007 111.796 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.509 ' NH1' HG23 ' A' ' 66' ' ' VAL . 10.4 tpp180 -148.54 117.02 6.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.485 1.114 . . . . 75.329999999999998 108.899 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.41 148.27 48.86 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.81 0.444 . . . . 61.329999999999998 111.36 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 85.3 t -134.98 136.0 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 124.489 1.116 . . . . 71.349999999999994 110.355 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.39 111.17 18.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.146 0.978 . . . . 75.140000000000001 110.1 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.408 ' HG3' HG11 ' A' ' 92' ' ' VAL . 36.2 mt-10 -115.11 157.82 23.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.386 1.074 . . . . 74.519999999999996 111.614 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.96 111.08 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.279 0.632 . . . . 63.509999999999998 109.656 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.8 117.46 60.63 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 124.751 1.22 . . . . 74.25 110.651 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.12 133.59 25.25 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.722 2.281 . . . . 71.140000000000001 113.901 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.26 -55.72 2.28 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.407 1.083 . . . . 73.200000000000003 110.083 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.5 t70 -126.15 169.18 13.08 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.883 1.273 . . . . 70.230000000000004 109.723 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 16.2 m-20 -57.27 -41.32 79.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.594 0.758 . . . . 70.519999999999996 112.035 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -106.05 10.04 32.27 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 123.312 0.645 . . . . 75.239999999999995 111.502 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 70.0 m80 -139.79 140.19 36.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 75.420000000000002 111.657 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.438 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.0 p -136.37 178.53 6.99 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.342 0.657 . . . . 71.140000000000001 110.221 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m -135.76 113.58 11.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.039 0.536 . . . . 65.319999999999993 111.039 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.2 107.53 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 109.628 -0.508 . . . . 73.219999999999999 109.628 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.74 99.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.085 0.954 . . . . 70.120000000000005 109.772 -174.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -103.5 118.82 37.61 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.292 0.567 . . . . 72.400000000000006 110.563 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.519 HG23 ' SD ' ' A' ' 110' ' ' MET . 34.6 m -119.58 139.86 51.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.823 1.249 . . . . 71.239999999999995 110.207 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.11 113.25 6.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.31 0.644 . . . . 74.329999999999998 111.326 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.519 ' SD ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -124.0 127.76 48.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.921 0.888 . . . . 73.019999999999996 110.239 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -146.07 156.01 43.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.895 0.878 . . . . 74.010000000000005 110.904 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 35.3 t70 -83.09 82.78 8.1 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.47 0.652 . . . . 60.039999999999999 110.142 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.644 ' HB2' HG23 ' A' ' 86' ' ' ILE . 51.9 t -120.52 149.87 41.73 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.244 -0.889 . . . . 74.420000000000002 111.327 178.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 128.35 93.75 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-O 118.225 -0.893 . . . . 74.129999999999995 110.451 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -39.68 -40.57 2.36 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 124.903 3.735 . . . . 75.5 116.725 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.49 -52.07 59.76 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.313 0.578 . . . . 75.530000000000001 110.578 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.3 m -68.57 -30.55 69.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.53 -0.759 . . . . 74.510000000000005 111.376 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.27 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.509 0.724 . . . . 72.299999999999997 111.912 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -71.97 -28.47 63.45 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 122.845 0.458 . . . . 72.299999999999997 111.143 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.08 -42.34 97.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.483 0.713 . . . . 74.319999999999993 110.238 170.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -74.99 -23.26 58.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.696 0.798 . . . . 71.549999999999997 111.688 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -60.71 -37.96 83.45 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.971 0.351 . . . . 72.540000000000006 110.481 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.2 m -73.06 -48.49 35.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.215 0.606 . . . . 74.400000000000006 112.538 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.9 -54.04 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 112.767 0.654 . . . . 74.209999999999994 112.767 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.57 -52.28 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.29 0.636 . . . . 52.119999999999997 111.146 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.59 -68.39 1.63 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 114.043 0.377 . . . . 72.439999999999998 114.043 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.305 0.642 . . . . 64.219999999999999 111.075 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.89 -96.72 0.26 Allowed Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.644 -0.531 . . . . 60.140000000000001 112.834 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.38 -49.22 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.574 1.149 . . . . 71.310000000000002 113.616 -171.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.17 -61.13 1.9 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.664 -0.698 . . . . 73.420000000000002 111.644 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.86 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.252 0.464 . . . . 63.130000000000003 112.252 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.45 -50.51 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.775 0.83 . . . . 75.200000000000003 111.431 171.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 32' ' ' PRO . . . -68.96 -37.74 83.77 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.058 -0.519 . . . . 52.340000000000003 113.287 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.62 -41.96 78.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.448 1.099 . . . . 75.430000000000007 111.778 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.52 -43.16 94.92 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.594 0.358 . . . . 74.510000000000005 110.843 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.35 -31.32 72.48 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.814 0.446 . . . . 64.430000000000007 112.055 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.52 -45.8 71.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.177 0.591 . . . . 74.299999999999997 109.682 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.95 95.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.483 0.713 . . . . 73.400000000000006 112.024 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.35 -40.18 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.956 . . . . 72.200000000000003 112.941 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -61.91 -36.11 80.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.756 0.65 . . . . 74.450000000000003 112.756 -172.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.24 -28.16 59.77 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.973 0.509 . . . . 73.129999999999995 111.947 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.467 0 CA-C-N 116.491 -0.322 . . . . 72.129999999999995 113.116 179.136 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 121.343 0.592 . . . . 63.25 109.979 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.4 m -108.73 113.14 25.85 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.587 0.755 . . . . 64.510000000000005 111.141 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.31 112.82 24.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.795 1.238 . . . . 72.230000000000004 110.511 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -112.57 133.08 54.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 122.02 -0.425 . . . . 74.319999999999993 110.43 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 143.53 44.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.168 0.587 . . . . 74.209999999999994 109.78 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -143.72 158.63 43.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 75.430000000000007 110.605 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.3 p -153.23 143.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.92 0.488 . . . . 62.140000000000001 111.222 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.43 108.62 18.58 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.793 -0.447 . . . . 74.209999999999994 109.793 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.464 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 48.6 t -90.99 128.06 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.643 0.777 . . . . 45.0 110.999 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -77.74 67.77 3.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.098 0.559 . . . . 65.310000000000002 111.36 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.61 153.61 2.82 Favored Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 123.55 0.74 . . . . 62.310000000000002 111.692 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.12 126.98 19.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.163 2.576 . . . . 74.549999999999997 113.146 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.06 -42.23 8.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.043 1.497 . . . . 61.43 115.043 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.83 85.7 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.771 0.428 . . . . 71.150000000000006 112.079 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.34 -36.49 84.29 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.647 0.779 . . . . 72.540000000000006 112.028 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -36.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.365 0.666 . . . . 64.219999999999999 110.203 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -67.7 -28.93 68.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.506 -0.77 . . . . 73.340000000000003 110.841 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.6 m -62.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.142 0.496 . . . . 74.400000000000006 111.017 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 30' ' ' TRP . 61.5 tp -70.8 -46.66 62.43 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.17 0.988 . . . . 75.439999999999998 111.536 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.57 8.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.681 0.792 . . . . 72.219999999999999 112.62 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.98 -9.86 79.81 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 123.282 0.468 . . . . 61.439999999999998 113.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.521 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 2.1 m-20 -106.7 132.81 52.26 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.294 0.568 . . . . 72.319999999999993 109.603 168.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -76.03 -5.99 48.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.737 0.815 . . . . 63.310000000000002 111.32 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -93.37 -10.3 35.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.415 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -97.45 22.88 8.24 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.442 0.904 . . . . 51.509999999999998 113.442 -153.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.6 HG12 HG21 ' A' ' 34' ' ' VAL . 19.2 tt -81.25 -18.2 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 O-C-N 122.259 -0.276 . . . . 74.239999999999995 111.31 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -65.62 -22.36 66.66 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.003 0.521 . . . . 75.030000000000001 111.827 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -68.96 -44.91 71.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.399 1.08 . . . . 74.299999999999997 112.422 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.43 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 28.3 p-90 -115.95 -37.64 3.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.153 0.797 . . . . 74.439999999999998 113.153 -169.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -83.44 110.72 26.23 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 109.959 -0.386 . . . . 74.420000000000002 109.959 -172.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.91 2.03 5.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.019 2.479 . . . . 74.430000000000007 116.312 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.473 ' N ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -102.74 -19.73 14.63 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.521 0.6 . . . . 72.409999999999997 111.866 176.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.6 HG21 HG12 ' A' ' 27' ' ' ILE . 57.6 t -70.11 118.86 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 112.188 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 t -88.61 38.12 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 74.400000000000006 111.448 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.2 109.28 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.292 1.437 . . . . 64.310000000000002 112.062 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.75 160.69 12.22 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.543 2.162 . . . . 73.409999999999997 112.992 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 m -99.53 122.59 42.82 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.213 -0.662 . . . . 74.439999999999998 109.213 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.58 122.63 31.52 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.9 -1.148 . . . . 74.310000000000002 107.9 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 99.3 mtt180 -110.57 126.15 54.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.725 0.81 . . . . 71.120000000000005 111.308 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.72 -176.68 0.01 OUTLIER Glycine 0 CA--C 1.547 2.048 0 N-CA-C 118.102 2.001 . . . . 73.200000000000003 118.102 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.48 -92.9 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.082 1.353 . . . . 74.400000000000006 112.942 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 t 165.65 147.16 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 125.954 1.702 . . . . 44.310000000000002 108.704 -173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.09 -4.43 6.24 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.515 2.143 . . . . 73.549999999999997 114.034 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.04 -10.0 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.7 0.8 . . . . 70.420000000000002 112.129 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -108.37 125.69 31.31 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 123.721 0.808 . . . . 72.439999999999998 112.143 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.594 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 98.9 Cg_exo -48.41 123.65 9.49 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 123.804 3.002 . . . . 73.409999999999997 114.081 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.68 -27.77 4.08 Favored Glycine 0 N--CA 1.474 1.21 0 CA-C-N 116.137 -0.483 . . . . 43.329999999999998 112.445 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.62 49.49 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.602 0.761 . . . . 73.510000000000005 112.548 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 45.1 mt-10 -130.21 120.74 24.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.819 0.447 . . . . 72.340000000000003 111.622 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.508 ' NH2' ' HB ' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -92.67 120.73 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.613 -0.884 . . . . 75.010000000000005 108.613 175.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.65 98.52 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.679 -0.638 . . . . 63.340000000000003 110.652 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -59.69 121.57 11.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 75.329999999999998 111.91 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.68 -51.45 4.57 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.967 -0.352 . . . . 73.349999999999994 112.886 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.83 33.86 23.79 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.353 1.061 . . . . 75.140000000000001 113.041 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.68 -24.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.971 -1.013 . . . . 72.519999999999996 111.74 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.6 p -63.13 141.1 58.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.6 0.76 . . . . 72.109999999999999 111.006 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.56 -30.98 65.68 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.352 0.661 . . . . 74.019999999999996 112.183 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -110.82 66.93 0.63 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.33 0.652 . . . . 74.219999999999999 110.392 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 164.16 23.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.193 0.521 . . . . 74.450000000000003 111.798 171.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.663 HD12 ' SD ' ' A' ' 79' ' ' MET . 56.2 tp -133.92 131.24 38.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.694 0.797 . . . . 74.150000000000006 109.745 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.6 125.68 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.430000000000007 109.928 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.676 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 32.2 mt-10 -118.37 126.53 52.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.551 0.74 . . . . 73.200000000000003 109.19 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -101.96 133.48 46.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.193 0.997 . . . . 75.140000000000001 111.322 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 13.4 tp -75.64 112.1 11.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.332 1.453 . . . . 72.140000000000001 111.089 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.29 -52.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.221 0.608 . . . . 72.319999999999993 111.328 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.72 154.72 22.79 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 111.181 -172.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.706 ' HE ' HD13 ' A' ' 75' ' ' LEU . 19.4 tpp85 -140.15 123.99 17.41 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.486 0.715 . . . . 74.409999999999997 111.201 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 12.4 m-20 -122.45 76.41 1.32 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.561 0.745 . . . . 71.129999999999995 110.356 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.53 -18.5 65.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 112.959 0.726 . . . . 65.409999999999997 112.959 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -46.5 76.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.246 0.619 . . . . 54.020000000000003 110.723 169.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.67 -2.35 58.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.064 0.946 . . . . 63.420000000000002 112.967 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 59.51 51.26 6.66 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.182 0.993 . . . . 74.519999999999996 111.182 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 28.6 ttm-85 -126.9 132.63 50.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.202 1.001 . . . . 74.230000000000004 110.364 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.706 HD13 ' HE ' ' A' ' 68' ' ' ARG . 6.1 tp -130.54 108.51 9.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.985 0.914 . . . . 75.140000000000001 109.954 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -106.57 129.65 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.592 0.757 . . . . 72.409999999999997 110.005 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.97 178.55 8.83 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.501 0.667 . . . . 74.409999999999997 112.759 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -149.57 141.84 24.14 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.199 1.399 . . . . 62.140000000000001 109.724 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.676 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 61.1 mtm -94.44 104.54 14.28 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 119.055 0.843 . . . . 73.349999999999994 111.064 174.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.52 -24.48 22.22 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.638 2.225 . . . . 70.310000000000002 112.716 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -126.34 78.84 71.16 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 123.545 0.738 . . . . 70.409999999999997 110.828 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HB3' ' HE3' ' A' ' 79' ' ' MET . 50.6 Cg_endo -88.74 147.55 5.9 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 C-N-CA 122.885 2.39 . . . . 74.340000000000003 113.211 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' HD13 ' A' ' 61' ' ' LEU . 65.3 Cg_endo -84.76 1.89 8.32 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.684 2.256 . . . . 74.439999999999998 112.655 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.1 155.44 36.46 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.224 1.009 . . . . 74.510000000000005 110.321 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.78 57.11 4.93 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.011 2.474 . . . . 73.510000000000005 112.898 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 113' ' ' CYS . 22.3 pt -121.95 134.63 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.564 1.146 . . . . 72.120000000000005 109.619 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 37.5 m -75.0 -81.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.193 0.442 . . . . 73.0 112.193 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -78.11 -56.34 4.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 112.233 0.457 . . . . 74.129999999999995 112.233 -172.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.08 127.58 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.745 1.618 . . . . 74.349999999999994 113.738 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -123.93 153.54 41.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.076 1.35 . . . . 74.230000000000004 108.366 169.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.4 135.71 12.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 72.319999999999993 110.528 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.7 p -136.85 138.61 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 N-CA-C 113.242 0.83 . . . . 74.450000000000003 113.242 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.5 mm? -104.66 119.4 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.845 1.258 . . . . 71.540000000000006 109.235 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -123.86 110.1 14.44 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.673 -0.491 . . . . 74.329999999999998 109.673 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.63 110.01 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.491 -0.559 . . . . 71.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.87 111.18 63.87 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.023 0.929 . . . . 74.430000000000007 110.385 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.28 109.92 1.89 Allowed 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.791 2.327 . . . . 61.130000000000003 113.005 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.406 ' H ' ' HA ' ' A' ' 103' ' ' CYS . 39.5 mmt180 -75.74 -46.65 29.76 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.525 0.679 . . . . 74.530000000000001 109.761 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -122.79 -166.23 1.41 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.84 1.256 . . . . 74.299999999999997 109.276 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -81.68 -35.35 29.97 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.717 0.407 . . . . 72.439999999999998 110.938 167.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -108.85 13.23 25.02 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.106 0.563 . . . . 75.319999999999993 111.587 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 53.1 m80 -142.1 152.56 43.38 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.747 0.819 . . . . 70.099999999999994 109.637 172.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -153.34 177.62 10.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.024 0.529 . . . . 74.340000000000003 111.738 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 82.3 m -133.99 111.86 10.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.832 0.853 . . . . 72.420000000000002 109.986 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.89 116.87 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.469 -0.567 . . . . 73.409999999999997 109.469 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.11 105.89 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.795 0.838 . . . . 75.120000000000005 109.513 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -102.97 116.96 33.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.23 -1.026 . . . . 71.519999999999996 108.23 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 152.8 46.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.707 0.803 . . . . 73.310000000000002 109.928 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 155.32 47.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.118 1.367 . . . . 73.430000000000007 109.596 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -163.47 126.11 2.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.039 0.936 . . . . 74.140000000000001 109.688 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.45 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 p90 -141.31 156.01 45.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.332 0.653 . . . . 75.409999999999997 112.023 -165.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.651 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 38.4 t70 -84.97 86.98 7.33 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.499 0.666 . . . . 74.439999999999998 110.316 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' HG21 ' A' ' 86' ' ' ILE . 48.9 t -145.59 165.22 29.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.92 -1.036 . . . . 74.209999999999994 110.861 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.1 p -68.53 148.82 98.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 123.18 0.592 . . . . 64.140000000000001 111.687 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.93 -22.16 68.59 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.298 1.999 . . . . 72.109999999999999 112.78 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -65.83 -43.72 87.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.01 0.924 . . . . 74.319999999999993 111.312 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.506 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 23.5 m -84.33 -31.16 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.091 0.557 . . . . 75.239999999999995 111.068 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -64.62 -33.92 77.05 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.54 0.736 . . . . 70.010000000000005 112.226 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -65.73 -33.85 76.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.107 0.563 . . . . 73.510000000000005 111.402 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.61 -38.74 73.99 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.721 0.809 . . . . 75.230000000000004 109.961 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.9 -24.84 61.72 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.287 -0.869 . . . . 74.230000000000004 111.828 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 51.3 mt-10 -61.61 -39.13 90.17 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 117.956 0.343 . . . . 72.209999999999994 110.362 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -66.75 -55.67 13.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.536 0.734 . . . . 54.200000000000003 112.102 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.53 -55.03 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.463 0.705 . . . . 75.040000000000006 112.708 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.3 mt -82.53 -58.17 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.536 -0.757 . . . . 71.219999999999999 111.099 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.71 -50.03 32.96 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 114.973 0.749 . . . . 60.340000000000003 114.973 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.75 -25.24 21.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.14 0.576 . . . . 64.430000000000007 111.177 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.07 -88.51 0.67 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.13 -0.486 . . . . 64.239999999999995 112.038 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.09 -47.01 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 124.559 1.144 . . . . 74.319999999999993 113.366 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -77.84 -50.14 12.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.106 0.562 . . . . 73.010000000000005 112.159 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.19 81.63 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.243 0.339 . . . . 71.310000000000002 111.063 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -56.8 -50.3 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.225 0.61 . . . . 63.450000000000003 112.047 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.64 -48.68 82.96 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 123.508 0.505 . . . . 64.329999999999998 113.391 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 mt -69.99 -37.37 75.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.78 0.832 . . . . 73.540000000000006 112.959 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.46 -52.04 50.49 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 110.261 -0.274 . . . . 70.420000000000002 110.261 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.14 69.62 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.287 0.635 . . . . 62.310000000000002 111.8 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.0 tt -68.23 -45.99 71.77 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.484 0.714 . . . . 75.430000000000007 110.18 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -28.17 64.4 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 112.082 0.401 . . . . 64.299999999999997 112.082 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.73 -44.78 48.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.121 0.968 . . . . 73.549999999999997 111.635 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 12.8 ptm180 -63.8 -29.34 70.55 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.133 0.573 . . . . 65.349999999999994 112.152 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.3 -22.06 38.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.974 0.731 . . . . 74.219999999999999 112.974 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.578 0 N-CA-C 115.225 0.85 . . . . 50.340000000000003 115.225 -179.196 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 121.121 0.486 . . . . 71.540000000000006 110.37 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.6 m -111.49 119.33 38.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.353 1.061 . . . . 75.239999999999995 110.039 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 122' ' ' GLU . 8.2 mp -96.0 139.78 31.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.694 1.197 . . . . 71.230000000000004 108.701 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -147.46 126.35 12.74 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.021 0.438 . . . . 72.209999999999994 111.184 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -130.32 158.27 40.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.05 1.34 . . . . 74.219999999999999 110.081 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.8 p -155.1 154.86 33.03 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.246 0.618 . . . . 75.109999999999999 112.005 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.5 p -152.17 145.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.086 0.555 . . . . 73.230000000000004 111.354 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.56 108.84 19.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 120.996 0.427 . . . . 74.209999999999994 110.694 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.436 HG22 HD22 ' A' ' 137' ' ' LEU . 95.2 t -94.05 137.77 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 73.230000000000004 110.411 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -83.16 41.9 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 112.936 0.717 . . . . 64.329999999999998 112.936 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HA ' HH11 ' A' ' 101' ' ' ARG . . . -142.06 148.18 47.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.675 0.79 . . . . 75.120000000000005 110.483 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.23 142.97 93.52 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.412 2.074 . . . . 73.439999999999998 112.375 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.08 -33.54 39.8 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.177 1.391 . . . . 74.200000000000003 114.503 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.7 69.75 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.082 0.553 . . . . 73.349999999999994 112.107 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.99 -39.38 85.52 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.465 0.706 . . . . 73.329999999999998 112.139 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.572 HG23 ' SG ' ' A' ' 103' ' ' CYS . 65.2 t -70.63 -35.53 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.273 0.629 . . . . 73.420000000000002 111.009 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.449 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 62.4 t-105 -68.46 -31.52 70.87 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.155 0.582 . . . . 72.319999999999993 110.864 176.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.7 m -65.96 -33.27 75.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.354 0.662 . . . . 74.219999999999999 110.672 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.7 tp -75.86 -52.79 9.57 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.806 0.842 . . . . 75.430000000000007 112.346 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 m -79.38 -32.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 113.124 0.787 . . . . 73.319999999999993 113.124 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.77 -31.68 81.61 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 114.544 0.578 . . . . 74.450000000000003 114.544 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.73 95.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.025 0.44 . . . . 72.340000000000003 109.967 171.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -67.18 -18.06 65.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.308 0.643 . . . . 71.409999999999997 112.246 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.6 p -77.57 -27.21 51.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.079 0.552 . . . . 74.310000000000002 111.191 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.32 29.13 6.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.857 0.863 . . . . 62.039999999999999 111.139 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.57 HG22 HG13 ' A' ' 34' ' ' VAL . 9.2 tt -64.85 -27.13 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 CA-C-N 115.09 -0.959 . . . . 62.299999999999997 111.555 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -59.95 -12.36 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.212 1.19 . . . . 73.329999999999998 114.212 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -71.24 -24.62 62.22 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.13 0.572 . . . . 74.439999999999998 112.502 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HB3' HD21 ' A' ' 20' ' ' LEU . 59.1 p-90 -122.51 -31.55 3.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.296 0.638 . . . . 75.150000000000006 111.404 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 22.1 t-80 -95.35 104.16 14.63 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.182 0.593 . . . . 72.340000000000003 110.206 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.3 -16.32 54.42 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.212 2.608 . . . . 75.209999999999994 114.617 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.0 mt-30 -95.25 -11.06 28.61 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.3 0.852 . . . . 61.43 113.3 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.57 HG13 HG22 ' A' ' 27' ' ' ILE . 56.1 t -75.04 116.48 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 118.346 0.521 . . . . 73.310000000000002 110.321 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -87.03 29.79 0.8 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.822 0.849 . . . . 75.310000000000002 112.137 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 68.08 121.7 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 125.706 1.602 . . . . 72.310000000000002 111.888 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.621 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 41.9 Cg_endo -96.26 155.26 1.34 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.024 2.483 . . . . 61.409999999999997 115.924 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -101.11 123.56 45.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.976 0.91 . . . . 74.420000000000002 109.938 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.21 123.36 28.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.256 0.55 . . . . 71.230000000000004 112.33 -172.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 10.3 mmm180 -103.07 121.81 43.36 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.722 1.209 . . . . 64.400000000000006 110.214 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.18 -178.53 0.01 OUTLIER Glycine 0 CA--C 1.549 2.18 0 N-CA-C 117.766 1.866 . . . . 64.239999999999995 117.766 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.672 ' HB1' ' HB3' ' A' ' 49' ' ' ALA . . . 40.27 -98.02 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 126.059 1.743 . . . . 73.409999999999997 115.111 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 30.0 t -176.81 149.36 0.85 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 124.461 1.104 . . . . 71.219999999999999 110.491 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.33 -11.97 21.71 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.871 2.381 . . . . 73.099999999999994 113.587 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -114.72 1.94 14.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.902 0.881 . . . . 74.5 112.498 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.8 m -97.53 117.52 65.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.361 -0.837 . . . . 75.439999999999998 110.204 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 22.0 Cg_endo -58.48 92.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.065 2.51 . . . . 72.439999999999998 112.752 176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.15 -42.5 0.27 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.279 -0.873 . . . . 54.130000000000003 112.115 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . . . -67.58 164.74 18.39 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.908 1.077 . . . . 62.340000000000003 113.908 -172.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 33.9 mt-10 -121.62 164.47 17.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.251 1.02 . . . . 63.420000000000002 110.097 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -146.68 146.29 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.004 0.43 . . . . 75.040000000000006 111.837 168.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 t -117.69 108.11 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.546 0.738 . . . . 72.329999999999998 111.158 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -66.27 110.31 2.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.442 1.097 . . . . 74.329999999999998 110.633 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.96 -63.33 1.5 Allowed Glycine 0 CA--C 1.539 1.563 0 N-CA-C 112.064 -0.414 . . . . 72.219999999999999 112.064 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.88 115.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.743 1.386 . . . . 75.120000000000005 114.743 171.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.02 17.97 66.14 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 121.237 0.354 . . . . 64.209999999999994 112.698 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 p -94.6 -171.25 2.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.288 . . . . 60.310000000000002 109.923 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.34 -26.63 19.86 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 120.811 0.338 . . . . 75.129999999999995 110.63 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.33 93.01 2.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.385 0.674 . . . . 62.109999999999999 110.116 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.33 -175.72 2.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.417 0.687 . . . . 74.310000000000002 111.512 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.575 HD11 ' HD3' ' A' ' 83' ' ' PRO . 34.9 tp -135.11 117.76 16.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.719 0.808 . . . . 74.25 110.347 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.98 121.81 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 109.173 -0.677 . . . . 75.129999999999995 109.173 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.61 167.19 14.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.424 0.69 . . . . 74.049999999999997 109.924 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 66' ' ' VAL . 3.1 tmt_? -140.7 109.07 5.83 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.088 0.955 . . . . 73.209999999999994 109.843 -165.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 29.8 tp -59.46 105.91 0.4 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.159 0.984 . . . . 71.409999999999997 110.96 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.491 ' HA ' HH11 ' A' ' 64' ' ' ARG . 89.3 t -78.27 -51.03 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.37 0.668 . . . . 73.019999999999996 111.307 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.25 151.45 34.25 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.153 0.581 . . . . 72.540000000000006 111.287 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -143.13 130.07 20.57 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.965 0.906 . . . . 74.340000000000003 110.479 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 14.7 m-20 -135.94 118.3 15.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.361 1.064 . . . . 74.540000000000006 110.466 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.449 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 3.9 mp0 -80.77 -36.54 31.72 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.84 0.456 . . . . 74.019999999999996 110.267 169.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 m -63.71 -37.61 87.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.893 0.877 . . . . 74.329999999999998 112.394 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.5 -12.36 24.25 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.234 0.614 . . . . 63.32 111.733 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 59.46 45.88 13.03 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 71.010000000000005 110.006 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 39.0 ttm180 -122.21 123.16 40.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.583 1.553 . . . . 75.150000000000006 111.022 -169.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 23.7 tp -123.22 106.64 10.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.501 0.72 . . . . 73.340000000000003 110.415 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.1 t -108.21 129.89 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.877 0.871 . . . . 70.430000000000007 111.583 -169.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -139.22 172.86 12.22 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 75.239999999999995 112.252 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -149.93 139.09 21.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.312 1.445 . . . . 73.310000000000002 109.257 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.405 ' SD ' HD13 ' A' ' 61' ' ' LEU . 69.6 mtm -94.66 105.59 19.43 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 118.51 0.595 . . . . 74.230000000000004 110.556 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.74 -18.28 22.26 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.006 2.47 . . . . 64.230000000000004 112.179 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.6 78.24 68.73 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.869 0.868 . . . . 64.129999999999995 109.032 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.84 140.39 16.23 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.684 2.256 . . . . 74.439999999999998 112.802 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.575 ' HD3' HD11 ' A' ' 61' ' ' LEU . 63.4 Cg_endo -85.24 8.41 4.62 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.944 2.43 . . . . 73.219999999999999 112.557 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.98 141.38 40.47 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 124.496 1.118 . . . . 75.510000000000005 109.383 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.67 88.23 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.578 2.186 . . . . 73.200000000000003 113.325 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 113' ' ' CYS . 14.8 pt -137.32 168.37 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 125.159 1.383 . . . . 73.420000000000002 109.43 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 28.8 m -93.57 -84.02 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.118 0.414 . . . . 75.430000000000007 112.118 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -86.26 -45.13 11.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.642 0.608 . . . . 65.420000000000002 112.642 -170.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 47.9 t-80 64.66 141.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.736 1.614 . . . . 74.140000000000001 113.529 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -150.77 152.73 34.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.403 1.081 . . . . 75.209999999999994 108.424 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -160.39 151.09 18.6 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.877 0.471 . . . . 75.230000000000004 111.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.78 150.86 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 113.024 0.75 . . . . 74.219999999999999 113.024 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -120.63 108.54 14.15 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.639 1.576 . . . . 74.030000000000001 107.58 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -126.76 115.1 18.86 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.948 0.499 . . . . 74.129999999999995 111.45 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -95.34 126.57 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 122.779 0.432 . . . . 75.510000000000005 110.292 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.58 117.72 44.36 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.397 1.079 . . . . 63.439999999999998 110.684 -173.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.64 108.23 2.41 Favored 'Trans proline' 0 CA--C 1.568 2.215 0 C-N-CA 122.826 2.351 . . . . 75.540000000000006 114.416 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -81.2 -34.73 32.07 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 123.864 0.866 . . . . 74.310000000000002 111.767 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 25.6 t70 -156.73 163.2 39.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.311 1.044 . . . . 74.519999999999996 109.986 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.04 -23.29 61.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.537 1.135 . . . . 72.329999999999998 113.119 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.583 HH11 ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -128.33 5.19 5.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.678 0.791 . . . . 73.530000000000001 111.07 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 51.2 m80 -138.51 130.47 28.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.812 . . . . 74.150000000000006 110.811 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' A' ' 17' ' ' VAL . 17.3 p -136.33 178.81 6.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.654 0.782 . . . . 65.040000000000006 110.226 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.9 m -133.9 118.08 17.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.074 0.55 . . . . 73.349999999999994 111.354 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.55 110.92 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.77 -0.456 . . . . 74.439999999999998 109.77 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.67 111.86 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.972 0.909 . . . . 72.540000000000006 109.633 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -111.32 124.67 52.72 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.912 0.485 . . . . 75.230000000000004 109.915 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -127.91 146.28 50.68 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.48 1.112 . . . . 70.209999999999994 110.84 -170.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.91 113.8 6.48 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.477 0.711 . . . . 73.430000000000007 111.87 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -116.9 125.69 51.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.56 1.144 . . . . 75.200000000000003 109.875 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.445 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 3.2 p90 -146.79 146.48 30.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.116 0.566 . . . . 71.209999999999994 112.521 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.45 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -76.93 86.44 3.47 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.477 0.656 . . . . 73.150000000000006 109.617 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.546 ' HB2' HG23 ' A' ' 86' ' ' ILE . 46.5 t -117.86 164.21 15.39 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.907 -1.042 . . . . 73.030000000000001 111.828 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -83.95 152.36 62.26 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.546 0.738 . . . . 65.030000000000001 110.981 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.41 -62.21 0.48 Allowed 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.956 3.104 . . . . 72.150000000000006 115.616 -170.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -31.71 72.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.7 0.8 . . . . 64.310000000000002 112.639 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.428 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 25.1 m -75.11 -34.31 61.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.315 0.246 . . . . 60.020000000000003 111.021 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.21 61.74 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.153 0.581 . . . . 63.149999999999999 111.351 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -22.93 66.61 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.259 0.466 . . . . 75.120000000000005 112.259 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.34 -41.3 56.98 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.12 0.568 . . . . 74.299999999999997 111.298 170.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 mt -75.38 -24.88 57.28 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.109 1.151 . . . . 74.049999999999997 114.109 -173.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.405 ' HA ' HD21 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -61.69 -36.39 80.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.558 0.947 . . . . 72.219999999999999 113.558 -175.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.9 m -79.31 -44.11 22.29 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.918 0.71 . . . . 62.119999999999997 112.918 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.92 -51.22 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.28 0.562 . . . . 75.319999999999993 111.87 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.6 mt -81.48 -49.0 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.705 0.802 . . . . 70.540000000000006 110.888 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.52 -42.68 95.57 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 114.849 0.699 . . . . 54.509999999999998 114.849 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -94.44 -58.95 2.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 122.093 -0.651 . . . . 74.219999999999999 110.932 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.95 -18.12 68.37 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.729 1.052 . . . . 45.340000000000003 115.729 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.31 -52.27 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 117.644 0.722 . . . . 70.329999999999998 110.977 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -74.85 -60.8 2.12 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.53 0.732 . . . . 74.230000000000004 112.123 -172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.77 65.42 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.475 0.485 . . . . 72.420000000000002 111.525 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.9 t -52.95 -56.54 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 C-N-CA 124.04 0.936 . . . . 74.030000000000001 112.442 171.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.3 -36.68 85.15 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 116.568 -0.287 . . . . 63.009999999999998 112.97 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.52 -47.45 81.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.167 0.987 . . . . 74.150000000000006 112.039 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.28 -47.71 83.13 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.28 0.632 . . . . 74.319999999999993 110.874 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.59 74.15 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.234 0.457 . . . . 73.340000000000003 112.234 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.436 HD22 HG22 ' A' ' 10' ' ' VAL . 3.8 tt -67.81 -43.17 80.28 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.01 0.524 . . . . 75.439999999999998 110.103 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.74 81.92 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.89 0.476 . . . . 74.129999999999995 111.837 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.42 -31.26 60.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.128 0.971 . . . . 71.400000000000006 112.905 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -67.15 -29.95 69.79 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.873 0.306 . . . . 74.120000000000005 111.337 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -93.42 -5.01 50.31 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.883 0.473 . . . . 72.209999999999994 112.196 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.21 0 N-CA-C 115.02 0.768 . . . . 70.129999999999995 115.02 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.771 0.319 . . . . 74.409999999999997 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -105.99 114.5 28.68 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.806 0.842 . . . . 74.329999999999998 110.182 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.36 114.68 26.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.886 1.274 . . . . 75.200000000000003 109.833 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -122.47 138.22 54.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.889 0.476 . . . . 72.209999999999994 111.968 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -138.96 155.08 48.3 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.934 1.294 . . . . 74.230000000000004 109.55 171.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.9 p -149.82 156.99 42.76 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.357 0.663 . . . . 73.200000000000003 110.357 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.1 p -145.53 146.09 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 112.084 0.402 . . . . 74.040000000000006 112.084 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.43 111.84 23.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.858 0.863 . . . . 64.120000000000005 109.71 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 60.7 t -104.29 130.76 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 73.019999999999996 110.82 -175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.93 71.54 6.63 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.113 0.482 . . . . 72.329999999999998 111.113 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.46 154.12 3.74 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.124 0.97 . . . . 73.420000000000002 111.197 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.54 136.17 49.05 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.865 2.376 . . . . 73.219999999999999 111.985 168.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.23 17.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.562 1.319 . . . . 71.109999999999999 114.562 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.9 -47.69 82.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.19 0.596 . . . . 72.239999999999995 112.57 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.47 -43.02 79.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.202 0.601 . . . . 72.439999999999998 111.784 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' SG ' ' A' ' 103' ' ' CYS . 42.5 t -69.18 -33.79 60.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 115.418 -0.81 . . . . 72.319999999999993 111.208 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.433 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 71.9 t-105 -69.54 -31.7 70.06 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 111.751 0.278 . . . . 71.409999999999997 111.751 175.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.7 m -64.31 -26.86 68.67 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.659 0.743 . . . . 74.5 110.818 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.438 HD21 HH11 ' A' ' 140' ' ' ARG . 49.2 tp -76.48 -56.33 4.72 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.795 1.238 . . . . 74.510000000000005 111.924 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.44 -9.62 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.547 0.943 . . . . 71.239999999999995 113.547 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -68.86 -27.9 73.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 113.768 0.267 . . . . 50.509999999999998 113.768 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.86 108.57 14.64 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.416 0.686 . . . . 73.319999999999993 110.258 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -59.01 -24.81 63.12 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.76 0.824 . . . . 72.400000000000006 111.421 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -34.29 26.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.273 1.029 . . . . 75.219999999999999 113.086 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.56 23.72 10.77 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.529 0.681 . . . . 74.420000000000002 111.449 -163.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.606 HG23 HG13 ' A' ' 34' ' ' VAL . 14.9 tt -57.31 -24.79 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.648 1.179 . . . . 65.319999999999993 112.463 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -65.56 -5.63 8.65 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.156 1.169 . . . . 75.200000000000003 114.156 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -78.72 -27.22 44.88 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.628 0.771 . . . . 75.010000000000005 112.416 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -122.31 -29.74 4.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.372 0.669 . . . . 74.349999999999994 111.376 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -95.17 111.68 55.78 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.318 0.647 . . . . 61.439999999999998 109.976 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.43 -22.01 52.75 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.225 2.617 . . . . 75.129999999999995 114.508 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.491 HE22 ' HA ' ' A' ' 129' ' ' VAL . 37.2 mt-30 -86.74 -25.11 24.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.146 0.579 . . . . 74.099999999999994 112.209 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.606 HG13 HG23 ' A' ' 27' ' ' ILE . 98.2 t -67.72 120.21 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 121.101 0.477 . . . . 64.310000000000002 111.142 177.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -88.51 23.59 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.335 1.054 . . . . 75.349999999999994 113.075 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.47 95.26 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 124.476 1.11 . . . . 72.430000000000007 110.418 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.71 178.79 4.16 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.319 2.68 . . . . 74.430000000000007 115.097 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.9 m -101.88 124.29 47.25 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.351 1.061 . . . . 73.129999999999995 110.079 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.85 135.68 48.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.496 0.718 . . . . 71.540000000000006 110.314 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.39 156.97 47.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.497 0.719 . . . . 74.439999999999998 110.636 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.81 157.96 0.01 OUTLIER Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.79 1.876 . . . . 60.5 117.79 -170.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.44 -98.9 0.09 Allowed 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.74 1.216 . . . . 71.209999999999994 113.359 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.9 t 171.3 149.42 0.18 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 125.459 1.504 . . . . 71.5 109.285 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.55 -19.74 18.91 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 123.059 2.506 . . . . 63.329999999999998 114.148 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -99.14 -30.26 12.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.515 0.726 . . . . 75.209999999999994 111.48 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.3 m -88.63 120.63 70.27 Favored Pre-proline 0 N--CA 1.49 1.554 0 C-N-CA 123.12 0.568 . . . . 71.329999999999998 111.071 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.495 ' HG3' ' H ' ' A' ' 68' ' ' ARG . 99.5 Cg_exo -45.77 130.18 12.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.957 3.105 . . . . 73.120000000000005 114.814 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.54 -24.21 6.2 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.412 -0.358 . . . . 62.329999999999998 113.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.49 49.86 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.49 0.716 . . . . 73.430000000000007 112.821 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.29 136.04 43.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.43 0.692 . . . . 74.420000000000002 110.716 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -115.36 108.6 16.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.204 1.002 . . . . 70.430000000000007 111.53 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 18.7 t -113.38 108.05 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.09 0.556 . . . . 73.140000000000001 110.326 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -68.35 -59.07 3.46 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.192 0.997 . . . . 73.400000000000006 113.65 -169.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.28 -12.35 84.67 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.82 -0.434 . . . . 64.049999999999997 113.477 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 66.62 -73.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.526 1.53 . . . . 63.439999999999998 113.281 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.0 44.66 0.7 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 113.492 0.157 . . . . 65.109999999999999 113.492 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.3 p -93.83 -118.33 0.09 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.905 0.882 . . . . 72.140000000000001 109.855 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -139.81 9.78 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 119.169 0.895 . . . . 71.510000000000005 110.849 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -146.57 20.63 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.322 0.649 . . . . 62.5 112.48 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.59 144.64 35.33 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.774 0.797 . . . . 75.010000000000005 112.493 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.646 HD12 ' HD3' ' A' ' 83' ' ' PRO . 16.8 tp -103.25 125.48 49.93 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.484 1.114 . . . . 73.400000000000006 109.278 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 54.0 t -96.95 114.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.078 -0.712 . . . . 65.140000000000001 109.078 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 27.8 tt0 -118.95 166.95 12.22 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.239 1.016 . . . . 74.25 109.584 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -152.2 136.72 16.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.418 0.525 . . . . 72.319999999999993 112.418 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.7 tp -77.76 116.96 18.69 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.99 1.316 . . . . 71.530000000000001 110.81 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 95.5 t -79.16 -53.01 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.02 0.528 . . . . 72.209999999999994 110.52 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -152.89 144.53 23.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.191 0.996 . . . . 72.549999999999997 109.748 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' A' ' 47' ' ' PRO . 4.2 tmt_? -131.84 112.09 12.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 72.519999999999996 107.441 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -114.08 115.13 27.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.001 0.52 . . . . 70.299999999999997 110.939 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.433 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 29.1 tt0 -83.86 -20.82 32.46 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.787 0.835 . . . . 72.019999999999996 111.668 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -68.93 -48.97 61.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.424 0.69 . . . . 75.209999999999994 111.936 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.09 2.82 51.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.107 0.563 . . . . 73.519999999999996 112.393 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 54.9 52.07 12.57 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.216 1.006 . . . . 72.129999999999995 111.943 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.36 119.65 26.72 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.453 1.101 . . . . 75.349999999999994 111.123 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 44.4 tp -109.57 106.77 16.61 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.447 1.099 . . . . 74.519999999999996 110.426 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.83 128.86 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.79 0.836 . . . . 74.430000000000007 111.248 -175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 51.7 p90 -150.83 179.11 8.5 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.827 0.677 . . . . 75.439999999999998 112.827 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 t -152.85 158.03 41.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.183 1.393 . . . . 75.230000000000004 109.5 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 16.7 ptt? -111.84 100.46 48.67 Favored Pre-proline 0 N--CA 1.485 1.319 0 CA-C-N 118.362 0.528 . . . . 63.420000000000002 110.226 169.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.33 -22.79 59.71 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.409 2.74 . . . . 73.319999999999993 113.644 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 25.8 t70 -128.75 81.35 70.94 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.396 0.678 . . . . 75.25 109.726 176.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.02 154.54 12.98 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.096 2.531 . . . . 73.25 113.885 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.646 ' HD3' HD12 ' A' ' 61' ' ' LEU . 71.4 Cg_endo -83.25 -4.5 11.06 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.662 2.241 . . . . 75.129999999999995 112.532 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.91 154.13 38.37 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.156 0.982 . . . . 74.530000000000001 110.757 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.02 61.49 8.18 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.717 2.278 . . . . 55.43 112.85 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.448 HG23 ' HB2' ' A' ' 113' ' ' CYS . 30.4 pt -121.06 167.91 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.289 1.036 . . . . 74.120000000000005 110.321 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 84.3 m -103.46 -85.19 0.46 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.793 0.437 . . . . 71.439999999999998 110.854 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.73 111.6 23.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.12 0.486 . . . . 74.439999999999998 111.115 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 26.5 t-80 -84.84 150.88 24.7 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.639 0.776 . . . . 74.340000000000003 111.768 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -154.78 110.28 3.12 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.662 0.785 . . . . 74.540000000000006 109.887 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.03 146.27 52.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.567 0.58 . . . . 50.240000000000002 112.567 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 40.6 t -134.73 143.98 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.142 0.977 . . . . 64.420000000000002 111.553 -173.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -112.65 109.48 19.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.973 1.309 . . . . 73.400000000000006 109.238 173.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HG3' HG13 ' A' ' 92' ' ' VAL . 42.3 mt-10 -117.7 112.48 20.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.445 0.566 . . . . 74.120000000000005 111.808 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 t -97.37 111.37 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.078 0.551 . . . . 65.409999999999997 110.007 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.84 131.26 22.21 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.987 0.915 . . . . 54.439999999999998 111.192 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.69 81.63 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.04 2.493 . . . . 74.109999999999999 111.965 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -35.46 81.1 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.092 0.957 . . . . 75.030000000000001 110.873 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 23.4 t70 -140.47 174.72 10.24 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 125.342 1.457 . . . . 74.340000000000003 108.946 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.47 -68.61 0.28 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.489 0.715 . . . . 73.030000000000001 111.084 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -81.8 -15.25 54.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.893 0.477 . . . . 72.310000000000002 111.775 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.3 m80 -120.1 146.97 45.43 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.864 -0.522 . . . . 73.140000000000001 111.385 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 17' ' ' VAL . 28.9 p -132.14 176.02 8.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.358 0.663 . . . . 75.299999999999997 109.836 177.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.7 m -130.41 125.09 33.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.175 0.59 . . . . 73.239999999999995 110.122 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.28 105.96 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.69 -0.856 . . . . 70.209999999999994 108.69 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.91 112.61 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.019 -0.734 . . . . 75.439999999999998 109.019 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -102.23 112.52 25.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.761 -0.829 . . . . 75.510000000000005 108.761 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 m -113.46 144.14 43.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.203 1.001 . . . . 73.450000000000003 109.433 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.18 149.45 36.46 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.871 0.868 . . . . 72.549999999999997 109.229 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.37 130.4 8.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.257 1.023 . . . . 74.540000000000006 108.585 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 7.8 p90 -148.58 152.03 36.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.12 0.568 . . . . 72.219999999999999 111.177 -171.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 13.5 t70 -76.59 85.84 3.27 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.817 -0.629 . . . . 73.430000000000007 109.396 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.448 ' HB2' HG23 ' A' ' 86' ' ' ILE . 48.4 t -120.27 147.63 44.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.009 -0.996 . . . . 75.120000000000005 111.026 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -60.19 132.03 90.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-O 118.404 -0.807 . . . . 74.319999999999993 110.694 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.56 -46.01 12.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.848 3.032 . . . . 75.109999999999999 114.458 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -62.98 -30.85 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.354 1.061 . . . . 64.349999999999994 112.426 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -90.7 -31.8 16.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.659 0.784 . . . . 72.400000000000006 112.257 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.0 -31.52 71.27 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.737 0.815 . . . . 64.25 112.265 -171.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.93 -34.61 78.37 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.214 1.006 . . . . 74.150000000000006 112.167 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.47 -44.41 51.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.228 0.611 . . . . 72.239999999999995 110.539 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.5 -23.81 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.429 0.692 . . . . 73.010000000000005 110.843 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.26 -52.75 64.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.886 0.874 . . . . 74.420000000000002 110.732 170.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.6 m -68.38 -42.69 78.76 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 112.885 0.698 . . . . 72.549999999999997 112.885 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.2 -55.05 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.25 0.547 . . . . 73.409999999999997 112.019 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -56.99 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.618 0.767 . . . . 74.230000000000004 111.323 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.22 -33.22 86.65 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 114.442 0.537 . . . . 52.140000000000001 114.442 -175.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -101.72 -61.49 1.38 Allowed 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.043 -0.681 . . . . 65.340000000000003 111.388 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.42 68.31 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.566 0.986 . . . . 75.109999999999999 115.566 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.491 ' HA ' HE22 ' A' ' 33' ' ' GLN . 87.8 t -106.78 -54.9 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 117.419 0.609 . . . . 74.239999999999995 111.136 175.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.4 m-30 -73.46 -59.13 2.85 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.067 0.547 . . . . 64.5 112.336 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.76 67.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 123.439 0.462 . . . . 63.149999999999999 111.79 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.2 t -62.45 -55.61 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.649 0.78 . . . . 73.329999999999998 112.085 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.84 98.38 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 116.182 -0.463 . . . . 62.520000000000003 113.909 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.73 -34.66 72.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.442 0.697 . . . . 75.439999999999998 112.27 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.502 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.8 m-20 -67.66 -42.16 82.6 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 110.455 -0.202 . . . . 70.409999999999997 110.455 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.53 77.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.255 0.622 . . . . 71.319999999999993 111.539 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.19 -37.46 87.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.696 0.798 . . . . 70.439999999999998 110.104 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.36 70.6 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.616 0.366 . . . . 72.409999999999997 111.674 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 38.2 mt-10 -68.53 -39.24 81.24 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.183 0.593 . . . . 75.450000000000003 112.178 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.438 HH11 HD21 ' A' ' 20' ' ' LEU . 5.4 ptm180 -66.51 -27.81 68.07 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.317 0.488 . . . . 73.200000000000003 112.317 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -98.57 -2.94 37.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.365 0.666 . . . . 71.219999999999999 111.228 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 C-N-CA 123.58 0.609 . . . . 52.020000000000003 113.745 177.444 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.139 0.495 . . . . 74.5 112.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.7 m -126.54 128.95 47.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.319 0.648 . . . . 73.209999999999994 110.738 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 7.5 mp -105.21 141.63 36.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.174 1.39 . . . . 71.299999999999997 108.426 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -150.06 130.8 14.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.321 0.582 . . . . 74.299999999999997 111.648 172.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -139.6 152.77 47.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.606 1.162 . . . . 74.439999999999998 108.542 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -150.18 161.59 42.1 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.764 0.426 . . . . 65.349999999999994 111.378 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 135' ' ' ASN . 9.9 p -148.32 145.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.545 0.572 . . . . 74.319999999999993 112.545 -177.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -91.24 119.43 31.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.849 0.86 . . . . 74.019999999999996 110.766 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.2 131.68 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 124.631 1.173 . . . . 73.519999999999996 110.959 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.28 68.79 10.31 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.134 0.492 . . . . 64.439999999999998 111.463 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.58 142.74 2.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.206 1.002 . . . . 72.319999999999993 109.546 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.96 138.44 82.25 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.893 2.396 . . . . 72.200000000000003 112.898 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.6 15.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.2 1.4 . . . . 71.340000000000003 114.778 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.38 64.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.435 0.694 . . . . 71.420000000000002 112.115 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.07 -37.49 82.86 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.721 0.808 . . . . 73.200000000000003 112.555 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.489 HG22 ' SG ' ' A' ' 103' ' ' CYS . 40.5 t -70.12 -37.42 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.238 0.615 . . . . 75.25 110.757 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -63.53 -31.06 72.11 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.36 -0.836 . . . . 73.310000000000002 111.523 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -59.09 -31.88 69.29 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.288 0.566 . . . . 73.530000000000001 111.572 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 30' ' ' TRP . 35.4 tp -75.76 -43.01 48.76 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.863 0.865 . . . . 75.200000000000003 111.797 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' O ' HD23 ' A' ' 75' ' ' LEU . 19.0 m -95.27 -3.35 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.264 0.839 . . . . 73.349999999999994 113.264 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.41 -28.02 60.52 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 123.152 0.406 . . . . 74.400000000000006 112.881 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.15 105.38 17.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.326 0.65 . . . . 64.129999999999995 110.078 169.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 35.9 t80 -61.61 -29.04 69.79 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.608 0.763 . . . . 71.030000000000001 111.348 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 33.9 t -77.74 -21.67 51.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.986 0.914 . . . . 75.209999999999994 112.783 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.16 25.84 10.5 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.891 0.477 . . . . 75.109999999999999 112.032 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.08 -27.31 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 123.743 0.817 . . . . 72.129999999999995 112.282 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.784 ' HA ' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -64.86 -6.74 8.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 114.134 1.161 . . . . 71.319999999999993 114.134 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -89.05 -17.58 29.05 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.734 0.642 . . . . 74.310000000000002 112.734 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.485 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.6 p-90 -129.3 -32.53 1.99 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.36 0.874 . . . . 73.450000000000003 113.36 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.401 ' HE1' ' HB2' ' A' ' 33' ' ' GLN . 17.5 t-80 -78.01 130.63 72.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.51 0.324 . . . . 74.209999999999994 110.294 -174.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.59 -29.07 3.1 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.721 2.281 . . . . 53.530000000000001 114.266 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -93.82 -6.86 44.9 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.222 0.823 . . . . 72.409999999999997 113.222 -175.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.784 HG13 ' HA ' ' A' ' 28' ' ' HIS . 7.1 p -56.87 128.39 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.518 0 CA-C-O 121.44 0.638 . . . . 74.010000000000005 112.19 176.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.7 m -91.62 23.18 3.64 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.078 0.951 . . . . 73.540000000000006 112.157 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.58 101.91 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 124.699 1.2 . . . . 74.510000000000005 111.26 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 37.3 Cg_endo -88.25 161.33 6.99 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.542 2.161 . . . . 74.329999999999998 114.386 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.9 m -105.94 123.55 48.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.883 0.873 . . . . 74.150000000000006 109.164 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 49' ' ' ALA . 1.6 tm? -88.38 113.59 24.14 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.437 -0.579 . . . . 72.439999999999998 109.437 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -99.59 153.13 19.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.949 1.3 . . . . 73.5 110.901 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.19 -126.56 23.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.948 0.78 . . . . 55.200000000000003 115.026 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.06 140.58 4.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.256 1.022 . . . . 73.25 113.246 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 m -56.58 158.13 8.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 124.534 1.133 . . . . 73.519999999999996 112.917 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.92 162.13 39.27 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.046 1.831 . . . . 74.109999999999999 111.283 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 72.75 -42.15 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.877 1.271 . . . . 75.030000000000001 112.118 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 m -68.87 123.0 87.06 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 124.395 1.078 . . . . 74.310000000000002 111.011 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.49 93.98 0.17 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.127 2.552 . . . . 71.030000000000001 113.251 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 -25.61 0.14 Allowed Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.083 -0.508 . . . . 64.219999999999999 113.156 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . -55.04 132.78 47.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.32 1.048 . . . . 62.299999999999997 113.385 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -117.6 116.57 27.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 74.420000000000002 111.355 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 38.1 ptt85 -94.03 119.07 32.4 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.135 0.493 . . . . 74.530000000000001 110.107 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 23.6 t -114.21 112.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.421 0.688 . . . . 74.420000000000002 110.511 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -68.7 117.45 10.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.264 1.026 . . . . 64.340000000000003 110.29 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.62 -65.53 3.77 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.734 -0.546 . . . . 61.509999999999998 111.734 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 62.48 10.34 3.95 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.746 1.219 . . . . 75.040000000000006 114.289 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.13 32.37 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.905 -0.878 . . . . 72.430000000000007 110.905 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -122.51 175.08 6.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 71.319999999999993 109.842 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.77 -4.02 48.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.827 0.451 . . . . 73.439999999999998 111.807 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -135.3 84.76 2.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.785 . . . . 73.120000000000005 109.025 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 176.94 4.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.318 1.047 . . . . 74.409999999999997 111.417 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.551 HD13 ' HD3' ' A' ' 83' ' ' PRO . 23.2 tp -143.26 113.94 7.55 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.279 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 45.1 t -97.46 116.72 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.336 0.654 . . . . 74.519999999999996 109.725 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.644 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 46.3 mt-10 -120.96 123.39 42.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 64.319999999999993 109.76 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 43.1 ttt180 -103.29 135.73 44.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.299 1.04 . . . . 73.239999999999995 111.764 -175.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -80.71 122.08 26.68 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.692 0.797 . . . . 74.230000000000004 110.773 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -95.88 -45.4 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.28 0.632 . . . . 72.420000000000002 111.263 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 26.4 tt0 -145.32 145.11 31.09 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.836 1.254 . . . . 73.109999999999999 110.382 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.18 116.03 14.03 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.801 -1.185 . . . . 74.340000000000003 107.801 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -117.5 104.53 11.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.756 0.822 . . . . 71.230000000000004 109.099 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -26.26 46.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.274 0.629 . . . . 74.450000000000003 112.688 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t -72.43 -42.75 64.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.779 0.832 . . . . 74.319999999999993 110.936 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.62 2.96 36.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.768 0.655 . . . . 54.439999999999998 112.768 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 57.03 43.02 25.14 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.424 1.09 . . . . 75.400000000000006 112.016 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -115.39 105.06 12.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.814 0.846 . . . . 72.439999999999998 110.648 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 59.2 tp -100.83 105.78 17.1 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.188 0.595 . . . . 74.409999999999997 109.69 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 57.7 t -106.74 133.82 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 118.688 0.676 . . . . 72.409999999999997 110.168 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 33.4 p90 -152.31 -178.66 6.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.042 0.537 . . . . 74.239999999999995 110.862 -178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.4 t -141.71 162.92 34.3 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.402 1.081 . . . . 74.439999999999998 110.177 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.644 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 79.0 mtp -110.1 85.75 4.52 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 108.811 -0.811 . . . . 75.239999999999995 108.811 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.78 -21.17 45.06 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.154 2.569 . . . . 72.409999999999997 113.564 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 24.4 t70 -139.25 84.21 16.82 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.762 0.425 . . . . 73.319999999999993 110.226 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.462 ' HB3' ' HE3' ' A' ' 79' ' ' MET . 44.2 Cg_endo -94.96 153.36 1.75 Allowed 'Trans proline' 0 CA--C 1.565 2.067 0 C-N-CA 123.234 2.622 . . . . 72.040000000000006 113.24 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.551 ' HD3' HD13 ' A' ' 61' ' ' LEU . 5.0 Cg_exo -80.48 22.68 0.75 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 122.893 2.396 . . . . 73.209999999999994 112.837 171.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.27 149.7 47.88 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.436 1.094 . . . . 75.450000000000003 110.356 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 68.02 6.24 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.835 2.357 . . . . 75.129999999999995 113.416 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.539 HG21 ' HB2' ' A' ' 113' ' ' CYS . 25.8 pt -132.97 135.9 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.542 1.137 . . . . 71.340000000000003 110.074 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 16.4 m -81.66 -82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 111.832 0.308 . . . . 75.129999999999995 111.832 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -102.07 108.0 19.28 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.257 0.551 . . . . 73.409999999999997 110.778 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -89.31 157.94 18.01 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.737 0.815 . . . . 74.409999999999997 111.685 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -156.01 124.11 5.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.587 0.755 . . . . 75.420000000000002 110.21 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.98 151.8 51.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.985 0.735 . . . . 63.0 112.985 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.5 p -138.35 137.43 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 C-N-CA 123.523 0.729 . . . . 73.030000000000001 112.483 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.2 mm? -101.28 108.3 19.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.065 -1.087 . . . . 74.329999999999998 108.065 166.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -124.51 110.73 14.85 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.641 -0.503 . . . . 72.219999999999999 109.641 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.9 110.89 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.532 -0.544 . . . . 74.420000000000002 109.532 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.6 117.5 68.61 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 124.187 0.995 . . . . 73.409999999999997 111.08 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.79 110.14 1.61 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.663 2.242 . . . . 73.5 111.494 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -107.33 -28.89 9.61 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.47 0.708 . . . . 72.319999999999993 111.834 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.9 t70 -149.96 163.05 39.12 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.762 0.825 . . . . 74.010000000000005 110.434 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.78 -39.03 73.35 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.517 1.127 . . . . 75.030000000000001 112.35 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -117.64 -4.34 11.22 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.846 . . . . 74.129999999999995 112.32 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.497 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -133.05 156.47 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.305 0.502 . . . . 64.040000000000006 111.208 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 17' ' ' VAL . 23.0 p -157.68 178.66 10.01 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.583 0.753 . . . . 50.119999999999997 111.017 -177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.6 m -134.73 125.77 27.66 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.034 0.534 . . . . 72.150000000000006 111.33 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.02 120.96 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.38 -0.6 . . . . 65.5 109.38 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.42 125.03 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.215 0.606 . . . . 73.519999999999996 109.713 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -114.31 116.75 29.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.591 0.757 . . . . 74.430000000000007 109.087 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.455 HG23 ' SD ' ' A' ' 110' ' ' MET . 76.3 m -119.82 138.9 53.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.029 0.932 . . . . 75.120000000000005 109.384 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.17 112.91 7.67 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.492 0.717 . . . . 62.530000000000001 111.61 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.455 ' SD ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -120.74 131.6 54.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 71.329999999999998 109.613 -177.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -142.68 155.06 44.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.625 0.77 . . . . 75.340000000000003 111.886 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 28.6 t70 -77.3 88.02 3.71 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.795 0.438 . . . . 75.230000000000004 110.115 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 38.7 t -145.99 164.76 31.06 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.971 -0.558 . . . . 71.150000000000006 112.493 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m -75.13 144.56 79.15 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.136 0.974 . . . . 55.119999999999997 111.676 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.27 -43.95 20.65 Favored 'Trans proline' 0 C--N 1.389 2.68 0 C-N-CA 124.23 3.287 . . . . 72.420000000000002 115.221 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.08 -42.53 72.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.341 1.056 . . . . 74.430000000000007 112.618 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.602 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 8.5 m -85.89 -31.47 22.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.506 0.723 . . . . 74.530000000000001 110.27 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.37 91.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.149 0.979 . . . . 75.530000000000001 112.488 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.53 -30.38 61.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.852 0.861 . . . . 72.329999999999998 112.219 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.71 -45.12 72.4 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.26 0.552 . . . . 72.140000000000001 109.865 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.06 -23.69 62.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.192 0.997 . . . . 70.239999999999995 110.943 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 40.7 tt0 -61.89 -47.09 86.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.8 0.44 . . . . 62.450000000000003 110.314 172.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -71.13 -43.74 66.99 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 112.822 0.675 . . . . 73.430000000000007 112.822 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.79 -55.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.384 0.674 . . . . 71.349999999999994 112.491 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.91 -55.23 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.736 0.815 . . . . 75.239999999999995 111.459 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -72.35 -71.23 1.09 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 114.066 0.386 . . . . 72.239999999999995 114.066 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.38 -3.64 31.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.544 0.738 . . . . 64.150000000000006 112.698 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.96 -83.13 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.061 -0.416 . . . . 70.540000000000006 112.061 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.48 -43.12 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.763 0.825 . . . . 70.400000000000006 112.593 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 6.7 m-30 -76.26 -43.7 40.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.751 0.421 . . . . 75.310000000000002 111.239 -175.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.95 -48.04 73.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.549 0.339 . . . . 73.510000000000005 111.3 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.22 -47.25 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 C-N-CA 123.357 0.663 . . . . 75.430000000000007 111.945 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -45.46 95.61 Favored Glycine 0 CA--C 1.54 1.594 0 CA-C-N 116.518 -0.31 . . . . 50.229999999999997 113.661 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.18 -46.04 57.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.372 1.069 . . . . 74.549999999999997 111.922 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.454 ' HA ' HG22 ' A' ' 8' ' ' VAL . 6.5 m-20 -61.7 -40.83 96.41 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.841 0.457 . . . . 73.099999999999994 110.999 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.49 85.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.017 0.527 . . . . 72.019999999999996 111.425 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.25 -44.87 92.37 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.443 0.697 . . . . 71.109999999999999 110.858 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.68 95.25 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.868 -0.605 . . . . 73.329999999999998 111.618 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -71.55 -30.84 66.34 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.411 0.684 . . . . 73.310000000000002 112.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -15.37 58.57 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.389 0.514 . . . . 74.140000000000001 112.389 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -85.45 -8.69 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 122.727 0.411 . . . . 74.150000000000006 111.48 162.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.057 0 N-CA-C 112.308 -0.317 . . . . 73.450000000000003 112.308 -177.032 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.642 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 112.844 0.683 . . . . 64.430000000000007 112.844 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.25 101.12 9.9 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.945 0.879 . . . . 72.329999999999998 110.281 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.583 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 4.0 mp -92.94 119.17 31.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.998 1.319 . . . . 74.450000000000003 108.932 -175.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -140.75 136.33 32.43 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.909 0.385 . . . . 75.430000000000007 110.274 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.11 138.81 31.93 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.101 -1.074 . . . . 74.530000000000001 108.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.7 p -128.92 147.11 50.81 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.874 0.869 . . . . 74.340000000000003 110.126 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.4 p -142.3 145.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.933 0.493 . . . . 73.109999999999999 110.469 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.98 112.71 24.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.349 0.595 . . . . 72.230000000000004 110.773 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.9 t -91.44 132.87 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.258 1.423 . . . . 74.530000000000001 110.632 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.13 51.37 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.409 0.683 . . . . 70.150000000000006 112.209 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.56 155.09 24.58 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.166 0.986 . . . . 62.240000000000002 110.605 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.1 142.21 73.24 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.863 2.376 . . . . 73.340000000000003 113.398 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.76 -38.91 23.11 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.911 1.684 . . . . 74.420000000000002 115.253 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.89 73.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.555 0.742 . . . . 73.120000000000005 112.767 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.85 -42.31 84.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.751 0.82 . . . . 72.549999999999997 112.307 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.435 HG13 HD21 ' A' ' 137' ' ' LEU . 29.2 t -70.83 -33.82 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.899 0.88 . . . . 74.450000000000003 110.784 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.517 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 49.5 t-105 -67.29 -28.99 68.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.425 0.69 . . . . 74.019999999999996 111.891 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -65.11 -36.13 83.32 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.175 0.512 . . . . 64.510000000000005 110.441 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 30' ' ' TRP . 66.2 tp -73.28 -51.44 17.58 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.192 0.997 . . . . 74.329999999999998 111.988 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.42 -33.26 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.606 0.762 . . . . 62.219999999999999 112.702 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.11 72.68 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 113.237 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.39 94.79 0.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.938 0.875 . . . . 73.310000000000002 110.474 168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.87 12.77 0.77 Allowed 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 124.873 1.269 . . . . 72.450000000000003 110.496 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.658 ' HA ' HD23 ' A' ' 39' ' ' LEU . 75.6 p -115.77 -1.73 12.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.554 1.141 . . . . 61.420000000000002 112.493 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.31 -83.36 0.61 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 119.071 -0.49 . . . . 70.140000000000001 110.867 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 HG13 ' A' ' 34' ' ' VAL 0.298 19.9 tt 52.81 -48.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 127.61 2.364 . . . . 74.140000000000001 116.457 -175.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -60.9 -4.08 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 120.284 1.402 . . . . 75.519999999999996 114.34 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -77.46 -16.61 58.67 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.867 0.867 . . . . 74.200000000000003 112.852 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.524 ' HB3' HD21 ' A' ' 20' ' ' LEU . 42.4 p-90 -132.13 -34.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.524 0.729 . . . . 73.310000000000002 111.816 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -87.53 110.74 36.65 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.89 0.876 . . . . 73.209999999999994 109.313 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.18 -8.62 24.1 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 71.019999999999996 114.902 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -109.02 -6.81 15.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.148 1.166 . . . . 73.010000000000005 114.148 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 27' ' ' ILE . 66.6 t -79.66 131.38 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 118.469 0.577 . . . . 71.420000000000002 112.5 177.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -93.03 34.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.252 1.021 . . . . 73.5 111.869 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 67.46 125.78 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 C-N-CA 125.8 1.64 . . . . 70.209999999999994 113.422 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 73.7 Cg_endo -84.79 149.7 11.14 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.742 2.295 . . . . 74.239999999999995 113.921 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.7 m -107.07 120.18 41.39 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.898 0.879 . . . . 73.329999999999998 109.645 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 25' ' ' SER . 3.9 mm? -91.51 137.7 32.15 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.481 0.658 . . . . 73.299999999999997 112.701 -167.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -130.13 165.07 23.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.153 1.381 . . . . 74.510000000000005 109.81 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.97 -150.89 5.97 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.541 0.977 . . . . 55.140000000000001 115.541 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.05 87.56 6.89 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.953 0.724 . . . . 74.409999999999997 112.953 -165.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.4 t 58.89 132.96 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 N-CA-C 116.001 1.852 . . . . 74.420000000000002 116.001 161.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.43 -16.44 41.82 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.082 2.521 . . . . 74.430000000000007 114.176 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -114.17 20.43 15.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 60.130000000000003 111.744 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 123.03 26.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 123.729 0.811 . . . . 65.439999999999998 109.345 172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.581 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 58.7 Cg_exo -53.95 89.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.656 2.904 . . . . 72.420000000000002 114.164 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.83 51.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.071 -0.513 . . . . 75.140000000000001 112.655 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.71 145.16 39.98 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.704 0.801 . . . . 64.349999999999994 111.006 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -109.93 153.07 25.02 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.257 0.623 . . . . 73.140000000000001 109.867 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 11.0 ptm180 -140.24 125.56 18.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.398 0.618 . . . . 74.120000000000005 109.844 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.39 101.13 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.777 0.831 . . . . 73.099999999999994 109.851 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -63.34 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.724 1.209 . . . . 75.450000000000003 111.953 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -59.91 0.64 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.005 -0.438 . . . . 74.120000000000005 112.005 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.36 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.52 1.528 . . . . 74.430000000000007 113.44 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.7 -19.86 0.44 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 115.002 0.761 . . . . 71.209999999999994 115.002 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 p -105.45 171.86 7.1 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.615 0.707 . . . . 72.420000000000002 111.518 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.85 7.02 43.88 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.965 0.906 . . . . 71.519999999999996 112.603 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.34 31.48 3.47 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.828 0.823 . . . . 73.439999999999998 110.521 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 151.06 45.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.752 0.821 . . . . 75.150000000000006 112.662 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -102.82 114.47 28.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.573 0.749 . . . . 73.019999999999996 110.266 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.6 t -114.4 115.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.157 0.583 . . . . 73.510000000000005 110.716 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.83 160.56 20.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.02 0.928 . . . . 75.430000000000007 110.613 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -143.36 132.23 22.76 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.199 1.0 . . . . 74.420000000000002 111.356 -170.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 18.6 tp -74.83 121.55 21.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.193 1.397 . . . . 74.340000000000003 112.374 -175.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -98.38 -48.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.95 0.9 . . . . 74.230000000000004 110.879 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 36.9 tt0 -144.13 134.65 24.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.441 1.096 . . . . 74.340000000000003 109.661 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.563 ' NH1' ' HB2' ' A' ' 70' ' ' GLU . 4.0 tmm_? -132.92 109.58 9.69 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.332 -0.618 . . . . 75.450000000000003 109.332 -176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.84 176.0 5.44 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.491 1.116 . . . . 75.219999999999999 109.356 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.563 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 24.4 tt0 -158.62 -34.65 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.865 -0.522 . . . . 74.420000000000002 112.336 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -63.86 -34.84 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.3 0.64 . . . . 64.439999999999998 111.358 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.65 -14.81 15.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.342 1.057 . . . . 75.430000000000007 110.773 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 68.25 69.29 0.32 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.936 1.294 . . . . 75.200000000000003 112.098 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.28 135.04 40.54 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.722 0.809 . . . . 72.209999999999994 111.505 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.57 118.18 31.0 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.764 1.225 . . . . 70.420000000000002 109.447 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 60.5 t -116.92 125.65 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.45 0.7 . . . . 64.409999999999997 109.981 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.17 -179.07 6.66 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.703 0.801 . . . . 74.540000000000006 111.319 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -145.97 162.99 36.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.425 1.09 . . . . 75.109999999999999 110.486 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 72.6 mtm -101.14 100.45 13.29 Favored Pre-proline 0 N--CA 1.484 1.259 0 N-CA-C 109.292 -0.633 . . . . 73.340000000000003 109.292 167.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.6 -21.04 30.14 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.002 2.468 . . . . 71.409999999999997 113.358 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -139.55 74.89 33.13 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.242 0.617 . . . . 65.129999999999995 109.63 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 64.7 Cg_endo -86.68 146.96 8.3 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.647 2.231 . . . . 70.319999999999993 113.468 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.1 Cg_endo -86.55 24.89 0.71 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.457 2.771 . . . . 73.120000000000005 113.347 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -123.33 149.4 57.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 123.912 0.885 . . . . 64.510000000000005 110.371 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.38 74.9 4.04 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.605 2.203 . . . . 73.310000000000002 112.031 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 113' ' ' CYS . 31.4 pt -133.78 165.11 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.338 1.055 . . . . 75.530000000000001 110.991 -174.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 5.8 m -136.02 159.89 40.31 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.663 0.785 . . . . 72.450000000000003 109.649 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.8 p30 37.73 71.67 0.14 Allowed 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 125.9 1.68 . . . . 71.030000000000001 114.547 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.454 ' HD2' ' HD2' ' A' ' 111' ' ' PHE . 41.8 t-80 -79.39 131.0 35.97 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 116.076 -0.511 . . . . 74.25 111.881 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -129.82 118.84 22.4 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.231 1.012 . . . . 73.310000000000002 109.787 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -127.23 125.44 40.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.372 0.669 . . . . 73.450000000000003 111.312 177.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 117.63 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.489 0.715 . . . . 73.049999999999997 110.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.35 117.32 33.85 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 72.319999999999993 109.116 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.08 150.1 52.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.345 0.658 . . . . 74.439999999999998 110.937 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.86 113.87 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.185 0.594 . . . . 74.209999999999994 109.508 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -92.55 115.52 64.94 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.161 0.985 . . . . 63.240000000000002 109.902 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 77.11 0.37 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.764 2.309 . . . . 74.200000000000003 112.938 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -69.53 -33.75 73.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.217 1.007 . . . . 75.450000000000003 111.944 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 24.9 t70 -154.92 165.17 37.52 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.098 1.359 . . . . 74.219999999999999 108.944 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.35 -48.88 79.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.853 0.861 . . . . 62.539999999999999 111.963 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 -6.4 27.72 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.858 0.863 . . . . 72.510000000000005 110.987 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.6 m80 -131.3 128.54 39.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.956 -1.09 . . . . 75.140000000000001 111.592 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' A' ' 17' ' ' VAL . 31.5 p -130.2 133.76 46.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.063 0.545 . . . . 73.230000000000004 110.129 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.9 m -92.14 110.37 21.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.344 0.258 . . . . 72.420000000000002 110.383 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.11 116.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 74.310000000000002 109.717 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.8 t -107.77 109.85 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.454 1.102 . . . . 63.420000000000002 109.995 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -103.35 125.31 49.9 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.102 -0.703 . . . . 75.530000000000001 109.102 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.3 m -131.55 147.46 52.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.051 0.94 . . . . 74.439999999999998 110.344 -172.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -147.96 156.26 42.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.195 1.398 . . . . 74.439999999999998 108.859 169.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -162.81 146.03 11.0 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.638 . . . . 73.239999999999995 110.753 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.454 ' HD2' ' HD2' ' A' ' 89' ' ' HIS . 2.5 p90 -158.84 155.5 27.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.717 0.807 . . . . 74.329999999999998 111.669 -168.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 30.2 t70 -82.99 85.44 7.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.022 0.929 . . . . 73.129999999999995 109.205 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.612 ' HB2' HG21 ' A' ' 86' ' ' ILE . 43.0 t -113.41 152.65 29.77 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.768 -1.105 . . . . 75.219999999999999 111.254 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.1 p -61.43 132.33 92.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.482 0.713 . . . . 73.549999999999997 110.633 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.95 -44.21 23.12 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 124.293 3.329 . . . . 73.329999999999998 116.02 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.03 -38.62 72.57 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 122.799 0.44 . . . . 74.299999999999997 112.001 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 m -75.41 -26.8 58.68 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.166 0.587 . . . . 62.310000000000002 110.931 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 2' ' ' ALA . . . -68.67 -51.29 43.5 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.235 1.014 . . . . 75.109999999999999 111.125 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -64.01 -30.57 71.64 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.687 -0.688 . . . . 73.230000000000004 111.442 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -66.98 -44.36 80.62 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.839 -0.619 . . . . 73.519999999999996 110.691 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.61 -25.51 62.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.126 0.57 . . . . 73.430000000000007 111.233 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.583 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 52.1 mt-10 -66.09 -34.51 78.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.430000000000007 111.511 173.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 t -76.6 -53.27 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.679 0.622 . . . . 51.530000000000001 112.679 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.81 -55.03 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.647 0.779 . . . . 74.140000000000001 112.147 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.03 -46.76 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.061 0.545 . . . . 73.310000000000002 110.653 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -16.18 68.04 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 115.488 0.955 . . . . 64.140000000000001 115.488 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.35 -57.47 1.99 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.983 0.892 . . . . 74.439999999999998 110.464 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.27 58.46 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 115.144 0.818 . . . . 74.030000000000001 115.144 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.0 t -111.77 -52.09 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.312 0.645 . . . . 75.099999999999994 110.372 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -75.05 -61.39 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.797 0.666 . . . . 74.239999999999995 112.797 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.59 71.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.879 0.371 . . . . 74.329999999999998 111.503 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.11 -56.28 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.109 0.964 . . . . 74.409999999999997 112.579 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.08 94.74 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 113.346 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.98 -39.39 83.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.952 0.901 . . . . 70.530000000000001 112.626 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -67.39 -45.46 76.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.388 0.275 . . . . 73.019999999999996 110.782 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.14 73.22 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.493 0.717 . . . . 73.340000000000003 111.567 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.435 HD21 HG13 ' A' ' 17' ' ' VAL . 6.8 tt -66.19 -43.65 86.19 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.788 0.835 . . . . 72.329999999999998 110.301 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.887 0.475 . . . . 71.230000000000004 112.193 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -72.25 -44.39 62.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.551 0.74 . . . . 73.400000000000006 111.768 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -73.99 -20.96 60.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.522 0.564 . . . . 73.310000000000002 112.522 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -100.56 -14.86 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.05 0.54 . . . . 74.409999999999997 111.219 168.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.203 0 CA-C-O 121.13 0.294 . . . . 61.119999999999997 112.503 177.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.771 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.8 m -115.13 117.87 31.77 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.652 1.181 . . . . 71.340000000000003 109.315 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -96.33 143.78 27.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.549 1.139 . . . . 75.299999999999997 109.931 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -143.72 135.2 26.05 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.248 0.547 . . . . 73.209999999999994 111.803 172.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -131.42 156.15 46.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.989 1.316 . . . . 73.120000000000005 109.008 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -145.02 157.02 44.25 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.617 0.767 . . . . 75.230000000000004 110.488 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.6 p -150.65 146.49 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.709 0.404 . . . . 74.25 111.149 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -93.01 123.64 36.41 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.855 -0.424 . . . . 72.349999999999994 109.855 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t -108.36 132.57 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.604 1.162 . . . . 75.519999999999996 110.638 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.69 64.23 8.5 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.24 0.616 . . . . 61.549999999999997 111.585 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.59 148.58 7.88 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.333 0.653 . . . . 73.150000000000006 111.037 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.07 128.76 31.15 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.29 2.66 . . . . 63.43 113.036 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.84 -37.27 13.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.981 1.475 . . . . 75.140000000000001 114.981 -175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.36 86.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.044 0.538 . . . . 75.010000000000005 112.227 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.52 -35.53 80.77 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.222 0.609 . . . . 54.149999999999999 112.332 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG22 ' SG ' ' A' ' 103' ' ' CYS . 58.8 t -71.25 -34.97 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.428 0.691 . . . . 73.400000000000006 110.345 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.492 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 63.2 t-105 -72.67 -27.66 62.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 111.775 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.4 m -69.31 -29.56 67.44 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.423 0.63 . . . . 53.439999999999998 110.077 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 30' ' ' TRP . 58.4 tp -75.16 -49.15 20.42 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.365 1.066 . . . . 75.040000000000006 111.68 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.44 -36.45 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 112.631 0.604 . . . . 74.0 112.631 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -65.36 -25.65 71.36 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 123.542 0.592 . . . . 55.340000000000003 114.352 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.07 108.21 11.2 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.123 -0.695 . . . . 62.32 109.123 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.405 ' HZ ' ' HG2' ' A' ' 63' ' ' GLU . 22.2 t80 -58.55 -27.66 64.77 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.093 0.957 . . . . 73.129999999999995 110.624 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.7 p -77.71 -24.46 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.209999999999994 113.263 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.19 10.34 39.41 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 122.805 0.442 . . . . 73.109999999999999 111.799 -168.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.741 HG23 HG13 ' A' ' 34' ' ' VAL . 18.5 tt -59.49 -25.51 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 C-N-CA 123.067 0.547 . . . . 73.439999999999998 112.114 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -63.78 -19.25 64.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.216 0.821 . . . . 51.409999999999997 113.216 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -78.25 -25.14 46.72 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.629 0.603 . . . . 74.219999999999999 112.629 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.537 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.8 p-90 -117.07 -33.18 4.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.948 0.499 . . . . 74.129999999999995 111.791 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.438 ' ND1' HG21 ' A' ' 34' ' ' VAL . 43.5 t-80 -89.34 109.79 33.96 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.247 0.619 . . . . 74.019999999999996 109.567 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.87 -15.65 36.75 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.928 2.419 . . . . 74.310000000000002 114.011 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.49 -26.3 19.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.45 0.7 . . . . 74.349999999999994 111.558 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 27' ' ' ILE . 99.3 t -74.41 103.55 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.327 0 CA-C-O 121.134 0.492 . . . . 75.319999999999993 110.434 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 m -93.45 40.98 1.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.093 0.957 . . . . 74.019999999999996 112.56 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.1 75.12 0.47 Allowed Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 124.801 1.241 . . . . 72.439999999999998 112.926 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.726 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 94.4 Cg_endo -82.44 -168.15 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.563 2.842 . . . . 71.099999999999994 115.278 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 86.7 m -113.77 139.58 49.0 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.596 1.158 . . . . 72.019999999999996 111.511 -167.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.08 143.5 26.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.272 0.629 . . . . 71.409999999999997 111.375 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.686 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.3 mmt180 -115.1 138.35 50.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.854 0.862 . . . . 73.319999999999993 110.009 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.85 -123.9 7.94 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 115.548 0.979 . . . . 75.230000000000004 115.548 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.74 139.11 0.32 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.153 1.781 . . . . 71.329999999999998 114.746 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -50.55 158.25 1.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 C-N-CA 125.403 1.481 . . . . 62.43 113.755 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -7.03 13.99 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 123.05 2.5 . . . . 64.200000000000003 114.494 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -109.55 -13.74 14.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.707 0.803 . . . . 73.319999999999993 111.445 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -88.57 118.43 69.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.627 0.771 . . . . 75.099999999999994 111.009 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.54 121.8 10.14 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.509 2.806 . . . . 72.25 113.319 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.83 -14.56 8.5 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 116.348 -0.387 . . . . 71.329999999999998 113.073 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.68 141.42 52.64 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.862 0.865 . . . . 75.230000000000004 112.425 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 34.7 mt-10 -116.5 163.53 15.94 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 122.751 0.421 . . . . 74.329999999999998 110.249 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' THR . 48.4 ttt85 -156.17 105.68 2.34 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.93 0.492 . . . . 74.230000000000004 110.87 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.84 113.82 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.289 0.636 . . . . 74.230000000000004 111.358 -170.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.726 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.4 m-85 -76.3 70.75 2.95 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.042 1.337 . . . . 73.420000000000002 111.658 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.49 -50.85 0.53 Allowed Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.814 -0.514 . . . . 71.109999999999999 111.814 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.04 24.19 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.52 1.128 . . . . 74.019999999999996 113.876 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.06 53.62 0.05 OUTLIER Glycine 0 N--CA 1.474 1.23 0 C-N-CA 122.75 0.214 . . . . 72.420000000000002 112.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -121.05 -135.37 0.32 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.22 1.008 . . . . 75.530000000000001 108.86 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.15 -1.9 4.56 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.307 0.958 . . . . 72.109999999999999 111.978 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.33 46.77 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.69 0.757 . . . . 74.019999999999996 111.946 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -87.15 152.35 22.41 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.384 -0.825 . . . . 72.340000000000003 112.004 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.89 132.54 43.39 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.838 0.855 . . . . 73.120000000000005 108.865 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.5 t -102.86 116.67 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.883 -0.511 . . . . 75.430000000000007 109.902 175.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 43.5 tt0 -109.55 154.5 22.63 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.37 1.468 . . . . 75.019999999999996 109.605 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -151.94 125.66 8.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 74.109999999999999 112.163 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -66.97 120.76 14.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.016 1.326 . . . . 73.340000000000003 111.31 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -88.1 -50.8 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.698 . . . . 62.399999999999999 110.826 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 37.5 tt0 -151.98 142.45 22.6 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.549 1.14 . . . . 74.010000000000005 109.953 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.448 HH21 ' HA3' ' A' ' 22' ' ' GLY . 3.6 tmt_? -134.23 111.46 10.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.884 -0.784 . . . . 73.109999999999999 108.884 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -117.33 125.73 51.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.727 0.811 . . . . 71.450000000000003 110.709 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 33.6 tt0 -90.63 -40.38 11.94 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.251 0.834 . . . . 73.510000000000005 113.251 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -67.26 -43.53 81.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.878 0.471 . . . . 62.310000000000002 111.951 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.35 0.93 54.72 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.063 0.545 . . . . 74.540000000000006 112.031 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 25.4 mmt85 60.1 38.31 20.51 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.355 1.062 . . . . 64.219999999999999 112.293 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.84 122.87 47.67 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.052 0.941 . . . . 71.120000000000005 111.729 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 50.1 tp -115.04 108.41 16.65 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.061 0.944 . . . . 75.140000000000001 110.213 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 54.1 t -106.35 123.21 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.464 0.706 . . . . 71.549999999999997 110.132 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' HE1' HD22 ' A' ' 93' ' ' LEU . 46.5 p90 -151.95 -178.71 6.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.928 0.491 . . . . 74.219999999999999 111.727 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.431 HG23 ' HD3' ' A' ' 80' ' ' PRO . 9.8 t -153.82 164.63 38.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.142 0.977 . . . . 73.120000000000005 111.184 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -106.99 100.28 31.2 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.964 -0.754 . . . . 74.140000000000001 108.964 160.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 36.1 Cg_endo -63.0 -23.03 74.07 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.944 2.429 . . . . 73.129999999999995 113.471 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.9 t70 -124.61 82.31 59.51 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.445 0.698 . . . . 75.5 110.028 175.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -101.56 144.67 0.26 Allowed 'Trans proline' 0 CA--C 1.573 2.466 0 C-N-CA 123.759 2.973 . . . . 73.230000000000004 114.291 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.81 -17.26 37.45 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.768 2.312 . . . . 72.120000000000005 113.596 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -80.78 155.67 73.1 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 123.942 0.897 . . . . 71.519999999999996 111.394 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.0 46.84 2.3 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.253 2.635 . . . . 73.209999999999994 112.949 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.53 116.8 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.197 0.999 . . . . 74.120000000000005 109.774 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.5 ' HG1' ' HB3' ' A' ' 112' ' ' ASP . 46.4 p -74.96 -79.38 0.09 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.088 0.555 . . . . 70.209999999999994 112.39 -172.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.38 72.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.929 0.871 . . . . 74.030000000000001 109.752 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' MET . 57.5 t-80 -76.03 118.95 19.32 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.622 -0.717 . . . . 72.439999999999998 111.818 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 150.05 23.6 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.978 0.911 . . . . 74.409999999999997 108.914 170.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.59 119.49 8.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 71.030000000000001 109.137 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 48.4 t -126.09 130.12 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.38 0.672 . . . . 72.319999999999993 111.869 -169.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.432 HD22 ' HE1' ' A' ' 77' ' ' TYR . 4.3 mm? -107.93 111.57 23.74 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.382 1.073 . . . . 74.400000000000006 109.359 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 51.0 mt-10 -116.58 111.23 19.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.952 0.501 . . . . 74.120000000000005 110.413 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.43 105.61 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.298 -1.001 . . . . 75.430000000000007 108.298 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 15.5 m -100.57 123.7 45.12 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 122.894 0.478 . . . . 64.239999999999995 110.405 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 16.4 Cg_exo -68.47 85.81 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.159 2.573 . . . . 74.319999999999993 112.614 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -32.93 74.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.143 0.977 . . . . 74.439999999999998 109.744 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.7 t70 -157.31 167.12 31.23 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.239 1.816 . . . . 74.540000000000006 108.259 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.7 -40.54 95.39 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.208 0.603 . . . . 65.310000000000002 112.434 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -108.98 -1.29 19.08 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.614 0.766 . . . . 75.430000000000007 111.888 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.0 m80 -132.5 124.5 28.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.243 -0.911 . . . . 71.129999999999995 110.153 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.506 ' SG ' HG22 ' A' ' 17' ' ' VAL . 29.1 p -133.1 142.88 48.96 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.003 0.521 . . . . 71.239999999999995 110.8 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 m -97.12 114.33 26.0 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.757 0.423 . . . . 60.140000000000001 110.156 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 t -95.3 112.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.428 -0.582 . . . . 74.019999999999996 109.428 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.77 117.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 75.140000000000001 109.655 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -108.73 112.73 25.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.123 -0.695 . . . . 75.25 109.123 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 m -125.22 128.09 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.506 0.722 . . . . 72.019999999999996 110.338 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.65 148.9 42.25 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.611 0.764 . . . . 75.049999999999997 111.053 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 1.8 mpt? -126.17 150.36 48.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.707 0.803 . . . . 71.430000000000007 109.139 172.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -162.77 153.14 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.323 0.649 . . . . 73.019999999999996 110.455 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.5 ' HB3' ' HG1' ' A' ' 87' ' ' THR . 36.8 t70 -102.57 78.58 1.73 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.748 0.785 . . . . 63.43 109.456 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t -125.15 168.14 13.83 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.779 -1.101 . . . . 71.329999999999998 110.984 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -65.05 147.47 98.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 C-N-CA 123.399 0.68 . . . . 74.140000000000001 112.174 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.7 -31.57 95.16 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.955 2.436 . . . . 55.450000000000003 113.411 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.94 -55.96 28.12 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.007 0.923 . . . . 72.409999999999997 111.604 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.7 m -74.48 -32.02 62.41 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.756 -0.657 . . . . 64.239999999999995 111.157 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -65.6 -41.53 92.69 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.085 0.554 . . . . 61.140000000000001 112.029 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -67.31 -31.35 71.58 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.648 0.379 . . . . 75.209999999999994 111.657 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.96 -42.62 94.44 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.652 -0.499 . . . . 73.329999999999998 109.652 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 117' ' ' THR . 92.8 mt -72.62 -25.33 61.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.374 0.67 . . . . 75.420000000000002 111.717 -176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 46.8 mt-10 -61.35 -38.18 86.01 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 118.14 0.427 . . . . 75.310000000000002 110.763 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 t -76.25 -51.43 12.06 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 112.694 0.627 . . . . 74.340000000000003 112.694 172.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.26 -55.02 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 112.863 0.69 . . . . 74.310000000000002 112.863 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.4 mt -77.5 -45.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.75 0.42 . . . . 72.329999999999998 110.522 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.45 -47.9 83.19 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 114.855 0.702 . . . . 71.420000000000002 114.855 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.99 -46.55 5.06 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.451 -1.029 . . . . 73.219999999999999 112.094 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.01 -19.58 71.96 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 114.94 0.736 . . . . 71.25 114.94 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.11 -53.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 117.88 0.84 . . . . 73.200000000000003 111.443 176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.6 m-30 -73.84 -54.62 7.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.333 0.494 . . . . 75.209999999999994 112.333 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.36 72.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.061 0.144 . . . . 74.010000000000005 110.968 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.75 -52.22 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.08 0.552 . . . . 75.510000000000005 111.754 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.26 -50.25 61.12 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 116.572 -0.285 . . . . 55.210000000000001 113.18 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.89 -41.65 99.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 74.329999999999998 112.716 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 92.8 m-20 -68.79 -41.5 78.64 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.2 -0.429 . . . . 74.430000000000007 110.438 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.35 75.5 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.85 0.46 . . . . 73.530000000000001 111.876 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.479 HD21 HG13 ' A' ' 17' ' ' VAL . 7.8 tt -67.86 -41.33 83.05 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.217 0.607 . . . . 74.310000000000002 109.898 173.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.47 -27.73 62.48 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 112.353 0.501 . . . . 75.019999999999996 112.353 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 52.7 mt-10 -78.77 -37.89 39.97 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.184 0.994 . . . . 63.350000000000001 112.118 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 8.7 ptm180 -67.71 -34.07 76.14 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.348 0.259 . . . . 74.25 110.971 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -88.94 -16.94 30.57 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.95 0.5 . . . . 71.200000000000003 110.539 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.329 0 CA-C-N 115.878 -0.601 . . . . 52.310000000000002 113.252 175.884 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.838 0.828 . . . . 73.340000000000003 110.876 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.8 m -128.62 116.67 19.96 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.184 0.994 . . . . 75.420000000000002 109.581 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 126' ' ' GLY . 8.3 mp -108.76 109.49 20.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.931 1.292 . . . . 70.5 109.539 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -129.48 135.2 48.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 74.019999999999996 112.214 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.56 156.08 49.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.736 1.214 . . . . 75.219999999999999 110.648 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -143.84 154.2 43.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.205 1.002 . . . . 74.319999999999993 109.321 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.8 p -150.09 147.54 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 111.591 0.219 . . . . 75.150000000000006 111.591 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.27 118.5 26.74 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.196 0.598 . . . . 75.109999999999999 110.546 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.0 121.05 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.671 1.188 . . . . 71.540000000000006 110.131 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.25 72.94 3.83 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.147 0.579 . . . . 52.5 111.044 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.02 155.76 2.42 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.646 0.778 . . . . 71.219999999999999 111.134 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -63.0 138.29 67.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.704 2.269 . . . . 75.219999999999999 111.86 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -25.13 11.16 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.165 0.802 . . . . 72.049999999999997 113.165 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.42 47.96 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.711 0.634 . . . . 73.120000000000005 112.711 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.54 -40.07 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.246 0.618 . . . . 73.219999999999999 111.636 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 137' ' ' LEU . 21.6 t -74.5 -34.86 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.524 0.73 . . . . 64.400000000000006 111.125 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 -70.1 -27.76 64.85 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.345 0.658 . . . . 71.299999999999997 111.419 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 m -63.76 -29.14 70.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.389 0.614 . . . . 74.430000000000007 111.147 170.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 30' ' ' TRP . 57.5 tp -86.07 -56.72 3.33 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.505 1.122 . . . . 62.329999999999998 111.924 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.56 -25.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 123.099 0.56 . . . . 72.439999999999998 112.501 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.13 0.61 62.53 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 114.408 0.523 . . . . 71.200000000000003 114.408 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.09 163.59 12.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.125 0.97 . . . . 73.439999999999998 109.206 165.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.09 -44.26 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.794 -0.566 . . . . 74.310000000000002 110.551 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.7 p -77.61 -20.26 54.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.192 0.441 . . . . 71.120000000000005 112.192 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.12 5.79 9.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.181 0.592 . . . . 71.140000000000001 112.549 -170.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 34' ' ' VAL . 19.1 tt -68.15 -27.31 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.305 0.642 . . . . 75.230000000000004 112.565 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -66.31 -15.89 63.6 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.365 0.505 . . . . 73.439999999999998 112.365 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -80.79 -38.33 28.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.757 0.823 . . . . 74.439999999999998 112.595 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.61 ' HB3' HD22 ' A' ' 20' ' ' LEU . 54.5 p-90 -108.81 -36.37 6.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 122.084 -0.385 . . . . 70.140000000000001 111.679 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -89.89 110.56 40.71 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.107 0.563 . . . . 73.109999999999999 109.619 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.06 -21.57 42.75 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.134 2.556 . . . . 75.439999999999998 114.318 -170.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.471 HE22 ' HA ' ' A' ' 129' ' ' VAL . 35.3 mt-30 -87.45 -16.76 33.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 74.239999999999995 112.838 -173.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 27' ' ' ILE . 76.4 t -61.62 127.28 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 122.967 0.507 . . . . 74.310000000000002 111.768 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -90.23 27.41 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.34 1.056 . . . . 74.329999999999998 112.384 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.46 101.61 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 124.437 1.095 . . . . 74.230000000000004 111.381 -172.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.46 177.51 4.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.863 2.375 . . . . 73.329999999999998 114.707 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 m -123.84 141.85 51.65 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.098 0.959 . . . . 72.409999999999997 110.731 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 126.25 40.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.299 0.64 . . . . 74.040000000000006 111.298 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.662 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 34.0 mmt180 -103.97 123.78 47.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.659 . . . . 75.310000000000002 110.1 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.55 -177.77 0.01 OUTLIER Glycine 0 CA--C 1.549 2.177 0 N-CA-C 118.199 2.039 . . . . 72.219999999999999 118.199 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.86 -106.23 0.26 Allowed 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.428 1.491 . . . . 50.240000000000002 113.687 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 40.4 t 179.01 147.34 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.454 1.102 . . . . 71.209999999999994 109.384 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.37 -20.9 21.55 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.301 2.667 . . . . 72.030000000000001 114.894 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.6 3.06 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.182 0.593 . . . . 73.25 112.547 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.4 m -102.38 118.92 57.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.729 0.812 . . . . 71.019999999999996 110.765 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 80.1 Cg_exo -50.38 102.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.52 2.813 . . . . 74.230000000000004 113.261 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -31.66 1.14 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.039 -0.528 . . . . 63.310000000000002 113.704 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.482 ' HB3' ' H ' ' A' ' 43' ' ' SER . . . -65.48 144.44 57.03 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.563 0.579 . . . . 54.149999999999999 112.563 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 46.7 mt-10 -110.92 146.67 36.14 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.33 0.652 . . . . 75.319999999999993 111.767 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -118.68 106.59 12.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.564 0.746 . . . . 71.230000000000004 110.786 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.34 102.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.905 0.882 . . . . 75.439999999999998 110.84 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.71 93.79 2.14 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.658 0.783 . . . . 74.030000000000001 112.505 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 60.43 1.87 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.296 -0.321 . . . . 51.119999999999997 112.296 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 107.63 1.44 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.645 0.778 . . . . 65.109999999999999 112.905 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 24.83 7.44 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 114.159 0.423 . . . . 64.430000000000007 114.159 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -96.52 -77.03 0.49 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.291 0.636 . . . . 75.340000000000003 110.669 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 163.11 -35.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.821 1.649 . . . . 74.310000000000002 108.491 -171.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -103.7 17.31 24.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.189 -0.914 . . . . 74.439999999999998 112.581 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 136.58 47.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.414 0.626 . . . . 73.099999999999994 112.38 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.561 HD13 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -101.69 118.93 37.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.606 0.762 . . . . 72.420000000000002 109.196 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 53.7 t -97.2 113.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.476 -0.564 . . . . 75.109999999999999 109.476 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 59.3 mt-10 -108.29 169.62 8.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.322 1.049 . . . . 74.420000000000002 110.059 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -150.43 121.43 7.68 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.114 0.566 . . . . 74.420000000000002 110.373 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.04 121.59 19.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.128 0.971 . . . . 75.200000000000003 111.887 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 82.9 t -90.99 -48.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.53 0.732 . . . . 74.200000000000003 111.594 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -166.72 152.75 8.33 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.556 0.343 . . . . 73.450000000000003 111.781 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.488 HH12 HD22 ' A' ' 75' ' ' LEU . 93.2 mtt-85 -134.9 119.7 18.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.719 0.808 . . . . 75.230000000000004 111.141 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.0 m-20 -95.91 99.74 11.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.453 1.101 . . . . 75.540000000000006 109.62 172.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.81 -57.87 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.126 0.57 . . . . 74.209999999999994 111.821 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.8 t -70.44 -36.69 74.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.15 0.58 . . . . 75.230000000000004 111.784 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -79.53 -7.6 58.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.267 0.627 . . . . 72.109999999999999 112.147 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 58.21 43.64 20.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.761 1.224 . . . . 75.420000000000002 112.297 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.2 ttp180 -124.66 143.72 50.58 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.227 1.011 . . . . 70.420000000000002 110.209 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.488 HD22 HH12 ' A' ' 68' ' ' ARG . 10.0 tp -130.39 125.87 35.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 109.233 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.14 130.28 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.685 0.794 . . . . 71.040000000000006 110.873 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -152.28 177.29 10.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.696 0.798 . . . . 74.430000000000007 110.706 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.7 t -154.97 150.66 27.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.684 0.794 . . . . 54.420000000000002 110.33 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.644 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 15.4 ptt? -98.65 106.2 35.31 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 122.579 0.351 . . . . 62.25 111.57 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.89 -25.8 44.91 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.356 2.704 . . . . 72.140000000000001 112.673 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 10.0 m-20 -123.71 80.1 55.69 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.412 0.685 . . . . 60.009999999999998 110.819 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.88 137.49 3.97 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.788 2.325 . . . . 74.310000000000002 112.511 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.37 -14.29 37.07 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.143 1.896 . . . . 74.099999999999994 112.118 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -76.53 147.51 78.77 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.575 1.15 . . . . 74.450000000000003 110.787 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.04 39.37 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.341 2.694 . . . . 71.25 114.094 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -103.28 152.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.063 0.945 . . . . 70.200000000000003 111.133 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -89.14 -86.24 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.522 0.329 . . . . 74.400000000000006 111.353 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -98.01 108.66 21.41 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.196 0.522 . . . . 74.319999999999993 110.881 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' HE1' ' HB3' ' A' ' 91' ' ' ALA . 39.1 t-80 -95.08 155.57 16.68 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.295 0.569 . . . . 73.450000000000003 111.963 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 16.1 tpt180 -145.83 122.69 11.29 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.564 1.146 . . . . 75.340000000000003 108.705 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.493 ' HB3' ' HE1' ' A' ' 89' ' ' HIS . . . -126.24 126.6 44.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.654 0.661 . . . . 71.409999999999997 111.432 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 75.1 t -130.24 129.58 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.377 0.671 . . . . 75.540000000000006 112.595 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.24 132.09 46.92 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.364 1.066 . . . . 73.310000000000002 108.586 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -143.94 112.57 6.55 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.28 0.945 . . . . 75.25 111.658 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.642 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 26.9 m -95.74 111.25 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 121.966 0.889 . . . . 65.239999999999995 110.533 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 104' ' ' THR . 6.6 m -103.58 116.7 61.51 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.834 0.853 . . . . 72.430000000000007 110.322 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.01 109.49 2.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.235 . . . . 75.209999999999994 113.269 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -66.3 -30.89 71.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.794 0.838 . . . . 73.450000000000003 110.719 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.0 t70 -158.54 174.04 15.69 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 125.199 1.399 . . . . 64.519999999999996 108.517 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.76 -37.65 66.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.555 0.742 . . . . 64.129999999999995 112.365 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -123.75 28.45 6.9 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.037 0.923 . . . . 74.219999999999999 111.564 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 62.1 m80 -138.03 130.44 29.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 72.409999999999997 109.488 171.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.642 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 46.9 t -130.89 162.83 28.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.858 0.863 . . . . 74.5 111.125 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.496 ' HB ' HG22 ' A' ' 96' ' ' VAL . 86.8 m -133.96 115.35 14.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.405 0.682 . . . . 74.340000000000003 110.042 174.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG23 HG11 ' A' ' 95' ' ' VAL . 15.2 t -90.35 114.61 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.625 -0.509 . . . . 71.340000000000003 109.625 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.81 110.91 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.899 0.88 . . . . 74.420000000000002 109.285 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.54 122.97 48.6 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.247 -0.649 . . . . 74.329999999999998 109.247 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.523 HG22 ' SD ' ' A' ' 110' ' ' MET . 21.4 m -129.86 135.98 49.01 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.41 0.684 . . . . 73.049999999999997 110.964 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.4 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.7 116.01 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.657 0.783 . . . . 73.209999999999994 112.041 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.57 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 3.1 mpp? -103.06 134.03 47.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.441 1.097 . . . . 74.319999999999993 109.121 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -157.62 143.56 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 120.731 0.3 . . . . 75.549999999999997 111.526 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.11 82.63 5.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.849 0.833 . . . . 75.310000000000002 109.434 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.575 ' HB2' HG21 ' A' ' 86' ' ' ILE . 41.1 t -110.97 160.54 16.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.414 -1.266 . . . . 73.109999999999999 111.444 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -64.84 134.88 96.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.655 0.782 . . . . 71.439999999999998 110.152 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.66 -42.82 64.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.544 2.829 . . . . 73.540000000000006 115.109 -167.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.57 -37.94 89.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.969 0.414 . . . . 63.299999999999997 111.903 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.6 m -74.41 -33.25 62.95 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 122.971 0.508 . . . . 73.530000000000001 110.773 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.74 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.873 0.869 . . . . 42.240000000000002 111.89 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -28.14 67.28 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.081 0.952 . . . . 75.230000000000004 112.149 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.98 -46.35 65.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.944 -0.391 . . . . 61.219999999999999 109.944 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.45 -22.68 61.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.334 0.654 . . . . 74.450000000000003 110.922 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -56.5 -46.47 80.48 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.27 1.028 . . . . 75.420000000000002 110.501 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 m -71.36 -50.01 36.5 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.481 -0.781 . . . . 74.420000000000002 112.683 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.93 -56.5 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 123.383 0.673 . . . . 73.040000000000006 112.404 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.27 -54.29 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.878 0.871 . . . . 74.549999999999997 110.624 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.408 ' N ' HD23 ' A' ' 4' ' ' LEU . . . -63.94 -33.8 88.23 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 115.655 1.022 . . . . 71.329999999999998 115.655 -172.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -117.07 -43.08 2.88 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.39 1.095 . . . . 71.510000000000005 111.744 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.72 -33.84 71.74 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.179 -0.464 . . . . 33.0 113.927 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.471 ' HA ' HE22 ' A' ' 33' ' ' GLN . 96.6 t -95.93 -56.28 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.069 0.548 . . . . 75.409999999999997 110.869 174.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.0 m-30 -70.63 -64.16 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.132 0.573 . . . . 75.120000000000005 112.483 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.73 71.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.287 0.367 . . . . 71.510000000000005 111.601 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 t -59.78 -54.32 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 C-N-CA 123.902 0.881 . . . . 64.430000000000007 112.277 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.45 -37.74 95.28 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.403 -0.362 . . . . 72.439999999999998 113.505 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.7 mt -70.93 -36.68 72.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.856 0.862 . . . . 72.129999999999995 111.972 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -68.77 -40.07 79.92 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.639 0.375 . . . . 51.329999999999998 110.694 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.65 91.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.076 0.55 . . . . 64.420000000000002 111.625 175.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 17' ' ' VAL . 9.0 tt -63.91 -43.0 97.24 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.475 0.71 . . . . 74.200000000000003 110.335 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.41 73.94 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.057 -0.52 . . . . 61.43 111.799 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.03 -40.08 54.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.439 0.696 . . . . 74.040000000000006 112.819 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -67.34 -29.58 69.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.21 0.448 . . . . 75.140000000000001 112.21 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -89.87 -29.18 18.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.203 -0.311 . . . . 74.519999999999996 111.366 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 CA-C-N 116.24 -0.436 . . . . 72.200000000000003 112.669 -179.755 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.372 0.129 . . . . 74.420000000000002 111.298 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.43 -14.46 61.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.861 0.464 . . . . 70.109999999999999 111.09 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -103.97 109.13 20.78 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.415 1.086 . . . . 74.319999999999993 109.793 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.39 140.64 29.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.782 0.833 . . . . 73.420000000000002 109.793 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -146.24 123.21 11.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.154 0.582 . . . . 74.400000000000006 109.867 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HD3' ' HB2' ' A' ' 130' ' ' PHE . 45.4 mtp85 -128.75 150.34 50.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 74.400000000000006 110.097 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -139.49 145.02 38.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.684 0.794 . . . . 54.149999999999999 110.519 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.7 p -136.23 144.91 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 122.558 0.343 . . . . 51.310000000000002 111.323 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.25 109.19 20.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.658 0.783 . . . . 72.120000000000005 110.489 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.9 t -101.19 127.17 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.984 0.914 . . . . 73.120000000000005 110.407 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 65.59 4.73 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.431 0.692 . . . . 74.209999999999994 111.491 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.0 155.13 3.62 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 124.002 0.921 . . . . 70.120000000000005 111.225 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.13 139.12 85.01 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.082 2.521 . . . . 70.310000000000002 113.865 167.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.47 64.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.258 1.577 . . . . 74.400000000000006 115.258 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.16 98.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.4 0.68 . . . . 64.319999999999993 112.426 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.22 -36.16 77.06 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.748 0.819 . . . . 72.540000000000006 112.34 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.467 HG22 ' SG ' ' A' ' 103' ' ' CYS . 41.3 t -73.57 -35.7 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.103 0.561 . . . . 72.140000000000001 111.345 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.62 -34.34 78.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.627 0.371 . . . . 74.349999999999994 111.309 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -58.84 -23.94 61.36 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.708 0.803 . . . . 65.219999999999999 111.604 171.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.8 tp -95.04 -58.47 2.14 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.067 0.947 . . . . 73.519999999999996 112.866 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.03 -34.14 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 123.607 0.763 . . . . 74.310000000000002 112.996 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.66 -45.27 94.95 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 115.216 0.846 . . . . 63.350000000000001 115.216 -166.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.78 -31.21 1.93 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.305 1.594 . . . . 74.349999999999994 115.305 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.4 t80 73.88 -59.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.03 1.332 . . . . 74.540000000000006 111.254 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -59.62 -38.16 80.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.926 0.89 . . . . 70.140000000000001 112.54 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HB2' ' HD3' ' A' ' 29' ' ' ARG . . . -99.58 27.21 5.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.631 0.772 . . . . 75.510000000000005 111.598 -166.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.522 HG12 HG23 ' A' ' 34' ' ' VAL . 19.0 tt -62.72 -22.98 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.286 1.034 . . . . 72.5 112.382 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -68.84 -3.73 13.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.163 0.801 . . . . 74.239999999999995 113.163 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.477 ' HD3' ' HB2' ' A' ' 26' ' ' ALA . 48.0 mtp180 -76.61 -24.37 53.41 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.826 0.85 . . . . 73.239999999999995 112.445 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -129.6 -37.56 1.57 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.255 0.835 . . . . 75.409999999999997 113.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -90.06 108.52 26.62 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.965 0.506 . . . . 73.310000000000002 109.798 -171.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.41 -23.59 32.21 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.154 2.57 . . . . 74.129999999999995 114.708 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -80.82 -15.65 55.81 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.989 0.516 . . . . 63.229999999999997 112.068 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.621 HG22 ' HE2' ' A' ' 53' ' ' PHE . 94.8 t -68.27 106.72 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.11 0.481 . . . . 75.549999999999997 111.37 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -89.11 54.92 3.13 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.491 0.716 . . . . 74.329999999999998 110.681 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.09 105.17 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 125.449 1.499 . . . . 72.030000000000001 113.429 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.646 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 64.4 Cg_endo -90.35 148.76 4.42 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.861 2.374 . . . . 74.310000000000002 113.149 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -101.02 115.14 29.77 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.127 0.571 . . . . 72.540000000000006 110.111 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.436 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.8 tm? -89.37 112.32 23.4 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 109.096 -0.705 . . . . 73.239999999999995 109.096 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -102.48 123.09 45.6 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.918 0.887 . . . . 70.040000000000006 110.856 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.32 -178.6 0.01 OUTLIER Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.716 2.247 . . . . 72.519999999999996 118.716 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 70.11 -31.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.86 1.8 . . . . 72.409999999999997 115.86 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m 83.13 137.64 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 126.202 1.801 . . . . 74.230000000000004 111.009 -167.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.14 -14.31 40.35 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.243 2.629 . . . . 73.510000000000005 115.244 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -92.21 -14.31 29.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.977 0.511 . . . . 74.209999999999994 111.541 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.3 m -95.55 123.98 54.53 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.006 0.922 . . . . 73.099999999999994 110.905 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.412 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.6 Cg_exo -48.5 98.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.735 2.957 . . . . 64.299999999999997 114.254 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.68 -39.19 0.47 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 113.922 0.329 . . . . 50.539999999999999 113.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.65 139.08 45.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.595 1.331 . . . . 74.140000000000001 114.595 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 4.2 mp0 -103.35 149.23 24.96 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.089 0.555 . . . . 74.120000000000005 110.857 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 34.4 ptt180 -127.04 119.78 27.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.48 0.582 . . . . 72.219999999999999 110.575 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.24 102.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.647 0.779 . . . . 74.219999999999999 110.795 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HE2' HG22 ' A' ' 34' ' ' VAL . 6.0 m-85 -64.0 123.03 17.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.438 1.095 . . . . 73.239999999999995 111.354 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.06 -66.27 3.89 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-O 120.143 -0.254 . . . . 73.400000000000006 112.783 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.61 35.06 20.05 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.415 1.086 . . . . 74.510000000000005 113.456 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.82 37.78 0.05 OUTLIER Glycine 0 N--CA 1.476 1.301 0 CA-C-N 115.781 -0.645 . . . . 45.43 112.198 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -147.16 162.42 38.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.338 1.055 . . . . 74.239999999999995 110.901 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.57 -23.39 65.4 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.379 0.672 . . . . 64.519999999999996 112.496 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -122.06 90.22 3.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.011 0.524 . . . . 72.25 111.355 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.34 171.15 7.49 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.457 0.646 . . . . 63.049999999999997 111.321 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.516 HD13 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -136.72 114.15 10.91 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.661 0.784 . . . . 74.120000000000005 109.17 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 44.0 t -99.23 113.79 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.524 -0.546 . . . . 73.219999999999999 109.524 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.474 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 58.0 mt-10 -107.21 167.22 10.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.431 1.093 . . . . 72.340000000000003 110.627 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -151.07 125.23 9.32 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 63.310000000000002 110.548 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 39.5 tp -69.09 116.36 9.44 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.87 1.268 . . . . 72.340000000000003 111.245 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -82.19 -51.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 122.924 0.49 . . . . 74.019999999999996 110.98 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.5 pt-20 -156.4 152.67 27.8 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.485 0.714 . . . . 75.239999999999995 110.032 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -142.48 131.72 23.41 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.264 0.554 . . . . 74.299999999999997 111.715 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.8 m-20 -119.09 102.58 8.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.913 1.285 . . . . 71.030000000000001 110.068 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.69 -52.73 55.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.866 0.866 . . . . 74.329999999999998 112.124 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -71.49 -33.42 69.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.102 0.561 . . . . 75.150000000000006 112.182 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -83.29 -10.36 58.56 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 112.75 0.648 . . . . 64.120000000000005 112.75 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 61.16 34.37 18.96 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.927 0.891 . . . . 74.430000000000007 111.65 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -119.06 112.23 19.29 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.877 0.871 . . . . 73.420000000000002 110.432 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -118.34 108.66 15.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.478 1.111 . . . . 74.540000000000006 111.631 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.542 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.8 t -108.48 127.78 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.693 -0.629 . . . . 71.519999999999996 111.685 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -135.89 -179.26 5.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.817 0.847 . . . . 64.120000000000005 111.203 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -146.01 164.29 32.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.608 1.163 . . . . 74.219999999999999 109.839 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 61' ' ' LEU . 73.6 mtm -103.52 97.07 9.67 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 122.988 0.515 . . . . 74.129999999999995 110.013 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.07 -13.42 31.36 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.155 2.57 . . . . 63.530000000000001 112.96 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 14.6 t70 -140.57 79.36 20.17 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 109.022 -0.733 . . . . 71.530000000000001 109.022 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -90.2 136.69 2.46 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.208 2.605 . . . . 74.239999999999995 113.747 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.54 -10.9 20.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.368 2.046 . . . . 74.219999999999999 113.231 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -94.02 131.53 31.5 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.713 0.805 . . . . 74.340000000000003 110.239 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 117' ' ' THR . 37.5 Cg_endo -63.92 88.86 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.973 2.448 . . . . 74.120000000000005 113.465 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.645 HG23 ' HB2' ' A' ' 113' ' ' CYS . 22.0 pt -134.87 165.19 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 124.998 1.319 . . . . 75.219999999999999 109.762 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.0 m -100.75 -76.9 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.898 0.479 . . . . 74.010000000000005 110.947 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.77 110.32 22.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.013 0.435 . . . . 64.540000000000006 111.073 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -89.21 147.26 24.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.03 0.532 . . . . 73.409999999999997 111.165 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -153.28 125.57 8.05 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.219 1.008 . . . . 74.420000000000002 108.869 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.61 146.86 44.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.725 0.693 . . . . 71.030000000000001 112.056 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.92 145.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.796 0.838 . . . . 75.140000000000001 110.955 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 108.78 15.9 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.572 1.149 . . . . 63.020000000000003 108.062 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.99 112.71 17.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.682 0.393 . . . . 73.239999999999995 110.533 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.605 HG13 HG23 ' A' ' 105' ' ' VAL . 21.6 t -90.54 108.12 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.819 -0.808 . . . . 75.230000000000004 108.819 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.6 t -99.39 108.92 52.87 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.398 1.079 . . . . 75.510000000000005 110.153 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.94 124.79 11.35 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.102 1.868 . . . . 71.219999999999999 113.018 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -93.81 -56.46 2.88 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.375 -0.972 . . . . 64.299999999999997 108.375 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -118.75 -169.35 1.71 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.724 1.209 . . . . 73.0 110.068 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.52 -27.25 46.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.131 0.572 . . . . 73.040000000000006 111.475 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -109.56 2.03 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.839 0.856 . . . . 75.010000000000005 112.634 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -136.93 125.24 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.873 0.469 . . . . 73.530000000000001 109.771 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' HG22 ' A' ' 17' ' ' VAL . 31.6 p -137.29 132.82 34.25 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.023 0.44 . . . . 64.430000000000007 110.657 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.2 m -91.66 109.82 21.14 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.931 -0.577 . . . . 64.409999999999997 110.828 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.605 HG23 HG13 ' A' ' 95' ' ' VAL . 27.1 t -88.34 111.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.585 -0.524 . . . . 74.230000000000004 109.585 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.09 114.75 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.562 0.745 . . . . 74.340000000000003 110.667 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -103.84 118.69 37.28 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.439 0.696 . . . . 72.450000000000003 109.178 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.5 m -112.47 139.48 48.02 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.359 1.064 . . . . 62.0 109.817 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.61 108.89 4.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.214 0.605 . . . . 63.210000000000001 111.505 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.36 135.4 54.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.308 1.043 . . . . 72.109999999999999 110.375 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.28 145.07 26.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.624 0.77 . . . . 74.409999999999997 111.274 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.42 79.6 9.51 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.849 0.833 . . . . 72.439999999999998 109.914 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.645 ' HB2' HG23 ' A' ' 86' ' ' ILE . 49.1 t -108.94 164.58 12.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.734 -1.121 . . . . 64.109999999999999 111.317 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.5 t -83.01 137.57 43.19 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.574 -0.727 . . . . 73.230000000000004 110.169 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -44.56 -49.05 9.61 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 124.617 3.545 . . . . 73.239999999999995 116.165 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.78 -32.17 73.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.836 0.68 . . . . 72.150000000000006 112.836 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.509 HG23 ' HG2' ' A' ' 85' ' ' PRO . 55.0 m -82.79 -33.51 27.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.825 0.45 . . . . 74.099999999999994 110.857 174.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.48 86.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.483 0.713 . . . . 73.239999999999995 111.76 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.18 -36.47 79.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.181 0.593 . . . . 61.530000000000001 111.88 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.32 -42.04 79.95 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.099999999999994 110.79 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.94 -24.49 64.28 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 71.140000000000001 112.016 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.59 -41.63 97.7 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.851 0.461 . . . . 62.200000000000003 111.826 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -76.94 -45.54 27.38 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.021 0.748 . . . . 72.299999999999997 113.021 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.6 -54.74 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 112.535 0.569 . . . . 44.439999999999998 112.535 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.95 -49.05 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.297 0.639 . . . . 75.310000000000002 110.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.03 -79.39 0.43 Allowed Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.251 -0.431 . . . . 61.329999999999998 113.592 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.59 -7.41 26.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.496 0.924 . . . . 65.010000000000005 113.496 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.23 -83.51 1.72 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 112.098 -0.401 . . . . 51.509999999999998 112.098 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.2 t -58.2 -46.66 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.048 0.939 . . . . 74.510000000000005 113.331 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.41 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 4.4 m-30 -77.57 -49.39 14.73 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.847 0.459 . . . . 73.129999999999995 111.21 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.55 -17.14 59.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.07 0.767 . . . . 73.230000000000004 113.07 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -85.2 -55.46 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 122.843 0.457 . . . . 74.420000000000002 111.376 166.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.72 -53.62 36.87 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 114.518 0.567 . . . . 71.340000000000003 114.518 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.86 -41.6 78.24 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.323 1.049 . . . . 70.040000000000006 112.138 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.406 ' HB3' ' HE1' ' A' ' 148' ' ' HIS . 2.6 m-20 -74.31 -39.4 62.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.349 -0.842 . . . . 72.510000000000005 111.953 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.41 75.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.408 0.683 . . . . 73.019999999999996 111.0 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 17' ' ' VAL . 9.7 tt -65.63 -43.27 90.0 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.785 0.834 . . . . 74.340000000000003 110.585 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.37 68.88 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 122.884 0.474 . . . . 72.340000000000003 111.839 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.11 -39.94 60.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.95 0.9 . . . . 74.439999999999998 112.512 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -73.83 -22.99 59.58 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.723 0.638 . . . . 73.109999999999999 112.723 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -90.09 -2.5 58.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.076 -0.39 . . . . 74.150000000000006 111.242 168.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -67.41 -8.18 49.83 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 116.285 -0.416 . . . . 74.530000000000001 114.031 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.65 ' HG3' HD11 ' A' ' 144' ' ' LEU . 8.8 ptm180 -61.28 -26.06 67.52 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.344 0.658 . . . . 75.109999999999999 111.987 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.65 HD11 ' HG3' ' A' ' 143' ' ' ARG . 6.4 mp -78.36 -62.82 1.56 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.773 0.429 . . . . 73.310000000000002 110.162 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -131.74 90.34 2.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 122.84 0.456 . . . . 74.340000000000003 112.04 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 55.79 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 C-N-CA 127.496 2.318 . . . . 75.019999999999996 116.579 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -89.2 162.03 16.13 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.301 -0.863 . . . . 71.099999999999994 110.63 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.406 ' HE1' ' HB3' ' A' ' 135' ' ' ASN . 29.0 p80 -129.48 178.0 6.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 73.409999999999997 110.09 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -61.89 126.34 27.01 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.798 0.439 . . . . 74.239999999999995 110.089 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -60.86 126.43 27.37 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.437 0.295 . . . . 74.329999999999998 110.77 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 123.734 0.814 . . . . 74.129999999999995 110.938 -169.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 121.022 0.439 . . . . 72.230000000000004 111.211 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.95 73.36 10.35 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.991 0.901 . . . . 63.520000000000003 110.306 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -142.39 131.18 22.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.06 -0.973 . . . . 75.430000000000007 110.746 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.53 121.08 44.39 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.033 1.333 . . . . 75.310000000000002 109.133 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -120.35 120.53 36.28 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.248 0.547 . . . . 73.140000000000001 110.111 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.43 147.29 46.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.542 1.137 . . . . 74.200000000000003 109.616 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.6 p -151.0 150.47 30.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.314 0.646 . . . . 61.329999999999998 111.018 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.3 p -146.82 138.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.175 0.59 . . . . 73.299999999999997 111.645 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.53 108.9 19.26 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.289 0.566 . . . . 72.25 110.036 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -101.62 131.36 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.71 1.204 . . . . 74.439999999999998 110.303 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.34 73.95 3.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.875 0.47 . . . . 75.230000000000004 111.133 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 155.81 7.51 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.393 0.677 . . . . 74.200000000000003 111.481 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.74 138.55 38.15 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.901 2.4 . . . . 73.219999999999999 111.905 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.35 -32.32 48.61 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.95 1.093 . . . . 74.219999999999999 113.95 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -50.26 66.81 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.952 0.501 . . . . 65.140000000000001 111.885 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.24 -39.23 82.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.467 0.707 . . . . 70.129999999999995 112.595 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.537 ' HA ' ' HH ' ' A' ' 141' ' ' TYR . 21.5 t -70.95 -34.37 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.491 0.316 . . . . 72.409999999999997 110.654 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.686 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 69.4 t-105 -67.31 -28.94 68.41 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.834 0.454 . . . . 71.25 111.316 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -64.17 -21.24 66.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.124 0.57 . . . . 73.439999999999998 111.579 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 tp -90.32 -43.13 10.55 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 124.465 1.106 . . . . 72.129999999999995 112.916 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -107.13 13.72 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 113.778 1.029 . . . . 75.230000000000004 113.778 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.06 -17.22 75.02 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 114.169 0.428 . . . . 75.450000000000003 114.169 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.9 m-20 -102.78 137.88 40.41 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.359 0.664 . . . . 73.400000000000006 110.307 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.67 -23.79 67.52 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.96 0.904 . . . . 73.200000000000003 111.008 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.7 p -89.21 -22.37 22.8 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.823 0.849 . . . . 60.439999999999998 112.803 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -81.92 4.17 23.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.159 0.429 . . . . 64.299999999999997 112.159 -166.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.635 HG23 HG13 ' A' ' 34' ' ' VAL . 19.4 tt -66.91 -25.29 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.131 0.572 . . . . 74.150000000000006 111.761 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -74.71 -7.06 52.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 122.08 -0.387 . . . . 75.409999999999997 111.987 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.77 -31.9 25.68 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.127 0.571 . . . . 73.319999999999993 111.752 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.7 p-90 -118.48 -29.05 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.673 0.62 . . . . 75.219999999999999 112.673 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.4 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 38.8 t-80 -94.16 107.62 30.02 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 109.741 -0.466 . . . . 72.409999999999997 109.741 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.05 -7.24 20.98 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.916 2.41 . . . . 72.239999999999995 114.96 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -87.63 -28.6 21.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.693 0.397 . . . . 75.319999999999993 111.269 172.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.635 HG13 HG23 ' A' ' 27' ' ' ILE . 46.4 t -80.97 107.45 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 109.902 -0.407 . . . . 73.129999999999995 109.902 174.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -72.75 -71.37 0.3 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.976 0.51 . . . . 74.319999999999993 110.951 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.62 104.38 0.46 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 123.986 0.915 . . . . 73.030000000000001 110.399 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 58.9 Cg_endo -84.97 166.6 11.27 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.985 2.457 . . . . 70.420000000000002 114.343 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -100.93 114.9 29.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.673 1.189 . . . . 73.420000000000002 110.122 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 4.2 mm? -90.85 134.73 34.22 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.727 0.411 . . . . 74.420000000000002 111.419 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -108.95 121.32 44.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.526 0.73 . . . . 75.530000000000001 111.322 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.02 -169.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 117.837 1.895 . . . . 65.129999999999995 117.837 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 56.63 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.635 1.174 . . . . 74.340000000000003 113.714 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.3 t 168.4 148.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 125.591 1.557 . . . . 71.040000000000006 108.766 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.17 -14.08 31.8 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.476 2.117 . . . . 73.129999999999995 112.792 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -95.82 -20.5 18.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.172 0.989 . . . . 64.25 112.789 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.8 m -99.78 123.37 47.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 122.692 0.397 . . . . 74.299999999999997 111.568 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.3 Cg_endo -57.16 126.9 23.6 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.056 2.504 . . . . 70.109999999999999 113.325 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.62 -24.75 4.58 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.918 -0.583 . . . . 44.210000000000001 112.331 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 138.75 55.67 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.155 0.582 . . . . 72.319999999999993 111.597 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 39.9 mt-10 -113.22 134.35 54.63 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.492 0.717 . . . . 70.310000000000002 110.603 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 25.1 ptt180 -108.41 118.98 38.2 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.301 0.572 . . . . 75.150000000000006 110.164 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG12 HG23 ' A' ' 62' ' ' VAL . 42.3 t -116.5 114.28 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.424 0.69 . . . . 75.420000000000002 110.611 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.56 ' HB2' ' H ' ' A' ' 61' ' ' LEU . 1.7 m-85 -71.77 90.83 1.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.919 0.887 . . . . 75.140000000000001 111.897 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.26 3.72 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 119.941 -0.366 . . . . 74.120000000000005 113.251 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.89 96.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.743 1.217 . . . . 75.310000000000002 112.195 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.49 4.65 Favored Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.112 -0.367 . . . . 74.129999999999995 113.855 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.7 p -104.59 -81.63 0.52 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.611 0.764 . . . . 73.129999999999995 110.793 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.014 0.926 . . . . 70.420000000000002 110.367 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -132.36 39.23 3.4 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.136 0.97 . . . . 75.200000000000003 109.572 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 122.56 16.09 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.112 -0.949 . . . . 73.349999999999994 111.291 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' H ' ' HB2' ' A' ' 53' ' ' PHE . 57.7 tp -97.23 116.87 30.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.573 0.749 . . . . 72.439999999999998 110.611 -174.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.544 HG23 HG12 ' A' ' 52' ' ' VAL . 48.6 t -98.55 114.92 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.7 -0.481 . . . . 74.040000000000006 109.7 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 79' ' ' MET . 41.7 mt-10 -118.24 164.06 15.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.219 1.008 . . . . 73.019999999999996 110.392 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -148.3 130.38 15.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.575 0.75 . . . . 73.409999999999997 110.944 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 28.7 tp -73.3 112.1 9.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.115 0.966 . . . . 70.5 110.817 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.14 -47.91 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.439 0.695 . . . . 74.200000000000003 110.84 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.324 1.05 . . . . 73.319999999999993 109.535 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -139.91 108.67 5.95 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.68 -0.638 . . . . 74.310000000000002 109.856 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.7 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 3.2 m-20 -91.3 71.26 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.708 0.803 . . . . 72.319999999999993 109.934 -175.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.686 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 44.1 tt0 -63.73 -31.96 73.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.019 -0.537 . . . . 75.299999999999997 111.631 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -66.8 -14.66 62.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.8 0.84 . . . . 71.409999999999997 112.568 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.22 4.99 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.769 0.828 . . . . 71.510000000000005 112.604 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 55.89 60.46 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.264 1.025 . . . . 73.340000000000003 112.46 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.7 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 42.5 ttm180 -143.0 147.33 34.95 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.195 0.998 . . . . 73.420000000000002 110.357 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.8 tp -137.49 108.45 6.72 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.366 1.066 . . . . 75.340000000000003 110.181 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.22 127.57 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.604 0.762 . . . . 72.450000000000003 111.1 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.2 177.69 10.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.045 0.538 . . . . 74.340000000000003 112.319 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -142.92 157.6 44.42 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.092 0.957 . . . . 75.239999999999995 110.781 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.61 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 18.0 ptt? -111.53 98.49 40.78 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 117.993 0.36 . . . . 73.540000000000006 110.231 163.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.47 -22.41 74.01 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.258 2.639 . . . . 73.230000000000004 112.726 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 3.9 m-20 -118.33 83.61 21.06 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.692 0.797 . . . . 73.420000000000002 109.909 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.74 144.51 3.02 Favored 'Trans proline' 0 CA--C 1.566 2.075 0 C-N-CA 122.806 2.337 . . . . 74.409999999999997 113.14 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.6 4.58 6.55 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.648 2.232 . . . . 74.030000000000001 112.921 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -105.36 153.64 39.55 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 124.061 0.945 . . . . 64.5 111.201 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.15 71.61 3.56 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.185 2.59 . . . . 73.420000000000002 113.12 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.728 HG21 ' HB2' ' A' ' 113' ' ' CYS . 21.4 pt -139.61 153.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.247 1.019 . . . . 73.140000000000001 110.65 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 15.9 m -95.36 -91.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.27 -0.395 . . . . 72.409999999999997 110.887 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -85.42 121.83 28.69 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-N 119.19 0.905 . . . . 74.230000000000004 109.654 175.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.417 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 52.7 t-80 -109.06 121.16 44.56 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.075 0.55 . . . . 74.430000000000007 111.875 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 146.53 28.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.296 1.038 . . . . 74.239999999999995 109.179 167.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.79 132.37 19.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.867 0.867 . . . . 74.540000000000006 109.747 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.2 p -133.82 129.9 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.159 0.584 . . . . 74.150000000000006 112.194 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.44 123.72 48.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.247 1.419 . . . . 75.129999999999995 108.618 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.05 149.25 50.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.13 0.572 . . . . 74.239999999999995 110.503 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.537 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 13.6 m -125.56 109.78 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.86 0.838 . . . . 65.510000000000005 109.419 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 125.59 76.34 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.024 0.929 . . . . 71.040000000000006 110.504 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.78 72.65 1.93 Allowed 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.722 2.281 . . . . 73.219999999999999 111.912 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -71.31 -35.19 71.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.733 0.813 . . . . 73.329999999999998 110.006 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 27.3 t70 -163.78 163.08 24.11 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.173 1.389 . . . . 74.209999999999994 108.655 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.81 -8.42 52.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.735 -0.603 . . . . 65.230000000000004 112.21 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -126.0 -2.86 7.07 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.489 1.116 . . . . 72.430000000000007 111.935 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 39.6 m170 -135.97 127.6 28.92 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.463 0.705 . . . . 73.430000000000007 110.453 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 39.7 t -129.88 134.22 47.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.526 0.73 . . . . 64.150000000000006 110.404 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 90.1 m -98.24 111.63 23.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.283 -0.266 . . . . 73.219999999999999 110.283 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG22 HG11 ' A' ' 95' ' ' VAL . 34.3 t -86.73 106.11 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.063 -0.717 . . . . 73.25 109.063 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.11 117.42 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.536 0.735 . . . . 74.319999999999993 110.189 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -118.82 121.42 39.99 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.166 -0.679 . . . . 73.540000000000006 109.166 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.567 HG23 ' SD ' ' A' ' 110' ' ' MET . 56.4 m -129.98 130.18 44.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.238 0.615 . . . . 72.409999999999997 110.791 -172.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.28 115.78 24.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 70.129999999999995 110.915 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.567 ' SD ' HG23 ' A' ' 108' ' ' THR . 3.5 mpp? -99.28 140.57 33.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.437 -0.949 . . . . 74.409999999999997 108.437 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.19 151.66 23.35 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.022 0.749 . . . . 74.530000000000001 113.022 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 20.2 t70 -83.7 85.29 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.146 -0.934 . . . . 74.409999999999997 109.42 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.728 ' HB2' HG21 ' A' ' 86' ' ' ILE . 43.7 t -128.83 163.58 24.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.986 -0.552 . . . . 73.400000000000006 112.406 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.4 p -75.19 141.4 74.11 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.587 -0.733 . . . . 54.43 111.47 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -48.37 -39.75 35.8 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.561 2.84 . . . . 71.239999999999995 113.866 170.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.57 -42.27 87.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.783 0.833 . . . . 64.340000000000003 112.572 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.543 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 27.0 m -82.47 -26.23 32.82 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.597 0.359 . . . . 72.109999999999999 111.424 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.89 76.42 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.544 0.738 . . . . 50.219999999999999 112.507 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -60.37 -33.56 72.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.974 0.51 . . . . 73.109999999999999 111.858 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -44.0 57.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.314 0.646 . . . . 74.519999999999996 110.601 174.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -34.65 77.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.076 0.398 . . . . 74.239999999999995 112.076 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.35 -43.8 97.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.886 0.474 . . . . 74.439999999999998 111.017 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.6 m -69.64 -56.41 7.35 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.223 0.609 . . . . 61.109999999999999 112.64 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.47 -49.65 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 124.644 1.177 . . . . 75.109999999999999 112.685 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.72 -48.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 122.604 0.361 . . . . 74.019999999999996 110.977 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.45 -75.53 0.6 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 114.126 0.411 . . . . 74.329999999999998 114.126 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.19 -26.7 68.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.181 0.592 . . . . 73.209999999999994 111.695 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.86 -89.54 0.55 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.281 -0.418 . . . . 75.329999999999998 112.777 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.21 -49.47 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.887 0.875 . . . . 74.310000000000002 113.175 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -73.36 -53.73 10.05 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.647 0.779 . . . . 73.099999999999994 112.111 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.34 73.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.677 0.391 . . . . 72.439999999999998 111.968 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.74 -49.87 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 74.329999999999998 111.329 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.34 87.21 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 116.476 -0.329 . . . . 72.540000000000006 113.602 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 mt -69.27 -38.22 78.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 74.439999999999998 112.152 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.9 m-20 -67.04 -43.11 83.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.728 0.411 . . . . 71.400000000000006 110.23 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.02 81.83 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.301 0.64 . . . . 74.230000000000004 111.737 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.446 HD23 HG13 ' A' ' 17' ' ' VAL . 7.4 tt -65.87 -41.96 90.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.359 0.664 . . . . 74.329999999999998 110.234 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.94 79.44 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 116.389 -0.369 . . . . 73.129999999999995 111.245 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 41.6 mt-10 -64.53 -41.52 96.31 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.53 0.937 . . . . 74.439999999999998 113.53 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -64.05 -32.26 73.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.164 0.431 . . . . 75.420000000000002 112.164 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.537 ' HH ' ' HA ' ' A' ' 17' ' ' VAL . 75.2 m-85 -88.8 -23.12 22.94 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.311 0.856 . . . . 73.439999999999998 113.311 -176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.99 6.75 0.03 OUTLIER Glycine 0 N--CA 1.486 1.995 0 N-CA-C 115.314 0.885 . . . . 73.430000000000007 115.314 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 49.1 mtp180 57.6 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.173 1.389 . . . . 74.129999999999995 113.032 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.86 107.73 14.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.414 0.686 . . . . 75.420000000000002 109.984 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -35.75 22.27 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.109 0.48 . . . . 72.209999999999994 110.247 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -146.74 -168.66 3.09 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.85 1.66 . . . . 75.299999999999997 108.708 171.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 70.63 154.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.034 1.334 . . . . 74.140000000000001 113.989 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -161.44 137.99 8.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.026 0.93 . . . . 72.439999999999998 110.16 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 61.22 63.75 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.74 1.216 . . . . 74.099999999999994 112.433 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -162.66 133.3 4.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.847 -1.069 . . . . 72.129999999999995 110.114 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 . . . . . 0 N--CA 1.486 1.339 0 C-N-CA 123.404 0.682 . . . . 72.040000000000006 111.137 177.125 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 119.683 -0.199 . . . . 75.430000000000007 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.61 31.43 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.792 0.837 . . . . 61.149999999999999 111.45 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 110' ' ' MET . 89.8 m -117.15 112.21 20.55 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.672 0.789 . . . . 71.120000000000005 109.922 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.42 126.32 45.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.933 1.293 . . . . 73.340000000000003 110.117 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -118.29 119.72 35.49 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.757 0.423 . . . . 75.200000000000003 109.879 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -127.64 139.29 52.82 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.594 0.757 . . . . 73.010000000000005 109.879 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 p -144.87 155.33 43.4 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.343 0.657 . . . . 75.310000000000002 111.382 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 104' ' ' THR . 13.7 p -150.31 147.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.219999999999999 110.641 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.86 109.09 21.86 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.332 0.587 . . . . 74.209999999999994 110.289 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.2 t -95.07 137.81 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.386 1.474 . . . . 74.530000000000001 110.834 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.61 67.68 5.44 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.484 0.714 . . . . 73.030000000000001 112.305 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB3' ' CD1' ' A' ' 141' ' ' TYR . . . -163.29 150.31 10.64 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.441 0.696 . . . . 74.409999999999997 111.449 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.82 144.24 76.6 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.711 2.274 . . . . 70.140000000000001 111.296 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -48.11 -41.22 25.82 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.234 1.568 . . . . 74.400000000000006 115.234 -172.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.31 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.967 0.507 . . . . 73.219999999999999 112.087 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.63 -41.99 87.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.858 0.863 . . . . 64.340000000000003 112.511 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -70.88 -36.27 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.042 0.449 . . . . 73.340000000000003 110.647 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -68.29 -27.61 66.46 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.246 0.618 . . . . 74.120000000000005 111.628 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m -62.11 -31.5 71.96 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.268 0.556 . . . . 74.439999999999998 110.886 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.0 tp -83.15 -58.29 2.91 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.479 1.112 . . . . 75.540000000000006 112.35 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.95 -20.16 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.068 0.766 . . . . 73.310000000000002 113.068 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.83 12.4 16.95 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.346 0.898 . . . . 74.129999999999995 115.346 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 11.1 t70 -120.61 120.6 36.23 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.072 0.949 . . . . 71.040000000000006 108.486 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.5 -31.38 72.42 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.92 0.888 . . . . 74.239999999999995 112.124 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.8 t -82.3 -22.81 35.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.432 0.693 . . . . 74.439999999999998 112.074 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.55 22.52 6.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.832 0.679 . . . . 51.5 112.832 -163.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.679 HG23 HG13 ' A' ' 34' ' ' VAL . 20.1 tt -69.02 -22.53 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 123.389 0.676 . . . . 74.25 111.605 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -62.1 -14.62 38.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.752 1.019 . . . . 73.310000000000002 113.752 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -78.97 -46.46 18.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.934 0.493 . . . . 73.349999999999994 111.945 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.418 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.9 p-90 -103.79 -30.89 10.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.684 0.393 . . . . 75.299999999999997 111.706 -171.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -91.34 107.85 24.57 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 122.98 0.512 . . . . 72.430000000000007 110.107 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.34 -19.42 61.73 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.072 2.515 . . . . 74.400000000000006 114.787 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.32 -23.6 30.16 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.608 0.363 . . . . 71.430000000000007 111.858 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 27' ' ' ILE . 84.8 t -76.21 118.8 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 120.843 0.354 . . . . 72.140000000000001 111.397 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.1 m -73.26 -74.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.965 0.906 . . . . 74.439999999999998 110.554 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -167.51 103.32 0.6 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.588 0.755 . . . . 72.439999999999998 110.72 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.35 150.3 17.26 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.762 2.308 . . . . 73.329999999999998 113.529 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.7 m -100.26 123.49 44.55 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.093 0.957 . . . . 72.140000000000001 108.853 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.8 128.54 40.1 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.242 -0.651 . . . . 63.340000000000003 109.242 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -124.93 148.59 48.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.195 0.998 . . . . 74.129999999999995 110.312 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.37 132.5 0.0 OUTLIER Glycine 0 CA--C 1.554 2.515 0 N-CA-C 117.584 1.794 . . . . 60.210000000000001 117.584 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 67.31 -90.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.146 1.378 . . . . 72.340000000000003 113.392 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t 179.77 150.11 0.51 Allowed Pre-proline 0 N--CA 1.492 1.645 0 C-N-CA 124.08 0.952 . . . . 74.140000000000001 110.52 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.19 -6.55 14.97 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.459 2.106 . . . . 64.299999999999997 113.343 173.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -109.6 -7.58 15.1 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.639 0.776 . . . . 63.32 111.877 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 m -103.73 121.85 46.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 122.8 0.44 . . . . 75.010000000000005 111.401 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.8 121.19 8.81 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.297 2.664 . . . . 75.239999999999995 113.104 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.29 -6.5 8.68 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 122.865 0.269 . . . . 54.119999999999997 113.379 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.12 172.82 11.68 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.578 0.751 . . . . 71.109999999999999 112.957 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.35 152.64 45.95 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.178 0.991 . . . . 62.340000000000003 111.12 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -130.94 132.0 44.8 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.496 0.718 . . . . 72.25 110.31 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.51 110.85 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.602 0.761 . . . . 75.519999999999996 110.139 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 78.4 m-85 -71.66 97.39 1.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.451 0.908 . . . . 74.450000000000003 113.451 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.85 -59.31 0.67 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.496 -0.642 . . . . 62.219999999999999 111.496 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.03 108.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.746 1.219 . . . . 75.409999999999997 112.616 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.79 54.41 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 116.515 -0.311 . . . . 70.030000000000001 113.268 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.9 p -116.27 -79.98 0.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.613 0.765 . . . . 71.409999999999997 111.087 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 177.42 -54.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.61 1.164 . . . . 72.25 107.913 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.1 14.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.792 1.237 . . . . 73.540000000000006 113.605 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.4 pt-20 -71.05 96.08 1.28 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.266 1.031 . . . . 74.310000000000002 112.59 -172.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -87.72 131.53 34.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.425 -1.261 . . . . 73.510000000000005 108.918 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -102.43 115.59 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.283 -0.636 . . . . 73.319999999999993 109.283 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.604 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 44.8 mt-10 -121.0 133.96 55.28 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 73.040000000000006 110.749 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.35 120.83 43.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.065 0.946 . . . . 73.109999999999999 110.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.71 119.59 11.46 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.645 1.178 . . . . 73.540000000000006 112.045 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.97 -51.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.508 0.723 . . . . 65.230000000000004 111.048 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 13.0 pt-20 -160.21 165.02 32.31 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 74.209999999999994 111.131 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.2 ttp85 -156.81 128.59 7.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.314 0.646 . . . . 75.140000000000001 109.917 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.39 123.88 38.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.747 0.819 . . . . 72.349999999999994 109.949 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.23 -46.64 49.0 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.823 0.849 . . . . 72.510000000000005 111.05 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.8 t -65.54 -25.14 67.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.136 0.974 . . . . 71.239999999999995 112.72 -170.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.54 -7.58 15.7 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.817 0.847 . . . . 74.299999999999997 112.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 11.6 mtm-85 58.93 45.62 14.84 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.93 0.892 . . . . 73.439999999999998 112.296 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -114.72 124.62 52.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.237 1.015 . . . . 73.120000000000005 111.054 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.4 tp -122.43 107.95 12.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.749 0.82 . . . . 73.409999999999997 110.043 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.621 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 39.4 t -111.06 136.08 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.555 0.616 . . . . 74.409999999999997 110.711 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -150.14 -179.91 7.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.047 0.939 . . . . 73.430000000000007 110.902 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 t -142.43 164.12 30.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.877 0.871 . . . . 73.099999999999994 110.593 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mtp -109.3 88.35 5.87 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 123.661 0.784 . . . . 74.030000000000001 110.305 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.604 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 34.9 Cg_endo -62.28 -34.27 78.33 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.558 2.839 . . . . 74.230000000000004 113.637 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -125.28 81.95 63.03 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.006 0.522 . . . . 74.409999999999997 109.736 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -94.39 147.38 1.86 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 123.072 2.515 . . . . 75.439999999999998 113.869 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.72 -2.2 11.72 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.412 2.075 . . . . 72.219999999999999 112.774 170.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -99.83 135.4 20.5 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.228 1.011 . . . . 73.329999999999998 109.449 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.92 82.01 0.6 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.923 2.416 . . . . 74.219999999999999 112.666 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.751 HG21 ' HB2' ' A' ' 113' ' ' CYS . 14.6 pt -135.09 141.6 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 124.229 1.012 . . . . 75.310000000000002 110.308 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.3 m -83.94 -75.65 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.173 -0.33 . . . . 74.230000000000004 110.875 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -107.92 111.02 22.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.19 0.519 . . . . 72.219999999999999 110.448 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -92.91 151.68 19.81 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.731 0.813 . . . . 75.239999999999995 111.775 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -150.19 126.49 10.72 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 74.019999999999996 109.702 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.86 143.23 49.39 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.882 0.765 . . . . 75.439999999999998 112.003 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 8.9 p -137.6 142.24 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 113.14 0.793 . . . . 64.319999999999993 113.14 -176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -108.42 117.11 33.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.869 1.268 . . . . 73.450000000000003 109.05 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 46.5 mt-10 -127.37 113.91 16.86 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.757 0.423 . . . . 71.109999999999999 111.345 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.06 111.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.081 0.467 . . . . 74.099999999999994 109.755 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.36 110.16 59.15 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.136 0.974 . . . . 73.310000000000002 110.261 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HA ' ' SG ' ' A' ' 103' ' ' CYS . 51.8 Cg_endo -66.16 114.43 3.02 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.703 2.269 . . . . 74.299999999999997 114.655 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.4 11.91 22.31 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.162 0.985 . . . . 75.439999999999998 111.304 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 67.85 175.28 0.26 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.475 1.51 . . . . 75.219999999999999 113.287 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 60.26 -86.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.277 1.431 . . . . 74.349999999999994 112.397 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -153.09 43.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.785 0.802 . . . . 74.230000000000004 109.98 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -142.65 139.5 31.26 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.408 0.683 . . . . 75.519999999999996 109.545 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 97' ' ' PRO . 75.5 m -153.63 138.97 17.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.507 0.723 . . . . 75.329999999999998 111.141 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 25.3 m -90.93 111.27 22.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.988 0.515 . . . . 73.209999999999994 111.163 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.34 118.88 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.897 0.479 . . . . 73.420000000000002 109.938 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.29 112.55 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.782 0.833 . . . . 74.209999999999994 109.965 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -107.49 112.03 24.6 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 108.812 -0.81 . . . . 73.120000000000005 108.812 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.7 m -123.83 127.2 47.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.59 0.756 . . . . 71.549999999999997 110.152 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.3 118.44 22.3 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.225 0.61 . . . . 75.129999999999995 111.362 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.612 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -118.8 128.83 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.588 1.155 . . . . 71.409999999999997 109.09 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -145.26 156.5 43.87 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.719 0.808 . . . . 74.109999999999999 111.498 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 25.3 t70 -89.86 85.15 6.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.372 0.606 . . . . 74.439999999999998 109.861 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.751 ' HB2' HG21 ' A' ' 86' ' ' ILE . 53.6 t -122.72 148.47 45.29 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.434 -0.803 . . . . 60.310000000000002 111.809 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 t -62.82 125.08 85.71 Favored Pre-proline 0 N--CA 1.485 1.298 0 CA-C-O 118.678 -0.677 . . . . 73.510000000000005 109.847 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.406 ' HA ' ' HB1' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -52.07 -22.29 14.44 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.523 2.815 . . . . 74.439999999999998 115.695 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.02 -50.23 67.06 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 122.796 0.439 . . . . 74.329999999999998 112.018 170.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.518 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 34.4 m -71.13 -36.85 72.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.912 0.485 . . . . 60.109999999999999 110.594 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 115' ' ' PRO . . . -69.61 -38.49 77.3 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.749 0.819 . . . . 74.340000000000003 112.542 -171.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -64.8 -34.11 77.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.288 0.566 . . . . 73.540000000000006 110.916 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.11 -34.12 74.58 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.416 -0.811 . . . . 73.340000000000003 110.275 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 117' ' ' THR . 77.8 mt -75.01 -25.62 58.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.433 0.693 . . . . 62.350000000000001 111.483 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.87 -32.7 74.14 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.496 0.589 . . . . 74.450000000000003 110.607 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 55.6 m -70.08 -58.12 4.18 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.556 0.576 . . . . 73.540000000000006 112.556 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.13 -55.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 122.968 0.507 . . . . 55.25 112.198 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 56.7 mt -74.32 -49.68 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.71 0.404 . . . . 72.0 110.39 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.96 -55.38 19.66 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.789 0.676 . . . . 72.439999999999998 114.789 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.69 -52.99 5.42 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.891 0.845 . . . . 73.549999999999997 111.59 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.51 -36.94 92.19 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 115.083 0.793 . . . . 72.450000000000003 115.083 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.66 -56.89 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 122.474 -0.427 . . . . 72.010000000000005 110.966 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -75.71 -61.97 1.74 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.727 0.64 . . . . 74.239999999999995 112.727 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.26 70.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.775 0.43 . . . . 73.120000000000005 111.11 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 t -65.58 -50.93 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.223 0.609 . . . . 73.219999999999999 111.823 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.32 95.77 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-O 120.97 0.206 . . . . 73.319999999999993 113.372 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.66 -39.44 70.32 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.448 1.099 . . . . 74.129999999999995 111.732 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 8.1 m-80 -69.77 -38.55 76.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.404 0.282 . . . . 65.209999999999994 110.402 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.71 76.65 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.679 0.792 . . . . 75.140000000000001 111.564 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 tt -66.52 -36.37 82.54 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.878 0.871 . . . . 74.219999999999999 109.568 173.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.04 62.46 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.189 0.595 . . . . 70.5 112.295 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 10.8 mm-40 -72.56 -42.53 64.56 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 122.949 0.5 . . . . 71.209999999999994 111.828 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.47 -41.29 96.59 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 120.718 0.294 . . . . 75.010000000000005 111.54 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 12' ' ' ALA . 71.5 m-85 -81.79 -2.94 52.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.501 0.321 . . . . 73.120000000000005 111.059 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.11 3.59 10.1 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 116.569 -0.287 . . . . 74.349999999999994 113.159 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -34.29 74.41 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.269 1.028 . . . . 73.439999999999998 109.582 165.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 -62.48 1.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.698 0.799 . . . . 74.040000000000006 110.417 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -98.01 94.28 6.77 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.939 -0.763 . . . . 75.439999999999998 108.939 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -69.82 -23.88 63.38 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.724 0.638 . . . . 75.140000000000001 112.724 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -86.65 107.94 18.41 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.942 0.497 . . . . 74.540000000000006 110.468 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -151.76 -51.47 0.12 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.892 0.877 . . . . 75.340000000000003 110.33 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 60.13 117.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.825 1.417 . . . . 74.049999999999997 114.825 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -131.76 -86.81 0.47 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.2 -0.667 . . . . 73.040000000000006 109.2 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 124.517 1.127 . . . . 74.109999999999999 110.53 175.706 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.784 0.326 . . . . 72.439999999999998 111.546 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.5 61.34 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.765 0.826 . . . . 70.299999999999997 112.54 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -79.67 110.18 14.76 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.424 0.631 . . . . 74.040000000000006 111.677 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.74 121.71 36.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.933 1.293 . . . . 75.340000000000003 109.143 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -130.69 137.89 49.76 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.185 0.517 . . . . 71.030000000000001 111.357 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -132.12 152.46 51.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.521 1.128 . . . . 72.439999999999998 109.441 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.0 p -149.45 149.62 31.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.452 0.701 . . . . 75.430000000000007 110.201 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.7 p -144.1 138.31 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.157 0.583 . . . . 74.120000000000005 111.852 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.96 108.5 16.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.31 -0.626 . . . . 74.439999999999998 109.31 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.89 130.83 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.441 1.096 . . . . 74.049999999999997 110.976 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.3 71.8 3.02 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.066 0.546 . . . . 73.230000000000004 111.203 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.08 141.71 0.83 Allowed Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.625 1.17 . . . . 74.450000000000003 110.664 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.44 141.25 95.06 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.866 2.377 . . . . 74.329999999999998 113.255 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.5 -42.66 23.54 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.296 1.591 . . . . 70.25 115.296 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.6 85.24 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.128 0.571 . . . . 75.329999999999998 112.153 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.49 -34.94 78.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.603 0.761 . . . . 71.329999999999998 112.278 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.33 -35.55 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.847 0.459 . . . . 71.420000000000002 110.716 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.661 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 60.4 t-105 -72.38 -25.89 61.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.036 0.534 . . . . 74.340000000000003 111.342 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.1 m -58.37 -29.5 66.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 75.109999999999999 110.654 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.578 HD22 HH11 ' A' ' 140' ' ' ARG . 62.1 tp -84.97 -59.68 2.27 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.748 1.219 . . . . 75.019999999999996 111.706 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.8 14.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 113.441 0.904 . . . . 74.230000000000004 113.441 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.16 33.28 5.52 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 112.356 -0.298 . . . . 72.219999999999999 112.356 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -154.82 148.17 25.03 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.94 0.896 . . . . 75.319999999999993 110.044 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -84.97 -25.66 27.63 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.465 0.706 . . . . 74.430000000000007 111.625 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -92.87 -21.39 19.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.495 0.718 . . . . 73.319999999999993 112.384 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.21 8.14 9.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.486 0.55 . . . . 72.129999999999995 112.486 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.617 HG22 ' NH1' ' A' ' 51' ' ' ARG . 20.5 tt -68.46 -23.92 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 C-N-CA 124.153 0.981 . . . . 75.319999999999993 112.611 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -74.51 0.42 14.83 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.835 0.68 . . . . 74.140000000000001 112.835 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -97.36 -15.54 20.66 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.795 . . . . 74.400000000000006 112.313 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.549 ' HB3' HD23 ' A' ' 20' ' ' LEU . 37.5 p-90 -128.68 -38.12 1.72 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.637 0.606 . . . . 75.230000000000004 112.637 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 64.2 t-80 -89.64 115.28 63.44 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 122.86 0.464 . . . . 74.040000000000006 110.365 -173.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 13.6 Cg_exo -69.97 -23.68 29.54 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.197 2.598 . . . . 53.420000000000002 114.885 -169.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.48 -15.36 52.77 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.215 0.45 . . . . 74.230000000000004 112.215 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.581 HG21 HG12 ' A' ' 27' ' ' ILE . 98.5 t -70.89 120.74 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 122.89 0.476 . . . . 61.109999999999999 112.211 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -93.37 20.5 7.07 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.034 0.934 . . . . 60.109999999999999 112.394 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 70.28 110.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.638 1.575 . . . . 54.219999999999999 112.186 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -86.05 168.79 9.08 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.193 2.595 . . . . 74.540000000000006 114.241 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.5 m -101.91 127.75 48.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.693 1.197 . . . . 73.420000000000002 110.171 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.61 125.29 37.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.071 0.938 . . . . 62.32 113.033 -171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 41.5 mmt180 -92.8 -174.46 3.62 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.695 1.998 . . . . 73.409999999999997 110.808 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.74 -128.79 0.44 Allowed Glycine 0 CA--C 1.547 2.081 0 N-CA-C 116.993 1.557 . . . . 71.409999999999997 116.993 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.97 -79.97 0.45 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.018 0.927 . . . . 75.140000000000001 112.393 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -121.99 141.0 33.21 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.8 0.84 . . . . 73.450000000000003 111.153 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.87 -8.33 13.42 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 123.249 2.633 . . . . 71.430000000000007 114.084 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -88.2 -25.53 22.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.916 0.486 . . . . 74.439999999999998 111.366 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.7 m -77.72 123.03 86.55 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 124.011 0.925 . . . . 75.340000000000003 112.527 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.603 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.0 Cg_endo -56.48 103.4 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.115 2.543 . . . . 75.129999999999995 112.058 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.72 -36.05 1.56 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.916 -0.584 . . . . 63.020000000000003 112.18 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 148.15 50.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.298 0.639 . . . . 50.020000000000003 111.587 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 32.2 mt-10 -124.69 140.3 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.894 0.478 . . . . 74.329999999999998 111.141 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.617 ' NH1' HG22 ' A' ' 27' ' ' ILE . 15.5 ptt180 -105.25 112.97 26.28 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.706 0.765 . . . . 74.120000000000005 109.68 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.579 HG13 HG21 ' A' ' 62' ' ' VAL . 45.1 t -111.33 100.03 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 55.210000000000001 109.833 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 38.4 m-85 -59.47 134.28 56.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.149 0.58 . . . . 74.329999999999998 110.097 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.8 -67.94 1.05 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 114.803 0.681 . . . . 73.099999999999994 114.803 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.73 95.68 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.403 1.481 . . . . 74.209999999999994 111.153 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.64 23.71 66.75 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-N 115.742 -0.663 . . . . 63.539999999999999 113.467 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 p -123.29 172.72 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.559 0.744 . . . . 63.140000000000001 111.323 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.7 -39.38 80.51 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.667 0.787 . . . . 73.230000000000004 111.708 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -90.12 64.58 6.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.875 0.845 . . . . 74.239999999999995 109.774 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.4 tt0 -108.28 137.3 46.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.754 -0.657 . . . . 73.340000000000003 112.276 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.516 HD13 ' HE3' ' A' ' 79' ' ' MET . 31.0 tp -144.21 113.19 6.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.824 0.85 . . . . 73.200000000000003 109.235 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 40.0 t -98.93 115.23 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.692 -0.485 . . . . 65.120000000000005 109.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.554 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 68.9 mt-10 -123.35 148.51 45.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.944 0.898 . . . . 74.129999999999995 110.079 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -124.22 132.34 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.133 0.573 . . . . 73.519999999999996 111.027 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -74.33 114.91 13.24 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.361 0.664 . . . . 75.439999999999998 110.535 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.3 t -79.36 -51.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 122.801 0.441 . . . . 61.310000000000002 110.916 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.671 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 10.1 pt-20 -153.86 155.49 35.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.433 0.693 . . . . 75.420000000000002 110.124 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttp85 -144.26 145.87 32.3 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.359 -0.608 . . . . 75.439999999999998 109.359 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -146.46 134.56 21.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.399 0.679 . . . . 73.25 109.746 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.661 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 46.7 mt-10 -90.16 -50.87 5.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.233 0.613 . . . . 75.329999999999998 112.332 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.7 p -70.84 -34.6 71.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.243 0.617 . . . . 75.150000000000006 111.969 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.14 -9.71 54.59 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.332 0.653 . . . . 74.019999999999996 112.094 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 61.62 43.33 10.05 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.884 0.873 . . . . 73.329999999999998 112.211 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -114.58 115.58 27.4 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.728 0.811 . . . . 75.510000000000005 111.947 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -113.67 108.45 17.14 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.766 0.827 . . . . 74.439999999999998 108.777 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.671 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 27.0 t -117.63 130.3 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.634 0.652 . . . . 70.310000000000002 110.822 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.76 178.95 7.29 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.689 0.796 . . . . 73.109999999999999 111.257 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.403 HG22 ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -135.98 159.34 42.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.351 1.06 . . . . 73.409999999999997 109.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.516 ' HE3' HD13 ' A' ' 61' ' ' LEU . 80.1 mtp -112.44 83.94 5.8 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.538 0.735 . . . . 72.129999999999995 109.046 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 81.2 Cg_endo -72.03 -16.6 28.84 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.253 2.635 . . . . 63.439999999999998 113.511 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.631 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 9.7 t70 -134.06 82.06 49.45 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 108.72 -0.845 . . . . 64.409999999999997 108.72 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -91.41 150.02 3.59 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.167 2.578 . . . . 71.409999999999997 113.34 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.499 ' HD3' HD11 ' A' ' 61' ' ' LEU . 72.7 Cg_endo -81.07 -0.68 10.73 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.739 2.292 . . . . 75.409999999999997 113.12 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -105.25 154.69 38.73 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.99 0.916 . . . . 74.219999999999999 110.673 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 70.67 3.96 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.832 2.355 . . . . 73.530000000000001 113.075 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.2 pt -137.52 133.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.588 1.155 . . . . 71.219999999999999 109.525 -177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 22.4 m -77.14 -79.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.941 -0.474 . . . . 71.519999999999996 111.894 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -108.88 104.69 13.99 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.928 0.491 . . . . 75.129999999999995 111.03 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.539 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 65.4 t-80 -93.38 146.26 23.87 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.742 0.817 . . . . 75.329999999999998 111.356 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -146.56 111.31 5.27 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.997 0.919 . . . . 74.230000000000004 110.094 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.539 ' HB1' ' HE1' ' A' ' 89' ' ' HIS . . . -124.11 149.06 46.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.075 0.768 . . . . 73.349999999999994 113.075 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.12 139.29 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 124.095 0.958 . . . . 73.239999999999995 111.668 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 110.6 22.97 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.202 1.001 . . . . 75.310000000000002 108.422 162.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -127.04 119.06 25.69 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.755 -0.832 . . . . 71.109999999999999 108.755 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG11 ' SG ' ' A' ' 103' ' ' CYS . 96.4 t -101.71 109.97 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.241 0.616 . . . . 75.409999999999997 110.858 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.32 113.02 55.95 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 124.8 1.24 . . . . 72.420000000000002 111.065 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.25 95.28 1.07 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.945 2.43 . . . . 72.530000000000001 113.156 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -79.26 -37.38 38.03 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.243 0.46 . . . . 75.140000000000001 112.243 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 35.0 t70 -157.07 162.58 39.48 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.28 0.632 . . . . 73.120000000000005 111.282 -169.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.66 -21.15 65.49 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.824 1.249 . . . . 72.099999999999994 113.075 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.06 0.83 5.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.474 0.71 . . . . 74.430000000000007 112.252 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 32.8 m80 -134.7 123.06 23.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.662 0.664 . . . . 74.120000000000005 109.901 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.467 ' SG ' HG11 ' A' ' 95' ' ' VAL . 38.2 t -142.95 137.63 29.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.425 0.29 . . . . 75.239999999999995 111.341 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.2 m -92.42 111.75 23.44 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.887 0.475 . . . . 74.450000000000003 111.3 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.1 112.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.141 -0.688 . . . . 75.519999999999996 109.141 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.34 119.15 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.356 0.662 . . . . 72.209999999999994 110.075 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -107.47 113.3 26.55 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.658 -0.867 . . . . 75.319999999999993 108.658 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -108.89 149.93 28.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.087 0.955 . . . . 74.439999999999998 109.502 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.14 145.31 27.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.477 1.111 . . . . 74.319999999999993 108.633 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -154.25 133.83 12.82 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.217 0.607 . . . . 70.319999999999993 110.104 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.53 153.36 48.73 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.647 -0.706 . . . . 75.099999999999994 111.305 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 34.2 t70 -77.14 87.13 3.61 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.231 -0.441 . . . . 75.439999999999998 110.055 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.9 t -156.1 169.8 23.67 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.616 -0.72 . . . . 73.510000000000005 111.883 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 m -76.52 148.28 79.84 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.457 1.103 . . . . 64.129999999999995 112.802 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.73 -34.91 92.3 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.821 3.014 . . . . 75.209999999999994 114.796 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.89 -31.09 67.63 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.294 0.638 . . . . 74.329999999999998 112.25 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 95.2 m -76.76 -38.08 54.79 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.02 0.438 . . . . 74.120000000000005 110.027 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -31.48 71.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.968 . . . . 71.329999999999998 112.881 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -75.74 -33.33 60.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.939 0.496 . . . . 74.409999999999997 111.43 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -42.21 83.49 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 75.040000000000006 110.225 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.99 -24.93 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.338 -0.846 . . . . 74.450000000000003 111.318 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -60.16 -36.11 76.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.013 0.525 . . . . 73.150000000000006 110.908 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -72.57 -53.56 11.58 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.951 -0.568 . . . . 74.209999999999994 111.856 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.76 -57.31 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 113.148 0.795 . . . . 75.400000000000006 113.148 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -77.83 -57.99 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.804 0.842 . . . . 75.219999999999999 110.942 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.53 -51.04 61.17 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 114.263 0.465 . . . . 64.439999999999998 114.263 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -95.22 -39.82 9.89 Favored 'General case' 0 CA--C 1.556 1.193 0 O-C-N 121.998 -0.707 . . . . 64.420000000000002 112.024 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.49 73.27 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.88 0.712 . . . . 73.129999999999995 114.88 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.93 -52.41 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 117.656 0.728 . . . . 72.209999999999994 111.024 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 2.8 m-30 -77.72 -53.58 7.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.102 0.408 . . . . 73.030000000000001 112.102 -172.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.32 -15.63 62.74 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.11 0.411 . . . . 62.149999999999999 112.11 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.6 t -80.86 -51.81 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 123.929 0.892 . . . . 74.5 110.985 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.33 -51.93 44.82 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.09 -0.505 . . . . 70.209999999999994 114.258 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.6 mt -58.52 -36.18 73.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.842 0.857 . . . . 74.409999999999997 112.776 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 6.3 m-20 -67.83 -46.06 72.9 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.669 -0.493 . . . . 73.209999999999994 109.669 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.0 74.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.6 0.76 . . . . 72.310000000000002 112.267 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.72 -49.24 78.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.312 1.045 . . . . 71.510000000000005 110.121 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -24.03 62.07 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.42 -0.809 . . . . 73.219999999999999 111.924 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 6.2 mm-40 -67.57 -50.73 57.05 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.589 0.756 . . . . 74.129999999999995 110.585 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.578 HH11 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.95 -15.83 62.09 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.737 0.643 . . . . 75.420000000000002 112.737 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -87.02 -22.62 25.38 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.803 0.668 . . . . 74.329999999999998 112.803 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.66 -33.18 0.06 OUTLIER Glycine 0 C--N 1.358 1.792 0 N-CA-C 116.227 1.251 . . . . 64.329999999999998 116.227 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 76.56 -4.6 2.33 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 124.73 1.212 . . . . 75.530000000000001 112.656 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.87 152.92 44.79 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.282 -0.886 . . . . 73.329999999999998 111.455 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 68.84 20.95 7.84 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.237 1.415 . . . . 74.120000000000005 114.545 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.89 74.66 9.71 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.045 0.45 . . . . 75.140000000000001 111.395 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -92.7 97.59 10.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.658 -0.867 . . . . 73.209999999999994 108.658 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -152.49 150.27 29.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.2 0.6 . . . . 73.129999999999995 111.227 -168.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -140.4 86.04 2.05 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.382 0.673 . . . . 74.319999999999993 110.03 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.79 173.72 11.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.1 0.96 . . . . 75.409999999999997 110.853 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 123.419 0.688 . . . . 74.430000000000007 110.584 178.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.743 0.306 . . . . 74.430000000000007 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.53 66.15 9.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.074 0.94 . . . . 64.549999999999997 110.408 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -144.48 119.33 9.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.279 -0.873 . . . . 75.219999999999999 110.38 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.17 147.54 23.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 74.219999999999999 109.226 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -149.53 129.96 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.138 0.575 . . . . 65.439999999999998 109.832 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -130.78 151.62 51.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.932 0.893 . . . . 75.239999999999995 108.751 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 96.3 p -146.85 163.34 36.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.991 0.516 . . . . 73.530000000000001 110.895 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.69 149.19 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.87 0.468 . . . . 74.140000000000001 111.057 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.56 109.22 19.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.029 0.532 . . . . 71.349999999999994 110.231 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 105' ' ' VAL . 85.8 t -96.49 129.9 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.312 1.045 . . . . 75.319999999999993 109.601 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.23 26.24 0.78 Allowed 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.563 0.949 . . . . 73.049999999999997 113.563 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' H ' HG11 ' A' ' 10' ' ' VAL . . . -131.55 150.57 76.72 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.583 0.753 . . . . 74.219999999999999 110.317 174.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.85 151.05 50.84 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.184 2.589 . . . . 72.109999999999999 112.984 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.02 -28.81 10.87 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.789 1.236 . . . . 73.230000000000004 114.27 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -50.9 64.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.774 0.657 . . . . 75.109999999999999 112.774 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -44.94 64.7 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.704 0.801 . . . . 71.329999999999998 111.901 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 HG13 HD23 ' A' ' 137' ' ' LEU . 15.0 t -73.36 -34.51 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 114.896 -1.047 . . . . 75.030000000000001 111.62 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.619 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 65.5 t-105 -73.48 -28.99 62.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.233 0.613 . . . . 72.129999999999995 111.505 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 m -60.65 -26.96 67.45 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.629 0.728 . . . . 74.25 110.838 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD21 HH11 ' A' ' 140' ' ' ARG . 54.4 tp -91.41 -44.03 9.38 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.361 1.064 . . . . 64.430000000000007 113.091 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.62 -21.72 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 113.588 0.959 . . . . 73.219999999999999 113.588 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.68 73.89 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 114.281 0.472 . . . . 75.040000000000006 114.281 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.436 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 3.6 m-20 -86.73 122.59 30.84 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.638 -1.245 . . . . 75.239999999999995 107.638 171.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 4.0 t80 -61.1 -27.84 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.992 0.517 . . . . 71.349999999999994 110.635 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -77.5 -23.51 50.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.024 0.93 . . . . 74.219999999999999 113.426 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -83.15 9.28 10.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 112.529 0.566 . . . . 60.140000000000001 112.529 -161.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.538 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 13.7 tt -62.64 -25.11 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 123.221 0.608 . . . . 73.540000000000006 111.52 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.622 ' HA ' HG13 ' A' ' 34' ' ' VAL . 26.4 p-80 -71.84 0.17 9.73 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.632 0.605 . . . . 74.239999999999995 112.632 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -102.92 -18.18 15.16 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.721 0.808 . . . . 62.43 112.754 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.538 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 33.0 p-90 -126.99 -42.24 1.75 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.433 1.271 . . . . 74.420000000000002 114.433 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.519 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.3 t-80 -72.73 119.86 77.6 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 117.985 0.357 . . . . 72.109999999999999 110.273 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 -22.33 73.86 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.373 2.048 . . . . 71.129999999999995 115.002 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.97 -4.19 22.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.041 0.756 . . . . 71.030000000000001 113.041 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' A' ' 28' ' ' HIS . 11.2 p -63.81 148.13 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 CA-C-N 118.228 0.467 . . . . 74.420000000000002 111.157 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -113.22 28.4 8.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.293 0.637 . . . . 72.439999999999998 111.402 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.41 85.97 0.18 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 123.781 0.832 . . . . 74.340000000000003 111.163 -173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.99 173.32 13.67 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.888 2.392 . . . . 73.450000000000003 114.077 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.7 m -112.97 130.51 56.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.33 1.052 . . . . 73.230000000000004 110.178 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.69 137.18 42.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.7 0.8 . . . . 73.430000000000007 110.07 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 50' ' ' GLU . 11.1 ptm180 -150.82 162.04 41.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.904 0.882 . . . . 74.310000000000002 111.012 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.74 143.89 0.0 OUTLIER Glycine 0 CA--C 1.557 2.68 0 N-CA-C 117.25 1.66 . . . . 71.549999999999997 117.25 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 57.97 -104.46 0.22 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.403 1.081 . . . . 64.129999999999995 112.165 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 m -170.73 151.19 3.37 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 125.204 1.402 . . . . 61.219999999999999 109.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.58 0.58 1.8 Allowed 'Trans proline' 0 N--CA 1.513 2.639 0 C-N-CA 123.453 2.769 . . . . 74.030000000000001 115.29 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -119.69 -18.38 8.37 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.534 0.734 . . . . 74.129999999999995 111.408 168.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 m -87.88 123.34 69.2 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 123.251 0.62 . . . . 75.420000000000002 111.22 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.522 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 71.2 Cg_exo -45.99 119.06 2.66 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.727 2.951 . . . . 74.140000000000001 114.22 171.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.43 -20.62 4.39 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.507 0.575 . . . . 61.25 112.726 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.34 141.54 54.2 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.26 0.837 . . . . 74.400000000000006 113.26 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 28.9 mt-10 -107.71 126.94 53.21 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.906 0.882 . . . . 75.150000000000006 110.698 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 24' ' ' PHE . 58.1 ttp180 -102.38 108.72 20.15 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.073 0.949 . . . . 74.329999999999998 109.869 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.467 HG12 HG22 ' A' ' 62' ' ' VAL . 41.8 t -112.11 112.98 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.844 0.858 . . . . 73.540000000000006 110.931 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -73.45 -58.1 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.959 0.725 . . . . 71.420000000000002 112.959 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.42 -50.27 39.26 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-N 116.436 -0.347 . . . . 63.25 112.776 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 51.07 24.66 1.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.938 1.295 . . . . 65.409999999999997 114.118 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.73 24.28 0.02 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 113.037 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.535 ' HG1' ' HB3' ' A' ' 60' ' ' GLU . 72.7 p -129.02 142.2 50.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.317 1.047 . . . . 75.439999999999998 109.779 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.18 -30.31 70.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.779 0.659 . . . . 74.439999999999998 112.779 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.04 75.38 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.731 0.776 . . . . 73.340000000000003 110.579 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.535 ' HB3' ' HG1' ' A' ' 57' ' ' THR . 14.0 pt-20 -109.16 164.51 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.648 1.179 . . . . 74.319999999999993 111.758 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.0 tp -103.21 124.11 47.99 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.999 0.52 . . . . 71.450000000000003 109.692 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.467 HG22 HG12 ' A' ' 52' ' ' VAL . 61.7 t -120.18 128.1 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.537 0.735 . . . . 64.230000000000004 109.688 173.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.508 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 35.2 mt-10 -117.45 149.42 40.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.47 1.108 . . . . 74.319999999999993 110.335 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.669 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 96.2 mtt180 -126.03 129.83 49.95 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.005 0.522 . . . . 75.519999999999996 111.378 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 14.5 tp -67.63 115.82 7.64 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.009 0.924 . . . . 74.319999999999993 111.034 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.443 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 98.0 t -84.98 -51.75 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.509 0.724 . . . . 72.530000000000001 111.297 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 6.3 pt-20 -158.15 140.49 14.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.527 0.731 . . . . 75.209999999999994 110.197 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.23 124.15 28.37 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.099 0.56 . . . . 74.319999999999993 110.224 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.57 100.45 8.29 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.525 -0.917 . . . . 71.420000000000002 108.525 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.619 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 25.5 tt0 -80.02 -31.08 39.65 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 112.374 0.509 . . . . 70.510000000000005 112.374 -172.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -69.86 -43.59 71.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.16 0.584 . . . . 74.329999999999998 111.71 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.8 -10.12 59.75 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 75.219999999999999 111.913 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 61.21 55.62 2.93 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.557 1.143 . . . . 61.420000000000002 112.005 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -132.38 135.05 45.87 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.278 -1.328 . . . . 74.209999999999994 110.139 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -124.39 132.23 53.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.167 1.387 . . . . 72.200000000000003 108.862 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 41.3 t -133.63 130.52 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 118.338 0.517 . . . . 63.149999999999999 111.078 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.443 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 54.9 p90 -141.26 -179.45 6.12 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.342 1.057 . . . . 75.439999999999998 110.573 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.482 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.3 t -130.44 162.76 28.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.649 1.18 . . . . 43.149999999999999 110.367 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.415 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.5 mtp -109.8 85.58 4.09 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.825 0.85 . . . . 73.299999999999997 109.278 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.508 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 71.8 Cg_endo -71.36 -24.5 22.74 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.48 2.787 . . . . 74.329999999999998 113.095 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.88 76.43 70.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 109.441 -0.577 . . . . 74.219999999999999 109.441 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -95.55 150.78 1.5 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.097 2.531 . . . . 75.200000000000003 113.456 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 -6.88 17.97 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.176 1.917 . . . . 74.25 112.21 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -92.32 143.28 27.14 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.477 1.111 . . . . 72.409999999999997 110.771 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.427 ' HG2' HG23 ' A' ' 117' ' ' THR . 90.5 Cg_endo -78.72 72.99 6.15 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.741 2.294 . . . . 74.329999999999998 112.689 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 113' ' ' CYS . 19.1 pt -127.87 145.52 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.356 1.062 . . . . 73.510000000000005 110.575 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.3 m -82.78 -78.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.616 0.366 . . . . 75.329999999999998 111.812 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.72 106.66 14.76 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.29 0.566 . . . . 75.099999999999994 109.944 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.607 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 56.1 t-80 -91.65 159.38 15.9 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.445 0.698 . . . . 74.230000000000004 111.673 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -165.47 103.25 0.72 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.104 0.962 . . . . 74.239999999999995 110.254 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.607 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -98.65 153.5 18.64 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.58 0.752 . . . . 70.310000000000002 112.544 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.49 132.56 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.883 0.873 . . . . 74.219999999999999 111.48 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -109.08 107.58 17.95 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.748 1.219 . . . . 75.030000000000001 109.268 166.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.92 130.71 48.92 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 122.002 -0.436 . . . . 72.120000000000005 110.434 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.6 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 27.8 m -99.67 111.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.672 0.749 . . . . 72.540000000000006 109.852 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.8 t -83.32 107.67 10.58 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.571 1.149 . . . . 74.439999999999998 109.448 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.25 108.23 2.62 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.789 2.326 . . . . 71.299999999999997 111.911 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -84.4 -60.44 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.186 0.594 . . . . 74.109999999999999 110.495 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.49 175.37 9.21 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.031 0.932 . . . . 75.230000000000004 110.366 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.69 -4.58 43.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.82 0.448 . . . . 52.200000000000003 110.578 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -23.96 11.68 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.823 1.249 . . . . 63.310000000000002 112.344 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.499 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 37.1 m80 -136.01 150.96 49.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.354 0.524 . . . . 74.120000000000005 112.014 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.6 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 45.5 t -143.56 173.6 11.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.358 1.063 . . . . 54.210000000000001 110.175 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.6 m -135.94 119.24 16.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.18 0.592 . . . . 73.019999999999996 110.835 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.437 HG22 HG23 ' A' ' 10' ' ' VAL . 26.0 t -91.27 113.06 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 122.144 -0.347 . . . . 73.519999999999996 110.199 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.54 109.91 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.473 1.109 . . . . 73.099999999999994 109.725 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -106.69 111.65 24.28 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 109.163 -0.68 . . . . 74.219999999999999 109.163 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.9 m -109.63 147.13 33.6 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.187 0.995 . . . . 73.319999999999993 109.964 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -131.78 111.27 11.49 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.956 0.903 . . . . 75.25 111.122 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.9 mtt -98.86 131.14 45.19 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.857 0.863 . . . . 75.409999999999997 108.978 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -156.96 144.68 19.12 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.413 0.523 . . . . 75.439999999999998 112.413 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.57 87.83 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.6 0.714 . . . . 71.209999999999994 110.676 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 53.5 t -134.28 169.09 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.643 -1.162 . . . . 71.439999999999998 111.411 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.2 m -68.44 146.93 98.09 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 62.009999999999998 112.222 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 -41.33 72.96 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.436 2.757 . . . . 73.540000000000006 114.29 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.77 -43.77 97.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.493 0.717 . . . . 62.439999999999998 111.813 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 21.3 m -71.81 -36.93 70.41 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.307 -0.406 . . . . 74.040000000000006 110.756 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.04 85.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.652 0.781 . . . . 71.239999999999995 112.322 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -28.54 63.49 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.484 0.314 . . . . 74.010000000000005 111.587 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.07 -42.04 89.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.223 0.535 . . . . 74.409999999999997 110.049 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.95 -22.88 62.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.904 0.882 . . . . 75.450000000000003 112.199 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -58.04 -43.37 86.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.299 0.5 . . . . 74.310000000000002 110.683 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -72.12 -49.79 33.31 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.6 0.593 . . . . 74.540000000000006 112.6 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.09 -54.61 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.207 0.527 . . . . 75.519999999999996 112.287 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.02 -56.45 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.78 0.832 . . . . 73.530000000000001 111.536 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.53 96.36 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 114.659 0.624 . . . . 73.219999999999999 114.659 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -88.72 -60.18 2.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.955 0.502 . . . . 74.519999999999996 110.634 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.84 -29.6 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 115.834 1.094 . . . . 73.340000000000003 115.834 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -105.16 -53.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 117.317 0.558 . . . . 72.010000000000005 110.873 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -75.43 -65.47 0.89 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.804 -0.634 . . . . 74.450000000000003 111.793 -170.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.06 66.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.856 0.462 . . . . 71.439999999999998 111.554 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.56 -53.73 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.986 0.914 . . . . 75.310000000000002 112.26 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.42 -35.17 81.32 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 116.402 -0.363 . . . . 75.129999999999995 113.395 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -44.83 61.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.3 1.04 . . . . 74.239999999999995 112.027 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -65.7 -38.19 88.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.376 0.27 . . . . 72.239999999999995 110.895 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.76 88.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.946 0.498 . . . . 74.140000000000001 111.611 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.531 HD23 HG13 ' A' ' 17' ' ' VAL . 7.0 tt -64.75 -42.5 95.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.693 0.797 . . . . 75.319999999999993 110.151 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.38 80.23 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.875 -0.602 . . . . 65.310000000000002 112.06 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.08 -33.12 61.62 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.754 0.822 . . . . 74.310000000000002 112.741 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.557 HH11 HD21 ' A' ' 20' ' ' LEU . 2.2 ptm180 -73.27 -24.72 60.47 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.773 0.32 . . . . 75.400000000000006 111.06 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 54.4 m-85 -100.75 4.14 42.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.432 0.693 . . . . 74.120000000000005 111.559 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -45.92 -50.41 11.99 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 115.156 0.823 . . . . 75.430000000000007 115.156 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 55.82 20.28 4.01 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.284 1.216 . . . . 74.310000000000002 114.284 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mp 61.94 20.51 11.58 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.167 1.387 . . . . 65.450000000000003 114.23 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -35.82 57.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.873 -0.517 . . . . 73.349999999999994 110.894 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -149.89 162.45 40.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.559 1.544 . . . . 72.420000000000002 109.291 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -98.14 103.19 15.12 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.068 -0.716 . . . . 74.239999999999995 109.068 168.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -67.92 109.68 3.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.748 0.819 . . . . 72.510000000000005 109.721 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -34.1 120.38 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.642 1.719 . . . . 74.319999999999993 115.642 -167.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -73.18 -34.29 65.92 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.942 1.297 . . . . 71.299999999999997 113.679 -171.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 124.19 0.996 . . . . 74.310000000000002 111.345 -171.473 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.675 0.274 . . . . 74.120000000000005 110.876 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 111' ' ' PHE . . . -89.27 -8.35 53.6 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.653 0.781 . . . . 71.329999999999998 111.221 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -108.13 112.62 25.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.156 0.982 . . . . 71.530000000000001 108.969 172.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.3 mp -97.14 121.76 39.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.774 1.23 . . . . 74.329999999999998 109.936 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -117.6 113.64 22.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.789 -0.449 . . . . 74.150000000000006 109.789 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -120.95 135.49 55.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.005 0.922 . . . . 75.200000000000003 109.818 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -138.1 159.93 40.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.688 0.795 . . . . 63.43 111.301 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.1 p -155.6 150.89 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.611 0.364 . . . . 74.530000000000001 111.874 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -92.34 119.09 31.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.959 0.504 . . . . 72.409999999999997 110.025 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.23 124.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.607 1.163 . . . . 70.349999999999994 109.82 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.76 71.68 4.25 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.569 0.7 . . . . 70.430000000000007 111.241 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.77 155.89 8.36 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.013 0.925 . . . . 75.420000000000002 110.909 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.39 137.84 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.777 2.318 . . . . 75.209999999999994 112.261 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.59 -46.69 10.15 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.233 1.568 . . . . 73.129999999999995 115.233 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.58 92.02 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 112.421 0.526 . . . . 54.340000000000003 112.421 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.16 -39.36 86.12 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.674 0.789 . . . . 61.240000000000002 112.051 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 103' ' ' CYS . 44.3 t -73.9 -34.35 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.501 0.72 . . . . 71.510000000000005 111.15 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.511 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 75.8 t-105 -67.66 -29.67 69.02 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.713 0.405 . . . . 74.319999999999993 111.558 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 m -60.24 -30.86 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.635 0.731 . . . . 74.340000000000003 110.737 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -83.5 -52.09 6.79 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.269 1.428 . . . . 75.219999999999999 112.143 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.31 -38.34 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.33 0.863 . . . . 62.100000000000001 113.33 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.58 -8.48 63.24 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.121 0.808 . . . . 74.450000000000003 115.121 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.99 113.92 26.34 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.612 -0.885 . . . . 74.129999999999995 108.612 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.15 -25.81 65.81 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.806 1.242 . . . . 74.120000000000005 113.303 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -96.7 -17.88 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.467 0.543 . . . . 73.299999999999997 112.467 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.77 15.42 4.8 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.196 0.598 . . . . 73.439999999999998 111.571 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 34' ' ' VAL . 20.2 tt -67.06 -24.9 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 C-N-CA 123.97 0.908 . . . . 72.400000000000006 111.88 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -64.55 -12.74 48.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.239 0.829 . . . . 74.120000000000005 113.239 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.35 -28.99 26.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.771 0.656 . . . . 75.329999999999998 112.771 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.455 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 48.0 p-90 -118.64 -35.49 3.71 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.034 0.534 . . . . 73.049999999999997 111.883 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -90.88 107.8 23.33 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.596 0.758 . . . . 74.219999999999999 109.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.29 -19.06 62.05 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.293 2.662 . . . . 75.409999999999997 114.715 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -96.77 0.67 49.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.02 0.748 . . . . 75.109999999999999 113.02 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 27' ' ' ILE . 60.7 t -78.56 117.71 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 120.817 0.342 . . . . 74.540000000000006 111.12 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -90.89 51.33 1.94 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.547 0.739 . . . . 55.009999999999998 111.915 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 58.9 99.81 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 124.953 1.301 . . . . 64.319999999999993 113.147 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 97.9 Cg_endo -77.46 147.26 25.27 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.821 2.347 . . . . 62.25 114.779 -172.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.6 m -105.47 120.93 42.85 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.625 1.17 . . . . 74.140000000000001 109.152 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.86 127.64 38.44 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.269 0.557 . . . . 73.340000000000003 112.187 -170.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.601 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -115.33 123.36 48.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.077 0.951 . . . . 73.409999999999997 110.659 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.68 178.35 0.01 OUTLIER Glycine 0 CA--C 1.546 1.981 0 N-CA-C 117.308 1.683 . . . . 60.439999999999998 117.308 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.26 -118.69 1.37 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 124.837 1.255 . . . . 72.25 112.967 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -175.24 162.3 2.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 124.122 0.969 . . . . 74.430000000000007 109.421 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.47 -5.29 4.08 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.798 2.332 . . . . 63.549999999999997 115.077 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.0 -10.43 9.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.729 -0.607 . . . . 75.030000000000001 112.195 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.8 m -98.73 122.0 54.45 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 123.097 0.559 . . . . 74.510000000000005 111.357 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 Cg_endo -55.87 113.67 1.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.308 2.672 . . . . 74.239999999999995 112.909 175.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.05 -22.76 2.1 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.132 -0.485 . . . . 72.120000000000005 113.172 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 141.49 57.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.51 0.724 . . . . 61.240000000000002 112.725 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 38.8 mt-10 -114.5 115.97 28.08 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.195 0.598 . . . . 74.129999999999995 109.938 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 29.3 ptt180 -93.36 123.78 36.89 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.441 0.696 . . . . 73.109999999999999 110.099 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -119.04 108.28 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.238 0.615 . . . . 74.540000000000006 110.209 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -66.63 101.75 0.83 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.623 0.769 . . . . 73.140000000000001 112.374 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.53 -71.18 2.3 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.339 -0.391 . . . . 63.219999999999999 112.306 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 68.37 136.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.166 1.386 . . . . 73.099999999999994 112.926 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.13 19.67 64.43 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-O 121.437 0.465 . . . . 63.409999999999997 112.191 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.3 p -117.84 -160.21 0.77 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.545 1.538 . . . . 73.150000000000006 110.132 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.87 5.6 15.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.803 0.841 . . . . 71.049999999999997 110.527 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.92 9.97 6.96 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.823 0.849 . . . . 75.540000000000006 113.233 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.28 144.31 44.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.016 0.747 . . . . 64.120000000000005 113.016 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.7 tp -120.71 126.11 49.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.375 1.07 . . . . 75.430000000000007 109.453 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.39 115.33 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.975 0.51 . . . . 64.409999999999997 109.854 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.62 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 43.6 mt-10 -120.0 137.72 53.92 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.024 0.93 . . . . 73.409999999999997 110.162 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -118.4 133.65 55.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.297 0.639 . . . . 73.120000000000005 112.102 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 23.0 tp -75.67 120.74 21.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.736 1.215 . . . . 73.519999999999996 111.133 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.72 -41.53 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.284 0.634 . . . . 73.209999999999994 111.256 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 10.7 tp10 -152.99 147.03 25.45 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.092 0.957 . . . . 73.409999999999997 110.145 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -146.67 123.44 11.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.687 0.395 . . . . 74.409999999999997 110.629 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -106.63 -177.66 3.43 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.967 0.907 . . . . 60.530000000000001 110.812 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 41.1 tt0 -147.95 -47.11 0.16 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.866 0.466 . . . . 71.209999999999994 110.706 172.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.8 p -64.31 -43.47 94.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.269 0.628 . . . . 62.149999999999999 111.186 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.09 -26.54 59.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.349 0.66 . . . . 62.140000000000001 112.512 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 60.28 59.45 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.853 0.861 . . . . 71.409999999999997 111.426 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -139.31 122.75 17.22 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.766 0.826 . . . . 74.549999999999997 110.117 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 66.1 tp -124.27 109.01 12.84 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.21 1.004 . . . . 71.010000000000005 111.459 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 56.4 t -106.4 132.0 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.014 0.825 . . . . 75.129999999999995 111.28 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -152.84 179.73 8.39 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.103 0.561 . . . . 75.439999999999998 111.865 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.2 t -144.66 166.02 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.529 1.132 . . . . 73.230000000000004 111.054 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.62 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.7 mtm -99.84 99.38 8.91 Favored Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 123.373 0.669 . . . . 74.450000000000003 110.492 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 22.5 Cg_endo -62.13 -20.34 69.53 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 123.517 2.812 . . . . 65.239999999999995 112.748 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.75 81.18 69.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.972 0.509 . . . . 74.420000000000002 110.436 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.32 123.35 1.02 Allowed 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.787 2.325 . . . . 73.340000000000003 112.774 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.98 27.11 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.641 2.228 . . . . 71.25 113.156 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.44 147.27 61.58 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.391 1.077 . . . . 73.25 109.87 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 76.69 0.94 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.099 2.533 . . . . 74.510000000000005 113.23 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.732 HG23 ' HB2' ' A' ' 113' ' ' CYS . 22.1 pt -132.75 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 124.47 1.108 . . . . 75.209999999999994 109.953 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.618 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 23.8 m -103.27 -78.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.406 0.282 . . . . 70.140000000000001 111.41 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -105.02 100.37 9.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.998 0.519 . . . . 74.140000000000001 111.171 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -88.61 144.74 26.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 75.200000000000003 112.826 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -137.33 158.04 45.29 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 72.439999999999998 109.592 168.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HB1' ' HE1' ' A' ' 107' ' ' TRP . . . -158.62 119.91 3.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.516 1.126 . . . . 71.310000000000002 109.111 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 31.9 t -125.74 132.23 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.13 0.572 . . . . 75.310000000000002 112.449 -168.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.42 119.33 38.68 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.648 0.779 . . . . 73.530000000000001 109.3 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -130.45 114.03 15.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.961 0.504 . . . . 72.400000000000006 110.567 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.46 116.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.298 0.639 . . . . 74.140000000000001 110.36 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' A' ' 104' ' ' THR . 4.9 m -113.42 123.04 34.01 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 123.902 0.881 . . . . 72.299999999999997 110.904 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 124.97 11.79 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.835 2.357 . . . . 70.200000000000003 113.483 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -109.24 -9.43 15.0 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.221 1.008 . . . . 61.229999999999997 112.143 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.68 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 34.9 t70 -175.87 167.9 3.05 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.157 1.383 . . . . 61.109999999999999 109.212 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.27 -39.3 66.74 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.045 0.938 . . . . 72.25 112.23 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -131.81 38.95 3.51 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.435 0.636 . . . . 71.120000000000005 110.377 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.68 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 77.9 m80 -148.95 135.6 19.61 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.293 1.037 . . . . 65.329999999999998 109.974 166.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 17' ' ' VAL . 32.0 p -148.98 144.95 27.1 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.395 0.678 . . . . 72.420000000000002 110.681 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 78.7 m -93.35 116.96 29.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.151 0.58 . . . . 70.549999999999997 110.681 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.79 118.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.04 0.536 . . . . 74.099999999999994 109.669 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.8 117.37 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 123.605 0.762 . . . . 73.530000000000001 110.45 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.507 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 5.2 t90 -105.3 116.4 31.89 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.974 -0.75 . . . . 74.140000000000001 108.974 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -124.46 123.82 40.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.586 0.754 . . . . 75.549999999999997 111.371 -170.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -106.93 141.03 38.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.871 0.868 . . . . 74.319999999999993 111.076 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -128.59 124.58 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.869 -0.789 . . . . 70.310000000000002 108.869 168.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.439 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 5.2 p90 -148.02 147.91 30.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.886 0.328 . . . . 72.219999999999999 111.886 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.618 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -84.18 86.83 7.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.365 0.602 . . . . 71.209999999999994 109.966 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.732 ' HB2' HG23 ' A' ' 86' ' ' ILE . 50.7 t -125.64 144.01 50.78 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.151 -0.931 . . . . 71.120000000000005 111.782 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.0 m -59.44 140.08 88.64 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.939 0.896 . . . . 74.510000000000005 111.516 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -56.83 -31.62 89.27 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.143 2.562 . . . . 74.200000000000003 114.171 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.09 -40.98 95.78 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.958 0.903 . . . . 72.420000000000002 112.013 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.536 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 24.3 m -88.11 -31.43 19.21 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.521 -0.763 . . . . 64.549999999999997 110.997 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.17 86.67 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.737 0.815 . . . . 73.5 111.64 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -61.63 -33.64 74.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.427 0.691 . . . . 75.120000000000005 111.185 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 -36.19 63.12 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.562 1.145 . . . . 61.100000000000001 110.411 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 117' ' ' THR . 86.9 mt -74.42 -24.08 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 72.319999999999993 111.746 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -63.23 -35.11 79.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 120.96 0.41 . . . . 75.140000000000001 110.703 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 m -72.37 -56.64 5.12 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.271 0.628 . . . . 73.340000000000003 112.098 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.69 -54.45 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 112.432 0.531 . . . . 74.329999999999998 112.432 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.8 mt -78.68 -51.07 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.033 0.533 . . . . 63.420000000000002 110.789 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.99 -49.13 69.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.68 0.632 . . . . 71.439999999999998 114.68 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.82 -52.68 4.62 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 121.85 -0.794 . . . . 74.230000000000004 111.212 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.54 -28.71 73.88 Favored Glycine 0 N--CA 1.476 1.362 0 N-CA-C 115.404 0.922 . . . . 61.350000000000001 115.404 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.8 t -105.55 -58.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.57 0.685 . . . . 75.420000000000002 110.543 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 3.5 m-30 -71.27 -64.96 0.81 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.07 0.548 . . . . 73.510000000000005 112.386 -170.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.44 69.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.993 0.517 . . . . 73.230000000000004 112.079 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -58.03 -54.41 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.563 0.745 . . . . 72.400000000000006 111.93 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.68 -41.07 94.07 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.304 0.377 . . . . 74.230000000000004 113.025 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.01 -43.3 88.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.081 0.953 . . . . 74.209999999999994 112.084 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.67 -38.0 76.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 119.47 -0.3 . . . . 72.219999999999999 111.107 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.84 81.6 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.136 0.493 . . . . 72.230000000000004 111.095 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.427 HD22 HG13 ' A' ' 17' ' ' VAL . 4.2 tt -66.58 -41.43 88.53 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 115.266 -0.879 . . . . 65.040000000000006 109.849 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.78 76.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.125 0.57 . . . . 71.329999999999998 112.352 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.24 -45.47 60.06 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.468 0.707 . . . . 75.209999999999994 111.574 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.38 -26.65 68.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 111.99 0.367 . . . . 70.409999999999997 111.99 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.84 -22.81 15.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.176 0.59 . . . . 73.010000000000005 112.316 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.01 -12.14 62.15 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 122.157 -0.339 . . . . 74.439999999999998 113.821 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.87 -16.27 18.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.997 0.919 . . . . 75.319999999999993 113.24 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 pp -96.98 2.45 51.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.823 0.449 . . . . 74.340000000000003 112.191 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.432 ' HG2' ' N ' ' A' ' 146' ' ' HIS . 28.8 tt0 -62.95 168.13 4.21 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.887 0.875 . . . . 72.450000000000003 110.674 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.432 ' N ' ' HG2' ' A' ' 145' ' ' GLU . 56.5 t-80 -69.34 -6.16 27.95 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.745 -0.597 . . . . 74.140000000000001 111.646 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 66.0 78.53 0.26 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.127 1.371 . . . . 74.120000000000005 110.891 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -113.48 -106.82 0.38 Allowed 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 118.649 -0.691 . . . . 74.310000000000002 110.098 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.9 m80 56.56 26.58 11.2 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.603 0.964 . . . . 71.140000000000001 113.603 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -82.55 122.41 28.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 122.108 -0.37 . . . . 74.519999999999996 110.957 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 79.0 t60 . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 65.310000000000002 111.225 -178.616 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.467 0.175 . . . . 74.340000000000003 110.663 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.54 9.27 39.24 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.429 0.692 . . . . 64.329999999999998 112.145 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 m -106.02 116.34 31.77 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.985 -0.746 . . . . 72.540000000000006 108.985 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 136.18 39.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.84 1.256 . . . . 75.120000000000005 109.298 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -133.9 130.33 37.64 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.201 0.524 . . . . 73.230000000000004 110.751 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.2 mmt-85 -138.07 153.68 49.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.501 1.12 . . . . 72.230000000000004 109.118 169.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 p -152.43 158.66 42.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.216 0.531 . . . . 64.129999999999995 111.443 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.9 p -149.82 152.49 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 72.530000000000001 109.398 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.96 123.47 48.22 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.705 0.684 . . . . 74.430000000000007 110.486 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.12 136.35 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 125.344 1.458 . . . . 75.239999999999995 110.372 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.77 66.51 4.27 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.359 0.599 . . . . 75.099999999999994 111.199 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.38 157.05 5.62 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.327 1.051 . . . . 72.310000000000002 111.023 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.92 140.96 68.87 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.95 2.433 . . . . 74.019999999999996 112.199 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.52 23.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.604 1.335 . . . . 61.329999999999998 114.604 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.51 82.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.483 0.713 . . . . 73.409999999999997 112.3 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 -37.51 86.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.387 0.675 . . . . 62.310000000000002 112.358 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG13 HD23 ' A' ' 137' ' ' LEU . 25.8 t -70.49 -36.76 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.528 -0.76 . . . . 74.109999999999999 110.645 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -70.89 -28.32 64.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.786 0.834 . . . . 72.310000000000002 111.408 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -63.61 -29.76 70.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.157 0.503 . . . . 75.310000000000002 111.028 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.09 -51.06 9.47 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.007 0.923 . . . . 74.140000000000001 112.047 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.49 -18.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 113.647 0.981 . . . . 62.399999999999999 113.647 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.23 -35.05 91.48 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 123.248 0.451 . . . . 74.420000000000002 113.221 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.15 97.96 8.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.321 -0.992 . . . . 60.43 108.321 165.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -75.61 -7.1 53.39 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.274 0.559 . . . . 74.430000000000007 112.311 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -70.4 -33.64 71.61 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.409 0.623 . . . . 71.209999999999994 110.628 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' HB2' ' NE ' ' A' ' 29' ' ' ARG . . . -87.5 16.39 5.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.26 1.024 . . . . 74.109999999999999 111.722 -167.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG12 HG23 ' A' ' 34' ' ' VAL . 19.9 tt -64.89 -22.63 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 C-N-CA 123.798 0.839 . . . . 72.230000000000004 111.667 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -69.87 -9.19 53.95 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.032 0.753 . . . . 75.519999999999996 113.032 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' NE ' ' HB2' ' A' ' 26' ' ' ALA . 75.7 mtm180 -88.92 -37.45 15.26 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.108 0.563 . . . . 74.200000000000003 111.919 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.435 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 58.5 p-90 -109.52 -39.13 5.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.613 0.597 . . . . 75.540000000000006 112.613 -171.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 60.8 t-80 -86.74 115.79 63.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.789 -0.819 . . . . 75.439999999999998 108.789 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -70.05 -19.79 34.28 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.882 2.388 . . . . 73.030000000000001 114.412 -165.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -98.81 -4.93 32.12 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.621 0.971 . . . . 75.340000000000003 113.621 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG23 HG12 ' A' ' 27' ' ' ILE . 63.0 t -67.14 128.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 111.906 0.335 . . . . 75.230000000000004 111.906 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -83.52 27.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.25 1.02 . . . . 74.219999999999999 112.881 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.87 107.82 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 125.011 1.324 . . . . 63.109999999999999 112.054 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.733 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 45.1 Cg_endo -85.7 154.05 10.23 Favored 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 122.295 1.997 . . . . 71.120000000000005 114.489 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.8 m -112.47 124.95 53.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.58 0.752 . . . . 64.200000000000003 109.984 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 49' ' ' ALA . 4.2 mm? -91.2 138.49 31.55 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.385 0.674 . . . . 74.209999999999994 112.345 -168.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.42 123.11 44.43 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.335 1.054 . . . . 75.150000000000006 109.022 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.05 176.95 0.01 OUTLIER Glycine 0 CA--C 1.547 2.091 0 N-CA-C 117.363 1.705 . . . . 74.109999999999999 117.363 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.82 -122.43 1.99 Allowed 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.341 1.056 . . . . 53.43 113.085 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p -168.95 164.0 7.48 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 123.848 0.859 . . . . 61.140000000000001 109.578 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.91 -24.18 30.6 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.032 2.488 . . . . 74.310000000000002 114.415 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.12 -44.99 7.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.194 0.597 . . . . 74.430000000000007 110.892 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -67.72 119.05 63.39 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.683 0.793 . . . . 75.150000000000006 112.644 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.88 113.75 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.428 2.752 . . . . 74.25 113.14 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.28 -26.22 2.46 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.878 -0.601 . . . . 75.540000000000006 112.594 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.482 ' HB3' HD13 ' A' ' 39' ' ' LEU . . . -65.42 137.31 57.38 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.637 0.606 . . . . 74.299999999999997 112.637 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 51.3 mt-10 -118.13 118.92 33.19 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.086 0.555 . . . . 72.120000000000005 110.671 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.733 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -106.98 134.28 50.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.084 0.468 . . . . 72.420000000000002 110.909 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.448 ' HB ' ' HB1' ' A' ' 55' ' ' ALA . 20.4 t -115.27 103.35 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.593 0.757 . . . . 74.200000000000003 110.581 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.76 99.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.476 1.11 . . . . 74.239999999999995 111.649 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.68 53.7 6.36 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 123.224 0.327 . . . . 55.25 112.892 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' A' ' 52' ' ' VAL . . . -65.43 90.44 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.065 0.459 . . . . 54.5 111.762 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.19 38.4 0.06 OUTLIER Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.819 -0.628 . . . . 62.549999999999997 112.25 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 59' ' ' GLU . 15.0 t -138.36 -162.53 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.173 0.989 . . . . 70.400000000000006 110.172 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.9 15.71 20.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.345 0.658 . . . . 75.400000000000006 112.263 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 57' ' ' THR . 11.0 pt-20 -168.51 40.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.3 0.852 . . . . 72.329999999999998 113.3 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.37 156.4 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.22 0.608 . . . . 71.439999999999998 112.163 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -107.95 120.92 43.66 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.724 0.809 . . . . 74.140000000000001 110.625 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.75 121.95 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.841 0.456 . . . . 74.439999999999998 110.202 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 47.5 mt-10 -118.26 139.01 51.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.788 0.835 . . . . 73.349999999999994 110.776 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -103.85 130.7 51.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.962 0.905 . . . . 71.439999999999998 109.69 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.73 120.88 26.92 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.038 0.535 . . . . 73.019999999999996 110.151 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.25 -45.88 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.28 0.632 . . . . 72.349999999999994 112.296 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 35.4 tt0 -159.69 157.48 29.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.221 0.609 . . . . 72.239999999999995 110.858 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -148.04 131.88 17.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.237 0.615 . . . . 74.219999999999999 109.968 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -124.4 116.4 22.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.69 0.796 . . . . 63.149999999999999 109.868 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.08 13.47 33.98 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.244 0.617 . . . . 60.0 112.495 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -94.31 -46.6 6.98 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.22 0.533 . . . . 65.109999999999999 110.159 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.24 8.56 25.81 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.64 0.776 . . . . 62.409999999999997 111.834 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 56.63 67.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.088 0.955 . . . . 72.120000000000005 112.136 175.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -135.96 110.29 8.44 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.852 0.861 . . . . 74.430000000000007 111.328 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.5 tp -107.19 108.76 20.35 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.757 1.223 . . . . 72.209999999999994 110.844 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 38.3 t -104.2 130.24 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.381 0.672 . . . . 74.310000000000002 111.069 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.47 -178.9 6.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.431 0.692 . . . . 74.010000000000005 111.573 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.499 ' HB ' ' NH1' ' A' ' 90' ' ' ARG . 6.0 t -149.88 162.44 40.32 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.327 1.051 . . . . 74.450000000000003 110.741 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.8 mtp -111.55 93.17 18.62 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.077 0.951 . . . . 74.230000000000004 109.862 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.494 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 56.0 Cg_endo -67.82 -20.92 45.19 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.442 2.761 . . . . 72.230000000000004 112.732 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.87 77.79 57.64 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.734 0.814 . . . . 71.430000000000007 109.944 172.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 63.9 Cg_endo -88.72 143.55 5.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.892 2.394 . . . . 75.200000000000003 113.296 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 6.7 Cg_exo -77.13 1.53 8.6 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.878 2.385 . . . . 74.329999999999998 113.159 173.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.0 147.44 44.45 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 123.787 0.835 . . . . 72.349999999999994 111.05 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.491 ' HG2' HG23 ' A' ' 117' ' ' THR . 73.9 Cg_endo -73.1 80.95 1.77 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.695 2.263 . . . . 64.049999999999997 112.81 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.687 HG21 ' HB2' ' A' ' 113' ' ' CYS . 20.1 pt -133.41 133.03 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.263 1.025 . . . . 73.040000000000006 110.301 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m -74.55 -78.08 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.798 0.439 . . . . 74.019999999999996 111.253 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -105.76 108.62 20.23 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.978 -0.451 . . . . 64.219999999999999 110.342 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -87.98 142.82 27.49 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.344 0.658 . . . . 72.5 111.356 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.499 ' NH1' ' HB ' ' A' ' 78' ' ' THR . 6.0 tpp180 -149.39 114.25 5.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.473 0.709 . . . . 74.299999999999997 109.433 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.42 50.98 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.355 0.525 . . . . 73.319999999999993 112.006 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 49.6 t -136.65 141.22 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.224 1.01 . . . . 63.130000000000003 111.261 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 3.4 mm? -98.1 140.26 32.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.282 -1.007 . . . . 74.109999999999999 108.282 165.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 35.0 tt0 -142.89 110.13 5.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.503 0.592 . . . . 71.319999999999993 110.716 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 t -94.03 108.95 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 72.540000000000006 108.872 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.4 119.93 54.74 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.644 0.778 . . . . 74.140000000000001 109.931 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.83 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.441 2.094 . . . . 71.120000000000005 112.249 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -68.22 -32.4 72.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.811 0.844 . . . . 75.430000000000007 110.202 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.7 t70 -147.92 165.25 31.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.11 1.364 . . . . 74.450000000000003 109.461 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.64 -47.0 85.88 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.279 1.032 . . . . 73.530000000000001 111.901 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -113.3 10.94 18.52 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.722 0.809 . . . . 74.219999999999999 112.205 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 37.2 m80 -137.59 118.63 14.37 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 118.984 0.811 . . . . 65.109999999999999 110.206 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m -136.08 133.83 37.75 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.843 0.457 . . . . 60.32 111.313 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.9 m -92.54 114.81 27.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.142 0.577 . . . . 75.219999999999999 111.88 -172.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -92.3 109.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.251 0.621 . . . . 74.430000000000007 109.552 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.18 113.1 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.873 0.869 . . . . 75.109999999999999 109.647 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -102.63 120.27 40.27 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.857 -0.794 . . . . 72.010000000000005 108.857 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.7 m -123.48 141.58 51.86 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.037 0.935 . . . . 63.439999999999998 110.426 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.63 110.18 5.76 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.303 0.573 . . . . 72.349999999999994 111.508 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -109.54 125.78 52.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.528 1.131 . . . . 73.519999999999996 109.161 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -139.35 154.23 47.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.714 0.806 . . . . 72.430000000000007 110.596 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 32.7 t70 -86.73 83.76 7.51 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.385 0.612 . . . . 64.530000000000001 110.093 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.687 ' HB2' HG21 ' A' ' 86' ' ' ILE . 50.1 t -125.37 156.33 38.92 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.641 -0.709 . . . . 64.030000000000001 111.754 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -65.36 132.92 95.29 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.487 0.715 . . . . 74.439999999999998 111.158 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.23 -38.97 20.68 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.83 3.02 . . . . 75.420000000000002 115.472 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.347 0.659 . . . . 74.230000000000004 112.127 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 85' ' ' PRO . 29.5 m -87.49 -29.07 21.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.824 0.45 . . . . 73.340000000000003 110.779 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.41 70.99 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.321 0.648 . . . . 71.120000000000005 111.931 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -66.92 -28.08 68.01 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.453 0.701 . . . . 74.310000000000002 111.94 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.78 -45.43 61.63 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.567 0.747 . . . . 72.310000000000002 110.028 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 117' ' ' THR . 78.3 mt -74.41 -31.63 62.39 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.47 -0.786 . . . . 74.549999999999997 113.045 -171.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.96 -34.56 78.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.159 0.436 . . . . 73.040000000000006 111.304 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.6 t -70.6 -59.87 2.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.104 0.562 . . . . 65.420000000000002 112.117 171.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.11 -55.55 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.266 0.626 . . . . 74.530000000000001 112.421 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.2 mt -76.64 -47.97 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 72.329999999999998 110.666 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -61.3 -66.19 2.81 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.765 0.666 . . . . 74.299999999999997 114.765 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.59 -41.22 12.12 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.834 -0.804 . . . . 63.130000000000003 111.461 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.32 79.02 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.228 0.851 . . . . 60.039999999999999 115.228 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.73 -55.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.683 0.742 . . . . 74.230000000000004 111.358 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.495 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 13.2 m-30 -70.31 -56.37 6.88 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.226 0.454 . . . . 74.349999999999994 112.226 -173.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.56 68.52 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.385 0.428 . . . . 71.409999999999997 111.525 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.9 t -59.06 -51.18 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 C-N-CA 123.951 0.901 . . . . 73.430000000000007 112.263 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -69.56 -34.88 73.95 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 116.607 -0.269 . . . . 64.310000000000002 113.633 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.25 -41.65 73.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.128 0.971 . . . . 63.32 111.554 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.64 -40.65 84.58 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.348 -0.387 . . . . 75.099999999999994 110.112 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.73 76.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.766 0.827 . . . . 64.430000000000007 111.706 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.445 ' HA ' HH11 ' A' ' 140' ' ' ARG . 5.4 tt -65.13 -39.02 92.47 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 115.419 -0.809 . . . . 75.439999999999998 110.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.26 -28.83 64.43 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.055 0.542 . . . . 70.140000000000001 112.289 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -67.7 -45.65 74.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.998 0.919 . . . . 74.219999999999999 112.099 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.445 HH11 ' HA ' ' A' ' 137' ' ' LEU . 8.8 ptp85 -71.33 -25.52 62.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.098 0.559 . . . . 75.219999999999999 112.498 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -93.94 -5.44 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.961 0.505 . . . . 72.430000000000007 111.009 170.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.03 5.38 26.08 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 122.847 0.261 . . . . 71.120000000000005 113.749 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -51.88 -24.27 6.04 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.47 1.508 . . . . 74.400000000000006 113.693 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.4 -28.22 69.09 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.706 0.802 . . . . 72.109999999999999 112.543 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG3' ' H ' ' A' ' 146' ' ' HIS . 7.0 pt-20 -139.6 -62.33 0.53 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.509 0.724 . . . . 64.340000000000003 111.074 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.463 ' H ' ' HG3' ' A' ' 145' ' ' GLU . 0.7 OUTLIER 49.65 71.63 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.423 1.489 . . . . 72.530000000000001 112.173 -174.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -66.19 103.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.728 -0.669 . . . . 74.519999999999996 109.76 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 63.02 -177.51 0.15 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.566 1.146 . . . . 75.329999999999998 111.615 -168.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -80.6 -81.47 0.13 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.762 -0.586 . . . . 74.340000000000003 110.359 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 50.2 64.66 1.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.423 1.089 . . . . 72.450000000000003 111.83 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 . . . . . 0 N--CA 1.495 1.776 0 C-N-CA 124.803 1.241 . . . . 75.200000000000003 112.481 -171.133 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.837 0.351 . . . . 71.310000000000002 111.746 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.99 13.78 24.47 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.816 0.846 . . . . 74.519999999999996 111.133 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.512 HG23 ' HB3' ' A' ' 110' ' ' MET . 23.5 m -107.55 110.15 21.99 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.765 0.826 . . . . 72.409999999999997 109.177 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -94.82 134.52 37.35 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.042 0.937 . . . . 74.040000000000006 109.022 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -136.81 137.24 39.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.811 0.444 . . . . 73.230000000000004 110.35 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.71 HH11 ' HB2' ' A' ' 131' ' ' ALA . 10.5 ttm180 -147.86 152.1 37.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.201 0.6 . . . . 72.299999999999997 109.944 175.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.6 p -141.22 166.38 24.94 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.091 0.472 . . . . 74.409999999999997 111.907 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.9 p -152.15 148.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.717 0.807 . . . . 70.140000000000001 110.425 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.83 112.08 23.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.236 0.541 . . . . 73.299999999999997 109.722 168.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -91.02 127.9 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.429 1.092 . . . . 74.329999999999998 109.762 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 71.16 3.3 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 121.618 0.723 . . . . 71.319999999999993 111.541 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.34 151.63 4.62 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.474 1.109 . . . . 72.310000000000002 110.247 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.42 140.73 58.9 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.323 2.015 . . . . 51.539999999999999 112.257 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.06 -35.49 11.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.505 1.668 . . . . 74.200000000000003 115.505 -172.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.19 -48.25 80.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.537 0.569 . . . . 73.109999999999999 112.537 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.39 -36.24 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.583 0.753 . . . . 72.409999999999997 112.05 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 137' ' ' LEU . 36.2 t -72.84 -36.65 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.518 0.727 . . . . 71.010000000000005 110.631 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.538 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 61.3 t-105 -69.03 -33.5 73.72 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.618 0.767 . . . . 75.109999999999999 112.032 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -65.03 -20.1 66.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.563 0.697 . . . . 74.530000000000001 111.317 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 HD23 ' HB3' ' A' ' 30' ' ' TRP . 54.2 tp -89.9 -52.67 4.86 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.001 0.921 . . . . 75.540000000000006 112.06 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.08 -48.45 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 112.867 0.692 . . . . 73.299999999999997 112.867 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.06 65.7 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 115.172 0.829 . . . . 74.310000000000002 115.172 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.44 -18.1 60.69 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.065 0.546 . . . . 72.239999999999995 111.477 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 t80 73.64 -66.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.785 1.634 . . . . 73.120000000000005 112.105 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.3 p -67.7 -14.34 62.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.994 0.918 . . . . 52.420000000000002 113.182 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.17 9.77 18.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.67 0.788 . . . . 72.109999999999999 111.674 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.622 HG23 HG11 ' A' ' 34' ' ' VAL . 19.9 tt -61.23 -31.15 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 N-CA-C 112.76 0.652 . . . . 74.209999999999994 112.76 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -70.47 -5.78 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.075 0.768 . . . . 73.019999999999996 113.075 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -91.45 -19.86 22.38 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.453 0.701 . . . . 74.310000000000002 112.495 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.514 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 60.0 p-90 -121.31 -30.6 4.25 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.037 0.535 . . . . 73.230000000000004 111.719 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -93.63 103.75 10.85 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.384 0.674 . . . . 75.439999999999998 109.815 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.14 -15.92 52.56 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.238 2.626 . . . . 72.329999999999998 115.21 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -85.07 -28.66 25.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.885 0.474 . . . . 74.219999999999999 111.446 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.622 HG11 HG23 ' A' ' 27' ' ' ILE . 49.1 t -78.7 113.57 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 110.218 -0.29 . . . . 74.310000000000002 110.218 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -73.58 -62.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.285 0.634 . . . . 62.439999999999998 110.399 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.62 116.01 0.59 Allowed Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 124.386 1.075 . . . . 75.439999999999998 110.189 173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.39 144.71 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.463 2.109 . . . . 73.329999999999998 113.381 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -95.91 126.7 41.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.193 0.997 . . . . 75.430000000000007 109.804 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 9.5 mp -110.03 145.75 36.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.648 0.737 . . . . 73.319999999999993 111.42 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -149.85 147.04 27.48 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.486 -1.234 . . . . 72.319999999999993 110.246 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.5 153.38 0.0 OUTLIER Glycine 0 CA--C 1.555 2.585 0 N-CA-C 117.687 1.835 . . . . 64.319999999999993 117.687 -167.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 72.9 -50.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.837 1.655 . . . . 65.329999999999998 115.312 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m 102.12 147.51 0.02 OUTLIER Pre-proline 0 N--CA 1.516 2.863 0 C-N-CA 127.709 2.404 . . . . 63.409999999999997 111.869 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.69 -38.53 46.27 Favored 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 124.427 3.418 . . . . 73.129999999999995 115.549 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -90.99 10.53 26.22 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.351 0.5 . . . . 73.299999999999997 112.351 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -123.75 119.13 26.99 Favored Pre-proline 0 N--CA 1.487 1.382 0 C-N-CA 123.833 0.853 . . . . 74.120000000000005 110.536 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.3 Cg_exo -52.52 129.22 31.08 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.335 2.69 . . . . 74.150000000000006 113.807 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.02 -10.5 13.59 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.392 0.52 . . . . 71.540000000000006 112.96 -175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.07 154.69 40.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.376 0.67 . . . . 71.530000000000001 111.95 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 50.6 mt-10 -112.79 128.81 56.54 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.938 0.495 . . . . 74.150000000000006 111.602 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -107.41 102.86 12.11 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.651 0.78 . . . . 75.129999999999995 109.554 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.1 t -106.7 104.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.313 0.577 . . . . 63.32 111.353 -170.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HD1' HG12 ' A' ' 34' ' ' VAL . 66.0 m-85 -75.34 82.68 2.45 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.307 1.043 . . . . 71.230000000000004 111.264 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.05 -63.11 0.58 Allowed Glycine 0 N--CA 1.478 1.449 0 CA-C-N 116.042 -0.526 . . . . 63.539999999999999 112.3 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.77 -53.23 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.079 1.751 . . . . 73.319999999999993 115.318 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.83 37.56 3.32 Favored Glycine 0 N--CA 1.487 2.065 0 CA-C-O 121.234 0.352 . . . . 75.040000000000006 112.932 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -120.63 -165.75 1.24 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.274 1.029 . . . . 71.099999999999994 110.62 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -122.77 27.41 7.77 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.952 0.901 . . . . 72.519999999999996 109.701 167.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.17 9.54 1.11 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.205 1.002 . . . . 74.319999999999993 111.913 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 152.21 39.4 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.367 0.604 . . . . 71.239999999999995 112.498 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.529 HD13 ' SD ' ' A' ' 79' ' ' MET . 29.2 tp -107.22 119.92 40.71 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.102 0.961 . . . . 73.150000000000006 109.224 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.749 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 94.5 t -95.99 114.34 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.283 0.563 . . . . 73.25 109.482 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 17.1 tt0 -115.24 167.88 10.45 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.445 1.098 . . . . 55.240000000000002 109.898 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.457 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 30.3 ttm-85 -150.82 128.88 11.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.126 0.97 . . . . 74.439999999999998 111.736 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 27.0 tp -67.79 129.2 39.19 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.951 0.9 . . . . 64.319999999999993 111.123 171.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.541 HG21 HH11 ' A' ' 90' ' ' ARG . 79.0 t -101.29 -51.13 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.772 0.829 . . . . 75.239999999999995 111.384 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -149.72 148.73 29.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.372 1.069 . . . . 70.150000000000006 109.136 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -140.02 119.6 13.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.966 -0.383 . . . . 75.329999999999998 109.966 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 24.5 m-20 -101.09 102.45 13.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.525 1.13 . . . . 72.239999999999995 109.773 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.538 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 31.4 tt0 -75.74 -41.14 54.13 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.26 -0.275 . . . . 74.409999999999997 111.008 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.9 m -68.76 -50.05 53.71 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.36 0.664 . . . . 63.43 111.146 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 69' ' ' ASP . . . -78.49 -6.14 54.55 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.983 0.734 . . . . 64.340000000000003 112.983 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 63.43 45.2 4.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.74 1.216 . . . . 74.530000000000001 111.945 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.1 ttm105 -129.39 135.36 48.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.913 1.285 . . . . 75.120000000000005 110.455 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 tp -125.43 106.15 9.59 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.043 0.537 . . . . 72.150000000000006 110.745 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -105.7 126.11 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.693 0.797 . . . . 75.299999999999997 110.519 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -146.57 179.51 7.5 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.426 0.69 . . . . 72.120000000000005 112.043 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 m -156.56 142.24 17.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.955 1.302 . . . . 71.530000000000001 109.74 -169.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.529 ' SD ' HD13 ' A' ' 61' ' ' LEU . 57.3 mtm -95.87 98.79 4.19 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 118.234 0.47 . . . . 73.450000000000003 109.79 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.82 -25.03 17.31 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.375 2.717 . . . . 75.150000000000006 112.901 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.749 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.7 t70 -129.59 80.04 72.55 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.464 0.706 . . . . 74.109999999999999 109.489 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -93.36 133.47 0.94 Allowed 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 122.964 2.443 . . . . 73.340000000000003 112.761 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD2' HD11 ' A' ' 61' ' ' LEU . 71.7 Cg_endo -72.27 -2.03 11.05 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.203 1.935 . . . . 71.420000000000002 112.073 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.84 140.77 50.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 124.454 1.102 . . . . 75.450000000000003 109.924 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 77.76 2.77 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.476 2.117 . . . . 73.239999999999995 112.889 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.523 HD11 ' HB2' ' A' ' 89' ' ' HIS . 7.4 pt -138.94 143.99 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.661 1.184 . . . . 72.310000000000002 110.412 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -72.17 -47.45 50.78 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.344 0.868 . . . . 75.25 113.344 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -131.97 -49.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.266 0.469 . . . . 73.099999999999994 112.266 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.523 ' HB2' HD11 ' A' ' 86' ' ' ILE . 47.9 t-80 65.35 145.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 125.417 1.487 . . . . 75.040000000000006 113.736 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.541 HH11 HG21 ' A' ' 66' ' ' VAL . 21.4 tpp180 -147.08 149.01 32.2 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.732 1.213 . . . . 74.129999999999995 108.347 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.7 146.44 20.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.968 0.507 . . . . 74.099999999999994 111.74 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.5 p -137.23 140.28 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.376 0 N-CA-C 113.106 0.78 . . . . 74.239999999999995 113.106 -174.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -107.62 108.48 19.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.504 1.121 . . . . 72.439999999999998 108.691 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -121.0 111.65 17.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.089 -0.708 . . . . 74.040000000000006 109.089 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.32 110.79 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.709 -0.849 . . . . 73.319999999999993 108.709 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.39 123.8 61.22 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.15 0.98 . . . . 75.310000000000002 109.928 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.64 137.31 41.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.448 2.099 . . . . 74.439999999999998 111.974 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.582 HH11 ' HB2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -138.05 -34.52 0.66 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.162 0.585 . . . . 71.420000000000002 111.403 -172.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.4 t70 -163.65 159.47 21.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.178 0.991 . . . . 75.450000000000003 110.01 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.5 -31.16 55.42 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.897 1.279 . . . . 75.310000000000002 113.092 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -140.18 26.69 2.19 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.167 0.587 . . . . 75.310000000000002 110.373 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.9 m80 -147.94 111.18 4.9 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.045 0.938 . . . . 73.409999999999997 109.32 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -133.76 137.02 44.95 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.241 0.616 . . . . 70.5 110.824 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.8 m -94.71 114.09 25.96 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.102 0.561 . . . . 74.019999999999996 112.231 -170.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.78 122.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.742 -0.466 . . . . 71.120000000000005 109.742 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.83 115.31 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.168 -0.678 . . . . 72.340000000000003 109.168 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.9 123.31 49.38 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.764 -0.828 . . . . 73.140000000000001 108.764 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.449 HG21 ' SD ' ' A' ' 110' ' ' MET . 91.8 m -130.58 135.37 47.83 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 74.299999999999997 110.382 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.504 ' HB1' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.75 115.13 15.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.84 0.856 . . . . 65.549999999999997 110.761 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.512 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -121.56 132.89 54.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.714 1.206 . . . . 73.200000000000003 109.871 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -145.46 147.81 32.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.31 0.644 . . . . 74.230000000000004 111.878 -171.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.86 87.57 5.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.235 -0.654 . . . . 72.349999999999994 109.235 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.522 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 42.0 t -143.5 167.5 22.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.808 0.67 . . . . 63.530000000000001 112.808 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.41 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.7 m -70.13 142.23 89.91 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.316 1.046 . . . . 71.420000000000002 112.435 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.47 -40.3 54.15 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.473 2.782 . . . . 73.340000000000003 114.724 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.74 -31.56 69.75 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.063 0.945 . . . . 74.310000000000002 112.764 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.522 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -89.9 -29.93 18.22 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.41 0.684 . . . . 52.130000000000003 111.113 176.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.13 77.27 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.622 0.769 . . . . 75.140000000000001 112.198 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -68.33 -36.56 79.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.031 0.932 . . . . 75.400000000000006 111.988 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.58 -49.17 72.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.402 0.681 . . . . 74.299999999999997 109.895 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -71.97 -23.67 61.47 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.931 -1.031 . . . . 74.329999999999998 111.352 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.19 -48.66 79.63 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.582 0.753 . . . . 75.200000000000003 110.817 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.7 m -69.23 -53.25 20.86 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.593 -0.731 . . . . 72.219999999999999 112.665 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.7 -53.85 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.53 0.567 . . . . 74.409999999999997 112.53 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.4 -48.18 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.131 0.572 . . . . 74.439999999999998 111.125 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.52 -52.39 35.27 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 114.629 0.611 . . . . 40.340000000000003 114.629 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.31 -44.63 10.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 122.062 -0.67 . . . . 74.400000000000006 112.033 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.89 -47.51 54.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 116.071 -0.513 . . . . 72.230000000000004 113.876 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.44 -53.24 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.96 0.504 . . . . 73.230000000000004 111.631 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.504 ' HZ ' ' HB1' ' A' ' 109' ' ' ALA . 4.1 m-30 -75.65 -56.92 4.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.321 0.489 . . . . 74.239999999999995 112.321 -171.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.71 ' HB2' HH11 ' A' ' 6' ' ' ARG . . . -55.93 -38.55 70.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.949 0.404 . . . . 73.329999999999998 111.768 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 t -65.78 -54.45 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 123.455 0.702 . . . . 70.239999999999995 112.347 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.98 71.81 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 113.851 0.3 . . . . 64.409999999999997 113.851 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.57 -42.89 99.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.361 1.065 . . . . 75.510000000000005 112.473 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 92.4 m-20 -70.01 -39.72 75.67 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 119.726 -0.178 . . . . 65.030000000000001 110.931 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.94 79.82 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.103 0.561 . . . . 75.5 111.234 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 17' ' ' VAL . 4.8 tt -65.49 -38.25 89.21 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.454 0.702 . . . . 74.409999999999997 110.324 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.69 68.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.939 0.496 . . . . 53.240000000000002 111.918 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 18.7 mm-40 -69.39 -42.88 74.53 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.446 0.699 . . . . 72.129999999999995 111.724 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.13 -28.92 67.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.601 0.36 . . . . 74.439999999999998 111.936 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -97.53 6.64 47.81 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.809 0.444 . . . . 75.109999999999999 111.828 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -65.27 12.46 0.28 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 116.434 1.334 . . . . 72.219999999999999 116.434 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -56.47 131.07 47.49 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.789 0.836 . . . . 74.25 110.934 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt 55.26 43.72 28.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.096 0.958 . . . . 70.540000000000006 111.977 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.49 137.1 58.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.668 1.187 . . . . 74.420000000000002 111.507 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -142.01 109.03 5.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.236 1.014 . . . . 71.450000000000003 109.895 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -68.37 107.76 2.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.87 0.468 . . . . 64.239999999999995 110.364 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -120.29 12.95 11.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.823 0.449 . . . . 74.209999999999994 111.033 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.1 -47.26 77.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.823 0.849 . . . . 73.519999999999996 111.989 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -79.45 -29.33 41.74 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.902 0.481 . . . . 63.439999999999998 111.912 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.3 p80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.421 0.629 . . . . 74.129999999999995 111.095 179.086 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.989 0.424 . . . . 63.219999999999999 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.21 89.19 3.01 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.51 0.724 . . . . 74.540000000000006 109.811 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 110' ' ' MET . 58.1 m -131.7 121.25 23.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.649 0.779 . . . . 75.109999999999999 110.01 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.75 111.47 23.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.622 1.169 . . . . 73.420000000000002 110.027 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -104.74 120.54 41.62 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.827 -0.805 . . . . 73.239999999999995 108.827 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.24 135.82 46.55 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.741 -0.466 . . . . 74.329999999999998 109.741 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.6 p -141.42 159.59 41.91 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.02 0.528 . . . . 74.120000000000005 112.294 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.9 p -147.27 141.28 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.777 0.831 . . . . 73.400000000000006 110.62 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.1 111.03 23.53 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.609 0.719 . . . . 75.019999999999996 110.276 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 137' ' ' LEU . 66.1 t -102.44 145.45 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 125.573 1.549 . . . . 75.430000000000007 112.1 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -79.66 59.74 3.13 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.031 0.932 . . . . 65.230000000000004 112.391 173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 141.64 6.55 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.349 0.659 . . . . 73.099999999999994 111.15 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.15 138.11 65.22 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.972 2.448 . . . . 71.239999999999995 113.382 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.4 -46.46 13.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.8 1.778 . . . . 70.109999999999999 115.8 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.02 90.82 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.521 0.563 . . . . 72.200000000000003 112.521 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.82 -30.44 68.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.474 0.546 . . . . 65.040000000000006 112.474 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.542 HG22 ' SG ' ' A' ' 103' ' ' CYS . 83.5 t -70.66 -35.44 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.783 0.433 . . . . 64.319999999999993 110.679 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -67.37 -27.6 67.25 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.778 0.431 . . . . 74.400000000000006 111.295 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.3 m -63.85 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.316 0.579 . . . . 73.049999999999997 111.529 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.6 tp -84.16 -56.83 3.45 Favored 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.486 1.114 . . . . 73.340000000000003 112.47 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.47 -21.61 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.727 1.01 . . . . 74.530000000000001 113.727 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.48 -50.37 59.73 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.526 0.516 . . . . 71.540000000000006 114.111 -170.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.67 127.79 34.32 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.209 -0.663 . . . . 73.439999999999998 109.209 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.68 -30.04 71.09 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.357 1.063 . . . . 74.120000000000005 112.491 -169.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -99.27 0.84 43.92 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.487 0.715 . . . . 71.010000000000005 112.476 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB2' HH11 ' A' ' 29' ' ' ARG . . . -89.94 8.88 30.07 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.199 0.6 . . . . 72.530000000000001 111.837 -174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.671 HG22 ' NH2' ' A' ' 51' ' ' ARG . 19.9 tt -65.8 -30.83 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.597 1.159 . . . . 75.099999999999994 113.208 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -66.11 -9.48 31.63 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.701 0.63 . . . . 73.319999999999993 112.701 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.455 HH11 ' HB2' ' A' ' 26' ' ' ALA . 69.8 mtp180 -83.87 -14.88 50.07 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.936 0.895 . . . . 74.120000000000005 112.354 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.431 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 51.7 p-90 -130.28 -40.83 1.27 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 112.77 0.656 . . . . 72.319999999999993 112.77 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' ND1' HG21 ' A' ' 34' ' ' VAL . 32.7 t-80 -85.79 113.17 49.92 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.073 0.549 . . . . 74.150000000000006 110.519 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -18.89 31.08 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.212 2.608 . . . . 53.340000000000003 114.525 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 4.2 mt-30 -94.69 -13.04 26.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.81 0.67 . . . . 71.099999999999994 112.81 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.451 HG21 ' ND1' ' A' ' 31' ' ' HIS . 90.9 t -73.12 114.38 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 121.072 0.463 . . . . 74.150000000000006 110.26 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -92.93 35.95 1.04 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.395 1.078 . . . . 63.310000000000002 111.64 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.03 115.32 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 C-N-CA 125.603 1.561 . . . . 62.219999999999999 112.483 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HG3' ' HE ' ' A' ' 51' ' ' ARG . 26.3 Cg_endo -95.71 177.99 0.7 Allowed 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.381 2.721 . . . . 72.140000000000001 114.703 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.1 m -119.42 132.34 55.8 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.322 1.049 . . . . 52.43 110.451 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.2 136.34 37.86 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.454 0.645 . . . . 75.420000000000002 111.416 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -121.74 145.05 48.42 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.512 1.125 . . . . 73.040000000000006 110.294 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 119.71 0.0 OUTLIER Glycine 0 CA--C 1.556 2.611 0 N-CA-C 117.613 1.805 . . . . 64.430000000000007 117.613 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.57 -96.41 0.05 OUTLIER 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 125.614 1.566 . . . . 72.319999999999993 113.644 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -158.71 150.76 17.35 Favored Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 123.29 0.636 . . . . 73.230000000000004 111.78 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.12 -12.58 33.13 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.11 2.54 . . . . 75.099999999999994 114.155 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 80.1 m-70 -97.06 -5.72 36.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.827 -0.545 . . . . 74.299999999999997 111.657 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.6 m -96.89 113.78 63.49 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.788 0.835 . . . . 72.409999999999997 110.758 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.2 Cg_endo -55.97 114.84 2.08 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.253 2.635 . . . . 65.510000000000005 112.87 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.36 -23.79 4.02 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-N 115.915 -0.584 . . . . 73.329999999999998 112.558 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.69 133.74 55.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.417 0.687 . . . . 74.239999999999995 112.254 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 43.4 mt-10 -103.26 138.57 39.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.966 0.506 . . . . 65.140000000000001 110.754 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.671 ' NH2' HG22 ' A' ' 27' ' ' ILE . 32.5 ttt-85 -125.15 106.01 9.58 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.176 0.99 . . . . 75.109999999999999 110.745 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 t -110.55 109.31 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.338 0.655 . . . . 74.230000000000004 111.4 -169.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HE2' HG22 ' A' ' 34' ' ' VAL . 46.2 m-85 -62.32 118.61 7.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.334 1.054 . . . . 74.040000000000006 111.326 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.84 -71.91 2.88 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 112.451 -0.26 . . . . 71.109999999999999 112.451 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.74 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.881 1.272 . . . . 74.219999999999999 113.468 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 25.52 3.98 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 116.348 -0.387 . . . . 60.439999999999998 113.948 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.5 -172.32 2.49 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.301 1.04 . . . . 70.140000000000001 110.205 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.4 0.96 54.7 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.808 0.443 . . . . 73.299999999999997 111.746 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.1 88.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.568 0.747 . . . . 63.450000000000003 110.034 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.38 139.6 49.35 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.376 0.671 . . . . 72.230000000000004 110.414 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -95.2 117.46 30.28 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.517 0.727 . . . . 73.310000000000002 109.902 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 43.6 t -96.17 115.97 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.735 -0.469 . . . . 75.030000000000001 109.735 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 23.3 tt0 -112.69 166.65 11.16 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.211 1.005 . . . . 72.109999999999999 109.837 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -151.6 124.98 8.84 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.926 0.49 . . . . 65.239999999999995 111.918 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 34.4 tp -68.2 120.07 13.78 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.833 1.253 . . . . 75.109999999999999 111.353 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -85.21 -52.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.246 0.618 . . . . 55.109999999999999 110.647 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 8.5 pt-20 -155.83 139.72 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.156 0.583 . . . . 73.040000000000006 110.456 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.686 HH12 ' HB3' ' A' ' 70' ' ' GLU . 41.4 tpt85 -131.94 106.85 8.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.608 0.763 . . . . 74.540000000000006 109.641 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.92 116.63 23.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.603 0.761 . . . . 50.329999999999998 111.355 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.686 ' HB3' HH12 ' A' ' 68' ' ' ARG . 13.1 pt-20 -84.6 -39.19 19.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.284 0.634 . . . . 75.310000000000002 112.63 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.7 m -71.83 -25.34 61.94 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.311 0.644 . . . . 53.450000000000003 111.262 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.9 -17.86 32.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.468 0.707 . . . . 72.329999999999998 111.784 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 55.49 43.75 28.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.985 0.914 . . . . 75.209999999999994 111.226 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -133.45 116.07 15.56 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 114.471 -1.241 . . . . 71.549999999999997 109.887 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.652 HD13 ' HD3' ' A' ' 68' ' ' ARG . 23.9 tp -119.03 109.67 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.867 1.267 . . . . 74.120000000000005 110.923 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.526 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 75.9 t -110.34 137.44 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.829 -0.545 . . . . 71.519999999999996 111.392 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -145.14 179.21 7.51 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.67 1.188 . . . . 73.0 110.507 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -163.32 152.79 14.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.463 1.105 . . . . 73.140000000000001 109.243 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.0 mpp? -91.03 109.72 37.17 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 118.024 0.375 . . . . 75.340000000000003 110.386 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.08 -21.19 63.32 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.664 2.242 . . . . 73.420000000000002 111.851 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 29.7 t70 -122.94 80.6 50.34 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.919 0.888 . . . . 62.399999999999999 109.558 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -94.88 137.29 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.069 2.513 . . . . 74.209999999999994 113.057 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.51 12.05 3.17 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.855 2.37 . . . . 73.519999999999996 113.447 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -108.43 144.97 30.57 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 124.005 0.922 . . . . 73.010000000000005 109.971 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.26 65.47 7.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.83 2.353 . . . . 72.120000000000005 112.289 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 22.2 pt -122.76 131.62 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.18 0.992 . . . . 74.430000000000007 110.955 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 26.4 m -78.44 134.51 37.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 110.069 -0.345 . . . . 75.310000000000002 110.069 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 56.1 -67.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 128.132 2.573 . . . . 63.009999999999998 114.721 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 109' ' ' ALA . 58.9 t-80 69.11 148.06 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.343 1.457 . . . . 74.040000000000006 111.516 -174.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.423 ' CZ ' HG13 ' A' ' 76' ' ' VAL . 64.8 ttt-85 -164.66 107.86 0.89 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 109.532 -0.544 . . . . 75.230000000000004 109.532 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.37 146.31 33.22 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.197 0.599 . . . . 64.439999999999998 112.016 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.6 p -138.09 144.43 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 113.501 0.926 . . . . 75.239999999999995 113.501 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.35 112.07 24.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.17 1.388 . . . . 72.200000000000003 109.297 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -119.06 113.69 21.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.197 0.999 . . . . 72.209999999999994 110.139 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 t -93.06 112.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.988 -0.445 . . . . 74.310000000000002 110.208 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.33 119.28 58.11 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.377 1.071 . . . . 63.439999999999998 110.961 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.5 107.68 2.05 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.504 2.136 . . . . 65.129999999999995 112.825 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -86.61 -42.66 13.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.984 0.914 . . . . 74.450000000000003 111.061 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.3 t70 -140.49 178.92 6.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.44 1.096 . . . . 74.109999999999999 109.058 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.09 -48.62 28.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.056 0.542 . . . . 73.299999999999997 111.031 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.404 ' O ' ' HD3' ' A' ' 101' ' ' ARG . 3.9 tmt_? -95.96 -1.52 48.93 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.89 0.876 . . . . 73.129999999999995 111.03 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.522 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -135.77 158.54 44.15 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.391 -0.818 . . . . 74.200000000000003 110.73 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.542 ' SG ' HG22 ' A' ' 17' ' ' VAL . 22.4 p -156.61 178.23 10.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.786 0.434 . . . . 73.329999999999998 111.514 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.4 m -119.43 127.35 53.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.888 0.875 . . . . 62.25 110.782 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t -95.26 110.35 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.959 -0.756 . . . . 74.209999999999994 108.959 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.2 t -99.68 108.83 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.382 0.673 . . . . 64.319999999999993 110.04 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -106.8 119.27 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.048 -0.723 . . . . 75.430000000000007 109.048 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.4 m -126.4 150.54 48.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.0 0.92 . . . . 74.120000000000005 109.943 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.456 ' HB2' ' HE2' ' A' ' 89' ' ' HIS . . . -147.61 120.03 8.46 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.236 0.614 . . . . 74.219999999999999 111.244 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.517 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -117.12 128.6 55.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.117 0.967 . . . . 74.230000000000004 110.211 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.42 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 19.2 p90 -146.91 143.01 28.2 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.205 1.402 . . . . 74.109999999999999 108.462 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.693 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 15.8 t70 -89.88 78.39 6.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.733 0.778 . . . . 74.510000000000005 109.659 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 52.6 t -117.82 163.1 17.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.203 0.601 . . . . 72.430000000000007 111.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.1 p -64.38 138.76 97.53 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.672 0.789 . . . . 74.340000000000003 112.018 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.55 -36.43 18.47 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.943 3.095 . . . . 61.109999999999999 115.169 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -61.06 -53.75 53.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.54 0.736 . . . . 73.530000000000001 111.352 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.435 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 48.7 m -72.84 -27.29 61.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.986 0.515 . . . . 75.040000000000006 111.517 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.42 -43.3 81.55 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.914 0.885 . . . . 73.340000000000003 112.57 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -68.51 -29.14 67.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.365 0.666 . . . . 73.219999999999999 111.484 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.49 -43.93 68.72 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.361 0.665 . . . . 64.219999999999999 110.498 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.06 -23.25 59.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.89 0.876 . . . . 73.439999999999998 111.536 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -57.54 -44.78 85.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.851 0.46 . . . . 72.219999999999999 110.18 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.8 t -71.61 -52.32 18.63 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 64.430000000000007 112.738 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.91 -54.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 123.447 0.699 . . . . 70.430000000000007 112.705 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.89 -50.58 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.135 0.574 . . . . 74.230000000000004 111.115 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -66.18 -49.31 58.4 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 114.652 0.621 . . . . 62.200000000000003 114.652 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.08 -48.99 7.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.126 -0.631 . . . . 75.230000000000004 111.56 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.51 -29.8 65.34 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 115.496 0.959 . . . . 73.450000000000003 115.496 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.93 -53.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 117.784 0.792 . . . . 73.120000000000005 110.96 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -73.25 -60.46 2.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.444 0.698 . . . . 75.209999999999994 112.287 -170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.81 66.98 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 123.497 0.498 . . . . 73.310000000000002 111.488 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -55.94 -54.82 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 123.666 0.786 . . . . 74.25 112.295 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.75 80.72 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 113.69 0.236 . . . . 74.519999999999996 113.69 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.58 -42.21 71.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.057 0.943 . . . . 73.299999999999997 111.884 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.68 -41.39 83.78 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.519 0.328 . . . . 71.120000000000005 110.289 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.34 80.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.802 0.841 . . . . 55.350000000000001 111.969 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 10' ' ' VAL . 7.8 tt -65.26 -43.22 91.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.715 0.806 . . . . 73.439999999999998 110.228 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.94 74.59 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 116.136 -0.484 . . . . 73.439999999999998 111.275 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 49.6 mt-10 -69.58 -48.13 61.27 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.865 0.866 . . . . 72.140000000000001 112.794 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -19.9 65.37 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.49 0.552 . . . . 72.299999999999997 112.49 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -91.34 -44.3 9.26 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.882 0.473 . . . . 74.040000000000006 111.864 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.91 56.29 0.04 OUTLIER Glycine 0 N--CA 1.479 1.526 0 N-CA-C 114.323 0.489 . . . . 74.329999999999998 114.323 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 12.4 ttm180 62.5 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 125.136 1.374 . . . . 73.450000000000003 112.942 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -173.99 166.53 4.29 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.956 1.302 . . . . 73.200000000000003 110.221 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -98.92 -41.56 7.55 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.834 0.453 . . . . 72.310000000000002 110.643 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -125.25 124.26 41.3 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.606 0.763 . . . . 72.129999999999995 110.651 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -78.0 121.89 24.81 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.084 0.554 . . . . 72.430000000000007 110.144 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.423 ' HE1' HG23 ' A' ' 8' ' ' VAL . 18.2 p-80 -123.08 118.51 27.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.219 1.007 . . . . 65.510000000000005 109.624 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -85.93 50.58 2.0 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.946 0.898 . . . . 74.519999999999996 111.429 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 62.65 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.47 1.108 . . . . 71.540000000000006 113.223 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 124.154 0.982 . . . . 71.140000000000001 111.039 177.263 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.69 0.281 . . . . 74.329999999999998 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 47.7 1.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.708 0.803 . . . . 53.240000000000002 110.964 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 m -121.92 111.28 16.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.811 0.844 . . . . 72.400000000000006 110.318 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.483 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 6.8 mp -96.08 109.59 21.99 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 62.119999999999997 110.039 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.53 123.71 39.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.898 0.479 . . . . 73.319999999999993 110.946 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.435 HH22 ' HG2' ' A' ' 122' ' ' GLU . 1.2 mmp_? -122.28 160.39 25.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.333 1.053 . . . . 74.530000000000001 108.817 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -153.31 146.81 24.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.11 0.564 . . . . 73.439999999999998 111.244 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.0 p -138.73 145.58 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.156 0.583 . . . . 75.109999999999999 111.314 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.94 110.88 22.72 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.495 0.718 . . . . 75.319999999999993 110.426 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 65.9 t -101.41 139.93 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.562 1.145 . . . . 73.150000000000006 111.578 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.72 40.78 0.61 Allowed 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 113.766 1.025 . . . . 71.319999999999993 113.766 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.54 32.27 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.205 0.602 . . . . 63.140000000000001 111.654 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.08 145.28 78.67 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.984 2.456 . . . . 74.329999999999998 113.265 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.31 -35.31 37.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.345 1.458 . . . . 72.319999999999993 114.72 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.69 -51.55 61.87 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.595 0.591 . . . . 72.420000000000002 112.595 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.77 -44.78 90.73 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.282 0.633 . . . . 63.450000000000003 111.162 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG21 ' SG ' ' A' ' 103' ' ' CYS . 49.2 t -68.72 -34.07 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.605 0.762 . . . . 72.319999999999993 111.08 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.537 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 55.8 t-105 -59.55 -40.99 89.07 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.458 0.303 . . . . 72.129999999999995 111.219 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -61.37 -24.99 66.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.796 0.438 . . . . 75.219999999999999 111.564 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 30' ' ' TRP . 29.5 tp -83.67 -44.29 14.66 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 112.736 0.643 . . . . 70.299999999999997 112.736 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.62 -26.26 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 114.098 1.147 . . . . 75.540000000000006 114.098 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.71 35.42 3.22 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 115.876 1.11 . . . . 51.119999999999997 115.876 -165.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.26 -162.07 0.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.806 0.842 . . . . 53.329999999999998 111.158 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.14 25.2 1.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.302 0.641 . . . . 75.109999999999999 110.195 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -152.15 -42.83 0.11 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.498 0.719 . . . . 74.109999999999999 111.763 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.4 3.12 48.34 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.221 1.008 . . . . 61.229999999999997 111.199 -170.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.66 HG23 HG13 ' A' ' 34' ' ' VAL . 14.3 tt -55.92 -19.76 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 C-N-CA 125.853 1.661 . . . . 72.209999999999994 113.108 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.37 -14.36 55.96 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.409 0.892 . . . . 73.409999999999997 113.409 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -71.85 -20.18 61.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.533 0.733 . . . . 74.299999999999997 112.374 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.465 ' HB3' HD21 ' A' ' 20' ' ' LEU . 31.5 p-90 -127.71 -35.08 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.008 0.523 . . . . 74.25 111.912 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -89.77 112.37 51.59 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 122.819 0.447 . . . . 74.340000000000003 110.337 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.68 -16.27 37.8 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.275 2.65 . . . . 70.319999999999993 114.083 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -93.15 -20.69 20.24 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.724 0.81 . . . . 73.510000000000005 112.12 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.66 HG13 HG23 ' A' ' 27' ' ' ILE . 72.9 t -69.32 111.79 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 120.919 0.39 . . . . 71.510000000000005 110.894 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -92.33 27.46 2.23 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.429 1.092 . . . . 62.229999999999997 111.9 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.03 98.1 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.577 1.151 . . . . 72.430000000000007 111.27 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.11 173.14 8.12 Favored 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 123.116 2.544 . . . . 75.530000000000001 114.693 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -99.96 123.02 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.0 0.92 . . . . 73.430000000000007 109.758 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.71 127.32 39.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.237 0.615 . . . . 73.010000000000005 111.204 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -104.64 123.23 47.22 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.719 -0.673 . . . . 74.530000000000001 109.612 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.33 -175.41 0.01 OUTLIER Glycine 0 CA--C 1.55 2.241 0 N-CA-C 117.543 1.777 . . . . 63.219999999999999 117.543 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 46.75 -121.31 1.14 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.839 1.256 . . . . 75.530000000000001 113.315 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -162.8 155.9 16.78 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 124.375 1.07 . . . . 75.349999999999994 108.985 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.42 -15.52 45.82 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.502 2.135 . . . . 72.0 114.859 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -111.41 0.77 16.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.66 -0.65 . . . . 74.129999999999995 111.546 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -110.77 127.69 26.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 123.732 0.813 . . . . 73.209999999999994 110.928 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.708 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 85.5 Cg_exo -50.15 138.68 36.21 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.68 2.92 . . . . 73.420000000000002 114.149 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.97 19.6 21.24 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 116.272 -0.422 . . . . 70.109999999999999 113.564 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.78 134.74 51.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.71 0.804 . . . . 74.409999999999997 110.737 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.35 118.44 35.85 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.952 0.501 . . . . 74.209999999999994 110.965 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -93.63 126.26 38.69 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.888 0.375 . . . . 73.400000000000006 110.042 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG13 HG22 ' A' ' 62' ' ' VAL . 20.6 t -122.42 122.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 122.902 0.481 . . . . 74.450000000000003 111.238 -171.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' HE2' HG11 ' A' ' 34' ' ' VAL . 48.6 m-85 -95.56 85.31 4.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.216 1.006 . . . . 73.530000000000001 111.118 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.25 -43.41 1.61 Allowed Glycine 0 N--CA 1.478 1.488 0 N-CA-C 112.722 -0.151 . . . . 74.230000000000004 112.722 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 17.7 4.12 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.949 1.463 . . . . 73.319999999999993 114.949 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.31 57.8 0.03 OUTLIER Glycine 0 N--CA 1.472 1.064 0 N-CA-C 112.595 -0.202 . . . . 73.239999999999995 112.595 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -105.87 -69.1 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.982 0.913 . . . . 72.0 109.729 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 176.64 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.527 1.531 . . . . 72.310000000000002 109.252 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.75 82.21 2.07 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.871 0.843 . . . . 74.319999999999993 108.818 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.72 -179.77 3.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.15 0.98 . . . . 74.120000000000005 110.601 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.455 HD13 ' SD ' ' A' ' 79' ' ' MET . 55.0 tp -141.14 123.53 15.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.799 0.44 . . . . 72.209999999999994 110.896 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.0 t -104.7 115.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.162 -0.681 . . . . 75.519999999999996 109.162 170.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -104.73 149.67 25.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.872 0.869 . . . . 71.319999999999993 109.889 171.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -127.5 127.39 43.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.068 1.347 . . . . 74.400000000000006 109.867 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.17 108.99 9.47 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.932 0.893 . . . . 73.120000000000005 110.662 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -73.26 -50.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.363 0.665 . . . . 74.439999999999998 110.555 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.708 ' HA ' ' HG3' ' A' ' 47' ' ' PRO . 8.6 pt-20 -166.81 155.46 10.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.541 0.736 . . . . 75.109999999999999 111.095 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -141.69 123.04 14.87 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.37 0.668 . . . . 70.209999999999994 110.497 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.35 -178.37 4.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.045 0.938 . . . . 74.239999999999995 111.826 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.537 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 55.4 mt-10 -138.92 -63.72 0.52 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.228 1.011 . . . . 75.219999999999999 109.955 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -69.57 -38.25 77.33 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.414 0.686 . . . . 62.350000000000001 111.439 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.67 -19.83 60.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.431 0.692 . . . . 75.209999999999994 112.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 55.74 45.0 25.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 75.230000000000004 112.253 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.418 HH11 HG23 ' A' ' 76' ' ' VAL . 9.0 tmm_? -130.7 130.99 44.55 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 115.031 -0.986 . . . . 74.349999999999994 110.475 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 46.2 tp -120.36 123.63 43.56 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.363 1.065 . . . . 74.400000000000006 110.212 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.5 t -114.38 132.35 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 118.958 0.799 . . . . 74.239999999999995 111.072 174.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -147.61 175.18 11.07 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 75.019999999999996 111.349 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.6 t -150.15 145.26 26.19 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.402 1.081 . . . . 73.239999999999995 109.55 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.455 ' SD ' HD13 ' A' ' 61' ' ' LEU . 20.3 ptt? -95.96 101.06 7.46 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 118.787 0.721 . . . . 74.430000000000007 110.7 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.47 -17.37 30.38 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 123.178 2.586 . . . . 63.109999999999999 113.229 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 34.9 t70 -132.8 79.18 64.49 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 123.427 0.691 . . . . 74.230000000000004 109.859 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -96.34 154.93 1.32 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.42 2.747 . . . . 75.319999999999993 114.033 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.94 -17.43 22.45 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.119 1.879 . . . . 74.150000000000006 112.554 168.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -80.33 142.2 54.25 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 123.812 0.845 . . . . 75.209999999999994 112.047 -175.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.07 77.4 3.49 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.717 2.278 . . . . 72.439999999999998 113.21 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.62 HG23 ' HB2' ' A' ' 113' ' ' CYS . 27.1 pt -133.54 154.7 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.285 1.034 . . . . 71.319999999999993 110.774 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 35.9 m -90.76 -79.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.985 -0.447 . . . . 64.150000000000006 110.757 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -106.37 107.82 19.03 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.358 0.599 . . . . 73.319999999999993 110.924 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -84.94 149.72 25.44 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.772 0.829 . . . . 64.329999999999998 111.06 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -153.31 106.89 3.01 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.492 0.717 . . . . 75.319999999999993 109.952 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -117.0 142.38 47.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.981 0.512 . . . . 63.299999999999997 111.926 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 92.8 t -133.6 134.83 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.25 1.02 . . . . 72.319999999999993 111.061 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 mm? -94.46 147.02 23.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.745 -0.835 . . . . 72.420000000000002 108.745 166.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.27 117.65 4.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.677 0.391 . . . . 75.430000000000007 110.179 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.05 112.46 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.784 -0.451 . . . . 62.409999999999997 109.784 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.84 120.7 67.02 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.737 0.815 . . . . 71.450000000000003 110.581 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.18 87.56 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.325 2.017 . . . . 64.129999999999995 112.123 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -76.17 -32.16 58.9 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.098 0.959 . . . . 74.340000000000003 111.148 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 16.6 t70 -158.73 170.9 21.1 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.65 1.58 . . . . 64.239999999999995 108.42 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -54.29 -52.86 60.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 61.240000000000002 112.475 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -119.85 23.25 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.533 0.682 . . . . 73.109999999999999 110.845 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.717 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.4 m80 -132.62 121.36 23.08 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.534 -0.729 . . . . 74.420000000000002 109.38 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.523 ' SG ' HG21 ' A' ' 17' ' ' VAL . 30.1 p -128.28 138.33 52.37 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.986 0.514 . . . . 75.140000000000001 109.647 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.9 m -96.05 109.7 22.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.834 -0.432 . . . . 74.439999999999998 109.834 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 108.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.134 -0.691 . . . . 74.239999999999995 109.134 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.89 112.5 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.261 1.024 . . . . 74.349999999999994 109.087 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -104.51 118.71 37.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.776 -0.824 . . . . 73.510000000000005 108.776 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -120.11 149.37 42.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.186 0.995 . . . . 75.420000000000002 110.023 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -146.08 157.96 43.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.557 1.143 . . . . 43.119999999999997 109.206 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -161.46 134.64 6.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.748 0.819 . . . . 75.030000000000001 109.783 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -145.51 152.98 40.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.146 0.578 . . . . 70.209999999999994 111.81 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.487 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 22.2 t70 -75.35 88.91 2.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.935 -0.575 . . . . 44.520000000000003 109.815 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.62 ' HB2' HG23 ' A' ' 86' ' ' ILE . 34.0 t -147.76 166.27 28.02 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.354 -0.839 . . . . 74.109999999999999 111.205 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.4 p -67.21 145.68 98.72 Favored Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 123.254 0.622 . . . . 72.030000000000001 111.445 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.49 -29.22 68.16 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.85 2.367 . . . . 72.030000000000001 112.963 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.08 -52.3 59.93 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.344 1.058 . . . . 71.120000000000005 112.001 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.496 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.2 m -72.46 -32.01 65.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.134 0.492 . . . . 75.340000000000003 110.82 177.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.41 -32.95 74.19 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.633 0.773 . . . . 73.099999999999994 112.055 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -69.08 -35.63 76.7 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.983 0.513 . . . . 71.010000000000005 110.952 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.95 -48.59 73.55 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.378 0.671 . . . . 72.450000000000003 110.077 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.05 -24.75 62.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.193 -0.912 . . . . 75.299999999999997 111.341 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.483 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 1.2 tm-20 -57.08 -42.05 79.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.795 0.838 . . . . 55.399999999999999 110.507 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.5 t -76.75 -49.81 15.09 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.527 0.565 . . . . 74.439999999999998 112.527 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.2 -56.75 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.925 0.713 . . . . 65.209999999999994 112.925 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.44 -42.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.184 0.593 . . . . 75.530000000000001 110.681 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.95 -66.2 2.83 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 116.398 -0.365 . . . . 72.140000000000001 113.787 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -80.97 -50.76 9.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.026 0.913 . . . . 73.5 112.025 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.28 -26.41 69.37 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 115.287 0.875 . . . . 64.310000000000002 115.287 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.09 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.759 0.779 . . . . 74.310000000000002 111.204 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 8.5 m-30 -71.72 -63.1 1.19 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.907 0.336 . . . . 71.019999999999996 111.907 -170.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.19 -28.53 69.21 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.47 0.481 . . . . 62.409999999999997 112.183 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.96 -53.47 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.439 0.696 . . . . 71.230000000000004 111.316 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.85 93.45 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 116.343 -0.39 . . . . 72.319999999999993 113.233 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.88 -40.28 91.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.069 0.948 . . . . 75.409999999999997 111.866 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.425 -0.352 . . . . 62.420000000000002 110.294 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.47 70.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.645 0.778 . . . . 71.540000000000006 112.246 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 tt -67.25 -48.45 67.73 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.958 0.903 . . . . 74.099999999999994 110.403 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.42 63.21 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.073 0.549 . . . . 61.409999999999997 111.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.635 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 40.1 mt-10 -66.23 -49.8 66.0 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.582 0.753 . . . . 73.340000000000003 111.422 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -14.41 61.64 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.305 0.483 . . . . 73.530000000000001 112.305 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -94.82 -30.58 14.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.186 0.81 . . . . 75.030000000000001 113.186 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.94 19.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 115.947 1.139 . . . . 31.120000000000001 115.947 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 71.6 mtp180 57.65 36.23 26.49 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.663 1.185 . . . . 75.420000000000002 113.9 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.91 84.81 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.936 0.894 . . . . 75.310000000000002 111.098 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.91 -53.4 56.23 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 116.753 -0.203 . . . . 65.120000000000005 111.067 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -93.86 99.7 12.02 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.363 -0.606 . . . . 64.200000000000003 109.363 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.27 145.92 43.62 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.731 0.813 . . . . 75.219999999999999 111.059 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -115.36 118.28 32.79 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.853 -0.795 . . . . 71.120000000000005 108.853 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -60.26 -42.17 94.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.442 0.904 . . . . 75.120000000000005 113.442 -172.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -76.53 -83.77 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.532 0.333 . . . . 75.140000000000001 111.458 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.7 p80 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.736 0.779 . . . . 74.349999999999994 111.804 179.032 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 112.168 0.433 . . . . 72.140000000000001 112.168 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.24 29.14 18.56 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 124.783 1.233 . . . . 61.149999999999999 113.155 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.2 m -91.33 117.95 30.09 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.26 0.624 . . . . 63.219999999999999 110.529 173.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.66 128.02 42.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.948 1.299 . . . . 74.530000000000001 108.155 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -133.87 127.75 33.19 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.165 0.439 . . . . 74.430000000000007 110.216 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.79 140.57 50.3 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.665 -0.865 . . . . 73.420000000000002 108.665 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 p -141.66 156.23 45.65 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.658 0.783 . . . . 73.400000000000006 110.575 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.39 148.37 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 N-CA-C 111.976 0.361 . . . . 73.209999999999994 111.976 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.68 113.5 18.93 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.289 0.635 . . . . 73.129999999999995 110.567 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 105' ' ' VAL . 43.1 t -106.57 124.11 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.309 0.644 . . . . 75.319999999999993 110.466 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.1 66.13 8.53 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.809 0.844 . . . . 71.310000000000002 112.185 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.41 152.88 3.41 Favored Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 123.959 0.904 . . . . 73.109999999999999 110.797 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 134.95 64.09 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.06 2.507 . . . . 65.319999999999993 113.143 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.77 50.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.381 1.622 . . . . 72.099999999999994 115.381 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.43 78.98 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.942 0.497 . . . . 72.519999999999996 111.926 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.21 -34.82 79.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 75.099999999999994 112.326 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.58 HG22 ' SG ' ' A' ' 103' ' ' CYS . 59.3 t -70.36 -36.69 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.221 0.608 . . . . 62.109999999999999 110.886 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -64.14 -28.84 70.04 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.982 -0.554 . . . . 74.329999999999998 110.661 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -59.54 -28.22 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.072 0.549 . . . . 73.140000000000001 111.432 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -76.48 -41.78 45.9 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.806 0.842 . . . . 73.209999999999994 111.666 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.37 13.96 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 123.943 0.897 . . . . 72.439999999999998 112.833 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.31 7.04 80.88 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 114.449 0.539 . . . . 74.329999999999998 114.449 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 1.3 m-20 -124.98 135.36 52.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 63.329999999999998 109.311 166.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.68 -24.77 67.92 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.986 0.914 . . . . 74.049999999999997 111.286 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.9 p -89.78 -16.43 30.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.317 1.047 . . . . 73.430000000000007 112.822 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -82.22 3.54 26.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.867 -0.52 . . . . 71.510000000000005 112.238 -168.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 34' ' ' VAL . 21.1 tt -63.79 -23.24 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.142 0.977 . . . . 75.040000000000006 112.766 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.48 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 57.0 p-80 -64.47 -23.23 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.801 0.667 . . . . 72.219999999999999 112.801 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -74.29 -39.04 63.19 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.512 0.56 . . . . 73.030000000000001 112.512 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.49 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 p-90 -107.57 -30.16 8.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.597 0.359 . . . . 72.409999999999997 111.334 -174.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -100.16 102.03 16.59 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 123.453 0.701 . . . . 75.450000000000003 109.842 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.512 ' HD2' HE22 ' A' ' 33' ' ' GLN . 32.5 Cg_exo -62.21 -13.3 31.32 Favored 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 123.537 2.825 . . . . 63.329999999999998 116.035 -171.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' HD2' ' A' ' 32' ' ' PRO . 2.2 mp0 -83.8 -25.79 30.11 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.355 0.662 . . . . 74.519999999999996 111.697 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.559 HG13 HG23 ' A' ' 27' ' ' ILE . 85.4 t -72.37 115.89 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 122.877 0.471 . . . . 74.349999999999994 111.465 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -95.25 30.32 2.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.974 0.91 . . . . 74.430000000000007 111.797 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.76 98.58 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 125.326 1.45 . . . . 70.430000000000007 112.643 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.9 -171.39 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.321 2.681 . . . . 75.409999999999997 114.252 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.8 m -115.52 124.53 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.785 0.834 . . . . 72.109999999999999 110.686 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.78 126.65 36.08 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.501 0.667 . . . . 74.099999999999994 111.313 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 mmt180 -111.65 148.25 33.77 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.535 1.134 . . . . 75.099999999999994 109.929 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.69 121.05 0.0 OUTLIER Glycine 0 CA--C 1.56 2.906 0 N-CA-C 117.715 1.846 . . . . 72.040000000000006 117.715 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.45 -98.35 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.421 1.488 . . . . 74.219999999999999 114.096 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -168.66 146.72 3.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 123.227 0.611 . . . . 70.030000000000001 111.68 -166.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.59 -1.2 2.39 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.675 2.917 . . . . 74.030000000000001 115.145 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -101.5 -24.8 14.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.538 0.735 . . . . 71.439999999999998 111.271 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -93.12 124.24 58.61 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.641 0.776 . . . . 61.299999999999997 111.731 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.62 118.91 4.86 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.221 2.614 . . . . 72.25 112.874 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.15 -9.46 7.89 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 112.484 -0.246 . . . . 74.010000000000005 112.484 -170.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.27 130.75 40.89 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.487 0.715 . . . . 74.219999999999999 111.05 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.599 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 36.2 mt-10 -118.88 115.16 23.82 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 122.099 -0.376 . . . . 72.530000000000001 110.558 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -93.73 119.11 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.337 0.589 . . . . 74.519999999999996 109.826 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 t -115.93 107.78 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 123.805 0.842 . . . . 73.129999999999995 110.227 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -76.85 73.64 3.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.041 0.936 . . . . 74.319999999999993 111.479 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.89 -62.44 0.48 Allowed Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.124 -0.489 . . . . 63.439999999999998 111.899 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.63 27.08 16.62 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.605 1.162 . . . . 75.239999999999995 113.663 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.27 41.48 0.03 OUTLIER Glycine 0 N--CA 1.471 1.005 0 CA-C-N 116.392 -0.367 . . . . 64.5 112.739 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -146.78 160.83 41.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.599 0.759 . . . . 74.420000000000002 110.767 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.08 -19.48 60.59 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.253 0.621 . . . . 74.519999999999996 111.858 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.12 85.98 2.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.735 0.814 . . . . 71.400000000000006 110.641 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.26 162.77 30.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 75.230000000000004 111.871 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.445 HD11 ' SD ' ' A' ' 79' ' ' MET . 51.1 tp -121.95 121.71 37.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.772 0.829 . . . . 74.109999999999999 109.89 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.54 130.09 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.066 -0.716 . . . . 73.310000000000002 109.066 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 40.1 mt-10 -130.25 128.87 42.5 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.413 0.685 . . . . 72.400000000000006 110.317 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.599 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 57.8 mtp180 -104.04 131.76 50.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.193 0.597 . . . . 74.120000000000005 111.204 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.403 HD13 ' HG2' ' A' ' 68' ' ' ARG . 16.3 tp -73.04 111.46 8.17 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.015 0.926 . . . . 75.420000000000002 110.161 175.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.72 -51.91 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.528 0.731 . . . . 62.210000000000001 111.731 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.584 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.8 pt-20 -153.18 151.81 30.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 71.219999999999999 110.579 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.578 HH21 HD23 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -133.78 113.48 12.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.189 0.596 . . . . 74.010000000000005 110.557 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.711 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.5 m-20 -115.68 72.18 0.8 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.816 0.847 . . . . 71.420000000000002 109.036 176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' HG3' ' HD2' ' A' ' 68' ' ' ARG . 53.3 mt-10 -67.38 -32.85 74.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.735 0.814 . . . . 74.219999999999999 113.109 -173.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -73.07 -18.56 61.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.171 0.589 . . . . 71.040000000000006 111.733 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.57 -1.82 22.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.69 0.796 . . . . 63.530000000000001 112.133 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 13.1 mtm105 62.71 42.82 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.433 1.093 . . . . 75.219999999999999 112.993 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.711 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 23.9 ttm180 -119.34 133.17 55.87 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.368 1.067 . . . . 75.5 110.781 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.578 HD23 HH21 ' A' ' 68' ' ' ARG . 13.6 tp -131.74 107.93 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.636 1.174 . . . . 64.409999999999997 110.037 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 52.0 t -113.12 132.99 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 118.491 0.587 . . . . 75.109999999999999 110.601 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -148.14 167.77 24.17 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.746 0.818 . . . . 73.219999999999999 111.339 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.0 t -134.82 158.25 44.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.12 0.968 . . . . 74.0 110.578 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.633 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 73.4 mtm -102.82 98.13 10.69 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.019 0.527 . . . . 71.120000000000005 110.309 170.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 56.8 Cg_endo -66.05 -28.21 49.4 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.371 2.714 . . . . 70.329999999999998 112.612 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.28 79.42 35.87 Favored Pre-proline 0 CA--C 1.555 1.164 0 N-CA-C 108.624 -0.88 . . . . 74.319999999999993 108.624 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.68 147.4 19.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.465 2.11 . . . . 73.120000000000005 113.12 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.38 -0.83 9.57 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.95 2.434 . . . . 64.140000000000001 112.782 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.18 150.38 63.35 Favored Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 74.420000000000002 111.513 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.38 80.57 1.05 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.107 2.538 . . . . 73.099999999999994 112.956 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 113' ' ' CYS . 23.5 pt -135.59 146.51 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.547 1.139 . . . . 74.349999999999994 110.383 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -89.87 -72.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.883 0.373 . . . . 54.43 110.921 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 9.1 m-20 -90.71 123.95 34.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.412 -0.959 . . . . 72.349999999999994 108.412 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -114.87 131.21 56.93 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.352 0.978 . . . . 75.439999999999998 113.237 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.529 ' HB2' ' HB2' ' A' ' 110' ' ' MET . 3.6 mpt_? -129.64 143.58 50.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.181 1.392 . . . . 75.209999999999994 109.02 165.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.81 125.6 15.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.068 0.947 . . . . 73.310000000000002 108.739 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.548 HG21 ' HG3' ' A' ' 94' ' ' GLU . 7.5 p -134.5 134.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.678 0.992 . . . . 74.340000000000003 113.678 -169.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -101.91 112.46 25.1 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.247 1.019 . . . . 75.150000000000006 109.156 171.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.548 ' HG3' HG21 ' A' ' 92' ' ' VAL . 44.3 mt-10 -122.22 111.26 16.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.618 0.767 . . . . 73.209999999999994 109.921 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -92.59 109.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.101 -0.703 . . . . 71.439999999999998 109.101 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG22 ' HB ' ' A' ' 104' ' ' THR . 4.4 m -100.7 114.03 65.72 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 123.856 0.863 . . . . 74.400000000000006 110.624 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.76 107.09 2.12 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.543 2.162 . . . . 72.109999999999999 113.04 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -63.47 -29.52 70.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.71 0.804 . . . . 73.310000000000002 111.144 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.2 t70 -154.63 173.13 16.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.396 1.478 . . . . 74.239999999999995 108.526 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.37 -44.19 92.77 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.979 0.512 . . . . 64.349999999999994 111.423 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.8 tmm_? -106.98 1.92 24.8 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.65 0.78 . . . . 73.150000000000006 111.468 -174.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 42.5 m80 -128.58 141.52 51.34 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.406 -0.809 . . . . 74.230000000000004 110.307 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.58 ' SG ' HG22 ' A' ' 17' ' ' VAL . 16.8 p -143.72 174.91 10.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.474 0.654 . . . . 75.219999999999999 112.407 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.406 ' HB ' HG22 ' A' ' 96' ' ' VAL . 99.4 m -138.58 118.95 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 64.200000000000003 109.65 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 10' ' ' VAL . 47.9 t -91.77 124.8 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 109.771 -0.455 . . . . 73.519999999999996 109.771 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.75 128.35 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 74.120000000000005 109.357 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 6.4 t90 -121.2 122.91 40.99 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.79 -0.818 . . . . 73.510000000000005 108.79 174.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -127.39 124.13 37.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.454 0.702 . . . . 72.140000000000001 111.491 -170.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.3 107.81 18.99 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 62.350000000000001 110.39 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 90' ' ' ARG . 41.8 mtt -97.62 130.35 44.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.888 -0.782 . . . . 74.319999999999993 108.888 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 88' ' ' ASN . 20.4 p90 -157.28 153.21 27.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.978 0.732 . . . . 75.340000000000003 112.978 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.65 84.25 2.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.237 -0.892 . . . . 73.409999999999997 109.427 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.572 ' HB2' HG21 ' A' ' 86' ' ' ILE . 42.2 t -119.28 155.78 31.18 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.324 -1.307 . . . . 74.219999999999999 110.711 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -58.61 138.45 86.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.933 0.893 . . . . 73.120000000000005 111.427 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.59 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 123.473 2.782 . . . . 72.219999999999999 114.857 -168.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.02 -37.98 89.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.104 0.561 . . . . 75.209999999999994 111.421 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.517 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 9.0 m -79.23 -27.25 42.46 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.015 0.526 . . . . 62.119999999999997 111.071 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.995 0.918 . . . . 73.319999999999993 111.896 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -74.8 -28.1 60.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.696 0.799 . . . . 75.010000000000005 111.586 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.32 -45.63 79.65 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.146 0.498 . . . . 74.030000000000001 110.161 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.22 -24.8 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.721 0.808 . . . . 75.040000000000006 111.275 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -58.18 -45.58 87.27 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.522 0.729 . . . . 73.549999999999997 110.519 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 m -69.99 -53.19 18.77 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.523 -0.762 . . . . 74.420000000000002 112.394 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.69 -55.25 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 C-N-CA 123.479 0.712 . . . . 75.129999999999995 112.595 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.6 mt -81.49 -57.32 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.836 0.854 . . . . 72.129999999999995 111.251 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.3 -63.33 3.3 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 114.349 0.5 . . . . 63.229999999999997 114.349 -173.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.45 -16.5 58.74 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 122.871 0.468 . . . . 72.450000000000003 111.441 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.19 -88.75 1.66 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.86 -0.411 . . . . 71.319999999999993 112.463 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.7 t -52.6 -46.78 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 124.935 1.294 . . . . 75.5 113.03 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -75.98 -47.85 23.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.443 0.697 . . . . 74.420000000000002 111.558 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.36 -41.85 85.65 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.226 0.329 . . . . 73.319999999999993 111.751 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.51 -54.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 123.955 0.902 . . . . 74.0 112.107 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.91 -46.21 76.05 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.423 0.452 . . . . 52.329999999999998 113.675 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.62 -41.48 96.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.561 0.745 . . . . 73.129999999999995 112.199 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.68 -41.64 92.19 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 119.73 -0.176 . . . . 72.230000000000004 110.675 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.91 90.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.94 0.496 . . . . 64.129999999999995 111.541 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.64 -40.12 96.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.603 0.761 . . . . 74.329999999999998 110.164 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.51 -33.19 68.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.859 0.463 . . . . 71.109999999999999 111.981 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.026 0.931 . . . . 75.319999999999993 113.042 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -66.77 -32.32 73.53 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 117.922 0.328 . . . . 74.530000000000001 111.289 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.98 -11.25 36.6 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.227 0.611 . . . . 74.239999999999995 110.661 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.79 7.03 44.34 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 114.569 0.588 . . . . 72.099999999999994 114.569 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -70.03 -22.1 63.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.139 0.576 . . . . 73.310000000000002 110.1 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.11 174.36 6.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.53 1.132 . . . . 75.340000000000003 109.912 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.566 ' HB3' ' HD2' ' A' ' 147' ' ' HIS . 18.9 mm-40 67.03 173.23 0.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.919 1.451 . . . . 60.109999999999999 114.919 170.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -114.01 79.66 1.28 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.974 0.91 . . . . 75.299999999999997 109.967 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.566 ' HD2' ' HB3' ' A' ' 145' ' ' GLU . 33.7 m-70 -124.85 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.435 0.694 . . . . 65.109999999999999 110.119 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -95.6 143.6 26.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.575 0.75 . . . . 75.430000000000007 112.577 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -137.73 95.79 3.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.094 0.958 . . . . 74.409999999999997 109.716 168.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -71.51 -29.7 65.09 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.083 0.953 . . . . 75.540000000000006 110.31 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 122.277 1.037 . . . . 71.519999999999996 110.559 173.272 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.848 0.356 . . . . 72.420000000000002 110.75 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.63 33.93 5.21 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.911 0.884 . . . . 74.439999999999998 110.371 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.6 m -119.72 124.5 46.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.901 0.88 . . . . 74.409999999999997 109.972 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.94 141.07 32.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 75.439999999999998 109.097 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -145.62 132.63 20.28 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.611 -0.515 . . . . 74.150000000000006 109.611 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.468 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 5.7 tpt180 -133.7 147.35 51.37 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.346 -0.613 . . . . 72.400000000000006 109.346 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.0 p -142.76 150.36 39.94 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.24 0.616 . . . . 61.210000000000001 111.246 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.92 149.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.156 0.582 . . . . 73.430000000000007 111.173 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.18 123.7 29.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.551 -0.537 . . . . 73.519999999999996 109.551 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.519 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 95.4 t -120.51 121.56 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.814 0.845 . . . . 72.329999999999998 110.017 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -76.26 71.3 2.96 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.084 0.553 . . . . 73.409999999999997 111.191 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.91 6.6 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 123.844 0.858 . . . . 72.040000000000006 111.392 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.69 144.62 78.8 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.778 2.318 . . . . 65.420000000000002 112.299 167.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.1 -31.5 30.89 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.027 1.121 . . . . 64.129999999999995 114.027 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.58 -49.22 72.02 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.439 0.696 . . . . 74.129999999999995 112.446 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.353 0.661 . . . . 72.209999999999994 111.916 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' SG ' ' A' ' 103' ' ' CYS . 25.0 t -71.76 -34.64 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.714 -0.675 . . . . 64.420000000000002 111.43 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -67.4 -31.19 71.25 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 122.58 0.352 . . . . 74.129999999999995 111.391 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -67.57 -21.66 65.43 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-O 121.382 0.61 . . . . 61.43 111.293 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.09 -50.03 6.65 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.061 0.944 . . . . 73.230000000000004 112.838 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.2 m -93.98 -26.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.703 1.001 . . . . 72.319999999999993 113.703 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.64 -11.85 66.19 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.384 1.313 . . . . 60.229999999999997 116.384 -165.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 4.6 m-20 -79.65 -14.03 59.08 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.939 0.496 . . . . 70.310000000000002 111.862 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 72.31 -59.05 0.57 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.163 1.385 . . . . 74.409999999999997 111.257 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -62.51 -18.34 61.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.295 1.038 . . . . 51.450000000000003 113.248 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -79.94 7.36 9.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.92 0.888 . . . . 74.319999999999993 112.722 -167.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.52 HG23 HG21 ' A' ' 34' ' ' VAL . 14.1 tt -61.7 -23.49 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 123.575 0.75 . . . . 64.439999999999998 112.082 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.565 ' HA ' HG13 ' A' ' 34' ' ' VAL . 39.5 p-80 -70.67 -3.9 20.81 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 113.154 0.798 . . . . 72.140000000000001 113.154 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HD3' ' HB2' ' A' ' 26' ' ' ALA . 58.6 mtp180 -92.76 -25.51 18.15 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.02 0.928 . . . . 75.120000000000005 112.724 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.514 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.0 p-90 -127.14 -34.48 2.32 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.246 1.202 . . . . 75.019999999999996 114.246 -171.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 33.6 t-80 -78.68 139.08 58.23 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 117.969 0.35 . . . . 71.019999999999996 110.932 -170.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.57 -37.75 3.87 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.136 1.891 . . . . 64.0 113.965 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.547 ' N ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.21 -22.82 47.94 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.522 0.564 . . . . 63.25 112.522 -172.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' A' ' 28' ' ' HIS . 9.4 p -61.71 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.352 0.596 . . . . 74.25 112.549 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -115.92 28.36 8.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.026 0.93 . . . . 74.230000000000004 111.673 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.4 96.83 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.071 0.948 . . . . 62.130000000000003 110.677 -170.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.23 158.46 15.09 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.594 2.196 . . . . 74.230000000000004 114.175 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -104.87 127.3 52.64 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.31 1.044 . . . . 72.340000000000003 109.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 49' ' ' ALA . 4.3 mm? -99.76 115.96 30.74 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.466 0.707 . . . . 75.239999999999995 110.689 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HE ' HG23 ' A' ' 52' ' ' VAL . 31.4 mmt180 -83.85 119.23 24.61 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.886 -0.413 . . . . 75.400000000000006 109.886 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.8 -167.47 0.01 OUTLIER Glycine 0 CA--C 1.545 1.939 0 N-CA-C 117.85 1.9 . . . . 64.209999999999994 117.85 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 76.07 -47.16 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 125.714 1.606 . . . . 63.439999999999998 115.141 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m 91.74 144.25 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 C-N-CA 126.825 2.05 . . . . 72.450000000000003 109.983 -162.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.95 -37.86 93.24 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.842 3.028 . . . . 61.210000000000001 116.244 -167.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -85.25 -13.91 48.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.371 0.508 . . . . 74.230000000000004 112.371 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -80.72 123.51 82.44 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.446 0.698 . . . . 74.219999999999999 111.46 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -48.84 98.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.632 2.888 . . . . 55.329999999999998 113.568 171.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.87 -14.71 2.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.089 -0.505 . . . . 53.130000000000003 112.992 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' HB3' HD11 ' A' ' 39' ' ' LEU . . . -67.09 122.37 17.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.53 0.732 . . . . 75.340000000000003 111.211 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.6 mt-10 -102.65 117.59 34.99 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.71 0.404 . . . . 74.040000000000006 111.484 -172.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 46.7 ttp180 -92.94 103.19 15.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.559 0.744 . . . . 72.430000000000007 110.763 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 62' ' ' VAL . 20.6 t -112.6 99.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.755 . . . . 75.400000000000006 110.242 -171.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -63.18 -48.97 76.13 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.708 1.003 . . . . 74.120000000000005 113.708 -168.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.01 52.91 0.61 Allowed Glycine 0 N--CA 1.478 1.466 0 N-CA-C 112.374 -0.291 . . . . 32.5 112.374 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.746 0.818 . . . . 74.319999999999993 112.994 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.53 33.36 3.63 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 115.965 -0.561 . . . . 75.430000000000007 113.529 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -120.61 177.69 4.97 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 123.577 0.751 . . . . 74.25 110.73 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.82 -55.27 13.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.811 0.444 . . . . 73.0 111.291 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -115.74 89.9 3.21 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.446 0.698 . . . . 73.420000000000002 110.997 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.17 163.55 12.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.975 0.91 . . . . 74.120000000000005 111.268 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' HE1' ' A' ' 79' ' ' MET . 49.9 tp -116.8 119.43 35.41 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.351 0.661 . . . . 71.540000000000006 110.122 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 48.9 t -104.51 114.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.42 0.688 . . . . 73.439999999999998 110.194 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 83.3 mt-10 -101.22 169.7 8.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.6 1.16 . . . . 74.530000000000001 110.578 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 50' ' ' GLU . 67.1 ttt180 -151.02 126.34 10.01 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.422 0.689 . . . . 75.439999999999998 110.801 176.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.52 127.4 32.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.975 0.91 . . . . 71.530000000000001 111.144 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.92 -40.35 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.301 0.64 . . . . 73.430000000000007 111.345 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -167.28 153.59 8.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.961 0.905 . . . . 71.040000000000006 109.835 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 153.08 35.87 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.203 0.601 . . . . 74.540000000000006 110.598 170.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.87 135.18 35.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 75.219999999999999 110.639 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.57 -57.65 3.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.608 0.763 . . . . 73.120000000000005 112.501 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.6 m -76.43 -14.83 60.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.937 0.717 . . . . 75.239999999999995 112.937 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.87 30.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.182 0.593 . . . . 64.129999999999995 111.165 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.48 36.92 18.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.868 1.267 . . . . 72.510000000000005 111.271 -176.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -110.23 97.02 6.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.14 0.976 . . . . 74.400000000000006 111.889 -166.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 14.6 tp -98.67 108.03 20.62 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.8 1.24 . . . . 71.299999999999997 110.215 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.9 t -108.97 121.68 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.055 0.942 . . . . 72.439999999999998 111.527 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -135.98 179.72 6.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.514 0.673 . . . . 73.319999999999993 112.209 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 t -133.6 163.15 30.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.117 1.367 . . . . 74.409999999999997 109.598 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.506 ' HE2' ' HB3' ' A' ' 82' ' ' PRO . 70.2 mtp -112.39 88.38 10.76 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 123.447 0.699 . . . . 75.120000000000005 109.377 172.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.51 -24.57 56.26 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.603 2.869 . . . . 75.299999999999997 113.62 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.661 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 22.1 t70 -135.44 78.4 51.02 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 122.786 0.434 . . . . 74.109999999999999 110.447 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.506 ' HB3' ' HE2' ' A' ' 79' ' ' MET . 61.4 Cg_endo -95.99 143.22 1.05 Allowed 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.133 2.555 . . . . 74.129999999999995 113.864 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.61 28.16 0.52 Allowed 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.943 2.428 . . . . 73.439999999999998 112.907 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.17 152.83 51.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.645 1.178 . . . . 71.120000000000005 110.008 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.31 41.11 0.74 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.629 2.886 . . . . 64.219999999999999 114.236 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -109.85 124.37 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 124.178 0.991 . . . . 70.450000000000003 110.743 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 8.9 m -68.25 -68.44 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.976 0.51 . . . . 75.120000000000005 112.156 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.71 110.08 16.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.255 0.55 . . . . 74.099999999999994 109.627 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 109' ' ' ALA . 58.7 t-80 -85.67 150.2 24.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.026 0.531 . . . . 72.409999999999997 111.334 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -152.62 117.36 5.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.842 0.857 . . . . 73.129999999999995 110.081 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.447 ' HB1' ' HE1' ' A' ' 89' ' ' HIS . . . -118.48 149.75 40.75 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.609 0.596 . . . . 74.099999999999994 112.609 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' A' ' 94' ' ' GLU . 61.4 t -135.02 137.26 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.353 1.061 . . . . 72.420000000000002 109.492 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -114.52 108.88 17.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.032 1.333 . . . . 74.030000000000001 107.46 -178.51 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG3' HG11 ' A' ' 92' ' ' VAL . 40.3 mt-10 -124.4 114.39 19.44 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.241 0.928 . . . . 62.450000000000003 111.875 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -89.09 109.06 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.745 -0.835 . . . . 75.140000000000001 108.745 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.9 117.9 66.79 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.117 0.967 . . . . 61.109999999999999 110.329 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 88.17 0.99 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.449 2.099 . . . . 73.010000000000005 111.902 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -34.54 78.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.059 0.943 . . . . 64.409999999999997 110.414 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.8 t70 -149.42 165.53 31.81 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.995 1.318 . . . . 54.350000000000001 109.042 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.13 -43.97 97.66 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.521 0.728 . . . . 75.329999999999998 111.897 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -91.87 -19.93 21.97 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.548 0.739 . . . . 64.129999999999995 110.835 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 39.3 m80 -127.34 138.43 53.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 72.120000000000005 111.833 -170.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -126.43 174.94 8.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.57 0.748 . . . . 73.430000000000007 110.517 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -137.01 111.01 8.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.518 0.727 . . . . 64.010000000000005 109.964 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -87.97 115.37 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.252 0.549 . . . . 73.349999999999994 110.222 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -105.81 111.84 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.826 1.25 . . . . 74.430000000000007 110.553 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -103.62 113.9 27.76 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 109.24 -0.652 . . . . 74.310000000000002 109.24 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.5 m -114.21 141.32 47.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.631 1.172 . . . . 54.100000000000001 110.054 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.49 ' HB3' ' HE2' ' A' ' 89' ' ' HIS . . . -150.65 112.18 4.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.066 0.546 . . . . 61.509999999999998 112.142 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -118.56 142.53 47.52 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.456 1.102 . . . . 75.540000000000006 110.299 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.66 153.1 33.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.532 0.733 . . . . 75.349999999999994 111.761 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 31.3 t70 -80.71 86.39 5.94 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.144 0.497 . . . . 72.430000000000007 110.021 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.421 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 36.5 t -151.39 157.77 42.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.457 -0.792 . . . . 73.109999999999999 111.979 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m -61.9 146.49 91.24 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 123.835 0.854 . . . . 73.420000000000002 112.351 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -60.98 -28.96 87.09 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.051 2.501 . . . . 75.209999999999994 113.867 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.14 -35.26 77.81 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.902 0.481 . . . . 73.420000000000002 112.074 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.421 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 19.0 m -74.8 -40.63 61.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.216 0.532 . . . . 74.239999999999995 110.071 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.97 81.98 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.135 -0.939 . . . . 63.439999999999998 112.826 -174.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.9 -33.82 72.7 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.922 0.489 . . . . 75.519999999999996 111.24 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.96 -41.52 97.54 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.056 -0.52 . . . . 63.229999999999997 109.735 171.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.53 -26.79 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.359 0.664 . . . . 73.200000000000003 112.313 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 118.615 0.643 . . . . 63.420000000000002 110.428 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 m -69.23 -59.68 2.86 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 115.691 -0.686 . . . . 71.310000000000002 111.896 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.0 -56.97 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.651 0.78 . . . . 65.5 112.483 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.2 -48.44 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.647 0.379 . . . . 74.230000000000004 110.581 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.6 -48.07 81.11 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 114.509 0.564 . . . . 72.439999999999998 114.509 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -101.23 -53.61 2.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.989 -0.712 . . . . 63.020000000000003 111.646 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.28 -22.75 69.49 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 115.399 0.92 . . . . 71.049999999999997 115.399 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -111.92 -54.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 117.548 0.674 . . . . 74.25 111.196 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 10.7 m-30 -72.8 -59.92 2.48 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.292 0.637 . . . . 65.219999999999999 112.092 -173.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HB1' ' HG2' ' A' ' 6' ' ' ARG . . . -57.84 -36.31 72.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 123.39 0.431 . . . . 72.430000000000007 111.484 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.69 -50.4 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 124.221 1.008 . . . . 73.540000000000006 111.956 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.84 97.75 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.178 -0.465 . . . . 70.219999999999999 113.103 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.49 -36.09 81.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.371 1.069 . . . . 73.230000000000004 111.946 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.91 -43.9 74.26 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.694 0.397 . . . . 74.530000000000001 110.47 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.4 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.219 0.608 . . . . 72.219999999999999 111.599 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.98 -42.58 97.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.641 0.776 . . . . 73.329999999999998 110.397 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.62 ' HB1' ' HA ' ' A' ' 144' ' ' LEU . . . -71.76 -29.59 64.67 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.325 0.491 . . . . 73.519999999999996 112.325 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 48.4 mt-10 -70.2 -41.32 73.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.459 0.703 . . . . 64.239999999999995 112.453 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.472 0.545 . . . . 74.200000000000003 112.472 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -87.16 -34.41 19.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.762 0.425 . . . . 75.140000000000001 112.133 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.73 51.12 0.02 OUTLIER Glycine 0 N--CA 1.48 1.586 0 N-CA-C 115.181 0.832 . . . . 74.299999999999997 115.181 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 80.9 mtp180 50.49 52.74 14.22 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 124.107 0.963 . . . . 74.430000000000007 113.152 172.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.62 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 10.0 mp 64.68 -85.32 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.669 1.187 . . . . 71.010000000000005 110.9 -170.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.95 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.377 0.671 . . . . 74.129999999999995 109.747 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -149.21 165.04 33.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.374 1.069 . . . . 74.310000000000002 110.348 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.5 t60 72.95 -15.82 0.5 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.197 1.184 . . . . 73.209999999999994 114.197 169.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.6 p80 50.18 -177.84 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.117 1.767 . . . . 73.120000000000005 112.958 -168.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -134.59 -177.92 4.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 75.120000000000005 113.044 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -71.03 -0.96 10.6 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.565 1.146 . . . . 75.400000000000006 113.495 -169.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 p80 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 123.74 0.816 . . . . 75.430000000000007 110.943 -176.138 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.821 0.343 . . . . 74.400000000000006 110.667 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.5 6.62 46.46 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.659 0.784 . . . . 73.430000000000007 111.57 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.433 HG23 ' HB3' ' A' ' 110' ' ' MET . 66.8 m -113.92 111.13 21.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.059 0.943 . . . . 75.450000000000003 109.442 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.24 137.32 36.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.21 1.004 . . . . 75.329999999999998 109.366 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -142.76 131.95 23.27 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 120.815 0.341 . . . . 74.219999999999999 110.218 168.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -125.38 157.42 36.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.547 1.139 . . . . 74.150000000000006 109.54 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.3 p -150.29 151.96 33.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.33 0.652 . . . . 75.219999999999999 110.697 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.7 p -148.38 145.2 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.75 0.42 . . . . 64.340000000000003 110.998 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -92.29 109.48 20.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.956 0.502 . . . . 70.430000000000007 110.996 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.423 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 61.0 t -95.14 139.01 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.566 1.146 . . . . 73.540000000000006 111.702 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 33.38 0.13 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.0 1.111 . . . . 71.450000000000003 114.0 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.06 149.23 34.81 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 123.582 0.753 . . . . 63.25 111.301 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 100' ' ' ASP . 13.8 Cg_endo -57.12 148.67 67.93 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.484 2.789 . . . . 75.120000000000005 114.176 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.56 -43.43 56.3 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.899 1.444 . . . . 74.209999999999994 114.899 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.22 76.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.223 0.609 . . . . 62.530000000000001 112.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.68 -47.04 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.402 1.081 . . . . 75.409999999999997 111.636 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.438 HG21 ' SG ' ' A' ' 103' ' ' CYS . 92.9 t -72.97 -34.91 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.998 0.919 . . . . 73.010000000000005 111.75 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.05 -28.5 69.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.819 0.447 . . . . 74.439999999999998 111.586 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 m -68.97 -30.78 69.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.168 0.587 . . . . 74.25 111.271 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.3 tp -77.76 -48.97 15.34 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.975 0.91 . . . . 73.239999999999995 111.848 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.3 -34.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 113.385 0.883 . . . . 73.400000000000006 113.385 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.29 -24.9 74.86 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 114.32 0.488 . . . . 62.200000000000003 114.32 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.77 111.31 21.22 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.073 -1.084 . . . . 74.519999999999996 108.073 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -6.44 47.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.762 1.023 . . . . 74.239999999999995 113.762 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -95.84 -8.17 34.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.822 0.449 . . . . 74.040000000000006 110.497 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.97 -2.87 36.31 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.751 . . . . 73.319999999999993 111.236 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 34' ' ' VAL . 20.4 tt -64.16 -26.63 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 123.052 0.541 . . . . 75.340000000000003 112.104 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.08 -9.05 57.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 112.822 0.675 . . . . 73.400000000000006 112.822 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.91 -28.22 30.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.52 0.728 . . . . 71.420000000000002 111.91 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.434 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.5 p-90 -116.24 -35.1 4.44 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.739 0.644 . . . . 75.239999999999995 112.739 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -84.82 112.65 44.39 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.488 -0.291 . . . . 75.019999999999996 110.762 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.428 ' HD2' ' HA2' ' A' ' 133' ' ' GLY . 38.9 Cg_endo -64.34 -16.39 54.81 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.371 2.714 . . . . 74.329999999999998 114.832 -175.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.441 ' N ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -88.54 -37.66 15.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.041 -0.412 . . . . 74.230000000000004 110.693 174.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 27' ' ' ILE . 61.6 t -78.2 102.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 120.829 0.347 . . . . 74.519999999999996 110.742 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -86.25 -49.88 7.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.203 0.601 . . . . 74.150000000000006 111.206 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.36 105.81 0.47 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 123.698 0.799 . . . . 61.229999999999997 111.489 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 68.6 Cg_endo -85.53 160.91 10.94 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.0 2.467 . . . . 72.129999999999995 113.842 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.4 m -103.95 120.98 42.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.848 0.859 . . . . 64.010000000000005 110.638 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.09 120.23 29.24 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.282 0.633 . . . . 73.239999999999995 110.929 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -108.24 120.63 42.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.896 0.879 . . . . 74.420000000000002 109.681 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.74 173.66 0.01 OUTLIER Glycine 0 CA--C 1.558 2.754 0 N-CA-C 119.045 2.378 . . . . 75.120000000000005 119.045 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 74.61 -39.29 0.41 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.94 1.829 . . . . 73.25 115.94 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m 87.11 135.48 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.843 0 C-N-CA 126.343 1.857 . . . . 71.109999999999999 111.555 -171.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.11 -25.37 45.26 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 124.473 3.449 . . . . 72.010000000000005 116.835 -166.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -85.32 -28.2 25.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.075 0.398 . . . . 75.239999999999995 112.075 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.7 m -81.38 123.83 80.92 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 123.834 0.853 . . . . 74.239999999999995 112.084 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 109.75 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 124.151 3.234 . . . . 71.120000000000005 114.206 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.24 -21.64 3.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 112.953 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 125.57 24.75 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.321 0.86 . . . . 71.109999999999999 113.321 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 37.3 mt-10 -104.61 137.43 42.45 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.224 0.61 . . . . 72.340000000000003 109.398 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -127.26 133.29 50.2 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.585 1.084 . . . . 72.140000000000001 111.122 167.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.51 107.66 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.553 -0.749 . . . . 71.140000000000001 109.877 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -70.77 79.87 0.61 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.406 1.082 . . . . 62.43 110.632 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.74 -65.68 0.59 Allowed Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.907 -0.588 . . . . 63.420000000000002 111.93 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.39 101.97 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.052 1.341 . . . . 55.119999999999997 113.349 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.13 66.5 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-O 121.27 0.372 . . . . 42.329999999999998 113.57 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -116.41 -162.1 0.83 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.5 1.12 . . . . 74.549999999999997 111.304 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.6 -52.33 6.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.475 0.71 . . . . 73.439999999999998 111.28 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 85.77 2.44 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.245 0.618 . . . . 75.439999999999998 111.138 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -112.19 155.72 23.5 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.189 0.518 . . . . 73.299999999999997 111.12 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD13 ' SD ' ' A' ' 79' ' ' MET . 57.4 tp -120.48 122.55 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.793 -0.817 . . . . 74.329999999999998 108.793 172.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 55.3 t -95.33 117.72 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.426 -0.953 . . . . 75.530000000000001 108.426 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -114.22 162.73 16.17 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.446 0.698 . . . . 71.540000000000006 110.011 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.46 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 4.6 tmt_? -151.45 125.12 9.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.408 0.683 . . . . 73.510000000000005 110.193 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.9 tp -82.23 127.74 33.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.802 0.841 . . . . 72.340000000000003 110.575 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG23 ' NH1' ' A' ' 90' ' ' ARG . 95.1 t -95.92 -44.46 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.313 0.645 . . . . 73.319999999999993 111.188 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -160.63 148.15 15.9 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.974 0.91 . . . . 72.519999999999996 110.163 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HG3' HD13 ' A' ' 75' ' ' LEU . 20.8 ttp85 -124.3 109.65 13.62 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.421 -0.585 . . . . 73.409999999999997 109.421 173.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.56 125.59 41.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.193 0.997 . . . . 74.219999999999999 109.125 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.18 -15.76 14.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.043 -0.41 . . . . 71.540000000000006 111.887 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 m -65.94 -39.66 90.69 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.374 0.669 . . . . 61.329999999999998 111.899 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.4 4.02 18.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.259 1.023 . . . . 73.439999999999998 111.415 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 53.23 64.03 2.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.505 1.122 . . . . 71.150000000000006 111.11 -173.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -129.11 111.55 13.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.072 0.949 . . . . 74.230000000000004 111.029 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 19.8 tp -104.23 105.63 15.85 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.482 0.713 . . . . 75.439999999999998 110.961 -173.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.1 t -101.07 124.32 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 123.852 0.861 . . . . 74.540000000000006 111.711 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -153.0 -178.01 6.65 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.484 0.659 . . . . 74.129999999999995 112.597 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 t -153.11 159.85 42.83 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.737 1.215 . . . . 70.030000000000001 110.348 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.423 ' SD ' HD13 ' A' ' 61' ' ' LEU . 20.6 ptt? -109.96 103.23 53.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.08 0.552 . . . . 75.430000000000007 109.758 171.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.59 -29.39 78.08 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.443 2.762 . . . . 75.209999999999994 113.726 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.1 m-20 -123.09 83.58 51.14 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 122.995 0.518 . . . . 54.43 110.659 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -88.98 147.08 5.59 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 123.154 2.569 . . . . 75.120000000000005 113.214 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -81.85 0.12 10.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.515 2.143 . . . . 75.019999999999996 112.671 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.83 141.75 23.36 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.196 0.999 . . . . 74.310000000000002 110.535 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HG2' HG23 ' A' ' 117' ' ' THR . 63.2 Cg_endo -71.1 81.99 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.647 2.231 . . . . 74.340000000000003 113.165 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.644 HG23 ' HB2' ' A' ' 113' ' ' CYS . 27.8 pt -133.04 151.85 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.428 1.091 . . . . 74.109999999999999 110.031 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 20.8 m -91.66 -85.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.517 0.327 . . . . 75.519999999999996 111.164 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.65 111.82 24.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.938 -0.477 . . . . 61.509999999999998 110.369 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -92.57 143.75 26.03 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.585 0.754 . . . . 74.430000000000007 111.796 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.509 ' NH1' HG23 ' A' ' 66' ' ' VAL . 10.4 tpp180 -148.54 117.02 6.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.485 1.114 . . . . 75.329999999999998 108.899 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.41 148.27 48.86 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.81 0.444 . . . . 61.329999999999998 111.36 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 85.3 t -134.98 136.0 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 124.489 1.116 . . . . 71.349999999999994 110.355 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.39 111.17 18.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.146 0.978 . . . . 75.140000000000001 110.1 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.408 ' HG3' HG11 ' A' ' 92' ' ' VAL . 36.2 mt-10 -115.11 157.82 23.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.386 1.074 . . . . 74.519999999999996 111.614 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.96 111.08 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.279 0.632 . . . . 63.509999999999998 109.656 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.8 117.46 60.63 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 124.751 1.22 . . . . 74.25 110.651 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.12 133.59 25.25 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.722 2.281 . . . . 71.140000000000001 113.901 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.26 -55.72 2.28 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.407 1.083 . . . . 73.200000000000003 110.083 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.5 t70 -126.15 169.18 13.08 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.883 1.273 . . . . 70.230000000000004 109.723 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 13' ' ' PRO . 16.2 m-20 -57.27 -41.32 79.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.594 0.758 . . . . 70.519999999999996 112.035 176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -106.05 10.04 32.27 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 123.312 0.645 . . . . 75.239999999999995 111.502 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 70.0 m80 -139.79 140.19 36.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 75.420000000000002 111.657 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.438 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.0 p -136.37 178.53 6.99 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.342 0.657 . . . . 71.140000000000001 110.221 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m -135.76 113.58 11.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.039 0.536 . . . . 65.319999999999993 111.039 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.2 107.53 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 109.628 -0.508 . . . . 73.219999999999999 109.628 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.74 99.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.085 0.954 . . . . 70.120000000000005 109.772 -174.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -103.5 118.82 37.61 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.292 0.567 . . . . 72.400000000000006 110.563 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.519 HG23 ' SD ' ' A' ' 110' ' ' MET . 34.6 m -119.58 139.86 51.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.823 1.249 . . . . 71.239999999999995 110.207 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.11 113.25 6.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.31 0.644 . . . . 74.329999999999998 111.326 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.519 ' SD ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -124.0 127.76 48.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.921 0.888 . . . . 73.019999999999996 110.239 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -146.07 156.01 43.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.895 0.878 . . . . 74.010000000000005 110.904 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 35.3 t70 -83.09 82.78 8.1 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.47 0.652 . . . . 60.039999999999999 110.142 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.644 ' HB2' HG23 ' A' ' 86' ' ' ILE . 51.9 t -120.52 149.87 41.73 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.244 -0.889 . . . . 74.420000000000002 111.327 178.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 128.35 93.75 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-O 118.225 -0.893 . . . . 74.129999999999995 110.451 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -39.68 -40.57 2.36 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 124.903 3.735 . . . . 75.5 116.725 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.49 -52.07 59.76 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.313 0.578 . . . . 75.530000000000001 110.578 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 85' ' ' PRO . 71.3 m -68.57 -30.55 69.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.53 -0.759 . . . . 74.510000000000005 111.376 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.27 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.509 0.724 . . . . 72.299999999999997 111.912 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -71.97 -28.47 63.45 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 122.845 0.458 . . . . 72.299999999999997 111.143 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.08 -42.34 97.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.483 0.713 . . . . 74.319999999999993 110.238 170.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -74.99 -23.26 58.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.696 0.798 . . . . 71.549999999999997 111.688 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -60.71 -37.96 83.45 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.971 0.351 . . . . 72.540000000000006 110.481 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.2 m -73.06 -48.49 35.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.215 0.606 . . . . 74.400000000000006 112.538 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.9 -54.04 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 112.767 0.654 . . . . 74.209999999999994 112.767 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.57 -52.28 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.29 0.636 . . . . 52.119999999999997 111.146 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.59 -68.39 1.63 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 114.043 0.377 . . . . 72.439999999999998 114.043 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.305 0.642 . . . . 64.219999999999999 111.075 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.89 -96.72 0.26 Allowed Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.644 -0.531 . . . . 60.140000000000001 112.834 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.38 -49.22 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.574 1.149 . . . . 71.310000000000002 113.616 -171.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.17 -61.13 1.9 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.664 -0.698 . . . . 73.420000000000002 111.644 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.86 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.252 0.464 . . . . 63.130000000000003 112.252 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.45 -50.51 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.775 0.83 . . . . 75.200000000000003 111.431 171.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 32' ' ' PRO . . . -68.96 -37.74 83.77 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.058 -0.519 . . . . 52.340000000000003 113.287 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.62 -41.96 78.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.448 1.099 . . . . 75.430000000000007 111.778 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.52 -43.16 94.92 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.594 0.358 . . . . 74.510000000000005 110.843 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.35 -31.32 72.48 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.814 0.446 . . . . 64.430000000000007 112.055 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.52 -45.8 71.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.177 0.591 . . . . 74.299999999999997 109.682 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.95 95.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.483 0.713 . . . . 73.400000000000006 112.024 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.35 -40.18 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.956 . . . . 72.200000000000003 112.941 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -61.91 -36.11 80.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.756 0.65 . . . . 74.450000000000003 112.756 -172.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.24 -28.16 59.77 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.973 0.509 . . . . 73.129999999999995 111.947 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.83 -1.03 68.17 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 116.491 -0.322 . . . . 72.129999999999995 113.116 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 58.21 30.37 19.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.805 1.242 . . . . 74.530000000000001 111.489 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.1 mp 67.77 114.68 0.04 OUTLIER 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.242 1.817 . . . . 64.430000000000007 111.689 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -55.57 5.3 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.424 0.69 . . . . 65.430000000000007 111.082 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -155.59 32.97 0.36 Allowed 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.024 0.53 . . . . 74.439999999999998 110.998 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.6 m80 66.34 -178.83 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 124.479 1.112 . . . . 74.030000000000001 112.97 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -114.28 23.29 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.205 0.602 . . . . 74.340000000000003 111.98 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.2 m80 71.67 -67.43 0.26 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 125.633 1.573 . . . . 75.319999999999993 113.65 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 81.9 t60 68.73 95.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.539 1.136 . . . . 72.340000000000003 110.672 -167.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 124.78 1.232 . . . . 74.239999999999995 112.374 178.148 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.88 0.372 . . . . 74.040000000000006 111.631 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.29 39.21 3.96 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.918 0.887 . . . . 63.25 109.979 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.4 m -108.73 113.14 25.85 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.587 0.755 . . . . 64.510000000000005 111.141 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.31 112.82 24.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.795 1.238 . . . . 72.230000000000004 110.511 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -112.57 133.08 54.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 122.02 -0.425 . . . . 74.319999999999993 110.43 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 143.53 44.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.168 0.587 . . . . 74.209999999999994 109.78 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -143.72 158.63 43.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 75.430000000000007 110.605 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.3 p -153.23 143.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.92 0.488 . . . . 62.140000000000001 111.222 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.43 108.62 18.58 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.793 -0.447 . . . . 74.209999999999994 109.793 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.464 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 48.6 t -90.99 128.06 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.643 0.777 . . . . 45.0 110.999 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -77.74 67.77 3.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.098 0.559 . . . . 65.310000000000002 111.36 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.61 153.61 2.82 Favored Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 123.55 0.74 . . . . 62.310000000000002 111.692 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.12 126.98 19.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.163 2.576 . . . . 74.549999999999997 113.146 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.06 -42.23 8.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.043 1.497 . . . . 61.43 115.043 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.83 85.7 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.771 0.428 . . . . 71.150000000000006 112.079 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.34 -36.49 84.29 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.647 0.779 . . . . 72.540000000000006 112.028 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -36.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.365 0.666 . . . . 64.219999999999999 110.203 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -67.7 -28.93 68.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.506 -0.77 . . . . 73.340000000000003 110.841 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.6 m -62.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.142 0.496 . . . . 74.400000000000006 111.017 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD23 ' HB3' ' A' ' 30' ' ' TRP . 61.5 tp -70.8 -46.66 62.43 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.17 0.988 . . . . 75.439999999999998 111.536 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.57 8.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.681 0.792 . . . . 72.219999999999999 112.62 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.98 -9.86 79.81 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 123.282 0.468 . . . . 61.439999999999998 113.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.521 ' HB2' ' HB1' ' A' ' 26' ' ' ALA . 2.1 m-20 -106.7 132.81 52.26 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.294 0.568 . . . . 72.319999999999993 109.603 168.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -76.03 -5.99 48.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.737 0.815 . . . . 63.310000000000002 111.32 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -93.37 -10.3 35.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.525 0.73 . . . . 73.430000000000007 111.415 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 23' ' ' ASP . . . -97.45 22.88 8.24 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.442 0.904 . . . . 51.509999999999998 113.442 -153.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.6 HG12 HG21 ' A' ' 34' ' ' VAL . 19.2 tt -81.25 -18.2 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 O-C-N 122.259 -0.276 . . . . 74.239999999999995 111.31 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -65.62 -22.36 66.66 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.003 0.521 . . . . 75.030000000000001 111.827 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -68.96 -44.91 71.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.399 1.08 . . . . 74.299999999999997 112.422 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.43 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 28.3 p-90 -115.95 -37.64 3.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.153 0.797 . . . . 74.439999999999998 113.153 -169.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -83.44 110.72 26.23 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 109.959 -0.386 . . . . 74.420000000000002 109.959 -172.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.91 2.03 5.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.019 2.479 . . . . 74.430000000000007 116.312 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.473 ' N ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -102.74 -19.73 14.63 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.521 0.6 . . . . 72.409999999999997 111.866 176.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.6 HG21 HG12 ' A' ' 27' ' ' ILE . 57.6 t -70.11 118.86 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-O 121.183 0.516 . . . . 70.329999999999998 112.188 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 t -88.61 38.12 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 74.400000000000006 111.448 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.2 109.28 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.292 1.437 . . . . 64.310000000000002 112.062 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.75 160.69 12.22 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.543 2.162 . . . . 73.409999999999997 112.992 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 m -99.53 122.59 42.82 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.213 -0.662 . . . . 74.439999999999998 109.213 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.58 122.63 31.52 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.9 -1.148 . . . . 74.310000000000002 107.9 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 99.3 mtt180 -110.57 126.15 54.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.725 0.81 . . . . 71.120000000000005 111.308 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.72 -176.68 0.01 OUTLIER Glycine 0 CA--C 1.547 2.048 0 N-CA-C 118.102 2.001 . . . . 73.200000000000003 118.102 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.48 -92.9 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.082 1.353 . . . . 74.400000000000006 112.942 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 t 165.65 147.16 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 125.954 1.702 . . . . 44.310000000000002 108.704 -173.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.09 -4.43 6.24 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.515 2.143 . . . . 73.549999999999997 114.034 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.04 -10.0 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.7 0.8 . . . . 70.420000000000002 112.129 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -108.37 125.69 31.31 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 123.721 0.808 . . . . 72.439999999999998 112.143 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.594 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 98.9 Cg_exo -48.41 123.65 9.49 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 123.804 3.002 . . . . 73.409999999999997 114.081 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.68 -27.77 4.08 Favored Glycine 0 N--CA 1.474 1.21 0 CA-C-N 116.137 -0.483 . . . . 43.329999999999998 112.445 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.62 49.49 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.602 0.761 . . . . 73.510000000000005 112.548 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 45.1 mt-10 -130.21 120.74 24.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.819 0.447 . . . . 72.340000000000003 111.622 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.508 ' NH2' ' HB ' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -92.67 120.73 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.613 -0.884 . . . . 75.010000000000005 108.613 175.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.65 98.52 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.679 -0.638 . . . . 63.340000000000003 110.652 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -59.69 121.57 11.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 75.329999999999998 111.91 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.68 -51.45 4.57 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.967 -0.352 . . . . 73.349999999999994 112.886 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.83 33.86 23.79 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.353 1.061 . . . . 75.140000000000001 113.041 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.68 -24.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.971 -1.013 . . . . 72.519999999999996 111.74 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.6 p -63.13 141.1 58.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.6 0.76 . . . . 72.109999999999999 111.006 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.56 -30.98 65.68 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.352 0.661 . . . . 74.019999999999996 112.183 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -110.82 66.93 0.63 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.33 0.652 . . . . 74.219999999999999 110.392 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 164.16 23.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.193 0.521 . . . . 74.450000000000003 111.798 171.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.663 HD12 ' SD ' ' A' ' 79' ' ' MET . 56.2 tp -133.92 131.24 38.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.694 0.797 . . . . 74.150000000000006 109.745 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.6 125.68 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.430000000000007 109.928 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.676 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 32.2 mt-10 -118.37 126.53 52.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.551 0.74 . . . . 73.200000000000003 109.19 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -101.96 133.48 46.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.193 0.997 . . . . 75.140000000000001 111.322 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 13.4 tp -75.64 112.1 11.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.332 1.453 . . . . 72.140000000000001 111.089 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.29 -52.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.221 0.608 . . . . 72.319999999999993 111.328 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.72 154.72 22.79 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 111.181 -172.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.706 ' HE ' HD13 ' A' ' 75' ' ' LEU . 19.4 tpp85 -140.15 123.99 17.41 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.486 0.715 . . . . 74.409999999999997 111.201 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 12.4 m-20 -122.45 76.41 1.32 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.561 0.745 . . . . 71.129999999999995 110.356 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.53 -18.5 65.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 112.959 0.726 . . . . 65.409999999999997 112.959 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -46.5 76.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.246 0.619 . . . . 54.020000000000003 110.723 169.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.67 -2.35 58.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.064 0.946 . . . . 63.420000000000002 112.967 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 59.51 51.26 6.66 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.182 0.993 . . . . 74.519999999999996 111.182 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 28.6 ttm-85 -126.9 132.63 50.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.202 1.001 . . . . 74.230000000000004 110.364 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.706 HD13 ' HE ' ' A' ' 68' ' ' ARG . 6.1 tp -130.54 108.51 9.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.985 0.914 . . . . 75.140000000000001 109.954 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -106.57 129.65 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.592 0.757 . . . . 72.409999999999997 110.005 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.97 178.55 8.83 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.501 0.667 . . . . 74.409999999999997 112.759 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -149.57 141.84 24.14 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.199 1.399 . . . . 62.140000000000001 109.724 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.676 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 61.1 mtm -94.44 104.54 14.28 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 119.055 0.843 . . . . 73.349999999999994 111.064 174.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.52 -24.48 22.22 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.638 2.225 . . . . 70.310000000000002 112.716 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -126.34 78.84 71.16 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 123.545 0.738 . . . . 70.409999999999997 110.828 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.415 ' HB3' ' HE3' ' A' ' 79' ' ' MET . 50.6 Cg_endo -88.74 147.55 5.9 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 C-N-CA 122.885 2.39 . . . . 74.340000000000003 113.211 174.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' HD13 ' A' ' 61' ' ' LEU . 65.3 Cg_endo -84.76 1.89 8.32 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.684 2.256 . . . . 74.439999999999998 112.655 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.1 155.44 36.46 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.224 1.009 . . . . 74.510000000000005 110.321 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.78 57.11 4.93 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.011 2.474 . . . . 73.510000000000005 112.898 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' A' ' 113' ' ' CYS . 22.3 pt -121.95 134.63 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.564 1.146 . . . . 72.120000000000005 109.619 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 37.5 m -75.0 -81.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.193 0.442 . . . . 73.0 112.193 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -78.11 -56.34 4.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 112.233 0.457 . . . . 74.129999999999995 112.233 -172.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.08 127.58 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.745 1.618 . . . . 74.349999999999994 113.738 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -123.93 153.54 41.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.076 1.35 . . . . 74.230000000000004 108.366 169.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.4 135.71 12.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 72.319999999999993 110.528 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.7 p -136.85 138.61 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 N-CA-C 113.242 0.83 . . . . 74.450000000000003 113.242 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.5 mm? -104.66 119.4 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.845 1.258 . . . . 71.540000000000006 109.235 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -123.86 110.1 14.44 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.673 -0.491 . . . . 74.329999999999998 109.673 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.63 110.01 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.491 -0.559 . . . . 71.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.87 111.18 63.87 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.023 0.929 . . . . 74.430000000000007 110.385 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.28 109.92 1.89 Allowed 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.791 2.327 . . . . 61.130000000000003 113.005 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' H ' ' HA ' ' A' ' 103' ' ' CYS . 39.5 mmt180 -75.74 -46.65 29.76 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.525 0.679 . . . . 74.530000000000001 109.761 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -122.79 -166.23 1.41 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.84 1.256 . . . . 74.299999999999997 109.276 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -81.68 -35.35 29.97 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.717 0.407 . . . . 72.439999999999998 110.938 167.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -108.85 13.23 25.02 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.106 0.563 . . . . 75.319999999999993 111.587 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 53.1 m80 -142.1 152.56 43.38 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.747 0.819 . . . . 70.099999999999994 109.637 172.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -153.34 177.62 10.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.024 0.529 . . . . 74.340000000000003 111.738 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 82.3 m -133.99 111.86 10.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.832 0.853 . . . . 72.420000000000002 109.986 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.89 116.87 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.469 -0.567 . . . . 73.409999999999997 109.469 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.11 105.89 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.795 0.838 . . . . 75.120000000000005 109.513 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -102.97 116.96 33.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.23 -1.026 . . . . 71.519999999999996 108.23 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 152.8 46.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.707 0.803 . . . . 73.310000000000002 109.928 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 155.32 47.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.118 1.367 . . . . 73.430000000000007 109.596 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -163.47 126.11 2.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.039 0.936 . . . . 74.140000000000001 109.688 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.45 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 p90 -141.31 156.01 45.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.332 0.653 . . . . 75.409999999999997 112.023 -165.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.651 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 38.4 t70 -84.97 86.98 7.33 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.499 0.666 . . . . 74.439999999999998 110.316 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' HG21 ' A' ' 86' ' ' ILE . 48.9 t -145.59 165.22 29.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.92 -1.036 . . . . 74.209999999999994 110.861 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.1 p -68.53 148.82 98.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 123.18 0.592 . . . . 64.140000000000001 111.687 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.93 -22.16 68.59 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.298 1.999 . . . . 72.109999999999999 112.78 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -65.83 -43.72 87.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.01 0.924 . . . . 74.319999999999993 111.312 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.506 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 23.5 m -84.33 -31.16 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.091 0.557 . . . . 75.239999999999995 111.068 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -64.62 -33.92 77.05 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.54 0.736 . . . . 70.010000000000005 112.226 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -65.73 -33.85 76.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.107 0.563 . . . . 73.510000000000005 111.402 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.61 -38.74 73.99 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.721 0.809 . . . . 75.230000000000004 109.961 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.9 -24.84 61.72 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.287 -0.869 . . . . 74.230000000000004 111.828 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 51.3 mt-10 -61.61 -39.13 90.17 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 117.956 0.343 . . . . 72.209999999999994 110.362 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -66.75 -55.67 13.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.536 0.734 . . . . 54.200000000000003 112.102 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.53 -55.03 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.463 0.705 . . . . 75.040000000000006 112.708 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.3 mt -82.53 -58.17 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.536 -0.757 . . . . 71.219999999999999 111.099 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.71 -50.03 32.96 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 114.973 0.749 . . . . 60.340000000000003 114.973 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.75 -25.24 21.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.14 0.576 . . . . 64.430000000000007 111.177 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.07 -88.51 0.67 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.13 -0.486 . . . . 64.239999999999995 112.038 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.09 -47.01 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 124.559 1.144 . . . . 74.319999999999993 113.366 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -77.84 -50.14 12.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.106 0.562 . . . . 73.010000000000005 112.159 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.19 81.63 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.243 0.339 . . . . 71.310000000000002 111.063 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -56.8 -50.3 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.225 0.61 . . . . 63.450000000000003 112.047 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.64 -48.68 82.96 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 123.508 0.505 . . . . 64.329999999999998 113.391 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 mt -69.99 -37.37 75.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.78 0.832 . . . . 73.540000000000006 112.959 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.46 -52.04 50.49 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 110.261 -0.274 . . . . 70.420000000000002 110.261 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.14 69.62 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.287 0.635 . . . . 62.310000000000002 111.8 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.0 tt -68.23 -45.99 71.77 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.484 0.714 . . . . 75.430000000000007 110.18 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -28.17 64.4 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 112.082 0.401 . . . . 64.299999999999997 112.082 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.73 -44.78 48.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.121 0.968 . . . . 73.549999999999997 111.635 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 12.8 ptm180 -63.8 -29.34 70.55 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.133 0.573 . . . . 65.349999999999994 112.152 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.3 -22.06 38.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.974 0.731 . . . . 74.219999999999999 112.974 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.65 -42.18 0.1 Allowed Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.225 0.85 . . . . 50.340000000000003 115.225 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? 69.94 16.95 7.58 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 124.867 1.267 . . . . 73.230000000000004 111.983 -169.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.34 47.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 75.219999999999999 109.448 167.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.08 -169.5 1.71 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.42 1.088 . . . . 70.349999999999994 111.931 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -58.79 -14.47 8.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.305 1.042 . . . . 73.25 113.712 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.2 m80 72.45 89.0 0.1 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.339 1.455 . . . . 74.150000000000006 111.137 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -77.29 -3.59 40.67 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.728 -1.124 . . . . 73.129999999999995 112.156 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 63.6 -79.46 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.352 1.461 . . . . 71.209999999999994 112.508 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.4 -60.42 1.53 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.686 . . . . 75.420000000000002 110.98 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.369 0.604 . . . . 74.129999999999995 109.928 -174.114 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.638 0.256 . . . . 74.140000000000001 110.826 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.42 21.7 9.8 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.989 0.916 . . . . 71.540000000000006 110.37 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.6 m -111.49 119.33 38.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.353 1.061 . . . . 75.239999999999995 110.039 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 122' ' ' GLU . 8.2 mp -96.0 139.78 31.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.694 1.197 . . . . 71.230000000000004 108.701 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -147.46 126.35 12.74 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.021 0.438 . . . . 72.209999999999994 111.184 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -130.32 158.27 40.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.05 1.34 . . . . 74.219999999999999 110.081 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.8 p -155.1 154.86 33.03 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.246 0.618 . . . . 75.109999999999999 112.005 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.5 p -152.17 145.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.086 0.555 . . . . 73.230000000000004 111.354 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.56 108.84 19.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 120.996 0.427 . . . . 74.209999999999994 110.694 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.436 HG22 HD22 ' A' ' 137' ' ' LEU . 95.2 t -94.05 137.77 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 73.230000000000004 110.411 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -83.16 41.9 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 112.936 0.717 . . . . 64.329999999999998 112.936 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HA ' HH11 ' A' ' 101' ' ' ARG . . . -142.06 148.18 47.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.675 0.79 . . . . 75.120000000000005 110.483 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.23 142.97 93.52 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.412 2.074 . . . . 73.439999999999998 112.375 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.08 -33.54 39.8 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.177 1.391 . . . . 74.200000000000003 114.503 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.7 69.75 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.082 0.553 . . . . 73.349999999999994 112.107 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.99 -39.38 85.52 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.465 0.706 . . . . 73.329999999999998 112.139 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.572 HG23 ' SG ' ' A' ' 103' ' ' CYS . 65.2 t -70.63 -35.53 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.273 0.629 . . . . 73.420000000000002 111.009 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.449 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 62.4 t-105 -68.46 -31.52 70.87 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.155 0.582 . . . . 72.319999999999993 110.864 176.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.7 m -65.96 -33.27 75.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.354 0.662 . . . . 74.219999999999999 110.672 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.7 tp -75.86 -52.79 9.57 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.806 0.842 . . . . 75.430000000000007 112.346 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 m -79.38 -32.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 113.124 0.787 . . . . 73.319999999999993 113.124 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.77 -31.68 81.61 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 114.544 0.578 . . . . 74.450000000000003 114.544 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.73 95.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.025 0.44 . . . . 72.340000000000003 109.967 171.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -67.18 -18.06 65.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.308 0.643 . . . . 71.409999999999997 112.246 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.6 p -77.57 -27.21 51.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.079 0.552 . . . . 74.310000000000002 111.191 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.32 29.13 6.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.857 0.863 . . . . 62.039999999999999 111.139 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.57 HG22 HG13 ' A' ' 34' ' ' VAL . 9.2 tt -64.85 -27.13 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 CA-C-N 115.09 -0.959 . . . . 62.299999999999997 111.555 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -59.95 -12.36 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.212 1.19 . . . . 73.329999999999998 114.212 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -71.24 -24.62 62.22 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.13 0.572 . . . . 74.439999999999998 112.502 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HB3' HD21 ' A' ' 20' ' ' LEU . 59.1 p-90 -122.51 -31.55 3.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.296 0.638 . . . . 75.150000000000006 111.404 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 22.1 t-80 -95.35 104.16 14.63 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.182 0.593 . . . . 72.340000000000003 110.206 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.3 -16.32 54.42 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.212 2.608 . . . . 75.209999999999994 114.617 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.437 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.0 mt-30 -95.25 -11.06 28.61 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.3 0.852 . . . . 61.43 113.3 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.57 HG13 HG22 ' A' ' 27' ' ' ILE . 56.1 t -75.04 116.48 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 118.346 0.521 . . . . 73.310000000000002 110.321 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -87.03 29.79 0.8 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.822 0.849 . . . . 75.310000000000002 112.137 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 68.08 121.7 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 125.706 1.602 . . . . 72.310000000000002 111.888 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.621 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 41.9 Cg_endo -96.26 155.26 1.34 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.024 2.483 . . . . 61.409999999999997 115.924 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -101.11 123.56 45.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.976 0.91 . . . . 74.420000000000002 109.938 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.21 123.36 28.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.256 0.55 . . . . 71.230000000000004 112.33 -172.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 10.3 mmm180 -103.07 121.81 43.36 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.722 1.209 . . . . 64.400000000000006 110.214 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.18 -178.53 0.01 OUTLIER Glycine 0 CA--C 1.549 2.18 0 N-CA-C 117.766 1.866 . . . . 64.239999999999995 117.766 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.672 ' HB1' ' HB3' ' A' ' 49' ' ' ALA . . . 40.27 -98.02 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 126.059 1.743 . . . . 73.409999999999997 115.111 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 30.0 t -176.81 149.36 0.85 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 124.461 1.104 . . . . 71.219999999999999 110.491 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.33 -11.97 21.71 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.871 2.381 . . . . 73.099999999999994 113.587 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -114.72 1.94 14.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.902 0.881 . . . . 74.5 112.498 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.8 m -97.53 117.52 65.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.361 -0.837 . . . . 75.439999999999998 110.204 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 22.0 Cg_endo -58.48 92.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.065 2.51 . . . . 72.439999999999998 112.752 176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.15 -42.5 0.27 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.279 -0.873 . . . . 54.130000000000003 112.115 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . . . -67.58 164.74 18.39 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.908 1.077 . . . . 62.340000000000003 113.908 -172.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 33.9 mt-10 -121.62 164.47 17.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.251 1.02 . . . . 63.420000000000002 110.097 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -146.68 146.29 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.004 0.43 . . . . 75.040000000000006 111.837 168.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 t -117.69 108.11 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.546 0.738 . . . . 72.329999999999998 111.158 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -66.27 110.31 2.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.442 1.097 . . . . 74.329999999999998 110.633 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.96 -63.33 1.5 Allowed Glycine 0 CA--C 1.539 1.563 0 N-CA-C 112.064 -0.414 . . . . 72.219999999999999 112.064 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.88 115.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.743 1.386 . . . . 75.120000000000005 114.743 171.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.02 17.97 66.14 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 121.237 0.354 . . . . 64.209999999999994 112.698 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 p -94.6 -171.25 2.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.288 . . . . 60.310000000000002 109.923 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.34 -26.63 19.86 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 120.811 0.338 . . . . 75.129999999999995 110.63 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.33 93.01 2.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.385 0.674 . . . . 62.109999999999999 110.116 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.33 -175.72 2.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.417 0.687 . . . . 74.310000000000002 111.512 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.575 HD11 ' HD3' ' A' ' 83' ' ' PRO . 34.9 tp -135.11 117.76 16.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.719 0.808 . . . . 74.25 110.347 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.98 121.81 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 109.173 -0.677 . . . . 75.129999999999995 109.173 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.61 167.19 14.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.424 0.69 . . . . 74.049999999999997 109.924 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.491 HH11 ' HA ' ' A' ' 66' ' ' VAL . 3.1 tmt_? -140.7 109.07 5.83 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.088 0.955 . . . . 73.209999999999994 109.843 -165.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 29.8 tp -59.46 105.91 0.4 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.159 0.984 . . . . 71.409999999999997 110.96 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.491 ' HA ' HH11 ' A' ' 64' ' ' ARG . 89.3 t -78.27 -51.03 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.37 0.668 . . . . 73.019999999999996 111.307 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.25 151.45 34.25 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.153 0.581 . . . . 72.540000000000006 111.287 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -143.13 130.07 20.57 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.965 0.906 . . . . 74.340000000000003 110.479 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 14.7 m-20 -135.94 118.3 15.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.361 1.064 . . . . 74.540000000000006 110.466 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.449 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 3.9 mp0 -80.77 -36.54 31.72 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.84 0.456 . . . . 74.019999999999996 110.267 169.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 m -63.71 -37.61 87.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.893 0.877 . . . . 74.329999999999998 112.394 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.5 -12.36 24.25 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.234 0.614 . . . . 63.32 111.733 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 59.46 45.88 13.03 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 71.010000000000005 110.006 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 39.0 ttm180 -122.21 123.16 40.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.583 1.553 . . . . 75.150000000000006 111.022 -169.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 23.7 tp -123.22 106.64 10.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.501 0.72 . . . . 73.340000000000003 110.415 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.1 t -108.21 129.89 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.877 0.871 . . . . 70.430000000000007 111.583 -169.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -139.22 172.86 12.22 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 75.239999999999995 112.252 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -149.93 139.09 21.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.312 1.445 . . . . 73.310000000000002 109.257 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.405 ' SD ' HD13 ' A' ' 61' ' ' LEU . 69.6 mtm -94.66 105.59 19.43 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 118.51 0.595 . . . . 74.230000000000004 110.556 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.74 -18.28 22.26 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.006 2.47 . . . . 64.230000000000004 112.179 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.6 78.24 68.73 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.869 0.868 . . . . 64.129999999999995 109.032 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.84 140.39 16.23 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.684 2.256 . . . . 74.439999999999998 112.802 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.575 ' HD3' HD11 ' A' ' 61' ' ' LEU . 63.4 Cg_endo -85.24 8.41 4.62 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.944 2.43 . . . . 73.219999999999999 112.557 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.98 141.38 40.47 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 124.496 1.118 . . . . 75.510000000000005 109.383 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.67 88.23 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.578 2.186 . . . . 73.200000000000003 113.325 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 113' ' ' CYS . 14.8 pt -137.32 168.37 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 125.159 1.383 . . . . 73.420000000000002 109.43 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 28.8 m -93.57 -84.02 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.118 0.414 . . . . 75.430000000000007 112.118 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -86.26 -45.13 11.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.642 0.608 . . . . 65.420000000000002 112.642 -170.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 47.9 t-80 64.66 141.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.736 1.614 . . . . 74.140000000000001 113.529 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -150.77 152.73 34.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.403 1.081 . . . . 75.209999999999994 108.424 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -160.39 151.09 18.6 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.877 0.471 . . . . 75.230000000000004 111.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.78 150.86 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 113.024 0.75 . . . . 74.219999999999999 113.024 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -120.63 108.54 14.15 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.639 1.576 . . . . 74.030000000000001 107.58 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -126.76 115.1 18.86 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.948 0.499 . . . . 74.129999999999995 111.45 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -95.34 126.57 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 122.779 0.432 . . . . 75.510000000000005 110.292 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.58 117.72 44.36 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.397 1.079 . . . . 63.439999999999998 110.684 -173.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.64 108.23 2.41 Favored 'Trans proline' 0 CA--C 1.568 2.215 0 C-N-CA 122.826 2.351 . . . . 75.540000000000006 114.416 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -81.2 -34.73 32.07 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 123.864 0.866 . . . . 74.310000000000002 111.767 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 25.6 t70 -156.73 163.2 39.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.311 1.044 . . . . 74.519999999999996 109.986 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.04 -23.29 61.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.537 1.135 . . . . 72.329999999999998 113.119 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.583 HH11 ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -128.33 5.19 5.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.678 0.791 . . . . 73.530000000000001 111.07 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.588 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 51.2 m80 -138.51 130.47 28.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.812 . . . . 74.150000000000006 110.811 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' A' ' 17' ' ' VAL . 17.3 p -136.33 178.81 6.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.654 0.782 . . . . 65.040000000000006 110.226 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.9 m -133.9 118.08 17.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.074 0.55 . . . . 73.349999999999994 111.354 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.55 110.92 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.77 -0.456 . . . . 74.439999999999998 109.77 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.67 111.86 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.972 0.909 . . . . 72.540000000000006 109.633 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -111.32 124.67 52.72 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.912 0.485 . . . . 75.230000000000004 109.915 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -127.91 146.28 50.68 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.48 1.112 . . . . 70.209999999999994 110.84 -170.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.91 113.8 6.48 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.477 0.711 . . . . 73.430000000000007 111.87 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -116.9 125.69 51.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.56 1.144 . . . . 75.200000000000003 109.875 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.445 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 3.2 p90 -146.79 146.48 30.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.116 0.566 . . . . 71.209999999999994 112.521 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.45 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -76.93 86.44 3.47 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.477 0.656 . . . . 73.150000000000006 109.617 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.546 ' HB2' HG23 ' A' ' 86' ' ' ILE . 46.5 t -117.86 164.21 15.39 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.907 -1.042 . . . . 73.030000000000001 111.828 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -83.95 152.36 62.26 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.546 0.738 . . . . 65.030000000000001 110.981 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.41 -62.21 0.48 Allowed 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.956 3.104 . . . . 72.150000000000006 115.616 -170.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -31.71 72.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.7 0.8 . . . . 64.310000000000002 112.639 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.428 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 25.1 m -75.11 -34.31 61.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.315 0.246 . . . . 60.020000000000003 111.021 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.21 61.74 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.153 0.581 . . . . 63.149999999999999 111.351 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -22.93 66.61 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.259 0.466 . . . . 75.120000000000005 112.259 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.34 -41.3 56.98 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.12 0.568 . . . . 74.299999999999997 111.298 170.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 mt -75.38 -24.88 57.28 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.109 1.151 . . . . 74.049999999999997 114.109 -173.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.405 ' HA ' HD21 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -61.69 -36.39 80.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.558 0.947 . . . . 72.219999999999999 113.558 -175.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.9 m -79.31 -44.11 22.29 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.918 0.71 . . . . 62.119999999999997 112.918 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.92 -51.22 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.28 0.562 . . . . 75.319999999999993 111.87 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.6 mt -81.48 -49.0 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.705 0.802 . . . . 70.540000000000006 110.888 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.52 -42.68 95.57 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 114.849 0.699 . . . . 54.509999999999998 114.849 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -94.44 -58.95 2.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 122.093 -0.651 . . . . 74.219999999999999 110.932 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.95 -18.12 68.37 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.729 1.052 . . . . 45.340000000000003 115.729 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.31 -52.27 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 117.644 0.722 . . . . 70.329999999999998 110.977 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -74.85 -60.8 2.12 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.53 0.732 . . . . 74.230000000000004 112.123 -172.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.77 65.42 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.475 0.485 . . . . 72.420000000000002 111.525 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.9 t -52.95 -56.54 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 C-N-CA 124.04 0.936 . . . . 74.030000000000001 112.442 171.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.3 -36.68 85.15 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 116.568 -0.287 . . . . 63.009999999999998 112.97 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.52 -47.45 81.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.167 0.987 . . . . 74.150000000000006 112.039 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.28 -47.71 83.13 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.28 0.632 . . . . 74.319999999999993 110.874 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.59 74.15 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.234 0.457 . . . . 73.340000000000003 112.234 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.436 HD22 HG22 ' A' ' 10' ' ' VAL . 3.8 tt -67.81 -43.17 80.28 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.01 0.524 . . . . 75.439999999999998 110.103 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.74 81.92 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.89 0.476 . . . . 74.129999999999995 111.837 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.42 -31.26 60.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.128 0.971 . . . . 71.400000000000006 112.905 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -67.15 -29.95 69.79 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.873 0.306 . . . . 74.120000000000005 111.337 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -93.42 -5.01 50.31 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.883 0.473 . . . . 72.209999999999994 112.196 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.71 24.0 0.8 Allowed Glycine 0 CA--C 1.549 2.21 0 N-CA-C 115.02 0.768 . . . . 70.129999999999995 115.02 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -66.75 -25.75 66.65 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.663 1.185 . . . . 71.239999999999995 112.492 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.47 HD22 ' H ' ' A' ' 144' ' ' LEU . 2.4 pt? -115.17 -7.78 12.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.597 0.591 . . . . 70.0 112.597 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.59 171.29 8.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.941 1.089 . . . . 75.420000000000002 113.941 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -127.49 167.29 16.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 113.904 -1.498 . . . . 74.299999999999997 110.669 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 63.45 97.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.866 1.266 . . . . 75.319999999999993 111.954 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -117.03 -174.36 2.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.186 0.994 . . . . 72.140000000000001 111.39 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 64.69 95.33 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.986 1.314 . . . . 74.140000000000001 110.349 -168.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -68.32 123.85 21.87 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.323 0.649 . . . . 73.409999999999997 111.774 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.442 0.639 . . . . 60.240000000000002 111.681 178.21 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.86 0.362 . . . . 74.200000000000003 111.077 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.12 13.77 27.01 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.697 0.799 . . . . 74.409999999999997 110.634 170.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -105.99 114.5 28.68 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.806 0.842 . . . . 74.329999999999998 110.182 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.36 114.68 26.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.886 1.274 . . . . 75.200000000000003 109.833 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -122.47 138.22 54.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.889 0.476 . . . . 72.209999999999994 111.968 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -138.96 155.08 48.3 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.934 1.294 . . . . 74.230000000000004 109.55 171.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.9 p -149.82 156.99 42.76 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.357 0.663 . . . . 73.200000000000003 110.357 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.1 p -145.53 146.09 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 112.084 0.402 . . . . 74.040000000000006 112.084 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.43 111.84 23.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.858 0.863 . . . . 64.120000000000005 109.71 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 60.7 t -104.29 130.76 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 73.019999999999996 110.82 -175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.93 71.54 6.63 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.113 0.482 . . . . 72.329999999999998 111.113 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.46 154.12 3.74 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.124 0.97 . . . . 73.420000000000002 111.197 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.54 136.17 49.05 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.865 2.376 . . . . 73.219999999999999 111.985 168.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.23 17.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.562 1.319 . . . . 71.109999999999999 114.562 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.9 -47.69 82.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.19 0.596 . . . . 72.239999999999995 112.57 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.47 -43.02 79.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.202 0.601 . . . . 72.439999999999998 111.784 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' SG ' ' A' ' 103' ' ' CYS . 42.5 t -69.18 -33.79 60.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 115.418 -0.81 . . . . 72.319999999999993 111.208 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.433 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 71.9 t-105 -69.54 -31.7 70.06 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 111.751 0.278 . . . . 71.409999999999997 111.751 175.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.7 m -64.31 -26.86 68.67 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.659 0.743 . . . . 74.5 110.818 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 HD21 HH11 ' A' ' 140' ' ' ARG . 49.2 tp -76.48 -56.33 4.72 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.795 1.238 . . . . 74.510000000000005 111.924 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.44 -9.62 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.547 0.943 . . . . 71.239999999999995 113.547 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -68.86 -27.9 73.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 113.768 0.267 . . . . 50.509999999999998 113.768 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.86 108.57 14.64 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.416 0.686 . . . . 73.319999999999993 110.258 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -59.01 -24.81 63.12 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.76 0.824 . . . . 72.400000000000006 111.421 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -34.29 26.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.273 1.029 . . . . 75.219999999999999 113.086 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -101.56 23.72 10.77 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.529 0.681 . . . . 74.420000000000002 111.449 -163.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.606 HG23 HG13 ' A' ' 34' ' ' VAL . 14.9 tt -57.31 -24.79 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.648 1.179 . . . . 65.319999999999993 112.463 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -65.56 -5.63 8.65 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.156 1.169 . . . . 75.200000000000003 114.156 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -78.72 -27.22 44.88 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.628 0.771 . . . . 75.010000000000005 112.416 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -122.31 -29.74 4.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.372 0.669 . . . . 74.349999999999994 111.376 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -95.17 111.68 55.78 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.318 0.647 . . . . 61.439999999999998 109.976 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.43 -22.01 52.75 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.225 2.617 . . . . 75.129999999999995 114.508 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.491 HE22 ' HA ' ' A' ' 129' ' ' VAL . 37.2 mt-30 -86.74 -25.11 24.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.146 0.579 . . . . 74.099999999999994 112.209 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.606 HG13 HG23 ' A' ' 27' ' ' ILE . 98.2 t -67.72 120.21 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 121.101 0.477 . . . . 64.310000000000002 111.142 177.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -88.51 23.59 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.335 1.054 . . . . 75.349999999999994 113.075 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.47 95.26 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 124.476 1.11 . . . . 72.430000000000007 110.418 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.71 178.79 4.16 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.319 2.68 . . . . 74.430000000000007 115.097 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.9 m -101.88 124.29 47.25 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.351 1.061 . . . . 73.129999999999995 110.079 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.85 135.68 48.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.496 0.718 . . . . 71.540000000000006 110.314 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.39 156.97 47.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.497 0.719 . . . . 74.439999999999998 110.636 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.81 157.96 0.01 OUTLIER Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.79 1.876 . . . . 60.5 117.79 -170.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.44 -98.9 0.09 Allowed 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.74 1.216 . . . . 71.209999999999994 113.359 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.9 t 171.3 149.42 0.18 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 125.459 1.504 . . . . 71.5 109.285 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.55 -19.74 18.91 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 123.059 2.506 . . . . 63.329999999999998 114.148 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -99.14 -30.26 12.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.515 0.726 . . . . 75.209999999999994 111.48 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.3 m -88.63 120.63 70.27 Favored Pre-proline 0 N--CA 1.49 1.554 0 C-N-CA 123.12 0.568 . . . . 71.329999999999998 111.071 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.495 ' HG3' ' H ' ' A' ' 68' ' ' ARG . 99.5 Cg_exo -45.77 130.18 12.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.957 3.105 . . . . 73.120000000000005 114.814 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.54 -24.21 6.2 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.412 -0.358 . . . . 62.329999999999998 113.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.49 49.86 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.49 0.716 . . . . 73.430000000000007 112.821 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.29 136.04 43.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.43 0.692 . . . . 74.420000000000002 110.716 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -115.36 108.6 16.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.204 1.002 . . . . 70.430000000000007 111.53 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 18.7 t -113.38 108.05 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.09 0.556 . . . . 73.140000000000001 110.326 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -68.35 -59.07 3.46 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.192 0.997 . . . . 73.400000000000006 113.65 -169.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.28 -12.35 84.67 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.82 -0.434 . . . . 64.049999999999997 113.477 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 66.62 -73.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.526 1.53 . . . . 63.439999999999998 113.281 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.0 44.66 0.7 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 113.492 0.157 . . . . 65.109999999999999 113.492 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.3 p -93.83 -118.33 0.09 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.905 0.882 . . . . 72.140000000000001 109.855 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -139.81 9.78 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 119.169 0.895 . . . . 71.510000000000005 110.849 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -146.57 20.63 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.322 0.649 . . . . 62.5 112.48 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.59 144.64 35.33 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.774 0.797 . . . . 75.010000000000005 112.493 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.646 HD12 ' HD3' ' A' ' 83' ' ' PRO . 16.8 tp -103.25 125.48 49.93 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.484 1.114 . . . . 73.400000000000006 109.278 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 54.0 t -96.95 114.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.078 -0.712 . . . . 65.140000000000001 109.078 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 27.8 tt0 -118.95 166.95 12.22 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.239 1.016 . . . . 74.25 109.584 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -152.2 136.72 16.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.418 0.525 . . . . 72.319999999999993 112.418 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.7 tp -77.76 116.96 18.69 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.99 1.316 . . . . 71.530000000000001 110.81 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.402 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 95.5 t -79.16 -53.01 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.02 0.528 . . . . 72.209999999999994 110.52 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -152.89 144.53 23.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.191 0.996 . . . . 72.549999999999997 109.748 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.495 ' H ' ' HG3' ' A' ' 47' ' ' PRO . 4.2 tmt_? -131.84 112.09 12.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 72.519999999999996 107.441 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -114.08 115.13 27.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.001 0.52 . . . . 70.299999999999997 110.939 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.433 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 29.1 tt0 -83.86 -20.82 32.46 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.787 0.835 . . . . 72.019999999999996 111.668 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -68.93 -48.97 61.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.424 0.69 . . . . 75.209999999999994 111.936 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.09 2.82 51.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.107 0.563 . . . . 73.519999999999996 112.393 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 54.9 52.07 12.57 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.216 1.006 . . . . 72.129999999999995 111.943 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.36 119.65 26.72 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.453 1.101 . . . . 75.349999999999994 111.123 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 44.4 tp -109.57 106.77 16.61 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.447 1.099 . . . . 74.519999999999996 110.426 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.83 128.86 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.79 0.836 . . . . 74.430000000000007 111.248 -175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.402 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 51.7 p90 -150.83 179.11 8.5 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.827 0.677 . . . . 75.439999999999998 112.827 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 t -152.85 158.03 41.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.183 1.393 . . . . 75.230000000000004 109.5 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 16.7 ptt? -111.84 100.46 48.67 Favored Pre-proline 0 N--CA 1.485 1.319 0 CA-C-N 118.362 0.528 . . . . 63.420000000000002 110.226 169.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.33 -22.79 59.71 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.409 2.74 . . . . 73.319999999999993 113.644 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 25.8 t70 -128.75 81.35 70.94 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.396 0.678 . . . . 75.25 109.726 176.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.02 154.54 12.98 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.096 2.531 . . . . 73.25 113.885 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.646 ' HD3' HD12 ' A' ' 61' ' ' LEU . 71.4 Cg_endo -83.25 -4.5 11.06 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.662 2.241 . . . . 75.129999999999995 112.532 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.91 154.13 38.37 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.156 0.982 . . . . 74.530000000000001 110.757 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.02 61.49 8.18 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.717 2.278 . . . . 55.43 112.85 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.448 HG23 ' HB2' ' A' ' 113' ' ' CYS . 30.4 pt -121.06 167.91 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.289 1.036 . . . . 74.120000000000005 110.321 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 84.3 m -103.46 -85.19 0.46 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.793 0.437 . . . . 71.439999999999998 110.854 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.73 111.6 23.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.12 0.486 . . . . 74.439999999999998 111.115 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 26.5 t-80 -84.84 150.88 24.7 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.639 0.776 . . . . 74.340000000000003 111.768 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -154.78 110.28 3.12 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.662 0.785 . . . . 74.540000000000006 109.887 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.03 146.27 52.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.567 0.58 . . . . 50.240000000000002 112.567 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 40.6 t -134.73 143.98 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.142 0.977 . . . . 64.420000000000002 111.553 -173.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -112.65 109.48 19.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.973 1.309 . . . . 73.400000000000006 109.238 173.583 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HG3' HG13 ' A' ' 92' ' ' VAL . 42.3 mt-10 -117.7 112.48 20.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.445 0.566 . . . . 74.120000000000005 111.808 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 t -97.37 111.37 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.078 0.551 . . . . 65.409999999999997 110.007 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.84 131.26 22.21 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.987 0.915 . . . . 54.439999999999998 111.192 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.69 81.63 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.04 2.493 . . . . 74.109999999999999 111.965 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -35.46 81.1 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.092 0.957 . . . . 75.030000000000001 110.873 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 23.4 t70 -140.47 174.72 10.24 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 125.342 1.457 . . . . 74.340000000000003 108.946 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.47 -68.61 0.28 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.489 0.715 . . . . 73.030000000000001 111.084 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -81.8 -15.25 54.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.893 0.477 . . . . 72.310000000000002 111.775 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.3 m80 -120.1 146.97 45.43 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.864 -0.522 . . . . 73.140000000000001 111.385 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 17' ' ' VAL . 28.9 p -132.14 176.02 8.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.358 0.663 . . . . 75.299999999999997 109.836 177.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.7 m -130.41 125.09 33.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.175 0.59 . . . . 73.239999999999995 110.122 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.28 105.96 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.69 -0.856 . . . . 70.209999999999994 108.69 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.91 112.61 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.019 -0.734 . . . . 75.439999999999998 109.019 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -102.23 112.52 25.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.761 -0.829 . . . . 75.510000000000005 108.761 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 m -113.46 144.14 43.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.203 1.001 . . . . 73.450000000000003 109.433 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.18 149.45 36.46 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.871 0.868 . . . . 72.549999999999997 109.229 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.37 130.4 8.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.257 1.023 . . . . 74.540000000000006 108.585 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 7.8 p90 -148.58 152.03 36.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.12 0.568 . . . . 72.219999999999999 111.177 -171.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.459 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 13.5 t70 -76.59 85.84 3.27 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.817 -0.629 . . . . 73.430000000000007 109.396 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.448 ' HB2' HG23 ' A' ' 86' ' ' ILE . 48.4 t -120.27 147.63 44.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.009 -0.996 . . . . 75.120000000000005 111.026 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -60.19 132.03 90.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-O 118.404 -0.807 . . . . 74.319999999999993 110.694 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.56 -46.01 12.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.848 3.032 . . . . 75.109999999999999 114.458 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -62.98 -30.85 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.354 1.061 . . . . 64.349999999999994 112.426 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.0 m -90.7 -31.8 16.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.659 0.784 . . . . 72.400000000000006 112.257 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.0 -31.52 71.27 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.737 0.815 . . . . 64.25 112.265 -171.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.93 -34.61 78.37 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.214 1.006 . . . . 74.150000000000006 112.167 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.47 -44.41 51.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.228 0.611 . . . . 72.239999999999995 110.539 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.5 -23.81 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.429 0.692 . . . . 73.010000000000005 110.843 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.26 -52.75 64.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.886 0.874 . . . . 74.420000000000002 110.732 170.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.6 m -68.38 -42.69 78.76 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 112.885 0.698 . . . . 72.549999999999997 112.885 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.2 -55.05 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.25 0.547 . . . . 73.409999999999997 112.019 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -56.99 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.618 0.767 . . . . 74.230000000000004 111.323 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.22 -33.22 86.65 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 114.442 0.537 . . . . 52.140000000000001 114.442 -175.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -101.72 -61.49 1.38 Allowed 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.043 -0.681 . . . . 65.340000000000003 111.388 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.42 68.31 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.566 0.986 . . . . 75.109999999999999 115.566 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.491 ' HA ' HE22 ' A' ' 33' ' ' GLN . 87.8 t -106.78 -54.9 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 117.419 0.609 . . . . 74.239999999999995 111.136 175.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.4 m-30 -73.46 -59.13 2.85 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.067 0.547 . . . . 64.5 112.336 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.76 67.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 123.439 0.462 . . . . 63.149999999999999 111.79 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.2 t -62.45 -55.61 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.649 0.78 . . . . 73.329999999999998 112.085 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.84 98.38 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 116.182 -0.463 . . . . 62.520000000000003 113.909 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.73 -34.66 72.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.442 0.697 . . . . 75.439999999999998 112.27 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.502 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.8 m-20 -67.66 -42.16 82.6 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 110.455 -0.202 . . . . 70.409999999999997 110.455 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.53 77.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.255 0.622 . . . . 71.319999999999993 111.539 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 tt -65.19 -37.46 87.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.696 0.798 . . . . 70.439999999999998 110.104 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.36 70.6 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.616 0.366 . . . . 72.409999999999997 111.674 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 147' ' ' HIS . 38.2 mt-10 -68.53 -39.24 81.24 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.183 0.593 . . . . 75.450000000000003 112.178 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.438 HH11 HD21 ' A' ' 20' ' ' LEU . 5.4 ptm180 -66.51 -27.81 68.07 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.317 0.488 . . . . 73.200000000000003 112.317 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -98.57 -2.94 37.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.365 0.666 . . . . 71.219999999999999 111.228 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.92 12.5 57.36 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 123.58 0.609 . . . . 52.020000000000003 113.745 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -92.1 -12.22 33.61 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 122.28 -0.541 . . . . 72.319999999999993 110.107 166.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.98 -45.01 17.27 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.644 0.778 . . . . 73.310000000000002 111.483 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -139.08 27.24 2.38 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 122.815 0.446 . . . . 75.030000000000001 111.485 -171.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 68.63 164.69 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.496 1.118 . . . . 75.140000000000001 112.438 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.505 ' HD2' ' HG2' ' A' ' 139' ' ' GLU . 71.8 m80 -57.88 -48.96 78.3 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.251 0.621 . . . . 74.140000000000001 112.418 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 t60 70.27 -60.93 0.48 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.585 1.554 . . . . 73.340000000000003 111.245 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -101.8 143.59 31.52 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.168 0.987 . . . . 75.129999999999995 109.839 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -133.1 -94.45 0.33 Allowed 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 108.846 -0.798 . . . . 75.140000000000001 108.846 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 . . . . . 0 N--CA 1.494 1.773 0 C-N-CA 123.768 0.827 . . . . 74.219999999999999 109.968 172.711 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 112.191 0.441 . . . . 55.020000000000003 112.191 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.85 71.42 0.58 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.579 1.152 . . . . 74.5 112.235 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.7 m -126.54 128.95 47.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.319 0.648 . . . . 73.209999999999994 110.738 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 7.5 mp -105.21 141.63 36.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.174 1.39 . . . . 71.299999999999997 108.426 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -150.06 130.8 14.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.321 0.582 . . . . 74.299999999999997 111.648 172.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -139.6 152.77 47.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.606 1.162 . . . . 74.439999999999998 108.542 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -150.18 161.59 42.1 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.764 0.426 . . . . 65.349999999999994 111.378 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 135' ' ' ASN . 9.9 p -148.32 145.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.545 0.572 . . . . 74.319999999999993 112.545 -177.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -91.24 119.43 31.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.849 0.86 . . . . 74.019999999999996 110.766 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.2 131.68 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 124.631 1.173 . . . . 73.519999999999996 110.959 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.28 68.79 10.31 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.134 0.492 . . . . 64.439999999999998 111.463 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.58 142.74 2.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.206 1.002 . . . . 72.319999999999993 109.546 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.96 138.44 82.25 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.893 2.396 . . . . 72.200000000000003 112.898 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.6 15.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.2 1.4 . . . . 71.340000000000003 114.778 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.38 64.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.435 0.694 . . . . 71.420000000000002 112.115 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.07 -37.49 82.86 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.721 0.808 . . . . 73.200000000000003 112.555 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.489 HG22 ' SG ' ' A' ' 103' ' ' CYS . 40.5 t -70.12 -37.42 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.238 0.615 . . . . 75.25 110.757 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -63.53 -31.06 72.11 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.36 -0.836 . . . . 73.310000000000002 111.523 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -59.09 -31.88 69.29 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.288 0.566 . . . . 73.530000000000001 111.572 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 30' ' ' TRP . 35.4 tp -75.76 -43.01 48.76 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.863 0.865 . . . . 75.200000000000003 111.797 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' O ' HD23 ' A' ' 75' ' ' LEU . 19.0 m -95.27 -3.35 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.264 0.839 . . . . 73.349999999999994 113.264 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.41 -28.02 60.52 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 123.152 0.406 . . . . 74.400000000000006 112.881 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.15 105.38 17.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.326 0.65 . . . . 64.129999999999995 110.078 169.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 35.9 t80 -61.61 -29.04 69.79 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.608 0.763 . . . . 71.030000000000001 111.348 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 39' ' ' LEU . 33.9 t -77.74 -21.67 51.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.986 0.914 . . . . 75.209999999999994 112.783 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.16 25.84 10.5 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.891 0.477 . . . . 75.109999999999999 112.032 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.08 -27.31 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 123.743 0.817 . . . . 72.129999999999995 112.282 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.784 ' HA ' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -64.86 -6.74 8.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 114.134 1.161 . . . . 71.319999999999993 114.134 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -89.05 -17.58 29.05 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.734 0.642 . . . . 74.310000000000002 112.734 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.485 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.6 p-90 -129.3 -32.53 1.99 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.36 0.874 . . . . 73.450000000000003 113.36 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.401 ' HE1' ' HB2' ' A' ' 33' ' ' GLN . 17.5 t-80 -78.01 130.63 72.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.51 0.324 . . . . 74.209999999999994 110.294 -174.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -79.59 -29.07 3.1 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.721 2.281 . . . . 53.530000000000001 114.266 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -93.82 -6.86 44.9 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.222 0.823 . . . . 72.409999999999997 113.222 -175.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.784 HG13 ' HA ' ' A' ' 28' ' ' HIS . 7.1 p -56.87 128.39 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.518 0 CA-C-O 121.44 0.638 . . . . 74.010000000000005 112.19 176.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.7 m -91.62 23.18 3.64 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.078 0.951 . . . . 73.540000000000006 112.157 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.58 101.91 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 124.699 1.2 . . . . 74.510000000000005 111.26 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 37.3 Cg_endo -88.25 161.33 6.99 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.542 2.161 . . . . 74.329999999999998 114.386 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.9 m -105.94 123.55 48.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.883 0.873 . . . . 74.150000000000006 109.164 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.443 HD22 ' HB1' ' A' ' 49' ' ' ALA . 1.6 tm? -88.38 113.59 24.14 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.437 -0.579 . . . . 72.439999999999998 109.437 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -99.59 153.13 19.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.949 1.3 . . . . 73.5 110.901 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.19 -126.56 23.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.948 0.78 . . . . 55.200000000000003 115.026 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.06 140.58 4.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.256 1.022 . . . . 73.25 113.246 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 m -56.58 158.13 8.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 124.534 1.133 . . . . 73.519999999999996 112.917 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.92 162.13 39.27 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.046 1.831 . . . . 74.109999999999999 111.283 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 72.75 -42.15 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.877 1.271 . . . . 75.030000000000001 112.118 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 m -68.87 123.0 87.06 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 124.395 1.078 . . . . 74.310000000000002 111.011 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.49 93.98 0.17 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.127 2.552 . . . . 71.030000000000001 113.251 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 -25.61 0.14 Allowed Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.083 -0.508 . . . . 64.219999999999999 113.156 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.443 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . -55.04 132.78 47.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.32 1.048 . . . . 62.299999999999997 113.385 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -117.6 116.57 27.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 74.420000000000002 111.355 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 38.1 ptt85 -94.03 119.07 32.4 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.135 0.493 . . . . 74.530000000000001 110.107 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 23.6 t -114.21 112.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.421 0.688 . . . . 74.420000000000002 110.511 -177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -68.7 117.45 10.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.264 1.026 . . . . 64.340000000000003 110.29 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.62 -65.53 3.77 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.734 -0.546 . . . . 61.509999999999998 111.734 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 62.48 10.34 3.95 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.746 1.219 . . . . 75.040000000000006 114.289 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.13 32.37 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.905 -0.878 . . . . 72.430000000000007 110.905 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -122.51 175.08 6.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 71.319999999999993 109.842 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.77 -4.02 48.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.827 0.451 . . . . 73.439999999999998 111.807 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -135.3 84.76 2.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.785 . . . . 73.120000000000005 109.025 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 176.94 4.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.318 1.047 . . . . 74.409999999999997 111.417 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.551 HD13 ' HD3' ' A' ' 83' ' ' PRO . 23.2 tp -143.26 113.94 7.55 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.279 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 45.1 t -97.46 116.72 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.336 0.654 . . . . 74.519999999999996 109.725 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.644 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 46.3 mt-10 -120.96 123.39 42.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 64.319999999999993 109.76 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 43.1 ttt180 -103.29 135.73 44.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.299 1.04 . . . . 73.239999999999995 111.764 -175.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -80.71 122.08 26.68 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.692 0.797 . . . . 74.230000000000004 110.773 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -95.88 -45.4 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.28 0.632 . . . . 72.420000000000002 111.263 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 26.4 tt0 -145.32 145.11 31.09 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.836 1.254 . . . . 73.109999999999999 110.382 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.18 116.03 14.03 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.801 -1.185 . . . . 74.340000000000003 107.801 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -117.5 104.53 11.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.756 0.822 . . . . 71.230000000000004 109.099 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -26.26 46.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.274 0.629 . . . . 74.450000000000003 112.688 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t -72.43 -42.75 64.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.779 0.832 . . . . 74.319999999999993 110.936 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.62 2.96 36.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.768 0.655 . . . . 54.439999999999998 112.768 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 57.03 43.02 25.14 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.424 1.09 . . . . 75.400000000000006 112.016 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -115.39 105.06 12.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.814 0.846 . . . . 72.439999999999998 110.648 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 59.2 tp -100.83 105.78 17.1 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.188 0.595 . . . . 74.409999999999997 109.69 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 57.7 t -106.74 133.82 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 118.688 0.676 . . . . 72.409999999999997 110.168 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 33.4 p90 -152.31 -178.66 6.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.042 0.537 . . . . 74.239999999999995 110.862 -178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.4 t -141.71 162.92 34.3 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.402 1.081 . . . . 74.439999999999998 110.177 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.644 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 79.0 mtp -110.1 85.75 4.52 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 108.811 -0.811 . . . . 75.239999999999995 108.811 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.78 -21.17 45.06 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.154 2.569 . . . . 72.409999999999997 113.564 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 24.4 t70 -139.25 84.21 16.82 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.762 0.425 . . . . 73.319999999999993 110.226 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.462 ' HB3' ' HE3' ' A' ' 79' ' ' MET . 44.2 Cg_endo -94.96 153.36 1.75 Allowed 'Trans proline' 0 CA--C 1.565 2.067 0 C-N-CA 123.234 2.622 . . . . 72.040000000000006 113.24 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.551 ' HD3' HD13 ' A' ' 61' ' ' LEU . 5.0 Cg_exo -80.48 22.68 0.75 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 122.893 2.396 . . . . 73.209999999999994 112.837 171.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.27 149.7 47.88 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.436 1.094 . . . . 75.450000000000003 110.356 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 68.02 6.24 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.835 2.357 . . . . 75.129999999999995 113.416 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.539 HG21 ' HB2' ' A' ' 113' ' ' CYS . 25.8 pt -132.97 135.9 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.542 1.137 . . . . 71.340000000000003 110.074 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 16.4 m -81.66 -82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 111.832 0.308 . . . . 75.129999999999995 111.832 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -102.07 108.0 19.28 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.257 0.551 . . . . 73.409999999999997 110.778 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -89.31 157.94 18.01 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.737 0.815 . . . . 74.409999999999997 111.685 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -156.01 124.11 5.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.587 0.755 . . . . 75.420000000000002 110.21 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.98 151.8 51.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.985 0.735 . . . . 63.0 112.985 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.5 p -138.35 137.43 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 C-N-CA 123.523 0.729 . . . . 73.030000000000001 112.483 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.2 mm? -101.28 108.3 19.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.065 -1.087 . . . . 74.329999999999998 108.065 166.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -124.51 110.73 14.85 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.641 -0.503 . . . . 72.219999999999999 109.641 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.9 110.89 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.532 -0.544 . . . . 74.420000000000002 109.532 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.6 117.5 68.61 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 124.187 0.995 . . . . 73.409999999999997 111.08 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.79 110.14 1.61 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.663 2.242 . . . . 73.5 111.494 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -107.33 -28.89 9.61 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.47 0.708 . . . . 72.319999999999993 111.834 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.9 t70 -149.96 163.05 39.12 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.762 0.825 . . . . 74.010000000000005 110.434 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.78 -39.03 73.35 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.517 1.127 . . . . 75.030000000000001 112.35 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -117.64 -4.34 11.22 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.846 . . . . 74.129999999999995 112.32 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.497 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -133.05 156.47 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.305 0.502 . . . . 64.040000000000006 111.208 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 17' ' ' VAL . 23.0 p -157.68 178.66 10.01 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.583 0.753 . . . . 50.119999999999997 111.017 -177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.6 m -134.73 125.77 27.66 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.034 0.534 . . . . 72.150000000000006 111.33 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.02 120.96 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.38 -0.6 . . . . 65.5 109.38 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.42 125.03 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.215 0.606 . . . . 73.519999999999996 109.713 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -114.31 116.75 29.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.591 0.757 . . . . 74.430000000000007 109.087 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.455 HG23 ' SD ' ' A' ' 110' ' ' MET . 76.3 m -119.82 138.9 53.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.029 0.932 . . . . 75.120000000000005 109.384 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.17 112.91 7.67 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.492 0.717 . . . . 62.530000000000001 111.61 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.455 ' SD ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -120.74 131.6 54.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 71.329999999999998 109.613 -177.45 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -142.68 155.06 44.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.625 0.77 . . . . 75.340000000000003 111.886 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 28.6 t70 -77.3 88.02 3.71 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.795 0.438 . . . . 75.230000000000004 110.115 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.602 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 38.7 t -145.99 164.76 31.06 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.971 -0.558 . . . . 71.150000000000006 112.493 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m -75.13 144.56 79.15 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.136 0.974 . . . . 55.119999999999997 111.676 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.27 -43.95 20.65 Favored 'Trans proline' 0 C--N 1.389 2.68 0 C-N-CA 124.23 3.287 . . . . 72.420000000000002 115.221 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.08 -42.53 72.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.341 1.056 . . . . 74.430000000000007 112.618 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.602 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 8.5 m -85.89 -31.47 22.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.506 0.723 . . . . 74.530000000000001 110.27 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.37 91.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.149 0.979 . . . . 75.530000000000001 112.488 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.53 -30.38 61.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.852 0.861 . . . . 72.329999999999998 112.219 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.71 -45.12 72.4 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.26 0.552 . . . . 72.140000000000001 109.865 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.06 -23.69 62.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.192 0.997 . . . . 70.239999999999995 110.943 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 40.7 tt0 -61.89 -47.09 86.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.8 0.44 . . . . 62.450000000000003 110.314 172.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -71.13 -43.74 66.99 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 112.822 0.675 . . . . 73.430000000000007 112.822 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.79 -55.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.384 0.674 . . . . 71.349999999999994 112.491 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.91 -55.23 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.736 0.815 . . . . 75.239999999999995 111.459 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -72.35 -71.23 1.09 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 114.066 0.386 . . . . 72.239999999999995 114.066 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.38 -3.64 31.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.544 0.738 . . . . 64.150000000000006 112.698 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.96 -83.13 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.061 -0.416 . . . . 70.540000000000006 112.061 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.48 -43.12 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.763 0.825 . . . . 70.400000000000006 112.593 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 6.7 m-30 -76.26 -43.7 40.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.751 0.421 . . . . 75.310000000000002 111.239 -175.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.95 -48.04 73.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.549 0.339 . . . . 73.510000000000005 111.3 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.22 -47.25 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 C-N-CA 123.357 0.663 . . . . 75.430000000000007 111.945 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -45.46 95.61 Favored Glycine 0 CA--C 1.54 1.594 0 CA-C-N 116.518 -0.31 . . . . 50.229999999999997 113.661 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.18 -46.04 57.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.372 1.069 . . . . 74.549999999999997 111.922 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.454 ' HA ' HG22 ' A' ' 8' ' ' VAL . 6.5 m-20 -61.7 -40.83 96.41 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.841 0.457 . . . . 73.099999999999994 110.999 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.49 85.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.017 0.527 . . . . 72.019999999999996 111.425 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.25 -44.87 92.37 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.443 0.697 . . . . 71.109999999999999 110.858 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.68 95.25 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.868 -0.605 . . . . 73.329999999999998 111.618 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -71.55 -30.84 66.34 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.411 0.684 . . . . 73.310000000000002 112.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -15.37 58.57 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.389 0.514 . . . . 74.140000000000001 112.389 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -85.45 -8.69 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 122.727 0.411 . . . . 74.150000000000006 111.48 162.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 71.57 67.58 1.83 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 112.308 -0.317 . . . . 73.450000000000003 112.308 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -67.34 130.88 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.575 0.583 . . . . 63.43 112.575 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.41 -5.87 18.65 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.276 0.63 . . . . 73.340000000000003 111.164 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.8 96.52 0.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.521 0.728 . . . . 65.0 109.841 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -79.37 75.51 5.96 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.947 -1.024 . . . . 72.349999999999994 110.788 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -82.38 68.41 8.81 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 107.805 -1.183 . . . . 74.319999999999993 107.805 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -76.09 100.32 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.262 -1.335 . . . . 73.099999999999994 112.583 -166.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -163.5 146.39 10.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.008 0.923 . . . . 63.100000000000001 109.88 172.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -79.96 106.71 12.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.866 0.466 . . . . 72.510000000000005 110.964 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 51.2 t60 . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 123.731 0.812 . . . . 75.450000000000003 110.056 -179.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 119.455 -0.307 . . . . 73.430000000000007 110.596 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.642 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 47.45 51.11 14.04 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.585 1.154 . . . . 64.430000000000007 112.844 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.25 101.12 9.9 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.945 0.879 . . . . 72.329999999999998 110.281 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.583 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 4.0 mp -92.94 119.17 31.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.998 1.319 . . . . 74.450000000000003 108.932 -175.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -140.75 136.33 32.43 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.909 0.385 . . . . 75.430000000000007 110.274 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.11 138.81 31.93 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.101 -1.074 . . . . 74.530000000000001 108.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.7 p -128.92 147.11 50.81 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.874 0.869 . . . . 74.340000000000003 110.126 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.4 p -142.3 145.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.933 0.493 . . . . 73.109999999999999 110.469 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.98 112.71 24.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.349 0.595 . . . . 72.230000000000004 110.773 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.9 t -91.44 132.87 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.258 1.423 . . . . 74.530000000000001 110.632 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.13 51.37 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.409 0.683 . . . . 70.150000000000006 112.209 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.56 155.09 24.58 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.166 0.986 . . . . 62.240000000000002 110.605 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.1 142.21 73.24 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.863 2.376 . . . . 73.340000000000003 113.398 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.76 -38.91 23.11 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.911 1.684 . . . . 74.420000000000002 115.253 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.89 73.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.555 0.742 . . . . 73.120000000000005 112.767 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.85 -42.31 84.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.751 0.82 . . . . 72.549999999999997 112.307 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.435 HG13 HD21 ' A' ' 137' ' ' LEU . 29.2 t -70.83 -33.82 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.899 0.88 . . . . 74.450000000000003 110.784 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.517 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 49.5 t-105 -67.29 -28.99 68.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.425 0.69 . . . . 74.019999999999996 111.891 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -65.11 -36.13 83.32 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.175 0.512 . . . . 64.510000000000005 110.441 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 30' ' ' TRP . 66.2 tp -73.28 -51.44 17.58 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.192 0.997 . . . . 74.329999999999998 111.988 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.42 -33.26 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.606 0.762 . . . . 62.219999999999999 112.702 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.11 72.68 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 113.237 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.39 94.79 0.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.938 0.875 . . . . 73.310000000000002 110.474 168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.87 12.77 0.77 Allowed 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 124.873 1.269 . . . . 72.450000000000003 110.496 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.658 ' HA ' HD23 ' A' ' 39' ' ' LEU . 75.6 p -115.77 -1.73 12.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.554 1.141 . . . . 61.420000000000002 112.493 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.31 -83.36 0.61 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 119.071 -0.49 . . . . 70.140000000000001 110.867 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 HG13 ' A' ' 34' ' ' VAL 0.298 19.9 tt 52.81 -48.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 127.61 2.364 . . . . 74.140000000000001 116.457 -175.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -60.9 -4.08 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 120.284 1.402 . . . . 75.519999999999996 114.34 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -77.46 -16.61 58.67 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.867 0.867 . . . . 74.200000000000003 112.852 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.524 ' HB3' HD21 ' A' ' 20' ' ' LEU . 42.4 p-90 -132.13 -34.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.524 0.729 . . . . 73.310000000000002 111.816 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -87.53 110.74 36.65 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.89 0.876 . . . . 73.209999999999994 109.313 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.18 -8.62 24.1 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 71.019999999999996 114.902 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -109.02 -6.81 15.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.148 1.166 . . . . 73.010000000000005 114.148 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 27' ' ' ILE . 66.6 t -79.66 131.38 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 118.469 0.577 . . . . 71.420000000000002 112.5 177.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -93.03 34.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.252 1.021 . . . . 73.5 111.869 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 67.46 125.78 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 C-N-CA 125.8 1.64 . . . . 70.209999999999994 113.422 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 73.7 Cg_endo -84.79 149.7 11.14 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.742 2.295 . . . . 74.239999999999995 113.921 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.7 m -107.07 120.18 41.39 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.898 0.879 . . . . 73.329999999999998 109.645 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.658 HD23 ' HA ' ' A' ' 25' ' ' SER . 3.9 mm? -91.51 137.7 32.15 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.481 0.658 . . . . 73.299999999999997 112.701 -167.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -130.13 165.07 23.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.153 1.381 . . . . 74.510000000000005 109.81 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.97 -150.89 5.97 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.541 0.977 . . . . 55.140000000000001 115.541 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.05 87.56 6.89 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.953 0.724 . . . . 74.409999999999997 112.953 -165.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.4 t 58.89 132.96 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 N-CA-C 116.001 1.852 . . . . 74.420000000000002 116.001 161.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.43 -16.44 41.82 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.082 2.521 . . . . 74.430000000000007 114.176 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -114.17 20.43 15.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 60.130000000000003 111.744 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 123.03 26.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 123.729 0.811 . . . . 65.439999999999998 109.345 172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.581 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 58.7 Cg_exo -53.95 89.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.656 2.904 . . . . 72.420000000000002 114.164 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.83 51.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.071 -0.513 . . . . 75.140000000000001 112.655 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.71 145.16 39.98 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.704 0.801 . . . . 64.349999999999994 111.006 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -109.93 153.07 25.02 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.257 0.623 . . . . 73.140000000000001 109.867 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.637 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 11.0 ptm180 -140.24 125.56 18.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.398 0.618 . . . . 74.120000000000005 109.844 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.39 101.13 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.777 0.831 . . . . 73.099999999999994 109.851 -174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -63.34 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.724 1.209 . . . . 75.450000000000003 111.953 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -59.91 0.64 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.005 -0.438 . . . . 74.120000000000005 112.005 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.36 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.52 1.528 . . . . 74.430000000000007 113.44 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.7 -19.86 0.44 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 115.002 0.761 . . . . 71.209999999999994 115.002 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 p -105.45 171.86 7.1 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.615 0.707 . . . . 72.420000000000002 111.518 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.85 7.02 43.88 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.965 0.906 . . . . 71.519999999999996 112.603 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.34 31.48 3.47 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.828 0.823 . . . . 73.439999999999998 110.521 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 151.06 45.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.752 0.821 . . . . 75.150000000000006 112.662 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -102.82 114.47 28.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.573 0.749 . . . . 73.019999999999996 110.266 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.6 t -114.4 115.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.157 0.583 . . . . 73.510000000000005 110.716 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.83 160.56 20.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.02 0.928 . . . . 75.430000000000007 110.613 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -143.36 132.23 22.76 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.199 1.0 . . . . 74.420000000000002 111.356 -170.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 18.6 tp -74.83 121.55 21.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.193 1.397 . . . . 74.340000000000003 112.374 -175.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -98.38 -48.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.95 0.9 . . . . 74.230000000000004 110.879 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 36.9 tt0 -144.13 134.65 24.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.441 1.096 . . . . 74.340000000000003 109.661 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.563 ' NH1' ' HB2' ' A' ' 70' ' ' GLU . 4.0 tmm_? -132.92 109.58 9.69 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.332 -0.618 . . . . 75.450000000000003 109.332 -176.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.84 176.0 5.44 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.491 1.116 . . . . 75.219999999999999 109.356 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.563 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 24.4 tt0 -158.62 -34.65 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.865 -0.522 . . . . 74.420000000000002 112.336 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -63.86 -34.84 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.3 0.64 . . . . 64.439999999999998 111.358 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.65 -14.81 15.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.342 1.057 . . . . 75.430000000000007 110.773 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 68.25 69.29 0.32 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.936 1.294 . . . . 75.200000000000003 112.098 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.28 135.04 40.54 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.722 0.809 . . . . 72.209999999999994 111.505 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.57 118.18 31.0 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.764 1.225 . . . . 70.420000000000002 109.447 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 60.5 t -116.92 125.65 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.45 0.7 . . . . 64.409999999999997 109.981 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.17 -179.07 6.66 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.703 0.801 . . . . 74.540000000000006 111.319 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -145.97 162.99 36.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.425 1.09 . . . . 75.109999999999999 110.486 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 72.6 mtm -101.14 100.45 13.29 Favored Pre-proline 0 N--CA 1.484 1.259 0 N-CA-C 109.292 -0.633 . . . . 73.340000000000003 109.292 167.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.6 -21.04 30.14 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.002 2.468 . . . . 71.409999999999997 113.358 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -139.55 74.89 33.13 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.242 0.617 . . . . 65.129999999999995 109.63 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 64.7 Cg_endo -86.68 146.96 8.3 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.647 2.231 . . . . 70.319999999999993 113.468 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.1 Cg_endo -86.55 24.89 0.71 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.457 2.771 . . . . 73.120000000000005 113.347 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -123.33 149.4 57.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 123.912 0.885 . . . . 64.510000000000005 110.371 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.38 74.9 4.04 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.605 2.203 . . . . 73.310000000000002 112.031 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.612 HG21 ' HB2' ' A' ' 113' ' ' CYS . 31.4 pt -133.78 165.11 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.338 1.055 . . . . 75.530000000000001 110.991 -174.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 5.8 m -136.02 159.89 40.31 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.663 0.785 . . . . 72.450000000000003 109.649 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.8 p30 37.73 71.67 0.14 Allowed 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 125.9 1.68 . . . . 71.030000000000001 114.547 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.454 ' HD2' ' HD2' ' A' ' 111' ' ' PHE . 41.8 t-80 -79.39 131.0 35.97 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 116.076 -0.511 . . . . 74.25 111.881 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -129.82 118.84 22.4 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.231 1.012 . . . . 73.310000000000002 109.787 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -127.23 125.44 40.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.372 0.669 . . . . 73.450000000000003 111.312 177.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 117.63 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.489 0.715 . . . . 73.049999999999997 110.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.35 117.32 33.85 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 72.319999999999993 109.116 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.08 150.1 52.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.345 0.658 . . . . 74.439999999999998 110.937 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.86 113.87 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.185 0.594 . . . . 74.209999999999994 109.508 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -92.55 115.52 64.94 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.161 0.985 . . . . 63.240000000000002 109.902 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 77.11 0.37 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.764 2.309 . . . . 74.200000000000003 112.938 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -69.53 -33.75 73.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.217 1.007 . . . . 75.450000000000003 111.944 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 24.9 t70 -154.92 165.17 37.52 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.098 1.359 . . . . 74.219999999999999 108.944 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.35 -48.88 79.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.853 0.861 . . . . 62.539999999999999 111.963 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 -6.4 27.72 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.858 0.863 . . . . 72.510000000000005 110.987 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.6 m80 -131.3 128.54 39.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.956 -1.09 . . . . 75.140000000000001 111.592 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.42 ' SG ' HG22 ' A' ' 17' ' ' VAL . 31.5 p -130.2 133.76 46.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.063 0.545 . . . . 73.230000000000004 110.129 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.9 m -92.14 110.37 21.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.344 0.258 . . . . 72.420000000000002 110.383 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.11 116.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 74.310000000000002 109.717 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.8 t -107.77 109.85 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.454 1.102 . . . . 63.420000000000002 109.995 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -103.35 125.31 49.9 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.102 -0.703 . . . . 75.530000000000001 109.102 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.3 m -131.55 147.46 52.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.051 0.94 . . . . 74.439999999999998 110.344 -172.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -147.96 156.26 42.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.195 1.398 . . . . 74.439999999999998 108.859 169.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -162.81 146.03 11.0 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.638 . . . . 73.239999999999995 110.753 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.454 ' HD2' ' HD2' ' A' ' 89' ' ' HIS . 2.5 p90 -158.84 155.5 27.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.717 0.807 . . . . 74.329999999999998 111.669 -168.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 30.2 t70 -82.99 85.44 7.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.022 0.929 . . . . 73.129999999999995 109.205 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.612 ' HB2' HG21 ' A' ' 86' ' ' ILE . 43.0 t -113.41 152.65 29.77 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.768 -1.105 . . . . 75.219999999999999 111.254 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.1 p -61.43 132.33 92.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.482 0.713 . . . . 73.549999999999997 110.633 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.95 -44.21 23.12 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 124.293 3.329 . . . . 73.329999999999998 116.02 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.03 -38.62 72.57 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 122.799 0.44 . . . . 74.299999999999997 112.001 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 m -75.41 -26.8 58.68 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.166 0.587 . . . . 62.310000000000002 110.931 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 2' ' ' ALA . . . -68.67 -51.29 43.5 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.235 1.014 . . . . 75.109999999999999 111.125 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -64.01 -30.57 71.64 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.687 -0.688 . . . . 73.230000000000004 111.442 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -66.98 -44.36 80.62 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.839 -0.619 . . . . 73.519999999999996 110.691 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.61 -25.51 62.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.126 0.57 . . . . 73.430000000000007 111.233 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.583 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 52.1 mt-10 -66.09 -34.51 78.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.430000000000007 111.511 173.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 t -76.6 -53.27 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.679 0.622 . . . . 51.530000000000001 112.679 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.81 -55.03 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.647 0.779 . . . . 74.140000000000001 112.147 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.03 -46.76 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.061 0.545 . . . . 73.310000000000002 110.653 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -16.18 68.04 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 115.488 0.955 . . . . 64.140000000000001 115.488 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.35 -57.47 1.99 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.983 0.892 . . . . 74.439999999999998 110.464 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.27 58.46 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 115.144 0.818 . . . . 74.030000000000001 115.144 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.0 t -111.77 -52.09 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.312 0.645 . . . . 75.099999999999994 110.372 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -75.05 -61.39 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.797 0.666 . . . . 74.239999999999995 112.797 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.59 71.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.879 0.371 . . . . 74.329999999999998 111.503 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.11 -56.28 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.109 0.964 . . . . 74.409999999999997 112.579 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.08 94.74 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.36 -0.382 . . . . 73.239999999999995 113.346 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.98 -39.39 83.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.952 0.901 . . . . 70.530000000000001 112.626 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -67.39 -45.46 76.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.388 0.275 . . . . 73.019999999999996 110.782 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.14 73.22 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.493 0.717 . . . . 73.340000000000003 111.567 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.435 HD21 HG13 ' A' ' 17' ' ' VAL . 6.8 tt -66.19 -43.65 86.19 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.788 0.835 . . . . 72.329999999999998 110.301 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.887 0.475 . . . . 71.230000000000004 112.193 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -72.25 -44.39 62.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.551 0.74 . . . . 73.400000000000006 111.768 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -73.99 -20.96 60.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.522 0.564 . . . . 73.310000000000002 112.522 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -100.56 -14.86 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.05 0.54 . . . . 74.409999999999997 111.219 168.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.81 4.5 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-O 121.13 0.294 . . . . 61.119999999999997 112.503 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -72.87 -29.92 63.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.606 1.162 . . . . 74.430000000000007 109.921 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.42 -39.18 82.66 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.163 . . . . 74.150000000000006 110.805 174.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.5 -67.03 0.82 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.456 0.703 . . . . 65.319999999999993 109.68 175.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.78 -11.11 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.634 1.574 . . . . 73.129999999999995 113.428 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -87.75 49.91 1.89 Allowed 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.471 0.709 . . . . 72.109999999999999 111.747 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -168.72 114.61 0.62 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.114 0.965 . . . . 73.200000000000003 109.536 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -131.42 129.07 40.79 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.068 0.547 . . . . 70.530000000000001 111.487 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -98.22 168.16 10.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.733 0.813 . . . . 75.450000000000003 110.945 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 N--CA 1.484 1.249 0 C-N-CA 123.444 0.697 . . . . 75.439999999999998 110.967 175.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.681 0.277 . . . . 73.239999999999995 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.03 10.81 20.23 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.327 0.584 . . . . 75.329999999999998 110.771 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.8 m -115.13 117.87 31.77 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.652 1.181 . . . . 71.340000000000003 109.315 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -96.33 143.78 27.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.549 1.139 . . . . 75.299999999999997 109.931 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -143.72 135.2 26.05 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.248 0.547 . . . . 73.209999999999994 111.803 172.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -131.42 156.15 46.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.989 1.316 . . . . 73.120000000000005 109.008 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -145.02 157.02 44.25 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.617 0.767 . . . . 75.230000000000004 110.488 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.6 p -150.65 146.49 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.709 0.404 . . . . 74.25 111.149 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -93.01 123.64 36.41 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.855 -0.424 . . . . 72.349999999999994 109.855 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t -108.36 132.57 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.604 1.162 . . . . 75.519999999999996 110.638 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.69 64.23 8.5 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.24 0.616 . . . . 61.549999999999997 111.585 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.59 148.58 7.88 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.333 0.653 . . . . 73.150000000000006 111.037 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.07 128.76 31.15 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.29 2.66 . . . . 63.43 113.036 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.84 -37.27 13.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.981 1.475 . . . . 75.140000000000001 114.981 -175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.36 86.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.044 0.538 . . . . 75.010000000000005 112.227 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.52 -35.53 80.77 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.222 0.609 . . . . 54.149999999999999 112.332 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG22 ' SG ' ' A' ' 103' ' ' CYS . 58.8 t -71.25 -34.97 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.428 0.691 . . . . 73.400000000000006 110.345 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.492 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 63.2 t-105 -72.67 -27.66 62.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.548 0.739 . . . . 74.439999999999998 111.775 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.4 m -69.31 -29.56 67.44 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.423 0.63 . . . . 53.439999999999998 110.077 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' A' ' 30' ' ' TRP . 58.4 tp -75.16 -49.15 20.42 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.365 1.066 . . . . 75.040000000000006 111.68 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.44 -36.45 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 112.631 0.604 . . . . 74.0 112.631 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -65.36 -25.65 71.36 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 123.542 0.592 . . . . 55.340000000000003 114.352 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.07 108.21 11.2 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.123 -0.695 . . . . 62.32 109.123 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.405 ' HZ ' ' HG2' ' A' ' 63' ' ' GLU . 22.2 t80 -58.55 -27.66 64.77 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.093 0.957 . . . . 73.129999999999995 110.624 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.7 p -77.71 -24.46 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.209999999999994 113.263 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.19 10.34 39.41 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 122.805 0.442 . . . . 73.109999999999999 111.799 -168.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.741 HG23 HG13 ' A' ' 34' ' ' VAL . 18.5 tt -59.49 -25.51 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 C-N-CA 123.067 0.547 . . . . 73.439999999999998 112.114 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -63.78 -19.25 64.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.216 0.821 . . . . 51.409999999999997 113.216 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -78.25 -25.14 46.72 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.629 0.603 . . . . 74.219999999999999 112.629 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.537 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.8 p-90 -117.07 -33.18 4.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.948 0.499 . . . . 74.129999999999995 111.791 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.438 ' ND1' HG21 ' A' ' 34' ' ' VAL . 43.5 t-80 -89.34 109.79 33.96 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.247 0.619 . . . . 74.019999999999996 109.567 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.87 -15.65 36.75 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.928 2.419 . . . . 74.310000000000002 114.011 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.49 -26.3 19.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.45 0.7 . . . . 74.349999999999994 111.558 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.741 HG13 HG23 ' A' ' 27' ' ' ILE . 99.3 t -74.41 103.55 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.327 0 CA-C-O 121.134 0.492 . . . . 75.319999999999993 110.434 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 m -93.45 40.98 1.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.093 0.957 . . . . 74.019999999999996 112.56 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.1 75.12 0.47 Allowed Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 124.801 1.241 . . . . 72.439999999999998 112.926 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.726 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 94.4 Cg_endo -82.44 -168.15 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.563 2.842 . . . . 71.099999999999994 115.278 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 86.7 m -113.77 139.58 49.0 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.596 1.158 . . . . 72.019999999999996 111.511 -167.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.08 143.5 26.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.272 0.629 . . . . 71.409999999999997 111.375 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.686 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.3 mmt180 -115.1 138.35 50.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.854 0.862 . . . . 73.319999999999993 110.009 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.85 -123.9 7.94 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 115.548 0.979 . . . . 75.230000000000004 115.548 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.74 139.11 0.32 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.153 1.781 . . . . 71.329999999999998 114.746 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -50.55 158.25 1.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 C-N-CA 125.403 1.481 . . . . 62.43 113.755 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -7.03 13.99 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 123.05 2.5 . . . . 64.200000000000003 114.494 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -109.55 -13.74 14.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.707 0.803 . . . . 73.319999999999993 111.445 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -88.57 118.43 69.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.627 0.771 . . . . 75.099999999999994 111.009 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.54 121.8 10.14 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.509 2.806 . . . . 72.25 113.319 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.83 -14.56 8.5 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 116.348 -0.387 . . . . 71.329999999999998 113.073 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.68 141.42 52.64 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.862 0.865 . . . . 75.230000000000004 112.425 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.686 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 34.7 mt-10 -116.5 163.53 15.94 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 122.751 0.421 . . . . 74.329999999999998 110.249 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' THR . 48.4 ttt85 -156.17 105.68 2.34 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.93 0.492 . . . . 74.230000000000004 110.87 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.84 113.82 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.289 0.636 . . . . 74.230000000000004 111.358 -170.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.726 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.4 m-85 -76.3 70.75 2.95 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.042 1.337 . . . . 73.420000000000002 111.658 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.49 -50.85 0.53 Allowed Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.814 -0.514 . . . . 71.109999999999999 111.814 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.04 24.19 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.52 1.128 . . . . 74.019999999999996 113.876 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.06 53.62 0.05 OUTLIER Glycine 0 N--CA 1.474 1.23 0 C-N-CA 122.75 0.214 . . . . 72.420000000000002 112.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -121.05 -135.37 0.32 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.22 1.008 . . . . 75.530000000000001 108.86 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.15 -1.9 4.56 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.307 0.958 . . . . 72.109999999999999 111.978 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.33 46.77 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.69 0.757 . . . . 74.019999999999996 111.946 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -87.15 152.35 22.41 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.384 -0.825 . . . . 72.340000000000003 112.004 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.89 132.54 43.39 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.838 0.855 . . . . 73.120000000000005 108.865 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.5 t -102.86 116.67 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.883 -0.511 . . . . 75.430000000000007 109.902 175.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 43.5 tt0 -109.55 154.5 22.63 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.37 1.468 . . . . 75.019999999999996 109.605 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -151.94 125.66 8.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 74.109999999999999 112.163 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -66.97 120.76 14.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.016 1.326 . . . . 73.340000000000003 111.31 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -88.1 -50.8 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.698 . . . . 62.399999999999999 110.826 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 37.5 tt0 -151.98 142.45 22.6 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.549 1.14 . . . . 74.010000000000005 109.953 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.448 HH21 ' HA3' ' A' ' 22' ' ' GLY . 3.6 tmt_? -134.23 111.46 10.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.884 -0.784 . . . . 73.109999999999999 108.884 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -117.33 125.73 51.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.727 0.811 . . . . 71.450000000000003 110.709 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.492 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 33.6 tt0 -90.63 -40.38 11.94 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.251 0.834 . . . . 73.510000000000005 113.251 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -67.26 -43.53 81.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.878 0.471 . . . . 62.310000000000002 111.951 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.35 0.93 54.72 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.063 0.545 . . . . 74.540000000000006 112.031 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 25.4 mmt85 60.1 38.31 20.51 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.355 1.062 . . . . 64.219999999999999 112.293 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.84 122.87 47.67 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.052 0.941 . . . . 71.120000000000005 111.729 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 50.1 tp -115.04 108.41 16.65 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.061 0.944 . . . . 75.140000000000001 110.213 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 54.1 t -106.35 123.21 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.464 0.706 . . . . 71.549999999999997 110.132 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' HE1' HD22 ' A' ' 93' ' ' LEU . 46.5 p90 -151.95 -178.71 6.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.928 0.491 . . . . 74.219999999999999 111.727 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.431 HG23 ' HD3' ' A' ' 80' ' ' PRO . 9.8 t -153.82 164.63 38.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.142 0.977 . . . . 73.120000000000005 111.184 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -106.99 100.28 31.2 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.964 -0.754 . . . . 74.140000000000001 108.964 160.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD3' HG23 ' A' ' 78' ' ' THR . 36.1 Cg_endo -63.0 -23.03 74.07 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.944 2.429 . . . . 73.129999999999995 113.471 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.619 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.9 t70 -124.61 82.31 59.51 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.445 0.698 . . . . 75.5 110.028 175.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -101.56 144.67 0.26 Allowed 'Trans proline' 0 CA--C 1.573 2.466 0 C-N-CA 123.759 2.973 . . . . 73.230000000000004 114.291 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -69.81 -17.26 37.45 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.768 2.312 . . . . 72.120000000000005 113.596 172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -80.78 155.67 73.1 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 123.942 0.897 . . . . 71.519999999999996 111.394 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.0 46.84 2.3 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.253 2.635 . . . . 73.209999999999994 112.949 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.53 116.8 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.197 0.999 . . . . 74.120000000000005 109.774 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.5 ' HG1' ' HB3' ' A' ' 112' ' ' ASP . 46.4 p -74.96 -79.38 0.09 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.088 0.555 . . . . 70.209999999999994 112.39 -172.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.38 72.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.929 0.871 . . . . 74.030000000000001 109.752 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 110' ' ' MET . 57.5 t-80 -76.03 118.95 19.32 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.622 -0.717 . . . . 72.439999999999998 111.818 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 150.05 23.6 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.978 0.911 . . . . 74.409999999999997 108.914 170.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.59 119.49 8.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 71.030000000000001 109.137 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 48.4 t -126.09 130.12 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.38 0.672 . . . . 72.319999999999993 111.869 -169.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.432 HD22 ' HE1' ' A' ' 77' ' ' TYR . 4.3 mm? -107.93 111.57 23.74 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.382 1.073 . . . . 74.400000000000006 109.359 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 51.0 mt-10 -116.58 111.23 19.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.952 0.501 . . . . 74.120000000000005 110.413 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.43 105.61 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.298 -1.001 . . . . 75.430000000000007 108.298 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 15.5 m -100.57 123.7 45.12 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 122.894 0.478 . . . . 64.239999999999995 110.405 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 16.4 Cg_exo -68.47 85.81 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.159 2.573 . . . . 74.319999999999993 112.614 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -32.93 74.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.143 0.977 . . . . 74.439999999999998 109.744 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.547 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.7 t70 -157.31 167.12 31.23 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.239 1.816 . . . . 74.540000000000006 108.259 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.7 -40.54 95.39 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.208 0.603 . . . . 65.310000000000002 112.434 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -108.98 -1.29 19.08 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.614 0.766 . . . . 75.430000000000007 111.888 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.0 m80 -132.5 124.5 28.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.243 -0.911 . . . . 71.129999999999995 110.153 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.506 ' SG ' HG22 ' A' ' 17' ' ' VAL . 29.1 p -133.1 142.88 48.96 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.003 0.521 . . . . 71.239999999999995 110.8 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 m -97.12 114.33 26.0 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.757 0.423 . . . . 60.140000000000001 110.156 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 t -95.3 112.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.428 -0.582 . . . . 74.019999999999996 109.428 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.77 117.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 75.140000000000001 109.655 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -108.73 112.73 25.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.123 -0.695 . . . . 75.25 109.123 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 m -125.22 128.09 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.506 0.722 . . . . 72.019999999999996 110.338 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.65 148.9 42.25 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.611 0.764 . . . . 75.049999999999997 111.053 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 1.8 mpt? -126.17 150.36 48.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.707 0.803 . . . . 71.430000000000007 109.139 172.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -162.77 153.14 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.323 0.649 . . . . 73.019999999999996 110.455 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.5 ' HB3' ' HG1' ' A' ' 87' ' ' THR . 36.8 t70 -102.57 78.58 1.73 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.748 0.785 . . . . 63.43 109.456 177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t -125.15 168.14 13.83 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.779 -1.101 . . . . 71.329999999999998 110.984 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -65.05 147.47 98.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 C-N-CA 123.399 0.68 . . . . 74.140000000000001 112.174 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.7 -31.57 95.16 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.955 2.436 . . . . 55.450000000000003 113.411 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.94 -55.96 28.12 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.007 0.923 . . . . 72.409999999999997 111.604 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.7 m -74.48 -32.02 62.41 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.756 -0.657 . . . . 64.239999999999995 111.157 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -65.6 -41.53 92.69 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.085 0.554 . . . . 61.140000000000001 112.029 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -67.31 -31.35 71.58 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.648 0.379 . . . . 75.209999999999994 111.657 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.96 -42.62 94.44 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.652 -0.499 . . . . 73.329999999999998 109.652 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 117' ' ' THR . 92.8 mt -72.62 -25.33 61.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.374 0.67 . . . . 75.420000000000002 111.717 -176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 46.8 mt-10 -61.35 -38.18 86.01 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 118.14 0.427 . . . . 75.310000000000002 110.763 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 t -76.25 -51.43 12.06 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 112.694 0.627 . . . . 74.340000000000003 112.694 172.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.26 -55.02 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 112.863 0.69 . . . . 74.310000000000002 112.863 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.4 mt -77.5 -45.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.75 0.42 . . . . 72.329999999999998 110.522 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.45 -47.9 83.19 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 114.855 0.702 . . . . 71.420000000000002 114.855 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.99 -46.55 5.06 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.451 -1.029 . . . . 73.219999999999999 112.094 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.01 -19.58 71.96 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 114.94 0.736 . . . . 71.25 114.94 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.11 -53.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 117.88 0.84 . . . . 73.200000000000003 111.443 176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.6 m-30 -73.84 -54.62 7.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.333 0.494 . . . . 75.209999999999994 112.333 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.36 72.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.061 0.144 . . . . 74.010000000000005 110.968 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.75 -52.22 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.08 0.552 . . . . 75.510000000000005 111.754 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.26 -50.25 61.12 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 116.572 -0.285 . . . . 55.210000000000001 113.18 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.89 -41.65 99.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 74.329999999999998 112.716 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 92.8 m-20 -68.79 -41.5 78.64 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.2 -0.429 . . . . 74.430000000000007 110.438 178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.35 75.5 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.85 0.46 . . . . 73.530000000000001 111.876 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.479 HD21 HG13 ' A' ' 17' ' ' VAL . 7.8 tt -67.86 -41.33 83.05 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.217 0.607 . . . . 74.310000000000002 109.898 173.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.47 -27.73 62.48 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 112.353 0.501 . . . . 75.019999999999996 112.353 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 52.7 mt-10 -78.77 -37.89 39.97 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.184 0.994 . . . . 63.350000000000001 112.118 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 8.7 ptm180 -67.71 -34.07 76.14 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.348 0.259 . . . . 74.25 110.971 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -88.94 -16.94 30.57 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.95 0.5 . . . . 71.200000000000003 110.539 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.83 -2.04 75.06 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.878 -0.601 . . . . 52.310000000000002 113.252 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -50.07 -33.53 18.72 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.966 1.307 . . . . 74.530000000000001 110.413 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.43 151.72 29.52 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.543 1.137 . . . . 75.230000000000004 109.607 167.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 73.38 -64.05 0.41 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 125.618 1.567 . . . . 75.120000000000005 113.962 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -64.31 126.84 29.08 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.607 0.763 . . . . 73.340000000000003 112.905 -171.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -79.83 -23.2 42.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.973 0.509 . . . . 63.210000000000001 110.809 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 60.39 45.31 11.17 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.782 1.233 . . . . 74.109999999999999 109.763 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -146.7 101.97 3.51 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.806 -0.634 . . . . 74.129999999999995 111.334 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -112.3 -16.58 12.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.955 0.902 . . . . 75.519999999999996 110.892 169.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.949 . . . . 72.109999999999999 109.651 171.629 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.971 -0.381 . . . . 71.049999999999997 109.971 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.99 79.29 1.25 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.838 0.828 . . . . 73.340000000000003 110.876 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.8 m -128.62 116.67 19.96 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.184 0.994 . . . . 75.420000000000002 109.581 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 126' ' ' GLY . 8.3 mp -108.76 109.49 20.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.931 1.292 . . . . 70.5 109.539 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -129.48 135.2 48.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 74.019999999999996 112.214 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.56 156.08 49.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.736 1.214 . . . . 75.219999999999999 110.648 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -143.84 154.2 43.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.205 1.002 . . . . 74.319999999999993 109.321 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.8 p -150.09 147.54 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 111.591 0.219 . . . . 75.150000000000006 111.591 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.27 118.5 26.74 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.196 0.598 . . . . 75.109999999999999 110.546 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.0 121.05 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.671 1.188 . . . . 71.540000000000006 110.131 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.25 72.94 3.83 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.147 0.579 . . . . 52.5 111.044 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.02 155.76 2.42 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.646 0.778 . . . . 71.219999999999999 111.134 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -63.0 138.29 67.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.704 2.269 . . . . 75.219999999999999 111.86 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -25.13 11.16 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.165 0.802 . . . . 72.049999999999997 113.165 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.42 47.96 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.711 0.634 . . . . 73.120000000000005 112.711 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.54 -40.07 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.246 0.618 . . . . 73.219999999999999 111.636 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 137' ' ' LEU . 21.6 t -74.5 -34.86 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.524 0.73 . . . . 64.400000000000006 111.125 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 -70.1 -27.76 64.85 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.345 0.658 . . . . 71.299999999999997 111.419 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 m -63.76 -29.14 70.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.389 0.614 . . . . 74.430000000000007 111.147 170.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.61 HD22 ' HB3' ' A' ' 30' ' ' TRP . 57.5 tp -86.07 -56.72 3.33 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.505 1.122 . . . . 62.329999999999998 111.924 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.56 -25.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 123.099 0.56 . . . . 72.439999999999998 112.501 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.13 0.61 62.53 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 114.408 0.523 . . . . 71.200000000000003 114.408 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.09 163.59 12.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.125 0.97 . . . . 73.439999999999998 109.206 165.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.09 -44.26 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.794 -0.566 . . . . 74.310000000000002 110.551 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.7 p -77.61 -20.26 54.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.192 0.441 . . . . 71.120000000000005 112.192 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.12 5.79 9.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.181 0.592 . . . . 71.140000000000001 112.549 -170.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG12 HG23 ' A' ' 34' ' ' VAL . 19.1 tt -68.15 -27.31 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.305 0.642 . . . . 75.230000000000004 112.565 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -66.31 -15.89 63.6 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.365 0.505 . . . . 73.439999999999998 112.365 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -80.79 -38.33 28.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.757 0.823 . . . . 74.439999999999998 112.595 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.61 ' HB3' HD22 ' A' ' 20' ' ' LEU . 54.5 p-90 -108.81 -36.37 6.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 122.084 -0.385 . . . . 70.140000000000001 111.679 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -89.89 110.56 40.71 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.107 0.563 . . . . 73.109999999999999 109.619 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.06 -21.57 42.75 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.134 2.556 . . . . 75.439999999999998 114.318 -170.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.471 HE22 ' HA ' ' A' ' 129' ' ' VAL . 35.3 mt-30 -87.45 -16.76 33.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 74.239999999999995 112.838 -173.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.533 HG23 HG12 ' A' ' 27' ' ' ILE . 76.4 t -61.62 127.28 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 122.967 0.507 . . . . 74.310000000000002 111.768 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -90.23 27.41 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.34 1.056 . . . . 74.329999999999998 112.384 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.46 101.61 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 124.437 1.095 . . . . 74.230000000000004 111.381 -172.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.46 177.51 4.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.863 2.375 . . . . 73.329999999999998 114.707 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 m -123.84 141.85 51.65 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.098 0.959 . . . . 72.409999999999997 110.731 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 126.25 40.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.299 0.64 . . . . 74.040000000000006 111.298 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.662 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 34.0 mmt180 -103.97 123.78 47.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.659 . . . . 75.310000000000002 110.1 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.55 -177.77 0.01 OUTLIER Glycine 0 CA--C 1.549 2.177 0 N-CA-C 118.199 2.039 . . . . 72.219999999999999 118.199 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.86 -106.23 0.26 Allowed 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.428 1.491 . . . . 50.240000000000002 113.687 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 49' ' ' ALA . 40.4 t 179.01 147.34 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.454 1.102 . . . . 71.209999999999994 109.384 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.37 -20.9 21.55 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.301 2.667 . . . . 72.030000000000001 114.894 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.6 3.06 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.182 0.593 . . . . 73.25 112.547 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.4 m -102.38 118.92 57.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.729 0.812 . . . . 71.019999999999996 110.765 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 80.1 Cg_exo -50.38 102.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.52 2.813 . . . . 74.230000000000004 113.261 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -31.66 1.14 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.039 -0.528 . . . . 63.310000000000002 113.704 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.482 ' HB3' ' H ' ' A' ' 43' ' ' SER . . . -65.48 144.44 57.03 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.563 0.579 . . . . 54.149999999999999 112.563 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.662 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 46.7 mt-10 -110.92 146.67 36.14 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.33 0.652 . . . . 75.319999999999993 111.767 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -118.68 106.59 12.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.564 0.746 . . . . 71.230000000000004 110.786 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.34 102.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.905 0.882 . . . . 75.439999999999998 110.84 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.71 93.79 2.14 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.658 0.783 . . . . 74.030000000000001 112.505 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 60.43 1.87 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.296 -0.321 . . . . 51.119999999999997 112.296 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 107.63 1.44 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.645 0.778 . . . . 65.109999999999999 112.905 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 24.83 7.44 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 114.159 0.423 . . . . 64.430000000000007 114.159 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -96.52 -77.03 0.49 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.291 0.636 . . . . 75.340000000000003 110.669 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 163.11 -35.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.821 1.649 . . . . 74.310000000000002 108.491 -171.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -103.7 17.31 24.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.189 -0.914 . . . . 74.439999999999998 112.581 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 136.58 47.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.414 0.626 . . . . 73.099999999999994 112.38 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.561 HD13 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -101.69 118.93 37.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.606 0.762 . . . . 72.420000000000002 109.196 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.532 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 53.7 t -97.2 113.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.476 -0.564 . . . . 75.109999999999999 109.476 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.644 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 59.3 mt-10 -108.29 169.62 8.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.322 1.049 . . . . 74.420000000000002 110.059 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -150.43 121.43 7.68 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.114 0.566 . . . . 74.420000000000002 110.373 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.04 121.59 19.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.128 0.971 . . . . 75.200000000000003 111.887 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 82.9 t -90.99 -48.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.53 0.732 . . . . 74.200000000000003 111.594 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -166.72 152.75 8.33 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.556 0.343 . . . . 73.450000000000003 111.781 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.488 HH12 HD22 ' A' ' 75' ' ' LEU . 93.2 mtt-85 -134.9 119.7 18.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.719 0.808 . . . . 75.230000000000004 111.141 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.0 m-20 -95.91 99.74 11.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.453 1.101 . . . . 75.540000000000006 109.62 172.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.81 -57.87 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.126 0.57 . . . . 74.209999999999994 111.821 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.8 t -70.44 -36.69 74.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.15 0.58 . . . . 75.230000000000004 111.784 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -79.53 -7.6 58.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.267 0.627 . . . . 72.109999999999999 112.147 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 58.21 43.64 20.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.761 1.224 . . . . 75.420000000000002 112.297 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.2 ttp180 -124.66 143.72 50.58 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.227 1.011 . . . . 70.420000000000002 110.209 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.488 HD22 HH12 ' A' ' 68' ' ' ARG . 10.0 tp -130.39 125.87 35.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 74.230000000000004 109.233 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.14 130.28 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.685 0.794 . . . . 71.040000000000006 110.873 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -152.28 177.29 10.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.696 0.798 . . . . 74.430000000000007 110.706 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.7 t -154.97 150.66 27.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.684 0.794 . . . . 54.420000000000002 110.33 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.644 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 15.4 ptt? -98.65 106.2 35.31 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 122.579 0.351 . . . . 62.25 111.57 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.89 -25.8 44.91 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.356 2.704 . . . . 72.140000000000001 112.673 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 10.0 m-20 -123.71 80.1 55.69 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.412 0.685 . . . . 60.009999999999998 110.819 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.88 137.49 3.97 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.788 2.325 . . . . 74.310000000000002 112.511 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.37 -14.29 37.07 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.143 1.896 . . . . 74.099999999999994 112.118 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -76.53 147.51 78.77 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.575 1.15 . . . . 74.450000000000003 110.787 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.04 39.37 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.341 2.694 . . . . 71.25 114.094 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -103.28 152.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.063 0.945 . . . . 70.200000000000003 111.133 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -89.14 -86.24 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.522 0.329 . . . . 74.400000000000006 111.353 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -98.01 108.66 21.41 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.196 0.522 . . . . 74.319999999999993 110.881 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' HE1' ' HB3' ' A' ' 91' ' ' ALA . 39.1 t-80 -95.08 155.57 16.68 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.295 0.569 . . . . 73.450000000000003 111.963 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 16.1 tpt180 -145.83 122.69 11.29 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.564 1.146 . . . . 75.340000000000003 108.705 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.493 ' HB3' ' HE1' ' A' ' 89' ' ' HIS . . . -126.24 126.6 44.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.654 0.661 . . . . 71.409999999999997 111.432 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 75.1 t -130.24 129.58 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.377 0.671 . . . . 75.540000000000006 112.595 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.24 132.09 46.92 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.364 1.066 . . . . 73.310000000000002 108.586 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -143.94 112.57 6.55 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.28 0.945 . . . . 75.25 111.658 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.642 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 26.9 m -95.74 111.25 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 121.966 0.889 . . . . 65.239999999999995 110.533 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 104' ' ' THR . 6.6 m -103.58 116.7 61.51 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.834 0.853 . . . . 72.430000000000007 110.322 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.01 109.49 2.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.235 . . . . 75.209999999999994 113.269 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -66.3 -30.89 71.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.794 0.838 . . . . 73.450000000000003 110.719 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.0 t70 -158.54 174.04 15.69 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 125.199 1.399 . . . . 64.519999999999996 108.517 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.76 -37.65 66.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.555 0.742 . . . . 64.129999999999995 112.365 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -123.75 28.45 6.9 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.037 0.923 . . . . 74.219999999999999 111.564 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 62.1 m80 -138.03 130.44 29.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 72.409999999999997 109.488 171.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.642 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 46.9 t -130.89 162.83 28.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.858 0.863 . . . . 74.5 111.125 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.496 ' HB ' HG22 ' A' ' 96' ' ' VAL . 86.8 m -133.96 115.35 14.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.405 0.682 . . . . 74.340000000000003 110.042 174.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG23 HG11 ' A' ' 95' ' ' VAL . 15.2 t -90.35 114.61 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.625 -0.509 . . . . 71.340000000000003 109.625 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.81 110.91 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.899 0.88 . . . . 74.420000000000002 109.285 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.54 122.97 48.6 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.247 -0.649 . . . . 74.329999999999998 109.247 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.523 HG22 ' SD ' ' A' ' 110' ' ' MET . 21.4 m -129.86 135.98 49.01 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.41 0.684 . . . . 73.049999999999997 110.964 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.4 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.7 116.01 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.657 0.783 . . . . 73.209999999999994 112.041 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.57 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 3.1 mpp? -103.06 134.03 47.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.441 1.097 . . . . 74.319999999999993 109.121 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -157.62 143.56 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 120.731 0.3 . . . . 75.549999999999997 111.526 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.11 82.63 5.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.849 0.833 . . . . 75.310000000000002 109.434 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.575 ' HB2' HG21 ' A' ' 86' ' ' ILE . 41.1 t -110.97 160.54 16.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.414 -1.266 . . . . 73.109999999999999 111.444 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -64.84 134.88 96.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.655 0.782 . . . . 71.439999999999998 110.152 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.66 -42.82 64.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.544 2.829 . . . . 73.540000000000006 115.109 -167.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.57 -37.94 89.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.969 0.414 . . . . 63.299999999999997 111.903 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 33.6 m -74.41 -33.25 62.95 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 122.971 0.508 . . . . 73.530000000000001 110.773 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.74 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.873 0.869 . . . . 42.240000000000002 111.89 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -28.14 67.28 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.081 0.952 . . . . 75.230000000000004 112.149 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.98 -46.35 65.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.944 -0.391 . . . . 61.219999999999999 109.944 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.45 -22.68 61.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.334 0.654 . . . . 74.450000000000003 110.922 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -56.5 -46.47 80.48 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.27 1.028 . . . . 75.420000000000002 110.501 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 m -71.36 -50.01 36.5 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.481 -0.781 . . . . 74.420000000000002 112.683 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.93 -56.5 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 123.383 0.673 . . . . 73.040000000000006 112.404 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.27 -54.29 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.878 0.871 . . . . 74.549999999999997 110.624 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' N ' HD23 ' A' ' 4' ' ' LEU . . . -63.94 -33.8 88.23 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 115.655 1.022 . . . . 71.329999999999998 115.655 -172.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -117.07 -43.08 2.88 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.39 1.095 . . . . 71.510000000000005 111.744 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.72 -33.84 71.74 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.179 -0.464 . . . . 33.0 113.927 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.471 ' HA ' HE22 ' A' ' 33' ' ' GLN . 96.6 t -95.93 -56.28 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.069 0.548 . . . . 75.409999999999997 110.869 174.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.0 m-30 -70.63 -64.16 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.132 0.573 . . . . 75.120000000000005 112.483 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.73 71.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.287 0.367 . . . . 71.510000000000005 111.601 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 t -59.78 -54.32 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 C-N-CA 123.902 0.881 . . . . 64.430000000000007 112.277 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.45 -37.74 95.28 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.403 -0.362 . . . . 72.439999999999998 113.505 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.7 mt -70.93 -36.68 72.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.856 0.862 . . . . 72.129999999999995 111.972 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -68.77 -40.07 79.92 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.639 0.375 . . . . 51.329999999999998 110.694 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.65 91.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.076 0.55 . . . . 64.420000000000002 111.625 175.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 17' ' ' VAL . 9.0 tt -63.91 -43.0 97.24 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.475 0.71 . . . . 74.200000000000003 110.335 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.41 73.94 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.057 -0.52 . . . . 61.43 111.799 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.03 -40.08 54.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.439 0.696 . . . . 74.040000000000006 112.819 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -67.34 -29.58 69.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.21 0.448 . . . . 75.140000000000001 112.21 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -89.87 -29.18 18.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.203 -0.311 . . . . 74.519999999999996 111.366 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 63.49 4.47 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.24 -0.436 . . . . 72.200000000000003 112.669 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -70.88 -4.57 25.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.137 0.975 . . . . 74.549999999999997 112.907 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.7 mt 68.25 121.16 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.725 1.21 . . . . 75.120000000000005 112.234 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.64 -16.37 62.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.82 0.848 . . . . 70.329999999999998 112.576 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -126.87 123.23 36.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.571 0.749 . . . . 75.25 110.069 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -67.66 115.99 7.87 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.277 0.631 . . . . 72.200000000000003 110.787 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -146.63 168.04 22.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.729 0.812 . . . . 72.150000000000006 110.286 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -156.62 142.14 17.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.37 0.668 . . . . 71.420000000000002 111.143 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -154.29 114.99 3.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.646 0.778 . . . . 74.450000000000003 110.073 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.399 0.618 . . . . 75.409999999999997 111.382 177.257 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.927 0.394 . . . . 54.03 111.09 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -103.97 109.13 20.78 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.415 1.086 . . . . 73.21 109.793 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.39 140.64 29.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.782 0.833 . . . . 71.24 109.793 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -146.24 123.21 11.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.154 0.582 . . . . 74.4 109.867 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 130' ' ' PHE . 45.4 mtp85 -128.75 150.34 50.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 73.53 110.097 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -139.49 145.02 38.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.684 0.794 . . . . 54.15 110.519 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.7 p -136.23 144.91 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 122.558 0.343 . . . . 51.31 111.323 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.25 109.19 20.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.658 0.783 . . . . 71.31 110.489 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 70.9 t -101.19 127.17 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.984 0.914 . . . . 73.12 110.407 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 65.59 4.73 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.431 0.692 . . . . 74.21 111.491 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.0 155.13 3.62 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 124.002 0.921 . . . . 70.12 111.225 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.13 139.12 85.01 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.082 2.521 . . . . 70.31 113.865 167.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.47 64.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.258 1.577 . . . . 74.4 115.258 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.16 98.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.4 0.68 . . . . 62.24 112.426 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.22 -36.16 77.06 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.748 0.819 . . . . 72.54 112.34 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.471 HG21 ' SG ' ' A' ' 103' ' ' CYS . 41.3 t -73.57 -35.7 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.103 0.561 . . . . 65.11 111.345 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.62 -34.34 78.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.627 0.371 . . . . 74.35 111.309 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -58.84 -23.94 61.36 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.708 0.803 . . . . 65.22 111.604 171.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.8 tp -95.04 -58.47 2.14 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.067 0.947 . . . . 73.35 112.866 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.03 -34.14 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 123.607 0.763 . . . . 70.41 112.996 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.66 -45.27 94.95 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 115.216 0.846 . . . . 63.35 115.216 -166.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.78 -31.21 1.93 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.305 1.594 . . . . 71.25 115.305 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.4 t80 73.88 -59.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.03 1.332 . . . . 72.1 111.254 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -59.62 -38.16 80.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.926 0.89 . . . . 70.14 112.54 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.576 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -99.58 27.21 5.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.631 0.772 . . . . 75.51 111.598 -166.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 HG11 ' A' ' 34' ' ' VAL . 19.0 tt -62.72 -22.98 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.286 1.034 . . . . 72.5 112.382 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -68.84 -3.73 13.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.163 0.801 . . . . 74.24 113.163 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 48.0 mtp180 -76.61 -24.37 53.41 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.826 0.85 . . . . 73.24 112.445 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -129.6 -37.56 1.57 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.255 0.835 . . . . 75.41 113.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.588 ' CD2' HG23 ' A' ' 34' ' ' VAL . 6.7 t60 -90.06 108.52 26.62 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.965 0.506 . . . . 73.31 109.798 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.41 -23.59 32.21 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.154 2.57 . . . . 74.13 114.708 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -80.82 -15.65 55.81 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.989 0.516 . . . . 63.23 112.068 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 53' ' ' PHE . 94.8 t -68.27 106.72 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.11 0.481 . . . . 72.12 111.37 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -89.11 54.92 3.13 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.491 0.716 . . . . 53.42 110.681 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.09 105.17 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 125.449 1.499 . . . . 72.03 113.429 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 64.4 Cg_endo -90.35 148.76 4.42 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.861 2.374 . . . . 60.41 113.149 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -101.02 115.14 29.77 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.127 0.571 . . . . 72.4 110.111 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.8 tm? -89.37 112.32 23.4 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 109.096 -0.705 . . . . 72.52 109.096 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -102.48 123.09 45.6 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.918 0.887 . . . . 70.04 110.856 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.32 -178.6 0.01 OUTLIER Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.716 2.247 . . . . 62.41 118.716 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 70.11 -31.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.86 1.8 . . . . 72.41 115.86 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m 83.13 137.64 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 126.202 1.801 . . . . 74.23 111.009 -167.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.14 -14.31 40.35 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.243 2.629 . . . . 73.51 115.244 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -92.21 -14.31 29.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.977 0.511 . . . . 74.21 111.541 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.3 m -95.55 123.98 54.53 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.006 0.922 . . . . 73.1 110.905 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.6 Cg_exo -48.5 98.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.735 2.957 . . . . 64.3 114.254 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.68 -39.19 0.47 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 113.922 0.329 . . . . 50.54 113.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.65 139.08 45.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.595 1.331 . . . . 43.24 114.595 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 4.2 mp0 -103.35 149.23 24.96 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.089 0.555 . . . . 72.33 110.857 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 34.4 ptt180 -127.04 119.78 27.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.48 0.582 . . . . 72.22 110.575 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.24 102.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.647 0.779 . . . . 64.14 110.795 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.624 ' HE2' HG22 ' A' ' 34' ' ' VAL . 6.0 m-85 -64.0 123.03 17.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.438 1.095 . . . . 73.24 111.354 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.06 -66.27 3.89 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-O 120.143 -0.254 . . . . 73.4 112.783 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.61 35.06 20.05 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.415 1.086 . . . . 74.51 113.456 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.82 37.78 0.05 OUTLIER Glycine 0 N--CA 1.476 1.301 0 CA-C-N 115.781 -0.645 . . . . 45.43 112.198 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -147.16 162.42 38.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.338 1.055 . . . . 74.24 110.901 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.57 -23.39 65.4 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.379 0.672 . . . . 64.52 112.496 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -122.06 90.22 3.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.011 0.524 . . . . 72.21 111.355 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.34 171.15 7.49 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.457 0.646 . . . . 63.05 111.321 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -136.72 114.15 10.91 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.661 0.784 . . . . 74.12 109.17 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 44.0 t -99.23 113.79 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.524 -0.546 . . . . 73.22 109.524 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 58.0 mt-10 -107.21 167.22 10.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.431 1.093 . . . . 60.41 110.627 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -151.07 125.23 9.32 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 52.22 110.548 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 39.5 tp -69.09 116.36 9.44 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.87 1.268 . . . . 64.33 111.245 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -82.19 -51.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 122.924 0.49 . . . . 64.34 110.98 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.5 pt-20 -156.4 152.67 27.8 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.485 0.714 . . . . 73.21 110.032 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -142.48 131.72 23.41 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.264 0.554 . . . . 74.3 111.715 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.8 m-20 -119.09 102.58 8.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.913 1.285 . . . . 71.03 110.068 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.69 -52.73 55.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.866 0.866 . . . . 72.35 112.124 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -71.49 -33.42 69.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.102 0.561 . . . . 75.15 112.182 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -83.29 -10.36 58.56 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 112.75 0.648 . . . . 64.12 112.75 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 61.16 34.37 18.96 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.927 0.891 . . . . 74.43 111.65 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -119.06 112.23 19.29 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.877 0.871 . . . . 70.14 110.432 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -118.34 108.66 15.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.478 1.111 . . . . 74.44 111.631 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.8 t -108.48 127.78 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.693 -0.629 . . . . 55.21 111.685 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -135.89 -179.26 5.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.817 0.847 . . . . 63.25 111.203 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -146.01 164.29 32.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.608 1.163 . . . . 73.12 109.839 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 61' ' ' LEU . 73.6 mtm -103.52 97.07 9.67 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 122.988 0.515 . . . . 73.31 110.013 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.07 -13.42 31.36 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.155 2.57 . . . . 55.42 112.96 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 14.6 t70 -140.57 79.36 20.17 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 109.022 -0.733 . . . . 71.53 109.022 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -90.2 136.69 2.46 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.208 2.605 . . . . 71.32 113.747 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.54 -10.9 20.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.368 2.046 . . . . 65.02 113.231 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -94.02 131.53 31.5 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.713 0.805 . . . . 74.34 110.239 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.528 ' HG2' HG21 ' A' ' 117' ' ' THR . 37.5 Cg_endo -63.92 88.86 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.973 2.448 . . . . 62.4 113.465 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.0 pt -134.87 165.19 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 124.998 1.319 . . . . 75.22 109.762 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.0 m -100.75 -76.9 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.898 0.479 . . . . 72.53 110.947 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.77 110.32 22.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.013 0.435 . . . . 64.54 111.073 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -89.21 147.26 24.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.03 0.532 . . . . 73.23 111.165 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -153.28 125.57 8.05 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.219 1.008 . . . . 63.25 108.869 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.61 146.86 44.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.725 0.693 . . . . 71.03 112.056 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.92 145.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.796 0.838 . . . . 75.14 110.955 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 108.78 15.9 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.572 1.149 . . . . 63.02 108.062 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.99 112.71 17.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.682 0.393 . . . . 73.24 110.533 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 HG22 ' A' ' 105' ' ' VAL . 21.6 t -90.54 108.12 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.819 -0.808 . . . . 25.52 108.819 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.6 t -99.39 108.92 52.87 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.398 1.079 . . . . 73.33 110.153 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.94 124.79 11.35 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.102 1.868 . . . . 35.32 113.018 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -93.81 -56.46 2.88 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.375 -0.972 . . . . 64.3 108.375 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -118.75 -169.35 1.71 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.724 1.209 . . . . 73.0 110.068 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.52 -27.25 46.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.131 0.572 . . . . 73.04 111.475 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -109.56 2.03 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.839 0.856 . . . . 75.01 112.634 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -136.93 125.24 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.873 0.469 . . . . 72.04 109.771 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.6 p -137.29 132.82 34.25 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.023 0.44 . . . . 62.22 110.657 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.2 m -91.66 109.82 21.14 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.931 -0.577 . . . . 64.41 110.828 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.622 HG22 HG13 ' A' ' 95' ' ' VAL . 27.1 t -88.34 111.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.585 -0.524 . . . . 73.14 109.585 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.09 114.75 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.562 0.745 . . . . 74.34 110.667 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -103.84 118.69 37.28 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.439 0.696 . . . . 72.45 109.178 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.5 m -112.47 139.48 48.02 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.359 1.064 . . . . 62.0 109.817 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.61 108.89 4.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.214 0.605 . . . . 45.14 111.505 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.36 135.4 54.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.308 1.043 . . . . 72.11 110.375 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.28 145.07 26.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.624 0.77 . . . . 65.43 111.274 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.42 79.6 9.51 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.849 0.833 . . . . 60.11 109.914 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.663 ' HB2' HG22 ' A' ' 86' ' ' ILE . 49.1 t -108.94 164.58 12.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.734 -1.121 . . . . 64.11 111.317 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.5 t -83.01 137.57 43.19 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.574 -0.727 . . . . 63.05 110.169 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -44.56 -49.05 9.61 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 124.617 3.545 . . . . 50.11 116.165 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.78 -32.17 73.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.836 0.68 . . . . 72.1 112.836 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.528 HG21 ' HG2' ' A' ' 85' ' ' PRO . 55.0 m -82.79 -33.51 27.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.825 0.45 . . . . 74.1 110.857 174.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.48 86.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.483 0.713 . . . . 72.52 111.76 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.18 -36.47 79.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.181 0.593 . . . . 54.31 111.88 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.32 -42.04 79.95 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.1 110.79 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.94 -24.49 64.28 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 71.14 112.016 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.59 -41.63 97.7 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.851 0.461 . . . . 62.2 111.826 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -76.94 -45.54 27.38 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.021 0.748 . . . . 72.3 113.021 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.6 -54.74 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 112.535 0.569 . . . . 44.44 112.535 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.95 -49.05 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.297 0.639 . . . . 72.13 110.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.03 -79.39 0.43 Allowed Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.251 -0.431 . . . . 61.33 113.592 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.59 -7.41 26.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.496 0.924 . . . . 65.01 113.496 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.23 -83.51 1.72 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 112.098 -0.401 . . . . 43.42 112.098 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.2 t -58.2 -46.66 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.048 0.939 . . . . 65.05 113.331 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.439 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 4.4 m-30 -77.57 -49.39 14.73 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.847 0.459 . . . . 65.31 111.21 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.55 -17.14 59.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.07 0.767 . . . . 73.23 113.07 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -85.2 -55.46 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 122.843 0.457 . . . . 74.12 111.376 166.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.72 -53.62 36.87 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 114.518 0.567 . . . . 62.23 114.518 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.86 -41.6 78.24 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.323 1.049 . . . . 60.01 112.138 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.31 -39.4 62.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.349 -0.842 . . . . 72.51 111.953 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.41 75.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.408 0.683 . . . . 73.02 111.0 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.421 HD21 HG13 ' A' ' 17' ' ' VAL . 9.7 tt -65.63 -43.27 90.0 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.785 0.834 . . . . 53.41 110.585 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.37 68.88 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 122.884 0.474 . . . . 71.43 111.839 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.11 -39.94 60.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.95 0.9 . . . . 61.02 112.512 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -73.83 -22.99 59.58 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.723 0.638 . . . . 72.04 112.723 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -90.09 -2.5 58.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.076 -0.39 . . . . 72.45 111.242 168.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-N 116.285 -0.416 . . . . 34.41 114.031 173.337 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 121.991 0.901 . . . . 63.52 110.306 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -142.39 131.18 22.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.06 -0.973 . . . . 64.34 110.746 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.53 121.08 44.39 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.033 1.333 . . . . 61.24 109.133 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -120.35 120.53 36.28 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.248 0.547 . . . . 73.14 110.111 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.43 147.29 46.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.542 1.137 . . . . 74.2 109.616 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.6 p -151.0 150.47 30.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.314 0.646 . . . . 50.14 111.018 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.3 p -146.82 138.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.175 0.59 . . . . 73.3 111.645 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.53 108.9 19.26 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.289 0.566 . . . . 72.25 110.036 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -101.62 131.36 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.71 1.204 . . . . 54.14 110.303 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.34 73.95 3.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.875 0.47 . . . . 75.23 111.133 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 155.81 7.51 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.393 0.677 . . . . 74.2 111.481 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.74 138.55 38.15 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.901 2.4 . . . . 73.22 111.905 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.35 -32.32 48.61 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.95 1.093 . . . . 51.13 113.95 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -50.26 66.81 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.952 0.501 . . . . 65.14 111.885 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.24 -39.23 82.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.467 0.707 . . . . 70.03 112.595 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 21.5 t -70.95 -34.37 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.491 0.316 . . . . 72.41 110.654 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.734 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 69.4 t-105 -67.31 -28.94 68.41 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.834 0.454 . . . . 71.25 111.316 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -64.17 -21.24 66.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.124 0.57 . . . . 73.44 111.579 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 tp -90.32 -43.13 10.55 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 124.465 1.106 . . . . 71.42 112.916 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -107.13 13.72 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 113.778 1.029 . . . . 70.32 113.778 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.06 -17.22 75.02 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 114.169 0.428 . . . . 75.45 114.169 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.9 m-20 -102.78 137.88 40.41 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.359 0.664 . . . . 73.4 110.307 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.67 -23.79 67.52 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.96 0.904 . . . . 72.24 111.008 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.7 p -89.21 -22.37 22.8 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.823 0.849 . . . . 55.24 112.803 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -81.92 4.17 23.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.159 0.429 . . . . 21.12 112.159 -166.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.664 HG23 HG11 ' A' ' 34' ' ' VAL . 19.4 tt -66.91 -25.29 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.131 0.572 . . . . 74.15 111.761 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -74.71 -7.06 52.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 122.08 -0.387 . . . . 75.41 111.987 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.77 -31.9 25.68 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.127 0.571 . . . . 51.34 111.752 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.7 p-90 -118.48 -29.05 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.673 0.62 . . . . 75.22 112.673 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 38.8 t-80 -94.16 107.62 30.02 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 109.741 -0.466 . . . . 72.41 109.741 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.05 -7.24 20.98 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.916 2.41 . . . . 72.24 114.96 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -87.63 -28.6 21.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.693 0.397 . . . . 74.53 111.269 172.228 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.664 HG11 HG23 ' A' ' 27' ' ' ILE . 46.4 t -80.97 107.45 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 109.902 -0.407 . . . . 73.13 109.902 174.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -72.75 -71.37 0.3 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.976 0.51 . . . . 61.23 110.951 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.62 104.38 0.46 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 123.986 0.915 . . . . 51.01 110.399 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 58.9 Cg_endo -84.97 166.6 11.27 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.985 2.457 . . . . 64.53 114.343 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -100.93 114.9 29.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.673 1.189 . . . . 71.34 110.122 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 4.2 mm? -90.85 134.73 34.22 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.727 0.411 . . . . 74.42 111.419 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -108.95 121.32 44.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.526 0.73 . . . . 73.22 111.322 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.02 -169.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 117.837 1.895 . . . . 65.13 117.837 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 56.63 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.635 1.174 . . . . 74.34 113.714 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.3 t 168.4 148.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 125.591 1.557 . . . . 63.55 108.766 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.17 -14.08 31.8 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.476 2.117 . . . . 64.02 112.792 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -95.82 -20.5 18.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.172 0.989 . . . . 64.25 112.789 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.8 m -99.78 123.37 47.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 122.692 0.397 . . . . 74.3 111.568 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.3 Cg_endo -57.16 126.9 23.6 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.056 2.504 . . . . 70.11 113.325 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.62 -24.75 4.58 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.918 -0.583 . . . . 43.41 112.331 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 138.75 55.67 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.155 0.582 . . . . 71.03 111.597 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 39.9 mt-10 -113.22 134.35 54.63 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.492 0.717 . . . . 44.42 110.603 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 25.1 ptt180 -108.41 118.98 38.2 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.301 0.572 . . . . 75.15 110.164 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 62' ' ' VAL . 42.3 t -116.5 114.28 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.424 0.69 . . . . 73.44 110.611 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.625 ' HB2' ' H ' ' A' ' 61' ' ' LEU . 1.7 m-85 -71.77 90.83 1.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.919 0.887 . . . . 75.14 111.897 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.26 3.72 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 119.941 -0.366 . . . . 73.32 113.251 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.89 96.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.743 1.217 . . . . 62.42 112.195 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.49 4.65 Favored Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.112 -0.367 . . . . 62.12 113.855 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.7 p -104.59 -81.63 0.52 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.611 0.764 . . . . 70.52 110.793 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.014 0.926 . . . . 70.42 110.367 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -132.36 39.23 3.4 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.136 0.97 . . . . 75.2 109.572 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 122.56 16.09 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.112 -0.949 . . . . 70.03 111.291 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.625 ' H ' ' HB2' ' A' ' 53' ' ' PHE . 57.7 tp -97.23 116.87 30.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.573 0.749 . . . . 71.12 110.611 -174.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 52' ' ' VAL . 48.6 t -98.55 114.92 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.7 -0.481 . . . . 74.04 109.7 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 79' ' ' MET . 41.7 mt-10 -118.24 164.06 15.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.219 1.008 . . . . 73.02 110.392 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -148.3 130.38 15.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.575 0.75 . . . . 64.33 110.944 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 28.7 tp -73.3 112.1 9.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.115 0.966 . . . . 63.32 110.817 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.14 -47.91 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.439 0.695 . . . . 65.31 110.84 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.324 1.05 . . . . 73.24 109.535 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -139.91 108.67 5.95 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.68 -0.638 . . . . 74.31 109.856 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 3.2 m-20 -91.3 71.26 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.708 0.803 . . . . 71.23 109.934 -175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 44.1 tt0 -63.73 -31.96 73.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.019 -0.537 . . . . 74.54 111.631 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -66.8 -14.66 62.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.8 0.84 . . . . 71.41 112.568 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.22 4.99 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.769 0.828 . . . . 54.01 112.604 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 97' ' ' PRO . 77.8 mtt180 55.89 60.46 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.264 1.025 . . . . 53.13 112.46 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 42.5 ttm180 -143.0 147.33 34.95 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.195 0.998 . . . . 62.1 110.357 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.8 tp -137.49 108.45 6.72 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.366 1.066 . . . . 75.34 110.181 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.22 127.57 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.604 0.762 . . . . 71.44 111.1 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.2 177.69 10.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.045 0.538 . . . . 74.34 112.319 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -142.92 157.6 44.42 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.092 0.957 . . . . 75.24 110.781 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.63 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 18.0 ptt? -111.53 98.49 40.78 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 117.993 0.36 . . . . 73.32 110.231 163.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.47 -22.41 74.01 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.258 2.639 . . . . 52.41 112.726 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 3.9 m-20 -118.33 83.61 21.06 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.692 0.797 . . . . 73.42 109.909 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.74 144.51 3.02 Favored 'Trans proline' 0 CA--C 1.566 2.075 0 C-N-CA 122.806 2.337 . . . . 73.31 113.14 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.6 4.58 6.55 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.648 2.232 . . . . 62.2 112.921 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -105.36 153.64 39.55 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 124.061 0.945 . . . . 64.5 111.201 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.15 71.61 3.56 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.185 2.59 . . . . 73.42 113.12 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 113' ' ' CYS . 21.4 pt -139.61 153.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.247 1.019 . . . . 73.14 110.65 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 15.9 m -95.36 -91.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.27 -0.395 . . . . 53.44 110.887 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -85.42 121.83 28.69 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-N 119.19 0.905 . . . . 74.23 109.654 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.43 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 52.7 t-80 -109.06 121.16 44.56 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.075 0.55 . . . . 74.43 111.875 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 146.53 28.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.296 1.038 . . . . 65.44 109.179 167.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.79 132.37 19.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.867 0.867 . . . . 73.53 109.747 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.2 p -133.82 129.9 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.159 0.584 . . . . 52.24 112.194 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.44 123.72 48.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.247 1.419 . . . . 75.13 108.618 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.05 149.25 50.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.13 0.572 . . . . 72.24 110.503 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 13.6 m -125.56 109.78 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.86 0.838 . . . . 65.14 109.419 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 125.59 76.34 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.024 0.929 . . . . 61.32 110.504 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG3' HH11 ' A' ' 73' ' ' ARG . 12.8 Cg_exo -70.78 72.65 1.93 Allowed 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.722 2.281 . . . . 72.1 111.912 170.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -71.31 -35.19 71.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.733 0.813 . . . . 52.42 110.006 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 27.3 t70 -163.78 163.08 24.11 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.173 1.389 . . . . 74.21 108.655 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.81 -8.42 52.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.735 -0.603 . . . . 64.23 112.21 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -126.0 -2.86 7.07 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.489 1.116 . . . . 65.35 111.935 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 39.6 m170 -135.97 127.6 28.92 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.463 0.705 . . . . 73.43 110.453 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.531 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 39.7 t -129.88 134.22 47.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.526 0.73 . . . . 45.02 110.404 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 90.1 m -98.24 111.63 23.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.283 -0.266 . . . . 71.34 110.283 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 95' ' ' VAL . 34.3 t -86.73 106.11 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.063 -0.717 . . . . 70.32 109.063 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.11 117.42 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.536 0.735 . . . . 71.23 110.189 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -118.82 121.42 39.99 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.166 -0.679 . . . . 63.45 109.166 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.576 HG22 ' SD ' ' A' ' 110' ' ' MET . 56.4 m -129.98 130.18 44.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.238 0.615 . . . . 62.53 110.791 -172.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.28 115.78 24.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 64.33 110.915 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 108' ' ' THR . 3.5 mpp? -99.28 140.57 33.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.437 -0.949 . . . . 74.41 108.437 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.19 151.66 23.35 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.022 0.749 . . . . 64.21 113.022 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 20.2 t70 -83.7 85.29 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.146 -0.934 . . . . 72.42 109.42 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.744 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.7 t -128.83 163.58 24.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.986 -0.552 . . . . 51.44 112.406 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.4 p -75.19 141.4 74.11 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.587 -0.733 . . . . 54.03 111.47 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -48.37 -39.75 35.8 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.561 2.84 . . . . 71.24 113.866 170.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.57 -42.27 87.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.783 0.833 . . . . 64.34 112.572 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 27.0 m -82.47 -26.23 32.82 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.597 0.359 . . . . 72.11 111.424 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.89 76.42 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.544 0.738 . . . . 50.22 112.507 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -60.37 -33.56 72.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.974 0.51 . . . . 73.11 111.858 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -44.0 57.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.314 0.646 . . . . 74.52 110.601 174.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -34.65 77.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.076 0.398 . . . . 61.45 112.076 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.35 -43.8 97.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.886 0.474 . . . . 62.31 111.017 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.6 m -69.64 -56.41 7.35 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.223 0.609 . . . . 54.44 112.64 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.47 -49.65 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 124.644 1.177 . . . . 52.11 112.685 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.72 -48.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 122.604 0.361 . . . . 74.02 110.977 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.45 -75.53 0.6 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 114.126 0.411 . . . . 53.4 114.126 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.19 -26.7 68.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.181 0.592 . . . . 73.21 111.695 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.86 -89.54 0.55 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.281 -0.418 . . . . 75.33 112.777 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.21 -49.47 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.887 0.875 . . . . 74.31 113.175 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -73.36 -53.73 10.05 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.647 0.779 . . . . 73.1 112.111 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.34 73.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.677 0.391 . . . . 71.22 111.968 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.74 -49.87 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 62.42 111.329 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.34 87.21 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 116.476 -0.329 . . . . 72.54 113.602 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 mt -69.27 -38.22 78.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 70.25 112.152 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.9 m-20 -67.04 -43.11 83.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.728 0.411 . . . . 71.4 110.23 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.02 81.83 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.301 0.64 . . . . 64.35 111.737 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 7.4 tt -65.87 -41.96 90.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.359 0.664 . . . . 74.33 110.234 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.94 79.44 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 116.389 -0.369 . . . . 72.35 111.245 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 41.6 mt-10 -64.53 -41.52 96.31 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.53 0.937 . . . . 74.24 113.53 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -64.05 -32.26 73.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.164 0.431 . . . . 75.22 112.164 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.8 -23.12 22.94 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.311 0.856 . . . . 73.44 113.311 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.995 0 N-CA-C 115.314 0.885 . . . . 73.43 115.314 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.382 0 CA-C-O 121.016 0.436 . . . . 43.44 111.45 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' HB3' ' A' ' 110' ' ' MET . 89.8 m -117.15 112.21 20.55 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.672 0.789 . . . . 71.12 109.922 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.42 126.32 45.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.933 1.293 . . . . 72.53 110.117 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -118.29 119.72 35.49 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.757 0.423 . . . . 73.03 109.879 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -127.64 139.29 52.82 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.594 0.757 . . . . 73.01 109.879 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 p -144.87 155.33 43.4 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.343 0.657 . . . . 65.42 111.382 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 104' ' ' THR . 13.7 p -150.31 147.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.22 110.641 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.86 109.09 21.86 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.332 0.587 . . . . 71.21 110.289 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.415 HG21 HD22 ' A' ' 137' ' ' LEU . 69.2 t -95.07 137.81 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.386 1.474 . . . . 71.01 110.834 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.61 67.68 5.44 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.484 0.714 . . . . 53.4 112.305 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 141' ' ' TYR . . . -163.29 150.31 10.64 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.441 0.696 . . . . 70.23 111.449 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.82 144.24 76.6 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.711 2.274 . . . . 70.14 111.296 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -48.11 -41.22 25.82 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.234 1.568 . . . . 72.51 115.234 -172.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.31 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.967 0.507 . . . . 73.22 112.087 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.63 -41.99 87.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.858 0.863 . . . . 64.34 112.511 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -70.88 -36.27 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.042 0.449 . . . . 65.13 110.647 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -68.29 -27.61 66.46 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.246 0.618 . . . . 74.12 111.628 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m -62.11 -31.5 71.96 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.268 0.556 . . . . 53.34 110.886 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.0 tp -83.15 -58.29 2.91 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.479 1.112 . . . . 75.01 112.35 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.95 -20.16 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.068 0.766 . . . . 62.42 113.068 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.83 12.4 16.95 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.346 0.898 . . . . 71.14 115.346 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 11.1 t70 -120.61 120.6 36.23 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.072 0.949 . . . . 54.0 108.486 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.5 -31.38 72.42 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.92 0.888 . . . . 74.24 112.124 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.8 t -82.3 -22.81 35.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.432 0.693 . . . . 74.44 112.074 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.55 22.52 6.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.832 0.679 . . . . 51.5 112.832 -163.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.691 HG23 HG11 ' A' ' 34' ' ' VAL . 20.1 tt -69.02 -22.53 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 123.389 0.676 . . . . 74.25 111.605 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -62.1 -14.62 38.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.752 1.019 . . . . 73.31 113.752 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.3 mtm180 -78.97 -46.46 18.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.934 0.493 . . . . 64.23 111.945 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.9 p-90 -103.79 -30.89 10.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.684 0.393 . . . . 74.11 111.706 -171.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -91.34 107.85 24.57 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 122.98 0.512 . . . . 71.11 110.107 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.34 -19.42 61.73 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.072 2.515 . . . . 74.4 114.787 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.53 HE22 HG11 ' A' ' 132' ' ' VAL . 26.5 mp0 -84.32 -23.6 30.16 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.608 0.363 . . . . 71.43 111.858 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.691 HG11 HG23 ' A' ' 27' ' ' ILE . 84.8 t -76.21 118.8 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 120.843 0.354 . . . . 72.14 111.397 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.1 m -73.26 -74.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.965 0.906 . . . . 74.44 110.554 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -167.51 103.32 0.6 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.588 0.755 . . . . 72.44 110.72 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.35 150.3 17.26 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.762 2.308 . . . . 72.54 113.529 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.7 m -100.26 123.49 44.55 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.093 0.957 . . . . 43.12 108.853 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.8 128.54 40.1 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.242 -0.651 . . . . 40.21 109.242 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -124.93 148.59 48.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.195 0.998 . . . . 74.1 110.312 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.37 132.5 0.0 OUTLIER Glycine 0 CA--C 1.554 2.515 0 N-CA-C 117.584 1.794 . . . . 60.21 117.584 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 67.31 -90.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.146 1.378 . . . . 42.41 113.392 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t 179.77 150.11 0.51 Allowed Pre-proline 0 N--CA 1.492 1.645 0 C-N-CA 124.08 0.952 . . . . 74.14 110.52 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.19 -6.55 14.97 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.459 2.106 . . . . 62.21 113.343 173.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -109.6 -7.58 15.1 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.639 0.776 . . . . 63.32 111.877 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 m -103.73 121.85 46.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 122.8 0.44 . . . . 75.01 111.401 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.8 121.19 8.81 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.297 2.664 . . . . 75.24 113.104 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.29 -6.5 8.68 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 122.865 0.269 . . . . 54.12 113.379 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.12 172.82 11.68 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.578 0.751 . . . . 71.11 112.957 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.35 152.64 45.95 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.178 0.991 . . . . 62.34 111.12 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -130.94 132.0 44.8 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.496 0.718 . . . . 71.01 110.31 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.51 110.85 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.602 0.761 . . . . 74.23 110.139 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -71.66 97.39 1.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.451 0.908 . . . . 74.45 113.451 -169.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.85 -59.31 0.67 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.496 -0.642 . . . . 62.22 111.496 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.03 108.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.746 1.219 . . . . 75.41 112.616 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.79 54.41 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 116.515 -0.311 . . . . 70.03 113.268 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.9 p -116.27 -79.98 0.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.613 0.765 . . . . 51.11 111.087 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 177.42 -54.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.61 1.164 . . . . 72.25 107.913 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.1 14.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.792 1.237 . . . . 73.54 113.605 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.05 96.08 1.28 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.266 1.031 . . . . 74.11 112.59 -172.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -87.72 131.53 34.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.425 -1.261 . . . . 65.42 108.918 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -102.43 115.59 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.283 -0.636 . . . . 73.32 109.283 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 44.8 mt-10 -121.0 133.96 55.28 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 72.34 110.749 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.35 120.83 43.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.065 0.946 . . . . 73.11 110.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.71 119.59 11.46 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.645 1.178 . . . . 71.14 112.045 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.97 -51.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.508 0.723 . . . . 65.23 111.048 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 13.0 pt-20 -160.21 165.02 32.31 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 64.33 111.131 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.2 ttp85 -156.81 128.59 7.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.314 0.646 . . . . 64.2 109.917 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.39 123.88 38.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.747 0.819 . . . . 72.35 109.949 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.23 -46.64 49.0 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.823 0.849 . . . . 72.51 111.05 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.8 t -65.54 -25.14 67.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.136 0.974 . . . . 53.55 112.72 -170.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.54 -7.58 15.7 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.817 0.847 . . . . 74.3 112.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 11.6 mtm-85 58.93 45.62 14.84 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.93 0.892 . . . . 73.44 112.296 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -114.72 124.62 52.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.237 1.015 . . . . 72.22 111.054 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.4 tp -122.43 107.95 12.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.749 0.82 . . . . 71.35 110.043 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 39.4 t -111.06 136.08 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.555 0.616 . . . . 74.41 110.711 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -150.14 -179.91 7.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.047 0.939 . . . . 73.43 110.902 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 t -142.43 164.12 30.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.877 0.871 . . . . 72.04 110.593 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mtp -109.3 88.35 5.87 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 123.661 0.784 . . . . 71.24 110.305 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 34.9 Cg_endo -62.28 -34.27 78.33 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.558 2.839 . . . . 51.3 113.637 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -125.28 81.95 63.03 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.006 0.522 . . . . 64.41 109.736 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -94.39 147.38 1.86 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 123.072 2.515 . . . . 62.34 113.869 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.72 -2.2 11.72 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.412 2.075 . . . . 62.11 112.774 170.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 40.2 m-85 -99.83 135.4 20.5 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.228 1.011 . . . . 73.04 109.449 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 15.0 Cg_exo -68.92 82.01 0.6 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.923 2.416 . . . . 60.32 112.666 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.768 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.6 pt -135.09 141.6 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 124.229 1.012 . . . . 63.44 110.308 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.3 m -83.94 -75.65 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.173 -0.33 . . . . 74.23 110.875 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -107.92 111.02 22.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.19 0.519 . . . . 72.22 110.448 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -92.91 151.68 19.81 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.731 0.813 . . . . 75.24 111.775 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -150.19 126.49 10.72 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 72.1 109.702 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.86 143.23 49.39 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.882 0.765 . . . . 75.44 112.003 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 8.9 p -137.6 142.24 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 113.14 0.793 . . . . 64.32 113.14 -176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -108.42 117.11 33.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.869 1.268 . . . . 73.45 109.05 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 46.5 mt-10 -127.37 113.91 16.86 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.757 0.423 . . . . 64.32 111.345 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.06 111.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.081 0.467 . . . . 74.1 109.755 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.36 110.16 59.15 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.136 0.974 . . . . 72.05 110.261 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HA ' ' SG ' ' A' ' 103' ' ' CYS . 51.8 Cg_endo -66.16 114.43 3.02 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.703 2.269 . . . . 64.22 114.655 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.4 11.91 22.31 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.162 0.985 . . . . 73.43 111.304 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 67.85 175.28 0.26 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.475 1.51 . . . . 73.42 113.287 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 60.26 -86.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.277 1.431 . . . . 70.35 112.397 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -153.09 43.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.785 0.802 . . . . 71.4 109.98 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -142.65 139.5 31.26 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.408 0.683 . . . . 74.32 109.545 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 97' ' ' PRO . 75.5 m -153.63 138.97 17.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.507 0.723 . . . . 75.33 111.141 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 25.3 m -90.93 111.27 22.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.988 0.515 . . . . 72.22 111.163 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.34 118.88 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.897 0.479 . . . . 72.41 109.938 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.29 112.55 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.782 0.833 . . . . 74.21 109.965 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -107.49 112.03 24.6 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 108.812 -0.81 . . . . 73.12 108.812 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.7 m -123.83 127.2 47.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.59 0.756 . . . . 61.23 110.152 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.3 118.44 22.3 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.225 0.61 . . . . 75.13 111.362 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.625 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -118.8 128.83 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.588 1.155 . . . . 71.15 109.09 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -145.26 156.5 43.87 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.719 0.808 . . . . 74.11 111.498 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 25.3 t70 -89.86 85.15 6.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.372 0.606 . . . . 74.44 109.861 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 86' ' ' ILE . 53.6 t -122.72 148.47 45.29 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.434 -0.803 . . . . 50.01 111.809 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 t -62.82 125.08 85.71 Favored Pre-proline 0 N--CA 1.485 1.298 0 CA-C-O 118.678 -0.677 . . . . 42.35 109.847 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -52.07 -22.29 14.44 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.523 2.815 . . . . 74.44 115.695 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.02 -50.23 67.06 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 122.796 0.439 . . . . 74.22 112.018 170.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.537 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 34.4 m -71.13 -36.85 72.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.912 0.485 . . . . 35.35 110.594 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 115' ' ' PRO . . . -69.61 -38.49 77.3 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.749 0.819 . . . . 74.34 112.542 -171.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -64.8 -34.11 77.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.288 0.566 . . . . 73.54 110.916 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.11 -34.12 74.58 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.275 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 117' ' ' THR . 77.8 mt -75.01 -25.62 58.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.433 0.693 . . . . 62.35 111.483 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.87 -32.7 74.14 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.496 0.589 . . . . 70.14 110.607 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 55.6 m -70.08 -58.12 4.18 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.556 0.576 . . . . 73.54 112.556 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.13 -55.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 122.968 0.507 . . . . 52.22 112.198 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 121' ' ' LEU . 56.7 mt -74.32 -49.68 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.71 0.404 . . . . 72.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.96 -55.38 19.66 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.789 0.676 . . . . 62.15 114.789 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.69 -52.99 5.42 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.891 0.845 . . . . 61.53 111.59 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.51 -36.94 92.19 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 115.083 0.793 . . . . 62.43 115.083 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.66 -56.89 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 122.474 -0.427 . . . . 72.01 110.966 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -75.71 -61.97 1.74 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.727 0.64 . . . . 74.24 112.727 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.26 70.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.775 0.43 . . . . 54.54 111.11 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.53 HG11 HE22 ' A' ' 33' ' ' GLN . 7.0 t -65.58 -50.93 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.223 0.609 . . . . 71.31 111.823 172.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.32 95.77 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-O 120.97 0.206 . . . . 73.32 113.372 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.66 -39.44 70.32 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.448 1.099 . . . . 74.13 111.732 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 8.1 m-80 -69.77 -38.55 76.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.404 0.282 . . . . 41.43 110.402 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.71 76.65 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.679 0.792 . . . . 75.14 111.564 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 10' ' ' VAL . 5.1 tt -66.52 -36.37 82.54 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.878 0.871 . . . . 43.22 109.568 173.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.04 62.46 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.189 0.595 . . . . 70.5 112.295 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 10.8 mm-40 -72.56 -42.53 64.56 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 122.949 0.5 . . . . 71.21 111.828 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.47 -41.29 96.59 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 120.718 0.294 . . . . 75.01 111.54 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 12' ' ' ALA . 71.5 m-85 -81.79 -2.94 52.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.501 0.321 . . . . 73.12 111.059 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.578 0 CA-C-N 116.569 -0.287 . . . . 74.35 113.159 168.945 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 112.54 0.57 . . . . 65.51 112.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -79.67 110.18 14.76 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.424 0.631 . . . . 71.42 111.677 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.74 121.71 36.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.933 1.293 . . . . 75.34 109.143 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -130.69 137.89 49.76 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.185 0.517 . . . . 71.03 111.357 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -132.12 152.46 51.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.521 1.128 . . . . 72.02 109.441 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.0 p -149.45 149.62 31.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.452 0.701 . . . . 72.22 110.201 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.7 p -144.1 138.31 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.157 0.583 . . . . 62.32 111.852 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.96 108.5 16.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.31 -0.626 . . . . 73.34 109.31 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.89 130.83 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.441 1.096 . . . . 63.32 110.976 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.3 71.8 3.02 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.066 0.546 . . . . 64.51 111.203 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.08 141.71 0.83 Allowed Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.625 1.17 . . . . 62.24 110.664 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.44 141.25 95.06 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.866 2.377 . . . . 44.34 113.255 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 103' ' ' CYS . . . -47.5 -42.66 23.54 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.296 1.591 . . . . 70.25 115.296 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.6 85.24 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.128 0.571 . . . . 75.33 112.153 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.49 -34.94 78.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.603 0.761 . . . . 71.33 112.278 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.33 -35.55 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.847 0.459 . . . . 61.04 110.716 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 60.4 t-105 -72.38 -25.89 61.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.036 0.534 . . . . 74.34 111.342 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.1 m -58.37 -29.5 66.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 72.33 110.654 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.571 HD22 HH11 ' A' ' 140' ' ' ARG . 62.1 tp -84.97 -59.68 2.27 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.748 1.219 . . . . 71.33 111.706 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.8 14.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 113.441 0.904 . . . . 63.14 113.441 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.16 33.28 5.52 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 112.356 -0.298 . . . . 63.54 112.356 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -154.82 148.17 25.03 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.94 0.896 . . . . 72.15 110.044 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -84.97 -25.66 27.63 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.465 0.706 . . . . 74.43 111.625 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -92.87 -21.39 19.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.495 0.718 . . . . 73.32 112.384 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.21 8.14 9.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.486 0.55 . . . . 71.14 112.486 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.631 HG21 ' NH1' ' A' ' 51' ' ' ARG . 20.5 tt -68.46 -23.92 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 C-N-CA 124.153 0.981 . . . . 74.31 112.611 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -74.51 0.42 14.83 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -97.36 -15.54 20.66 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.795 . . . . 74.4 112.313 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.569 ' HB3' HD21 ' A' ' 20' ' ' LEU . 37.5 p-90 -128.68 -38.12 1.72 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.637 0.606 . . . . 75.23 112.637 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 64.2 t-80 -89.64 115.28 63.44 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 122.86 0.464 . . . . 74.04 110.365 -173.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 13.6 Cg_exo -69.97 -23.68 29.54 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.197 2.598 . . . . 45.34 114.885 -169.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.48 -15.36 52.77 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.215 0.45 . . . . 73.13 112.215 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 36' ' ' ALA . 98.5 t -70.89 120.74 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 122.89 0.476 . . . . 54.51 112.211 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -93.37 20.5 7.07 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.034 0.934 . . . . 60.11 112.394 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 70.28 110.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.638 1.575 . . . . 51.23 112.186 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -86.05 168.79 9.08 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.193 2.595 . . . . 74.54 114.241 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.5 m -101.91 127.75 48.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.693 1.197 . . . . 61.01 110.171 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.61 125.29 37.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.071 0.938 . . . . 54.43 113.033 -171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 41.5 mmt180 -92.8 -174.46 3.62 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.695 1.998 . . . . 72.51 110.808 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.74 -128.79 0.44 Allowed Glycine 0 CA--C 1.547 2.081 0 N-CA-C 116.993 1.557 . . . . 71.41 116.993 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.97 -79.97 0.45 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.018 0.927 . . . . 75.14 112.393 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -121.99 141.0 33.21 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.8 0.84 . . . . 65.21 111.153 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.87 -8.33 13.42 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 123.249 2.633 . . . . 44.23 114.084 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -88.2 -25.53 22.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.916 0.486 . . . . 74.44 111.366 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 81.7 m -77.72 123.03 86.55 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 124.011 0.925 . . . . 75.34 112.527 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.0 Cg_endo -56.48 103.4 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.115 2.543 . . . . 52.22 112.058 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.72 -36.05 1.56 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.916 -0.584 . . . . 50.32 112.18 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 148.15 50.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.298 0.639 . . . . 30.33 111.587 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 32.2 mt-10 -124.69 140.3 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.894 0.478 . . . . 73.44 111.141 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.631 ' NH1' HG21 ' A' ' 27' ' ' ILE . 15.5 ptt180 -105.25 112.97 26.28 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.706 0.765 . . . . 74.12 109.68 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 62' ' ' VAL . 45.1 t -111.33 100.03 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 55.21 109.833 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 38.4 m-85 -59.47 134.28 56.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.149 0.58 . . . . 74.33 110.097 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.8 -67.94 1.05 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 114.803 0.681 . . . . 54.24 114.803 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.73 95.68 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.403 1.481 . . . . 61.22 111.153 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.64 23.71 66.75 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-N 115.742 -0.663 . . . . 55.12 113.467 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 p -123.29 172.72 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.559 0.744 . . . . 63.14 111.323 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.7 -39.38 80.51 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.667 0.787 . . . . 73.23 111.708 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -90.12 64.58 6.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.875 0.845 . . . . 74.24 109.774 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.4 tt0 -108.28 137.3 46.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.754 -0.657 . . . . 73.34 112.276 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 83' ' ' PRO . 31.0 tp -144.21 113.19 6.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.824 0.85 . . . . 73.11 109.235 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 40.0 t -98.93 115.23 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.692 -0.485 . . . . 63.2 109.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 68.9 mt-10 -123.35 148.51 45.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.944 0.898 . . . . 64.52 110.079 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -124.22 132.34 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.133 0.573 . . . . 71.44 111.027 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -74.33 114.91 13.24 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.361 0.664 . . . . 65.32 110.535 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG11 HH12 ' A' ' 90' ' ' ARG . 61.3 t -79.36 -51.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 122.801 0.441 . . . . 40.44 110.916 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 10.1 pt-20 -153.86 155.49 35.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.433 0.693 . . . . 75.42 110.124 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttp85 -144.26 145.87 32.3 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.359 -0.608 . . . . 71.14 109.359 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -146.46 134.56 21.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.399 0.679 . . . . 73.25 109.746 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 46.7 mt-10 -90.16 -50.87 5.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.233 0.613 . . . . 61.51 112.332 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.7 p -70.84 -34.6 71.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.243 0.617 . . . . 75.15 111.969 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.14 -9.71 54.59 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.332 0.653 . . . . 53.25 112.094 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 61.62 43.33 10.05 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.884 0.873 . . . . 73.33 112.211 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -114.58 115.58 27.4 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.728 0.811 . . . . 64.14 111.947 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -113.67 108.45 17.14 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.766 0.827 . . . . 74.44 108.777 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 27.0 t -117.63 130.3 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.634 0.652 . . . . 70.31 110.822 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.76 178.95 7.29 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.689 0.796 . . . . 73.11 111.257 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -135.98 159.34 42.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.351 1.06 . . . . 53.21 109.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 80.1 mtp -112.44 83.94 5.8 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.538 0.735 . . . . 70.32 109.046 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 81.2 Cg_endo -72.03 -16.6 28.84 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.253 2.635 . . . . 63.44 113.511 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 9.7 t70 -134.06 82.06 49.45 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 108.72 -0.845 . . . . 62.34 108.72 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -91.41 150.02 3.59 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.167 2.578 . . . . 71.41 113.34 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD3' HD13 ' A' ' 61' ' ' LEU . 72.7 Cg_endo -81.07 -0.68 10.73 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.739 2.292 . . . . 75.41 113.12 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -105.25 154.69 38.73 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.99 0.916 . . . . 71.23 110.673 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 70.67 3.96 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.832 2.355 . . . . 73.53 113.075 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -137.52 133.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.588 1.155 . . . . 71.22 109.525 -177.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 22.4 m -77.14 -79.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.941 -0.474 . . . . 51.02 111.894 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -108.88 104.69 13.99 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.928 0.491 . . . . 75.13 111.03 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.427 ' CE1' ' HB1' ' A' ' 109' ' ' ALA . 18.0 t60 -93.38 146.26 23.87 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.742 0.817 . . . . 75.33 111.356 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.402 HH12 HG11 ' A' ' 66' ' ' VAL . 14.8 tpt180 -146.56 111.31 5.27 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.997 0.919 . . . . 53.42 110.094 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.11 149.06 46.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.075 0.768 . . . . 73.35 113.075 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.12 139.29 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 124.095 0.958 . . . . 71.53 111.668 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 110.6 22.97 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.202 1.001 . . . . 72.41 108.422 162.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -127.04 119.06 25.69 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.755 -0.832 . . . . 64.14 108.755 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 103' ' ' CYS . 96.4 t -101.71 109.97 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.241 0.616 . . . . 72.1 110.858 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.32 113.02 55.95 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 124.8 1.24 . . . . 63.22 111.065 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.25 95.28 1.07 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.945 2.43 . . . . 63.51 113.156 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -79.26 -37.38 38.03 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.243 0.46 . . . . 75.14 112.243 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 35.0 t70 -157.07 162.58 39.48 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.28 0.632 . . . . 73.12 111.282 -169.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.66 -21.15 65.49 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.824 1.249 . . . . 72.1 113.075 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.06 0.83 5.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.474 0.71 . . . . 72.41 112.252 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 32.8 m80 -134.7 123.06 23.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.662 0.664 . . . . 74.12 109.901 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 95' ' ' VAL . 38.2 t -142.95 137.63 29.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.425 0.29 . . . . 62.34 111.341 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.2 m -92.42 111.75 23.44 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.887 0.475 . . . . 74.45 111.3 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.1 112.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.141 -0.688 . . . . 73.5 109.141 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.34 119.15 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.356 0.662 . . . . 71.24 110.075 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -107.47 113.3 26.55 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.658 -0.867 . . . . 75.32 108.658 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -108.89 149.93 28.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.087 0.955 . . . . 63.42 109.502 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 89' ' ' HIS . . . -149.14 145.31 27.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.477 1.111 . . . . 74.32 108.633 171.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -154.25 133.83 12.82 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.217 0.607 . . . . 65.42 110.104 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.53 153.36 48.73 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.647 -0.706 . . . . 63.24 111.305 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 34.2 t70 -77.14 87.13 3.61 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.055 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.406 ' HB2' HG22 ' A' ' 86' ' ' ILE . 27.9 t -156.1 169.8 23.67 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.616 -0.72 . . . . 64.05 111.883 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 m -76.52 148.28 79.84 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.457 1.103 . . . . 64.13 112.802 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.73 -34.91 92.3 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.821 3.014 . . . . 75.21 114.796 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.89 -31.09 67.63 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.294 0.638 . . . . 74.33 112.25 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 95.2 m -76.76 -38.08 54.79 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.02 0.438 . . . . 74.12 110.027 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -31.48 71.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.968 . . . . 25.05 112.881 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -75.74 -33.33 60.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.939 0.496 . . . . 71.32 111.43 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -42.21 83.49 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 75.04 110.225 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.99 -24.93 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.338 -0.846 . . . . 74.45 111.318 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -60.16 -36.11 76.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.013 0.525 . . . . 73.15 110.908 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -72.57 -53.56 11.58 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.951 -0.568 . . . . 74.21 111.856 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.76 -57.31 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 113.148 0.795 . . . . 74.24 113.148 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -77.83 -57.99 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.804 0.842 . . . . 64.23 110.942 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.53 -51.04 61.17 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 114.263 0.465 . . . . 64.44 114.263 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -95.22 -39.82 9.89 Favored 'General case' 0 CA--C 1.556 1.193 0 O-C-N 121.998 -0.707 . . . . 52.13 112.024 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.49 73.27 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.88 0.712 . . . . 73.13 114.88 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.93 -52.41 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 117.656 0.728 . . . . 72.21 111.024 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 2.8 m-30 -77.72 -53.58 7.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.102 0.408 . . . . 73.03 112.102 -172.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.32 -15.63 62.74 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.11 0.411 . . . . 62.15 112.11 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.6 t -80.86 -51.81 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 123.929 0.892 . . . . 73.32 110.985 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.33 -51.93 44.82 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.09 -0.505 . . . . 70.21 114.258 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.6 mt -58.52 -36.18 73.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.842 0.857 . . . . 71.12 112.776 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 6.3 m-20 -67.83 -46.06 72.9 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.669 -0.493 . . . . 73.21 109.669 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.0 74.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.6 0.76 . . . . 72.31 112.267 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.72 -49.24 78.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.312 1.045 . . . . 71.51 110.121 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -24.03 62.07 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.42 -0.809 . . . . 73.22 111.924 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 6.2 mm-40 -67.57 -50.73 57.05 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.589 0.756 . . . . 74.13 110.585 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.571 HH11 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.95 -15.83 62.09 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.737 0.643 . . . . 72.4 112.737 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -87.02 -22.62 25.38 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.803 0.668 . . . . 74.33 112.803 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 1.792 0 N-CA-C 116.227 1.251 . . . . 64.33 116.227 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 122.074 0.94 . . . . 64.55 110.408 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -144.48 119.33 9.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.279 -0.873 . . . . 40.32 110.38 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.17 147.54 23.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 60.1 109.226 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -149.53 129.96 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.138 0.575 . . . . 65.44 109.832 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -130.78 151.62 51.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.932 0.893 . . . . 62.31 108.751 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 96.3 p -146.85 163.34 36.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.991 0.516 . . . . 73.53 110.895 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.69 149.19 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.87 0.468 . . . . 65.25 111.057 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.56 109.22 19.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.029 0.532 . . . . 50.34 110.231 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 12' ' ' ALA . 85.8 t -96.49 129.9 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.312 1.045 . . . . 75.32 109.601 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 141' ' ' TYR . . . -84.23 26.24 0.78 Allowed 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.563 0.949 . . . . 73.05 113.563 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 10' ' ' VAL . . . -131.55 150.57 76.72 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.583 0.753 . . . . 71.14 110.317 174.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.85 151.05 50.84 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.184 2.589 . . . . 72.11 112.984 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.02 -28.81 10.87 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.789 1.236 . . . . 54.51 114.27 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -50.9 64.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.774 0.657 . . . . 75.04 112.774 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -44.94 64.7 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.704 0.801 . . . . 71.0 111.901 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG13 HD21 ' A' ' 137' ' ' LEU . 15.0 t -73.36 -34.51 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 114.896 -1.047 . . . . 71.32 111.62 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 65.5 t-105 -73.48 -28.99 62.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.233 0.613 . . . . 72.13 111.505 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 m -60.65 -26.96 67.45 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.629 0.728 . . . . 74.25 110.838 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.549 HD22 HH11 ' A' ' 140' ' ' ARG . 54.4 tp -91.41 -44.03 9.38 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.361 1.064 . . . . 61.41 113.091 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.62 -21.72 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 113.588 0.959 . . . . 73.22 113.588 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.68 73.89 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 114.281 0.472 . . . . 75.04 114.281 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 3.6 m-20 -86.73 122.59 30.84 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.638 -1.245 . . . . 75.24 107.638 171.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 4.0 t80 -61.1 -27.84 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.992 0.517 . . . . 63.43 110.635 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -77.5 -23.51 50.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.024 0.93 . . . . 72.14 113.426 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -83.15 9.28 10.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 112.529 0.566 . . . . 60.14 112.529 -161.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.541 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 13.7 tt -62.64 -25.11 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 123.221 0.608 . . . . 73.54 111.52 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.766 ' HA ' HG11 ' A' ' 34' ' ' VAL . 26.4 p-80 -71.84 0.17 9.73 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.632 0.605 . . . . 63.42 112.632 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -102.92 -18.18 15.16 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.721 0.808 . . . . 25.53 112.754 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.541 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 33.0 p-90 -126.99 -42.24 1.75 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.433 1.271 . . . . 74.42 114.433 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.609 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.3 t-80 -72.73 119.86 77.6 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 117.985 0.357 . . . . 72.11 110.273 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 -22.33 73.86 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.373 2.048 . . . . 71.13 115.002 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -104.97 -4.19 22.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.041 0.756 . . . . 70.44 113.041 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.766 HG11 ' HA ' ' A' ' 28' ' ' HIS . 11.2 p -63.81 148.13 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 CA-C-N 118.228 0.467 . . . . 74.42 111.157 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -113.22 28.4 8.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.293 0.637 . . . . 53.3 111.402 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.41 85.97 0.18 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 123.781 0.832 . . . . 74.34 111.163 -173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.99 173.32 13.67 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.888 2.392 . . . . 73.45 114.077 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.7 m -112.97 130.51 56.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.33 1.052 . . . . 62.0 110.178 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.69 137.18 42.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.7 0.8 . . . . 61.31 110.07 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.548 ' HG3' ' HB2' ' A' ' 50' ' ' GLU . 11.1 ptm180 -150.82 162.04 41.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.904 0.882 . . . . 74.31 111.012 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.74 143.89 0.0 OUTLIER Glycine 0 CA--C 1.557 2.68 0 N-CA-C 117.25 1.66 . . . . 65.24 117.25 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 57.97 -104.46 0.22 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.403 1.081 . . . . 63.42 112.165 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 m -170.73 151.19 3.37 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 125.204 1.402 . . . . 61.22 109.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.58 0.58 1.8 Allowed 'Trans proline' 0 N--CA 1.513 2.639 0 C-N-CA 123.453 2.769 . . . . 72.13 115.29 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -119.69 -18.38 8.37 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.534 0.734 . . . . 74.13 111.408 168.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 m -87.88 123.34 69.2 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 123.251 0.62 . . . . 75.42 111.22 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 71.2 Cg_exo -45.99 119.06 2.66 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.727 2.951 . . . . 71.04 114.22 171.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.43 -20.62 4.39 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.507 0.575 . . . . 61.25 112.726 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.34 141.54 54.2 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.26 0.837 . . . . 74.4 113.26 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.684 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 28.9 mt-10 -107.71 126.94 53.21 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.906 0.882 . . . . 75.15 110.698 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 24' ' ' PHE . 58.1 ttp180 -102.38 108.72 20.15 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.073 0.949 . . . . 74.33 109.869 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 62' ' ' VAL . 41.8 t -112.11 112.98 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.844 0.858 . . . . 60.3 110.931 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 34' ' ' VAL . 76.3 m-85 -73.45 -58.1 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.959 0.725 . . . . 71.42 112.959 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.42 -50.27 39.26 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-N 116.436 -0.347 . . . . 44.2 112.776 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 51.07 24.66 1.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.938 1.295 . . . . 65.41 114.118 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.73 24.28 0.02 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-N 116.196 -0.456 . . . . 72.11 113.037 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 60' ' ' GLU . 72.7 p -129.02 142.2 50.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.317 1.047 . . . . 73.34 109.779 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.18 -30.31 70.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.779 0.659 . . . . 74.44 112.779 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.04 75.38 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.731 0.776 . . . . 73.22 110.579 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 14.0 pt-20 -109.16 164.51 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.648 1.179 . . . . 71.54 111.758 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.0 tp -103.21 124.11 47.99 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.999 0.52 . . . . 71.45 109.692 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 52' ' ' VAL . 61.7 t -120.18 128.1 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.537 0.735 . . . . 64.23 109.688 173.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 35.2 mt-10 -117.45 149.42 40.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.47 1.108 . . . . 72.21 110.335 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.684 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 96.2 mtt180 -126.03 129.83 49.95 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.005 0.522 . . . . 63.11 111.378 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 14.5 tp -67.63 115.82 7.64 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.009 0.924 . . . . 73.33 111.034 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.477 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 98.0 t -84.98 -51.75 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.509 0.724 . . . . 71.24 111.297 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 6.3 pt-20 -158.15 140.49 14.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.527 0.731 . . . . 75.2 110.197 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.23 124.15 28.37 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.099 0.56 . . . . 63.15 110.224 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.57 100.45 8.29 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.525 -0.917 . . . . 62.1 108.525 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 25.5 tt0 -80.02 -31.08 39.65 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 112.374 0.509 . . . . 70.51 112.374 -172.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -69.86 -43.59 71.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.16 0.584 . . . . 63.5 111.71 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.8 -10.12 59.75 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 55.3 111.913 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 61.21 55.62 2.93 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.557 1.143 . . . . 61.42 112.005 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -132.38 135.05 45.87 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.278 -1.328 . . . . 74.21 110.139 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -124.39 132.23 53.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.167 1.387 . . . . 72.2 108.862 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 41.3 t -133.63 130.52 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 118.338 0.517 . . . . 63.15 111.078 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 54.9 p90 -141.26 -179.45 6.12 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.342 1.057 . . . . 72.15 110.573 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.484 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.3 t -130.44 162.76 28.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.649 1.18 . . . . 43.15 110.367 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.441 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.5 mtp -109.8 85.58 4.09 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.825 0.85 . . . . 65.33 109.278 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 71.8 Cg_endo -71.36 -24.5 22.74 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.48 2.787 . . . . 74.33 113.095 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.88 76.43 70.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 109.441 -0.577 . . . . 73.44 109.441 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -95.55 150.78 1.5 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.097 2.531 . . . . 61.51 113.456 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 -6.88 17.97 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.176 1.917 . . . . 71.04 112.21 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -92.32 143.28 27.14 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.477 1.111 . . . . 72.33 110.771 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HG2' HG21 ' A' ' 117' ' ' THR . 90.5 Cg_endo -78.72 72.99 6.15 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.741 2.294 . . . . 71.13 112.689 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 113' ' ' CYS . 19.1 pt -127.87 145.52 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.356 1.062 . . . . 61.13 110.575 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.3 m -82.78 -78.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.616 0.366 . . . . 75.33 111.812 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.72 106.66 14.76 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.29 0.566 . . . . 75.1 109.944 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.422 ' HE1' ' HB1' ' A' ' 109' ' ' ALA . 37.7 t60 -91.65 159.38 15.9 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.445 0.698 . . . . 43.2 111.673 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -165.47 103.25 0.72 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.104 0.962 . . . . 74.24 110.254 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.65 153.5 18.64 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.58 0.752 . . . . 70.31 112.544 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.49 132.56 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.883 0.873 . . . . 74.22 111.48 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -109.08 107.58 17.95 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.748 1.219 . . . . 75.03 109.268 166.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.92 130.71 48.92 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 122.002 -0.436 . . . . 72.12 110.434 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.601 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 27.8 m -99.67 111.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.672 0.749 . . . . 72.54 109.852 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 95.8 t -83.32 107.67 10.58 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.571 1.149 . . . . 74.44 109.448 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 5.4 Cg_exo -74.25 108.23 2.62 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.789 2.326 . . . . 71.3 111.911 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -84.4 -60.44 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.186 0.594 . . . . 74.11 110.495 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.49 175.37 9.21 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.031 0.932 . . . . 71.5 110.366 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.69 -4.58 43.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.82 0.448 . . . . 52.2 110.578 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -23.96 11.68 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.823 1.249 . . . . 63.31 112.344 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -136.01 150.96 49.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.354 0.524 . . . . 62.44 112.014 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 45.5 t -143.56 173.6 11.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.358 1.063 . . . . 35.34 110.175 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.6 m -135.94 119.24 16.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.18 0.592 . . . . 70.44 110.835 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG23 HG21 ' A' ' 10' ' ' VAL . 26.0 t -91.27 113.06 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 122.144 -0.347 . . . . 73.52 110.199 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.54 109.91 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.473 1.109 . . . . 64.42 109.725 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -106.69 111.65 24.28 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 109.163 -0.68 . . . . 74.22 109.163 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.9 m -109.63 147.13 33.6 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.187 0.995 . . . . 73.32 109.964 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.422 ' HB1' ' HE1' ' A' ' 89' ' ' HIS . . . -131.78 111.27 11.49 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.956 0.903 . . . . 70.01 111.122 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.9 mtt -98.86 131.14 45.19 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.857 0.863 . . . . 75.41 108.978 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -156.96 144.68 19.12 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.413 0.523 . . . . 75.44 112.413 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.57 87.83 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.6 0.714 . . . . 52.14 110.676 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 53.5 t -134.28 169.09 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.643 -1.162 . . . . 71.44 111.411 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.2 m -68.44 146.93 98.09 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 62.01 112.222 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 -41.33 72.96 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.436 2.757 . . . . 73.54 114.29 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.77 -43.77 97.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.493 0.717 . . . . 62.44 111.813 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.45 HG21 ' HG2' ' A' ' 85' ' ' PRO . 21.3 m -71.81 -36.93 70.41 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.307 -0.406 . . . . 74.04 110.756 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.04 85.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.652 0.781 . . . . 62.23 112.322 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -28.54 63.49 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.484 0.314 . . . . 65.34 111.587 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.07 -42.04 89.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.223 0.535 . . . . 74.41 110.049 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.95 -22.88 62.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.904 0.882 . . . . 75.45 112.199 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -58.04 -43.37 86.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.299 0.5 . . . . 52.32 110.683 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -72.12 -49.79 33.31 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.6 0.593 . . . . 74.54 112.6 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.09 -54.61 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.207 0.527 . . . . 75.33 112.287 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.02 -56.45 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.78 0.832 . . . . 62.31 111.536 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.53 96.36 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 114.659 0.624 . . . . 73.22 114.659 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -88.72 -60.18 2.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.955 0.502 . . . . 74.25 110.634 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.84 -29.6 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 115.834 1.094 . . . . 73.13 115.834 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -105.16 -53.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 117.317 0.558 . . . . 72.01 110.873 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 5.2 m-30 -75.43 -65.47 0.89 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.804 -0.634 . . . . 65.04 111.793 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.06 66.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.856 0.462 . . . . 55.12 111.554 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.56 -53.73 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.986 0.914 . . . . 75.31 112.26 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.42 -35.17 81.32 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 116.402 -0.363 . . . . 63.15 113.395 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -44.83 61.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.3 1.04 . . . . 74.24 112.027 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -65.7 -38.19 88.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.376 0.27 . . . . 62.42 110.895 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.76 88.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.946 0.498 . . . . 42.55 111.611 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.538 HD21 HG13 ' A' ' 17' ' ' VAL . 7.0 tt -64.75 -42.5 95.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.693 0.797 . . . . 71.43 110.151 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.38 80.23 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.875 -0.602 . . . . 64.1 112.06 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.08 -33.12 61.62 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.754 0.822 . . . . 74.31 112.741 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.549 HH11 HD22 ' A' ' 20' ' ' LEU . 2.2 ptm180 -73.27 -24.72 60.47 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.773 0.32 . . . . 75.4 111.06 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 54.4 m-85 -100.75 4.14 42.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.432 0.693 . . . . 74.12 111.559 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.997 0 N-CA-C 115.156 0.823 . . . . 72.3 115.156 -179.698 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 111' ' ' PHE . . . . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 120.869 0.366 . . . . 64.35 111.221 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -108.13 112.62 25.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.156 0.982 . . . . 64.34 108.969 172.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.3 mp -97.14 121.76 39.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.774 1.23 . . . . 74.33 109.936 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -117.6 113.64 22.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.789 -0.449 . . . . 74.15 109.789 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -120.95 135.49 55.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.005 0.922 . . . . 74.33 109.818 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -138.1 159.93 40.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.688 0.795 . . . . 63.43 111.301 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.1 p -155.6 150.89 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.611 0.364 . . . . 74.4 111.874 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -92.34 119.09 31.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.959 0.504 . . . . 52.43 110.025 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.23 124.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.607 1.163 . . . . 70.35 109.82 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.76 71.68 4.25 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.569 0.7 . . . . 70.43 111.241 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.77 155.89 8.36 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.013 0.925 . . . . 75.0 110.909 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.39 137.84 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.777 2.318 . . . . 75.21 112.261 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.59 -46.69 10.15 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.233 1.568 . . . . 63.12 115.233 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.58 92.02 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 112.421 0.526 . . . . 54.34 112.421 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.16 -39.36 86.12 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.674 0.789 . . . . 61.24 112.051 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 HD21 ' A' ' 137' ' ' LEU . 44.3 t -73.9 -34.35 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.501 0.72 . . . . 71.5 111.15 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.531 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 75.8 t-105 -67.66 -29.67 69.02 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.713 0.405 . . . . 74.32 111.558 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 m -60.24 -30.86 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.635 0.731 . . . . 64.44 110.737 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 63.0 tp -83.5 -52.09 6.79 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.269 1.428 . . . . 71.24 112.143 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.31 -38.34 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.33 0.863 . . . . 62.1 113.33 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.58 -8.48 63.24 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.121 0.808 . . . . 74.45 115.121 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.99 113.92 26.34 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.612 -0.885 . . . . 60.31 108.612 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.15 -25.81 65.81 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.806 1.242 . . . . 60.12 113.303 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -96.7 -17.88 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.467 0.543 . . . . 73.3 112.467 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.77 15.42 4.8 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.196 0.598 . . . . 72.51 111.571 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 34' ' ' VAL . 20.2 tt -67.06 -24.9 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 C-N-CA 123.97 0.908 . . . . 72.34 111.88 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -64.55 -12.74 48.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.239 0.829 . . . . 73.43 113.239 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.35 -28.99 26.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.771 0.656 . . . . 71.3 112.771 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 48.0 p-90 -118.64 -35.49 3.71 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.034 0.534 . . . . 64.23 111.883 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -90.88 107.8 23.33 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.596 0.758 . . . . 51.04 109.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.29 -19.06 62.05 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.293 2.662 . . . . 75.41 114.715 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.77 0.67 49.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.02 0.748 . . . . 75.11 113.02 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 27' ' ' ILE . 60.7 t -78.56 117.71 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 120.817 0.342 . . . . 74.54 111.12 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -90.89 51.33 1.94 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.547 0.739 . . . . 55.01 111.915 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 58.9 99.81 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 124.953 1.301 . . . . 42.52 113.147 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.65 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 97.9 Cg_endo -77.46 147.26 25.27 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.821 2.347 . . . . 62.25 114.779 -172.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.6 m -105.47 120.93 42.85 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.625 1.17 . . . . 74.14 109.152 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.86 127.64 38.44 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.269 0.557 . . . . 54.11 112.187 -170.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -115.33 123.36 48.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.077 0.951 . . . . 71.03 110.659 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.68 178.35 0.01 OUTLIER Glycine 0 CA--C 1.546 1.981 0 N-CA-C 117.308 1.683 . . . . 60.44 117.308 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.26 -118.69 1.37 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 124.837 1.255 . . . . 70.1 112.967 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -175.24 162.3 2.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 124.122 0.969 . . . . 74.43 109.421 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.47 -5.29 4.08 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.798 2.332 . . . . 63.55 115.077 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.0 -10.43 9.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.729 -0.607 . . . . 73.53 112.195 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.8 m -98.73 122.0 54.45 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 123.097 0.559 . . . . 70.21 111.357 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.87 113.67 1.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.308 2.672 . . . . 72.43 112.909 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.05 -22.76 2.1 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.132 -0.485 . . . . 72.12 113.172 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 141.49 57.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.51 0.724 . . . . 55.22 112.725 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 38.8 mt-10 -114.5 115.97 28.08 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.195 0.598 . . . . 74.13 109.938 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 29.3 ptt180 -93.36 123.78 36.89 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.441 0.696 . . . . 60.12 110.099 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -119.04 108.28 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.238 0.615 . . . . 74.54 110.209 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -66.63 101.75 0.83 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.623 0.769 . . . . 73.14 112.374 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.53 -71.18 2.3 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.339 -0.391 . . . . 63.22 112.306 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 68.37 136.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.166 1.386 . . . . 42.21 112.926 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.13 19.67 64.43 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-O 121.437 0.465 . . . . 62.32 112.191 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.3 p -117.84 -160.21 0.77 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.545 1.538 . . . . 42.5 110.132 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.87 5.6 15.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.803 0.841 . . . . 71.05 110.527 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.92 9.97 6.96 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.823 0.849 . . . . 75.54 113.233 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.28 144.31 44.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.016 0.747 . . . . 64.12 113.016 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.7 tp -120.71 126.11 49.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.375 1.07 . . . . 73.14 109.453 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.39 115.33 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.975 0.51 . . . . 52.21 109.854 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 43.6 mt-10 -120.0 137.72 53.92 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.024 0.93 . . . . 73.41 110.162 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -118.4 133.65 55.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.297 0.639 . . . . 61.44 112.102 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.67 120.74 21.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.736 1.215 . . . . 70.1 111.133 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.72 -41.53 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.284 0.634 . . . . 73.21 111.256 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 10.7 tp10 -152.99 147.03 25.45 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.092 0.957 . . . . 71.54 110.145 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -146.67 123.44 11.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.687 0.395 . . . . 65.43 110.629 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -106.63 -177.66 3.43 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.967 0.907 . . . . 60.53 110.812 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 41.1 tt0 -147.95 -47.11 0.16 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.866 0.466 . . . . 71.21 110.706 172.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.8 p -64.31 -43.47 94.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.269 0.628 . . . . 60.15 111.186 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.09 -26.54 59.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.349 0.66 . . . . 62.14 112.512 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 60.28 59.45 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.853 0.861 . . . . 71.31 111.426 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -139.31 122.75 17.22 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.766 0.826 . . . . 74.55 110.117 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 66.1 tp -124.27 109.01 12.84 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.21 1.004 . . . . 71.01 111.459 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 56.4 t -106.4 132.0 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.014 0.825 . . . . 75.13 111.28 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -152.84 179.73 8.39 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.103 0.561 . . . . 74.04 111.865 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.2 t -144.66 166.02 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.529 1.132 . . . . 73.23 111.054 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.646 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.7 mtm -99.84 99.38 8.91 Favored Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 123.373 0.669 . . . . 74.45 110.492 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 22.5 Cg_endo -62.13 -20.34 69.53 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 123.517 2.812 . . . . 65.24 112.748 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.75 81.18 69.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.972 0.509 . . . . 74.42 110.436 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.32 123.35 1.02 Allowed 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.787 2.325 . . . . 73.34 112.774 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.98 27.11 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.641 2.228 . . . . 71.25 113.156 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.44 147.27 61.58 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.391 1.077 . . . . 73.25 109.87 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 76.69 0.94 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.099 2.533 . . . . 74.51 113.23 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.1 pt -132.75 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 124.47 1.108 . . . . 75.21 109.953 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 23.8 m -103.27 -78.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.406 0.282 . . . . 70.14 111.41 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -105.02 100.37 9.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.998 0.519 . . . . 74.14 111.171 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -88.61 144.74 26.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 42.35 112.826 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -137.33 158.04 45.29 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 72.44 109.592 168.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HB1' ' HE1' ' A' ' 107' ' ' TRP . . . -158.62 119.91 3.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.516 1.126 . . . . 71.22 109.111 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 31.9 t -125.74 132.23 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.13 0.572 . . . . 75.31 112.449 -168.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.42 119.33 38.68 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.648 0.779 . . . . 73.53 109.3 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -130.45 114.03 15.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.961 0.504 . . . . 72.4 110.567 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.46 116.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.298 0.639 . . . . 71.12 110.36 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.9 m -113.42 123.04 34.01 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 123.902 0.881 . . . . 72.3 110.904 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 124.97 11.79 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.835 2.357 . . . . 70.2 113.483 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -109.24 -9.43 15.0 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.221 1.008 . . . . 61.23 112.143 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 34.9 t70 -175.87 167.9 3.05 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.157 1.383 . . . . 54.22 109.212 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.27 -39.3 66.74 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.045 0.938 . . . . 72.25 112.23 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -131.81 38.95 3.51 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.435 0.636 . . . . 71.12 110.377 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 77.9 m80 -148.95 135.6 19.61 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.293 1.037 . . . . 65.33 109.974 166.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 17' ' ' VAL . 32.0 p -148.98 144.95 27.1 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.395 0.678 . . . . 72.42 110.681 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 78.7 m -93.35 116.96 29.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.151 0.58 . . . . 40.25 110.681 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.79 118.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.04 0.536 . . . . 44.54 109.669 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.8 117.37 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 123.605 0.762 . . . . 73.53 110.45 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.556 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 5.2 t90 -105.3 116.4 31.89 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.974 -0.75 . . . . 73.13 108.974 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -124.46 123.82 40.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.586 0.754 . . . . 63.41 111.371 -170.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -106.93 141.03 38.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.871 0.868 . . . . 74.32 111.076 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -128.59 124.58 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.869 -0.789 . . . . 70.31 108.869 168.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.455 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 5.2 p90 -148.02 147.91 30.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.886 0.328 . . . . 53.42 111.886 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.605 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -84.18 86.83 7.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.365 0.602 . . . . 71.21 109.966 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.746 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.7 t -125.64 144.01 50.78 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.151 -0.931 . . . . 55.25 111.782 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.0 m -59.44 140.08 88.64 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.939 0.896 . . . . 70.32 111.516 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -56.83 -31.62 89.27 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.143 2.562 . . . . 74.2 114.171 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.09 -40.98 95.78 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.958 0.903 . . . . 61.54 112.013 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 24.3 m -88.11 -31.43 19.21 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.521 -0.763 . . . . 52.51 110.997 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -67.15 -40.17 86.67 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.737 0.815 . . . . 70.11 111.64 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -61.63 -33.64 74.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.427 0.691 . . . . 75.12 111.185 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 -36.19 63.12 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.562 1.145 . . . . 60.05 110.411 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 117' ' ' THR . 86.9 mt -74.42 -24.08 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 51.14 111.746 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 49.3 mt-10 -63.23 -35.11 79.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 120.96 0.41 . . . . 75.14 110.703 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 m -72.37 -56.64 5.12 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.271 0.628 . . . . 73.22 112.098 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.69 -54.45 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 112.432 0.531 . . . . 74.33 112.432 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.8 mt -78.68 -51.07 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.033 0.533 . . . . 54.34 110.789 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.99 -49.13 69.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.68 0.632 . . . . 71.44 114.68 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 29.7 t70 -91.82 -52.68 4.62 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 121.85 -0.794 . . . . 70.23 111.212 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.54 -28.71 73.88 Favored Glycine 0 N--CA 1.476 1.362 0 N-CA-C 115.404 0.922 . . . . 54.33 115.404 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.8 t -105.55 -58.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.57 0.685 . . . . 62.13 110.543 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 3.5 m-30 -71.27 -64.96 0.81 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.07 0.548 . . . . 73.51 112.386 -170.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -59.58 -31.44 69.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.993 0.517 . . . . 73.23 112.079 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -58.03 -54.41 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.563 0.745 . . . . 71.02 111.93 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.68 -41.07 94.07 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.304 0.377 . . . . 74.23 113.025 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.01 -43.3 88.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.081 0.953 . . . . 74.21 112.084 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.67 -38.0 76.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 119.47 -0.3 . . . . 72.22 111.107 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.84 81.6 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.136 0.493 . . . . 72.23 111.095 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 HG13 ' A' ' 17' ' ' VAL . 4.2 tt -66.58 -41.43 88.53 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 115.266 -0.879 . . . . 64.34 109.849 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.78 76.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.125 0.57 . . . . 53.25 112.352 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.24 -45.47 60.06 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.468 0.707 . . . . 75.21 111.574 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.38 -26.65 68.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 111.99 0.367 . . . . 70.34 111.99 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.84 -22.81 15.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.176 0.59 . . . . 62.0 112.316 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 O-C-N 122.157 -0.339 . . . . 71.52 113.821 179.572 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 112.145 0.424 . . . . 62.42 112.145 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 m -106.02 116.34 31.77 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.985 -0.746 . . . . 72.54 108.985 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 136.18 39.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.84 1.256 . . . . 75.12 109.298 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -133.9 130.33 37.64 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.201 0.524 . . . . 64.14 110.751 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 32.2 mmt-85 -138.07 153.68 49.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.501 1.12 . . . . 72.23 109.118 169.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 p -152.43 158.66 42.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.216 0.531 . . . . 64.13 111.443 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.9 p -149.82 152.49 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 72.22 109.398 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.96 123.47 48.22 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.705 0.684 . . . . 74.43 110.486 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.12 136.35 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 125.344 1.458 . . . . 55.52 110.372 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.77 66.51 4.27 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.359 0.599 . . . . 50.21 111.199 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.38 157.05 5.62 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.327 1.051 . . . . 72.31 111.023 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.92 140.96 68.87 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.95 2.433 . . . . 73.42 112.199 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.52 23.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.604 1.335 . . . . 54.42 114.604 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.51 82.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.483 0.713 . . . . 71.23 112.3 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 -37.51 86.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.387 0.675 . . . . 55.41 112.358 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG13 HD21 ' A' ' 137' ' ' LEU . 25.8 t -70.49 -36.76 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.528 -0.76 . . . . 72.12 110.645 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -70.89 -28.32 64.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.786 0.834 . . . . 71.23 111.408 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -63.61 -29.76 70.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.157 0.503 . . . . 75.31 111.028 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.09 -51.06 9.47 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.007 0.923 . . . . 64.33 112.047 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.49 -18.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 113.647 0.981 . . . . 55.15 113.647 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.23 -35.05 91.48 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 123.248 0.451 . . . . 71.43 113.221 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.15 97.96 8.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.321 -0.992 . . . . 60.43 108.321 165.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -75.61 -7.1 53.39 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.274 0.559 . . . . 54.41 112.311 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -70.4 -33.64 71.61 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.409 0.623 . . . . 64.21 110.628 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HB1' ' NE ' ' A' ' 29' ' ' ARG . . . -87.5 16.39 5.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.26 1.024 . . . . 64.43 111.722 -167.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 34' ' ' VAL . 19.9 tt -64.89 -22.63 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 C-N-CA 123.798 0.839 . . . . 71.04 111.667 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -69.87 -9.19 53.95 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.032 0.753 . . . . 73.31 113.032 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.7 mtm180 -88.92 -37.45 15.26 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.108 0.563 . . . . 74.2 111.919 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 58.5 p-90 -109.52 -39.13 5.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.613 0.597 . . . . 75.54 112.613 -171.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 60.8 t-80 -86.74 115.79 63.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.789 -0.819 . . . . 72.24 108.789 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -70.05 -19.79 34.28 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.882 2.388 . . . . 73.03 114.412 -165.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.81 -4.93 32.12 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.621 0.971 . . . . 75.34 113.621 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 27' ' ' ILE . 63.0 t -67.14 128.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 111.906 0.335 . . . . 75.23 111.906 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -83.52 27.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.25 1.02 . . . . 74.22 112.881 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.87 107.82 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 125.011 1.324 . . . . 41.11 112.054 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 45.1 Cg_endo -85.7 154.05 10.23 Favored 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 122.295 1.997 . . . . 71.12 114.489 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.8 m -112.47 124.95 53.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.58 0.752 . . . . 64.2 109.984 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.2 mm? -91.2 138.49 31.55 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.385 0.674 . . . . 72.03 112.345 -168.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.42 123.11 44.43 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.335 1.054 . . . . 73.2 109.022 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.05 176.95 0.01 OUTLIER Glycine 0 CA--C 1.547 2.091 0 N-CA-C 117.363 1.705 . . . . 61.44 117.363 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.82 -122.43 1.99 Allowed 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.341 1.056 . . . . 33.53 113.085 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p -168.95 164.0 7.48 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 123.848 0.859 . . . . 61.14 109.578 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.91 -24.18 30.6 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.032 2.488 . . . . 74.31 114.415 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.12 -44.99 7.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.194 0.597 . . . . 74.43 110.892 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -67.72 119.05 63.39 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.683 0.793 . . . . 61.01 112.644 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.88 113.75 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.428 2.752 . . . . 42.44 113.14 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.28 -26.22 2.46 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.878 -0.601 . . . . 75.54 112.594 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -65.42 137.31 57.38 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.637 0.606 . . . . 64.52 112.637 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 51.3 mt-10 -118.13 118.92 33.19 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.086 0.555 . . . . 72.12 110.671 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -106.98 134.28 50.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.084 0.468 . . . . 72.42 110.909 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 20.4 t -115.27 103.35 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.593 0.757 . . . . 74.2 110.581 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.76 99.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.476 1.11 . . . . 74.24 111.649 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.68 53.7 6.36 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 123.224 0.327 . . . . 53.43 112.892 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -65.43 90.44 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.065 0.459 . . . . 54.5 111.762 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.19 38.4 0.06 OUTLIER Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.819 -0.628 . . . . 44.42 112.25 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 59' ' ' GLU . 15.0 t -138.36 -162.53 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.173 0.989 . . . . 70.4 110.172 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.9 15.71 20.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.345 0.658 . . . . 75.4 112.263 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 57' ' ' THR . 11.0 pt-20 -168.51 40.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.3 0.852 . . . . 72.33 113.3 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.37 156.4 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.22 0.608 . . . . 71.44 112.163 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -107.95 120.92 43.66 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.724 0.809 . . . . 50.1 110.625 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.75 121.95 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.841 0.456 . . . . 74.44 110.202 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 47.5 mt-10 -118.26 139.01 51.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.788 0.835 . . . . 71.01 110.776 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 10.4 tpp180 -103.85 130.7 51.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.962 0.905 . . . . 71.44 109.69 174.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.73 120.88 26.92 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.038 0.535 . . . . 63.12 110.151 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.25 -45.88 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.28 0.632 . . . . 65.13 112.296 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 35.4 tt0 -159.69 157.48 29.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.221 0.609 . . . . 72.24 110.858 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -148.04 131.88 17.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.237 0.615 . . . . 71.33 109.968 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -124.4 116.4 22.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.69 0.796 . . . . 63.15 109.868 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.08 13.47 33.98 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.244 0.617 . . . . 50.53 112.495 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -94.31 -46.6 6.98 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.22 0.533 . . . . 65.11 110.159 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.24 8.56 25.81 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.64 0.776 . . . . 52.03 111.834 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 56.63 67.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.088 0.955 . . . . 72.12 112.136 175.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -135.96 110.29 8.44 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.852 0.861 . . . . 64.53 111.328 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.5 tp -107.19 108.76 20.35 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.757 1.223 . . . . 65.04 110.844 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 38.3 t -104.2 130.24 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.381 0.672 . . . . 74.31 111.069 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.47 -178.9 6.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.431 0.692 . . . . 73.35 111.573 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.476 ' HB ' ' NH1' ' A' ' 90' ' ' ARG . 6.0 t -149.88 162.44 40.32 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.327 1.051 . . . . 74.45 110.741 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.8 mtp -111.55 93.17 18.62 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.077 0.951 . . . . 63.52 109.862 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 56.0 Cg_endo -67.82 -20.92 45.19 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.442 2.761 . . . . 62.44 112.732 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.87 77.79 57.64 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.734 0.814 . . . . 71.43 109.944 172.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 63.9 Cg_endo -88.72 143.55 5.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.892 2.394 . . . . 75.2 113.296 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 6.7 Cg_exo -77.13 1.53 8.6 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.878 2.385 . . . . 74.33 113.159 173.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.0 147.44 44.45 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 123.787 0.835 . . . . 61.11 111.05 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' HG2' HG21 ' A' ' 117' ' ' THR . 73.9 Cg_endo -73.1 80.95 1.77 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.695 2.263 . . . . 64.05 112.81 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.697 HG22 ' HB2' ' A' ' 113' ' ' CYS . 20.1 pt -133.41 133.03 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.263 1.025 . . . . 71.11 110.301 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m -74.55 -78.08 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.798 0.439 . . . . 62.43 111.253 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -105.76 108.62 20.23 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.978 -0.451 . . . . 52.04 110.342 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -87.98 142.82 27.49 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.344 0.658 . . . . 51.22 111.356 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.476 ' NH1' ' HB ' ' A' ' 78' ' ' THR . 6.0 tpp180 -149.39 114.25 5.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.473 0.709 . . . . 74.3 109.433 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.42 50.98 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.355 0.525 . . . . 35.42 112.006 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 49.6 t -136.65 141.22 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.224 1.01 . . . . 53.21 111.261 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 3.4 mm? -98.1 140.26 32.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.282 -1.007 . . . . 63.54 108.282 165.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 35.0 tt0 -142.89 110.13 5.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.503 0.592 . . . . 60.43 110.716 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 t -94.03 108.95 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 65.54 108.872 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.4 119.93 54.74 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.644 0.778 . . . . 42.42 109.931 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.83 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.441 2.094 . . . . 65.04 112.249 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -68.22 -32.4 72.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.811 0.844 . . . . 63.4 110.202 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.7 t70 -147.92 165.25 31.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.11 1.364 . . . . 74.45 109.461 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.64 -47.0 85.88 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.279 1.032 . . . . 73.53 111.901 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -113.3 10.94 18.52 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.722 0.809 . . . . 73.54 112.205 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 37.2 m80 -137.59 118.63 14.37 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 118.984 0.811 . . . . 60.31 110.206 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m -136.08 133.83 37.75 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.843 0.457 . . . . 60.32 111.313 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.9 m -92.54 114.81 27.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.142 0.577 . . . . 71.42 111.88 -172.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -92.3 109.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.251 0.621 . . . . 65.21 109.552 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.18 113.1 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.873 0.869 . . . . 74.41 109.647 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -102.63 120.27 40.27 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.857 -0.794 . . . . 71.1 108.857 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.7 m -123.48 141.58 51.86 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.037 0.935 . . . . 63.04 110.426 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.63 110.18 5.76 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.303 0.573 . . . . 72.35 111.508 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -109.54 125.78 52.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.528 1.131 . . . . 62.42 109.161 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -139.35 154.23 47.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.714 0.806 . . . . 72.43 110.596 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 32.7 t70 -86.73 83.76 7.51 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.385 0.612 . . . . 64.53 110.093 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.697 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.1 t -125.37 156.33 38.92 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.641 -0.709 . . . . 64.03 111.754 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -65.36 132.92 95.29 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.487 0.715 . . . . 64.13 111.158 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.23 -38.97 20.68 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.83 3.02 . . . . 71.01 115.472 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.347 0.659 . . . . 71.33 112.127 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' HG2' ' A' ' 85' ' ' PRO . 29.5 m -87.49 -29.07 21.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.824 0.45 . . . . 73.34 110.779 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.41 70.99 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.321 0.648 . . . . 61.11 111.931 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -66.92 -28.08 68.01 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.453 0.701 . . . . 74.31 111.94 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.78 -45.43 61.63 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.567 0.747 . . . . 72.14 110.028 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 117' ' ' THR . 78.3 mt -74.41 -31.63 62.39 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.47 -0.786 . . . . 65.33 113.045 -171.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.96 -34.56 78.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.159 0.436 . . . . 73.04 111.304 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.6 t -70.6 -59.87 2.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.104 0.562 . . . . 65.42 112.117 171.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.11 -55.55 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.266 0.626 . . . . 72.31 112.421 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 121' ' ' LEU . 63.2 mt -76.64 -47.97 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 53.51 110.666 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -61.3 -66.19 2.81 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.765 0.666 . . . . 74.3 114.765 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.59 -41.22 12.12 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.834 -0.804 . . . . 63.13 111.461 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.32 79.02 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.228 0.851 . . . . 60.04 115.228 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.73 -55.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.683 0.742 . . . . 72.35 111.358 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 13.2 m-30 -70.31 -56.37 6.88 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.226 0.454 . . . . 74.34 112.226 -173.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.56 68.52 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.385 0.428 . . . . 71.41 111.525 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.9 t -59.06 -51.18 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 C-N-CA 123.951 0.901 . . . . 52.33 112.263 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -69.56 -34.88 73.95 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 116.607 -0.269 . . . . 64.31 113.633 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.25 -41.65 73.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.128 0.971 . . . . 63.32 111.554 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.64 -40.65 84.58 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.348 -0.387 . . . . 64.11 110.112 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.73 76.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.766 0.827 . . . . 50.42 111.706 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.449 HD21 HG13 ' A' ' 17' ' ' VAL . 5.4 tt -65.13 -39.02 92.47 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 115.419 -0.809 . . . . 73.24 110.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.26 -28.83 64.43 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.055 0.542 . . . . 70.14 112.289 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -67.7 -45.65 74.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.998 0.919 . . . . 74.22 112.099 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.43 HH11 ' HA ' ' A' ' 137' ' ' LEU . 8.8 ptp85 -71.33 -25.52 62.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.098 0.559 . . . . 75.22 112.498 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -93.94 -5.44 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.961 0.505 . . . . 72.43 111.009 170.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.435 0 C-N-CA 122.847 0.261 . . . . 65.12 113.749 176.098 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.902 0.382 . . . . 74.52 111.133 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 110' ' ' MET . 23.5 m -107.55 110.15 21.99 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.765 0.826 . . . . 72.41 109.177 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -94.82 134.52 37.35 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.042 0.937 . . . . 73.21 109.022 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -136.81 137.24 39.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.811 0.444 . . . . 72.44 110.35 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.754 HH11 ' HB2' ' A' ' 131' ' ' ALA . 10.5 ttm180 -147.86 152.1 37.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.201 0.6 . . . . 72.3 109.944 175.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.6 p -141.22 166.38 24.94 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.091 0.472 . . . . 74.41 111.907 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.9 p -152.15 148.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.717 0.807 . . . . 70.14 110.425 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.83 112.08 23.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.236 0.541 . . . . 73.3 109.722 168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 137' ' ' LEU . 88.8 t -91.02 127.9 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.429 1.092 . . . . 71.24 109.762 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 71.16 3.3 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 121.618 0.723 . . . . 71.32 111.541 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.34 151.63 4.62 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.474 1.109 . . . . 72.31 110.247 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.42 140.73 58.9 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.323 2.015 . . . . 51.54 112.257 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.06 -35.49 11.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.505 1.668 . . . . 74.2 115.505 -172.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.19 -48.25 80.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.537 0.569 . . . . 73.11 112.537 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.39 -36.24 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.583 0.753 . . . . 72.41 112.05 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 36.2 t -72.84 -36.65 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.518 0.727 . . . . 71.01 110.631 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.573 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 61.3 t-105 -69.03 -33.5 73.72 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.618 0.767 . . . . 73.24 112.032 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -65.03 -20.1 66.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.563 0.697 . . . . 74.53 111.317 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.2 tp -89.9 -52.67 4.86 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.001 0.921 . . . . 74.21 112.06 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.08 -48.45 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 112.867 0.692 . . . . 65.14 112.867 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.06 65.7 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 115.172 0.829 . . . . 74.31 115.172 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.44 -18.1 60.69 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.065 0.546 . . . . 72.24 111.477 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 t80 73.64 -66.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.785 1.634 . . . . 73.12 112.105 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.3 p -67.7 -14.34 62.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.994 0.918 . . . . 45.22 113.182 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.17 9.77 18.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.67 0.788 . . . . 72.11 111.674 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG23 HG11 ' A' ' 34' ' ' VAL . 19.9 tt -61.23 -31.15 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 N-CA-C 112.76 0.652 . . . . 54.44 112.76 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -70.47 -5.78 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.075 0.768 . . . . 73.02 113.075 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -91.45 -19.86 22.38 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.453 0.701 . . . . 74.31 112.495 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 60.0 p-90 -121.31 -30.6 4.25 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.037 0.535 . . . . 73.23 111.719 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -93.63 103.75 10.85 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.384 0.674 . . . . 75.44 109.815 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.14 -15.92 52.56 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.238 2.626 . . . . 72.33 115.21 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -85.07 -28.66 25.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.885 0.474 . . . . 64.14 111.446 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 27' ' ' ILE . 49.1 t -78.7 113.57 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 110.218 -0.29 . . . . 61.3 110.218 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -73.58 -62.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.285 0.634 . . . . 44.25 110.399 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.62 116.01 0.59 Allowed Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 124.386 1.075 . . . . 63.43 110.189 173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.39 144.71 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.463 2.109 . . . . 73.33 113.381 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -95.91 126.7 41.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.193 0.997 . . . . 62.11 109.804 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 9.5 mp -110.03 145.75 36.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.648 0.737 . . . . 65.21 111.42 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -149.85 147.04 27.48 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.486 -1.234 . . . . 72.32 110.246 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.5 153.38 0.0 OUTLIER Glycine 0 CA--C 1.555 2.585 0 N-CA-C 117.687 1.835 . . . . 62.3 117.687 -167.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 72.9 -50.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.837 1.655 . . . . 65.33 115.312 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m 102.12 147.51 0.02 OUTLIER Pre-proline 0 N--CA 1.516 2.863 0 C-N-CA 127.709 2.404 . . . . 63.41 111.869 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.69 -38.53 46.27 Favored 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 124.427 3.418 . . . . 63.33 115.549 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -90.99 10.53 26.22 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.351 0.5 . . . . 73.0 112.351 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -123.75 119.13 26.99 Favored Pre-proline 0 N--CA 1.487 1.382 0 C-N-CA 123.833 0.853 . . . . 42.04 110.536 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 129.22 31.08 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.335 2.69 . . . . 65.45 113.807 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.02 -10.5 13.59 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.392 0.52 . . . . 71.54 112.96 -175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.07 154.69 40.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.376 0.67 . . . . 70.43 111.95 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 50.6 mt-10 -112.79 128.81 56.54 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.938 0.495 . . . . 72.05 111.602 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -107.41 102.86 12.11 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.651 0.78 . . . . 73.2 109.554 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.1 t -106.7 104.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.313 0.577 . . . . 63.32 111.353 -170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' ' 34' ' ' VAL . 66.0 m-85 -75.34 82.68 2.45 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.307 1.043 . . . . 70.42 111.264 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.05 -63.11 0.58 Allowed Glycine 0 N--CA 1.478 1.449 0 CA-C-N 116.042 -0.526 . . . . 60.41 112.3 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.77 -53.23 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.079 1.751 . . . . 73.32 115.318 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.83 37.56 3.32 Favored Glycine 0 N--CA 1.487 2.065 0 CA-C-O 121.234 0.352 . . . . 75.04 112.932 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -120.63 -165.75 1.24 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.274 1.029 . . . . 42.44 110.62 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -122.77 27.41 7.77 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.952 0.901 . . . . 63.31 109.701 167.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.17 9.54 1.11 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.205 1.002 . . . . 51.23 111.913 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 152.21 39.4 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.367 0.604 . . . . 54.02 112.498 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.545 HD11 ' SD ' ' A' ' 79' ' ' MET . 29.2 tp -107.22 119.92 40.71 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.102 0.961 . . . . 72.44 109.224 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.755 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 94.5 t -95.99 114.34 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.283 0.563 . . . . 72.33 109.482 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 17.1 tt0 -115.24 167.88 10.45 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.445 1.098 . . . . 54.24 109.898 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 30.3 ttm-85 -150.82 128.88 11.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.126 0.97 . . . . 54.44 111.736 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.79 129.2 39.19 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.951 0.9 . . . . 63.12 111.123 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.595 HG21 HH11 ' A' ' 90' ' ' ARG . 79.0 t -101.29 -51.13 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.772 0.829 . . . . 75.24 111.384 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -149.72 148.73 29.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.372 1.069 . . . . 70.15 109.136 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -140.02 119.6 13.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.966 -0.383 . . . . 73.54 109.966 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 24.5 m-20 -101.09 102.45 13.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.525 1.13 . . . . 72.24 109.773 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 31.4 tt0 -75.74 -41.14 54.13 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.26 -0.275 . . . . 74.41 111.008 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.9 m -68.76 -50.05 53.71 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.36 0.664 . . . . 62.54 111.146 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -78.49 -6.14 54.55 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.983 0.734 . . . . 55.21 112.983 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 63.43 45.2 4.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.74 1.216 . . . . 74.53 111.945 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.1 ttm105 -129.39 135.36 48.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.913 1.285 . . . . 75.12 110.455 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 tp -125.43 106.15 9.59 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.043 0.537 . . . . 51.35 110.745 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -105.7 126.11 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.693 0.797 . . . . 74.25 110.519 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -146.57 179.51 7.5 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.426 0.69 . . . . 71.13 112.043 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 m -156.56 142.24 17.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.955 1.302 . . . . 71.53 109.74 -169.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.545 ' SD ' HD11 ' A' ' 61' ' ' LEU . 57.3 mtm -95.87 98.79 4.19 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 118.234 0.47 . . . . 61.14 109.79 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.82 -25.03 17.31 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.375 2.717 . . . . 51.22 112.901 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.7 t70 -129.59 80.04 72.55 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.464 0.706 . . . . 74.11 109.489 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -93.36 133.47 0.94 Allowed 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 122.964 2.443 . . . . 54.05 112.761 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.479 ' HD2' HD13 ' A' ' 61' ' ' LEU . 71.7 Cg_endo -72.27 -2.03 11.05 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.203 1.935 . . . . 71.42 112.073 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.84 140.77 50.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 124.454 1.102 . . . . 71.43 109.924 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 77.76 2.77 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.476 2.117 . . . . 73.24 112.889 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 89' ' ' HIS . 7.4 pt -138.94 143.99 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.661 1.184 . . . . 72.31 110.412 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -72.17 -47.45 50.78 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.344 0.868 . . . . 75.25 113.344 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -131.97 -49.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.266 0.469 . . . . 52.34 112.266 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.561 ' HB2' HD12 ' A' ' 86' ' ' ILE . 47.9 t-80 65.35 145.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 125.417 1.487 . . . . 75.04 113.736 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.595 HH11 HG21 ' A' ' 66' ' ' VAL . 21.4 tpp180 -147.08 149.01 32.2 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.732 1.213 . . . . 74.13 108.347 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.7 146.44 20.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.968 0.507 . . . . 74.1 111.74 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.5 p -137.23 140.28 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.376 0 N-CA-C 113.106 0.78 . . . . 74.03 113.106 -174.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -107.62 108.48 19.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.504 1.121 . . . . 52.24 108.691 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -121.0 111.65 17.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.089 -0.708 . . . . 74.04 109.089 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.32 110.79 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.709 -0.849 . . . . 73.32 108.709 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.39 123.8 61.22 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.15 0.98 . . . . 64.22 109.928 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.64 137.31 41.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.448 2.099 . . . . 74.44 111.974 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.605 HH11 ' HB2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -138.05 -34.52 0.66 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.162 0.585 . . . . 64.25 111.403 -172.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.4 t70 -163.65 159.47 21.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.178 0.991 . . . . 53.11 110.01 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.5 -31.16 55.42 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.897 1.279 . . . . 73.23 113.092 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -140.18 26.69 2.19 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.167 0.587 . . . . 75.13 110.373 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.9 m80 -147.94 111.18 4.9 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.045 0.938 . . . . 73.41 109.32 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -133.76 137.02 44.95 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.241 0.616 . . . . 62.22 110.824 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.8 m -94.71 114.09 25.96 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.102 0.561 . . . . 71.2 112.231 -170.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.78 122.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.742 -0.466 . . . . 71.12 109.742 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.83 115.31 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.168 -0.678 . . . . 71.32 109.168 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.9 123.31 49.38 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.449 HG22 ' SD ' ' A' ' 110' ' ' MET . 91.8 m -130.58 135.37 47.83 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 62.23 110.382 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.75 115.13 15.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.84 0.856 . . . . 65.55 110.761 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.518 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -121.56 132.89 54.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.714 1.206 . . . . 73.2 109.871 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -145.46 147.81 32.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.31 0.644 . . . . 74.23 111.878 -171.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.86 87.57 5.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.235 -0.654 . . . . 72.35 109.235 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 42.0 t -143.5 167.5 22.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.808 0.67 . . . . 63.53 112.808 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.41 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.7 m -70.13 142.23 89.91 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.316 1.046 . . . . 65.42 112.435 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.47 -40.3 54.15 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.473 2.782 . . . . 73.34 114.724 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.74 -31.56 69.75 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.063 0.945 . . . . 73.32 112.764 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -89.9 -29.93 18.22 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.41 0.684 . . . . 52.13 111.113 176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.13 77.27 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.622 0.769 . . . . 70.12 112.198 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -68.33 -36.56 79.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.031 0.932 . . . . 75.4 111.988 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.58 -49.17 72.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.402 0.681 . . . . 74.3 109.895 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -71.97 -23.67 61.47 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.931 -1.031 . . . . 65.22 111.352 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.19 -48.66 79.63 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.582 0.753 . . . . 75.2 110.817 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.7 m -69.23 -53.25 20.86 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.593 -0.731 . . . . 65.13 112.665 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.7 -53.85 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.53 0.567 . . . . 74.41 112.53 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.4 -48.18 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.131 0.572 . . . . 73.33 111.125 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.52 -52.39 35.27 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 114.629 0.611 . . . . 32.25 114.629 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.31 -44.63 10.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 122.062 -0.67 . . . . 74.4 112.033 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.89 -47.51 54.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 116.071 -0.513 . . . . 72.23 113.876 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.44 -53.24 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.96 0.504 . . . . 71.51 111.631 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.1 m-30 -75.65 -56.92 4.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.321 0.489 . . . . 74.23 112.321 -171.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB2' HH11 ' A' ' 6' ' ' ARG . . . -55.93 -38.55 70.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.949 0.404 . . . . 44.14 111.768 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 t -65.78 -54.45 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 123.455 0.702 . . . . 70.24 112.347 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.98 71.81 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 113.851 0.3 . . . . 64.41 113.851 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.57 -42.89 99.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.361 1.065 . . . . 75.22 112.473 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 92.4 m-20 -70.01 -39.72 75.67 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 119.726 -0.178 . . . . 65.03 110.931 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.94 79.82 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.103 0.561 . . . . 75.5 111.234 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 4.8 tt -65.49 -38.25 89.21 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.454 0.702 . . . . 74.41 110.324 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.69 68.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.939 0.496 . . . . 53.24 111.918 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 18.7 mm-40 -69.39 -42.88 74.53 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.446 0.699 . . . . 72.13 111.724 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.13 -28.92 67.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.601 0.36 . . . . 74.42 111.936 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -97.53 6.64 47.81 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.809 0.444 . . . . 71.14 111.828 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 116.434 1.334 . . . . 72.22 116.434 -177.593 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.359 0.6 . . . . 74.54 109.811 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 110' ' ' MET . 58.1 m -131.7 121.25 23.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.649 0.779 . . . . 62.53 110.01 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.75 111.47 23.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.622 1.169 . . . . 73.04 110.027 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -104.74 120.54 41.62 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.827 -0.805 . . . . 73.24 108.827 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.24 135.82 46.55 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.741 -0.466 . . . . 73.21 109.741 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.6 p -141.42 159.59 41.91 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.02 0.528 . . . . 61.14 112.294 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.9 p -147.27 141.28 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.777 0.831 . . . . 73.21 110.62 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.1 111.03 23.53 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.609 0.719 . . . . 71.34 110.276 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 137' ' ' LEU . 66.1 t -102.44 145.45 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 125.573 1.549 . . . . 72.32 112.1 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.66 59.74 3.13 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.031 0.932 . . . . 65.23 112.391 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 141.64 6.55 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.349 0.659 . . . . 71.4 111.15 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.15 138.11 65.22 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.972 2.448 . . . . 44.12 113.382 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.4 -46.46 13.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.8 1.778 . . . . 52.01 115.8 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.02 90.82 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.521 0.563 . . . . 72.2 112.521 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.82 -30.44 68.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.474 0.546 . . . . 65.04 112.474 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' SG ' ' A' ' 103' ' ' CYS . 83.5 t -70.66 -35.44 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.783 0.433 . . . . 64.3 110.679 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -67.37 -27.6 67.25 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.778 0.431 . . . . 74.4 111.295 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.3 m -63.85 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.316 0.579 . . . . 63.42 111.529 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.6 tp -84.16 -56.83 3.45 Favored 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.486 1.114 . . . . 41.14 112.47 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.47 -21.61 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.727 1.01 . . . . 74.53 113.727 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.48 -50.37 59.73 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.526 0.516 . . . . 71.54 114.111 -170.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.67 127.79 34.32 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.209 -0.663 . . . . 51.23 109.209 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.68 -30.04 71.09 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.357 1.063 . . . . 74.12 112.491 -169.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -99.27 0.84 43.92 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.487 0.715 . . . . 71.01 112.476 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -89.94 8.88 30.07 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.199 0.6 . . . . 72.53 111.837 -174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.685 HG21 ' NH2' ' A' ' 51' ' ' ARG . 19.9 tt -65.8 -30.83 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.597 1.159 . . . . 72.42 113.208 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -66.11 -9.48 31.63 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.701 0.63 . . . . 73.32 112.701 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 69.8 mtp180 -83.87 -14.88 50.07 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.936 0.895 . . . . 74.12 112.354 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 51.7 p-90 -130.28 -40.83 1.27 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 112.77 0.656 . . . . 72.32 112.77 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.452 ' ND1' HG23 ' A' ' 34' ' ' VAL . 32.7 t-80 -85.79 113.17 49.92 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.073 0.549 . . . . 74.15 110.519 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -18.89 31.08 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.212 2.608 . . . . 53.34 114.525 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 35.5 mt-30 -94.69 -13.04 26.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.81 0.67 . . . . 64.34 112.81 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.452 HG23 ' ND1' ' A' ' 31' ' ' HIS . 90.9 t -73.12 114.38 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 121.072 0.463 . . . . 74.15 110.26 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -92.93 35.95 1.04 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.395 1.078 . . . . 63.31 111.64 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.03 115.32 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 C-N-CA 125.603 1.561 . . . . 62.22 112.483 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HG3' ' HE ' ' A' ' 51' ' ' ARG . 26.3 Cg_endo -95.71 177.99 0.7 Allowed 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.381 2.721 . . . . 61.0 114.703 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.1 m -119.42 132.34 55.8 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.322 1.049 . . . . 52.43 110.451 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.2 136.34 37.86 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.454 0.645 . . . . 73.43 111.416 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.513 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -121.74 145.05 48.42 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.512 1.125 . . . . 65.14 110.294 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 119.71 0.0 OUTLIER Glycine 0 CA--C 1.556 2.611 0 N-CA-C 117.613 1.805 . . . . 42.11 117.613 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.57 -96.41 0.05 OUTLIER 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 125.614 1.566 . . . . 72.32 113.644 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -158.71 150.76 17.35 Favored Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 123.29 0.636 . . . . 62.42 111.78 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.12 -12.58 33.13 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.11 2.54 . . . . 74.22 114.155 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 80.1 m-70 -97.06 -5.72 36.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.827 -0.545 . . . . 73.44 111.657 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.6 m -96.89 113.78 63.49 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.788 0.835 . . . . 71.12 110.758 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.2 Cg_endo -55.97 114.84 2.08 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.253 2.635 . . . . 52.35 112.87 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.36 -23.79 4.02 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-N 115.915 -0.584 . . . . 73.33 112.558 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.69 133.74 55.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.417 0.687 . . . . 43.42 112.254 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 43.4 mt-10 -103.26 138.57 39.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.966 0.506 . . . . 65.11 110.754 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.685 ' NH2' HG21 ' A' ' 27' ' ' ILE . 32.5 ttt-85 -125.15 106.01 9.58 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.176 0.99 . . . . 74.25 110.745 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 t -110.55 109.31 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.338 0.655 . . . . 72.31 111.4 -169.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HE2' HG22 ' A' ' 34' ' ' VAL . 46.2 m-85 -62.32 118.61 7.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.334 1.054 . . . . 73.43 111.326 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.84 -71.91 2.88 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 112.451 -0.26 . . . . 71.11 112.451 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.74 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.881 1.272 . . . . 74.22 113.468 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 25.52 3.98 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 116.348 -0.387 . . . . 45.41 113.948 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.5 -172.32 2.49 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.301 1.04 . . . . 51.53 110.205 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.4 0.96 54.7 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.808 0.443 . . . . 71.35 111.746 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.1 88.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.568 0.747 . . . . 63.45 110.034 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.38 139.6 49.35 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.376 0.671 . . . . 65.11 110.414 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -95.2 117.46 30.28 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.517 0.727 . . . . 73.31 109.902 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 43.6 t -96.17 115.97 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.735 -0.469 . . . . 62.4 109.735 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 23.3 tt0 -112.69 166.65 11.16 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.211 1.005 . . . . 72.11 109.837 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -151.6 124.98 8.84 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.926 0.49 . . . . 34.23 111.918 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 34.4 tp -68.2 120.07 13.78 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.833 1.253 . . . . 75.11 111.353 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -85.21 -52.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.246 0.618 . . . . 52.4 110.647 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 8.5 pt-20 -155.83 139.72 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.156 0.583 . . . . 72.21 110.456 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.718 HH12 ' HB3' ' A' ' 70' ' ' GLU . 41.4 tpt85 -131.94 106.85 8.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.608 0.763 . . . . 60.23 109.641 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.92 116.63 23.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.603 0.761 . . . . 42.44 111.355 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' HH12 ' A' ' 68' ' ' ARG . 13.1 pt-20 -84.6 -39.19 19.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.284 0.634 . . . . 75.31 112.63 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.7 m -71.83 -25.34 61.94 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.311 0.644 . . . . 52.14 111.262 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.9 -17.86 32.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.468 0.707 . . . . 72.33 111.784 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 55.49 43.75 28.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.985 0.914 . . . . 71.24 111.226 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -133.45 116.07 15.56 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 114.471 -1.241 . . . . 71.55 109.887 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.672 HD13 ' HD3' ' A' ' 68' ' ' ARG . 23.9 tp -119.03 109.67 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.867 1.267 . . . . 61.31 110.923 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 75.9 t -110.34 137.44 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.829 -0.545 . . . . 70.14 111.392 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -145.14 179.21 7.51 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.67 1.188 . . . . 73.0 110.507 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -163.32 152.79 14.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.463 1.105 . . . . 73.14 109.243 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.0 mpp? -91.03 109.72 37.17 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 118.024 0.375 . . . . 64.52 110.386 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.08 -21.19 63.32 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.664 2.242 . . . . 73.1 111.851 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 29.7 t70 -122.94 80.6 50.34 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.919 0.888 . . . . 62.4 109.558 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -94.88 137.29 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.069 2.513 . . . . 74.21 113.057 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.51 12.05 3.17 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.855 2.37 . . . . 61.32 113.447 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -108.43 144.97 30.57 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 124.005 0.922 . . . . 73.01 109.971 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.26 65.47 7.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.83 2.353 . . . . 72.12 112.289 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 22.2 pt -122.76 131.62 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.18 0.992 . . . . 74.43 110.955 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 26.4 m -78.44 134.51 37.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 110.069 -0.345 . . . . 71.42 110.069 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 56.1 -67.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 128.132 2.573 . . . . 63.01 114.721 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 69.11 148.06 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.343 1.457 . . . . 62.22 111.516 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.449 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 64.8 ttt-85 -164.66 107.86 0.89 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 109.532 -0.544 . . . . 74.41 109.532 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.37 146.31 33.22 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.197 0.599 . . . . 64.44 112.016 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.6 p -138.09 144.43 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 113.501 0.926 . . . . 75.24 113.501 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.35 112.07 24.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.17 1.388 . . . . 60.43 109.297 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -119.06 113.69 21.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.197 0.999 . . . . 72.21 110.139 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 t -93.06 112.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.988 -0.445 . . . . 53.0 110.208 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.33 119.28 58.11 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.377 1.071 . . . . 63.32 110.961 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.5 107.68 2.05 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.504 2.136 . . . . 65.13 112.825 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -86.61 -42.66 13.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.984 0.914 . . . . 74.4 111.061 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.3 t70 -140.49 178.92 6.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.44 1.096 . . . . 74.11 109.058 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.09 -48.62 28.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.056 0.542 . . . . 73.3 111.031 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.9 tmt_? -95.96 -1.52 48.93 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.89 0.876 . . . . 73.13 111.03 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 59.4 m-70 -135.77 158.54 44.15 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.391 -0.818 . . . . 74.2 110.73 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.4 p -156.61 178.23 10.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.786 0.434 . . . . 73.33 111.514 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.4 m -119.43 127.35 53.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.888 0.875 . . . . 54.44 110.782 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t -95.26 110.35 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.2 t -99.68 108.83 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.382 0.673 . . . . 60.42 110.04 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -106.8 119.27 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.048 -0.723 . . . . 75.43 109.048 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.4 m -126.4 150.54 48.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.0 0.92 . . . . 72.12 109.943 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.61 120.03 8.46 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.236 0.614 . . . . 65.33 111.244 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.515 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -117.12 128.6 55.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.117 0.967 . . . . 74.23 110.211 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 19.2 p90 -146.91 143.01 28.2 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.205 1.402 . . . . 74.11 108.462 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 15.8 t70 -89.88 78.39 6.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.733 0.778 . . . . 74.33 109.659 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 52.6 t -117.82 163.1 17.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.203 0.601 . . . . 71.44 111.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.1 p -64.38 138.76 97.53 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.672 0.789 . . . . 71.13 112.018 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.55 -36.43 18.47 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.943 3.095 . . . . 61.11 115.169 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -61.06 -53.75 53.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.54 0.736 . . . . 65.14 111.352 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.43 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 48.7 m -72.84 -27.29 61.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.986 0.515 . . . . 73.33 111.517 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.42 -43.3 81.55 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.914 0.885 . . . . 54.22 112.57 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -68.51 -29.14 67.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.365 0.666 . . . . 70.03 111.484 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.49 -43.93 68.72 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.361 0.665 . . . . 62.33 110.498 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.06 -23.25 59.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.89 0.876 . . . . 71.33 111.536 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -57.54 -44.78 85.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.851 0.46 . . . . 70.31 110.18 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.8 t -71.61 -52.32 18.63 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 63.14 112.738 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.91 -54.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 123.447 0.699 . . . . 62.25 112.705 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.89 -50.58 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.135 0.574 . . . . 74.23 111.115 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.18 -49.31 58.4 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 114.652 0.621 . . . . 45.43 114.652 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.08 -48.99 7.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.126 -0.631 . . . . 75.23 111.56 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.51 -29.8 65.34 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 115.496 0.959 . . . . 62.13 115.496 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.93 -53.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 117.784 0.792 . . . . 73.12 110.96 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.0 m-30 -73.25 -60.46 2.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.444 0.698 . . . . 75.21 112.287 -170.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.81 66.98 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 123.497 0.498 . . . . 73.31 111.488 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -55.94 -54.82 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 123.666 0.786 . . . . 74.25 112.295 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.75 80.72 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 113.69 0.236 . . . . 74.52 113.69 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.58 -42.21 71.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.057 0.943 . . . . 73.3 111.884 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.68 -41.39 83.78 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.519 0.328 . . . . 71.12 110.289 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.34 80.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.802 0.841 . . . . 55.35 111.969 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.427 HD22 HG21 ' A' ' 10' ' ' VAL . 7.8 tt -65.26 -43.22 91.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.715 0.806 . . . . 55.31 110.228 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.94 74.59 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.275 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.58 -48.13 61.27 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.865 0.866 . . . . 72.14 112.794 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -19.9 65.37 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.49 0.552 . . . . 55.25 112.49 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -91.34 -44.3 9.26 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.882 0.473 . . . . 74.04 111.864 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 114.323 0.489 . . . . 74.33 114.323 -174.95 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.26 0.552 . . . . 43.41 110.964 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 m -121.92 111.28 16.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.811 0.844 . . . . 72.4 110.318 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 6.8 mp -96.08 109.59 21.99 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 45.44 110.039 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.53 123.71 39.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.898 0.479 . . . . 63.32 110.946 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.465 HH22 ' HG2' ' A' ' 122' ' ' GLU . 1.2 mmp_? -122.28 160.39 25.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.333 1.053 . . . . 74.53 108.817 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -153.31 146.81 24.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.11 0.564 . . . . 70.25 111.244 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.0 p -138.73 145.58 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.156 0.583 . . . . 72.42 111.314 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.94 110.88 22.72 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.495 0.718 . . . . 71.4 110.426 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 65.9 t -101.41 139.93 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.562 1.145 . . . . 73.15 111.578 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.72 40.78 0.61 Allowed 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 113.766 1.025 . . . . 52.21 113.766 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.54 32.27 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.205 0.602 . . . . 34.15 111.654 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.08 145.28 78.67 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.984 2.456 . . . . 74.33 113.265 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.31 -35.31 37.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.345 1.458 . . . . 72.32 114.72 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.69 -51.55 61.87 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.77 -44.78 90.73 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.282 0.633 . . . . 63.45 111.162 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 103' ' ' CYS . 49.2 t -68.72 -34.07 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.605 0.762 . . . . 62.25 111.08 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.559 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 55.8 t-105 -59.55 -40.99 89.07 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.458 0.303 . . . . 72.13 111.219 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -61.37 -24.99 66.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.796 0.438 . . . . 75.15 111.564 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 30' ' ' TRP . 29.5 tp -83.67 -44.29 14.66 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 112.736 0.643 . . . . 70.3 112.736 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.62 -26.26 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 114.098 1.147 . . . . 75.54 114.098 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.71 35.42 3.22 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 115.876 1.11 . . . . 43.14 115.876 -165.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.26 -162.07 0.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.806 0.842 . . . . 53.33 111.158 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.14 25.2 1.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.302 0.641 . . . . 51.43 110.195 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -152.15 -42.83 0.11 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.498 0.719 . . . . 74.11 111.763 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.4 3.12 48.34 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.221 1.008 . . . . 61.23 111.199 -170.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 34' ' ' VAL . 14.3 tt -55.92 -19.76 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 C-N-CA 125.853 1.661 . . . . 72.21 113.108 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.37 -14.36 55.96 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.409 0.892 . . . . 73.41 113.409 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -71.85 -20.18 61.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.533 0.733 . . . . 72.22 112.374 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HB3' HD21 ' A' ' 20' ' ' LEU . 31.5 p-90 -127.71 -35.08 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.008 0.523 . . . . 74.25 111.912 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -89.77 112.37 51.59 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 122.819 0.447 . . . . 74.34 110.337 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.68 -16.27 37.8 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.275 2.65 . . . . 70.32 114.083 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -93.15 -20.69 20.24 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.724 0.81 . . . . 73.51 112.12 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 27' ' ' ILE . 72.9 t -69.32 111.79 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 120.919 0.39 . . . . 61.54 110.894 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -92.33 27.46 2.23 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.429 1.092 . . . . 35.5 111.9 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.03 98.1 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.577 1.151 . . . . 62.22 111.27 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.11 173.14 8.12 Favored 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 123.116 2.544 . . . . 62.34 114.693 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -99.96 123.02 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.0 0.92 . . . . 65.2 109.758 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.71 127.32 39.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.237 0.615 . . . . 73.01 111.204 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -104.64 123.23 47.22 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.719 -0.673 . . . . 74.24 109.612 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.33 -175.41 0.01 OUTLIER Glycine 0 CA--C 1.55 2.241 0 N-CA-C 117.543 1.777 . . . . 61.13 117.543 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 46.75 -121.31 1.14 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.839 1.256 . . . . 75.53 113.315 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -162.8 155.9 16.78 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 124.375 1.07 . . . . 75.35 108.985 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.42 -15.52 45.82 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.502 2.135 . . . . 72.0 114.859 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -111.41 0.77 16.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.66 -0.65 . . . . 55.14 111.546 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -110.77 127.69 26.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 123.732 0.813 . . . . 73.21 110.928 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 85.5 Cg_exo -50.15 138.68 36.21 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.68 2.92 . . . . 73.42 114.149 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.97 19.6 21.24 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 116.272 -0.422 . . . . 63.34 113.564 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.78 134.74 51.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.71 0.804 . . . . 74.41 110.737 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.35 118.44 35.85 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.952 0.501 . . . . 74.21 110.965 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -93.63 126.26 38.69 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.888 0.375 . . . . 73.4 110.042 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 62' ' ' VAL . 20.6 t -122.42 122.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 122.902 0.481 . . . . 74.45 111.238 -171.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' HE2' HG13 ' A' ' 34' ' ' VAL . 48.6 m-85 -95.56 85.31 4.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.216 1.006 . . . . 73.53 111.118 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.25 -43.41 1.61 Allowed Glycine 0 N--CA 1.478 1.488 0 N-CA-C 112.722 -0.151 . . . . 74.23 112.722 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 17.7 4.12 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.949 1.463 . . . . 73.32 114.949 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.31 57.8 0.03 OUTLIER Glycine 0 N--CA 1.472 1.064 0 N-CA-C 112.595 -0.202 . . . . 43.32 112.595 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -105.87 -69.1 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.982 0.913 . . . . 52.51 109.729 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 176.64 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.527 1.531 . . . . 72.31 109.252 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.75 82.21 2.07 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.871 0.843 . . . . 74.32 108.818 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.72 -179.77 3.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.15 0.98 . . . . 74.12 110.601 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD11 ' SD ' ' A' ' 79' ' ' MET . 55.0 tp -141.14 123.53 15.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.799 0.44 . . . . 72.21 110.896 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.0 t -104.7 115.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.162 -0.681 . . . . 70.55 109.162 170.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -104.73 149.67 25.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.872 0.869 . . . . 55.4 109.889 171.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -127.5 127.39 43.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.068 1.347 . . . . 74.4 109.867 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.17 108.99 9.47 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.932 0.893 . . . . 54.13 110.662 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -73.26 -50.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.363 0.665 . . . . 54.21 110.555 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.723 ' HA ' ' HG3' ' A' ' 47' ' ' PRO . 8.6 pt-20 -166.81 155.46 10.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.541 0.736 . . . . 73.34 111.095 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -141.69 123.04 14.87 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.37 0.668 . . . . 70.21 110.497 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.35 -178.37 4.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.045 0.938 . . . . 74.24 111.826 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.559 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 55.4 mt-10 -138.92 -63.72 0.52 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.228 1.011 . . . . 75.22 109.955 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -69.57 -38.25 77.33 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.414 0.686 . . . . 62.35 111.439 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.67 -19.83 60.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.431 0.692 . . . . 55.41 112.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 55.74 45.0 25.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 65.3 112.253 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.45 HH11 HG23 ' A' ' 76' ' ' VAL . 9.0 tmm_? -130.7 130.99 44.55 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 115.031 -0.986 . . . . 63.44 110.475 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 46.2 tp -120.36 123.63 43.56 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.363 1.065 . . . . 74.4 110.212 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.5 t -114.38 132.35 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 118.958 0.799 . . . . 54.41 111.072 174.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -147.61 175.18 11.07 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 51.55 111.349 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.6 t -150.15 145.26 26.19 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.402 1.081 . . . . 73.24 109.55 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.3 ptt? -95.96 101.06 7.46 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 118.787 0.721 . . . . 74.43 110.7 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.47 -17.37 30.38 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 123.178 2.586 . . . . 63.11 113.229 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 34.9 t70 -132.8 79.18 64.49 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 123.427 0.691 . . . . 74.23 109.859 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -96.34 154.93 1.32 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.42 2.747 . . . . 75.32 114.033 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.94 -17.43 22.45 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.119 1.879 . . . . 71.51 112.554 168.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -80.33 142.2 54.25 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 123.812 0.845 . . . . 75.21 112.047 -175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.07 77.4 3.49 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.717 2.278 . . . . 62.12 113.21 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.1 pt -133.54 154.7 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.285 1.034 . . . . 71.32 110.774 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 35.9 m -90.76 -79.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.985 -0.447 . . . . 63.4 110.757 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -106.37 107.82 19.03 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.358 0.599 . . . . 73.32 110.924 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.407 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 43.5 t-80 -84.94 149.72 25.44 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.772 0.829 . . . . 64.33 111.06 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -153.31 106.89 3.01 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.492 0.717 . . . . 73.12 109.952 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -117.0 142.38 47.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.981 0.512 . . . . 54.24 111.926 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 92.8 t -133.6 134.83 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.25 1.02 . . . . 63.25 111.061 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 mm? -94.46 147.02 23.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.745 -0.835 . . . . 63.4 108.745 166.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.27 117.65 4.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.677 0.391 . . . . 75.43 110.179 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.05 112.46 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.784 -0.451 . . . . 60.41 109.784 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.84 120.7 67.02 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.737 0.815 . . . . 71.45 110.581 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.18 87.56 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.325 2.017 . . . . 52.43 112.123 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -76.17 -32.16 58.9 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.098 0.959 . . . . 71.52 111.148 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 16.6 t70 -158.73 170.9 21.1 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.65 1.58 . . . . 63.34 108.42 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -54.29 -52.86 60.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 61.24 112.475 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -119.85 23.25 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.533 0.682 . . . . 73.11 110.845 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.734 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.4 m80 -132.62 121.36 23.08 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.534 -0.729 . . . . 73.12 109.38 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 17' ' ' VAL . 30.1 p -128.28 138.33 52.37 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.986 0.514 . . . . 74.13 109.647 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.9 m -96.05 109.7 22.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.834 -0.432 . . . . 73.11 109.834 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 108.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.134 -0.691 . . . . 74.24 109.134 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.89 112.5 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.261 1.024 . . . . 64.5 109.087 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -104.51 118.71 37.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.776 -0.824 . . . . 71.05 108.776 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -120.11 149.37 42.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.186 0.995 . . . . 74.53 110.023 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -146.08 157.96 43.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.557 1.143 . . . . 43.12 109.206 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -161.46 134.64 6.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.748 0.819 . . . . 75.03 109.783 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -145.51 152.98 40.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.146 0.578 . . . . 70.21 111.81 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 22.2 t70 -75.35 88.91 2.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.935 -0.575 . . . . 44.52 109.815 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.632 ' HB2' HG22 ' A' ' 86' ' ' ILE . 34.0 t -147.76 166.27 28.02 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.354 -0.839 . . . . 73.13 111.205 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.4 p -67.21 145.68 98.72 Favored Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 123.254 0.622 . . . . 72.03 111.445 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.49 -29.22 68.16 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.85 2.367 . . . . 60.32 112.963 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.08 -52.3 59.93 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.344 1.058 . . . . 71.12 112.001 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.49 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.2 m -72.46 -32.01 65.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.134 0.492 . . . . 75.34 110.82 177.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.41 -32.95 74.19 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.633 0.773 . . . . 55.04 112.055 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -69.08 -35.63 76.7 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.983 0.513 . . . . 71.01 110.952 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.95 -48.59 73.55 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.378 0.671 . . . . 72.45 110.077 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.05 -24.75 62.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.193 -0.912 . . . . 72.34 111.341 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HG2' HH22 ' A' ' 6' ' ' ARG . 1.2 tm-20 -57.08 -42.05 79.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.795 0.838 . . . . 55.4 110.507 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.5 t -76.75 -49.81 15.09 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.527 0.565 . . . . 74.44 112.527 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.2 -56.75 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.925 0.713 . . . . 63.22 112.925 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.44 -42.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.184 0.593 . . . . 73.24 110.681 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.95 -66.2 2.83 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 116.398 -0.365 . . . . 64.23 113.787 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 69.8 m-20 -80.97 -50.76 9.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.026 0.913 . . . . 73.5 112.025 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.28 -26.41 69.37 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 115.287 0.875 . . . . 54.33 115.287 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.09 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.759 0.779 . . . . 61.34 111.204 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 8.5 m-30 -71.72 -63.1 1.19 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.907 0.336 . . . . 65.21 111.907 -170.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -61.19 -28.53 69.21 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.47 0.481 . . . . 31.2 112.183 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.96 -53.47 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.439 0.696 . . . . 71.23 111.316 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.85 93.45 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 116.343 -0.39 . . . . 72.32 113.233 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.88 -40.28 91.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.069 0.948 . . . . 61.33 111.866 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.425 -0.352 . . . . 54.33 110.294 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.47 70.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.645 0.778 . . . . 64.25 112.246 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 tt -67.25 -48.45 67.73 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.958 0.903 . . . . 74.1 110.403 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.42 63.21 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.073 0.549 . . . . 54.33 111.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.23 -49.8 66.0 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.582 0.753 . . . . 73.34 111.422 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -14.41 61.64 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.305 0.483 . . . . 71.12 112.305 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -94.82 -30.58 14.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.186 0.81 . . . . 75.03 113.186 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 115.947 1.139 . . . . 23.4 115.947 -177.653 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.413 0 N-CA-C 113.155 0.798 . . . . 61.15 113.155 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.2 m -91.33 117.95 30.09 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.26 0.624 . . . . 55.0 110.529 173.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.66 128.02 42.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.948 1.299 . . . . 70.12 108.155 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -133.87 127.75 33.19 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.165 0.439 . . . . 71.55 110.216 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.79 140.57 50.3 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.665 -0.865 . . . . 65.51 108.665 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 p -141.66 156.23 45.65 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.658 0.783 . . . . 50.14 110.575 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.39 148.37 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 N-CA-C 111.976 0.361 . . . . 73.21 111.976 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.68 113.5 18.93 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.289 0.635 . . . . 64.34 110.567 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 105' ' ' VAL . 43.1 t -106.57 124.11 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.309 0.644 . . . . 72.23 110.466 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.1 66.13 8.53 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.809 0.844 . . . . 64.15 112.185 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.41 152.88 3.41 Favored Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 123.959 0.904 . . . . 73.11 110.797 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 134.95 64.09 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.06 2.507 . . . . 62.15 113.143 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.77 50.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.381 1.622 . . . . 72.1 115.381 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.43 78.98 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.942 0.497 . . . . 72.52 111.926 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.21 -34.82 79.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 75.1 112.326 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.587 HG21 ' SG ' ' A' ' 103' ' ' CYS . 59.3 t -70.36 -36.69 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.221 0.608 . . . . 62.11 110.886 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -64.14 -28.84 70.04 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.982 -0.554 . . . . 71.25 110.661 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -59.54 -28.22 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.072 0.549 . . . . 73.14 111.432 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -76.48 -41.78 45.9 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.806 0.842 . . . . 71.21 111.666 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.37 13.96 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 123.943 0.897 . . . . 71.3 112.833 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.31 7.04 80.88 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 114.449 0.539 . . . . 74.33 114.449 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.3 m-20 -124.98 135.36 52.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 63.33 109.311 166.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.68 -24.77 67.92 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.986 0.914 . . . . 74.05 111.286 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.9 p -89.78 -16.43 30.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.317 1.047 . . . . 73.43 112.822 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -82.22 3.54 26.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.867 -0.52 . . . . 61.24 112.238 -168.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 HG11 ' A' ' 34' ' ' VAL . 21.1 tt -63.79 -23.24 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.142 0.977 . . . . 75.04 112.766 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.481 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 57.0 p-80 -64.47 -23.23 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.801 0.667 . . . . 72.22 112.801 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -74.29 -39.04 63.19 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.512 0.56 . . . . 64.34 112.512 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 p-90 -107.57 -30.16 8.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.597 0.359 . . . . 72.41 111.334 -174.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -100.16 102.03 16.59 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 123.453 0.701 . . . . 75.45 109.842 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.21 -13.3 31.32 Favored 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 123.537 2.825 . . . . 63.33 116.035 -171.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -83.8 -25.79 30.11 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.355 0.662 . . . . 74.52 111.697 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 27' ' ' ILE . 85.4 t -72.37 115.89 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 122.877 0.471 . . . . 71.02 111.465 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -95.25 30.32 2.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.974 0.91 . . . . 74.43 111.797 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.76 98.58 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 125.326 1.45 . . . . 70.43 112.643 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.9 -171.39 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.321 2.681 . . . . 75.41 114.252 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.8 m -115.52 124.53 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.785 0.834 . . . . 50.33 110.686 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.402 HD12 ' HB1' ' A' ' 49' ' ' ALA . 3.8 mm? -90.78 126.65 36.08 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.501 0.667 . . . . 73.42 111.313 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 mmt180 -111.65 148.25 33.77 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.535 1.134 . . . . 63.31 109.929 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.69 121.05 0.0 OUTLIER Glycine 0 CA--C 1.56 2.906 0 N-CA-C 117.715 1.846 . . . . 64.01 117.715 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.45 -98.35 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.421 1.488 . . . . 74.22 114.096 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -168.66 146.72 3.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 123.227 0.611 . . . . 62.35 111.68 -166.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.59 -1.2 2.39 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.675 2.917 . . . . 64.54 115.145 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -101.5 -24.8 14.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.538 0.735 . . . . 64.23 111.271 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -93.12 124.24 58.61 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.641 0.776 . . . . 52.2 111.731 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.62 118.91 4.86 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.221 2.614 . . . . 71.31 112.874 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.15 -9.46 7.89 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 112.484 -0.246 . . . . 74.01 112.484 -170.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -73.27 130.75 40.89 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.487 0.715 . . . . 51.02 111.05 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 36.2 mt-10 -118.88 115.16 23.82 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 122.099 -0.376 . . . . 71.4 110.558 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -93.73 119.11 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.337 0.589 . . . . 72.21 109.826 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 t -115.93 107.78 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 123.805 0.842 . . . . 52.23 110.227 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -76.85 73.64 3.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.041 0.936 . . . . 74.32 111.479 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.89 -62.44 0.48 Allowed Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.124 -0.489 . . . . 63.44 111.899 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.63 27.08 16.62 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.605 1.162 . . . . 62.35 113.663 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.27 41.48 0.03 OUTLIER Glycine 0 N--CA 1.471 1.005 0 CA-C-N 116.392 -0.367 . . . . 64.5 112.739 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -146.78 160.83 41.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.599 0.759 . . . . 64.41 110.767 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.08 -19.48 60.59 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.253 0.621 . . . . 72.44 111.858 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.12 85.98 2.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.735 0.814 . . . . 71.4 110.641 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.26 162.77 30.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 75.23 111.871 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 79' ' ' MET . 51.1 tp -121.95 121.71 37.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.772 0.829 . . . . 72.42 109.89 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.54 130.09 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.066 -0.716 . . . . 73.31 109.066 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.638 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 40.1 mt-10 -130.25 128.87 42.5 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.413 0.685 . . . . 72.4 110.317 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 57.8 mtp180 -104.04 131.76 50.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.193 0.597 . . . . 74.12 111.204 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -73.04 111.46 8.17 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.015 0.926 . . . . 54.11 110.161 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.72 -51.91 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.528 0.731 . . . . 62.21 111.731 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.8 pt-20 -153.18 151.81 30.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 70.35 110.579 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.597 HH21 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -133.78 113.48 12.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.189 0.596 . . . . 74.01 110.557 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.5 m-20 -115.68 72.18 0.8 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.816 0.847 . . . . 71.42 109.036 176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HG3' ' HD2' ' A' ' 68' ' ' ARG . 53.3 mt-10 -67.38 -32.85 74.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.735 0.814 . . . . 74.22 113.109 -173.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -73.07 -18.56 61.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.171 0.589 . . . . 71.04 111.733 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.57 -1.82 22.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.69 0.796 . . . . 63.53 112.133 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 13.1 mtm105 62.71 42.82 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.433 1.093 . . . . 75.22 112.993 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 23.9 ttm180 -119.34 133.17 55.87 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.368 1.067 . . . . 75.5 110.781 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.597 HD22 HH21 ' A' ' 68' ' ' ARG . 13.6 tp -131.74 107.93 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.636 1.174 . . . . 33.42 110.037 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 52.0 t -113.12 132.99 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 118.491 0.587 . . . . 75.11 110.601 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -148.14 167.77 24.17 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.746 0.818 . . . . 73.22 111.339 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.0 t -134.82 158.25 44.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.12 0.968 . . . . 72.45 110.578 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.638 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 73.4 mtm -102.82 98.13 10.69 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.019 0.527 . . . . 71.12 110.309 170.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.487 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 56.8 Cg_endo -66.05 -28.21 49.4 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.371 2.714 . . . . 70.33 112.612 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.28 79.42 35.87 Favored Pre-proline 0 CA--C 1.555 1.164 0 N-CA-C 108.624 -0.88 . . . . 71.14 108.624 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 83.1 Cg_endo -79.68 147.4 19.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.465 2.11 . . . . 44.14 113.12 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.8 Cg_endo -84.38 -0.83 9.57 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.95 2.434 . . . . 62.44 112.782 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.18 150.38 63.35 Favored Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 74.42 111.513 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.38 80.57 1.05 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.107 2.538 . . . . 73.1 112.956 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.577 HG22 ' HB2' ' A' ' 113' ' ' CYS . 23.5 pt -135.59 146.51 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.547 1.139 . . . . 74.35 110.383 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -89.87 -72.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.883 0.373 . . . . 54.43 110.921 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 9.1 m-20 -90.71 123.95 34.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.412 -0.959 . . . . 72.35 108.412 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -114.87 131.21 56.93 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.352 0.978 . . . . 75.44 113.237 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 110' ' ' MET . 3.6 mpt_? -129.64 143.58 50.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.181 1.392 . . . . 74.43 109.02 165.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.81 125.6 15.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.068 0.947 . . . . 73.31 108.739 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 94' ' ' GLU . 7.5 p -134.5 134.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.678 0.992 . . . . 74.34 113.678 -169.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -101.91 112.46 25.1 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.247 1.019 . . . . 74.24 109.156 171.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 92' ' ' VAL . 44.3 mt-10 -122.22 111.26 16.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.618 0.767 . . . . 65.41 109.921 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -92.59 109.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.101 -0.703 . . . . 51.24 109.101 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.417 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.4 m -100.7 114.03 65.72 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 123.856 0.863 . . . . 73.02 110.624 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.76 107.09 2.12 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.543 2.162 . . . . 64.41 113.04 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -63.47 -29.52 70.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.71 0.804 . . . . 72.2 111.144 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.2 t70 -154.63 173.13 16.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.396 1.478 . . . . 74.24 108.526 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.37 -44.19 92.77 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.979 0.512 . . . . 45.43 111.423 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.8 tmm_? -106.98 1.92 24.8 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.65 0.78 . . . . 73.15 111.468 -174.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 42.5 m80 -128.58 141.52 51.34 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.406 -0.809 . . . . 74.23 110.307 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.587 ' SG ' HG21 ' A' ' 17' ' ' VAL . 16.8 p -143.72 174.91 10.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.474 0.654 . . . . 75.22 112.407 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 96' ' ' VAL . 99.4 m -138.58 118.95 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 53.31 109.65 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 10' ' ' VAL . 47.9 t -91.77 124.8 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 109.771 -0.455 . . . . 73.22 109.771 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.75 128.35 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 73.25 109.357 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 6.4 t90 -121.2 122.91 40.99 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.79 -0.818 . . . . 62.43 108.79 174.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -127.39 124.13 37.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.454 0.702 . . . . 70.41 111.491 -170.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -105.3 107.81 18.99 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 62.35 110.39 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ARG . 41.8 mtt -97.62 130.35 44.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.888 -0.782 . . . . 74.32 108.888 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 88' ' ' ASN . 20.4 p90 -157.28 153.21 27.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.978 0.732 . . . . 75.34 112.978 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.65 84.25 2.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.237 -0.892 . . . . 73.41 109.427 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.577 ' HB2' HG22 ' A' ' 86' ' ' ILE . 42.2 t -119.28 155.78 31.18 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.324 -1.307 . . . . 74.22 110.711 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -58.61 138.45 86.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.933 0.893 . . . . 61.43 111.427 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.59 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 123.473 2.782 . . . . 71.0 114.857 -168.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.02 -37.98 89.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.104 0.561 . . . . 75.21 111.421 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 9.0 m -79.23 -27.25 42.46 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.015 0.526 . . . . 62.12 111.071 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.995 0.918 . . . . 72.01 111.896 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -74.8 -28.1 60.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.696 0.799 . . . . 75.01 111.586 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.32 -45.63 79.65 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.146 0.498 . . . . 74.03 110.161 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.22 -24.8 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.721 0.808 . . . . 65.22 111.275 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -58.18 -45.58 87.27 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.522 0.729 . . . . 73.52 110.519 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 m -69.99 -53.19 18.77 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.523 -0.762 . . . . 62.32 112.394 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.69 -55.25 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 C-N-CA 123.479 0.712 . . . . 75.02 112.595 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.6 mt -81.49 -57.32 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.836 0.854 . . . . 72.13 111.251 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.3 -63.33 3.3 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 114.349 0.5 . . . . 44.31 114.349 -173.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.45 -16.5 58.74 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 122.871 0.468 . . . . 72.45 111.441 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.19 -88.75 1.66 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.86 -0.411 . . . . 35.42 112.463 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.7 t -52.6 -46.78 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 124.935 1.294 . . . . 73.02 113.03 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 3.8 m-30 -75.98 -47.85 23.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.443 0.697 . . . . 73.04 111.558 -173.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.36 -41.85 85.65 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.226 0.329 . . . . 73.32 111.751 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.51 -54.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 123.955 0.902 . . . . 74.0 112.107 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.91 -46.21 76.05 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.423 0.452 . . . . 52.33 113.675 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.62 -41.48 96.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.561 0.745 . . . . 73.13 112.199 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.68 -41.64 92.19 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 119.73 -0.176 . . . . 72.23 110.675 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.91 90.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.94 0.496 . . . . 64.13 111.541 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.64 -40.12 96.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.603 0.761 . . . . 42.15 110.164 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.51 -33.19 68.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.859 0.463 . . . . 71.11 111.981 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.026 0.931 . . . . 72.3 113.042 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -66.77 -32.32 73.53 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 117.922 0.328 . . . . 63.22 111.289 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.98 -11.25 36.6 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.227 0.611 . . . . 74.24 110.661 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.447 0 N-CA-C 114.569 0.588 . . . . 72.1 114.569 -177.901 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.421 0.629 . . . . 70.2 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.6 m -119.72 124.5 46.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.901 0.88 . . . . 73.44 109.972 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.94 141.07 32.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 74.04 109.097 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -145.62 132.63 20.28 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.611 -0.515 . . . . 74.15 109.611 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 131' ' ' ALA . 5.7 tpt180 -133.7 147.35 51.37 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.346 -0.613 . . . . 63.44 109.346 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.0 p -142.76 150.36 39.94 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.24 0.616 . . . . 52.41 111.246 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.92 149.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.156 0.582 . . . . 52.51 111.173 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.18 123.7 29.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.551 -0.537 . . . . 73.52 109.551 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 95.4 t -120.51 121.56 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.814 0.845 . . . . 61.41 110.017 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.26 71.3 2.96 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.084 0.553 . . . . 72.42 111.191 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.91 6.6 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 123.844 0.858 . . . . 72.04 111.392 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.69 144.62 78.8 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.778 2.318 . . . . 65.42 112.299 167.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.1 -31.5 30.89 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.027 1.121 . . . . 54.54 114.027 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.58 -49.22 72.02 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.439 0.696 . . . . 72.24 112.446 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.353 0.661 . . . . 72.21 111.916 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 103' ' ' CYS . 25.0 t -71.76 -34.64 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.714 -0.675 . . . . 55.04 111.43 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -67.4 -31.19 71.25 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 122.58 0.352 . . . . 74.13 111.391 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -67.57 -21.66 65.43 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-O 121.382 0.61 . . . . 60.25 111.293 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.09 -50.03 6.65 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.061 0.944 . . . . 61.23 112.838 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.2 m -93.98 -26.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.703 1.001 . . . . 72.32 113.703 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.64 -11.85 66.19 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.384 1.313 . . . . 60.23 116.384 -165.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 4.6 m-20 -79.65 -14.03 59.08 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.939 0.496 . . . . 70.31 111.862 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 72.31 -59.05 0.57 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.163 1.385 . . . . 74.41 111.257 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -62.51 -18.34 61.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.295 1.038 . . . . 35.23 113.248 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -79.94 7.36 9.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.92 0.888 . . . . 74.32 112.722 -167.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.52 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 14.1 tt -61.7 -23.49 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 123.575 0.75 . . . . 63.4 112.082 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.647 ' HA ' HG11 ' A' ' 34' ' ' VAL . 39.5 p-80 -70.67 -3.9 20.81 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 113.154 0.798 . . . . 55.45 113.154 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 58.6 mtp180 -92.76 -25.51 18.15 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.02 0.928 . . . . 55.15 112.724 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.0 p-90 -127.14 -34.48 2.32 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.246 1.202 . . . . 75.02 114.246 -171.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 33.6 t-80 -78.68 139.08 58.23 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 117.969 0.35 . . . . 71.02 110.932 -170.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.57 -37.75 3.87 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.136 1.891 . . . . 54.52 113.965 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 4.3 mp0 -78.21 -22.82 47.94 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.522 0.564 . . . . 62.21 112.522 -172.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 28' ' ' HIS . 9.4 p -61.71 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.352 0.596 . . . . 74.25 112.549 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -115.92 28.36 8.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.026 0.93 . . . . 74.23 111.673 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 61.4 96.83 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.071 0.948 . . . . 54.43 110.677 -170.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.23 158.46 15.09 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.594 2.196 . . . . 74.23 114.175 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -104.87 127.3 52.64 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.31 1.044 . . . . 72.34 109.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.3 mm? -99.76 115.96 30.74 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.466 0.707 . . . . 75.24 110.689 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 52' ' ' VAL . 31.4 mmt180 -83.85 119.23 24.61 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.886 -0.413 . . . . 75.4 109.886 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.8 -167.47 0.01 OUTLIER Glycine 0 CA--C 1.545 1.939 0 N-CA-C 117.85 1.9 . . . . 64.01 117.85 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 76.07 -47.16 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 125.714 1.606 . . . . 63.44 115.141 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m 91.74 144.25 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 C-N-CA 126.825 2.05 . . . . 62.24 109.983 -162.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.95 -37.86 93.24 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.842 3.028 . . . . 61.21 116.244 -167.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -85.25 -13.91 48.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.371 0.508 . . . . 74.23 112.371 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -80.72 123.51 82.44 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.446 0.698 . . . . 70.02 111.46 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -48.84 98.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.632 2.888 . . . . 55.33 113.568 171.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.87 -14.71 2.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.089 -0.505 . . . . 53.13 112.992 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -67.09 122.37 17.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.53 0.732 . . . . 75.34 111.211 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.6 mt-10 -102.65 117.59 34.99 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.71 0.404 . . . . 71.41 111.484 -172.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 46.7 ttp180 -92.94 103.19 15.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.559 0.744 . . . . 72.43 110.763 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 62' ' ' VAL . 20.6 t -112.6 99.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.755 . . . . 75.4 110.242 -171.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -63.18 -48.97 76.13 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.708 1.003 . . . . 65.31 113.708 -168.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.01 52.91 0.61 Allowed Glycine 0 N--CA 1.478 1.466 0 N-CA-C 112.374 -0.291 . . . . 32.5 112.374 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.746 0.818 . . . . 44.34 112.994 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.53 33.36 3.63 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 115.965 -0.561 . . . . 72.4 113.529 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -120.61 177.69 4.97 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 123.577 0.751 . . . . 74.23 110.73 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.82 -55.27 13.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.811 0.444 . . . . 71.1 111.291 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -115.74 89.9 3.21 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.446 0.698 . . . . 65.34 110.997 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.17 163.55 12.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.975 0.91 . . . . 74.12 111.268 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -116.8 119.43 35.41 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.351 0.661 . . . . 70.53 110.122 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 48.9 t -104.51 114.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.42 0.688 . . . . 65.31 110.194 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 83.3 mt-10 -101.22 169.7 8.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.6 1.16 . . . . 74.53 110.578 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -151.02 126.34 10.01 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.422 0.689 . . . . 75.44 110.801 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.52 127.4 32.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.975 0.91 . . . . 51.34 111.144 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.92 -40.35 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.301 0.64 . . . . 73.43 111.345 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -167.28 153.59 8.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.961 0.905 . . . . 54.02 109.835 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 153.08 35.87 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.203 0.601 . . . . 64.13 110.598 170.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.87 135.18 35.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 74.32 110.639 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.57 -57.65 3.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.608 0.763 . . . . 73.12 112.501 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.6 m -76.43 -14.83 60.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.937 0.717 . . . . 25.43 112.937 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.87 30.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.182 0.593 . . . . 55.51 111.165 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.48 36.92 18.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.868 1.267 . . . . 63.43 111.271 -176.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -110.23 97.02 6.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.14 0.976 . . . . 74.4 111.889 -166.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 14.6 tp -98.67 108.03 20.62 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.8 1.24 . . . . 65.32 110.215 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.9 t -108.97 121.68 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.055 0.942 . . . . 72.44 111.527 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -135.98 179.72 6.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.514 0.673 . . . . 71.14 112.209 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 t -133.6 163.15 30.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.117 1.367 . . . . 74.41 109.598 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.2 mtp -112.39 88.38 10.76 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 123.447 0.699 . . . . 75.12 109.377 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 49.4 Cg_endo -65.51 -24.57 56.26 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.603 2.869 . . . . 70.53 113.62 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 22.1 t70 -135.44 78.4 51.02 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 122.786 0.434 . . . . 74.11 110.447 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 61.4 Cg_endo -95.99 143.22 1.05 Allowed 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.133 2.555 . . . . 74.13 113.864 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 3.0 Cg_exo -79.61 28.16 0.52 Allowed 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.943 2.428 . . . . 73.41 112.907 169.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.17 152.83 51.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.645 1.178 . . . . 71.12 110.008 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.31 41.11 0.74 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.629 2.886 . . . . 62.1 114.236 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -109.85 124.37 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 124.178 0.991 . . . . 64.13 110.743 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 8.9 m -68.25 -68.44 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.976 0.51 . . . . 75.12 112.156 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.71 110.08 16.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.255 0.55 . . . . 65.23 109.627 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 58.7 t-80 -85.67 150.2 24.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.026 0.531 . . . . 72.23 111.334 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -152.62 117.36 5.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.842 0.857 . . . . 73.13 110.081 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -118.48 149.75 40.75 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.609 0.596 . . . . 74.1 112.609 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 94' ' ' GLU . 61.4 t -135.02 137.26 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.353 1.061 . . . . 71.1 109.492 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -114.52 108.88 17.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.032 1.333 . . . . 74.03 107.46 -178.51 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' A' ' 92' ' ' VAL . 40.3 mt-10 -124.4 114.39 19.44 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.241 0.928 . . . . 53.32 111.875 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -89.09 109.06 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.745 -0.835 . . . . 75.14 108.745 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.9 117.9 66.79 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.117 0.967 . . . . 45.12 110.329 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 88.17 0.99 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.449 2.099 . . . . 53.33 111.902 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -34.54 78.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.059 0.943 . . . . 64.41 110.414 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.8 t70 -149.42 165.53 31.81 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.995 1.318 . . . . 53.13 109.042 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.13 -43.97 97.66 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.521 0.728 . . . . 72.41 111.897 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -91.87 -19.93 21.97 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.548 0.739 . . . . 64.02 110.835 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 91.3 m-70 -127.34 138.43 53.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 72.12 111.833 -170.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -126.43 174.94 8.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.57 0.748 . . . . 73.43 110.517 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -137.01 111.01 8.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.518 0.727 . . . . 54.52 109.964 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -87.97 115.37 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.252 0.549 . . . . 70.02 110.222 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -105.81 111.84 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.826 1.25 . . . . 60.1 110.553 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -103.62 113.9 27.76 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 109.24 -0.652 . . . . 74.31 109.24 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.5 m -114.21 141.32 47.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.631 1.172 . . . . 51.52 110.054 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.65 112.18 4.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.066 0.546 . . . . 61.51 112.142 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -118.56 142.53 47.52 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.456 1.102 . . . . 75.54 110.299 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.66 153.1 33.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.532 0.733 . . . . 64.32 111.761 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 31.3 t70 -80.71 86.39 5.94 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.144 0.497 . . . . 64.12 110.021 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 36.5 t -151.39 157.77 42.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.457 -0.792 . . . . 73.11 111.979 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m -61.9 146.49 91.24 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 123.835 0.854 . . . . 73.42 112.351 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -60.98 -28.96 87.09 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.051 2.501 . . . . 61.34 113.867 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.14 -35.26 77.81 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.902 0.481 . . . . 73.42 112.074 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.405 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 19.0 m -74.8 -40.63 61.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.216 0.532 . . . . 71.53 110.071 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.97 81.98 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.135 -0.939 . . . . 41.21 112.826 -174.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.9 -33.82 72.7 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.922 0.489 . . . . 62.24 111.24 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.96 -41.52 97.54 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.056 -0.52 . . . . 54.14 109.735 171.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.53 -26.79 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.359 0.664 . . . . 73.2 112.313 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 118.615 0.643 . . . . 61.02 110.428 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 m -69.23 -59.68 2.86 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 115.691 -0.686 . . . . 65.4 111.896 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.0 -56.97 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.651 0.78 . . . . 65.5 112.483 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.2 -48.44 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.647 0.379 . . . . 53.44 110.581 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.6 -48.07 81.11 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 114.509 0.564 . . . . 71.5 114.509 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -101.23 -53.61 2.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.989 -0.712 . . . . 63.02 111.646 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.28 -22.75 69.49 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 115.399 0.92 . . . . 71.05 115.399 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -111.92 -54.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 117.548 0.674 . . . . 74.25 111.196 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 10.7 m-30 -72.8 -59.92 2.48 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.292 0.637 . . . . 62.31 112.092 -173.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -57.84 -36.31 72.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 123.39 0.431 . . . . 65.25 111.484 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.69 -50.4 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 124.221 1.008 . . . . 61.5 111.956 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.84 97.75 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.178 -0.465 . . . . 70.22 113.103 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.49 -36.09 81.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.371 1.069 . . . . 64.23 111.946 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.91 -43.9 74.26 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.694 0.397 . . . . 74.53 110.47 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.4 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.219 0.608 . . . . 31.01 111.599 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.98 -42.58 97.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.641 0.776 . . . . 73.33 110.397 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.76 -29.59 64.67 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.325 0.491 . . . . 62.52 112.325 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.2 -41.32 73.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.459 0.703 . . . . 64.24 112.453 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.472 0.545 . . . . 64.32 112.472 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -87.16 -34.41 19.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.762 0.425 . . . . 75.14 112.133 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 115.181 0.832 . . . . 63.2 115.181 179.546 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.59 0.233 . . . . 73.43 111.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 110' ' ' MET . 66.8 m -113.92 111.13 21.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.059 0.943 . . . . 75.45 109.442 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.24 137.32 36.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.21 1.004 . . . . 75.33 109.366 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -142.76 131.95 23.27 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 120.815 0.341 . . . . 74.22 110.218 168.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -125.38 157.42 36.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.547 1.139 . . . . 65.24 109.54 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.3 p -150.29 151.96 33.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.33 0.652 . . . . 75.22 110.697 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.7 p -148.38 145.2 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.75 0.42 . . . . 64.34 110.998 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -92.29 109.48 20.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.956 0.502 . . . . 65.23 110.996 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 61.0 t -95.14 139.01 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.566 1.146 . . . . 73.54 111.702 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 33.38 0.13 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.0 1.111 . . . . 64.35 114.0 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.06 149.23 34.81 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 123.582 0.753 . . . . 63.25 111.301 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.12 148.67 67.93 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.484 2.789 . . . . 73.41 114.176 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.56 -43.43 56.3 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.899 1.444 . . . . 71.3 114.899 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.22 76.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.223 0.609 . . . . 62.53 112.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.68 -47.04 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.402 1.081 . . . . 73.31 111.636 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' SG ' ' A' ' 103' ' ' CYS . 92.9 t -72.97 -34.91 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.998 0.919 . . . . 72.13 111.75 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.05 -28.5 69.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.819 0.447 . . . . 72.01 111.586 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 m -68.97 -30.78 69.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.168 0.587 . . . . 74.14 111.271 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.3 tp -77.76 -48.97 15.34 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.975 0.91 . . . . 62.3 111.848 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.3 -34.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 113.385 0.883 . . . . 62.41 113.385 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.29 -24.9 74.86 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 114.32 0.488 . . . . 30.1 114.32 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.77 111.31 21.22 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -6.44 47.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.762 1.023 . . . . 72.02 113.762 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -95.84 -8.17 34.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.822 0.449 . . . . 74.04 110.497 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.97 -2.87 36.31 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.751 . . . . 73.32 111.236 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.721 HG23 HG11 ' A' ' 34' ' ' VAL . 20.4 tt -64.16 -26.63 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 123.052 0.541 . . . . 73.13 112.104 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.08 -9.05 57.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 112.822 0.675 . . . . 54.32 112.822 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.91 -28.22 30.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.52 0.728 . . . . 60.43 111.91 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.5 p-90 -116.24 -35.1 4.44 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.739 0.644 . . . . 73.11 112.739 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -84.82 112.65 44.39 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.488 -0.291 . . . . 75.02 110.762 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HD2' ' HA2' ' A' ' 133' ' ' GLY . 38.9 Cg_endo -64.34 -16.39 54.81 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.371 2.714 . . . . 53.23 114.832 -175.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -88.54 -37.66 15.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.041 -0.412 . . . . 74.23 110.693 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.721 HG11 HG23 ' A' ' 27' ' ' ILE . 61.6 t -78.2 102.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 120.829 0.347 . . . . 72.0 110.742 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -86.25 -49.88 7.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.203 0.601 . . . . 72.12 111.206 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.36 105.81 0.47 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 123.698 0.799 . . . . 24.1 111.489 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 68.6 Cg_endo -85.53 160.91 10.94 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.0 2.467 . . . . 72.13 113.842 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.4 m -103.95 120.98 42.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.848 0.859 . . . . 64.01 110.638 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.09 120.23 29.24 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.282 0.633 . . . . 73.24 110.929 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -108.24 120.63 42.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.896 0.879 . . . . 74.42 109.681 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.74 173.66 0.01 OUTLIER Glycine 0 CA--C 1.558 2.754 0 N-CA-C 119.045 2.378 . . . . 75.12 119.045 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 74.61 -39.29 0.41 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.94 1.829 . . . . 73.25 115.94 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m 87.11 135.48 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.843 0 C-N-CA 126.343 1.857 . . . . 71.11 111.555 -171.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.11 -25.37 45.26 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 124.473 3.449 . . . . 72.01 116.835 -166.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -85.32 -28.2 25.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.075 0.398 . . . . 73.43 112.075 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.7 m -81.38 123.83 80.92 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 123.834 0.853 . . . . 73.43 112.084 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 109.75 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 124.151 3.234 . . . . 53.52 114.206 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.24 -21.64 3.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.222 -0.445 . . . . 72.14 112.953 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 125.57 24.75 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.321 0.86 . . . . 43.12 113.321 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 37.3 mt-10 -104.61 137.43 42.45 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.224 0.61 . . . . 65.23 109.398 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -127.26 133.29 50.2 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.585 1.084 . . . . 63.3 111.122 167.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.51 107.66 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.553 -0.749 . . . . 60.05 109.877 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -70.77 79.87 0.61 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.406 1.082 . . . . 62.43 110.632 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.74 -65.68 0.59 Allowed Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.907 -0.588 . . . . 40.33 111.93 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.39 101.97 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.052 1.341 . . . . 55.12 113.349 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.13 66.5 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-O 121.27 0.372 . . . . 22.15 113.57 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -116.41 -162.1 0.83 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.5 1.12 . . . . 74.55 111.304 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.6 -52.33 6.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.475 0.71 . . . . 73.44 111.28 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 85.77 2.44 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.245 0.618 . . . . 74.11 111.138 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -112.19 155.72 23.5 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.189 0.518 . . . . 73.3 111.12 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 ' SD ' ' A' ' 79' ' ' MET . 57.4 tp -120.48 122.55 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.793 -0.817 . . . . 70.03 108.793 172.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 55.3 t -95.33 117.72 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.426 -0.953 . . . . 74.05 108.426 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 2.1 tt0 -114.22 162.73 16.17 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.446 0.698 . . . . 71.54 110.011 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 4.6 tmt_? -151.45 125.12 9.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.408 0.683 . . . . 73.51 110.193 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.9 tp -82.23 127.74 33.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.802 0.841 . . . . 72.34 110.575 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.511 HG21 ' NH1' ' A' ' 90' ' ' ARG . 95.1 t -95.92 -44.46 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.313 0.645 . . . . 73.32 111.188 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -160.63 148.15 15.9 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.974 0.91 . . . . 71.13 110.163 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -124.3 109.65 13.62 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.421 -0.585 . . . . 73.34 109.421 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.56 125.59 41.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.193 0.997 . . . . 74.22 109.125 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.18 -15.76 14.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.043 -0.41 . . . . 71.54 111.887 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 m -65.94 -39.66 90.69 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.374 0.669 . . . . 54.03 111.899 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.4 4.02 18.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.259 1.023 . . . . 62.14 111.415 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 80.2 mtt-85 53.23 64.03 2.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.505 1.122 . . . . 71.15 111.11 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -129.11 111.55 13.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.072 0.949 . . . . 73.5 111.029 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 19.8 tp -104.23 105.63 15.85 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.482 0.713 . . . . 72.31 110.961 -173.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.1 t -101.07 124.32 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 123.852 0.861 . . . . 72.13 111.711 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -153.0 -178.01 6.65 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.484 0.659 . . . . 74.13 112.597 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 t -153.11 159.85 42.83 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.737 1.215 . . . . 52.42 110.348 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.44 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.6 ptt? -109.96 103.23 53.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.08 0.552 . . . . 75.43 109.758 171.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 79' ' ' MET . 36.8 Cg_endo -62.59 -29.39 78.08 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.443 2.762 . . . . 73.43 113.726 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.1 m-20 -123.09 83.58 51.14 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 122.995 0.518 . . . . 54.31 110.659 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -88.98 147.08 5.59 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 123.154 2.569 . . . . 75.12 113.214 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -81.85 0.12 10.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.515 2.143 . . . . 75.02 112.671 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.83 141.75 23.36 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.196 0.999 . . . . 74.31 110.535 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' ' 117' ' ' THR . 63.2 Cg_endo -71.1 81.99 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.647 2.231 . . . . 73.14 113.165 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.8 pt -133.04 151.85 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.428 1.091 . . . . 74.11 110.031 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 20.8 m -91.66 -85.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.517 0.327 . . . . 74.35 111.164 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.65 111.82 24.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.938 -0.477 . . . . 61.51 110.369 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -92.57 143.75 26.03 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.585 0.754 . . . . 74.43 111.796 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.511 ' NH1' HG21 ' A' ' 66' ' ' VAL . 10.4 tpp180 -148.54 117.02 6.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.485 1.114 . . . . 72.15 108.899 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.41 148.27 48.86 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.81 0.444 . . . . 43.25 111.36 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 85.3 t -134.98 136.0 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 124.489 1.116 . . . . 71.35 110.355 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.39 111.17 18.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.146 0.978 . . . . 72.2 110.1 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG12 ' A' ' 92' ' ' VAL . 36.2 mt-10 -115.11 157.82 23.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.386 1.074 . . . . 74.52 111.614 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.96 111.08 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.279 0.632 . . . . 63.51 109.656 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.8 117.46 60.63 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 124.751 1.22 . . . . 74.14 110.651 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.12 133.59 25.25 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.722 2.281 . . . . 63.11 113.901 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.26 -55.72 2.28 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.407 1.083 . . . . 64.12 110.083 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.5 t70 -126.15 169.18 13.08 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.883 1.273 . . . . 70.23 109.723 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.27 -41.32 79.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.594 0.758 . . . . 70.52 112.035 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -106.05 10.04 32.27 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 123.312 0.645 . . . . 75.24 111.502 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 70.0 m80 -139.79 140.19 36.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 64.31 111.657 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.0 p -136.37 178.53 6.99 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.342 0.657 . . . . 71.14 110.221 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m -135.76 113.58 11.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.039 0.536 . . . . 61.05 111.039 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.2 107.53 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 109.628 -0.508 . . . . 73.22 109.628 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.74 99.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.085 0.954 . . . . 65.42 109.772 -174.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -103.5 118.82 37.61 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.292 0.567 . . . . 72.4 110.563 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.528 HG22 ' SD ' ' A' ' 110' ' ' MET . 34.6 m -119.58 139.86 51.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.823 1.249 . . . . 71.24 110.207 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.11 113.25 6.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.31 0.644 . . . . 72.12 111.326 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.528 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -124.0 127.76 48.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.921 0.888 . . . . 73.02 110.239 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -146.07 156.01 43.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.895 0.878 . . . . 74.01 110.904 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 35.3 t70 -83.09 82.78 8.1 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.47 0.652 . . . . 60.04 110.142 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.662 ' HB2' HG22 ' A' ' 86' ' ' ILE . 51.9 t -120.52 149.87 41.73 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.244 -0.889 . . . . 64.21 111.327 178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 128.35 93.75 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-O 118.225 -0.893 . . . . 54.34 110.451 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -39.68 -40.57 2.36 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 124.903 3.735 . . . . 75.5 116.725 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.49 -52.07 59.76 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.313 0.578 . . . . 75.53 110.578 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 85' ' ' PRO . 71.3 m -68.57 -30.55 69.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.53 -0.759 . . . . 70.01 111.376 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.27 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.509 0.724 . . . . 63.34 111.912 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -71.97 -28.47 63.45 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 122.845 0.458 . . . . 71.35 111.143 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.08 -42.34 97.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.483 0.713 . . . . 63.22 110.238 170.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -74.99 -23.26 58.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.696 0.798 . . . . 71.44 111.688 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -60.71 -37.96 83.45 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.971 0.351 . . . . 72.54 110.481 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.2 m -73.06 -48.49 35.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.215 0.606 . . . . 74.4 112.538 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.9 -54.04 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 112.767 0.654 . . . . 74.21 112.767 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.57 -52.28 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.29 0.636 . . . . 44.24 111.146 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.59 -68.39 1.63 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 114.043 0.377 . . . . 72.44 114.043 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.305 0.642 . . . . 64.22 111.075 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.89 -96.72 0.26 Allowed Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.644 -0.531 . . . . 52.51 112.834 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.38 -49.22 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.574 1.149 . . . . 71.31 113.616 -171.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.17 -61.13 1.9 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.664 -0.698 . . . . 72.44 111.644 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.86 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.252 0.464 . . . . 62.34 112.252 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.45 -50.51 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.775 0.83 . . . . 53.51 111.431 171.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 32' ' ' PRO . . . -68.96 -37.74 83.77 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.058 -0.519 . . . . 52.34 113.287 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.62 -41.96 78.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.448 1.099 . . . . 71.22 111.778 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.52 -43.16 94.92 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.594 0.358 . . . . 74.51 110.843 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.35 -31.32 72.48 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.814 0.446 . . . . 63.41 112.055 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.52 -45.8 71.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.177 0.591 . . . . 65.03 109.682 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.95 95.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.483 0.713 . . . . 73.34 112.024 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.35 -40.18 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.956 . . . . 63.13 112.941 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -61.91 -36.11 80.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.756 0.65 . . . . 74.45 112.756 -172.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.24 -28.16 59.77 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.973 0.509 . . . . 73.13 111.947 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.467 0 CA-C-N 116.491 -0.322 . . . . 72.13 113.116 179.136 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 121.343 0.592 . . . . 60.52 109.979 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.4 m -108.73 113.14 25.85 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.587 0.755 . . . . 64.51 111.141 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.31 112.82 24.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.795 1.238 . . . . 55.03 110.511 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -112.57 133.08 54.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 122.02 -0.425 . . . . 70.31 110.43 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 143.53 44.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.168 0.587 . . . . 72.35 109.78 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -143.72 158.63 43.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 64.23 110.605 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.3 p -153.23 143.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.92 0.488 . . . . 62.14 111.222 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.43 108.62 18.58 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.793 -0.447 . . . . 74.21 109.793 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 48.6 t -90.99 128.06 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.643 0.777 . . . . 31.3 110.999 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.74 67.77 3.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.098 0.559 . . . . 65.31 111.36 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.61 153.61 2.82 Favored Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 123.55 0.74 . . . . 62.31 111.692 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.12 126.98 19.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.163 2.576 . . . . 73.43 113.146 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.06 -42.23 8.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.043 1.497 . . . . 61.43 115.043 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.83 85.7 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.771 0.428 . . . . 54.13 112.079 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.34 -36.49 84.29 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.647 0.779 . . . . 72.54 112.028 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -36.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.365 0.666 . . . . 55.25 110.203 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -67.7 -28.93 68.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.506 -0.77 . . . . 73.34 110.841 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.6 m -62.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.142 0.496 . . . . 74.04 111.017 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 30' ' ' TRP . 61.5 tp -70.8 -46.66 62.43 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.17 0.988 . . . . 75.44 111.536 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.57 8.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.681 0.792 . . . . 72.22 112.62 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.98 -9.86 79.81 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 123.282 0.468 . . . . 54.22 113.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-20 -106.7 132.81 52.26 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.294 0.568 . . . . 72.32 109.603 168.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -76.03 -5.99 48.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.737 0.815 . . . . 63.31 111.32 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -93.37 -10.3 35.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.525 0.73 . . . . 44.22 111.415 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -97.45 22.88 8.24 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.442 0.904 . . . . 51.51 113.442 -153.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 34' ' ' VAL . 19.2 tt -81.25 -18.2 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 O-C-N 122.259 -0.276 . . . . 74.24 111.31 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -65.62 -22.36 66.66 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.003 0.521 . . . . 75.03 111.827 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -68.96 -44.91 71.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.399 1.08 . . . . 72.31 112.422 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' HB3' HD21 ' A' ' 20' ' ' LEU . 28.3 p-90 -115.95 -37.64 3.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.153 0.797 . . . . 74.44 113.153 -169.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -83.44 110.72 26.23 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 109.959 -0.386 . . . . 74.42 109.959 -172.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.91 2.03 5.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.019 2.479 . . . . 74.43 116.312 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.755 HE22 HG11 ' A' ' 132' ' ' VAL . 21.6 mp0 -102.74 -19.73 14.63 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.521 0.6 . . . . 60.42 111.866 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 27' ' ' ILE . 57.6 t -70.11 118.86 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-O 121.183 0.516 . . . . 70.33 112.188 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 t -88.61 38.12 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 74.4 111.448 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.2 109.28 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.292 1.437 . . . . 64.31 112.062 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.75 160.69 12.22 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.543 2.162 . . . . 71.43 112.992 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 m -99.53 122.59 42.82 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.213 -0.662 . . . . 74.44 109.213 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.58 122.63 31.52 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.9 -1.148 . . . . 32.44 107.9 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 99.3 mtt180 -110.57 126.15 54.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.725 0.81 . . . . 63.32 111.308 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.72 -176.68 0.01 OUTLIER Glycine 0 CA--C 1.547 2.048 0 N-CA-C 118.102 2.001 . . . . 53.33 118.102 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.48 -92.9 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.082 1.353 . . . . 74.4 112.942 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 t 165.65 147.16 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 125.954 1.702 . . . . 43.51 108.704 -173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.09 -4.43 6.24 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.515 2.143 . . . . 71.13 114.034 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.04 -10.0 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.7 0.8 . . . . 62.31 112.129 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -108.37 125.69 31.31 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 123.721 0.808 . . . . 52.33 112.143 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 98.9 Cg_exo -48.41 123.65 9.49 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 123.804 3.002 . . . . 73.41 114.081 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.68 -27.77 4.08 Favored Glycine 0 N--CA 1.474 1.21 0 CA-C-N 116.137 -0.483 . . . . 32.14 112.445 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.62 49.49 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.602 0.761 . . . . 73.51 112.548 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 45.1 mt-10 -130.21 120.74 24.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.819 0.447 . . . . 72.34 111.622 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' NH2' ' HB ' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -92.67 120.73 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.613 -0.884 . . . . 74.15 108.613 175.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.65 98.52 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.679 -0.638 . . . . 62.43 110.652 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -59.69 121.57 11.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 74.41 111.91 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.68 -51.45 4.57 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.967 -0.352 . . . . 73.35 112.886 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.83 33.86 23.79 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.353 1.061 . . . . 74.45 113.041 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.68 -24.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.971 -1.013 . . . . 70.34 111.74 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.6 p -63.13 141.1 58.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.6 0.76 . . . . 72.11 111.006 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.56 -30.98 65.68 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.352 0.661 . . . . 62.12 112.183 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -110.82 66.93 0.63 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.33 0.652 . . . . 71.4 110.392 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 164.16 23.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.193 0.521 . . . . 74.45 111.798 171.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 79' ' ' MET . 56.2 tp -133.92 131.24 38.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.694 0.797 . . . . 62.22 109.745 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.6 125.68 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.43 109.928 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.677 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 32.2 mt-10 -118.37 126.53 52.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.551 0.74 . . . . 73.2 109.19 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -101.96 133.48 46.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.193 0.997 . . . . 75.14 111.322 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 13.4 tp -75.64 112.1 11.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.332 1.453 . . . . 72.14 111.089 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.29 -52.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.221 0.608 . . . . 72.32 111.328 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.72 154.72 22.79 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.098 -0.501 . . . . 71.1 111.181 -172.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.751 ' HE ' HD13 ' A' ' 75' ' ' LEU . 19.4 tpp85 -140.15 123.99 17.41 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.486 0.715 . . . . 74.41 111.201 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 12.4 m-20 -122.45 76.41 1.32 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.561 0.745 . . . . 71.13 110.356 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.53 -18.5 65.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 112.959 0.726 . . . . 65.41 112.959 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -46.5 76.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.246 0.619 . . . . 54.02 110.723 169.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.67 -2.35 58.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.064 0.946 . . . . 63.42 112.967 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 59.51 51.26 6.66 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.182 0.993 . . . . 74.52 111.182 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 28.6 ttm-85 -126.9 132.63 50.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.202 1.001 . . . . 74.23 110.364 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.751 HD13 ' HE ' ' A' ' 68' ' ' ARG . 6.1 tp -130.54 108.51 9.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.985 0.914 . . . . 73.52 109.954 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -106.57 129.65 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.592 0.757 . . . . 72.41 110.005 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.97 178.55 8.83 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.501 0.667 . . . . 74.41 112.759 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -149.57 141.84 24.14 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.199 1.399 . . . . 44.4 109.724 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 61' ' ' LEU . 61.1 mtm -94.44 104.54 14.28 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 119.055 0.843 . . . . 73.35 111.064 174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.52 -24.48 22.22 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.638 2.225 . . . . 64.05 112.716 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -126.34 78.84 71.16 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 123.545 0.738 . . . . 62.23 110.828 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.74 147.55 5.9 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 C-N-CA 122.885 2.39 . . . . 73.53 113.211 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 61' ' ' LEU . 65.3 Cg_endo -84.76 1.89 8.32 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.684 2.256 . . . . 74.44 112.655 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.1 155.44 36.46 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.224 1.009 . . . . 73.25 110.321 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.78 57.11 4.93 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.011 2.474 . . . . 64.13 112.898 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.3 pt -121.95 134.63 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.564 1.146 . . . . 72.12 109.619 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 37.5 m -75.0 -81.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.193 0.442 . . . . 64.15 112.193 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -78.11 -56.34 4.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -172.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.08 127.58 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.745 1.618 . . . . 72.4 113.738 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -123.93 153.54 41.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.076 1.35 . . . . 73.2 108.366 169.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.4 135.71 12.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 72.11 110.528 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.7 p -136.85 138.61 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 N-CA-C 113.242 0.83 . . . . 73.4 113.242 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.5 mm? -104.66 119.4 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.845 1.258 . . . . 71.54 109.235 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -123.86 110.1 14.44 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.673 -0.491 . . . . 71.32 109.673 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.63 110.01 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.491 -0.559 . . . . 71.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.87 111.18 63.87 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.023 0.929 . . . . 64.51 110.385 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.28 109.92 1.89 Allowed 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.791 2.327 . . . . 45.34 113.005 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.438 ' H ' ' HA ' ' A' ' 103' ' ' CYS . 39.5 mmt180 -75.74 -46.65 29.76 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.525 0.679 . . . . 74.53 109.761 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -122.79 -166.23 1.41 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.84 1.256 . . . . 74.3 109.276 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -81.68 -35.35 29.97 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.717 0.407 . . . . 72.44 110.938 167.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -108.85 13.23 25.02 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.106 0.563 . . . . 75.32 111.587 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -142.1 152.56 43.38 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.747 0.819 . . . . 70.1 109.637 172.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -153.34 177.62 10.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.024 0.529 . . . . 42.32 111.738 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 82.3 m -133.99 111.86 10.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.832 0.853 . . . . 72.42 109.986 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.89 116.87 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.469 -0.567 . . . . 51.21 109.469 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.11 105.89 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.795 0.838 . . . . 75.12 109.513 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -102.97 116.96 33.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.23 -1.026 . . . . 71.52 108.23 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 152.8 46.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.707 0.803 . . . . 65.33 109.928 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 155.32 47.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.118 1.367 . . . . 73.23 109.596 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -163.47 126.11 2.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.039 0.936 . . . . 54.02 109.688 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 p90 -141.31 156.01 45.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.332 0.653 . . . . 75.41 112.023 -165.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 38.4 t70 -84.97 86.98 7.33 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.499 0.666 . . . . 74.44 110.316 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.9 t -145.59 165.22 29.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.92 -1.036 . . . . 62.12 110.861 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.1 p -68.53 148.82 98.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 123.18 0.592 . . . . 64.14 111.687 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.93 -22.16 68.59 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.298 1.999 . . . . 72.11 112.78 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -65.83 -43.72 87.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.01 0.924 . . . . 74.32 111.312 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.499 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 23.5 m -84.33 -31.16 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.091 0.557 . . . . 65.41 111.068 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -64.62 -33.92 77.05 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.54 0.736 . . . . 63.14 112.226 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -65.73 -33.85 76.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.107 0.563 . . . . 73.51 111.402 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.61 -38.74 73.99 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.721 0.809 . . . . 75.23 109.961 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.9 -24.84 61.72 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.287 -0.869 . . . . 71.32 111.828 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 51.3 mt-10 -61.61 -39.13 90.17 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 117.956 0.343 . . . . 72.21 110.362 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -66.75 -55.67 13.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.536 0.734 . . . . 53.55 112.102 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.53 -55.03 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.463 0.705 . . . . 71.13 112.708 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.3 mt -82.53 -58.17 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.536 -0.757 . . . . 65.43 111.099 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.71 -50.03 32.96 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 114.973 0.749 . . . . 25.31 114.973 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.75 -25.24 21.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.14 0.576 . . . . 60.44 111.177 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.07 -88.51 0.67 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.13 -0.486 . . . . 64.24 112.038 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.09 -47.01 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 124.559 1.144 . . . . 33.43 113.366 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -77.84 -50.14 12.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.106 0.562 . . . . 73.01 112.159 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.19 81.63 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.243 0.339 . . . . 71.31 111.063 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.755 HG11 HE22 ' A' ' 33' ' ' GLN . 8.1 t -56.8 -50.3 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.225 0.61 . . . . 63.45 112.047 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.64 -48.68 82.96 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 123.508 0.505 . . . . 63.32 113.391 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 mt -69.99 -37.37 75.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.78 0.832 . . . . 72.11 112.959 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.46 -52.04 50.49 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 110.261 -0.274 . . . . 65.53 110.261 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.14 69.62 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.287 0.635 . . . . 42.11 111.8 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.437 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.0 tt -68.23 -45.99 71.77 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.484 0.714 . . . . 71.14 110.18 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -28.17 64.4 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 112.082 0.401 . . . . 64.3 112.082 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.73 -44.78 48.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.121 0.968 . . . . 63.22 111.635 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 12.8 ptm180 -63.8 -29.34 70.55 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.133 0.573 . . . . 63.43 112.152 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.3 -22.06 38.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.974 0.731 . . . . 72.41 112.974 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.578 0 N-CA-C 115.225 0.85 . . . . 50.34 115.225 -179.196 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 121.121 0.486 . . . . 71.54 110.37 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.6 m -111.49 119.33 38.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.353 1.061 . . . . 73.54 110.039 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.0 139.78 31.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.694 1.197 . . . . 65.44 108.701 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -147.46 126.35 12.74 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.021 0.438 . . . . 72.21 111.184 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -130.32 158.27 40.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.05 1.34 . . . . 61.13 110.081 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.8 p -155.1 154.86 33.03 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.246 0.618 . . . . 75.11 112.005 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.5 p -152.17 145.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.086 0.555 . . . . 73.23 111.354 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.56 108.84 19.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 120.996 0.427 . . . . 74.21 110.694 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 137' ' ' LEU . 95.2 t -94.05 137.77 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 63.2 110.411 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -83.16 41.9 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 112.936 0.717 . . . . 64.33 112.936 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.607 ' HA ' HH11 ' A' ' 101' ' ' ARG . . . -142.06 148.18 47.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.675 0.79 . . . . 60.55 110.483 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.23 142.97 93.52 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.412 2.074 . . . . 73.44 112.375 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.08 -33.54 39.8 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.177 1.391 . . . . 74.2 114.503 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.7 69.75 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.082 0.553 . . . . 73.35 112.107 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.99 -39.38 85.52 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.465 0.706 . . . . 73.33 112.139 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG21 ' SG ' ' A' ' 103' ' ' CYS . 65.2 t -70.63 -35.53 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.273 0.629 . . . . 62.13 111.009 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 62.4 t-105 -68.46 -31.52 70.87 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.155 0.582 . . . . 63.12 110.864 176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.7 m -65.96 -33.27 75.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.354 0.662 . . . . 74.22 110.672 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.7 tp -75.86 -52.79 9.57 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.806 0.842 . . . . 75.43 112.346 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 m -79.38 -32.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 113.124 0.787 . . . . 63.21 113.124 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.77 -31.68 81.61 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 114.544 0.578 . . . . 74.45 114.544 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.73 95.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.025 0.44 . . . . 72.34 109.967 171.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -67.18 -18.06 65.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.308 0.643 . . . . 65.34 112.246 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.6 p -77.57 -27.21 51.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.079 0.552 . . . . 71.11 111.191 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.32 29.13 6.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.857 0.863 . . . . 31.11 111.139 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.604 HG23 HG11 ' A' ' 34' ' ' VAL . 9.2 tt -64.85 -27.13 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 CA-C-N 115.09 -0.959 . . . . 52.52 111.555 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -59.95 -12.36 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.212 1.19 . . . . 73.33 114.212 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -71.24 -24.62 62.22 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.13 0.572 . . . . 70.01 112.502 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.42 ' HB3' HD21 ' A' ' 20' ' ' LEU . 59.1 p-90 -122.51 -31.55 3.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.296 0.638 . . . . 73.02 111.404 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 22.1 t-80 -95.35 104.16 14.63 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.182 0.593 . . . . 72.34 110.206 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.3 -16.32 54.42 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.212 2.608 . . . . 75.21 114.617 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 48.0 mt-30 -95.25 -11.06 28.61 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.3 0.852 . . . . 61.43 113.3 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 27' ' ' ILE . 56.1 t -75.04 116.48 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 118.346 0.521 . . . . 64.34 110.321 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -87.03 29.79 0.8 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.822 0.849 . . . . 64.25 112.137 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 68.08 121.7 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 125.706 1.602 . . . . 72.31 111.888 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 41.9 Cg_endo -96.26 155.26 1.34 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.024 2.483 . . . . 34.41 115.924 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -101.11 123.56 45.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.976 0.91 . . . . 74.42 109.938 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.21 123.36 28.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.256 0.55 . . . . 71.23 112.33 -172.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 10.3 mmm180 -103.07 121.81 43.36 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.722 1.209 . . . . 63.31 110.214 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.18 -178.53 0.01 OUTLIER Glycine 0 CA--C 1.549 2.18 0 N-CA-C 117.766 1.866 . . . . 53.31 117.766 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . . . 40.27 -98.02 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 126.059 1.743 . . . . 73.41 115.111 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 30.0 t -176.81 149.36 0.85 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 124.461 1.104 . . . . 71.22 110.491 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.33 -11.97 21.71 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.871 2.381 . . . . 53.32 113.587 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -114.72 1.94 14.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.902 0.881 . . . . 74.5 112.498 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.8 m -97.53 117.52 65.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.361 -0.837 . . . . 65.04 110.204 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 22.0 Cg_endo -58.48 92.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.065 2.51 . . . . 72.44 112.752 176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.15 -42.5 0.27 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.279 -0.873 . . . . 54.13 112.115 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . . . -67.58 164.74 18.39 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.908 1.077 . . . . 55.12 113.908 -172.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 33.9 mt-10 -121.62 164.47 17.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.251 1.02 . . . . 62.52 110.097 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -146.68 146.29 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.004 0.43 . . . . 65.2 111.837 168.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 t -117.69 108.11 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.546 0.738 . . . . 72.33 111.158 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -66.27 110.31 2.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.442 1.097 . . . . 74.32 110.633 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.96 -63.33 1.5 Allowed Glycine 0 CA--C 1.539 1.563 0 N-CA-C 112.064 -0.414 . . . . 64.12 112.064 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.88 115.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.743 1.386 . . . . 75.12 114.743 171.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.02 17.97 66.14 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 121.237 0.354 . . . . 62.52 112.698 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 p -94.6 -171.25 2.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.288 . . . . 60.31 109.923 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.34 -26.63 19.86 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 120.811 0.338 . . . . 75.13 110.63 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.33 93.01 2.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.385 0.674 . . . . 62.11 110.116 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.33 -175.72 2.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.417 0.687 . . . . 74.31 111.512 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 83' ' ' PRO . 34.9 tp -135.11 117.76 16.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.719 0.808 . . . . 74.25 110.347 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.98 121.81 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 109.173 -0.677 . . . . 54.44 109.173 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.61 167.19 14.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.424 0.69 . . . . 65.02 109.924 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.511 HH11 ' HA ' ' A' ' 66' ' ' VAL . 3.1 tmt_? -140.7 109.07 5.83 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.088 0.955 . . . . 70.35 109.843 -165.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 29.8 tp -59.46 105.91 0.4 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.159 0.984 . . . . 63.31 110.96 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.511 ' HA ' HH11 ' A' ' 64' ' ' ARG . 89.3 t -78.27 -51.03 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.37 0.668 . . . . 51.12 111.307 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.25 151.45 34.25 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.153 0.581 . . . . 72.54 111.287 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -143.13 130.07 20.57 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.965 0.906 . . . . 61.01 110.479 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 14.7 m-20 -135.94 118.3 15.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.361 1.064 . . . . 72.24 110.466 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 3.9 mp0 -80.77 -36.54 31.72 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.84 0.456 . . . . 74.02 110.267 169.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 m -63.71 -37.61 87.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.893 0.877 . . . . 74.33 112.394 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.5 -12.36 24.25 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.234 0.614 . . . . 63.32 111.733 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 59.46 45.88 13.03 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 71.01 110.006 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 39.0 ttm180 -122.21 123.16 40.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.583 1.553 . . . . 75.15 111.022 -169.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 23.7 tp -123.22 106.64 10.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.501 0.72 . . . . 73.34 110.415 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.1 t -108.21 129.89 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.877 0.871 . . . . 70.43 111.583 -169.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -139.22 172.86 12.22 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 75.24 112.252 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -149.93 139.09 21.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.312 1.445 . . . . 73.11 109.257 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.415 ' SD ' HD11 ' A' ' 61' ' ' LEU . 69.6 mtm -94.66 105.59 19.43 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 118.51 0.595 . . . . 74.23 110.556 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.74 -18.28 22.26 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.006 2.47 . . . . 42.1 112.179 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.6 78.24 68.73 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.869 0.868 . . . . 64.13 109.032 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.84 140.39 16.23 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.684 2.256 . . . . 74.23 112.802 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' HD13 ' A' ' 61' ' ' LEU . 63.4 Cg_endo -85.24 8.41 4.62 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.944 2.43 . . . . 72.14 112.557 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.98 141.38 40.47 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 124.496 1.118 . . . . 75.51 109.383 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.67 88.23 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.578 2.186 . . . . 61.42 113.325 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.8 pt -137.32 168.37 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 125.159 1.383 . . . . 73.42 109.43 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 28.8 m -93.57 -84.02 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.118 0.414 . . . . 71.43 112.118 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -86.26 -45.13 11.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.642 0.608 . . . . 65.42 112.642 -170.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 47.9 t-80 64.66 141.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.736 1.614 . . . . 72.05 113.529 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -150.77 152.73 34.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.403 1.081 . . . . 75.21 108.424 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -160.39 151.09 18.6 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.877 0.471 . . . . 75.23 111.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.78 150.86 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 113.024 0.75 . . . . 72.34 113.024 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -120.63 108.54 14.15 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.639 1.576 . . . . 74.03 107.58 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -126.76 115.1 18.86 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.948 0.499 . . . . 72.21 111.45 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -95.34 126.57 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 122.779 0.432 . . . . 75.51 110.292 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.58 117.72 44.36 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.397 1.079 . . . . 60.35 110.684 -173.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.64 108.23 2.41 Favored 'Trans proline' 0 CA--C 1.568 2.215 0 C-N-CA 122.826 2.351 . . . . 75.54 114.416 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -81.2 -34.73 32.07 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 123.864 0.866 . . . . 71.41 111.767 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 25.6 t70 -156.73 163.2 39.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.311 1.044 . . . . 74.52 109.986 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.04 -23.29 61.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.537 1.135 . . . . 72.33 113.119 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.607 HH11 ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -128.33 5.19 5.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.678 0.791 . . . . 63.52 111.07 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 51.2 m80 -138.51 130.47 28.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.812 . . . . 74.15 110.811 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' HG21 ' A' ' 17' ' ' VAL . 17.3 p -136.33 178.81 6.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.654 0.782 . . . . 65.04 110.226 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.9 m -133.9 118.08 17.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.074 0.55 . . . . 73.35 111.354 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.55 110.92 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.77 -0.456 . . . . 74.44 109.77 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.67 111.86 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.972 0.909 . . . . 63.52 109.633 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -111.32 124.67 52.72 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.912 0.485 . . . . 74.34 109.915 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -127.91 146.28 50.68 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.48 1.112 . . . . 70.21 110.84 -170.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.91 113.8 6.48 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.477 0.711 . . . . 73.43 111.87 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -116.9 125.69 51.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.56 1.144 . . . . 75.2 109.875 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 3.2 p90 -146.79 146.48 30.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.116 0.566 . . . . 71.21 112.521 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.438 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -76.93 86.44 3.47 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.477 0.656 . . . . 72.14 109.617 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.562 ' HB2' HG22 ' A' ' 86' ' ' ILE . 46.5 t -117.86 164.21 15.39 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.907 -1.042 . . . . 73.03 111.828 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -83.95 152.36 62.26 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.546 0.738 . . . . 65.03 110.981 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.41 -62.21 0.48 Allowed 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.956 3.104 . . . . 72.15 115.616 -170.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -31.71 72.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.7 0.8 . . . . 53.41 112.639 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 25.1 m -75.11 -34.31 61.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.315 0.246 . . . . 60.02 111.021 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.21 61.74 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.153 0.581 . . . . 63.15 111.351 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -22.93 66.61 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.259 0.466 . . . . 65.03 112.259 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.34 -41.3 56.98 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.12 0.568 . . . . 74.3 111.298 170.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 mt -75.38 -24.88 57.28 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.109 1.151 . . . . 72.5 114.109 -173.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.39 80.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.558 0.947 . . . . 71.34 113.558 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.9 m -79.31 -44.11 22.29 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.918 0.71 . . . . 62.12 112.918 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.92 -51.22 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.28 0.562 . . . . 75.32 111.87 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.6 mt -81.48 -49.0 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.705 0.802 . . . . 53.41 110.888 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.52 -42.68 95.57 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 114.849 0.699 . . . . 44.51 114.849 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -94.44 -58.95 2.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 122.093 -0.651 . . . . 62.01 110.932 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.95 -18.12 68.37 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.729 1.052 . . . . 45.34 115.729 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.31 -52.27 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 117.644 0.722 . . . . 70.33 110.977 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -74.85 -60.8 2.12 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.53 0.732 . . . . 74.23 112.123 -172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.77 65.42 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.475 0.485 . . . . 72.42 111.525 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.9 t -52.95 -56.54 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 C-N-CA 124.04 0.936 . . . . 73.14 112.442 171.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.3 -36.68 85.15 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 116.568 -0.287 . . . . 31.43 112.97 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.52 -47.45 81.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.167 0.987 . . . . 74.15 112.039 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.28 -47.71 83.13 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.28 0.632 . . . . 74.32 110.874 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.59 74.15 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.234 0.457 . . . . 63.55 112.234 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.445 HD22 HG21 ' A' ' 10' ' ' VAL . 3.8 tt -67.81 -43.17 80.28 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.01 0.524 . . . . 64.53 110.103 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.74 81.92 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.89 0.476 . . . . 74.13 111.837 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.42 -31.26 60.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.128 0.971 . . . . 71.4 112.905 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -67.15 -29.95 69.79 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.873 0.306 . . . . 73.1 111.337 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -93.42 -5.01 50.31 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.883 0.473 . . . . 71.34 112.196 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.21 0 N-CA-C 115.02 0.768 . . . . 70.13 115.02 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.771 0.319 . . . . 64.11 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -105.99 114.5 28.68 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.806 0.842 . . . . 74.33 110.182 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.36 114.68 26.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.886 1.274 . . . . 75.2 109.833 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -122.47 138.22 54.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.889 0.476 . . . . 72.13 111.968 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -138.96 155.08 48.3 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.934 1.294 . . . . 73.01 109.55 171.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.9 p -149.82 156.99 42.76 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.357 0.663 . . . . 72.11 110.357 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.1 p -145.53 146.09 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 112.084 0.402 . . . . 74.04 112.084 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.43 111.84 23.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.858 0.863 . . . . 62.4 109.71 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 60.7 t -104.29 130.76 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 62.44 110.82 -175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.93 71.54 6.63 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.113 0.482 . . . . 60.22 111.113 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.46 154.12 3.74 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.124 0.97 . . . . 73.42 111.197 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.54 136.17 49.05 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.865 2.376 . . . . 34.32 111.985 168.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.23 17.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.562 1.319 . . . . 71.11 114.562 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.9 -47.69 82.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.19 0.596 . . . . 72.24 112.57 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.47 -43.02 79.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.202 0.601 . . . . 72.15 111.784 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.516 HG21 ' SG ' ' A' ' 103' ' ' CYS . 42.5 t -69.18 -33.79 60.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 115.418 -0.81 . . . . 51.43 111.208 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.444 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 71.9 t-105 -69.54 -31.7 70.06 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 111.751 0.278 . . . . 71.41 111.751 175.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.7 m -64.31 -26.86 68.67 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.659 0.743 . . . . 62.3 110.818 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.446 HD22 HH11 ' A' ' 140' ' ' ARG . 49.2 tp -76.48 -56.33 4.72 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.795 1.238 . . . . 63.43 111.924 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.44 -9.62 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.547 0.943 . . . . 64.45 113.547 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -68.86 -27.9 73.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 113.768 0.267 . . . . 50.51 113.768 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.1 m-20 -80.86 108.57 14.64 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.416 0.686 . . . . 71.32 110.258 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -59.01 -24.81 63.12 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.76 0.824 . . . . 72.22 111.421 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -34.29 26.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.273 1.029 . . . . 75.22 113.086 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -101.56 23.72 10.77 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.529 0.681 . . . . 63.51 111.449 -163.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 HG11 ' A' ' 34' ' ' VAL . 14.9 tt -57.31 -24.79 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.648 1.179 . . . . 65.3 112.463 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -65.56 -5.63 8.65 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.156 1.169 . . . . 71.21 114.156 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -78.72 -27.22 44.88 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.628 0.771 . . . . 72.03 112.416 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -122.31 -29.74 4.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.372 0.669 . . . . 74.35 111.376 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -95.17 111.68 55.78 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.318 0.647 . . . . 61.44 109.976 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.43 -22.01 52.75 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.225 2.617 . . . . 71.12 114.508 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -86.74 -25.11 24.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.146 0.579 . . . . 62.42 112.209 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 27' ' ' ILE . 98.2 t -67.72 120.21 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 121.101 0.477 . . . . 64.31 111.142 177.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -88.51 23.59 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.335 1.054 . . . . 75.35 113.075 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.47 95.26 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 124.476 1.11 . . . . 72.43 110.418 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.71 178.79 4.16 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.319 2.68 . . . . 74.42 115.097 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.9 m -101.88 124.29 47.25 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.351 1.061 . . . . 72.44 110.079 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.85 135.68 48.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.496 0.718 . . . . 71.54 110.314 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.39 156.97 47.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.497 0.719 . . . . 63.25 110.636 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.81 157.96 0.01 OUTLIER Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.79 1.876 . . . . 60.5 117.79 -170.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.44 -98.9 0.09 Allowed 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.74 1.216 . . . . 71.21 113.359 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.9 t 171.3 149.42 0.18 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 125.459 1.504 . . . . 71.5 109.285 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.55 -19.74 18.91 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 123.059 2.506 . . . . 63.33 114.148 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -99.14 -30.26 12.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.515 0.726 . . . . 74.13 111.48 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.3 m -88.63 120.63 70.27 Favored Pre-proline 0 N--CA 1.49 1.554 0 C-N-CA 123.12 0.568 . . . . 62.02 111.071 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.542 ' HG3' ' H ' ' A' ' 68' ' ' ARG . 99.5 Cg_exo -45.77 130.18 12.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.957 3.105 . . . . 73.0 114.814 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.54 -24.21 6.2 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.412 -0.358 . . . . 52.51 113.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.49 49.86 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.49 0.716 . . . . 73.43 112.821 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.29 136.04 43.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.43 0.692 . . . . 74.42 110.716 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -115.36 108.6 16.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.204 1.002 . . . . 53.51 111.53 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 18.7 t -113.38 108.05 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.09 0.556 . . . . 71.15 110.326 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -68.35 -59.07 3.46 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.192 0.997 . . . . 73.4 113.65 -169.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.28 -12.35 84.67 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.82 -0.434 . . . . 54.05 113.477 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 66.62 -73.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.526 1.53 . . . . 63.44 113.281 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.0 44.66 0.7 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 113.492 0.157 . . . . 65.11 113.492 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.3 p -93.83 -118.33 0.09 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.905 0.882 . . . . 72.14 109.855 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -139.81 9.78 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 119.169 0.895 . . . . 71.51 110.849 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -146.57 20.63 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.322 0.649 . . . . 55.14 112.48 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.59 144.64 35.33 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.774 0.797 . . . . 72.11 112.493 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.668 HD13 ' HD3' ' A' ' 83' ' ' PRO . 16.8 tp -103.25 125.48 49.93 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.484 1.114 . . . . 53.41 109.278 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 54.0 t -96.95 114.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.078 -0.712 . . . . 65.14 109.078 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 27.8 tt0 -118.95 166.95 12.22 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.239 1.016 . . . . 74.25 109.584 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -152.2 136.72 16.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.418 0.525 . . . . 64.54 112.418 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.7 tp -77.76 116.96 18.69 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.99 1.316 . . . . 71.53 110.81 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 95.5 t -79.16 -53.01 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.02 0.528 . . . . 33.31 110.52 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -152.89 144.53 23.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.191 0.996 . . . . 72.55 109.748 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.542 ' H ' ' HG3' ' A' ' 47' ' ' PRO . 4.2 tmt_? -131.84 112.09 12.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 72.52 107.441 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -114.08 115.13 27.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.001 0.52 . . . . 51.32 110.939 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 29.1 tt0 -83.86 -20.82 32.46 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.787 0.835 . . . . 72.02 111.668 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -68.93 -48.97 61.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.424 0.69 . . . . 74.34 111.936 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.09 2.82 51.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.107 0.563 . . . . 73.52 112.393 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 54.9 52.07 12.57 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.216 1.006 . . . . 72.13 111.943 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.36 119.65 26.72 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.453 1.101 . . . . 63.44 111.123 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 44.4 tp -109.57 106.77 16.61 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.447 1.099 . . . . 74.52 110.426 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.83 128.86 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.79 0.836 . . . . 74.43 111.248 -175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 51.7 p90 -150.83 179.11 8.5 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.827 0.677 . . . . 75.44 112.827 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 t -152.85 158.03 41.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.183 1.393 . . . . 74.2 109.5 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 16.7 ptt? -111.84 100.46 48.67 Favored Pre-proline 0 N--CA 1.485 1.319 0 CA-C-N 118.362 0.528 . . . . 63.42 110.226 169.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.33 -22.79 59.71 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.409 2.74 . . . . 73.32 113.644 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 25.8 t70 -128.75 81.35 70.94 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.396 0.678 . . . . 75.25 109.726 176.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.02 154.54 12.98 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.096 2.531 . . . . 70.24 113.885 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.668 ' HD3' HD13 ' A' ' 61' ' ' LEU . 71.4 Cg_endo -83.25 -4.5 11.06 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.662 2.241 . . . . 70.25 112.532 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.91 154.13 38.37 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.156 0.982 . . . . 74.53 110.757 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HG2' HG21 ' A' ' 117' ' ' THR . 89.8 Cg_endo -79.02 61.49 8.18 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.717 2.278 . . . . 55.43 112.85 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 113' ' ' CYS . 30.4 pt -121.06 167.91 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.289 1.036 . . . . 73.41 110.321 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 84.3 m -103.46 -85.19 0.46 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.793 0.437 . . . . 71.44 110.854 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.73 111.6 23.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.12 0.486 . . . . 73.13 111.115 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 26.5 t-80 -84.84 150.88 24.7 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.639 0.776 . . . . 74.34 111.768 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -154.78 110.28 3.12 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.662 0.785 . . . . 64.51 109.887 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.03 146.27 52.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.567 0.58 . . . . 43.43 112.567 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 40.6 t -134.73 143.98 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.142 0.977 . . . . 63.11 111.553 -173.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -112.65 109.48 19.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.973 1.309 . . . . 73.4 109.238 173.583 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 92' ' ' VAL . 42.3 mt-10 -117.7 112.48 20.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.445 0.566 . . . . 74.12 111.808 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 t -97.37 111.37 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.078 0.551 . . . . 64.33 110.007 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.84 131.26 22.21 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.987 0.915 . . . . 54.33 111.192 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.69 81.63 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.04 2.493 . . . . 74.11 111.965 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -35.46 81.1 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.092 0.957 . . . . 73.41 110.873 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 23.4 t70 -140.47 174.72 10.24 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 125.342 1.457 . . . . 74.34 108.946 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.47 -68.61 0.28 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.489 0.715 . . . . 73.03 111.084 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -81.8 -15.25 54.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.893 0.477 . . . . 72.11 111.775 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.3 m80 -120.1 146.97 45.43 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.864 -0.522 . . . . 72.15 111.385 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 17' ' ' VAL . 28.9 p -132.14 176.02 8.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.358 0.663 . . . . 73.2 109.836 177.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.7 m -130.41 125.09 33.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.175 0.59 . . . . 73.24 110.122 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.28 105.96 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.69 -0.856 . . . . 61.53 108.69 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.91 112.61 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.019 -0.734 . . . . 53.53 109.019 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -102.23 112.52 25.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.761 -0.829 . . . . 75.51 108.761 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 m -113.46 144.14 43.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.203 1.001 . . . . 73.32 109.433 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.18 149.45 36.46 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.871 0.868 . . . . 51.4 109.229 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.37 130.4 8.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.257 1.023 . . . . 74.54 108.585 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 7.8 p90 -148.58 152.03 36.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.12 0.568 . . . . 72.22 111.177 -171.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 13.5 t70 -76.59 85.84 3.27 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.817 -0.629 . . . . 73.43 109.396 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.4 t -120.27 147.63 44.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.009 -0.996 . . . . 75.12 111.026 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -60.19 132.03 90.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-O 118.404 -0.807 . . . . 74.32 110.694 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.56 -46.01 12.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.848 3.032 . . . . 75.11 114.458 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -62.98 -30.85 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.354 1.061 . . . . 64.35 112.426 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.405 HG21 ' HG2' ' A' ' 85' ' ' PRO . 20.0 m -90.7 -31.8 16.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.659 0.784 . . . . 72.4 112.257 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.0 -31.52 71.27 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.737 0.815 . . . . 64.25 112.265 -171.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.93 -34.61 78.37 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.214 1.006 . . . . 63.14 112.167 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.47 -44.41 51.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.228 0.611 . . . . 72.24 110.539 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.5 -23.81 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.429 0.692 . . . . 65.0 110.843 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.26 -52.75 64.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.886 0.874 . . . . 70.41 110.732 170.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.6 m -68.38 -42.69 78.76 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 112.885 0.698 . . . . 71.35 112.885 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.2 -55.05 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.25 0.547 . . . . 64.22 112.019 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -56.99 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.618 0.767 . . . . 74.23 111.323 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.22 -33.22 86.65 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 114.442 0.537 . . . . 52.14 114.442 -175.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -101.72 -61.49 1.38 Allowed 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.043 -0.681 . . . . 65.34 111.388 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.42 68.31 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.566 0.986 . . . . 72.04 115.566 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.78 -54.9 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 117.419 0.609 . . . . 63.24 111.136 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.4 m-30 -73.46 -59.13 2.85 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.067 0.547 . . . . 64.5 112.336 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.76 67.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 123.439 0.462 . . . . 63.15 111.79 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.2 t -62.45 -55.61 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.649 0.78 . . . . 73.33 112.085 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.84 98.38 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 116.182 -0.463 . . . . 62.52 113.909 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.73 -34.66 72.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.442 0.697 . . . . 75.44 112.27 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.8 m-20 -67.66 -42.16 82.6 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 110.455 -0.202 . . . . 70.41 110.455 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.53 77.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.255 0.622 . . . . 64.43 111.539 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 17' ' ' VAL . 7.5 tt -65.19 -37.46 87.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.696 0.798 . . . . 70.44 110.104 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.36 70.6 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.616 0.366 . . . . 72.41 111.674 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 38.2 mt-10 -68.53 -39.24 81.24 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.183 0.593 . . . . 73.32 112.178 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.446 HH11 HD22 ' A' ' 20' ' ' LEU . 5.4 ptm180 -66.51 -27.81 68.07 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.317 0.488 . . . . 73.2 112.317 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -98.57 -2.94 37.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.365 0.666 . . . . 62.22 111.228 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 C-N-CA 123.58 0.609 . . . . 25.03 113.745 177.444 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.139 0.495 . . . . 74.5 112.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.7 m -126.54 128.95 47.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.319 0.648 . . . . 52.55 110.738 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 7.5 mp -105.21 141.63 36.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.174 1.39 . . . . 71.3 108.426 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -150.06 130.8 14.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.321 0.582 . . . . 71.03 111.648 172.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -139.6 152.77 47.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.606 1.162 . . . . 74.44 108.542 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -150.18 161.59 42.1 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.764 0.426 . . . . 65.35 111.378 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 135' ' ' ASN . 9.9 p -148.32 145.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.545 0.572 . . . . 74.32 112.545 -177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -91.24 119.43 31.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.849 0.86 . . . . 73.0 110.766 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.2 131.68 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 124.631 1.173 . . . . 71.04 110.959 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.28 68.79 10.31 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.134 0.492 . . . . 54.44 111.463 173.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.58 142.74 2.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.206 1.002 . . . . 54.34 109.546 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.96 138.44 82.25 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.893 2.396 . . . . 72.2 112.898 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.6 15.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.2 1.4 . . . . 71.34 114.778 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.38 64.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.435 0.694 . . . . 62.52 112.115 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.07 -37.49 82.86 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.721 0.808 . . . . 73.2 112.555 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG21 ' SG ' ' A' ' 103' ' ' CYS . 40.5 t -70.12 -37.42 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.238 0.615 . . . . 75.25 110.757 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -63.53 -31.06 72.11 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.36 -0.836 . . . . 73.31 111.523 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -59.09 -31.88 69.29 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.288 0.566 . . . . 73.53 111.572 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 30' ' ' TRP . 35.4 tp -75.76 -43.01 48.76 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.863 0.865 . . . . 70.15 111.797 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' O ' HD22 ' A' ' 75' ' ' LEU . 19.0 m -95.27 -3.35 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.264 0.839 . . . . 73.11 113.264 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.41 -28.02 60.52 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 123.152 0.406 . . . . 74.4 112.881 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.15 105.38 17.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.326 0.65 . . . . 64.13 110.078 169.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 35.9 t80 -61.61 -29.04 69.79 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.608 0.763 . . . . 71.03 111.348 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -77.74 -21.67 51.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.986 0.914 . . . . 62.51 112.783 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.16 25.84 10.5 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.891 0.477 . . . . 74.23 112.032 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.08 -27.31 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 123.743 0.817 . . . . 72.13 112.282 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.827 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -64.86 -6.74 8.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 114.134 1.161 . . . . 64.23 114.134 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -89.05 -17.58 29.05 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.734 0.642 . . . . 74.31 112.734 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.6 p-90 -129.3 -32.53 1.99 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.36 0.874 . . . . 65.54 113.36 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 17.5 t-80 -78.01 130.63 72.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.51 0.324 . . . . 74.21 110.294 -174.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -79.59 -29.07 3.1 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.721 2.281 . . . . 51.41 114.266 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 31' ' ' HIS . 6.3 mt-30 -93.82 -6.86 44.9 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.222 0.823 . . . . 71.3 113.222 -175.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 28' ' ' HIS . 7.1 p -56.87 128.39 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.518 0 CA-C-O 121.44 0.638 . . . . 71.14 112.19 176.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PHE . 31.7 m -91.62 23.18 3.64 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.078 0.951 . . . . 73.02 112.157 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 60.58 101.91 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 124.699 1.2 . . . . 65.42 111.26 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 37.3 Cg_endo -88.25 161.33 6.99 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.542 2.161 . . . . 32.35 114.386 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.9 m -105.94 123.55 48.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.883 0.873 . . . . 74.15 109.164 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 49' ' ' ALA . 1.6 tm? -88.38 113.59 24.14 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.437 -0.579 . . . . 72.44 109.437 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -99.59 153.13 19.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.949 1.3 . . . . 73.5 110.901 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.19 -126.56 23.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.948 0.78 . . . . 44.41 115.026 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.06 140.58 4.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.256 1.022 . . . . 73.25 113.246 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 m -56.58 158.13 8.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 124.534 1.133 . . . . 73.52 112.917 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.92 162.13 39.27 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.046 1.831 . . . . 74.05 111.283 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 72.75 -42.15 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.877 1.271 . . . . 75.03 112.118 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 m -68.87 123.0 87.06 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 124.395 1.078 . . . . 62.11 111.011 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.49 93.98 0.17 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.127 2.552 . . . . 71.03 113.251 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 -25.61 0.14 Allowed Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.083 -0.508 . . . . 64.22 113.156 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.04 132.78 47.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.32 1.048 . . . . 42.33 113.385 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -117.6 116.57 27.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 64.43 111.355 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 38.1 ptt85 -94.03 119.07 32.4 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.135 0.493 . . . . 74.53 110.107 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 t -114.21 112.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.421 0.688 . . . . 73.31 110.511 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HD2' ' H ' ' A' ' 35' ' ' SER . 8.3 m-85 -68.7 117.45 10.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.264 1.026 . . . . 64.34 110.29 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.62 -65.53 3.77 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.734 -0.546 . . . . 61.31 111.734 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 62.48 10.34 3.95 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.746 1.219 . . . . 75.04 114.289 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.13 32.37 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.905 -0.878 . . . . 72.1 110.905 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -122.51 175.08 6.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 71.32 109.842 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.77 -4.02 48.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.827 0.451 . . . . 62.33 111.807 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -135.3 84.76 2.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.785 . . . . 73.12 109.025 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 176.94 4.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.318 1.047 . . . . 74.41 111.417 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.571 HD13 ' HD3' ' A' ' 83' ' ' PRO . 23.2 tp -143.26 113.94 7.55 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.074 -0.512 . . . . 53.24 110.279 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 45.1 t -97.46 116.72 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.336 0.654 . . . . 73.25 109.725 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.655 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 46.3 mt-10 -120.96 123.39 42.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 64.32 109.76 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 43.1 ttt180 -103.29 135.73 44.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.299 1.04 . . . . 73.24 111.764 -175.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -80.71 122.08 26.68 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.692 0.797 . . . . 72.2 110.773 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -95.88 -45.4 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.28 0.632 . . . . 64.1 111.263 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 26.4 tt0 -145.32 145.11 31.09 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.836 1.254 . . . . 61.35 110.382 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.18 116.03 14.03 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.801 -1.185 . . . . 71.14 107.801 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -117.5 104.53 11.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.756 0.822 . . . . 64.05 109.099 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -26.26 46.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.274 0.629 . . . . 74.45 112.688 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t -72.43 -42.75 64.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.779 0.832 . . . . 74.24 110.936 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.62 2.96 36.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.768 0.655 . . . . 52.42 112.768 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 57.03 43.02 25.14 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.424 1.09 . . . . 74.22 112.016 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -115.39 105.06 12.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.814 0.846 . . . . 50.31 110.648 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 59.2 tp -100.83 105.78 17.1 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.188 0.595 . . . . 74.41 109.69 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 57.7 t -106.74 133.82 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 118.688 0.676 . . . . 72.41 110.168 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 33.4 p90 -152.31 -178.66 6.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.042 0.537 . . . . 73.32 110.862 -178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.4 t -141.71 162.92 34.3 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.402 1.081 . . . . 74.44 110.177 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.655 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 79.0 mtp -110.1 85.75 4.52 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 108.811 -0.811 . . . . 63.03 108.811 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.78 -21.17 45.06 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.154 2.569 . . . . 53.45 113.564 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 24.4 t70 -139.25 84.21 16.82 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.762 0.425 . . . . 73.32 110.226 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 44.2 Cg_endo -94.96 153.36 1.75 Allowed 'Trans proline' 0 CA--C 1.565 2.067 0 C-N-CA 123.234 2.622 . . . . 64.34 113.24 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD3' HD13 ' A' ' 61' ' ' LEU . 5.0 Cg_exo -80.48 22.68 0.75 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 122.893 2.396 . . . . 73.21 112.837 171.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.27 149.7 47.88 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.436 1.094 . . . . 75.45 110.356 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 68.02 6.24 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.835 2.357 . . . . 71.43 113.416 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.8 pt -132.97 135.9 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.542 1.137 . . . . 63.31 110.074 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 16.4 m -81.66 -82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 111.832 0.308 . . . . 73.34 111.832 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -102.07 108.0 19.28 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.257 0.551 . . . . 71.53 110.778 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -89.31 157.94 18.01 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.737 0.815 . . . . 72.31 111.685 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -156.01 124.11 5.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.587 0.755 . . . . 75.42 110.21 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.98 151.8 51.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.985 0.735 . . . . 53.21 112.985 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.5 p -138.35 137.43 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 C-N-CA 123.523 0.729 . . . . 73.03 112.483 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.2 mm? -101.28 108.3 19.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.065 -1.087 . . . . 74.01 108.065 166.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -124.51 110.73 14.85 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.641 -0.503 . . . . 72.22 109.641 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.9 110.89 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.532 -0.544 . . . . 74.42 109.532 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.6 117.5 68.61 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 124.187 0.995 . . . . 72.32 111.08 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.79 110.14 1.61 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.663 2.242 . . . . 44.22 111.494 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -107.33 -28.89 9.61 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.47 0.708 . . . . 63.41 111.834 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.9 t70 -149.96 163.05 39.12 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.762 0.825 . . . . 71.34 110.434 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.78 -39.03 73.35 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.517 1.127 . . . . 75.03 112.35 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -117.64 -4.34 11.22 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.846 . . . . 74.12 112.32 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 61.4 m-70 -133.05 156.47 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.305 0.502 . . . . 55.44 111.208 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 17' ' ' VAL . 23.0 p -157.68 178.66 10.01 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.583 0.753 . . . . 45.4 111.017 -177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.6 m -134.73 125.77 27.66 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.034 0.534 . . . . 72.15 111.33 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.02 120.96 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.38 -0.6 . . . . 61.33 109.38 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.42 125.03 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.215 0.606 . . . . 73.52 109.713 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -114.31 116.75 29.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.591 0.757 . . . . 74.43 109.087 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.468 HG22 ' SD ' ' A' ' 110' ' ' MET . 76.3 m -119.82 138.9 53.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.029 0.932 . . . . 75.12 109.384 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.17 112.91 7.67 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.492 0.717 . . . . 44.42 111.61 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.468 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -120.74 131.6 54.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 64.21 109.613 -177.45 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -142.68 155.06 44.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.625 0.77 . . . . 75.34 111.886 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 28.6 t70 -77.3 88.02 3.71 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.795 0.438 . . . . 75.23 110.115 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 38.7 t -145.99 164.76 31.06 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.971 -0.558 . . . . 71.15 112.493 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m -75.13 144.56 79.15 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.136 0.974 . . . . 55.12 111.676 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.27 -43.95 20.65 Favored 'Trans proline' 0 C--N 1.389 2.68 0 C-N-CA 124.23 3.287 . . . . 70.41 115.221 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.08 -42.53 72.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.341 1.056 . . . . 74.43 112.618 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 8.5 m -85.89 -31.47 22.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.506 0.723 . . . . 71.01 110.27 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.37 91.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.149 0.979 . . . . 75.53 112.488 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.53 -30.38 61.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.852 0.861 . . . . 72.33 112.219 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.71 -45.12 72.4 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.26 0.552 . . . . 72.14 109.865 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.06 -23.69 62.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.192 0.997 . . . . 53.11 110.943 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 40.7 tt0 -61.89 -47.09 86.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.8 0.44 . . . . 61.33 110.314 172.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -71.13 -43.74 66.99 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 112.822 0.675 . . . . 73.05 112.822 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.79 -55.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.384 0.674 . . . . 71.34 112.491 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.91 -55.23 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.736 0.815 . . . . 73.41 111.459 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -72.35 -71.23 1.09 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 114.066 0.386 . . . . 72.24 114.066 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.38 -3.64 31.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.544 0.738 . . . . 64.15 112.698 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.96 -83.13 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.061 -0.416 . . . . 70.54 112.061 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.48 -43.12 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.763 0.825 . . . . 70.4 112.593 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 6.7 m-30 -76.26 -43.7 40.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.751 0.421 . . . . 75.31 111.239 -175.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.95 -48.04 73.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.549 0.339 . . . . 73.51 111.3 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.22 -47.25 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 C-N-CA 123.357 0.663 . . . . 70.24 111.945 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -45.46 95.61 Favored Glycine 0 CA--C 1.54 1.594 0 CA-C-N 116.518 -0.31 . . . . 42.44 113.661 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.18 -46.04 57.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.372 1.069 . . . . 73.12 111.922 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.45 ' HA ' HG21 ' A' ' 8' ' ' VAL . 6.5 m-20 -61.7 -40.83 96.41 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.841 0.457 . . . . 73.1 110.999 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.49 85.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.017 0.527 . . . . 62.12 111.425 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.25 -44.87 92.37 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.443 0.697 . . . . 71.11 110.858 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.68 95.25 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.868 -0.605 . . . . 73.33 111.618 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -71.55 -30.84 66.34 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.411 0.684 . . . . 54.43 112.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -15.37 58.57 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.389 0.514 . . . . 72.02 112.389 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -85.45 -8.69 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 122.727 0.411 . . . . 74.15 111.48 162.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.057 0 N-CA-C 112.308 -0.317 . . . . 73.45 112.308 -177.032 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 112.844 0.683 . . . . 64.43 112.844 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.25 101.12 9.9 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.945 0.879 . . . . 72.33 110.281 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 4.0 mp -92.94 119.17 31.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.998 1.319 . . . . 73.35 108.932 -175.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -140.75 136.33 32.43 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.909 0.385 . . . . 75.43 110.274 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.11 138.81 31.93 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.101 -1.074 . . . . 74.41 108.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.7 p -128.92 147.11 50.81 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.874 0.869 . . . . 74.03 110.126 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.4 p -142.3 145.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.933 0.493 . . . . 51.15 110.469 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.98 112.71 24.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.349 0.595 . . . . 72.23 110.773 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.9 t -91.44 132.87 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.258 1.423 . . . . 73.32 110.632 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.13 51.37 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.409 0.683 . . . . 70.15 112.209 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.56 155.09 24.58 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.166 0.986 . . . . 61.15 110.605 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.1 142.21 73.24 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.863 2.376 . . . . 72.4 113.398 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.76 -38.91 23.11 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.911 1.684 . . . . 74.34 115.253 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.89 73.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.555 0.742 . . . . 73.12 112.767 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.85 -42.31 84.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.751 0.82 . . . . 72.55 112.307 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 137' ' ' LEU . 29.2 t -70.83 -33.82 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.899 0.88 . . . . 74.45 110.784 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 49.5 t-105 -67.29 -28.99 68.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.425 0.69 . . . . 72.43 111.891 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -65.11 -36.13 83.32 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.175 0.512 . . . . 64.51 110.441 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 30' ' ' TRP . 66.2 tp -73.28 -51.44 17.58 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.192 0.997 . . . . 64.02 111.988 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.42 -33.26 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.606 0.762 . . . . 62.22 112.702 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.11 72.68 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.177 -0.465 . . . . 74.42 113.237 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.39 94.79 0.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.938 0.875 . . . . 73.31 110.474 168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.87 12.77 0.77 Allowed 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 124.873 1.269 . . . . 54.25 110.496 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.661 ' HA ' HD21 ' A' ' 39' ' ' LEU . 75.6 p -115.77 -1.73 12.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.554 1.141 . . . . 61.42 112.493 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.31 -83.36 0.61 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 119.071 -0.49 . . . . 70.14 110.867 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.596 HG23 HG11 ' A' ' 34' ' ' VAL 0.298 19.9 tt 52.81 -48.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 127.61 2.364 . . . . 54.31 116.457 -175.295 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -60.9 -4.08 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 120.284 1.402 . . . . 75.52 114.34 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -77.46 -16.61 58.67 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.867 0.867 . . . . 71.31 112.852 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HB3' HD21 ' A' ' 20' ' ' LEU . 42.4 p-90 -132.13 -34.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.524 0.729 . . . . 71.11 111.816 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -87.53 110.74 36.65 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.89 0.876 . . . . 62.01 109.313 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.18 -8.62 24.1 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 70.53 114.902 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -109.02 -6.81 15.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.148 1.166 . . . . 73.01 114.148 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 36' ' ' ALA . 66.6 t -79.66 131.38 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 118.469 0.577 . . . . 71.42 112.5 177.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -93.03 34.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.252 1.021 . . . . 61.43 111.869 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.641 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 67.46 125.78 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 C-N-CA 125.8 1.64 . . . . 70.21 113.422 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 73.7 Cg_endo -84.79 149.7 11.14 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.742 2.295 . . . . 74.24 113.921 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.7 m -107.07 120.18 41.39 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.898 0.879 . . . . 73.33 109.645 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 25' ' ' SER . 3.9 mm? -91.51 137.7 32.15 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.481 0.658 . . . . 73.3 112.701 -167.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -130.13 165.07 23.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.153 1.381 . . . . 74.04 109.81 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.97 -150.89 5.97 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.541 0.977 . . . . 43.32 115.541 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 46' ' ' THR . . . -83.05 87.56 6.89 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.953 0.724 . . . . 72.34 112.953 -165.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.4 t 58.89 132.96 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 N-CA-C 116.001 1.852 . . . . 74.42 116.001 161.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.43 -16.44 41.82 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.082 2.521 . . . . 74.43 114.176 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -114.17 20.43 15.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 54.22 111.744 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 42' ' ' ALA . 99.5 m -123.85 123.03 26.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 123.729 0.811 . . . . 63.13 109.345 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 58.7 Cg_exo -53.95 89.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.656 2.904 . . . . 55.23 114.164 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.83 51.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.071 -0.513 . . . . 23.11 112.655 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.71 145.16 39.98 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.704 0.801 . . . . 64.35 111.006 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -109.93 153.07 25.02 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.257 0.623 . . . . 73.14 109.867 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 11.0 ptm180 -140.24 125.56 18.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.398 0.618 . . . . 74.12 109.844 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 62' ' ' VAL . 22.0 t -109.39 101.13 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.777 0.831 . . . . 73.1 109.851 -174.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -63.34 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.724 1.209 . . . . 75.45 111.953 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -59.91 0.64 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.005 -0.438 . . . . 61.13 112.005 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.36 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.52 1.528 . . . . 62.31 113.44 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.7 -19.86 0.44 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 115.002 0.761 . . . . 71.21 115.002 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 p -105.45 171.86 7.1 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.615 0.707 . . . . 70.12 111.518 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.85 7.02 43.88 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.965 0.906 . . . . 71.52 112.603 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.34 31.48 3.47 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.828 0.823 . . . . 73.44 110.521 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 151.06 45.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.752 0.821 . . . . 75.15 112.662 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -102.82 114.47 28.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.573 0.749 . . . . 62.31 110.266 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' VAL . 32.6 t -114.4 115.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.157 0.583 . . . . 53.34 110.716 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.83 160.56 20.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.02 0.928 . . . . 74.43 110.613 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -143.36 132.23 22.76 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.199 1.0 . . . . 73.33 111.356 -170.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 18.6 tp -74.83 121.55 21.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.193 1.397 . . . . 74.34 112.374 -175.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -98.38 -48.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.95 0.9 . . . . 74.23 110.879 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 36.9 tt0 -144.13 134.65 24.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.441 1.096 . . . . 74.34 109.661 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 70' ' ' GLU . 4.0 tmm_? -132.92 109.58 9.69 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.332 -0.618 . . . . 75.45 109.332 -176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.84 176.0 5.44 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.491 1.116 . . . . 73.01 109.356 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 24.4 tt0 -158.62 -34.65 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.865 -0.522 . . . . 74.42 112.336 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -63.86 -34.84 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.3 0.64 . . . . 64.44 111.358 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.65 -14.81 15.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.342 1.057 . . . . 75.43 110.773 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 68.25 69.29 0.32 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.936 1.294 . . . . 72.0 112.098 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.28 135.04 40.54 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.722 0.809 . . . . 65.43 111.505 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.57 118.18 31.0 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.764 1.225 . . . . 70.42 109.447 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 60.5 t -116.92 125.65 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.45 0.7 . . . . 64.41 109.981 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.17 -179.07 6.66 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.703 0.801 . . . . 74.53 111.319 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -145.97 162.99 36.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.425 1.09 . . . . 75.11 110.486 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 72.6 mtm -101.14 100.45 13.29 Favored Pre-proline 0 N--CA 1.484 1.259 0 N-CA-C 109.292 -0.633 . . . . 61.23 109.292 167.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.6 -21.04 30.14 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.002 2.468 . . . . 71.41 113.358 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -139.55 74.89 33.13 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.242 0.617 . . . . 65.13 109.63 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 64.7 Cg_endo -86.68 146.96 8.3 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.647 2.231 . . . . 70.32 113.468 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.1 Cg_endo -86.55 24.89 0.71 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.457 2.771 . . . . 73.12 113.347 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -123.33 149.4 57.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 123.912 0.885 . . . . 64.11 110.371 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.38 74.9 4.04 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.605 2.203 . . . . 73.24 112.031 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 113' ' ' CYS . 31.4 pt -133.78 165.11 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.338 1.055 . . . . 74.3 110.991 -174.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 5.8 m -136.02 159.89 40.31 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.663 0.785 . . . . 62.11 109.649 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.8 p30 37.73 71.67 0.14 Allowed 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 125.9 1.68 . . . . 62.14 114.547 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HD2' ' HD2' ' A' ' 111' ' ' PHE . 41.8 t-80 -79.39 131.0 35.97 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 116.076 -0.511 . . . . 73.25 111.881 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -129.82 118.84 22.4 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.231 1.012 . . . . 62.53 109.787 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.23 125.44 40.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.372 0.669 . . . . 61.43 111.312 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 117.63 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.489 0.715 . . . . 72.03 110.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.35 117.32 33.85 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 72.32 109.116 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.08 150.1 52.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.345 0.658 . . . . 74.44 110.937 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.86 113.87 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.185 0.594 . . . . 74.21 109.508 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -92.55 115.52 64.94 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.161 0.985 . . . . 63.24 109.902 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 77.11 0.37 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.764 2.309 . . . . 73.01 112.938 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -69.53 -33.75 73.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.217 1.007 . . . . 54.13 111.944 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 24.9 t70 -154.92 165.17 37.52 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.098 1.359 . . . . 74.22 108.944 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.35 -48.88 79.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.853 0.861 . . . . 62.32 111.963 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 -6.4 27.72 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.858 0.863 . . . . 72.51 110.987 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.6 m80 -131.3 128.54 39.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.956 -1.09 . . . . 75.14 111.592 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.423 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.5 p -130.2 133.76 46.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.063 0.545 . . . . 73.23 110.129 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.9 m -92.14 110.37 21.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.344 0.258 . . . . 72.42 110.383 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.11 116.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 70.35 109.717 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.8 t -107.77 109.85 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.454 1.102 . . . . 63.42 109.995 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -103.35 125.31 49.9 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.102 -0.703 . . . . 75.53 109.102 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.3 m -131.55 147.46 52.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.051 0.94 . . . . 74.44 110.344 -172.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.96 156.26 42.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.195 1.398 . . . . 70.14 108.859 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -162.81 146.03 11.0 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.638 . . . . 53.14 110.753 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HD2' ' HD2' ' A' ' 89' ' ' HIS . 2.5 p90 -158.84 155.5 27.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.717 0.807 . . . . 73.2 111.669 -168.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 30.2 t70 -82.99 85.44 7.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.022 0.929 . . . . 61.21 109.205 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.619 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.0 t -113.41 152.65 29.77 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.768 -1.105 . . . . 75.22 111.254 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.1 p -61.43 132.33 92.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.482 0.713 . . . . 73.55 110.633 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.95 -44.21 23.12 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 124.293 3.329 . . . . 73.33 116.02 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.03 -38.62 72.57 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 122.799 0.44 . . . . 74.3 112.001 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 m -75.41 -26.8 58.68 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.166 0.587 . . . . 62.31 110.931 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 2' ' ' ALA . . . -68.67 -51.29 43.5 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.235 1.014 . . . . 24.23 111.125 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -64.01 -30.57 71.64 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.687 -0.688 . . . . 73.0 111.442 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -66.98 -44.36 80.62 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.839 -0.619 . . . . 73.03 110.691 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.61 -25.51 62.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.126 0.57 . . . . 73.43 111.233 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.575 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 52.1 mt-10 -66.09 -34.51 78.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.43 111.511 173.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 t -76.6 -53.27 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.679 0.622 . . . . 51.53 112.679 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.81 -55.03 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.647 0.779 . . . . 74.14 112.147 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.03 -46.76 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.061 0.545 . . . . 73.31 110.653 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -16.18 68.04 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 115.488 0.955 . . . . 64.14 115.488 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.35 -57.47 1.99 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.983 0.892 . . . . 74.44 110.464 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.27 58.46 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 115.144 0.818 . . . . 74.03 115.144 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.0 t -111.77 -52.09 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.312 0.645 . . . . 60.43 110.372 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -75.05 -61.39 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.797 0.666 . . . . 74.24 112.797 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.59 71.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.879 0.371 . . . . 74.33 111.503 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.11 -56.28 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.109 0.964 . . . . 73.43 112.579 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.08 94.74 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.36 -0.382 . . . . 54.34 113.346 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.98 -39.39 83.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.952 0.901 . . . . 53.21 112.626 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -67.39 -45.46 76.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.388 0.275 . . . . 72.35 110.782 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.14 73.22 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.493 0.717 . . . . 64.15 111.567 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.444 HD21 HG13 ' A' ' 17' ' ' VAL . 6.8 tt -66.19 -43.65 86.19 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.788 0.835 . . . . 72.04 110.301 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.887 0.475 . . . . 71.23 112.193 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -72.25 -44.39 62.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.551 0.74 . . . . 64.03 111.768 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -73.99 -20.96 60.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.522 0.564 . . . . 73.31 112.522 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -100.56 -14.86 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.05 0.54 . . . . 72.52 111.219 168.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.203 0 CA-C-O 121.13 0.294 . . . . 53.11 112.503 177.918 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.327 0.584 . . . . 75.33 110.771 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.8 m -115.13 117.87 31.77 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.652 1.181 . . . . 71.34 109.315 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -96.33 143.78 27.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.549 1.139 . . . . 63.13 109.931 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -143.72 135.2 26.05 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.248 0.547 . . . . 73.21 111.803 172.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -131.42 156.15 46.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.989 1.316 . . . . 73.12 109.008 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -145.02 157.02 44.25 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.617 0.767 . . . . 75.23 110.488 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.6 p -150.65 146.49 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.709 0.404 . . . . 73.02 111.149 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -93.01 123.64 36.41 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.855 -0.424 . . . . 72.35 109.855 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t -108.36 132.57 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.604 1.162 . . . . 75.52 110.638 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.69 64.23 8.5 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.24 0.616 . . . . 61.51 111.585 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.59 148.58 7.88 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.333 0.653 . . . . 73.15 111.037 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.07 128.76 31.15 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.29 2.66 . . . . 44.12 113.036 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.84 -37.27 13.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.981 1.475 . . . . 75.14 114.981 -175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.36 86.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.044 0.538 . . . . 71.43 112.227 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.52 -35.53 80.77 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.222 0.609 . . . . 54.15 112.332 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' SG ' ' A' ' 103' ' ' CYS . 58.8 t -71.25 -34.97 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.428 0.691 . . . . 52.11 110.345 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 63.2 t-105 -72.67 -27.66 62.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.548 0.739 . . . . 73.13 111.775 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.4 m -69.31 -29.56 67.44 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.423 0.63 . . . . 53.44 110.077 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 30' ' ' TRP . 58.4 tp -75.16 -49.15 20.42 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.365 1.066 . . . . 75.04 111.68 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.44 -36.45 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 112.631 0.604 . . . . 64.43 112.631 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -65.36 -25.65 71.36 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 123.542 0.592 . . . . 55.34 114.352 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.07 108.21 11.2 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.123 -0.695 . . . . 54.33 109.123 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HZ ' ' HG2' ' A' ' 63' ' ' GLU . 22.2 t80 -58.55 -27.66 64.77 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.093 0.957 . . . . 73.13 110.624 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.7 p -77.71 -24.46 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.21 113.263 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.19 10.34 39.41 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 122.805 0.442 . . . . 73.11 111.799 -168.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.743 HG23 HG11 ' A' ' 34' ' ' VAL . 18.5 tt -59.49 -25.51 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 C-N-CA 123.067 0.547 . . . . 72.43 112.114 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -63.78 -19.25 64.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.216 0.821 . . . . 51.34 113.216 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -78.25 -25.14 46.72 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.629 0.603 . . . . 74.22 112.629 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.8 p-90 -117.07 -33.18 4.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.948 0.499 . . . . 64.24 111.791 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.457 ' ND1' HG23 ' A' ' 34' ' ' VAL . 43.5 t-80 -89.34 109.79 33.96 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.247 0.619 . . . . 74.02 109.567 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.87 -15.65 36.75 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.928 2.419 . . . . 74.31 114.011 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 20.5 mt-30 -90.49 -26.3 19.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.45 0.7 . . . . 74.35 111.558 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.743 HG11 HG23 ' A' ' 27' ' ' ILE . 99.3 t -74.41 103.55 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.327 0 CA-C-O 121.134 0.492 . . . . 73.14 110.434 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 m -93.45 40.98 1.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.093 0.957 . . . . 72.12 112.56 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.1 75.12 0.47 Allowed Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 124.801 1.241 . . . . 71.21 112.926 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.73 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 94.4 Cg_endo -82.44 -168.15 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.563 2.842 . . . . 71.1 115.278 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 86.7 m -113.77 139.58 49.0 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.596 1.158 . . . . 72.02 111.511 -167.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.08 143.5 26.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.272 0.629 . . . . 51.45 111.375 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.3 mmt180 -115.1 138.35 50.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.854 0.862 . . . . 71.42 110.009 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.85 -123.9 7.94 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 115.548 0.979 . . . . 53.13 115.548 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.74 139.11 0.32 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.153 1.781 . . . . 71.33 114.746 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -50.55 158.25 1.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 C-N-CA 125.403 1.481 . . . . 62.43 113.755 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -7.03 13.99 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 123.05 2.5 . . . . 62.25 114.494 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -109.55 -13.74 14.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.707 0.803 . . . . 71.11 111.445 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -88.57 118.43 69.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.627 0.771 . . . . 51.22 111.009 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.54 121.8 10.14 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.509 2.806 . . . . 72.25 113.319 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.83 -14.56 8.5 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 116.348 -0.387 . . . . 71.33 113.073 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.68 141.42 52.64 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.862 0.865 . . . . 64.42 112.425 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 34.7 mt-10 -116.5 163.53 15.94 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 122.751 0.421 . . . . 64.22 110.249 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 38' ' ' THR . 48.4 ttt85 -156.17 105.68 2.34 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.93 0.492 . . . . 74.23 110.87 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 55' ' ' ALA . 22.0 t -106.84 113.82 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.289 0.636 . . . . 74.23 111.358 -170.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.4 m-85 -76.3 70.75 2.95 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.042 1.337 . . . . 72.53 111.658 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.49 -50.85 0.53 Allowed Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.814 -0.514 . . . . 71.11 111.814 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 52' ' ' VAL . . . 60.04 24.19 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.52 1.128 . . . . 53.44 113.876 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.06 53.62 0.05 OUTLIER Glycine 0 N--CA 1.474 1.23 0 C-N-CA 122.75 0.214 . . . . 42.05 112.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -121.05 -135.37 0.32 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.22 1.008 . . . . 75.53 108.86 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.15 -1.9 4.56 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.307 0.958 . . . . 65.01 111.978 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.33 46.77 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.69 0.757 . . . . 61.32 111.946 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -87.15 152.35 22.41 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.384 -0.825 . . . . 60.34 112.004 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.89 132.54 43.39 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.838 0.855 . . . . 73.12 108.865 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.5 t -102.86 116.67 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.883 -0.511 . . . . 75.43 109.902 175.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 43.5 tt0 -109.55 154.5 22.63 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.37 1.468 . . . . 75.02 109.605 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -151.94 125.66 8.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 74.11 112.163 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -66.97 120.76 14.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.016 1.326 . . . . 53.54 111.31 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -88.1 -50.8 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.698 . . . . 55.14 110.826 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 37.5 tt0 -151.98 142.45 22.6 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.549 1.14 . . . . 74.01 109.953 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.483 HH21 ' HA3' ' A' ' 22' ' ' GLY . 3.6 tmt_? -134.23 111.46 10.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.884 -0.784 . . . . 73.11 108.884 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -117.33 125.73 51.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.727 0.811 . . . . 71.45 110.709 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 33.6 tt0 -90.63 -40.38 11.94 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.251 0.834 . . . . 73.33 113.251 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -67.26 -43.53 81.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.878 0.471 . . . . 62.31 111.951 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.35 0.93 54.72 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.063 0.545 . . . . 65.23 112.031 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 25.4 mmt85 60.1 38.31 20.51 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.355 1.062 . . . . 60.01 112.293 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.84 122.87 47.67 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.052 0.941 . . . . 71.12 111.729 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 50.1 tp -115.04 108.41 16.65 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.061 0.944 . . . . 71.04 110.213 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 54.1 t -106.35 123.21 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.464 0.706 . . . . 62.23 110.132 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.43 ' HE1' HD23 ' A' ' 93' ' ' LEU . 46.5 p90 -151.95 -178.71 6.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.928 0.491 . . . . 65.25 111.727 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.433 HG23 ' HD3' ' A' ' 80' ' ' PRO . 9.8 t -153.82 164.63 38.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.142 0.977 . . . . 61.21 111.184 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -106.99 100.28 31.2 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.964 -0.754 . . . . 71.3 108.964 160.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' HG23 ' A' ' 78' ' ' THR . 36.1 Cg_endo -63.0 -23.03 74.07 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.944 2.429 . . . . 61.43 113.471 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.9 t70 -124.61 82.31 59.51 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.445 0.698 . . . . 72.43 110.028 175.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 45.7 Cg_endo -101.56 144.67 0.26 Allowed 'Trans proline' 0 CA--C 1.573 2.466 0 C-N-CA 123.759 2.973 . . . . 72.34 114.291 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 20.0 Cg_exo -69.81 -17.26 37.45 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.768 2.312 . . . . 71.21 113.596 172.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -80.78 155.67 73.1 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 123.942 0.897 . . . . 64.45 111.394 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.0 46.84 2.3 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.253 2.635 . . . . 42.31 112.949 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.53 116.8 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.197 0.999 . . . . 35.13 109.774 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.4 p -74.96 -79.38 0.09 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.088 0.555 . . . . 70.21 112.39 -172.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.38 72.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.929 0.871 . . . . 74.03 109.752 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 110' ' ' MET . 57.5 t-80 -76.03 118.95 19.32 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.622 -0.717 . . . . 72.44 111.818 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 150.05 23.6 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.978 0.911 . . . . 74.41 108.914 170.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.59 119.49 8.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 71.03 109.137 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 48.4 t -126.09 130.12 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.38 0.672 . . . . 54.34 111.869 -169.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD23 ' HE1' ' A' ' 77' ' ' TYR . 4.3 mm? -107.93 111.57 23.74 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.382 1.073 . . . . 62.12 109.359 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 51.0 mt-10 -116.58 111.23 19.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.952 0.501 . . . . 74.12 110.413 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.43 105.61 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.298 -1.001 . . . . 75.43 108.298 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 15.5 m -100.57 123.7 45.12 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 122.894 0.478 . . . . 64.24 110.405 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 16.4 Cg_exo -68.47 85.81 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.159 2.573 . . . . 74.32 112.614 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -32.93 74.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.143 0.977 . . . . 71.34 109.744 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.7 t70 -157.31 167.12 31.23 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.239 1.816 . . . . 62.44 108.259 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.7 -40.54 95.39 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.208 0.603 . . . . 53.42 112.434 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -108.98 -1.29 19.08 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.614 0.766 . . . . 75.43 111.888 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.0 m80 -132.5 124.5 28.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.243 -0.911 . . . . 71.13 110.153 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 17' ' ' VAL . 29.1 p -133.1 142.88 48.96 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.003 0.521 . . . . 71.23 110.8 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 m -97.12 114.33 26.0 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.757 0.423 . . . . 60.14 110.156 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 t -95.3 112.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.428 -0.582 . . . . 74.02 109.428 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.77 117.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 41.34 109.655 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -108.73 112.73 25.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.123 -0.695 . . . . 75.25 109.123 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 m -125.22 128.09 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.506 0.722 . . . . 72.02 110.338 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.65 148.9 42.25 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.611 0.764 . . . . 75.05 111.053 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 1.8 mpt? -126.17 150.36 48.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.707 0.803 . . . . 71.23 109.139 172.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -162.77 153.14 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.323 0.649 . . . . 73.02 110.455 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -102.57 78.58 1.73 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.748 0.785 . . . . 63.42 109.456 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t -125.15 168.14 13.83 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.779 -1.101 . . . . 71.33 110.984 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -65.05 147.47 98.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 C-N-CA 123.399 0.68 . . . . 74.14 112.174 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.7 -31.57 95.16 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.955 2.436 . . . . 55.45 113.411 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.94 -55.96 28.12 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.007 0.923 . . . . 72.41 111.604 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.43 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.7 m -74.48 -32.02 62.41 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.756 -0.657 . . . . 64.24 111.157 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -65.6 -41.53 92.69 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.085 0.554 . . . . 61.14 112.029 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -67.31 -31.35 71.58 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.648 0.379 . . . . 75.21 111.657 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.96 -42.62 94.44 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.652 -0.499 . . . . 72.23 109.652 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 117' ' ' THR . 92.8 mt -72.62 -25.33 61.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.374 0.67 . . . . 75.42 111.717 -176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 46.8 mt-10 -61.35 -38.18 86.01 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 118.14 0.427 . . . . 75.31 110.763 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 t -76.25 -51.43 12.06 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 112.694 0.627 . . . . 72.4 112.694 172.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.26 -55.02 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 112.863 0.69 . . . . 63.31 112.863 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.4 mt -77.5 -45.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.75 0.42 . . . . 72.33 110.522 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.45 -47.9 83.19 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 114.855 0.702 . . . . 71.42 114.855 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.99 -46.55 5.06 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.451 -1.029 . . . . 73.22 112.094 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.01 -19.58 71.96 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 114.94 0.736 . . . . 71.25 114.94 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.11 -53.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 117.88 0.84 . . . . 73.2 111.443 176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.6 m-30 -73.84 -54.62 7.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.36 72.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.061 0.144 . . . . 74.01 110.968 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.75 -52.22 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.08 0.552 . . . . 75.51 111.754 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.26 -50.25 61.12 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 116.572 -0.285 . . . . 55.21 113.18 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.89 -41.65 99.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 74.33 112.716 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.79 -41.5 78.64 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.2 -0.429 . . . . 74.43 110.438 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.35 75.5 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.85 0.46 . . . . 73.53 111.876 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 HG13 ' A' ' 17' ' ' VAL . 7.8 tt -67.86 -41.33 83.05 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.217 0.607 . . . . 60.12 109.898 173.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.47 -27.73 62.48 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 112.353 0.501 . . . . 75.02 112.353 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.77 -37.89 39.97 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.184 0.994 . . . . 63.24 112.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 8.7 ptm180 -67.71 -34.07 76.14 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.348 0.259 . . . . 65.53 110.971 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -88.94 -16.94 30.57 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.95 0.5 . . . . 71.2 110.539 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.329 0 CA-C-N 115.878 -0.601 . . . . 35.23 113.252 175.884 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.838 0.828 . . . . 73.34 110.876 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.8 m -128.62 116.67 19.96 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.184 0.994 . . . . 62.31 109.581 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 126' ' ' GLY . 8.3 mp -108.76 109.49 20.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.931 1.292 . . . . 55.32 109.539 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -129.48 135.2 48.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 70.12 112.214 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.56 156.08 49.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.736 1.214 . . . . 74.52 110.648 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -143.84 154.2 43.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.205 1.002 . . . . 74.32 109.321 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.8 p -150.09 147.54 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 111.591 0.219 . . . . 75.15 111.591 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.27 118.5 26.74 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.196 0.598 . . . . 72.03 110.546 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.0 121.05 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.671 1.188 . . . . 61.23 110.131 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.25 72.94 3.83 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.147 0.579 . . . . 52.5 111.044 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.02 155.76 2.42 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.646 0.778 . . . . 71.22 111.134 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -63.0 138.29 67.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.704 2.269 . . . . 54.23 111.86 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -25.13 11.16 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.165 0.802 . . . . 72.05 113.165 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.42 47.96 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.711 0.634 . . . . 65.44 112.711 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.54 -40.07 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.246 0.618 . . . . 71.44 111.636 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.429 HG13 HD21 ' A' ' 137' ' ' LEU . 21.6 t -74.5 -34.86 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.524 0.73 . . . . 55.44 111.125 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 -70.1 -27.76 64.85 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.345 0.658 . . . . 63.14 111.419 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 m -63.76 -29.14 70.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.389 0.614 . . . . 72.35 111.147 170.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 30' ' ' TRP . 57.5 tp -86.07 -56.72 3.33 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.505 1.122 . . . . 55.24 111.924 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.56 -25.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 123.099 0.56 . . . . 72.44 112.501 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.13 0.61 62.53 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 114.408 0.523 . . . . 71.2 114.408 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.09 163.59 12.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.125 0.97 . . . . 73.44 109.206 165.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.09 -44.26 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.794 -0.566 . . . . 74.31 110.551 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.7 p -77.61 -20.26 54.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.192 0.441 . . . . 71.12 112.192 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.12 5.79 9.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.181 0.592 . . . . 62.51 112.549 -170.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 34' ' ' VAL . 19.1 tt -68.15 -27.31 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.305 0.642 . . . . 71.31 112.565 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -66.31 -15.89 63.6 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.365 0.505 . . . . 73.13 112.365 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -80.79 -38.33 28.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.757 0.823 . . . . 74.21 112.595 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.63 ' HB3' HD21 ' A' ' 20' ' ' LEU . 54.5 p-90 -108.81 -36.37 6.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 122.084 -0.385 . . . . 61.12 111.679 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -89.89 110.56 40.71 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.107 0.563 . . . . 71.44 109.619 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.06 -21.57 42.75 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.134 2.556 . . . . 75.44 114.318 -170.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -87.45 -16.76 33.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 74.24 112.838 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 27' ' ' ILE . 76.4 t -61.62 127.28 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 122.967 0.507 . . . . 61.34 111.768 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -90.23 27.41 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.34 1.056 . . . . 74.33 112.384 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 62.46 101.61 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 124.437 1.095 . . . . 74.23 111.381 -172.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.46 177.51 4.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.863 2.375 . . . . 73.22 114.707 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 m -123.84 141.85 51.65 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.098 0.959 . . . . 70.43 110.731 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 126.25 40.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.299 0.64 . . . . 65.42 111.298 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 34.0 mmt180 -103.97 123.78 47.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.659 . . . . 74.42 110.1 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.55 -177.77 0.01 OUTLIER Glycine 0 CA--C 1.549 2.177 0 N-CA-C 118.199 2.039 . . . . 63.13 118.199 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.86 -106.23 0.26 Allowed 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.428 1.491 . . . . 50.24 113.687 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.523 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 40.4 t 179.01 147.34 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.454 1.102 . . . . 71.21 109.384 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.37 -20.9 21.55 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.301 2.667 . . . . 72.03 114.894 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.6 3.06 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.182 0.593 . . . . 73.25 112.547 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.4 m -102.38 118.92 57.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.729 0.812 . . . . 71.02 110.765 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 80.1 Cg_exo -50.38 102.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.52 2.813 . . . . 74.23 113.261 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -31.66 1.14 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.039 -0.528 . . . . 63.31 113.704 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -65.48 144.44 57.03 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.563 0.579 . . . . 54.15 112.563 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 46.7 mt-10 -110.92 146.67 36.14 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.33 0.652 . . . . 75.32 111.767 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -118.68 106.59 12.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.564 0.746 . . . . 71.23 110.786 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 25.1 t -109.34 102.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.905 0.882 . . . . 75.44 110.84 -173.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.71 93.79 2.14 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.658 0.783 . . . . 74.03 112.505 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 60.43 1.87 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.296 -0.321 . . . . 41.41 112.296 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 107.63 1.44 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.645 0.778 . . . . 61.53 112.905 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 24.83 7.44 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 114.159 0.423 . . . . 61.25 114.159 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -96.52 -77.03 0.49 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.291 0.636 . . . . 75.34 110.669 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 163.11 -35.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.821 1.649 . . . . 62.31 108.491 -171.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -103.7 17.31 24.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.189 -0.914 . . . . 74.44 112.581 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 136.58 47.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.414 0.626 . . . . 54.33 112.38 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -101.69 118.93 37.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.606 0.762 . . . . 72.42 109.196 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 53.7 t -97.2 113.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.476 -0.564 . . . . 75.11 109.476 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 59.3 mt-10 -108.29 169.62 8.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.322 1.049 . . . . 74.42 110.059 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -150.43 121.43 7.68 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.114 0.566 . . . . 74.42 110.373 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.04 121.59 19.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.128 0.971 . . . . 72.05 111.887 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 82.9 t -90.99 -48.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.53 0.732 . . . . 65.52 111.594 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -166.72 152.75 8.33 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.556 0.343 . . . . 64.22 111.781 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.511 HH12 HD22 ' A' ' 75' ' ' LEU . 93.2 mtt-85 -134.9 119.7 18.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.719 0.808 . . . . 75.23 111.141 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.0 m-20 -95.91 99.74 11.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.453 1.101 . . . . 71.42 109.62 172.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.81 -57.87 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.126 0.57 . . . . 74.21 111.821 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.8 t -70.44 -36.69 74.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.15 0.58 . . . . 75.23 111.784 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -79.53 -7.6 58.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.267 0.627 . . . . 33.11 112.147 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 58.21 43.64 20.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.761 1.224 . . . . 71.54 112.297 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.2 ttp180 -124.66 143.72 50.58 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.227 1.011 . . . . 63.45 110.209 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.511 HD22 HH12 ' A' ' 68' ' ' ARG . 10.0 tp -130.39 125.87 35.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 72.34 109.233 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.14 130.28 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.685 0.794 . . . . 71.04 110.873 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -152.28 177.29 10.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.696 0.798 . . . . 74.41 110.706 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.7 t -154.97 150.66 27.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.684 0.794 . . . . 53.45 110.33 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.641 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 15.4 ptt? -98.65 106.2 35.31 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 122.579 0.351 . . . . 62.25 111.57 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.89 -25.8 44.91 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.356 2.704 . . . . 72.14 112.673 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 10.0 m-20 -123.71 80.1 55.69 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.412 0.685 . . . . 53.45 110.819 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.88 137.49 3.97 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.788 2.325 . . . . 73.53 112.511 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.37 -14.29 37.07 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.143 1.896 . . . . 73.23 112.118 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 62.9 m-85 -76.53 147.51 78.77 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.575 1.15 . . . . 74.34 110.787 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 5.5 Cg_exo -77.04 39.37 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.341 2.694 . . . . 71.25 114.094 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -103.28 152.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.063 0.945 . . . . 70.2 111.133 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -89.14 -86.24 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.522 0.329 . . . . 71.13 111.353 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -98.01 108.66 21.41 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.196 0.522 . . . . 74.32 110.881 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -95.08 155.57 16.68 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.295 0.569 . . . . 65.14 111.963 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 16.1 tpt180 -145.83 122.69 11.29 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.564 1.146 . . . . 72.33 108.705 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 126.6 44.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.654 0.661 . . . . 64.12 111.432 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 75.1 t -130.24 129.58 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.377 0.671 . . . . 75.54 112.595 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.24 132.09 46.92 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.364 1.066 . . . . 62.15 108.586 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -143.94 112.57 6.55 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.28 0.945 . . . . 75.25 111.658 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.631 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 26.9 m -95.74 111.25 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 121.966 0.889 . . . . 64.41 110.533 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.497 HG23 ' HB ' ' A' ' 104' ' ' THR . 6.6 m -103.58 116.7 61.51 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.834 0.853 . . . . 53.22 110.322 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.01 109.49 2.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.235 . . . . 75.21 113.269 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -66.3 -30.89 71.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.794 0.838 . . . . 62.23 110.719 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.0 t70 -158.54 174.04 15.69 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 125.199 1.399 . . . . 64.52 108.517 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.76 -37.65 66.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.555 0.742 . . . . 64.13 112.365 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -123.75 28.45 6.9 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.037 0.923 . . . . 74.22 111.564 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 62.1 m80 -138.03 130.44 29.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 72.41 109.488 171.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 46.9 t -130.89 162.83 28.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.858 0.863 . . . . 44.31 111.125 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.497 ' HB ' HG23 ' A' ' 96' ' ' VAL . 86.8 m -133.96 115.35 14.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.405 0.682 . . . . 71.43 110.042 174.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 95' ' ' VAL . 15.2 t -90.35 114.61 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.625 -0.509 . . . . 71.12 109.625 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.81 110.91 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.899 0.88 . . . . 65.33 109.285 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.54 122.97 48.6 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.247 -0.649 . . . . 74.33 109.247 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.53 HG22 ' SD ' ' A' ' 110' ' ' MET . 21.4 m -129.86 135.98 49.01 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.41 0.684 . . . . 51.14 110.964 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.7 116.01 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.657 0.783 . . . . 73.21 112.041 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 3.1 mpp? -103.06 134.03 47.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.441 1.097 . . . . 70.22 109.121 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -157.62 143.56 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 120.731 0.3 . . . . 75.52 111.526 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.11 82.63 5.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.849 0.833 . . . . 75.31 109.434 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.593 ' HB2' HG22 ' A' ' 86' ' ' ILE . 41.1 t -110.97 160.54 16.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.414 -1.266 . . . . 73.11 111.444 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -64.84 134.88 96.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.655 0.782 . . . . 71.44 110.152 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.66 -42.82 64.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.544 2.829 . . . . 73.54 115.109 -167.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.57 -37.94 89.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.969 0.414 . . . . 63.3 111.903 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.41 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -74.41 -33.25 62.95 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 122.971 0.508 . . . . 73.42 110.773 175.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.74 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.873 0.869 . . . . 42.24 111.89 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -28.14 67.28 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.081 0.952 . . . . 75.23 112.149 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.98 -46.35 65.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.944 -0.391 . . . . 61.22 109.944 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.45 -22.68 61.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.334 0.654 . . . . 74.45 110.922 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -56.5 -46.47 80.48 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.27 1.028 . . . . 75.42 110.501 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 m -71.36 -50.01 36.5 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.481 -0.781 . . . . 73.42 112.683 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.93 -56.5 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 123.383 0.673 . . . . 73.04 112.404 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.27 -54.29 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.878 0.871 . . . . 74.55 110.624 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.423 ' N ' HD23 ' A' ' 4' ' ' LEU . . . -63.94 -33.8 88.23 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 115.655 1.022 . . . . 62.42 115.655 -172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -117.07 -43.08 2.88 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.39 1.095 . . . . 53.52 111.744 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.72 -33.84 71.74 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.179 -0.464 . . . . 33.0 113.927 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.93 -56.28 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.069 0.548 . . . . 75.21 110.869 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.0 m-30 -70.63 -64.16 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.132 0.573 . . . . 73.22 112.483 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.73 71.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.287 0.367 . . . . 50.11 111.601 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 t -59.78 -54.32 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 C-N-CA 123.902 0.881 . . . . 64.43 112.277 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.45 -37.74 95.28 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.403 -0.362 . . . . 72.44 113.505 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.7 mt -70.93 -36.68 72.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.856 0.862 . . . . 63.05 111.972 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -68.77 -40.07 79.92 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.639 0.375 . . . . 51.33 110.694 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.65 91.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.076 0.55 . . . . 60.42 111.625 175.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 17' ' ' VAL . 9.0 tt -63.91 -43.0 97.24 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.475 0.71 . . . . 74.2 110.335 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.41 73.94 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.057 -0.52 . . . . 61.43 111.799 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.03 -40.08 54.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.439 0.696 . . . . 52.51 112.819 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -67.34 -29.58 69.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.21 0.448 . . . . 75.14 112.21 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -89.87 -29.18 18.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.203 -0.311 . . . . 71.32 111.366 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 CA-C-N 116.24 -0.436 . . . . 50.11 112.669 -179.755 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.372 0.129 . . . . 74.42 111.298 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.43 -14.46 61.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.861 0.464 . . . . 54.03 111.09 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -103.97 109.13 20.78 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.415 1.086 . . . . 73.21 109.793 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.39 140.64 29.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.782 0.833 . . . . 71.24 109.793 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -146.24 123.21 11.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.154 0.582 . . . . 74.4 109.867 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 130' ' ' PHE . 45.4 mtp85 -128.75 150.34 50.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 73.53 110.097 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -139.49 145.02 38.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.684 0.794 . . . . 54.15 110.519 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.7 p -136.23 144.91 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 122.558 0.343 . . . . 51.31 111.323 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.25 109.19 20.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.658 0.783 . . . . 71.31 110.489 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 70.9 t -101.19 127.17 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.984 0.914 . . . . 73.12 110.407 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 65.59 4.73 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.431 0.692 . . . . 74.21 111.491 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.0 155.13 3.62 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 124.002 0.921 . . . . 70.12 111.225 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.13 139.12 85.01 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.082 2.521 . . . . 70.31 113.865 167.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.47 64.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.258 1.577 . . . . 74.4 115.258 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.16 98.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.4 0.68 . . . . 62.24 112.426 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.22 -36.16 77.06 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.748 0.819 . . . . 72.54 112.34 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.471 HG21 ' SG ' ' A' ' 103' ' ' CYS . 41.3 t -73.57 -35.7 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.103 0.561 . . . . 65.11 111.345 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.62 -34.34 78.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.627 0.371 . . . . 74.35 111.309 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -58.84 -23.94 61.36 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.708 0.803 . . . . 65.22 111.604 171.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.8 tp -95.04 -58.47 2.14 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.067 0.947 . . . . 73.35 112.866 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.03 -34.14 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 123.607 0.763 . . . . 70.41 112.996 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.66 -45.27 94.95 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 115.216 0.846 . . . . 63.35 115.216 -166.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.78 -31.21 1.93 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.305 1.594 . . . . 71.25 115.305 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.4 t80 73.88 -59.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.03 1.332 . . . . 72.1 111.254 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -59.62 -38.16 80.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.926 0.89 . . . . 70.14 112.54 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.576 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -99.58 27.21 5.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.631 0.772 . . . . 75.51 111.598 -166.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 HG11 ' A' ' 34' ' ' VAL . 19.0 tt -62.72 -22.98 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.286 1.034 . . . . 72.5 112.382 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -68.84 -3.73 13.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.163 0.801 . . . . 74.24 113.163 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 48.0 mtp180 -76.61 -24.37 53.41 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.826 0.85 . . . . 73.24 112.445 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -129.6 -37.56 1.57 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.255 0.835 . . . . 75.41 113.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.588 ' CD2' HG23 ' A' ' 34' ' ' VAL . 6.7 t60 -90.06 108.52 26.62 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.965 0.506 . . . . 73.31 109.798 -171.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.41 -23.59 32.21 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.154 2.57 . . . . 74.13 114.708 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -80.82 -15.65 55.81 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.989 0.516 . . . . 63.23 112.068 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 53' ' ' PHE . 94.8 t -68.27 106.72 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.11 0.481 . . . . 72.12 111.37 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -89.11 54.92 3.13 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.491 0.716 . . . . 53.42 110.681 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.09 105.17 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 125.449 1.499 . . . . 72.03 113.429 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 64.4 Cg_endo -90.35 148.76 4.42 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.861 2.374 . . . . 60.41 113.149 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -101.02 115.14 29.77 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.127 0.571 . . . . 72.4 110.111 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.8 tm? -89.37 112.32 23.4 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 109.096 -0.705 . . . . 72.52 109.096 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -102.48 123.09 45.6 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.918 0.887 . . . . 70.04 110.856 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.32 -178.6 0.01 OUTLIER Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.716 2.247 . . . . 62.41 118.716 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 70.11 -31.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.86 1.8 . . . . 72.41 115.86 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m 83.13 137.64 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 126.202 1.801 . . . . 74.23 111.009 -167.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.14 -14.31 40.35 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.243 2.629 . . . . 73.51 115.244 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -92.21 -14.31 29.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.977 0.511 . . . . 74.21 111.541 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.3 m -95.55 123.98 54.53 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.006 0.922 . . . . 73.1 110.905 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.6 Cg_exo -48.5 98.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.735 2.957 . . . . 64.3 114.254 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.68 -39.19 0.47 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 113.922 0.329 . . . . 50.54 113.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.65 139.08 45.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.595 1.331 . . . . 43.24 114.595 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 4.2 mp0 -103.35 149.23 24.96 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.089 0.555 . . . . 72.33 110.857 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 34.4 ptt180 -127.04 119.78 27.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.48 0.582 . . . . 72.22 110.575 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.24 102.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.647 0.779 . . . . 64.14 110.795 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.624 ' HE2' HG22 ' A' ' 34' ' ' VAL . 6.0 m-85 -64.0 123.03 17.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.438 1.095 . . . . 73.24 111.354 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.06 -66.27 3.89 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-O 120.143 -0.254 . . . . 73.4 112.783 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.61 35.06 20.05 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.415 1.086 . . . . 74.51 113.456 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.82 37.78 0.05 OUTLIER Glycine 0 N--CA 1.476 1.301 0 CA-C-N 115.781 -0.645 . . . . 45.43 112.198 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -147.16 162.42 38.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.338 1.055 . . . . 74.24 110.901 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.57 -23.39 65.4 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.379 0.672 . . . . 64.52 112.496 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -122.06 90.22 3.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.011 0.524 . . . . 72.21 111.355 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.34 171.15 7.49 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.457 0.646 . . . . 63.05 111.321 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -136.72 114.15 10.91 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.661 0.784 . . . . 74.12 109.17 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 44.0 t -99.23 113.79 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.524 -0.546 . . . . 73.22 109.524 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 58.0 mt-10 -107.21 167.22 10.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.431 1.093 . . . . 60.41 110.627 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -151.07 125.23 9.32 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 52.22 110.548 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 39.5 tp -69.09 116.36 9.44 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.87 1.268 . . . . 64.33 111.245 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -82.19 -51.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 122.924 0.49 . . . . 64.34 110.98 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.5 pt-20 -156.4 152.67 27.8 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.485 0.714 . . . . 73.21 110.032 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -142.48 131.72 23.41 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.264 0.554 . . . . 74.3 111.715 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.8 m-20 -119.09 102.58 8.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.913 1.285 . . . . 71.03 110.068 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.69 -52.73 55.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.866 0.866 . . . . 72.35 112.124 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -71.49 -33.42 69.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.102 0.561 . . . . 75.15 112.182 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -83.29 -10.36 58.56 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 112.75 0.648 . . . . 64.12 112.75 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 61.16 34.37 18.96 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.927 0.891 . . . . 74.43 111.65 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -119.06 112.23 19.29 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.877 0.871 . . . . 70.14 110.432 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -118.34 108.66 15.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.478 1.111 . . . . 74.44 111.631 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.8 t -108.48 127.78 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.693 -0.629 . . . . 55.21 111.685 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -135.89 -179.26 5.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.817 0.847 . . . . 63.25 111.203 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -146.01 164.29 32.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.608 1.163 . . . . 73.12 109.839 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 61' ' ' LEU . 73.6 mtm -103.52 97.07 9.67 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 122.988 0.515 . . . . 73.31 110.013 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.07 -13.42 31.36 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.155 2.57 . . . . 55.42 112.96 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 14.6 t70 -140.57 79.36 20.17 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 109.022 -0.733 . . . . 71.53 109.022 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -90.2 136.69 2.46 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.208 2.605 . . . . 71.32 113.747 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.54 -10.9 20.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.368 2.046 . . . . 65.02 113.231 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -94.02 131.53 31.5 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.713 0.805 . . . . 74.34 110.239 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.528 ' HG2' HG21 ' A' ' 117' ' ' THR . 37.5 Cg_endo -63.92 88.86 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.973 2.448 . . . . 62.4 113.465 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.0 pt -134.87 165.19 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 124.998 1.319 . . . . 75.22 109.762 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.0 m -100.75 -76.9 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.898 0.479 . . . . 72.53 110.947 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.77 110.32 22.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.013 0.435 . . . . 64.54 111.073 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -89.21 147.26 24.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.03 0.532 . . . . 73.23 111.165 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -153.28 125.57 8.05 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.219 1.008 . . . . 63.25 108.869 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.61 146.86 44.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.725 0.693 . . . . 71.03 112.056 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.92 145.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.796 0.838 . . . . 75.14 110.955 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 108.78 15.9 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.572 1.149 . . . . 63.02 108.062 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.99 112.71 17.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.682 0.393 . . . . 73.24 110.533 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 HG22 ' A' ' 105' ' ' VAL . 21.6 t -90.54 108.12 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.819 -0.808 . . . . 25.52 108.819 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.6 t -99.39 108.92 52.87 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.398 1.079 . . . . 73.33 110.153 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.94 124.79 11.35 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.102 1.868 . . . . 35.32 113.018 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -93.81 -56.46 2.88 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.375 -0.972 . . . . 64.3 108.375 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -118.75 -169.35 1.71 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.724 1.209 . . . . 73.0 110.068 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.52 -27.25 46.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.131 0.572 . . . . 73.04 111.475 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -109.56 2.03 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.839 0.856 . . . . 75.01 112.634 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -136.93 125.24 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.873 0.469 . . . . 72.04 109.771 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.6 p -137.29 132.82 34.25 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.023 0.44 . . . . 62.22 110.657 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.2 m -91.66 109.82 21.14 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.931 -0.577 . . . . 64.41 110.828 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.622 HG22 HG13 ' A' ' 95' ' ' VAL . 27.1 t -88.34 111.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.585 -0.524 . . . . 73.14 109.585 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.09 114.75 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.562 0.745 . . . . 74.34 110.667 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -103.84 118.69 37.28 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.439 0.696 . . . . 72.45 109.178 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.5 m -112.47 139.48 48.02 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.359 1.064 . . . . 62.0 109.817 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.61 108.89 4.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.214 0.605 . . . . 45.14 111.505 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.36 135.4 54.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.308 1.043 . . . . 72.11 110.375 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.28 145.07 26.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.624 0.77 . . . . 65.43 111.274 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.42 79.6 9.51 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.849 0.833 . . . . 60.11 109.914 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.663 ' HB2' HG22 ' A' ' 86' ' ' ILE . 49.1 t -108.94 164.58 12.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.734 -1.121 . . . . 64.11 111.317 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.5 t -83.01 137.57 43.19 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.574 -0.727 . . . . 63.05 110.169 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -44.56 -49.05 9.61 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 124.617 3.545 . . . . 50.11 116.165 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.78 -32.17 73.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.836 0.68 . . . . 72.1 112.836 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.528 HG21 ' HG2' ' A' ' 85' ' ' PRO . 55.0 m -82.79 -33.51 27.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.825 0.45 . . . . 74.1 110.857 174.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.48 86.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.483 0.713 . . . . 72.52 111.76 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.18 -36.47 79.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.181 0.593 . . . . 54.31 111.88 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.32 -42.04 79.95 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.1 110.79 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.94 -24.49 64.28 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 71.14 112.016 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.59 -41.63 97.7 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.851 0.461 . . . . 62.2 111.826 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -76.94 -45.54 27.38 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.021 0.748 . . . . 72.3 113.021 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.6 -54.74 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 112.535 0.569 . . . . 44.44 112.535 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.95 -49.05 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.297 0.639 . . . . 72.13 110.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.03 -79.39 0.43 Allowed Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.251 -0.431 . . . . 61.33 113.592 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.59 -7.41 26.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.496 0.924 . . . . 65.01 113.496 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.23 -83.51 1.72 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 112.098 -0.401 . . . . 43.42 112.098 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.2 t -58.2 -46.66 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.048 0.939 . . . . 65.05 113.331 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.439 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 4.4 m-30 -77.57 -49.39 14.73 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.847 0.459 . . . . 65.31 111.21 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.55 -17.14 59.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.07 0.767 . . . . 73.23 113.07 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -85.2 -55.46 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 122.843 0.457 . . . . 74.12 111.376 166.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.72 -53.62 36.87 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 114.518 0.567 . . . . 62.23 114.518 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.86 -41.6 78.24 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.323 1.049 . . . . 60.01 112.138 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.407 ' HB3' ' HE1' ' A' ' 148' ' ' HIS . 2.6 m-20 -74.31 -39.4 62.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.349 -0.842 . . . . 72.51 111.953 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.41 75.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.408 0.683 . . . . 73.02 111.0 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.421 HD21 HG13 ' A' ' 17' ' ' VAL . 9.7 tt -65.63 -43.27 90.0 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.785 0.834 . . . . 53.41 110.585 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.37 68.88 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 122.884 0.474 . . . . 71.43 111.839 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.11 -39.94 60.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.95 0.9 . . . . 61.02 112.512 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -73.83 -22.99 59.58 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.723 0.638 . . . . 72.04 112.723 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -90.09 -2.5 58.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.076 -0.39 . . . . 72.45 111.242 168.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -67.41 -8.18 49.83 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 116.285 -0.416 . . . . 34.41 114.031 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.651 ' HG3' HD12 ' A' ' 144' ' ' LEU . 8.8 ptm180 -61.28 -26.06 67.52 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.344 0.658 . . . . 75.11 111.987 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.651 HD12 ' HG3' ' A' ' 143' ' ' ARG . 6.4 mp -78.36 -62.82 1.56 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.773 0.429 . . . . 63.04 110.162 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -131.74 90.34 2.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 122.84 0.456 . . . . 74.34 112.04 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 55.79 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 C-N-CA 127.496 2.318 . . . . 73.1 116.579 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -89.2 162.03 16.13 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.301 -0.863 . . . . 71.1 110.63 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.407 ' HE1' ' HB3' ' A' ' 135' ' ' ASN . 29.0 p80 -129.48 178.0 6.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 72.12 110.09 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -61.89 126.34 27.01 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.798 0.439 . . . . 71.44 110.089 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -60.86 126.43 27.37 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.437 0.295 . . . . 74.33 110.77 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 123.734 0.814 . . . . 64.41 110.938 -169.899 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 121.022 0.439 . . . . 72.23 111.211 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.95 73.36 10.35 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.991 0.901 . . . . 63.52 110.306 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -142.39 131.18 22.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.06 -0.973 . . . . 64.34 110.746 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.53 121.08 44.39 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.033 1.333 . . . . 61.24 109.133 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -120.35 120.53 36.28 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.248 0.547 . . . . 73.14 110.111 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.43 147.29 46.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.542 1.137 . . . . 74.2 109.616 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.6 p -151.0 150.47 30.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.314 0.646 . . . . 50.14 111.018 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.3 p -146.82 138.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.175 0.59 . . . . 73.3 111.645 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.53 108.9 19.26 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.289 0.566 . . . . 72.25 110.036 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -101.62 131.36 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.71 1.204 . . . . 54.14 110.303 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.34 73.95 3.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.875 0.47 . . . . 75.23 111.133 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 155.81 7.51 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.393 0.677 . . . . 74.2 111.481 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.74 138.55 38.15 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.901 2.4 . . . . 73.22 111.905 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.35 -32.32 48.61 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.95 1.093 . . . . 51.13 113.95 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -50.26 66.81 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.952 0.501 . . . . 65.14 111.885 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.24 -39.23 82.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.467 0.707 . . . . 70.03 112.595 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 21.5 t -70.95 -34.37 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.491 0.316 . . . . 72.41 110.654 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.734 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 69.4 t-105 -67.31 -28.94 68.41 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.834 0.454 . . . . 71.25 111.316 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -64.17 -21.24 66.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.124 0.57 . . . . 73.44 111.579 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 tp -90.32 -43.13 10.55 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 124.465 1.106 . . . . 71.42 112.916 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -107.13 13.72 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 113.778 1.029 . . . . 70.32 113.778 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.06 -17.22 75.02 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 114.169 0.428 . . . . 75.45 114.169 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.9 m-20 -102.78 137.88 40.41 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.359 0.664 . . . . 73.4 110.307 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.67 -23.79 67.52 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.96 0.904 . . . . 72.24 111.008 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.7 p -89.21 -22.37 22.8 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.823 0.849 . . . . 55.24 112.803 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -81.92 4.17 23.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.159 0.429 . . . . 21.12 112.159 -166.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.664 HG23 HG11 ' A' ' 34' ' ' VAL . 19.4 tt -66.91 -25.29 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.131 0.572 . . . . 74.15 111.761 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -74.71 -7.06 52.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 122.08 -0.387 . . . . 75.41 111.987 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.77 -31.9 25.68 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.127 0.571 . . . . 51.34 111.752 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.7 p-90 -118.48 -29.05 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.673 0.62 . . . . 75.22 112.673 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 38.8 t-80 -94.16 107.62 30.02 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 109.741 -0.466 . . . . 72.41 109.741 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.05 -7.24 20.98 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.916 2.41 . . . . 72.24 114.96 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -87.63 -28.6 21.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.693 0.397 . . . . 74.53 111.269 172.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.664 HG11 HG23 ' A' ' 27' ' ' ILE . 46.4 t -80.97 107.45 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 109.902 -0.407 . . . . 73.13 109.902 174.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -72.75 -71.37 0.3 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.976 0.51 . . . . 61.23 110.951 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.62 104.38 0.46 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 123.986 0.915 . . . . 51.01 110.399 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 58.9 Cg_endo -84.97 166.6 11.27 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.985 2.457 . . . . 64.53 114.343 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -100.93 114.9 29.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.673 1.189 . . . . 71.34 110.122 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 4.2 mm? -90.85 134.73 34.22 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.727 0.411 . . . . 74.42 111.419 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -108.95 121.32 44.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.526 0.73 . . . . 73.22 111.322 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.02 -169.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 117.837 1.895 . . . . 65.13 117.837 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 56.63 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.635 1.174 . . . . 74.34 113.714 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.3 t 168.4 148.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 125.591 1.557 . . . . 63.55 108.766 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.17 -14.08 31.8 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.476 2.117 . . . . 64.02 112.792 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -95.82 -20.5 18.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.172 0.989 . . . . 64.25 112.789 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.8 m -99.78 123.37 47.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 122.692 0.397 . . . . 74.3 111.568 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.3 Cg_endo -57.16 126.9 23.6 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.056 2.504 . . . . 70.11 113.325 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.62 -24.75 4.58 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.918 -0.583 . . . . 43.41 112.331 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 138.75 55.67 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.155 0.582 . . . . 71.03 111.597 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 39.9 mt-10 -113.22 134.35 54.63 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.492 0.717 . . . . 44.42 110.603 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 25.1 ptt180 -108.41 118.98 38.2 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.301 0.572 . . . . 75.15 110.164 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 62' ' ' VAL . 42.3 t -116.5 114.28 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.424 0.69 . . . . 73.44 110.611 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.625 ' HB2' ' H ' ' A' ' 61' ' ' LEU . 1.7 m-85 -71.77 90.83 1.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.919 0.887 . . . . 75.14 111.897 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.26 3.72 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 119.941 -0.366 . . . . 73.32 113.251 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.89 96.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.743 1.217 . . . . 62.42 112.195 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.49 4.65 Favored Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.112 -0.367 . . . . 62.12 113.855 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.7 p -104.59 -81.63 0.52 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.611 0.764 . . . . 70.52 110.793 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.014 0.926 . . . . 70.42 110.367 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -132.36 39.23 3.4 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.136 0.97 . . . . 75.2 109.572 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 122.56 16.09 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.112 -0.949 . . . . 70.03 111.291 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.625 ' H ' ' HB2' ' A' ' 53' ' ' PHE . 57.7 tp -97.23 116.87 30.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.573 0.749 . . . . 71.12 110.611 -174.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 52' ' ' VAL . 48.6 t -98.55 114.92 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.7 -0.481 . . . . 74.04 109.7 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 79' ' ' MET . 41.7 mt-10 -118.24 164.06 15.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.219 1.008 . . . . 73.02 110.392 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -148.3 130.38 15.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.575 0.75 . . . . 64.33 110.944 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 28.7 tp -73.3 112.1 9.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.115 0.966 . . . . 63.32 110.817 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.14 -47.91 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.439 0.695 . . . . 65.31 110.84 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.324 1.05 . . . . 73.24 109.535 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -139.91 108.67 5.95 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.68 -0.638 . . . . 74.31 109.856 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 3.2 m-20 -91.3 71.26 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.708 0.803 . . . . 71.23 109.934 -175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 44.1 tt0 -63.73 -31.96 73.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.019 -0.537 . . . . 74.54 111.631 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -66.8 -14.66 62.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.8 0.84 . . . . 71.41 112.568 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.22 4.99 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.769 0.828 . . . . 54.01 112.604 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 97' ' ' PRO . 77.8 mtt180 55.89 60.46 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.264 1.025 . . . . 53.13 112.46 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 42.5 ttm180 -143.0 147.33 34.95 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.195 0.998 . . . . 62.1 110.357 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.8 tp -137.49 108.45 6.72 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.366 1.066 . . . . 75.34 110.181 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.22 127.57 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.604 0.762 . . . . 71.44 111.1 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.2 177.69 10.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.045 0.538 . . . . 74.34 112.319 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -142.92 157.6 44.42 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.092 0.957 . . . . 75.24 110.781 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.63 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 18.0 ptt? -111.53 98.49 40.78 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 117.993 0.36 . . . . 73.32 110.231 163.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.47 -22.41 74.01 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.258 2.639 . . . . 52.41 112.726 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 3.9 m-20 -118.33 83.61 21.06 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.692 0.797 . . . . 73.42 109.909 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.74 144.51 3.02 Favored 'Trans proline' 0 CA--C 1.566 2.075 0 C-N-CA 122.806 2.337 . . . . 73.31 113.14 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.6 4.58 6.55 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.648 2.232 . . . . 62.2 112.921 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -105.36 153.64 39.55 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 124.061 0.945 . . . . 64.5 111.201 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.15 71.61 3.56 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.185 2.59 . . . . 73.42 113.12 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 113' ' ' CYS . 21.4 pt -139.61 153.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.247 1.019 . . . . 73.14 110.65 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 15.9 m -95.36 -91.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.27 -0.395 . . . . 53.44 110.887 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -85.42 121.83 28.69 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-N 119.19 0.905 . . . . 74.23 109.654 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.43 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 52.7 t-80 -109.06 121.16 44.56 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.075 0.55 . . . . 74.43 111.875 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 146.53 28.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.296 1.038 . . . . 65.44 109.179 167.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.79 132.37 19.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.867 0.867 . . . . 73.53 109.747 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.2 p -133.82 129.9 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.159 0.584 . . . . 52.24 112.194 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.44 123.72 48.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.247 1.419 . . . . 75.13 108.618 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.05 149.25 50.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.13 0.572 . . . . 72.24 110.503 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 13.6 m -125.56 109.78 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.86 0.838 . . . . 65.14 109.419 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 125.59 76.34 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.024 0.929 . . . . 61.32 110.504 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG3' HH11 ' A' ' 73' ' ' ARG . 12.8 Cg_exo -70.78 72.65 1.93 Allowed 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.722 2.281 . . . . 72.1 111.912 170.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -71.31 -35.19 71.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.733 0.813 . . . . 52.42 110.006 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 27.3 t70 -163.78 163.08 24.11 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.173 1.389 . . . . 74.21 108.655 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.81 -8.42 52.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.735 -0.603 . . . . 64.23 112.21 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -126.0 -2.86 7.07 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.489 1.116 . . . . 65.35 111.935 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 39.6 m170 -135.97 127.6 28.92 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.463 0.705 . . . . 73.43 110.453 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.531 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 39.7 t -129.88 134.22 47.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.526 0.73 . . . . 45.02 110.404 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 90.1 m -98.24 111.63 23.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.283 -0.266 . . . . 71.34 110.283 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 95' ' ' VAL . 34.3 t -86.73 106.11 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.063 -0.717 . . . . 70.32 109.063 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.11 117.42 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.536 0.735 . . . . 71.23 110.189 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -118.82 121.42 39.99 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.166 -0.679 . . . . 63.45 109.166 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.576 HG22 ' SD ' ' A' ' 110' ' ' MET . 56.4 m -129.98 130.18 44.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.238 0.615 . . . . 62.53 110.791 -172.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.28 115.78 24.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 64.33 110.915 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 108' ' ' THR . 3.5 mpp? -99.28 140.57 33.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.437 -0.949 . . . . 74.41 108.437 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.19 151.66 23.35 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.022 0.749 . . . . 64.21 113.022 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 20.2 t70 -83.7 85.29 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.146 -0.934 . . . . 72.42 109.42 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.744 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.7 t -128.83 163.58 24.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.986 -0.552 . . . . 51.44 112.406 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.4 p -75.19 141.4 74.11 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.587 -0.733 . . . . 54.03 111.47 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -48.37 -39.75 35.8 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.561 2.84 . . . . 71.24 113.866 170.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.57 -42.27 87.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.783 0.833 . . . . 64.34 112.572 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 27.0 m -82.47 -26.23 32.82 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.597 0.359 . . . . 72.11 111.424 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.89 76.42 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.544 0.738 . . . . 50.22 112.507 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -60.37 -33.56 72.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.974 0.51 . . . . 73.11 111.858 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -44.0 57.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.314 0.646 . . . . 74.52 110.601 174.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -34.65 77.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.076 0.398 . . . . 61.45 112.076 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.35 -43.8 97.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.886 0.474 . . . . 62.31 111.017 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.6 m -69.64 -56.41 7.35 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.223 0.609 . . . . 54.44 112.64 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.47 -49.65 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 124.644 1.177 . . . . 52.11 112.685 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.72 -48.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 122.604 0.361 . . . . 74.02 110.977 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.45 -75.53 0.6 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 114.126 0.411 . . . . 53.4 114.126 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.19 -26.7 68.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.181 0.592 . . . . 73.21 111.695 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.86 -89.54 0.55 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.281 -0.418 . . . . 75.33 112.777 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.21 -49.47 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.887 0.875 . . . . 74.31 113.175 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -73.36 -53.73 10.05 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.647 0.779 . . . . 73.1 112.111 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.34 73.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.677 0.391 . . . . 71.22 111.968 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.74 -49.87 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 62.42 111.329 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.34 87.21 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 116.476 -0.329 . . . . 72.54 113.602 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 mt -69.27 -38.22 78.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 70.25 112.152 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.9 m-20 -67.04 -43.11 83.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.728 0.411 . . . . 71.4 110.23 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.02 81.83 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.301 0.64 . . . . 64.35 111.737 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 7.4 tt -65.87 -41.96 90.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.359 0.664 . . . . 74.33 110.234 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.94 79.44 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 116.389 -0.369 . . . . 72.35 111.245 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 41.6 mt-10 -64.53 -41.52 96.31 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.53 0.937 . . . . 74.24 113.53 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -64.05 -32.26 73.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.164 0.431 . . . . 75.22 112.164 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.8 -23.12 22.94 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.311 0.856 . . . . 73.44 113.311 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.99 6.75 0.03 OUTLIER Glycine 0 N--CA 1.486 1.995 0 N-CA-C 115.314 0.885 . . . . 73.43 115.314 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 49.1 mtp180 57.6 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.173 1.389 . . . . 73.44 113.032 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.86 107.73 14.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.414 0.686 . . . . 75.42 109.984 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -35.75 22.27 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.109 0.48 . . . . 72.21 110.247 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -146.74 -168.66 3.09 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.85 1.66 . . . . 62.32 108.708 171.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 70.63 154.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.034 1.334 . . . . 72.03 113.989 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -161.44 137.99 8.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.026 0.93 . . . . 72.44 110.16 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 61.22 63.75 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.74 1.216 . . . . 63.13 112.433 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -162.66 133.3 4.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.847 -1.069 . . . . 72.13 110.114 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 . . . . . 0 N--CA 1.486 1.339 0 C-N-CA 123.404 0.682 . . . . 71.34 111.137 177.125 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 119.683 -0.199 . . . . 75.43 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.61 31.43 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.792 0.837 . . . . 43.44 111.45 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' HB3' ' A' ' 110' ' ' MET . 89.8 m -117.15 112.21 20.55 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.672 0.789 . . . . 71.12 109.922 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.42 126.32 45.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.933 1.293 . . . . 72.53 110.117 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -118.29 119.72 35.49 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.757 0.423 . . . . 73.03 109.879 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -127.64 139.29 52.82 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.594 0.757 . . . . 73.01 109.879 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 p -144.87 155.33 43.4 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.343 0.657 . . . . 65.42 111.382 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 104' ' ' THR . 13.7 p -150.31 147.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.22 110.641 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.86 109.09 21.86 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.332 0.587 . . . . 71.21 110.289 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.415 HG21 HD22 ' A' ' 137' ' ' LEU . 69.2 t -95.07 137.81 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.386 1.474 . . . . 71.01 110.834 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.61 67.68 5.44 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.484 0.714 . . . . 53.4 112.305 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 141' ' ' TYR . . . -163.29 150.31 10.64 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.441 0.696 . . . . 70.23 111.449 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.82 144.24 76.6 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.711 2.274 . . . . 70.14 111.296 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -48.11 -41.22 25.82 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.234 1.568 . . . . 72.51 115.234 -172.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.31 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.967 0.507 . . . . 73.22 112.087 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.63 -41.99 87.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.858 0.863 . . . . 64.34 112.511 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -70.88 -36.27 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.042 0.449 . . . . 65.13 110.647 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -68.29 -27.61 66.46 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.246 0.618 . . . . 74.12 111.628 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m -62.11 -31.5 71.96 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.268 0.556 . . . . 53.34 110.886 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.0 tp -83.15 -58.29 2.91 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.479 1.112 . . . . 75.01 112.35 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.95 -20.16 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.068 0.766 . . . . 62.42 113.068 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.83 12.4 16.95 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.346 0.898 . . . . 71.14 115.346 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 11.1 t70 -120.61 120.6 36.23 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.072 0.949 . . . . 54.0 108.486 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.5 -31.38 72.42 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.92 0.888 . . . . 74.24 112.124 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.8 t -82.3 -22.81 35.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.432 0.693 . . . . 74.44 112.074 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.55 22.52 6.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.832 0.679 . . . . 51.5 112.832 -163.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.691 HG23 HG11 ' A' ' 34' ' ' VAL . 20.1 tt -69.02 -22.53 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 123.389 0.676 . . . . 74.25 111.605 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -62.1 -14.62 38.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.752 1.019 . . . . 73.31 113.752 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.3 mtm180 -78.97 -46.46 18.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.934 0.493 . . . . 64.23 111.945 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.9 p-90 -103.79 -30.89 10.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.684 0.393 . . . . 74.11 111.706 -171.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -91.34 107.85 24.57 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 122.98 0.512 . . . . 71.11 110.107 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.34 -19.42 61.73 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.072 2.515 . . . . 74.4 114.787 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.53 HE22 HG11 ' A' ' 132' ' ' VAL . 26.5 mp0 -84.32 -23.6 30.16 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.608 0.363 . . . . 71.43 111.858 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.691 HG11 HG23 ' A' ' 27' ' ' ILE . 84.8 t -76.21 118.8 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 120.843 0.354 . . . . 72.14 111.397 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.1 m -73.26 -74.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.965 0.906 . . . . 74.44 110.554 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -167.51 103.32 0.6 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.588 0.755 . . . . 72.44 110.72 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.35 150.3 17.26 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.762 2.308 . . . . 72.54 113.529 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.7 m -100.26 123.49 44.55 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.093 0.957 . . . . 43.12 108.853 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.8 128.54 40.1 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.242 -0.651 . . . . 40.21 109.242 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -124.93 148.59 48.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.195 0.998 . . . . 74.1 110.312 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.37 132.5 0.0 OUTLIER Glycine 0 CA--C 1.554 2.515 0 N-CA-C 117.584 1.794 . . . . 60.21 117.584 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 67.31 -90.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.146 1.378 . . . . 42.41 113.392 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t 179.77 150.11 0.51 Allowed Pre-proline 0 N--CA 1.492 1.645 0 C-N-CA 124.08 0.952 . . . . 74.14 110.52 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.19 -6.55 14.97 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.459 2.106 . . . . 62.21 113.343 173.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -109.6 -7.58 15.1 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.639 0.776 . . . . 63.32 111.877 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 m -103.73 121.85 46.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 122.8 0.44 . . . . 75.01 111.401 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.8 121.19 8.81 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.297 2.664 . . . . 75.24 113.104 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.29 -6.5 8.68 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 122.865 0.269 . . . . 54.12 113.379 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.12 172.82 11.68 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.578 0.751 . . . . 71.11 112.957 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.35 152.64 45.95 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.178 0.991 . . . . 62.34 111.12 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -130.94 132.0 44.8 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.496 0.718 . . . . 71.01 110.31 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.51 110.85 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.602 0.761 . . . . 74.23 110.139 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -71.66 97.39 1.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.451 0.908 . . . . 74.45 113.451 -169.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.85 -59.31 0.67 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.496 -0.642 . . . . 62.22 111.496 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.03 108.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.746 1.219 . . . . 75.41 112.616 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.79 54.41 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 116.515 -0.311 . . . . 70.03 113.268 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.9 p -116.27 -79.98 0.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.613 0.765 . . . . 51.11 111.087 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 177.42 -54.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.61 1.164 . . . . 72.25 107.913 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.1 14.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.792 1.237 . . . . 73.54 113.605 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.05 96.08 1.28 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.266 1.031 . . . . 74.11 112.59 -172.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -87.72 131.53 34.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.425 -1.261 . . . . 65.42 108.918 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -102.43 115.59 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.283 -0.636 . . . . 73.32 109.283 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 44.8 mt-10 -121.0 133.96 55.28 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 72.34 110.749 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.35 120.83 43.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.065 0.946 . . . . 73.11 110.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.71 119.59 11.46 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.645 1.178 . . . . 71.14 112.045 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.97 -51.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.508 0.723 . . . . 65.23 111.048 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 13.0 pt-20 -160.21 165.02 32.31 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 64.33 111.131 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.2 ttp85 -156.81 128.59 7.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.314 0.646 . . . . 64.2 109.917 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.39 123.88 38.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.747 0.819 . . . . 72.35 109.949 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.23 -46.64 49.0 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.823 0.849 . . . . 72.51 111.05 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.8 t -65.54 -25.14 67.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.136 0.974 . . . . 53.55 112.72 -170.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.54 -7.58 15.7 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.817 0.847 . . . . 74.3 112.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 11.6 mtm-85 58.93 45.62 14.84 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.93 0.892 . . . . 73.44 112.296 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -114.72 124.62 52.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.237 1.015 . . . . 72.22 111.054 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.4 tp -122.43 107.95 12.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.749 0.82 . . . . 71.35 110.043 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 39.4 t -111.06 136.08 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.555 0.616 . . . . 74.41 110.711 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -150.14 -179.91 7.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.047 0.939 . . . . 73.43 110.902 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 t -142.43 164.12 30.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.877 0.871 . . . . 72.04 110.593 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mtp -109.3 88.35 5.87 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 123.661 0.784 . . . . 71.24 110.305 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 34.9 Cg_endo -62.28 -34.27 78.33 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.558 2.839 . . . . 51.3 113.637 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -125.28 81.95 63.03 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.006 0.522 . . . . 64.41 109.736 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -94.39 147.38 1.86 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 123.072 2.515 . . . . 62.34 113.869 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.72 -2.2 11.72 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.412 2.075 . . . . 62.11 112.774 170.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 40.2 m-85 -99.83 135.4 20.5 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.228 1.011 . . . . 73.04 109.449 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 15.0 Cg_exo -68.92 82.01 0.6 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.923 2.416 . . . . 60.32 112.666 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.768 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.6 pt -135.09 141.6 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 124.229 1.012 . . . . 63.44 110.308 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.3 m -83.94 -75.65 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.173 -0.33 . . . . 74.23 110.875 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -107.92 111.02 22.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.19 0.519 . . . . 72.22 110.448 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -92.91 151.68 19.81 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.731 0.813 . . . . 75.24 111.775 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -150.19 126.49 10.72 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 72.1 109.702 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.86 143.23 49.39 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.882 0.765 . . . . 75.44 112.003 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 8.9 p -137.6 142.24 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 113.14 0.793 . . . . 64.32 113.14 -176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -108.42 117.11 33.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.869 1.268 . . . . 73.45 109.05 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 46.5 mt-10 -127.37 113.91 16.86 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.757 0.423 . . . . 64.32 111.345 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.06 111.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.081 0.467 . . . . 74.1 109.755 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.36 110.16 59.15 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.136 0.974 . . . . 72.05 110.261 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HA ' ' SG ' ' A' ' 103' ' ' CYS . 51.8 Cg_endo -66.16 114.43 3.02 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.703 2.269 . . . . 64.22 114.655 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.4 11.91 22.31 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.162 0.985 . . . . 73.43 111.304 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 67.85 175.28 0.26 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.475 1.51 . . . . 73.42 113.287 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 60.26 -86.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.277 1.431 . . . . 70.35 112.397 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -153.09 43.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.785 0.802 . . . . 71.4 109.98 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -142.65 139.5 31.26 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.408 0.683 . . . . 74.32 109.545 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 97' ' ' PRO . 75.5 m -153.63 138.97 17.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.507 0.723 . . . . 75.33 111.141 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 25.3 m -90.93 111.27 22.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.988 0.515 . . . . 72.22 111.163 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.34 118.88 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.897 0.479 . . . . 72.41 109.938 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.29 112.55 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.782 0.833 . . . . 74.21 109.965 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -107.49 112.03 24.6 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 108.812 -0.81 . . . . 73.12 108.812 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.7 m -123.83 127.2 47.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.59 0.756 . . . . 61.23 110.152 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.3 118.44 22.3 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.225 0.61 . . . . 75.13 111.362 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.625 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -118.8 128.83 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.588 1.155 . . . . 71.15 109.09 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -145.26 156.5 43.87 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.719 0.808 . . . . 74.11 111.498 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 25.3 t70 -89.86 85.15 6.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.372 0.606 . . . . 74.44 109.861 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 86' ' ' ILE . 53.6 t -122.72 148.47 45.29 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.434 -0.803 . . . . 50.01 111.809 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 t -62.82 125.08 85.71 Favored Pre-proline 0 N--CA 1.485 1.298 0 CA-C-O 118.678 -0.677 . . . . 42.35 109.847 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -52.07 -22.29 14.44 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.523 2.815 . . . . 74.44 115.695 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.02 -50.23 67.06 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 122.796 0.439 . . . . 74.22 112.018 170.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.537 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 34.4 m -71.13 -36.85 72.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.912 0.485 . . . . 35.35 110.594 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 115' ' ' PRO . . . -69.61 -38.49 77.3 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.749 0.819 . . . . 74.34 112.542 -171.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -64.8 -34.11 77.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.288 0.566 . . . . 73.54 110.916 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.11 -34.12 74.58 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.275 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 117' ' ' THR . 77.8 mt -75.01 -25.62 58.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.433 0.693 . . . . 62.35 111.483 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.87 -32.7 74.14 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.496 0.589 . . . . 70.14 110.607 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 55.6 m -70.08 -58.12 4.18 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.556 0.576 . . . . 73.54 112.556 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.13 -55.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 122.968 0.507 . . . . 52.22 112.198 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 121' ' ' LEU . 56.7 mt -74.32 -49.68 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.71 0.404 . . . . 72.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.96 -55.38 19.66 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.789 0.676 . . . . 62.15 114.789 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.69 -52.99 5.42 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.891 0.845 . . . . 61.53 111.59 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.51 -36.94 92.19 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 115.083 0.793 . . . . 62.43 115.083 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.66 -56.89 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 122.474 -0.427 . . . . 72.01 110.966 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -75.71 -61.97 1.74 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.727 0.64 . . . . 74.24 112.727 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.26 70.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.775 0.43 . . . . 54.54 111.11 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.53 HG11 HE22 ' A' ' 33' ' ' GLN . 7.0 t -65.58 -50.93 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.223 0.609 . . . . 71.31 111.823 172.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.32 95.77 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-O 120.97 0.206 . . . . 73.32 113.372 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.66 -39.44 70.32 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.448 1.099 . . . . 74.13 111.732 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 8.1 m-80 -69.77 -38.55 76.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.404 0.282 . . . . 41.43 110.402 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.71 76.65 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.679 0.792 . . . . 75.14 111.564 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 10' ' ' VAL . 5.1 tt -66.52 -36.37 82.54 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.878 0.871 . . . . 43.22 109.568 173.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.04 62.46 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.189 0.595 . . . . 70.5 112.295 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 10.8 mm-40 -72.56 -42.53 64.56 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 122.949 0.5 . . . . 71.21 111.828 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.47 -41.29 96.59 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 120.718 0.294 . . . . 75.01 111.54 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 12' ' ' ALA . 71.5 m-85 -81.79 -2.94 52.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.501 0.321 . . . . 73.12 111.059 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.11 3.59 10.1 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 116.569 -0.287 . . . . 74.35 113.159 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -34.29 74.41 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.269 1.028 . . . . 73.44 109.582 165.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 -62.48 1.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.698 0.799 . . . . 71.15 110.417 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -98.01 94.28 6.77 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.939 -0.763 . . . . 75.44 108.939 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -69.82 -23.88 63.38 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.724 0.638 . . . . 75.14 112.724 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -86.65 107.94 18.41 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.942 0.497 . . . . 65.54 110.468 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -151.76 -51.47 0.12 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.892 0.877 . . . . 73.41 110.33 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 60.13 117.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.825 1.417 . . . . 74.05 114.825 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -131.76 -86.81 0.47 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.2 -0.667 . . . . 63.24 109.2 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 124.517 1.127 . . . . 53.45 110.53 175.706 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.784 0.326 . . . . 72.44 111.546 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.5 61.34 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.765 0.826 . . . . 65.51 112.54 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -79.67 110.18 14.76 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.424 0.631 . . . . 71.42 111.677 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.74 121.71 36.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.933 1.293 . . . . 75.34 109.143 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -130.69 137.89 49.76 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.185 0.517 . . . . 71.03 111.357 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -132.12 152.46 51.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.521 1.128 . . . . 72.02 109.441 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.0 p -149.45 149.62 31.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.452 0.701 . . . . 72.22 110.201 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.7 p -144.1 138.31 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.157 0.583 . . . . 62.32 111.852 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.96 108.5 16.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.31 -0.626 . . . . 73.34 109.31 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.89 130.83 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.441 1.096 . . . . 63.32 110.976 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.3 71.8 3.02 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.066 0.546 . . . . 64.51 111.203 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.08 141.71 0.83 Allowed Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.625 1.17 . . . . 62.24 110.664 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.44 141.25 95.06 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.866 2.377 . . . . 44.34 113.255 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 103' ' ' CYS . . . -47.5 -42.66 23.54 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.296 1.591 . . . . 70.25 115.296 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.6 85.24 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.128 0.571 . . . . 75.33 112.153 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.49 -34.94 78.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.603 0.761 . . . . 71.33 112.278 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.33 -35.55 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.847 0.459 . . . . 61.04 110.716 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 60.4 t-105 -72.38 -25.89 61.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.036 0.534 . . . . 74.34 111.342 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.1 m -58.37 -29.5 66.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 72.33 110.654 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.571 HD22 HH11 ' A' ' 140' ' ' ARG . 62.1 tp -84.97 -59.68 2.27 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.748 1.219 . . . . 71.33 111.706 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.8 14.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 113.441 0.904 . . . . 63.14 113.441 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.16 33.28 5.52 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 112.356 -0.298 . . . . 63.54 112.356 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -154.82 148.17 25.03 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.94 0.896 . . . . 72.15 110.044 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -84.97 -25.66 27.63 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.465 0.706 . . . . 74.43 111.625 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -92.87 -21.39 19.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.495 0.718 . . . . 73.32 112.384 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.21 8.14 9.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.486 0.55 . . . . 71.14 112.486 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.631 HG21 ' NH1' ' A' ' 51' ' ' ARG . 20.5 tt -68.46 -23.92 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 C-N-CA 124.153 0.981 . . . . 74.31 112.611 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -74.51 0.42 14.83 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -97.36 -15.54 20.66 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.795 . . . . 74.4 112.313 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.569 ' HB3' HD21 ' A' ' 20' ' ' LEU . 37.5 p-90 -128.68 -38.12 1.72 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.637 0.606 . . . . 75.23 112.637 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 64.2 t-80 -89.64 115.28 63.44 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 122.86 0.464 . . . . 74.04 110.365 -173.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 13.6 Cg_exo -69.97 -23.68 29.54 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.197 2.598 . . . . 45.34 114.885 -169.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.48 -15.36 52.77 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.215 0.45 . . . . 73.13 112.215 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 36' ' ' ALA . 98.5 t -70.89 120.74 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 122.89 0.476 . . . . 54.51 112.211 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -93.37 20.5 7.07 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.034 0.934 . . . . 60.11 112.394 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 70.28 110.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.638 1.575 . . . . 51.23 112.186 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -86.05 168.79 9.08 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.193 2.595 . . . . 74.54 114.241 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.5 m -101.91 127.75 48.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.693 1.197 . . . . 61.01 110.171 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.61 125.29 37.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.071 0.938 . . . . 54.43 113.033 -171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 41.5 mmt180 -92.8 -174.46 3.62 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.695 1.998 . . . . 72.51 110.808 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.74 -128.79 0.44 Allowed Glycine 0 CA--C 1.547 2.081 0 N-CA-C 116.993 1.557 . . . . 71.41 116.993 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.97 -79.97 0.45 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.018 0.927 . . . . 75.14 112.393 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -121.99 141.0 33.21 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.8 0.84 . . . . 65.21 111.153 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.87 -8.33 13.42 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 123.249 2.633 . . . . 44.23 114.084 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -88.2 -25.53 22.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.916 0.486 . . . . 74.44 111.366 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 81.7 m -77.72 123.03 86.55 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 124.011 0.925 . . . . 75.34 112.527 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.0 Cg_endo -56.48 103.4 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.115 2.543 . . . . 52.22 112.058 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.72 -36.05 1.56 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.916 -0.584 . . . . 50.32 112.18 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 148.15 50.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.298 0.639 . . . . 30.33 111.587 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 32.2 mt-10 -124.69 140.3 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.894 0.478 . . . . 73.44 111.141 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.631 ' NH1' HG21 ' A' ' 27' ' ' ILE . 15.5 ptt180 -105.25 112.97 26.28 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.706 0.765 . . . . 74.12 109.68 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 62' ' ' VAL . 45.1 t -111.33 100.03 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 55.21 109.833 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 38.4 m-85 -59.47 134.28 56.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.149 0.58 . . . . 74.33 110.097 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.8 -67.94 1.05 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 114.803 0.681 . . . . 54.24 114.803 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.73 95.68 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.403 1.481 . . . . 61.22 111.153 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.64 23.71 66.75 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-N 115.742 -0.663 . . . . 55.12 113.467 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 p -123.29 172.72 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.559 0.744 . . . . 63.14 111.323 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.7 -39.38 80.51 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.667 0.787 . . . . 73.23 111.708 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -90.12 64.58 6.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.875 0.845 . . . . 74.24 109.774 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.4 tt0 -108.28 137.3 46.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.754 -0.657 . . . . 73.34 112.276 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 83' ' ' PRO . 31.0 tp -144.21 113.19 6.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.824 0.85 . . . . 73.11 109.235 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 40.0 t -98.93 115.23 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.692 -0.485 . . . . 63.2 109.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 68.9 mt-10 -123.35 148.51 45.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.944 0.898 . . . . 64.52 110.079 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -124.22 132.34 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.133 0.573 . . . . 71.44 111.027 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -74.33 114.91 13.24 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.361 0.664 . . . . 65.32 110.535 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG11 HH12 ' A' ' 90' ' ' ARG . 61.3 t -79.36 -51.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 122.801 0.441 . . . . 40.44 110.916 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 10.1 pt-20 -153.86 155.49 35.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.433 0.693 . . . . 75.42 110.124 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttp85 -144.26 145.87 32.3 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.359 -0.608 . . . . 71.14 109.359 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -146.46 134.56 21.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.399 0.679 . . . . 73.25 109.746 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 46.7 mt-10 -90.16 -50.87 5.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.233 0.613 . . . . 61.51 112.332 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.7 p -70.84 -34.6 71.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.243 0.617 . . . . 75.15 111.969 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.14 -9.71 54.59 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.332 0.653 . . . . 53.25 112.094 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 61.62 43.33 10.05 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.884 0.873 . . . . 73.33 112.211 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -114.58 115.58 27.4 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.728 0.811 . . . . 64.14 111.947 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -113.67 108.45 17.14 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.766 0.827 . . . . 74.44 108.777 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 27.0 t -117.63 130.3 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.634 0.652 . . . . 70.31 110.822 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.76 178.95 7.29 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.689 0.796 . . . . 73.11 111.257 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -135.98 159.34 42.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.351 1.06 . . . . 53.21 109.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 80.1 mtp -112.44 83.94 5.8 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.538 0.735 . . . . 70.32 109.046 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 81.2 Cg_endo -72.03 -16.6 28.84 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.253 2.635 . . . . 63.44 113.511 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 9.7 t70 -134.06 82.06 49.45 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 108.72 -0.845 . . . . 62.34 108.72 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -91.41 150.02 3.59 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.167 2.578 . . . . 71.41 113.34 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD3' HD13 ' A' ' 61' ' ' LEU . 72.7 Cg_endo -81.07 -0.68 10.73 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.739 2.292 . . . . 75.41 113.12 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -105.25 154.69 38.73 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.99 0.916 . . . . 71.23 110.673 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 70.67 3.96 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.832 2.355 . . . . 73.53 113.075 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -137.52 133.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.588 1.155 . . . . 71.22 109.525 -177.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 22.4 m -77.14 -79.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.941 -0.474 . . . . 51.02 111.894 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -108.88 104.69 13.99 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.928 0.491 . . . . 75.13 111.03 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.427 ' CE1' ' HB1' ' A' ' 109' ' ' ALA . 18.0 t60 -93.38 146.26 23.87 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.742 0.817 . . . . 75.33 111.356 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.402 HH12 HG11 ' A' ' 66' ' ' VAL . 14.8 tpt180 -146.56 111.31 5.27 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.997 0.919 . . . . 53.42 110.094 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.11 149.06 46.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.075 0.768 . . . . 73.35 113.075 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.12 139.29 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 124.095 0.958 . . . . 71.53 111.668 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 110.6 22.97 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.202 1.001 . . . . 72.41 108.422 162.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -127.04 119.06 25.69 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.755 -0.832 . . . . 64.14 108.755 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 103' ' ' CYS . 96.4 t -101.71 109.97 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.241 0.616 . . . . 72.1 110.858 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.32 113.02 55.95 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 124.8 1.24 . . . . 63.22 111.065 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.25 95.28 1.07 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.945 2.43 . . . . 63.51 113.156 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -79.26 -37.38 38.03 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.243 0.46 . . . . 75.14 112.243 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 35.0 t70 -157.07 162.58 39.48 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.28 0.632 . . . . 73.12 111.282 -169.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.66 -21.15 65.49 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.824 1.249 . . . . 72.1 113.075 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.06 0.83 5.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.474 0.71 . . . . 72.41 112.252 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 32.8 m80 -134.7 123.06 23.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.662 0.664 . . . . 74.12 109.901 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 95' ' ' VAL . 38.2 t -142.95 137.63 29.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.425 0.29 . . . . 62.34 111.341 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.2 m -92.42 111.75 23.44 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.887 0.475 . . . . 74.45 111.3 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.1 112.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.141 -0.688 . . . . 73.5 109.141 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.34 119.15 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.356 0.662 . . . . 71.24 110.075 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -107.47 113.3 26.55 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.658 -0.867 . . . . 75.32 108.658 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -108.89 149.93 28.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.087 0.955 . . . . 63.42 109.502 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 89' ' ' HIS . . . -149.14 145.31 27.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.477 1.111 . . . . 74.32 108.633 171.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -154.25 133.83 12.82 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.217 0.607 . . . . 65.42 110.104 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.53 153.36 48.73 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.647 -0.706 . . . . 63.24 111.305 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 34.2 t70 -77.14 87.13 3.61 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.055 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.406 ' HB2' HG22 ' A' ' 86' ' ' ILE . 27.9 t -156.1 169.8 23.67 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.616 -0.72 . . . . 64.05 111.883 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 m -76.52 148.28 79.84 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.457 1.103 . . . . 64.13 112.802 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.73 -34.91 92.3 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.821 3.014 . . . . 75.21 114.796 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.89 -31.09 67.63 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.294 0.638 . . . . 74.33 112.25 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 95.2 m -76.76 -38.08 54.79 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.02 0.438 . . . . 74.12 110.027 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -31.48 71.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.968 . . . . 25.05 112.881 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -75.74 -33.33 60.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.939 0.496 . . . . 71.32 111.43 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -42.21 83.49 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 75.04 110.225 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.99 -24.93 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.338 -0.846 . . . . 74.45 111.318 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -60.16 -36.11 76.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.013 0.525 . . . . 73.15 110.908 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -72.57 -53.56 11.58 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.951 -0.568 . . . . 74.21 111.856 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.76 -57.31 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 113.148 0.795 . . . . 74.24 113.148 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -77.83 -57.99 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.804 0.842 . . . . 64.23 110.942 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.53 -51.04 61.17 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 114.263 0.465 . . . . 64.44 114.263 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -95.22 -39.82 9.89 Favored 'General case' 0 CA--C 1.556 1.193 0 O-C-N 121.998 -0.707 . . . . 52.13 112.024 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.49 73.27 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.88 0.712 . . . . 73.13 114.88 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.93 -52.41 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 117.656 0.728 . . . . 72.21 111.024 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 2.8 m-30 -77.72 -53.58 7.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.102 0.408 . . . . 73.03 112.102 -172.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.32 -15.63 62.74 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.11 0.411 . . . . 62.15 112.11 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.6 t -80.86 -51.81 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 123.929 0.892 . . . . 73.32 110.985 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.33 -51.93 44.82 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.09 -0.505 . . . . 70.21 114.258 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.6 mt -58.52 -36.18 73.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.842 0.857 . . . . 71.12 112.776 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 6.3 m-20 -67.83 -46.06 72.9 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.669 -0.493 . . . . 73.21 109.669 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.0 74.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.6 0.76 . . . . 72.31 112.267 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.72 -49.24 78.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.312 1.045 . . . . 71.51 110.121 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -24.03 62.07 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.42 -0.809 . . . . 73.22 111.924 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 6.2 mm-40 -67.57 -50.73 57.05 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.589 0.756 . . . . 74.13 110.585 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.571 HH11 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.95 -15.83 62.09 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.737 0.643 . . . . 72.4 112.737 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -87.02 -22.62 25.38 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.803 0.668 . . . . 74.33 112.803 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.66 -33.18 0.06 OUTLIER Glycine 0 C--N 1.358 1.792 0 N-CA-C 116.227 1.251 . . . . 64.33 116.227 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 76.56 -4.6 2.33 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 124.73 1.212 . . . . 75.52 112.656 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.87 152.92 44.79 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.282 -0.886 . . . . 73.33 111.455 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 68.84 20.95 7.84 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.237 1.415 . . . . 74.12 114.545 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.89 74.66 9.71 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.045 0.45 . . . . 75.14 111.395 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -92.7 97.59 10.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -152.49 150.27 29.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.2 0.6 . . . . 73.03 111.227 -168.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -140.4 86.04 2.05 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.382 0.673 . . . . 74.32 110.03 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.79 173.72 11.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.1 0.96 . . . . 74.52 110.853 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 123.419 0.688 . . . . 74.43 110.584 178.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.743 0.306 . . . . 74.24 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.53 66.15 9.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.074 0.94 . . . . 64.55 110.408 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -144.48 119.33 9.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.279 -0.873 . . . . 40.32 110.38 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.17 147.54 23.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 60.1 109.226 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -149.53 129.96 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.138 0.575 . . . . 65.44 109.832 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -130.78 151.62 51.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.932 0.893 . . . . 62.31 108.751 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 96.3 p -146.85 163.34 36.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.991 0.516 . . . . 73.53 110.895 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.69 149.19 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.87 0.468 . . . . 65.25 111.057 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.56 109.22 19.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.029 0.532 . . . . 50.34 110.231 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 12' ' ' ALA . 85.8 t -96.49 129.9 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.312 1.045 . . . . 75.32 109.601 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.23 26.24 0.78 Allowed 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.563 0.949 . . . . 73.05 113.563 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 10' ' ' VAL . . . -131.55 150.57 76.72 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.583 0.753 . . . . 71.14 110.317 174.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.85 151.05 50.84 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.184 2.589 . . . . 72.11 112.984 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.02 -28.81 10.87 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.789 1.236 . . . . 54.51 114.27 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -50.9 64.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.774 0.657 . . . . 75.04 112.774 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -44.94 64.7 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.704 0.801 . . . . 71.0 111.901 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG13 HD21 ' A' ' 137' ' ' LEU . 15.0 t -73.36 -34.51 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 114.896 -1.047 . . . . 71.32 111.62 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 65.5 t-105 -73.48 -28.99 62.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.233 0.613 . . . . 72.13 111.505 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 m -60.65 -26.96 67.45 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.629 0.728 . . . . 74.25 110.838 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.549 HD22 HH11 ' A' ' 140' ' ' ARG . 54.4 tp -91.41 -44.03 9.38 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.361 1.064 . . . . 61.41 113.091 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.62 -21.72 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 113.588 0.959 . . . . 73.22 113.588 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.68 73.89 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 114.281 0.472 . . . . 75.04 114.281 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 3.6 m-20 -86.73 122.59 30.84 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.638 -1.245 . . . . 75.24 107.638 171.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 4.0 t80 -61.1 -27.84 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.992 0.517 . . . . 63.43 110.635 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -77.5 -23.51 50.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.024 0.93 . . . . 72.14 113.426 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -83.15 9.28 10.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 112.529 0.566 . . . . 60.14 112.529 -161.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.541 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 13.7 tt -62.64 -25.11 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 123.221 0.608 . . . . 73.54 111.52 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.766 ' HA ' HG11 ' A' ' 34' ' ' VAL . 26.4 p-80 -71.84 0.17 9.73 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.632 0.605 . . . . 63.42 112.632 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -102.92 -18.18 15.16 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.721 0.808 . . . . 25.53 112.754 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.541 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 33.0 p-90 -126.99 -42.24 1.75 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.433 1.271 . . . . 74.42 114.433 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.609 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.3 t-80 -72.73 119.86 77.6 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 117.985 0.357 . . . . 72.11 110.273 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 -22.33 73.86 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.373 2.048 . . . . 71.13 115.002 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -104.97 -4.19 22.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.041 0.756 . . . . 70.44 113.041 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.766 HG11 ' HA ' ' A' ' 28' ' ' HIS . 11.2 p -63.81 148.13 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 CA-C-N 118.228 0.467 . . . . 74.42 111.157 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -113.22 28.4 8.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.293 0.637 . . . . 53.3 111.402 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.41 85.97 0.18 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 123.781 0.832 . . . . 74.34 111.163 -173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.99 173.32 13.67 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.888 2.392 . . . . 73.45 114.077 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.7 m -112.97 130.51 56.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.33 1.052 . . . . 62.0 110.178 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.69 137.18 42.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.7 0.8 . . . . 61.31 110.07 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.548 ' HG3' ' HB2' ' A' ' 50' ' ' GLU . 11.1 ptm180 -150.82 162.04 41.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.904 0.882 . . . . 74.31 111.012 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.74 143.89 0.0 OUTLIER Glycine 0 CA--C 1.557 2.68 0 N-CA-C 117.25 1.66 . . . . 65.24 117.25 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 57.97 -104.46 0.22 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.403 1.081 . . . . 63.42 112.165 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 m -170.73 151.19 3.37 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 125.204 1.402 . . . . 61.22 109.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.58 0.58 1.8 Allowed 'Trans proline' 0 N--CA 1.513 2.639 0 C-N-CA 123.453 2.769 . . . . 72.13 115.29 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -119.69 -18.38 8.37 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.534 0.734 . . . . 74.13 111.408 168.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 m -87.88 123.34 69.2 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 123.251 0.62 . . . . 75.42 111.22 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 71.2 Cg_exo -45.99 119.06 2.66 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.727 2.951 . . . . 71.04 114.22 171.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.43 -20.62 4.39 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.507 0.575 . . . . 61.25 112.726 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.34 141.54 54.2 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.26 0.837 . . . . 74.4 113.26 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.684 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 28.9 mt-10 -107.71 126.94 53.21 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.906 0.882 . . . . 75.15 110.698 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 24' ' ' PHE . 58.1 ttp180 -102.38 108.72 20.15 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.073 0.949 . . . . 74.33 109.869 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 62' ' ' VAL . 41.8 t -112.11 112.98 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.844 0.858 . . . . 60.3 110.931 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 34' ' ' VAL . 76.3 m-85 -73.45 -58.1 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.959 0.725 . . . . 71.42 112.959 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.42 -50.27 39.26 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-N 116.436 -0.347 . . . . 44.2 112.776 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 51.07 24.66 1.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.938 1.295 . . . . 65.41 114.118 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.73 24.28 0.02 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-N 116.196 -0.456 . . . . 72.11 113.037 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 60' ' ' GLU . 72.7 p -129.02 142.2 50.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.317 1.047 . . . . 73.34 109.779 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.18 -30.31 70.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.779 0.659 . . . . 74.44 112.779 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.04 75.38 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.731 0.776 . . . . 73.22 110.579 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 14.0 pt-20 -109.16 164.51 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.648 1.179 . . . . 71.54 111.758 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.0 tp -103.21 124.11 47.99 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.999 0.52 . . . . 71.45 109.692 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 52' ' ' VAL . 61.7 t -120.18 128.1 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.537 0.735 . . . . 64.23 109.688 173.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 35.2 mt-10 -117.45 149.42 40.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.47 1.108 . . . . 72.21 110.335 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.684 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 96.2 mtt180 -126.03 129.83 49.95 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.005 0.522 . . . . 63.11 111.378 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 14.5 tp -67.63 115.82 7.64 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.009 0.924 . . . . 73.33 111.034 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.477 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 98.0 t -84.98 -51.75 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.509 0.724 . . . . 71.24 111.297 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 6.3 pt-20 -158.15 140.49 14.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.527 0.731 . . . . 75.2 110.197 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.23 124.15 28.37 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.099 0.56 . . . . 63.15 110.224 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.57 100.45 8.29 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.525 -0.917 . . . . 62.1 108.525 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 25.5 tt0 -80.02 -31.08 39.65 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 112.374 0.509 . . . . 70.51 112.374 -172.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -69.86 -43.59 71.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.16 0.584 . . . . 63.5 111.71 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.8 -10.12 59.75 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 55.3 111.913 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 61.21 55.62 2.93 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.557 1.143 . . . . 61.42 112.005 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -132.38 135.05 45.87 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.278 -1.328 . . . . 74.21 110.139 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -124.39 132.23 53.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.167 1.387 . . . . 72.2 108.862 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 41.3 t -133.63 130.52 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 118.338 0.517 . . . . 63.15 111.078 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 54.9 p90 -141.26 -179.45 6.12 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.342 1.057 . . . . 72.15 110.573 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.484 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.3 t -130.44 162.76 28.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.649 1.18 . . . . 43.15 110.367 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.441 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.5 mtp -109.8 85.58 4.09 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.825 0.85 . . . . 65.33 109.278 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 71.8 Cg_endo -71.36 -24.5 22.74 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.48 2.787 . . . . 74.33 113.095 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.88 76.43 70.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 109.441 -0.577 . . . . 73.44 109.441 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -95.55 150.78 1.5 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.097 2.531 . . . . 61.51 113.456 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 -6.88 17.97 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.176 1.917 . . . . 71.04 112.21 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -92.32 143.28 27.14 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.477 1.111 . . . . 72.33 110.771 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HG2' HG21 ' A' ' 117' ' ' THR . 90.5 Cg_endo -78.72 72.99 6.15 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.741 2.294 . . . . 71.13 112.689 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 113' ' ' CYS . 19.1 pt -127.87 145.52 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.356 1.062 . . . . 61.13 110.575 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.3 m -82.78 -78.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.616 0.366 . . . . 75.33 111.812 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.72 106.66 14.76 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.29 0.566 . . . . 75.1 109.944 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.422 ' HE1' ' HB1' ' A' ' 109' ' ' ALA . 37.7 t60 -91.65 159.38 15.9 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.445 0.698 . . . . 43.2 111.673 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -165.47 103.25 0.72 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.104 0.962 . . . . 74.24 110.254 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.65 153.5 18.64 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.58 0.752 . . . . 70.31 112.544 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.49 132.56 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.883 0.873 . . . . 74.22 111.48 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -109.08 107.58 17.95 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.748 1.219 . . . . 75.03 109.268 166.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.92 130.71 48.92 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 122.002 -0.436 . . . . 72.12 110.434 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.601 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 27.8 m -99.67 111.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.672 0.749 . . . . 72.54 109.852 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 95.8 t -83.32 107.67 10.58 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.571 1.149 . . . . 74.44 109.448 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 5.4 Cg_exo -74.25 108.23 2.62 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.789 2.326 . . . . 71.3 111.911 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -84.4 -60.44 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.186 0.594 . . . . 74.11 110.495 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.49 175.37 9.21 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.031 0.932 . . . . 71.5 110.366 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.69 -4.58 43.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.82 0.448 . . . . 52.2 110.578 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -23.96 11.68 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.823 1.249 . . . . 63.31 112.344 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 37.1 m80 -136.01 150.96 49.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.354 0.524 . . . . 62.44 112.014 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 45.5 t -143.56 173.6 11.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.358 1.063 . . . . 35.34 110.175 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.6 m -135.94 119.24 16.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.18 0.592 . . . . 70.44 110.835 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG23 HG21 ' A' ' 10' ' ' VAL . 26.0 t -91.27 113.06 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 122.144 -0.347 . . . . 73.52 110.199 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.54 109.91 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.473 1.109 . . . . 64.42 109.725 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -106.69 111.65 24.28 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 109.163 -0.68 . . . . 74.22 109.163 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.9 m -109.63 147.13 33.6 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.187 0.995 . . . . 73.32 109.964 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.422 ' HB1' ' HE1' ' A' ' 89' ' ' HIS . . . -131.78 111.27 11.49 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.956 0.903 . . . . 70.01 111.122 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.9 mtt -98.86 131.14 45.19 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.857 0.863 . . . . 75.41 108.978 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -156.96 144.68 19.12 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.413 0.523 . . . . 75.44 112.413 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.57 87.83 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.6 0.714 . . . . 52.14 110.676 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 53.5 t -134.28 169.09 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.643 -1.162 . . . . 71.44 111.411 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.2 m -68.44 146.93 98.09 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 62.01 112.222 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 -41.33 72.96 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.436 2.757 . . . . 73.54 114.29 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.77 -43.77 97.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.493 0.717 . . . . 62.44 111.813 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.45 HG21 ' HG2' ' A' ' 85' ' ' PRO . 21.3 m -71.81 -36.93 70.41 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.307 -0.406 . . . . 74.04 110.756 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.04 85.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.652 0.781 . . . . 62.23 112.322 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -28.54 63.49 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.484 0.314 . . . . 65.34 111.587 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.07 -42.04 89.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.223 0.535 . . . . 74.41 110.049 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.95 -22.88 62.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.904 0.882 . . . . 75.45 112.199 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -58.04 -43.37 86.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.299 0.5 . . . . 52.32 110.683 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -72.12 -49.79 33.31 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.6 0.593 . . . . 74.54 112.6 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.09 -54.61 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.207 0.527 . . . . 75.33 112.287 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.02 -56.45 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.78 0.832 . . . . 62.31 111.536 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.53 96.36 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 114.659 0.624 . . . . 73.22 114.659 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -88.72 -60.18 2.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.955 0.502 . . . . 74.25 110.634 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.84 -29.6 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 115.834 1.094 . . . . 73.13 115.834 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -105.16 -53.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 117.317 0.558 . . . . 72.01 110.873 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 5.2 m-30 -75.43 -65.47 0.89 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.804 -0.634 . . . . 65.04 111.793 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.06 66.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.856 0.462 . . . . 55.12 111.554 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.56 -53.73 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.986 0.914 . . . . 75.31 112.26 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.42 -35.17 81.32 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 116.402 -0.363 . . . . 63.15 113.395 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -44.83 61.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.3 1.04 . . . . 74.24 112.027 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -65.7 -38.19 88.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.376 0.27 . . . . 62.42 110.895 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.76 88.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.946 0.498 . . . . 42.55 111.611 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.538 HD21 HG13 ' A' ' 17' ' ' VAL . 7.0 tt -64.75 -42.5 95.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.693 0.797 . . . . 71.43 110.151 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.38 80.23 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.875 -0.602 . . . . 64.1 112.06 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.08 -33.12 61.62 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.754 0.822 . . . . 74.31 112.741 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.549 HH11 HD22 ' A' ' 20' ' ' LEU . 2.2 ptm180 -73.27 -24.72 60.47 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.773 0.32 . . . . 75.4 111.06 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 54.4 m-85 -100.75 4.14 42.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.432 0.693 . . . . 74.12 111.559 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -45.92 -50.41 11.99 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 115.156 0.823 . . . . 72.3 115.156 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 55.82 20.28 4.01 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.284 1.216 . . . . 74.31 114.284 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mp 61.94 20.51 11.58 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.167 1.387 . . . . 61.15 114.23 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -35.82 57.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.873 -0.517 . . . . 71.1 110.894 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -149.89 162.45 40.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.559 1.544 . . . . 72.42 109.291 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -98.14 103.19 15.12 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.068 -0.716 . . . . 74.24 109.068 168.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -67.92 109.68 3.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.748 0.819 . . . . 72.51 109.721 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -34.1 120.38 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.642 1.719 . . . . 71.01 115.642 -167.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -73.18 -34.29 65.92 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.942 1.297 . . . . 71.3 113.679 -171.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 124.19 0.996 . . . . 74.31 111.345 -171.473 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.675 0.274 . . . . 74.12 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 111' ' ' PHE . . . -89.27 -8.35 53.6 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.653 0.781 . . . . 64.35 111.221 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -108.13 112.62 25.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.156 0.982 . . . . 64.34 108.969 172.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.3 mp -97.14 121.76 39.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.774 1.23 . . . . 74.33 109.936 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -117.6 113.64 22.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.789 -0.449 . . . . 74.15 109.789 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -120.95 135.49 55.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.005 0.922 . . . . 74.33 109.818 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -138.1 159.93 40.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.688 0.795 . . . . 63.43 111.301 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.1 p -155.6 150.89 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.611 0.364 . . . . 74.4 111.874 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -92.34 119.09 31.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.959 0.504 . . . . 52.43 110.025 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.23 124.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.607 1.163 . . . . 70.35 109.82 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.76 71.68 4.25 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.569 0.7 . . . . 70.43 111.241 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.77 155.89 8.36 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.013 0.925 . . . . 75.0 110.909 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.39 137.84 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.777 2.318 . . . . 75.21 112.261 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.59 -46.69 10.15 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.233 1.568 . . . . 63.12 115.233 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.58 92.02 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 112.421 0.526 . . . . 54.34 112.421 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.16 -39.36 86.12 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.674 0.789 . . . . 61.24 112.051 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 HD21 ' A' ' 137' ' ' LEU . 44.3 t -73.9 -34.35 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.501 0.72 . . . . 71.5 111.15 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.531 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 75.8 t-105 -67.66 -29.67 69.02 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.713 0.405 . . . . 74.32 111.558 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 m -60.24 -30.86 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.635 0.731 . . . . 64.44 110.737 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 63.0 tp -83.5 -52.09 6.79 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.269 1.428 . . . . 71.24 112.143 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.31 -38.34 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.33 0.863 . . . . 62.1 113.33 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.58 -8.48 63.24 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.121 0.808 . . . . 74.45 115.121 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.99 113.92 26.34 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.612 -0.885 . . . . 60.31 108.612 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.15 -25.81 65.81 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.806 1.242 . . . . 60.12 113.303 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -96.7 -17.88 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.467 0.543 . . . . 73.3 112.467 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.77 15.42 4.8 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.196 0.598 . . . . 72.51 111.571 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 34' ' ' VAL . 20.2 tt -67.06 -24.9 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 C-N-CA 123.97 0.908 . . . . 72.34 111.88 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -64.55 -12.74 48.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.239 0.829 . . . . 73.43 113.239 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.35 -28.99 26.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.771 0.656 . . . . 71.3 112.771 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 48.0 p-90 -118.64 -35.49 3.71 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.034 0.534 . . . . 64.23 111.883 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -90.88 107.8 23.33 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.596 0.758 . . . . 51.04 109.356 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.29 -19.06 62.05 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.293 2.662 . . . . 75.41 114.715 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -96.77 0.67 49.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.02 0.748 . . . . 75.11 113.02 -171.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 27' ' ' ILE . 60.7 t -78.56 117.71 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 120.817 0.342 . . . . 74.54 111.12 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -90.89 51.33 1.94 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.547 0.739 . . . . 55.01 111.915 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 58.9 99.81 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 124.953 1.301 . . . . 42.52 113.147 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.65 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 97.9 Cg_endo -77.46 147.26 25.27 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.821 2.347 . . . . 62.25 114.779 -172.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.6 m -105.47 120.93 42.85 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.625 1.17 . . . . 74.14 109.152 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.86 127.64 38.44 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.269 0.557 . . . . 54.11 112.187 -170.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -115.33 123.36 48.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.077 0.951 . . . . 71.03 110.659 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.68 178.35 0.01 OUTLIER Glycine 0 CA--C 1.546 1.981 0 N-CA-C 117.308 1.683 . . . . 60.44 117.308 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.26 -118.69 1.37 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 124.837 1.255 . . . . 70.1 112.967 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -175.24 162.3 2.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 124.122 0.969 . . . . 74.43 109.421 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.47 -5.29 4.08 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.798 2.332 . . . . 63.55 115.077 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.0 -10.43 9.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.729 -0.607 . . . . 73.53 112.195 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.8 m -98.73 122.0 54.45 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 123.097 0.559 . . . . 70.21 111.357 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.87 113.67 1.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.308 2.672 . . . . 72.43 112.909 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.05 -22.76 2.1 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.132 -0.485 . . . . 72.12 113.172 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 141.49 57.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.51 0.724 . . . . 55.22 112.725 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 38.8 mt-10 -114.5 115.97 28.08 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.195 0.598 . . . . 74.13 109.938 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 29.3 ptt180 -93.36 123.78 36.89 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.441 0.696 . . . . 60.12 110.099 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -119.04 108.28 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.238 0.615 . . . . 74.54 110.209 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -66.63 101.75 0.83 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.623 0.769 . . . . 73.14 112.374 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.53 -71.18 2.3 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.339 -0.391 . . . . 63.22 112.306 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 68.37 136.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.166 1.386 . . . . 42.21 112.926 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.13 19.67 64.43 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-O 121.437 0.465 . . . . 62.32 112.191 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.3 p -117.84 -160.21 0.77 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.545 1.538 . . . . 42.5 110.132 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.87 5.6 15.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.803 0.841 . . . . 71.05 110.527 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.92 9.97 6.96 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.823 0.849 . . . . 75.54 113.233 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.28 144.31 44.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.016 0.747 . . . . 64.12 113.016 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.7 tp -120.71 126.11 49.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.375 1.07 . . . . 73.14 109.453 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.39 115.33 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.975 0.51 . . . . 52.21 109.854 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 43.6 mt-10 -120.0 137.72 53.92 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.024 0.93 . . . . 73.41 110.162 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -118.4 133.65 55.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.297 0.639 . . . . 61.44 112.102 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.67 120.74 21.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.736 1.215 . . . . 70.1 111.133 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.72 -41.53 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.284 0.634 . . . . 73.21 111.256 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 10.7 tp10 -152.99 147.03 25.45 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.092 0.957 . . . . 71.54 110.145 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -146.67 123.44 11.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.687 0.395 . . . . 65.43 110.629 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -106.63 -177.66 3.43 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.967 0.907 . . . . 60.53 110.812 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 41.1 tt0 -147.95 -47.11 0.16 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.866 0.466 . . . . 71.21 110.706 172.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.8 p -64.31 -43.47 94.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.269 0.628 . . . . 60.15 111.186 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.09 -26.54 59.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.349 0.66 . . . . 62.14 112.512 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 60.28 59.45 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.853 0.861 . . . . 71.31 111.426 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -139.31 122.75 17.22 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.766 0.826 . . . . 74.55 110.117 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 66.1 tp -124.27 109.01 12.84 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.21 1.004 . . . . 71.01 111.459 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 56.4 t -106.4 132.0 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.014 0.825 . . . . 75.13 111.28 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -152.84 179.73 8.39 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.103 0.561 . . . . 74.04 111.865 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.2 t -144.66 166.02 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.529 1.132 . . . . 73.23 111.054 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.646 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.7 mtm -99.84 99.38 8.91 Favored Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 123.373 0.669 . . . . 74.45 110.492 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 22.5 Cg_endo -62.13 -20.34 69.53 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 123.517 2.812 . . . . 65.24 112.748 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.75 81.18 69.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.972 0.509 . . . . 74.42 110.436 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.32 123.35 1.02 Allowed 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.787 2.325 . . . . 73.34 112.774 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.98 27.11 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.641 2.228 . . . . 71.25 113.156 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.44 147.27 61.58 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.391 1.077 . . . . 73.25 109.87 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 76.69 0.94 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.099 2.533 . . . . 74.51 113.23 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.1 pt -132.75 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 124.47 1.108 . . . . 75.21 109.953 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 23.8 m -103.27 -78.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.406 0.282 . . . . 70.14 111.41 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -105.02 100.37 9.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.998 0.519 . . . . 74.14 111.171 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -88.61 144.74 26.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 42.35 112.826 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -137.33 158.04 45.29 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 72.44 109.592 168.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HB1' ' HE1' ' A' ' 107' ' ' TRP . . . -158.62 119.91 3.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.516 1.126 . . . . 71.22 109.111 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 31.9 t -125.74 132.23 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.13 0.572 . . . . 75.31 112.449 -168.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.42 119.33 38.68 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.648 0.779 . . . . 73.53 109.3 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -130.45 114.03 15.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.961 0.504 . . . . 72.4 110.567 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.46 116.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.298 0.639 . . . . 71.12 110.36 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.9 m -113.42 123.04 34.01 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 123.902 0.881 . . . . 72.3 110.904 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 124.97 11.79 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.835 2.357 . . . . 70.2 113.483 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -109.24 -9.43 15.0 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.221 1.008 . . . . 61.23 112.143 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 34.9 t70 -175.87 167.9 3.05 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.157 1.383 . . . . 54.22 109.212 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.27 -39.3 66.74 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.045 0.938 . . . . 72.25 112.23 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -131.81 38.95 3.51 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.435 0.636 . . . . 71.12 110.377 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 77.9 m80 -148.95 135.6 19.61 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.293 1.037 . . . . 65.33 109.974 166.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 17' ' ' VAL . 32.0 p -148.98 144.95 27.1 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.395 0.678 . . . . 72.42 110.681 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 78.7 m -93.35 116.96 29.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.151 0.58 . . . . 40.25 110.681 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.79 118.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.04 0.536 . . . . 44.54 109.669 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.8 117.37 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 123.605 0.762 . . . . 73.53 110.45 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.556 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 5.2 t90 -105.3 116.4 31.89 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.974 -0.75 . . . . 73.13 108.974 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -124.46 123.82 40.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.586 0.754 . . . . 63.41 111.371 -170.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -106.93 141.03 38.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.871 0.868 . . . . 74.32 111.076 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -128.59 124.58 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.869 -0.789 . . . . 70.31 108.869 168.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.455 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 5.2 p90 -148.02 147.91 30.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.886 0.328 . . . . 53.42 111.886 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.605 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -84.18 86.83 7.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.365 0.602 . . . . 71.21 109.966 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.746 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.7 t -125.64 144.01 50.78 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.151 -0.931 . . . . 55.25 111.782 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.0 m -59.44 140.08 88.64 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.939 0.896 . . . . 70.32 111.516 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -56.83 -31.62 89.27 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.143 2.562 . . . . 74.2 114.171 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.09 -40.98 95.78 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.958 0.903 . . . . 61.54 112.013 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 24.3 m -88.11 -31.43 19.21 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.521 -0.763 . . . . 52.51 110.997 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -67.15 -40.17 86.67 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.737 0.815 . . . . 70.11 111.64 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -61.63 -33.64 74.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.427 0.691 . . . . 75.12 111.185 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 -36.19 63.12 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.562 1.145 . . . . 60.05 110.411 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 117' ' ' THR . 86.9 mt -74.42 -24.08 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 51.14 111.746 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 49.3 mt-10 -63.23 -35.11 79.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 120.96 0.41 . . . . 75.14 110.703 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 m -72.37 -56.64 5.12 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.271 0.628 . . . . 73.22 112.098 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.69 -54.45 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 112.432 0.531 . . . . 74.33 112.432 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.8 mt -78.68 -51.07 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.033 0.533 . . . . 54.34 110.789 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.99 -49.13 69.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.68 0.632 . . . . 71.44 114.68 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 29.7 t70 -91.82 -52.68 4.62 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 121.85 -0.794 . . . . 70.23 111.212 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.54 -28.71 73.88 Favored Glycine 0 N--CA 1.476 1.362 0 N-CA-C 115.404 0.922 . . . . 54.33 115.404 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.8 t -105.55 -58.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.57 0.685 . . . . 62.13 110.543 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 3.5 m-30 -71.27 -64.96 0.81 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.07 0.548 . . . . 73.51 112.386 -170.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -59.58 -31.44 69.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.993 0.517 . . . . 73.23 112.079 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -58.03 -54.41 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.563 0.745 . . . . 71.02 111.93 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.68 -41.07 94.07 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.304 0.377 . . . . 74.23 113.025 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.01 -43.3 88.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.081 0.953 . . . . 74.21 112.084 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.67 -38.0 76.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 119.47 -0.3 . . . . 72.22 111.107 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.84 81.6 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.136 0.493 . . . . 72.23 111.095 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 HG13 ' A' ' 17' ' ' VAL . 4.2 tt -66.58 -41.43 88.53 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 115.266 -0.879 . . . . 64.34 109.849 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.78 76.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.125 0.57 . . . . 53.25 112.352 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.24 -45.47 60.06 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.468 0.707 . . . . 75.21 111.574 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.38 -26.65 68.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 111.99 0.367 . . . . 70.34 111.99 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.84 -22.81 15.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.176 0.59 . . . . 62.0 112.316 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.01 -12.14 62.15 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 122.157 -0.339 . . . . 71.52 113.821 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.87 -16.27 18.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.997 0.919 . . . . 75.32 113.24 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 pp -96.98 2.45 51.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.823 0.449 . . . . 74.34 112.191 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 146' ' ' HIS . 28.8 tt0 -62.95 168.13 4.21 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.887 0.875 . . . . 72.45 110.674 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.439 ' N ' ' HG2' ' A' ' 145' ' ' GLU . 56.5 t-80 -69.34 -6.16 27.95 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.745 -0.597 . . . . 71.34 111.646 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 66.0 78.53 0.26 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.127 1.371 . . . . 72.24 110.891 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -113.48 -106.82 0.38 Allowed 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 118.649 -0.691 . . . . 74.31 110.098 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.9 m80 56.56 26.58 11.2 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.603 0.964 . . . . 65.53 113.603 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -82.55 122.41 28.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 122.108 -0.37 . . . . 74.21 110.957 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 79.0 t60 . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 63.04 111.225 -178.616 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.467 0.175 . . . . 72.14 110.663 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.54 9.27 39.24 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.429 0.692 . . . . 62.42 112.145 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 m -106.02 116.34 31.77 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.985 -0.746 . . . . 72.54 108.985 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 136.18 39.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.84 1.256 . . . . 75.12 109.298 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -133.9 130.33 37.64 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.201 0.524 . . . . 64.14 110.751 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 32.2 mmt-85 -138.07 153.68 49.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.501 1.12 . . . . 72.23 109.118 169.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 p -152.43 158.66 42.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.216 0.531 . . . . 64.13 111.443 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.9 p -149.82 152.49 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 72.22 109.398 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.96 123.47 48.22 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.705 0.684 . . . . 74.43 110.486 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.12 136.35 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 125.344 1.458 . . . . 55.52 110.372 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.77 66.51 4.27 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.359 0.599 . . . . 50.21 111.199 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.38 157.05 5.62 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.327 1.051 . . . . 72.31 111.023 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.92 140.96 68.87 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.95 2.433 . . . . 73.42 112.199 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.52 23.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.604 1.335 . . . . 54.42 114.604 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.51 82.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.483 0.713 . . . . 71.23 112.3 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 -37.51 86.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.387 0.675 . . . . 55.41 112.358 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG13 HD21 ' A' ' 137' ' ' LEU . 25.8 t -70.49 -36.76 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.528 -0.76 . . . . 72.12 110.645 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -70.89 -28.32 64.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.786 0.834 . . . . 71.23 111.408 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -63.61 -29.76 70.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.157 0.503 . . . . 75.31 111.028 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.09 -51.06 9.47 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.007 0.923 . . . . 64.33 112.047 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.49 -18.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 113.647 0.981 . . . . 55.15 113.647 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.23 -35.05 91.48 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 123.248 0.451 . . . . 71.43 113.221 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.15 97.96 8.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.321 -0.992 . . . . 60.43 108.321 165.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -75.61 -7.1 53.39 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.274 0.559 . . . . 54.41 112.311 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -70.4 -33.64 71.61 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.409 0.623 . . . . 64.21 110.628 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HB1' ' NE ' ' A' ' 29' ' ' ARG . . . -87.5 16.39 5.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.26 1.024 . . . . 64.43 111.722 -167.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 34' ' ' VAL . 19.9 tt -64.89 -22.63 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 C-N-CA 123.798 0.839 . . . . 71.04 111.667 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -69.87 -9.19 53.95 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.032 0.753 . . . . 73.31 113.032 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.7 mtm180 -88.92 -37.45 15.26 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.108 0.563 . . . . 74.2 111.919 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 58.5 p-90 -109.52 -39.13 5.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.613 0.597 . . . . 75.54 112.613 -171.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 60.8 t-80 -86.74 115.79 63.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.789 -0.819 . . . . 72.24 108.789 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -70.05 -19.79 34.28 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.882 2.388 . . . . 73.03 114.412 -165.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.81 -4.93 32.12 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.621 0.971 . . . . 75.34 113.621 -169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 27' ' ' ILE . 63.0 t -67.14 128.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 111.906 0.335 . . . . 75.23 111.906 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -83.52 27.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.25 1.02 . . . . 74.22 112.881 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.87 107.82 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 125.011 1.324 . . . . 41.11 112.054 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 45.1 Cg_endo -85.7 154.05 10.23 Favored 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 122.295 1.997 . . . . 71.12 114.489 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.8 m -112.47 124.95 53.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.58 0.752 . . . . 64.2 109.984 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.2 mm? -91.2 138.49 31.55 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.385 0.674 . . . . 72.03 112.345 -168.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.42 123.11 44.43 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.335 1.054 . . . . 73.2 109.022 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.05 176.95 0.01 OUTLIER Glycine 0 CA--C 1.547 2.091 0 N-CA-C 117.363 1.705 . . . . 61.44 117.363 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.82 -122.43 1.99 Allowed 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.341 1.056 . . . . 33.53 113.085 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p -168.95 164.0 7.48 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 123.848 0.859 . . . . 61.14 109.578 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.91 -24.18 30.6 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.032 2.488 . . . . 74.31 114.415 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.12 -44.99 7.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.194 0.597 . . . . 74.43 110.892 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -67.72 119.05 63.39 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.683 0.793 . . . . 61.01 112.644 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.88 113.75 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.428 2.752 . . . . 42.44 113.14 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.28 -26.22 2.46 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.878 -0.601 . . . . 75.54 112.594 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -65.42 137.31 57.38 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.637 0.606 . . . . 64.52 112.637 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 51.3 mt-10 -118.13 118.92 33.19 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.086 0.555 . . . . 72.12 110.671 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -106.98 134.28 50.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.084 0.468 . . . . 72.42 110.909 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 20.4 t -115.27 103.35 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.593 0.757 . . . . 74.2 110.581 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.76 99.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.476 1.11 . . . . 74.24 111.649 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.68 53.7 6.36 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 123.224 0.327 . . . . 53.43 112.892 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -65.43 90.44 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.065 0.459 . . . . 54.5 111.762 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.19 38.4 0.06 OUTLIER Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.819 -0.628 . . . . 44.42 112.25 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 59' ' ' GLU . 15.0 t -138.36 -162.53 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.173 0.989 . . . . 70.4 110.172 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.9 15.71 20.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.345 0.658 . . . . 75.4 112.263 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 57' ' ' THR . 11.0 pt-20 -168.51 40.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.3 0.852 . . . . 72.33 113.3 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.37 156.4 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.22 0.608 . . . . 71.44 112.163 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -107.95 120.92 43.66 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.724 0.809 . . . . 50.1 110.625 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.75 121.95 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.841 0.456 . . . . 74.44 110.202 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 47.5 mt-10 -118.26 139.01 51.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.788 0.835 . . . . 71.01 110.776 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 10.4 tpp180 -103.85 130.7 51.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.962 0.905 . . . . 71.44 109.69 174.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.73 120.88 26.92 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.038 0.535 . . . . 63.12 110.151 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.25 -45.88 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.28 0.632 . . . . 65.13 112.296 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 35.4 tt0 -159.69 157.48 29.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.221 0.609 . . . . 72.24 110.858 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -148.04 131.88 17.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.237 0.615 . . . . 71.33 109.968 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -124.4 116.4 22.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.69 0.796 . . . . 63.15 109.868 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.08 13.47 33.98 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.244 0.617 . . . . 50.53 112.495 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -94.31 -46.6 6.98 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.22 0.533 . . . . 65.11 110.159 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.24 8.56 25.81 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.64 0.776 . . . . 52.03 111.834 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 56.63 67.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.088 0.955 . . . . 72.12 112.136 175.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -135.96 110.29 8.44 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.852 0.861 . . . . 64.53 111.328 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.5 tp -107.19 108.76 20.35 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.757 1.223 . . . . 65.04 110.844 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 38.3 t -104.2 130.24 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.381 0.672 . . . . 74.31 111.069 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.47 -178.9 6.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.431 0.692 . . . . 73.35 111.573 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.476 ' HB ' ' NH1' ' A' ' 90' ' ' ARG . 6.0 t -149.88 162.44 40.32 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.327 1.051 . . . . 74.45 110.741 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.8 mtp -111.55 93.17 18.62 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.077 0.951 . . . . 63.52 109.862 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 56.0 Cg_endo -67.82 -20.92 45.19 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.442 2.761 . . . . 62.44 112.732 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.87 77.79 57.64 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.734 0.814 . . . . 71.43 109.944 172.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 63.9 Cg_endo -88.72 143.55 5.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.892 2.394 . . . . 75.2 113.296 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 6.7 Cg_exo -77.13 1.53 8.6 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.878 2.385 . . . . 74.33 113.159 173.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.0 147.44 44.45 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 123.787 0.835 . . . . 61.11 111.05 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' HG2' HG21 ' A' ' 117' ' ' THR . 73.9 Cg_endo -73.1 80.95 1.77 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.695 2.263 . . . . 64.05 112.81 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.697 HG22 ' HB2' ' A' ' 113' ' ' CYS . 20.1 pt -133.41 133.03 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.263 1.025 . . . . 71.11 110.301 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m -74.55 -78.08 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.798 0.439 . . . . 62.43 111.253 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -105.76 108.62 20.23 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.978 -0.451 . . . . 52.04 110.342 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -87.98 142.82 27.49 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.344 0.658 . . . . 51.22 111.356 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.476 ' NH1' ' HB ' ' A' ' 78' ' ' THR . 6.0 tpp180 -149.39 114.25 5.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.473 0.709 . . . . 74.3 109.433 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.42 50.98 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.355 0.525 . . . . 35.42 112.006 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 49.6 t -136.65 141.22 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.224 1.01 . . . . 53.21 111.261 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 3.4 mm? -98.1 140.26 32.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.282 -1.007 . . . . 63.54 108.282 165.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 35.0 tt0 -142.89 110.13 5.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.503 0.592 . . . . 60.43 110.716 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 t -94.03 108.95 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 65.54 108.872 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.4 119.93 54.74 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.644 0.778 . . . . 42.42 109.931 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.83 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.441 2.094 . . . . 65.04 112.249 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -68.22 -32.4 72.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.811 0.844 . . . . 63.4 110.202 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.7 t70 -147.92 165.25 31.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.11 1.364 . . . . 74.45 109.461 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.64 -47.0 85.88 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.279 1.032 . . . . 73.53 111.901 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -113.3 10.94 18.52 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.722 0.809 . . . . 73.54 112.205 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 37.2 m80 -137.59 118.63 14.37 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 118.984 0.811 . . . . 60.31 110.206 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m -136.08 133.83 37.75 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.843 0.457 . . . . 60.32 111.313 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.9 m -92.54 114.81 27.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.142 0.577 . . . . 71.42 111.88 -172.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -92.3 109.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.251 0.621 . . . . 65.21 109.552 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.18 113.1 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.873 0.869 . . . . 74.41 109.647 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -102.63 120.27 40.27 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.857 -0.794 . . . . 71.1 108.857 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.7 m -123.48 141.58 51.86 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.037 0.935 . . . . 63.04 110.426 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.63 110.18 5.76 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.303 0.573 . . . . 72.35 111.508 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -109.54 125.78 52.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.528 1.131 . . . . 62.42 109.161 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -139.35 154.23 47.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.714 0.806 . . . . 72.43 110.596 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 32.7 t70 -86.73 83.76 7.51 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.385 0.612 . . . . 64.53 110.093 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.697 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.1 t -125.37 156.33 38.92 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.641 -0.709 . . . . 64.03 111.754 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -65.36 132.92 95.29 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.487 0.715 . . . . 64.13 111.158 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.23 -38.97 20.68 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.83 3.02 . . . . 71.01 115.472 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.347 0.659 . . . . 71.33 112.127 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' HG2' ' A' ' 85' ' ' PRO . 29.5 m -87.49 -29.07 21.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.824 0.45 . . . . 73.34 110.779 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.41 70.99 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.321 0.648 . . . . 61.11 111.931 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -66.92 -28.08 68.01 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.453 0.701 . . . . 74.31 111.94 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.78 -45.43 61.63 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.567 0.747 . . . . 72.14 110.028 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 117' ' ' THR . 78.3 mt -74.41 -31.63 62.39 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.47 -0.786 . . . . 65.33 113.045 -171.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.96 -34.56 78.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.159 0.436 . . . . 73.04 111.304 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.6 t -70.6 -59.87 2.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.104 0.562 . . . . 65.42 112.117 171.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.11 -55.55 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.266 0.626 . . . . 72.31 112.421 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 121' ' ' LEU . 63.2 mt -76.64 -47.97 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 53.51 110.666 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -61.3 -66.19 2.81 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.765 0.666 . . . . 74.3 114.765 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.59 -41.22 12.12 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.834 -0.804 . . . . 63.13 111.461 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.32 79.02 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.228 0.851 . . . . 60.04 115.228 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.73 -55.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.683 0.742 . . . . 72.35 111.358 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 13.2 m-30 -70.31 -56.37 6.88 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.226 0.454 . . . . 74.34 112.226 -173.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.56 68.52 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.385 0.428 . . . . 71.41 111.525 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.9 t -59.06 -51.18 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 C-N-CA 123.951 0.901 . . . . 52.33 112.263 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -69.56 -34.88 73.95 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 116.607 -0.269 . . . . 64.31 113.633 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.25 -41.65 73.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.128 0.971 . . . . 63.32 111.554 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.64 -40.65 84.58 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.348 -0.387 . . . . 64.11 110.112 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.73 76.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.766 0.827 . . . . 50.42 111.706 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.449 HD21 HG13 ' A' ' 17' ' ' VAL . 5.4 tt -65.13 -39.02 92.47 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 115.419 -0.809 . . . . 73.24 110.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.26 -28.83 64.43 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.055 0.542 . . . . 70.14 112.289 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -67.7 -45.65 74.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.998 0.919 . . . . 74.22 112.099 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.43 HH11 ' HA ' ' A' ' 137' ' ' LEU . 8.8 ptp85 -71.33 -25.52 62.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.098 0.559 . . . . 75.22 112.498 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -93.94 -5.44 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.961 0.505 . . . . 72.43 111.009 170.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.03 5.38 26.08 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 122.847 0.261 . . . . 65.12 113.749 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -51.88 -24.27 6.04 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.47 1.508 . . . . 74.4 113.693 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.4 -28.22 69.09 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.706 0.802 . . . . 71.42 112.543 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 146' ' ' HIS . 7.0 pt-20 -139.6 -62.33 0.53 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.509 0.724 . . . . 64.34 111.074 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.471 ' H ' ' HG3' ' A' ' 145' ' ' GLU . 0.7 OUTLIER 49.65 71.63 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.423 1.489 . . . . 70.45 112.173 -174.301 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -66.19 103.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.728 -0.669 . . . . 64.02 109.76 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 63.02 -177.51 0.15 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.566 1.146 . . . . 75.33 111.615 -168.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -80.6 -81.47 0.13 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.762 -0.586 . . . . 74.34 110.359 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 50.2 64.66 1.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.423 1.089 . . . . 72.45 111.83 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 . . . . . 0 N--CA 1.495 1.776 0 C-N-CA 124.803 1.241 . . . . 75.2 112.481 -171.133 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.837 0.351 . . . . 71.05 111.746 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.99 13.78 24.47 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.816 0.846 . . . . 74.52 111.133 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 110' ' ' MET . 23.5 m -107.55 110.15 21.99 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.765 0.826 . . . . 72.41 109.177 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -94.82 134.52 37.35 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.042 0.937 . . . . 73.21 109.022 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -136.81 137.24 39.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.811 0.444 . . . . 72.44 110.35 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.754 HH11 ' HB2' ' A' ' 131' ' ' ALA . 10.5 ttm180 -147.86 152.1 37.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.201 0.6 . . . . 72.3 109.944 175.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.6 p -141.22 166.38 24.94 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.091 0.472 . . . . 74.41 111.907 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.9 p -152.15 148.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.717 0.807 . . . . 70.14 110.425 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.83 112.08 23.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.236 0.541 . . . . 73.3 109.722 168.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 137' ' ' LEU . 88.8 t -91.02 127.9 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.429 1.092 . . . . 71.24 109.762 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 71.16 3.3 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 121.618 0.723 . . . . 71.32 111.541 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.34 151.63 4.62 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.474 1.109 . . . . 72.31 110.247 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.42 140.73 58.9 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.323 2.015 . . . . 51.54 112.257 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.06 -35.49 11.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.505 1.668 . . . . 74.2 115.505 -172.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.19 -48.25 80.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.537 0.569 . . . . 73.11 112.537 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.39 -36.24 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.583 0.753 . . . . 72.41 112.05 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 36.2 t -72.84 -36.65 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.518 0.727 . . . . 71.01 110.631 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.573 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 61.3 t-105 -69.03 -33.5 73.72 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.618 0.767 . . . . 73.24 112.032 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -65.03 -20.1 66.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.563 0.697 . . . . 74.53 111.317 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.2 tp -89.9 -52.67 4.86 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.001 0.921 . . . . 74.21 112.06 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.08 -48.45 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 112.867 0.692 . . . . 65.14 112.867 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.06 65.7 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 115.172 0.829 . . . . 74.31 115.172 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.44 -18.1 60.69 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.065 0.546 . . . . 72.24 111.477 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 t80 73.64 -66.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.785 1.634 . . . . 73.12 112.105 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.3 p -67.7 -14.34 62.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.994 0.918 . . . . 45.22 113.182 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.17 9.77 18.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.67 0.788 . . . . 72.11 111.674 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG23 HG11 ' A' ' 34' ' ' VAL . 19.9 tt -61.23 -31.15 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 N-CA-C 112.76 0.652 . . . . 54.44 112.76 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -70.47 -5.78 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.075 0.768 . . . . 73.02 113.075 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -91.45 -19.86 22.38 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.453 0.701 . . . . 74.31 112.495 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 60.0 p-90 -121.31 -30.6 4.25 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.037 0.535 . . . . 73.23 111.719 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -93.63 103.75 10.85 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.384 0.674 . . . . 75.44 109.815 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.14 -15.92 52.56 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.238 2.626 . . . . 72.33 115.21 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -85.07 -28.66 25.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.885 0.474 . . . . 64.14 111.446 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 27' ' ' ILE . 49.1 t -78.7 113.57 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 110.218 -0.29 . . . . 61.3 110.218 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -73.58 -62.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.285 0.634 . . . . 44.25 110.399 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.62 116.01 0.59 Allowed Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 124.386 1.075 . . . . 63.43 110.189 173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.39 144.71 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.463 2.109 . . . . 73.33 113.381 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -95.91 126.7 41.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.193 0.997 . . . . 62.11 109.804 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 9.5 mp -110.03 145.75 36.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.648 0.737 . . . . 65.21 111.42 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -149.85 147.04 27.48 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.486 -1.234 . . . . 72.32 110.246 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.5 153.38 0.0 OUTLIER Glycine 0 CA--C 1.555 2.585 0 N-CA-C 117.687 1.835 . . . . 62.3 117.687 -167.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 72.9 -50.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.837 1.655 . . . . 65.33 115.312 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m 102.12 147.51 0.02 OUTLIER Pre-proline 0 N--CA 1.516 2.863 0 C-N-CA 127.709 2.404 . . . . 63.41 111.869 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.69 -38.53 46.27 Favored 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 124.427 3.418 . . . . 63.33 115.549 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -90.99 10.53 26.22 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.351 0.5 . . . . 73.0 112.351 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -123.75 119.13 26.99 Favored Pre-proline 0 N--CA 1.487 1.382 0 C-N-CA 123.833 0.853 . . . . 42.04 110.536 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 129.22 31.08 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.335 2.69 . . . . 65.45 113.807 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.02 -10.5 13.59 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.392 0.52 . . . . 71.54 112.96 -175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.07 154.69 40.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.376 0.67 . . . . 70.43 111.95 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 50.6 mt-10 -112.79 128.81 56.54 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.938 0.495 . . . . 72.05 111.602 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -107.41 102.86 12.11 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.651 0.78 . . . . 73.2 109.554 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.1 t -106.7 104.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.313 0.577 . . . . 63.32 111.353 -170.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' ' 34' ' ' VAL . 66.0 m-85 -75.34 82.68 2.45 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.307 1.043 . . . . 70.42 111.264 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.05 -63.11 0.58 Allowed Glycine 0 N--CA 1.478 1.449 0 CA-C-N 116.042 -0.526 . . . . 60.41 112.3 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.77 -53.23 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.079 1.751 . . . . 73.32 115.318 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.83 37.56 3.32 Favored Glycine 0 N--CA 1.487 2.065 0 CA-C-O 121.234 0.352 . . . . 75.04 112.932 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -120.63 -165.75 1.24 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.274 1.029 . . . . 42.44 110.62 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -122.77 27.41 7.77 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.952 0.901 . . . . 63.31 109.701 167.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.17 9.54 1.11 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.205 1.002 . . . . 51.23 111.913 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 152.21 39.4 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.367 0.604 . . . . 54.02 112.498 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.545 HD11 ' SD ' ' A' ' 79' ' ' MET . 29.2 tp -107.22 119.92 40.71 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.102 0.961 . . . . 72.44 109.224 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.755 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 94.5 t -95.99 114.34 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.283 0.563 . . . . 72.33 109.482 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 17.1 tt0 -115.24 167.88 10.45 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.445 1.098 . . . . 54.24 109.898 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 30.3 ttm-85 -150.82 128.88 11.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.126 0.97 . . . . 54.44 111.736 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.79 129.2 39.19 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.951 0.9 . . . . 63.12 111.123 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.595 HG21 HH11 ' A' ' 90' ' ' ARG . 79.0 t -101.29 -51.13 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.772 0.829 . . . . 75.24 111.384 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -149.72 148.73 29.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.372 1.069 . . . . 70.15 109.136 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -140.02 119.6 13.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.966 -0.383 . . . . 73.54 109.966 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 24.5 m-20 -101.09 102.45 13.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.525 1.13 . . . . 72.24 109.773 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 31.4 tt0 -75.74 -41.14 54.13 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.26 -0.275 . . . . 74.41 111.008 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.9 m -68.76 -50.05 53.71 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.36 0.664 . . . . 62.54 111.146 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -78.49 -6.14 54.55 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.983 0.734 . . . . 55.21 112.983 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 63.43 45.2 4.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.74 1.216 . . . . 74.53 111.945 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.1 ttm105 -129.39 135.36 48.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.913 1.285 . . . . 75.12 110.455 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 tp -125.43 106.15 9.59 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.043 0.537 . . . . 51.35 110.745 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -105.7 126.11 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.693 0.797 . . . . 74.25 110.519 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -146.57 179.51 7.5 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.426 0.69 . . . . 71.13 112.043 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 m -156.56 142.24 17.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.955 1.302 . . . . 71.53 109.74 -169.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.545 ' SD ' HD11 ' A' ' 61' ' ' LEU . 57.3 mtm -95.87 98.79 4.19 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 118.234 0.47 . . . . 61.14 109.79 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.82 -25.03 17.31 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.375 2.717 . . . . 51.22 112.901 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.7 t70 -129.59 80.04 72.55 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.464 0.706 . . . . 74.11 109.489 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -93.36 133.47 0.94 Allowed 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 122.964 2.443 . . . . 54.05 112.761 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.479 ' HD2' HD13 ' A' ' 61' ' ' LEU . 71.7 Cg_endo -72.27 -2.03 11.05 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.203 1.935 . . . . 71.42 112.073 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.84 140.77 50.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 124.454 1.102 . . . . 71.43 109.924 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 77.76 2.77 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.476 2.117 . . . . 73.24 112.889 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 89' ' ' HIS . 7.4 pt -138.94 143.99 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.661 1.184 . . . . 72.31 110.412 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -72.17 -47.45 50.78 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.344 0.868 . . . . 75.25 113.344 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -131.97 -49.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.266 0.469 . . . . 52.34 112.266 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.561 ' HB2' HD12 ' A' ' 86' ' ' ILE . 47.9 t-80 65.35 145.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 125.417 1.487 . . . . 75.04 113.736 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.595 HH11 HG21 ' A' ' 66' ' ' VAL . 21.4 tpp180 -147.08 149.01 32.2 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.732 1.213 . . . . 74.13 108.347 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.7 146.44 20.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.968 0.507 . . . . 74.1 111.74 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.5 p -137.23 140.28 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.376 0 N-CA-C 113.106 0.78 . . . . 74.03 113.106 -174.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -107.62 108.48 19.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.504 1.121 . . . . 52.24 108.691 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -121.0 111.65 17.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.089 -0.708 . . . . 74.04 109.089 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.32 110.79 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.709 -0.849 . . . . 73.32 108.709 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.39 123.8 61.22 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.15 0.98 . . . . 64.22 109.928 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.64 137.31 41.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.448 2.099 . . . . 74.44 111.974 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.605 HH11 ' HB2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -138.05 -34.52 0.66 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.162 0.585 . . . . 64.25 111.403 -172.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.4 t70 -163.65 159.47 21.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.178 0.991 . . . . 53.11 110.01 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.5 -31.16 55.42 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.897 1.279 . . . . 73.23 113.092 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -140.18 26.69 2.19 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.167 0.587 . . . . 75.13 110.373 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.9 m80 -147.94 111.18 4.9 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.045 0.938 . . . . 73.41 109.32 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -133.76 137.02 44.95 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.241 0.616 . . . . 62.22 110.824 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.8 m -94.71 114.09 25.96 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.102 0.561 . . . . 71.2 112.231 -170.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.78 122.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.742 -0.466 . . . . 71.12 109.742 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.83 115.31 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.168 -0.678 . . . . 71.32 109.168 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.9 123.31 49.38 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.449 HG22 ' SD ' ' A' ' 110' ' ' MET . 91.8 m -130.58 135.37 47.83 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 62.23 110.382 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.75 115.13 15.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.84 0.856 . . . . 65.55 110.761 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.518 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -121.56 132.89 54.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.714 1.206 . . . . 73.2 109.871 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -145.46 147.81 32.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.31 0.644 . . . . 74.23 111.878 -171.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.86 87.57 5.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.235 -0.654 . . . . 72.35 109.235 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 42.0 t -143.5 167.5 22.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.808 0.67 . . . . 63.53 112.808 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.41 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.7 m -70.13 142.23 89.91 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.316 1.046 . . . . 65.42 112.435 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.47 -40.3 54.15 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.473 2.782 . . . . 73.34 114.724 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.74 -31.56 69.75 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.063 0.945 . . . . 73.32 112.764 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -89.9 -29.93 18.22 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.41 0.684 . . . . 52.13 111.113 176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.13 77.27 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.622 0.769 . . . . 70.12 112.198 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -68.33 -36.56 79.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.031 0.932 . . . . 75.4 111.988 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.58 -49.17 72.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.402 0.681 . . . . 74.3 109.895 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -71.97 -23.67 61.47 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.931 -1.031 . . . . 65.22 111.352 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.19 -48.66 79.63 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.582 0.753 . . . . 75.2 110.817 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.7 m -69.23 -53.25 20.86 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.593 -0.731 . . . . 65.13 112.665 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.7 -53.85 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.53 0.567 . . . . 74.41 112.53 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.4 -48.18 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.131 0.572 . . . . 73.33 111.125 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.52 -52.39 35.27 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 114.629 0.611 . . . . 32.25 114.629 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.31 -44.63 10.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 122.062 -0.67 . . . . 74.4 112.033 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.89 -47.51 54.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 116.071 -0.513 . . . . 72.23 113.876 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.44 -53.24 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.96 0.504 . . . . 71.51 111.631 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.1 m-30 -75.65 -56.92 4.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.321 0.489 . . . . 74.23 112.321 -171.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB2' HH11 ' A' ' 6' ' ' ARG . . . -55.93 -38.55 70.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.949 0.404 . . . . 44.14 111.768 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 t -65.78 -54.45 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 123.455 0.702 . . . . 70.24 112.347 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.98 71.81 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 113.851 0.3 . . . . 64.41 113.851 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.57 -42.89 99.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.361 1.065 . . . . 75.22 112.473 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 92.4 m-20 -70.01 -39.72 75.67 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 119.726 -0.178 . . . . 65.03 110.931 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.94 79.82 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.103 0.561 . . . . 75.5 111.234 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 4.8 tt -65.49 -38.25 89.21 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.454 0.702 . . . . 74.41 110.324 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.69 68.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.939 0.496 . . . . 53.24 111.918 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 18.7 mm-40 -69.39 -42.88 74.53 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.446 0.699 . . . . 72.13 111.724 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.13 -28.92 67.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.601 0.36 . . . . 74.42 111.936 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -97.53 6.64 47.81 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.809 0.444 . . . . 71.14 111.828 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -65.27 12.46 0.28 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 116.434 1.334 . . . . 72.22 116.434 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -56.47 131.07 47.49 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.789 0.836 . . . . 74.11 110.934 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt 55.26 43.72 28.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.096 0.958 . . . . 70.54 111.977 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.49 137.1 58.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.668 1.187 . . . . 74.42 111.507 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -142.01 109.03 5.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.236 1.014 . . . . 71.45 109.895 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -68.37 107.76 2.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.87 0.468 . . . . 62.23 110.364 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -120.29 12.95 11.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.823 0.449 . . . . 74.21 111.033 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.1 -47.26 77.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.823 0.849 . . . . 73.52 111.989 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -79.45 -29.33 41.74 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.902 0.481 . . . . 63.44 111.912 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.3 p80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.421 0.629 . . . . 73.05 111.095 179.086 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.989 0.424 . . . . 63.22 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.21 89.19 3.01 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.51 0.724 . . . . 74.54 109.811 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 110' ' ' MET . 58.1 m -131.7 121.25 23.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.649 0.779 . . . . 62.53 110.01 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.75 111.47 23.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.622 1.169 . . . . 73.04 110.027 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -104.74 120.54 41.62 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.827 -0.805 . . . . 73.24 108.827 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.24 135.82 46.55 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.741 -0.466 . . . . 73.21 109.741 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.6 p -141.42 159.59 41.91 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.02 0.528 . . . . 61.14 112.294 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.9 p -147.27 141.28 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.777 0.831 . . . . 73.21 110.62 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.1 111.03 23.53 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.609 0.719 . . . . 71.34 110.276 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 137' ' ' LEU . 66.1 t -102.44 145.45 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 125.573 1.549 . . . . 72.32 112.1 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.66 59.74 3.13 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.031 0.932 . . . . 65.23 112.391 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 141.64 6.55 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.349 0.659 . . . . 71.4 111.15 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.15 138.11 65.22 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.972 2.448 . . . . 44.12 113.382 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.4 -46.46 13.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.8 1.778 . . . . 52.01 115.8 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.02 90.82 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.521 0.563 . . . . 72.2 112.521 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.82 -30.44 68.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.474 0.546 . . . . 65.04 112.474 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' SG ' ' A' ' 103' ' ' CYS . 83.5 t -70.66 -35.44 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.783 0.433 . . . . 64.3 110.679 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -67.37 -27.6 67.25 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.778 0.431 . . . . 74.4 111.295 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.3 m -63.85 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.316 0.579 . . . . 63.42 111.529 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.6 tp -84.16 -56.83 3.45 Favored 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.486 1.114 . . . . 41.14 112.47 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.47 -21.61 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.727 1.01 . . . . 74.53 113.727 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.48 -50.37 59.73 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.526 0.516 . . . . 71.54 114.111 -170.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.67 127.79 34.32 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.209 -0.663 . . . . 51.23 109.209 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.68 -30.04 71.09 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.357 1.063 . . . . 74.12 112.491 -169.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -99.27 0.84 43.92 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.487 0.715 . . . . 71.01 112.476 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -89.94 8.88 30.07 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.199 0.6 . . . . 72.53 111.837 -174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.685 HG21 ' NH2' ' A' ' 51' ' ' ARG . 19.9 tt -65.8 -30.83 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.597 1.159 . . . . 72.42 113.208 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -66.11 -9.48 31.63 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.701 0.63 . . . . 73.32 112.701 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 69.8 mtp180 -83.87 -14.88 50.07 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.936 0.895 . . . . 74.12 112.354 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 51.7 p-90 -130.28 -40.83 1.27 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 112.77 0.656 . . . . 72.32 112.77 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.452 ' ND1' HG23 ' A' ' 34' ' ' VAL . 32.7 t-80 -85.79 113.17 49.92 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.073 0.549 . . . . 74.15 110.519 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -18.89 31.08 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.212 2.608 . . . . 53.34 114.525 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.429 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 35.5 mt-30 -94.69 -13.04 26.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.81 0.67 . . . . 64.34 112.81 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.452 HG23 ' ND1' ' A' ' 31' ' ' HIS . 90.9 t -73.12 114.38 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 121.072 0.463 . . . . 74.15 110.26 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -92.93 35.95 1.04 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.395 1.078 . . . . 63.31 111.64 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.03 115.32 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 C-N-CA 125.603 1.561 . . . . 62.22 112.483 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HG3' ' HE ' ' A' ' 51' ' ' ARG . 26.3 Cg_endo -95.71 177.99 0.7 Allowed 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.381 2.721 . . . . 61.0 114.703 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.1 m -119.42 132.34 55.8 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.322 1.049 . . . . 52.43 110.451 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.2 136.34 37.86 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.454 0.645 . . . . 73.43 111.416 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -121.74 145.05 48.42 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.512 1.125 . . . . 65.14 110.294 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 119.71 0.0 OUTLIER Glycine 0 CA--C 1.556 2.611 0 N-CA-C 117.613 1.805 . . . . 42.11 117.613 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.57 -96.41 0.05 OUTLIER 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 125.614 1.566 . . . . 72.32 113.644 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -158.71 150.76 17.35 Favored Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 123.29 0.636 . . . . 62.42 111.78 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.12 -12.58 33.13 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.11 2.54 . . . . 74.22 114.155 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 80.1 m-70 -97.06 -5.72 36.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.827 -0.545 . . . . 73.44 111.657 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.6 m -96.89 113.78 63.49 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.788 0.835 . . . . 71.12 110.758 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.2 Cg_endo -55.97 114.84 2.08 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.253 2.635 . . . . 52.35 112.87 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.36 -23.79 4.02 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-N 115.915 -0.584 . . . . 73.33 112.558 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.69 133.74 55.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.417 0.687 . . . . 43.42 112.254 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 43.4 mt-10 -103.26 138.57 39.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.966 0.506 . . . . 65.11 110.754 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.685 ' NH2' HG21 ' A' ' 27' ' ' ILE . 32.5 ttt-85 -125.15 106.01 9.58 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.176 0.99 . . . . 74.25 110.745 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 t -110.55 109.31 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.338 0.655 . . . . 72.31 111.4 -169.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HE2' HG22 ' A' ' 34' ' ' VAL . 46.2 m-85 -62.32 118.61 7.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.334 1.054 . . . . 73.43 111.326 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.84 -71.91 2.88 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 112.451 -0.26 . . . . 71.11 112.451 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.74 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.881 1.272 . . . . 74.22 113.468 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 25.52 3.98 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 116.348 -0.387 . . . . 45.41 113.948 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.5 -172.32 2.49 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.301 1.04 . . . . 51.53 110.205 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.4 0.96 54.7 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.808 0.443 . . . . 71.35 111.746 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.1 88.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.568 0.747 . . . . 63.45 110.034 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.38 139.6 49.35 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.376 0.671 . . . . 65.11 110.414 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -95.2 117.46 30.28 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.517 0.727 . . . . 73.31 109.902 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 43.6 t -96.17 115.97 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.735 -0.469 . . . . 62.4 109.735 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 23.3 tt0 -112.69 166.65 11.16 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.211 1.005 . . . . 72.11 109.837 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -151.6 124.98 8.84 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.926 0.49 . . . . 34.23 111.918 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 34.4 tp -68.2 120.07 13.78 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.833 1.253 . . . . 75.11 111.353 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -85.21 -52.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.246 0.618 . . . . 52.4 110.647 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 8.5 pt-20 -155.83 139.72 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.156 0.583 . . . . 72.21 110.456 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.718 HH12 ' HB3' ' A' ' 70' ' ' GLU . 41.4 tpt85 -131.94 106.85 8.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.608 0.763 . . . . 60.23 109.641 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.92 116.63 23.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.603 0.761 . . . . 42.44 111.355 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' HH12 ' A' ' 68' ' ' ARG . 13.1 pt-20 -84.6 -39.19 19.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.284 0.634 . . . . 75.31 112.63 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.7 m -71.83 -25.34 61.94 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.311 0.644 . . . . 52.14 111.262 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.9 -17.86 32.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.468 0.707 . . . . 72.33 111.784 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 55.49 43.75 28.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.985 0.914 . . . . 71.24 111.226 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -133.45 116.07 15.56 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 114.471 -1.241 . . . . 71.55 109.887 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.672 HD13 ' HD3' ' A' ' 68' ' ' ARG . 23.9 tp -119.03 109.67 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.867 1.267 . . . . 61.31 110.923 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 75.9 t -110.34 137.44 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.829 -0.545 . . . . 70.14 111.392 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -145.14 179.21 7.51 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.67 1.188 . . . . 73.0 110.507 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -163.32 152.79 14.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.463 1.105 . . . . 73.14 109.243 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.0 mpp? -91.03 109.72 37.17 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 118.024 0.375 . . . . 64.52 110.386 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.08 -21.19 63.32 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.664 2.242 . . . . 73.1 111.851 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 29.7 t70 -122.94 80.6 50.34 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.919 0.888 . . . . 62.4 109.558 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -94.88 137.29 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.069 2.513 . . . . 74.21 113.057 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.51 12.05 3.17 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.855 2.37 . . . . 61.32 113.447 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -108.43 144.97 30.57 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 124.005 0.922 . . . . 73.01 109.971 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.26 65.47 7.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.83 2.353 . . . . 72.12 112.289 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 22.2 pt -122.76 131.62 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.18 0.992 . . . . 74.43 110.955 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 26.4 m -78.44 134.51 37.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 110.069 -0.345 . . . . 71.42 110.069 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 56.1 -67.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 128.132 2.573 . . . . 63.01 114.721 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 69.11 148.06 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.343 1.457 . . . . 62.22 111.516 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.449 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 64.8 ttt-85 -164.66 107.86 0.89 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 109.532 -0.544 . . . . 74.41 109.532 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.37 146.31 33.22 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.197 0.599 . . . . 64.44 112.016 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.6 p -138.09 144.43 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 113.501 0.926 . . . . 75.24 113.501 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.35 112.07 24.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.17 1.388 . . . . 60.43 109.297 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -119.06 113.69 21.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.197 0.999 . . . . 72.21 110.139 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 t -93.06 112.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.988 -0.445 . . . . 53.0 110.208 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.33 119.28 58.11 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.377 1.071 . . . . 63.32 110.961 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.5 107.68 2.05 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.504 2.136 . . . . 65.13 112.825 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -86.61 -42.66 13.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.984 0.914 . . . . 74.4 111.061 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.3 t70 -140.49 178.92 6.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.44 1.096 . . . . 74.11 109.058 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.09 -48.62 28.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.056 0.542 . . . . 73.3 111.031 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.9 tmt_? -95.96 -1.52 48.93 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.89 0.876 . . . . 73.13 111.03 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 59.4 m-70 -135.77 158.54 44.15 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.391 -0.818 . . . . 74.2 110.73 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.4 p -156.61 178.23 10.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.786 0.434 . . . . 73.33 111.514 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.4 m -119.43 127.35 53.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.888 0.875 . . . . 54.44 110.782 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t -95.26 110.35 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.2 t -99.68 108.83 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.382 0.673 . . . . 60.42 110.04 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -106.8 119.27 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.048 -0.723 . . . . 75.43 109.048 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.4 m -126.4 150.54 48.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.0 0.92 . . . . 72.12 109.943 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.61 120.03 8.46 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.236 0.614 . . . . 65.33 111.244 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.515 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -117.12 128.6 55.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.117 0.967 . . . . 74.23 110.211 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 19.2 p90 -146.91 143.01 28.2 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.205 1.402 . . . . 74.11 108.462 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 15.8 t70 -89.88 78.39 6.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.733 0.778 . . . . 74.33 109.659 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 52.6 t -117.82 163.1 17.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.203 0.601 . . . . 71.44 111.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.1 p -64.38 138.76 97.53 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.672 0.789 . . . . 71.13 112.018 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.55 -36.43 18.47 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.943 3.095 . . . . 61.11 115.169 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -61.06 -53.75 53.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.54 0.736 . . . . 65.14 111.352 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.43 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 48.7 m -72.84 -27.29 61.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.986 0.515 . . . . 73.33 111.517 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.42 -43.3 81.55 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.914 0.885 . . . . 54.22 112.57 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -68.51 -29.14 67.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.365 0.666 . . . . 70.03 111.484 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.49 -43.93 68.72 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.361 0.665 . . . . 62.33 110.498 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.06 -23.25 59.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.89 0.876 . . . . 71.33 111.536 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -57.54 -44.78 85.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.851 0.46 . . . . 70.31 110.18 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.8 t -71.61 -52.32 18.63 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 63.14 112.738 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.91 -54.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 123.447 0.699 . . . . 62.25 112.705 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.89 -50.58 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.135 0.574 . . . . 74.23 111.115 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.18 -49.31 58.4 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 114.652 0.621 . . . . 45.43 114.652 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.08 -48.99 7.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.126 -0.631 . . . . 75.23 111.56 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.51 -29.8 65.34 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 115.496 0.959 . . . . 62.13 115.496 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.93 -53.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 117.784 0.792 . . . . 73.12 110.96 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.0 m-30 -73.25 -60.46 2.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.444 0.698 . . . . 75.21 112.287 -170.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.81 66.98 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 123.497 0.498 . . . . 73.31 111.488 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -55.94 -54.82 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 123.666 0.786 . . . . 74.25 112.295 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.75 80.72 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 113.69 0.236 . . . . 74.52 113.69 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.58 -42.21 71.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.057 0.943 . . . . 73.3 111.884 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.68 -41.39 83.78 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.519 0.328 . . . . 71.12 110.289 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.34 80.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.802 0.841 . . . . 55.35 111.969 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.427 HD22 HG21 ' A' ' 10' ' ' VAL . 7.8 tt -65.26 -43.22 91.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.715 0.806 . . . . 55.31 110.228 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.94 74.59 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.275 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 49.6 mt-10 -69.58 -48.13 61.27 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.865 0.866 . . . . 72.14 112.794 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -19.9 65.37 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.49 0.552 . . . . 55.25 112.49 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -91.34 -44.3 9.26 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.882 0.473 . . . . 74.04 111.864 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.91 56.29 0.04 OUTLIER Glycine 0 N--CA 1.479 1.526 0 N-CA-C 114.323 0.489 . . . . 74.33 114.323 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 12.4 ttm180 62.5 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 125.136 1.374 . . . . 52.42 112.942 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -173.99 166.53 4.29 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.956 1.302 . . . . 73.2 110.221 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -98.92 -41.56 7.55 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.834 0.453 . . . . 54.41 110.643 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -125.25 124.26 41.3 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.606 0.763 . . . . 63.21 110.651 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -78.0 121.89 24.81 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.084 0.554 . . . . 72.43 110.144 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.431 ' HE1' HG23 ' A' ' 8' ' ' VAL . 18.2 p-80 -123.08 118.51 27.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.219 1.007 . . . . 65.51 109.624 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -85.93 50.58 2.0 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.946 0.898 . . . . 70.21 111.429 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 62.65 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.47 1.108 . . . . 71.54 113.223 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 124.154 0.982 . . . . 62.12 111.039 177.263 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.69 0.281 . . . . 74.33 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 47.7 1.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.708 0.803 . . . . 43.41 110.964 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 m -121.92 111.28 16.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.811 0.844 . . . . 72.4 110.318 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 6.8 mp -96.08 109.59 21.99 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 45.44 110.039 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.53 123.71 39.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.898 0.479 . . . . 63.32 110.946 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.465 HH22 ' HG2' ' A' ' 122' ' ' GLU . 1.2 mmp_? -122.28 160.39 25.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.333 1.053 . . . . 74.53 108.817 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -153.31 146.81 24.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.11 0.564 . . . . 70.25 111.244 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.0 p -138.73 145.58 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.156 0.583 . . . . 72.42 111.314 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.94 110.88 22.72 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.495 0.718 . . . . 71.4 110.426 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 65.9 t -101.41 139.93 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.562 1.145 . . . . 73.15 111.578 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.72 40.78 0.61 Allowed 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 113.766 1.025 . . . . 52.21 113.766 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.54 32.27 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.205 0.602 . . . . 34.15 111.654 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.08 145.28 78.67 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.984 2.456 . . . . 74.33 113.265 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.31 -35.31 37.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.345 1.458 . . . . 72.32 114.72 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.69 -51.55 61.87 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.77 -44.78 90.73 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.282 0.633 . . . . 63.45 111.162 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 103' ' ' CYS . 49.2 t -68.72 -34.07 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.605 0.762 . . . . 62.25 111.08 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.559 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 55.8 t-105 -59.55 -40.99 89.07 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.458 0.303 . . . . 72.13 111.219 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -61.37 -24.99 66.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.796 0.438 . . . . 75.15 111.564 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 30' ' ' TRP . 29.5 tp -83.67 -44.29 14.66 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 112.736 0.643 . . . . 70.3 112.736 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.62 -26.26 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 114.098 1.147 . . . . 75.54 114.098 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.71 35.42 3.22 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 115.876 1.11 . . . . 43.14 115.876 -165.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.26 -162.07 0.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.806 0.842 . . . . 53.33 111.158 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.14 25.2 1.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.302 0.641 . . . . 51.43 110.195 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -152.15 -42.83 0.11 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.498 0.719 . . . . 74.11 111.763 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.4 3.12 48.34 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.221 1.008 . . . . 61.23 111.199 -170.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 34' ' ' VAL . 14.3 tt -55.92 -19.76 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 C-N-CA 125.853 1.661 . . . . 72.21 113.108 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.37 -14.36 55.96 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.409 0.892 . . . . 73.41 113.409 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -71.85 -20.18 61.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.533 0.733 . . . . 72.22 112.374 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HB3' HD21 ' A' ' 20' ' ' LEU . 31.5 p-90 -127.71 -35.08 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.008 0.523 . . . . 74.25 111.912 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -89.77 112.37 51.59 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 122.819 0.447 . . . . 74.34 110.337 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.68 -16.27 37.8 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.275 2.65 . . . . 70.32 114.083 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -93.15 -20.69 20.24 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.724 0.81 . . . . 73.51 112.12 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 27' ' ' ILE . 72.9 t -69.32 111.79 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 120.919 0.39 . . . . 61.54 110.894 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -92.33 27.46 2.23 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.429 1.092 . . . . 35.5 111.9 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.03 98.1 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.577 1.151 . . . . 62.22 111.27 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.11 173.14 8.12 Favored 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 123.116 2.544 . . . . 62.34 114.693 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -99.96 123.02 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.0 0.92 . . . . 65.2 109.758 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.71 127.32 39.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.237 0.615 . . . . 73.01 111.204 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -104.64 123.23 47.22 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.719 -0.673 . . . . 74.24 109.612 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.33 -175.41 0.01 OUTLIER Glycine 0 CA--C 1.55 2.241 0 N-CA-C 117.543 1.777 . . . . 61.13 117.543 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 46.75 -121.31 1.14 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.839 1.256 . . . . 75.53 113.315 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -162.8 155.9 16.78 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 124.375 1.07 . . . . 75.35 108.985 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.42 -15.52 45.82 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.502 2.135 . . . . 72.0 114.859 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -111.41 0.77 16.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.66 -0.65 . . . . 55.14 111.546 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -110.77 127.69 26.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 123.732 0.813 . . . . 73.21 110.928 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 85.5 Cg_exo -50.15 138.68 36.21 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.68 2.92 . . . . 73.42 114.149 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.97 19.6 21.24 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 116.272 -0.422 . . . . 63.34 113.564 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.78 134.74 51.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.71 0.804 . . . . 74.41 110.737 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.35 118.44 35.85 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.952 0.501 . . . . 74.21 110.965 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -93.63 126.26 38.69 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.888 0.375 . . . . 73.4 110.042 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 62' ' ' VAL . 20.6 t -122.42 122.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 122.902 0.481 . . . . 74.45 111.238 -171.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' HE2' HG13 ' A' ' 34' ' ' VAL . 48.6 m-85 -95.56 85.31 4.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.216 1.006 . . . . 73.53 111.118 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.25 -43.41 1.61 Allowed Glycine 0 N--CA 1.478 1.488 0 N-CA-C 112.722 -0.151 . . . . 74.23 112.722 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 17.7 4.12 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.949 1.463 . . . . 73.32 114.949 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.31 57.8 0.03 OUTLIER Glycine 0 N--CA 1.472 1.064 0 N-CA-C 112.595 -0.202 . . . . 43.32 112.595 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -105.87 -69.1 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.982 0.913 . . . . 52.51 109.729 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 176.64 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.527 1.531 . . . . 72.31 109.252 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.75 82.21 2.07 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.871 0.843 . . . . 74.32 108.818 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.72 -179.77 3.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.15 0.98 . . . . 74.12 110.601 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD11 ' SD ' ' A' ' 79' ' ' MET . 55.0 tp -141.14 123.53 15.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.799 0.44 . . . . 72.21 110.896 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.0 t -104.7 115.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.162 -0.681 . . . . 70.55 109.162 170.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -104.73 149.67 25.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.872 0.869 . . . . 55.4 109.889 171.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -127.5 127.39 43.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.068 1.347 . . . . 74.4 109.867 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.17 108.99 9.47 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.932 0.893 . . . . 54.13 110.662 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -73.26 -50.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.363 0.665 . . . . 54.21 110.555 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.723 ' HA ' ' HG3' ' A' ' 47' ' ' PRO . 8.6 pt-20 -166.81 155.46 10.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.541 0.736 . . . . 73.34 111.095 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -141.69 123.04 14.87 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.37 0.668 . . . . 70.21 110.497 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.35 -178.37 4.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.045 0.938 . . . . 74.24 111.826 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.559 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 55.4 mt-10 -138.92 -63.72 0.52 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.228 1.011 . . . . 75.22 109.955 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -69.57 -38.25 77.33 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.414 0.686 . . . . 62.35 111.439 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.67 -19.83 60.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.431 0.692 . . . . 55.41 112.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 55.74 45.0 25.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 65.3 112.253 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.45 HH11 HG23 ' A' ' 76' ' ' VAL . 9.0 tmm_? -130.7 130.99 44.55 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 115.031 -0.986 . . . . 63.44 110.475 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 46.2 tp -120.36 123.63 43.56 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.363 1.065 . . . . 74.4 110.212 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.5 t -114.38 132.35 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 118.958 0.799 . . . . 54.41 111.072 174.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -147.61 175.18 11.07 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 51.55 111.349 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.6 t -150.15 145.26 26.19 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.402 1.081 . . . . 73.24 109.55 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.3 ptt? -95.96 101.06 7.46 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 118.787 0.721 . . . . 74.43 110.7 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.47 -17.37 30.38 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 123.178 2.586 . . . . 63.11 113.229 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 34.9 t70 -132.8 79.18 64.49 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 123.427 0.691 . . . . 74.23 109.859 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -96.34 154.93 1.32 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.42 2.747 . . . . 75.32 114.033 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.94 -17.43 22.45 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.119 1.879 . . . . 71.51 112.554 168.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -80.33 142.2 54.25 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 123.812 0.845 . . . . 75.21 112.047 -175.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.07 77.4 3.49 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.717 2.278 . . . . 62.12 113.21 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.1 pt -133.54 154.7 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.285 1.034 . . . . 71.32 110.774 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 35.9 m -90.76 -79.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.985 -0.447 . . . . 63.4 110.757 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -106.37 107.82 19.03 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.358 0.599 . . . . 73.32 110.924 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.407 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 43.5 t-80 -84.94 149.72 25.44 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.772 0.829 . . . . 64.33 111.06 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -153.31 106.89 3.01 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.492 0.717 . . . . 73.12 109.952 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -117.0 142.38 47.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.981 0.512 . . . . 54.24 111.926 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 92.8 t -133.6 134.83 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.25 1.02 . . . . 63.25 111.061 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 mm? -94.46 147.02 23.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.745 -0.835 . . . . 63.4 108.745 166.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.27 117.65 4.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.677 0.391 . . . . 75.43 110.179 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.05 112.46 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.784 -0.451 . . . . 60.41 109.784 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.84 120.7 67.02 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.737 0.815 . . . . 71.45 110.581 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.18 87.56 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.325 2.017 . . . . 52.43 112.123 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -76.17 -32.16 58.9 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.098 0.959 . . . . 71.52 111.148 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 16.6 t70 -158.73 170.9 21.1 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.65 1.58 . . . . 63.34 108.42 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -54.29 -52.86 60.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 61.24 112.475 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -119.85 23.25 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.533 0.682 . . . . 73.11 110.845 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.734 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.4 m80 -132.62 121.36 23.08 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.534 -0.729 . . . . 73.12 109.38 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 17' ' ' VAL . 30.1 p -128.28 138.33 52.37 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.986 0.514 . . . . 74.13 109.647 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.9 m -96.05 109.7 22.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.834 -0.432 . . . . 73.11 109.834 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 108.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.134 -0.691 . . . . 74.24 109.134 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.89 112.5 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.261 1.024 . . . . 64.5 109.087 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -104.51 118.71 37.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.776 -0.824 . . . . 71.05 108.776 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -120.11 149.37 42.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.186 0.995 . . . . 74.53 110.023 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -146.08 157.96 43.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.557 1.143 . . . . 43.12 109.206 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -161.46 134.64 6.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.748 0.819 . . . . 75.03 109.783 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -145.51 152.98 40.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.146 0.578 . . . . 70.21 111.81 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 22.2 t70 -75.35 88.91 2.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.935 -0.575 . . . . 44.52 109.815 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.632 ' HB2' HG22 ' A' ' 86' ' ' ILE . 34.0 t -147.76 166.27 28.02 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.354 -0.839 . . . . 73.13 111.205 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.4 p -67.21 145.68 98.72 Favored Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 123.254 0.622 . . . . 72.03 111.445 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.49 -29.22 68.16 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.85 2.367 . . . . 60.32 112.963 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.08 -52.3 59.93 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.344 1.058 . . . . 71.12 112.001 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.49 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.2 m -72.46 -32.01 65.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.134 0.492 . . . . 75.34 110.82 177.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.41 -32.95 74.19 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.633 0.773 . . . . 55.04 112.055 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -69.08 -35.63 76.7 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.983 0.513 . . . . 71.01 110.952 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.95 -48.59 73.55 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.378 0.671 . . . . 72.45 110.077 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.05 -24.75 62.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.193 -0.912 . . . . 72.34 111.341 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HG2' HH22 ' A' ' 6' ' ' ARG . 1.2 tm-20 -57.08 -42.05 79.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.795 0.838 . . . . 55.4 110.507 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.5 t -76.75 -49.81 15.09 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.527 0.565 . . . . 74.44 112.527 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.2 -56.75 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.925 0.713 . . . . 63.22 112.925 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.44 -42.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.184 0.593 . . . . 73.24 110.681 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.95 -66.2 2.83 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 116.398 -0.365 . . . . 64.23 113.787 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 69.8 m-20 -80.97 -50.76 9.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.026 0.913 . . . . 73.5 112.025 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.28 -26.41 69.37 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 115.287 0.875 . . . . 54.33 115.287 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.09 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.759 0.779 . . . . 61.34 111.204 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 8.5 m-30 -71.72 -63.1 1.19 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.907 0.336 . . . . 65.21 111.907 -170.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -61.19 -28.53 69.21 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.47 0.481 . . . . 31.2 112.183 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.96 -53.47 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.439 0.696 . . . . 71.23 111.316 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.85 93.45 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 116.343 -0.39 . . . . 72.32 113.233 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.88 -40.28 91.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.069 0.948 . . . . 61.33 111.866 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.425 -0.352 . . . . 54.33 110.294 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.47 70.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.645 0.778 . . . . 64.25 112.246 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 tt -67.25 -48.45 67.73 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.958 0.903 . . . . 74.1 110.403 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.42 63.21 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.073 0.549 . . . . 54.33 111.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 40.1 mt-10 -66.23 -49.8 66.0 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.582 0.753 . . . . 73.34 111.422 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -14.41 61.64 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.305 0.483 . . . . 71.12 112.305 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -94.82 -30.58 14.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.186 0.81 . . . . 75.03 113.186 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.94 19.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 115.947 1.139 . . . . 23.4 115.947 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 71.6 mtp180 57.65 36.23 26.49 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.663 1.185 . . . . 75.42 113.9 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.91 84.81 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.936 0.894 . . . . 64.3 111.098 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.91 -53.4 56.23 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 116.753 -0.203 . . . . 63.12 111.067 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -93.86 99.7 12.02 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.363 -0.606 . . . . 63.34 109.363 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.27 145.92 43.62 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.731 0.813 . . . . 75.22 111.059 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -115.36 118.28 32.79 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.853 -0.795 . . . . 71.12 108.853 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -60.26 -42.17 94.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.442 0.904 . . . . 72.02 113.442 -172.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -76.53 -83.77 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.532 0.333 . . . . 74.24 111.458 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.7 p80 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.736 0.779 . . . . 74.35 111.804 179.032 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 112.168 0.433 . . . . 60.11 112.168 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.24 29.14 18.56 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 124.783 1.233 . . . . 61.15 113.155 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.2 m -91.33 117.95 30.09 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.26 0.624 . . . . 55.0 110.529 173.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.66 128.02 42.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.948 1.299 . . . . 70.12 108.155 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -133.87 127.75 33.19 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.165 0.439 . . . . 71.55 110.216 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.79 140.57 50.3 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.665 -0.865 . . . . 65.51 108.665 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 p -141.66 156.23 45.65 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.658 0.783 . . . . 50.14 110.575 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.39 148.37 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 N-CA-C 111.976 0.361 . . . . 73.21 111.976 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.68 113.5 18.93 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.289 0.635 . . . . 64.34 110.567 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 105' ' ' VAL . 43.1 t -106.57 124.11 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.309 0.644 . . . . 72.23 110.466 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.1 66.13 8.53 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.809 0.844 . . . . 64.15 112.185 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.41 152.88 3.41 Favored Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 123.959 0.904 . . . . 73.11 110.797 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 134.95 64.09 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.06 2.507 . . . . 62.15 113.143 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.77 50.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.381 1.622 . . . . 72.1 115.381 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.43 78.98 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.942 0.497 . . . . 72.52 111.926 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.21 -34.82 79.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 75.1 112.326 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.587 HG21 ' SG ' ' A' ' 103' ' ' CYS . 59.3 t -70.36 -36.69 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.221 0.608 . . . . 62.11 110.886 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -64.14 -28.84 70.04 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.982 -0.554 . . . . 71.25 110.661 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -59.54 -28.22 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.072 0.549 . . . . 73.14 111.432 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -76.48 -41.78 45.9 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.806 0.842 . . . . 71.21 111.666 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.37 13.96 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 123.943 0.897 . . . . 71.3 112.833 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.31 7.04 80.88 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 114.449 0.539 . . . . 74.33 114.449 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.3 m-20 -124.98 135.36 52.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 63.33 109.311 166.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.68 -24.77 67.92 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.986 0.914 . . . . 74.05 111.286 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.9 p -89.78 -16.43 30.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.317 1.047 . . . . 73.43 112.822 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -82.22 3.54 26.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.867 -0.52 . . . . 61.24 112.238 -168.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 HG11 ' A' ' 34' ' ' VAL . 21.1 tt -63.79 -23.24 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.142 0.977 . . . . 75.04 112.766 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.481 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 57.0 p-80 -64.47 -23.23 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.801 0.667 . . . . 72.22 112.801 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -74.29 -39.04 63.19 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.512 0.56 . . . . 64.34 112.512 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 p-90 -107.57 -30.16 8.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.597 0.359 . . . . 72.41 111.334 -174.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -100.16 102.03 16.59 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 123.453 0.701 . . . . 75.45 109.842 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.21 -13.3 31.32 Favored 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 123.537 2.825 . . . . 63.33 116.035 -171.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -83.8 -25.79 30.11 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.355 0.662 . . . . 74.52 111.697 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 27' ' ' ILE . 85.4 t -72.37 115.89 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 122.877 0.471 . . . . 71.02 111.465 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -95.25 30.32 2.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.974 0.91 . . . . 74.43 111.797 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.76 98.58 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 125.326 1.45 . . . . 70.43 112.643 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.9 -171.39 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.321 2.681 . . . . 75.41 114.252 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.8 m -115.52 124.53 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.785 0.834 . . . . 50.33 110.686 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.402 HD12 ' HB1' ' A' ' 49' ' ' ALA . 3.8 mm? -90.78 126.65 36.08 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.501 0.667 . . . . 73.42 111.313 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 mmt180 -111.65 148.25 33.77 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.535 1.134 . . . . 63.31 109.929 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.69 121.05 0.0 OUTLIER Glycine 0 CA--C 1.56 2.906 0 N-CA-C 117.715 1.846 . . . . 64.01 117.715 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.45 -98.35 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.421 1.488 . . . . 74.22 114.096 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -168.66 146.72 3.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 123.227 0.611 . . . . 62.35 111.68 -166.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.59 -1.2 2.39 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.675 2.917 . . . . 64.54 115.145 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -101.5 -24.8 14.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.538 0.735 . . . . 64.23 111.271 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -93.12 124.24 58.61 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.641 0.776 . . . . 52.2 111.731 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.62 118.91 4.86 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.221 2.614 . . . . 71.31 112.874 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.15 -9.46 7.89 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 112.484 -0.246 . . . . 74.01 112.484 -170.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -73.27 130.75 40.89 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.487 0.715 . . . . 51.02 111.05 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 36.2 mt-10 -118.88 115.16 23.82 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 122.099 -0.376 . . . . 71.4 110.558 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -93.73 119.11 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.337 0.589 . . . . 72.21 109.826 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 t -115.93 107.78 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 123.805 0.842 . . . . 52.23 110.227 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -76.85 73.64 3.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.041 0.936 . . . . 74.32 111.479 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.89 -62.44 0.48 Allowed Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.124 -0.489 . . . . 63.44 111.899 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.63 27.08 16.62 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.605 1.162 . . . . 62.35 113.663 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.27 41.48 0.03 OUTLIER Glycine 0 N--CA 1.471 1.005 0 CA-C-N 116.392 -0.367 . . . . 64.5 112.739 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -146.78 160.83 41.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.599 0.759 . . . . 64.41 110.767 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.08 -19.48 60.59 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.253 0.621 . . . . 72.44 111.858 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.12 85.98 2.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.735 0.814 . . . . 71.4 110.641 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.26 162.77 30.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 75.23 111.871 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 79' ' ' MET . 51.1 tp -121.95 121.71 37.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.772 0.829 . . . . 72.42 109.89 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.54 130.09 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.066 -0.716 . . . . 73.31 109.066 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.638 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 40.1 mt-10 -130.25 128.87 42.5 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.413 0.685 . . . . 72.4 110.317 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 57.8 mtp180 -104.04 131.76 50.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.193 0.597 . . . . 74.12 111.204 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -73.04 111.46 8.17 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.015 0.926 . . . . 54.11 110.161 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.72 -51.91 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.528 0.731 . . . . 62.21 111.731 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.8 pt-20 -153.18 151.81 30.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 70.35 110.579 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.597 HH21 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -133.78 113.48 12.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.189 0.596 . . . . 74.01 110.557 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.5 m-20 -115.68 72.18 0.8 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.816 0.847 . . . . 71.42 109.036 176.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HG3' ' HD2' ' A' ' 68' ' ' ARG . 53.3 mt-10 -67.38 -32.85 74.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.735 0.814 . . . . 74.22 113.109 -173.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -73.07 -18.56 61.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.171 0.589 . . . . 71.04 111.733 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.57 -1.82 22.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.69 0.796 . . . . 63.53 112.133 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 13.1 mtm105 62.71 42.82 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.433 1.093 . . . . 75.22 112.993 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 23.9 ttm180 -119.34 133.17 55.87 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.368 1.067 . . . . 75.5 110.781 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.597 HD22 HH21 ' A' ' 68' ' ' ARG . 13.6 tp -131.74 107.93 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.636 1.174 . . . . 33.42 110.037 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 52.0 t -113.12 132.99 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 118.491 0.587 . . . . 75.11 110.601 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -148.14 167.77 24.17 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.746 0.818 . . . . 73.22 111.339 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.0 t -134.82 158.25 44.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.12 0.968 . . . . 72.45 110.578 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.638 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 73.4 mtm -102.82 98.13 10.69 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.019 0.527 . . . . 71.12 110.309 170.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.487 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 56.8 Cg_endo -66.05 -28.21 49.4 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.371 2.714 . . . . 70.33 112.612 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.28 79.42 35.87 Favored Pre-proline 0 CA--C 1.555 1.164 0 N-CA-C 108.624 -0.88 . . . . 71.14 108.624 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 83.1 Cg_endo -79.68 147.4 19.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.465 2.11 . . . . 44.14 113.12 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.8 Cg_endo -84.38 -0.83 9.57 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.95 2.434 . . . . 62.44 112.782 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.18 150.38 63.35 Favored Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 74.42 111.513 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.38 80.57 1.05 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.107 2.538 . . . . 73.1 112.956 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.577 HG22 ' HB2' ' A' ' 113' ' ' CYS . 23.5 pt -135.59 146.51 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.547 1.139 . . . . 74.35 110.383 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -89.87 -72.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.883 0.373 . . . . 54.43 110.921 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 9.1 m-20 -90.71 123.95 34.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.412 -0.959 . . . . 72.35 108.412 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -114.87 131.21 56.93 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.352 0.978 . . . . 75.44 113.237 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 110' ' ' MET . 3.6 mpt_? -129.64 143.58 50.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.181 1.392 . . . . 74.43 109.02 165.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.81 125.6 15.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.068 0.947 . . . . 73.31 108.739 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 94' ' ' GLU . 7.5 p -134.5 134.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.678 0.992 . . . . 74.34 113.678 -169.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -101.91 112.46 25.1 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.247 1.019 . . . . 74.24 109.156 171.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 92' ' ' VAL . 44.3 mt-10 -122.22 111.26 16.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.618 0.767 . . . . 65.41 109.921 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -92.59 109.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.101 -0.703 . . . . 51.24 109.101 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.417 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.4 m -100.7 114.03 65.72 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 123.856 0.863 . . . . 73.02 110.624 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.76 107.09 2.12 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.543 2.162 . . . . 64.41 113.04 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -63.47 -29.52 70.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.71 0.804 . . . . 72.2 111.144 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.2 t70 -154.63 173.13 16.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.396 1.478 . . . . 74.24 108.526 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.37 -44.19 92.77 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.979 0.512 . . . . 45.43 111.423 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.8 tmm_? -106.98 1.92 24.8 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.65 0.78 . . . . 73.15 111.468 -174.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 42.5 m80 -128.58 141.52 51.34 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.406 -0.809 . . . . 74.23 110.307 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.587 ' SG ' HG21 ' A' ' 17' ' ' VAL . 16.8 p -143.72 174.91 10.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.474 0.654 . . . . 75.22 112.407 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 96' ' ' VAL . 99.4 m -138.58 118.95 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 53.31 109.65 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 10' ' ' VAL . 47.9 t -91.77 124.8 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 109.771 -0.455 . . . . 73.22 109.771 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.75 128.35 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 73.25 109.357 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 6.4 t90 -121.2 122.91 40.99 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.79 -0.818 . . . . 62.43 108.79 174.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -127.39 124.13 37.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.454 0.702 . . . . 70.41 111.491 -170.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -105.3 107.81 18.99 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 62.35 110.39 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ARG . 41.8 mtt -97.62 130.35 44.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.888 -0.782 . . . . 74.32 108.888 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 88' ' ' ASN . 20.4 p90 -157.28 153.21 27.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.978 0.732 . . . . 75.34 112.978 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.65 84.25 2.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.237 -0.892 . . . . 73.41 109.427 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.577 ' HB2' HG22 ' A' ' 86' ' ' ILE . 42.2 t -119.28 155.78 31.18 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.324 -1.307 . . . . 74.22 110.711 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -58.61 138.45 86.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.933 0.893 . . . . 61.43 111.427 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.59 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 123.473 2.782 . . . . 71.0 114.857 -168.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.02 -37.98 89.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.104 0.561 . . . . 75.21 111.421 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 9.0 m -79.23 -27.25 42.46 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.015 0.526 . . . . 62.12 111.071 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.995 0.918 . . . . 72.01 111.896 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -74.8 -28.1 60.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.696 0.799 . . . . 75.01 111.586 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.32 -45.63 79.65 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.146 0.498 . . . . 74.03 110.161 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.22 -24.8 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.721 0.808 . . . . 65.22 111.275 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -58.18 -45.58 87.27 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.522 0.729 . . . . 73.52 110.519 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 m -69.99 -53.19 18.77 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.523 -0.762 . . . . 62.32 112.394 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.69 -55.25 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 C-N-CA 123.479 0.712 . . . . 75.02 112.595 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.6 mt -81.49 -57.32 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.836 0.854 . . . . 72.13 111.251 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.3 -63.33 3.3 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 114.349 0.5 . . . . 44.31 114.349 -173.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.45 -16.5 58.74 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 122.871 0.468 . . . . 72.45 111.441 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.19 -88.75 1.66 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.86 -0.411 . . . . 35.42 112.463 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.7 t -52.6 -46.78 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 124.935 1.294 . . . . 73.02 113.03 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 3.8 m-30 -75.98 -47.85 23.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.443 0.697 . . . . 73.04 111.558 -173.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.36 -41.85 85.65 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.226 0.329 . . . . 73.32 111.751 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.51 -54.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 123.955 0.902 . . . . 74.0 112.107 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.91 -46.21 76.05 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.423 0.452 . . . . 52.33 113.675 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.62 -41.48 96.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.561 0.745 . . . . 73.13 112.199 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.68 -41.64 92.19 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 119.73 -0.176 . . . . 72.23 110.675 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.91 90.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.94 0.496 . . . . 64.13 111.541 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.64 -40.12 96.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.603 0.761 . . . . 42.15 110.164 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.51 -33.19 68.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.859 0.463 . . . . 71.11 111.981 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.026 0.931 . . . . 72.3 113.042 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -66.77 -32.32 73.53 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 117.922 0.328 . . . . 63.22 111.289 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.98 -11.25 36.6 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.227 0.611 . . . . 74.24 110.661 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.79 7.03 44.34 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 114.569 0.588 . . . . 72.1 114.569 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -70.03 -22.1 63.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.139 0.576 . . . . 73.31 110.1 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.11 174.36 6.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.53 1.132 . . . . 75.34 109.912 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 67.03 173.23 0.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.919 1.451 . . . . 60.11 114.919 170.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -114.01 79.66 1.28 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.974 0.91 . . . . 41.04 109.967 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -124.85 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.435 0.694 . . . . 62.41 110.119 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -95.6 143.6 26.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.575 0.75 . . . . 73.14 112.577 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -137.73 95.79 3.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.094 0.958 . . . . 74.41 109.716 168.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -71.51 -29.7 65.09 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.083 0.953 . . . . 73.3 110.31 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 122.277 1.037 . . . . 71.52 110.559 173.272 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.848 0.356 . . . . 64.45 110.75 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.63 33.93 5.21 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.911 0.884 . . . . 70.2 110.371 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.6 m -119.72 124.5 46.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.901 0.88 . . . . 73.44 109.972 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.94 141.07 32.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 74.04 109.097 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -145.62 132.63 20.28 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.611 -0.515 . . . . 74.15 109.611 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 131' ' ' ALA . 5.7 tpt180 -133.7 147.35 51.37 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.346 -0.613 . . . . 63.44 109.346 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.0 p -142.76 150.36 39.94 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.24 0.616 . . . . 52.41 111.246 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.92 149.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.156 0.582 . . . . 52.51 111.173 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.18 123.7 29.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.551 -0.537 . . . . 73.52 109.551 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 95.4 t -120.51 121.56 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.814 0.845 . . . . 61.41 110.017 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.26 71.3 2.96 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.084 0.553 . . . . 72.42 111.191 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.91 6.6 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 123.844 0.858 . . . . 72.04 111.392 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.69 144.62 78.8 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.778 2.318 . . . . 65.42 112.299 167.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.1 -31.5 30.89 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.027 1.121 . . . . 54.54 114.027 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.58 -49.22 72.02 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.439 0.696 . . . . 72.24 112.446 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.353 0.661 . . . . 72.21 111.916 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 103' ' ' CYS . 25.0 t -71.76 -34.64 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.714 -0.675 . . . . 55.04 111.43 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -67.4 -31.19 71.25 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 122.58 0.352 . . . . 74.13 111.391 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -67.57 -21.66 65.43 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-O 121.382 0.61 . . . . 60.25 111.293 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.09 -50.03 6.65 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.061 0.944 . . . . 61.23 112.838 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.2 m -93.98 -26.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.703 1.001 . . . . 72.32 113.703 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.64 -11.85 66.19 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.384 1.313 . . . . 60.23 116.384 -165.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 4.6 m-20 -79.65 -14.03 59.08 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.939 0.496 . . . . 70.31 111.862 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 72.31 -59.05 0.57 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.163 1.385 . . . . 74.41 111.257 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -62.51 -18.34 61.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.295 1.038 . . . . 35.23 113.248 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -79.94 7.36 9.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.92 0.888 . . . . 74.32 112.722 -167.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.52 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 14.1 tt -61.7 -23.49 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 123.575 0.75 . . . . 63.4 112.082 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.647 ' HA ' HG11 ' A' ' 34' ' ' VAL . 39.5 p-80 -70.67 -3.9 20.81 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 113.154 0.798 . . . . 55.45 113.154 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 58.6 mtp180 -92.76 -25.51 18.15 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.02 0.928 . . . . 55.15 112.724 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.0 p-90 -127.14 -34.48 2.32 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.246 1.202 . . . . 75.02 114.246 -171.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 33.6 t-80 -78.68 139.08 58.23 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 117.969 0.35 . . . . 71.02 110.932 -170.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.57 -37.75 3.87 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.136 1.891 . . . . 54.52 113.965 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.414 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 4.3 mp0 -78.21 -22.82 47.94 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.522 0.564 . . . . 62.21 112.522 -172.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 28' ' ' HIS . 9.4 p -61.71 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.352 0.596 . . . . 74.25 112.549 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -115.92 28.36 8.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.026 0.93 . . . . 74.23 111.673 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 61.4 96.83 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.071 0.948 . . . . 54.43 110.677 -170.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.23 158.46 15.09 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.594 2.196 . . . . 74.23 114.175 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -104.87 127.3 52.64 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.31 1.044 . . . . 72.34 109.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.3 mm? -99.76 115.96 30.74 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.466 0.707 . . . . 75.24 110.689 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 52' ' ' VAL . 31.4 mmt180 -83.85 119.23 24.61 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.886 -0.413 . . . . 75.4 109.886 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.8 -167.47 0.01 OUTLIER Glycine 0 CA--C 1.545 1.939 0 N-CA-C 117.85 1.9 . . . . 64.01 117.85 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 76.07 -47.16 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 125.714 1.606 . . . . 63.44 115.141 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m 91.74 144.25 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 C-N-CA 126.825 2.05 . . . . 62.24 109.983 -162.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.95 -37.86 93.24 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.842 3.028 . . . . 61.21 116.244 -167.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -85.25 -13.91 48.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.371 0.508 . . . . 74.23 112.371 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -80.72 123.51 82.44 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.446 0.698 . . . . 70.02 111.46 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -48.84 98.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.632 2.888 . . . . 55.33 113.568 171.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.87 -14.71 2.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.089 -0.505 . . . . 53.13 112.992 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -67.09 122.37 17.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.53 0.732 . . . . 75.34 111.211 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.6 mt-10 -102.65 117.59 34.99 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.71 0.404 . . . . 71.41 111.484 -172.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 46.7 ttp180 -92.94 103.19 15.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.559 0.744 . . . . 72.43 110.763 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 62' ' ' VAL . 20.6 t -112.6 99.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.755 . . . . 75.4 110.242 -171.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -63.18 -48.97 76.13 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.708 1.003 . . . . 65.31 113.708 -168.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.01 52.91 0.61 Allowed Glycine 0 N--CA 1.478 1.466 0 N-CA-C 112.374 -0.291 . . . . 32.5 112.374 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.746 0.818 . . . . 44.34 112.994 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.53 33.36 3.63 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 115.965 -0.561 . . . . 72.4 113.529 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -120.61 177.69 4.97 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 123.577 0.751 . . . . 74.23 110.73 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.82 -55.27 13.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.811 0.444 . . . . 71.1 111.291 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -115.74 89.9 3.21 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.446 0.698 . . . . 65.34 110.997 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.17 163.55 12.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.975 0.91 . . . . 74.12 111.268 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -116.8 119.43 35.41 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.351 0.661 . . . . 70.53 110.122 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 48.9 t -104.51 114.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.42 0.688 . . . . 65.31 110.194 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 83.3 mt-10 -101.22 169.7 8.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.6 1.16 . . . . 74.53 110.578 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -151.02 126.34 10.01 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.422 0.689 . . . . 75.44 110.801 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.52 127.4 32.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.975 0.91 . . . . 51.34 111.144 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.92 -40.35 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.301 0.64 . . . . 73.43 111.345 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -167.28 153.59 8.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.961 0.905 . . . . 54.02 109.835 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 153.08 35.87 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.203 0.601 . . . . 64.13 110.598 170.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.87 135.18 35.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 74.32 110.639 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.57 -57.65 3.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.608 0.763 . . . . 73.12 112.501 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.6 m -76.43 -14.83 60.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.937 0.717 . . . . 25.43 112.937 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.87 30.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.182 0.593 . . . . 55.51 111.165 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.48 36.92 18.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.868 1.267 . . . . 63.43 111.271 -176.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -110.23 97.02 6.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.14 0.976 . . . . 74.4 111.889 -166.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 14.6 tp -98.67 108.03 20.62 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.8 1.24 . . . . 65.32 110.215 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.9 t -108.97 121.68 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.055 0.942 . . . . 72.44 111.527 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -135.98 179.72 6.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.514 0.673 . . . . 71.14 112.209 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 t -133.6 163.15 30.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.117 1.367 . . . . 74.41 109.598 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.2 mtp -112.39 88.38 10.76 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 123.447 0.699 . . . . 75.12 109.377 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 49.4 Cg_endo -65.51 -24.57 56.26 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.603 2.869 . . . . 70.53 113.62 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 22.1 t70 -135.44 78.4 51.02 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 122.786 0.434 . . . . 74.11 110.447 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 61.4 Cg_endo -95.99 143.22 1.05 Allowed 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.133 2.555 . . . . 74.13 113.864 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 3.0 Cg_exo -79.61 28.16 0.52 Allowed 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.943 2.428 . . . . 73.41 112.907 169.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.17 152.83 51.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.645 1.178 . . . . 71.12 110.008 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.31 41.11 0.74 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.629 2.886 . . . . 62.1 114.236 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -109.85 124.37 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 124.178 0.991 . . . . 64.13 110.743 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 8.9 m -68.25 -68.44 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.976 0.51 . . . . 75.12 112.156 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -118.71 110.08 16.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.255 0.55 . . . . 65.23 109.627 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 58.7 t-80 -85.67 150.2 24.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.026 0.531 . . . . 72.23 111.334 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -152.62 117.36 5.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.842 0.857 . . . . 73.13 110.081 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -118.48 149.75 40.75 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.609 0.596 . . . . 74.1 112.609 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 94' ' ' GLU . 61.4 t -135.02 137.26 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.353 1.061 . . . . 71.1 109.492 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -114.52 108.88 17.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.032 1.333 . . . . 74.03 107.46 -178.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' A' ' 92' ' ' VAL . 40.3 mt-10 -124.4 114.39 19.44 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.241 0.928 . . . . 53.32 111.875 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -89.09 109.06 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.745 -0.835 . . . . 75.14 108.745 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.9 117.9 66.79 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.117 0.967 . . . . 45.12 110.329 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 88.17 0.99 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.449 2.099 . . . . 53.33 111.902 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -34.54 78.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.059 0.943 . . . . 64.41 110.414 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.8 t70 -149.42 165.53 31.81 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.995 1.318 . . . . 53.13 109.042 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.13 -43.97 97.66 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.521 0.728 . . . . 72.41 111.897 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -91.87 -19.93 21.97 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.548 0.739 . . . . 64.02 110.835 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 91.3 m-70 -127.34 138.43 53.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 72.12 111.833 -170.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -126.43 174.94 8.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.57 0.748 . . . . 73.43 110.517 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -137.01 111.01 8.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.518 0.727 . . . . 54.52 109.964 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -87.97 115.37 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.252 0.549 . . . . 70.02 110.222 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -105.81 111.84 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.826 1.25 . . . . 60.1 110.553 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -103.62 113.9 27.76 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 109.24 -0.652 . . . . 74.31 109.24 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.5 m -114.21 141.32 47.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.631 1.172 . . . . 51.52 110.054 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.65 112.18 4.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.066 0.546 . . . . 61.51 112.142 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -118.56 142.53 47.52 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.456 1.102 . . . . 75.54 110.299 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.66 153.1 33.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.532 0.733 . . . . 64.32 111.761 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 31.3 t70 -80.71 86.39 5.94 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.144 0.497 . . . . 64.12 110.021 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 36.5 t -151.39 157.77 42.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.457 -0.792 . . . . 73.11 111.979 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m -61.9 146.49 91.24 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 123.835 0.854 . . . . 73.42 112.351 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -60.98 -28.96 87.09 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.051 2.501 . . . . 61.34 113.867 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.14 -35.26 77.81 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.902 0.481 . . . . 73.42 112.074 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.405 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 19.0 m -74.8 -40.63 61.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.216 0.532 . . . . 71.53 110.071 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.97 81.98 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.135 -0.939 . . . . 41.21 112.826 -174.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.9 -33.82 72.7 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.922 0.489 . . . . 62.24 111.24 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.96 -41.52 97.54 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.056 -0.52 . . . . 54.14 109.735 171.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.53 -26.79 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.359 0.664 . . . . 73.2 112.313 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 118.615 0.643 . . . . 61.02 110.428 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 m -69.23 -59.68 2.86 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 115.691 -0.686 . . . . 65.4 111.896 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.0 -56.97 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.651 0.78 . . . . 65.5 112.483 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.2 -48.44 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.647 0.379 . . . . 53.44 110.581 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.6 -48.07 81.11 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 114.509 0.564 . . . . 71.5 114.509 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -101.23 -53.61 2.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.989 -0.712 . . . . 63.02 111.646 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.28 -22.75 69.49 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 115.399 0.92 . . . . 71.05 115.399 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -111.92 -54.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 117.548 0.674 . . . . 74.25 111.196 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 10.7 m-30 -72.8 -59.92 2.48 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.292 0.637 . . . . 62.31 112.092 -173.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -57.84 -36.31 72.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 123.39 0.431 . . . . 65.25 111.484 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.69 -50.4 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 124.221 1.008 . . . . 61.5 111.956 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.84 97.75 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.178 -0.465 . . . . 70.22 113.103 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.49 -36.09 81.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.371 1.069 . . . . 64.23 111.946 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.91 -43.9 74.26 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.694 0.397 . . . . 74.53 110.47 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.4 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.219 0.608 . . . . 31.01 111.599 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.98 -42.58 97.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.641 0.776 . . . . 73.33 110.397 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 144' ' ' LEU . . . -71.76 -29.59 64.67 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.325 0.491 . . . . 62.52 112.325 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 48.4 mt-10 -70.2 -41.32 73.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.459 0.703 . . . . 64.24 112.453 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.472 0.545 . . . . 64.32 112.472 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -87.16 -34.41 19.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.762 0.425 . . . . 75.14 112.133 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.73 51.12 0.02 OUTLIER Glycine 0 N--CA 1.48 1.586 0 N-CA-C 115.181 0.832 . . . . 63.2 115.181 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 80.9 mtp180 50.49 52.74 14.22 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 124.107 0.963 . . . . 65.2 113.152 172.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.644 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 10.0 mp 64.68 -85.32 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.669 1.187 . . . . 64.34 110.9 -170.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.95 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.377 0.671 . . . . 70.3 109.747 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -149.21 165.04 33.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.374 1.069 . . . . 74.23 110.348 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.5 t60 72.95 -15.82 0.5 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.197 1.184 . . . . 73.21 114.197 169.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.6 p80 50.18 -177.84 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.117 1.767 . . . . 64.21 112.958 -168.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -134.59 -177.92 4.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 75.12 113.044 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -71.03 -0.96 10.6 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.565 1.146 . . . . 75.4 113.495 -169.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 p80 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 123.74 0.816 . . . . 75.43 110.943 -176.138 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.821 0.343 . . . . 71.52 110.667 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.5 6.62 46.46 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.659 0.784 . . . . 73.43 111.57 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 110' ' ' MET . 66.8 m -113.92 111.13 21.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.059 0.943 . . . . 75.45 109.442 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.24 137.32 36.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.21 1.004 . . . . 75.33 109.366 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -142.76 131.95 23.27 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 120.815 0.341 . . . . 74.22 110.218 168.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -125.38 157.42 36.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.547 1.139 . . . . 65.24 109.54 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.3 p -150.29 151.96 33.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.33 0.652 . . . . 75.22 110.697 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.7 p -148.38 145.2 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.75 0.42 . . . . 64.34 110.998 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -92.29 109.48 20.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.956 0.502 . . . . 65.23 110.996 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 61.0 t -95.14 139.01 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.566 1.146 . . . . 73.54 111.702 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 33.38 0.13 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.0 1.111 . . . . 64.35 114.0 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.06 149.23 34.81 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 123.582 0.753 . . . . 63.25 111.301 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.12 148.67 67.93 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.484 2.789 . . . . 73.41 114.176 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.56 -43.43 56.3 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.899 1.444 . . . . 71.3 114.899 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.22 76.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.223 0.609 . . . . 62.53 112.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.68 -47.04 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.402 1.081 . . . . 73.31 111.636 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' SG ' ' A' ' 103' ' ' CYS . 92.9 t -72.97 -34.91 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.998 0.919 . . . . 72.13 111.75 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.05 -28.5 69.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.819 0.447 . . . . 72.01 111.586 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 m -68.97 -30.78 69.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.168 0.587 . . . . 74.14 111.271 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.3 tp -77.76 -48.97 15.34 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.975 0.91 . . . . 62.3 111.848 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.3 -34.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 113.385 0.883 . . . . 62.41 113.385 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.29 -24.9 74.86 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 114.32 0.488 . . . . 30.1 114.32 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.77 111.31 21.22 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -6.44 47.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.762 1.023 . . . . 72.02 113.762 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -95.84 -8.17 34.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.822 0.449 . . . . 74.04 110.497 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.97 -2.87 36.31 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.751 . . . . 73.32 111.236 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.721 HG23 HG11 ' A' ' 34' ' ' VAL . 20.4 tt -64.16 -26.63 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 123.052 0.541 . . . . 73.13 112.104 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.08 -9.05 57.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 112.822 0.675 . . . . 54.32 112.822 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.91 -28.22 30.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.52 0.728 . . . . 60.43 111.91 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.5 p-90 -116.24 -35.1 4.44 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.739 0.644 . . . . 73.11 112.739 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -84.82 112.65 44.39 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.488 -0.291 . . . . 75.02 110.762 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HD2' ' HA2' ' A' ' 133' ' ' GLY . 38.9 Cg_endo -64.34 -16.39 54.81 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.371 2.714 . . . . 53.23 114.832 -175.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -88.54 -37.66 15.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.041 -0.412 . . . . 74.23 110.693 174.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.721 HG11 HG23 ' A' ' 27' ' ' ILE . 61.6 t -78.2 102.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 120.829 0.347 . . . . 72.0 110.742 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -86.25 -49.88 7.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.203 0.601 . . . . 72.12 111.206 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.36 105.81 0.47 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 123.698 0.799 . . . . 24.1 111.489 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 68.6 Cg_endo -85.53 160.91 10.94 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.0 2.467 . . . . 72.13 113.842 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.4 m -103.95 120.98 42.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.848 0.859 . . . . 64.01 110.638 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.09 120.23 29.24 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.282 0.633 . . . . 73.24 110.929 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -108.24 120.63 42.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.896 0.879 . . . . 74.42 109.681 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.74 173.66 0.01 OUTLIER Glycine 0 CA--C 1.558 2.754 0 N-CA-C 119.045 2.378 . . . . 75.12 119.045 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 74.61 -39.29 0.41 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.94 1.829 . . . . 73.25 115.94 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m 87.11 135.48 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.843 0 C-N-CA 126.343 1.857 . . . . 71.11 111.555 -171.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.11 -25.37 45.26 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 124.473 3.449 . . . . 72.01 116.835 -166.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -85.32 -28.2 25.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.075 0.398 . . . . 73.43 112.075 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.7 m -81.38 123.83 80.92 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 123.834 0.853 . . . . 73.43 112.084 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 109.75 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 124.151 3.234 . . . . 53.52 114.206 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.24 -21.64 3.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.222 -0.445 . . . . 72.14 112.953 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 125.57 24.75 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.321 0.86 . . . . 43.12 113.321 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 37.3 mt-10 -104.61 137.43 42.45 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.224 0.61 . . . . 65.23 109.398 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -127.26 133.29 50.2 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.585 1.084 . . . . 63.3 111.122 167.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.51 107.66 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.553 -0.749 . . . . 60.05 109.877 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -70.77 79.87 0.61 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.406 1.082 . . . . 62.43 110.632 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.74 -65.68 0.59 Allowed Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.907 -0.588 . . . . 40.33 111.93 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.39 101.97 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.052 1.341 . . . . 55.12 113.349 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.13 66.5 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-O 121.27 0.372 . . . . 22.15 113.57 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -116.41 -162.1 0.83 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.5 1.12 . . . . 74.55 111.304 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.6 -52.33 6.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.475 0.71 . . . . 73.44 111.28 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 85.77 2.44 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.245 0.618 . . . . 74.11 111.138 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -112.19 155.72 23.5 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.189 0.518 . . . . 73.3 111.12 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 ' SD ' ' A' ' 79' ' ' MET . 57.4 tp -120.48 122.55 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.793 -0.817 . . . . 70.03 108.793 172.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 55.3 t -95.33 117.72 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.426 -0.953 . . . . 74.05 108.426 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 2.1 tt0 -114.22 162.73 16.17 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.446 0.698 . . . . 71.54 110.011 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 4.6 tmt_? -151.45 125.12 9.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.408 0.683 . . . . 73.51 110.193 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.9 tp -82.23 127.74 33.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.802 0.841 . . . . 72.34 110.575 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.511 HG21 ' NH1' ' A' ' 90' ' ' ARG . 95.1 t -95.92 -44.46 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.313 0.645 . . . . 73.32 111.188 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -160.63 148.15 15.9 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.974 0.91 . . . . 71.13 110.163 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -124.3 109.65 13.62 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.421 -0.585 . . . . 73.34 109.421 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.56 125.59 41.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.193 0.997 . . . . 74.22 109.125 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.18 -15.76 14.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.043 -0.41 . . . . 71.54 111.887 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 m -65.94 -39.66 90.69 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.374 0.669 . . . . 54.03 111.899 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.4 4.02 18.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.259 1.023 . . . . 62.14 111.415 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 80.2 mtt-85 53.23 64.03 2.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.505 1.122 . . . . 71.15 111.11 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -129.11 111.55 13.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.072 0.949 . . . . 73.5 111.029 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 19.8 tp -104.23 105.63 15.85 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.482 0.713 . . . . 72.31 110.961 -173.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.1 t -101.07 124.32 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 123.852 0.861 . . . . 72.13 111.711 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -153.0 -178.01 6.65 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.484 0.659 . . . . 74.13 112.597 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 t -153.11 159.85 42.83 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.737 1.215 . . . . 52.42 110.348 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.44 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.6 ptt? -109.96 103.23 53.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.08 0.552 . . . . 75.43 109.758 171.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 79' ' ' MET . 36.8 Cg_endo -62.59 -29.39 78.08 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.443 2.762 . . . . 73.43 113.726 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.1 m-20 -123.09 83.58 51.14 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 122.995 0.518 . . . . 54.31 110.659 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -88.98 147.08 5.59 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 123.154 2.569 . . . . 75.12 113.214 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -81.85 0.12 10.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.515 2.143 . . . . 75.02 112.671 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.83 141.75 23.36 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.196 0.999 . . . . 74.31 110.535 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' ' 117' ' ' THR . 63.2 Cg_endo -71.1 81.99 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.647 2.231 . . . . 73.14 113.165 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.8 pt -133.04 151.85 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.428 1.091 . . . . 74.11 110.031 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 20.8 m -91.66 -85.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.517 0.327 . . . . 74.35 111.164 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.65 111.82 24.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.938 -0.477 . . . . 61.51 110.369 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -92.57 143.75 26.03 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.585 0.754 . . . . 74.43 111.796 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.511 ' NH1' HG21 ' A' ' 66' ' ' VAL . 10.4 tpp180 -148.54 117.02 6.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.485 1.114 . . . . 72.15 108.899 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.41 148.27 48.86 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.81 0.444 . . . . 43.25 111.36 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 85.3 t -134.98 136.0 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 124.489 1.116 . . . . 71.35 110.355 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.39 111.17 18.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.146 0.978 . . . . 72.2 110.1 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG12 ' A' ' 92' ' ' VAL . 36.2 mt-10 -115.11 157.82 23.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.386 1.074 . . . . 74.52 111.614 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.96 111.08 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.279 0.632 . . . . 63.51 109.656 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.8 117.46 60.63 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 124.751 1.22 . . . . 74.14 110.651 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.12 133.59 25.25 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.722 2.281 . . . . 63.11 113.901 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.26 -55.72 2.28 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.407 1.083 . . . . 64.12 110.083 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.5 t70 -126.15 169.18 13.08 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.883 1.273 . . . . 70.23 109.723 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.27 -41.32 79.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.594 0.758 . . . . 70.52 112.035 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -106.05 10.04 32.27 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 123.312 0.645 . . . . 75.24 111.502 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 70.0 m80 -139.79 140.19 36.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 64.31 111.657 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.0 p -136.37 178.53 6.99 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.342 0.657 . . . . 71.14 110.221 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m -135.76 113.58 11.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.039 0.536 . . . . 61.05 111.039 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.2 107.53 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 109.628 -0.508 . . . . 73.22 109.628 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.74 99.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.085 0.954 . . . . 65.42 109.772 -174.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -103.5 118.82 37.61 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.292 0.567 . . . . 72.4 110.563 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.528 HG22 ' SD ' ' A' ' 110' ' ' MET . 34.6 m -119.58 139.86 51.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.823 1.249 . . . . 71.24 110.207 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.11 113.25 6.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.31 0.644 . . . . 72.12 111.326 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.528 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -124.0 127.76 48.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.921 0.888 . . . . 73.02 110.239 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -146.07 156.01 43.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.895 0.878 . . . . 74.01 110.904 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 35.3 t70 -83.09 82.78 8.1 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.47 0.652 . . . . 60.04 110.142 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.662 ' HB2' HG22 ' A' ' 86' ' ' ILE . 51.9 t -120.52 149.87 41.73 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.244 -0.889 . . . . 64.21 111.327 178.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 128.35 93.75 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-O 118.225 -0.893 . . . . 54.34 110.451 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -39.68 -40.57 2.36 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 124.903 3.735 . . . . 75.5 116.725 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.49 -52.07 59.76 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.313 0.578 . . . . 75.53 110.578 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 85' ' ' PRO . 71.3 m -68.57 -30.55 69.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.53 -0.759 . . . . 70.01 111.376 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.27 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.509 0.724 . . . . 63.34 111.912 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -71.97 -28.47 63.45 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 122.845 0.458 . . . . 71.35 111.143 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.08 -42.34 97.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.483 0.713 . . . . 63.22 110.238 170.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -74.99 -23.26 58.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.696 0.798 . . . . 71.44 111.688 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -60.71 -37.96 83.45 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.971 0.351 . . . . 72.54 110.481 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.2 m -73.06 -48.49 35.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.215 0.606 . . . . 74.4 112.538 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.9 -54.04 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 112.767 0.654 . . . . 74.21 112.767 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.57 -52.28 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.29 0.636 . . . . 44.24 111.146 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.59 -68.39 1.63 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 114.043 0.377 . . . . 72.44 114.043 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.305 0.642 . . . . 64.22 111.075 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.89 -96.72 0.26 Allowed Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.644 -0.531 . . . . 52.51 112.834 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.38 -49.22 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.574 1.149 . . . . 71.31 113.616 -171.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.17 -61.13 1.9 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.664 -0.698 . . . . 72.44 111.644 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.86 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.252 0.464 . . . . 62.34 112.252 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.45 -50.51 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.775 0.83 . . . . 53.51 111.431 171.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 32' ' ' PRO . . . -68.96 -37.74 83.77 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.058 -0.519 . . . . 52.34 113.287 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.62 -41.96 78.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.448 1.099 . . . . 71.22 111.778 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.52 -43.16 94.92 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.594 0.358 . . . . 74.51 110.843 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.35 -31.32 72.48 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.814 0.446 . . . . 63.41 112.055 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.52 -45.8 71.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.177 0.591 . . . . 65.03 109.682 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.95 95.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.483 0.713 . . . . 73.34 112.024 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.35 -40.18 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.956 . . . . 63.13 112.941 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -61.91 -36.11 80.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.756 0.65 . . . . 74.45 112.756 -172.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.24 -28.16 59.77 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.973 0.509 . . . . 73.13 111.947 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.83 -1.03 68.17 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 116.491 -0.322 . . . . 72.13 113.116 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 58.21 30.37 19.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.805 1.242 . . . . 74.53 111.489 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.1 mp 67.77 114.68 0.04 OUTLIER 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.242 1.817 . . . . 64.43 111.689 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -55.57 5.3 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.424 0.69 . . . . 64.23 111.082 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -155.59 32.97 0.36 Allowed 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.024 0.53 . . . . 74.44 110.998 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.6 m80 66.34 -178.83 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 124.479 1.112 . . . . 65.33 112.97 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -114.28 23.29 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.205 0.602 . . . . 73.43 111.98 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.2 m80 71.67 -67.43 0.26 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 125.633 1.573 . . . . 71.12 113.65 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 81.9 t60 68.73 95.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.539 1.136 . . . . 72.34 110.672 -167.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 124.78 1.232 . . . . 74.24 112.374 178.148 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.88 0.372 . . . . 64.33 111.631 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.29 39.21 3.96 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.918 0.887 . . . . 60.52 109.979 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.4 m -108.73 113.14 25.85 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.587 0.755 . . . . 64.51 111.141 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.31 112.82 24.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.795 1.238 . . . . 55.03 110.511 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -112.57 133.08 54.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 122.02 -0.425 . . . . 70.31 110.43 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 143.53 44.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.168 0.587 . . . . 72.35 109.78 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -143.72 158.63 43.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 64.23 110.605 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.3 p -153.23 143.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.92 0.488 . . . . 62.14 111.222 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.43 108.62 18.58 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.793 -0.447 . . . . 74.21 109.793 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 48.6 t -90.99 128.06 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.643 0.777 . . . . 31.3 110.999 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.74 67.77 3.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.098 0.559 . . . . 65.31 111.36 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.61 153.61 2.82 Favored Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 123.55 0.74 . . . . 62.31 111.692 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.12 126.98 19.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.163 2.576 . . . . 73.43 113.146 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.06 -42.23 8.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.043 1.497 . . . . 61.43 115.043 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.83 85.7 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.771 0.428 . . . . 54.13 112.079 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.34 -36.49 84.29 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.647 0.779 . . . . 72.54 112.028 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -36.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.365 0.666 . . . . 55.25 110.203 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -67.7 -28.93 68.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.506 -0.77 . . . . 73.34 110.841 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.6 m -62.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.142 0.496 . . . . 74.04 111.017 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 30' ' ' TRP . 61.5 tp -70.8 -46.66 62.43 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.17 0.988 . . . . 75.44 111.536 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.57 8.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.681 0.792 . . . . 72.22 112.62 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.98 -9.86 79.81 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 123.282 0.468 . . . . 54.22 113.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-20 -106.7 132.81 52.26 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.294 0.568 . . . . 72.32 109.603 168.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -76.03 -5.99 48.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.737 0.815 . . . . 63.31 111.32 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -93.37 -10.3 35.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.525 0.73 . . . . 44.22 111.415 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -97.45 22.88 8.24 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.442 0.904 . . . . 51.51 113.442 -153.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 34' ' ' VAL . 19.2 tt -81.25 -18.2 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 O-C-N 122.259 -0.276 . . . . 74.24 111.31 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -65.62 -22.36 66.66 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.003 0.521 . . . . 75.03 111.827 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -68.96 -44.91 71.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.399 1.08 . . . . 72.31 112.422 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' HB3' HD21 ' A' ' 20' ' ' LEU . 28.3 p-90 -115.95 -37.64 3.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.153 0.797 . . . . 74.44 113.153 -169.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -83.44 110.72 26.23 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 109.959 -0.386 . . . . 74.42 109.959 -172.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.91 2.03 5.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.019 2.479 . . . . 74.43 116.312 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.755 HE22 HG11 ' A' ' 132' ' ' VAL . 21.6 mp0 -102.74 -19.73 14.63 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.521 0.6 . . . . 60.42 111.866 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 27' ' ' ILE . 57.6 t -70.11 118.86 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-O 121.183 0.516 . . . . 70.33 112.188 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 t -88.61 38.12 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 74.4 111.448 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.2 109.28 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.292 1.437 . . . . 64.31 112.062 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.75 160.69 12.22 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.543 2.162 . . . . 71.43 112.992 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 m -99.53 122.59 42.82 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.213 -0.662 . . . . 74.44 109.213 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.58 122.63 31.52 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.9 -1.148 . . . . 32.44 107.9 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 99.3 mtt180 -110.57 126.15 54.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.725 0.81 . . . . 63.32 111.308 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.72 -176.68 0.01 OUTLIER Glycine 0 CA--C 1.547 2.048 0 N-CA-C 118.102 2.001 . . . . 53.33 118.102 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.48 -92.9 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.082 1.353 . . . . 74.4 112.942 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 t 165.65 147.16 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 125.954 1.702 . . . . 43.51 108.704 -173.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.09 -4.43 6.24 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.515 2.143 . . . . 71.13 114.034 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.04 -10.0 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.7 0.8 . . . . 62.31 112.129 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -108.37 125.69 31.31 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 123.721 0.808 . . . . 52.33 112.143 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 98.9 Cg_exo -48.41 123.65 9.49 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 123.804 3.002 . . . . 73.41 114.081 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.68 -27.77 4.08 Favored Glycine 0 N--CA 1.474 1.21 0 CA-C-N 116.137 -0.483 . . . . 32.14 112.445 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.62 49.49 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.602 0.761 . . . . 73.51 112.548 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 45.1 mt-10 -130.21 120.74 24.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.819 0.447 . . . . 72.34 111.622 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' NH2' ' HB ' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -92.67 120.73 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.613 -0.884 . . . . 74.15 108.613 175.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.65 98.52 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.679 -0.638 . . . . 62.43 110.652 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -59.69 121.57 11.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 74.41 111.91 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.68 -51.45 4.57 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.967 -0.352 . . . . 73.35 112.886 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.83 33.86 23.79 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.353 1.061 . . . . 74.45 113.041 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.68 -24.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.971 -1.013 . . . . 70.34 111.74 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.6 p -63.13 141.1 58.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.6 0.76 . . . . 72.11 111.006 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.56 -30.98 65.68 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.352 0.661 . . . . 62.12 112.183 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -110.82 66.93 0.63 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.33 0.652 . . . . 71.4 110.392 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 164.16 23.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.193 0.521 . . . . 74.45 111.798 171.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 79' ' ' MET . 56.2 tp -133.92 131.24 38.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.694 0.797 . . . . 62.22 109.745 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.6 125.68 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.43 109.928 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.677 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 32.2 mt-10 -118.37 126.53 52.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.551 0.74 . . . . 73.2 109.19 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -101.96 133.48 46.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.193 0.997 . . . . 75.14 111.322 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 13.4 tp -75.64 112.1 11.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.332 1.453 . . . . 72.14 111.089 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.29 -52.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.221 0.608 . . . . 72.32 111.328 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.72 154.72 22.79 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.098 -0.501 . . . . 71.1 111.181 -172.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.751 ' HE ' HD13 ' A' ' 75' ' ' LEU . 19.4 tpp85 -140.15 123.99 17.41 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.486 0.715 . . . . 74.41 111.201 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 12.4 m-20 -122.45 76.41 1.32 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.561 0.745 . . . . 71.13 110.356 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.53 -18.5 65.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 112.959 0.726 . . . . 65.41 112.959 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -46.5 76.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.246 0.619 . . . . 54.02 110.723 169.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.67 -2.35 58.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.064 0.946 . . . . 63.42 112.967 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 59.51 51.26 6.66 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.182 0.993 . . . . 74.52 111.182 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 28.6 ttm-85 -126.9 132.63 50.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.202 1.001 . . . . 74.23 110.364 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.751 HD13 ' HE ' ' A' ' 68' ' ' ARG . 6.1 tp -130.54 108.51 9.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.985 0.914 . . . . 73.52 109.954 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -106.57 129.65 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.592 0.757 . . . . 72.41 110.005 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.97 178.55 8.83 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.501 0.667 . . . . 74.41 112.759 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -149.57 141.84 24.14 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.199 1.399 . . . . 44.4 109.724 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 61' ' ' LEU . 61.1 mtm -94.44 104.54 14.28 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 119.055 0.843 . . . . 73.35 111.064 174.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.52 -24.48 22.22 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.638 2.225 . . . . 64.05 112.716 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -126.34 78.84 71.16 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 123.545 0.738 . . . . 62.23 110.828 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.74 147.55 5.9 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 C-N-CA 122.885 2.39 . . . . 73.53 113.211 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 61' ' ' LEU . 65.3 Cg_endo -84.76 1.89 8.32 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.684 2.256 . . . . 74.44 112.655 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.1 155.44 36.46 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.224 1.009 . . . . 73.25 110.321 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.78 57.11 4.93 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.011 2.474 . . . . 64.13 112.898 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.3 pt -121.95 134.63 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.564 1.146 . . . . 72.12 109.619 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 37.5 m -75.0 -81.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.193 0.442 . . . . 64.15 112.193 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -78.11 -56.34 4.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -172.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.08 127.58 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.745 1.618 . . . . 72.4 113.738 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -123.93 153.54 41.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.076 1.35 . . . . 73.2 108.366 169.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.4 135.71 12.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 72.11 110.528 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.7 p -136.85 138.61 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 N-CA-C 113.242 0.83 . . . . 73.4 113.242 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.5 mm? -104.66 119.4 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.845 1.258 . . . . 71.54 109.235 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -123.86 110.1 14.44 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.673 -0.491 . . . . 71.32 109.673 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.63 110.01 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.491 -0.559 . . . . 71.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.87 111.18 63.87 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.023 0.929 . . . . 64.51 110.385 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.28 109.92 1.89 Allowed 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.791 2.327 . . . . 45.34 113.005 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.438 ' H ' ' HA ' ' A' ' 103' ' ' CYS . 39.5 mmt180 -75.74 -46.65 29.76 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.525 0.679 . . . . 74.53 109.761 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -122.79 -166.23 1.41 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.84 1.256 . . . . 74.3 109.276 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -81.68 -35.35 29.97 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.717 0.407 . . . . 72.44 110.938 167.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -108.85 13.23 25.02 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.106 0.563 . . . . 75.32 111.587 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -142.1 152.56 43.38 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.747 0.819 . . . . 70.1 109.637 172.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -153.34 177.62 10.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.024 0.529 . . . . 42.32 111.738 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 82.3 m -133.99 111.86 10.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.832 0.853 . . . . 72.42 109.986 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.89 116.87 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.469 -0.567 . . . . 51.21 109.469 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.11 105.89 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.795 0.838 . . . . 75.12 109.513 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -102.97 116.96 33.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.23 -1.026 . . . . 71.52 108.23 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 152.8 46.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.707 0.803 . . . . 65.33 109.928 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 155.32 47.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.118 1.367 . . . . 73.23 109.596 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -163.47 126.11 2.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.039 0.936 . . . . 54.02 109.688 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 p90 -141.31 156.01 45.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.332 0.653 . . . . 75.41 112.023 -165.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 38.4 t70 -84.97 86.98 7.33 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.499 0.666 . . . . 74.44 110.316 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.9 t -145.59 165.22 29.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.92 -1.036 . . . . 62.12 110.861 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.1 p -68.53 148.82 98.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 123.18 0.592 . . . . 64.14 111.687 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.93 -22.16 68.59 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.298 1.999 . . . . 72.11 112.78 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -65.83 -43.72 87.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.01 0.924 . . . . 74.32 111.312 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.499 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 23.5 m -84.33 -31.16 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.091 0.557 . . . . 65.41 111.068 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -64.62 -33.92 77.05 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.54 0.736 . . . . 63.14 112.226 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -65.73 -33.85 76.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.107 0.563 . . . . 73.51 111.402 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.61 -38.74 73.99 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.721 0.809 . . . . 75.23 109.961 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.9 -24.84 61.72 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.287 -0.869 . . . . 71.32 111.828 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 51.3 mt-10 -61.61 -39.13 90.17 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 117.956 0.343 . . . . 72.21 110.362 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -66.75 -55.67 13.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.536 0.734 . . . . 53.55 112.102 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.53 -55.03 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.463 0.705 . . . . 71.13 112.708 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.3 mt -82.53 -58.17 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.536 -0.757 . . . . 65.43 111.099 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.71 -50.03 32.96 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 114.973 0.749 . . . . 25.31 114.973 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.75 -25.24 21.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.14 0.576 . . . . 60.44 111.177 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.07 -88.51 0.67 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.13 -0.486 . . . . 64.24 112.038 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.09 -47.01 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 124.559 1.144 . . . . 33.43 113.366 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -77.84 -50.14 12.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.106 0.562 . . . . 73.01 112.159 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.19 81.63 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.243 0.339 . . . . 71.31 111.063 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.755 HG11 HE22 ' A' ' 33' ' ' GLN . 8.1 t -56.8 -50.3 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.225 0.61 . . . . 63.45 112.047 174.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.64 -48.68 82.96 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 123.508 0.505 . . . . 63.32 113.391 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 mt -69.99 -37.37 75.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.78 0.832 . . . . 72.11 112.959 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.46 -52.04 50.49 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 110.261 -0.274 . . . . 65.53 110.261 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.14 69.62 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.287 0.635 . . . . 42.11 111.8 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.437 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.0 tt -68.23 -45.99 71.77 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.484 0.714 . . . . 71.14 110.18 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -28.17 64.4 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 112.082 0.401 . . . . 64.3 112.082 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.73 -44.78 48.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.121 0.968 . . . . 63.22 111.635 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 12.8 ptm180 -63.8 -29.34 70.55 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.133 0.573 . . . . 63.43 112.152 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.3 -22.06 38.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.974 0.731 . . . . 72.41 112.974 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.65 -42.18 0.1 Allowed Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.225 0.85 . . . . 50.34 115.225 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? 69.94 16.95 7.58 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 124.867 1.267 . . . . 73.23 111.983 -169.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.34 47.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 63.11 109.448 167.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.08 -169.5 1.71 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.42 1.088 . . . . 70.35 111.931 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -58.79 -14.47 8.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.305 1.042 . . . . 73.25 113.712 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.2 m80 72.45 89.0 0.1 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.339 1.455 . . . . 74.04 111.137 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -77.29 -3.59 40.67 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.728 -1.124 . . . . 73.13 112.156 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 63.6 -79.46 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.352 1.461 . . . . 71.21 112.508 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.4 -60.42 1.53 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.686 . . . . 71.33 110.98 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.369 0.604 . . . . 74.13 109.928 -174.114 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.638 0.256 . . . . 74.14 110.826 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.42 21.7 9.8 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.989 0.916 . . . . 71.54 110.37 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.6 m -111.49 119.33 38.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.353 1.061 . . . . 73.54 110.039 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.0 139.78 31.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.694 1.197 . . . . 65.44 108.701 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -147.46 126.35 12.74 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.021 0.438 . . . . 72.21 111.184 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -130.32 158.27 40.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.05 1.34 . . . . 61.13 110.081 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.8 p -155.1 154.86 33.03 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.246 0.618 . . . . 75.11 112.005 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.5 p -152.17 145.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.086 0.555 . . . . 73.23 111.354 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.56 108.84 19.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 120.996 0.427 . . . . 74.21 110.694 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 137' ' ' LEU . 95.2 t -94.05 137.77 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 63.2 110.411 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -83.16 41.9 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 112.936 0.717 . . . . 64.33 112.936 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.607 ' HA ' HH11 ' A' ' 101' ' ' ARG . . . -142.06 148.18 47.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.675 0.79 . . . . 60.55 110.483 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.23 142.97 93.52 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.412 2.074 . . . . 73.44 112.375 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.08 -33.54 39.8 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.177 1.391 . . . . 74.2 114.503 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.7 69.75 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.082 0.553 . . . . 73.35 112.107 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.99 -39.38 85.52 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.465 0.706 . . . . 73.33 112.139 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG21 ' SG ' ' A' ' 103' ' ' CYS . 65.2 t -70.63 -35.53 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.273 0.629 . . . . 62.13 111.009 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 62.4 t-105 -68.46 -31.52 70.87 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.155 0.582 . . . . 63.12 110.864 176.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.7 m -65.96 -33.27 75.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.354 0.662 . . . . 74.22 110.672 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.7 tp -75.86 -52.79 9.57 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.806 0.842 . . . . 75.43 112.346 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 m -79.38 -32.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 113.124 0.787 . . . . 63.21 113.124 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.77 -31.68 81.61 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 114.544 0.578 . . . . 74.45 114.544 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.73 95.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.025 0.44 . . . . 72.34 109.967 171.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -67.18 -18.06 65.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.308 0.643 . . . . 65.34 112.246 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.6 p -77.57 -27.21 51.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.079 0.552 . . . . 71.11 111.191 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.32 29.13 6.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.857 0.863 . . . . 31.11 111.139 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.604 HG23 HG11 ' A' ' 34' ' ' VAL . 9.2 tt -64.85 -27.13 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 CA-C-N 115.09 -0.959 . . . . 52.52 111.555 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -59.95 -12.36 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.212 1.19 . . . . 73.33 114.212 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -71.24 -24.62 62.22 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.13 0.572 . . . . 70.01 112.502 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.42 ' HB3' HD21 ' A' ' 20' ' ' LEU . 59.1 p-90 -122.51 -31.55 3.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.296 0.638 . . . . 73.02 111.404 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 22.1 t-80 -95.35 104.16 14.63 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.182 0.593 . . . . 72.34 110.206 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.3 -16.32 54.42 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.212 2.608 . . . . 75.21 114.617 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.446 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 48.0 mt-30 -95.25 -11.06 28.61 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.3 0.852 . . . . 61.43 113.3 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 27' ' ' ILE . 56.1 t -75.04 116.48 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 118.346 0.521 . . . . 64.34 110.321 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -87.03 29.79 0.8 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.822 0.849 . . . . 64.25 112.137 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 68.08 121.7 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 125.706 1.602 . . . . 72.31 111.888 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 41.9 Cg_endo -96.26 155.26 1.34 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.024 2.483 . . . . 34.41 115.924 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -101.11 123.56 45.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.976 0.91 . . . . 74.42 109.938 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.21 123.36 28.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.256 0.55 . . . . 71.23 112.33 -172.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 10.3 mmm180 -103.07 121.81 43.36 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.722 1.209 . . . . 63.31 110.214 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.18 -178.53 0.01 OUTLIER Glycine 0 CA--C 1.549 2.18 0 N-CA-C 117.766 1.866 . . . . 53.31 117.766 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . . . 40.27 -98.02 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 126.059 1.743 . . . . 73.41 115.111 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 30.0 t -176.81 149.36 0.85 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 124.461 1.104 . . . . 71.22 110.491 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.33 -11.97 21.71 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.871 2.381 . . . . 53.32 113.587 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -114.72 1.94 14.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.902 0.881 . . . . 74.5 112.498 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.8 m -97.53 117.52 65.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.361 -0.837 . . . . 65.04 110.204 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 22.0 Cg_endo -58.48 92.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.065 2.51 . . . . 72.44 112.752 176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.15 -42.5 0.27 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.279 -0.873 . . . . 54.13 112.115 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . . . -67.58 164.74 18.39 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.908 1.077 . . . . 55.12 113.908 -172.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 33.9 mt-10 -121.62 164.47 17.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.251 1.02 . . . . 62.52 110.097 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -146.68 146.29 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.004 0.43 . . . . 65.2 111.837 168.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 t -117.69 108.11 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.546 0.738 . . . . 72.33 111.158 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -66.27 110.31 2.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.442 1.097 . . . . 74.32 110.633 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.96 -63.33 1.5 Allowed Glycine 0 CA--C 1.539 1.563 0 N-CA-C 112.064 -0.414 . . . . 64.12 112.064 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.88 115.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.743 1.386 . . . . 75.12 114.743 171.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.02 17.97 66.14 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 121.237 0.354 . . . . 62.52 112.698 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 p -94.6 -171.25 2.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.288 . . . . 60.31 109.923 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.34 -26.63 19.86 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 120.811 0.338 . . . . 75.13 110.63 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.33 93.01 2.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.385 0.674 . . . . 62.11 110.116 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.33 -175.72 2.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.417 0.687 . . . . 74.31 111.512 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 83' ' ' PRO . 34.9 tp -135.11 117.76 16.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.719 0.808 . . . . 74.25 110.347 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.98 121.81 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 109.173 -0.677 . . . . 54.44 109.173 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.61 167.19 14.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.424 0.69 . . . . 65.02 109.924 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.511 HH11 ' HA ' ' A' ' 66' ' ' VAL . 3.1 tmt_? -140.7 109.07 5.83 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.088 0.955 . . . . 70.35 109.843 -165.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 29.8 tp -59.46 105.91 0.4 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.159 0.984 . . . . 63.31 110.96 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.511 ' HA ' HH11 ' A' ' 64' ' ' ARG . 89.3 t -78.27 -51.03 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.37 0.668 . . . . 51.12 111.307 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.25 151.45 34.25 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.153 0.581 . . . . 72.54 111.287 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -143.13 130.07 20.57 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.965 0.906 . . . . 61.01 110.479 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 14.7 m-20 -135.94 118.3 15.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.361 1.064 . . . . 72.24 110.466 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 3.9 mp0 -80.77 -36.54 31.72 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.84 0.456 . . . . 74.02 110.267 169.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 m -63.71 -37.61 87.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.893 0.877 . . . . 74.33 112.394 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.5 -12.36 24.25 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.234 0.614 . . . . 63.32 111.733 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 59.46 45.88 13.03 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 71.01 110.006 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 39.0 ttm180 -122.21 123.16 40.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.583 1.553 . . . . 75.15 111.022 -169.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 23.7 tp -123.22 106.64 10.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.501 0.72 . . . . 73.34 110.415 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.1 t -108.21 129.89 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.877 0.871 . . . . 70.43 111.583 -169.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -139.22 172.86 12.22 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 75.24 112.252 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -149.93 139.09 21.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.312 1.445 . . . . 73.11 109.257 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.415 ' SD ' HD11 ' A' ' 61' ' ' LEU . 69.6 mtm -94.66 105.59 19.43 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 118.51 0.595 . . . . 74.23 110.556 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.74 -18.28 22.26 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.006 2.47 . . . . 42.1 112.179 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.6 78.24 68.73 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.869 0.868 . . . . 64.13 109.032 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.84 140.39 16.23 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.684 2.256 . . . . 74.23 112.802 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' HD13 ' A' ' 61' ' ' LEU . 63.4 Cg_endo -85.24 8.41 4.62 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.944 2.43 . . . . 72.14 112.557 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.98 141.38 40.47 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 124.496 1.118 . . . . 75.51 109.383 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.67 88.23 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.578 2.186 . . . . 61.42 113.325 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.8 pt -137.32 168.37 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 125.159 1.383 . . . . 73.42 109.43 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 28.8 m -93.57 -84.02 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.118 0.414 . . . . 71.43 112.118 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -86.26 -45.13 11.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.642 0.608 . . . . 65.42 112.642 -170.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 47.9 t-80 64.66 141.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.736 1.614 . . . . 72.05 113.529 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -150.77 152.73 34.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.403 1.081 . . . . 75.21 108.424 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -160.39 151.09 18.6 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.877 0.471 . . . . 75.23 111.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.78 150.86 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 113.024 0.75 . . . . 72.34 113.024 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -120.63 108.54 14.15 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.639 1.576 . . . . 74.03 107.58 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -126.76 115.1 18.86 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.948 0.499 . . . . 72.21 111.45 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -95.34 126.57 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 122.779 0.432 . . . . 75.51 110.292 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.58 117.72 44.36 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.397 1.079 . . . . 60.35 110.684 -173.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.64 108.23 2.41 Favored 'Trans proline' 0 CA--C 1.568 2.215 0 C-N-CA 122.826 2.351 . . . . 75.54 114.416 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -81.2 -34.73 32.07 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 123.864 0.866 . . . . 71.41 111.767 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 25.6 t70 -156.73 163.2 39.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.311 1.044 . . . . 74.52 109.986 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.04 -23.29 61.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.537 1.135 . . . . 72.33 113.119 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.607 HH11 ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -128.33 5.19 5.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.678 0.791 . . . . 63.52 111.07 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 51.2 m80 -138.51 130.47 28.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.812 . . . . 74.15 110.811 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' HG21 ' A' ' 17' ' ' VAL . 17.3 p -136.33 178.81 6.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.654 0.782 . . . . 65.04 110.226 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.9 m -133.9 118.08 17.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.074 0.55 . . . . 73.35 111.354 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.55 110.92 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.77 -0.456 . . . . 74.44 109.77 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.67 111.86 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.972 0.909 . . . . 63.52 109.633 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -111.32 124.67 52.72 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.912 0.485 . . . . 74.34 109.915 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -127.91 146.28 50.68 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.48 1.112 . . . . 70.21 110.84 -170.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.91 113.8 6.48 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.477 0.711 . . . . 73.43 111.87 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -116.9 125.69 51.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.56 1.144 . . . . 75.2 109.875 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 3.2 p90 -146.79 146.48 30.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.116 0.566 . . . . 71.21 112.521 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.438 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -76.93 86.44 3.47 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.477 0.656 . . . . 72.14 109.617 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.562 ' HB2' HG22 ' A' ' 86' ' ' ILE . 46.5 t -117.86 164.21 15.39 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.907 -1.042 . . . . 73.03 111.828 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -83.95 152.36 62.26 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.546 0.738 . . . . 65.03 110.981 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.41 -62.21 0.48 Allowed 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.956 3.104 . . . . 72.15 115.616 -170.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -31.71 72.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.7 0.8 . . . . 53.41 112.639 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 25.1 m -75.11 -34.31 61.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.315 0.246 . . . . 60.02 111.021 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.21 61.74 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.153 0.581 . . . . 63.15 111.351 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -22.93 66.61 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.259 0.466 . . . . 65.03 112.259 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.34 -41.3 56.98 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.12 0.568 . . . . 74.3 111.298 170.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 mt -75.38 -24.88 57.28 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.109 1.151 . . . . 72.5 114.109 -173.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.39 80.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.558 0.947 . . . . 71.34 113.558 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.9 m -79.31 -44.11 22.29 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.918 0.71 . . . . 62.12 112.918 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.92 -51.22 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.28 0.562 . . . . 75.32 111.87 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.6 mt -81.48 -49.0 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.705 0.802 . . . . 53.41 110.888 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.52 -42.68 95.57 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 114.849 0.699 . . . . 44.51 114.849 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -94.44 -58.95 2.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 122.093 -0.651 . . . . 62.01 110.932 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.95 -18.12 68.37 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.729 1.052 . . . . 45.34 115.729 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.31 -52.27 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 117.644 0.722 . . . . 70.33 110.977 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -74.85 -60.8 2.12 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.53 0.732 . . . . 74.23 112.123 -172.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.77 65.42 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.475 0.485 . . . . 72.42 111.525 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.9 t -52.95 -56.54 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 C-N-CA 124.04 0.936 . . . . 73.14 112.442 171.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.3 -36.68 85.15 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 116.568 -0.287 . . . . 31.43 112.97 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.52 -47.45 81.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.167 0.987 . . . . 74.15 112.039 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.28 -47.71 83.13 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.28 0.632 . . . . 74.32 110.874 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.59 74.15 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.234 0.457 . . . . 63.55 112.234 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.445 HD22 HG21 ' A' ' 10' ' ' VAL . 3.8 tt -67.81 -43.17 80.28 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.01 0.524 . . . . 64.53 110.103 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.74 81.92 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.89 0.476 . . . . 74.13 111.837 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.42 -31.26 60.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.128 0.971 . . . . 71.4 112.905 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -67.15 -29.95 69.79 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.873 0.306 . . . . 73.1 111.337 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -93.42 -5.01 50.31 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.883 0.473 . . . . 71.34 112.196 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.71 24.0 0.8 Allowed Glycine 0 CA--C 1.549 2.21 0 N-CA-C 115.02 0.768 . . . . 70.13 115.02 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -66.75 -25.75 66.65 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.663 1.185 . . . . 63.01 112.492 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 144' ' ' LEU . 2.4 pt? -115.17 -7.78 12.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.597 0.591 . . . . 70.0 112.597 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.59 171.29 8.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.941 1.089 . . . . 75.42 113.941 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -127.49 167.29 16.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 113.904 -1.498 . . . . 74.3 110.669 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 63.45 97.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.866 1.266 . . . . 75.32 111.954 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -117.03 -174.36 2.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.186 0.994 . . . . 72.14 111.39 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 64.69 95.33 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.986 1.314 . . . . 74.14 110.349 -168.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -68.32 123.85 21.87 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.323 0.649 . . . . 63.21 111.774 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.442 0.639 . . . . 55.22 111.681 178.21 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.86 0.362 . . . . 74.2 111.077 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.12 13.77 27.01 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.697 0.799 . . . . 64.11 110.634 170.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -105.99 114.5 28.68 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.806 0.842 . . . . 74.33 110.182 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.36 114.68 26.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.886 1.274 . . . . 75.2 109.833 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -122.47 138.22 54.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.889 0.476 . . . . 72.13 111.968 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -138.96 155.08 48.3 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.934 1.294 . . . . 73.01 109.55 171.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.9 p -149.82 156.99 42.76 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.357 0.663 . . . . 72.11 110.357 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.1 p -145.53 146.09 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 112.084 0.402 . . . . 74.04 112.084 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.43 111.84 23.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.858 0.863 . . . . 62.4 109.71 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 60.7 t -104.29 130.76 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 62.44 110.82 -175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.93 71.54 6.63 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.113 0.482 . . . . 60.22 111.113 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.46 154.12 3.74 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.124 0.97 . . . . 73.42 111.197 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.54 136.17 49.05 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.865 2.376 . . . . 34.32 111.985 168.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.23 17.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.562 1.319 . . . . 71.11 114.562 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.9 -47.69 82.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.19 0.596 . . . . 72.24 112.57 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.47 -43.02 79.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.202 0.601 . . . . 72.15 111.784 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.516 HG21 ' SG ' ' A' ' 103' ' ' CYS . 42.5 t -69.18 -33.79 60.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 115.418 -0.81 . . . . 51.43 111.208 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.444 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 71.9 t-105 -69.54 -31.7 70.06 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 111.751 0.278 . . . . 71.41 111.751 175.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.7 m -64.31 -26.86 68.67 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.659 0.743 . . . . 62.3 110.818 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.446 HD22 HH11 ' A' ' 140' ' ' ARG . 49.2 tp -76.48 -56.33 4.72 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.795 1.238 . . . . 63.43 111.924 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.44 -9.62 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.547 0.943 . . . . 64.45 113.547 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -68.86 -27.9 73.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 113.768 0.267 . . . . 50.51 113.768 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.1 m-20 -80.86 108.57 14.64 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.416 0.686 . . . . 71.32 110.258 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -59.01 -24.81 63.12 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.76 0.824 . . . . 72.22 111.421 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -34.29 26.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.273 1.029 . . . . 75.22 113.086 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -101.56 23.72 10.77 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.529 0.681 . . . . 63.51 111.449 -163.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 HG11 ' A' ' 34' ' ' VAL . 14.9 tt -57.31 -24.79 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.648 1.179 . . . . 65.3 112.463 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -65.56 -5.63 8.65 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.156 1.169 . . . . 71.21 114.156 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -78.72 -27.22 44.88 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.628 0.771 . . . . 72.03 112.416 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -122.31 -29.74 4.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.372 0.669 . . . . 74.35 111.376 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -95.17 111.68 55.78 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.318 0.647 . . . . 61.44 109.976 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.43 -22.01 52.75 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.225 2.617 . . . . 71.12 114.508 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -86.74 -25.11 24.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.146 0.579 . . . . 62.42 112.209 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 27' ' ' ILE . 98.2 t -67.72 120.21 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 121.101 0.477 . . . . 64.31 111.142 177.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -88.51 23.59 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.335 1.054 . . . . 75.35 113.075 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.47 95.26 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 124.476 1.11 . . . . 72.43 110.418 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.71 178.79 4.16 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.319 2.68 . . . . 74.42 115.097 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.9 m -101.88 124.29 47.25 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.351 1.061 . . . . 72.44 110.079 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.85 135.68 48.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.496 0.718 . . . . 71.54 110.314 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.39 156.97 47.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.497 0.719 . . . . 63.25 110.636 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.81 157.96 0.01 OUTLIER Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.79 1.876 . . . . 60.5 117.79 -170.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.44 -98.9 0.09 Allowed 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.74 1.216 . . . . 71.21 113.359 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.9 t 171.3 149.42 0.18 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 125.459 1.504 . . . . 71.5 109.285 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.55 -19.74 18.91 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 123.059 2.506 . . . . 63.33 114.148 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -99.14 -30.26 12.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.515 0.726 . . . . 74.13 111.48 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.3 m -88.63 120.63 70.27 Favored Pre-proline 0 N--CA 1.49 1.554 0 C-N-CA 123.12 0.568 . . . . 62.02 111.071 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.542 ' HG3' ' H ' ' A' ' 68' ' ' ARG . 99.5 Cg_exo -45.77 130.18 12.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.957 3.105 . . . . 73.0 114.814 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.54 -24.21 6.2 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.412 -0.358 . . . . 52.51 113.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.49 49.86 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.49 0.716 . . . . 73.43 112.821 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.29 136.04 43.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.43 0.692 . . . . 74.42 110.716 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -115.36 108.6 16.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.204 1.002 . . . . 53.51 111.53 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 18.7 t -113.38 108.05 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.09 0.556 . . . . 71.15 110.326 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -68.35 -59.07 3.46 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.192 0.997 . . . . 73.4 113.65 -169.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.28 -12.35 84.67 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.82 -0.434 . . . . 54.05 113.477 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 66.62 -73.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.526 1.53 . . . . 63.44 113.281 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.0 44.66 0.7 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 113.492 0.157 . . . . 65.11 113.492 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.3 p -93.83 -118.33 0.09 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.905 0.882 . . . . 72.14 109.855 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -139.81 9.78 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 119.169 0.895 . . . . 71.51 110.849 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -146.57 20.63 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.322 0.649 . . . . 55.14 112.48 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.59 144.64 35.33 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.774 0.797 . . . . 72.11 112.493 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.668 HD13 ' HD3' ' A' ' 83' ' ' PRO . 16.8 tp -103.25 125.48 49.93 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.484 1.114 . . . . 53.41 109.278 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 54.0 t -96.95 114.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.078 -0.712 . . . . 65.14 109.078 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 27.8 tt0 -118.95 166.95 12.22 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.239 1.016 . . . . 74.25 109.584 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -152.2 136.72 16.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.418 0.525 . . . . 64.54 112.418 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.7 tp -77.76 116.96 18.69 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.99 1.316 . . . . 71.53 110.81 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 95.5 t -79.16 -53.01 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.02 0.528 . . . . 33.31 110.52 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -152.89 144.53 23.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.191 0.996 . . . . 72.55 109.748 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' H ' ' HG3' ' A' ' 47' ' ' PRO . 4.2 tmt_? -131.84 112.09 12.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 72.52 107.441 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -114.08 115.13 27.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.001 0.52 . . . . 51.32 110.939 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 29.1 tt0 -83.86 -20.82 32.46 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.787 0.835 . . . . 72.02 111.668 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -68.93 -48.97 61.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.424 0.69 . . . . 74.34 111.936 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.09 2.82 51.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.107 0.563 . . . . 73.52 112.393 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 54.9 52.07 12.57 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.216 1.006 . . . . 72.13 111.943 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.36 119.65 26.72 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.453 1.101 . . . . 63.44 111.123 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 44.4 tp -109.57 106.77 16.61 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.447 1.099 . . . . 74.52 110.426 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.83 128.86 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.79 0.836 . . . . 74.43 111.248 -175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 51.7 p90 -150.83 179.11 8.5 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.827 0.677 . . . . 75.44 112.827 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 t -152.85 158.03 41.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.183 1.393 . . . . 74.2 109.5 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 16.7 ptt? -111.84 100.46 48.67 Favored Pre-proline 0 N--CA 1.485 1.319 0 CA-C-N 118.362 0.528 . . . . 63.42 110.226 169.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.33 -22.79 59.71 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.409 2.74 . . . . 73.32 113.644 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 25.8 t70 -128.75 81.35 70.94 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.396 0.678 . . . . 75.25 109.726 176.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.02 154.54 12.98 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.096 2.531 . . . . 70.24 113.885 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.668 ' HD3' HD13 ' A' ' 61' ' ' LEU . 71.4 Cg_endo -83.25 -4.5 11.06 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.662 2.241 . . . . 70.25 112.532 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.91 154.13 38.37 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.156 0.982 . . . . 74.53 110.757 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HG2' HG21 ' A' ' 117' ' ' THR . 89.8 Cg_endo -79.02 61.49 8.18 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.717 2.278 . . . . 55.43 112.85 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 113' ' ' CYS . 30.4 pt -121.06 167.91 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.289 1.036 . . . . 73.41 110.321 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 84.3 m -103.46 -85.19 0.46 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.793 0.437 . . . . 71.44 110.854 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.73 111.6 23.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.12 0.486 . . . . 73.13 111.115 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 26.5 t-80 -84.84 150.88 24.7 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.639 0.776 . . . . 74.34 111.768 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -154.78 110.28 3.12 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.662 0.785 . . . . 64.51 109.887 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.03 146.27 52.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.567 0.58 . . . . 43.43 112.567 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 40.6 t -134.73 143.98 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.142 0.977 . . . . 63.11 111.553 -173.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -112.65 109.48 19.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.973 1.309 . . . . 73.4 109.238 173.583 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 92' ' ' VAL . 42.3 mt-10 -117.7 112.48 20.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.445 0.566 . . . . 74.12 111.808 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 t -97.37 111.37 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.078 0.551 . . . . 64.33 110.007 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.84 131.26 22.21 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.987 0.915 . . . . 54.33 111.192 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.69 81.63 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.04 2.493 . . . . 74.11 111.965 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -35.46 81.1 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.092 0.957 . . . . 73.41 110.873 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 23.4 t70 -140.47 174.72 10.24 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 125.342 1.457 . . . . 74.34 108.946 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.47 -68.61 0.28 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.489 0.715 . . . . 73.03 111.084 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -81.8 -15.25 54.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.893 0.477 . . . . 72.11 111.775 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.3 m80 -120.1 146.97 45.43 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.864 -0.522 . . . . 72.15 111.385 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 17' ' ' VAL . 28.9 p -132.14 176.02 8.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.358 0.663 . . . . 73.2 109.836 177.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.7 m -130.41 125.09 33.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.175 0.59 . . . . 73.24 110.122 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.28 105.96 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.69 -0.856 . . . . 61.53 108.69 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.91 112.61 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.019 -0.734 . . . . 53.53 109.019 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -102.23 112.52 25.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.761 -0.829 . . . . 75.51 108.761 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 m -113.46 144.14 43.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.203 1.001 . . . . 73.32 109.433 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.18 149.45 36.46 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.871 0.868 . . . . 51.4 109.229 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.37 130.4 8.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.257 1.023 . . . . 74.54 108.585 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 7.8 p90 -148.58 152.03 36.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.12 0.568 . . . . 72.22 111.177 -171.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 13.5 t70 -76.59 85.84 3.27 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.817 -0.629 . . . . 73.43 109.396 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.4 t -120.27 147.63 44.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.009 -0.996 . . . . 75.12 111.026 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -60.19 132.03 90.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-O 118.404 -0.807 . . . . 74.32 110.694 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.56 -46.01 12.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.848 3.032 . . . . 75.11 114.458 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -62.98 -30.85 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.354 1.061 . . . . 64.35 112.426 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.405 HG21 ' HG2' ' A' ' 85' ' ' PRO . 20.0 m -90.7 -31.8 16.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.659 0.784 . . . . 72.4 112.257 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.0 -31.52 71.27 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.737 0.815 . . . . 64.25 112.265 -171.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.93 -34.61 78.37 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.214 1.006 . . . . 63.14 112.167 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.47 -44.41 51.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.228 0.611 . . . . 72.24 110.539 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.5 -23.81 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.429 0.692 . . . . 65.0 110.843 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.26 -52.75 64.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.886 0.874 . . . . 70.41 110.732 170.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.6 m -68.38 -42.69 78.76 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 112.885 0.698 . . . . 71.35 112.885 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.2 -55.05 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.25 0.547 . . . . 64.22 112.019 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -56.99 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.618 0.767 . . . . 74.23 111.323 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.22 -33.22 86.65 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 114.442 0.537 . . . . 52.14 114.442 -175.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -101.72 -61.49 1.38 Allowed 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.043 -0.681 . . . . 65.34 111.388 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.42 68.31 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.566 0.986 . . . . 72.04 115.566 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.78 -54.9 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 117.419 0.609 . . . . 63.24 111.136 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.4 m-30 -73.46 -59.13 2.85 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.067 0.547 . . . . 64.5 112.336 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.76 67.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 123.439 0.462 . . . . 63.15 111.79 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.2 t -62.45 -55.61 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.649 0.78 . . . . 73.33 112.085 171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.84 98.38 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 116.182 -0.463 . . . . 62.52 113.909 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.73 -34.66 72.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.442 0.697 . . . . 75.44 112.27 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.8 m-20 -67.66 -42.16 82.6 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 110.455 -0.202 . . . . 70.41 110.455 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.53 77.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.255 0.622 . . . . 64.43 111.539 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 17' ' ' VAL . 7.5 tt -65.19 -37.46 87.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.696 0.798 . . . . 70.44 110.104 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.36 70.6 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.616 0.366 . . . . 72.41 111.674 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 38.2 mt-10 -68.53 -39.24 81.24 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.183 0.593 . . . . 73.32 112.178 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.446 HH11 HD22 ' A' ' 20' ' ' LEU . 5.4 ptm180 -66.51 -27.81 68.07 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.317 0.488 . . . . 73.2 112.317 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -98.57 -2.94 37.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.365 0.666 . . . . 62.22 111.228 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.92 12.5 57.36 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 123.58 0.609 . . . . 25.03 113.745 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -92.1 -12.22 33.61 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 122.28 -0.541 . . . . 63.33 110.107 166.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.98 -45.01 17.27 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.644 0.778 . . . . 72.51 111.483 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -139.08 27.24 2.38 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 122.815 0.446 . . . . 75.03 111.485 -171.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 68.63 164.69 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.496 1.118 . . . . 75.14 112.438 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -57.88 -48.96 78.3 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.251 0.621 . . . . 74.14 112.418 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 t60 70.27 -60.93 0.48 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.585 1.554 . . . . 52.43 111.245 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -101.8 143.59 31.52 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.168 0.987 . . . . 75.13 109.839 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -133.1 -94.45 0.33 Allowed 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 108.846 -0.798 . . . . 64.32 108.846 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 . . . . . 0 N--CA 1.494 1.773 0 C-N-CA 123.768 0.827 . . . . 74.22 109.968 172.711 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 112.191 0.441 . . . . 23.24 112.191 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.85 71.42 0.58 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.579 1.152 . . . . 74.5 112.235 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.7 m -126.54 128.95 47.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.319 0.648 . . . . 52.55 110.738 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 7.5 mp -105.21 141.63 36.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.174 1.39 . . . . 71.3 108.426 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -150.06 130.8 14.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.321 0.582 . . . . 71.03 111.648 172.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -139.6 152.77 47.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.606 1.162 . . . . 74.44 108.542 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -150.18 161.59 42.1 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.764 0.426 . . . . 65.35 111.378 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 135' ' ' ASN . 9.9 p -148.32 145.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.545 0.572 . . . . 74.32 112.545 -177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -91.24 119.43 31.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.849 0.86 . . . . 73.0 110.766 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.2 131.68 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 124.631 1.173 . . . . 71.04 110.959 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.28 68.79 10.31 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.134 0.492 . . . . 54.44 111.463 173.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.58 142.74 2.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.206 1.002 . . . . 54.34 109.546 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.96 138.44 82.25 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.893 2.396 . . . . 72.2 112.898 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.6 15.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.2 1.4 . . . . 71.34 114.778 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.38 64.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.435 0.694 . . . . 62.52 112.115 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.07 -37.49 82.86 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.721 0.808 . . . . 73.2 112.555 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG21 ' SG ' ' A' ' 103' ' ' CYS . 40.5 t -70.12 -37.42 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.238 0.615 . . . . 75.25 110.757 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -63.53 -31.06 72.11 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.36 -0.836 . . . . 73.31 111.523 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -59.09 -31.88 69.29 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.288 0.566 . . . . 73.53 111.572 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 30' ' ' TRP . 35.4 tp -75.76 -43.01 48.76 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.863 0.865 . . . . 70.15 111.797 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' O ' HD22 ' A' ' 75' ' ' LEU . 19.0 m -95.27 -3.35 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.264 0.839 . . . . 73.11 113.264 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.41 -28.02 60.52 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 123.152 0.406 . . . . 74.4 112.881 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.15 105.38 17.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.326 0.65 . . . . 64.13 110.078 169.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 35.9 t80 -61.61 -29.04 69.79 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.608 0.763 . . . . 71.03 111.348 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -77.74 -21.67 51.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.986 0.914 . . . . 62.51 112.783 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.16 25.84 10.5 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.891 0.477 . . . . 74.23 112.032 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.08 -27.31 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 123.743 0.817 . . . . 72.13 112.282 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.827 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -64.86 -6.74 8.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 114.134 1.161 . . . . 64.23 114.134 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -89.05 -17.58 29.05 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.734 0.642 . . . . 74.31 112.734 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.6 p-90 -129.3 -32.53 1.99 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.36 0.874 . . . . 65.54 113.36 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 17.5 t-80 -78.01 130.63 72.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.51 0.324 . . . . 74.21 110.294 -174.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -79.59 -29.07 3.1 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.721 2.281 . . . . 51.41 114.266 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 31' ' ' HIS . 6.3 mt-30 -93.82 -6.86 44.9 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.222 0.823 . . . . 71.3 113.222 -175.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 28' ' ' HIS . 7.1 p -56.87 128.39 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.518 0 CA-C-O 121.44 0.638 . . . . 71.14 112.19 176.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PHE . 31.7 m -91.62 23.18 3.64 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.078 0.951 . . . . 73.02 112.157 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 60.58 101.91 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 124.699 1.2 . . . . 65.42 111.26 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 37.3 Cg_endo -88.25 161.33 6.99 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.542 2.161 . . . . 32.35 114.386 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.9 m -105.94 123.55 48.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.883 0.873 . . . . 74.15 109.164 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 49' ' ' ALA . 1.6 tm? -88.38 113.59 24.14 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.437 -0.579 . . . . 72.44 109.437 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -99.59 153.13 19.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.949 1.3 . . . . 73.5 110.901 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.19 -126.56 23.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.948 0.78 . . . . 44.41 115.026 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.06 140.58 4.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.256 1.022 . . . . 73.25 113.246 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 m -56.58 158.13 8.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 124.534 1.133 . . . . 73.52 112.917 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.92 162.13 39.27 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.046 1.831 . . . . 74.05 111.283 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 72.75 -42.15 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.877 1.271 . . . . 75.03 112.118 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 m -68.87 123.0 87.06 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 124.395 1.078 . . . . 62.11 111.011 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.49 93.98 0.17 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.127 2.552 . . . . 71.03 113.251 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 -25.61 0.14 Allowed Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.083 -0.508 . . . . 64.22 113.156 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.04 132.78 47.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.32 1.048 . . . . 42.33 113.385 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -117.6 116.57 27.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 64.43 111.355 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 38.1 ptt85 -94.03 119.07 32.4 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.135 0.493 . . . . 74.53 110.107 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 t -114.21 112.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.421 0.688 . . . . 73.31 110.511 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HD2' ' H ' ' A' ' 35' ' ' SER . 8.3 m-85 -68.7 117.45 10.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.264 1.026 . . . . 64.34 110.29 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.62 -65.53 3.77 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.734 -0.546 . . . . 61.31 111.734 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 62.48 10.34 3.95 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.746 1.219 . . . . 75.04 114.289 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.13 32.37 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.905 -0.878 . . . . 72.1 110.905 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -122.51 175.08 6.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 71.32 109.842 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.77 -4.02 48.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.827 0.451 . . . . 62.33 111.807 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -135.3 84.76 2.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.785 . . . . 73.12 109.025 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 176.94 4.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.318 1.047 . . . . 74.41 111.417 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.571 HD13 ' HD3' ' A' ' 83' ' ' PRO . 23.2 tp -143.26 113.94 7.55 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.074 -0.512 . . . . 53.24 110.279 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 45.1 t -97.46 116.72 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.336 0.654 . . . . 73.25 109.725 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.655 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 46.3 mt-10 -120.96 123.39 42.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 64.32 109.76 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 43.1 ttt180 -103.29 135.73 44.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.299 1.04 . . . . 73.24 111.764 -175.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -80.71 122.08 26.68 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.692 0.797 . . . . 72.2 110.773 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -95.88 -45.4 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.28 0.632 . . . . 64.1 111.263 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 26.4 tt0 -145.32 145.11 31.09 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.836 1.254 . . . . 61.35 110.382 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.18 116.03 14.03 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.801 -1.185 . . . . 71.14 107.801 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -117.5 104.53 11.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.756 0.822 . . . . 64.05 109.099 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -26.26 46.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.274 0.629 . . . . 74.45 112.688 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t -72.43 -42.75 64.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.779 0.832 . . . . 74.24 110.936 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.62 2.96 36.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.768 0.655 . . . . 52.42 112.768 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 57.03 43.02 25.14 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.424 1.09 . . . . 74.22 112.016 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -115.39 105.06 12.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.814 0.846 . . . . 50.31 110.648 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 59.2 tp -100.83 105.78 17.1 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.188 0.595 . . . . 74.41 109.69 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 57.7 t -106.74 133.82 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 118.688 0.676 . . . . 72.41 110.168 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 33.4 p90 -152.31 -178.66 6.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.042 0.537 . . . . 73.32 110.862 -178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.4 t -141.71 162.92 34.3 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.402 1.081 . . . . 74.44 110.177 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.655 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 79.0 mtp -110.1 85.75 4.52 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 108.811 -0.811 . . . . 63.03 108.811 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.78 -21.17 45.06 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.154 2.569 . . . . 53.45 113.564 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 24.4 t70 -139.25 84.21 16.82 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.762 0.425 . . . . 73.32 110.226 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 44.2 Cg_endo -94.96 153.36 1.75 Allowed 'Trans proline' 0 CA--C 1.565 2.067 0 C-N-CA 123.234 2.622 . . . . 64.34 113.24 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD3' HD13 ' A' ' 61' ' ' LEU . 5.0 Cg_exo -80.48 22.68 0.75 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 122.893 2.396 . . . . 73.21 112.837 171.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.27 149.7 47.88 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.436 1.094 . . . . 75.45 110.356 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 68.02 6.24 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.835 2.357 . . . . 71.43 113.416 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.8 pt -132.97 135.9 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.542 1.137 . . . . 63.31 110.074 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 16.4 m -81.66 -82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 111.832 0.308 . . . . 73.34 111.832 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -102.07 108.0 19.28 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.257 0.551 . . . . 71.53 110.778 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -89.31 157.94 18.01 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.737 0.815 . . . . 72.31 111.685 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -156.01 124.11 5.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.587 0.755 . . . . 75.42 110.21 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.98 151.8 51.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.985 0.735 . . . . 53.21 112.985 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.5 p -138.35 137.43 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 C-N-CA 123.523 0.729 . . . . 73.03 112.483 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.2 mm? -101.28 108.3 19.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.065 -1.087 . . . . 74.01 108.065 166.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -124.51 110.73 14.85 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.641 -0.503 . . . . 72.22 109.641 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.9 110.89 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.532 -0.544 . . . . 74.42 109.532 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.6 117.5 68.61 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 124.187 0.995 . . . . 72.32 111.08 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.79 110.14 1.61 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.663 2.242 . . . . 44.22 111.494 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -107.33 -28.89 9.61 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.47 0.708 . . . . 63.41 111.834 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.9 t70 -149.96 163.05 39.12 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.762 0.825 . . . . 71.34 110.434 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.78 -39.03 73.35 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.517 1.127 . . . . 75.03 112.35 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -117.64 -4.34 11.22 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.846 . . . . 74.12 112.32 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 61.4 m-70 -133.05 156.47 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.305 0.502 . . . . 55.44 111.208 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 17' ' ' VAL . 23.0 p -157.68 178.66 10.01 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.583 0.753 . . . . 45.4 111.017 -177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.6 m -134.73 125.77 27.66 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.034 0.534 . . . . 72.15 111.33 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.02 120.96 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.38 -0.6 . . . . 61.33 109.38 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.42 125.03 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.215 0.606 . . . . 73.52 109.713 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -114.31 116.75 29.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.591 0.757 . . . . 74.43 109.087 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.468 HG22 ' SD ' ' A' ' 110' ' ' MET . 76.3 m -119.82 138.9 53.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.029 0.932 . . . . 75.12 109.384 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.17 112.91 7.67 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.492 0.717 . . . . 44.42 111.61 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.468 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -120.74 131.6 54.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 64.21 109.613 -177.45 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -142.68 155.06 44.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.625 0.77 . . . . 75.34 111.886 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 28.6 t70 -77.3 88.02 3.71 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.795 0.438 . . . . 75.23 110.115 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 38.7 t -145.99 164.76 31.06 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.971 -0.558 . . . . 71.15 112.493 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m -75.13 144.56 79.15 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.136 0.974 . . . . 55.12 111.676 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.27 -43.95 20.65 Favored 'Trans proline' 0 C--N 1.389 2.68 0 C-N-CA 124.23 3.287 . . . . 70.41 115.221 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.08 -42.53 72.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.341 1.056 . . . . 74.43 112.618 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 8.5 m -85.89 -31.47 22.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.506 0.723 . . . . 71.01 110.27 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.37 91.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.149 0.979 . . . . 75.53 112.488 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.53 -30.38 61.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.852 0.861 . . . . 72.33 112.219 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.71 -45.12 72.4 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.26 0.552 . . . . 72.14 109.865 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.06 -23.69 62.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.192 0.997 . . . . 53.11 110.943 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 40.7 tt0 -61.89 -47.09 86.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.8 0.44 . . . . 61.33 110.314 172.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -71.13 -43.74 66.99 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 112.822 0.675 . . . . 73.05 112.822 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.79 -55.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.384 0.674 . . . . 71.34 112.491 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.91 -55.23 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.736 0.815 . . . . 73.41 111.459 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -72.35 -71.23 1.09 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 114.066 0.386 . . . . 72.24 114.066 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.38 -3.64 31.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.544 0.738 . . . . 64.15 112.698 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.96 -83.13 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.061 -0.416 . . . . 70.54 112.061 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.48 -43.12 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.763 0.825 . . . . 70.4 112.593 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 6.7 m-30 -76.26 -43.7 40.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.751 0.421 . . . . 75.31 111.239 -175.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.95 -48.04 73.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.549 0.339 . . . . 73.51 111.3 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.22 -47.25 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 C-N-CA 123.357 0.663 . . . . 70.24 111.945 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -45.46 95.61 Favored Glycine 0 CA--C 1.54 1.594 0 CA-C-N 116.518 -0.31 . . . . 42.44 113.661 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.18 -46.04 57.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.372 1.069 . . . . 73.12 111.922 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.45 ' HA ' HG21 ' A' ' 8' ' ' VAL . 6.5 m-20 -61.7 -40.83 96.41 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.841 0.457 . . . . 73.1 110.999 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.49 85.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.017 0.527 . . . . 62.12 111.425 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.25 -44.87 92.37 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.443 0.697 . . . . 71.11 110.858 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.68 95.25 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.868 -0.605 . . . . 73.33 111.618 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -71.55 -30.84 66.34 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.411 0.684 . . . . 54.43 112.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -15.37 58.57 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.389 0.514 . . . . 72.02 112.389 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -85.45 -8.69 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 122.727 0.411 . . . . 74.15 111.48 162.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 71.57 67.58 1.83 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 112.308 -0.317 . . . . 73.45 112.308 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -67.34 130.88 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.575 0.583 . . . . 63.43 112.575 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.41 -5.87 18.65 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.276 0.63 . . . . 73.34 111.164 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.8 96.52 0.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.521 0.728 . . . . 65.0 109.841 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -79.37 75.51 5.96 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.947 -1.024 . . . . 70.12 110.788 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -82.38 68.41 8.81 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 107.805 -1.183 . . . . 74.32 107.805 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -76.09 100.32 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.262 -1.335 . . . . 73.1 112.583 -166.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -163.5 146.39 10.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.008 0.923 . . . . 63.02 109.88 172.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -79.96 106.71 12.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.866 0.466 . . . . 71.33 110.964 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 51.2 t60 . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 123.731 0.812 . . . . 74.34 110.056 -179.575 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 119.455 -0.307 . . . . 64.44 110.596 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 47.45 51.11 14.04 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.585 1.154 . . . . 64.43 112.844 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.25 101.12 9.9 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.945 0.879 . . . . 72.33 110.281 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 4.0 mp -92.94 119.17 31.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.998 1.319 . . . . 73.35 108.932 -175.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -140.75 136.33 32.43 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.909 0.385 . . . . 75.43 110.274 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.11 138.81 31.93 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.101 -1.074 . . . . 74.41 108.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.7 p -128.92 147.11 50.81 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.874 0.869 . . . . 74.03 110.126 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.4 p -142.3 145.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.933 0.493 . . . . 51.15 110.469 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.98 112.71 24.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.349 0.595 . . . . 72.23 110.773 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.9 t -91.44 132.87 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.258 1.423 . . . . 73.32 110.632 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.13 51.37 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.409 0.683 . . . . 70.15 112.209 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.56 155.09 24.58 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.166 0.986 . . . . 61.15 110.605 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.1 142.21 73.24 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.863 2.376 . . . . 72.4 113.398 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.76 -38.91 23.11 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.911 1.684 . . . . 74.34 115.253 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.89 73.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.555 0.742 . . . . 73.12 112.767 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.85 -42.31 84.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.751 0.82 . . . . 72.55 112.307 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 137' ' ' LEU . 29.2 t -70.83 -33.82 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.899 0.88 . . . . 74.45 110.784 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 49.5 t-105 -67.29 -28.99 68.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.425 0.69 . . . . 72.43 111.891 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -65.11 -36.13 83.32 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.175 0.512 . . . . 64.51 110.441 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 30' ' ' TRP . 66.2 tp -73.28 -51.44 17.58 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.192 0.997 . . . . 64.02 111.988 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.42 -33.26 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.606 0.762 . . . . 62.22 112.702 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.11 72.68 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.177 -0.465 . . . . 74.42 113.237 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.39 94.79 0.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.938 0.875 . . . . 73.31 110.474 168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.87 12.77 0.77 Allowed 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 124.873 1.269 . . . . 54.25 110.496 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.661 ' HA ' HD21 ' A' ' 39' ' ' LEU . 75.6 p -115.77 -1.73 12.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.554 1.141 . . . . 61.42 112.493 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.31 -83.36 0.61 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 119.071 -0.49 . . . . 70.14 110.867 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.596 HG23 HG11 ' A' ' 34' ' ' VAL 0.298 19.9 tt 52.81 -48.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 127.61 2.364 . . . . 54.31 116.457 -175.295 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -60.9 -4.08 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 120.284 1.402 . . . . 75.52 114.34 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -77.46 -16.61 58.67 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.867 0.867 . . . . 71.31 112.852 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HB3' HD21 ' A' ' 20' ' ' LEU . 42.4 p-90 -132.13 -34.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.524 0.729 . . . . 71.11 111.816 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -87.53 110.74 36.65 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.89 0.876 . . . . 62.01 109.313 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.18 -8.62 24.1 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 70.53 114.902 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -109.02 -6.81 15.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.148 1.166 . . . . 73.01 114.148 -170.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 36' ' ' ALA . 66.6 t -79.66 131.38 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 118.469 0.577 . . . . 71.42 112.5 177.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -93.03 34.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.252 1.021 . . . . 61.43 111.869 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.641 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 67.46 125.78 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 C-N-CA 125.8 1.64 . . . . 70.21 113.422 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 73.7 Cg_endo -84.79 149.7 11.14 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.742 2.295 . . . . 74.24 113.921 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.7 m -107.07 120.18 41.39 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.898 0.879 . . . . 73.33 109.645 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 25' ' ' SER . 3.9 mm? -91.51 137.7 32.15 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.481 0.658 . . . . 73.3 112.701 -167.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -130.13 165.07 23.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.153 1.381 . . . . 74.04 109.81 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.97 -150.89 5.97 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.541 0.977 . . . . 43.32 115.541 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 46' ' ' THR . . . -83.05 87.56 6.89 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.953 0.724 . . . . 72.34 112.953 -165.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.4 t 58.89 132.96 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 N-CA-C 116.001 1.852 . . . . 74.42 116.001 161.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.43 -16.44 41.82 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.082 2.521 . . . . 74.43 114.176 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -114.17 20.43 15.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 54.22 111.744 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 42' ' ' ALA . 99.5 m -123.85 123.03 26.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 123.729 0.811 . . . . 63.13 109.345 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 58.7 Cg_exo -53.95 89.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.656 2.904 . . . . 55.23 114.164 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.83 51.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.071 -0.513 . . . . 23.11 112.655 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.71 145.16 39.98 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.704 0.801 . . . . 64.35 111.006 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -109.93 153.07 25.02 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.257 0.623 . . . . 73.14 109.867 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 11.0 ptm180 -140.24 125.56 18.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.398 0.618 . . . . 74.12 109.844 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 62' ' ' VAL . 22.0 t -109.39 101.13 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.777 0.831 . . . . 73.1 109.851 -174.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -63.34 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.724 1.209 . . . . 75.45 111.953 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -59.91 0.64 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.005 -0.438 . . . . 61.13 112.005 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.36 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.52 1.528 . . . . 62.31 113.44 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.7 -19.86 0.44 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 115.002 0.761 . . . . 71.21 115.002 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 p -105.45 171.86 7.1 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.615 0.707 . . . . 70.12 111.518 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.85 7.02 43.88 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.965 0.906 . . . . 71.52 112.603 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.34 31.48 3.47 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.828 0.823 . . . . 73.44 110.521 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 151.06 45.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.752 0.821 . . . . 75.15 112.662 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -102.82 114.47 28.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.573 0.749 . . . . 62.31 110.266 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' VAL . 32.6 t -114.4 115.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.157 0.583 . . . . 53.34 110.716 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.83 160.56 20.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.02 0.928 . . . . 74.43 110.613 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -143.36 132.23 22.76 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.199 1.0 . . . . 73.33 111.356 -170.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 18.6 tp -74.83 121.55 21.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.193 1.397 . . . . 74.34 112.374 -175.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -98.38 -48.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.95 0.9 . . . . 74.23 110.879 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 36.9 tt0 -144.13 134.65 24.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.441 1.096 . . . . 74.34 109.661 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 70' ' ' GLU . 4.0 tmm_? -132.92 109.58 9.69 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.332 -0.618 . . . . 75.45 109.332 -176.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.84 176.0 5.44 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.491 1.116 . . . . 73.01 109.356 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 24.4 tt0 -158.62 -34.65 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.865 -0.522 . . . . 74.42 112.336 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -63.86 -34.84 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.3 0.64 . . . . 64.44 111.358 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.65 -14.81 15.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.342 1.057 . . . . 75.43 110.773 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 68.25 69.29 0.32 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.936 1.294 . . . . 72.0 112.098 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.28 135.04 40.54 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.722 0.809 . . . . 65.43 111.505 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.57 118.18 31.0 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.764 1.225 . . . . 70.42 109.447 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 60.5 t -116.92 125.65 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.45 0.7 . . . . 64.41 109.981 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.17 -179.07 6.66 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.703 0.801 . . . . 74.53 111.319 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -145.97 162.99 36.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.425 1.09 . . . . 75.11 110.486 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 72.6 mtm -101.14 100.45 13.29 Favored Pre-proline 0 N--CA 1.484 1.259 0 N-CA-C 109.292 -0.633 . . . . 61.23 109.292 167.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.6 -21.04 30.14 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.002 2.468 . . . . 71.41 113.358 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -139.55 74.89 33.13 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.242 0.617 . . . . 65.13 109.63 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 64.7 Cg_endo -86.68 146.96 8.3 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.647 2.231 . . . . 70.32 113.468 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.1 Cg_endo -86.55 24.89 0.71 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.457 2.771 . . . . 73.12 113.347 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -123.33 149.4 57.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 123.912 0.885 . . . . 64.11 110.371 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.38 74.9 4.04 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.605 2.203 . . . . 73.24 112.031 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 113' ' ' CYS . 31.4 pt -133.78 165.11 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.338 1.055 . . . . 74.3 110.991 -174.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 5.8 m -136.02 159.89 40.31 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.663 0.785 . . . . 62.11 109.649 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.8 p30 37.73 71.67 0.14 Allowed 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 125.9 1.68 . . . . 62.14 114.547 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HD2' ' HD2' ' A' ' 111' ' ' PHE . 41.8 t-80 -79.39 131.0 35.97 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 116.076 -0.511 . . . . 73.25 111.881 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -129.82 118.84 22.4 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.231 1.012 . . . . 62.53 109.787 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.23 125.44 40.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.372 0.669 . . . . 61.43 111.312 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 117.63 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.489 0.715 . . . . 72.03 110.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.35 117.32 33.85 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 72.32 109.116 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.08 150.1 52.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.345 0.658 . . . . 74.44 110.937 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.86 113.87 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.185 0.594 . . . . 74.21 109.508 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -92.55 115.52 64.94 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.161 0.985 . . . . 63.24 109.902 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 77.11 0.37 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.764 2.309 . . . . 73.01 112.938 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -69.53 -33.75 73.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.217 1.007 . . . . 54.13 111.944 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 24.9 t70 -154.92 165.17 37.52 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.098 1.359 . . . . 74.22 108.944 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.35 -48.88 79.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.853 0.861 . . . . 62.32 111.963 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 -6.4 27.72 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.858 0.863 . . . . 72.51 110.987 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.6 m80 -131.3 128.54 39.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.956 -1.09 . . . . 75.14 111.592 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.423 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.5 p -130.2 133.76 46.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.063 0.545 . . . . 73.23 110.129 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.9 m -92.14 110.37 21.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.344 0.258 . . . . 72.42 110.383 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.11 116.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 70.35 109.717 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.8 t -107.77 109.85 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.454 1.102 . . . . 63.42 109.995 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -103.35 125.31 49.9 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.102 -0.703 . . . . 75.53 109.102 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.3 m -131.55 147.46 52.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.051 0.94 . . . . 74.44 110.344 -172.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.96 156.26 42.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.195 1.398 . . . . 70.14 108.859 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -162.81 146.03 11.0 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.638 . . . . 53.14 110.753 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HD2' ' HD2' ' A' ' 89' ' ' HIS . 2.5 p90 -158.84 155.5 27.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.717 0.807 . . . . 73.2 111.669 -168.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 30.2 t70 -82.99 85.44 7.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.022 0.929 . . . . 61.21 109.205 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.619 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.0 t -113.41 152.65 29.77 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.768 -1.105 . . . . 75.22 111.254 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.1 p -61.43 132.33 92.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.482 0.713 . . . . 73.55 110.633 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.95 -44.21 23.12 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 124.293 3.329 . . . . 73.33 116.02 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.03 -38.62 72.57 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 122.799 0.44 . . . . 74.3 112.001 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 m -75.41 -26.8 58.68 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.166 0.587 . . . . 62.31 110.931 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 2' ' ' ALA . . . -68.67 -51.29 43.5 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.235 1.014 . . . . 24.23 111.125 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -64.01 -30.57 71.64 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.687 -0.688 . . . . 73.0 111.442 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -66.98 -44.36 80.62 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.839 -0.619 . . . . 73.03 110.691 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.61 -25.51 62.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.126 0.57 . . . . 73.43 111.233 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.575 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 52.1 mt-10 -66.09 -34.51 78.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.43 111.511 173.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 t -76.6 -53.27 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.679 0.622 . . . . 51.53 112.679 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.81 -55.03 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.647 0.779 . . . . 74.14 112.147 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.03 -46.76 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.061 0.545 . . . . 73.31 110.653 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -16.18 68.04 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 115.488 0.955 . . . . 64.14 115.488 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.35 -57.47 1.99 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.983 0.892 . . . . 74.44 110.464 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.27 58.46 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 115.144 0.818 . . . . 74.03 115.144 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.0 t -111.77 -52.09 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.312 0.645 . . . . 60.43 110.372 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -75.05 -61.39 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.797 0.666 . . . . 74.24 112.797 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.59 71.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.879 0.371 . . . . 74.33 111.503 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.11 -56.28 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.109 0.964 . . . . 73.43 112.579 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.08 94.74 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.36 -0.382 . . . . 54.34 113.346 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.98 -39.39 83.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.952 0.901 . . . . 53.21 112.626 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -67.39 -45.46 76.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.388 0.275 . . . . 72.35 110.782 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.14 73.22 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.493 0.717 . . . . 64.15 111.567 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.444 HD21 HG13 ' A' ' 17' ' ' VAL . 6.8 tt -66.19 -43.65 86.19 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.788 0.835 . . . . 72.04 110.301 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.887 0.475 . . . . 71.23 112.193 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -72.25 -44.39 62.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.551 0.74 . . . . 64.03 111.768 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -73.99 -20.96 60.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.522 0.564 . . . . 73.31 112.522 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -100.56 -14.86 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.05 0.54 . . . . 72.52 111.219 168.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.81 4.5 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-O 121.13 0.294 . . . . 53.11 112.503 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -72.87 -29.92 63.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.606 1.162 . . . . 74.34 109.921 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.42 -39.18 82.66 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.163 . . . . 74.15 110.805 174.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.5 -67.03 0.82 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.456 0.703 . . . . 65.32 109.68 175.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.78 -11.11 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.634 1.574 . . . . 64.4 113.428 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -87.75 49.91 1.89 Allowed 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.471 0.709 . . . . 64.23 111.747 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -168.72 114.61 0.62 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.114 0.965 . . . . 73.2 109.536 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -131.42 129.07 40.79 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.068 0.547 . . . . 70.53 111.487 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -98.22 168.16 10.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.733 0.813 . . . . 75.45 110.945 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 N--CA 1.484 1.249 0 C-N-CA 123.444 0.697 . . . . 54.13 110.967 175.939 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.681 0.277 . . . . 73.24 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.03 10.81 20.23 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.327 0.584 . . . . 75.33 110.771 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.8 m -115.13 117.87 31.77 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.652 1.181 . . . . 71.34 109.315 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -96.33 143.78 27.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.549 1.139 . . . . 63.13 109.931 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -143.72 135.2 26.05 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.248 0.547 . . . . 73.21 111.803 172.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -131.42 156.15 46.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.989 1.316 . . . . 73.12 109.008 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -145.02 157.02 44.25 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.617 0.767 . . . . 75.23 110.488 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.6 p -150.65 146.49 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.709 0.404 . . . . 73.02 111.149 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -93.01 123.64 36.41 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.855 -0.424 . . . . 72.35 109.855 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t -108.36 132.57 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.604 1.162 . . . . 75.52 110.638 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.69 64.23 8.5 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.24 0.616 . . . . 61.51 111.585 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.59 148.58 7.88 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.333 0.653 . . . . 73.15 111.037 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.07 128.76 31.15 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.29 2.66 . . . . 44.12 113.036 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.84 -37.27 13.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.981 1.475 . . . . 75.14 114.981 -175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.36 86.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.044 0.538 . . . . 71.43 112.227 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.52 -35.53 80.77 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.222 0.609 . . . . 54.15 112.332 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' SG ' ' A' ' 103' ' ' CYS . 58.8 t -71.25 -34.97 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.428 0.691 . . . . 52.11 110.345 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 63.2 t-105 -72.67 -27.66 62.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.548 0.739 . . . . 73.13 111.775 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.4 m -69.31 -29.56 67.44 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.423 0.63 . . . . 53.44 110.077 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 30' ' ' TRP . 58.4 tp -75.16 -49.15 20.42 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.365 1.066 . . . . 75.04 111.68 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.44 -36.45 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 112.631 0.604 . . . . 64.43 112.631 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -65.36 -25.65 71.36 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 123.542 0.592 . . . . 55.34 114.352 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.07 108.21 11.2 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.123 -0.695 . . . . 54.33 109.123 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HZ ' ' HG2' ' A' ' 63' ' ' GLU . 22.2 t80 -58.55 -27.66 64.77 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.093 0.957 . . . . 73.13 110.624 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.7 p -77.71 -24.46 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.21 113.263 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.19 10.34 39.41 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 122.805 0.442 . . . . 73.11 111.799 -168.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.743 HG23 HG11 ' A' ' 34' ' ' VAL . 18.5 tt -59.49 -25.51 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 C-N-CA 123.067 0.547 . . . . 72.43 112.114 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -63.78 -19.25 64.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.216 0.821 . . . . 51.34 113.216 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -78.25 -25.14 46.72 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.629 0.603 . . . . 74.22 112.629 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.8 p-90 -117.07 -33.18 4.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.948 0.499 . . . . 64.24 111.791 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.457 ' ND1' HG23 ' A' ' 34' ' ' VAL . 43.5 t-80 -89.34 109.79 33.96 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.247 0.619 . . . . 74.02 109.567 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.87 -15.65 36.75 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.928 2.419 . . . . 74.31 114.011 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 20.5 mt-30 -90.49 -26.3 19.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.45 0.7 . . . . 74.35 111.558 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.743 HG11 HG23 ' A' ' 27' ' ' ILE . 99.3 t -74.41 103.55 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.327 0 CA-C-O 121.134 0.492 . . . . 73.14 110.434 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 m -93.45 40.98 1.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.093 0.957 . . . . 72.12 112.56 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.1 75.12 0.47 Allowed Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 124.801 1.241 . . . . 71.21 112.926 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.73 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 94.4 Cg_endo -82.44 -168.15 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.563 2.842 . . . . 71.1 115.278 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 86.7 m -113.77 139.58 49.0 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.596 1.158 . . . . 72.02 111.511 -167.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.08 143.5 26.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.272 0.629 . . . . 51.45 111.375 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.3 mmt180 -115.1 138.35 50.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.854 0.862 . . . . 71.42 110.009 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.85 -123.9 7.94 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 115.548 0.979 . . . . 53.13 115.548 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.74 139.11 0.32 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.153 1.781 . . . . 71.33 114.746 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -50.55 158.25 1.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 C-N-CA 125.403 1.481 . . . . 62.43 113.755 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -7.03 13.99 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 123.05 2.5 . . . . 62.25 114.494 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -109.55 -13.74 14.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.707 0.803 . . . . 71.11 111.445 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -88.57 118.43 69.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.627 0.771 . . . . 51.22 111.009 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.54 121.8 10.14 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.509 2.806 . . . . 72.25 113.319 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.83 -14.56 8.5 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 116.348 -0.387 . . . . 71.33 113.073 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.68 141.42 52.64 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.862 0.865 . . . . 64.42 112.425 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 34.7 mt-10 -116.5 163.53 15.94 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 122.751 0.421 . . . . 64.22 110.249 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 38' ' ' THR . 48.4 ttt85 -156.17 105.68 2.34 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.93 0.492 . . . . 74.23 110.87 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 55' ' ' ALA . 22.0 t -106.84 113.82 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.289 0.636 . . . . 74.23 111.358 -170.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.4 m-85 -76.3 70.75 2.95 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.042 1.337 . . . . 72.53 111.658 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.49 -50.85 0.53 Allowed Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.814 -0.514 . . . . 71.11 111.814 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 52' ' ' VAL . . . 60.04 24.19 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.52 1.128 . . . . 53.44 113.876 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.06 53.62 0.05 OUTLIER Glycine 0 N--CA 1.474 1.23 0 C-N-CA 122.75 0.214 . . . . 42.05 112.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -121.05 -135.37 0.32 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.22 1.008 . . . . 75.53 108.86 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.15 -1.9 4.56 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.307 0.958 . . . . 65.01 111.978 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.33 46.77 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.69 0.757 . . . . 61.32 111.946 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -87.15 152.35 22.41 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.384 -0.825 . . . . 60.34 112.004 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.89 132.54 43.39 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.838 0.855 . . . . 73.12 108.865 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.5 t -102.86 116.67 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.883 -0.511 . . . . 75.43 109.902 175.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 43.5 tt0 -109.55 154.5 22.63 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.37 1.468 . . . . 75.02 109.605 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -151.94 125.66 8.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 74.11 112.163 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -66.97 120.76 14.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.016 1.326 . . . . 53.54 111.31 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -88.1 -50.8 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.698 . . . . 55.14 110.826 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 37.5 tt0 -151.98 142.45 22.6 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.549 1.14 . . . . 74.01 109.953 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.483 HH21 ' HA3' ' A' ' 22' ' ' GLY . 3.6 tmt_? -134.23 111.46 10.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.884 -0.784 . . . . 73.11 108.884 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -117.33 125.73 51.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.727 0.811 . . . . 71.45 110.709 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 33.6 tt0 -90.63 -40.38 11.94 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.251 0.834 . . . . 73.33 113.251 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -67.26 -43.53 81.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.878 0.471 . . . . 62.31 111.951 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.35 0.93 54.72 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.063 0.545 . . . . 65.23 112.031 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 25.4 mmt85 60.1 38.31 20.51 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.355 1.062 . . . . 60.01 112.293 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.84 122.87 47.67 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.052 0.941 . . . . 71.12 111.729 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 50.1 tp -115.04 108.41 16.65 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.061 0.944 . . . . 71.04 110.213 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 54.1 t -106.35 123.21 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.464 0.706 . . . . 62.23 110.132 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.43 ' HE1' HD23 ' A' ' 93' ' ' LEU . 46.5 p90 -151.95 -178.71 6.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.928 0.491 . . . . 65.25 111.727 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.433 HG23 ' HD3' ' A' ' 80' ' ' PRO . 9.8 t -153.82 164.63 38.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.142 0.977 . . . . 61.21 111.184 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -106.99 100.28 31.2 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.964 -0.754 . . . . 71.3 108.964 160.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' HG23 ' A' ' 78' ' ' THR . 36.1 Cg_endo -63.0 -23.03 74.07 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.944 2.429 . . . . 61.43 113.471 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.9 t70 -124.61 82.31 59.51 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.445 0.698 . . . . 72.43 110.028 175.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 45.7 Cg_endo -101.56 144.67 0.26 Allowed 'Trans proline' 0 CA--C 1.573 2.466 0 C-N-CA 123.759 2.973 . . . . 72.34 114.291 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 20.0 Cg_exo -69.81 -17.26 37.45 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.768 2.312 . . . . 71.21 113.596 172.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -80.78 155.67 73.1 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 123.942 0.897 . . . . 64.45 111.394 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.0 46.84 2.3 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.253 2.635 . . . . 42.31 112.949 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.53 116.8 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.197 0.999 . . . . 35.13 109.774 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.4 p -74.96 -79.38 0.09 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.088 0.555 . . . . 70.21 112.39 -172.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.38 72.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.929 0.871 . . . . 74.03 109.752 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 110' ' ' MET . 57.5 t-80 -76.03 118.95 19.32 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.622 -0.717 . . . . 72.44 111.818 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 150.05 23.6 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.978 0.911 . . . . 74.41 108.914 170.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.59 119.49 8.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 71.03 109.137 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 48.4 t -126.09 130.12 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.38 0.672 . . . . 54.34 111.869 -169.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD23 ' HE1' ' A' ' 77' ' ' TYR . 4.3 mm? -107.93 111.57 23.74 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.382 1.073 . . . . 62.12 109.359 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 51.0 mt-10 -116.58 111.23 19.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.952 0.501 . . . . 74.12 110.413 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.43 105.61 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.298 -1.001 . . . . 75.43 108.298 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 15.5 m -100.57 123.7 45.12 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 122.894 0.478 . . . . 64.24 110.405 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 16.4 Cg_exo -68.47 85.81 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.159 2.573 . . . . 74.32 112.614 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -32.93 74.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.143 0.977 . . . . 71.34 109.744 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.7 t70 -157.31 167.12 31.23 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.239 1.816 . . . . 62.44 108.259 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.7 -40.54 95.39 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.208 0.603 . . . . 53.42 112.434 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -108.98 -1.29 19.08 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.614 0.766 . . . . 75.43 111.888 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.0 m80 -132.5 124.5 28.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.243 -0.911 . . . . 71.13 110.153 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 17' ' ' VAL . 29.1 p -133.1 142.88 48.96 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.003 0.521 . . . . 71.23 110.8 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 m -97.12 114.33 26.0 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.757 0.423 . . . . 60.14 110.156 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 t -95.3 112.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.428 -0.582 . . . . 74.02 109.428 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.77 117.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 41.34 109.655 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -108.73 112.73 25.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.123 -0.695 . . . . 75.25 109.123 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 m -125.22 128.09 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.506 0.722 . . . . 72.02 110.338 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.65 148.9 42.25 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.611 0.764 . . . . 75.05 111.053 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 1.8 mpt? -126.17 150.36 48.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.707 0.803 . . . . 71.23 109.139 172.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -162.77 153.14 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.323 0.649 . . . . 73.02 110.455 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -102.57 78.58 1.73 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.748 0.785 . . . . 63.42 109.456 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t -125.15 168.14 13.83 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.779 -1.101 . . . . 71.33 110.984 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -65.05 147.47 98.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 C-N-CA 123.399 0.68 . . . . 74.14 112.174 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.7 -31.57 95.16 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.955 2.436 . . . . 55.45 113.411 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.94 -55.96 28.12 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.007 0.923 . . . . 72.41 111.604 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.43 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.7 m -74.48 -32.02 62.41 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.756 -0.657 . . . . 64.24 111.157 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -65.6 -41.53 92.69 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.085 0.554 . . . . 61.14 112.029 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -67.31 -31.35 71.58 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.648 0.379 . . . . 75.21 111.657 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.96 -42.62 94.44 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.652 -0.499 . . . . 72.23 109.652 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 117' ' ' THR . 92.8 mt -72.62 -25.33 61.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.374 0.67 . . . . 75.42 111.717 -176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 46.8 mt-10 -61.35 -38.18 86.01 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 118.14 0.427 . . . . 75.31 110.763 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 t -76.25 -51.43 12.06 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 112.694 0.627 . . . . 72.4 112.694 172.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.26 -55.02 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 112.863 0.69 . . . . 63.31 112.863 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.4 mt -77.5 -45.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.75 0.42 . . . . 72.33 110.522 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.45 -47.9 83.19 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 114.855 0.702 . . . . 71.42 114.855 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.99 -46.55 5.06 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.451 -1.029 . . . . 73.22 112.094 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.01 -19.58 71.96 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 114.94 0.736 . . . . 71.25 114.94 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.11 -53.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 117.88 0.84 . . . . 73.2 111.443 176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.6 m-30 -73.84 -54.62 7.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.36 72.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.061 0.144 . . . . 74.01 110.968 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.75 -52.22 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.08 0.552 . . . . 75.51 111.754 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.26 -50.25 61.12 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 116.572 -0.285 . . . . 55.21 113.18 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.89 -41.65 99.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 74.33 112.716 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.79 -41.5 78.64 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.2 -0.429 . . . . 74.43 110.438 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.35 75.5 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.85 0.46 . . . . 73.53 111.876 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 HG13 ' A' ' 17' ' ' VAL . 7.8 tt -67.86 -41.33 83.05 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.217 0.607 . . . . 60.12 109.898 173.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.47 -27.73 62.48 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 112.353 0.501 . . . . 75.02 112.353 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.77 -37.89 39.97 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.184 0.994 . . . . 63.24 112.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 8.7 ptm180 -67.71 -34.07 76.14 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.348 0.259 . . . . 65.53 110.971 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -88.94 -16.94 30.57 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.95 0.5 . . . . 71.2 110.539 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.83 -2.04 75.06 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.878 -0.601 . . . . 35.23 113.252 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -50.07 -33.53 18.72 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.966 1.307 . . . . 74.53 110.413 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.43 151.72 29.52 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.543 1.137 . . . . 60.33 109.607 167.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 73.38 -64.05 0.41 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 125.618 1.567 . . . . 52.3 113.962 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -64.31 126.84 29.08 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.607 0.763 . . . . 73.05 112.905 -171.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -79.83 -23.2 42.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.973 0.509 . . . . 62.44 110.809 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 60.39 45.31 11.17 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.782 1.233 . . . . 74.11 109.763 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -146.7 101.97 3.51 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.806 -0.634 . . . . 74.13 111.334 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -112.3 -16.58 12.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.955 0.902 . . . . 75.35 110.892 169.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.949 . . . . 72.11 109.651 171.629 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.971 -0.381 . . . . 71.05 109.971 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.99 79.29 1.25 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.838 0.828 . . . . 73.34 110.876 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.8 m -128.62 116.67 19.96 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.184 0.994 . . . . 62.31 109.581 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 126' ' ' GLY . 8.3 mp -108.76 109.49 20.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.931 1.292 . . . . 55.32 109.539 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -129.48 135.2 48.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 70.12 112.214 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.56 156.08 49.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.736 1.214 . . . . 74.52 110.648 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -143.84 154.2 43.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.205 1.002 . . . . 74.32 109.321 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.8 p -150.09 147.54 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 111.591 0.219 . . . . 75.15 111.591 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.27 118.5 26.74 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.196 0.598 . . . . 72.03 110.546 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.0 121.05 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.671 1.188 . . . . 61.23 110.131 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.25 72.94 3.83 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.147 0.579 . . . . 52.5 111.044 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.02 155.76 2.42 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.646 0.778 . . . . 71.22 111.134 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -63.0 138.29 67.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.704 2.269 . . . . 54.23 111.86 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -25.13 11.16 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.165 0.802 . . . . 72.05 113.165 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.42 47.96 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.711 0.634 . . . . 65.44 112.711 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.54 -40.07 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.246 0.618 . . . . 71.44 111.636 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.429 HG13 HD21 ' A' ' 137' ' ' LEU . 21.6 t -74.5 -34.86 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.524 0.73 . . . . 55.44 111.125 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 -70.1 -27.76 64.85 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.345 0.658 . . . . 63.14 111.419 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 m -63.76 -29.14 70.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.389 0.614 . . . . 72.35 111.147 170.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 30' ' ' TRP . 57.5 tp -86.07 -56.72 3.33 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.505 1.122 . . . . 55.24 111.924 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.56 -25.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 123.099 0.56 . . . . 72.44 112.501 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.13 0.61 62.53 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 114.408 0.523 . . . . 71.2 114.408 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.09 163.59 12.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.125 0.97 . . . . 73.44 109.206 165.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.09 -44.26 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.794 -0.566 . . . . 74.31 110.551 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.7 p -77.61 -20.26 54.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.192 0.441 . . . . 71.12 112.192 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.12 5.79 9.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.181 0.592 . . . . 62.51 112.549 -170.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 34' ' ' VAL . 19.1 tt -68.15 -27.31 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.305 0.642 . . . . 71.31 112.565 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -66.31 -15.89 63.6 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.365 0.505 . . . . 73.13 112.365 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -80.79 -38.33 28.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.757 0.823 . . . . 74.21 112.595 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.63 ' HB3' HD21 ' A' ' 20' ' ' LEU . 54.5 p-90 -108.81 -36.37 6.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 122.084 -0.385 . . . . 61.12 111.679 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -89.89 110.56 40.71 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.107 0.563 . . . . 71.44 109.619 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.06 -21.57 42.75 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.134 2.556 . . . . 75.44 114.318 -170.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -87.45 -16.76 33.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 74.24 112.838 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 27' ' ' ILE . 76.4 t -61.62 127.28 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 122.967 0.507 . . . . 61.34 111.768 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -90.23 27.41 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.34 1.056 . . . . 74.33 112.384 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 62.46 101.61 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 124.437 1.095 . . . . 74.23 111.381 -172.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.46 177.51 4.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.863 2.375 . . . . 73.22 114.707 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 m -123.84 141.85 51.65 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.098 0.959 . . . . 70.43 110.731 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 126.25 40.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.299 0.64 . . . . 65.42 111.298 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 34.0 mmt180 -103.97 123.78 47.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.659 . . . . 74.42 110.1 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.55 -177.77 0.01 OUTLIER Glycine 0 CA--C 1.549 2.177 0 N-CA-C 118.199 2.039 . . . . 63.13 118.199 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.86 -106.23 0.26 Allowed 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.428 1.491 . . . . 50.24 113.687 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.523 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 40.4 t 179.01 147.34 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.454 1.102 . . . . 71.21 109.384 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.37 -20.9 21.55 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.301 2.667 . . . . 72.03 114.894 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.6 3.06 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.182 0.593 . . . . 73.25 112.547 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.4 m -102.38 118.92 57.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.729 0.812 . . . . 71.02 110.765 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 80.1 Cg_exo -50.38 102.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.52 2.813 . . . . 74.23 113.261 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -31.66 1.14 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.039 -0.528 . . . . 63.31 113.704 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -65.48 144.44 57.03 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.563 0.579 . . . . 54.15 112.563 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 46.7 mt-10 -110.92 146.67 36.14 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.33 0.652 . . . . 75.32 111.767 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -118.68 106.59 12.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.564 0.746 . . . . 71.23 110.786 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 25.1 t -109.34 102.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.905 0.882 . . . . 75.44 110.84 -173.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.71 93.79 2.14 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.658 0.783 . . . . 74.03 112.505 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 60.43 1.87 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.296 -0.321 . . . . 41.41 112.296 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 107.63 1.44 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.645 0.778 . . . . 61.53 112.905 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 24.83 7.44 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 114.159 0.423 . . . . 61.25 114.159 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -96.52 -77.03 0.49 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.291 0.636 . . . . 75.34 110.669 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 163.11 -35.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.821 1.649 . . . . 62.31 108.491 -171.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -103.7 17.31 24.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.189 -0.914 . . . . 74.44 112.581 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 136.58 47.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.414 0.626 . . . . 54.33 112.38 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -101.69 118.93 37.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.606 0.762 . . . . 72.42 109.196 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 53.7 t -97.2 113.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.476 -0.564 . . . . 75.11 109.476 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 59.3 mt-10 -108.29 169.62 8.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.322 1.049 . . . . 74.42 110.059 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -150.43 121.43 7.68 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.114 0.566 . . . . 74.42 110.373 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.04 121.59 19.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.128 0.971 . . . . 72.05 111.887 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 82.9 t -90.99 -48.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.53 0.732 . . . . 65.52 111.594 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -166.72 152.75 8.33 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.556 0.343 . . . . 64.22 111.781 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.511 HH12 HD22 ' A' ' 75' ' ' LEU . 93.2 mtt-85 -134.9 119.7 18.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.719 0.808 . . . . 75.23 111.141 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.0 m-20 -95.91 99.74 11.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.453 1.101 . . . . 71.42 109.62 172.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.81 -57.87 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.126 0.57 . . . . 74.21 111.821 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.8 t -70.44 -36.69 74.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.15 0.58 . . . . 75.23 111.784 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -79.53 -7.6 58.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.267 0.627 . . . . 33.11 112.147 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 58.21 43.64 20.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.761 1.224 . . . . 71.54 112.297 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.2 ttp180 -124.66 143.72 50.58 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.227 1.011 . . . . 63.45 110.209 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.511 HD22 HH12 ' A' ' 68' ' ' ARG . 10.0 tp -130.39 125.87 35.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 72.34 109.233 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.14 130.28 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.685 0.794 . . . . 71.04 110.873 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -152.28 177.29 10.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.696 0.798 . . . . 74.41 110.706 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.7 t -154.97 150.66 27.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.684 0.794 . . . . 53.45 110.33 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.641 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 15.4 ptt? -98.65 106.2 35.31 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 122.579 0.351 . . . . 62.25 111.57 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.89 -25.8 44.91 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.356 2.704 . . . . 72.14 112.673 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 10.0 m-20 -123.71 80.1 55.69 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.412 0.685 . . . . 53.45 110.819 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.88 137.49 3.97 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.788 2.325 . . . . 73.53 112.511 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.37 -14.29 37.07 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.143 1.896 . . . . 73.23 112.118 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 62.9 m-85 -76.53 147.51 78.77 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.575 1.15 . . . . 74.34 110.787 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 5.5 Cg_exo -77.04 39.37 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.341 2.694 . . . . 71.25 114.094 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -103.28 152.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.063 0.945 . . . . 70.2 111.133 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -89.14 -86.24 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.522 0.329 . . . . 71.13 111.353 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -98.01 108.66 21.41 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.196 0.522 . . . . 74.32 110.881 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -95.08 155.57 16.68 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.295 0.569 . . . . 65.14 111.963 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 16.1 tpt180 -145.83 122.69 11.29 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.564 1.146 . . . . 72.33 108.705 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 126.6 44.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.654 0.661 . . . . 64.12 111.432 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 75.1 t -130.24 129.58 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.377 0.671 . . . . 75.54 112.595 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.24 132.09 46.92 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.364 1.066 . . . . 62.15 108.586 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -143.94 112.57 6.55 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.28 0.945 . . . . 75.25 111.658 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.631 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 26.9 m -95.74 111.25 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 121.966 0.889 . . . . 64.41 110.533 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.497 HG23 ' HB ' ' A' ' 104' ' ' THR . 6.6 m -103.58 116.7 61.51 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.834 0.853 . . . . 53.22 110.322 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.01 109.49 2.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.235 . . . . 75.21 113.269 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -66.3 -30.89 71.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.794 0.838 . . . . 62.23 110.719 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.0 t70 -158.54 174.04 15.69 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 125.199 1.399 . . . . 64.52 108.517 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.76 -37.65 66.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.555 0.742 . . . . 64.13 112.365 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -123.75 28.45 6.9 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.037 0.923 . . . . 74.22 111.564 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 62.1 m80 -138.03 130.44 29.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 72.41 109.488 171.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 46.9 t -130.89 162.83 28.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.858 0.863 . . . . 44.31 111.125 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.497 ' HB ' HG23 ' A' ' 96' ' ' VAL . 86.8 m -133.96 115.35 14.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.405 0.682 . . . . 71.43 110.042 174.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 95' ' ' VAL . 15.2 t -90.35 114.61 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.625 -0.509 . . . . 71.12 109.625 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.81 110.91 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.899 0.88 . . . . 65.33 109.285 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.54 122.97 48.6 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.247 -0.649 . . . . 74.33 109.247 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.53 HG22 ' SD ' ' A' ' 110' ' ' MET . 21.4 m -129.86 135.98 49.01 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.41 0.684 . . . . 51.14 110.964 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.7 116.01 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.657 0.783 . . . . 73.21 112.041 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 3.1 mpp? -103.06 134.03 47.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.441 1.097 . . . . 70.22 109.121 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -157.62 143.56 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 120.731 0.3 . . . . 75.52 111.526 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.11 82.63 5.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.849 0.833 . . . . 75.31 109.434 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.593 ' HB2' HG22 ' A' ' 86' ' ' ILE . 41.1 t -110.97 160.54 16.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.414 -1.266 . . . . 73.11 111.444 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -64.84 134.88 96.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.655 0.782 . . . . 71.44 110.152 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.66 -42.82 64.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.544 2.829 . . . . 73.54 115.109 -167.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.57 -37.94 89.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.969 0.414 . . . . 63.3 111.903 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.41 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -74.41 -33.25 62.95 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 122.971 0.508 . . . . 73.42 110.773 175.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.74 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.873 0.869 . . . . 42.24 111.89 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -28.14 67.28 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.081 0.952 . . . . 75.23 112.149 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.98 -46.35 65.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.944 -0.391 . . . . 61.22 109.944 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.45 -22.68 61.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.334 0.654 . . . . 74.45 110.922 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -56.5 -46.47 80.48 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.27 1.028 . . . . 75.42 110.501 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 m -71.36 -50.01 36.5 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.481 -0.781 . . . . 73.42 112.683 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.93 -56.5 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 123.383 0.673 . . . . 73.04 112.404 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.27 -54.29 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.878 0.871 . . . . 74.55 110.624 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.423 ' N ' HD23 ' A' ' 4' ' ' LEU . . . -63.94 -33.8 88.23 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 115.655 1.022 . . . . 62.42 115.655 -172.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -117.07 -43.08 2.88 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.39 1.095 . . . . 53.52 111.744 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.72 -33.84 71.74 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.179 -0.464 . . . . 33.0 113.927 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 96.6 t -95.93 -56.28 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.069 0.548 . . . . 75.21 110.869 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.0 m-30 -70.63 -64.16 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.132 0.573 . . . . 73.22 112.483 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.73 71.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.287 0.367 . . . . 50.11 111.601 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 t -59.78 -54.32 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 C-N-CA 123.902 0.881 . . . . 64.43 112.277 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.45 -37.74 95.28 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.403 -0.362 . . . . 72.44 113.505 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.7 mt -70.93 -36.68 72.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.856 0.862 . . . . 63.05 111.972 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -68.77 -40.07 79.92 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.639 0.375 . . . . 51.33 110.694 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.65 91.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.076 0.55 . . . . 60.42 111.625 175.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 17' ' ' VAL . 9.0 tt -63.91 -43.0 97.24 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.475 0.71 . . . . 74.2 110.335 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.41 73.94 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.057 -0.52 . . . . 61.43 111.799 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.03 -40.08 54.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.439 0.696 . . . . 52.51 112.819 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -67.34 -29.58 69.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.21 0.448 . . . . 75.14 112.21 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -89.87 -29.18 18.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.203 -0.311 . . . . 71.32 111.366 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 63.49 4.47 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.24 -0.436 . . . . 50.11 112.669 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -70.88 -4.57 25.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.137 0.975 . . . . 74.55 112.907 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.7 mt 68.25 121.16 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.725 1.21 . . . . 65.44 112.234 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.64 -16.37 62.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.82 0.848 . . . . 70.33 112.576 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -126.87 123.23 36.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.571 0.749 . . . . 72.02 110.069 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -67.66 115.99 7.87 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.277 0.631 . . . . 63.12 110.787 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -146.63 168.04 22.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.729 0.812 . . . . 60.11 110.286 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -156.62 142.14 17.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.37 0.668 . . . . 64.44 111.143 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -154.29 114.99 3.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.646 0.778 . . . . 74.45 110.073 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.399 0.618 . . . . 75.41 111.382 177.257 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.927 0.394 . . . . 54.03 111.09 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -103.97 109.13 20.78 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.415 1.086 . . . . 73.21 109.793 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.39 140.64 29.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.782 0.833 . . . . 71.24 109.793 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -146.24 123.21 11.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.154 0.582 . . . . 74.4 109.867 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 130' ' ' PHE . 45.4 mtp85 -128.75 150.34 50.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 73.53 110.097 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -139.49 145.02 38.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.684 0.794 . . . . 54.15 110.519 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.7 p -136.23 144.91 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 122.558 0.343 . . . . 51.31 111.323 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.25 109.19 20.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.658 0.783 . . . . 71.31 110.489 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 70.9 t -101.19 127.17 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.984 0.914 . . . . 73.12 110.407 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 65.59 4.73 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.431 0.692 . . . . 74.21 111.491 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.0 155.13 3.62 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 124.002 0.921 . . . . 70.12 111.225 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.13 139.12 85.01 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.082 2.521 . . . . 70.31 113.865 167.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.47 64.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.258 1.577 . . . . 74.4 115.258 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.16 98.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.4 0.68 . . . . 62.24 112.426 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.22 -36.16 77.06 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.748 0.819 . . . . 72.54 112.34 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.471 HG21 ' SG ' ' A' ' 103' ' ' CYS . 41.3 t -73.57 -35.7 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.103 0.561 . . . . 65.11 111.345 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.62 -34.34 78.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.627 0.371 . . . . 74.35 111.309 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -58.84 -23.94 61.36 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.708 0.803 . . . . 65.22 111.604 171.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.8 tp -95.04 -58.47 2.14 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.067 0.947 . . . . 73.35 112.866 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.03 -34.14 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 123.607 0.763 . . . . 70.41 112.996 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.66 -45.27 94.95 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 115.216 0.846 . . . . 63.35 115.216 -166.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.78 -31.21 1.93 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.305 1.594 . . . . 71.25 115.305 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.4 t80 73.88 -59.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.03 1.332 . . . . 72.1 111.254 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -59.62 -38.16 80.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.926 0.89 . . . . 70.14 112.54 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.576 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -99.58 27.21 5.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.631 0.772 . . . . 75.51 111.598 -166.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 HG11 ' A' ' 34' ' ' VAL . 19.0 tt -62.72 -22.98 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.286 1.034 . . . . 72.5 112.382 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -68.84 -3.73 13.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.163 0.801 . . . . 74.24 113.163 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 48.0 mtp180 -76.61 -24.37 53.41 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.826 0.85 . . . . 73.24 112.445 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -129.6 -37.56 1.57 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.255 0.835 . . . . 75.41 113.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -90.06 108.52 26.62 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.965 0.506 . . . . 73.31 109.798 -171.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.41 -23.59 32.21 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.154 2.57 . . . . 74.13 114.708 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -80.82 -15.65 55.81 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.989 0.516 . . . . 63.23 112.068 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 53' ' ' PHE . 94.8 t -68.27 106.72 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.11 0.481 . . . . 72.12 111.37 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -89.11 54.92 3.13 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.491 0.716 . . . . 53.42 110.681 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.09 105.17 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 125.449 1.499 . . . . 72.03 113.429 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 64.4 Cg_endo -90.35 148.76 4.42 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.861 2.374 . . . . 60.41 113.149 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -101.02 115.14 29.77 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.127 0.571 . . . . 72.4 110.111 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.8 tm? -89.37 112.32 23.4 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 109.096 -0.705 . . . . 72.52 109.096 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -102.48 123.09 45.6 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.918 0.887 . . . . 70.04 110.856 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.32 -178.6 0.01 OUTLIER Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.716 2.247 . . . . 62.41 118.716 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 70.11 -31.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.86 1.8 . . . . 72.41 115.86 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m 83.13 137.64 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 126.202 1.801 . . . . 74.23 111.009 -167.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.14 -14.31 40.35 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.243 2.629 . . . . 73.51 115.244 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -92.21 -14.31 29.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.977 0.511 . . . . 74.21 111.541 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.3 m -95.55 123.98 54.53 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.006 0.922 . . . . 73.1 110.905 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.6 Cg_exo -48.5 98.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.735 2.957 . . . . 64.3 114.254 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.68 -39.19 0.47 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 113.922 0.329 . . . . 50.54 113.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.65 139.08 45.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.595 1.331 . . . . 43.24 114.595 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 4.2 mp0 -103.35 149.23 24.96 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.089 0.555 . . . . 72.33 110.857 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 34.4 ptt180 -127.04 119.78 27.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.48 0.582 . . . . 72.22 110.575 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.24 102.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.647 0.779 . . . . 64.14 110.795 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.624 ' HE2' HG22 ' A' ' 34' ' ' VAL . 6.0 m-85 -64.0 123.03 17.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.438 1.095 . . . . 73.24 111.354 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.06 -66.27 3.89 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-O 120.143 -0.254 . . . . 73.4 112.783 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.61 35.06 20.05 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.415 1.086 . . . . 74.51 113.456 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.82 37.78 0.05 OUTLIER Glycine 0 N--CA 1.476 1.301 0 CA-C-N 115.781 -0.645 . . . . 45.43 112.198 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -147.16 162.42 38.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.338 1.055 . . . . 74.24 110.901 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.57 -23.39 65.4 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.379 0.672 . . . . 64.52 112.496 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -122.06 90.22 3.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.011 0.524 . . . . 72.21 111.355 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.34 171.15 7.49 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.457 0.646 . . . . 63.05 111.321 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -136.72 114.15 10.91 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.661 0.784 . . . . 74.12 109.17 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 44.0 t -99.23 113.79 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.524 -0.546 . . . . 73.22 109.524 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 58.0 mt-10 -107.21 167.22 10.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.431 1.093 . . . . 60.41 110.627 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -151.07 125.23 9.32 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 52.22 110.548 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 39.5 tp -69.09 116.36 9.44 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.87 1.268 . . . . 64.33 111.245 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -82.19 -51.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 122.924 0.49 . . . . 64.34 110.98 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.5 pt-20 -156.4 152.67 27.8 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.485 0.714 . . . . 73.21 110.032 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -142.48 131.72 23.41 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.264 0.554 . . . . 74.3 111.715 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.8 m-20 -119.09 102.58 8.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.913 1.285 . . . . 71.03 110.068 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.69 -52.73 55.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.866 0.866 . . . . 72.35 112.124 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -71.49 -33.42 69.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.102 0.561 . . . . 75.15 112.182 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -83.29 -10.36 58.56 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 112.75 0.648 . . . . 64.12 112.75 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 61.16 34.37 18.96 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.927 0.891 . . . . 74.43 111.65 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -119.06 112.23 19.29 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.877 0.871 . . . . 70.14 110.432 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -118.34 108.66 15.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.478 1.111 . . . . 74.44 111.631 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.8 t -108.48 127.78 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.693 -0.629 . . . . 55.21 111.685 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -135.89 -179.26 5.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.817 0.847 . . . . 63.25 111.203 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -146.01 164.29 32.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.608 1.163 . . . . 73.12 109.839 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 61' ' ' LEU . 73.6 mtm -103.52 97.07 9.67 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 122.988 0.515 . . . . 73.31 110.013 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.07 -13.42 31.36 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.155 2.57 . . . . 55.42 112.96 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 14.6 t70 -140.57 79.36 20.17 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 109.022 -0.733 . . . . 71.53 109.022 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -90.2 136.69 2.46 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.208 2.605 . . . . 71.32 113.747 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.54 -10.9 20.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.368 2.046 . . . . 65.02 113.231 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -94.02 131.53 31.5 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.713 0.805 . . . . 74.34 110.239 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.528 ' HG2' HG21 ' A' ' 117' ' ' THR . 37.5 Cg_endo -63.92 88.86 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.973 2.448 . . . . 62.4 113.465 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.0 pt -134.87 165.19 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 124.998 1.319 . . . . 75.22 109.762 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.0 m -100.75 -76.9 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.898 0.479 . . . . 72.53 110.947 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.77 110.32 22.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.013 0.435 . . . . 64.54 111.073 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -89.21 147.26 24.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.03 0.532 . . . . 73.23 111.165 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -153.28 125.57 8.05 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.219 1.008 . . . . 63.25 108.869 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.61 146.86 44.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.725 0.693 . . . . 71.03 112.056 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.92 145.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.796 0.838 . . . . 75.14 110.955 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 108.78 15.9 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.572 1.149 . . . . 63.02 108.062 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.99 112.71 17.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.682 0.393 . . . . 73.24 110.533 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 HG22 ' A' ' 105' ' ' VAL . 21.6 t -90.54 108.12 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.819 -0.808 . . . . 25.52 108.819 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.6 t -99.39 108.92 52.87 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.398 1.079 . . . . 73.33 110.153 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.94 124.79 11.35 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.102 1.868 . . . . 35.32 113.018 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -93.81 -56.46 2.88 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.375 -0.972 . . . . 64.3 108.375 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -118.75 -169.35 1.71 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.724 1.209 . . . . 73.0 110.068 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.52 -27.25 46.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.131 0.572 . . . . 73.04 111.475 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -109.56 2.03 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.839 0.856 . . . . 75.01 112.634 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -136.93 125.24 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.873 0.469 . . . . 72.04 109.771 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.6 p -137.29 132.82 34.25 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.023 0.44 . . . . 62.22 110.657 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.2 m -91.66 109.82 21.14 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.931 -0.577 . . . . 64.41 110.828 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.622 HG22 HG13 ' A' ' 95' ' ' VAL . 27.1 t -88.34 111.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.585 -0.524 . . . . 73.14 109.585 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.09 114.75 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.562 0.745 . . . . 74.34 110.667 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -103.84 118.69 37.28 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.439 0.696 . . . . 72.45 109.178 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.5 m -112.47 139.48 48.02 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.359 1.064 . . . . 62.0 109.817 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.61 108.89 4.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.214 0.605 . . . . 45.14 111.505 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.36 135.4 54.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.308 1.043 . . . . 72.11 110.375 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.28 145.07 26.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.624 0.77 . . . . 65.43 111.274 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.42 79.6 9.51 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.849 0.833 . . . . 60.11 109.914 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.663 ' HB2' HG22 ' A' ' 86' ' ' ILE . 49.1 t -108.94 164.58 12.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.734 -1.121 . . . . 64.11 111.317 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.5 t -83.01 137.57 43.19 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.574 -0.727 . . . . 63.05 110.169 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -44.56 -49.05 9.61 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 124.617 3.545 . . . . 50.11 116.165 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.78 -32.17 73.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.836 0.68 . . . . 72.1 112.836 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.528 HG21 ' HG2' ' A' ' 85' ' ' PRO . 55.0 m -82.79 -33.51 27.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.825 0.45 . . . . 74.1 110.857 174.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.48 86.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.483 0.713 . . . . 72.52 111.76 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.18 -36.47 79.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.181 0.593 . . . . 54.31 111.88 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.32 -42.04 79.95 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.1 110.79 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.94 -24.49 64.28 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 71.14 112.016 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.59 -41.63 97.7 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.851 0.461 . . . . 62.2 111.826 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -76.94 -45.54 27.38 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.021 0.748 . . . . 72.3 113.021 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.6 -54.74 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 112.535 0.569 . . . . 44.44 112.535 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.95 -49.05 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.297 0.639 . . . . 72.13 110.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.03 -79.39 0.43 Allowed Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.251 -0.431 . . . . 61.33 113.592 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.59 -7.41 26.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.496 0.924 . . . . 65.01 113.496 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.23 -83.51 1.72 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 112.098 -0.401 . . . . 43.42 112.098 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.2 t -58.2 -46.66 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.048 0.939 . . . . 65.05 113.331 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.439 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 4.4 m-30 -77.57 -49.39 14.73 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.847 0.459 . . . . 65.31 111.21 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.55 -17.14 59.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.07 0.767 . . . . 73.23 113.07 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -85.2 -55.46 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 122.843 0.457 . . . . 74.12 111.376 166.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.72 -53.62 36.87 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 114.518 0.567 . . . . 62.23 114.518 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.86 -41.6 78.24 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.323 1.049 . . . . 60.01 112.138 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.31 -39.4 62.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.349 -0.842 . . . . 72.51 111.953 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.41 75.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.408 0.683 . . . . 73.02 111.0 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.421 HD21 HG13 ' A' ' 17' ' ' VAL . 9.7 tt -65.63 -43.27 90.0 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.785 0.834 . . . . 53.41 110.585 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.37 68.88 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 122.884 0.474 . . . . 71.43 111.839 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.11 -39.94 60.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.95 0.9 . . . . 61.02 112.512 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -73.83 -22.99 59.58 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.723 0.638 . . . . 72.04 112.723 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -90.09 -2.5 58.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.076 -0.39 . . . . 72.45 111.242 168.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.465 0 CA-C-N 116.285 -0.416 . . . . 34.41 114.031 173.337 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 121.991 0.901 . . . . 63.52 110.306 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -142.39 131.18 22.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.06 -0.973 . . . . 64.34 110.746 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.53 121.08 44.39 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.033 1.333 . . . . 61.24 109.133 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -120.35 120.53 36.28 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.248 0.547 . . . . 73.14 110.111 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.43 147.29 46.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.542 1.137 . . . . 74.2 109.616 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.6 p -151.0 150.47 30.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.314 0.646 . . . . 50.14 111.018 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.3 p -146.82 138.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.175 0.59 . . . . 73.3 111.645 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.53 108.9 19.26 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.289 0.566 . . . . 72.25 110.036 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -101.62 131.36 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.71 1.204 . . . . 54.14 110.303 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.34 73.95 3.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.875 0.47 . . . . 75.23 111.133 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 155.81 7.51 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.393 0.677 . . . . 74.2 111.481 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.74 138.55 38.15 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.901 2.4 . . . . 73.22 111.905 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.35 -32.32 48.61 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.95 1.093 . . . . 51.13 113.95 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -50.26 66.81 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.952 0.501 . . . . 65.14 111.885 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.24 -39.23 82.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.467 0.707 . . . . 70.03 112.595 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 21.5 t -70.95 -34.37 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.491 0.316 . . . . 72.41 110.654 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.734 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 69.4 t-105 -67.31 -28.94 68.41 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.834 0.454 . . . . 71.25 111.316 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -64.17 -21.24 66.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.124 0.57 . . . . 73.44 111.579 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 tp -90.32 -43.13 10.55 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 124.465 1.106 . . . . 71.42 112.916 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -107.13 13.72 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 113.778 1.029 . . . . 70.32 113.778 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.06 -17.22 75.02 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 114.169 0.428 . . . . 75.45 114.169 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.9 m-20 -102.78 137.88 40.41 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.359 0.664 . . . . 73.4 110.307 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.67 -23.79 67.52 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.96 0.904 . . . . 72.24 111.008 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.7 p -89.21 -22.37 22.8 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.823 0.849 . . . . 55.24 112.803 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -81.92 4.17 23.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.159 0.429 . . . . 21.12 112.159 -166.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.664 HG23 HG11 ' A' ' 34' ' ' VAL . 19.4 tt -66.91 -25.29 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.131 0.572 . . . . 74.15 111.761 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -74.71 -7.06 52.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 122.08 -0.387 . . . . 75.41 111.987 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.77 -31.9 25.68 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.127 0.571 . . . . 51.34 111.752 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.7 p-90 -118.48 -29.05 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.673 0.62 . . . . 75.22 112.673 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 38.8 t-80 -94.16 107.62 30.02 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 109.741 -0.466 . . . . 72.41 109.741 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.05 -7.24 20.98 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.916 2.41 . . . . 72.24 114.96 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -87.63 -28.6 21.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.693 0.397 . . . . 74.53 111.269 172.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.664 HG11 HG23 ' A' ' 27' ' ' ILE . 46.4 t -80.97 107.45 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 109.902 -0.407 . . . . 73.13 109.902 174.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -72.75 -71.37 0.3 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.976 0.51 . . . . 61.23 110.951 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.62 104.38 0.46 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 123.986 0.915 . . . . 51.01 110.399 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 58.9 Cg_endo -84.97 166.6 11.27 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.985 2.457 . . . . 64.53 114.343 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -100.93 114.9 29.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.673 1.189 . . . . 71.34 110.122 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 4.2 mm? -90.85 134.73 34.22 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.727 0.411 . . . . 74.42 111.419 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -108.95 121.32 44.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.526 0.73 . . . . 73.22 111.322 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.02 -169.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 117.837 1.895 . . . . 65.13 117.837 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 56.63 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.635 1.174 . . . . 74.34 113.714 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.3 t 168.4 148.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 125.591 1.557 . . . . 63.55 108.766 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.17 -14.08 31.8 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.476 2.117 . . . . 64.02 112.792 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -95.82 -20.5 18.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.172 0.989 . . . . 64.25 112.789 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.8 m -99.78 123.37 47.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 122.692 0.397 . . . . 74.3 111.568 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.3 Cg_endo -57.16 126.9 23.6 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.056 2.504 . . . . 70.11 113.325 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.62 -24.75 4.58 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.918 -0.583 . . . . 43.41 112.331 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 138.75 55.67 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.155 0.582 . . . . 71.03 111.597 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 39.9 mt-10 -113.22 134.35 54.63 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.492 0.717 . . . . 44.42 110.603 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 25.1 ptt180 -108.41 118.98 38.2 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.301 0.572 . . . . 75.15 110.164 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 62' ' ' VAL . 42.3 t -116.5 114.28 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.424 0.69 . . . . 73.44 110.611 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.625 ' HB2' ' H ' ' A' ' 61' ' ' LEU . 1.7 m-85 -71.77 90.83 1.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.919 0.887 . . . . 75.14 111.897 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.26 3.72 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 119.941 -0.366 . . . . 73.32 113.251 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.89 96.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.743 1.217 . . . . 62.42 112.195 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.49 4.65 Favored Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.112 -0.367 . . . . 62.12 113.855 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.7 p -104.59 -81.63 0.52 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.611 0.764 . . . . 70.52 110.793 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.014 0.926 . . . . 70.42 110.367 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -132.36 39.23 3.4 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.136 0.97 . . . . 75.2 109.572 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 122.56 16.09 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.112 -0.949 . . . . 70.03 111.291 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.625 ' H ' ' HB2' ' A' ' 53' ' ' PHE . 57.7 tp -97.23 116.87 30.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.573 0.749 . . . . 71.12 110.611 -174.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 52' ' ' VAL . 48.6 t -98.55 114.92 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.7 -0.481 . . . . 74.04 109.7 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 79' ' ' MET . 41.7 mt-10 -118.24 164.06 15.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.219 1.008 . . . . 73.02 110.392 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -148.3 130.38 15.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.575 0.75 . . . . 64.33 110.944 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 28.7 tp -73.3 112.1 9.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.115 0.966 . . . . 63.32 110.817 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.14 -47.91 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.439 0.695 . . . . 65.31 110.84 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.324 1.05 . . . . 73.24 109.535 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -139.91 108.67 5.95 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.68 -0.638 . . . . 74.31 109.856 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 3.2 m-20 -91.3 71.26 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.708 0.803 . . . . 71.23 109.934 -175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 44.1 tt0 -63.73 -31.96 73.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.019 -0.537 . . . . 74.54 111.631 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -66.8 -14.66 62.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.8 0.84 . . . . 71.41 112.568 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.22 4.99 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.769 0.828 . . . . 54.01 112.604 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 97' ' ' PRO . 77.8 mtt180 55.89 60.46 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.264 1.025 . . . . 53.13 112.46 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 42.5 ttm180 -143.0 147.33 34.95 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.195 0.998 . . . . 62.1 110.357 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.8 tp -137.49 108.45 6.72 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.366 1.066 . . . . 75.34 110.181 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.22 127.57 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.604 0.762 . . . . 71.44 111.1 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.2 177.69 10.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.045 0.538 . . . . 74.34 112.319 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -142.92 157.6 44.42 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.092 0.957 . . . . 75.24 110.781 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.63 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 18.0 ptt? -111.53 98.49 40.78 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 117.993 0.36 . . . . 73.32 110.231 163.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.47 -22.41 74.01 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.258 2.639 . . . . 52.41 112.726 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 3.9 m-20 -118.33 83.61 21.06 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.692 0.797 . . . . 73.42 109.909 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.74 144.51 3.02 Favored 'Trans proline' 0 CA--C 1.566 2.075 0 C-N-CA 122.806 2.337 . . . . 73.31 113.14 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.6 4.58 6.55 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.648 2.232 . . . . 62.2 112.921 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -105.36 153.64 39.55 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 124.061 0.945 . . . . 64.5 111.201 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.15 71.61 3.56 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.185 2.59 . . . . 73.42 113.12 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 113' ' ' CYS . 21.4 pt -139.61 153.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.247 1.019 . . . . 73.14 110.65 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 15.9 m -95.36 -91.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.27 -0.395 . . . . 53.44 110.887 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -85.42 121.83 28.69 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-N 119.19 0.905 . . . . 74.23 109.654 175.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.43 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 52.7 t-80 -109.06 121.16 44.56 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.075 0.55 . . . . 74.43 111.875 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 146.53 28.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.296 1.038 . . . . 65.44 109.179 167.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.79 132.37 19.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.867 0.867 . . . . 73.53 109.747 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.2 p -133.82 129.9 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.159 0.584 . . . . 52.24 112.194 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.44 123.72 48.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.247 1.419 . . . . 75.13 108.618 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.05 149.25 50.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.13 0.572 . . . . 72.24 110.503 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 13.6 m -125.56 109.78 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.86 0.838 . . . . 65.14 109.419 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 125.59 76.34 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.024 0.929 . . . . 61.32 110.504 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG3' HH11 ' A' ' 73' ' ' ARG . 12.8 Cg_exo -70.78 72.65 1.93 Allowed 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.722 2.281 . . . . 72.1 111.912 170.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -71.31 -35.19 71.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.733 0.813 . . . . 52.42 110.006 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 27.3 t70 -163.78 163.08 24.11 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.173 1.389 . . . . 74.21 108.655 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.81 -8.42 52.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.735 -0.603 . . . . 64.23 112.21 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -126.0 -2.86 7.07 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.489 1.116 . . . . 65.35 111.935 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 39.6 m170 -135.97 127.6 28.92 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.463 0.705 . . . . 73.43 110.453 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.531 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 39.7 t -129.88 134.22 47.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.526 0.73 . . . . 45.02 110.404 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 90.1 m -98.24 111.63 23.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.283 -0.266 . . . . 71.34 110.283 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 95' ' ' VAL . 34.3 t -86.73 106.11 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.063 -0.717 . . . . 70.32 109.063 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.11 117.42 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.536 0.735 . . . . 71.23 110.189 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -118.82 121.42 39.99 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.166 -0.679 . . . . 63.45 109.166 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.576 HG22 ' SD ' ' A' ' 110' ' ' MET . 56.4 m -129.98 130.18 44.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.238 0.615 . . . . 62.53 110.791 -172.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.28 115.78 24.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 64.33 110.915 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 108' ' ' THR . 3.5 mpp? -99.28 140.57 33.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.437 -0.949 . . . . 74.41 108.437 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.19 151.66 23.35 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.022 0.749 . . . . 64.21 113.022 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 20.2 t70 -83.7 85.29 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.146 -0.934 . . . . 72.42 109.42 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.744 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.7 t -128.83 163.58 24.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.986 -0.552 . . . . 51.44 112.406 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.4 p -75.19 141.4 74.11 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.587 -0.733 . . . . 54.03 111.47 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -48.37 -39.75 35.8 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.561 2.84 . . . . 71.24 113.866 170.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.57 -42.27 87.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.783 0.833 . . . . 64.34 112.572 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 27.0 m -82.47 -26.23 32.82 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.597 0.359 . . . . 72.11 111.424 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.89 76.42 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.544 0.738 . . . . 50.22 112.507 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -60.37 -33.56 72.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.974 0.51 . . . . 73.11 111.858 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -44.0 57.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.314 0.646 . . . . 74.52 110.601 174.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -34.65 77.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.076 0.398 . . . . 61.45 112.076 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.35 -43.8 97.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.886 0.474 . . . . 62.31 111.017 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.6 m -69.64 -56.41 7.35 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.223 0.609 . . . . 54.44 112.64 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.47 -49.65 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 124.644 1.177 . . . . 52.11 112.685 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.72 -48.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 122.604 0.361 . . . . 74.02 110.977 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.45 -75.53 0.6 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 114.126 0.411 . . . . 53.4 114.126 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.19 -26.7 68.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.181 0.592 . . . . 73.21 111.695 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.86 -89.54 0.55 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.281 -0.418 . . . . 75.33 112.777 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.21 -49.47 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.887 0.875 . . . . 74.31 113.175 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -73.36 -53.73 10.05 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.647 0.779 . . . . 73.1 112.111 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.34 73.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.677 0.391 . . . . 71.22 111.968 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.74 -49.87 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 62.42 111.329 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.34 87.21 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 116.476 -0.329 . . . . 72.54 113.602 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 mt -69.27 -38.22 78.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 70.25 112.152 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.9 m-20 -67.04 -43.11 83.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.728 0.411 . . . . 71.4 110.23 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.02 81.83 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.301 0.64 . . . . 64.35 111.737 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 7.4 tt -65.87 -41.96 90.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.359 0.664 . . . . 74.33 110.234 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.94 79.44 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 116.389 -0.369 . . . . 72.35 111.245 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 41.6 mt-10 -64.53 -41.52 96.31 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.53 0.937 . . . . 74.24 113.53 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -64.05 -32.26 73.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.164 0.431 . . . . 75.22 112.164 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.8 -23.12 22.94 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.311 0.856 . . . . 73.44 113.311 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.995 0 N-CA-C 115.314 0.885 . . . . 73.43 115.314 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.382 0 CA-C-O 121.016 0.436 . . . . 43.44 111.45 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' HB3' ' A' ' 110' ' ' MET . 89.8 m -117.15 112.21 20.55 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.672 0.789 . . . . 71.12 109.922 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.42 126.32 45.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.933 1.293 . . . . 72.53 110.117 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -118.29 119.72 35.49 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.757 0.423 . . . . 73.03 109.879 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -127.64 139.29 52.82 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.594 0.757 . . . . 73.01 109.879 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 p -144.87 155.33 43.4 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.343 0.657 . . . . 65.42 111.382 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 104' ' ' THR . 13.7 p -150.31 147.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.22 110.641 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.86 109.09 21.86 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.332 0.587 . . . . 71.21 110.289 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.415 HG21 HD22 ' A' ' 137' ' ' LEU . 69.2 t -95.07 137.81 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.386 1.474 . . . . 71.01 110.834 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.61 67.68 5.44 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.484 0.714 . . . . 53.4 112.305 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 141' ' ' TYR . . . -163.29 150.31 10.64 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.441 0.696 . . . . 70.23 111.449 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.82 144.24 76.6 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.711 2.274 . . . . 70.14 111.296 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -48.11 -41.22 25.82 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.234 1.568 . . . . 72.51 115.234 -172.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.31 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.967 0.507 . . . . 73.22 112.087 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.63 -41.99 87.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.858 0.863 . . . . 64.34 112.511 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -70.88 -36.27 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.042 0.449 . . . . 65.13 110.647 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -68.29 -27.61 66.46 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.246 0.618 . . . . 74.12 111.628 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m -62.11 -31.5 71.96 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.268 0.556 . . . . 53.34 110.886 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.0 tp -83.15 -58.29 2.91 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.479 1.112 . . . . 75.01 112.35 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.95 -20.16 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.068 0.766 . . . . 62.42 113.068 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.83 12.4 16.95 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.346 0.898 . . . . 71.14 115.346 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 11.1 t70 -120.61 120.6 36.23 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.072 0.949 . . . . 54.0 108.486 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.5 -31.38 72.42 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.92 0.888 . . . . 74.24 112.124 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.8 t -82.3 -22.81 35.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.432 0.693 . . . . 74.44 112.074 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.55 22.52 6.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.832 0.679 . . . . 51.5 112.832 -163.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.691 HG23 HG11 ' A' ' 34' ' ' VAL . 20.1 tt -69.02 -22.53 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 123.389 0.676 . . . . 74.25 111.605 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -62.1 -14.62 38.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.752 1.019 . . . . 73.31 113.752 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.3 mtm180 -78.97 -46.46 18.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.934 0.493 . . . . 64.23 111.945 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.9 p-90 -103.79 -30.89 10.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.684 0.393 . . . . 74.11 111.706 -171.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.452 ' CE1' HE21 ' A' ' 33' ' ' GLN . 35.2 t-80 -91.34 107.85 24.57 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 122.98 0.512 . . . . 71.11 110.107 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.34 -19.42 61.73 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.072 2.515 . . . . 74.4 114.787 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.452 HE21 ' CE1' ' A' ' 31' ' ' HIS . 2.3 mp0 -84.32 -23.6 30.16 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.608 0.363 . . . . 71.43 111.858 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.691 HG11 HG23 ' A' ' 27' ' ' ILE . 84.8 t -76.21 118.8 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 120.843 0.354 . . . . 72.14 111.397 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.1 m -73.26 -74.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.965 0.906 . . . . 74.44 110.554 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -167.51 103.32 0.6 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.588 0.755 . . . . 72.44 110.72 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.35 150.3 17.26 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.762 2.308 . . . . 72.54 113.529 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.7 m -100.26 123.49 44.55 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.093 0.957 . . . . 43.12 108.853 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.8 128.54 40.1 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.242 -0.651 . . . . 40.21 109.242 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -124.93 148.59 48.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.195 0.998 . . . . 74.1 110.312 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.37 132.5 0.0 OUTLIER Glycine 0 CA--C 1.554 2.515 0 N-CA-C 117.584 1.794 . . . . 60.21 117.584 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 67.31 -90.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.146 1.378 . . . . 42.41 113.392 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t 179.77 150.11 0.51 Allowed Pre-proline 0 N--CA 1.492 1.645 0 C-N-CA 124.08 0.952 . . . . 74.14 110.52 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.19 -6.55 14.97 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.459 2.106 . . . . 62.21 113.343 173.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -109.6 -7.58 15.1 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.639 0.776 . . . . 63.32 111.877 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 m -103.73 121.85 46.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 122.8 0.44 . . . . 75.01 111.401 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.8 121.19 8.81 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.297 2.664 . . . . 75.24 113.104 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.29 -6.5 8.68 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 122.865 0.269 . . . . 54.12 113.379 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.12 172.82 11.68 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.578 0.751 . . . . 71.11 112.957 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.35 152.64 45.95 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.178 0.991 . . . . 62.34 111.12 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -130.94 132.0 44.8 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.496 0.718 . . . . 71.01 110.31 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.51 110.85 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.602 0.761 . . . . 74.23 110.139 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -71.66 97.39 1.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.451 0.908 . . . . 74.45 113.451 -169.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.85 -59.31 0.67 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.496 -0.642 . . . . 62.22 111.496 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.03 108.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.746 1.219 . . . . 75.41 112.616 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.79 54.41 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 116.515 -0.311 . . . . 70.03 113.268 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.9 p -116.27 -79.98 0.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.613 0.765 . . . . 51.11 111.087 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 177.42 -54.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.61 1.164 . . . . 72.25 107.913 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.1 14.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.792 1.237 . . . . 73.54 113.605 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.05 96.08 1.28 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.266 1.031 . . . . 74.11 112.59 -172.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -87.72 131.53 34.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.425 -1.261 . . . . 65.42 108.918 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -102.43 115.59 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.283 -0.636 . . . . 73.32 109.283 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 44.8 mt-10 -121.0 133.96 55.28 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 72.34 110.749 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.35 120.83 43.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.065 0.946 . . . . 73.11 110.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.71 119.59 11.46 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.645 1.178 . . . . 71.14 112.045 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.97 -51.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.508 0.723 . . . . 65.23 111.048 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 13.0 pt-20 -160.21 165.02 32.31 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 64.33 111.131 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.2 ttp85 -156.81 128.59 7.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.314 0.646 . . . . 64.2 109.917 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.39 123.88 38.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.747 0.819 . . . . 72.35 109.949 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.23 -46.64 49.0 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.823 0.849 . . . . 72.51 111.05 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.8 t -65.54 -25.14 67.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.136 0.974 . . . . 53.55 112.72 -170.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.54 -7.58 15.7 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.817 0.847 . . . . 74.3 112.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 11.6 mtm-85 58.93 45.62 14.84 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.93 0.892 . . . . 73.44 112.296 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -114.72 124.62 52.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.237 1.015 . . . . 72.22 111.054 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.4 tp -122.43 107.95 12.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.749 0.82 . . . . 71.35 110.043 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 39.4 t -111.06 136.08 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.555 0.616 . . . . 74.41 110.711 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -150.14 -179.91 7.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.047 0.939 . . . . 73.43 110.902 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 t -142.43 164.12 30.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.877 0.871 . . . . 72.04 110.593 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mtp -109.3 88.35 5.87 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 123.661 0.784 . . . . 71.24 110.305 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 34.9 Cg_endo -62.28 -34.27 78.33 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.558 2.839 . . . . 51.3 113.637 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -125.28 81.95 63.03 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.006 0.522 . . . . 64.41 109.736 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -94.39 147.38 1.86 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 123.072 2.515 . . . . 62.34 113.869 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.72 -2.2 11.72 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.412 2.075 . . . . 62.11 112.774 170.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 40.2 m-85 -99.83 135.4 20.5 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.228 1.011 . . . . 73.04 109.449 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 15.0 Cg_exo -68.92 82.01 0.6 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.923 2.416 . . . . 60.32 112.666 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.768 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.6 pt -135.09 141.6 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 124.229 1.012 . . . . 63.44 110.308 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.3 m -83.94 -75.65 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.173 -0.33 . . . . 74.23 110.875 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -107.92 111.02 22.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.19 0.519 . . . . 72.22 110.448 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -92.91 151.68 19.81 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.731 0.813 . . . . 75.24 111.775 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -150.19 126.49 10.72 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 72.1 109.702 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.86 143.23 49.39 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.882 0.765 . . . . 75.44 112.003 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 8.9 p -137.6 142.24 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 113.14 0.793 . . . . 64.32 113.14 -176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -108.42 117.11 33.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.869 1.268 . . . . 73.45 109.05 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 46.5 mt-10 -127.37 113.91 16.86 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.757 0.423 . . . . 64.32 111.345 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.06 111.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.081 0.467 . . . . 74.1 109.755 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.36 110.16 59.15 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.136 0.974 . . . . 72.05 110.261 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HA ' ' SG ' ' A' ' 103' ' ' CYS . 51.8 Cg_endo -66.16 114.43 3.02 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.703 2.269 . . . . 64.22 114.655 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.4 11.91 22.31 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.162 0.985 . . . . 73.43 111.304 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 67.85 175.28 0.26 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.475 1.51 . . . . 73.42 113.287 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 60.26 -86.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.277 1.431 . . . . 70.35 112.397 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -153.09 43.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.785 0.802 . . . . 71.4 109.98 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -142.65 139.5 31.26 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.408 0.683 . . . . 74.32 109.545 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 97' ' ' PRO . 75.5 m -153.63 138.97 17.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.507 0.723 . . . . 75.33 111.141 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 25.3 m -90.93 111.27 22.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.988 0.515 . . . . 72.22 111.163 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.34 118.88 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.897 0.479 . . . . 72.41 109.938 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.29 112.55 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.782 0.833 . . . . 74.21 109.965 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -107.49 112.03 24.6 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 108.812 -0.81 . . . . 73.12 108.812 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.7 m -123.83 127.2 47.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.59 0.756 . . . . 61.23 110.152 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.3 118.44 22.3 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.225 0.61 . . . . 75.13 111.362 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.625 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -118.8 128.83 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.588 1.155 . . . . 71.15 109.09 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -145.26 156.5 43.87 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.719 0.808 . . . . 74.11 111.498 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 25.3 t70 -89.86 85.15 6.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.372 0.606 . . . . 74.44 109.861 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 86' ' ' ILE . 53.6 t -122.72 148.47 45.29 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.434 -0.803 . . . . 50.01 111.809 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 t -62.82 125.08 85.71 Favored Pre-proline 0 N--CA 1.485 1.298 0 CA-C-O 118.678 -0.677 . . . . 42.35 109.847 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -52.07 -22.29 14.44 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.523 2.815 . . . . 74.44 115.695 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.02 -50.23 67.06 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 122.796 0.439 . . . . 74.22 112.018 170.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.537 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 34.4 m -71.13 -36.85 72.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.912 0.485 . . . . 35.35 110.594 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 115' ' ' PRO . . . -69.61 -38.49 77.3 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.749 0.819 . . . . 74.34 112.542 -171.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -64.8 -34.11 77.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.288 0.566 . . . . 73.54 110.916 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.11 -34.12 74.58 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.275 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 117' ' ' THR . 77.8 mt -75.01 -25.62 58.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.433 0.693 . . . . 62.35 111.483 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.87 -32.7 74.14 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.496 0.589 . . . . 70.14 110.607 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 55.6 m -70.08 -58.12 4.18 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.556 0.576 . . . . 73.54 112.556 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.13 -55.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 122.968 0.507 . . . . 52.22 112.198 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 121' ' ' LEU . 56.7 mt -74.32 -49.68 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.71 0.404 . . . . 72.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.96 -55.38 19.66 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.789 0.676 . . . . 62.15 114.789 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.69 -52.99 5.42 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.891 0.845 . . . . 61.53 111.59 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.51 -36.94 92.19 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 115.083 0.793 . . . . 62.43 115.083 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.66 -56.89 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 122.474 -0.427 . . . . 72.01 110.966 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -75.71 -61.97 1.74 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.727 0.64 . . . . 74.24 112.727 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.26 70.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.775 0.43 . . . . 54.54 111.11 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 t -65.58 -50.93 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.223 0.609 . . . . 71.31 111.823 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.32 95.77 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-O 120.97 0.206 . . . . 73.32 113.372 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.66 -39.44 70.32 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.448 1.099 . . . . 74.13 111.732 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 8.1 m-80 -69.77 -38.55 76.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.404 0.282 . . . . 41.43 110.402 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.71 76.65 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.679 0.792 . . . . 75.14 111.564 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 10' ' ' VAL . 5.1 tt -66.52 -36.37 82.54 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.878 0.871 . . . . 43.22 109.568 173.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.04 62.46 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.189 0.595 . . . . 70.5 112.295 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 10.8 mm-40 -72.56 -42.53 64.56 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 122.949 0.5 . . . . 71.21 111.828 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.47 -41.29 96.59 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 120.718 0.294 . . . . 75.01 111.54 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 12' ' ' ALA . 71.5 m-85 -81.79 -2.94 52.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.501 0.321 . . . . 73.12 111.059 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.578 0 CA-C-N 116.569 -0.287 . . . . 74.35 113.159 168.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 112.54 0.57 . . . . 65.51 112.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -79.67 110.18 14.76 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.424 0.631 . . . . 71.42 111.677 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.74 121.71 36.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.933 1.293 . . . . 75.34 109.143 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -130.69 137.89 49.76 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.185 0.517 . . . . 71.03 111.357 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -132.12 152.46 51.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.521 1.128 . . . . 72.02 109.441 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.0 p -149.45 149.62 31.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.452 0.701 . . . . 72.22 110.201 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.7 p -144.1 138.31 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.157 0.583 . . . . 62.32 111.852 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.96 108.5 16.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.31 -0.626 . . . . 73.34 109.31 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.89 130.83 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.441 1.096 . . . . 63.32 110.976 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.3 71.8 3.02 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.066 0.546 . . . . 64.51 111.203 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.08 141.71 0.83 Allowed Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.625 1.17 . . . . 62.24 110.664 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.44 141.25 95.06 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.866 2.377 . . . . 44.34 113.255 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 103' ' ' CYS . . . -47.5 -42.66 23.54 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.296 1.591 . . . . 70.25 115.296 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.6 85.24 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.128 0.571 . . . . 75.33 112.153 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.49 -34.94 78.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.603 0.761 . . . . 71.33 112.278 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.33 -35.55 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.847 0.459 . . . . 61.04 110.716 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 60.4 t-105 -72.38 -25.89 61.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.036 0.534 . . . . 74.34 111.342 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.1 m -58.37 -29.5 66.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 72.33 110.654 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.571 HD22 HH11 ' A' ' 140' ' ' ARG . 62.1 tp -84.97 -59.68 2.27 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.748 1.219 . . . . 71.33 111.706 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.8 14.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 113.441 0.904 . . . . 63.14 113.441 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.16 33.28 5.52 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 112.356 -0.298 . . . . 63.54 112.356 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -154.82 148.17 25.03 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.94 0.896 . . . . 72.15 110.044 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -84.97 -25.66 27.63 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.465 0.706 . . . . 74.43 111.625 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -92.87 -21.39 19.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.495 0.718 . . . . 73.32 112.384 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.21 8.14 9.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.486 0.55 . . . . 71.14 112.486 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.631 HG21 ' NH1' ' A' ' 51' ' ' ARG . 20.5 tt -68.46 -23.92 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 C-N-CA 124.153 0.981 . . . . 74.31 112.611 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -74.51 0.42 14.83 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -97.36 -15.54 20.66 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.795 . . . . 74.4 112.313 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.569 ' HB3' HD21 ' A' ' 20' ' ' LEU . 37.5 p-90 -128.68 -38.12 1.72 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.637 0.606 . . . . 75.23 112.637 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 64.2 t-80 -89.64 115.28 63.44 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 122.86 0.464 . . . . 74.04 110.365 -173.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 13.6 Cg_exo -69.97 -23.68 29.54 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.197 2.598 . . . . 45.34 114.885 -169.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.48 -15.36 52.77 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.215 0.45 . . . . 73.13 112.215 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 36' ' ' ALA . 98.5 t -70.89 120.74 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 122.89 0.476 . . . . 54.51 112.211 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -93.37 20.5 7.07 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.034 0.934 . . . . 60.11 112.394 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 70.28 110.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.638 1.575 . . . . 51.23 112.186 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -86.05 168.79 9.08 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.193 2.595 . . . . 74.54 114.241 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.5 m -101.91 127.75 48.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.693 1.197 . . . . 61.01 110.171 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.61 125.29 37.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.071 0.938 . . . . 54.43 113.033 -171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 41.5 mmt180 -92.8 -174.46 3.62 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.695 1.998 . . . . 72.51 110.808 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.74 -128.79 0.44 Allowed Glycine 0 CA--C 1.547 2.081 0 N-CA-C 116.993 1.557 . . . . 71.41 116.993 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.97 -79.97 0.45 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.018 0.927 . . . . 75.14 112.393 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -121.99 141.0 33.21 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.8 0.84 . . . . 65.21 111.153 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.87 -8.33 13.42 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 123.249 2.633 . . . . 44.23 114.084 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -88.2 -25.53 22.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.916 0.486 . . . . 74.44 111.366 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 81.7 m -77.72 123.03 86.55 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 124.011 0.925 . . . . 75.34 112.527 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.0 Cg_endo -56.48 103.4 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.115 2.543 . . . . 52.22 112.058 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.72 -36.05 1.56 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.916 -0.584 . . . . 50.32 112.18 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 148.15 50.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.298 0.639 . . . . 30.33 111.587 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 32.2 mt-10 -124.69 140.3 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.894 0.478 . . . . 73.44 111.141 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.631 ' NH1' HG21 ' A' ' 27' ' ' ILE . 15.5 ptt180 -105.25 112.97 26.28 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.706 0.765 . . . . 74.12 109.68 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 62' ' ' VAL . 45.1 t -111.33 100.03 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 55.21 109.833 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 38.4 m-85 -59.47 134.28 56.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.149 0.58 . . . . 74.33 110.097 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.8 -67.94 1.05 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 114.803 0.681 . . . . 54.24 114.803 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.73 95.68 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.403 1.481 . . . . 61.22 111.153 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.64 23.71 66.75 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-N 115.742 -0.663 . . . . 55.12 113.467 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 p -123.29 172.72 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.559 0.744 . . . . 63.14 111.323 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.7 -39.38 80.51 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.667 0.787 . . . . 73.23 111.708 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -90.12 64.58 6.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.875 0.845 . . . . 74.24 109.774 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.4 tt0 -108.28 137.3 46.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.754 -0.657 . . . . 73.34 112.276 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 83' ' ' PRO . 31.0 tp -144.21 113.19 6.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.824 0.85 . . . . 73.11 109.235 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 40.0 t -98.93 115.23 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.692 -0.485 . . . . 63.2 109.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 68.9 mt-10 -123.35 148.51 45.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.944 0.898 . . . . 64.52 110.079 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -124.22 132.34 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.133 0.573 . . . . 71.44 111.027 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -74.33 114.91 13.24 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.361 0.664 . . . . 65.32 110.535 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.402 HG11 HH12 ' A' ' 90' ' ' ARG . 61.3 t -79.36 -51.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 122.801 0.441 . . . . 40.44 110.916 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 10.1 pt-20 -153.86 155.49 35.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.433 0.693 . . . . 75.42 110.124 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttp85 -144.26 145.87 32.3 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.359 -0.608 . . . . 71.14 109.359 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -146.46 134.56 21.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.399 0.679 . . . . 73.25 109.746 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 46.7 mt-10 -90.16 -50.87 5.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.233 0.613 . . . . 61.51 112.332 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.7 p -70.84 -34.6 71.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.243 0.617 . . . . 75.15 111.969 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.14 -9.71 54.59 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.332 0.653 . . . . 53.25 112.094 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 61.62 43.33 10.05 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.884 0.873 . . . . 73.33 112.211 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -114.58 115.58 27.4 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.728 0.811 . . . . 64.14 111.947 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -113.67 108.45 17.14 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.766 0.827 . . . . 74.44 108.777 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 27.0 t -117.63 130.3 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.634 0.652 . . . . 70.31 110.822 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.76 178.95 7.29 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.689 0.796 . . . . 73.11 111.257 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -135.98 159.34 42.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.351 1.06 . . . . 53.21 109.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 80.1 mtp -112.44 83.94 5.8 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.538 0.735 . . . . 70.32 109.046 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 81.2 Cg_endo -72.03 -16.6 28.84 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.253 2.635 . . . . 63.44 113.511 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 9.7 t70 -134.06 82.06 49.45 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 108.72 -0.845 . . . . 62.34 108.72 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -91.41 150.02 3.59 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.167 2.578 . . . . 71.41 113.34 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD3' HD13 ' A' ' 61' ' ' LEU . 72.7 Cg_endo -81.07 -0.68 10.73 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.739 2.292 . . . . 75.41 113.12 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -105.25 154.69 38.73 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.99 0.916 . . . . 71.23 110.673 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 70.67 3.96 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.832 2.355 . . . . 73.53 113.075 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -137.52 133.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.588 1.155 . . . . 71.22 109.525 -177.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 22.4 m -77.14 -79.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.941 -0.474 . . . . 51.02 111.894 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -108.88 104.69 13.99 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.928 0.491 . . . . 75.13 111.03 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.53 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 65.4 t-80 -93.38 146.26 23.87 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.742 0.817 . . . . 75.33 111.356 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.402 HH12 HG11 ' A' ' 66' ' ' VAL . 14.8 tpt180 -146.56 111.31 5.27 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.997 0.919 . . . . 53.42 110.094 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.53 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -124.11 149.06 46.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.075 0.768 . . . . 73.35 113.075 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.12 139.29 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 124.095 0.958 . . . . 71.53 111.668 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 110.6 22.97 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.202 1.001 . . . . 72.41 108.422 162.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -127.04 119.06 25.69 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.755 -0.832 . . . . 64.14 108.755 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 103' ' ' CYS . 96.4 t -101.71 109.97 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.241 0.616 . . . . 72.1 110.858 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.32 113.02 55.95 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 124.8 1.24 . . . . 63.22 111.065 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.25 95.28 1.07 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.945 2.43 . . . . 63.51 113.156 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -79.26 -37.38 38.03 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.243 0.46 . . . . 75.14 112.243 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 35.0 t70 -157.07 162.58 39.48 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.28 0.632 . . . . 73.12 111.282 -169.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.66 -21.15 65.49 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.824 1.249 . . . . 72.1 113.075 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.06 0.83 5.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.474 0.71 . . . . 72.41 112.252 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 32.8 m80 -134.7 123.06 23.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.662 0.664 . . . . 74.12 109.901 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 95' ' ' VAL . 38.2 t -142.95 137.63 29.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.425 0.29 . . . . 62.34 111.341 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.2 m -92.42 111.75 23.44 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.887 0.475 . . . . 74.45 111.3 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.1 112.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.141 -0.688 . . . . 73.5 109.141 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.34 119.15 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.356 0.662 . . . . 71.24 110.075 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -107.47 113.3 26.55 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.658 -0.867 . . . . 75.32 108.658 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -108.89 149.93 28.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.087 0.955 . . . . 63.42 109.502 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.14 145.31 27.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.477 1.111 . . . . 74.32 108.633 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -154.25 133.83 12.82 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.217 0.607 . . . . 65.42 110.104 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.53 153.36 48.73 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.647 -0.706 . . . . 63.24 111.305 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 34.2 t70 -77.14 87.13 3.61 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.055 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.406 ' HB2' HG22 ' A' ' 86' ' ' ILE . 27.9 t -156.1 169.8 23.67 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.616 -0.72 . . . . 64.05 111.883 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 m -76.52 148.28 79.84 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.457 1.103 . . . . 64.13 112.802 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.73 -34.91 92.3 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.821 3.014 . . . . 75.21 114.796 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.89 -31.09 67.63 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.294 0.638 . . . . 74.33 112.25 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 95.2 m -76.76 -38.08 54.79 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.02 0.438 . . . . 74.12 110.027 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -31.48 71.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.968 . . . . 25.05 112.881 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -75.74 -33.33 60.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.939 0.496 . . . . 71.32 111.43 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -42.21 83.49 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 75.04 110.225 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.99 -24.93 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.338 -0.846 . . . . 74.45 111.318 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -60.16 -36.11 76.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.013 0.525 . . . . 73.15 110.908 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -72.57 -53.56 11.58 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.951 -0.568 . . . . 74.21 111.856 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.76 -57.31 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 113.148 0.795 . . . . 74.24 113.148 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -77.83 -57.99 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.804 0.842 . . . . 64.23 110.942 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.53 -51.04 61.17 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 114.263 0.465 . . . . 64.44 114.263 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -95.22 -39.82 9.89 Favored 'General case' 0 CA--C 1.556 1.193 0 O-C-N 121.998 -0.707 . . . . 52.13 112.024 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.49 73.27 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.88 0.712 . . . . 73.13 114.88 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.93 -52.41 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 117.656 0.728 . . . . 72.21 111.024 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 2.8 m-30 -77.72 -53.58 7.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.102 0.408 . . . . 73.03 112.102 -172.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.32 -15.63 62.74 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.11 0.411 . . . . 62.15 112.11 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.6 t -80.86 -51.81 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 123.929 0.892 . . . . 73.32 110.985 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.33 -51.93 44.82 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.09 -0.505 . . . . 70.21 114.258 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.6 mt -58.52 -36.18 73.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.842 0.857 . . . . 71.12 112.776 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 6.3 m-20 -67.83 -46.06 72.9 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.669 -0.493 . . . . 73.21 109.669 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.0 74.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.6 0.76 . . . . 72.31 112.267 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.72 -49.24 78.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.312 1.045 . . . . 71.51 110.121 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -24.03 62.07 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.42 -0.809 . . . . 73.22 111.924 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 6.2 mm-40 -67.57 -50.73 57.05 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.589 0.756 . . . . 74.13 110.585 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.571 HH11 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.95 -15.83 62.09 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.737 0.643 . . . . 72.4 112.737 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -87.02 -22.62 25.38 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.803 0.668 . . . . 74.33 112.803 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 1.792 0 N-CA-C 116.227 1.251 . . . . 64.33 116.227 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 122.074 0.94 . . . . 64.55 110.408 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -144.48 119.33 9.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.279 -0.873 . . . . 40.32 110.38 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.17 147.54 23.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 60.1 109.226 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -149.53 129.96 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.138 0.575 . . . . 65.44 109.832 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -130.78 151.62 51.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.932 0.893 . . . . 62.31 108.751 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 96.3 p -146.85 163.34 36.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.991 0.516 . . . . 73.53 110.895 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.69 149.19 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.87 0.468 . . . . 65.25 111.057 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.56 109.22 19.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.029 0.532 . . . . 50.34 110.231 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 12' ' ' ALA . 85.8 t -96.49 129.9 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.312 1.045 . . . . 75.32 109.601 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.23 26.24 0.78 Allowed 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.563 0.949 . . . . 73.05 113.563 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 10' ' ' VAL . . . -131.55 150.57 76.72 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.583 0.753 . . . . 71.14 110.317 174.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.85 151.05 50.84 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.184 2.589 . . . . 72.11 112.984 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.02 -28.81 10.87 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.789 1.236 . . . . 54.51 114.27 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -50.9 64.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.774 0.657 . . . . 75.04 112.774 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -44.94 64.7 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.704 0.801 . . . . 71.0 111.901 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG13 HD21 ' A' ' 137' ' ' LEU . 15.0 t -73.36 -34.51 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 114.896 -1.047 . . . . 71.32 111.62 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 65.5 t-105 -73.48 -28.99 62.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.233 0.613 . . . . 72.13 111.505 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 m -60.65 -26.96 67.45 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.629 0.728 . . . . 74.25 110.838 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.549 HD22 HH11 ' A' ' 140' ' ' ARG . 54.4 tp -91.41 -44.03 9.38 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.361 1.064 . . . . 61.41 113.091 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.62 -21.72 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 113.588 0.959 . . . . 73.22 113.588 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.68 73.89 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 114.281 0.472 . . . . 75.04 114.281 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 3.6 m-20 -86.73 122.59 30.84 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.638 -1.245 . . . . 75.24 107.638 171.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.423 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 4.0 t80 -61.1 -27.84 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.992 0.517 . . . . 63.43 110.635 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -77.5 -23.51 50.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.024 0.93 . . . . 72.14 113.426 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -83.15 9.28 10.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 112.529 0.566 . . . . 60.14 112.529 -161.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.541 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 13.7 tt -62.64 -25.11 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 123.221 0.608 . . . . 73.54 111.52 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.766 ' HA ' HG11 ' A' ' 34' ' ' VAL . 26.4 p-80 -71.84 0.17 9.73 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.632 0.605 . . . . 63.42 112.632 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -102.92 -18.18 15.16 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.721 0.808 . . . . 25.53 112.754 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.541 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 33.0 p-90 -126.99 -42.24 1.75 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.433 1.271 . . . . 74.42 114.433 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.609 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.3 t-80 -72.73 119.86 77.6 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 117.985 0.357 . . . . 72.11 110.273 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 -22.33 73.86 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.373 2.048 . . . . 71.13 115.002 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.97 -4.19 22.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.041 0.756 . . . . 70.44 113.041 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.766 HG11 ' HA ' ' A' ' 28' ' ' HIS . 11.2 p -63.81 148.13 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 CA-C-N 118.228 0.467 . . . . 74.42 111.157 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -113.22 28.4 8.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.293 0.637 . . . . 53.3 111.402 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.41 85.97 0.18 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 123.781 0.832 . . . . 74.34 111.163 -173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.99 173.32 13.67 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.888 2.392 . . . . 73.45 114.077 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.7 m -112.97 130.51 56.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.33 1.052 . . . . 62.0 110.178 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.69 137.18 42.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.7 0.8 . . . . 61.31 110.07 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.548 ' HG3' ' HB2' ' A' ' 50' ' ' GLU . 11.1 ptm180 -150.82 162.04 41.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.904 0.882 . . . . 74.31 111.012 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.74 143.89 0.0 OUTLIER Glycine 0 CA--C 1.557 2.68 0 N-CA-C 117.25 1.66 . . . . 65.24 117.25 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 57.97 -104.46 0.22 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.403 1.081 . . . . 63.42 112.165 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 m -170.73 151.19 3.37 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 125.204 1.402 . . . . 61.22 109.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.58 0.58 1.8 Allowed 'Trans proline' 0 N--CA 1.513 2.639 0 C-N-CA 123.453 2.769 . . . . 72.13 115.29 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -119.69 -18.38 8.37 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.534 0.734 . . . . 74.13 111.408 168.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 m -87.88 123.34 69.2 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 123.251 0.62 . . . . 75.42 111.22 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 71.2 Cg_exo -45.99 119.06 2.66 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.727 2.951 . . . . 71.04 114.22 171.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.43 -20.62 4.39 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.507 0.575 . . . . 61.25 112.726 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.34 141.54 54.2 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.26 0.837 . . . . 74.4 113.26 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.684 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 28.9 mt-10 -107.71 126.94 53.21 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.906 0.882 . . . . 75.15 110.698 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 24' ' ' PHE . 58.1 ttp180 -102.38 108.72 20.15 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.073 0.949 . . . . 74.33 109.869 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 62' ' ' VAL . 41.8 t -112.11 112.98 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.844 0.858 . . . . 60.3 110.931 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 34' ' ' VAL . 76.3 m-85 -73.45 -58.1 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.959 0.725 . . . . 71.42 112.959 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.42 -50.27 39.26 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-N 116.436 -0.347 . . . . 44.2 112.776 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 51.07 24.66 1.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.938 1.295 . . . . 65.41 114.118 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.73 24.28 0.02 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-N 116.196 -0.456 . . . . 72.11 113.037 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 60' ' ' GLU . 72.7 p -129.02 142.2 50.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.317 1.047 . . . . 73.34 109.779 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.18 -30.31 70.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.779 0.659 . . . . 74.44 112.779 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.04 75.38 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.731 0.776 . . . . 73.22 110.579 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 14.0 pt-20 -109.16 164.51 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.648 1.179 . . . . 71.54 111.758 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.0 tp -103.21 124.11 47.99 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.999 0.52 . . . . 71.45 109.692 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 52' ' ' VAL . 61.7 t -120.18 128.1 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.537 0.735 . . . . 64.23 109.688 173.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 35.2 mt-10 -117.45 149.42 40.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.47 1.108 . . . . 72.21 110.335 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.684 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 96.2 mtt180 -126.03 129.83 49.95 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.005 0.522 . . . . 63.11 111.378 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 14.5 tp -67.63 115.82 7.64 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.009 0.924 . . . . 73.33 111.034 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.477 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 98.0 t -84.98 -51.75 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.509 0.724 . . . . 71.24 111.297 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 6.3 pt-20 -158.15 140.49 14.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.527 0.731 . . . . 75.2 110.197 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.23 124.15 28.37 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.099 0.56 . . . . 63.15 110.224 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.57 100.45 8.29 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.525 -0.917 . . . . 62.1 108.525 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 25.5 tt0 -80.02 -31.08 39.65 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 112.374 0.509 . . . . 70.51 112.374 -172.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -69.86 -43.59 71.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.16 0.584 . . . . 63.5 111.71 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.8 -10.12 59.75 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 55.3 111.913 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 61.21 55.62 2.93 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.557 1.143 . . . . 61.42 112.005 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -132.38 135.05 45.87 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.278 -1.328 . . . . 74.21 110.139 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -124.39 132.23 53.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.167 1.387 . . . . 72.2 108.862 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 41.3 t -133.63 130.52 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 118.338 0.517 . . . . 63.15 111.078 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 54.9 p90 -141.26 -179.45 6.12 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.342 1.057 . . . . 72.15 110.573 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.484 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.3 t -130.44 162.76 28.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.649 1.18 . . . . 43.15 110.367 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.441 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.5 mtp -109.8 85.58 4.09 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.825 0.85 . . . . 65.33 109.278 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 71.8 Cg_endo -71.36 -24.5 22.74 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.48 2.787 . . . . 74.33 113.095 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.88 76.43 70.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 109.441 -0.577 . . . . 73.44 109.441 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -95.55 150.78 1.5 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.097 2.531 . . . . 61.51 113.456 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 -6.88 17.97 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.176 1.917 . . . . 71.04 112.21 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -92.32 143.28 27.14 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.477 1.111 . . . . 72.33 110.771 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HG2' HG21 ' A' ' 117' ' ' THR . 90.5 Cg_endo -78.72 72.99 6.15 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.741 2.294 . . . . 71.13 112.689 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 113' ' ' CYS . 19.1 pt -127.87 145.52 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.356 1.062 . . . . 61.13 110.575 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.3 m -82.78 -78.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.616 0.366 . . . . 75.33 111.812 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.72 106.66 14.76 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.29 0.566 . . . . 75.1 109.944 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.595 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 56.1 t-80 -91.65 159.38 15.9 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.445 0.698 . . . . 43.2 111.673 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -165.47 103.25 0.72 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.104 0.962 . . . . 74.24 110.254 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.595 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -98.65 153.5 18.64 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.58 0.752 . . . . 70.31 112.544 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.49 132.56 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.883 0.873 . . . . 74.22 111.48 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -109.08 107.58 17.95 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.748 1.219 . . . . 75.03 109.268 166.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.92 130.71 48.92 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 122.002 -0.436 . . . . 72.12 110.434 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.601 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 27.8 m -99.67 111.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.672 0.749 . . . . 72.54 109.852 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 95.8 t -83.32 107.67 10.58 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.571 1.149 . . . . 74.44 109.448 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 5.4 Cg_exo -74.25 108.23 2.62 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.789 2.326 . . . . 71.3 111.911 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -84.4 -60.44 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.186 0.594 . . . . 74.11 110.495 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.49 175.37 9.21 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.031 0.932 . . . . 71.5 110.366 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.69 -4.58 43.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.82 0.448 . . . . 52.2 110.578 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -23.96 11.68 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.823 1.249 . . . . 63.31 112.344 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 37.1 m80 -136.01 150.96 49.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.354 0.524 . . . . 62.44 112.014 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 45.5 t -143.56 173.6 11.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.358 1.063 . . . . 35.34 110.175 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.6 m -135.94 119.24 16.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.18 0.592 . . . . 70.44 110.835 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG23 HG21 ' A' ' 10' ' ' VAL . 26.0 t -91.27 113.06 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 122.144 -0.347 . . . . 73.52 110.199 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.54 109.91 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.473 1.109 . . . . 64.42 109.725 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -106.69 111.65 24.28 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 109.163 -0.68 . . . . 74.22 109.163 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.9 m -109.63 147.13 33.6 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.187 0.995 . . . . 73.32 109.964 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -131.78 111.27 11.49 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.956 0.903 . . . . 70.01 111.122 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.9 mtt -98.86 131.14 45.19 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.857 0.863 . . . . 75.41 108.978 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -156.96 144.68 19.12 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.413 0.523 . . . . 75.44 112.413 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.57 87.83 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.6 0.714 . . . . 52.14 110.676 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 53.5 t -134.28 169.09 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.643 -1.162 . . . . 71.44 111.411 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.2 m -68.44 146.93 98.09 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 62.01 112.222 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 -41.33 72.96 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.436 2.757 . . . . 73.54 114.29 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.77 -43.77 97.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.493 0.717 . . . . 62.44 111.813 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.45 HG21 ' HG2' ' A' ' 85' ' ' PRO . 21.3 m -71.81 -36.93 70.41 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.307 -0.406 . . . . 74.04 110.756 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.04 85.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.652 0.781 . . . . 62.23 112.322 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -28.54 63.49 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.484 0.314 . . . . 65.34 111.587 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.07 -42.04 89.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.223 0.535 . . . . 74.41 110.049 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.95 -22.88 62.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.904 0.882 . . . . 75.45 112.199 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -58.04 -43.37 86.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.299 0.5 . . . . 52.32 110.683 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -72.12 -49.79 33.31 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.6 0.593 . . . . 74.54 112.6 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.09 -54.61 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.207 0.527 . . . . 75.33 112.287 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.02 -56.45 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.78 0.832 . . . . 62.31 111.536 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.53 96.36 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 114.659 0.624 . . . . 73.22 114.659 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -88.72 -60.18 2.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.955 0.502 . . . . 74.25 110.634 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.84 -29.6 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 115.834 1.094 . . . . 73.13 115.834 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -105.16 -53.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 117.317 0.558 . . . . 72.01 110.873 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 5.2 m-30 -75.43 -65.47 0.89 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.804 -0.634 . . . . 65.04 111.793 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.06 66.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.856 0.462 . . . . 55.12 111.554 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.56 -53.73 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.986 0.914 . . . . 75.31 112.26 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.42 -35.17 81.32 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 116.402 -0.363 . . . . 63.15 113.395 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -44.83 61.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.3 1.04 . . . . 74.24 112.027 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -65.7 -38.19 88.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.376 0.27 . . . . 62.42 110.895 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.76 88.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.946 0.498 . . . . 42.55 111.611 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.538 HD21 HG13 ' A' ' 17' ' ' VAL . 7.0 tt -64.75 -42.5 95.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.693 0.797 . . . . 71.43 110.151 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.38 80.23 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.875 -0.602 . . . . 64.1 112.06 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.08 -33.12 61.62 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.754 0.822 . . . . 74.31 112.741 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.549 HH11 HD22 ' A' ' 20' ' ' LEU . 2.2 ptm180 -73.27 -24.72 60.47 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.773 0.32 . . . . 75.4 111.06 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 54.4 m-85 -100.75 4.14 42.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.432 0.693 . . . . 74.12 111.559 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.997 0 N-CA-C 115.156 0.823 . . . . 72.3 115.156 -179.698 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 111' ' ' PHE . . . . . . . . 0 CA--C 1.558 1.273 0 CA-C-O 120.869 0.366 . . . . 64.35 111.221 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -108.13 112.62 25.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.156 0.982 . . . . 64.34 108.969 172.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.3 mp -97.14 121.76 39.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.774 1.23 . . . . 74.33 109.936 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -117.6 113.64 22.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.789 -0.449 . . . . 74.15 109.789 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -120.95 135.49 55.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.005 0.922 . . . . 74.33 109.818 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -138.1 159.93 40.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.688 0.795 . . . . 63.43 111.301 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.1 p -155.6 150.89 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.611 0.364 . . . . 74.4 111.874 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -92.34 119.09 31.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.959 0.504 . . . . 52.43 110.025 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.23 124.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.607 1.163 . . . . 70.35 109.82 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.76 71.68 4.25 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.569 0.7 . . . . 70.43 111.241 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.77 155.89 8.36 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.013 0.925 . . . . 75.0 110.909 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.39 137.84 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.777 2.318 . . . . 75.21 112.261 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.59 -46.69 10.15 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.233 1.568 . . . . 63.12 115.233 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.58 92.02 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 112.421 0.526 . . . . 54.34 112.421 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.16 -39.36 86.12 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.674 0.789 . . . . 61.24 112.051 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 HD21 ' A' ' 137' ' ' LEU . 44.3 t -73.9 -34.35 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.501 0.72 . . . . 71.5 111.15 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.531 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 75.8 t-105 -67.66 -29.67 69.02 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.713 0.405 . . . . 74.32 111.558 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 m -60.24 -30.86 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.635 0.731 . . . . 64.44 110.737 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 63.0 tp -83.5 -52.09 6.79 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.269 1.428 . . . . 71.24 112.143 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.31 -38.34 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.33 0.863 . . . . 62.1 113.33 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.58 -8.48 63.24 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.121 0.808 . . . . 74.45 115.121 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.99 113.92 26.34 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.612 -0.885 . . . . 60.31 108.612 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.15 -25.81 65.81 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.806 1.242 . . . . 60.12 113.303 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -96.7 -17.88 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.467 0.543 . . . . 73.3 112.467 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.77 15.42 4.8 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.196 0.598 . . . . 72.51 111.571 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 34' ' ' VAL . 20.2 tt -67.06 -24.9 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 C-N-CA 123.97 0.908 . . . . 72.34 111.88 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -64.55 -12.74 48.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.239 0.829 . . . . 73.43 113.239 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.35 -28.99 26.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.771 0.656 . . . . 71.3 112.771 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 48.0 p-90 -118.64 -35.49 3.71 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.034 0.534 . . . . 64.23 111.883 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.434 ' CE1' HE21 ' A' ' 33' ' ' GLN . 53.1 t-80 -90.88 107.8 23.33 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.596 0.758 . . . . 51.04 109.356 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.29 -19.06 62.05 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.293 2.662 . . . . 75.41 114.715 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.434 HE21 ' CE1' ' A' ' 31' ' ' HIS . 5.0 mt-30 -96.77 0.67 49.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.02 0.748 . . . . 75.11 113.02 -171.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 27' ' ' ILE . 60.7 t -78.56 117.71 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 120.817 0.342 . . . . 74.54 111.12 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -90.89 51.33 1.94 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.547 0.739 . . . . 55.01 111.915 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 58.9 99.81 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 124.953 1.301 . . . . 42.52 113.147 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.65 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 97.9 Cg_endo -77.46 147.26 25.27 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.821 2.347 . . . . 62.25 114.779 -172.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.6 m -105.47 120.93 42.85 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.625 1.17 . . . . 74.14 109.152 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.86 127.64 38.44 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.269 0.557 . . . . 54.11 112.187 -170.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -115.33 123.36 48.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.077 0.951 . . . . 71.03 110.659 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.68 178.35 0.01 OUTLIER Glycine 0 CA--C 1.546 1.981 0 N-CA-C 117.308 1.683 . . . . 60.44 117.308 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.26 -118.69 1.37 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 124.837 1.255 . . . . 70.1 112.967 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -175.24 162.3 2.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 124.122 0.969 . . . . 74.43 109.421 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.47 -5.29 4.08 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.798 2.332 . . . . 63.55 115.077 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.0 -10.43 9.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.729 -0.607 . . . . 73.53 112.195 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.8 m -98.73 122.0 54.45 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 123.097 0.559 . . . . 70.21 111.357 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.87 113.67 1.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.308 2.672 . . . . 72.43 112.909 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.05 -22.76 2.1 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.132 -0.485 . . . . 72.12 113.172 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 141.49 57.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.51 0.724 . . . . 55.22 112.725 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 38.8 mt-10 -114.5 115.97 28.08 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.195 0.598 . . . . 74.13 109.938 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 29.3 ptt180 -93.36 123.78 36.89 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.441 0.696 . . . . 60.12 110.099 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -119.04 108.28 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.238 0.615 . . . . 74.54 110.209 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -66.63 101.75 0.83 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.623 0.769 . . . . 73.14 112.374 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.53 -71.18 2.3 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.339 -0.391 . . . . 63.22 112.306 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 68.37 136.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.166 1.386 . . . . 42.21 112.926 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.13 19.67 64.43 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-O 121.437 0.465 . . . . 62.32 112.191 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.3 p -117.84 -160.21 0.77 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.545 1.538 . . . . 42.5 110.132 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.87 5.6 15.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.803 0.841 . . . . 71.05 110.527 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.92 9.97 6.96 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.823 0.849 . . . . 75.54 113.233 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.28 144.31 44.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.016 0.747 . . . . 64.12 113.016 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.7 tp -120.71 126.11 49.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.375 1.07 . . . . 73.14 109.453 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.39 115.33 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.975 0.51 . . . . 52.21 109.854 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 43.6 mt-10 -120.0 137.72 53.92 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.024 0.93 . . . . 73.41 110.162 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -118.4 133.65 55.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.297 0.639 . . . . 61.44 112.102 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.67 120.74 21.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.736 1.215 . . . . 70.1 111.133 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.72 -41.53 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.284 0.634 . . . . 73.21 111.256 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 10.7 tp10 -152.99 147.03 25.45 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.092 0.957 . . . . 71.54 110.145 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -146.67 123.44 11.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.687 0.395 . . . . 65.43 110.629 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -106.63 -177.66 3.43 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.967 0.907 . . . . 60.53 110.812 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 41.1 tt0 -147.95 -47.11 0.16 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.866 0.466 . . . . 71.21 110.706 172.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.8 p -64.31 -43.47 94.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.269 0.628 . . . . 60.15 111.186 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.09 -26.54 59.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.349 0.66 . . . . 62.14 112.512 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 60.28 59.45 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.853 0.861 . . . . 71.31 111.426 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -139.31 122.75 17.22 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.766 0.826 . . . . 74.55 110.117 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 66.1 tp -124.27 109.01 12.84 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.21 1.004 . . . . 71.01 111.459 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 56.4 t -106.4 132.0 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.014 0.825 . . . . 75.13 111.28 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -152.84 179.73 8.39 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.103 0.561 . . . . 74.04 111.865 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.2 t -144.66 166.02 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.529 1.132 . . . . 73.23 111.054 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.646 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.7 mtm -99.84 99.38 8.91 Favored Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 123.373 0.669 . . . . 74.45 110.492 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 22.5 Cg_endo -62.13 -20.34 69.53 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 123.517 2.812 . . . . 65.24 112.748 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.75 81.18 69.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.972 0.509 . . . . 74.42 110.436 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.32 123.35 1.02 Allowed 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.787 2.325 . . . . 73.34 112.774 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.98 27.11 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.641 2.228 . . . . 71.25 113.156 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.44 147.27 61.58 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.391 1.077 . . . . 73.25 109.87 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 76.69 0.94 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.099 2.533 . . . . 74.51 113.23 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.1 pt -132.75 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 124.47 1.108 . . . . 75.21 109.953 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 23.8 m -103.27 -78.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.406 0.282 . . . . 70.14 111.41 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -105.02 100.37 9.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.998 0.519 . . . . 74.14 111.171 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -88.61 144.74 26.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 42.35 112.826 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -137.33 158.04 45.29 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 72.44 109.592 168.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HB1' ' HE1' ' A' ' 107' ' ' TRP . . . -158.62 119.91 3.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.516 1.126 . . . . 71.22 109.111 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 31.9 t -125.74 132.23 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.13 0.572 . . . . 75.31 112.449 -168.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.42 119.33 38.68 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.648 0.779 . . . . 73.53 109.3 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -130.45 114.03 15.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.961 0.504 . . . . 72.4 110.567 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.46 116.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.298 0.639 . . . . 71.12 110.36 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.9 m -113.42 123.04 34.01 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 123.902 0.881 . . . . 72.3 110.904 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 124.97 11.79 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.835 2.357 . . . . 70.2 113.483 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -109.24 -9.43 15.0 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.221 1.008 . . . . 61.23 112.143 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 34.9 t70 -175.87 167.9 3.05 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.157 1.383 . . . . 54.22 109.212 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.27 -39.3 66.74 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.045 0.938 . . . . 72.25 112.23 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -131.81 38.95 3.51 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.435 0.636 . . . . 71.12 110.377 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 77.9 m80 -148.95 135.6 19.61 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.293 1.037 . . . . 65.33 109.974 166.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 17' ' ' VAL . 32.0 p -148.98 144.95 27.1 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.395 0.678 . . . . 72.42 110.681 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 78.7 m -93.35 116.96 29.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.151 0.58 . . . . 40.25 110.681 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.79 118.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.04 0.536 . . . . 44.54 109.669 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.8 117.37 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 123.605 0.762 . . . . 73.53 110.45 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.556 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 5.2 t90 -105.3 116.4 31.89 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.974 -0.75 . . . . 73.13 108.974 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -124.46 123.82 40.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.586 0.754 . . . . 63.41 111.371 -170.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -106.93 141.03 38.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.871 0.868 . . . . 74.32 111.076 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -128.59 124.58 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.869 -0.789 . . . . 70.31 108.869 168.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.455 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 5.2 p90 -148.02 147.91 30.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.886 0.328 . . . . 53.42 111.886 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.605 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -84.18 86.83 7.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.365 0.602 . . . . 71.21 109.966 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.746 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.7 t -125.64 144.01 50.78 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.151 -0.931 . . . . 55.25 111.782 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.0 m -59.44 140.08 88.64 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.939 0.896 . . . . 70.32 111.516 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -56.83 -31.62 89.27 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.143 2.562 . . . . 74.2 114.171 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.09 -40.98 95.78 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.958 0.903 . . . . 61.54 112.013 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 24.3 m -88.11 -31.43 19.21 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.521 -0.763 . . . . 52.51 110.997 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -67.15 -40.17 86.67 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.737 0.815 . . . . 70.11 111.64 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -61.63 -33.64 74.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.427 0.691 . . . . 75.12 111.185 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 -36.19 63.12 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.562 1.145 . . . . 60.05 110.411 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 117' ' ' THR . 86.9 mt -74.42 -24.08 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 51.14 111.746 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 49.3 mt-10 -63.23 -35.11 79.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 120.96 0.41 . . . . 75.14 110.703 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 m -72.37 -56.64 5.12 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.271 0.628 . . . . 73.22 112.098 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.69 -54.45 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 112.432 0.531 . . . . 74.33 112.432 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.8 mt -78.68 -51.07 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.033 0.533 . . . . 54.34 110.789 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.99 -49.13 69.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.68 0.632 . . . . 71.44 114.68 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 29.7 t70 -91.82 -52.68 4.62 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 121.85 -0.794 . . . . 70.23 111.212 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.54 -28.71 73.88 Favored Glycine 0 N--CA 1.476 1.362 0 N-CA-C 115.404 0.922 . . . . 54.33 115.404 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.8 t -105.55 -58.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.57 0.685 . . . . 62.13 110.543 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 3.5 m-30 -71.27 -64.96 0.81 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.07 0.548 . . . . 73.51 112.386 -170.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -59.58 -31.44 69.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.993 0.517 . . . . 73.23 112.079 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -58.03 -54.41 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.563 0.745 . . . . 71.02 111.93 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.68 -41.07 94.07 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.304 0.377 . . . . 74.23 113.025 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.01 -43.3 88.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.081 0.953 . . . . 74.21 112.084 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.67 -38.0 76.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 119.47 -0.3 . . . . 72.22 111.107 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.84 81.6 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.136 0.493 . . . . 72.23 111.095 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 HG13 ' A' ' 17' ' ' VAL . 4.2 tt -66.58 -41.43 88.53 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 115.266 -0.879 . . . . 64.34 109.849 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.78 76.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.125 0.57 . . . . 53.25 112.352 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.24 -45.47 60.06 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.468 0.707 . . . . 75.21 111.574 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.38 -26.65 68.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 111.99 0.367 . . . . 70.34 111.99 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.84 -22.81 15.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.176 0.59 . . . . 62.0 112.316 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 O-C-N 122.157 -0.339 . . . . 71.52 113.821 179.572 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 112.145 0.424 . . . . 62.42 112.145 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 m -106.02 116.34 31.77 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.985 -0.746 . . . . 72.54 108.985 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 136.18 39.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.84 1.256 . . . . 75.12 109.298 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -133.9 130.33 37.64 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.201 0.524 . . . . 64.14 110.751 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 32.2 mmt-85 -138.07 153.68 49.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.501 1.12 . . . . 72.23 109.118 169.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 p -152.43 158.66 42.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.216 0.531 . . . . 64.13 111.443 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.9 p -149.82 152.49 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 72.22 109.398 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.96 123.47 48.22 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.705 0.684 . . . . 74.43 110.486 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.12 136.35 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 125.344 1.458 . . . . 55.52 110.372 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.77 66.51 4.27 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.359 0.599 . . . . 50.21 111.199 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.38 157.05 5.62 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.327 1.051 . . . . 72.31 111.023 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.92 140.96 68.87 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.95 2.433 . . . . 73.42 112.199 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.52 23.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.604 1.335 . . . . 54.42 114.604 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.51 82.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.483 0.713 . . . . 71.23 112.3 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 -37.51 86.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.387 0.675 . . . . 55.41 112.358 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG13 HD21 ' A' ' 137' ' ' LEU . 25.8 t -70.49 -36.76 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.528 -0.76 . . . . 72.12 110.645 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -70.89 -28.32 64.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.786 0.834 . . . . 71.23 111.408 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -63.61 -29.76 70.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.157 0.503 . . . . 75.31 111.028 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.09 -51.06 9.47 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.007 0.923 . . . . 64.33 112.047 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.49 -18.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 113.647 0.981 . . . . 55.15 113.647 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.23 -35.05 91.48 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 123.248 0.451 . . . . 71.43 113.221 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.15 97.96 8.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.321 -0.992 . . . . 60.43 108.321 165.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -75.61 -7.1 53.39 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.274 0.559 . . . . 54.41 112.311 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -70.4 -33.64 71.61 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.409 0.623 . . . . 64.21 110.628 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HB1' ' NE ' ' A' ' 29' ' ' ARG . . . -87.5 16.39 5.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.26 1.024 . . . . 64.43 111.722 -167.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 34' ' ' VAL . 19.9 tt -64.89 -22.63 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 C-N-CA 123.798 0.839 . . . . 71.04 111.667 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -69.87 -9.19 53.95 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.032 0.753 . . . . 73.31 113.032 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.7 mtm180 -88.92 -37.45 15.26 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.108 0.563 . . . . 74.2 111.919 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 58.5 p-90 -109.52 -39.13 5.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.613 0.597 . . . . 75.54 112.613 -171.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 60.8 t-80 -86.74 115.79 63.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.789 -0.819 . . . . 72.24 108.789 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -70.05 -19.79 34.28 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.882 2.388 . . . . 73.03 114.412 -165.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' CE1' ' A' ' 31' ' ' HIS . 2.5 mt-30 -98.81 -4.93 32.12 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.621 0.971 . . . . 75.34 113.621 -169.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 27' ' ' ILE . 63.0 t -67.14 128.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 111.906 0.335 . . . . 75.23 111.906 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -83.52 27.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.25 1.02 . . . . 74.22 112.881 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.87 107.82 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 125.011 1.324 . . . . 41.11 112.054 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 45.1 Cg_endo -85.7 154.05 10.23 Favored 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 122.295 1.997 . . . . 71.12 114.489 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.8 m -112.47 124.95 53.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.58 0.752 . . . . 64.2 109.984 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.2 mm? -91.2 138.49 31.55 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.385 0.674 . . . . 72.03 112.345 -168.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.42 123.11 44.43 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.335 1.054 . . . . 73.2 109.022 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.05 176.95 0.01 OUTLIER Glycine 0 CA--C 1.547 2.091 0 N-CA-C 117.363 1.705 . . . . 61.44 117.363 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.82 -122.43 1.99 Allowed 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.341 1.056 . . . . 33.53 113.085 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p -168.95 164.0 7.48 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 123.848 0.859 . . . . 61.14 109.578 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.91 -24.18 30.6 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.032 2.488 . . . . 74.31 114.415 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.12 -44.99 7.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.194 0.597 . . . . 74.43 110.892 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -67.72 119.05 63.39 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.683 0.793 . . . . 61.01 112.644 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.88 113.75 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.428 2.752 . . . . 42.44 113.14 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.28 -26.22 2.46 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.878 -0.601 . . . . 75.54 112.594 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -65.42 137.31 57.38 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.637 0.606 . . . . 64.52 112.637 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 51.3 mt-10 -118.13 118.92 33.19 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.086 0.555 . . . . 72.12 110.671 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -106.98 134.28 50.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.084 0.468 . . . . 72.42 110.909 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 20.4 t -115.27 103.35 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.593 0.757 . . . . 74.2 110.581 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.76 99.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.476 1.11 . . . . 74.24 111.649 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.68 53.7 6.36 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 123.224 0.327 . . . . 53.43 112.892 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -65.43 90.44 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.065 0.459 . . . . 54.5 111.762 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.19 38.4 0.06 OUTLIER Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.819 -0.628 . . . . 44.42 112.25 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 59' ' ' GLU . 15.0 t -138.36 -162.53 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.173 0.989 . . . . 70.4 110.172 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.9 15.71 20.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.345 0.658 . . . . 75.4 112.263 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 57' ' ' THR . 11.0 pt-20 -168.51 40.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.3 0.852 . . . . 72.33 113.3 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.37 156.4 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.22 0.608 . . . . 71.44 112.163 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -107.95 120.92 43.66 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.724 0.809 . . . . 50.1 110.625 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.75 121.95 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.841 0.456 . . . . 74.44 110.202 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 47.5 mt-10 -118.26 139.01 51.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.788 0.835 . . . . 71.01 110.776 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 10.4 tpp180 -103.85 130.7 51.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.962 0.905 . . . . 71.44 109.69 174.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.73 120.88 26.92 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.038 0.535 . . . . 63.12 110.151 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.25 -45.88 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.28 0.632 . . . . 65.13 112.296 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 35.4 tt0 -159.69 157.48 29.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.221 0.609 . . . . 72.24 110.858 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -148.04 131.88 17.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.237 0.615 . . . . 71.33 109.968 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -124.4 116.4 22.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.69 0.796 . . . . 63.15 109.868 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.08 13.47 33.98 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.244 0.617 . . . . 50.53 112.495 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -94.31 -46.6 6.98 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.22 0.533 . . . . 65.11 110.159 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.24 8.56 25.81 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.64 0.776 . . . . 52.03 111.834 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 56.63 67.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.088 0.955 . . . . 72.12 112.136 175.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -135.96 110.29 8.44 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.852 0.861 . . . . 64.53 111.328 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.5 tp -107.19 108.76 20.35 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.757 1.223 . . . . 65.04 110.844 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 38.3 t -104.2 130.24 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.381 0.672 . . . . 74.31 111.069 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.47 -178.9 6.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.431 0.692 . . . . 73.35 111.573 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.476 ' HB ' ' NH1' ' A' ' 90' ' ' ARG . 6.0 t -149.88 162.44 40.32 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.327 1.051 . . . . 74.45 110.741 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.8 mtp -111.55 93.17 18.62 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.077 0.951 . . . . 63.52 109.862 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 56.0 Cg_endo -67.82 -20.92 45.19 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.442 2.761 . . . . 62.44 112.732 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.87 77.79 57.64 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.734 0.814 . . . . 71.43 109.944 172.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 63.9 Cg_endo -88.72 143.55 5.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.892 2.394 . . . . 75.2 113.296 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 6.7 Cg_exo -77.13 1.53 8.6 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.878 2.385 . . . . 74.33 113.159 173.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.0 147.44 44.45 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 123.787 0.835 . . . . 61.11 111.05 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.516 ' HG2' HG21 ' A' ' 117' ' ' THR . 73.9 Cg_endo -73.1 80.95 1.77 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.695 2.263 . . . . 64.05 112.81 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.697 HG22 ' HB2' ' A' ' 113' ' ' CYS . 20.1 pt -133.41 133.03 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.263 1.025 . . . . 71.11 110.301 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m -74.55 -78.08 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.798 0.439 . . . . 62.43 111.253 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -105.76 108.62 20.23 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.978 -0.451 . . . . 52.04 110.342 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -87.98 142.82 27.49 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.344 0.658 . . . . 51.22 111.356 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.476 ' NH1' ' HB ' ' A' ' 78' ' ' THR . 6.0 tpp180 -149.39 114.25 5.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.473 0.709 . . . . 74.3 109.433 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.42 50.98 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.355 0.525 . . . . 35.42 112.006 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 49.6 t -136.65 141.22 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.224 1.01 . . . . 53.21 111.261 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 3.4 mm? -98.1 140.26 32.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.282 -1.007 . . . . 63.54 108.282 165.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 35.0 tt0 -142.89 110.13 5.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.503 0.592 . . . . 60.43 110.716 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 t -94.03 108.95 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 65.54 108.872 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.4 119.93 54.74 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.644 0.778 . . . . 42.42 109.931 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.83 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.441 2.094 . . . . 65.04 112.249 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -68.22 -32.4 72.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.811 0.844 . . . . 63.4 110.202 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.7 t70 -147.92 165.25 31.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.11 1.364 . . . . 74.45 109.461 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.64 -47.0 85.88 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.279 1.032 . . . . 73.53 111.901 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -113.3 10.94 18.52 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.722 0.809 . . . . 73.54 112.205 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 37.2 m80 -137.59 118.63 14.37 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 118.984 0.811 . . . . 60.31 110.206 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m -136.08 133.83 37.75 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.843 0.457 . . . . 60.32 111.313 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.9 m -92.54 114.81 27.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.142 0.577 . . . . 71.42 111.88 -172.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -92.3 109.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.251 0.621 . . . . 65.21 109.552 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.18 113.1 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.873 0.869 . . . . 74.41 109.647 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -102.63 120.27 40.27 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.857 -0.794 . . . . 71.1 108.857 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.7 m -123.48 141.58 51.86 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.037 0.935 . . . . 63.04 110.426 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.63 110.18 5.76 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.303 0.573 . . . . 72.35 111.508 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -109.54 125.78 52.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.528 1.131 . . . . 62.42 109.161 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -139.35 154.23 47.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.714 0.806 . . . . 72.43 110.596 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 32.7 t70 -86.73 83.76 7.51 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.385 0.612 . . . . 64.53 110.093 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.697 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.1 t -125.37 156.33 38.92 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.641 -0.709 . . . . 64.03 111.754 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -65.36 132.92 95.29 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.487 0.715 . . . . 64.13 111.158 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.23 -38.97 20.68 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.83 3.02 . . . . 71.01 115.472 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.347 0.659 . . . . 71.33 112.127 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' HG2' ' A' ' 85' ' ' PRO . 29.5 m -87.49 -29.07 21.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.824 0.45 . . . . 73.34 110.779 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.41 70.99 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.321 0.648 . . . . 61.11 111.931 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -66.92 -28.08 68.01 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.453 0.701 . . . . 74.31 111.94 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.78 -45.43 61.63 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.567 0.747 . . . . 72.14 110.028 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 117' ' ' THR . 78.3 mt -74.41 -31.63 62.39 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.47 -0.786 . . . . 65.33 113.045 -171.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.96 -34.56 78.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.159 0.436 . . . . 73.04 111.304 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.6 t -70.6 -59.87 2.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.104 0.562 . . . . 65.42 112.117 171.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.11 -55.55 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.266 0.626 . . . . 72.31 112.421 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 121' ' ' LEU . 63.2 mt -76.64 -47.97 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 53.51 110.666 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -61.3 -66.19 2.81 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.765 0.666 . . . . 74.3 114.765 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.59 -41.22 12.12 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.834 -0.804 . . . . 63.13 111.461 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.32 79.02 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.228 0.851 . . . . 60.04 115.228 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.73 -55.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.683 0.742 . . . . 72.35 111.358 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 13.2 m-30 -70.31 -56.37 6.88 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.226 0.454 . . . . 74.34 112.226 -173.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.56 68.52 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.385 0.428 . . . . 71.41 111.525 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.9 t -59.06 -51.18 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 C-N-CA 123.951 0.901 . . . . 52.33 112.263 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -69.56 -34.88 73.95 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 116.607 -0.269 . . . . 64.31 113.633 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.25 -41.65 73.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.128 0.971 . . . . 63.32 111.554 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.64 -40.65 84.58 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.348 -0.387 . . . . 64.11 110.112 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.73 76.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.766 0.827 . . . . 50.42 111.706 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.449 HD21 HG13 ' A' ' 17' ' ' VAL . 5.4 tt -65.13 -39.02 92.47 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 115.419 -0.809 . . . . 73.24 110.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.26 -28.83 64.43 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.055 0.542 . . . . 70.14 112.289 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -67.7 -45.65 74.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.998 0.919 . . . . 74.22 112.099 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.43 HH11 ' HA ' ' A' ' 137' ' ' LEU . 8.8 ptp85 -71.33 -25.52 62.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.098 0.559 . . . . 75.22 112.498 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -93.94 -5.44 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.961 0.505 . . . . 72.43 111.009 170.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.435 0 C-N-CA 122.847 0.261 . . . . 65.12 113.749 176.098 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.902 0.382 . . . . 74.52 111.133 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 110' ' ' MET . 23.5 m -107.55 110.15 21.99 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.765 0.826 . . . . 72.41 109.177 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -94.82 134.52 37.35 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.042 0.937 . . . . 73.21 109.022 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -136.81 137.24 39.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.811 0.444 . . . . 72.44 110.35 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.754 HH11 ' HB2' ' A' ' 131' ' ' ALA . 10.5 ttm180 -147.86 152.1 37.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.201 0.6 . . . . 72.3 109.944 175.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.6 p -141.22 166.38 24.94 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.091 0.472 . . . . 74.41 111.907 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.9 p -152.15 148.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.717 0.807 . . . . 70.14 110.425 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.83 112.08 23.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.236 0.541 . . . . 73.3 109.722 168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 137' ' ' LEU . 88.8 t -91.02 127.9 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.429 1.092 . . . . 71.24 109.762 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 71.16 3.3 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 121.618 0.723 . . . . 71.32 111.541 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.34 151.63 4.62 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.474 1.109 . . . . 72.31 110.247 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.42 140.73 58.9 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.323 2.015 . . . . 51.54 112.257 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.06 -35.49 11.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.505 1.668 . . . . 74.2 115.505 -172.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.19 -48.25 80.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.537 0.569 . . . . 73.11 112.537 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.39 -36.24 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.583 0.753 . . . . 72.41 112.05 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 36.2 t -72.84 -36.65 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.518 0.727 . . . . 71.01 110.631 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.573 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 61.3 t-105 -69.03 -33.5 73.72 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.618 0.767 . . . . 73.24 112.032 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -65.03 -20.1 66.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.563 0.697 . . . . 74.53 111.317 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.2 tp -89.9 -52.67 4.86 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.001 0.921 . . . . 74.21 112.06 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.08 -48.45 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 112.867 0.692 . . . . 65.14 112.867 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.06 65.7 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 115.172 0.829 . . . . 74.31 115.172 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.44 -18.1 60.69 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.065 0.546 . . . . 72.24 111.477 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 t80 73.64 -66.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.785 1.634 . . . . 73.12 112.105 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.3 p -67.7 -14.34 62.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.994 0.918 . . . . 45.22 113.182 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.17 9.77 18.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.67 0.788 . . . . 72.11 111.674 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG23 HG11 ' A' ' 34' ' ' VAL . 19.9 tt -61.23 -31.15 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 N-CA-C 112.76 0.652 . . . . 54.44 112.76 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -70.47 -5.78 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.075 0.768 . . . . 73.02 113.075 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -91.45 -19.86 22.38 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.453 0.701 . . . . 74.31 112.495 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 60.0 p-90 -121.31 -30.6 4.25 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.037 0.535 . . . . 73.23 111.719 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -93.63 103.75 10.85 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.384 0.674 . . . . 75.44 109.815 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.14 -15.92 52.56 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.238 2.626 . . . . 72.33 115.21 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' A' ' 129' ' ' VAL . 27.5 mt-30 -85.07 -28.66 25.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.885 0.474 . . . . 64.14 111.446 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 27' ' ' ILE . 49.1 t -78.7 113.57 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 110.218 -0.29 . . . . 61.3 110.218 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -73.58 -62.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.285 0.634 . . . . 44.25 110.399 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.62 116.01 0.59 Allowed Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 124.386 1.075 . . . . 63.43 110.189 173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.39 144.71 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.463 2.109 . . . . 73.33 113.381 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -95.91 126.7 41.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.193 0.997 . . . . 62.11 109.804 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 9.5 mp -110.03 145.75 36.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.648 0.737 . . . . 65.21 111.42 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -149.85 147.04 27.48 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.486 -1.234 . . . . 72.32 110.246 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.5 153.38 0.0 OUTLIER Glycine 0 CA--C 1.555 2.585 0 N-CA-C 117.687 1.835 . . . . 62.3 117.687 -167.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 72.9 -50.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.837 1.655 . . . . 65.33 115.312 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m 102.12 147.51 0.02 OUTLIER Pre-proline 0 N--CA 1.516 2.863 0 C-N-CA 127.709 2.404 . . . . 63.41 111.869 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.69 -38.53 46.27 Favored 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 124.427 3.418 . . . . 63.33 115.549 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -90.99 10.53 26.22 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.351 0.5 . . . . 73.0 112.351 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -123.75 119.13 26.99 Favored Pre-proline 0 N--CA 1.487 1.382 0 C-N-CA 123.833 0.853 . . . . 42.04 110.536 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 129.22 31.08 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.335 2.69 . . . . 65.45 113.807 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.02 -10.5 13.59 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.392 0.52 . . . . 71.54 112.96 -175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.07 154.69 40.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.376 0.67 . . . . 70.43 111.95 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 50.6 mt-10 -112.79 128.81 56.54 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.938 0.495 . . . . 72.05 111.602 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -107.41 102.86 12.11 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.651 0.78 . . . . 73.2 109.554 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.1 t -106.7 104.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.313 0.577 . . . . 63.32 111.353 -170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' ' 34' ' ' VAL . 66.0 m-85 -75.34 82.68 2.45 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.307 1.043 . . . . 70.42 111.264 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.05 -63.11 0.58 Allowed Glycine 0 N--CA 1.478 1.449 0 CA-C-N 116.042 -0.526 . . . . 60.41 112.3 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.77 -53.23 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.079 1.751 . . . . 73.32 115.318 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.83 37.56 3.32 Favored Glycine 0 N--CA 1.487 2.065 0 CA-C-O 121.234 0.352 . . . . 75.04 112.932 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -120.63 -165.75 1.24 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.274 1.029 . . . . 42.44 110.62 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -122.77 27.41 7.77 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.952 0.901 . . . . 63.31 109.701 167.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.17 9.54 1.11 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.205 1.002 . . . . 51.23 111.913 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 152.21 39.4 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.367 0.604 . . . . 54.02 112.498 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.545 HD11 ' SD ' ' A' ' 79' ' ' MET . 29.2 tp -107.22 119.92 40.71 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.102 0.961 . . . . 72.44 109.224 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.755 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 94.5 t -95.99 114.34 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.283 0.563 . . . . 72.33 109.482 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 17.1 tt0 -115.24 167.88 10.45 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.445 1.098 . . . . 54.24 109.898 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 30.3 ttm-85 -150.82 128.88 11.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.126 0.97 . . . . 54.44 111.736 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.79 129.2 39.19 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.951 0.9 . . . . 63.12 111.123 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.595 HG21 HH11 ' A' ' 90' ' ' ARG . 79.0 t -101.29 -51.13 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.772 0.829 . . . . 75.24 111.384 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -149.72 148.73 29.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.372 1.069 . . . . 70.15 109.136 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -140.02 119.6 13.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.966 -0.383 . . . . 73.54 109.966 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 24.5 m-20 -101.09 102.45 13.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.525 1.13 . . . . 72.24 109.773 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 31.4 tt0 -75.74 -41.14 54.13 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.26 -0.275 . . . . 74.41 111.008 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.9 m -68.76 -50.05 53.71 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.36 0.664 . . . . 62.54 111.146 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -78.49 -6.14 54.55 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.983 0.734 . . . . 55.21 112.983 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 63.43 45.2 4.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.74 1.216 . . . . 74.53 111.945 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.1 ttm105 -129.39 135.36 48.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.913 1.285 . . . . 75.12 110.455 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 tp -125.43 106.15 9.59 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.043 0.537 . . . . 51.35 110.745 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -105.7 126.11 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.693 0.797 . . . . 74.25 110.519 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -146.57 179.51 7.5 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.426 0.69 . . . . 71.13 112.043 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 m -156.56 142.24 17.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.955 1.302 . . . . 71.53 109.74 -169.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.545 ' SD ' HD11 ' A' ' 61' ' ' LEU . 57.3 mtm -95.87 98.79 4.19 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 118.234 0.47 . . . . 61.14 109.79 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.82 -25.03 17.31 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.375 2.717 . . . . 51.22 112.901 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.7 t70 -129.59 80.04 72.55 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.464 0.706 . . . . 74.11 109.489 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -93.36 133.47 0.94 Allowed 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 122.964 2.443 . . . . 54.05 112.761 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.479 ' HD2' HD13 ' A' ' 61' ' ' LEU . 71.7 Cg_endo -72.27 -2.03 11.05 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.203 1.935 . . . . 71.42 112.073 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.84 140.77 50.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 124.454 1.102 . . . . 71.43 109.924 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 77.76 2.77 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.476 2.117 . . . . 73.24 112.889 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 89' ' ' HIS . 7.4 pt -138.94 143.99 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.661 1.184 . . . . 72.31 110.412 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -72.17 -47.45 50.78 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.344 0.868 . . . . 75.25 113.344 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -131.97 -49.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.266 0.469 . . . . 52.34 112.266 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.561 ' HB2' HD12 ' A' ' 86' ' ' ILE . 47.9 t-80 65.35 145.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 125.417 1.487 . . . . 75.04 113.736 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.595 HH11 HG21 ' A' ' 66' ' ' VAL . 21.4 tpp180 -147.08 149.01 32.2 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.732 1.213 . . . . 74.13 108.347 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.7 146.44 20.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.968 0.507 . . . . 74.1 111.74 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.5 p -137.23 140.28 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.376 0 N-CA-C 113.106 0.78 . . . . 74.03 113.106 -174.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -107.62 108.48 19.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.504 1.121 . . . . 52.24 108.691 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -121.0 111.65 17.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.089 -0.708 . . . . 74.04 109.089 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.32 110.79 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.709 -0.849 . . . . 73.32 108.709 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.39 123.8 61.22 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.15 0.98 . . . . 64.22 109.928 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.64 137.31 41.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.448 2.099 . . . . 74.44 111.974 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.605 HH11 ' HB2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -138.05 -34.52 0.66 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.162 0.585 . . . . 64.25 111.403 -172.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.4 t70 -163.65 159.47 21.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.178 0.991 . . . . 53.11 110.01 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.5 -31.16 55.42 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.897 1.279 . . . . 73.23 113.092 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -140.18 26.69 2.19 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.167 0.587 . . . . 75.13 110.373 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.9 m80 -147.94 111.18 4.9 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.045 0.938 . . . . 73.41 109.32 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -133.76 137.02 44.95 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.241 0.616 . . . . 62.22 110.824 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.8 m -94.71 114.09 25.96 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.102 0.561 . . . . 71.2 112.231 -170.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.78 122.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.742 -0.466 . . . . 71.12 109.742 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.83 115.31 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.168 -0.678 . . . . 71.32 109.168 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.9 123.31 49.38 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.449 HG22 ' SD ' ' A' ' 110' ' ' MET . 91.8 m -130.58 135.37 47.83 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 62.23 110.382 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.75 115.13 15.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.84 0.856 . . . . 65.55 110.761 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.518 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -121.56 132.89 54.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.714 1.206 . . . . 73.2 109.871 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -145.46 147.81 32.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.31 0.644 . . . . 74.23 111.878 -171.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.86 87.57 5.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.235 -0.654 . . . . 72.35 109.235 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 42.0 t -143.5 167.5 22.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.808 0.67 . . . . 63.53 112.808 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.41 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.7 m -70.13 142.23 89.91 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.316 1.046 . . . . 65.42 112.435 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.47 -40.3 54.15 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.473 2.782 . . . . 73.34 114.724 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.74 -31.56 69.75 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.063 0.945 . . . . 73.32 112.764 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -89.9 -29.93 18.22 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.41 0.684 . . . . 52.13 111.113 176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.13 77.27 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.622 0.769 . . . . 70.12 112.198 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -68.33 -36.56 79.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.031 0.932 . . . . 75.4 111.988 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.58 -49.17 72.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.402 0.681 . . . . 74.3 109.895 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -71.97 -23.67 61.47 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.931 -1.031 . . . . 65.22 111.352 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.19 -48.66 79.63 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.582 0.753 . . . . 75.2 110.817 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.7 m -69.23 -53.25 20.86 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.593 -0.731 . . . . 65.13 112.665 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.7 -53.85 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.53 0.567 . . . . 74.41 112.53 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.4 -48.18 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.131 0.572 . . . . 73.33 111.125 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.52 -52.39 35.27 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 114.629 0.611 . . . . 32.25 114.629 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.31 -44.63 10.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 122.062 -0.67 . . . . 74.4 112.033 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.89 -47.51 54.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 116.071 -0.513 . . . . 72.23 113.876 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.439 ' HA ' HE22 ' A' ' 33' ' ' GLN . 96.4 t -91.44 -53.24 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.96 0.504 . . . . 71.51 111.631 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.1 m-30 -75.65 -56.92 4.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.321 0.489 . . . . 74.23 112.321 -171.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB2' HH11 ' A' ' 6' ' ' ARG . . . -55.93 -38.55 70.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.949 0.404 . . . . 44.14 111.768 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 t -65.78 -54.45 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 123.455 0.702 . . . . 70.24 112.347 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.98 71.81 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 113.851 0.3 . . . . 64.41 113.851 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.57 -42.89 99.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.361 1.065 . . . . 75.22 112.473 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 92.4 m-20 -70.01 -39.72 75.67 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 119.726 -0.178 . . . . 65.03 110.931 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.94 79.82 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.103 0.561 . . . . 75.5 111.234 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 4.8 tt -65.49 -38.25 89.21 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.454 0.702 . . . . 74.41 110.324 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.69 68.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.939 0.496 . . . . 53.24 111.918 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 18.7 mm-40 -69.39 -42.88 74.53 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.446 0.699 . . . . 72.13 111.724 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.13 -28.92 67.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.601 0.36 . . . . 74.42 111.936 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -97.53 6.64 47.81 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.809 0.444 . . . . 71.14 111.828 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.134 0 N-CA-C 116.434 1.334 . . . . 72.22 116.434 -177.593 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.359 0.6 . . . . 74.54 109.811 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 110' ' ' MET . 58.1 m -131.7 121.25 23.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.649 0.779 . . . . 62.53 110.01 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.75 111.47 23.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.622 1.169 . . . . 73.04 110.027 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -104.74 120.54 41.62 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.827 -0.805 . . . . 73.24 108.827 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.24 135.82 46.55 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.741 -0.466 . . . . 73.21 109.741 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.6 p -141.42 159.59 41.91 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.02 0.528 . . . . 61.14 112.294 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.9 p -147.27 141.28 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.777 0.831 . . . . 73.21 110.62 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.1 111.03 23.53 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.609 0.719 . . . . 71.34 110.276 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 137' ' ' LEU . 66.1 t -102.44 145.45 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 125.573 1.549 . . . . 72.32 112.1 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -79.66 59.74 3.13 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.031 0.932 . . . . 65.23 112.391 173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 141.64 6.55 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.349 0.659 . . . . 71.4 111.15 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.15 138.11 65.22 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.972 2.448 . . . . 44.12 113.382 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.4 -46.46 13.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.8 1.778 . . . . 52.01 115.8 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.02 90.82 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.521 0.563 . . . . 72.2 112.521 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.82 -30.44 68.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.474 0.546 . . . . 65.04 112.474 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' SG ' ' A' ' 103' ' ' CYS . 83.5 t -70.66 -35.44 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.783 0.433 . . . . 64.3 110.679 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -67.37 -27.6 67.25 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.778 0.431 . . . . 74.4 111.295 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.3 m -63.85 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.316 0.579 . . . . 63.42 111.529 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.6 tp -84.16 -56.83 3.45 Favored 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.486 1.114 . . . . 41.14 112.47 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.47 -21.61 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.727 1.01 . . . . 74.53 113.727 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.48 -50.37 59.73 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.526 0.516 . . . . 71.54 114.111 -170.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.67 127.79 34.32 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.209 -0.663 . . . . 51.23 109.209 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.68 -30.04 71.09 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.357 1.063 . . . . 74.12 112.491 -169.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -99.27 0.84 43.92 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.487 0.715 . . . . 71.01 112.476 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -89.94 8.88 30.07 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.199 0.6 . . . . 72.53 111.837 -174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.685 HG21 ' NH2' ' A' ' 51' ' ' ARG . 19.9 tt -65.8 -30.83 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.597 1.159 . . . . 72.42 113.208 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -66.11 -9.48 31.63 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.701 0.63 . . . . 73.32 112.701 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 69.8 mtp180 -83.87 -14.88 50.07 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.936 0.895 . . . . 74.12 112.354 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 51.7 p-90 -130.28 -40.83 1.27 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 112.77 0.656 . . . . 72.32 112.77 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' CE1' HE21 ' A' ' 33' ' ' GLN . 32.7 t-80 -85.79 113.17 49.92 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.073 0.549 . . . . 74.15 110.519 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -18.89 31.08 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.212 2.608 . . . . 53.34 114.525 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.469 HE21 ' CE1' ' A' ' 31' ' ' HIS . 4.2 mt-30 -94.69 -13.04 26.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.81 0.67 . . . . 64.34 112.81 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.452 HG23 ' ND1' ' A' ' 31' ' ' HIS . 90.9 t -73.12 114.38 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 121.072 0.463 . . . . 74.15 110.26 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -92.93 35.95 1.04 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.395 1.078 . . . . 63.31 111.64 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.03 115.32 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 C-N-CA 125.603 1.561 . . . . 62.22 112.483 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HG3' ' HE ' ' A' ' 51' ' ' ARG . 26.3 Cg_endo -95.71 177.99 0.7 Allowed 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.381 2.721 . . . . 61.0 114.703 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.1 m -119.42 132.34 55.8 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.322 1.049 . . . . 52.43 110.451 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.2 136.34 37.86 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.454 0.645 . . . . 73.43 111.416 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.513 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -121.74 145.05 48.42 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.512 1.125 . . . . 65.14 110.294 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 119.71 0.0 OUTLIER Glycine 0 CA--C 1.556 2.611 0 N-CA-C 117.613 1.805 . . . . 42.11 117.613 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.57 -96.41 0.05 OUTLIER 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 125.614 1.566 . . . . 72.32 113.644 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -158.71 150.76 17.35 Favored Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 123.29 0.636 . . . . 62.42 111.78 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.12 -12.58 33.13 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.11 2.54 . . . . 74.22 114.155 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 80.1 m-70 -97.06 -5.72 36.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.827 -0.545 . . . . 73.44 111.657 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.6 m -96.89 113.78 63.49 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.788 0.835 . . . . 71.12 110.758 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.2 Cg_endo -55.97 114.84 2.08 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.253 2.635 . . . . 52.35 112.87 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.36 -23.79 4.02 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-N 115.915 -0.584 . . . . 73.33 112.558 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.69 133.74 55.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.417 0.687 . . . . 43.42 112.254 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 43.4 mt-10 -103.26 138.57 39.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.966 0.506 . . . . 65.11 110.754 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.685 ' NH2' HG21 ' A' ' 27' ' ' ILE . 32.5 ttt-85 -125.15 106.01 9.58 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.176 0.99 . . . . 74.25 110.745 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 t -110.55 109.31 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.338 0.655 . . . . 72.31 111.4 -169.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HE2' HG22 ' A' ' 34' ' ' VAL . 46.2 m-85 -62.32 118.61 7.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.334 1.054 . . . . 73.43 111.326 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.84 -71.91 2.88 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 112.451 -0.26 . . . . 71.11 112.451 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.74 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.881 1.272 . . . . 74.22 113.468 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 25.52 3.98 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 116.348 -0.387 . . . . 45.41 113.948 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.5 -172.32 2.49 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.301 1.04 . . . . 51.53 110.205 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.4 0.96 54.7 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.808 0.443 . . . . 71.35 111.746 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.1 88.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.568 0.747 . . . . 63.45 110.034 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.38 139.6 49.35 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.376 0.671 . . . . 65.11 110.414 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -95.2 117.46 30.28 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.517 0.727 . . . . 73.31 109.902 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 43.6 t -96.17 115.97 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.735 -0.469 . . . . 62.4 109.735 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 23.3 tt0 -112.69 166.65 11.16 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.211 1.005 . . . . 72.11 109.837 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -151.6 124.98 8.84 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.926 0.49 . . . . 34.23 111.918 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 34.4 tp -68.2 120.07 13.78 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.833 1.253 . . . . 75.11 111.353 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -85.21 -52.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.246 0.618 . . . . 52.4 110.647 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 8.5 pt-20 -155.83 139.72 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.156 0.583 . . . . 72.21 110.456 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.718 HH12 ' HB3' ' A' ' 70' ' ' GLU . 41.4 tpt85 -131.94 106.85 8.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.608 0.763 . . . . 60.23 109.641 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.92 116.63 23.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.603 0.761 . . . . 42.44 111.355 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' HH12 ' A' ' 68' ' ' ARG . 13.1 pt-20 -84.6 -39.19 19.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.284 0.634 . . . . 75.31 112.63 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.7 m -71.83 -25.34 61.94 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.311 0.644 . . . . 52.14 111.262 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.9 -17.86 32.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.468 0.707 . . . . 72.33 111.784 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 55.49 43.75 28.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.985 0.914 . . . . 71.24 111.226 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -133.45 116.07 15.56 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 114.471 -1.241 . . . . 71.55 109.887 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.672 HD13 ' HD3' ' A' ' 68' ' ' ARG . 23.9 tp -119.03 109.67 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.867 1.267 . . . . 61.31 110.923 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 75.9 t -110.34 137.44 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.829 -0.545 . . . . 70.14 111.392 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -145.14 179.21 7.51 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.67 1.188 . . . . 73.0 110.507 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -163.32 152.79 14.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.463 1.105 . . . . 73.14 109.243 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.0 mpp? -91.03 109.72 37.17 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 118.024 0.375 . . . . 64.52 110.386 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.08 -21.19 63.32 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.664 2.242 . . . . 73.1 111.851 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 29.7 t70 -122.94 80.6 50.34 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.919 0.888 . . . . 62.4 109.558 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -94.88 137.29 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.069 2.513 . . . . 74.21 113.057 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.51 12.05 3.17 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.855 2.37 . . . . 61.32 113.447 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -108.43 144.97 30.57 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 124.005 0.922 . . . . 73.01 109.971 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.26 65.47 7.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.83 2.353 . . . . 72.12 112.289 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 22.2 pt -122.76 131.62 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.18 0.992 . . . . 74.43 110.955 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 26.4 m -78.44 134.51 37.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 110.069 -0.345 . . . . 71.42 110.069 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 56.1 -67.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 128.132 2.573 . . . . 63.01 114.721 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 69.11 148.06 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.343 1.457 . . . . 62.22 111.516 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.449 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 64.8 ttt-85 -164.66 107.86 0.89 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 109.532 -0.544 . . . . 74.41 109.532 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.37 146.31 33.22 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.197 0.599 . . . . 64.44 112.016 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.6 p -138.09 144.43 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 113.501 0.926 . . . . 75.24 113.501 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.35 112.07 24.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.17 1.388 . . . . 60.43 109.297 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -119.06 113.69 21.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.197 0.999 . . . . 72.21 110.139 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 t -93.06 112.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.988 -0.445 . . . . 53.0 110.208 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.33 119.28 58.11 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.377 1.071 . . . . 63.32 110.961 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.5 107.68 2.05 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.504 2.136 . . . . 65.13 112.825 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -86.61 -42.66 13.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.984 0.914 . . . . 74.4 111.061 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.3 t70 -140.49 178.92 6.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.44 1.096 . . . . 74.11 109.058 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.09 -48.62 28.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.056 0.542 . . . . 73.3 111.031 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.9 tmt_? -95.96 -1.52 48.93 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.89 0.876 . . . . 73.13 111.03 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -135.77 158.54 44.15 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.391 -0.818 . . . . 74.2 110.73 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.4 p -156.61 178.23 10.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.786 0.434 . . . . 73.33 111.514 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.4 m -119.43 127.35 53.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.888 0.875 . . . . 54.44 110.782 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t -95.26 110.35 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.2 t -99.68 108.83 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.382 0.673 . . . . 60.42 110.04 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -106.8 119.27 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.048 -0.723 . . . . 75.43 109.048 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.4 m -126.4 150.54 48.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.0 0.92 . . . . 72.12 109.943 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.61 120.03 8.46 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.236 0.614 . . . . 65.33 111.244 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.515 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -117.12 128.6 55.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.117 0.967 . . . . 74.23 110.211 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 19.2 p90 -146.91 143.01 28.2 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.205 1.402 . . . . 74.11 108.462 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 15.8 t70 -89.88 78.39 6.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.733 0.778 . . . . 74.33 109.659 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 52.6 t -117.82 163.1 17.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.203 0.601 . . . . 71.44 111.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.1 p -64.38 138.76 97.53 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.672 0.789 . . . . 71.13 112.018 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.55 -36.43 18.47 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.943 3.095 . . . . 61.11 115.169 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -61.06 -53.75 53.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.54 0.736 . . . . 65.14 111.352 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.43 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 48.7 m -72.84 -27.29 61.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.986 0.515 . . . . 73.33 111.517 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.42 -43.3 81.55 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.914 0.885 . . . . 54.22 112.57 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -68.51 -29.14 67.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.365 0.666 . . . . 70.03 111.484 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.49 -43.93 68.72 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.361 0.665 . . . . 62.33 110.498 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.06 -23.25 59.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.89 0.876 . . . . 71.33 111.536 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -57.54 -44.78 85.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.851 0.46 . . . . 70.31 110.18 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.8 t -71.61 -52.32 18.63 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 63.14 112.738 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.91 -54.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 123.447 0.699 . . . . 62.25 112.705 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.89 -50.58 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.135 0.574 . . . . 74.23 111.115 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.18 -49.31 58.4 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 114.652 0.621 . . . . 45.43 114.652 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.08 -48.99 7.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.126 -0.631 . . . . 75.23 111.56 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.51 -29.8 65.34 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 115.496 0.959 . . . . 62.13 115.496 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.93 -53.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 117.784 0.792 . . . . 73.12 110.96 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.0 m-30 -73.25 -60.46 2.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.444 0.698 . . . . 75.21 112.287 -170.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.81 66.98 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 123.497 0.498 . . . . 73.31 111.488 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -55.94 -54.82 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 123.666 0.786 . . . . 74.25 112.295 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.75 80.72 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 113.69 0.236 . . . . 74.52 113.69 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.58 -42.21 71.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.057 0.943 . . . . 73.3 111.884 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.68 -41.39 83.78 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.519 0.328 . . . . 71.12 110.289 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.34 80.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.802 0.841 . . . . 55.35 111.969 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.427 HD22 HG21 ' A' ' 10' ' ' VAL . 7.8 tt -65.26 -43.22 91.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.715 0.806 . . . . 55.31 110.228 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.94 74.59 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.275 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -69.58 -48.13 61.27 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.865 0.866 . . . . 72.14 112.794 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -19.9 65.37 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.49 0.552 . . . . 55.25 112.49 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -91.34 -44.3 9.26 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.882 0.473 . . . . 74.04 111.864 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.526 0 N-CA-C 114.323 0.489 . . . . 74.33 114.323 -174.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.26 0.552 . . . . 43.41 110.964 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 m -121.92 111.28 16.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.811 0.844 . . . . 72.4 110.318 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 6.8 mp -96.08 109.59 21.99 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 45.44 110.039 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.53 123.71 39.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.898 0.479 . . . . 63.32 110.946 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.465 HH22 ' HG2' ' A' ' 122' ' ' GLU . 1.2 mmp_? -122.28 160.39 25.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.333 1.053 . . . . 74.53 108.817 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -153.31 146.81 24.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.11 0.564 . . . . 70.25 111.244 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.0 p -138.73 145.58 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.156 0.583 . . . . 72.42 111.314 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.94 110.88 22.72 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.495 0.718 . . . . 71.4 110.426 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 65.9 t -101.41 139.93 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.562 1.145 . . . . 73.15 111.578 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.72 40.78 0.61 Allowed 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 113.766 1.025 . . . . 52.21 113.766 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.54 32.27 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.205 0.602 . . . . 34.15 111.654 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.08 145.28 78.67 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.984 2.456 . . . . 74.33 113.265 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.31 -35.31 37.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.345 1.458 . . . . 72.32 114.72 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.69 -51.55 61.87 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.77 -44.78 90.73 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.282 0.633 . . . . 63.45 111.162 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 103' ' ' CYS . 49.2 t -68.72 -34.07 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.605 0.762 . . . . 62.25 111.08 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.559 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 55.8 t-105 -59.55 -40.99 89.07 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.458 0.303 . . . . 72.13 111.219 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -61.37 -24.99 66.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.796 0.438 . . . . 75.15 111.564 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 30' ' ' TRP . 29.5 tp -83.67 -44.29 14.66 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 112.736 0.643 . . . . 70.3 112.736 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.62 -26.26 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 114.098 1.147 . . . . 75.54 114.098 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.71 35.42 3.22 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 115.876 1.11 . . . . 43.14 115.876 -165.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.26 -162.07 0.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.806 0.842 . . . . 53.33 111.158 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.14 25.2 1.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.302 0.641 . . . . 51.43 110.195 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -152.15 -42.83 0.11 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.498 0.719 . . . . 74.11 111.763 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.4 3.12 48.34 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.221 1.008 . . . . 61.23 111.199 -170.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 34' ' ' VAL . 14.3 tt -55.92 -19.76 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 C-N-CA 125.853 1.661 . . . . 72.21 113.108 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.37 -14.36 55.96 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.409 0.892 . . . . 73.41 113.409 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -71.85 -20.18 61.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.533 0.733 . . . . 72.22 112.374 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HB3' HD21 ' A' ' 20' ' ' LEU . 31.5 p-90 -127.71 -35.08 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.008 0.523 . . . . 74.25 111.912 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -89.77 112.37 51.59 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 122.819 0.447 . . . . 74.34 110.337 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.68 -16.27 37.8 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.275 2.65 . . . . 70.32 114.083 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -93.15 -20.69 20.24 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.724 0.81 . . . . 73.51 112.12 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 27' ' ' ILE . 72.9 t -69.32 111.79 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 120.919 0.39 . . . . 61.54 110.894 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -92.33 27.46 2.23 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.429 1.092 . . . . 35.5 111.9 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.03 98.1 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.577 1.151 . . . . 62.22 111.27 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.11 173.14 8.12 Favored 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 123.116 2.544 . . . . 62.34 114.693 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -99.96 123.02 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.0 0.92 . . . . 65.2 109.758 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.71 127.32 39.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.237 0.615 . . . . 73.01 111.204 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -104.64 123.23 47.22 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.719 -0.673 . . . . 74.24 109.612 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.33 -175.41 0.01 OUTLIER Glycine 0 CA--C 1.55 2.241 0 N-CA-C 117.543 1.777 . . . . 61.13 117.543 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 46.75 -121.31 1.14 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.839 1.256 . . . . 75.53 113.315 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -162.8 155.9 16.78 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 124.375 1.07 . . . . 75.35 108.985 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.42 -15.52 45.82 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.502 2.135 . . . . 72.0 114.859 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -111.41 0.77 16.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.66 -0.65 . . . . 55.14 111.546 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -110.77 127.69 26.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 123.732 0.813 . . . . 73.21 110.928 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 85.5 Cg_exo -50.15 138.68 36.21 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.68 2.92 . . . . 73.42 114.149 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.97 19.6 21.24 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 116.272 -0.422 . . . . 63.34 113.564 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.78 134.74 51.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.71 0.804 . . . . 74.41 110.737 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.35 118.44 35.85 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.952 0.501 . . . . 74.21 110.965 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -93.63 126.26 38.69 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.888 0.375 . . . . 73.4 110.042 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 62' ' ' VAL . 20.6 t -122.42 122.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 122.902 0.481 . . . . 74.45 111.238 -171.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' HE2' HG13 ' A' ' 34' ' ' VAL . 48.6 m-85 -95.56 85.31 4.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.216 1.006 . . . . 73.53 111.118 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.25 -43.41 1.61 Allowed Glycine 0 N--CA 1.478 1.488 0 N-CA-C 112.722 -0.151 . . . . 74.23 112.722 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 17.7 4.12 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.949 1.463 . . . . 73.32 114.949 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.31 57.8 0.03 OUTLIER Glycine 0 N--CA 1.472 1.064 0 N-CA-C 112.595 -0.202 . . . . 43.32 112.595 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -105.87 -69.1 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.982 0.913 . . . . 52.51 109.729 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 176.64 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.527 1.531 . . . . 72.31 109.252 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.75 82.21 2.07 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.871 0.843 . . . . 74.32 108.818 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.72 -179.77 3.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.15 0.98 . . . . 74.12 110.601 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD11 ' SD ' ' A' ' 79' ' ' MET . 55.0 tp -141.14 123.53 15.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.799 0.44 . . . . 72.21 110.896 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.0 t -104.7 115.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.162 -0.681 . . . . 70.55 109.162 170.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -104.73 149.67 25.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.872 0.869 . . . . 55.4 109.889 171.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -127.5 127.39 43.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.068 1.347 . . . . 74.4 109.867 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.17 108.99 9.47 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.932 0.893 . . . . 54.13 110.662 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -73.26 -50.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.363 0.665 . . . . 54.21 110.555 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.723 ' HA ' ' HG3' ' A' ' 47' ' ' PRO . 8.6 pt-20 -166.81 155.46 10.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.541 0.736 . . . . 73.34 111.095 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -141.69 123.04 14.87 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.37 0.668 . . . . 70.21 110.497 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.35 -178.37 4.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.045 0.938 . . . . 74.24 111.826 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.559 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 55.4 mt-10 -138.92 -63.72 0.52 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.228 1.011 . . . . 75.22 109.955 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -69.57 -38.25 77.33 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.414 0.686 . . . . 62.35 111.439 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.67 -19.83 60.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.431 0.692 . . . . 55.41 112.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 55.74 45.0 25.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 65.3 112.253 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.45 HH11 HG23 ' A' ' 76' ' ' VAL . 9.0 tmm_? -130.7 130.99 44.55 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 115.031 -0.986 . . . . 63.44 110.475 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 46.2 tp -120.36 123.63 43.56 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.363 1.065 . . . . 74.4 110.212 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.5 t -114.38 132.35 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 118.958 0.799 . . . . 54.41 111.072 174.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -147.61 175.18 11.07 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 51.55 111.349 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.6 t -150.15 145.26 26.19 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.402 1.081 . . . . 73.24 109.55 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.3 ptt? -95.96 101.06 7.46 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 118.787 0.721 . . . . 74.43 110.7 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.47 -17.37 30.38 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 123.178 2.586 . . . . 63.11 113.229 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 34.9 t70 -132.8 79.18 64.49 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 123.427 0.691 . . . . 74.23 109.859 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -96.34 154.93 1.32 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.42 2.747 . . . . 75.32 114.033 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.94 -17.43 22.45 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.119 1.879 . . . . 71.51 112.554 168.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -80.33 142.2 54.25 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 123.812 0.845 . . . . 75.21 112.047 -175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.07 77.4 3.49 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.717 2.278 . . . . 62.12 113.21 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.1 pt -133.54 154.7 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.285 1.034 . . . . 71.32 110.774 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 35.9 m -90.76 -79.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.985 -0.447 . . . . 63.4 110.757 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -106.37 107.82 19.03 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.358 0.599 . . . . 73.32 110.924 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.407 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 43.5 t-80 -84.94 149.72 25.44 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.772 0.829 . . . . 64.33 111.06 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -153.31 106.89 3.01 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.492 0.717 . . . . 73.12 109.952 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -117.0 142.38 47.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.981 0.512 . . . . 54.24 111.926 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 92.8 t -133.6 134.83 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.25 1.02 . . . . 63.25 111.061 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 mm? -94.46 147.02 23.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.745 -0.835 . . . . 63.4 108.745 166.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.27 117.65 4.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.677 0.391 . . . . 75.43 110.179 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.05 112.46 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.784 -0.451 . . . . 60.41 109.784 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.84 120.7 67.02 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.737 0.815 . . . . 71.45 110.581 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.18 87.56 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.325 2.017 . . . . 52.43 112.123 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -76.17 -32.16 58.9 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.098 0.959 . . . . 71.52 111.148 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 16.6 t70 -158.73 170.9 21.1 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.65 1.58 . . . . 63.34 108.42 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -54.29 -52.86 60.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 61.24 112.475 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -119.85 23.25 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.533 0.682 . . . . 73.11 110.845 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.734 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.4 m80 -132.62 121.36 23.08 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.534 -0.729 . . . . 73.12 109.38 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 17' ' ' VAL . 30.1 p -128.28 138.33 52.37 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.986 0.514 . . . . 74.13 109.647 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.9 m -96.05 109.7 22.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.834 -0.432 . . . . 73.11 109.834 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 108.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.134 -0.691 . . . . 74.24 109.134 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.89 112.5 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.261 1.024 . . . . 64.5 109.087 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -104.51 118.71 37.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.776 -0.824 . . . . 71.05 108.776 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -120.11 149.37 42.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.186 0.995 . . . . 74.53 110.023 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -146.08 157.96 43.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.557 1.143 . . . . 43.12 109.206 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -161.46 134.64 6.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.748 0.819 . . . . 75.03 109.783 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -145.51 152.98 40.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.146 0.578 . . . . 70.21 111.81 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 22.2 t70 -75.35 88.91 2.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.935 -0.575 . . . . 44.52 109.815 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.632 ' HB2' HG22 ' A' ' 86' ' ' ILE . 34.0 t -147.76 166.27 28.02 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.354 -0.839 . . . . 73.13 111.205 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.4 p -67.21 145.68 98.72 Favored Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 123.254 0.622 . . . . 72.03 111.445 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.49 -29.22 68.16 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.85 2.367 . . . . 60.32 112.963 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.08 -52.3 59.93 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.344 1.058 . . . . 71.12 112.001 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.49 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.2 m -72.46 -32.01 65.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.134 0.492 . . . . 75.34 110.82 177.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.41 -32.95 74.19 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.633 0.773 . . . . 55.04 112.055 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -69.08 -35.63 76.7 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.983 0.513 . . . . 71.01 110.952 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.95 -48.59 73.55 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.378 0.671 . . . . 72.45 110.077 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.05 -24.75 62.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.193 -0.912 . . . . 72.34 111.341 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HG2' HH22 ' A' ' 6' ' ' ARG . 1.2 tm-20 -57.08 -42.05 79.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.795 0.838 . . . . 55.4 110.507 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.5 t -76.75 -49.81 15.09 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.527 0.565 . . . . 74.44 112.527 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.2 -56.75 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.925 0.713 . . . . 63.22 112.925 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.44 -42.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.184 0.593 . . . . 73.24 110.681 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.95 -66.2 2.83 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 116.398 -0.365 . . . . 64.23 113.787 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 69.8 m-20 -80.97 -50.76 9.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.026 0.913 . . . . 73.5 112.025 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.28 -26.41 69.37 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 115.287 0.875 . . . . 54.33 115.287 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.09 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.759 0.779 . . . . 61.34 111.204 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 8.5 m-30 -71.72 -63.1 1.19 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.907 0.336 . . . . 65.21 111.907 -170.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -61.19 -28.53 69.21 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.47 0.481 . . . . 31.2 112.183 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.96 -53.47 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.439 0.696 . . . . 71.23 111.316 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.85 93.45 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 116.343 -0.39 . . . . 72.32 113.233 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.88 -40.28 91.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.069 0.948 . . . . 61.33 111.866 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.425 -0.352 . . . . 54.33 110.294 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.47 70.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.645 0.778 . . . . 64.25 112.246 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 tt -67.25 -48.45 67.73 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.958 0.903 . . . . 74.1 110.403 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.42 63.21 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.073 0.549 . . . . 54.33 111.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -66.23 -49.8 66.0 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.582 0.753 . . . . 73.34 111.422 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -14.41 61.64 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.305 0.483 . . . . 71.12 112.305 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -94.82 -30.58 14.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.186 0.81 . . . . 75.03 113.186 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 115.947 1.139 . . . . 23.4 115.947 -177.653 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 1.413 0 N-CA-C 113.155 0.798 . . . . 61.15 113.155 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.2 m -91.33 117.95 30.09 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.26 0.624 . . . . 55.0 110.529 173.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.66 128.02 42.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.948 1.299 . . . . 70.12 108.155 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -133.87 127.75 33.19 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.165 0.439 . . . . 71.55 110.216 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.79 140.57 50.3 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.665 -0.865 . . . . 65.51 108.665 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 p -141.66 156.23 45.65 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.658 0.783 . . . . 50.14 110.575 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.39 148.37 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 N-CA-C 111.976 0.361 . . . . 73.21 111.976 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.68 113.5 18.93 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.289 0.635 . . . . 64.34 110.567 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 105' ' ' VAL . 43.1 t -106.57 124.11 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.309 0.644 . . . . 72.23 110.466 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.1 66.13 8.53 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.809 0.844 . . . . 64.15 112.185 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.41 152.88 3.41 Favored Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 123.959 0.904 . . . . 73.11 110.797 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 134.95 64.09 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.06 2.507 . . . . 62.15 113.143 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.77 50.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.381 1.622 . . . . 72.1 115.381 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.43 78.98 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.942 0.497 . . . . 72.52 111.926 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.21 -34.82 79.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 75.1 112.326 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.587 HG21 ' SG ' ' A' ' 103' ' ' CYS . 59.3 t -70.36 -36.69 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.221 0.608 . . . . 62.11 110.886 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -64.14 -28.84 70.04 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.982 -0.554 . . . . 71.25 110.661 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -59.54 -28.22 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.072 0.549 . . . . 73.14 111.432 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -76.48 -41.78 45.9 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.806 0.842 . . . . 71.21 111.666 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.37 13.96 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 123.943 0.897 . . . . 71.3 112.833 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.31 7.04 80.88 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 114.449 0.539 . . . . 74.33 114.449 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.3 m-20 -124.98 135.36 52.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 63.33 109.311 166.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.68 -24.77 67.92 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.986 0.914 . . . . 74.05 111.286 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.9 p -89.78 -16.43 30.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.317 1.047 . . . . 73.43 112.822 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -82.22 3.54 26.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.867 -0.52 . . . . 61.24 112.238 -168.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 HG11 ' A' ' 34' ' ' VAL . 21.1 tt -63.79 -23.24 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.142 0.977 . . . . 75.04 112.766 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.481 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 57.0 p-80 -64.47 -23.23 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.801 0.667 . . . . 72.22 112.801 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -74.29 -39.04 63.19 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.512 0.56 . . . . 64.34 112.512 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 p-90 -107.57 -30.16 8.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.597 0.359 . . . . 72.41 111.334 -174.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -100.16 102.03 16.59 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 123.453 0.701 . . . . 75.45 109.842 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HD2' HE22 ' A' ' 33' ' ' GLN . 32.5 Cg_exo -62.21 -13.3 31.32 Favored 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 123.537 2.825 . . . . 63.33 116.035 -171.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.537 HE22 ' HD2' ' A' ' 32' ' ' PRO . 2.2 mp0 -83.8 -25.79 30.11 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.355 0.662 . . . . 74.52 111.697 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 27' ' ' ILE . 85.4 t -72.37 115.89 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 122.877 0.471 . . . . 71.02 111.465 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -95.25 30.32 2.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.974 0.91 . . . . 74.43 111.797 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.76 98.58 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 125.326 1.45 . . . . 70.43 112.643 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.9 -171.39 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.321 2.681 . . . . 75.41 114.252 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.8 m -115.52 124.53 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.785 0.834 . . . . 50.33 110.686 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.402 HD12 ' HB1' ' A' ' 49' ' ' ALA . 3.8 mm? -90.78 126.65 36.08 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.501 0.667 . . . . 73.42 111.313 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 mmt180 -111.65 148.25 33.77 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.535 1.134 . . . . 63.31 109.929 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.69 121.05 0.0 OUTLIER Glycine 0 CA--C 1.56 2.906 0 N-CA-C 117.715 1.846 . . . . 64.01 117.715 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.45 -98.35 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.421 1.488 . . . . 74.22 114.096 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -168.66 146.72 3.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 123.227 0.611 . . . . 62.35 111.68 -166.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.59 -1.2 2.39 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.675 2.917 . . . . 64.54 115.145 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -101.5 -24.8 14.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.538 0.735 . . . . 64.23 111.271 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -93.12 124.24 58.61 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.641 0.776 . . . . 52.2 111.731 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.62 118.91 4.86 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.221 2.614 . . . . 71.31 112.874 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.15 -9.46 7.89 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 112.484 -0.246 . . . . 74.01 112.484 -170.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -73.27 130.75 40.89 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.487 0.715 . . . . 51.02 111.05 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 36.2 mt-10 -118.88 115.16 23.82 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 122.099 -0.376 . . . . 71.4 110.558 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -93.73 119.11 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.337 0.589 . . . . 72.21 109.826 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 t -115.93 107.78 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 123.805 0.842 . . . . 52.23 110.227 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -76.85 73.64 3.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.041 0.936 . . . . 74.32 111.479 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.89 -62.44 0.48 Allowed Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.124 -0.489 . . . . 63.44 111.899 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.63 27.08 16.62 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.605 1.162 . . . . 62.35 113.663 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.27 41.48 0.03 OUTLIER Glycine 0 N--CA 1.471 1.005 0 CA-C-N 116.392 -0.367 . . . . 64.5 112.739 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -146.78 160.83 41.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.599 0.759 . . . . 64.41 110.767 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.08 -19.48 60.59 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.253 0.621 . . . . 72.44 111.858 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.12 85.98 2.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.735 0.814 . . . . 71.4 110.641 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.26 162.77 30.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 75.23 111.871 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 79' ' ' MET . 51.1 tp -121.95 121.71 37.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.772 0.829 . . . . 72.42 109.89 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.54 130.09 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.066 -0.716 . . . . 73.31 109.066 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.638 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 40.1 mt-10 -130.25 128.87 42.5 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.413 0.685 . . . . 72.4 110.317 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 57.8 mtp180 -104.04 131.76 50.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.193 0.597 . . . . 74.12 111.204 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -73.04 111.46 8.17 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.015 0.926 . . . . 54.11 110.161 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.72 -51.91 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.528 0.731 . . . . 62.21 111.731 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.8 pt-20 -153.18 151.81 30.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 70.35 110.579 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.597 HH21 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -133.78 113.48 12.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.189 0.596 . . . . 74.01 110.557 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.5 m-20 -115.68 72.18 0.8 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.816 0.847 . . . . 71.42 109.036 176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HG3' ' HD2' ' A' ' 68' ' ' ARG . 53.3 mt-10 -67.38 -32.85 74.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.735 0.814 . . . . 74.22 113.109 -173.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -73.07 -18.56 61.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.171 0.589 . . . . 71.04 111.733 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.57 -1.82 22.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.69 0.796 . . . . 63.53 112.133 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 13.1 mtm105 62.71 42.82 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.433 1.093 . . . . 75.22 112.993 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 23.9 ttm180 -119.34 133.17 55.87 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.368 1.067 . . . . 75.5 110.781 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.597 HD22 HH21 ' A' ' 68' ' ' ARG . 13.6 tp -131.74 107.93 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.636 1.174 . . . . 33.42 110.037 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 52.0 t -113.12 132.99 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 118.491 0.587 . . . . 75.11 110.601 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -148.14 167.77 24.17 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.746 0.818 . . . . 73.22 111.339 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.0 t -134.82 158.25 44.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.12 0.968 . . . . 72.45 110.578 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.638 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 73.4 mtm -102.82 98.13 10.69 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.019 0.527 . . . . 71.12 110.309 170.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.487 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 56.8 Cg_endo -66.05 -28.21 49.4 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.371 2.714 . . . . 70.33 112.612 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.28 79.42 35.87 Favored Pre-proline 0 CA--C 1.555 1.164 0 N-CA-C 108.624 -0.88 . . . . 71.14 108.624 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 83.1 Cg_endo -79.68 147.4 19.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.465 2.11 . . . . 44.14 113.12 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.8 Cg_endo -84.38 -0.83 9.57 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.95 2.434 . . . . 62.44 112.782 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.18 150.38 63.35 Favored Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 74.42 111.513 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.38 80.57 1.05 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.107 2.538 . . . . 73.1 112.956 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.577 HG22 ' HB2' ' A' ' 113' ' ' CYS . 23.5 pt -135.59 146.51 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.547 1.139 . . . . 74.35 110.383 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -89.87 -72.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.883 0.373 . . . . 54.43 110.921 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 9.1 m-20 -90.71 123.95 34.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.412 -0.959 . . . . 72.35 108.412 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -114.87 131.21 56.93 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.352 0.978 . . . . 75.44 113.237 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 110' ' ' MET . 3.6 mpt_? -129.64 143.58 50.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.181 1.392 . . . . 74.43 109.02 165.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.81 125.6 15.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.068 0.947 . . . . 73.31 108.739 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 94' ' ' GLU . 7.5 p -134.5 134.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.678 0.992 . . . . 74.34 113.678 -169.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -101.91 112.46 25.1 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.247 1.019 . . . . 74.24 109.156 171.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 92' ' ' VAL . 44.3 mt-10 -122.22 111.26 16.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.618 0.767 . . . . 65.41 109.921 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -92.59 109.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.101 -0.703 . . . . 51.24 109.101 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.417 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.4 m -100.7 114.03 65.72 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 123.856 0.863 . . . . 73.02 110.624 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.76 107.09 2.12 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.543 2.162 . . . . 64.41 113.04 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -63.47 -29.52 70.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.71 0.804 . . . . 72.2 111.144 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.2 t70 -154.63 173.13 16.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.396 1.478 . . . . 74.24 108.526 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.37 -44.19 92.77 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.979 0.512 . . . . 45.43 111.423 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.8 tmm_? -106.98 1.92 24.8 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.65 0.78 . . . . 73.15 111.468 -174.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 42.5 m80 -128.58 141.52 51.34 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.406 -0.809 . . . . 74.23 110.307 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.587 ' SG ' HG21 ' A' ' 17' ' ' VAL . 16.8 p -143.72 174.91 10.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.474 0.654 . . . . 75.22 112.407 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 96' ' ' VAL . 99.4 m -138.58 118.95 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 53.31 109.65 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 10' ' ' VAL . 47.9 t -91.77 124.8 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 109.771 -0.455 . . . . 73.22 109.771 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.75 128.35 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 73.25 109.357 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 6.4 t90 -121.2 122.91 40.99 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.79 -0.818 . . . . 62.43 108.79 174.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -127.39 124.13 37.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.454 0.702 . . . . 70.41 111.491 -170.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -105.3 107.81 18.99 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 62.35 110.39 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ARG . 41.8 mtt -97.62 130.35 44.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.888 -0.782 . . . . 74.32 108.888 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 88' ' ' ASN . 20.4 p90 -157.28 153.21 27.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.978 0.732 . . . . 75.34 112.978 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.65 84.25 2.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.237 -0.892 . . . . 73.41 109.427 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.577 ' HB2' HG22 ' A' ' 86' ' ' ILE . 42.2 t -119.28 155.78 31.18 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.324 -1.307 . . . . 74.22 110.711 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -58.61 138.45 86.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.933 0.893 . . . . 61.43 111.427 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.59 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 123.473 2.782 . . . . 71.0 114.857 -168.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.02 -37.98 89.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.104 0.561 . . . . 75.21 111.421 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 9.0 m -79.23 -27.25 42.46 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.015 0.526 . . . . 62.12 111.071 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.995 0.918 . . . . 72.01 111.896 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -74.8 -28.1 60.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.696 0.799 . . . . 75.01 111.586 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.32 -45.63 79.65 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.146 0.498 . . . . 74.03 110.161 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.22 -24.8 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.721 0.808 . . . . 65.22 111.275 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -58.18 -45.58 87.27 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.522 0.729 . . . . 73.52 110.519 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 m -69.99 -53.19 18.77 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.523 -0.762 . . . . 62.32 112.394 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.69 -55.25 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 C-N-CA 123.479 0.712 . . . . 75.02 112.595 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.6 mt -81.49 -57.32 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.836 0.854 . . . . 72.13 111.251 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.3 -63.33 3.3 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 114.349 0.5 . . . . 44.31 114.349 -173.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.45 -16.5 58.74 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 122.871 0.468 . . . . 72.45 111.441 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.19 -88.75 1.66 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.86 -0.411 . . . . 35.42 112.463 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.7 t -52.6 -46.78 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 124.935 1.294 . . . . 73.02 113.03 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 3.8 m-30 -75.98 -47.85 23.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.443 0.697 . . . . 73.04 111.558 -173.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.36 -41.85 85.65 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.226 0.329 . . . . 73.32 111.751 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.51 -54.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 123.955 0.902 . . . . 74.0 112.107 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.91 -46.21 76.05 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.423 0.452 . . . . 52.33 113.675 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.62 -41.48 96.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.561 0.745 . . . . 73.13 112.199 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.68 -41.64 92.19 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 119.73 -0.176 . . . . 72.23 110.675 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.91 90.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.94 0.496 . . . . 64.13 111.541 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.64 -40.12 96.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.603 0.761 . . . . 42.15 110.164 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.51 -33.19 68.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.859 0.463 . . . . 71.11 111.981 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.026 0.931 . . . . 72.3 113.042 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -66.77 -32.32 73.53 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 117.922 0.328 . . . . 63.22 111.289 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.98 -11.25 36.6 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.227 0.611 . . . . 74.24 110.661 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.447 0 N-CA-C 114.569 0.588 . . . . 72.1 114.569 -177.901 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.421 0.629 . . . . 70.2 110.371 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.6 m -119.72 124.5 46.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.901 0.88 . . . . 73.44 109.972 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.94 141.07 32.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 74.04 109.097 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -145.62 132.63 20.28 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.611 -0.515 . . . . 74.15 109.611 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 131' ' ' ALA . 5.7 tpt180 -133.7 147.35 51.37 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.346 -0.613 . . . . 63.44 109.346 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.0 p -142.76 150.36 39.94 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.24 0.616 . . . . 52.41 111.246 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.92 149.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.156 0.582 . . . . 52.51 111.173 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.18 123.7 29.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.551 -0.537 . . . . 73.52 109.551 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 95.4 t -120.51 121.56 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.814 0.845 . . . . 61.41 110.017 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -76.26 71.3 2.96 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.084 0.553 . . . . 72.42 111.191 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.91 6.6 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 123.844 0.858 . . . . 72.04 111.392 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.69 144.62 78.8 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.778 2.318 . . . . 65.42 112.299 167.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.1 -31.5 30.89 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.027 1.121 . . . . 54.54 114.027 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.58 -49.22 72.02 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.439 0.696 . . . . 72.24 112.446 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.353 0.661 . . . . 72.21 111.916 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 103' ' ' CYS . 25.0 t -71.76 -34.64 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.714 -0.675 . . . . 55.04 111.43 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -67.4 -31.19 71.25 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 122.58 0.352 . . . . 74.13 111.391 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -67.57 -21.66 65.43 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-O 121.382 0.61 . . . . 60.25 111.293 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.09 -50.03 6.65 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.061 0.944 . . . . 61.23 112.838 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.2 m -93.98 -26.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.703 1.001 . . . . 72.32 113.703 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.64 -11.85 66.19 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.384 1.313 . . . . 60.23 116.384 -165.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 4.6 m-20 -79.65 -14.03 59.08 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.939 0.496 . . . . 70.31 111.862 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 72.31 -59.05 0.57 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.163 1.385 . . . . 74.41 111.257 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -62.51 -18.34 61.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.295 1.038 . . . . 35.23 113.248 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -79.94 7.36 9.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.92 0.888 . . . . 74.32 112.722 -167.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.52 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 14.1 tt -61.7 -23.49 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 123.575 0.75 . . . . 63.4 112.082 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.647 ' HA ' HG11 ' A' ' 34' ' ' VAL . 39.5 p-80 -70.67 -3.9 20.81 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 113.154 0.798 . . . . 55.45 113.154 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 58.6 mtp180 -92.76 -25.51 18.15 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.02 0.928 . . . . 55.15 112.724 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.0 p-90 -127.14 -34.48 2.32 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.246 1.202 . . . . 75.02 114.246 -171.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 33.6 t-80 -78.68 139.08 58.23 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 117.969 0.35 . . . . 71.02 110.932 -170.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.57 -37.75 3.87 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.136 1.891 . . . . 54.52 113.965 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.645 HE21 ' N ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.21 -22.82 47.94 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.522 0.564 . . . . 62.21 112.522 -172.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 28' ' ' HIS . 9.4 p -61.71 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.352 0.596 . . . . 74.25 112.549 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -115.92 28.36 8.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.026 0.93 . . . . 74.23 111.673 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 61.4 96.83 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.071 0.948 . . . . 54.43 110.677 -170.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.23 158.46 15.09 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.594 2.196 . . . . 74.23 114.175 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -104.87 127.3 52.64 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.31 1.044 . . . . 72.34 109.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.3 mm? -99.76 115.96 30.74 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.466 0.707 . . . . 75.24 110.689 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 52' ' ' VAL . 31.4 mmt180 -83.85 119.23 24.61 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.886 -0.413 . . . . 75.4 109.886 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.8 -167.47 0.01 OUTLIER Glycine 0 CA--C 1.545 1.939 0 N-CA-C 117.85 1.9 . . . . 64.01 117.85 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 76.07 -47.16 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 125.714 1.606 . . . . 63.44 115.141 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m 91.74 144.25 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 C-N-CA 126.825 2.05 . . . . 62.24 109.983 -162.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.95 -37.86 93.24 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.842 3.028 . . . . 61.21 116.244 -167.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -85.25 -13.91 48.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.371 0.508 . . . . 74.23 112.371 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -80.72 123.51 82.44 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.446 0.698 . . . . 70.02 111.46 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -48.84 98.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.632 2.888 . . . . 55.33 113.568 171.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.87 -14.71 2.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.089 -0.505 . . . . 53.13 112.992 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -67.09 122.37 17.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.53 0.732 . . . . 75.34 111.211 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.6 mt-10 -102.65 117.59 34.99 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.71 0.404 . . . . 71.41 111.484 -172.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 46.7 ttp180 -92.94 103.19 15.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.559 0.744 . . . . 72.43 110.763 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 62' ' ' VAL . 20.6 t -112.6 99.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.755 . . . . 75.4 110.242 -171.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -63.18 -48.97 76.13 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.708 1.003 . . . . 65.31 113.708 -168.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.01 52.91 0.61 Allowed Glycine 0 N--CA 1.478 1.466 0 N-CA-C 112.374 -0.291 . . . . 32.5 112.374 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.746 0.818 . . . . 44.34 112.994 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.53 33.36 3.63 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 115.965 -0.561 . . . . 72.4 113.529 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -120.61 177.69 4.97 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 123.577 0.751 . . . . 74.23 110.73 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.82 -55.27 13.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.811 0.444 . . . . 71.1 111.291 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -115.74 89.9 3.21 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.446 0.698 . . . . 65.34 110.997 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.17 163.55 12.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.975 0.91 . . . . 74.12 111.268 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -116.8 119.43 35.41 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.351 0.661 . . . . 70.53 110.122 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 48.9 t -104.51 114.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.42 0.688 . . . . 65.31 110.194 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 83.3 mt-10 -101.22 169.7 8.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.6 1.16 . . . . 74.53 110.578 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -151.02 126.34 10.01 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.422 0.689 . . . . 75.44 110.801 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.52 127.4 32.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.975 0.91 . . . . 51.34 111.144 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.92 -40.35 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.301 0.64 . . . . 73.43 111.345 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -167.28 153.59 8.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.961 0.905 . . . . 54.02 109.835 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 153.08 35.87 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.203 0.601 . . . . 64.13 110.598 170.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.87 135.18 35.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 74.32 110.639 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.57 -57.65 3.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.608 0.763 . . . . 73.12 112.501 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.6 m -76.43 -14.83 60.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.937 0.717 . . . . 25.43 112.937 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.87 30.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.182 0.593 . . . . 55.51 111.165 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.48 36.92 18.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.868 1.267 . . . . 63.43 111.271 -176.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -110.23 97.02 6.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.14 0.976 . . . . 74.4 111.889 -166.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 14.6 tp -98.67 108.03 20.62 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.8 1.24 . . . . 65.32 110.215 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.9 t -108.97 121.68 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.055 0.942 . . . . 72.44 111.527 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -135.98 179.72 6.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.514 0.673 . . . . 71.14 112.209 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 t -133.6 163.15 30.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.117 1.367 . . . . 74.41 109.598 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.2 mtp -112.39 88.38 10.76 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 123.447 0.699 . . . . 75.12 109.377 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 49.4 Cg_endo -65.51 -24.57 56.26 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.603 2.869 . . . . 70.53 113.62 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 22.1 t70 -135.44 78.4 51.02 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 122.786 0.434 . . . . 74.11 110.447 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 61.4 Cg_endo -95.99 143.22 1.05 Allowed 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.133 2.555 . . . . 74.13 113.864 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 3.0 Cg_exo -79.61 28.16 0.52 Allowed 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.943 2.428 . . . . 73.41 112.907 169.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.17 152.83 51.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.645 1.178 . . . . 71.12 110.008 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.31 41.11 0.74 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.629 2.886 . . . . 62.1 114.236 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -109.85 124.37 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 124.178 0.991 . . . . 64.13 110.743 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 8.9 m -68.25 -68.44 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.976 0.51 . . . . 75.12 112.156 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.71 110.08 16.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.255 0.55 . . . . 65.23 109.627 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 58.7 t-80 -85.67 150.2 24.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.026 0.531 . . . . 72.23 111.334 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -152.62 117.36 5.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.842 0.857 . . . . 73.13 110.081 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -118.48 149.75 40.75 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.609 0.596 . . . . 74.1 112.609 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 94' ' ' GLU . 61.4 t -135.02 137.26 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.353 1.061 . . . . 71.1 109.492 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -114.52 108.88 17.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.032 1.333 . . . . 74.03 107.46 -178.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' A' ' 92' ' ' VAL . 40.3 mt-10 -124.4 114.39 19.44 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.241 0.928 . . . . 53.32 111.875 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -89.09 109.06 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.745 -0.835 . . . . 75.14 108.745 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.9 117.9 66.79 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.117 0.967 . . . . 45.12 110.329 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 88.17 0.99 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.449 2.099 . . . . 53.33 111.902 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -34.54 78.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.059 0.943 . . . . 64.41 110.414 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.8 t70 -149.42 165.53 31.81 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.995 1.318 . . . . 53.13 109.042 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.13 -43.97 97.66 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.521 0.728 . . . . 72.41 111.897 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -91.87 -19.93 21.97 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.548 0.739 . . . . 64.02 110.835 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 39.3 m80 -127.34 138.43 53.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 72.12 111.833 -170.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -126.43 174.94 8.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.57 0.748 . . . . 73.43 110.517 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -137.01 111.01 8.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.518 0.727 . . . . 54.52 109.964 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -87.97 115.37 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.252 0.549 . . . . 70.02 110.222 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -105.81 111.84 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.826 1.25 . . . . 60.1 110.553 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -103.62 113.9 27.76 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 109.24 -0.652 . . . . 74.31 109.24 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.5 m -114.21 141.32 47.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.631 1.172 . . . . 51.52 110.054 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.65 112.18 4.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.066 0.546 . . . . 61.51 112.142 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -118.56 142.53 47.52 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.456 1.102 . . . . 75.54 110.299 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.66 153.1 33.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.532 0.733 . . . . 64.32 111.761 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 31.3 t70 -80.71 86.39 5.94 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.144 0.497 . . . . 64.12 110.021 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 36.5 t -151.39 157.77 42.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.457 -0.792 . . . . 73.11 111.979 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m -61.9 146.49 91.24 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 123.835 0.854 . . . . 73.42 112.351 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -60.98 -28.96 87.09 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.051 2.501 . . . . 61.34 113.867 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.14 -35.26 77.81 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.902 0.481 . . . . 73.42 112.074 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.405 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 19.0 m -74.8 -40.63 61.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.216 0.532 . . . . 71.53 110.071 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.97 81.98 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.135 -0.939 . . . . 41.21 112.826 -174.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.9 -33.82 72.7 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.922 0.489 . . . . 62.24 111.24 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.96 -41.52 97.54 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.056 -0.52 . . . . 54.14 109.735 171.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.53 -26.79 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.359 0.664 . . . . 73.2 112.313 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 118.615 0.643 . . . . 61.02 110.428 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 m -69.23 -59.68 2.86 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 115.691 -0.686 . . . . 65.4 111.896 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.0 -56.97 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.651 0.78 . . . . 65.5 112.483 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.2 -48.44 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.647 0.379 . . . . 53.44 110.581 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.6 -48.07 81.11 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 114.509 0.564 . . . . 71.5 114.509 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -101.23 -53.61 2.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.989 -0.712 . . . . 63.02 111.646 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.28 -22.75 69.49 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 115.399 0.92 . . . . 71.05 115.399 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -111.92 -54.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 117.548 0.674 . . . . 74.25 111.196 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 10.7 m-30 -72.8 -59.92 2.48 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.292 0.637 . . . . 62.31 112.092 -173.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.504 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -57.84 -36.31 72.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 123.39 0.431 . . . . 65.25 111.484 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.69 -50.4 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 124.221 1.008 . . . . 61.5 111.956 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.84 97.75 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.178 -0.465 . . . . 70.22 113.103 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.49 -36.09 81.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.371 1.069 . . . . 64.23 111.946 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.91 -43.9 74.26 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.694 0.397 . . . . 74.53 110.47 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.4 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.219 0.608 . . . . 31.01 111.599 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.98 -42.58 97.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.641 0.776 . . . . 73.33 110.397 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.76 -29.59 64.67 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.325 0.491 . . . . 62.52 112.325 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.2 -41.32 73.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.459 0.703 . . . . 64.24 112.453 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.472 0.545 . . . . 64.32 112.472 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -87.16 -34.41 19.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.762 0.425 . . . . 75.14 112.133 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 115.181 0.832 . . . . 63.2 115.181 179.546 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.59 0.233 . . . . 73.43 111.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 110' ' ' MET . 66.8 m -113.92 111.13 21.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.059 0.943 . . . . 75.45 109.442 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.24 137.32 36.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.21 1.004 . . . . 75.33 109.366 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -142.76 131.95 23.27 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 120.815 0.341 . . . . 74.22 110.218 168.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -125.38 157.42 36.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.547 1.139 . . . . 65.24 109.54 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.3 p -150.29 151.96 33.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.33 0.652 . . . . 75.22 110.697 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.7 p -148.38 145.2 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.75 0.42 . . . . 64.34 110.998 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -92.29 109.48 20.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.956 0.502 . . . . 65.23 110.996 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 61.0 t -95.14 139.01 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.566 1.146 . . . . 73.54 111.702 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 33.38 0.13 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.0 1.111 . . . . 64.35 114.0 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.06 149.23 34.81 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 123.582 0.753 . . . . 63.25 111.301 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.12 148.67 67.93 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.484 2.789 . . . . 73.41 114.176 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.56 -43.43 56.3 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.899 1.444 . . . . 71.3 114.899 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.22 76.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.223 0.609 . . . . 62.53 112.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.68 -47.04 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.402 1.081 . . . . 73.31 111.636 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' SG ' ' A' ' 103' ' ' CYS . 92.9 t -72.97 -34.91 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.998 0.919 . . . . 72.13 111.75 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.05 -28.5 69.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.819 0.447 . . . . 72.01 111.586 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 m -68.97 -30.78 69.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.168 0.587 . . . . 74.14 111.271 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.3 tp -77.76 -48.97 15.34 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.975 0.91 . . . . 62.3 111.848 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.3 -34.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 113.385 0.883 . . . . 62.41 113.385 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.29 -24.9 74.86 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 114.32 0.488 . . . . 30.1 114.32 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.77 111.31 21.22 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -6.44 47.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.762 1.023 . . . . 72.02 113.762 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -95.84 -8.17 34.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.822 0.449 . . . . 74.04 110.497 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.97 -2.87 36.31 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.751 . . . . 73.32 111.236 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.721 HG23 HG11 ' A' ' 34' ' ' VAL . 20.4 tt -64.16 -26.63 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 123.052 0.541 . . . . 73.13 112.104 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.08 -9.05 57.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 112.822 0.675 . . . . 54.32 112.822 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.91 -28.22 30.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.52 0.728 . . . . 60.43 111.91 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.5 p-90 -116.24 -35.1 4.44 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.739 0.644 . . . . 73.11 112.739 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -84.82 112.65 44.39 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.488 -0.291 . . . . 75.02 110.762 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HD2' ' HA2' ' A' ' 133' ' ' GLY . 38.9 Cg_endo -64.34 -16.39 54.81 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.371 2.714 . . . . 53.23 114.832 -175.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.493 HE21 ' H ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -88.54 -37.66 15.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.041 -0.412 . . . . 74.23 110.693 174.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.721 HG11 HG23 ' A' ' 27' ' ' ILE . 61.6 t -78.2 102.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 120.829 0.347 . . . . 72.0 110.742 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -86.25 -49.88 7.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.203 0.601 . . . . 72.12 111.206 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.36 105.81 0.47 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 123.698 0.799 . . . . 24.1 111.489 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 68.6 Cg_endo -85.53 160.91 10.94 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.0 2.467 . . . . 72.13 113.842 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.4 m -103.95 120.98 42.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.848 0.859 . . . . 64.01 110.638 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.09 120.23 29.24 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.282 0.633 . . . . 73.24 110.929 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -108.24 120.63 42.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.896 0.879 . . . . 74.42 109.681 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.74 173.66 0.01 OUTLIER Glycine 0 CA--C 1.558 2.754 0 N-CA-C 119.045 2.378 . . . . 75.12 119.045 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 74.61 -39.29 0.41 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.94 1.829 . . . . 73.25 115.94 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m 87.11 135.48 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.843 0 C-N-CA 126.343 1.857 . . . . 71.11 111.555 -171.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.11 -25.37 45.26 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 124.473 3.449 . . . . 72.01 116.835 -166.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -85.32 -28.2 25.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.075 0.398 . . . . 73.43 112.075 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.7 m -81.38 123.83 80.92 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 123.834 0.853 . . . . 73.43 112.084 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 109.75 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 124.151 3.234 . . . . 53.52 114.206 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.24 -21.64 3.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.222 -0.445 . . . . 72.14 112.953 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 125.57 24.75 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.321 0.86 . . . . 43.12 113.321 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 37.3 mt-10 -104.61 137.43 42.45 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.224 0.61 . . . . 65.23 109.398 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -127.26 133.29 50.2 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.585 1.084 . . . . 63.3 111.122 167.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.51 107.66 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.553 -0.749 . . . . 60.05 109.877 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -70.77 79.87 0.61 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.406 1.082 . . . . 62.43 110.632 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.74 -65.68 0.59 Allowed Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.907 -0.588 . . . . 40.33 111.93 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.39 101.97 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.052 1.341 . . . . 55.12 113.349 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.13 66.5 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-O 121.27 0.372 . . . . 22.15 113.57 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -116.41 -162.1 0.83 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.5 1.12 . . . . 74.55 111.304 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.6 -52.33 6.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.475 0.71 . . . . 73.44 111.28 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 85.77 2.44 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.245 0.618 . . . . 74.11 111.138 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -112.19 155.72 23.5 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.189 0.518 . . . . 73.3 111.12 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 ' SD ' ' A' ' 79' ' ' MET . 57.4 tp -120.48 122.55 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.793 -0.817 . . . . 70.03 108.793 172.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 55.3 t -95.33 117.72 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.426 -0.953 . . . . 74.05 108.426 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 2.1 tt0 -114.22 162.73 16.17 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.446 0.698 . . . . 71.54 110.011 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 4.6 tmt_? -151.45 125.12 9.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.408 0.683 . . . . 73.51 110.193 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.9 tp -82.23 127.74 33.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.802 0.841 . . . . 72.34 110.575 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.511 HG21 ' NH1' ' A' ' 90' ' ' ARG . 95.1 t -95.92 -44.46 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.313 0.645 . . . . 73.32 111.188 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -160.63 148.15 15.9 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.974 0.91 . . . . 71.13 110.163 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -124.3 109.65 13.62 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.421 -0.585 . . . . 73.34 109.421 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.56 125.59 41.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.193 0.997 . . . . 74.22 109.125 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.18 -15.76 14.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.043 -0.41 . . . . 71.54 111.887 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 m -65.94 -39.66 90.69 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.374 0.669 . . . . 54.03 111.899 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.4 4.02 18.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.259 1.023 . . . . 62.14 111.415 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 80.2 mtt-85 53.23 64.03 2.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.505 1.122 . . . . 71.15 111.11 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -129.11 111.55 13.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.072 0.949 . . . . 73.5 111.029 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 19.8 tp -104.23 105.63 15.85 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.482 0.713 . . . . 72.31 110.961 -173.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.1 t -101.07 124.32 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 123.852 0.861 . . . . 72.13 111.711 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -153.0 -178.01 6.65 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.484 0.659 . . . . 74.13 112.597 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 t -153.11 159.85 42.83 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.737 1.215 . . . . 52.42 110.348 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.44 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.6 ptt? -109.96 103.23 53.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.08 0.552 . . . . 75.43 109.758 171.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 79' ' ' MET . 36.8 Cg_endo -62.59 -29.39 78.08 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.443 2.762 . . . . 73.43 113.726 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.1 m-20 -123.09 83.58 51.14 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 122.995 0.518 . . . . 54.31 110.659 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -88.98 147.08 5.59 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 123.154 2.569 . . . . 75.12 113.214 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -81.85 0.12 10.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.515 2.143 . . . . 75.02 112.671 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.83 141.75 23.36 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.196 0.999 . . . . 74.31 110.535 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' ' 117' ' ' THR . 63.2 Cg_endo -71.1 81.99 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.647 2.231 . . . . 73.14 113.165 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.8 pt -133.04 151.85 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.428 1.091 . . . . 74.11 110.031 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 20.8 m -91.66 -85.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.517 0.327 . . . . 74.35 111.164 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.65 111.82 24.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.938 -0.477 . . . . 61.51 110.369 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -92.57 143.75 26.03 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.585 0.754 . . . . 74.43 111.796 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.511 ' NH1' HG21 ' A' ' 66' ' ' VAL . 10.4 tpp180 -148.54 117.02 6.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.485 1.114 . . . . 72.15 108.899 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.41 148.27 48.86 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.81 0.444 . . . . 43.25 111.36 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 85.3 t -134.98 136.0 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 124.489 1.116 . . . . 71.35 110.355 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.39 111.17 18.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.146 0.978 . . . . 72.2 110.1 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG12 ' A' ' 92' ' ' VAL . 36.2 mt-10 -115.11 157.82 23.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.386 1.074 . . . . 74.52 111.614 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.96 111.08 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.279 0.632 . . . . 63.51 109.656 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.8 117.46 60.63 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 124.751 1.22 . . . . 74.14 110.651 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.12 133.59 25.25 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.722 2.281 . . . . 63.11 113.901 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.26 -55.72 2.28 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.407 1.083 . . . . 64.12 110.083 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.5 t70 -126.15 169.18 13.08 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.883 1.273 . . . . 70.23 109.723 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.27 -41.32 79.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.594 0.758 . . . . 70.52 112.035 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -106.05 10.04 32.27 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 123.312 0.645 . . . . 75.24 111.502 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 70.0 m80 -139.79 140.19 36.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 64.31 111.657 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.0 p -136.37 178.53 6.99 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.342 0.657 . . . . 71.14 110.221 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m -135.76 113.58 11.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.039 0.536 . . . . 61.05 111.039 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.2 107.53 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 109.628 -0.508 . . . . 73.22 109.628 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.74 99.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.085 0.954 . . . . 65.42 109.772 -174.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -103.5 118.82 37.61 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.292 0.567 . . . . 72.4 110.563 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.528 HG22 ' SD ' ' A' ' 110' ' ' MET . 34.6 m -119.58 139.86 51.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.823 1.249 . . . . 71.24 110.207 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.11 113.25 6.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.31 0.644 . . . . 72.12 111.326 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.528 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -124.0 127.76 48.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.921 0.888 . . . . 73.02 110.239 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -146.07 156.01 43.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.895 0.878 . . . . 74.01 110.904 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 35.3 t70 -83.09 82.78 8.1 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.47 0.652 . . . . 60.04 110.142 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.662 ' HB2' HG22 ' A' ' 86' ' ' ILE . 51.9 t -120.52 149.87 41.73 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.244 -0.889 . . . . 64.21 111.327 178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 128.35 93.75 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-O 118.225 -0.893 . . . . 54.34 110.451 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -39.68 -40.57 2.36 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 124.903 3.735 . . . . 75.5 116.725 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.49 -52.07 59.76 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.313 0.578 . . . . 75.53 110.578 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 85' ' ' PRO . 71.3 m -68.57 -30.55 69.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.53 -0.759 . . . . 70.01 111.376 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.27 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.509 0.724 . . . . 63.34 111.912 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -71.97 -28.47 63.45 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 122.845 0.458 . . . . 71.35 111.143 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.08 -42.34 97.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.483 0.713 . . . . 63.22 110.238 170.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -74.99 -23.26 58.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.696 0.798 . . . . 71.44 111.688 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -60.71 -37.96 83.45 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.971 0.351 . . . . 72.54 110.481 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.2 m -73.06 -48.49 35.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.215 0.606 . . . . 74.4 112.538 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.9 -54.04 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 112.767 0.654 . . . . 74.21 112.767 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.57 -52.28 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.29 0.636 . . . . 44.24 111.146 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.59 -68.39 1.63 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 114.043 0.377 . . . . 72.44 114.043 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.305 0.642 . . . . 64.22 111.075 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.89 -96.72 0.26 Allowed Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.644 -0.531 . . . . 52.51 112.834 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.38 -49.22 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.574 1.149 . . . . 71.31 113.616 -171.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.17 -61.13 1.9 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.664 -0.698 . . . . 72.44 111.644 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.86 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.252 0.464 . . . . 62.34 112.252 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.45 -50.51 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.775 0.83 . . . . 53.51 111.431 171.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 32' ' ' PRO . . . -68.96 -37.74 83.77 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.058 -0.519 . . . . 52.34 113.287 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.62 -41.96 78.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.448 1.099 . . . . 71.22 111.778 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.52 -43.16 94.92 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.594 0.358 . . . . 74.51 110.843 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.35 -31.32 72.48 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.814 0.446 . . . . 63.41 112.055 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.52 -45.8 71.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.177 0.591 . . . . 65.03 109.682 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.95 95.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.483 0.713 . . . . 73.34 112.024 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.35 -40.18 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.956 . . . . 63.13 112.941 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -61.91 -36.11 80.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.756 0.65 . . . . 74.45 112.756 -172.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.24 -28.16 59.77 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.973 0.509 . . . . 73.13 111.947 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.467 0 CA-C-N 116.491 -0.322 . . . . 72.13 113.116 179.136 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 121.343 0.592 . . . . 60.52 109.979 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.4 m -108.73 113.14 25.85 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.587 0.755 . . . . 64.51 111.141 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.31 112.82 24.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.795 1.238 . . . . 55.03 110.511 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -112.57 133.08 54.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 122.02 -0.425 . . . . 70.31 110.43 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 143.53 44.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.168 0.587 . . . . 72.35 109.78 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -143.72 158.63 43.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 64.23 110.605 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.3 p -153.23 143.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.92 0.488 . . . . 62.14 111.222 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.43 108.62 18.58 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.793 -0.447 . . . . 74.21 109.793 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 48.6 t -90.99 128.06 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.643 0.777 . . . . 31.3 110.999 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -77.74 67.77 3.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.098 0.559 . . . . 65.31 111.36 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.61 153.61 2.82 Favored Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 123.55 0.74 . . . . 62.31 111.692 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.12 126.98 19.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.163 2.576 . . . . 73.43 113.146 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.06 -42.23 8.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.043 1.497 . . . . 61.43 115.043 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.83 85.7 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.771 0.428 . . . . 54.13 112.079 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.34 -36.49 84.29 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.647 0.779 . . . . 72.54 112.028 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -36.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.365 0.666 . . . . 55.25 110.203 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -67.7 -28.93 68.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.506 -0.77 . . . . 73.34 110.841 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.6 m -62.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.142 0.496 . . . . 74.04 111.017 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 30' ' ' TRP . 61.5 tp -70.8 -46.66 62.43 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.17 0.988 . . . . 75.44 111.536 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.57 8.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.681 0.792 . . . . 72.22 112.62 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.98 -9.86 79.81 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 123.282 0.468 . . . . 54.22 113.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-20 -106.7 132.81 52.26 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.294 0.568 . . . . 72.32 109.603 168.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -76.03 -5.99 48.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.737 0.815 . . . . 63.31 111.32 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -93.37 -10.3 35.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.525 0.73 . . . . 44.22 111.415 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -97.45 22.88 8.24 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.442 0.904 . . . . 51.51 113.442 -153.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 34' ' ' VAL . 19.2 tt -81.25 -18.2 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 O-C-N 122.259 -0.276 . . . . 74.24 111.31 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -65.62 -22.36 66.66 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.003 0.521 . . . . 75.03 111.827 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -68.96 -44.91 71.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.399 1.08 . . . . 72.31 112.422 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' HB3' HD21 ' A' ' 20' ' ' LEU . 28.3 p-90 -115.95 -37.64 3.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.153 0.797 . . . . 74.44 113.153 -169.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -83.44 110.72 26.23 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 109.959 -0.386 . . . . 74.42 109.959 -172.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.91 2.03 5.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.019 2.479 . . . . 74.43 116.312 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.517 HE21 ' N ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -102.74 -19.73 14.63 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.521 0.6 . . . . 60.42 111.866 176.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 27' ' ' ILE . 57.6 t -70.11 118.86 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-O 121.183 0.516 . . . . 70.33 112.188 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 t -88.61 38.12 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 74.4 111.448 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.2 109.28 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.292 1.437 . . . . 64.31 112.062 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.75 160.69 12.22 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.543 2.162 . . . . 71.43 112.992 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 m -99.53 122.59 42.82 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.213 -0.662 . . . . 74.44 109.213 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.58 122.63 31.52 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.9 -1.148 . . . . 32.44 107.9 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 99.3 mtt180 -110.57 126.15 54.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.725 0.81 . . . . 63.32 111.308 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.72 -176.68 0.01 OUTLIER Glycine 0 CA--C 1.547 2.048 0 N-CA-C 118.102 2.001 . . . . 53.33 118.102 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.48 -92.9 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.082 1.353 . . . . 74.4 112.942 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 t 165.65 147.16 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 125.954 1.702 . . . . 43.51 108.704 -173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.09 -4.43 6.24 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.515 2.143 . . . . 71.13 114.034 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.04 -10.0 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.7 0.8 . . . . 62.31 112.129 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -108.37 125.69 31.31 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 123.721 0.808 . . . . 52.33 112.143 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 98.9 Cg_exo -48.41 123.65 9.49 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 123.804 3.002 . . . . 73.41 114.081 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.68 -27.77 4.08 Favored Glycine 0 N--CA 1.474 1.21 0 CA-C-N 116.137 -0.483 . . . . 32.14 112.445 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.62 49.49 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.602 0.761 . . . . 73.51 112.548 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 45.1 mt-10 -130.21 120.74 24.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.819 0.447 . . . . 72.34 111.622 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' NH2' ' HB ' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -92.67 120.73 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.613 -0.884 . . . . 74.15 108.613 175.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.65 98.52 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.679 -0.638 . . . . 62.43 110.652 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -59.69 121.57 11.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 74.41 111.91 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.68 -51.45 4.57 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.967 -0.352 . . . . 73.35 112.886 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.83 33.86 23.79 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.353 1.061 . . . . 74.45 113.041 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.68 -24.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.971 -1.013 . . . . 70.34 111.74 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.6 p -63.13 141.1 58.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.6 0.76 . . . . 72.11 111.006 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.56 -30.98 65.68 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.352 0.661 . . . . 62.12 112.183 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -110.82 66.93 0.63 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.33 0.652 . . . . 71.4 110.392 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 164.16 23.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.193 0.521 . . . . 74.45 111.798 171.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 79' ' ' MET . 56.2 tp -133.92 131.24 38.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.694 0.797 . . . . 62.22 109.745 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.6 125.68 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.43 109.928 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.677 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 32.2 mt-10 -118.37 126.53 52.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.551 0.74 . . . . 73.2 109.19 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -101.96 133.48 46.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.193 0.997 . . . . 75.14 111.322 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 13.4 tp -75.64 112.1 11.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.332 1.453 . . . . 72.14 111.089 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.29 -52.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.221 0.608 . . . . 72.32 111.328 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.72 154.72 22.79 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.098 -0.501 . . . . 71.1 111.181 -172.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.751 ' HE ' HD13 ' A' ' 75' ' ' LEU . 19.4 tpp85 -140.15 123.99 17.41 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.486 0.715 . . . . 74.41 111.201 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 12.4 m-20 -122.45 76.41 1.32 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.561 0.745 . . . . 71.13 110.356 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.53 -18.5 65.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 112.959 0.726 . . . . 65.41 112.959 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -46.5 76.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.246 0.619 . . . . 54.02 110.723 169.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.67 -2.35 58.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.064 0.946 . . . . 63.42 112.967 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 59.51 51.26 6.66 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.182 0.993 . . . . 74.52 111.182 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 28.6 ttm-85 -126.9 132.63 50.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.202 1.001 . . . . 74.23 110.364 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.751 HD13 ' HE ' ' A' ' 68' ' ' ARG . 6.1 tp -130.54 108.51 9.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.985 0.914 . . . . 73.52 109.954 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -106.57 129.65 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.592 0.757 . . . . 72.41 110.005 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.97 178.55 8.83 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.501 0.667 . . . . 74.41 112.759 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -149.57 141.84 24.14 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.199 1.399 . . . . 44.4 109.724 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 61' ' ' LEU . 61.1 mtm -94.44 104.54 14.28 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 119.055 0.843 . . . . 73.35 111.064 174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.52 -24.48 22.22 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.638 2.225 . . . . 64.05 112.716 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -126.34 78.84 71.16 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 123.545 0.738 . . . . 62.23 110.828 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.74 147.55 5.9 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 C-N-CA 122.885 2.39 . . . . 73.53 113.211 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 61' ' ' LEU . 65.3 Cg_endo -84.76 1.89 8.32 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.684 2.256 . . . . 74.44 112.655 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.1 155.44 36.46 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.224 1.009 . . . . 73.25 110.321 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.78 57.11 4.93 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.011 2.474 . . . . 64.13 112.898 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.3 pt -121.95 134.63 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.564 1.146 . . . . 72.12 109.619 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 37.5 m -75.0 -81.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.193 0.442 . . . . 64.15 112.193 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -78.11 -56.34 4.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -172.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.08 127.58 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.745 1.618 . . . . 72.4 113.738 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -123.93 153.54 41.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.076 1.35 . . . . 73.2 108.366 169.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.4 135.71 12.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 72.11 110.528 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.7 p -136.85 138.61 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 N-CA-C 113.242 0.83 . . . . 73.4 113.242 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.5 mm? -104.66 119.4 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.845 1.258 . . . . 71.54 109.235 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -123.86 110.1 14.44 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.673 -0.491 . . . . 71.32 109.673 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.63 110.01 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.491 -0.559 . . . . 71.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.87 111.18 63.87 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.023 0.929 . . . . 64.51 110.385 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.28 109.92 1.89 Allowed 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.791 2.327 . . . . 45.34 113.005 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.438 ' H ' ' HA ' ' A' ' 103' ' ' CYS . 39.5 mmt180 -75.74 -46.65 29.76 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.525 0.679 . . . . 74.53 109.761 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -122.79 -166.23 1.41 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.84 1.256 . . . . 74.3 109.276 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -81.68 -35.35 29.97 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.717 0.407 . . . . 72.44 110.938 167.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -108.85 13.23 25.02 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.106 0.563 . . . . 75.32 111.587 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 53.1 m80 -142.1 152.56 43.38 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.747 0.819 . . . . 70.1 109.637 172.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -153.34 177.62 10.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.024 0.529 . . . . 42.32 111.738 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 82.3 m -133.99 111.86 10.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.832 0.853 . . . . 72.42 109.986 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.89 116.87 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.469 -0.567 . . . . 51.21 109.469 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.11 105.89 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.795 0.838 . . . . 75.12 109.513 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -102.97 116.96 33.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.23 -1.026 . . . . 71.52 108.23 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 152.8 46.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.707 0.803 . . . . 65.33 109.928 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 155.32 47.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.118 1.367 . . . . 73.23 109.596 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -163.47 126.11 2.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.039 0.936 . . . . 54.02 109.688 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 p90 -141.31 156.01 45.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.332 0.653 . . . . 75.41 112.023 -165.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 38.4 t70 -84.97 86.98 7.33 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.499 0.666 . . . . 74.44 110.316 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.9 t -145.59 165.22 29.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.92 -1.036 . . . . 62.12 110.861 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.1 p -68.53 148.82 98.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 123.18 0.592 . . . . 64.14 111.687 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.93 -22.16 68.59 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.298 1.999 . . . . 72.11 112.78 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -65.83 -43.72 87.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.01 0.924 . . . . 74.32 111.312 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.499 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 23.5 m -84.33 -31.16 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.091 0.557 . . . . 65.41 111.068 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -64.62 -33.92 77.05 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.54 0.736 . . . . 63.14 112.226 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -65.73 -33.85 76.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.107 0.563 . . . . 73.51 111.402 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.61 -38.74 73.99 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.721 0.809 . . . . 75.23 109.961 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.9 -24.84 61.72 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.287 -0.869 . . . . 71.32 111.828 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 51.3 mt-10 -61.61 -39.13 90.17 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 117.956 0.343 . . . . 72.21 110.362 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -66.75 -55.67 13.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.536 0.734 . . . . 53.55 112.102 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.53 -55.03 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.463 0.705 . . . . 71.13 112.708 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.3 mt -82.53 -58.17 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.536 -0.757 . . . . 65.43 111.099 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.71 -50.03 32.96 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 114.973 0.749 . . . . 25.31 114.973 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.75 -25.24 21.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.14 0.576 . . . . 60.44 111.177 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.07 -88.51 0.67 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.13 -0.486 . . . . 64.24 112.038 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.09 -47.01 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 124.559 1.144 . . . . 33.43 113.366 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -77.84 -50.14 12.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.106 0.562 . . . . 73.01 112.159 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.19 81.63 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.243 0.339 . . . . 71.31 111.063 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -56.8 -50.3 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.225 0.61 . . . . 63.45 112.047 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.64 -48.68 82.96 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 123.508 0.505 . . . . 63.32 113.391 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 mt -69.99 -37.37 75.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.78 0.832 . . . . 72.11 112.959 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.46 -52.04 50.49 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 110.261 -0.274 . . . . 65.53 110.261 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.14 69.62 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.287 0.635 . . . . 42.11 111.8 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.437 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.0 tt -68.23 -45.99 71.77 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.484 0.714 . . . . 71.14 110.18 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -28.17 64.4 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 112.082 0.401 . . . . 64.3 112.082 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.73 -44.78 48.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.121 0.968 . . . . 63.22 111.635 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 12.8 ptm180 -63.8 -29.34 70.55 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.133 0.573 . . . . 63.43 112.152 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.3 -22.06 38.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.974 0.731 . . . . 72.41 112.974 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.578 0 N-CA-C 115.225 0.85 . . . . 50.34 115.225 -179.196 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 121.121 0.486 . . . . 71.54 110.37 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.6 m -111.49 119.33 38.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.353 1.061 . . . . 73.54 110.039 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.0 139.78 31.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.694 1.197 . . . . 65.44 108.701 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -147.46 126.35 12.74 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.021 0.438 . . . . 72.21 111.184 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -130.32 158.27 40.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.05 1.34 . . . . 61.13 110.081 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.8 p -155.1 154.86 33.03 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.246 0.618 . . . . 75.11 112.005 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.5 p -152.17 145.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.086 0.555 . . . . 73.23 111.354 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.56 108.84 19.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 120.996 0.427 . . . . 74.21 110.694 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 137' ' ' LEU . 95.2 t -94.05 137.77 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 63.2 110.411 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -83.16 41.9 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 112.936 0.717 . . . . 64.33 112.936 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.607 ' HA ' HH11 ' A' ' 101' ' ' ARG . . . -142.06 148.18 47.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.675 0.79 . . . . 60.55 110.483 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.23 142.97 93.52 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.412 2.074 . . . . 73.44 112.375 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.08 -33.54 39.8 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.177 1.391 . . . . 74.2 114.503 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.7 69.75 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.082 0.553 . . . . 73.35 112.107 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.99 -39.38 85.52 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.465 0.706 . . . . 73.33 112.139 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG21 ' SG ' ' A' ' 103' ' ' CYS . 65.2 t -70.63 -35.53 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.273 0.629 . . . . 62.13 111.009 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 62.4 t-105 -68.46 -31.52 70.87 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.155 0.582 . . . . 63.12 110.864 176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.7 m -65.96 -33.27 75.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.354 0.662 . . . . 74.22 110.672 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.7 tp -75.86 -52.79 9.57 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.806 0.842 . . . . 75.43 112.346 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 m -79.38 -32.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 113.124 0.787 . . . . 63.21 113.124 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.77 -31.68 81.61 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 114.544 0.578 . . . . 74.45 114.544 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.73 95.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.025 0.44 . . . . 72.34 109.967 171.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -67.18 -18.06 65.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.308 0.643 . . . . 65.34 112.246 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.6 p -77.57 -27.21 51.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.079 0.552 . . . . 71.11 111.191 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.32 29.13 6.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.857 0.863 . . . . 31.11 111.139 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.604 HG23 HG11 ' A' ' 34' ' ' VAL . 9.2 tt -64.85 -27.13 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 CA-C-N 115.09 -0.959 . . . . 52.52 111.555 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -59.95 -12.36 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.212 1.19 . . . . 73.33 114.212 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -71.24 -24.62 62.22 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.13 0.572 . . . . 70.01 112.502 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.42 ' HB3' HD21 ' A' ' 20' ' ' LEU . 59.1 p-90 -122.51 -31.55 3.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.296 0.638 . . . . 73.02 111.404 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' CE1' HE21 ' A' ' 33' ' ' GLN . 22.1 t-80 -95.35 104.16 14.63 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.182 0.593 . . . . 72.34 110.206 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.3 -16.32 54.42 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.212 2.608 . . . . 75.21 114.617 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.469 HE21 ' CE1' ' A' ' 31' ' ' HIS . 6.0 mt-30 -95.25 -11.06 28.61 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.3 0.852 . . . . 61.43 113.3 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 27' ' ' ILE . 56.1 t -75.04 116.48 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 118.346 0.521 . . . . 64.34 110.321 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -87.03 29.79 0.8 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.822 0.849 . . . . 64.25 112.137 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.469 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 68.08 121.7 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 125.706 1.602 . . . . 72.31 111.888 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 41.9 Cg_endo -96.26 155.26 1.34 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.024 2.483 . . . . 34.41 115.924 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -101.11 123.56 45.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.976 0.91 . . . . 74.42 109.938 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.21 123.36 28.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.256 0.55 . . . . 71.23 112.33 -172.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 10.3 mmm180 -103.07 121.81 43.36 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.722 1.209 . . . . 63.31 110.214 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.18 -178.53 0.01 OUTLIER Glycine 0 CA--C 1.549 2.18 0 N-CA-C 117.766 1.866 . . . . 53.31 117.766 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . . . 40.27 -98.02 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 126.059 1.743 . . . . 73.41 115.111 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 30.0 t -176.81 149.36 0.85 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 124.461 1.104 . . . . 71.22 110.491 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.33 -11.97 21.71 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.871 2.381 . . . . 53.32 113.587 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -114.72 1.94 14.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.902 0.881 . . . . 74.5 112.498 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.8 m -97.53 117.52 65.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.361 -0.837 . . . . 65.04 110.204 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 22.0 Cg_endo -58.48 92.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.065 2.51 . . . . 72.44 112.752 176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.15 -42.5 0.27 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.279 -0.873 . . . . 54.13 112.115 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . . . -67.58 164.74 18.39 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.908 1.077 . . . . 55.12 113.908 -172.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 33.9 mt-10 -121.62 164.47 17.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.251 1.02 . . . . 62.52 110.097 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -146.68 146.29 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.004 0.43 . . . . 65.2 111.837 168.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 t -117.69 108.11 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.546 0.738 . . . . 72.33 111.158 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -66.27 110.31 2.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.442 1.097 . . . . 74.32 110.633 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.96 -63.33 1.5 Allowed Glycine 0 CA--C 1.539 1.563 0 N-CA-C 112.064 -0.414 . . . . 64.12 112.064 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.88 115.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.743 1.386 . . . . 75.12 114.743 171.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.02 17.97 66.14 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 121.237 0.354 . . . . 62.52 112.698 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 p -94.6 -171.25 2.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.288 . . . . 60.31 109.923 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.34 -26.63 19.86 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 120.811 0.338 . . . . 75.13 110.63 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.33 93.01 2.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.385 0.674 . . . . 62.11 110.116 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.33 -175.72 2.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.417 0.687 . . . . 74.31 111.512 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 83' ' ' PRO . 34.9 tp -135.11 117.76 16.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.719 0.808 . . . . 74.25 110.347 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.98 121.81 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 109.173 -0.677 . . . . 54.44 109.173 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.61 167.19 14.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.424 0.69 . . . . 65.02 109.924 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.511 HH11 ' HA ' ' A' ' 66' ' ' VAL . 3.1 tmt_? -140.7 109.07 5.83 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.088 0.955 . . . . 70.35 109.843 -165.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 29.8 tp -59.46 105.91 0.4 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.159 0.984 . . . . 63.31 110.96 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.511 ' HA ' HH11 ' A' ' 64' ' ' ARG . 89.3 t -78.27 -51.03 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.37 0.668 . . . . 51.12 111.307 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.25 151.45 34.25 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.153 0.581 . . . . 72.54 111.287 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -143.13 130.07 20.57 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.965 0.906 . . . . 61.01 110.479 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 14.7 m-20 -135.94 118.3 15.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.361 1.064 . . . . 72.24 110.466 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 3.9 mp0 -80.77 -36.54 31.72 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.84 0.456 . . . . 74.02 110.267 169.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 m -63.71 -37.61 87.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.893 0.877 . . . . 74.33 112.394 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.5 -12.36 24.25 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.234 0.614 . . . . 63.32 111.733 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 59.46 45.88 13.03 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 71.01 110.006 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 39.0 ttm180 -122.21 123.16 40.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.583 1.553 . . . . 75.15 111.022 -169.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 23.7 tp -123.22 106.64 10.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.501 0.72 . . . . 73.34 110.415 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.1 t -108.21 129.89 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.877 0.871 . . . . 70.43 111.583 -169.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -139.22 172.86 12.22 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 75.24 112.252 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -149.93 139.09 21.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.312 1.445 . . . . 73.11 109.257 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.415 ' SD ' HD11 ' A' ' 61' ' ' LEU . 69.6 mtm -94.66 105.59 19.43 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 118.51 0.595 . . . . 74.23 110.556 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.74 -18.28 22.26 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.006 2.47 . . . . 42.1 112.179 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.6 78.24 68.73 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.869 0.868 . . . . 64.13 109.032 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.84 140.39 16.23 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.684 2.256 . . . . 74.23 112.802 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' HD13 ' A' ' 61' ' ' LEU . 63.4 Cg_endo -85.24 8.41 4.62 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.944 2.43 . . . . 72.14 112.557 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.98 141.38 40.47 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 124.496 1.118 . . . . 75.51 109.383 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.67 88.23 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.578 2.186 . . . . 61.42 113.325 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.8 pt -137.32 168.37 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 125.159 1.383 . . . . 73.42 109.43 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 28.8 m -93.57 -84.02 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.118 0.414 . . . . 71.43 112.118 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -86.26 -45.13 11.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.642 0.608 . . . . 65.42 112.642 -170.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 47.9 t-80 64.66 141.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.736 1.614 . . . . 72.05 113.529 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -150.77 152.73 34.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.403 1.081 . . . . 75.21 108.424 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -160.39 151.09 18.6 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.877 0.471 . . . . 75.23 111.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.78 150.86 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 113.024 0.75 . . . . 72.34 113.024 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -120.63 108.54 14.15 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.639 1.576 . . . . 74.03 107.58 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -126.76 115.1 18.86 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.948 0.499 . . . . 72.21 111.45 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -95.34 126.57 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 122.779 0.432 . . . . 75.51 110.292 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.58 117.72 44.36 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.397 1.079 . . . . 60.35 110.684 -173.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.64 108.23 2.41 Favored 'Trans proline' 0 CA--C 1.568 2.215 0 C-N-CA 122.826 2.351 . . . . 75.54 114.416 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -81.2 -34.73 32.07 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 123.864 0.866 . . . . 71.41 111.767 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 25.6 t70 -156.73 163.2 39.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.311 1.044 . . . . 74.52 109.986 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.04 -23.29 61.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.537 1.135 . . . . 72.33 113.119 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.607 HH11 ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -128.33 5.19 5.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.678 0.791 . . . . 63.52 111.07 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 51.2 m80 -138.51 130.47 28.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.812 . . . . 74.15 110.811 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' HG21 ' A' ' 17' ' ' VAL . 17.3 p -136.33 178.81 6.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.654 0.782 . . . . 65.04 110.226 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.9 m -133.9 118.08 17.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.074 0.55 . . . . 73.35 111.354 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.55 110.92 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.77 -0.456 . . . . 74.44 109.77 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.67 111.86 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.972 0.909 . . . . 63.52 109.633 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -111.32 124.67 52.72 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.912 0.485 . . . . 74.34 109.915 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -127.91 146.28 50.68 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.48 1.112 . . . . 70.21 110.84 -170.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.91 113.8 6.48 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.477 0.711 . . . . 73.43 111.87 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -116.9 125.69 51.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.56 1.144 . . . . 75.2 109.875 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 3.2 p90 -146.79 146.48 30.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.116 0.566 . . . . 71.21 112.521 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.438 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -76.93 86.44 3.47 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.477 0.656 . . . . 72.14 109.617 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.562 ' HB2' HG22 ' A' ' 86' ' ' ILE . 46.5 t -117.86 164.21 15.39 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.907 -1.042 . . . . 73.03 111.828 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -83.95 152.36 62.26 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.546 0.738 . . . . 65.03 110.981 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.41 -62.21 0.48 Allowed 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.956 3.104 . . . . 72.15 115.616 -170.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -31.71 72.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.7 0.8 . . . . 53.41 112.639 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 25.1 m -75.11 -34.31 61.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.315 0.246 . . . . 60.02 111.021 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.21 61.74 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.153 0.581 . . . . 63.15 111.351 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -22.93 66.61 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.259 0.466 . . . . 65.03 112.259 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.34 -41.3 56.98 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.12 0.568 . . . . 74.3 111.298 170.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 mt -75.38 -24.88 57.28 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.109 1.151 . . . . 72.5 114.109 -173.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.39 80.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.558 0.947 . . . . 71.34 113.558 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.9 m -79.31 -44.11 22.29 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.918 0.71 . . . . 62.12 112.918 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.92 -51.22 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.28 0.562 . . . . 75.32 111.87 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.6 mt -81.48 -49.0 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.705 0.802 . . . . 53.41 110.888 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.52 -42.68 95.57 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 114.849 0.699 . . . . 44.51 114.849 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -94.44 -58.95 2.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 122.093 -0.651 . . . . 62.01 110.932 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.95 -18.12 68.37 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.729 1.052 . . . . 45.34 115.729 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.31 -52.27 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 117.644 0.722 . . . . 70.33 110.977 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -74.85 -60.8 2.12 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.53 0.732 . . . . 74.23 112.123 -172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.77 65.42 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.475 0.485 . . . . 72.42 111.525 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.9 t -52.95 -56.54 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 C-N-CA 124.04 0.936 . . . . 73.14 112.442 171.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.3 -36.68 85.15 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 116.568 -0.287 . . . . 31.43 112.97 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.52 -47.45 81.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.167 0.987 . . . . 74.15 112.039 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.28 -47.71 83.13 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.28 0.632 . . . . 74.32 110.874 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.59 74.15 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.234 0.457 . . . . 63.55 112.234 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.445 HD22 HG21 ' A' ' 10' ' ' VAL . 3.8 tt -67.81 -43.17 80.28 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.01 0.524 . . . . 64.53 110.103 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.74 81.92 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.89 0.476 . . . . 74.13 111.837 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.42 -31.26 60.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.128 0.971 . . . . 71.4 112.905 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -67.15 -29.95 69.79 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.873 0.306 . . . . 73.1 111.337 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -93.42 -5.01 50.31 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.883 0.473 . . . . 71.34 112.196 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.21 0 N-CA-C 115.02 0.768 . . . . 70.13 115.02 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.771 0.319 . . . . 64.11 110.634 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -105.99 114.5 28.68 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.806 0.842 . . . . 74.33 110.182 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.36 114.68 26.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.886 1.274 . . . . 75.2 109.833 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -122.47 138.22 54.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.889 0.476 . . . . 72.13 111.968 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -138.96 155.08 48.3 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.934 1.294 . . . . 73.01 109.55 171.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.9 p -149.82 156.99 42.76 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.357 0.663 . . . . 72.11 110.357 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.1 p -145.53 146.09 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 112.084 0.402 . . . . 74.04 112.084 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.43 111.84 23.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.858 0.863 . . . . 62.4 109.71 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 60.7 t -104.29 130.76 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 62.44 110.82 -175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.93 71.54 6.63 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.113 0.482 . . . . 60.22 111.113 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.46 154.12 3.74 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.124 0.97 . . . . 73.42 111.197 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.54 136.17 49.05 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.865 2.376 . . . . 34.32 111.985 168.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.23 17.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.562 1.319 . . . . 71.11 114.562 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.9 -47.69 82.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.19 0.596 . . . . 72.24 112.57 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.47 -43.02 79.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.202 0.601 . . . . 72.15 111.784 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.516 HG21 ' SG ' ' A' ' 103' ' ' CYS . 42.5 t -69.18 -33.79 60.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 115.418 -0.81 . . . . 51.43 111.208 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.444 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 71.9 t-105 -69.54 -31.7 70.06 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 111.751 0.278 . . . . 71.41 111.751 175.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.7 m -64.31 -26.86 68.67 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.659 0.743 . . . . 62.3 110.818 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.446 HD22 HH11 ' A' ' 140' ' ' ARG . 49.2 tp -76.48 -56.33 4.72 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.795 1.238 . . . . 63.43 111.924 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.44 -9.62 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.547 0.943 . . . . 64.45 113.547 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -68.86 -27.9 73.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 113.768 0.267 . . . . 50.51 113.768 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.1 m-20 -80.86 108.57 14.64 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.416 0.686 . . . . 71.32 110.258 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -59.01 -24.81 63.12 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.76 0.824 . . . . 72.22 111.421 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -34.29 26.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.273 1.029 . . . . 75.22 113.086 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -101.56 23.72 10.77 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.529 0.681 . . . . 63.51 111.449 -163.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 HG11 ' A' ' 34' ' ' VAL . 14.9 tt -57.31 -24.79 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.648 1.179 . . . . 65.3 112.463 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -65.56 -5.63 8.65 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.156 1.169 . . . . 71.21 114.156 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -78.72 -27.22 44.88 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.628 0.771 . . . . 72.03 112.416 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -122.31 -29.74 4.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.372 0.669 . . . . 74.35 111.376 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -95.17 111.68 55.78 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.318 0.647 . . . . 61.44 109.976 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.43 -22.01 52.75 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.225 2.617 . . . . 71.12 114.508 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' HA ' ' A' ' 129' ' ' VAL . 37.2 mt-30 -86.74 -25.11 24.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.146 0.579 . . . . 62.42 112.209 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 27' ' ' ILE . 98.2 t -67.72 120.21 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 121.101 0.477 . . . . 64.31 111.142 177.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -88.51 23.59 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.335 1.054 . . . . 75.35 113.075 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.47 95.26 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 124.476 1.11 . . . . 72.43 110.418 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.71 178.79 4.16 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.319 2.68 . . . . 74.42 115.097 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.9 m -101.88 124.29 47.25 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.351 1.061 . . . . 72.44 110.079 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.85 135.68 48.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.496 0.718 . . . . 71.54 110.314 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.39 156.97 47.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.497 0.719 . . . . 63.25 110.636 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.81 157.96 0.01 OUTLIER Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.79 1.876 . . . . 60.5 117.79 -170.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.44 -98.9 0.09 Allowed 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.74 1.216 . . . . 71.21 113.359 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.9 t 171.3 149.42 0.18 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 125.459 1.504 . . . . 71.5 109.285 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.55 -19.74 18.91 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 123.059 2.506 . . . . 63.33 114.148 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -99.14 -30.26 12.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.515 0.726 . . . . 74.13 111.48 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.3 m -88.63 120.63 70.27 Favored Pre-proline 0 N--CA 1.49 1.554 0 C-N-CA 123.12 0.568 . . . . 62.02 111.071 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.542 ' HG3' ' H ' ' A' ' 68' ' ' ARG . 99.5 Cg_exo -45.77 130.18 12.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.957 3.105 . . . . 73.0 114.814 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.54 -24.21 6.2 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.412 -0.358 . . . . 52.51 113.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.49 49.86 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.49 0.716 . . . . 73.43 112.821 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.29 136.04 43.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.43 0.692 . . . . 74.42 110.716 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -115.36 108.6 16.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.204 1.002 . . . . 53.51 111.53 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 18.7 t -113.38 108.05 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.09 0.556 . . . . 71.15 110.326 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -68.35 -59.07 3.46 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.192 0.997 . . . . 73.4 113.65 -169.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.28 -12.35 84.67 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.82 -0.434 . . . . 54.05 113.477 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 66.62 -73.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.526 1.53 . . . . 63.44 113.281 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.0 44.66 0.7 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 113.492 0.157 . . . . 65.11 113.492 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.3 p -93.83 -118.33 0.09 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.905 0.882 . . . . 72.14 109.855 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -139.81 9.78 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 119.169 0.895 . . . . 71.51 110.849 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -146.57 20.63 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.322 0.649 . . . . 55.14 112.48 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.59 144.64 35.33 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.774 0.797 . . . . 72.11 112.493 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.668 HD13 ' HD3' ' A' ' 83' ' ' PRO . 16.8 tp -103.25 125.48 49.93 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.484 1.114 . . . . 53.41 109.278 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 54.0 t -96.95 114.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.078 -0.712 . . . . 65.14 109.078 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 27.8 tt0 -118.95 166.95 12.22 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.239 1.016 . . . . 74.25 109.584 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -152.2 136.72 16.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.418 0.525 . . . . 64.54 112.418 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.7 tp -77.76 116.96 18.69 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.99 1.316 . . . . 71.53 110.81 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 95.5 t -79.16 -53.01 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.02 0.528 . . . . 33.31 110.52 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -152.89 144.53 23.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.191 0.996 . . . . 72.55 109.748 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.542 ' H ' ' HG3' ' A' ' 47' ' ' PRO . 4.2 tmt_? -131.84 112.09 12.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 72.52 107.441 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -114.08 115.13 27.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.001 0.52 . . . . 51.32 110.939 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 29.1 tt0 -83.86 -20.82 32.46 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.787 0.835 . . . . 72.02 111.668 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -68.93 -48.97 61.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.424 0.69 . . . . 74.34 111.936 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.09 2.82 51.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.107 0.563 . . . . 73.52 112.393 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 54.9 52.07 12.57 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.216 1.006 . . . . 72.13 111.943 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.36 119.65 26.72 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.453 1.101 . . . . 63.44 111.123 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 44.4 tp -109.57 106.77 16.61 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.447 1.099 . . . . 74.52 110.426 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.83 128.86 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.79 0.836 . . . . 74.43 111.248 -175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 51.7 p90 -150.83 179.11 8.5 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.827 0.677 . . . . 75.44 112.827 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 t -152.85 158.03 41.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.183 1.393 . . . . 74.2 109.5 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 16.7 ptt? -111.84 100.46 48.67 Favored Pre-proline 0 N--CA 1.485 1.319 0 CA-C-N 118.362 0.528 . . . . 63.42 110.226 169.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.33 -22.79 59.71 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.409 2.74 . . . . 73.32 113.644 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 25.8 t70 -128.75 81.35 70.94 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.396 0.678 . . . . 75.25 109.726 176.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.02 154.54 12.98 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.096 2.531 . . . . 70.24 113.885 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.668 ' HD3' HD13 ' A' ' 61' ' ' LEU . 71.4 Cg_endo -83.25 -4.5 11.06 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.662 2.241 . . . . 70.25 112.532 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.91 154.13 38.37 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.156 0.982 . . . . 74.53 110.757 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HG2' HG21 ' A' ' 117' ' ' THR . 89.8 Cg_endo -79.02 61.49 8.18 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.717 2.278 . . . . 55.43 112.85 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 113' ' ' CYS . 30.4 pt -121.06 167.91 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.289 1.036 . . . . 73.41 110.321 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 84.3 m -103.46 -85.19 0.46 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.793 0.437 . . . . 71.44 110.854 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.73 111.6 23.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.12 0.486 . . . . 73.13 111.115 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 26.5 t-80 -84.84 150.88 24.7 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.639 0.776 . . . . 74.34 111.768 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -154.78 110.28 3.12 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.662 0.785 . . . . 64.51 109.887 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.03 146.27 52.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.567 0.58 . . . . 43.43 112.567 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 40.6 t -134.73 143.98 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.142 0.977 . . . . 63.11 111.553 -173.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -112.65 109.48 19.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.973 1.309 . . . . 73.4 109.238 173.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 92' ' ' VAL . 42.3 mt-10 -117.7 112.48 20.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.445 0.566 . . . . 74.12 111.808 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 t -97.37 111.37 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.078 0.551 . . . . 64.33 110.007 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.84 131.26 22.21 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.987 0.915 . . . . 54.33 111.192 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.69 81.63 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.04 2.493 . . . . 74.11 111.965 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -35.46 81.1 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.092 0.957 . . . . 73.41 110.873 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 23.4 t70 -140.47 174.72 10.24 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 125.342 1.457 . . . . 74.34 108.946 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.47 -68.61 0.28 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.489 0.715 . . . . 73.03 111.084 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -81.8 -15.25 54.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.893 0.477 . . . . 72.11 111.775 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.3 m80 -120.1 146.97 45.43 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.864 -0.522 . . . . 72.15 111.385 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 17' ' ' VAL . 28.9 p -132.14 176.02 8.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.358 0.663 . . . . 73.2 109.836 177.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.7 m -130.41 125.09 33.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.175 0.59 . . . . 73.24 110.122 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.28 105.96 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.69 -0.856 . . . . 61.53 108.69 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.91 112.61 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.019 -0.734 . . . . 53.53 109.019 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -102.23 112.52 25.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.761 -0.829 . . . . 75.51 108.761 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 m -113.46 144.14 43.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.203 1.001 . . . . 73.32 109.433 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.18 149.45 36.46 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.871 0.868 . . . . 51.4 109.229 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.37 130.4 8.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.257 1.023 . . . . 74.54 108.585 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 7.8 p90 -148.58 152.03 36.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.12 0.568 . . . . 72.22 111.177 -171.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 13.5 t70 -76.59 85.84 3.27 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.817 -0.629 . . . . 73.43 109.396 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.4 t -120.27 147.63 44.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.009 -0.996 . . . . 75.12 111.026 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -60.19 132.03 90.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-O 118.404 -0.807 . . . . 74.32 110.694 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.56 -46.01 12.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.848 3.032 . . . . 75.11 114.458 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -62.98 -30.85 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.354 1.061 . . . . 64.35 112.426 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.405 HG21 ' HG2' ' A' ' 85' ' ' PRO . 20.0 m -90.7 -31.8 16.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.659 0.784 . . . . 72.4 112.257 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.0 -31.52 71.27 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.737 0.815 . . . . 64.25 112.265 -171.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.93 -34.61 78.37 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.214 1.006 . . . . 63.14 112.167 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.47 -44.41 51.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.228 0.611 . . . . 72.24 110.539 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.5 -23.81 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.429 0.692 . . . . 65.0 110.843 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.26 -52.75 64.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.886 0.874 . . . . 70.41 110.732 170.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.6 m -68.38 -42.69 78.76 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 112.885 0.698 . . . . 71.35 112.885 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.2 -55.05 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.25 0.547 . . . . 64.22 112.019 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -56.99 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.618 0.767 . . . . 74.23 111.323 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.22 -33.22 86.65 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 114.442 0.537 . . . . 52.14 114.442 -175.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -101.72 -61.49 1.38 Allowed 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.043 -0.681 . . . . 65.34 111.388 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.42 68.31 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.566 0.986 . . . . 72.04 115.566 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.512 ' HA ' HE22 ' A' ' 33' ' ' GLN . 87.8 t -106.78 -54.9 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 117.419 0.609 . . . . 63.24 111.136 175.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.4 m-30 -73.46 -59.13 2.85 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.067 0.547 . . . . 64.5 112.336 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.76 67.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 123.439 0.462 . . . . 63.15 111.79 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.411 HG11 HE21 ' A' ' 33' ' ' GLN . 16.2 t -62.45 -55.61 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.649 0.78 . . . . 73.33 112.085 171.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.84 98.38 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 116.182 -0.463 . . . . 62.52 113.909 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.73 -34.66 72.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.442 0.697 . . . . 75.44 112.27 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.8 m-20 -67.66 -42.16 82.6 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 110.455 -0.202 . . . . 70.41 110.455 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.53 77.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.255 0.622 . . . . 64.43 111.539 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 17' ' ' VAL . 7.5 tt -65.19 -37.46 87.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.696 0.798 . . . . 70.44 110.104 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.36 70.6 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.616 0.366 . . . . 72.41 111.674 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 38.2 mt-10 -68.53 -39.24 81.24 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.183 0.593 . . . . 73.32 112.178 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.446 HH11 HD22 ' A' ' 20' ' ' LEU . 5.4 ptm180 -66.51 -27.81 68.07 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.317 0.488 . . . . 73.2 112.317 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -98.57 -2.94 37.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.365 0.666 . . . . 62.22 111.228 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 C-N-CA 123.58 0.609 . . . . 25.03 113.745 177.444 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.139 0.495 . . . . 74.5 112.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.7 m -126.54 128.95 47.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.319 0.648 . . . . 52.55 110.738 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 7.5 mp -105.21 141.63 36.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.174 1.39 . . . . 71.3 108.426 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -150.06 130.8 14.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.321 0.582 . . . . 71.03 111.648 172.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -139.6 152.77 47.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.606 1.162 . . . . 74.44 108.542 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -150.18 161.59 42.1 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.764 0.426 . . . . 65.35 111.378 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 135' ' ' ASN . 9.9 p -148.32 145.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.545 0.572 . . . . 74.32 112.545 -177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -91.24 119.43 31.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.849 0.86 . . . . 73.0 110.766 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.2 131.68 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 124.631 1.173 . . . . 71.04 110.959 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.28 68.79 10.31 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.134 0.492 . . . . 54.44 111.463 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.58 142.74 2.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.206 1.002 . . . . 54.34 109.546 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.96 138.44 82.25 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.893 2.396 . . . . 72.2 112.898 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.6 15.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.2 1.4 . . . . 71.34 114.778 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.38 64.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.435 0.694 . . . . 62.52 112.115 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.07 -37.49 82.86 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.721 0.808 . . . . 73.2 112.555 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG21 ' SG ' ' A' ' 103' ' ' CYS . 40.5 t -70.12 -37.42 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.238 0.615 . . . . 75.25 110.757 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -63.53 -31.06 72.11 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.36 -0.836 . . . . 73.31 111.523 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -59.09 -31.88 69.29 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.288 0.566 . . . . 73.53 111.572 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 30' ' ' TRP . 35.4 tp -75.76 -43.01 48.76 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.863 0.865 . . . . 70.15 111.797 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' O ' HD22 ' A' ' 75' ' ' LEU . 19.0 m -95.27 -3.35 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.264 0.839 . . . . 73.11 113.264 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.41 -28.02 60.52 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 123.152 0.406 . . . . 74.4 112.881 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.15 105.38 17.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.326 0.65 . . . . 64.13 110.078 169.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 35.9 t80 -61.61 -29.04 69.79 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.608 0.763 . . . . 71.03 111.348 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -77.74 -21.67 51.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.986 0.914 . . . . 62.51 112.783 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.16 25.84 10.5 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.891 0.477 . . . . 74.23 112.032 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.08 -27.31 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 123.743 0.817 . . . . 72.13 112.282 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.827 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -64.86 -6.74 8.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 114.134 1.161 . . . . 64.23 114.134 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -89.05 -17.58 29.05 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.734 0.642 . . . . 74.31 112.734 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.6 p-90 -129.3 -32.53 1.99 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.36 0.874 . . . . 65.54 113.36 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 17.5 t-80 -78.01 130.63 72.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.51 0.324 . . . . 74.21 110.294 -174.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -79.59 -29.07 3.1 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.721 2.281 . . . . 51.41 114.266 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -93.82 -6.86 44.9 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.222 0.823 . . . . 71.3 113.222 -175.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 28' ' ' HIS . 7.1 p -56.87 128.39 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.518 0 CA-C-O 121.44 0.638 . . . . 71.14 112.19 176.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PHE . 31.7 m -91.62 23.18 3.64 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.078 0.951 . . . . 73.02 112.157 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 60.58 101.91 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 124.699 1.2 . . . . 65.42 111.26 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 37.3 Cg_endo -88.25 161.33 6.99 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.542 2.161 . . . . 32.35 114.386 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.9 m -105.94 123.55 48.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.883 0.873 . . . . 74.15 109.164 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 49' ' ' ALA . 1.6 tm? -88.38 113.59 24.14 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.437 -0.579 . . . . 72.44 109.437 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -99.59 153.13 19.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.949 1.3 . . . . 73.5 110.901 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.19 -126.56 23.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.948 0.78 . . . . 44.41 115.026 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.06 140.58 4.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.256 1.022 . . . . 73.25 113.246 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 m -56.58 158.13 8.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 124.534 1.133 . . . . 73.52 112.917 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.92 162.13 39.27 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.046 1.831 . . . . 74.05 111.283 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 72.75 -42.15 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.877 1.271 . . . . 75.03 112.118 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 m -68.87 123.0 87.06 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 124.395 1.078 . . . . 62.11 111.011 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.49 93.98 0.17 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.127 2.552 . . . . 71.03 113.251 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 -25.61 0.14 Allowed Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.083 -0.508 . . . . 64.22 113.156 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.04 132.78 47.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.32 1.048 . . . . 42.33 113.385 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -117.6 116.57 27.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 64.43 111.355 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 38.1 ptt85 -94.03 119.07 32.4 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.135 0.493 . . . . 74.53 110.107 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 t -114.21 112.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.421 0.688 . . . . 73.31 110.511 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HD2' ' H ' ' A' ' 35' ' ' SER . 8.3 m-85 -68.7 117.45 10.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.264 1.026 . . . . 64.34 110.29 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.62 -65.53 3.77 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.734 -0.546 . . . . 61.31 111.734 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 62.48 10.34 3.95 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.746 1.219 . . . . 75.04 114.289 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.13 32.37 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.905 -0.878 . . . . 72.1 110.905 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -122.51 175.08 6.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 71.32 109.842 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.77 -4.02 48.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.827 0.451 . . . . 62.33 111.807 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -135.3 84.76 2.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.785 . . . . 73.12 109.025 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 176.94 4.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.318 1.047 . . . . 74.41 111.417 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.571 HD13 ' HD3' ' A' ' 83' ' ' PRO . 23.2 tp -143.26 113.94 7.55 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.074 -0.512 . . . . 53.24 110.279 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 45.1 t -97.46 116.72 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.336 0.654 . . . . 73.25 109.725 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.655 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 46.3 mt-10 -120.96 123.39 42.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 64.32 109.76 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 43.1 ttt180 -103.29 135.73 44.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.299 1.04 . . . . 73.24 111.764 -175.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -80.71 122.08 26.68 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.692 0.797 . . . . 72.2 110.773 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -95.88 -45.4 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.28 0.632 . . . . 64.1 111.263 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 26.4 tt0 -145.32 145.11 31.09 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.836 1.254 . . . . 61.35 110.382 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.18 116.03 14.03 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.801 -1.185 . . . . 71.14 107.801 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -117.5 104.53 11.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.756 0.822 . . . . 64.05 109.099 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -26.26 46.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.274 0.629 . . . . 74.45 112.688 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t -72.43 -42.75 64.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.779 0.832 . . . . 74.24 110.936 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.62 2.96 36.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.768 0.655 . . . . 52.42 112.768 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 57.03 43.02 25.14 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.424 1.09 . . . . 74.22 112.016 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -115.39 105.06 12.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.814 0.846 . . . . 50.31 110.648 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 59.2 tp -100.83 105.78 17.1 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.188 0.595 . . . . 74.41 109.69 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 57.7 t -106.74 133.82 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 118.688 0.676 . . . . 72.41 110.168 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 33.4 p90 -152.31 -178.66 6.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.042 0.537 . . . . 73.32 110.862 -178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.4 t -141.71 162.92 34.3 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.402 1.081 . . . . 74.44 110.177 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.655 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 79.0 mtp -110.1 85.75 4.52 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 108.811 -0.811 . . . . 63.03 108.811 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.78 -21.17 45.06 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.154 2.569 . . . . 53.45 113.564 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 24.4 t70 -139.25 84.21 16.82 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.762 0.425 . . . . 73.32 110.226 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 44.2 Cg_endo -94.96 153.36 1.75 Allowed 'Trans proline' 0 CA--C 1.565 2.067 0 C-N-CA 123.234 2.622 . . . . 64.34 113.24 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD3' HD13 ' A' ' 61' ' ' LEU . 5.0 Cg_exo -80.48 22.68 0.75 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 122.893 2.396 . . . . 73.21 112.837 171.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.27 149.7 47.88 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.436 1.094 . . . . 75.45 110.356 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 68.02 6.24 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.835 2.357 . . . . 71.43 113.416 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.8 pt -132.97 135.9 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.542 1.137 . . . . 63.31 110.074 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 16.4 m -81.66 -82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 111.832 0.308 . . . . 73.34 111.832 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -102.07 108.0 19.28 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.257 0.551 . . . . 71.53 110.778 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -89.31 157.94 18.01 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.737 0.815 . . . . 72.31 111.685 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -156.01 124.11 5.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.587 0.755 . . . . 75.42 110.21 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.98 151.8 51.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.985 0.735 . . . . 53.21 112.985 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.5 p -138.35 137.43 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 C-N-CA 123.523 0.729 . . . . 73.03 112.483 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.2 mm? -101.28 108.3 19.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.065 -1.087 . . . . 74.01 108.065 166.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -124.51 110.73 14.85 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.641 -0.503 . . . . 72.22 109.641 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.9 110.89 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.532 -0.544 . . . . 74.42 109.532 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.6 117.5 68.61 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 124.187 0.995 . . . . 72.32 111.08 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.79 110.14 1.61 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.663 2.242 . . . . 44.22 111.494 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -107.33 -28.89 9.61 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.47 0.708 . . . . 63.41 111.834 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.9 t70 -149.96 163.05 39.12 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.762 0.825 . . . . 71.34 110.434 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.78 -39.03 73.35 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.517 1.127 . . . . 75.03 112.35 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -117.64 -4.34 11.22 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.846 . . . . 74.12 112.32 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -133.05 156.47 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.305 0.502 . . . . 55.44 111.208 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 17' ' ' VAL . 23.0 p -157.68 178.66 10.01 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.583 0.753 . . . . 45.4 111.017 -177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.6 m -134.73 125.77 27.66 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.034 0.534 . . . . 72.15 111.33 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.02 120.96 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.38 -0.6 . . . . 61.33 109.38 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.42 125.03 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.215 0.606 . . . . 73.52 109.713 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -114.31 116.75 29.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.591 0.757 . . . . 74.43 109.087 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.468 HG22 ' SD ' ' A' ' 110' ' ' MET . 76.3 m -119.82 138.9 53.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.029 0.932 . . . . 75.12 109.384 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.17 112.91 7.67 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.492 0.717 . . . . 44.42 111.61 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.468 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -120.74 131.6 54.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 64.21 109.613 -177.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -142.68 155.06 44.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.625 0.77 . . . . 75.34 111.886 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 28.6 t70 -77.3 88.02 3.71 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.795 0.438 . . . . 75.23 110.115 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 38.7 t -145.99 164.76 31.06 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.971 -0.558 . . . . 71.15 112.493 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m -75.13 144.56 79.15 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.136 0.974 . . . . 55.12 111.676 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.27 -43.95 20.65 Favored 'Trans proline' 0 C--N 1.389 2.68 0 C-N-CA 124.23 3.287 . . . . 70.41 115.221 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.08 -42.53 72.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.341 1.056 . . . . 74.43 112.618 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 8.5 m -85.89 -31.47 22.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.506 0.723 . . . . 71.01 110.27 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.37 91.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.149 0.979 . . . . 75.53 112.488 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.53 -30.38 61.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.852 0.861 . . . . 72.33 112.219 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.71 -45.12 72.4 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.26 0.552 . . . . 72.14 109.865 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.06 -23.69 62.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.192 0.997 . . . . 53.11 110.943 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 40.7 tt0 -61.89 -47.09 86.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.8 0.44 . . . . 61.33 110.314 172.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -71.13 -43.74 66.99 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 112.822 0.675 . . . . 73.05 112.822 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.79 -55.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.384 0.674 . . . . 71.34 112.491 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.91 -55.23 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.736 0.815 . . . . 73.41 111.459 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -72.35 -71.23 1.09 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 114.066 0.386 . . . . 72.24 114.066 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.38 -3.64 31.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.544 0.738 . . . . 64.15 112.698 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.96 -83.13 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.061 -0.416 . . . . 70.54 112.061 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.48 -43.12 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.763 0.825 . . . . 70.4 112.593 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 6.7 m-30 -76.26 -43.7 40.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.751 0.421 . . . . 75.31 111.239 -175.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.95 -48.04 73.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.549 0.339 . . . . 73.51 111.3 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.22 -47.25 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 C-N-CA 123.357 0.663 . . . . 70.24 111.945 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -45.46 95.61 Favored Glycine 0 CA--C 1.54 1.594 0 CA-C-N 116.518 -0.31 . . . . 42.44 113.661 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.18 -46.04 57.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.372 1.069 . . . . 73.12 111.922 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.45 ' HA ' HG21 ' A' ' 8' ' ' VAL . 6.5 m-20 -61.7 -40.83 96.41 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.841 0.457 . . . . 73.1 110.999 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.49 85.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.017 0.527 . . . . 62.12 111.425 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.25 -44.87 92.37 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.443 0.697 . . . . 71.11 110.858 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.68 95.25 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.868 -0.605 . . . . 73.33 111.618 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -71.55 -30.84 66.34 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.411 0.684 . . . . 54.43 112.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -15.37 58.57 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.389 0.514 . . . . 72.02 112.389 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -85.45 -8.69 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 122.727 0.411 . . . . 74.15 111.48 162.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.057 0 N-CA-C 112.308 -0.317 . . . . 73.45 112.308 -177.032 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 112.844 0.683 . . . . 64.43 112.844 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.25 101.12 9.9 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.945 0.879 . . . . 72.33 110.281 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 4.0 mp -92.94 119.17 31.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.998 1.319 . . . . 73.35 108.932 -175.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -140.75 136.33 32.43 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.909 0.385 . . . . 75.43 110.274 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.11 138.81 31.93 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.101 -1.074 . . . . 74.41 108.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.7 p -128.92 147.11 50.81 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.874 0.869 . . . . 74.03 110.126 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.4 p -142.3 145.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.933 0.493 . . . . 51.15 110.469 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.98 112.71 24.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.349 0.595 . . . . 72.23 110.773 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.9 t -91.44 132.87 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.258 1.423 . . . . 73.32 110.632 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.13 51.37 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.409 0.683 . . . . 70.15 112.209 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.56 155.09 24.58 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.166 0.986 . . . . 61.15 110.605 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.1 142.21 73.24 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.863 2.376 . . . . 72.4 113.398 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.76 -38.91 23.11 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.911 1.684 . . . . 74.34 115.253 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.89 73.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.555 0.742 . . . . 73.12 112.767 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.85 -42.31 84.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.751 0.82 . . . . 72.55 112.307 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 137' ' ' LEU . 29.2 t -70.83 -33.82 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.899 0.88 . . . . 74.45 110.784 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 49.5 t-105 -67.29 -28.99 68.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.425 0.69 . . . . 72.43 111.891 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -65.11 -36.13 83.32 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.175 0.512 . . . . 64.51 110.441 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 30' ' ' TRP . 66.2 tp -73.28 -51.44 17.58 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.192 0.997 . . . . 64.02 111.988 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.42 -33.26 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.606 0.762 . . . . 62.22 112.702 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.11 72.68 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.177 -0.465 . . . . 74.42 113.237 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.39 94.79 0.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.938 0.875 . . . . 73.31 110.474 168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.87 12.77 0.77 Allowed 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 124.873 1.269 . . . . 54.25 110.496 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.661 ' HA ' HD21 ' A' ' 39' ' ' LEU . 75.6 p -115.77 -1.73 12.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.554 1.141 . . . . 61.42 112.493 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.31 -83.36 0.61 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 119.071 -0.49 . . . . 70.14 110.867 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.596 HG23 HG11 ' A' ' 34' ' ' VAL 0.298 19.9 tt 52.81 -48.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 127.61 2.364 . . . . 54.31 116.457 -175.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -60.9 -4.08 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 120.284 1.402 . . . . 75.52 114.34 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -77.46 -16.61 58.67 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.867 0.867 . . . . 71.31 112.852 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HB3' HD21 ' A' ' 20' ' ' LEU . 42.4 p-90 -132.13 -34.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.524 0.729 . . . . 71.11 111.816 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CE1' HE21 ' A' ' 33' ' ' GLN . 34.4 t-80 -87.53 110.74 36.65 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.89 0.876 . . . . 62.01 109.313 -176.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.18 -8.62 24.1 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 70.53 114.902 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' CE1' ' A' ' 31' ' ' HIS . 6.1 mt-30 -109.02 -6.81 15.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.148 1.166 . . . . 73.01 114.148 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 36' ' ' ALA . 66.6 t -79.66 131.38 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 118.469 0.577 . . . . 71.42 112.5 177.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -93.03 34.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.252 1.021 . . . . 61.43 111.869 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.641 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 67.46 125.78 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 C-N-CA 125.8 1.64 . . . . 70.21 113.422 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 73.7 Cg_endo -84.79 149.7 11.14 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.742 2.295 . . . . 74.24 113.921 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.7 m -107.07 120.18 41.39 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.898 0.879 . . . . 73.33 109.645 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 25' ' ' SER . 3.9 mm? -91.51 137.7 32.15 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.481 0.658 . . . . 73.3 112.701 -167.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -130.13 165.07 23.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.153 1.381 . . . . 74.04 109.81 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.97 -150.89 5.97 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.541 0.977 . . . . 43.32 115.541 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 46' ' ' THR . . . -83.05 87.56 6.89 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.953 0.724 . . . . 72.34 112.953 -165.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.4 t 58.89 132.96 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 N-CA-C 116.001 1.852 . . . . 74.42 116.001 161.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.43 -16.44 41.82 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.082 2.521 . . . . 74.43 114.176 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -114.17 20.43 15.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 54.22 111.744 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 42' ' ' ALA . 99.5 m -123.85 123.03 26.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 123.729 0.811 . . . . 63.13 109.345 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 58.7 Cg_exo -53.95 89.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.656 2.904 . . . . 55.23 114.164 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.83 51.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.071 -0.513 . . . . 23.11 112.655 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.71 145.16 39.98 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.704 0.801 . . . . 64.35 111.006 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -109.93 153.07 25.02 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.257 0.623 . . . . 73.14 109.867 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 11.0 ptm180 -140.24 125.56 18.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.398 0.618 . . . . 74.12 109.844 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 62' ' ' VAL . 22.0 t -109.39 101.13 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.777 0.831 . . . . 73.1 109.851 -174.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -63.34 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.724 1.209 . . . . 75.45 111.953 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -59.91 0.64 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.005 -0.438 . . . . 61.13 112.005 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.36 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.52 1.528 . . . . 62.31 113.44 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.7 -19.86 0.44 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 115.002 0.761 . . . . 71.21 115.002 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 p -105.45 171.86 7.1 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.615 0.707 . . . . 70.12 111.518 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.85 7.02 43.88 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.965 0.906 . . . . 71.52 112.603 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.34 31.48 3.47 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.828 0.823 . . . . 73.44 110.521 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 151.06 45.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.752 0.821 . . . . 75.15 112.662 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -102.82 114.47 28.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.573 0.749 . . . . 62.31 110.266 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' VAL . 32.6 t -114.4 115.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.157 0.583 . . . . 53.34 110.716 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.83 160.56 20.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.02 0.928 . . . . 74.43 110.613 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -143.36 132.23 22.76 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.199 1.0 . . . . 73.33 111.356 -170.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 18.6 tp -74.83 121.55 21.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.193 1.397 . . . . 74.34 112.374 -175.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -98.38 -48.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.95 0.9 . . . . 74.23 110.879 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 36.9 tt0 -144.13 134.65 24.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.441 1.096 . . . . 74.34 109.661 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 70' ' ' GLU . 4.0 tmm_? -132.92 109.58 9.69 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.332 -0.618 . . . . 75.45 109.332 -176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.84 176.0 5.44 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.491 1.116 . . . . 73.01 109.356 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 24.4 tt0 -158.62 -34.65 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.865 -0.522 . . . . 74.42 112.336 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -63.86 -34.84 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.3 0.64 . . . . 64.44 111.358 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.65 -14.81 15.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.342 1.057 . . . . 75.43 110.773 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 68.25 69.29 0.32 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.936 1.294 . . . . 72.0 112.098 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.28 135.04 40.54 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.722 0.809 . . . . 65.43 111.505 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.57 118.18 31.0 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.764 1.225 . . . . 70.42 109.447 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 60.5 t -116.92 125.65 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.45 0.7 . . . . 64.41 109.981 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.17 -179.07 6.66 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.703 0.801 . . . . 74.53 111.319 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -145.97 162.99 36.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.425 1.09 . . . . 75.11 110.486 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 72.6 mtm -101.14 100.45 13.29 Favored Pre-proline 0 N--CA 1.484 1.259 0 N-CA-C 109.292 -0.633 . . . . 61.23 109.292 167.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.6 -21.04 30.14 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.002 2.468 . . . . 71.41 113.358 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -139.55 74.89 33.13 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.242 0.617 . . . . 65.13 109.63 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 64.7 Cg_endo -86.68 146.96 8.3 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.647 2.231 . . . . 70.32 113.468 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.1 Cg_endo -86.55 24.89 0.71 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.457 2.771 . . . . 73.12 113.347 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -123.33 149.4 57.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 123.912 0.885 . . . . 64.11 110.371 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.38 74.9 4.04 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.605 2.203 . . . . 73.24 112.031 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 113' ' ' CYS . 31.4 pt -133.78 165.11 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.338 1.055 . . . . 74.3 110.991 -174.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 5.8 m -136.02 159.89 40.31 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.663 0.785 . . . . 62.11 109.649 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.8 p30 37.73 71.67 0.14 Allowed 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 125.9 1.68 . . . . 62.14 114.547 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HD2' ' HD2' ' A' ' 111' ' ' PHE . 41.8 t-80 -79.39 131.0 35.97 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 116.076 -0.511 . . . . 73.25 111.881 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -129.82 118.84 22.4 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.231 1.012 . . . . 62.53 109.787 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.23 125.44 40.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.372 0.669 . . . . 61.43 111.312 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 117.63 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.489 0.715 . . . . 72.03 110.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.35 117.32 33.85 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 72.32 109.116 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.08 150.1 52.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.345 0.658 . . . . 74.44 110.937 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.86 113.87 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.185 0.594 . . . . 74.21 109.508 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -92.55 115.52 64.94 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.161 0.985 . . . . 63.24 109.902 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 77.11 0.37 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.764 2.309 . . . . 73.01 112.938 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -69.53 -33.75 73.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.217 1.007 . . . . 54.13 111.944 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 24.9 t70 -154.92 165.17 37.52 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.098 1.359 . . . . 74.22 108.944 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.35 -48.88 79.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.853 0.861 . . . . 62.32 111.963 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 -6.4 27.72 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.858 0.863 . . . . 72.51 110.987 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.6 m80 -131.3 128.54 39.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.956 -1.09 . . . . 75.14 111.592 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.423 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.5 p -130.2 133.76 46.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.063 0.545 . . . . 73.23 110.129 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.9 m -92.14 110.37 21.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.344 0.258 . . . . 72.42 110.383 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.11 116.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 70.35 109.717 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.8 t -107.77 109.85 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.454 1.102 . . . . 63.42 109.995 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -103.35 125.31 49.9 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.102 -0.703 . . . . 75.53 109.102 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.3 m -131.55 147.46 52.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.051 0.94 . . . . 74.44 110.344 -172.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.96 156.26 42.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.195 1.398 . . . . 70.14 108.859 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -162.81 146.03 11.0 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.638 . . . . 53.14 110.753 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HD2' ' HD2' ' A' ' 89' ' ' HIS . 2.5 p90 -158.84 155.5 27.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.717 0.807 . . . . 73.2 111.669 -168.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 30.2 t70 -82.99 85.44 7.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.022 0.929 . . . . 61.21 109.205 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.619 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.0 t -113.41 152.65 29.77 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.768 -1.105 . . . . 75.22 111.254 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.1 p -61.43 132.33 92.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.482 0.713 . . . . 73.55 110.633 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.95 -44.21 23.12 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 124.293 3.329 . . . . 73.33 116.02 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.03 -38.62 72.57 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 122.799 0.44 . . . . 74.3 112.001 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 m -75.41 -26.8 58.68 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.166 0.587 . . . . 62.31 110.931 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 2' ' ' ALA . . . -68.67 -51.29 43.5 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.235 1.014 . . . . 24.23 111.125 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -64.01 -30.57 71.64 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.687 -0.688 . . . . 73.0 111.442 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -66.98 -44.36 80.62 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.839 -0.619 . . . . 73.03 110.691 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.61 -25.51 62.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.126 0.57 . . . . 73.43 111.233 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.575 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 52.1 mt-10 -66.09 -34.51 78.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.43 111.511 173.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 t -76.6 -53.27 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.679 0.622 . . . . 51.53 112.679 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.81 -55.03 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.647 0.779 . . . . 74.14 112.147 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.03 -46.76 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.061 0.545 . . . . 73.31 110.653 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -16.18 68.04 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 115.488 0.955 . . . . 64.14 115.488 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.35 -57.47 1.99 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.983 0.892 . . . . 74.44 110.464 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.27 58.46 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 115.144 0.818 . . . . 74.03 115.144 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.0 t -111.77 -52.09 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.312 0.645 . . . . 60.43 110.372 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -75.05 -61.39 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.797 0.666 . . . . 74.24 112.797 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.59 71.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.879 0.371 . . . . 74.33 111.503 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.11 -56.28 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.109 0.964 . . . . 73.43 112.579 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.08 94.74 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.36 -0.382 . . . . 54.34 113.346 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.98 -39.39 83.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.952 0.901 . . . . 53.21 112.626 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -67.39 -45.46 76.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.388 0.275 . . . . 72.35 110.782 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.14 73.22 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.493 0.717 . . . . 64.15 111.567 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.444 HD21 HG13 ' A' ' 17' ' ' VAL . 6.8 tt -66.19 -43.65 86.19 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.788 0.835 . . . . 72.04 110.301 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.887 0.475 . . . . 71.23 112.193 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -72.25 -44.39 62.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.551 0.74 . . . . 64.03 111.768 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -73.99 -20.96 60.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.522 0.564 . . . . 73.31 112.522 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -100.56 -14.86 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.05 0.54 . . . . 72.52 111.219 168.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.203 0 CA-C-O 121.13 0.294 . . . . 53.11 112.503 177.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.327 0.584 . . . . 75.33 110.771 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.8 m -115.13 117.87 31.77 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.652 1.181 . . . . 71.34 109.315 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -96.33 143.78 27.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.549 1.139 . . . . 63.13 109.931 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -143.72 135.2 26.05 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.248 0.547 . . . . 73.21 111.803 172.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -131.42 156.15 46.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.989 1.316 . . . . 73.12 109.008 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -145.02 157.02 44.25 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.617 0.767 . . . . 75.23 110.488 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.6 p -150.65 146.49 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.709 0.404 . . . . 73.02 111.149 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -93.01 123.64 36.41 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.855 -0.424 . . . . 72.35 109.855 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t -108.36 132.57 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.604 1.162 . . . . 75.52 110.638 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.69 64.23 8.5 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.24 0.616 . . . . 61.51 111.585 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.59 148.58 7.88 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.333 0.653 . . . . 73.15 111.037 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.07 128.76 31.15 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.29 2.66 . . . . 44.12 113.036 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.84 -37.27 13.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.981 1.475 . . . . 75.14 114.981 -175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.36 86.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.044 0.538 . . . . 71.43 112.227 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.52 -35.53 80.77 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.222 0.609 . . . . 54.15 112.332 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' SG ' ' A' ' 103' ' ' CYS . 58.8 t -71.25 -34.97 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.428 0.691 . . . . 52.11 110.345 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 63.2 t-105 -72.67 -27.66 62.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.548 0.739 . . . . 73.13 111.775 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.4 m -69.31 -29.56 67.44 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.423 0.63 . . . . 53.44 110.077 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 30' ' ' TRP . 58.4 tp -75.16 -49.15 20.42 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.365 1.066 . . . . 75.04 111.68 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.44 -36.45 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 112.631 0.604 . . . . 64.43 112.631 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -65.36 -25.65 71.36 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 123.542 0.592 . . . . 55.34 114.352 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.07 108.21 11.2 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.123 -0.695 . . . . 54.33 109.123 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HZ ' ' HG2' ' A' ' 63' ' ' GLU . 22.2 t80 -58.55 -27.66 64.77 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.093 0.957 . . . . 73.13 110.624 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.7 p -77.71 -24.46 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.21 113.263 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.19 10.34 39.41 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 122.805 0.442 . . . . 73.11 111.799 -168.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.743 HG23 HG11 ' A' ' 34' ' ' VAL . 18.5 tt -59.49 -25.51 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 C-N-CA 123.067 0.547 . . . . 72.43 112.114 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -63.78 -19.25 64.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.216 0.821 . . . . 51.34 113.216 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -78.25 -25.14 46.72 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.629 0.603 . . . . 74.22 112.629 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.8 p-90 -117.07 -33.18 4.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.948 0.499 . . . . 64.24 111.791 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.457 ' ND1' HG23 ' A' ' 34' ' ' VAL . 43.5 t-80 -89.34 109.79 33.96 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.247 0.619 . . . . 74.02 109.567 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.87 -15.65 36.75 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.928 2.419 . . . . 74.31 114.011 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.425 HE21 ' CE1' ' A' ' 31' ' ' HIS . 2.4 mt-30 -90.49 -26.3 19.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.45 0.7 . . . . 74.35 111.558 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.743 HG11 HG23 ' A' ' 27' ' ' ILE . 99.3 t -74.41 103.55 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.327 0 CA-C-O 121.134 0.492 . . . . 73.14 110.434 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 m -93.45 40.98 1.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.093 0.957 . . . . 72.12 112.56 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.1 75.12 0.47 Allowed Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 124.801 1.241 . . . . 71.21 112.926 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.73 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 94.4 Cg_endo -82.44 -168.15 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.563 2.842 . . . . 71.1 115.278 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 86.7 m -113.77 139.58 49.0 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.596 1.158 . . . . 72.02 111.511 -167.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.08 143.5 26.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.272 0.629 . . . . 51.45 111.375 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.3 mmt180 -115.1 138.35 50.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.854 0.862 . . . . 71.42 110.009 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.85 -123.9 7.94 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 115.548 0.979 . . . . 53.13 115.548 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.74 139.11 0.32 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.153 1.781 . . . . 71.33 114.746 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -50.55 158.25 1.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 C-N-CA 125.403 1.481 . . . . 62.43 113.755 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -7.03 13.99 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 123.05 2.5 . . . . 62.25 114.494 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -109.55 -13.74 14.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.707 0.803 . . . . 71.11 111.445 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -88.57 118.43 69.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.627 0.771 . . . . 51.22 111.009 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.54 121.8 10.14 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.509 2.806 . . . . 72.25 113.319 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.83 -14.56 8.5 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 116.348 -0.387 . . . . 71.33 113.073 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.68 141.42 52.64 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.862 0.865 . . . . 64.42 112.425 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 34.7 mt-10 -116.5 163.53 15.94 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 122.751 0.421 . . . . 64.22 110.249 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 38' ' ' THR . 48.4 ttt85 -156.17 105.68 2.34 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.93 0.492 . . . . 74.23 110.87 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 55' ' ' ALA . 22.0 t -106.84 113.82 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.289 0.636 . . . . 74.23 111.358 -170.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.4 m-85 -76.3 70.75 2.95 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.042 1.337 . . . . 72.53 111.658 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.49 -50.85 0.53 Allowed Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.814 -0.514 . . . . 71.11 111.814 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 52' ' ' VAL . . . 60.04 24.19 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.52 1.128 . . . . 53.44 113.876 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.06 53.62 0.05 OUTLIER Glycine 0 N--CA 1.474 1.23 0 C-N-CA 122.75 0.214 . . . . 42.05 112.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -121.05 -135.37 0.32 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.22 1.008 . . . . 75.53 108.86 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.15 -1.9 4.56 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.307 0.958 . . . . 65.01 111.978 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.33 46.77 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.69 0.757 . . . . 61.32 111.946 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -87.15 152.35 22.41 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.384 -0.825 . . . . 60.34 112.004 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.89 132.54 43.39 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.838 0.855 . . . . 73.12 108.865 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.5 t -102.86 116.67 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.883 -0.511 . . . . 75.43 109.902 175.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 43.5 tt0 -109.55 154.5 22.63 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.37 1.468 . . . . 75.02 109.605 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -151.94 125.66 8.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 74.11 112.163 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -66.97 120.76 14.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.016 1.326 . . . . 53.54 111.31 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -88.1 -50.8 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.698 . . . . 55.14 110.826 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 37.5 tt0 -151.98 142.45 22.6 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.549 1.14 . . . . 74.01 109.953 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.483 HH21 ' HA3' ' A' ' 22' ' ' GLY . 3.6 tmt_? -134.23 111.46 10.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.884 -0.784 . . . . 73.11 108.884 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -117.33 125.73 51.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.727 0.811 . . . . 71.45 110.709 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 33.6 tt0 -90.63 -40.38 11.94 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.251 0.834 . . . . 73.33 113.251 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -67.26 -43.53 81.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.878 0.471 . . . . 62.31 111.951 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.35 0.93 54.72 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.063 0.545 . . . . 65.23 112.031 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 25.4 mmt85 60.1 38.31 20.51 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.355 1.062 . . . . 60.01 112.293 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.84 122.87 47.67 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.052 0.941 . . . . 71.12 111.729 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 50.1 tp -115.04 108.41 16.65 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.061 0.944 . . . . 71.04 110.213 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 54.1 t -106.35 123.21 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.464 0.706 . . . . 62.23 110.132 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.43 ' HE1' HD23 ' A' ' 93' ' ' LEU . 46.5 p90 -151.95 -178.71 6.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.928 0.491 . . . . 65.25 111.727 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.433 HG23 ' HD3' ' A' ' 80' ' ' PRO . 9.8 t -153.82 164.63 38.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.142 0.977 . . . . 61.21 111.184 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -106.99 100.28 31.2 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.964 -0.754 . . . . 71.3 108.964 160.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' HG23 ' A' ' 78' ' ' THR . 36.1 Cg_endo -63.0 -23.03 74.07 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.944 2.429 . . . . 61.43 113.471 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.9 t70 -124.61 82.31 59.51 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.445 0.698 . . . . 72.43 110.028 175.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 45.7 Cg_endo -101.56 144.67 0.26 Allowed 'Trans proline' 0 CA--C 1.573 2.466 0 C-N-CA 123.759 2.973 . . . . 72.34 114.291 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 20.0 Cg_exo -69.81 -17.26 37.45 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.768 2.312 . . . . 71.21 113.596 172.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -80.78 155.67 73.1 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 123.942 0.897 . . . . 64.45 111.394 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.0 46.84 2.3 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.253 2.635 . . . . 42.31 112.949 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.53 116.8 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.197 0.999 . . . . 35.13 109.774 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.4 p -74.96 -79.38 0.09 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.088 0.555 . . . . 70.21 112.39 -172.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.38 72.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.929 0.871 . . . . 74.03 109.752 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 110' ' ' MET . 57.5 t-80 -76.03 118.95 19.32 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.622 -0.717 . . . . 72.44 111.818 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 150.05 23.6 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.978 0.911 . . . . 74.41 108.914 170.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.59 119.49 8.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 71.03 109.137 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 48.4 t -126.09 130.12 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.38 0.672 . . . . 54.34 111.869 -169.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.43 HD23 ' HE1' ' A' ' 77' ' ' TYR . 4.3 mm? -107.93 111.57 23.74 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.382 1.073 . . . . 62.12 109.359 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 51.0 mt-10 -116.58 111.23 19.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.952 0.501 . . . . 74.12 110.413 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.43 105.61 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.298 -1.001 . . . . 75.43 108.298 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 15.5 m -100.57 123.7 45.12 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 122.894 0.478 . . . . 64.24 110.405 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 16.4 Cg_exo -68.47 85.81 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.159 2.573 . . . . 74.32 112.614 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -32.93 74.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.143 0.977 . . . . 71.34 109.744 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.7 t70 -157.31 167.12 31.23 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.239 1.816 . . . . 62.44 108.259 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.7 -40.54 95.39 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.208 0.603 . . . . 53.42 112.434 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -108.98 -1.29 19.08 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.614 0.766 . . . . 75.43 111.888 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.0 m80 -132.5 124.5 28.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.243 -0.911 . . . . 71.13 110.153 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 17' ' ' VAL . 29.1 p -133.1 142.88 48.96 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.003 0.521 . . . . 71.23 110.8 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 m -97.12 114.33 26.0 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.757 0.423 . . . . 60.14 110.156 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 t -95.3 112.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.428 -0.582 . . . . 74.02 109.428 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.77 117.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 41.34 109.655 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -108.73 112.73 25.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.123 -0.695 . . . . 75.25 109.123 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 m -125.22 128.09 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.506 0.722 . . . . 72.02 110.338 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.65 148.9 42.25 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.611 0.764 . . . . 75.05 111.053 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 1.8 mpt? -126.17 150.36 48.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.707 0.803 . . . . 71.23 109.139 172.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -162.77 153.14 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.323 0.649 . . . . 73.02 110.455 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -102.57 78.58 1.73 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.748 0.785 . . . . 63.42 109.456 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t -125.15 168.14 13.83 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.779 -1.101 . . . . 71.33 110.984 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -65.05 147.47 98.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 C-N-CA 123.399 0.68 . . . . 74.14 112.174 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.7 -31.57 95.16 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.955 2.436 . . . . 55.45 113.411 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.94 -55.96 28.12 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.007 0.923 . . . . 72.41 111.604 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.43 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.7 m -74.48 -32.02 62.41 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.756 -0.657 . . . . 64.24 111.157 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -65.6 -41.53 92.69 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.085 0.554 . . . . 61.14 112.029 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -67.31 -31.35 71.58 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.648 0.379 . . . . 75.21 111.657 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.96 -42.62 94.44 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.652 -0.499 . . . . 72.23 109.652 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 117' ' ' THR . 92.8 mt -72.62 -25.33 61.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.374 0.67 . . . . 75.42 111.717 -176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 46.8 mt-10 -61.35 -38.18 86.01 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 118.14 0.427 . . . . 75.31 110.763 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 t -76.25 -51.43 12.06 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 112.694 0.627 . . . . 72.4 112.694 172.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.26 -55.02 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 112.863 0.69 . . . . 63.31 112.863 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.4 mt -77.5 -45.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.75 0.42 . . . . 72.33 110.522 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.45 -47.9 83.19 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 114.855 0.702 . . . . 71.42 114.855 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.99 -46.55 5.06 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.451 -1.029 . . . . 73.22 112.094 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.01 -19.58 71.96 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 114.94 0.736 . . . . 71.25 114.94 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.11 -53.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 117.88 0.84 . . . . 73.2 111.443 176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.6 m-30 -73.84 -54.62 7.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.36 72.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.061 0.144 . . . . 74.01 110.968 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.75 -52.22 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.08 0.552 . . . . 75.51 111.754 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.26 -50.25 61.12 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 116.572 -0.285 . . . . 55.21 113.18 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.89 -41.65 99.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 74.33 112.716 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.79 -41.5 78.64 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.2 -0.429 . . . . 74.43 110.438 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.35 75.5 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.85 0.46 . . . . 73.53 111.876 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 HG13 ' A' ' 17' ' ' VAL . 7.8 tt -67.86 -41.33 83.05 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.217 0.607 . . . . 60.12 109.898 173.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.47 -27.73 62.48 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 112.353 0.501 . . . . 75.02 112.353 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.77 -37.89 39.97 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.184 0.994 . . . . 63.24 112.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 8.7 ptm180 -67.71 -34.07 76.14 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.348 0.259 . . . . 65.53 110.971 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -88.94 -16.94 30.57 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.95 0.5 . . . . 71.2 110.539 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.329 0 CA-C-N 115.878 -0.601 . . . . 35.23 113.252 175.884 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.838 0.828 . . . . 73.34 110.876 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.8 m -128.62 116.67 19.96 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.184 0.994 . . . . 62.31 109.581 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 126' ' ' GLY . 8.3 mp -108.76 109.49 20.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.931 1.292 . . . . 55.32 109.539 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -129.48 135.2 48.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 70.12 112.214 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.56 156.08 49.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.736 1.214 . . . . 74.52 110.648 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -143.84 154.2 43.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.205 1.002 . . . . 74.32 109.321 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.8 p -150.09 147.54 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 111.591 0.219 . . . . 75.15 111.591 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.27 118.5 26.74 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.196 0.598 . . . . 72.03 110.546 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.0 121.05 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.671 1.188 . . . . 61.23 110.131 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.25 72.94 3.83 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.147 0.579 . . . . 52.5 111.044 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.02 155.76 2.42 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.646 0.778 . . . . 71.22 111.134 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -63.0 138.29 67.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.704 2.269 . . . . 54.23 111.86 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -25.13 11.16 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.165 0.802 . . . . 72.05 113.165 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.42 47.96 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.711 0.634 . . . . 65.44 112.711 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.54 -40.07 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.246 0.618 . . . . 71.44 111.636 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.429 HG13 HD21 ' A' ' 137' ' ' LEU . 21.6 t -74.5 -34.86 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.524 0.73 . . . . 55.44 111.125 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 -70.1 -27.76 64.85 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.345 0.658 . . . . 63.14 111.419 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 m -63.76 -29.14 70.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.389 0.614 . . . . 72.35 111.147 170.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 30' ' ' TRP . 57.5 tp -86.07 -56.72 3.33 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.505 1.122 . . . . 55.24 111.924 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.56 -25.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 123.099 0.56 . . . . 72.44 112.501 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.13 0.61 62.53 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 114.408 0.523 . . . . 71.2 114.408 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.09 163.59 12.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.125 0.97 . . . . 73.44 109.206 165.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.09 -44.26 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.794 -0.566 . . . . 74.31 110.551 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.7 p -77.61 -20.26 54.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.192 0.441 . . . . 71.12 112.192 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.12 5.79 9.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.181 0.592 . . . . 62.51 112.549 -170.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 34' ' ' VAL . 19.1 tt -68.15 -27.31 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.305 0.642 . . . . 71.31 112.565 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -66.31 -15.89 63.6 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.365 0.505 . . . . 73.13 112.365 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -80.79 -38.33 28.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.757 0.823 . . . . 74.21 112.595 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.63 ' HB3' HD21 ' A' ' 20' ' ' LEU . 54.5 p-90 -108.81 -36.37 6.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 122.084 -0.385 . . . . 61.12 111.679 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -89.89 110.56 40.71 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.107 0.563 . . . . 71.44 109.619 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.06 -21.57 42.75 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.134 2.556 . . . . 75.44 114.318 -170.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.501 HE22 ' HA ' ' A' ' 129' ' ' VAL . 35.3 mt-30 -87.45 -16.76 33.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 74.24 112.838 -173.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 27' ' ' ILE . 76.4 t -61.62 127.28 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 122.967 0.507 . . . . 61.34 111.768 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -90.23 27.41 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.34 1.056 . . . . 74.33 112.384 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 62.46 101.61 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 124.437 1.095 . . . . 74.23 111.381 -172.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.46 177.51 4.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.863 2.375 . . . . 73.22 114.707 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 m -123.84 141.85 51.65 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.098 0.959 . . . . 70.43 110.731 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 126.25 40.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.299 0.64 . . . . 65.42 111.298 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 34.0 mmt180 -103.97 123.78 47.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.659 . . . . 74.42 110.1 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.55 -177.77 0.01 OUTLIER Glycine 0 CA--C 1.549 2.177 0 N-CA-C 118.199 2.039 . . . . 63.13 118.199 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.86 -106.23 0.26 Allowed 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.428 1.491 . . . . 50.24 113.687 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.523 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 40.4 t 179.01 147.34 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.454 1.102 . . . . 71.21 109.384 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.37 -20.9 21.55 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.301 2.667 . . . . 72.03 114.894 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.6 3.06 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.182 0.593 . . . . 73.25 112.547 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.4 m -102.38 118.92 57.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.729 0.812 . . . . 71.02 110.765 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 80.1 Cg_exo -50.38 102.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.52 2.813 . . . . 74.23 113.261 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -31.66 1.14 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.039 -0.528 . . . . 63.31 113.704 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -65.48 144.44 57.03 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.563 0.579 . . . . 54.15 112.563 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 46.7 mt-10 -110.92 146.67 36.14 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.33 0.652 . . . . 75.32 111.767 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -118.68 106.59 12.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.564 0.746 . . . . 71.23 110.786 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 25.1 t -109.34 102.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.905 0.882 . . . . 75.44 110.84 -173.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.71 93.79 2.14 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.658 0.783 . . . . 74.03 112.505 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 60.43 1.87 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.296 -0.321 . . . . 41.41 112.296 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 107.63 1.44 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.645 0.778 . . . . 61.53 112.905 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 24.83 7.44 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 114.159 0.423 . . . . 61.25 114.159 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -96.52 -77.03 0.49 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.291 0.636 . . . . 75.34 110.669 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 163.11 -35.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.821 1.649 . . . . 62.31 108.491 -171.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -103.7 17.31 24.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.189 -0.914 . . . . 74.44 112.581 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 136.58 47.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.414 0.626 . . . . 54.33 112.38 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -101.69 118.93 37.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.606 0.762 . . . . 72.42 109.196 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 53.7 t -97.2 113.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.476 -0.564 . . . . 75.11 109.476 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 59.3 mt-10 -108.29 169.62 8.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.322 1.049 . . . . 74.42 110.059 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -150.43 121.43 7.68 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.114 0.566 . . . . 74.42 110.373 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.04 121.59 19.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.128 0.971 . . . . 72.05 111.887 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 82.9 t -90.99 -48.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.53 0.732 . . . . 65.52 111.594 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -166.72 152.75 8.33 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.556 0.343 . . . . 64.22 111.781 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.511 HH12 HD22 ' A' ' 75' ' ' LEU . 93.2 mtt-85 -134.9 119.7 18.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.719 0.808 . . . . 75.23 111.141 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.0 m-20 -95.91 99.74 11.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.453 1.101 . . . . 71.42 109.62 172.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.81 -57.87 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.126 0.57 . . . . 74.21 111.821 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.8 t -70.44 -36.69 74.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.15 0.58 . . . . 75.23 111.784 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -79.53 -7.6 58.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.267 0.627 . . . . 33.11 112.147 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 58.21 43.64 20.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.761 1.224 . . . . 71.54 112.297 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.2 ttp180 -124.66 143.72 50.58 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.227 1.011 . . . . 63.45 110.209 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.511 HD22 HH12 ' A' ' 68' ' ' ARG . 10.0 tp -130.39 125.87 35.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 72.34 109.233 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.14 130.28 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.685 0.794 . . . . 71.04 110.873 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -152.28 177.29 10.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.696 0.798 . . . . 74.41 110.706 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.7 t -154.97 150.66 27.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.684 0.794 . . . . 53.45 110.33 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.641 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 15.4 ptt? -98.65 106.2 35.31 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 122.579 0.351 . . . . 62.25 111.57 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.89 -25.8 44.91 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.356 2.704 . . . . 72.14 112.673 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 10.0 m-20 -123.71 80.1 55.69 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.412 0.685 . . . . 53.45 110.819 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.88 137.49 3.97 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.788 2.325 . . . . 73.53 112.511 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.37 -14.29 37.07 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.143 1.896 . . . . 73.23 112.118 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 62.9 m-85 -76.53 147.51 78.77 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.575 1.15 . . . . 74.34 110.787 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 5.5 Cg_exo -77.04 39.37 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.341 2.694 . . . . 71.25 114.094 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -103.28 152.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.063 0.945 . . . . 70.2 111.133 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -89.14 -86.24 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.522 0.329 . . . . 71.13 111.353 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -98.01 108.66 21.41 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.196 0.522 . . . . 74.32 110.881 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.512 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 39.1 t-80 -95.08 155.57 16.68 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.295 0.569 . . . . 65.14 111.963 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 16.1 tpt180 -145.83 122.69 11.29 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.564 1.146 . . . . 72.33 108.705 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.512 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -126.24 126.6 44.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.654 0.661 . . . . 64.12 111.432 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 75.1 t -130.24 129.58 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.377 0.671 . . . . 75.54 112.595 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.24 132.09 46.92 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.364 1.066 . . . . 62.15 108.586 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -143.94 112.57 6.55 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.28 0.945 . . . . 75.25 111.658 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.631 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 26.9 m -95.74 111.25 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 121.966 0.889 . . . . 64.41 110.533 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.497 HG23 ' HB ' ' A' ' 104' ' ' THR . 6.6 m -103.58 116.7 61.51 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.834 0.853 . . . . 53.22 110.322 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.01 109.49 2.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.235 . . . . 75.21 113.269 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -66.3 -30.89 71.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.794 0.838 . . . . 62.23 110.719 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.0 t70 -158.54 174.04 15.69 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 125.199 1.399 . . . . 64.52 108.517 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.76 -37.65 66.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.555 0.742 . . . . 64.13 112.365 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -123.75 28.45 6.9 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.037 0.923 . . . . 74.22 111.564 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 62.1 m80 -138.03 130.44 29.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 72.41 109.488 171.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 46.9 t -130.89 162.83 28.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.858 0.863 . . . . 44.31 111.125 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.497 ' HB ' HG23 ' A' ' 96' ' ' VAL . 86.8 m -133.96 115.35 14.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.405 0.682 . . . . 71.43 110.042 174.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 95' ' ' VAL . 15.2 t -90.35 114.61 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.625 -0.509 . . . . 71.12 109.625 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.81 110.91 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.899 0.88 . . . . 65.33 109.285 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.54 122.97 48.6 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.247 -0.649 . . . . 74.33 109.247 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.53 HG22 ' SD ' ' A' ' 110' ' ' MET . 21.4 m -129.86 135.98 49.01 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.41 0.684 . . . . 51.14 110.964 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.7 116.01 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.657 0.783 . . . . 73.21 112.041 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 3.1 mpp? -103.06 134.03 47.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.441 1.097 . . . . 70.22 109.121 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -157.62 143.56 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 120.731 0.3 . . . . 75.52 111.526 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.11 82.63 5.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.849 0.833 . . . . 75.31 109.434 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.593 ' HB2' HG22 ' A' ' 86' ' ' ILE . 41.1 t -110.97 160.54 16.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.414 -1.266 . . . . 73.11 111.444 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -64.84 134.88 96.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.655 0.782 . . . . 71.44 110.152 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.66 -42.82 64.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.544 2.829 . . . . 73.54 115.109 -167.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.57 -37.94 89.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.969 0.414 . . . . 63.3 111.903 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.41 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -74.41 -33.25 62.95 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 122.971 0.508 . . . . 73.42 110.773 175.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.74 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.873 0.869 . . . . 42.24 111.89 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -28.14 67.28 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.081 0.952 . . . . 75.23 112.149 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.98 -46.35 65.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.944 -0.391 . . . . 61.22 109.944 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.45 -22.68 61.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.334 0.654 . . . . 74.45 110.922 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -56.5 -46.47 80.48 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.27 1.028 . . . . 75.42 110.501 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 m -71.36 -50.01 36.5 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.481 -0.781 . . . . 73.42 112.683 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.93 -56.5 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 123.383 0.673 . . . . 73.04 112.404 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.27 -54.29 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.878 0.871 . . . . 74.55 110.624 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.423 ' N ' HD23 ' A' ' 4' ' ' LEU . . . -63.94 -33.8 88.23 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 115.655 1.022 . . . . 62.42 115.655 -172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -117.07 -43.08 2.88 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.39 1.095 . . . . 53.52 111.744 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.72 -33.84 71.74 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.179 -0.464 . . . . 33.0 113.927 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.501 ' HA ' HE22 ' A' ' 33' ' ' GLN . 96.6 t -95.93 -56.28 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.069 0.548 . . . . 75.21 110.869 174.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.0 m-30 -70.63 -64.16 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.132 0.573 . . . . 73.22 112.483 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.73 71.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.287 0.367 . . . . 50.11 111.601 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 t -59.78 -54.32 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 C-N-CA 123.902 0.881 . . . . 64.43 112.277 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.45 -37.74 95.28 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.403 -0.362 . . . . 72.44 113.505 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.7 mt -70.93 -36.68 72.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.856 0.862 . . . . 63.05 111.972 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -68.77 -40.07 79.92 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.639 0.375 . . . . 51.33 110.694 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.65 91.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.076 0.55 . . . . 60.42 111.625 175.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 17' ' ' VAL . 9.0 tt -63.91 -43.0 97.24 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.475 0.71 . . . . 74.2 110.335 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.41 73.94 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.057 -0.52 . . . . 61.43 111.799 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.03 -40.08 54.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.439 0.696 . . . . 52.51 112.819 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -67.34 -29.58 69.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.21 0.448 . . . . 75.14 112.21 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -89.87 -29.18 18.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.203 -0.311 . . . . 71.32 111.366 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 CA-C-N 116.24 -0.436 . . . . 50.11 112.669 -179.755 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.372 0.129 . . . . 74.42 111.298 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.43 -14.46 61.26 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.861 0.464 . . . . 54.03 111.09 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 33.7 m -103.97 109.13 20.78 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.415 1.086 . . . . 73.21 109.793 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.39 140.64 29.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.782 0.833 . . . . 71.24 109.793 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -146.24 123.21 11.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.154 0.582 . . . . 74.4 109.867 174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.439 ' HD3' ' HB2' ' A' ' 130' ' ' PHE . 45.4 mtp85 -128.75 150.34 50.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.649 0.78 . . . . 73.53 110.097 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -139.49 145.02 38.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.684 0.794 . . . . 54.15 110.519 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.7 p -136.23 144.91 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 122.558 0.343 . . . . 51.31 111.323 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.25 109.19 20.29 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.658 0.783 . . . . 71.31 110.489 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 70.9 t -101.19 127.17 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.984 0.914 . . . . 73.12 110.407 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.52 65.59 4.73 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.431 0.692 . . . . 74.21 111.491 175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.0 155.13 3.62 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 124.002 0.921 . . . . 70.12 111.225 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.13 139.12 85.01 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 123.082 2.521 . . . . 70.31 113.865 167.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.62 -38.47 64.06 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 115.258 1.577 . . . . 74.4 115.258 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.13 -42.16 98.03 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.4 0.68 . . . . 62.24 112.426 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.22 -36.16 77.06 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.748 0.819 . . . . 72.54 112.34 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.471 HG21 ' SG ' ' A' ' 103' ' ' CYS . 41.3 t -73.57 -35.7 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.103 0.561 . . . . 65.11 111.345 177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.62 -34.34 78.05 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.627 0.371 . . . . 74.35 111.309 175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.0 m -58.84 -23.94 61.36 Favored 'General case' 0 CA--C 1.564 1.497 0 C-N-CA 123.708 0.803 . . . . 65.22 111.604 171.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.8 tp -95.04 -58.47 2.14 Favored 'General case' 0 CA--C 1.567 1.606 0 C-N-CA 124.067 0.947 . . . . 73.35 112.866 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.03 -34.14 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 123.607 0.763 . . . . 70.41 112.996 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.66 -45.27 94.95 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 115.216 0.846 . . . . 63.35 115.216 -166.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -45.78 -31.21 1.93 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 115.305 1.594 . . . . 71.25 115.305 -171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.4 t80 73.88 -59.73 0.55 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.03 1.332 . . . . 72.1 111.254 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -59.62 -38.16 80.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.926 0.89 . . . . 70.14 112.54 173.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.576 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -99.58 27.21 5.47 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.631 0.772 . . . . 75.51 111.598 -166.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.552 HG23 HG11 ' A' ' 34' ' ' VAL . 19.0 tt -62.72 -22.98 31.55 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 C-N-CA 124.286 1.034 . . . . 72.5 112.382 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -68.84 -3.73 13.6 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.163 0.801 . . . . 74.24 113.163 175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.576 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 48.0 mtp180 -76.61 -24.37 53.41 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.826 0.85 . . . . 73.24 112.445 173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -129.6 -37.56 1.57 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.255 0.835 . . . . 75.41 113.255 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -90.06 108.52 26.62 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.965 0.506 . . . . 73.31 109.798 -171.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.41 -23.59 32.21 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.154 2.57 . . . . 74.13 114.708 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -80.82 -15.65 55.81 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.989 0.516 . . . . 63.23 112.068 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.624 HG22 ' HE2' ' A' ' 53' ' ' PHE . 94.8 t -68.27 106.72 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.11 0.481 . . . . 72.12 111.37 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -89.11 54.92 3.13 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.491 0.716 . . . . 53.42 110.681 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.09 105.17 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 125.449 1.499 . . . . 72.03 113.429 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.66 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 64.4 Cg_endo -90.35 148.76 4.42 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.861 2.374 . . . . 60.41 113.149 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.1 m -101.02 115.14 29.77 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.127 0.571 . . . . 72.4 110.111 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 1.8 tm? -89.37 112.32 23.4 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 109.096 -0.705 . . . . 72.52 109.096 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -102.48 123.09 45.6 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.918 0.887 . . . . 70.04 110.856 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.32 -178.6 0.01 OUTLIER Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.716 2.247 . . . . 62.41 118.716 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 70.11 -31.5 0.22 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.86 1.8 . . . . 72.41 115.86 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.1 m 83.13 137.64 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 C-N-CA 126.202 1.801 . . . . 74.23 111.009 -167.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.14 -14.31 40.35 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.243 2.629 . . . . 73.51 115.244 -170.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -92.21 -14.31 29.2 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.977 0.511 . . . . 74.21 111.541 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.3 m -95.55 123.98 54.53 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 124.006 0.922 . . . . 73.1 110.905 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 82.6 Cg_exo -48.5 98.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 123.735 2.957 . . . . 64.3 114.254 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.68 -39.19 0.47 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 113.922 0.329 . . . . 50.54 113.922 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.65 139.08 45.81 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 114.595 1.331 . . . . 43.24 114.595 -171.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 4.2 mp0 -103.35 149.23 24.96 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.089 0.555 . . . . 72.33 110.857 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 34.4 ptt180 -127.04 119.78 27.43 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 118.48 0.582 . . . . 72.22 110.575 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.2 t -107.24 102.31 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.647 0.779 . . . . 64.14 110.795 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.624 ' HE2' HG22 ' A' ' 34' ' ' VAL . 6.0 m-85 -64.0 123.03 17.96 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.438 1.095 . . . . 73.24 111.354 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.06 -66.27 3.89 Favored Glycine 0 CA--C 1.535 1.333 0 CA-C-O 120.143 -0.254 . . . . 73.4 112.783 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.61 35.06 20.05 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.415 1.086 . . . . 74.51 113.456 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.82 37.78 0.05 OUTLIER Glycine 0 N--CA 1.476 1.301 0 CA-C-N 115.781 -0.645 . . . . 45.43 112.198 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.8 t -147.16 162.42 38.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.338 1.055 . . . . 74.24 110.901 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.57 -23.39 65.4 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.379 0.672 . . . . 64.52 112.496 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -122.06 90.22 3.27 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.011 0.524 . . . . 72.21 111.355 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.34 171.15 7.49 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.457 0.646 . . . . 63.05 111.321 171.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -136.72 114.15 10.91 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.661 0.784 . . . . 74.12 109.17 174.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 44.0 t -99.23 113.79 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.524 -0.546 . . . . 73.22 109.524 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 58.0 mt-10 -107.21 167.22 10.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.431 1.093 . . . . 60.41 110.627 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -151.07 125.23 9.32 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.796 0.838 . . . . 52.22 110.548 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 39.5 tp -69.09 116.36 9.44 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 124.87 1.268 . . . . 64.33 111.245 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -82.19 -51.96 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 122.924 0.49 . . . . 64.34 110.98 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.5 pt-20 -156.4 152.67 27.8 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.485 0.714 . . . . 73.21 110.032 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -142.48 131.72 23.41 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.264 0.554 . . . . 74.3 111.715 -175.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.8 m-20 -119.09 102.58 8.84 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.913 1.285 . . . . 71.03 110.068 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.69 -52.73 55.64 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.866 0.866 . . . . 72.35 112.124 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.4 m -71.49 -33.42 69.26 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.102 0.561 . . . . 75.15 112.182 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -83.29 -10.36 58.56 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 112.75 0.648 . . . . 64.12 112.75 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 61.16 34.37 18.96 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.927 0.891 . . . . 74.43 111.65 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -119.06 112.23 19.29 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.877 0.871 . . . . 70.14 110.432 -172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -118.34 108.66 15.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.478 1.111 . . . . 74.44 111.631 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.8 t -108.48 127.78 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.693 -0.629 . . . . 55.21 111.685 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -135.89 -179.26 5.55 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 123.817 0.847 . . . . 63.25 111.203 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -146.01 164.29 32.55 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.608 1.163 . . . . 73.12 109.839 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.523 ' SD ' HD11 ' A' ' 61' ' ' LEU . 73.6 mtm -103.52 97.07 9.67 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 122.988 0.515 . . . . 73.31 110.013 169.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.07 -13.42 31.36 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.155 2.57 . . . . 55.42 112.96 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 14.6 t70 -140.57 79.36 20.17 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 109.022 -0.733 . . . . 71.53 109.022 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -90.2 136.69 2.46 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.208 2.605 . . . . 71.32 113.747 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.54 -10.9 20.5 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.368 2.046 . . . . 65.02 113.231 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -94.02 131.53 31.5 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 123.713 0.805 . . . . 74.34 110.239 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.528 ' HG2' HG21 ' A' ' 117' ' ' THR . 37.5 Cg_endo -63.92 88.86 0.15 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.973 2.448 . . . . 62.4 113.465 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.663 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.0 pt -134.87 165.19 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 124.998 1.319 . . . . 75.22 109.762 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 86.0 m -100.75 -76.9 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.898 0.479 . . . . 72.53 110.947 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -106.77 110.32 22.47 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.013 0.435 . . . . 64.54 111.073 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -89.21 147.26 24.26 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.03 0.532 . . . . 73.23 111.165 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -153.28 125.57 8.05 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.219 1.008 . . . . 63.25 108.869 174.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.61 146.86 44.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.725 0.693 . . . . 71.03 112.056 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 t -131.92 145.67 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.796 0.838 . . . . 75.14 110.955 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.56 108.78 15.9 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.572 1.149 . . . . 63.02 108.062 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.99 112.71 17.51 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.682 0.393 . . . . 73.24 110.533 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.622 HG13 HG22 ' A' ' 105' ' ' VAL . 21.6 t -90.54 108.12 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.819 -0.808 . . . . 25.52 108.819 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.6 t -99.39 108.92 52.87 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.398 1.079 . . . . 73.33 110.153 -173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.94 124.79 11.35 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.102 1.868 . . . . 35.32 113.018 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -93.81 -56.46 2.88 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.375 -0.972 . . . . 64.3 108.375 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -118.75 -169.35 1.71 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.724 1.209 . . . . 73.0 110.068 170.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.52 -27.25 46.02 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.131 0.572 . . . . 73.04 111.475 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -109.56 2.03 20.1 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.839 0.856 . . . . 75.01 112.634 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -136.93 125.24 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.873 0.469 . . . . 72.04 109.771 -177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.471 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.6 p -137.29 132.82 34.25 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.023 0.44 . . . . 62.22 110.657 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 33.2 m -91.66 109.82 21.14 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.931 -0.577 . . . . 64.41 110.828 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.622 HG22 HG13 ' A' ' 95' ' ' VAL . 27.1 t -88.34 111.0 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.585 -0.524 . . . . 73.14 109.585 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 40.3 t -102.09 114.75 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 123.562 0.745 . . . . 74.34 110.667 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -103.84 118.69 37.28 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.439 0.696 . . . . 72.45 109.178 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.5 m -112.47 139.48 48.02 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.359 1.064 . . . . 62.0 109.817 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.61 108.89 4.45 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.214 0.605 . . . . 45.14 111.505 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.36 135.4 54.17 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.308 1.043 . . . . 72.11 110.375 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -149.28 145.07 26.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.624 0.77 . . . . 65.43 111.274 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.42 79.6 9.51 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.849 0.833 . . . . 60.11 109.914 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.663 ' HB2' HG22 ' A' ' 86' ' ' ILE . 49.1 t -108.94 164.58 12.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.734 -1.121 . . . . 64.11 111.317 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.5 t -83.01 137.57 43.19 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 118.574 -0.727 . . . . 63.05 110.169 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -44.56 -49.05 9.61 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 124.617 3.545 . . . . 50.11 116.165 -169.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.78 -32.17 73.59 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 112.836 0.68 . . . . 72.1 112.836 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.528 HG21 ' HG2' ' A' ' 85' ' ' PRO . 55.0 m -82.79 -33.51 27.28 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.825 0.45 . . . . 74.1 110.857 174.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.48 86.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.483 0.713 . . . . 72.52 111.76 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -61.18 -36.47 79.94 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.181 0.593 . . . . 54.31 111.88 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.32 -42.04 79.95 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.637 0.775 . . . . 74.1 110.79 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -68.94 -24.49 64.28 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.524 0.73 . . . . 71.14 112.016 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.59 -41.63 97.7 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.851 0.461 . . . . 62.2 111.826 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.7 m -76.94 -45.54 27.38 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.021 0.748 . . . . 72.3 113.021 174.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 80.8 t -67.6 -54.74 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 112.535 0.569 . . . . 44.44 112.535 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.8 mt -76.95 -49.05 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.297 0.639 . . . . 72.13 110.562 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.03 -79.39 0.43 Allowed Glycine 0 CA--C 1.535 1.341 0 CA-C-N 116.251 -0.431 . . . . 61.33 113.592 -179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.59 -7.41 26.06 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 113.496 0.924 . . . . 65.01 113.496 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.23 -83.51 1.72 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 112.098 -0.401 . . . . 43.42 112.098 171.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.2 t -58.2 -46.66 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 124.048 0.939 . . . . 65.05 113.331 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.439 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 4.4 m-30 -77.57 -49.39 14.73 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.847 0.459 . . . . 65.31 111.21 -176.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.55 -17.14 59.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.07 0.767 . . . . 73.23 113.07 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -85.2 -55.46 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 122.843 0.457 . . . . 74.12 111.376 166.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.72 -53.62 36.87 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 114.518 0.567 . . . . 62.23 114.518 -170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.3 mt -56.86 -41.6 78.24 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.323 1.049 . . . . 60.01 112.138 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.407 ' HB3' ' HE1' ' A' ' 148' ' ' HIS . 2.6 m-20 -74.31 -39.4 62.9 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.349 -0.842 . . . . 72.51 111.953 -174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.41 75.46 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.408 0.683 . . . . 73.02 111.0 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.421 HD21 HG13 ' A' ' 17' ' ' VAL . 9.7 tt -65.63 -43.27 90.0 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.785 0.834 . . . . 53.41 110.585 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.67 -27.37 68.88 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 122.884 0.474 . . . . 71.43 111.839 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -75.11 -39.94 60.23 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.95 0.9 . . . . 61.02 112.512 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -73.83 -22.99 59.58 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.723 0.638 . . . . 72.04 112.723 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -90.09 -2.5 58.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 122.076 -0.39 . . . . 72.45 111.242 168.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -67.41 -8.18 49.83 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-N 116.285 -0.416 . . . . 34.41 114.031 173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.651 ' HG3' HD12 ' A' ' 144' ' ' LEU . 8.8 ptm180 -61.28 -26.06 67.52 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.344 0.658 . . . . 75.11 111.987 169.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.651 HD12 ' HG3' ' A' ' 143' ' ' ARG . 6.4 mp -78.36 -62.82 1.56 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 122.773 0.429 . . . . 63.04 110.162 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -131.74 90.34 2.82 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 122.84 0.456 . . . . 74.34 112.04 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 31.8 p-80 55.79 152.2 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.412 0 C-N-CA 127.496 2.318 . . . . 73.1 116.579 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -89.2 162.03 16.13 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.301 -0.863 . . . . 71.1 110.63 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.407 ' HE1' ' HB3' ' A' ' 135' ' ' ASN . 29.0 p80 -129.48 178.0 6.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.534 0.734 . . . . 72.12 110.09 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -61.89 126.34 27.01 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.798 0.439 . . . . 71.44 110.089 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -60.86 126.43 27.37 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.437 0.295 . . . . 74.33 110.77 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 . . . . . 0 N--CA 1.485 1.3 0 C-N-CA 123.734 0.814 . . . . 64.41 110.938 -169.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 121.022 0.439 . . . . 72.23 111.211 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.95 73.36 10.35 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.991 0.901 . . . . 63.52 110.306 175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 94.8 m -142.39 131.18 22.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.06 -0.973 . . . . 64.34 110.746 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.9 mp -109.53 121.08 44.39 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 125.033 1.333 . . . . 61.24 109.133 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -120.35 120.53 36.28 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.248 0.547 . . . . 73.14 110.111 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -122.43 147.29 46.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.542 1.137 . . . . 74.2 109.616 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.6 p -151.0 150.47 30.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.314 0.646 . . . . 50.14 111.018 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.3 p -146.82 138.85 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.175 0.59 . . . . 73.3 111.645 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.53 108.9 19.26 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.289 0.566 . . . . 72.25 110.036 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -101.62 131.36 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.71 1.204 . . . . 54.14 110.303 -177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.34 73.95 3.12 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 122.875 0.47 . . . . 75.23 111.133 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.38 155.81 7.51 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 123.393 0.677 . . . . 74.2 111.481 -176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.74 138.55 38.15 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.901 2.4 . . . . 73.22 111.905 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.35 -32.32 48.61 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.95 1.093 . . . . 51.13 113.95 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.1 -50.26 66.81 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.952 0.501 . . . . 65.14 111.885 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.24 -39.23 82.09 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.467 0.707 . . . . 70.03 112.595 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 21.5 t -70.95 -34.37 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 122.491 0.316 . . . . 72.41 110.654 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.734 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 69.4 t-105 -67.31 -28.94 68.41 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.834 0.454 . . . . 71.25 111.316 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.7 m -64.17 -21.24 66.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.124 0.57 . . . . 73.44 111.579 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 tp -90.32 -43.13 10.55 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 124.465 1.106 . . . . 71.42 112.916 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.8 m -107.13 13.72 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 N-CA-C 113.778 1.029 . . . . 70.32 113.778 -176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -80.06 -17.22 75.02 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 114.169 0.428 . . . . 75.45 114.169 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.9 m-20 -102.78 137.88 40.41 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.359 0.664 . . . . 73.4 110.307 176.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.67 -23.79 67.52 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.96 0.904 . . . . 72.24 111.008 172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.7 p -89.21 -22.37 22.8 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.823 0.849 . . . . 55.24 112.803 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -81.92 4.17 23.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.159 0.429 . . . . 21.12 112.159 -166.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.664 HG23 HG11 ' A' ' 34' ' ' VAL . 19.4 tt -66.91 -25.29 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 C-N-CA 123.131 0.572 . . . . 74.15 111.761 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -74.71 -7.06 52.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 122.08 -0.387 . . . . 75.41 111.987 176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -83.77 -31.9 25.68 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.127 0.571 . . . . 51.34 111.752 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.48 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.7 p-90 -118.48 -29.05 5.56 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 112.673 0.62 . . . . 75.22 112.673 -172.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 38.8 t-80 -94.16 107.62 30.02 Favored Pre-proline 0 CA--C 1.556 1.202 0 N-CA-C 109.741 -0.466 . . . . 72.41 109.741 -175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -71.05 -7.24 20.98 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.916 2.41 . . . . 72.24 114.96 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -87.63 -28.6 21.77 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.693 0.397 . . . . 74.53 111.269 172.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.664 HG11 HG23 ' A' ' 27' ' ' ILE . 46.4 t -80.97 107.45 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 N-CA-C 109.902 -0.407 . . . . 73.13 109.902 174.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -72.75 -71.37 0.3 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.976 0.51 . . . . 61.23 110.951 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.62 104.38 0.46 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 123.986 0.915 . . . . 51.01 110.399 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 58.9 Cg_endo -84.97 166.6 11.27 Favored 'Trans proline' 0 CA--C 1.562 1.915 0 C-N-CA 122.985 2.457 . . . . 64.53 114.343 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -100.93 114.9 29.21 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.673 1.189 . . . . 71.34 110.122 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 4.2 mm? -90.85 134.73 34.22 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.727 0.411 . . . . 74.42 111.419 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -108.95 121.32 44.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.526 0.73 . . . . 73.22 111.322 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.02 -169.59 0.01 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 117.837 1.895 . . . . 65.13 117.837 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 56.63 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.635 1.174 . . . . 74.34 113.714 174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.3 t 168.4 148.98 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 125.591 1.557 . . . . 63.55 108.766 -171.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.17 -14.08 31.8 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.476 2.117 . . . . 64.02 112.792 168.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -95.82 -20.5 18.77 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.172 0.989 . . . . 64.25 112.789 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.8 m -99.78 123.37 47.87 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 122.692 0.397 . . . . 74.3 111.568 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.437 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.3 Cg_endo -57.16 126.9 23.6 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 123.056 2.504 . . . . 70.11 113.325 176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.62 -24.75 4.58 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.918 -0.583 . . . . 43.41 112.331 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 138.75 55.67 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.155 0.582 . . . . 71.03 111.597 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 39.9 mt-10 -113.22 134.35 54.63 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 123.492 0.717 . . . . 44.42 110.603 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 25.1 ptt180 -108.41 118.98 38.2 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.301 0.572 . . . . 75.15 110.164 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 62' ' ' VAL . 42.3 t -116.5 114.28 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 123.424 0.69 . . . . 73.44 110.611 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.625 ' HB2' ' H ' ' A' ' 61' ' ' LEU . 1.7 m-85 -71.77 90.83 1.1 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.919 0.887 . . . . 75.14 111.897 -172.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.26 3.72 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 119.941 -0.366 . . . . 73.32 113.251 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 67.89 96.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.743 1.217 . . . . 62.42 112.195 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.52 35.49 4.65 Favored Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.112 -0.367 . . . . 62.12 113.855 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.7 p -104.59 -81.63 0.52 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.611 0.764 . . . . 70.52 110.793 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.59 -35.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.014 0.926 . . . . 70.42 110.367 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -132.36 39.23 3.4 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-O 122.136 0.97 . . . . 75.2 109.572 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.54 122.56 16.09 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-N 115.112 -0.949 . . . . 70.03 111.291 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.625 ' H ' ' HB2' ' A' ' 53' ' ' PHE . 57.7 tp -97.23 116.87 30.23 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.573 0.749 . . . . 71.12 110.611 -174.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.561 HG22 HG13 ' A' ' 52' ' ' VAL . 48.6 t -98.55 114.92 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 109.7 -0.481 . . . . 74.04 109.7 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.63 ' HG2' ' HB3' ' A' ' 79' ' ' MET . 41.7 mt-10 -118.24 164.06 15.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.219 1.008 . . . . 73.02 110.392 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -148.3 130.38 15.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.575 0.75 . . . . 64.33 110.944 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 28.7 tp -73.3 112.1 9.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.115 0.966 . . . . 63.32 110.817 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.14 -47.91 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.439 0.695 . . . . 65.31 110.84 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -156.36 150.58 25.38 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.324 1.05 . . . . 73.24 109.535 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -139.91 108.67 5.95 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 121.68 -0.638 . . . . 74.31 109.856 174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.695 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 3.2 m-20 -91.3 71.26 6.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.708 0.803 . . . . 71.23 109.934 -175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 44.1 tt0 -63.73 -31.96 73.31 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.019 -0.537 . . . . 74.54 111.631 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -66.8 -14.66 62.89 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.8 0.84 . . . . 71.41 112.568 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.22 4.99 6.37 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.769 0.828 . . . . 54.01 112.604 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 97' ' ' PRO . 77.8 mtt180 55.89 60.46 3.25 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.264 1.025 . . . . 53.13 112.46 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.695 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 42.5 ttm180 -143.0 147.33 34.95 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.195 0.998 . . . . 62.1 110.357 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 18.8 tp -137.49 108.45 6.72 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.366 1.066 . . . . 75.34 110.181 -175.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -110.22 127.57 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 C-N-CA 123.604 0.762 . . . . 71.44 111.1 -174.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.2 177.69 10.56 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.045 0.538 . . . . 74.34 112.319 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -142.92 157.6 44.42 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.092 0.957 . . . . 75.24 110.781 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.63 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 18.0 ptt? -111.53 98.49 40.78 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 117.993 0.36 . . . . 73.32 110.231 163.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -62.47 -22.41 74.01 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 123.258 2.639 . . . . 52.41 112.726 174.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 3.9 m-20 -118.33 83.61 21.06 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.692 0.797 . . . . 73.42 109.909 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -91.74 144.51 3.02 Favored 'Trans proline' 0 CA--C 1.566 2.075 0 C-N-CA 122.806 2.337 . . . . 73.31 113.14 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.6 4.58 6.55 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.648 2.232 . . . . 62.2 112.921 171.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -105.36 153.64 39.55 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 124.061 0.945 . . . . 64.5 111.201 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.15 71.61 3.56 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.185 2.59 . . . . 73.42 113.12 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.744 HG22 ' HB2' ' A' ' 113' ' ' CYS . 21.4 pt -139.61 153.96 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 124.247 1.019 . . . . 73.14 110.65 -175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 15.9 m -95.36 -91.62 0.21 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 119.27 -0.395 . . . . 53.44 110.887 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 112' ' ' ASP . 0.1 OUTLIER -85.42 121.83 28.69 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-N 119.19 0.905 . . . . 74.23 109.654 175.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.43 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 52.7 t-80 -109.06 121.16 44.56 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.075 0.55 . . . . 74.43 111.875 175.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 146.53 28.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.296 1.038 . . . . 65.44 109.179 167.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -145.79 132.37 19.83 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.867 0.867 . . . . 73.53 109.747 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.2 p -133.82 129.9 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.159 0.584 . . . . 52.24 112.194 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.44 123.72 48.35 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.247 1.419 . . . . 75.13 108.618 177.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.05 149.25 50.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.13 0.572 . . . . 72.24 110.503 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 13.6 m -125.56 109.78 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.86 0.838 . . . . 65.14 109.419 169.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.9 t -82.29 125.59 76.34 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.024 0.929 . . . . 61.32 110.504 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG3' HH11 ' A' ' 73' ' ' ARG . 12.8 Cg_exo -70.78 72.65 1.93 Allowed 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.722 2.281 . . . . 72.1 111.912 170.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -71.31 -35.19 71.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.733 0.813 . . . . 52.42 110.006 -178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 27.3 t70 -163.78 163.08 24.11 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.173 1.389 . . . . 74.21 108.655 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.81 -8.42 52.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.735 -0.603 . . . . 64.23 112.21 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -126.0 -2.86 7.07 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.489 1.116 . . . . 65.35 111.935 177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 39.6 m170 -135.97 127.6 28.92 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.463 0.705 . . . . 73.43 110.453 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.531 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 39.7 t -129.88 134.22 47.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.526 0.73 . . . . 45.02 110.404 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 90.1 m -98.24 111.63 23.9 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.283 -0.266 . . . . 71.34 110.283 178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.5 HG22 HG12 ' A' ' 95' ' ' VAL . 34.3 t -86.73 106.11 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.063 -0.717 . . . . 70.32 109.063 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -100.11 117.42 45.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.536 0.735 . . . . 71.23 110.189 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 8.1 t90 -118.82 121.42 39.99 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.166 -0.679 . . . . 63.45 109.166 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.576 HG22 ' SD ' ' A' ' 110' ' ' MET . 56.4 m -129.98 130.18 44.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.238 0.615 . . . . 62.53 110.791 -172.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.28 115.78 24.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 64.33 110.915 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 108' ' ' THR . 3.5 mpp? -99.28 140.57 33.26 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.437 -0.949 . . . . 74.41 108.437 174.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -158.19 151.66 23.35 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.022 0.749 . . . . 64.21 113.022 177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 20.2 t70 -83.7 85.29 7.3 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.146 -0.934 . . . . 72.42 109.42 175.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.744 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.7 t -128.83 163.58 24.92 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.986 -0.552 . . . . 51.44 112.406 178.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.4 p -75.19 141.4 74.11 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.587 -0.733 . . . . 54.03 111.47 177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -48.37 -39.75 35.8 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.561 2.84 . . . . 71.24 113.866 170.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.57 -42.27 87.59 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.783 0.833 . . . . 64.34 112.572 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.551 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 27.0 m -82.47 -26.23 32.82 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 122.597 0.359 . . . . 72.11 111.424 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.89 76.42 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.544 0.738 . . . . 50.22 112.507 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -60.37 -33.56 72.62 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 122.974 0.51 . . . . 73.11 111.858 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.65 -44.0 57.97 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.314 0.646 . . . . 74.52 110.601 174.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -67.67 -34.65 77.35 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.076 0.398 . . . . 61.45 112.076 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.35 -43.8 97.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.886 0.474 . . . . 62.31 111.017 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.6 m -69.64 -56.41 7.35 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.223 0.609 . . . . 54.44 112.64 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.5 t -72.47 -49.65 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 124.644 1.177 . . . . 52.11 112.685 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.7 mt -81.72 -48.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 122.604 0.361 . . . . 74.02 110.977 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.45 -75.53 0.6 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 114.126 0.411 . . . . 53.4 114.126 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.19 -26.7 68.26 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.181 0.592 . . . . 73.21 111.695 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.86 -89.54 0.55 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-N 116.281 -0.418 . . . . 75.33 112.777 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.21 -49.47 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.887 0.875 . . . . 74.31 113.175 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -73.36 -53.73 10.05 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.647 0.779 . . . . 73.1 112.111 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.34 73.19 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.677 0.391 . . . . 71.22 111.968 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.74 -49.87 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.365 0.666 . . . . 62.42 111.329 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.1 -41.34 87.21 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 116.476 -0.329 . . . . 72.54 113.602 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 59.9 mt -69.27 -38.22 78.29 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.635 0.774 . . . . 70.25 112.152 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.9 m-20 -67.04 -43.11 83.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.728 0.411 . . . . 71.4 110.23 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.35 -37.02 81.83 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.301 0.64 . . . . 64.35 111.737 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 7.4 tt -65.87 -41.96 90.96 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.359 0.664 . . . . 74.33 110.234 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.94 79.44 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 116.389 -0.369 . . . . 72.35 111.245 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 41.6 mt-10 -64.53 -41.52 96.31 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.53 0.937 . . . . 74.24 113.53 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -64.05 -32.26 73.75 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.164 0.431 . . . . 75.22 112.164 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.8 -23.12 22.94 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.311 0.856 . . . . 73.44 113.311 -176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.99 6.75 0.03 OUTLIER Glycine 0 N--CA 1.486 1.995 0 N-CA-C 115.314 0.885 . . . . 73.43 115.314 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 49.1 mtp180 57.6 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 125.173 1.389 . . . . 73.44 113.032 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.86 107.73 14.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.414 0.686 . . . . 75.42 109.984 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -35.75 22.27 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.109 0.48 . . . . 72.21 110.247 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -146.74 -168.66 3.09 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.85 1.66 . . . . 62.32 108.708 171.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 70.63 154.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 125.034 1.334 . . . . 72.03 113.989 173.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -161.44 137.99 8.36 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.026 0.93 . . . . 72.44 110.16 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 61.22 63.75 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.74 1.216 . . . . 63.13 112.433 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -162.66 133.3 4.77 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.847 -1.069 . . . . 72.13 110.114 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 . . . . . 0 N--CA 1.486 1.339 0 C-N-CA 123.404 0.682 . . . . 71.34 111.137 177.125 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 119.683 -0.199 . . . . 75.43 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.61 31.43 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 123.792 0.837 . . . . 43.44 111.45 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' HB3' ' A' ' 110' ' ' MET . 89.8 m -117.15 112.21 20.55 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.672 0.789 . . . . 71.12 109.922 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.4 mp -99.42 126.32 45.3 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.933 1.293 . . . . 72.53 110.117 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -118.29 119.72 35.49 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 122.757 0.423 . . . . 73.03 109.879 172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mmt180 -127.64 139.29 52.82 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.594 0.757 . . . . 73.01 109.879 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 p -144.87 155.33 43.4 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.343 0.657 . . . . 65.42 111.382 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 104' ' ' THR . 13.7 p -150.31 147.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.385 0.674 . . . . 72.22 110.641 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -96.86 109.09 21.86 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.332 0.587 . . . . 71.21 110.289 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.415 HG21 HD22 ' A' ' 137' ' ' LEU . 69.2 t -95.07 137.81 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.386 1.474 . . . . 71.01 110.834 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.61 67.68 5.44 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.484 0.714 . . . . 53.4 112.305 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 141' ' ' TYR . . . -163.29 150.31 10.64 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.441 0.696 . . . . 70.23 111.449 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.82 144.24 76.6 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.711 2.274 . . . . 70.14 111.296 168.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' SG ' ' A' ' 103' ' ' CYS . . . -48.11 -41.22 25.82 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.234 1.568 . . . . 72.51 115.234 -172.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.33 -45.19 94.31 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.967 0.507 . . . . 73.22 112.087 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.63 -41.99 87.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.858 0.863 . . . . 64.34 112.511 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -70.88 -36.27 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 CA-C-O 121.042 0.449 . . . . 65.13 110.647 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -68.29 -27.61 66.46 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.246 0.618 . . . . 74.12 111.628 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.9 m -62.11 -31.5 71.96 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 121.268 0.556 . . . . 53.34 110.886 171.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.438 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.0 tp -83.15 -58.29 2.91 Favored 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.479 1.112 . . . . 75.01 112.35 -178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.2 m -82.95 -20.16 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 113.068 0.766 . . . . 62.42 113.068 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.83 12.4 16.95 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 115.346 0.898 . . . . 71.14 115.346 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 11.1 t70 -120.61 120.6 36.23 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 124.072 0.949 . . . . 54.0 108.486 171.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -65.5 -31.38 72.42 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.92 0.888 . . . . 74.24 112.124 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.8 t -82.3 -22.81 35.5 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.432 0.693 . . . . 74.44 112.074 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -94.55 22.52 6.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.832 0.679 . . . . 51.5 112.832 -163.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.691 HG23 HG11 ' A' ' 34' ' ' VAL . 20.1 tt -69.02 -22.53 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.461 0 C-N-CA 123.389 0.676 . . . . 74.25 111.605 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -62.1 -14.62 38.48 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.752 1.019 . . . . 73.31 113.752 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.3 mtm180 -78.97 -46.46 18.22 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.934 0.493 . . . . 64.23 111.945 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HB3' HD21 ' A' ' 20' ' ' LEU . 41.9 p-90 -103.79 -30.89 10.1 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.684 0.393 . . . . 74.11 111.706 -171.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.452 ' CE1' HE21 ' A' ' 33' ' ' GLN . 35.2 t-80 -91.34 107.85 24.57 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 122.98 0.512 . . . . 71.11 110.107 -176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.34 -19.42 61.73 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.072 2.515 . . . . 74.4 114.787 -172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.452 HE21 ' CE1' ' A' ' 31' ' ' HIS . 2.3 mp0 -84.32 -23.6 30.16 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.608 0.363 . . . . 71.43 111.858 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.691 HG11 HG23 ' A' ' 27' ' ' ILE . 84.8 t -76.21 118.8 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 120.843 0.354 . . . . 72.14 111.397 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.1 m -73.26 -74.59 0.17 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.965 0.906 . . . . 74.44 110.554 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -167.51 103.32 0.6 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.588 0.755 . . . . 72.44 110.72 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.35 150.3 17.26 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.762 2.308 . . . . 72.54 113.529 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 77.7 m -100.26 123.49 44.55 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.093 0.957 . . . . 43.12 108.853 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.8 128.54 40.1 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.242 -0.651 . . . . 40.21 109.242 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -124.93 148.59 48.28 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.195 0.998 . . . . 74.1 110.312 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.37 132.5 0.0 OUTLIER Glycine 0 CA--C 1.554 2.515 0 N-CA-C 117.584 1.794 . . . . 60.21 117.584 -175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 67.31 -90.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 125.146 1.378 . . . . 42.41 113.392 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.6 t 179.77 150.11 0.51 Allowed Pre-proline 0 N--CA 1.492 1.645 0 C-N-CA 124.08 0.952 . . . . 74.14 110.52 -170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.19 -6.55 14.97 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.459 2.106 . . . . 62.21 113.343 173.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -109.6 -7.58 15.1 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.639 0.776 . . . . 63.32 111.877 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.4 m -103.73 121.85 46.71 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 122.8 0.44 . . . . 75.01 111.401 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.8 121.19 8.81 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.297 2.664 . . . . 75.24 113.104 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.29 -6.5 8.68 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 122.865 0.269 . . . . 54.12 113.379 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.12 172.82 11.68 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.578 0.751 . . . . 71.11 112.957 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.35 152.64 45.95 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 124.178 0.991 . . . . 62.34 111.12 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -130.94 132.0 44.8 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.496 0.718 . . . . 71.01 110.31 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.51 110.85 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.602 0.761 . . . . 74.23 110.139 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -71.66 97.39 1.72 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.451 0.908 . . . . 74.45 113.451 -169.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.85 -59.31 0.67 Allowed Glycine 0 CA--C 1.531 1.078 0 N-CA-C 111.496 -0.642 . . . . 62.22 111.496 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.03 108.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.746 1.219 . . . . 75.41 112.616 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.79 54.41 Favored Glycine 0 N--CA 1.477 1.403 0 CA-C-N 116.515 -0.311 . . . . 70.03 113.268 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.9 p -116.27 -79.98 0.6 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.613 0.765 . . . . 51.11 111.087 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 177.42 -54.03 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.61 1.164 . . . . 72.25 107.913 -174.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.1 14.38 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.792 1.237 . . . . 73.54 113.605 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -71.05 96.08 1.28 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.266 1.031 . . . . 74.11 112.59 -172.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -87.72 131.53 34.45 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.425 -1.261 . . . . 65.42 108.918 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -102.43 115.59 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.283 -0.636 . . . . 73.32 109.283 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 44.8 mt-10 -121.0 133.96 55.28 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.575 0.75 . . . . 72.34 110.749 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.35 120.83 43.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.065 0.946 . . . . 73.11 110.337 -175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.6 tp -65.71 119.59 11.46 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.645 1.178 . . . . 71.14 112.045 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.0 t -84.97 -51.68 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.508 0.723 . . . . 65.23 111.048 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.631 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 13.0 pt-20 -160.21 165.02 32.31 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.446 0.698 . . . . 64.33 111.131 -178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.2 ttp85 -156.81 128.59 7.18 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.314 0.646 . . . . 64.2 109.917 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.39 123.88 38.94 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.747 0.819 . . . . 72.35 109.949 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.23 -46.64 49.0 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.823 0.849 . . . . 72.51 111.05 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.8 t -65.54 -25.14 67.31 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.136 0.974 . . . . 53.55 112.72 -170.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.54 -7.58 15.7 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.817 0.847 . . . . 74.3 112.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 11.6 mtm-85 58.93 45.62 14.84 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.93 0.892 . . . . 73.44 112.296 -178.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -114.72 124.62 52.25 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.237 1.015 . . . . 72.22 111.054 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.4 tp -122.43 107.95 12.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.749 0.82 . . . . 71.35 110.043 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.631 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 39.4 t -111.06 136.08 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.555 0.616 . . . . 74.41 110.711 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 37.6 p90 -150.14 -179.91 7.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.047 0.939 . . . . 73.43 110.902 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.1 t -142.43 164.12 30.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.877 0.871 . . . . 72.04 110.593 -178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mtp -109.3 88.35 5.87 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 123.661 0.784 . . . . 71.24 110.305 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 34.9 Cg_endo -62.28 -34.27 78.33 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.558 2.839 . . . . 51.3 113.637 178.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -125.28 81.95 63.03 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 123.006 0.522 . . . . 64.41 109.736 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -94.39 147.38 1.86 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 123.072 2.515 . . . . 62.34 113.869 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -80.72 -2.2 11.72 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.412 2.075 . . . . 62.11 112.774 170.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 40.2 m-85 -99.83 135.4 20.5 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.228 1.011 . . . . 73.04 109.449 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 15.0 Cg_exo -68.92 82.01 0.6 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.923 2.416 . . . . 60.32 112.666 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.768 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.6 pt -135.09 141.6 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 124.229 1.012 . . . . 63.44 110.308 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.3 m -83.94 -75.65 0.33 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 122.173 -0.33 . . . . 74.23 110.875 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -107.92 111.02 22.92 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.19 0.519 . . . . 72.22 110.448 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -92.91 151.68 19.81 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.731 0.813 . . . . 75.24 111.775 174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.7 tpp180 -150.19 126.49 10.72 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.589 0.756 . . . . 72.1 109.702 171.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.86 143.23 49.39 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 118.882 0.765 . . . . 75.44 112.003 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 8.9 p -137.6 142.24 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 N-CA-C 113.14 0.793 . . . . 64.32 113.14 -176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.1 mm? -108.42 117.11 33.31 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.869 1.268 . . . . 73.45 109.05 169.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 46.5 mt-10 -127.37 113.91 16.86 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.757 0.423 . . . . 64.32 111.345 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.06 111.36 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 CA-C-O 121.081 0.467 . . . . 74.1 109.755 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.36 110.16 59.15 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.136 0.974 . . . . 72.05 110.261 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HA ' ' SG ' ' A' ' 103' ' ' CYS . 51.8 Cg_endo -66.16 114.43 3.02 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.703 2.269 . . . . 64.22 114.655 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.4 11.91 22.31 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.162 0.985 . . . . 73.43 111.304 168.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 67.85 175.28 0.26 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.475 1.51 . . . . 73.42 113.287 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 60.26 -86.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.277 1.431 . . . . 70.35 112.397 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -153.09 43.09 0.61 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.785 0.802 . . . . 71.4 109.98 174.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -142.65 139.5 31.26 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.408 0.683 . . . . 74.32 109.545 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.546 ' SG ' ' HA ' ' A' ' 97' ' ' PRO . 75.5 m -153.63 138.97 17.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.507 0.723 . . . . 75.33 111.141 177.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 25.3 m -90.93 111.27 22.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.988 0.515 . . . . 72.22 111.163 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.3 t -91.34 118.88 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.897 0.479 . . . . 72.41 109.938 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -105.29 112.55 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 123.782 0.833 . . . . 74.21 109.965 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -107.49 112.03 24.6 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 108.812 -0.81 . . . . 73.12 108.812 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.7 m -123.83 127.2 47.71 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.59 0.756 . . . . 61.23 110.152 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.3 118.44 22.3 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.225 0.61 . . . . 75.13 111.362 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.625 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -118.8 128.83 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.588 1.155 . . . . 71.15 109.09 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -145.26 156.5 43.87 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.719 0.808 . . . . 74.11 111.498 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 25.3 t70 -89.86 85.15 6.31 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.372 0.606 . . . . 74.44 109.861 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.768 ' HB2' HG22 ' A' ' 86' ' ' ILE . 53.6 t -122.72 148.47 45.29 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.434 -0.803 . . . . 50.01 111.809 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.5 t -62.82 125.08 85.71 Favored Pre-proline 0 N--CA 1.485 1.298 0 CA-C-O 118.678 -0.677 . . . . 42.35 109.847 174.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HA ' ' HB3' ' A' ' 118' ' ' ALA . 10.5 Cg_endo -52.07 -22.29 14.44 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 123.523 2.815 . . . . 74.44 115.695 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -65.02 -50.23 67.06 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 122.796 0.439 . . . . 74.22 112.018 170.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.537 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 34.4 m -71.13 -36.85 72.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.912 0.485 . . . . 35.35 110.594 176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 115' ' ' PRO . . . -69.61 -38.49 77.3 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.749 0.819 . . . . 74.34 112.542 -171.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -64.8 -34.11 77.57 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.288 0.566 . . . . 73.54 110.916 174.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.11 -34.12 74.58 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.416 -0.811 . . . . 73.34 110.275 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 117' ' ' THR . 77.8 mt -75.01 -25.62 58.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.433 0.693 . . . . 62.35 111.483 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.87 -32.7 74.14 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 118.496 0.589 . . . . 70.14 110.607 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 55.6 m -70.08 -58.12 4.18 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.556 0.576 . . . . 73.54 112.556 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.13 -55.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 122.968 0.507 . . . . 52.22 112.198 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 121' ' ' LEU . 56.7 mt -74.32 -49.68 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.71 0.404 . . . . 72.0 110.39 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.96 -55.38 19.66 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 114.789 0.676 . . . . 62.15 114.789 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.69 -52.99 5.42 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.891 0.845 . . . . 61.53 111.59 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.51 -36.94 92.19 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 115.083 0.793 . . . . 62.43 115.083 -171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.2 t -97.66 -56.89 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 122.474 -0.427 . . . . 72.01 110.966 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -75.71 -61.97 1.74 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.727 0.64 . . . . 74.24 112.727 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.26 70.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.775 0.43 . . . . 54.54 111.11 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 t -65.58 -50.93 68.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 123.223 0.609 . . . . 71.31 111.823 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -38.32 95.77 Favored Glycine 0 N--CA 1.481 1.647 0 CA-C-O 120.97 0.206 . . . . 73.32 113.372 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 75.7 mt -71.66 -39.44 70.32 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.448 1.099 . . . . 74.13 111.732 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 8.1 m-80 -69.77 -38.55 76.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 122.404 0.282 . . . . 41.43 110.402 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.86 -33.71 76.65 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.679 0.792 . . . . 75.14 111.564 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 10' ' ' VAL . 5.1 tt -66.52 -36.37 82.54 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.878 0.871 . . . . 43.22 109.568 173.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.68 -28.04 62.46 Favored 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 123.189 0.595 . . . . 70.5 112.295 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 10.8 mm-40 -72.56 -42.53 64.56 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 122.949 0.5 . . . . 71.21 111.828 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -64.47 -41.29 96.59 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 120.718 0.294 . . . . 75.01 111.54 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.446 ' CD1' ' HB2' ' A' ' 12' ' ' ALA . 71.5 m-85 -81.79 -2.94 52.58 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.501 0.321 . . . . 73.12 111.059 174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.11 3.59 10.1 Favored Glycine 0 CA--C 1.539 1.578 0 CA-C-N 116.569 -0.287 . . . . 74.35 113.159 168.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -34.29 74.41 Favored 'General case' 0 CA--C 1.565 1.52 0 C-N-CA 124.269 1.028 . . . . 73.44 109.582 165.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 -62.48 1.59 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.698 0.799 . . . . 71.15 110.417 173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -98.01 94.28 6.77 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.939 -0.763 . . . . 75.44 108.939 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -69.82 -23.88 63.38 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 112.724 0.638 . . . . 75.14 112.724 -170.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -86.65 107.94 18.41 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 122.942 0.497 . . . . 65.54 110.468 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -151.76 -51.47 0.12 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.892 0.877 . . . . 73.41 110.33 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 60.13 117.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.825 1.417 . . . . 74.05 114.825 169.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -131.76 -86.81 0.47 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.2 -0.667 . . . . 63.24 109.2 168.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 124.517 1.127 . . . . 53.45 110.53 175.706 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.784 0.326 . . . . 72.44 111.546 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.5 61.34 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.765 0.826 . . . . 65.51 112.54 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.0 m -79.67 110.18 14.76 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.424 0.631 . . . . 71.42 111.677 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.74 121.71 36.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.933 1.293 . . . . 75.34 109.143 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -130.69 137.89 49.76 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.185 0.517 . . . . 71.03 111.357 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -132.12 152.46 51.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.521 1.128 . . . . 72.02 109.441 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.0 p -149.45 149.62 31.08 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.452 0.701 . . . . 72.22 110.201 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.7 p -144.1 138.31 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.157 0.583 . . . . 62.32 111.852 -171.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.96 108.5 16.97 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.31 -0.626 . . . . 73.34 109.31 172.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.89 130.83 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.441 1.096 . . . . 63.32 110.976 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.3 71.8 3.02 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.066 0.546 . . . . 64.51 111.203 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.08 141.71 0.83 Allowed Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.625 1.17 . . . . 62.24 110.664 178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.44 141.25 95.06 Favored 'Trans proline' 0 CA--C 1.564 1.984 0 C-N-CA 122.866 2.377 . . . . 44.34 113.255 170.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 103' ' ' CYS . . . -47.5 -42.66 23.54 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 115.296 1.591 . . . . 70.25 115.296 -174.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -47.6 85.24 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.128 0.571 . . . . 75.33 112.153 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.49 -34.94 78.88 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.603 0.761 . . . . 71.33 112.278 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.33 -35.55 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 122.847 0.459 . . . . 61.04 110.716 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 60.4 t-105 -72.38 -25.89 61.68 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.036 0.534 . . . . 74.34 111.342 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.1 m -58.37 -29.5 66.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 72.33 110.654 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.571 HD22 HH11 ' A' ' 140' ' ' ARG . 62.1 tp -84.97 -59.68 2.27 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.748 1.219 . . . . 71.33 111.706 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.8 14.52 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 113.441 0.904 . . . . 63.14 113.441 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.16 33.28 5.52 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 112.356 -0.298 . . . . 63.54 112.356 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -154.82 148.17 25.03 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.94 0.896 . . . . 72.15 110.044 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -84.97 -25.66 27.63 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 123.465 0.706 . . . . 74.43 111.625 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -92.87 -21.39 19.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.495 0.718 . . . . 73.32 112.384 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.21 8.14 9.61 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 112.486 0.55 . . . . 71.14 112.486 -166.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.631 HG21 ' NH1' ' A' ' 51' ' ' ARG . 20.5 tt -68.46 -23.92 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 C-N-CA 124.153 0.981 . . . . 74.31 112.611 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -74.51 0.42 14.83 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 112.835 0.68 . . . . 74.14 112.835 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 -97.36 -15.54 20.66 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.689 0.795 . . . . 74.4 112.313 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.569 ' HB3' HD21 ' A' ' 20' ' ' LEU . 37.5 p-90 -128.68 -38.12 1.72 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 112.637 0.606 . . . . 75.23 112.637 177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 64.2 t-80 -89.64 115.28 63.44 Favored Pre-proline 0 CA--C 1.556 1.204 0 C-N-CA 122.86 0.464 . . . . 74.04 110.365 -173.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 13.6 Cg_exo -69.97 -23.68 29.54 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.197 2.598 . . . . 45.34 114.885 -169.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.48 -15.36 52.77 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.215 0.45 . . . . 73.13 112.215 -175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 36' ' ' ALA . 98.5 t -70.89 120.74 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 122.89 0.476 . . . . 54.51 112.211 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.1 m -93.37 20.5 7.07 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.034 0.934 . . . . 60.11 112.394 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 70.28 110.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.638 1.575 . . . . 51.23 112.186 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -86.05 168.79 9.08 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.193 2.595 . . . . 74.54 114.241 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.5 m -101.91 127.75 48.6 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.693 1.197 . . . . 61.01 110.171 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.61 125.29 37.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.071 0.938 . . . . 54.43 113.033 -171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 41.5 mmt180 -92.8 -174.46 3.62 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.695 1.998 . . . . 72.51 110.808 173.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 33.74 -128.79 0.44 Allowed Glycine 0 CA--C 1.547 2.081 0 N-CA-C 116.993 1.557 . . . . 71.41 116.993 -161.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.97 -79.97 0.45 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.018 0.927 . . . . 75.14 112.393 -174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -121.99 141.0 33.21 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.8 0.84 . . . . 65.21 111.153 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.87 -8.33 13.42 Favored 'Trans proline' 0 N--CA 1.502 2.007 0 C-N-CA 123.249 2.633 . . . . 44.23 114.084 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -88.2 -25.53 22.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 122.916 0.486 . . . . 74.44 111.366 171.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 81.7 m -77.72 123.03 86.55 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 124.011 0.925 . . . . 75.34 112.527 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.0 Cg_endo -56.48 103.4 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 123.115 2.543 . . . . 52.22 112.058 170.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.72 -36.05 1.56 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 115.916 -0.584 . . . . 50.32 112.18 -175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.8 148.15 50.0 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.298 0.639 . . . . 30.33 111.587 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 32.2 mt-10 -124.69 140.3 53.06 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 122.894 0.478 . . . . 73.44 111.141 -172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.631 ' NH1' HG21 ' A' ' 27' ' ' ILE . 15.5 ptt180 -105.25 112.97 26.28 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.706 0.765 . . . . 74.12 109.68 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.605 HG13 HG22 ' A' ' 62' ' ' VAL . 45.1 t -111.33 100.03 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.588 0.755 . . . . 55.21 109.833 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 60' ' ' GLU . 38.4 m-85 -59.47 134.28 56.87 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.149 0.58 . . . . 74.33 110.097 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.8 -67.94 1.05 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 114.803 0.681 . . . . 54.24 114.803 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 71.73 95.68 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.403 1.481 . . . . 61.22 111.153 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.64 23.71 66.75 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-N 115.742 -0.663 . . . . 55.12 113.467 -174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.0 p -123.29 172.72 8.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.559 0.744 . . . . 63.14 111.323 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -68.7 -39.38 80.51 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.667 0.787 . . . . 73.23 111.708 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -90.12 64.58 6.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.875 0.845 . . . . 74.24 109.774 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 33.4 tt0 -108.28 137.3 46.48 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.754 -0.657 . . . . 73.34 112.276 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD13 ' HD3' ' A' ' 83' ' ' PRO . 31.0 tp -144.21 113.19 6.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.824 0.85 . . . . 73.11 109.235 173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 40.0 t -98.93 115.23 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.692 -0.485 . . . . 63.2 109.692 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 68.9 mt-10 -123.35 148.51 45.96 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.944 0.898 . . . . 64.52 110.079 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -124.22 132.34 53.59 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.133 0.573 . . . . 71.44 111.027 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.2 tp -74.33 114.91 13.24 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.361 0.664 . . . . 65.32 110.535 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.402 HG11 HH12 ' A' ' 90' ' ' ARG . 61.3 t -79.36 -51.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 122.801 0.441 . . . . 40.44 110.916 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 10.1 pt-20 -153.86 155.49 35.85 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.433 0.693 . . . . 75.42 110.124 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 42.7 ttp85 -144.26 145.87 32.3 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.359 -0.608 . . . . 71.14 109.359 174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -146.46 134.56 21.57 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.399 0.679 . . . . 73.25 109.746 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 46.7 mt-10 -90.16 -50.87 5.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.233 0.613 . . . . 61.51 112.332 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.7 p -70.84 -34.6 71.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.243 0.617 . . . . 75.15 111.969 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.14 -9.71 54.59 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.332 0.653 . . . . 53.25 112.094 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 61.62 43.33 10.05 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.884 0.873 . . . . 73.33 112.211 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -114.58 115.58 27.4 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.728 0.811 . . . . 64.14 111.947 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -113.67 108.45 17.14 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.766 0.827 . . . . 74.44 108.777 170.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 27.0 t -117.63 130.3 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.634 0.652 . . . . 70.31 110.822 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -142.76 178.95 7.29 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.689 0.796 . . . . 73.11 111.257 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.401 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.7 t -135.98 159.34 42.0 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.351 1.06 . . . . 53.21 109.87 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.428 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 80.1 mtp -112.44 83.94 5.8 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 123.538 0.735 . . . . 70.32 109.046 171.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.571 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 81.2 Cg_endo -72.03 -16.6 28.84 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 123.253 2.635 . . . . 63.44 113.511 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.638 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 9.7 t70 -134.06 82.06 49.45 Favored Pre-proline 0 CA--C 1.556 1.209 0 N-CA-C 108.72 -0.845 . . . . 62.34 108.72 172.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -91.41 150.02 3.59 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.167 2.578 . . . . 71.41 113.34 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.519 ' HD3' HD13 ' A' ' 61' ' ' LEU . 72.7 Cg_endo -81.07 -0.68 10.73 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.739 2.292 . . . . 75.41 113.12 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -105.25 154.69 38.73 Favored Pre-proline 0 N--CA 1.483 1.214 0 C-N-CA 123.99 0.916 . . . . 71.23 110.673 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.42 70.67 3.96 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 122.832 2.355 . . . . 73.53 113.075 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -137.52 133.73 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.588 1.155 . . . . 71.22 109.525 -177.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 22.4 m -77.14 -79.11 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.941 -0.474 . . . . 51.02 111.894 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -108.88 104.69 13.99 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.928 0.491 . . . . 75.13 111.03 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.53 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 65.4 t-80 -93.38 146.26 23.87 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 123.742 0.817 . . . . 75.33 111.356 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.402 HH12 HG11 ' A' ' 66' ' ' VAL . 14.8 tpt180 -146.56 111.31 5.27 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 123.997 0.919 . . . . 53.42 110.094 -176.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.53 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -124.11 149.06 46.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 113.075 0.768 . . . . 73.35 113.075 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.5 t -136.12 139.29 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 C-N-CA 124.095 0.958 . . . . 71.53 111.668 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.71 110.6 22.97 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.202 1.001 . . . . 72.41 108.422 162.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -127.04 119.06 25.69 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.755 -0.832 . . . . 64.14 108.755 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 103' ' ' CYS . 96.4 t -101.71 109.97 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.241 0.616 . . . . 72.1 110.858 -172.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.32 113.02 55.95 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 124.8 1.24 . . . . 63.22 111.065 -175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -77.25 95.28 1.07 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.945 2.43 . . . . 63.51 113.156 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -79.26 -37.38 38.03 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 112.243 0.46 . . . . 75.14 112.243 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 35.0 t70 -157.07 162.58 39.48 Favored 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 123.28 0.632 . . . . 73.12 111.282 -169.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -62.66 -21.15 65.49 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.824 1.249 . . . . 72.1 113.075 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.06 0.83 5.25 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.474 0.71 . . . . 72.41 112.252 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 32.8 m80 -134.7 123.06 23.09 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.662 0.664 . . . . 74.12 109.901 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 95' ' ' VAL . 38.2 t -142.95 137.63 29.55 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.425 0.29 . . . . 62.34 111.341 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.2 m -92.42 111.75 23.44 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.887 0.475 . . . . 74.45 111.3 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.4 t -92.1 112.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 109.141 -0.688 . . . . 73.5 109.141 176.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.34 119.15 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.356 0.662 . . . . 71.24 110.075 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -107.47 113.3 26.55 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 108.658 -0.867 . . . . 75.32 108.658 174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.8 m -108.89 149.93 28.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.087 0.955 . . . . 63.42 109.502 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.14 145.31 27.13 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.477 1.111 . . . . 74.32 108.633 171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -154.25 133.83 12.82 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.217 0.607 . . . . 65.42 110.104 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -138.53 153.36 48.73 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.647 -0.706 . . . . 63.24 111.305 -169.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 34.2 t70 -77.14 87.13 3.61 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 116.231 -0.441 . . . . 75.44 110.055 175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.406 ' HB2' HG22 ' A' ' 86' ' ' ILE . 27.9 t -156.1 169.8 23.67 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.616 -0.72 . . . . 64.05 111.883 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.0 m -76.52 148.28 79.84 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 124.457 1.103 . . . . 64.13 112.802 -175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.73 -34.91 92.3 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.821 3.014 . . . . 75.21 114.796 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.89 -31.09 67.63 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.294 0.638 . . . . 74.33 112.25 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 95.2 m -76.76 -38.08 54.79 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.02 0.438 . . . . 74.12 110.027 169.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -31.48 71.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.968 . . . . 25.05 112.881 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -75.74 -33.33 60.25 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.939 0.496 . . . . 71.32 111.43 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -42.21 83.49 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.213 0.605 . . . . 75.04 110.225 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.99 -24.93 59.66 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.338 -0.846 . . . . 74.45 111.318 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -60.16 -36.11 76.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.013 0.525 . . . . 73.15 110.908 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -72.57 -53.56 11.58 Favored 'General case' 0 CA--C 1.557 1.22 0 CA-C-N 115.951 -0.568 . . . . 74.21 111.856 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.4 t -73.76 -57.31 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 113.148 0.795 . . . . 74.24 113.148 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.1 mt -77.83 -57.99 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.804 0.842 . . . . 64.23 110.942 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.53 -51.04 61.17 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 114.263 0.465 . . . . 64.44 114.263 -174.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -95.22 -39.82 9.89 Favored 'General case' 0 CA--C 1.556 1.193 0 O-C-N 121.998 -0.707 . . . . 52.13 112.024 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.49 73.27 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 114.88 0.712 . . . . 73.13 114.88 -175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.93 -52.41 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 117.656 0.728 . . . . 72.21 111.024 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 2.8 m-30 -77.72 -53.58 7.37 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.102 0.408 . . . . 73.03 112.102 -172.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.32 -15.63 62.74 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 112.11 0.411 . . . . 62.15 112.11 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.6 t -80.86 -51.81 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 123.929 0.892 . . . . 73.32 110.985 169.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.33 -51.93 44.82 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.09 -0.505 . . . . 70.21 114.258 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 47.6 mt -58.52 -36.18 73.42 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.842 0.857 . . . . 71.12 112.776 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 6.3 m-20 -67.83 -46.06 72.9 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.669 -0.493 . . . . 73.21 109.669 175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.05 -34.0 74.18 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.6 0.76 . . . . 72.31 112.267 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.72 -49.24 78.5 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.312 1.045 . . . . 71.51 110.121 171.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -24.03 62.07 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-N 115.42 -0.809 . . . . 73.22 111.924 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 6.2 mm-40 -67.57 -50.73 57.05 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.589 0.756 . . . . 74.13 110.585 176.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.571 HH11 HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.95 -15.83 62.09 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.737 0.643 . . . . 72.4 112.737 -177.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -87.02 -22.62 25.38 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.803 0.668 . . . . 74.33 112.803 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.66 -33.18 0.06 OUTLIER Glycine 0 C--N 1.358 1.792 0 N-CA-C 116.227 1.251 . . . . 64.33 116.227 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 76.56 -4.6 2.33 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 124.73 1.212 . . . . 75.52 112.656 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.87 152.92 44.79 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 121.282 -0.886 . . . . 73.33 111.455 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 68.84 20.95 7.84 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.237 1.415 . . . . 74.12 114.545 170.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -86.89 74.66 9.71 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.045 0.45 . . . . 75.14 111.395 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -92.7 97.59 10.88 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -152.49 150.27 29.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.2 0.6 . . . . 73.03 111.227 -168.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -140.4 86.04 2.05 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.382 0.673 . . . . 74.32 110.03 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -142.79 173.72 11.29 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.1 0.96 . . . . 74.52 110.853 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 123.419 0.688 . . . . 74.43 110.584 178.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.5 ptp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.743 0.306 . . . . 74.24 111.094 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.53 66.15 9.35 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 122.074 0.94 . . . . 64.55 110.408 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.4 m -144.48 119.33 9.91 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.279 -0.873 . . . . 40.32 110.38 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.17 147.54 23.06 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.635 1.174 . . . . 60.1 109.226 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -149.53 129.96 13.85 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.138 0.575 . . . . 65.44 109.832 170.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -130.78 151.62 51.01 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.932 0.893 . . . . 62.31 108.751 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 96.3 p -146.85 163.34 36.4 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.991 0.516 . . . . 73.53 110.895 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.69 149.19 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 122.87 0.468 . . . . 65.25 111.057 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -87.56 109.22 19.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.029 0.532 . . . . 50.34 110.231 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 12' ' ' ALA . 85.8 t -96.49 129.9 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.312 1.045 . . . . 75.32 109.601 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.495 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.23 26.24 0.78 Allowed 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.563 0.949 . . . . 73.05 113.563 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 10' ' ' VAL . . . -131.55 150.57 76.72 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.583 0.753 . . . . 71.14 110.317 174.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.85 151.05 50.84 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.184 2.589 . . . . 72.11 112.984 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.02 -28.81 10.87 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.789 1.236 . . . . 54.51 114.27 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.9 -50.9 64.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.774 0.657 . . . . 75.04 112.774 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -44.94 64.7 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.704 0.801 . . . . 71.0 111.901 173.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG13 HD21 ' A' ' 137' ' ' LEU . 15.0 t -73.36 -34.51 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 114.896 -1.047 . . . . 71.32 111.62 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.683 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 65.5 t-105 -73.48 -28.99 62.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.233 0.613 . . . . 72.13 111.505 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 m -60.65 -26.96 67.45 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.629 0.728 . . . . 74.25 110.838 168.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.549 HD22 HH11 ' A' ' 140' ' ' ARG . 54.4 tp -91.41 -44.03 9.38 Favored 'General case' 0 CA--C 1.567 1.607 0 C-N-CA 124.361 1.064 . . . . 61.41 113.091 -173.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.62 -21.72 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 N-CA-C 113.588 0.959 . . . . 73.22 113.588 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.68 73.89 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 114.281 0.472 . . . . 75.04 114.281 -176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 3.6 m-20 -86.73 122.59 30.84 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.638 -1.245 . . . . 75.24 107.638 171.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.423 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 4.0 t80 -61.1 -27.84 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.992 0.517 . . . . 63.43 110.635 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -77.5 -23.51 50.27 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.024 0.93 . . . . 72.14 113.426 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -83.15 9.28 10.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 112.529 0.566 . . . . 60.14 112.529 -161.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.541 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 13.7 tt -62.64 -25.11 37.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 123.221 0.608 . . . . 73.54 111.52 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.766 ' HA ' HG11 ' A' ' 34' ' ' VAL . 26.4 p-80 -71.84 0.17 9.73 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 112.632 0.605 . . . . 63.42 112.632 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -102.92 -18.18 15.16 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.721 0.808 . . . . 25.53 112.754 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.541 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 33.0 p-90 -126.99 -42.24 1.75 Allowed 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.433 1.271 . . . . 74.42 114.433 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.609 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.3 t-80 -72.73 119.86 77.6 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 117.985 0.357 . . . . 72.11 110.273 -169.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.57 -22.33 73.86 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.373 2.048 . . . . 71.13 115.002 -175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.97 -4.19 22.39 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 113.041 0.756 . . . . 70.44 113.041 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.766 HG11 ' HA ' ' A' ' 28' ' ' HIS . 11.2 p -63.81 148.13 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.357 0 CA-C-N 118.228 0.467 . . . . 74.42 111.157 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.9 t -113.22 28.4 8.81 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.293 0.637 . . . . 53.3 111.402 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.41 85.97 0.18 Allowed Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 123.781 0.832 . . . . 74.34 111.163 -173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.99 173.32 13.67 Favored 'Trans proline' 0 CA--C 1.556 1.622 0 C-N-CA 122.888 2.392 . . . . 73.45 114.077 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 40.7 m -112.97 130.51 56.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.33 1.052 . . . . 62.0 110.178 -177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.69 137.18 42.09 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.7 0.8 . . . . 61.31 110.07 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.548 ' HG3' ' HB2' ' A' ' 50' ' ' GLU . 11.1 ptm180 -150.82 162.04 41.51 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.904 0.882 . . . . 74.31 111.012 -176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.74 143.89 0.0 OUTLIER Glycine 0 CA--C 1.557 2.68 0 N-CA-C 117.25 1.66 . . . . 65.24 117.25 -169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 57.97 -104.46 0.22 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.403 1.081 . . . . 63.42 112.165 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 m -170.73 151.19 3.37 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 125.204 1.402 . . . . 61.22 109.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.58 0.58 1.8 Allowed 'Trans proline' 0 N--CA 1.513 2.639 0 C-N-CA 123.453 2.769 . . . . 72.13 115.29 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -119.69 -18.38 8.37 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.534 0.734 . . . . 74.13 111.408 168.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.2 m -87.88 123.34 69.2 Favored Pre-proline 0 N--CA 1.487 1.379 0 C-N-CA 123.251 0.62 . . . . 75.42 111.22 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 71.2 Cg_exo -45.99 119.06 2.66 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.727 2.951 . . . . 71.04 114.22 171.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.43 -20.62 4.39 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.507 0.575 . . . . 61.25 112.726 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.34 141.54 54.2 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.26 0.837 . . . . 74.4 113.26 -177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.684 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 28.9 mt-10 -107.71 126.94 53.21 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.906 0.882 . . . . 75.15 110.698 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 24' ' ' PHE . 58.1 ttp180 -102.38 108.72 20.15 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.073 0.949 . . . . 74.33 109.869 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG13 HG22 ' A' ' 62' ' ' VAL . 41.8 t -112.11 112.98 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 C-N-CA 123.844 0.858 . . . . 60.3 110.931 -172.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 34' ' ' VAL . 76.3 m-85 -73.45 -58.1 3.54 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 112.959 0.725 . . . . 71.42 112.959 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.42 -50.27 39.26 Favored Glycine 0 N--CA 1.474 1.211 0 CA-C-N 116.436 -0.347 . . . . 44.2 112.776 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 51.07 24.66 1.98 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.938 1.295 . . . . 65.41 114.118 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.73 24.28 0.02 OUTLIER Glycine 0 CA--C 1.534 1.224 0 CA-C-N 116.196 -0.456 . . . . 72.11 113.037 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 60' ' ' GLU . 72.7 p -129.02 142.2 50.99 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.317 1.047 . . . . 73.34 109.779 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -62.18 -30.31 70.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 112.779 0.659 . . . . 74.44 112.779 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.04 75.38 1.22 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 121.731 0.776 . . . . 73.22 110.579 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 14.0 pt-20 -109.16 164.51 12.38 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.648 1.179 . . . . 71.54 111.758 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.0 tp -103.21 124.11 47.99 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.999 0.52 . . . . 71.45 109.692 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG22 HG13 ' A' ' 52' ' ' VAL . 61.7 t -120.18 128.1 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.537 0.735 . . . . 64.23 109.688 173.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.525 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 35.2 mt-10 -117.45 149.42 40.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.47 1.108 . . . . 72.21 110.335 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.684 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 96.2 mtt180 -126.03 129.83 49.95 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.005 0.522 . . . . 63.11 111.378 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 14.5 tp -67.63 115.82 7.64 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.009 0.924 . . . . 73.33 111.034 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.477 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 98.0 t -84.98 -51.75 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.509 0.724 . . . . 71.24 111.297 -178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 6.3 pt-20 -158.15 140.49 14.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.527 0.731 . . . . 75.2 110.197 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.23 124.15 28.37 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.099 0.56 . . . . 63.15 110.224 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.57 100.45 8.29 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.525 -0.917 . . . . 62.1 108.525 173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 25.5 tt0 -80.02 -31.08 39.65 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 112.374 0.509 . . . . 70.51 112.374 -172.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -69.86 -43.59 71.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.16 0.584 . . . . 63.5 111.71 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.8 -10.12 59.75 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.398 0.679 . . . . 55.3 111.913 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 61.21 55.62 2.93 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.557 1.143 . . . . 61.42 112.005 -178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -132.38 135.05 45.87 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.278 -1.328 . . . . 74.21 110.139 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -124.39 132.23 53.52 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.167 1.387 . . . . 72.2 108.862 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 41.3 t -133.63 130.52 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-N 118.338 0.517 . . . . 63.15 111.078 177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 54.9 p90 -141.26 -179.45 6.12 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.342 1.057 . . . . 72.15 110.573 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.484 HG23 ' HD3' ' A' ' 80' ' ' PRO . 5.3 t -130.44 162.76 28.45 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.649 1.18 . . . . 43.15 110.367 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.441 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.5 mtp -109.8 85.58 4.09 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.825 0.85 . . . . 65.33 109.278 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 71.8 Cg_endo -71.36 -24.5 22.74 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 123.48 2.787 . . . . 74.33 113.095 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.88 76.43 70.99 Favored Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 109.441 -0.577 . . . . 73.44 109.441 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -95.55 150.78 1.5 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.097 2.531 . . . . 61.51 113.456 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.82 -6.88 17.97 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.176 1.917 . . . . 71.04 112.21 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -92.32 143.28 27.14 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.477 1.111 . . . . 72.33 110.771 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.45 ' HG2' HG21 ' A' ' 117' ' ' THR . 90.5 Cg_endo -78.72 72.99 6.15 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.741 2.294 . . . . 71.13 112.689 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 113' ' ' CYS . 19.1 pt -127.87 145.52 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.356 1.062 . . . . 61.13 110.575 -176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.3 m -82.78 -78.23 0.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.616 0.366 . . . . 75.33 111.812 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -113.72 106.66 14.76 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.29 0.566 . . . . 75.1 109.944 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.595 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 56.1 t-80 -91.65 159.38 15.9 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.445 0.698 . . . . 43.2 111.673 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -165.47 103.25 0.72 Allowed 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 124.104 0.962 . . . . 74.24 110.254 174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.595 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -98.65 153.5 18.64 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.58 0.752 . . . . 70.31 112.544 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.49 132.56 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.883 0.873 . . . . 74.22 111.48 -178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -109.08 107.58 17.95 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.748 1.219 . . . . 75.03 109.268 166.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -127.92 130.71 48.92 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 122.002 -0.436 . . . . 72.12 110.434 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.601 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 27.8 m -99.67 111.12 28.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 CA-C-O 121.672 0.749 . . . . 72.54 109.852 175.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 95.8 t -83.32 107.67 10.58 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.571 1.149 . . . . 74.44 109.448 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 5.4 Cg_exo -74.25 108.23 2.62 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.789 2.326 . . . . 71.3 111.911 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -84.4 -60.44 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.186 0.594 . . . . 74.11 110.495 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -131.49 175.37 9.21 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.031 0.932 . . . . 71.5 110.366 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -76.69 -4.58 43.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.82 0.448 . . . . 52.2 110.578 166.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -23.96 11.68 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.823 1.249 . . . . 63.31 112.344 175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 37.1 m80 -136.01 150.96 49.42 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 118.354 0.524 . . . . 62.44 112.014 -172.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.601 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 45.5 t -143.56 173.6 11.5 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.358 1.063 . . . . 35.34 110.175 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.6 m -135.94 119.24 16.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.18 0.592 . . . . 70.44 110.835 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG23 HG21 ' A' ' 10' ' ' VAL . 26.0 t -91.27 113.06 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 122.144 -0.347 . . . . 73.52 110.199 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.54 109.91 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.473 1.109 . . . . 64.42 109.725 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -106.69 111.65 24.28 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 109.163 -0.68 . . . . 74.22 109.163 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.9 m -109.63 147.13 33.6 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.187 0.995 . . . . 73.32 109.964 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -131.78 111.27 11.49 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.956 0.903 . . . . 70.01 111.122 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.9 mtt -98.86 131.14 45.19 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.857 0.863 . . . . 75.41 108.978 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -156.96 144.68 19.12 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.413 0.523 . . . . 75.44 112.413 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.57 87.83 6.89 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.6 0.714 . . . . 52.14 110.676 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 53.5 t -134.28 169.09 17.72 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 114.643 -1.162 . . . . 71.44 111.411 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.409 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.2 m -68.44 146.93 98.09 Favored Pre-proline 0 N--CA 1.485 1.285 0 C-N-CA 124.025 0.93 . . . . 62.01 112.222 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.49 -41.33 72.96 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.436 2.757 . . . . 73.54 114.29 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.77 -43.77 97.62 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.493 0.717 . . . . 62.44 111.813 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.45 HG21 ' HG2' ' A' ' 85' ' ' PRO . 21.3 m -71.81 -36.93 70.41 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.307 -0.406 . . . . 74.04 110.756 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.06 -38.04 85.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.652 0.781 . . . . 62.23 112.322 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -28.54 63.49 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.484 0.314 . . . . 65.34 111.587 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.07 -42.04 89.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.223 0.535 . . . . 74.41 110.049 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.7 mt -70.95 -22.88 62.16 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.904 0.882 . . . . 75.45 112.199 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -58.04 -43.37 86.79 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.299 0.5 . . . . 52.32 110.683 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.2 t -72.12 -49.79 33.31 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 112.6 0.593 . . . . 74.54 112.6 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.09 -54.61 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.207 0.527 . . . . 75.33 112.287 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.02 -56.45 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 123.78 0.832 . . . . 62.31 111.536 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.59 -43.53 96.36 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 114.659 0.624 . . . . 73.22 114.659 -173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -88.72 -60.18 2.03 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.955 0.502 . . . . 74.25 110.634 174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.84 -29.6 75.24 Favored Glycine 0 CA--C 1.535 1.304 0 N-CA-C 115.834 1.094 . . . . 73.13 115.834 -169.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 56.0 t -105.16 -53.94 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 117.317 0.558 . . . . 72.01 110.873 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 5.2 m-30 -75.43 -65.47 0.89 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.804 -0.634 . . . . 65.04 111.793 -170.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.12 -37.06 66.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.856 0.462 . . . . 55.12 111.554 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.56 -53.73 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.429 0 C-N-CA 123.986 0.914 . . . . 75.31 112.26 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.42 -35.17 81.32 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-N 116.402 -0.363 . . . . 63.15 113.395 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.5 mt -72.67 -44.83 61.31 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.3 1.04 . . . . 74.24 112.027 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -65.7 -38.19 88.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.376 0.27 . . . . 62.42 110.895 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.16 -37.76 88.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.946 0.498 . . . . 42.55 111.611 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.538 HD21 HG13 ' A' ' 17' ' ' VAL . 7.0 tt -64.75 -42.5 95.12 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.693 0.797 . . . . 71.43 110.151 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.29 -35.38 80.23 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.875 -0.602 . . . . 64.1 112.06 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.08 -33.12 61.62 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.754 0.822 . . . . 74.31 112.741 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.549 HH11 HD22 ' A' ' 20' ' ' LEU . 2.2 ptm180 -73.27 -24.72 60.47 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 120.773 0.32 . . . . 75.4 111.06 177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 54.4 m-85 -100.75 4.14 42.79 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.432 0.693 . . . . 74.12 111.559 172.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -45.92 -50.41 11.99 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 115.156 0.823 . . . . 72.3 115.156 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 55.82 20.28 4.01 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.284 1.216 . . . . 74.31 114.284 170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mp 61.94 20.51 11.58 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.167 1.387 . . . . 61.15 114.23 171.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -35.82 57.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.873 -0.517 . . . . 71.1 110.894 173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -149.89 162.45 40.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.559 1.544 . . . . 72.42 109.291 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -98.14 103.19 15.12 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.068 -0.716 . . . . 74.24 109.068 168.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -67.92 109.68 3.53 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.748 0.819 . . . . 72.51 109.721 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -34.1 120.38 0.44 Allowed 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.642 1.719 . . . . 71.01 115.642 -167.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -73.18 -34.29 65.92 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.942 1.297 . . . . 71.3 113.679 -171.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 N--CA 1.493 1.692 0 C-N-CA 124.19 0.996 . . . . 74.31 111.345 -171.473 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.675 0.274 . . . . 74.12 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 111' ' ' PHE . . . -89.27 -8.35 53.6 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.653 0.781 . . . . 64.35 111.221 176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -108.13 112.62 25.23 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.156 0.982 . . . . 64.34 108.969 172.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.3 mp -97.14 121.76 39.39 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.774 1.23 . . . . 74.33 109.936 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -117.6 113.64 22.24 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.789 -0.449 . . . . 74.15 109.789 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -120.95 135.49 55.19 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.005 0.922 . . . . 74.33 109.818 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.8 p -138.1 159.93 40.72 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.688 0.795 . . . . 63.43 111.301 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.1 p -155.6 150.89 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.611 0.364 . . . . 74.4 111.874 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -92.34 119.09 31.57 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.959 0.504 . . . . 52.43 110.025 172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 86.6 t -107.23 124.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.607 1.163 . . . . 70.35 109.82 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.76 71.68 4.25 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.569 0.7 . . . . 70.43 111.241 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.77 155.89 8.36 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.013 0.925 . . . . 75.0 110.909 -176.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.39 137.84 37.52 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.777 2.318 . . . . 75.21 112.261 175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.59 -46.69 10.15 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.233 1.568 . . . . 63.12 115.233 -177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.75 -45.58 92.02 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 112.421 0.526 . . . . 54.34 112.421 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.16 -39.36 86.12 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.674 0.789 . . . . 61.24 112.051 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 HD21 ' A' ' 137' ' ' LEU . 44.3 t -73.9 -34.35 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.501 0.72 . . . . 71.5 111.15 176.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.531 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 75.8 t-105 -67.66 -29.67 69.02 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.713 0.405 . . . . 74.32 111.558 177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.5 m -60.24 -30.86 69.69 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.635 0.731 . . . . 64.44 110.737 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 63.0 tp -83.5 -52.09 6.79 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 125.269 1.428 . . . . 71.24 112.143 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.31 -38.34 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 113.33 0.863 . . . . 62.1 113.33 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.58 -8.48 63.24 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 115.121 0.808 . . . . 74.45 115.121 -174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.99 113.92 26.34 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.612 -0.885 . . . . 60.31 108.612 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -60.15 -25.81 65.81 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.806 1.242 . . . . 60.12 113.303 -173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.5 p -96.7 -17.88 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.467 0.543 . . . . 73.3 112.467 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.77 15.42 4.8 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.196 0.598 . . . . 72.51 111.571 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 34' ' ' VAL . 20.2 tt -67.06 -24.9 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.365 0 C-N-CA 123.97 0.908 . . . . 72.34 111.88 -178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -64.55 -12.74 48.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 113.239 0.829 . . . . 73.43 113.239 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -84.35 -28.99 26.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 112.771 0.656 . . . . 71.3 112.771 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 48.0 p-90 -118.64 -35.49 3.71 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 123.034 0.534 . . . . 64.23 111.883 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.434 ' CE1' HE21 ' A' ' 33' ' ' GLN . 53.1 t-80 -90.88 107.8 23.33 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.596 0.758 . . . . 51.04 109.356 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -65.29 -19.06 62.05 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 123.293 2.662 . . . . 75.41 114.715 -171.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.434 HE21 ' CE1' ' A' ' 31' ' ' HIS . 5.0 mt-30 -96.77 0.67 49.8 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.02 0.748 . . . . 75.11 113.02 -171.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.538 HG21 HG12 ' A' ' 27' ' ' ILE . 60.7 t -78.56 117.71 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 120.817 0.342 . . . . 74.54 111.12 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 56.5 m -90.89 51.33 1.94 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.547 0.739 . . . . 55.01 111.915 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 58.9 99.81 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 C-N-CA 124.953 1.301 . . . . 42.52 113.147 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.65 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 97.9 Cg_endo -77.46 147.26 25.27 Favored 'Trans proline' 0 CA--C 1.561 1.837 0 C-N-CA 122.821 2.347 . . . . 62.25 114.779 -172.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 74.6 m -105.47 120.93 42.85 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.625 1.17 . . . . 74.14 109.152 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -92.86 127.64 38.44 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.269 0.557 . . . . 54.11 112.187 -170.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.598 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -115.33 123.36 48.52 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.077 0.951 . . . . 71.03 110.659 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.68 178.35 0.01 OUTLIER Glycine 0 CA--C 1.546 1.981 0 N-CA-C 117.308 1.683 . . . . 60.44 117.308 -170.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.26 -118.69 1.37 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 124.837 1.255 . . . . 70.1 112.967 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -175.24 162.3 2.27 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 124.122 0.969 . . . . 74.43 109.421 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -60.47 -5.29 4.08 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.798 2.332 . . . . 63.55 115.077 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -119.0 -10.43 9.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.729 -0.607 . . . . 73.53 112.195 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.8 m -98.73 122.0 54.45 Favored Pre-proline 0 N--CA 1.492 1.641 0 C-N-CA 123.097 0.559 . . . . 70.21 111.357 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -55.87 113.67 1.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.308 2.672 . . . . 72.43 112.909 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.05 -22.76 2.1 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.132 -0.485 . . . . 72.12 113.172 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.56 141.49 57.83 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.51 0.724 . . . . 55.22 112.725 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 38.8 mt-10 -114.5 115.97 28.08 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.195 0.598 . . . . 74.13 109.938 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 29.3 ptt180 -93.36 123.78 36.89 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.441 0.696 . . . . 60.12 110.099 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.4 t -119.04 108.28 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.238 0.615 . . . . 74.54 110.209 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -66.63 101.75 0.83 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.623 0.769 . . . . 73.14 112.374 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.53 -71.18 2.3 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 116.339 -0.391 . . . . 63.22 112.306 -177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 68.37 136.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.166 1.386 . . . . 42.21 112.926 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.13 19.67 64.43 Favored Glycine 0 N--CA 1.48 1.582 0 CA-C-O 121.437 0.465 . . . . 62.32 112.191 -175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 71.3 p -117.84 -160.21 0.77 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.545 1.538 . . . . 42.5 110.132 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -114.87 5.6 15.19 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.803 0.841 . . . . 71.05 110.527 168.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -126.92 9.97 6.96 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.823 0.849 . . . . 75.54 113.233 -168.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.28 144.31 44.65 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.016 0.747 . . . . 64.12 113.016 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.7 tp -120.71 126.11 49.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.375 1.07 . . . . 73.14 109.453 176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.39 115.33 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 122.975 0.51 . . . . 52.21 109.854 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 43.6 mt-10 -120.0 137.72 53.92 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.024 0.93 . . . . 73.41 110.162 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -118.4 133.65 55.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.297 0.639 . . . . 61.44 112.102 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.67 120.74 21.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.736 1.215 . . . . 70.1 111.133 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.72 -41.53 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.284 0.634 . . . . 73.21 111.256 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 10.7 tp10 -152.99 147.03 25.45 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.092 0.957 . . . . 71.54 110.145 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -146.67 123.44 11.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 122.687 0.395 . . . . 65.43 110.629 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -106.63 -177.66 3.43 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.967 0.907 . . . . 60.53 110.812 172.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 41.1 tt0 -147.95 -47.11 0.16 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.866 0.466 . . . . 71.21 110.706 172.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 78.8 p -64.31 -43.47 94.6 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.269 0.628 . . . . 60.15 111.186 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.09 -26.54 59.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.349 0.66 . . . . 62.14 112.512 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 60.28 59.45 2.31 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.853 0.861 . . . . 71.31 111.426 -171.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -139.31 122.75 17.22 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 123.766 0.826 . . . . 74.55 110.117 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 66.1 tp -124.27 109.01 12.84 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 124.21 1.004 . . . . 71.01 111.459 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 56.4 t -106.4 132.0 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.014 0.825 . . . . 75.13 111.28 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -152.84 179.73 8.39 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.103 0.561 . . . . 74.04 111.865 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.2 t -144.66 166.02 26.37 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.529 1.132 . . . . 73.23 111.054 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.646 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 75.7 mtm -99.84 99.38 8.91 Favored Pre-proline 0 CA--C 1.565 1.547 0 C-N-CA 123.373 0.669 . . . . 74.45 110.492 167.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 22.5 Cg_endo -62.13 -20.34 69.53 Favored 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 123.517 2.812 . . . . 65.24 112.748 167.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -126.75 81.18 69.42 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.972 0.509 . . . . 74.42 110.436 170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.32 123.35 1.02 Allowed 'Trans proline' 0 CA--C 1.565 2.031 0 C-N-CA 122.787 2.325 . . . . 73.34 112.774 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.98 27.11 0.6 Allowed 'Trans proline' 0 CA--C 1.565 2.046 0 C-N-CA 122.641 2.228 . . . . 71.25 113.156 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.44 147.27 61.58 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.391 1.077 . . . . 73.25 109.87 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 76.69 0.94 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.099 2.533 . . . . 74.51 113.23 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.746 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.1 pt -132.75 160.06 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 124.47 1.108 . . . . 75.21 109.953 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 23.8 m -103.27 -78.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 122.406 0.282 . . . . 70.14 111.41 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -105.02 100.37 9.96 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.998 0.519 . . . . 74.14 111.171 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -88.61 144.74 26.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.469 0.708 . . . . 42.35 112.826 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -137.33 158.04 45.29 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 72.44 109.592 168.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HB1' ' HE1' ' A' ' 107' ' ' TRP . . . -158.62 119.91 3.42 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.516 1.126 . . . . 71.22 109.111 178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 31.9 t -125.74 132.23 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 123.13 0.572 . . . . 75.31 112.449 -168.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.42 119.33 38.68 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.648 0.779 . . . . 73.53 109.3 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -130.45 114.03 15.03 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.961 0.504 . . . . 72.4 110.567 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.46 116.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.298 0.639 . . . . 71.12 110.36 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.9 m -113.42 123.04 34.01 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 123.902 0.881 . . . . 72.3 110.904 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.36 124.97 11.79 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.835 2.357 . . . . 70.2 113.483 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -109.24 -9.43 15.0 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.221 1.008 . . . . 61.23 112.143 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.695 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 34.9 t70 -175.87 167.9 3.05 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 125.157 1.383 . . . . 54.22 109.212 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.27 -39.3 66.74 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.045 0.938 . . . . 72.25 112.23 174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -131.81 38.95 3.51 Favored 'General case' 0 CA--C 1.556 1.205 0 CA-C-O 121.435 0.636 . . . . 71.12 110.377 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 77.9 m80 -148.95 135.6 19.61 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.293 1.037 . . . . 65.33 109.974 166.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' A' ' 17' ' ' VAL . 32.0 p -148.98 144.95 27.1 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.395 0.678 . . . . 72.42 110.681 177.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 78.7 m -93.35 116.96 29.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.151 0.58 . . . . 40.25 110.681 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 43.2 t -97.79 118.3 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.04 0.536 . . . . 44.54 109.669 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.8 117.37 54.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 123.605 0.762 . . . . 73.53 110.45 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.556 ' HE1' ' HB1' ' A' ' 91' ' ' ALA . 5.2 t90 -105.3 116.4 31.89 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 108.974 -0.75 . . . . 73.13 108.974 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -124.46 123.82 40.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.586 0.754 . . . . 63.41 111.371 -170.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 4' ' ' LEU . . . -106.93 141.03 38.8 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.871 0.868 . . . . 74.32 111.076 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -128.59 124.58 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.869 -0.789 . . . . 70.31 108.869 168.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.455 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 5.2 p90 -148.02 147.91 30.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.886 0.328 . . . . 53.42 111.886 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.605 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -84.18 86.83 7.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.365 0.602 . . . . 71.21 109.966 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.746 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.7 t -125.64 144.01 50.78 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.151 -0.931 . . . . 55.25 111.782 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.0 m -59.44 140.08 88.64 Favored Pre-proline 0 N--CA 1.487 1.385 0 C-N-CA 123.939 0.896 . . . . 70.32 111.516 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -56.83 -31.62 89.27 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.143 2.562 . . . . 74.2 114.171 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.09 -40.98 95.78 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.958 0.903 . . . . 61.54 112.013 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.556 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 24.3 m -88.11 -31.43 19.21 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.521 -0.763 . . . . 52.51 110.997 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -67.15 -40.17 86.67 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.737 0.815 . . . . 70.11 111.64 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -61.63 -33.64 74.29 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.427 0.691 . . . . 75.12 111.185 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 -36.19 63.12 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.562 1.145 . . . . 60.05 110.411 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 117' ' ' THR . 86.9 mt -74.42 -24.08 59.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 51.14 111.746 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 49.3 mt-10 -63.23 -35.11 79.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 120.96 0.41 . . . . 75.14 110.703 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.2 m -72.37 -56.64 5.12 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.271 0.628 . . . . 73.22 112.098 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.69 -54.45 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 112.432 0.531 . . . . 74.33 112.432 -173.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.8 mt -78.68 -51.07 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.033 0.533 . . . . 54.34 110.789 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.99 -49.13 69.47 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 114.68 0.632 . . . . 71.44 114.68 -175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 29.7 t70 -91.82 -52.68 4.62 Favored 'General case' 0 CA--C 1.553 1.072 0 O-C-N 121.85 -0.794 . . . . 70.23 111.212 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.54 -28.71 73.88 Favored Glycine 0 N--CA 1.476 1.362 0 N-CA-C 115.404 0.922 . . . . 54.33 115.404 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 63.8 t -105.55 -58.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.57 0.685 . . . . 62.13 110.543 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 3.5 m-30 -71.27 -64.96 0.81 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.07 0.548 . . . . 73.51 112.386 -170.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -59.58 -31.44 69.45 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.993 0.517 . . . . 73.23 112.079 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -58.03 -54.41 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.563 0.745 . . . . 71.02 111.93 171.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.68 -41.07 94.07 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.304 0.377 . . . . 74.23 113.025 -177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.01 -43.3 88.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.081 0.953 . . . . 74.21 112.084 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -69.67 -38.0 76.89 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 119.47 -0.3 . . . . 72.22 111.107 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.1 -35.84 81.6 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.136 0.493 . . . . 72.23 111.095 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.468 HD21 HG13 ' A' ' 17' ' ' VAL . 4.2 tt -66.58 -41.43 88.53 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 115.266 -0.879 . . . . 64.34 109.849 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.78 76.27 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.125 0.57 . . . . 53.25 112.352 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -72.24 -45.47 60.06 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.468 0.707 . . . . 75.21 111.574 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -65.38 -26.65 68.1 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 111.99 0.367 . . . . 70.34 111.99 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -98.84 -22.81 15.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.176 0.59 . . . . 62.0 112.316 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -68.01 -12.14 62.15 Favored Glycine 0 N--CA 1.481 1.665 0 O-C-N 122.157 -0.339 . . . . 71.52 113.821 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.87 -16.27 18.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.997 0.919 . . . . 75.32 113.24 -177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.0 pp -96.98 2.45 51.53 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.823 0.449 . . . . 74.34 112.191 176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 146' ' ' HIS . 28.8 tt0 -62.95 168.13 4.21 Favored 'General case' 0 CA--C 1.569 1.678 0 C-N-CA 123.887 0.875 . . . . 72.45 110.674 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.439 ' N ' ' HG2' ' A' ' 145' ' ' GLU . 56.5 t-80 -69.34 -6.16 27.95 Favored 'General case' 0 CA--C 1.565 1.528 0 O-C-N 121.745 -0.597 . . . . 71.34 111.646 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 66.0 78.53 0.26 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.127 1.371 . . . . 72.24 110.891 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -113.48 -106.82 0.38 Allowed 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 118.649 -0.691 . . . . 74.31 110.098 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.9 m80 56.56 26.58 11.2 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.603 0.964 . . . . 65.53 113.603 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -82.55 122.41 28.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 122.108 -0.37 . . . . 74.21 110.957 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 79.0 t60 . . . . . 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 63.04 111.225 -178.616 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.467 0.175 . . . . 72.14 110.663 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.54 9.27 39.24 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.429 0.692 . . . . 62.42 112.145 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.4 m -106.02 116.34 31.77 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.985 -0.746 . . . . 72.54 108.985 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.13 136.18 39.46 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.84 1.256 . . . . 75.12 109.298 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -133.9 130.33 37.64 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.201 0.524 . . . . 64.14 110.751 175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 6' ' ' ARG . 32.2 mmt-85 -138.07 153.68 49.3 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.501 1.12 . . . . 72.23 109.118 169.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 p -152.43 158.66 42.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.216 0.531 . . . . 64.13 111.443 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.9 p -149.82 152.49 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.12 0.968 . . . . 72.22 109.398 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.96 123.47 48.22 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.705 0.684 . . . . 74.43 110.486 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.2 t -97.12 136.35 28.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 125.344 1.458 . . . . 55.52 110.372 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.77 66.51 4.27 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.359 0.599 . . . . 50.21 111.199 174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.38 157.05 5.62 Favored Pre-proline 0 N--CA 1.482 1.172 0 C-N-CA 124.327 1.051 . . . . 72.31 111.023 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.92 140.96 68.87 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.95 2.433 . . . . 73.42 112.199 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.52 23.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.604 1.335 . . . . 54.42 114.604 -176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.46 -46.51 82.77 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.483 0.713 . . . . 71.23 112.3 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.55 -37.51 86.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.387 0.675 . . . . 55.41 112.358 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG13 HD21 ' A' ' 137' ' ' LEU . 25.8 t -70.49 -36.76 67.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.528 -0.76 . . . . 72.12 110.645 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -70.89 -28.32 64.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.786 0.834 . . . . 71.23 111.408 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.4 m -63.61 -29.76 70.97 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.157 0.503 . . . . 75.31 111.028 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.4 tp -80.09 -51.06 9.47 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 124.007 0.923 . . . . 64.33 112.047 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.49 -18.71 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 113.647 0.981 . . . . 55.15 113.647 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.23 -35.05 91.48 Favored Glycine 0 N--CA 1.482 1.758 0 C-N-CA 123.248 0.451 . . . . 71.43 113.221 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -82.15 97.96 8.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.321 -0.992 . . . . 60.43 108.321 165.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -75.61 -7.1 53.39 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 121.274 0.559 . . . . 54.41 112.311 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -70.4 -33.64 71.61 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.409 0.623 . . . . 64.21 110.628 164.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.482 ' HB1' ' NE ' ' A' ' 29' ' ' ARG . . . -87.5 16.39 5.55 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.26 1.024 . . . . 64.43 111.722 -167.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.529 HG12 HG21 ' A' ' 34' ' ' VAL . 19.9 tt -64.89 -22.63 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.362 0 C-N-CA 123.798 0.839 . . . . 71.04 111.667 176.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -69.87 -9.19 53.95 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.032 0.753 . . . . 73.31 113.032 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' NE ' ' HB1' ' A' ' 26' ' ' ALA . 75.7 mtm180 -88.92 -37.45 15.26 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.108 0.563 . . . . 74.2 111.919 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 58.5 p-90 -109.52 -39.13 5.26 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.613 0.597 . . . . 75.54 112.613 -171.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 60.8 t-80 -86.74 115.79 63.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 108.789 -0.819 . . . . 72.24 108.789 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -70.05 -19.79 34.28 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.882 2.388 . . . . 73.03 114.412 -165.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' CE1' ' A' ' 31' ' ' HIS . 2.5 mt-30 -98.81 -4.93 32.12 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.621 0.971 . . . . 75.34 113.621 -169.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.529 HG21 HG12 ' A' ' 27' ' ' ILE . 63.0 t -67.14 128.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 111.906 0.335 . . . . 75.23 111.906 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.6 m -83.52 27.32 0.61 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.25 1.02 . . . . 74.22 112.881 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 60.87 107.82 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 125.011 1.324 . . . . 41.11 112.054 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.752 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 45.1 Cg_endo -85.7 154.05 10.23 Favored 'Trans proline' 0 CA--C 1.556 1.616 0 C-N-CA 122.295 1.997 . . . . 71.12 114.489 -174.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.8 m -112.47 124.95 53.65 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.58 0.752 . . . . 64.2 109.984 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.2 mm? -91.2 138.49 31.55 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.385 0.674 . . . . 72.03 112.345 -168.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -118.42 123.11 44.43 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.335 1.054 . . . . 73.2 109.022 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.05 176.95 0.01 OUTLIER Glycine 0 CA--C 1.547 2.091 0 N-CA-C 117.363 1.705 . . . . 61.44 117.363 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 53.82 -122.43 1.99 Allowed 'General case' 0 CA--C 1.571 1.759 0 C-N-CA 124.341 1.056 . . . . 33.53 113.085 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p -168.95 164.0 7.48 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 123.848 0.859 . . . . 61.14 109.578 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.91 -24.18 30.6 Favored 'Trans proline' 0 C--N 1.387 2.573 0 C-N-CA 123.032 2.488 . . . . 74.31 114.415 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -94.12 -44.99 7.75 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.194 0.597 . . . . 74.43 110.892 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.2 m -67.72 119.05 63.39 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.683 0.793 . . . . 61.01 112.644 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -53.88 113.75 1.47 Allowed 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.428 2.752 . . . . 42.44 113.14 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.28 -26.22 2.46 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.878 -0.601 . . . . 75.54 112.594 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -65.42 137.31 57.38 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.637 0.606 . . . . 64.52 112.637 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 51.3 mt-10 -118.13 118.92 33.19 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.086 0.555 . . . . 72.12 110.671 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.752 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -106.98 134.28 50.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.084 0.468 . . . . 72.42 110.909 -177.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' A' ' 55' ' ' ALA . 20.4 t -115.27 103.35 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 C-N-CA 123.593 0.757 . . . . 74.2 110.581 -173.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -61.76 99.95 0.13 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.476 1.11 . . . . 74.24 111.649 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.68 53.7 6.36 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 123.224 0.327 . . . . 53.43 112.892 -177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -65.43 90.44 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.065 0.459 . . . . 54.5 111.762 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 145.19 38.4 0.06 OUTLIER Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.819 -0.628 . . . . 44.42 112.25 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 59' ' ' GLU . 15.0 t -138.36 -162.53 1.32 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.173 0.989 . . . . 70.4 110.172 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -111.9 15.71 20.67 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.345 0.658 . . . . 75.4 112.263 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 57' ' ' THR . 11.0 pt-20 -168.51 40.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.3 0.852 . . . . 72.33 113.3 -172.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -77.37 156.4 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.22 0.608 . . . . 71.44 112.163 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -107.95 120.92 43.66 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.724 0.809 . . . . 50.1 110.625 -176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.75 121.95 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.841 0.456 . . . . 74.44 110.202 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 47.5 mt-10 -118.26 139.01 51.97 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.788 0.835 . . . . 71.01 110.776 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 50' ' ' GLU . 10.4 tpp180 -103.85 130.7 51.44 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.962 0.905 . . . . 71.44 109.69 174.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.73 120.88 26.92 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.038 0.535 . . . . 63.12 110.151 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.4 t -91.25 -45.88 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.28 0.632 . . . . 65.13 112.296 -172.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 35.4 tt0 -159.69 157.48 29.63 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.221 0.609 . . . . 72.24 110.858 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -148.04 131.88 17.06 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.237 0.615 . . . . 71.33 109.968 171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -124.4 116.4 22.5 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.69 0.796 . . . . 63.15 109.868 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.08 13.47 33.98 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.244 0.617 . . . . 50.53 112.495 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.2 t -94.31 -46.6 6.98 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.22 0.533 . . . . 65.11 110.159 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -109.24 8.56 25.81 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.64 0.776 . . . . 52.03 111.834 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER 56.63 67.44 0.99 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.088 0.955 . . . . 72.12 112.136 175.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -135.96 110.29 8.44 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.852 0.861 . . . . 64.53 111.328 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 54.5 tp -107.19 108.76 20.35 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.757 1.223 . . . . 65.04 110.844 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 38.3 t -104.2 130.24 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 123.381 0.672 . . . . 74.31 111.069 -175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.47 -178.9 6.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.431 0.692 . . . . 73.35 111.573 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.476 ' HB ' ' NH1' ' A' ' 90' ' ' ARG . 6.0 t -149.88 162.44 40.32 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.327 1.051 . . . . 74.45 110.741 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 52.8 mtp -111.55 93.17 18.62 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.077 0.951 . . . . 63.52 109.862 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.528 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 56.0 Cg_endo -67.82 -20.92 45.19 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.442 2.761 . . . . 62.44 112.732 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.87 77.79 57.64 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.734 0.814 . . . . 71.43 109.944 172.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 63.9 Cg_endo -88.72 143.55 5.19 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.892 2.394 . . . . 75.2 113.296 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 6.7 Cg_exo -77.13 1.53 8.6 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.878 2.385 . . . . 74.33 113.159 173.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.0 147.44 44.45 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 123.787 0.835 . . . . 61.11 111.05 -173.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' HG2' HG21 ' A' ' 117' ' ' THR . 73.9 Cg_endo -73.1 80.95 1.77 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.695 2.263 . . . . 64.05 112.81 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.697 HG22 ' HB2' ' A' ' 113' ' ' CYS . 20.1 pt -133.41 133.03 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 C-N-CA 124.263 1.025 . . . . 71.11 110.301 -177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m -74.55 -78.08 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.798 0.439 . . . . 62.43 111.253 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -105.76 108.62 20.23 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 121.978 -0.451 . . . . 52.04 110.342 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -87.98 142.82 27.49 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.344 0.658 . . . . 51.22 111.356 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.476 ' NH1' ' HB ' ' A' ' 78' ' ' THR . 6.0 tpp180 -149.39 114.25 5.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.473 0.709 . . . . 74.3 109.433 174.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.42 50.98 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 118.355 0.525 . . . . 35.42 112.006 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 49.6 t -136.65 141.22 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 124.224 1.01 . . . . 53.21 111.261 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 3.4 mm? -98.1 140.26 32.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.282 -1.007 . . . . 63.54 108.282 165.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 35.0 tt0 -142.89 110.13 5.67 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.503 0.592 . . . . 60.43 110.716 174.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.5 t -94.03 108.95 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 65.54 108.872 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.4 119.93 54.74 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 123.644 0.778 . . . . 42.42 109.931 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.83 83.05 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.441 2.094 . . . . 65.04 112.249 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -68.22 -32.4 72.58 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.811 0.844 . . . . 63.4 110.202 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.7 t70 -147.92 165.25 31.24 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.11 1.364 . . . . 74.45 109.461 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.64 -47.0 85.88 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.279 1.032 . . . . 73.53 111.901 -178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -113.3 10.94 18.52 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.722 0.809 . . . . 73.54 112.205 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 37.2 m80 -137.59 118.63 14.37 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 118.984 0.811 . . . . 60.31 110.206 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 79.0 m -136.08 133.83 37.75 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.843 0.457 . . . . 60.32 111.313 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 24.9 m -92.54 114.81 27.46 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.142 0.577 . . . . 71.42 111.88 -172.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.6 t -92.3 109.38 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.251 0.621 . . . . 65.21 109.552 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.18 113.1 36.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 123.873 0.869 . . . . 74.41 109.647 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -102.63 120.27 40.27 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 108.857 -0.794 . . . . 71.1 108.857 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.7 m -123.48 141.58 51.86 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.037 0.935 . . . . 63.04 110.426 -175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.63 110.18 5.76 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.303 0.573 . . . . 72.35 111.508 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -109.54 125.78 52.87 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.528 1.131 . . . . 62.42 109.161 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -139.35 154.23 47.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.714 0.806 . . . . 72.43 110.596 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 32.7 t70 -86.73 83.76 7.51 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.385 0.612 . . . . 64.53 110.093 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.697 ' HB2' HG22 ' A' ' 86' ' ' ILE . 50.1 t -125.37 156.33 38.92 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 115.641 -0.709 . . . . 64.03 111.754 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -65.36 132.92 95.29 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 123.487 0.715 . . . . 64.13 111.158 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.23 -38.97 20.68 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.83 3.02 . . . . 71.01 115.472 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.4 -32.43 74.05 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.347 0.659 . . . . 71.33 112.127 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.516 HG21 ' HG2' ' A' ' 85' ' ' PRO . 29.5 m -87.49 -29.07 21.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.824 0.45 . . . . 73.34 110.779 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -31.41 70.99 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.321 0.648 . . . . 61.11 111.931 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -66.92 -28.08 68.01 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.453 0.701 . . . . 74.31 111.94 174.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.78 -45.43 61.63 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.567 0.747 . . . . 72.14 110.028 171.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 117' ' ' THR . 78.3 mt -74.41 -31.63 62.39 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 115.47 -0.786 . . . . 65.33 113.045 -171.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.96 -34.56 78.26 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.159 0.436 . . . . 73.04 111.304 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 42.6 t -70.6 -59.87 2.59 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.104 0.562 . . . . 65.42 112.117 171.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.11 -55.55 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.266 0.626 . . . . 72.31 112.421 -172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 121' ' ' LEU . 63.2 mt -76.64 -47.97 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 53.51 110.666 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -61.3 -66.19 2.81 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 114.765 0.666 . . . . 74.3 114.765 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.59 -41.22 12.12 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.834 -0.804 . . . . 63.13 111.461 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.49 -22.32 79.02 Favored Glycine 0 CA--C 1.542 1.734 0 N-CA-C 115.228 0.851 . . . . 60.04 115.228 -174.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.73 -55.04 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-N 117.683 0.742 . . . . 72.35 111.358 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 13.2 m-30 -70.31 -56.37 6.88 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 112.226 0.454 . . . . 74.34 112.226 -173.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.27 -32.56 68.52 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 123.385 0.428 . . . . 71.41 111.525 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.9 t -59.06 -51.18 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 C-N-CA 123.951 0.901 . . . . 52.33 112.263 172.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 32' ' ' PRO . . . -69.56 -34.88 73.95 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 116.607 -0.269 . . . . 64.31 113.633 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.25 -41.65 73.23 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.128 0.971 . . . . 63.32 111.554 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.64 -40.65 84.58 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.348 -0.387 . . . . 64.11 110.112 176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.73 76.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.766 0.827 . . . . 50.42 111.706 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.449 HD21 HG13 ' A' ' 17' ' ' VAL . 5.4 tt -65.13 -39.02 92.47 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 115.419 -0.809 . . . . 73.24 110.082 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.26 -28.83 64.43 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 123.055 0.542 . . . . 70.14 112.289 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -67.7 -45.65 74.53 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.998 0.919 . . . . 74.22 112.099 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.43 HH11 ' HA ' ' A' ' 137' ' ' LEU . 8.8 ptp85 -71.33 -25.52 62.44 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.098 0.559 . . . . 75.22 112.498 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -93.94 -5.44 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.961 0.505 . . . . 72.43 111.009 170.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.03 5.38 26.08 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 122.847 0.261 . . . . 65.12 113.749 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -51.88 -24.27 6.04 Favored 'General case' 0 CA--C 1.564 1.493 0 C-N-CA 125.47 1.508 . . . . 74.4 113.693 174.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.4 -28.22 69.09 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.706 0.802 . . . . 71.42 112.543 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 146' ' ' HIS . 7.0 pt-20 -139.6 -62.33 0.53 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.509 0.724 . . . . 64.34 111.074 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.471 ' H ' ' HG3' ' A' ' 145' ' ' GLU . 0.7 OUTLIER 49.65 71.63 0.38 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.423 1.489 . . . . 70.45 112.173 -174.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -66.19 103.12 0.92 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.728 -0.669 . . . . 64.02 109.76 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 63.02 -177.51 0.15 Allowed 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 124.566 1.146 . . . . 75.33 111.615 -168.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -80.6 -81.47 0.13 Allowed 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.762 -0.586 . . . . 74.34 110.359 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 50.2 64.66 1.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.423 1.089 . . . . 72.45 111.83 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 . . . . . 0 N--CA 1.495 1.776 0 C-N-CA 124.803 1.241 . . . . 75.2 112.481 -171.133 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.837 0.351 . . . . 71.05 111.746 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.99 13.78 24.47 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.816 0.846 . . . . 74.52 111.133 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.518 HG23 ' HB3' ' A' ' 110' ' ' MET . 23.5 m -107.55 110.15 21.99 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.765 0.826 . . . . 72.41 109.177 175.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -94.82 134.52 37.35 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.042 0.937 . . . . 73.21 109.022 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -136.81 137.24 39.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.811 0.444 . . . . 72.44 110.35 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.754 HH11 ' HB2' ' A' ' 131' ' ' ALA . 10.5 ttm180 -147.86 152.1 37.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.201 0.6 . . . . 72.3 109.944 175.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.6 p -141.22 166.38 24.94 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.091 0.472 . . . . 74.41 111.907 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.9 p -152.15 148.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.717 0.807 . . . . 70.14 110.425 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -93.83 112.08 23.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.236 0.541 . . . . 73.3 109.722 168.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 137' ' ' LEU . 88.8 t -91.02 127.9 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.429 1.092 . . . . 71.24 109.762 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 71.16 3.3 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 121.618 0.723 . . . . 71.32 111.541 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.34 151.63 4.62 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.474 1.109 . . . . 72.31 110.247 -177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.42 140.73 58.9 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.323 2.015 . . . . 51.54 112.257 170.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.06 -35.49 11.32 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.505 1.668 . . . . 74.2 115.505 -172.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.19 -48.25 80.88 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.537 0.569 . . . . 73.11 112.537 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.39 -36.24 75.44 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.583 0.753 . . . . 72.41 112.05 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG13 HD21 ' A' ' 137' ' ' LEU . 36.2 t -72.84 -36.65 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 123.518 0.727 . . . . 71.01 110.631 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.573 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 61.3 t-105 -69.03 -33.5 73.72 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.618 0.767 . . . . 73.24 112.032 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.5 m -65.03 -20.1 66.32 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.563 0.697 . . . . 74.53 111.317 174.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.452 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.2 tp -89.9 -52.67 4.86 Favored 'General case' 0 CA--C 1.564 1.489 0 C-N-CA 124.001 0.921 . . . . 74.21 112.06 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.5 m -81.08 -48.45 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 112.867 0.692 . . . . 65.14 112.867 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.06 65.7 Favored Glycine 0 N--CA 1.479 1.522 0 N-CA-C 115.172 0.829 . . . . 74.31 115.172 -174.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.44 -18.1 60.69 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.065 0.546 . . . . 72.24 111.477 168.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.9 t80 73.64 -66.03 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.785 1.634 . . . . 73.12 112.105 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.3 p -67.7 -14.34 62.86 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.994 0.918 . . . . 45.22 113.182 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.17 9.77 18.95 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.67 0.788 . . . . 72.11 111.674 -175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG23 HG11 ' A' ' 34' ' ' VAL . 19.9 tt -61.23 -31.15 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 N-CA-C 112.76 0.652 . . . . 54.44 112.76 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -70.47 -5.78 31.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 113.075 0.768 . . . . 73.02 113.075 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -91.45 -19.86 22.38 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.453 0.701 . . . . 74.31 112.495 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 60.0 p-90 -121.31 -30.6 4.25 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.037 0.535 . . . . 73.23 111.719 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -93.63 103.75 10.85 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.384 0.674 . . . . 75.44 109.815 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.14 -15.92 52.56 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.238 2.626 . . . . 72.33 115.21 -172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' A' ' 129' ' ' VAL . 27.5 mt-30 -85.07 -28.66 25.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.885 0.474 . . . . 64.14 111.446 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 27' ' ' ILE . 49.1 t -78.7 113.57 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 110.218 -0.29 . . . . 61.3 110.218 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 m -73.58 -62.4 1.5 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.285 0.634 . . . . 44.25 110.399 176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.62 116.01 0.59 Allowed Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 124.386 1.075 . . . . 63.43 110.189 173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.39 144.71 8.02 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.463 2.109 . . . . 73.33 113.381 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -95.91 126.7 41.34 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.193 0.997 . . . . 62.11 109.804 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 50' ' ' GLU . 9.5 mp -110.03 145.75 36.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.648 0.737 . . . . 65.21 111.42 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -149.85 147.04 27.48 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.486 -1.234 . . . . 72.32 110.246 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.5 153.38 0.0 OUTLIER Glycine 0 CA--C 1.555 2.585 0 N-CA-C 117.687 1.835 . . . . 62.3 117.687 -167.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 72.9 -50.54 0.71 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.837 1.655 . . . . 65.33 115.312 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.6 m 102.12 147.51 0.02 OUTLIER Pre-proline 0 N--CA 1.516 2.863 0 C-N-CA 127.709 2.404 . . . . 63.41 111.869 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.69 -38.53 46.27 Favored 'Trans proline' 0 C--N 1.395 2.976 0 C-N-CA 124.427 3.418 . . . . 63.33 115.549 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -90.99 10.53 26.22 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.351 0.5 . . . . 73.0 112.351 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -123.75 119.13 26.99 Favored Pre-proline 0 N--CA 1.487 1.382 0 C-N-CA 123.833 0.853 . . . . 42.04 110.536 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 129.22 31.08 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.335 2.69 . . . . 65.45 113.807 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.02 -10.5 13.59 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.392 0.52 . . . . 71.54 112.96 -175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.07 154.69 40.96 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.376 0.67 . . . . 70.43 111.95 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 50.6 mt-10 -112.79 128.81 56.54 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.938 0.495 . . . . 72.05 111.602 176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -107.41 102.86 12.11 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.651 0.78 . . . . 73.2 109.554 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.1 t -106.7 104.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-O 121.313 0.577 . . . . 63.32 111.353 -170.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HD1' HG13 ' A' ' 34' ' ' VAL . 66.0 m-85 -75.34 82.68 2.45 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.307 1.043 . . . . 70.42 111.264 -178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.05 -63.11 0.58 Allowed Glycine 0 N--CA 1.478 1.449 0 CA-C-N 116.042 -0.526 . . . . 60.41 112.3 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 72.77 -53.23 0.7 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.079 1.751 . . . . 73.32 115.318 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.83 37.56 3.32 Favored Glycine 0 N--CA 1.487 2.065 0 CA-C-O 121.234 0.352 . . . . 75.04 112.932 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.7 p -120.63 -165.75 1.24 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.274 1.029 . . . . 42.44 110.62 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -122.77 27.41 7.77 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.952 0.901 . . . . 63.31 109.701 167.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -146.17 9.54 1.11 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.205 1.002 . . . . 51.23 111.913 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.51 152.21 39.4 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.367 0.604 . . . . 54.02 112.498 -173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.545 HD11 ' SD ' ' A' ' 79' ' ' MET . 29.2 tp -107.22 119.92 40.71 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.102 0.961 . . . . 72.44 109.224 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.755 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 94.5 t -95.99 114.34 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.283 0.563 . . . . 72.33 109.482 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 17.1 tt0 -115.24 167.88 10.45 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.445 1.098 . . . . 54.24 109.898 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.436 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 30.3 ttm-85 -150.82 128.88 11.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.126 0.97 . . . . 54.44 111.736 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -67.79 129.2 39.19 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.951 0.9 . . . . 63.12 111.123 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.595 HG21 HH11 ' A' ' 90' ' ' ARG . 79.0 t -101.29 -51.13 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.772 0.829 . . . . 75.24 111.384 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -149.72 148.73 29.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.372 1.069 . . . . 70.15 109.136 177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -140.02 119.6 13.19 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.966 -0.383 . . . . 73.54 109.966 174.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 24.5 m-20 -101.09 102.45 13.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.525 1.13 . . . . 72.24 109.773 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 31.4 tt0 -75.74 -41.14 54.13 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 122.26 -0.275 . . . . 74.41 111.008 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.9 m -68.76 -50.05 53.71 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.36 0.664 . . . . 62.54 111.146 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -78.49 -6.14 54.55 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.983 0.734 . . . . 55.21 112.983 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 63.43 45.2 4.95 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.74 1.216 . . . . 74.53 111.945 170.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 43.1 ttm105 -129.39 135.36 48.61 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.913 1.285 . . . . 75.12 110.455 -175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 46.0 tp -125.43 106.15 9.59 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.043 0.537 . . . . 51.35 110.745 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.6 t -105.7 126.11 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 123.693 0.797 . . . . 74.25 110.519 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -146.57 179.51 7.5 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.426 0.69 . . . . 71.13 112.043 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.1 m -156.56 142.24 17.75 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.955 1.302 . . . . 71.53 109.74 -169.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.545 ' SD ' HD11 ' A' ' 61' ' ' LEU . 57.3 mtm -95.87 98.79 4.19 Favored Pre-proline 0 CA--C 1.562 1.427 0 CA-C-N 118.234 0.47 . . . . 61.14 109.79 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.82 -25.03 17.31 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.375 2.717 . . . . 51.22 112.901 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.755 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.7 t70 -129.59 80.04 72.55 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.464 0.706 . . . . 74.11 109.489 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -93.36 133.47 0.94 Allowed 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 122.964 2.443 . . . . 54.05 112.761 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.479 ' HD2' HD13 ' A' ' 61' ' ' LEU . 71.7 Cg_endo -72.27 -2.03 11.05 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.203 1.935 . . . . 71.42 112.073 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -80.84 140.77 50.71 Favored Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 124.454 1.102 . . . . 71.43 109.924 170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.24 77.76 2.77 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.476 2.117 . . . . 73.24 112.889 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.561 HD12 ' HB2' ' A' ' 89' ' ' HIS . 7.4 pt -138.94 143.99 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 124.661 1.184 . . . . 72.31 110.412 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.1 m -72.17 -47.45 50.78 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.344 0.868 . . . . 75.25 113.344 -170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -131.97 -49.66 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.266 0.469 . . . . 52.34 112.266 -171.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.561 ' HB2' HD12 ' A' ' 86' ' ' ILE . 47.9 t-80 65.35 145.02 0.03 OUTLIER 'General case' 0 CA--C 1.564 1.49 0 C-N-CA 125.417 1.487 . . . . 75.04 113.736 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.595 HH11 HG21 ' A' ' 66' ' ' VAL . 21.4 tpp180 -147.08 149.01 32.2 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.732 1.213 . . . . 74.13 108.347 168.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.7 146.44 20.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.968 0.507 . . . . 74.1 111.74 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.5 p -137.23 140.28 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.376 0 N-CA-C 113.106 0.78 . . . . 74.03 113.106 -174.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -107.62 108.48 19.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.504 1.121 . . . . 52.24 108.691 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -121.0 111.65 17.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.089 -0.708 . . . . 74.04 109.089 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.32 110.79 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 108.709 -0.849 . . . . 73.32 108.709 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.39 123.8 61.22 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.15 0.98 . . . . 64.22 109.928 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.64 137.31 41.94 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.448 2.099 . . . . 74.44 111.974 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.605 HH11 ' HB2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -138.05 -34.52 0.66 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.162 0.585 . . . . 64.25 111.403 -172.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.4 t70 -163.65 159.47 21.68 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.178 0.991 . . . . 53.11 110.01 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -54.5 -31.16 55.42 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.897 1.279 . . . . 73.23 113.092 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -140.18 26.69 2.19 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.167 0.587 . . . . 75.13 110.373 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.9 m80 -147.94 111.18 4.9 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.045 0.938 . . . . 73.41 109.32 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 72.6 m -133.76 137.02 44.95 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.241 0.616 . . . . 62.22 110.824 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.8 m -94.71 114.09 25.96 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.102 0.561 . . . . 71.2 112.231 -170.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.9 t -88.78 122.38 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 109.742 -0.466 . . . . 71.12 109.742 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.83 115.31 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 109.168 -0.678 . . . . 71.32 109.168 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.9 123.31 49.38 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.449 HG22 ' SD ' ' A' ' 110' ' ' MET . 91.8 m -130.58 135.37 47.83 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.732 0.813 . . . . 62.23 110.382 -174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.478 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.75 115.13 15.59 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.84 0.856 . . . . 65.55 110.761 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.518 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -121.56 132.89 54.95 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.714 1.206 . . . . 73.2 109.871 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -145.46 147.81 32.6 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.31 0.644 . . . . 74.23 111.878 -171.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.86 87.57 5.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.235 -0.654 . . . . 72.35 109.235 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 42.0 t -143.5 167.5 22.07 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.808 0.67 . . . . 63.53 112.808 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.41 ' N ' ' SG ' ' A' ' 113' ' ' CYS . 49.7 m -70.13 142.23 89.91 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.316 1.046 . . . . 65.42 112.435 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -50.47 -40.3 54.15 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.473 2.782 . . . . 73.34 114.724 174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -59.74 -31.56 69.75 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.063 0.945 . . . . 73.32 112.764 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.524 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -89.9 -29.93 18.22 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.41 0.684 . . . . 52.13 111.113 176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.13 77.27 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.622 0.769 . . . . 70.12 112.198 -177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -68.33 -36.56 79.45 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.031 0.932 . . . . 75.4 111.988 173.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -64.58 -49.17 72.24 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.402 0.681 . . . . 74.3 109.895 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.6 mt -71.97 -23.67 61.47 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.931 -1.031 . . . . 65.22 111.352 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.19 -48.66 79.63 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.582 0.753 . . . . 75.2 110.817 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.7 m -69.23 -53.25 20.86 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 115.593 -0.731 . . . . 65.13 112.665 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.2 t -64.7 -53.85 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 112.53 0.567 . . . . 74.41 112.53 -174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.4 -48.18 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.131 0.572 . . . . 73.33 111.125 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.52 -52.39 35.27 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 114.629 0.611 . . . . 32.25 114.629 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.31 -44.63 10.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 122.062 -0.67 . . . . 74.4 112.033 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.89 -47.51 54.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 116.071 -0.513 . . . . 72.23 113.876 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.439 ' HA ' HE22 ' A' ' 33' ' ' GLN . 96.4 t -91.44 -53.24 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.96 0.504 . . . . 71.51 111.631 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.1 m-30 -75.65 -56.92 4.22 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.321 0.489 . . . . 74.23 112.321 -171.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.754 ' HB2' HH11 ' A' ' 6' ' ' ARG . . . -55.93 -38.55 70.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.949 0.404 . . . . 44.14 111.768 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.8 t -65.78 -54.45 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.464 0 C-N-CA 123.455 0.702 . . . . 70.24 112.347 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.76 -48.98 71.81 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 113.851 0.3 . . . . 64.41 113.851 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 93.4 mt -61.57 -42.89 99.51 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.361 1.065 . . . . 75.22 112.473 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 139' ' ' GLU . 92.4 m-20 -70.01 -39.72 75.67 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 119.726 -0.178 . . . . 65.03 110.931 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.88 -35.94 79.82 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.103 0.561 . . . . 75.5 111.234 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.442 HD21 HG13 ' A' ' 17' ' ' VAL . 4.8 tt -65.49 -38.25 89.21 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.454 0.702 . . . . 74.41 110.324 175.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.69 68.05 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.939 0.496 . . . . 53.24 111.918 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 135' ' ' ASN . 18.7 mm-40 -69.39 -42.88 74.53 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.446 0.699 . . . . 72.13 111.724 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -68.13 -28.92 67.73 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 122.601 0.36 . . . . 74.42 111.936 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -97.53 6.64 47.81 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.809 0.444 . . . . 71.14 111.828 172.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -65.27 12.46 0.28 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 116.434 1.334 . . . . 72.22 116.434 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -56.47 131.07 47.49 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.789 0.836 . . . . 74.11 110.934 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.2 mt 55.26 43.72 28.69 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.096 0.958 . . . . 70.54 111.977 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.49 137.1 58.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.668 1.187 . . . . 74.42 111.507 177.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -142.01 109.03 5.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.236 1.014 . . . . 71.45 109.895 175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -68.37 107.76 2.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.87 0.468 . . . . 62.23 110.364 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -120.29 12.95 11.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.823 0.449 . . . . 74.21 111.033 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -65.1 -47.26 77.83 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.823 0.849 . . . . 73.52 111.989 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -79.45 -29.33 41.74 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.902 0.481 . . . . 63.44 111.912 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.3 p80 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 121.421 0.629 . . . . 73.05 111.095 179.086 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.989 0.424 . . . . 63.22 110.794 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.21 89.19 3.01 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.51 0.724 . . . . 74.54 109.811 177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.515 HG23 ' HB3' ' A' ' 110' ' ' MET . 58.1 m -131.7 121.25 23.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.649 0.779 . . . . 62.53 110.01 -175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.75 111.47 23.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.622 1.169 . . . . 73.04 110.027 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -104.74 120.54 41.62 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.827 -0.805 . . . . 73.24 108.827 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -132.24 135.82 46.55 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.741 -0.466 . . . . 73.21 109.741 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.6 p -141.42 159.59 41.91 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.02 0.528 . . . . 61.14 112.294 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.9 p -147.27 141.28 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 123.777 0.831 . . . . 73.21 110.62 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -99.1 111.03 23.53 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.609 0.719 . . . . 71.34 110.276 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 137' ' ' LEU . 66.1 t -102.44 145.45 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 125.573 1.549 . . . . 72.32 112.1 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.521 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -79.66 59.74 3.13 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 124.031 0.932 . . . . 65.23 112.391 173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.98 141.64 6.55 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 123.349 0.659 . . . . 71.4 111.15 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.15 138.11 65.22 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.972 2.448 . . . . 44.12 113.382 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.4 -46.46 13.29 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.8 1.778 . . . . 52.01 115.8 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.18 -41.02 90.82 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.521 0.563 . . . . 72.2 112.521 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.82 -30.44 68.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 112.474 0.546 . . . . 65.04 112.474 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' SG ' ' A' ' 103' ' ' CYS . 83.5 t -70.66 -35.44 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 122.783 0.433 . . . . 64.3 110.679 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -67.37 -27.6 67.25 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.778 0.431 . . . . 74.4 111.295 173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.3 m -63.85 -26.4 68.6 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.316 0.579 . . . . 63.42 111.529 171.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 30' ' ' TRP . 54.6 tp -84.16 -56.83 3.45 Favored 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.486 1.114 . . . . 41.14 112.47 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.47 -21.61 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.727 1.01 . . . . 74.53 113.727 -176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -64.48 -50.37 59.73 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.526 0.516 . . . . 71.54 114.111 -170.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.67 127.79 34.32 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 109.209 -0.663 . . . . 51.23 109.209 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -62.68 -30.04 71.09 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.357 1.063 . . . . 74.12 112.491 -169.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.9 p -99.27 0.84 43.92 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.487 0.715 . . . . 71.01 112.476 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -89.94 8.88 30.07 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 123.199 0.6 . . . . 72.53 111.837 -174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.685 HG21 ' NH2' ' A' ' 51' ' ' ARG . 19.9 tt -65.8 -30.83 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.597 1.159 . . . . 72.42 113.208 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -66.11 -9.48 31.63 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.701 0.63 . . . . 73.32 112.701 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 69.8 mtp180 -83.87 -14.88 50.07 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.936 0.895 . . . . 74.12 112.354 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 51.7 p-90 -130.28 -40.83 1.27 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 112.77 0.656 . . . . 72.32 112.77 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.469 ' CE1' HE21 ' A' ' 33' ' ' GLN . 32.7 t-80 -85.79 113.17 49.92 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.073 0.549 . . . . 74.15 110.519 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -18.89 31.08 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.212 2.608 . . . . 53.34 114.525 -171.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.469 HE21 ' CE1' ' A' ' 31' ' ' HIS . 4.2 mt-30 -94.69 -13.04 26.18 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.81 0.67 . . . . 64.34 112.81 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.452 HG23 ' ND1' ' A' ' 31' ' ' HIS . 90.9 t -73.12 114.38 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 121.072 0.463 . . . . 74.15 110.26 173.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -92.93 35.95 1.04 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.395 1.078 . . . . 63.31 111.64 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.03 115.32 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 C-N-CA 125.603 1.561 . . . . 62.22 112.483 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HG3' ' HE ' ' A' ' 51' ' ' ARG . 26.3 Cg_endo -95.71 177.99 0.7 Allowed 'Trans proline' 0 CA--C 1.563 1.956 0 C-N-CA 123.381 2.721 . . . . 61.0 114.703 176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.1 m -119.42 132.34 55.8 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.322 1.049 . . . . 52.43 110.451 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.2 136.34 37.86 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.454 0.645 . . . . 73.43 111.416 -176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 28.5 mmt180 -121.74 145.05 48.42 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.512 1.125 . . . . 65.14 110.294 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 49.04 119.71 0.0 OUTLIER Glycine 0 CA--C 1.556 2.611 0 N-CA-C 117.613 1.805 . . . . 42.11 117.613 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.57 -96.41 0.05 OUTLIER 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 125.614 1.566 . . . . 72.32 113.644 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.4 m -158.71 150.76 17.35 Favored Pre-proline 0 N--CA 1.491 1.625 0 C-N-CA 123.29 0.636 . . . . 62.42 111.78 -167.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.12 -12.58 33.13 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.11 2.54 . . . . 74.22 114.155 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 80.1 m-70 -97.06 -5.72 36.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.827 -0.545 . . . . 73.44 111.657 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.6 m -96.89 113.78 63.49 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 123.788 0.835 . . . . 71.12 110.758 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 67' ' ' GLU . 19.2 Cg_endo -55.97 114.84 2.08 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.253 2.635 . . . . 52.35 112.87 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 132.36 -23.79 4.02 Favored Glycine 0 N--CA 1.474 1.207 0 CA-C-N 115.915 -0.584 . . . . 73.33 112.558 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.69 133.74 55.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.417 0.687 . . . . 43.42 112.254 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 43.4 mt-10 -103.26 138.57 39.87 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.966 0.506 . . . . 65.11 110.754 -174.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.685 ' NH2' HG21 ' A' ' 27' ' ' ILE . 32.5 ttt-85 -125.15 106.01 9.58 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.176 0.99 . . . . 74.25 110.745 -171.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 t -110.55 109.31 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.338 0.655 . . . . 72.31 111.4 -169.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HE2' HG22 ' A' ' 34' ' ' VAL . 46.2 m-85 -62.32 118.61 7.69 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.334 1.054 . . . . 73.43 111.326 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.84 -71.91 2.88 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 112.451 -0.26 . . . . 71.11 112.451 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 60.74 101.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.881 1.272 . . . . 74.22 113.468 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.57 25.52 3.98 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-N 116.348 -0.387 . . . . 45.41 113.948 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.4 p -123.5 -172.32 2.49 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.301 1.04 . . . . 51.53 110.205 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -87.4 0.96 54.7 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 122.808 0.443 . . . . 71.35 111.746 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.1 88.25 0.95 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.568 0.747 . . . . 63.45 110.034 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.38 139.6 49.35 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.376 0.671 . . . . 65.11 110.414 170.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -95.2 117.46 30.28 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.517 0.727 . . . . 73.31 109.902 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 43.6 t -96.17 115.97 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 109.735 -0.469 . . . . 62.4 109.735 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 23.3 tt0 -112.69 166.65 11.16 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 124.211 1.005 . . . . 72.11 109.837 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -151.6 124.98 8.84 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.926 0.49 . . . . 34.23 111.918 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 34.4 tp -68.2 120.07 13.78 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.833 1.253 . . . . 75.11 111.353 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -85.21 -52.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.246 0.618 . . . . 52.4 110.647 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 8.5 pt-20 -155.83 139.72 16.26 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.156 0.583 . . . . 72.21 110.456 -177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.718 HH12 ' HB3' ' A' ' 70' ' ' GLU . 41.4 tpt85 -131.94 106.85 8.32 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.608 0.763 . . . . 60.23 109.641 -174.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.92 116.63 23.22 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.603 0.761 . . . . 42.44 111.355 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HB3' HH12 ' A' ' 68' ' ' ARG . 13.1 pt-20 -84.6 -39.19 19.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.284 0.634 . . . . 75.31 112.63 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.7 m -71.83 -25.34 61.94 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.311 0.644 . . . . 52.14 111.262 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.9 -17.86 32.22 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.468 0.707 . . . . 72.33 111.784 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 55.49 43.75 28.02 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.985 0.914 . . . . 71.24 111.226 -173.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -133.45 116.07 15.56 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 114.471 -1.241 . . . . 71.55 109.887 -173.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.672 HD13 ' HD3' ' A' ' 68' ' ' ARG . 23.9 tp -119.03 109.67 16.21 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.867 1.267 . . . . 61.31 110.923 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 75.9 t -110.34 137.44 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.829 -0.545 . . . . 70.14 111.392 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -145.14 179.21 7.51 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.67 1.188 . . . . 73.0 110.507 174.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -163.32 152.79 14.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.463 1.105 . . . . 73.14 109.243 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.0 mpp? -91.03 109.72 37.17 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 118.024 0.375 . . . . 64.52 110.386 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.08 -21.19 63.32 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.664 2.242 . . . . 73.1 111.851 171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 29.7 t70 -122.94 80.6 50.34 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.919 0.888 . . . . 62.4 109.558 173.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -94.88 137.29 0.85 Allowed 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 123.069 2.513 . . . . 74.21 113.057 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.51 12.05 3.17 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.855 2.37 . . . . 61.32 113.447 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -108.43 144.97 30.57 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 124.005 0.922 . . . . 73.01 109.971 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.26 65.47 7.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.83 2.353 . . . . 72.12 112.289 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 111' ' ' PHE . 22.2 pt -122.76 131.62 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.18 0.992 . . . . 74.43 110.955 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 26.4 m -78.44 134.51 37.36 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 110.069 -0.345 . . . . 71.42 110.069 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 56.1 -67.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 128.132 2.573 . . . . 63.01 114.721 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 69.11 148.06 0.06 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.343 1.457 . . . . 62.22 111.516 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.449 ' CZ ' HG11 ' A' ' 76' ' ' VAL . 64.8 ttt-85 -164.66 107.86 0.89 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 109.532 -0.544 . . . . 74.41 109.532 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.37 146.31 33.22 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.197 0.599 . . . . 64.44 112.016 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.6 p -138.09 144.43 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 113.501 0.926 . . . . 75.24 113.501 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.35 112.07 24.93 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.17 1.388 . . . . 60.43 109.297 170.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -119.06 113.69 21.33 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.197 0.999 . . . . 72.21 110.139 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.4 t -93.06 112.0 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 O-C-N 121.988 -0.445 . . . . 53.0 110.208 178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.33 119.28 58.11 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.377 1.071 . . . . 63.32 110.961 -176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.5 107.68 2.05 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.504 2.136 . . . . 65.13 112.825 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -86.61 -42.66 13.28 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.984 0.914 . . . . 74.4 111.061 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.3 t70 -140.49 178.92 6.98 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.44 1.096 . . . . 74.11 109.058 -175.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.09 -48.62 28.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.056 0.542 . . . . 73.3 111.031 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 3.9 tmt_? -95.96 -1.52 48.93 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 123.89 0.876 . . . . 73.13 111.03 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -135.77 158.54 44.15 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.391 -0.818 . . . . 74.2 110.73 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.543 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.4 p -156.61 178.23 10.57 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.786 0.434 . . . . 73.33 111.514 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.4 m -119.43 127.35 53.02 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.888 0.875 . . . . 54.44 110.782 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.6 t -95.26 110.35 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 108.959 -0.756 . . . . 74.21 108.959 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 64.2 t -99.68 108.83 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.382 0.673 . . . . 60.42 110.04 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -106.8 119.27 38.89 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.048 -0.723 . . . . 75.43 109.048 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 29.4 m -126.4 150.54 48.55 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.0 0.92 . . . . 72.12 109.943 -172.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.61 120.03 8.46 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.236 0.614 . . . . 65.33 111.244 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.515 ' HB3' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -117.12 128.6 55.29 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.117 0.967 . . . . 74.23 110.211 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.408 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 19.2 p90 -146.91 143.01 28.2 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.205 1.402 . . . . 74.11 108.462 -175.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.701 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 15.8 t70 -89.88 78.39 6.82 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.733 0.778 . . . . 74.33 109.659 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 52.6 t -117.82 163.1 17.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.203 0.601 . . . . 71.44 111.882 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.1 p -64.38 138.76 97.53 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 123.672 0.789 . . . . 71.13 112.018 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -46.55 -36.43 18.47 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 123.943 3.095 . . . . 61.11 115.169 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -61.06 -53.75 53.3 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.54 0.736 . . . . 65.14 111.352 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.43 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 48.7 m -72.84 -27.29 61.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.986 0.515 . . . . 73.33 111.517 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.42 -43.3 81.55 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.914 0.885 . . . . 54.22 112.57 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -68.51 -29.14 67.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.365 0.666 . . . . 70.03 111.484 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.49 -43.93 68.72 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.361 0.665 . . . . 62.33 110.498 174.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.1 mt -74.06 -23.25 59.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.89 0.876 . . . . 71.33 111.536 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -57.54 -44.78 85.42 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.851 0.46 . . . . 70.31 110.18 170.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.8 t -71.61 -52.32 18.63 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 123.622 0.769 . . . . 63.14 112.738 173.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.91 -54.9 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 123.447 0.699 . . . . 62.25 112.705 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -79.89 -50.58 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.135 0.574 . . . . 74.23 111.115 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -66.18 -49.31 58.4 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 114.652 0.621 . . . . 45.43 114.652 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.08 -48.99 7.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.126 -0.631 . . . . 75.23 111.56 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -72.51 -29.8 65.34 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 115.496 0.959 . . . . 62.13 115.496 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.93 -53.72 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 117.784 0.792 . . . . 73.12 110.96 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.0 m-30 -73.25 -60.46 2.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.444 0.698 . . . . 75.21 112.287 -170.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.91 -35.81 66.98 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 123.497 0.498 . . . . 73.31 111.488 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 20.9 t -55.94 -54.82 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.37 0 C-N-CA 123.666 0.786 . . . . 74.25 112.295 172.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.78 -35.75 80.72 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 113.69 0.236 . . . . 74.52 113.69 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.0 mt -70.58 -42.21 71.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.057 0.943 . . . . 73.3 111.884 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -67.68 -41.39 83.78 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.519 0.328 . . . . 71.12 110.289 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.44 -37.34 80.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.802 0.841 . . . . 55.35 111.969 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.427 HD22 HG21 ' A' ' 10' ' ' VAL . 7.8 tt -65.26 -43.22 91.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.715 0.806 . . . . 55.31 110.228 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.58 -32.94 74.59 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 116.136 -0.484 . . . . 73.44 111.275 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 49.6 mt-10 -69.58 -48.13 61.27 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.865 0.866 . . . . 72.14 112.794 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -19.9 65.37 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 112.49 0.552 . . . . 55.25 112.49 -178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -91.34 -44.3 9.26 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.882 0.473 . . . . 74.04 111.864 170.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.91 56.29 0.04 OUTLIER Glycine 0 N--CA 1.479 1.526 0 N-CA-C 114.323 0.489 . . . . 74.33 114.323 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 12.4 ttm180 62.5 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 125.136 1.374 . . . . 52.42 112.942 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -173.99 166.53 4.29 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.956 1.302 . . . . 73.2 110.221 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -98.92 -41.56 7.55 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 122.834 0.453 . . . . 54.41 110.643 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -125.25 124.26 41.3 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.606 0.763 . . . . 63.21 110.651 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -78.0 121.89 24.81 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.084 0.554 . . . . 72.43 110.144 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.431 ' HE1' HG23 ' A' ' 8' ' ' VAL . 18.2 p-80 -123.08 118.51 27.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.219 1.007 . . . . 65.51 109.624 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -85.93 50.58 2.0 Favored 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 123.946 0.898 . . . . 70.21 111.429 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 62.65 -78.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.47 1.108 . . . . 71.54 113.223 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 38.3 m80 . . . . . 0 N--CA 1.489 1.485 0 C-N-CA 124.154 0.982 . . . . 62.12 111.039 177.263 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 120.69 0.281 . . . . 74.33 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 47.7 1.48 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.708 0.803 . . . . 43.41 110.964 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.8 m -121.92 111.28 16.88 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.811 0.844 . . . . 72.4 110.318 -173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 6.8 mp -96.08 109.59 21.99 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.813 1.245 . . . . 45.44 110.039 -174.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -125.53 123.71 39.72 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.898 0.479 . . . . 63.32 110.946 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.465 HH22 ' HG2' ' A' ' 122' ' ' GLU . 1.2 mmp_? -122.28 160.39 25.39 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.333 1.053 . . . . 74.53 108.817 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -153.31 146.81 24.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.11 0.564 . . . . 70.25 111.244 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 104' ' ' THR . 14.0 p -138.73 145.58 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.156 0.583 . . . . 72.42 111.314 -175.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -94.94 110.88 22.72 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.495 0.718 . . . . 71.4 110.426 176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 102' ' ' HIS . 65.9 t -101.41 139.93 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 124.562 1.145 . . . . 73.15 111.578 -172.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.72 40.78 0.61 Allowed 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 113.766 1.025 . . . . 52.21 113.766 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.3 154.54 32.27 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 123.205 0.602 . . . . 34.15 111.654 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -66.08 145.28 78.67 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 122.984 2.456 . . . . 74.33 113.265 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.31 -35.31 37.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.345 1.458 . . . . 72.32 114.72 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.69 -51.55 61.87 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 112.595 0.591 . . . . 72.42 112.595 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.77 -44.78 90.73 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.282 0.633 . . . . 63.45 111.162 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.53 HG21 ' SG ' ' A' ' 103' ' ' CYS . 49.2 t -68.72 -34.07 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.605 0.762 . . . . 62.25 111.08 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.559 ' HE1' ' HA ' ' A' ' 70' ' ' GLU . 55.8 t-105 -59.55 -40.99 89.07 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.458 0.303 . . . . 72.13 111.219 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.3 m -61.37 -24.99 66.87 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.796 0.438 . . . . 75.15 111.564 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 30' ' ' TRP . 29.5 tp -83.67 -44.29 14.66 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 112.736 0.643 . . . . 70.3 112.736 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.9 m -88.62 -26.26 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 N-CA-C 114.098 1.147 . . . . 75.54 114.098 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.71 35.42 3.22 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 115.876 1.11 . . . . 43.14 115.876 -165.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.26 -162.07 0.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.806 0.842 . . . . 53.33 111.158 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -147.14 25.2 1.13 Allowed 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.302 0.641 . . . . 51.43 110.195 173.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.7 p -152.15 -42.83 0.11 Allowed 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 123.498 0.719 . . . . 74.11 111.763 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.4 3.12 48.34 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.221 1.008 . . . . 61.23 111.199 -170.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.692 HG23 HG11 ' A' ' 34' ' ' VAL . 14.3 tt -55.92 -19.76 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.616 0 C-N-CA 125.853 1.661 . . . . 72.21 113.108 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -64.37 -14.36 55.96 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.409 0.892 . . . . 73.41 113.409 174.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -71.85 -20.18 61.86 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.533 0.733 . . . . 72.22 112.374 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HB3' HD21 ' A' ' 20' ' ' LEU . 31.5 p-90 -127.71 -35.08 2.14 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.008 0.523 . . . . 74.25 111.912 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -89.77 112.37 51.59 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 122.819 0.447 . . . . 74.34 110.337 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.68 -16.27 37.8 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 123.275 2.65 . . . . 70.32 114.083 -173.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -93.15 -20.69 20.24 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.724 0.81 . . . . 73.51 112.12 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.692 HG11 HG23 ' A' ' 27' ' ' ILE . 72.9 t -69.32 111.79 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 120.919 0.39 . . . . 61.54 110.894 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.6 t -92.33 27.46 2.23 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.429 1.092 . . . . 35.5 111.9 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.03 98.1 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 124.577 1.151 . . . . 62.22 111.27 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -85.11 173.14 8.12 Favored 'Trans proline' 0 CA--C 1.561 1.843 0 C-N-CA 123.116 2.544 . . . . 62.34 114.693 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 96.8 m -99.96 123.02 43.76 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.0 0.92 . . . . 65.2 109.758 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -93.71 127.32 39.36 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.237 0.615 . . . . 73.01 111.204 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -104.64 123.23 47.22 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.719 -0.673 . . . . 74.24 109.612 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.33 -175.41 0.01 OUTLIER Glycine 0 CA--C 1.55 2.241 0 N-CA-C 117.543 1.777 . . . . 61.13 117.543 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 46.75 -121.31 1.14 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 124.839 1.256 . . . . 75.53 113.315 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -162.8 155.9 16.78 Favored Pre-proline 0 N--CA 1.488 1.448 0 C-N-CA 124.375 1.07 . . . . 75.35 108.985 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -62.42 -15.52 45.82 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.502 2.135 . . . . 72.0 114.859 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -111.41 0.77 16.69 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.66 -0.65 . . . . 55.14 111.546 173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.5 m -110.77 127.69 26.53 Favored Pre-proline 0 N--CA 1.492 1.637 0 C-N-CA 123.732 0.813 . . . . 73.21 110.928 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 85.5 Cg_exo -50.15 138.68 36.21 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.68 2.92 . . . . 73.42 114.149 174.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.97 19.6 21.24 Favored Glycine 0 N--CA 1.477 1.429 0 CA-C-N 116.272 -0.422 . . . . 63.34 113.564 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.78 134.74 51.69 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.71 0.804 . . . . 74.41 110.737 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -111.35 118.44 35.85 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 122.952 0.501 . . . . 74.21 110.965 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -93.63 126.26 38.69 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.888 0.375 . . . . 73.4 110.042 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 62' ' ' VAL . 20.6 t -122.42 122.1 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 122.902 0.481 . . . . 74.45 111.238 -171.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' HE2' HG13 ' A' ' 34' ' ' VAL . 48.6 m-85 -95.56 85.31 4.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.216 1.006 . . . . 73.53 111.118 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.25 -43.41 1.61 Allowed Glycine 0 N--CA 1.478 1.488 0 N-CA-C 112.722 -0.151 . . . . 74.23 112.722 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.56 17.7 4.12 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.949 1.463 . . . . 73.32 114.949 175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.31 57.8 0.03 OUTLIER Glycine 0 N--CA 1.472 1.064 0 N-CA-C 112.595 -0.202 . . . . 43.32 112.595 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -105.87 -69.1 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.982 0.913 . . . . 52.51 109.729 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 176.64 -46.13 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.527 1.531 . . . . 72.31 109.252 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -127.75 82.21 2.07 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.871 0.843 . . . . 74.32 108.818 176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.72 -179.77 3.75 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.15 0.98 . . . . 74.12 110.601 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD11 ' SD ' ' A' ' 79' ' ' MET . 55.0 tp -141.14 123.53 15.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.799 0.44 . . . . 72.21 110.896 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.0 t -104.7 115.0 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 109.162 -0.681 . . . . 70.55 109.162 170.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -104.73 149.67 25.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.872 0.869 . . . . 55.4 109.889 171.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -127.5 127.39 43.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.068 1.347 . . . . 74.4 109.867 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.17 108.99 9.47 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.932 0.893 . . . . 54.13 110.662 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.8 t -73.26 -50.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.363 0.665 . . . . 54.21 110.555 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.723 ' HA ' ' HG3' ' A' ' 47' ' ' PRO . 8.6 pt-20 -166.81 155.46 10.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.541 0.736 . . . . 73.34 111.095 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -141.69 123.04 14.87 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.37 0.668 . . . . 70.21 110.497 -174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.35 -178.37 4.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.045 0.938 . . . . 74.24 111.826 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.559 ' HA ' ' HE1' ' A' ' 18' ' ' TRP . 55.4 mt-10 -138.92 -63.72 0.52 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.228 1.011 . . . . 75.22 109.955 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.0 p -69.57 -38.25 77.33 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.414 0.686 . . . . 62.35 111.439 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.67 -19.83 60.72 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.431 0.692 . . . . 55.41 112.263 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 55.74 45.0 25.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.312 1.045 . . . . 65.3 112.253 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.45 HH11 HG23 ' A' ' 76' ' ' VAL . 9.0 tmm_? -130.7 130.99 44.55 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 115.031 -0.986 . . . . 63.44 110.475 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 46.2 tp -120.36 123.63 43.56 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.363 1.065 . . . . 74.4 110.212 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 44.5 t -114.38 132.35 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-N 118.958 0.799 . . . . 54.41 111.072 174.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -147.61 175.18 11.07 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 51.55 111.349 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.6 t -150.15 145.26 26.19 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.402 1.081 . . . . 73.24 109.55 176.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.3 ptt? -95.96 101.06 7.46 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 118.787 0.721 . . . . 74.43 110.7 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.47 -17.37 30.38 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 123.178 2.586 . . . . 63.11 113.229 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 34.9 t70 -132.8 79.18 64.49 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 123.427 0.691 . . . . 74.23 109.859 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -96.34 154.93 1.32 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 123.42 2.747 . . . . 75.32 114.033 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.94 -17.43 22.45 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.119 1.879 . . . . 71.51 112.554 168.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -80.33 142.2 54.25 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 123.812 0.845 . . . . 75.21 112.047 -175.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.07 77.4 3.49 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.717 2.278 . . . . 62.12 113.21 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.1 pt -133.54 154.7 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.285 1.034 . . . . 71.32 110.774 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 35.9 m -90.76 -79.31 0.36 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.985 -0.447 . . . . 63.4 110.757 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -106.37 107.82 19.03 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.358 0.599 . . . . 73.32 110.924 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.407 ' ND1' ' HG2' ' A' ' 79' ' ' MET . 43.5 t-80 -84.94 149.72 25.44 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.772 0.829 . . . . 64.33 111.06 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -153.31 106.89 3.01 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.492 0.717 . . . . 73.12 109.952 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . . . -117.0 142.38 47.02 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.981 0.512 . . . . 54.24 111.926 178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 92.8 t -133.6 134.83 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.25 1.02 . . . . 63.25 111.061 -175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 1.1 mm? -94.46 147.02 23.67 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.745 -0.835 . . . . 63.4 108.745 166.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.27 117.65 4.92 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.677 0.391 . . . . 75.43 110.179 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.05 112.46 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.784 -0.451 . . . . 60.41 109.784 178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.84 120.7 67.02 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 123.737 0.815 . . . . 71.45 110.581 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.18 87.56 0.6 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.325 2.017 . . . . 52.43 112.123 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -76.17 -32.16 58.9 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.098 0.959 . . . . 71.52 111.148 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 16.6 t70 -158.73 170.9 21.1 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.65 1.58 . . . . 63.34 108.42 -175.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -54.29 -52.86 60.1 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.742 0.817 . . . . 61.24 112.475 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -119.85 23.25 11.18 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.533 0.682 . . . . 73.11 110.845 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.734 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.4 m80 -132.62 121.36 23.08 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.534 -0.729 . . . . 73.12 109.38 170.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.53 ' SG ' HG21 ' A' ' 17' ' ' VAL . 30.1 p -128.28 138.33 52.37 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.986 0.514 . . . . 74.13 109.647 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 35.9 m -96.05 109.7 22.06 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.834 -0.432 . . . . 73.11 109.834 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.4 t -89.87 108.52 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.134 -0.691 . . . . 74.24 109.134 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.3 t -97.89 112.5 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.261 1.024 . . . . 64.5 109.087 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -104.51 118.71 37.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.776 -0.824 . . . . 71.05 108.776 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.6 m -120.11 149.37 42.32 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.186 0.995 . . . . 74.53 110.023 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . . . -146.08 157.96 43.86 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.557 1.143 . . . . 43.12 109.206 170.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -161.46 134.64 6.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.748 0.819 . . . . 75.03 109.783 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -145.51 152.98 40.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.146 0.578 . . . . 70.21 111.81 -170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 22.2 t70 -75.35 88.91 2.59 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.935 -0.575 . . . . 44.52 109.815 175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.632 ' HB2' HG22 ' A' ' 86' ' ' ILE . 34.0 t -147.76 166.27 28.02 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.354 -0.839 . . . . 73.13 111.205 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.4 p -67.21 145.68 98.72 Favored Pre-proline 0 N--CA 1.485 1.301 0 C-N-CA 123.254 0.622 . . . . 72.03 111.445 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.49 -29.22 68.16 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.85 2.367 . . . . 60.32 112.963 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -64.08 -52.3 59.93 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.344 1.058 . . . . 71.12 112.001 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.49 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.2 m -72.46 -32.01 65.91 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.134 0.492 . . . . 75.34 110.82 177.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.41 -32.95 74.19 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.633 0.773 . . . . 55.04 112.055 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -69.08 -35.63 76.7 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.983 0.513 . . . . 71.01 110.952 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.95 -48.59 73.55 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.378 0.671 . . . . 72.45 110.077 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.05 -24.75 62.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.193 -0.912 . . . . 72.34 111.341 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' HG2' HH22 ' A' ' 6' ' ' ARG . 1.2 tm-20 -57.08 -42.05 79.98 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.795 0.838 . . . . 55.4 110.507 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.5 t -76.75 -49.81 15.09 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.527 0.565 . . . . 74.44 112.527 171.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -70.2 -56.75 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 112.925 0.713 . . . . 63.22 112.925 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.44 -42.68 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.184 0.593 . . . . 73.24 110.681 178.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -60.95 -66.2 2.83 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-N 116.398 -0.365 . . . . 64.23 113.787 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' A' ' 131' ' ' ALA . 69.8 m-20 -80.97 -50.76 9.32 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 118.026 0.913 . . . . 73.5 112.025 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -63.28 -26.41 69.37 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 115.287 0.875 . . . . 54.33 115.287 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.09 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.759 0.779 . . . . 61.34 111.204 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 8.5 m-30 -71.72 -63.1 1.19 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.907 0.336 . . . . 65.21 111.907 -170.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 127' ' ' ASP . . . -61.19 -28.53 69.21 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 123.47 0.481 . . . . 31.2 112.183 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.0 t -59.96 -53.47 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 123.439 0.696 . . . . 71.23 111.316 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.72 -38.85 93.45 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-N 116.343 -0.39 . . . . 72.32 113.233 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 73.3 mt -65.88 -40.28 91.46 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.069 0.948 . . . . 61.33 111.866 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -66.23 -45.25 81.33 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.425 -0.352 . . . . 54.33 110.294 175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.47 70.64 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.645 0.778 . . . . 64.25 112.246 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 tt -67.25 -48.45 67.73 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.958 0.903 . . . . 74.1 110.403 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.93 -23.42 63.21 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.073 0.549 . . . . 54.33 111.843 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 40.1 mt-10 -66.23 -49.8 66.0 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.582 0.753 . . . . 73.34 111.422 175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -14.41 61.64 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.305 0.483 . . . . 71.12 112.305 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -94.82 -30.58 14.15 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.186 0.81 . . . . 75.03 113.186 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.94 19.16 0.03 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 115.947 1.139 . . . . 23.4 115.947 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 71.6 mtp180 57.65 36.23 26.49 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 124.663 1.185 . . . . 75.42 113.9 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 57.91 84.81 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 123.936 0.894 . . . . 64.3 111.098 -176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.91 -53.4 56.23 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 116.753 -0.203 . . . . 63.12 111.067 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -93.86 99.7 12.02 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 109.363 -0.606 . . . . 63.34 109.363 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -74.27 145.92 43.62 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.731 0.813 . . . . 75.22 111.059 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -115.36 118.28 32.79 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.853 -0.795 . . . . 71.12 108.853 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -60.26 -42.17 94.78 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.442 0.904 . . . . 72.02 113.442 -172.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -76.53 -83.77 0.07 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.532 0.333 . . . . 74.24 111.458 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.7 p80 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.736 0.779 . . . . 74.35 111.804 179.032 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 112.168 0.433 . . . . 60.11 112.168 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.24 29.14 18.56 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 124.783 1.233 . . . . 61.15 113.155 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.2 m -91.33 117.95 30.09 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.26 0.624 . . . . 55.0 110.529 173.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 mp -95.66 128.02 42.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.948 1.299 . . . . 70.12 108.155 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -133.87 127.75 33.19 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 118.165 0.439 . . . . 71.55 110.216 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.79 140.57 50.3 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.665 -0.865 . . . . 65.51 108.665 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 p -141.66 156.23 45.65 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.658 0.783 . . . . 50.14 110.575 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -150.39 148.37 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 N-CA-C 111.976 0.361 . . . . 73.21 111.976 -173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -80.68 113.5 18.93 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.289 0.635 . . . . 64.34 110.567 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 105' ' ' VAL . 43.1 t -106.57 124.11 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 123.309 0.644 . . . . 72.23 110.466 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.1 66.13 8.53 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.809 0.844 . . . . 64.15 112.185 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.41 152.88 3.41 Favored Pre-proline 0 CA--C 1.561 1.392 0 C-N-CA 123.959 0.904 . . . . 73.11 110.797 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 134.95 64.09 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.06 2.507 . . . . 62.15 113.143 173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.53 -37.77 50.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.381 1.622 . . . . 72.1 115.381 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.66 -45.43 78.98 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.942 0.497 . . . . 72.52 111.926 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -65.21 -34.82 79.27 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.477 0.711 . . . . 75.1 112.326 175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.587 HG21 ' SG ' ' A' ' 103' ' ' CYS . 59.3 t -70.36 -36.69 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.221 0.608 . . . . 62.11 110.886 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -64.14 -28.84 70.04 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 115.982 -0.554 . . . . 71.25 110.661 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.6 m -59.54 -28.22 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.072 0.549 . . . . 73.14 111.432 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.0 tp -76.48 -41.78 45.9 Favored 'General case' 0 CA--C 1.561 1.398 0 C-N-CA 123.806 0.842 . . . . 71.21 111.666 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.6 m -104.37 13.96 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 C-N-CA 123.943 0.897 . . . . 71.3 112.833 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -91.31 7.04 80.88 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 114.449 0.539 . . . . 74.33 114.449 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 1.3 m-20 -124.98 135.36 52.73 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 63.33 109.311 166.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -63.68 -24.77 67.92 Favored 'General case' 0 CA--C 1.563 1.463 0 C-N-CA 123.986 0.914 . . . . 74.05 111.286 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.9 p -89.78 -16.43 30.27 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.317 1.047 . . . . 73.43 112.822 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -82.22 3.54 26.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.867 -0.52 . . . . 61.24 112.238 -168.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 HG11 ' A' ' 34' ' ' VAL . 21.1 tt -63.79 -23.24 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 C-N-CA 124.142 0.977 . . . . 75.04 112.766 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.481 ' HA ' ' HB ' ' A' ' 34' ' ' VAL . 57.0 p-80 -64.47 -23.23 67.21 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.801 0.667 . . . . 72.22 112.801 176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -74.29 -39.04 63.19 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 112.512 0.56 . . . . 64.34 112.512 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.495 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.9 p-90 -107.57 -30.16 8.77 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 122.597 0.359 . . . . 72.41 111.334 -174.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -100.16 102.03 16.59 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 123.453 0.701 . . . . 75.45 109.842 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HD2' HE22 ' A' ' 33' ' ' GLN . 32.5 Cg_exo -62.21 -13.3 31.32 Favored 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 123.537 2.825 . . . . 63.33 116.035 -171.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.537 HE22 ' HD2' ' A' ' 32' ' ' PRO . 2.2 mp0 -83.8 -25.79 30.11 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.355 0.662 . . . . 74.52 111.697 -175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 27' ' ' ILE . 85.4 t -72.37 115.89 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 C-N-CA 122.877 0.471 . . . . 71.02 111.465 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.2 t -95.25 30.32 2.23 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.974 0.91 . . . . 74.43 111.797 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.76 98.58 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 125.326 1.45 . . . . 70.43 112.643 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.9 -171.39 1.18 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.321 2.681 . . . . 75.41 114.252 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.8 m -115.52 124.53 51.29 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.785 0.834 . . . . 50.33 110.686 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.402 HD12 ' HB1' ' A' ' 49' ' ' ALA . 3.8 mm? -90.78 126.65 36.08 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.501 0.667 . . . . 73.42 111.313 -175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.546 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.5 mmt180 -111.65 148.25 33.77 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.535 1.134 . . . . 63.31 109.929 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 48.69 121.05 0.0 OUTLIER Glycine 0 CA--C 1.56 2.906 0 N-CA-C 117.715 1.846 . . . . 64.01 117.715 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 69.45 -98.35 0.04 OUTLIER 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.421 1.488 . . . . 74.22 114.096 173.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -168.66 146.72 3.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 C-N-CA 123.227 0.611 . . . . 62.35 111.68 -166.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.59 -1.2 2.39 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.675 2.917 . . . . 64.54 115.145 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -101.5 -24.8 14.1 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.538 0.735 . . . . 64.23 111.271 171.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -93.12 124.24 58.61 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.641 0.776 . . . . 52.2 111.731 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.62 118.91 4.86 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.221 2.614 . . . . 71.31 112.874 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 125.15 -9.46 7.89 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 112.484 -0.246 . . . . 74.01 112.484 -170.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -73.27 130.75 40.89 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.487 0.715 . . . . 51.02 111.05 174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 36.2 mt-10 -118.88 115.16 23.82 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 122.099 -0.376 . . . . 71.4 110.558 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -93.73 119.11 32.3 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.337 0.589 . . . . 72.21 109.826 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 t -115.93 107.78 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 123.805 0.842 . . . . 52.23 110.227 -172.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -76.85 73.64 3.48 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.041 0.936 . . . . 74.32 111.479 -173.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.89 -62.44 0.48 Allowed Glycine 0 C--N 1.344 1.012 0 CA-C-N 116.124 -0.489 . . . . 63.44 111.899 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.63 27.08 16.62 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 124.605 1.162 . . . . 62.35 113.663 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.27 41.48 0.03 OUTLIER Glycine 0 N--CA 1.471 1.005 0 CA-C-N 116.392 -0.367 . . . . 64.5 112.739 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -146.78 160.83 41.77 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.599 0.759 . . . . 64.41 110.767 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -74.08 -19.48 60.59 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.253 0.621 . . . . 72.44 111.858 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.12 85.98 2.5 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.735 0.814 . . . . 71.4 110.641 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.26 162.77 30.15 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.359 0.663 . . . . 75.23 111.871 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 79' ' ' MET . 51.1 tp -121.95 121.71 37.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.772 0.829 . . . . 72.42 109.89 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.1 t -99.54 130.09 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.066 -0.716 . . . . 73.31 109.066 173.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.638 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 40.1 mt-10 -130.25 128.87 42.5 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.413 0.685 . . . . 72.4 110.317 176.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 57.8 mtp180 -104.04 131.76 50.97 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.193 0.597 . . . . 74.12 111.204 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.3 tp -73.04 111.46 8.17 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.015 0.926 . . . . 54.11 110.161 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.2 t -78.72 -51.91 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.528 0.731 . . . . 62.21 111.731 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.591 ' HG2' ' HB ' ' A' ' 76' ' ' VAL . 11.8 pt-20 -153.18 151.81 30.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 70.35 110.579 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.597 HH21 HD22 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -133.78 113.48 12.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.189 0.596 . . . . 74.01 110.557 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.721 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.5 m-20 -115.68 72.18 0.8 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.816 0.847 . . . . 71.42 109.036 176.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.491 ' HG3' ' HD2' ' A' ' 68' ' ' ARG . 53.3 mt-10 -67.38 -32.85 74.05 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.735 0.814 . . . . 74.22 113.109 -173.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.3 t -73.07 -18.56 61.3 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.171 0.589 . . . . 71.04 111.733 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.57 -1.82 22.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.69 0.796 . . . . 63.53 112.133 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 13.1 mtm105 62.71 42.82 7.81 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.433 1.093 . . . . 75.22 112.993 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.721 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 23.9 ttm180 -119.34 133.17 55.87 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.368 1.067 . . . . 75.5 110.781 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.597 HD22 HH21 ' A' ' 68' ' ' ARG . 13.6 tp -131.74 107.93 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.636 1.174 . . . . 33.42 110.037 175.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.591 ' HB ' ' HG2' ' A' ' 67' ' ' GLU . 52.0 t -113.12 132.99 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-N 118.491 0.587 . . . . 75.11 110.601 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -148.14 167.77 24.17 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.746 0.818 . . . . 73.22 111.339 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.0 t -134.82 158.25 44.7 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.12 0.968 . . . . 72.45 110.578 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.638 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 73.4 mtm -102.82 98.13 10.69 Favored Pre-proline 0 CA--C 1.562 1.419 0 C-N-CA 123.019 0.527 . . . . 71.12 110.309 170.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.487 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 56.8 Cg_endo -66.05 -28.21 49.4 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.371 2.714 . . . . 70.33 112.612 172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -121.28 79.42 35.87 Favored Pre-proline 0 CA--C 1.555 1.164 0 N-CA-C 108.624 -0.88 . . . . 71.14 108.624 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.456 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 83.1 Cg_endo -79.68 147.4 19.56 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.465 2.11 . . . . 44.14 113.12 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.8 Cg_endo -84.38 -0.83 9.57 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.95 2.434 . . . . 62.44 112.782 175.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.18 150.38 63.35 Favored Pre-proline 0 N--CA 1.485 1.303 0 C-N-CA 123.877 0.871 . . . . 74.42 111.513 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.38 80.57 1.05 Allowed 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.107 2.538 . . . . 73.1 112.956 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.577 HG22 ' HB2' ' A' ' 113' ' ' CYS . 23.5 pt -135.59 146.51 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.547 1.139 . . . . 74.35 110.383 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -89.87 -72.3 0.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 120.883 0.373 . . . . 54.43 110.921 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 111' ' ' PHE . 9.1 m-20 -90.71 123.95 34.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.412 -0.959 . . . . 72.35 108.412 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -114.87 131.21 56.93 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 119.352 0.978 . . . . 75.44 113.237 171.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.528 ' HB2' ' HB2' ' A' ' 110' ' ' MET . 3.6 mpt_? -129.64 143.58 50.89 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.181 1.392 . . . . 74.43 109.02 165.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -143.81 125.6 15.14 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.068 0.947 . . . . 73.31 108.739 172.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.525 HG22 ' HG3' ' A' ' 94' ' ' GLU . 7.5 p -134.5 134.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.678 0.992 . . . . 74.34 113.678 -169.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.3 mm? -101.91 112.46 25.1 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.247 1.019 . . . . 74.24 109.156 171.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 92' ' ' VAL . 44.3 mt-10 -122.22 111.26 16.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.618 0.767 . . . . 65.41 109.921 175.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 t -92.59 109.29 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 109.101 -0.703 . . . . 51.24 109.101 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.417 HG23 ' HB ' ' A' ' 104' ' ' THR . 4.4 m -100.7 114.03 65.72 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 123.856 0.863 . . . . 73.02 110.624 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.76 107.09 2.12 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 122.543 2.162 . . . . 64.41 113.04 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -63.47 -29.52 70.78 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.71 0.804 . . . . 72.2 111.144 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 26.2 t70 -154.63 173.13 16.78 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.396 1.478 . . . . 74.24 108.526 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.37 -44.19 92.77 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.979 0.512 . . . . 45.43 111.423 174.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 5.8 tmm_? -106.98 1.92 24.8 Favored 'General case' 0 CA--C 1.569 1.691 0 C-N-CA 123.65 0.78 . . . . 73.15 111.468 -174.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 42.5 m80 -128.58 141.52 51.34 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.406 -0.809 . . . . 74.23 110.307 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.587 ' SG ' HG21 ' A' ' 17' ' ' VAL . 16.8 p -143.72 174.91 10.39 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.474 0.654 . . . . 75.22 112.407 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.417 ' HB ' HG23 ' A' ' 96' ' ' VAL . 99.4 m -138.58 118.95 13.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.45 1.1 . . . . 53.31 109.65 176.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.551 HG23 HG21 ' A' ' 10' ' ' VAL . 47.9 t -91.77 124.8 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 109.771 -0.455 . . . . 73.22 109.771 177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.75 128.35 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 73.25 109.357 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 6.4 t90 -121.2 122.91 40.99 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.79 -0.818 . . . . 62.43 108.79 174.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 90.9 m -127.39 124.13 37.82 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.454 0.702 . . . . 70.41 111.491 -170.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 130' ' ' PHE . . . -105.3 107.81 18.99 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.078 0.951 . . . . 62.35 110.39 176.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ARG . 41.8 mtt -97.62 130.35 44.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.888 -0.782 . . . . 74.32 108.888 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 88' ' ' ASN . 20.4 p90 -157.28 153.21 27.1 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.978 0.732 . . . . 75.34 112.978 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.65 84.25 2.71 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.237 -0.892 . . . . 73.41 109.427 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.577 ' HB2' HG22 ' A' ' 86' ' ' ILE . 42.2 t -119.28 155.78 31.18 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.324 -1.307 . . . . 74.22 110.711 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -58.61 138.45 86.08 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 123.933 0.893 . . . . 61.43 111.427 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.59 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 123.473 2.782 . . . . 71.0 114.857 -168.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.02 -37.98 89.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.104 0.561 . . . . 75.21 111.421 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 9.0 m -79.23 -27.25 42.46 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.015 0.526 . . . . 62.12 111.071 177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.96 71.24 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.995 0.918 . . . . 72.01 111.896 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -74.8 -28.1 60.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.696 0.799 . . . . 75.01 111.586 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -66.32 -45.63 79.65 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.146 0.498 . . . . 74.03 110.161 170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -72.22 -24.8 61.45 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.721 0.808 . . . . 65.22 111.275 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -58.18 -45.58 87.27 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.522 0.729 . . . . 73.52 110.519 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 m -69.99 -53.19 18.77 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.523 -0.762 . . . . 62.32 112.394 174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.69 -55.25 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 C-N-CA 123.479 0.712 . . . . 75.02 112.595 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.6 mt -81.49 -57.32 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 C-N-CA 123.836 0.854 . . . . 72.13 111.251 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.3 -63.33 3.3 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 114.349 0.5 . . . . 44.31 114.349 -173.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.45 -16.5 58.74 Favored 'General case' 0 CA--C 1.558 1.25 0 C-N-CA 122.871 0.468 . . . . 72.45 111.441 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.19 -88.75 1.66 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-O 119.86 -0.411 . . . . 35.42 112.463 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.7 t -52.6 -46.78 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 124.935 1.294 . . . . 73.02 113.03 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 109' ' ' ALA . 3.8 m-30 -75.98 -47.85 23.41 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.443 0.697 . . . . 73.04 111.558 -173.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.36 -41.85 85.65 Favored 'General case' 0 N--CA 1.482 1.141 0 O-C-N 123.226 0.329 . . . . 73.32 111.751 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.7 t -57.51 -54.42 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 123.955 0.902 . . . . 74.0 112.107 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.91 -46.21 76.05 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.423 0.452 . . . . 52.33 113.675 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.62 -41.48 96.15 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.561 0.745 . . . . 73.13 112.199 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.68 -41.64 92.19 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 119.73 -0.176 . . . . 72.23 110.675 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.91 90.7 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.94 0.496 . . . . 64.13 111.541 176.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.64 -40.12 96.06 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.603 0.761 . . . . 42.15 110.164 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.51 -33.19 68.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.859 0.463 . . . . 71.11 111.981 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.026 0.931 . . . . 72.3 113.042 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -66.77 -32.32 73.53 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 117.922 0.328 . . . . 63.22 111.289 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -91.98 -11.25 36.6 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.227 0.611 . . . . 74.24 110.661 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.79 7.03 44.34 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 114.569 0.588 . . . . 72.1 114.569 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -70.03 -22.1 63.13 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.139 0.576 . . . . 73.31 110.1 165.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.11 174.36 6.95 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.53 1.132 . . . . 75.34 109.912 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.578 ' HB3' ' HD2' ' A' ' 147' ' ' HIS . 18.9 mm-40 67.03 173.23 0.26 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.919 1.451 . . . . 60.11 114.919 170.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -114.01 79.66 1.28 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.974 0.91 . . . . 41.04 109.967 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.578 ' HD2' ' HB3' ' A' ' 145' ' ' GLU . 33.7 m-70 -124.85 142.12 51.65 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.435 0.694 . . . . 62.41 110.119 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -95.6 143.6 26.75 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.575 0.75 . . . . 73.14 112.577 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -137.73 95.79 3.11 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.094 0.958 . . . . 74.41 109.716 168.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -71.51 -29.7 65.09 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.083 0.953 . . . . 73.3 110.31 174.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 122.277 1.037 . . . . 71.52 110.559 173.272 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.848 0.356 . . . . 64.45 110.75 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.63 33.93 5.21 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.911 0.884 . . . . 70.2 110.371 171.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 74.6 m -119.72 124.5 46.36 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.901 0.88 . . . . 73.44 109.972 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -98.94 141.07 32.18 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 74.04 109.097 176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -145.62 132.63 20.28 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.611 -0.515 . . . . 74.15 109.611 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 131' ' ' ALA . 5.7 tpt180 -133.7 147.35 51.37 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.346 -0.613 . . . . 63.44 109.346 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.0 p -142.76 150.36 39.94 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.24 0.616 . . . . 52.41 111.246 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.6 p -140.92 149.13 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.156 0.582 . . . . 52.51 111.173 -177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -82.18 123.7 29.24 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 109.551 -0.537 . . . . 73.52 109.551 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 95.4 t -120.51 121.56 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 123.814 0.845 . . . . 61.41 110.017 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -76.26 71.3 2.96 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.084 0.553 . . . . 72.42 111.191 174.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.76 154.91 6.6 Favored Pre-proline 0 N--CA 1.483 1.186 0 C-N-CA 123.844 0.858 . . . . 72.04 111.392 -176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.69 144.62 78.8 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.778 2.318 . . . . 65.42 112.299 167.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.1 -31.5 30.89 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 114.027 1.121 . . . . 54.54 114.027 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.58 -49.22 72.02 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.439 0.696 . . . . 72.24 112.446 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.353 0.661 . . . . 72.21 111.916 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.43 HG21 ' SG ' ' A' ' 103' ' ' CYS . 25.0 t -71.76 -34.64 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.714 -0.675 . . . . 55.04 111.43 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -67.4 -31.19 71.25 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 122.58 0.352 . . . . 74.13 111.391 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -67.57 -21.66 65.43 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-O 121.382 0.61 . . . . 60.25 111.293 172.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.6 tp -88.09 -50.03 6.65 Favored 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.061 0.944 . . . . 61.23 112.838 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.2 m -93.98 -26.53 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 113.703 1.001 . . . . 72.32 113.703 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.64 -11.85 66.19 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 116.384 1.313 . . . . 60.23 116.384 -165.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 4.6 m-20 -79.65 -14.03 59.08 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.939 0.496 . . . . 70.31 111.862 176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.3 t80 72.31 -59.05 0.57 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.163 1.385 . . . . 74.41 111.257 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -62.51 -18.34 61.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.295 1.038 . . . . 35.23 113.248 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' HB1' ' HD3' ' A' ' 29' ' ' ARG . . . -79.94 7.36 9.08 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.92 0.888 . . . . 74.32 112.722 -167.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.52 ' HA ' ' NE1' ' A' ' 30' ' ' TRP . 14.1 tt -61.7 -23.49 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 123.575 0.75 . . . . 63.4 112.082 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.647 ' HA ' HG11 ' A' ' 34' ' ' VAL . 39.5 p-80 -70.67 -3.9 20.81 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 113.154 0.798 . . . . 55.45 113.154 177.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.526 ' HD3' ' HB1' ' A' ' 26' ' ' ALA . 58.6 mtp180 -92.76 -25.51 18.15 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.02 0.928 . . . . 55.15 112.724 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 47.0 p-90 -127.14 -34.48 2.32 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.246 1.202 . . . . 75.02 114.246 -171.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 33' ' ' GLN . 33.6 t-80 -78.68 139.08 58.23 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-N 117.969 0.35 . . . . 71.02 110.932 -170.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -72.57 -37.75 3.87 Favored 'Trans proline' 0 CA--C 1.564 2.008 0 C-N-CA 122.136 1.891 . . . . 54.52 113.965 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.645 HE21 ' N ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -78.21 -22.82 47.94 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 112.522 0.564 . . . . 62.21 112.522 -172.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 28' ' ' HIS . 9.4 p -61.71 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 121.352 0.596 . . . . 74.25 112.549 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.9 t -115.92 28.36 8.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.026 0.93 . . . . 74.23 111.673 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 61.4 96.83 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.071 0.948 . . . . 54.43 110.677 -170.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -83.23 158.46 15.09 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.594 2.196 . . . . 74.23 114.175 -172.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.5 m -104.87 127.3 52.64 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.31 1.044 . . . . 72.34 109.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.3 mm? -99.76 115.96 30.74 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.466 0.707 . . . . 75.24 110.689 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.462 ' HE ' HG21 ' A' ' 52' ' ' VAL . 31.4 mmt180 -83.85 119.23 24.61 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.886 -0.413 . . . . 75.4 109.886 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 42.8 -167.47 0.01 OUTLIER Glycine 0 CA--C 1.545 1.939 0 N-CA-C 117.85 1.9 . . . . 64.01 117.85 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 76.07 -47.16 0.56 Allowed 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 125.714 1.606 . . . . 63.44 115.141 168.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.9 m 91.74 144.25 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.381 0 C-N-CA 126.825 2.05 . . . . 62.24 109.983 -162.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.95 -37.86 93.24 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.842 3.028 . . . . 61.21 116.244 -167.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -85.25 -13.91 48.37 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 112.371 0.508 . . . . 74.23 112.371 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -80.72 123.51 82.44 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.446 0.698 . . . . 70.02 111.46 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -48.84 98.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.632 2.888 . . . . 55.33 113.568 171.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 143.87 -14.71 2.18 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 116.089 -0.505 . . . . 53.13 112.992 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 39' ' ' LEU . . . -67.09 122.37 17.64 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.53 0.732 . . . . 75.34 111.211 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 41.6 mt-10 -102.65 117.59 34.99 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.71 0.404 . . . . 71.41 111.484 -172.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' GLU . 46.7 ttp180 -92.94 103.19 15.54 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.559 0.744 . . . . 72.43 110.763 -172.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 62' ' ' VAL . 20.6 t -112.6 99.35 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.586 0.755 . . . . 75.4 110.242 -171.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -63.18 -48.97 76.13 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.708 1.003 . . . . 65.31 113.708 -168.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.01 52.91 0.61 Allowed Glycine 0 N--CA 1.478 1.466 0 N-CA-C 112.374 -0.291 . . . . 32.5 112.374 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.38 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.746 0.818 . . . . 44.34 112.994 -176.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.53 33.36 3.63 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-N 115.965 -0.561 . . . . 72.4 113.529 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -120.61 177.69 4.97 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 123.577 0.751 . . . . 74.23 110.73 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -67.82 -55.27 13.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.811 0.444 . . . . 71.1 111.291 176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -115.74 89.9 3.21 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.446 0.698 . . . . 65.34 110.997 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -107.17 163.55 12.91 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.975 0.91 . . . . 74.12 111.268 174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -116.8 119.43 35.41 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.351 0.661 . . . . 70.53 110.122 178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.664 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 48.9 t -104.51 114.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 123.42 0.688 . . . . 65.31 110.194 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 83.3 mt-10 -101.22 169.7 8.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.6 1.16 . . . . 74.53 110.578 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -151.02 126.34 10.01 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.422 0.689 . . . . 75.44 110.801 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.52 127.4 32.45 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.975 0.91 . . . . 51.34 111.144 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.92 -40.35 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.301 0.64 . . . . 73.43 111.345 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -167.28 153.59 8.06 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.961 0.905 . . . . 54.02 109.835 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 153.08 35.87 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.203 0.601 . . . . 64.13 110.598 170.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.87 135.18 35.91 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.098 0.559 . . . . 74.32 110.639 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -74.57 -57.65 3.79 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.608 0.763 . . . . 73.12 112.501 -175.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 37.6 m -76.43 -14.83 60.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.937 0.717 . . . . 25.43 112.937 -172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.46 -4.87 30.43 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.182 0.593 . . . . 55.51 111.165 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.48 36.92 18.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.868 1.267 . . . . 63.43 111.271 -176.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -110.23 97.02 6.59 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.14 0.976 . . . . 74.4 111.889 -166.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 14.6 tp -98.67 108.03 20.62 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 124.8 1.24 . . . . 65.32 110.215 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.9 t -108.97 121.68 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.055 0.942 . . . . 72.44 111.527 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -135.98 179.72 6.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.514 0.673 . . . . 71.14 112.209 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.0 t -133.6 163.15 30.05 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.117 1.367 . . . . 74.41 109.598 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.2 mtp -112.39 88.38 10.76 Favored Pre-proline 0 CA--C 1.559 1.313 0 C-N-CA 123.447 0.699 . . . . 75.12 109.377 172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 63' ' ' GLU . 49.4 Cg_endo -65.51 -24.57 56.26 Favored 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 123.603 2.869 . . . . 70.53 113.62 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.664 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 22.1 t70 -135.44 78.4 51.02 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 122.786 0.434 . . . . 74.11 110.447 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 61.4 Cg_endo -95.99 143.22 1.05 Allowed 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.133 2.555 . . . . 74.13 113.864 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 3.0 Cg_exo -79.61 28.16 0.52 Allowed 'Trans proline' 0 CA--C 1.566 2.103 0 C-N-CA 122.943 2.428 . . . . 73.41 112.907 169.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.17 152.83 51.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 124.645 1.178 . . . . 71.12 110.008 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.31 41.11 0.74 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.629 2.886 . . . . 62.1 114.236 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.3 pt -109.85 124.37 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 124.178 0.991 . . . . 64.13 110.743 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 8.9 m -68.25 -68.44 0.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.976 0.51 . . . . 75.12 112.156 -172.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -118.71 110.08 16.86 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.255 0.55 . . . . 65.23 109.627 172.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.424 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 58.7 t-80 -85.67 150.2 24.78 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.026 0.531 . . . . 72.23 111.334 175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -152.62 117.36 5.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.842 0.857 . . . . 73.13 110.081 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.424 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -118.48 149.75 40.75 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 112.609 0.596 . . . . 74.1 112.609 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 94' ' ' GLU . 61.4 t -135.02 137.26 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.353 1.061 . . . . 71.1 109.492 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -114.52 108.88 17.44 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.032 1.333 . . . . 74.03 107.46 -178.51 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.48 ' HG3' HG12 ' A' ' 92' ' ' VAL . 40.3 mt-10 -124.4 114.39 19.44 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 119.241 0.928 . . . . 53.32 111.875 -177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -89.09 109.06 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 108.745 -0.835 . . . . 75.14 108.745 173.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.9 117.9 66.79 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.117 0.967 . . . . 45.12 110.329 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 88.17 0.99 Allowed 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.449 2.099 . . . . 53.33 111.902 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -34.54 78.53 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.059 0.943 . . . . 64.41 110.414 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 20.8 t70 -149.42 165.53 31.81 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.995 1.318 . . . . 53.13 109.042 -175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.13 -43.97 97.66 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.521 0.728 . . . . 72.41 111.897 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -91.87 -19.93 21.97 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.548 0.739 . . . . 64.02 110.835 -178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 39.3 m80 -127.34 138.43 53.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.42 -0.8 . . . . 72.12 111.833 -170.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -126.43 174.94 8.23 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.57 0.748 . . . . 73.43 110.517 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 87.1 m -137.01 111.01 8.25 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.518 0.727 . . . . 54.52 109.964 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.0 t -87.97 115.37 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.252 0.549 . . . . 70.02 110.222 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -105.81 111.84 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.826 1.25 . . . . 60.1 110.553 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -103.62 113.9 27.76 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 109.24 -0.652 . . . . 74.31 109.24 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 51.5 m -114.21 141.32 47.69 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.631 1.172 . . . . 51.52 110.054 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.65 112.18 4.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.066 0.546 . . . . 61.51 112.142 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -118.56 142.53 47.52 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.456 1.102 . . . . 75.54 110.299 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -151.66 153.1 33.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.532 0.733 . . . . 64.32 111.761 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 31.3 t70 -80.71 86.39 5.94 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.144 0.497 . . . . 64.12 110.021 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 36.5 t -151.39 157.77 42.86 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.457 -0.792 . . . . 73.11 111.979 178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m -61.9 146.49 91.24 Favored Pre-proline 0 N--CA 1.492 1.673 0 C-N-CA 123.835 0.854 . . . . 73.42 112.351 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -60.98 -28.96 87.09 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.051 2.501 . . . . 61.34 113.867 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.14 -35.26 77.81 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.902 0.481 . . . . 73.42 112.074 177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.405 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 19.0 m -74.8 -40.63 61.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.216 0.532 . . . . 71.53 110.071 172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.05 -35.97 81.98 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.135 -0.939 . . . . 41.21 112.826 -174.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.9 -33.82 72.7 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.922 0.489 . . . . 62.24 111.24 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.96 -41.52 97.54 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.056 -0.52 . . . . 54.14 109.735 171.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.53 -26.79 60.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.359 0.664 . . . . 73.2 112.313 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -65.75 -37.5 86.53 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 118.615 0.643 . . . . 61.02 110.428 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 m -69.23 -59.68 2.86 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 115.691 -0.686 . . . . 65.4 111.896 173.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 91.2 t -73.0 -56.97 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 123.651 0.78 . . . . 65.5 112.483 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 59.5 mt -76.2 -48.44 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 122.647 0.379 . . . . 53.44 110.581 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.6 -48.07 81.11 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 114.509 0.564 . . . . 71.5 114.509 -175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -101.23 -53.61 2.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.989 -0.712 . . . . 63.02 111.646 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.28 -22.75 69.49 Favored Glycine 0 CA--C 1.54 1.641 0 N-CA-C 115.399 0.92 . . . . 71.05 115.399 -173.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -111.92 -54.4 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 117.548 0.674 . . . . 74.25 111.196 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 10.7 m-30 -72.8 -59.92 2.48 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.292 0.637 . . . . 62.31 112.092 -173.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.504 ' HB2' ' HG2' ' A' ' 6' ' ' ARG . . . -57.84 -36.31 72.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 123.39 0.431 . . . . 65.25 111.484 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.69 -50.4 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 124.221 1.008 . . . . 61.5 111.956 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.84 97.75 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.178 -0.465 . . . . 70.22 113.103 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.49 -36.09 81.87 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.371 1.069 . . . . 64.23 111.946 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -68.91 -43.9 74.26 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.694 0.397 . . . . 74.53 110.47 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.4 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.219 0.608 . . . . 31.01 111.599 176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.98 -42.58 97.18 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.641 0.776 . . . . 73.33 110.397 173.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 144' ' ' LEU . . . -71.76 -29.59 64.67 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.325 0.491 . . . . 62.52 112.325 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 143' ' ' ARG . 48.4 mt-10 -70.2 -41.32 73.84 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.459 0.703 . . . . 64.24 112.453 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -26.85 68.61 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.472 0.545 . . . . 64.32 112.472 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -87.16 -34.41 19.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.762 0.425 . . . . 75.14 112.133 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 165.73 51.12 0.02 OUTLIER Glycine 0 N--CA 1.48 1.586 0 N-CA-C 115.181 0.832 . . . . 63.2 115.181 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 139' ' ' GLU . 80.9 mtp180 50.49 52.74 14.22 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 124.107 0.963 . . . . 65.2 113.152 172.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.644 ' HA ' ' HB1' ' A' ' 138' ' ' ALA . 10.0 mp 64.68 -85.32 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.669 1.187 . . . . 64.34 110.9 -170.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -163.95 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.377 0.671 . . . . 70.3 109.747 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -149.21 165.04 33.05 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.374 1.069 . . . . 74.23 110.348 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 82.5 t60 72.95 -15.82 0.5 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.197 1.184 . . . . 73.21 114.197 169.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.6 p80 50.18 -177.84 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.117 1.767 . . . . 64.21 112.958 -168.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -134.59 -177.92 4.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 75.12 113.044 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -71.03 -0.96 10.6 Favored 'General case' 0 CA--C 1.566 1.565 0 C-N-CA 124.565 1.146 . . . . 75.4 113.495 -169.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 p80 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 123.74 0.816 . . . . 75.43 110.943 -176.138 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.821 0.343 . . . . 71.52 110.667 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.5 6.62 46.46 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.659 0.784 . . . . 73.43 111.57 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 110' ' ' MET . 66.8 m -113.92 111.13 21.2 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.059 0.943 . . . . 75.45 109.442 175.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.24 137.32 36.44 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.21 1.004 . . . . 75.33 109.366 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -142.76 131.95 23.27 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 120.815 0.341 . . . . 74.22 110.218 168.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -125.38 157.42 36.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.547 1.139 . . . . 65.24 109.54 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.3 p -150.29 151.96 33.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.33 0.652 . . . . 75.22 110.697 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.7 p -148.38 145.2 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.75 0.42 . . . . 64.34 110.998 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -92.29 109.48 20.86 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.956 0.502 . . . . 65.23 110.996 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 61.0 t -95.14 139.01 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.566 1.146 . . . . 73.54 111.702 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 33.38 0.13 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 114.0 1.111 . . . . 64.35 114.0 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.06 149.23 34.81 Favored Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 123.582 0.753 . . . . 63.25 111.301 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.12 148.67 67.93 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.484 2.789 . . . . 73.41 114.176 174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.56 -43.43 56.3 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.899 1.444 . . . . 71.3 114.899 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.22 76.33 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.223 0.609 . . . . 62.53 112.105 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.68 -47.04 67.45 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.402 1.081 . . . . 73.31 111.636 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG21 ' SG ' ' A' ' 103' ' ' CYS . 92.9 t -72.97 -34.91 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.998 0.919 . . . . 72.13 111.75 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.9 t-105 -65.05 -28.5 69.52 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 122.819 0.447 . . . . 72.01 111.586 178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.3 m -68.97 -30.78 69.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.168 0.587 . . . . 74.14 111.271 172.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.3 tp -77.76 -48.97 15.34 Favored 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 123.975 0.91 . . . . 62.3 111.848 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -86.3 -34.31 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 113.385 0.883 . . . . 62.41 113.385 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.29 -24.9 74.86 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 114.32 0.488 . . . . 30.1 114.32 -174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -87.77 111.31 21.22 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 169.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.02 -6.44 47.46 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.762 1.023 . . . . 72.02 113.762 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 t -95.84 -8.17 34.92 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.822 0.449 . . . . 74.04 110.497 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.97 -2.87 36.31 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.579 0.751 . . . . 73.32 111.236 -177.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.721 HG23 HG11 ' A' ' 34' ' ' VAL . 20.4 tt -64.16 -26.63 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 C-N-CA 123.052 0.541 . . . . 73.13 112.104 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.08 -9.05 57.88 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 112.822 0.675 . . . . 54.32 112.822 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -82.91 -28.22 30.1 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.52 0.728 . . . . 60.43 111.91 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' NE1' ' HA ' ' A' ' 27' ' ' ILE . 63.5 p-90 -116.24 -35.1 4.44 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.739 0.644 . . . . 73.11 112.739 -174.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -84.82 112.65 44.39 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-O 119.488 -0.291 . . . . 75.02 110.762 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.446 ' HD2' ' HA2' ' A' ' 133' ' ' GLY . 38.9 Cg_endo -64.34 -16.39 54.81 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.371 2.714 . . . . 53.23 114.832 -175.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.493 HE21 ' H ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -88.54 -37.66 15.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.041 -0.412 . . . . 74.23 110.693 174.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.721 HG11 HG23 ' A' ' 27' ' ' ILE . 61.6 t -78.2 102.6 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 120.829 0.347 . . . . 72.0 110.742 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -86.25 -49.88 7.38 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.203 0.601 . . . . 72.12 111.206 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.36 105.81 0.47 Allowed Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 123.698 0.799 . . . . 24.1 111.489 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 68.6 Cg_endo -85.53 160.91 10.94 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 123.0 2.467 . . . . 72.13 113.842 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.4 m -103.95 120.98 42.18 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.848 0.859 . . . . 64.01 110.638 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.09 120.23 29.24 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.282 0.633 . . . . 73.24 110.929 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -108.24 120.63 42.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.896 0.879 . . . . 74.42 109.681 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 43.74 173.66 0.01 OUTLIER Glycine 0 CA--C 1.558 2.754 0 N-CA-C 119.045 2.378 . . . . 75.12 119.045 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 74.61 -39.29 0.41 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.94 1.829 . . . . 73.25 115.94 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.6 m 87.11 135.48 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.843 0 C-N-CA 126.343 1.857 . . . . 71.11 111.555 -171.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.11 -25.37 45.26 Favored 'Trans proline' 0 C--N 1.396 3.04 0 C-N-CA 124.473 3.449 . . . . 72.01 116.835 -166.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -85.32 -28.2 25.42 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 112.075 0.398 . . . . 73.43 112.075 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.7 m -81.38 123.83 80.92 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 123.834 0.853 . . . . 73.43 112.084 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -44.06 109.75 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 124.151 3.234 . . . . 53.52 114.206 171.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 134.24 -21.64 3.85 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 116.222 -0.445 . . . . 72.14 112.953 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.73 125.57 24.75 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 113.321 0.86 . . . . 43.12 113.321 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 64' ' ' ARG . 37.3 mt-10 -104.61 137.43 42.45 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.224 0.61 . . . . 65.23 109.398 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -127.26 133.29 50.2 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 119.585 1.084 . . . . 63.3 111.122 167.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.51 107.66 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.553 -0.749 . . . . 60.05 109.877 -175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -70.77 79.87 0.61 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.406 1.082 . . . . 62.43 110.632 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.74 -65.68 0.59 Allowed Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.907 -0.588 . . . . 40.33 111.93 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 65.39 101.97 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.052 1.341 . . . . 55.12 113.349 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.74 35.13 66.5 Favored Glycine 0 N--CA 1.482 1.704 0 CA-C-O 121.27 0.372 . . . . 22.15 113.57 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -116.41 -162.1 0.83 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.5 1.12 . . . . 74.55 111.304 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.6 -52.33 6.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.475 0.71 . . . . 73.44 111.28 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 85.77 2.44 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.245 0.618 . . . . 74.11 111.138 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -112.19 155.72 23.5 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.189 0.518 . . . . 73.3 111.12 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 ' SD ' ' A' ' 79' ' ' MET . 57.4 tp -120.48 122.55 40.89 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.793 -0.817 . . . . 70.03 108.793 172.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 55.3 t -95.33 117.72 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.426 -0.953 . . . . 74.05 108.426 177.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 2.1 tt0 -114.22 162.73 16.17 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.446 0.698 . . . . 71.54 110.011 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG2' ' HG2' ' A' ' 50' ' ' GLU . 4.6 tmt_? -151.45 125.12 9.01 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.408 0.683 . . . . 73.51 110.193 -173.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.9 tp -82.23 127.74 33.49 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.802 0.841 . . . . 72.34 110.575 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.511 HG21 ' NH1' ' A' ' 90' ' ' ARG . 95.1 t -95.92 -44.46 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.313 0.645 . . . . 73.32 111.188 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -160.63 148.15 15.9 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.974 0.91 . . . . 71.13 110.163 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -124.3 109.65 13.62 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.421 -0.585 . . . . 73.34 109.421 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.56 125.59 41.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.193 0.997 . . . . 74.22 109.125 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -106.18 -15.76 14.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 122.043 -0.41 . . . . 71.54 111.887 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 m -65.94 -39.66 90.69 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.374 0.669 . . . . 54.03 111.899 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.4 4.02 18.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.259 1.023 . . . . 62.14 111.415 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 80.2 mtt-85 53.23 64.03 2.01 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.505 1.122 . . . . 71.15 111.11 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -129.11 111.55 13.06 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.072 0.949 . . . . 73.5 111.029 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 19.8 tp -104.23 105.63 15.85 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.482 0.713 . . . . 72.31 110.961 -173.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.1 t -101.07 124.32 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 123.852 0.861 . . . . 72.13 111.711 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -153.0 -178.01 6.65 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.484 0.659 . . . . 74.13 112.597 -175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 t -153.11 159.85 42.83 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.737 1.215 . . . . 52.42 110.348 173.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.44 ' SD ' HD11 ' A' ' 61' ' ' LEU . 20.6 ptt? -109.96 103.23 53.02 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 123.08 0.552 . . . . 75.43 109.758 171.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 79' ' ' MET . 36.8 Cg_endo -62.59 -29.39 78.08 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.443 2.762 . . . . 73.43 113.726 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.1 m-20 -123.09 83.58 51.14 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 122.995 0.518 . . . . 54.31 110.659 176.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -88.98 147.08 5.59 Favored 'Trans proline' 0 CA--C 1.566 2.107 0 C-N-CA 123.154 2.569 . . . . 75.12 113.214 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -81.85 0.12 10.03 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.515 2.143 . . . . 75.02 112.671 172.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.83 141.75 23.36 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 124.196 0.999 . . . . 74.31 110.535 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' HG2' HG21 ' A' ' 117' ' ' THR . 63.2 Cg_endo -71.1 81.99 1.09 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.647 2.231 . . . . 73.14 113.165 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.662 HG22 ' HB2' ' A' ' 113' ' ' CYS . 27.8 pt -133.04 151.85 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 124.428 1.091 . . . . 74.11 110.031 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 20.8 m -91.66 -85.25 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 122.517 0.327 . . . . 74.35 111.164 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -98.65 111.82 24.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.938 -0.477 . . . . 61.51 110.369 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -92.57 143.75 26.03 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.585 0.754 . . . . 74.43 111.796 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.511 ' NH1' HG21 ' A' ' 66' ' ' VAL . 10.4 tpp180 -148.54 117.02 6.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.485 1.114 . . . . 72.15 108.899 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -125.41 148.27 48.86 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.81 0.444 . . . . 43.25 111.36 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 85.3 t -134.98 136.0 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.228 0 C-N-CA 124.489 1.116 . . . . 71.35 110.355 -177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.39 111.17 18.96 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.146 0.978 . . . . 72.2 110.1 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG3' HG12 ' A' ' 92' ' ' VAL . 36.2 mt-10 -115.11 157.82 23.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.386 1.074 . . . . 74.52 111.614 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.9 t -132.96 111.08 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.279 0.632 . . . . 63.51 109.656 171.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.8 117.46 60.63 Favored Pre-proline 0 CA--C 1.563 1.449 0 C-N-CA 124.751 1.22 . . . . 74.14 110.651 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.12 133.59 25.25 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.722 2.281 . . . . 63.11 113.901 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -105.26 -55.72 2.28 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 124.407 1.083 . . . . 64.12 110.083 174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.5 t70 -126.15 169.18 13.08 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.883 1.273 . . . . 70.23 109.723 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.27 -41.32 79.46 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.594 0.758 . . . . 70.52 112.035 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -106.05 10.04 32.27 Favored 'General case' 0 CA--C 1.563 1.443 0 C-N-CA 123.312 0.645 . . . . 75.24 111.502 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 70.0 m80 -139.79 140.19 36.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 64.31 111.657 -177.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.431 ' SG ' HG21 ' A' ' 17' ' ' VAL . 22.0 p -136.37 178.53 6.99 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.342 0.657 . . . . 71.14 110.221 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.7 m -135.76 113.58 11.07 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.039 0.536 . . . . 61.05 111.039 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.9 t -85.2 107.53 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 109.628 -0.508 . . . . 73.22 109.628 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -96.74 99.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.085 0.954 . . . . 65.42 109.772 -174.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -103.5 118.82 37.61 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.292 0.567 . . . . 72.4 110.563 -175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.528 HG22 ' SD ' ' A' ' 110' ' ' MET . 34.6 m -119.58 139.86 51.48 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.823 1.249 . . . . 71.24 110.207 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.11 113.25 6.51 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.31 0.644 . . . . 72.12 111.326 175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.528 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -124.0 127.76 48.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.921 0.888 . . . . 73.02 110.239 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -146.07 156.01 43.16 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.895 0.878 . . . . 74.01 110.904 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 35.3 t70 -83.09 82.78 8.1 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.47 0.652 . . . . 60.04 110.142 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.662 ' HB2' HG22 ' A' ' 86' ' ' ILE . 51.9 t -120.52 149.87 41.73 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.244 -0.889 . . . . 64.21 111.327 178.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -65.76 128.35 93.75 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-O 118.225 -0.893 . . . . 54.34 110.451 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -39.68 -40.57 2.36 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 124.903 3.735 . . . . 75.5 116.725 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.49 -52.07 59.76 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.313 0.578 . . . . 75.53 110.578 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 85' ' ' PRO . 71.3 m -68.57 -30.55 69.35 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.53 -0.759 . . . . 70.01 111.376 176.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.64 -43.27 76.64 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.509 0.724 . . . . 63.34 111.912 -175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -71.97 -28.47 63.45 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 122.845 0.458 . . . . 71.35 111.143 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.08 -42.34 97.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.483 0.713 . . . . 63.22 110.238 170.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 80.8 mt -74.99 -23.26 58.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.696 0.798 . . . . 71.44 111.688 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -60.71 -37.96 83.45 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 117.971 0.351 . . . . 72.54 110.481 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.2 m -73.06 -48.49 35.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.215 0.606 . . . . 74.4 112.538 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.9 -54.04 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 112.767 0.654 . . . . 74.21 112.767 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.2 mt -79.57 -52.28 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 123.29 0.636 . . . . 44.24 111.146 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.59 -68.39 1.63 Allowed Glycine 0 N--CA 1.477 1.425 0 N-CA-C 114.043 0.377 . . . . 72.44 114.043 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.305 0.642 . . . . 64.22 111.075 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.89 -96.72 0.26 Allowed Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.644 -0.531 . . . . 52.51 112.834 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.5 t -48.38 -49.22 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 124.574 1.149 . . . . 71.31 113.616 -171.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.17 -61.13 1.9 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.664 -0.698 . . . . 72.44 111.644 -174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.32 70.86 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.252 0.464 . . . . 62.34 112.252 -174.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.8 t -60.45 -50.51 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 C-N-CA 123.775 0.83 . . . . 53.51 111.431 171.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.446 ' HA2' ' HD2' ' A' ' 32' ' ' PRO . . . -68.96 -37.74 83.77 Favored Glycine 0 C--N 1.349 1.276 0 CA-C-N 116.058 -0.519 . . . . 52.34 113.287 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.5 mt -68.62 -41.96 78.76 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.448 1.099 . . . . 71.22 111.778 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -64.52 -43.16 94.92 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.594 0.358 . . . . 74.51 110.843 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.35 -31.32 72.48 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.814 0.446 . . . . 63.41 112.055 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 tt -68.52 -45.8 71.31 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.177 0.591 . . . . 65.03 109.682 174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.95 95.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.483 0.713 . . . . 73.34 112.024 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.35 -40.18 58.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.089 0.956 . . . . 63.13 112.941 -175.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -61.91 -36.11 80.35 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 112.756 0.65 . . . . 74.45 112.756 -172.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.24 -28.16 59.77 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.973 0.509 . . . . 73.13 111.947 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.83 -1.03 68.17 Favored Glycine 0 N--CA 1.478 1.467 0 CA-C-N 116.491 -0.322 . . . . 72.13 113.116 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 58.21 30.37 19.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.805 1.242 . . . . 74.53 111.489 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.1 mp 67.77 114.68 0.04 OUTLIER 'General case' 0 C--N 1.359 1.017 0 C-N-CA 126.242 1.817 . . . . 64.43 111.689 178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -55.57 5.3 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.424 0.69 . . . . 64.23 111.082 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -155.59 32.97 0.36 Allowed 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 123.024 0.53 . . . . 74.44 110.998 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 43.6 m80 66.34 -178.83 0.2 Allowed 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 124.479 1.112 . . . . 65.33 112.97 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -114.28 23.29 12.98 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.205 0.602 . . . . 73.43 111.98 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 74.2 m80 71.67 -67.43 0.26 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 125.633 1.573 . . . . 71.12 113.65 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 81.9 t60 68.73 95.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.539 1.136 . . . . 72.34 110.672 -167.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 124.78 1.232 . . . . 74.24 112.374 178.148 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.88 0.372 . . . . 64.33 111.631 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.29 39.21 3.96 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.918 0.887 . . . . 60.52 109.979 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.4 m -108.73 113.14 25.85 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.587 0.755 . . . . 64.51 111.141 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -98.31 112.82 24.68 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.795 1.238 . . . . 55.03 110.511 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 -112.57 133.08 54.81 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 122.02 -0.425 . . . . 70.31 110.43 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.4 143.53 44.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.168 0.587 . . . . 72.35 109.78 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 98.1 p -143.72 158.63 43.54 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.525 0.73 . . . . 64.23 110.605 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.3 p -153.23 143.17 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.92 0.488 . . . . 62.14 111.222 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -86.43 108.62 18.58 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.793 -0.447 . . . . 74.21 109.793 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 48.6 t -90.99 128.06 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.643 0.777 . . . . 31.3 110.999 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -77.74 67.77 3.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.098 0.559 . . . . 65.31 111.36 175.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.61 153.61 2.82 Favored Pre-proline 0 N--CA 1.486 1.35 0 C-N-CA 123.55 0.74 . . . . 62.31 111.692 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.12 126.98 19.05 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.163 2.576 . . . . 73.43 113.146 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.06 -42.23 8.4 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.043 1.497 . . . . 61.43 115.043 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.83 85.7 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.771 0.428 . . . . 54.13 112.079 177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.34 -36.49 84.29 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.647 0.779 . . . . 72.54 112.028 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.72 -36.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.365 0.666 . . . . 55.25 110.203 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -67.7 -28.93 68.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.506 -0.77 . . . . 73.34 110.841 175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.6 m -62.58 -32.9 73.96 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.142 0.496 . . . . 74.04 111.017 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 30' ' ' TRP . 61.5 tp -70.8 -46.66 62.43 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.17 0.988 . . . . 75.44 111.536 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.57 8.14 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 123.681 0.792 . . . . 72.22 112.62 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.98 -9.86 79.81 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 123.282 0.468 . . . . 54.22 113.936 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' A' ' 26' ' ' ALA . 2.1 m-20 -106.7 132.81 52.26 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.294 0.568 . . . . 72.32 109.603 168.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -76.03 -5.99 48.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.737 0.815 . . . . 63.31 111.32 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.5 p -93.37 -10.3 35.76 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 123.525 0.73 . . . . 44.22 111.415 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -97.45 22.88 8.24 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 113.442 0.904 . . . . 51.51 113.442 -153.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.601 HG12 HG21 ' A' ' 34' ' ' VAL . 19.2 tt -81.25 -18.2 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 O-C-N 122.259 -0.276 . . . . 74.24 111.31 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -65.62 -22.36 66.66 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.003 0.521 . . . . 75.03 111.827 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -68.96 -44.91 71.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.399 1.08 . . . . 72.31 112.422 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' HB3' HD21 ' A' ' 20' ' ' LEU . 28.3 p-90 -115.95 -37.64 3.83 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.153 0.797 . . . . 74.44 113.153 -169.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -83.44 110.72 26.23 Favored Pre-proline 0 CA--C 1.562 1.407 0 N-CA-C 109.959 -0.386 . . . . 74.42 109.959 -172.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.91 2.03 5.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.019 2.479 . . . . 74.43 116.312 -165.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.517 HE21 ' N ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -102.74 -19.73 14.63 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 118.521 0.6 . . . . 60.42 111.866 176.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.601 HG21 HG12 ' A' ' 27' ' ' ILE . 57.6 t -70.11 118.86 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-O 121.183 0.516 . . . . 70.33 112.188 -174.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 t -88.61 38.12 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.602 1.161 . . . . 74.4 111.448 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.2 109.28 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 125.292 1.437 . . . . 64.31 112.062 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.75 160.69 12.22 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.543 2.162 . . . . 71.43 112.992 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.8 m -99.53 122.59 42.82 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.213 -0.662 . . . . 74.44 109.213 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -87.58 122.63 31.52 Favored 'General case' 0 CA--C 1.554 1.123 0 N-CA-C 107.9 -1.148 . . . . 32.44 107.9 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.487 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 99.3 mtt180 -110.57 126.15 54.13 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.725 0.81 . . . . 63.32 111.308 -175.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.72 -176.68 0.01 OUTLIER Glycine 0 CA--C 1.547 2.048 0 N-CA-C 118.102 2.001 . . . . 53.33 118.102 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.48 -92.9 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 125.082 1.353 . . . . 74.4 112.942 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 t 165.65 147.16 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 C-N-CA 125.954 1.702 . . . . 43.51 108.704 -173.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.09 -4.43 6.24 Favored 'Trans proline' 0 CA--C 1.566 2.102 0 C-N-CA 122.515 2.143 . . . . 71.13 114.034 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.04 -10.0 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.7 0.8 . . . . 62.31 112.129 173.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -108.37 125.69 31.31 Favored Pre-proline 0 N--CA 1.497 1.892 0 C-N-CA 123.721 0.808 . . . . 52.33 112.143 -176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.579 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 98.9 Cg_exo -48.41 123.65 9.49 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 123.804 3.002 . . . . 73.41 114.081 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.68 -27.77 4.08 Favored Glycine 0 N--CA 1.474 1.21 0 CA-C-N 116.137 -0.483 . . . . 32.14 112.445 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.83 147.62 49.49 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.602 0.761 . . . . 73.51 112.548 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 45.1 mt-10 -130.21 120.74 24.98 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 122.819 0.447 . . . . 72.34 111.622 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' NH2' ' HB ' ' A' ' 27' ' ' ILE . 0.7 OUTLIER -92.67 120.73 33.37 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.613 -0.884 . . . . 74.15 108.613 175.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.65 98.52 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.679 -0.638 . . . . 62.43 110.652 -174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -59.69 121.57 11.97 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.133 1.373 . . . . 74.41 111.91 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.68 -51.45 4.57 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-O 119.967 -0.352 . . . . 73.35 112.886 -178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 56.83 33.86 23.79 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.353 1.061 . . . . 74.45 113.041 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.68 -24.86 0.12 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.971 -1.013 . . . . 70.34 111.74 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.6 p -63.13 141.1 58.89 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.6 0.76 . . . . 72.11 111.006 171.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.56 -30.98 65.68 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.352 0.661 . . . . 62.12 112.183 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -110.82 66.93 0.63 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.33 0.652 . . . . 71.4 110.392 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.86 164.16 23.8 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.193 0.521 . . . . 74.45 111.798 171.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 79' ' ' MET . 56.2 tp -133.92 131.24 38.83 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.694 0.797 . . . . 62.22 109.745 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.6 125.68 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.43 109.928 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.677 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 32.2 mt-10 -118.37 126.53 52.28 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.551 0.74 . . . . 73.2 109.19 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -101.96 133.48 46.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.193 0.997 . . . . 75.14 111.322 176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.579 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 13.4 tp -75.64 112.1 11.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.332 1.453 . . . . 72.14 111.089 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.7 t -77.29 -52.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.221 0.608 . . . . 72.32 111.328 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -160.72 154.72 22.79 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 116.098 -0.501 . . . . 71.1 111.181 -172.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.751 ' HE ' HD13 ' A' ' 75' ' ' LEU . 19.4 tpp85 -140.15 123.99 17.41 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.486 0.715 . . . . 74.41 111.201 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.555 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 12.4 m-20 -122.45 76.41 1.32 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.561 0.745 . . . . 71.13 110.356 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -66.53 -18.5 65.4 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 112.959 0.726 . . . . 65.41 112.959 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.1 m -66.44 -46.5 76.25 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.246 0.619 . . . . 54.02 110.723 169.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.67 -2.35 58.55 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.064 0.946 . . . . 63.42 112.967 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 59.51 51.26 6.66 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.182 0.993 . . . . 74.52 111.182 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 28.6 ttm-85 -126.9 132.63 50.86 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.202 1.001 . . . . 74.23 110.364 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.751 HD13 ' HE ' ' A' ' 68' ' ' ARG . 6.1 tp -130.54 108.51 9.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.985 0.914 . . . . 73.52 109.954 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.6 t -106.57 129.65 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.592 0.757 . . . . 72.41 110.005 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -149.97 178.55 8.83 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-O 121.501 0.667 . . . . 74.41 112.759 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -149.57 141.84 24.14 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.199 1.399 . . . . 44.4 109.724 -170.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 61' ' ' LEU . 61.1 mtm -94.44 104.54 14.28 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 119.055 0.843 . . . . 73.35 111.064 174.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.52 -24.48 22.22 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.638 2.225 . . . . 64.05 112.716 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -126.34 78.84 71.16 Favored Pre-proline 0 CA--C 1.557 1.234 0 C-N-CA 123.545 0.738 . . . . 62.23 110.828 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.74 147.55 5.9 Favored 'Trans proline' 0 CA--C 1.569 2.248 0 C-N-CA 122.885 2.39 . . . . 73.53 113.211 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 61' ' ' LEU . 65.3 Cg_endo -84.76 1.89 8.32 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.684 2.256 . . . . 74.44 112.655 172.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.1 155.44 36.46 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.224 1.009 . . . . 73.25 110.321 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.78 57.11 4.93 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.011 2.474 . . . . 64.13 112.898 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 113' ' ' CYS . 22.3 pt -121.95 134.63 64.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.564 1.146 . . . . 72.12 109.619 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 37.5 m -75.0 -81.78 0.07 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.193 0.442 . . . . 64.15 112.193 -173.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -78.11 -56.34 4.55 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 112.233 0.457 . . . . 74.13 112.233 -172.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 58.08 127.58 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 125.745 1.618 . . . . 72.4 113.738 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -123.93 153.54 41.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.076 1.35 . . . . 73.2 108.366 169.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -156.4 135.71 12.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 72.11 110.528 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 7.7 p -136.85 138.61 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.3 0 N-CA-C 113.242 0.83 . . . . 73.4 113.242 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.5 mm? -104.66 119.4 38.91 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.845 1.258 . . . . 71.54 109.235 172.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -123.86 110.1 14.44 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.673 -0.491 . . . . 71.32 109.673 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.63 110.01 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 109.491 -0.559 . . . . 71.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.87 111.18 63.87 Favored Pre-proline 0 CA--C 1.558 1.28 0 C-N-CA 124.023 0.929 . . . . 64.51 110.385 -172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.28 109.92 1.89 Allowed 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.791 2.327 . . . . 45.34 113.005 -177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.438 ' H ' ' HA ' ' A' ' 103' ' ' CYS . 39.5 mmt180 -75.74 -46.65 29.76 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.525 0.679 . . . . 74.53 109.761 171.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -122.79 -166.23 1.41 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.84 1.256 . . . . 74.3 109.276 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -81.68 -35.35 29.97 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.717 0.407 . . . . 72.44 110.938 167.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -108.85 13.23 25.02 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.106 0.563 . . . . 75.32 111.587 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 53.1 m80 -142.1 152.56 43.38 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 123.747 0.819 . . . . 70.1 109.637 172.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 10' ' ' VAL . 28.8 p -153.34 177.62 10.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.024 0.529 . . . . 42.32 111.738 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 82.3 m -133.99 111.86 10.75 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.832 0.853 . . . . 72.42 109.986 174.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.89 116.87 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.469 -0.567 . . . . 51.21 109.469 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -100.11 105.89 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.795 0.838 . . . . 75.12 109.513 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 7.4 t90 -102.97 116.96 33.56 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.23 -1.026 . . . . 71.52 108.23 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 152.8 46.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.707 0.803 . . . . 65.33 109.928 -171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -139.9 155.32 47.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.118 1.367 . . . . 73.23 109.596 175.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 12.1 ptt? -163.47 126.11 2.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.039 0.936 . . . . 54.02 109.688 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 3.9 p90 -141.31 156.01 45.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.332 0.653 . . . . 75.41 112.023 -165.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.645 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 38.4 t70 -84.97 86.98 7.33 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.499 0.666 . . . . 74.44 110.316 177.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.9 t -145.59 165.22 29.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.92 -1.036 . . . . 62.12 110.861 175.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.1 p -68.53 148.82 98.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 123.18 0.592 . . . . 64.14 111.687 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -63.93 -22.16 68.59 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.298 1.999 . . . . 72.11 112.78 175.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -65.83 -43.72 87.71 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.01 0.924 . . . . 74.32 111.312 175.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.499 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 23.5 m -84.33 -31.16 24.97 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.091 0.557 . . . . 65.41 111.068 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -64.62 -33.92 77.05 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.54 0.736 . . . . 63.14 112.226 -175.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -65.73 -33.85 76.83 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.107 0.563 . . . . 73.51 111.402 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -70.61 -38.74 73.99 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.721 0.809 . . . . 75.23 109.961 174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -71.9 -24.84 61.72 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.287 -0.869 . . . . 71.32 111.828 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 51.3 mt-10 -61.61 -39.13 90.17 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 117.956 0.343 . . . . 72.21 110.362 171.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -66.75 -55.67 13.97 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.536 0.734 . . . . 53.55 112.102 173.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.53 -55.03 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 123.463 0.705 . . . . 71.13 112.708 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 69.3 mt -82.53 -58.17 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.536 -0.757 . . . . 65.43 111.099 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.71 -50.03 32.96 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 114.973 0.749 . . . . 25.31 114.973 -173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -89.75 -25.24 21.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.14 0.576 . . . . 60.44 111.177 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -82.07 -88.51 0.67 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-N 116.13 -0.486 . . . . 64.24 112.038 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.4 t -56.09 -47.01 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 124.559 1.144 . . . . 33.43 113.366 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -77.84 -50.14 12.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.106 0.562 . . . . 73.01 112.159 -171.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.77 -46.19 81.63 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 123.243 0.339 . . . . 71.31 111.063 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 t -56.8 -50.3 75.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.225 0.61 . . . . 63.45 112.047 174.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.64 -48.68 82.96 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 123.508 0.505 . . . . 63.32 113.391 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.2 mt -69.99 -37.37 75.69 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.78 0.832 . . . . 72.11 112.959 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -66.46 -52.04 50.49 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 110.261 -0.274 . . . . 65.53 110.261 177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.14 69.62 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.287 0.635 . . . . 42.11 111.8 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.437 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 10.0 tt -68.23 -45.99 71.77 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.484 0.714 . . . . 71.14 110.18 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.84 -28.17 64.4 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 112.082 0.401 . . . . 64.3 112.082 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.73 -44.78 48.11 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.121 0.968 . . . . 63.22 111.635 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 12.8 ptm180 -63.8 -29.34 70.55 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.133 0.573 . . . . 63.43 112.152 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -81.3 -22.06 38.83 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.974 0.731 . . . . 72.41 112.974 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.65 -42.18 0.1 Allowed Glycine 0 C--N 1.354 1.578 0 N-CA-C 115.225 0.85 . . . . 50.34 115.225 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? 69.94 16.95 7.58 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 124.867 1.267 . . . . 73.23 111.983 -169.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.34 47.18 1.38 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.449 -0.782 . . . . 63.11 109.448 167.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.08 -169.5 1.71 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.42 1.088 . . . . 70.35 111.931 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -58.79 -14.47 8.86 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.305 1.042 . . . . 73.25 113.712 -176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.2 m80 72.45 89.0 0.1 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.339 1.455 . . . . 74.04 111.137 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -77.29 -3.59 40.67 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.728 -1.124 . . . . 73.13 112.156 175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 63.6 -79.46 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.352 1.461 . . . . 71.21 112.508 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -101.4 -60.42 1.53 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.414 0.686 . . . . 71.33 110.98 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 121.369 0.604 . . . . 74.13 109.928 -174.114 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 120.638 0.256 . . . . 74.14 110.826 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.42 21.7 9.8 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.989 0.916 . . . . 71.54 110.37 172.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.6 m -111.49 119.33 38.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.353 1.061 . . . . 73.54 110.039 -175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.0 139.78 31.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.694 1.197 . . . . 65.44 108.701 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -147.46 126.35 12.74 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 121.021 0.438 . . . . 72.21 111.184 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -130.32 158.27 40.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.05 1.34 . . . . 61.13 110.081 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.8 p -155.1 154.86 33.03 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.246 0.618 . . . . 75.11 112.005 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.5 p -152.17 145.8 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.086 0.555 . . . . 73.23 111.354 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -87.56 108.84 19.24 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 120.996 0.427 . . . . 74.21 110.694 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.445 HG21 HD22 ' A' ' 137' ' ' LEU . 95.2 t -94.05 137.77 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 63.2 110.411 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -83.16 41.9 0.78 Allowed 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 112.936 0.717 . . . . 64.33 112.936 178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.607 ' HA ' HH11 ' A' ' 101' ' ' ARG . . . -142.06 148.18 47.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.675 0.79 . . . . 60.55 110.483 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.23 142.97 93.52 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.412 2.074 . . . . 73.44 112.375 171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.08 -33.54 39.8 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 125.177 1.391 . . . . 74.2 114.503 -174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.76 -49.7 69.75 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.082 0.553 . . . . 73.35 112.107 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.99 -39.38 85.52 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.465 0.706 . . . . 73.33 112.139 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG21 ' SG ' ' A' ' 103' ' ' CYS . 65.2 t -70.63 -35.53 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.273 0.629 . . . . 62.13 111.009 177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.487 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 62.4 t-105 -68.46 -31.52 70.87 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.155 0.582 . . . . 63.12 110.864 176.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.7 m -65.96 -33.27 75.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.354 0.662 . . . . 74.22 110.672 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 30' ' ' TRP . 53.7 tp -75.86 -52.79 9.57 Favored 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 123.806 0.842 . . . . 75.43 112.346 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 m -79.38 -32.81 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 113.124 0.787 . . . . 63.21 113.124 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.77 -31.68 81.61 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 114.544 0.578 . . . . 74.45 114.544 -174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -72.73 95.76 1.94 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.025 0.44 . . . . 72.34 109.967 171.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HD1' ' HA ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -67.18 -18.06 65.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.308 0.643 . . . . 65.34 112.246 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.6 p -77.57 -27.21 51.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.079 0.552 . . . . 71.11 111.191 172.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -124.32 29.13 6.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.857 0.863 . . . . 31.11 111.139 -168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.604 HG23 HG11 ' A' ' 34' ' ' VAL . 9.2 tt -64.85 -27.13 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.419 0 CA-C-N 115.09 -0.959 . . . . 52.52 111.555 175.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -59.95 -12.36 7.67 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 114.212 1.19 . . . . 73.33 114.212 175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -71.24 -24.62 62.22 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.13 0.572 . . . . 70.01 112.502 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.42 ' HB3' HD21 ' A' ' 20' ' ' LEU . 59.1 p-90 -122.51 -31.55 3.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.296 0.638 . . . . 73.02 111.404 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.469 ' CE1' HE21 ' A' ' 33' ' ' GLN . 22.1 t-80 -95.35 104.16 14.63 Favored Pre-proline 0 CA--C 1.558 1.252 0 C-N-CA 123.182 0.593 . . . . 72.34 110.206 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.3 -16.32 54.42 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.212 2.608 . . . . 75.21 114.617 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.469 HE21 ' CE1' ' A' ' 31' ' ' HIS . 6.0 mt-30 -95.25 -11.06 28.61 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.3 0.852 . . . . 61.43 113.3 -174.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.604 HG11 HG23 ' A' ' 27' ' ' ILE . 56.1 t -75.04 116.48 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 CA-C-N 118.346 0.521 . . . . 64.34 110.321 170.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -87.03 29.79 0.8 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.822 0.849 . . . . 64.25 112.137 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.469 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 68.08 121.7 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 125.706 1.602 . . . . 72.31 111.888 -175.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 41.9 Cg_endo -96.26 155.26 1.34 Allowed 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.024 2.483 . . . . 34.41 115.924 -175.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 78.3 m -101.11 123.56 45.46 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.976 0.91 . . . . 74.42 109.938 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -82.21 123.36 28.94 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.256 0.55 . . . . 71.23 112.33 -172.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 10.3 mmm180 -103.07 121.81 43.36 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.722 1.209 . . . . 63.31 110.214 177.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.18 -178.53 0.01 OUTLIER Glycine 0 CA--C 1.549 2.18 0 N-CA-C 117.766 1.866 . . . . 53.31 117.766 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.654 ' HB3' ' HB2' ' A' ' 49' ' ' ALA . . . 40.27 -98.02 0.02 OUTLIER 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 126.059 1.743 . . . . 73.41 115.111 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.426 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 30.0 t -176.81 149.36 0.85 Allowed Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 124.461 1.104 . . . . 71.22 110.491 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.33 -11.97 21.71 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.871 2.381 . . . . 53.32 113.587 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -114.72 1.94 14.3 Favored 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 123.902 0.881 . . . . 74.5 112.498 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.8 m -97.53 117.52 65.31 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.361 -0.837 . . . . 65.04 110.204 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 22.0 Cg_endo -58.48 92.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.065 2.51 . . . . 72.44 112.752 176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.15 -42.5 0.27 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.279 -0.873 . . . . 54.13 112.115 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.654 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . . . -67.58 164.74 18.39 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 113.908 1.077 . . . . 55.12 113.908 -172.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 33.9 mt-10 -121.62 164.47 17.25 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.251 1.02 . . . . 62.52 110.097 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -146.68 146.29 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.004 0.43 . . . . 65.2 111.837 168.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.1 t -117.69 108.11 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.546 0.738 . . . . 72.33 111.158 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -66.27 110.31 2.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.442 1.097 . . . . 74.32 110.633 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.96 -63.33 1.5 Allowed Glycine 0 CA--C 1.539 1.563 0 N-CA-C 112.064 -0.414 . . . . 64.12 112.064 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 61.88 115.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 114.743 1.386 . . . . 75.12 114.743 171.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.02 17.97 66.14 Favored Glycine 0 N--CA 1.478 1.458 0 CA-C-O 121.237 0.354 . . . . 62.52 112.698 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 76.8 p -94.6 -171.25 2.43 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.921 1.288 . . . . 60.31 109.923 175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -90.34 -26.63 19.86 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 120.811 0.338 . . . . 75.13 110.63 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.33 93.01 2.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.385 0.674 . . . . 62.11 110.116 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.33 -175.72 2.75 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.417 0.687 . . . . 74.31 111.512 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 83' ' ' PRO . 34.9 tp -135.11 117.76 16.0 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.719 0.808 . . . . 74.25 110.347 178.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.3 t -100.98 121.81 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 109.173 -0.677 . . . . 54.44 109.173 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.61 167.19 14.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.424 0.69 . . . . 65.02 109.924 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.511 HH11 ' HA ' ' A' ' 66' ' ' VAL . 3.1 tmt_? -140.7 109.07 5.83 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.088 0.955 . . . . 70.35 109.843 -165.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 29.8 tp -59.46 105.91 0.4 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.159 0.984 . . . . 63.31 110.96 174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.511 ' HA ' HH11 ' A' ' 64' ' ' ARG . 89.3 t -78.27 -51.03 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.37 0.668 . . . . 51.12 111.307 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -149.25 151.45 34.25 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.153 0.581 . . . . 72.54 111.287 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -143.13 130.07 20.57 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.965 0.906 . . . . 61.01 110.479 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 14.7 m-20 -135.94 118.3 15.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.361 1.064 . . . . 72.24 110.466 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 3.9 mp0 -80.77 -36.54 31.72 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.84 0.456 . . . . 74.02 110.267 169.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 47.1 m -63.71 -37.61 87.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.893 0.877 . . . . 74.33 112.394 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.5 -12.36 24.25 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.234 0.614 . . . . 63.32 111.733 175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 59.46 45.88 13.03 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.771 1.228 . . . . 71.01 110.006 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 39.0 ttm180 -122.21 123.16 40.84 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.583 1.553 . . . . 75.15 111.022 -169.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 93' ' ' LEU . 23.7 tp -123.22 106.64 10.91 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.501 0.72 . . . . 73.34 110.415 -176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.1 t -108.21 129.89 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 123.877 0.871 . . . . 70.43 111.583 -169.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -139.22 172.86 12.22 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.565 0.746 . . . . 75.24 112.252 176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.1 m -149.93 139.09 21.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.312 1.445 . . . . 73.11 109.257 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.415 ' SD ' HD11 ' A' ' 61' ' ' LEU . 69.6 mtm -94.66 105.59 19.43 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-N 118.51 0.595 . . . . 74.23 110.556 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.74 -18.28 22.26 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.006 2.47 . . . . 42.1 112.179 171.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -125.6 78.24 68.73 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 123.869 0.868 . . . . 64.13 109.032 171.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.84 140.39 16.23 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.684 2.256 . . . . 74.23 112.802 -178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.577 ' HD3' HD13 ' A' ' 61' ' ' LEU . 63.4 Cg_endo -85.24 8.41 4.62 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.944 2.43 . . . . 72.14 112.557 174.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -126.98 141.38 40.47 Favored Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 124.496 1.118 . . . . 75.51 109.383 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.67 88.23 0.22 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.578 2.186 . . . . 61.42 113.325 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' HB2' ' A' ' 113' ' ' CYS . 14.8 pt -137.32 168.37 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 125.159 1.383 . . . . 73.42 109.43 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 28.8 m -93.57 -84.02 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 112.118 0.414 . . . . 71.43 112.118 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -86.26 -45.13 11.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 112.642 0.608 . . . . 65.42 112.642 -170.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 47.9 t-80 64.66 141.6 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.736 1.614 . . . . 72.05 113.529 -172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -150.77 152.73 34.27 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.403 1.081 . . . . 75.21 108.424 166.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -160.39 151.09 18.6 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.877 0.471 . . . . 75.23 111.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.78 150.86 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 113.024 0.75 . . . . 72.34 113.024 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB3' ' HB3' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -120.63 108.54 14.15 Favored 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 125.639 1.576 . . . . 74.03 107.58 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -126.76 115.1 18.86 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.948 0.499 . . . . 72.21 111.45 -176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.8 t -95.34 126.57 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 122.779 0.432 . . . . 75.51 110.292 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -113.58 117.72 44.36 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.397 1.079 . . . . 60.35 110.684 -173.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.64 108.23 2.41 Favored 'Trans proline' 0 CA--C 1.568 2.215 0 C-N-CA 122.826 2.351 . . . . 75.54 114.416 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -81.2 -34.73 32.07 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 123.864 0.866 . . . . 71.41 111.767 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 25.6 t70 -156.73 163.2 39.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.311 1.044 . . . . 74.52 109.986 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -59.04 -23.29 61.87 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.537 1.135 . . . . 72.33 113.119 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.607 HH11 ' HA ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -128.33 5.19 5.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.678 0.791 . . . . 63.52 111.07 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 51.2 m80 -138.51 130.47 28.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.812 . . . . 74.15 110.811 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' HG21 ' A' ' 17' ' ' VAL . 17.3 p -136.33 178.81 6.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.654 0.782 . . . . 65.04 110.226 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 60.9 m -133.9 118.08 17.52 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.074 0.55 . . . . 73.35 111.354 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.55 110.92 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 109.77 -0.456 . . . . 74.44 109.77 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.6 t -100.67 111.86 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.972 0.909 . . . . 63.52 109.633 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -111.32 124.67 52.72 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.912 0.485 . . . . 74.34 109.915 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.2 m -127.91 146.28 50.68 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.48 1.112 . . . . 70.21 110.84 -170.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -145.91 113.8 6.48 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.477 0.711 . . . . 73.43 111.87 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 110' ' ' MET . 0.0 OUTLIER -116.9 125.69 51.86 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.56 1.144 . . . . 75.2 109.875 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 3.2 p90 -146.79 146.48 30.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.116 0.566 . . . . 71.21 112.521 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.438 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 37.6 t70 -76.93 86.44 3.47 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.477 0.656 . . . . 72.14 109.617 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.562 ' HB2' HG22 ' A' ' 86' ' ' ILE . 46.5 t -117.86 164.21 15.39 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.907 -1.042 . . . . 73.03 111.828 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 78.0 p -83.95 152.36 62.26 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.546 0.738 . . . . 65.03 110.981 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.41 -62.21 0.48 Allowed 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 123.956 3.104 . . . . 72.15 115.616 -170.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 -31.71 72.14 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.7 0.8 . . . . 53.41 112.639 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 25.1 m -75.11 -34.31 61.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.315 0.246 . . . . 60.02 111.021 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -45.21 61.74 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.153 0.581 . . . . 63.15 111.351 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -22.93 66.61 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.259 0.466 . . . . 65.03 112.259 173.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -75.34 -41.3 56.98 Favored 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.12 0.568 . . . . 74.3 111.298 170.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.1 mt -75.38 -24.88 57.28 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.109 1.151 . . . . 72.5 114.109 -173.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.39 80.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 113.558 0.947 . . . . 71.34 113.558 -175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 73.9 m -79.31 -44.11 22.29 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.918 0.71 . . . . 62.12 112.918 170.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.92 -51.22 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.28 0.562 . . . . 75.32 111.87 -176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.6 mt -81.48 -49.0 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 123.705 0.802 . . . . 53.41 110.888 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -65.52 -42.68 95.57 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 114.849 0.699 . . . . 44.51 114.849 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -94.44 -58.95 2.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 122.093 -0.651 . . . . 62.01 110.932 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -66.95 -18.12 68.37 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.729 1.052 . . . . 45.34 115.729 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.31 -52.27 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-N 117.644 0.722 . . . . 70.33 110.977 176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -74.85 -60.8 2.12 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.53 0.732 . . . . 74.23 112.123 -172.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.71 -34.77 65.42 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 123.475 0.485 . . . . 72.42 111.525 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.9 t -52.95 -56.54 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.571 0 C-N-CA 124.04 0.936 . . . . 73.14 112.442 171.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -68.3 -36.68 85.15 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 116.568 -0.287 . . . . 31.43 112.97 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.52 -47.45 81.64 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.167 0.987 . . . . 74.15 112.039 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -62.28 -47.71 83.13 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.28 0.632 . . . . 74.32 110.874 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.59 74.15 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.234 0.457 . . . . 63.55 112.234 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.445 HD22 HG21 ' A' ' 10' ' ' VAL . 3.8 tt -67.81 -43.17 80.28 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.01 0.524 . . . . 64.53 110.103 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.06 -43.74 81.92 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.89 0.476 . . . . 74.13 111.837 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.42 -31.26 60.31 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.128 0.971 . . . . 71.4 112.905 -173.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -67.15 -29.95 69.79 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 117.873 0.306 . . . . 73.1 111.337 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -93.42 -5.01 50.31 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.883 0.473 . . . . 71.34 112.196 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.71 24.0 0.8 Allowed Glycine 0 CA--C 1.549 2.21 0 N-CA-C 115.02 0.768 . . . . 70.13 115.02 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -66.75 -25.75 66.65 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.663 1.185 . . . . 63.01 112.492 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 144' ' ' LEU . 2.4 pt? -115.17 -7.78 12.41 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.597 0.591 . . . . 70.0 112.597 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -97.59 171.29 8.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.941 1.089 . . . . 75.42 113.941 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -127.49 167.29 16.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 113.904 -1.498 . . . . 74.3 110.669 -174.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 63.45 97.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.866 1.266 . . . . 75.32 111.954 -173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -117.03 -174.36 2.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.186 0.994 . . . . 72.14 111.39 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 64.69 95.33 0.05 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.986 1.314 . . . . 74.14 110.349 -168.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -68.32 123.85 21.87 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.323 0.649 . . . . 63.21 111.774 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 121.442 0.639 . . . . 55.22 111.681 178.21 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.86 0.362 . . . . 74.2 111.077 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.12 13.77 27.01 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.697 0.799 . . . . 64.11 110.634 170.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.4 m -105.99 114.5 28.68 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.806 0.842 . . . . 74.33 110.182 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.36 114.68 26.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.886 1.274 . . . . 75.2 109.833 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -122.47 138.22 54.62 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.889 0.476 . . . . 72.13 111.968 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -138.96 155.08 48.3 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.934 1.294 . . . . 73.01 109.55 171.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 90.9 p -149.82 156.99 42.76 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.357 0.663 . . . . 72.11 110.357 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 104' ' ' THR . 11.1 p -145.53 146.09 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 112.084 0.402 . . . . 74.04 112.084 -175.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -91.43 111.84 23.5 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.858 0.863 . . . . 62.4 109.71 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 60.7 t -104.29 130.76 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.195 0.998 . . . . 62.44 110.82 -175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.93 71.54 6.63 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-O 121.113 0.482 . . . . 60.22 111.113 173.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.46 154.12 3.74 Favored Pre-proline 0 N--CA 1.484 1.257 0 C-N-CA 124.124 0.97 . . . . 73.42 111.197 -177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.54 136.17 49.05 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.865 2.376 . . . . 34.32 111.985 168.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.23 17.78 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 114.562 1.319 . . . . 71.11 114.562 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.9 -47.69 82.21 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.19 0.596 . . . . 72.24 112.57 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.47 -43.02 79.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.202 0.601 . . . . 72.15 111.784 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.516 HG21 ' SG ' ' A' ' 103' ' ' CYS . 42.5 t -69.18 -33.79 60.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 115.418 -0.81 . . . . 51.43 111.208 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.444 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 71.9 t-105 -69.54 -31.7 70.06 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 111.751 0.278 . . . . 71.41 111.751 175.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.7 m -64.31 -26.86 68.67 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.659 0.743 . . . . 62.3 110.818 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.446 HD22 HH11 ' A' ' 140' ' ' ARG . 49.2 tp -76.48 -56.33 4.72 Favored 'General case' 0 CA--C 1.565 1.527 0 C-N-CA 124.795 1.238 . . . . 63.43 111.924 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.44 -9.62 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 N-CA-C 113.547 0.943 . . . . 64.45 113.547 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -68.86 -27.9 73.51 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 113.768 0.267 . . . . 50.51 113.768 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.461 ' HB2' ' HB3' ' A' ' 26' ' ' ALA . 2.1 m-20 -80.86 108.57 14.64 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.416 0.686 . . . . 71.32 110.258 171.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -59.01 -24.81 63.12 Favored 'General case' 0 CA--C 1.565 1.546 0 C-N-CA 123.76 0.824 . . . . 72.22 111.421 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.9 t -83.02 -34.29 26.31 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.273 1.029 . . . . 75.22 113.086 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -101.56 23.72 10.77 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.529 0.681 . . . . 63.51 111.449 -163.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.623 HG23 HG11 ' A' ' 34' ' ' VAL . 14.9 tt -57.31 -24.79 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.648 1.179 . . . . 65.3 112.463 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -65.56 -5.63 8.65 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 114.156 1.169 . . . . 71.21 114.156 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -78.72 -27.22 44.88 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.628 0.771 . . . . 72.03 112.416 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -122.31 -29.74 4.1 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.372 0.669 . . . . 74.35 111.376 -177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -95.17 111.68 55.78 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.318 0.647 . . . . 61.44 109.976 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.43 -22.01 52.75 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.225 2.617 . . . . 71.12 114.508 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' HA ' ' A' ' 129' ' ' VAL . 37.2 mt-30 -86.74 -25.11 24.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.146 0.579 . . . . 62.42 112.209 -170.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG11 HG23 ' A' ' 27' ' ' ILE . 98.2 t -67.72 120.21 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 CA-C-O 121.101 0.477 . . . . 64.31 111.142 177.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.9 m -88.51 23.59 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.335 1.054 . . . . 75.35 113.075 -172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 63.47 95.26 0.05 OUTLIER Pre-proline 0 CA--C 1.566 1.568 0 C-N-CA 124.476 1.11 . . . . 72.43 110.418 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -85.71 178.79 4.16 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.319 2.68 . . . . 74.42 115.097 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 97.9 m -101.88 124.29 47.25 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.351 1.061 . . . . 72.44 110.079 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.85 135.68 48.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.496 0.718 . . . . 71.54 110.314 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.39 156.97 47.87 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.497 0.719 . . . . 63.25 110.636 177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 47.81 157.96 0.01 OUTLIER Glycine 0 CA--C 1.551 2.332 0 N-CA-C 117.79 1.876 . . . . 60.5 117.79 -170.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 55.44 -98.9 0.09 Allowed 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 124.74 1.216 . . . . 71.21 113.359 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.9 t 171.3 149.42 0.18 Allowed Pre-proline 0 N--CA 1.495 1.811 0 C-N-CA 125.459 1.504 . . . . 71.5 109.285 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.55 -19.74 18.91 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 123.059 2.506 . . . . 63.33 114.148 174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 -99.14 -30.26 12.39 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.515 0.726 . . . . 74.13 111.48 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.3 m -88.63 120.63 70.27 Favored Pre-proline 0 N--CA 1.49 1.554 0 C-N-CA 123.12 0.568 . . . . 62.02 111.071 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.542 ' HG3' ' H ' ' A' ' 68' ' ' ARG . 99.5 Cg_exo -45.77 130.18 12.38 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.957 3.105 . . . . 73.0 114.814 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.54 -24.21 6.2 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-N 116.412 -0.358 . . . . 52.51 113.443 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.94 131.49 49.86 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.49 0.716 . . . . 73.43 112.821 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -103.29 136.04 43.79 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.43 0.692 . . . . 74.42 110.716 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -115.36 108.6 16.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.204 1.002 . . . . 53.51 111.53 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 18.7 t -113.38 108.05 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.09 0.556 . . . . 71.15 110.326 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -68.35 -59.07 3.46 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.192 0.997 . . . . 73.4 113.65 -169.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.28 -12.35 84.67 Favored Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.82 -0.434 . . . . 54.05 113.477 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 66.62 -73.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.526 1.53 . . . . 63.44 113.281 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.0 44.66 0.7 Allowed Glycine 0 N--CA 1.477 1.371 0 N-CA-C 113.492 0.157 . . . . 65.11 113.492 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.3 p -93.83 -118.33 0.09 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 123.905 0.882 . . . . 72.14 109.855 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -139.81 9.78 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 119.169 0.895 . . . . 71.51 110.849 176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -146.57 20.63 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.322 0.649 . . . . 55.14 112.48 -168.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.59 144.64 35.33 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.774 0.797 . . . . 72.11 112.493 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.668 HD13 ' HD3' ' A' ' 83' ' ' PRO . 16.8 tp -103.25 125.48 49.93 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.484 1.114 . . . . 53.41 109.278 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.712 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 54.0 t -96.95 114.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.078 -0.712 . . . . 65.14 109.078 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 27.8 tt0 -118.95 166.95 12.22 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.239 1.016 . . . . 74.25 109.584 -175.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -152.2 136.72 16.85 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.418 0.525 . . . . 64.54 112.418 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.7 tp -77.76 116.96 18.69 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 124.99 1.316 . . . . 71.53 110.81 176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' TYR . 95.5 t -79.16 -53.01 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.02 0.528 . . . . 33.31 110.52 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -152.89 144.53 23.47 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.191 0.996 . . . . 72.55 109.748 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' H ' ' HG3' ' A' ' 47' ' ' PRO . 4.2 tmt_? -131.84 112.09 12.17 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.441 -1.318 . . . . 72.52 107.441 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -114.08 115.13 27.06 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.001 0.52 . . . . 51.32 110.939 -177.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 29.1 tt0 -83.86 -20.82 32.46 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.787 0.835 . . . . 72.02 111.668 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.9 t -68.93 -48.97 61.93 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.424 0.69 . . . . 74.34 111.936 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.09 2.82 51.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.107 0.563 . . . . 73.52 112.393 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 54.9 52.07 12.57 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.216 1.006 . . . . 72.13 111.943 -177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.36 119.65 26.72 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 124.453 1.101 . . . . 63.44 111.123 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 93' ' ' LEU . 44.4 tp -109.57 106.77 16.61 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.447 1.099 . . . . 74.52 110.426 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.83 128.86 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 123.79 0.836 . . . . 74.43 111.248 -175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 66' ' ' VAL . 51.7 p90 -150.83 179.11 8.5 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 112.827 0.677 . . . . 75.44 112.827 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.1 t -152.85 158.03 41.59 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.183 1.393 . . . . 74.2 109.5 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 16.7 ptt? -111.84 100.46 48.67 Favored Pre-proline 0 N--CA 1.485 1.319 0 CA-C-N 118.362 0.528 . . . . 63.42 110.226 169.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.33 -22.79 59.71 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.409 2.74 . . . . 73.32 113.644 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.712 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 25.8 t70 -128.75 81.35 70.94 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 123.396 0.678 . . . . 75.25 109.726 176.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -84.02 154.54 12.98 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.096 2.531 . . . . 70.24 113.885 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.668 ' HD3' HD13 ' A' ' 61' ' ' LEU . 71.4 Cg_endo -83.25 -4.5 11.06 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.662 2.241 . . . . 70.25 112.532 170.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.91 154.13 38.37 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.156 0.982 . . . . 74.53 110.757 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HG2' HG21 ' A' ' 117' ' ' THR . 89.8 Cg_endo -79.02 61.49 8.18 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.717 2.278 . . . . 55.43 112.85 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 113' ' ' CYS . 30.4 pt -121.06 167.91 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 124.289 1.036 . . . . 73.41 110.321 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 84.3 m -103.46 -85.19 0.46 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 122.793 0.437 . . . . 71.44 110.854 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.73 111.6 23.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.12 0.486 . . . . 73.13 111.115 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 26.5 t-80 -84.84 150.88 24.7 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.639 0.776 . . . . 74.34 111.768 175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -154.78 110.28 3.12 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.662 0.785 . . . . 64.51 109.887 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -131.03 146.27 52.32 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 112.567 0.58 . . . . 43.43 112.567 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 40.6 t -134.73 143.98 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.756 0 C-N-CA 124.142 0.977 . . . . 63.11 111.553 -173.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -112.65 109.48 19.03 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.973 1.309 . . . . 73.4 109.238 173.583 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 92' ' ' VAL . 42.3 mt-10 -117.7 112.48 20.53 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 118.445 0.566 . . . . 74.12 111.808 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.9 t -97.37 111.37 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 123.078 0.551 . . . . 64.33 110.007 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.84 131.26 22.21 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 123.987 0.915 . . . . 54.33 111.192 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.69 81.63 1.29 Allowed 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 123.04 2.493 . . . . 74.11 111.965 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.64 -35.46 81.1 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.092 0.957 . . . . 73.41 110.873 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 23.4 t70 -140.47 174.72 10.24 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 125.342 1.457 . . . . 74.34 108.946 -178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.47 -68.61 0.28 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.489 0.715 . . . . 73.03 111.084 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -81.8 -15.25 54.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.893 0.477 . . . . 72.11 111.775 -176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.514 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.3 m80 -120.1 146.97 45.43 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.864 -0.522 . . . . 72.15 111.385 -174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 17' ' ' VAL . 28.9 p -132.14 176.02 8.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.358 0.663 . . . . 73.2 109.836 177.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 73.7 m -130.41 125.09 33.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.175 0.59 . . . . 73.24 110.122 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.1 t -100.28 105.96 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.69 -0.856 . . . . 61.53 108.69 175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.91 112.61 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.019 -0.734 . . . . 53.53 109.019 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -102.23 112.52 25.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.761 -0.829 . . . . 75.51 108.761 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.5 m -113.46 144.14 43.32 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.203 1.001 . . . . 73.32 109.433 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.18 149.45 36.46 Favored 'General case' 0 C--O 1.217 -0.652 0 C-N-CA 123.871 0.868 . . . . 51.4 109.229 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.37 130.4 8.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.257 1.023 . . . . 74.54 108.585 175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.419 ' HB3' ' HA ' ' A' ' 89' ' ' HIS . 7.8 p90 -148.58 152.03 36.08 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.12 0.568 . . . . 72.22 111.177 -171.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 13.5 t70 -76.59 85.84 3.27 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.817 -0.629 . . . . 73.43 109.396 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.466 ' HB2' HG22 ' A' ' 86' ' ' ILE . 48.4 t -120.27 147.63 44.73 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.009 -0.996 . . . . 75.12 111.026 178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.6 m -60.19 132.03 90.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 CA-C-O 118.404 -0.807 . . . . 74.32 110.694 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.56 -46.01 12.57 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.848 3.032 . . . . 75.11 114.458 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -62.98 -30.85 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.354 1.061 . . . . 64.35 112.426 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.405 HG21 ' HG2' ' A' ' 85' ' ' PRO . 20.0 m -90.7 -31.8 16.44 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.659 0.784 . . . . 72.4 112.257 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.0 -31.52 71.27 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.737 0.815 . . . . 64.25 112.265 -171.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -63.93 -34.61 78.37 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.214 1.006 . . . . 63.14 112.167 172.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.47 -44.41 51.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.228 0.611 . . . . 72.24 110.539 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 83.4 mt -69.5 -23.81 63.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.429 0.692 . . . . 65.0 110.843 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.26 -52.75 64.08 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.886 0.874 . . . . 70.41 110.732 170.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.6 m -68.38 -42.69 78.76 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 112.885 0.698 . . . . 71.35 112.885 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.8 t -69.2 -55.05 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.25 0.547 . . . . 64.22 112.019 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 67.3 mt -83.07 -56.99 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.618 0.767 . . . . 74.23 111.323 -174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.22 -33.22 86.65 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 114.442 0.537 . . . . 52.14 114.442 -175.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -101.72 -61.49 1.38 Allowed 'General case' 0 CA--C 1.559 1.309 0 O-C-N 122.043 -0.681 . . . . 65.34 111.388 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.42 68.31 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 115.566 0.986 . . . . 72.04 115.566 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.512 ' HA ' HE22 ' A' ' 33' ' ' GLN . 87.8 t -106.78 -54.9 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 117.419 0.609 . . . . 63.24 111.136 175.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 4.4 m-30 -73.46 -59.13 2.85 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.067 0.547 . . . . 64.5 112.336 -171.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.76 67.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 123.439 0.462 . . . . 63.15 111.79 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.411 HG11 HE21 ' A' ' 33' ' ' GLN . 16.2 t -62.45 -55.61 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.649 0.78 . . . . 73.33 112.085 171.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.84 98.38 Favored Glycine 0 CA--C 1.536 1.361 0 CA-C-N 116.182 -0.463 . . . . 62.52 113.909 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.2 mt -70.73 -34.66 72.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.442 0.697 . . . . 75.44 112.27 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.504 ' O ' ' HG3' ' A' ' 139' ' ' GLU . 5.8 m-20 -67.66 -42.16 82.6 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 110.455 -0.202 . . . . 70.41 110.455 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.04 -34.53 77.77 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.255 0.622 . . . . 64.43 111.539 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.406 HD21 HG13 ' A' ' 17' ' ' VAL . 7.5 tt -65.19 -37.46 87.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.696 0.798 . . . . 70.44 110.104 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.83 -33.36 70.6 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.616 0.366 . . . . 72.41 111.674 174.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 135' ' ' ASN . 38.2 mt-10 -68.53 -39.24 81.24 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.183 0.593 . . . . 73.32 112.178 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.446 HH11 HD22 ' A' ' 20' ' ' LEU . 5.4 ptm180 -66.51 -27.81 68.07 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.317 0.488 . . . . 73.2 112.317 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -98.57 -2.94 37.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.365 0.666 . . . . 62.22 111.228 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -84.92 12.5 57.36 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 123.58 0.609 . . . . 25.03 113.745 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -92.1 -12.22 33.61 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 122.28 -0.541 . . . . 63.33 110.107 166.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -80.98 -45.01 17.27 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.644 0.778 . . . . 72.51 111.483 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -139.08 27.24 2.38 Favored 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 122.815 0.446 . . . . 75.03 111.485 -171.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 68.63 164.69 0.24 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.496 1.118 . . . . 75.14 112.438 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.498 ' HD2' ' HG2' ' A' ' 139' ' ' GLU . 71.8 m80 -57.88 -48.96 78.3 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.251 0.621 . . . . 74.14 112.418 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.4 t60 70.27 -60.93 0.48 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.585 1.554 . . . . 52.43 111.245 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -101.8 143.59 31.52 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.168 0.987 . . . . 75.13 109.839 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -133.1 -94.45 0.33 Allowed 'General case' 0 CA--C 1.561 1.388 0 N-CA-C 108.846 -0.798 . . . . 64.32 108.846 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 . . . . . 0 N--CA 1.494 1.773 0 C-N-CA 123.768 0.827 . . . . 74.22 109.968 172.711 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 112.191 0.441 . . . . 23.24 112.191 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.85 71.42 0.58 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.579 1.152 . . . . 74.5 112.235 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.7 m -126.54 128.95 47.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.319 0.648 . . . . 52.55 110.738 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 7.5 mp -105.21 141.63 36.4 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.174 1.39 . . . . 71.3 108.426 177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -150.06 130.8 14.1 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.321 0.582 . . . . 71.03 111.648 172.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -139.6 152.77 47.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.606 1.162 . . . . 74.44 108.542 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.2 p -150.18 161.59 42.1 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 122.764 0.426 . . . . 65.35 111.378 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 135' ' ' ASN . 9.9 p -148.32 145.88 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 112.545 0.572 . . . . 74.32 112.545 -177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -91.24 119.43 31.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.849 0.86 . . . . 73.0 110.766 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.2 131.68 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 124.631 1.173 . . . . 71.04 110.959 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' HD2' ' A' ' 102' ' ' HIS . . . -84.28 68.79 10.31 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.134 0.492 . . . . 54.44 111.463 173.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.58 142.74 2.61 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 124.206 1.002 . . . . 54.34 109.546 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.96 138.44 82.25 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.893 2.396 . . . . 72.2 112.898 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -33.6 15.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 125.2 1.4 . . . . 71.34 114.778 -173.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.38 64.9 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.435 0.694 . . . . 62.52 112.115 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.07 -37.49 82.86 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.721 0.808 . . . . 73.2 112.555 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG21 ' SG ' ' A' ' 103' ' ' CYS . 40.5 t -70.12 -37.42 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.238 0.615 . . . . 75.25 110.757 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -63.53 -31.06 72.11 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.36 -0.836 . . . . 73.31 111.523 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.5 m -59.09 -31.88 69.29 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.288 0.566 . . . . 73.53 111.572 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' A' ' 30' ' ' TRP . 35.4 tp -75.76 -43.01 48.76 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 123.863 0.865 . . . . 70.15 111.797 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' O ' HD22 ' A' ' 75' ' ' LEU . 19.0 m -95.27 -3.35 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 113.264 0.839 . . . . 73.11 113.264 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.41 -28.02 60.52 Favored Glycine 0 N--CA 1.482 1.761 0 C-N-CA 123.152 0.406 . . . . 74.4 112.881 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.15 105.38 17.15 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.326 0.65 . . . . 64.13 110.078 169.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 35.9 t80 -61.61 -29.04 69.79 Favored 'General case' 0 CA--C 1.562 1.44 0 C-N-CA 123.608 0.763 . . . . 71.03 111.348 176.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -77.74 -21.67 51.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.986 0.914 . . . . 62.51 112.783 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.16 25.84 10.5 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.891 0.477 . . . . 74.23 112.032 -165.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.08 -27.31 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 C-N-CA 123.743 0.817 . . . . 72.13 112.282 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.827 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -64.86 -6.74 8.95 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 114.134 1.161 . . . . 64.23 114.134 -179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -89.05 -17.58 29.05 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 112.734 0.642 . . . . 74.31 112.734 -178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.6 p-90 -129.3 -32.53 1.99 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 113.36 0.874 . . . . 65.54 113.36 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 17.5 t-80 -78.01 130.63 72.11 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 122.51 0.324 . . . . 74.21 110.294 -174.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 31' ' ' HIS . 7.5 Cg_exo -79.59 -29.07 3.1 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.721 2.281 . . . . 51.41 114.266 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HB2' ' HE1' ' A' ' 31' ' ' HIS . 0.6 OUTLIER -93.82 -6.86 44.9 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.222 0.823 . . . . 71.3 113.222 -175.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 28' ' ' HIS . 7.1 p -56.87 128.39 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.518 0 CA-C-O 121.44 0.638 . . . . 71.14 112.19 176.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' H ' ' HD2' ' A' ' 53' ' ' PHE . 31.7 m -91.62 23.18 3.64 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.078 0.951 . . . . 73.02 112.157 -178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.465 ' H ' HG22 ' A' ' 34' ' ' VAL . . . 60.58 101.91 0.04 OUTLIER Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 124.699 1.2 . . . . 65.42 111.26 -173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.527 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 37.3 Cg_endo -88.25 161.33 6.99 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.542 2.161 . . . . 32.35 114.386 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.9 m -105.94 123.55 48.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.883 0.873 . . . . 74.15 109.164 173.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 49' ' ' ALA . 1.6 tm? -88.38 113.59 24.14 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.437 -0.579 . . . . 72.44 109.437 -176.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -99.59 153.13 19.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.949 1.3 . . . . 73.5 110.901 -174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.19 -126.56 23.42 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.948 0.78 . . . . 44.41 115.026 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -47.06 140.58 4.85 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.256 1.022 . . . . 73.25 113.246 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.4 m -56.58 158.13 8.78 Favored Pre-proline 0 N--CA 1.493 1.704 0 C-N-CA 124.534 1.133 . . . . 73.52 112.917 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.92 162.13 39.27 Favored 'Trans proline' 0 C--N 1.389 2.682 0 C-N-CA 122.046 1.831 . . . . 74.05 111.283 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 72.75 -42.15 0.52 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.877 1.271 . . . . 75.03 112.118 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.4 m -68.87 123.0 87.06 Favored Pre-proline 0 CA--C 1.561 1.366 0 C-N-CA 124.395 1.078 . . . . 62.11 111.011 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.49 93.98 0.17 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.127 2.552 . . . . 71.03 113.251 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 -25.61 0.14 Allowed Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.083 -0.508 . . . . 64.22 113.156 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.04 132.78 47.94 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.32 1.048 . . . . 42.33 113.385 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -117.6 116.57 27.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.961 -0.462 . . . . 64.43 111.355 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 38.1 ptt85 -94.03 119.07 32.4 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.135 0.493 . . . . 74.53 110.107 177.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 t -114.21 112.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.421 0.688 . . . . 73.31 110.511 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HD2' ' H ' ' A' ' 35' ' ' SER . 8.3 m-85 -68.7 117.45 10.43 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.264 1.026 . . . . 64.34 110.29 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.62 -65.53 3.77 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 111.734 -0.546 . . . . 61.31 111.734 -172.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 62.48 10.34 3.95 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 124.746 1.219 . . . . 75.04 114.289 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.13 32.37 0.41 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.905 -0.878 . . . . 72.1 110.905 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -122.51 175.08 6.65 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 71.32 109.842 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.77 -4.02 48.03 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.827 0.451 . . . . 62.33 111.807 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -135.3 84.76 2.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.664 0.785 . . . . 73.12 109.025 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 176.94 4.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.318 1.047 . . . . 74.41 111.417 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.571 HD13 ' HD3' ' A' ' 83' ' ' PRO . 23.2 tp -143.26 113.94 7.55 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.074 -0.512 . . . . 53.24 110.279 175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 45.1 t -97.46 116.72 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.336 0.654 . . . . 73.25 109.725 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.655 ' HG2' ' HG2' ' A' ' 79' ' ' MET . 46.3 mt-10 -120.96 123.39 42.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.692 0.797 . . . . 64.32 109.76 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' TYR . 43.1 ttt180 -103.29 135.73 44.38 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.299 1.04 . . . . 73.24 111.764 -175.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.8 tp -80.71 122.08 26.68 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.692 0.797 . . . . 72.2 110.773 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -95.88 -45.4 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.28 0.632 . . . . 64.1 111.263 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 26.4 tt0 -145.32 145.11 31.09 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.836 1.254 . . . . 61.35 110.382 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.18 116.03 14.03 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.801 -1.185 . . . . 71.14 107.801 171.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -117.5 104.53 11.17 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.756 0.822 . . . . 64.05 109.099 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.35 -26.26 46.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.274 0.629 . . . . 74.45 112.688 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t -72.43 -42.75 64.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.779 0.832 . . . . 74.24 110.936 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.62 2.96 36.72 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 112.768 0.655 . . . . 52.42 112.768 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 57.03 43.02 25.14 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.424 1.09 . . . . 74.22 112.016 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -115.39 105.06 12.41 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.814 0.846 . . . . 50.31 110.648 -176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 59.2 tp -100.83 105.78 17.1 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.188 0.595 . . . . 74.41 109.69 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 57.7 t -106.74 133.82 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 118.688 0.676 . . . . 72.41 110.168 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 33.4 p90 -152.31 -178.66 6.95 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.042 0.537 . . . . 73.32 110.862 -178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.4 t -141.71 162.92 34.3 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.402 1.081 . . . . 74.44 110.177 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.655 ' HG2' ' HG2' ' A' ' 63' ' ' GLU . 79.0 mtp -110.1 85.75 4.52 Favored Pre-proline 0 CA--C 1.558 1.257 0 N-CA-C 108.811 -0.811 . . . . 63.03 108.811 170.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.78 -21.17 45.06 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.154 2.569 . . . . 53.45 113.564 -176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 24.4 t70 -139.25 84.21 16.82 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 122.762 0.425 . . . . 73.32 110.226 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 44.2 Cg_endo -94.96 153.36 1.75 Allowed 'Trans proline' 0 CA--C 1.565 2.067 0 C-N-CA 123.234 2.622 . . . . 64.34 113.24 172.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.571 ' HD3' HD13 ' A' ' 61' ' ' LEU . 5.0 Cg_exo -80.48 22.68 0.75 Allowed 'Trans proline' 0 CA--C 1.565 2.028 0 C-N-CA 122.893 2.396 . . . . 73.21 112.837 171.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -119.27 149.7 47.88 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.436 1.094 . . . . 75.45 110.356 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 68.02 6.24 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.835 2.357 . . . . 71.43 113.416 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.8 pt -132.97 135.9 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.542 1.137 . . . . 63.31 110.074 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 16.4 m -81.66 -82.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 111.832 0.308 . . . . 73.34 111.832 -174.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -102.07 108.0 19.28 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.257 0.551 . . . . 71.53 110.778 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -89.31 157.94 18.01 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.737 0.815 . . . . 72.31 111.685 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -156.01 124.11 5.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.587 0.755 . . . . 75.42 110.21 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.98 151.8 51.16 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.985 0.735 . . . . 53.21 112.985 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 3.5 p -138.35 137.43 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 C-N-CA 123.523 0.729 . . . . 73.03 112.483 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 4.2 mm? -101.28 108.3 19.9 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 108.065 -1.087 . . . . 74.01 108.065 166.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -124.51 110.73 14.85 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.641 -0.503 . . . . 72.22 109.641 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.0 t -92.9 110.89 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 109.532 -0.544 . . . . 74.42 109.532 -176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.6 117.5 68.61 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 124.187 0.995 . . . . 72.32 111.08 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.79 110.14 1.61 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.663 2.242 . . . . 44.22 111.494 170.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -107.33 -28.89 9.61 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.47 0.708 . . . . 63.41 111.834 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.9 t70 -149.96 163.05 39.12 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.762 0.825 . . . . 71.34 110.434 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -56.78 -39.03 73.35 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.517 1.127 . . . . 75.03 112.35 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -117.64 -4.34 11.22 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.814 0.846 . . . . 74.12 112.32 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 23.9 m80 -133.05 156.47 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 118.305 0.502 . . . . 55.44 111.208 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.491 ' SG ' HG21 ' A' ' 17' ' ' VAL . 23.0 p -157.68 178.66 10.01 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.583 0.753 . . . . 45.4 111.017 -177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.6 m -134.73 125.77 27.66 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.034 0.534 . . . . 72.15 111.33 175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.02 120.96 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 109.38 -0.6 . . . . 61.33 109.38 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.42 125.03 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.215 0.606 . . . . 73.52 109.713 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -114.31 116.75 29.46 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.591 0.757 . . . . 74.43 109.087 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.468 HG22 ' SD ' ' A' ' 110' ' ' MET . 76.3 m -119.82 138.9 53.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.029 0.932 . . . . 75.12 109.384 -176.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -141.17 112.91 7.67 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.492 0.717 . . . . 44.42 111.61 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.468 ' SD ' HG22 ' A' ' 108' ' ' THR . 0.0 OUTLIER -120.74 131.6 54.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 64.21 109.613 -177.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -142.68 155.06 44.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.625 0.77 . . . . 75.34 111.886 -171.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 28.6 t70 -77.3 88.02 3.71 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.795 0.438 . . . . 75.23 110.115 177.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 117' ' ' THR . 38.7 t -145.99 164.76 31.06 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.971 -0.558 . . . . 71.15 112.493 177.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.6 m -75.13 144.56 79.15 Favored Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 124.136 0.974 . . . . 55.12 111.676 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.27 -43.95 20.65 Favored 'Trans proline' 0 C--N 1.389 2.68 0 C-N-CA 124.23 3.287 . . . . 70.41 115.221 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -55.08 -42.53 72.95 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.341 1.056 . . . . 74.43 112.618 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 8.5 m -85.89 -31.47 22.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.506 0.723 . . . . 71.01 110.27 -177.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.37 91.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.149 0.979 . . . . 75.53 112.488 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.53 -30.38 61.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.852 0.861 . . . . 72.33 112.219 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.71 -45.12 72.4 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.26 0.552 . . . . 72.14 109.865 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -71.06 -23.69 62.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.192 0.997 . . . . 53.11 110.943 176.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 40.7 tt0 -61.89 -47.09 86.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.8 0.44 . . . . 61.33 110.314 172.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -71.13 -43.74 66.99 Favored 'General case' 0 CA--C 1.56 1.337 0 N-CA-C 112.822 0.675 . . . . 73.05 112.822 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.3 t -70.79 -55.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.384 0.674 . . . . 71.34 112.491 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.91 -55.23 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.736 0.815 . . . . 73.41 111.459 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -72.35 -71.23 1.09 Allowed Glycine 0 N--CA 1.484 1.851 0 N-CA-C 114.066 0.386 . . . . 72.24 114.066 -174.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.38 -3.64 31.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.544 0.738 . . . . 64.15 112.698 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.96 -83.13 1.71 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 112.061 -0.416 . . . . 70.54 112.061 173.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.48 -43.12 96.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.763 0.825 . . . . 70.4 112.593 -174.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 6.7 m-30 -76.26 -43.7 40.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.751 0.421 . . . . 75.31 111.239 -175.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.95 -48.04 73.7 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.549 0.339 . . . . 73.51 111.3 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 t -60.22 -47.25 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 C-N-CA 123.357 0.663 . . . . 70.24 111.945 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -45.46 95.61 Favored Glycine 0 CA--C 1.54 1.594 0 CA-C-N 116.518 -0.31 . . . . 42.44 113.661 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.18 -46.04 57.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.372 1.069 . . . . 73.12 111.922 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.45 ' HA ' HG21 ' A' ' 8' ' ' VAL . 6.5 m-20 -61.7 -40.83 96.41 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.841 0.457 . . . . 73.1 110.999 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.17 -38.49 85.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.017 0.527 . . . . 62.12 111.425 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.5 tt -59.25 -44.87 92.37 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.443 0.697 . . . . 71.11 110.858 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.68 95.25 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.868 -0.605 . . . . 73.33 111.618 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -71.55 -30.84 66.34 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.411 0.684 . . . . 54.43 112.658 -176.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.67 -15.37 58.57 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.389 0.514 . . . . 72.02 112.389 176.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -85.45 -8.69 58.25 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 122.727 0.411 . . . . 74.15 111.48 162.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 71.57 67.58 1.83 Allowed Glycine 0 C--N 1.345 1.057 0 N-CA-C 112.308 -0.317 . . . . 73.45 112.308 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -67.34 130.88 44.48 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.575 0.583 . . . . 63.43 112.575 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.41 -5.87 18.65 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.276 0.63 . . . . 73.34 111.164 171.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -68.8 96.52 0.75 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.521 0.728 . . . . 65.0 109.841 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -79.37 75.51 5.96 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 114.947 -1.024 . . . . 70.12 110.788 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -82.38 68.41 8.81 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 107.805 -1.183 . . . . 74.32 107.805 173.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -76.09 100.32 4.92 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.262 -1.335 . . . . 73.1 112.583 -166.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 53.5 p-80 -163.5 146.39 10.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.008 0.923 . . . . 63.02 109.88 172.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -79.96 106.71 12.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.866 0.466 . . . . 71.33 110.964 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 51.2 t60 . . . . . 0 N--CA 1.484 1.258 0 C-N-CA 123.731 0.812 . . . . 74.34 110.056 -179.575 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 119.455 -0.307 . . . . 64.44 110.596 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . 47.45 51.11 14.04 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.585 1.154 . . . . 64.43 112.844 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.3 m -110.25 101.12 9.9 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.945 0.879 . . . . 72.33 110.281 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 122' ' ' GLU . 4.0 mp -92.94 119.17 31.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.998 1.319 . . . . 73.35 108.932 -175.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -140.75 136.33 32.43 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.909 0.385 . . . . 75.43 110.274 173.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -142.11 138.81 31.93 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.101 -1.074 . . . . 74.41 108.101 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.7 p -128.92 147.11 50.81 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.874 0.869 . . . . 74.03 110.126 -178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' THR . 8.4 p -142.3 145.0 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 122.933 0.493 . . . . 51.15 110.469 -178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -98.98 112.71 24.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.349 0.595 . . . . 72.23 110.773 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.9 t -91.44 132.87 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 125.258 1.423 . . . . 73.32 110.632 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.13 51.37 1.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.409 0.683 . . . . 70.15 112.209 175.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.56 155.09 24.58 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.166 0.986 . . . . 61.15 110.605 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.1 142.21 73.24 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.863 2.376 . . . . 72.4 113.398 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.76 -38.91 23.11 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.911 1.684 . . . . 74.34 115.253 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.89 73.47 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.555 0.742 . . . . 73.12 112.767 -176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -57.85 -42.31 84.19 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.751 0.82 . . . . 72.55 112.307 176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG13 HD21 ' A' ' 137' ' ' LEU . 29.2 t -70.83 -33.82 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.899 0.88 . . . . 74.45 110.784 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 49.5 t-105 -67.29 -28.99 68.47 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.425 0.69 . . . . 72.43 111.891 177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.0 m -65.11 -36.13 83.32 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 121.175 0.512 . . . . 64.51 110.441 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 30' ' ' TRP . 66.2 tp -73.28 -51.44 17.58 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.192 0.997 . . . . 64.02 111.988 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.42 -33.26 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.606 0.762 . . . . 62.22 112.702 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.11 72.68 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.177 -0.465 . . . . 74.42 113.237 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.39 94.79 0.12 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 121.938 0.875 . . . . 73.31 110.474 168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -74.87 12.77 0.77 Allowed 'General case' 0 CA--C 1.576 1.971 0 C-N-CA 124.873 1.269 . . . . 54.25 110.496 172.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.661 ' HA ' HD21 ' A' ' 39' ' ' LEU . 75.6 p -115.77 -1.73 12.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.554 1.141 . . . . 61.42 112.493 172.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -114.31 -83.36 0.61 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 119.071 -0.49 . . . . 70.14 110.867 -169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.596 HG23 HG11 ' A' ' 34' ' ' VAL 0.298 19.9 tt 52.81 -48.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 C-N-CA 127.61 2.364 . . . . 54.31 116.457 -175.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -60.9 -4.08 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 120.284 1.402 . . . . 75.52 114.34 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -77.46 -16.61 58.67 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.867 0.867 . . . . 71.31 112.852 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HB3' HD21 ' A' ' 20' ' ' LEU . 42.4 p-90 -132.13 -34.25 1.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.524 0.729 . . . . 71.11 111.816 176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.43 ' CE1' HE21 ' A' ' 33' ' ' GLN . 34.4 t-80 -87.53 110.74 36.65 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.89 0.876 . . . . 62.01 109.313 -176.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.18 -8.62 24.1 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 123.268 2.645 . . . . 70.53 114.902 -171.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' CE1' ' A' ' 31' ' ' HIS . 6.1 mt-30 -109.02 -6.81 15.51 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 114.148 1.166 . . . . 73.01 114.148 -170.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 36' ' ' ALA . 66.6 t -79.66 131.38 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 118.469 0.577 . . . . 71.42 112.5 177.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 m -93.03 34.29 1.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.252 1.021 . . . . 61.43 111.869 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.641 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 67.46 125.78 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 C-N-CA 125.8 1.64 . . . . 70.21 113.422 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.645 ' HB2' ' HB2' ' A' ' 51' ' ' ARG . 73.7 Cg_endo -84.79 149.7 11.14 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.742 2.295 . . . . 74.24 113.921 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.7 m -107.07 120.18 41.39 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.898 0.879 . . . . 73.33 109.645 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.661 HD21 ' HA ' ' A' ' 25' ' ' SER . 3.9 mm? -91.51 137.7 32.15 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.481 0.658 . . . . 73.3 112.701 -167.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -130.13 165.07 23.05 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.153 1.381 . . . . 74.04 109.81 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 50.97 -150.89 5.97 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.541 0.977 . . . . 43.32 115.541 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' O ' ' HB ' ' A' ' 46' ' ' THR . . . -83.05 87.56 6.89 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.953 0.724 . . . . 72.34 112.953 -165.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.4 t 58.89 132.96 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 N-CA-C 116.001 1.852 . . . . 74.42 116.001 161.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -60.43 -16.44 41.82 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.082 2.521 . . . . 74.43 114.176 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -114.17 20.43 15.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.6 -0.688 . . . . 54.22 111.744 176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 42' ' ' ALA . 99.5 m -123.85 123.03 26.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 123.729 0.811 . . . . 63.13 109.345 172.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 58.7 Cg_exo -53.95 89.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 123.656 2.904 . . . . 55.23 114.164 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.83 51.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.071 -0.513 . . . . 23.11 112.655 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -138.71 145.16 39.98 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.704 0.801 . . . . 64.35 111.006 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -109.93 153.07 25.02 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.257 0.623 . . . . 73.14 109.867 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 37' ' ' PRO . 11.0 ptm180 -140.24 125.56 18.85 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.398 0.618 . . . . 74.12 109.844 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 62' ' ' VAL . 22.0 t -109.39 101.13 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.777 0.831 . . . . 73.1 109.851 -174.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -63.34 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.724 1.209 . . . . 75.45 111.953 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.55 -59.91 0.64 Allowed Glycine 0 CA--C 1.531 1.073 0 N-CA-C 112.005 -0.438 . . . . 61.13 112.005 -177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 53.36 89.28 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 125.52 1.528 . . . . 62.31 113.44 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 156.7 -19.86 0.44 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 115.002 0.761 . . . . 71.21 115.002 176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 p -105.45 171.86 7.1 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 117.615 0.707 . . . . 70.12 111.518 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -91.85 7.02 43.88 Favored 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.965 0.906 . . . . 71.52 112.603 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.34 31.48 3.47 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.828 0.823 . . . . 73.44 110.521 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.21 151.06 45.8 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.752 0.821 . . . . 75.15 112.662 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 54.3 tp -102.82 114.47 28.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.573 0.749 . . . . 62.31 110.266 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG22 HG13 ' A' ' 52' ' ' VAL . 32.6 t -114.4 115.59 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.157 0.583 . . . . 53.34 110.716 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.83 160.56 20.65 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.02 0.928 . . . . 74.43 110.613 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -143.36 132.23 22.76 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.199 1.0 . . . . 73.33 111.356 -170.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.576 ' HG ' ' HA ' ' A' ' 47' ' ' PRO . 18.6 tp -74.83 121.55 21.99 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.193 1.397 . . . . 74.34 112.374 -175.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.3 t -98.38 -48.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.95 0.9 . . . . 74.23 110.879 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 36.9 tt0 -144.13 134.65 24.74 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.441 1.096 . . . . 74.34 109.661 -177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH1' ' HB2' ' A' ' 70' ' ' GLU . 4.0 tmm_? -132.92 109.58 9.69 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.332 -0.618 . . . . 75.45 109.332 -176.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -100.84 176.0 5.44 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 124.491 1.116 . . . . 73.01 109.356 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.58 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 24.4 tt0 -158.62 -34.65 0.07 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.865 -0.522 . . . . 74.42 112.336 177.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.9 m -63.86 -34.84 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.3 0.64 . . . . 64.44 111.358 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.65 -14.81 15.99 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.342 1.057 . . . . 75.43 110.773 175.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 68.25 69.29 0.32 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.936 1.294 . . . . 72.0 112.098 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -135.28 135.04 40.54 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.722 0.809 . . . . 65.43 111.505 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.57 118.18 31.0 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.764 1.225 . . . . 70.42 109.447 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 60.5 t -116.92 125.65 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 123.45 0.7 . . . . 64.41 109.981 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -148.17 -179.07 6.66 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.703 0.801 . . . . 74.53 111.319 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -145.97 162.99 36.57 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.425 1.09 . . . . 75.11 110.486 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 72.6 mtm -101.14 100.45 13.29 Favored Pre-proline 0 N--CA 1.484 1.259 0 N-CA-C 109.292 -0.633 . . . . 61.23 109.292 167.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.6 -21.04 30.14 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.002 2.468 . . . . 71.41 113.358 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -139.55 74.89 33.13 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.242 0.617 . . . . 65.13 109.63 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 64.7 Cg_endo -86.68 146.96 8.3 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.647 2.231 . . . . 70.32 113.468 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 1.1 Cg_endo -86.55 24.89 0.71 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.457 2.771 . . . . 73.12 113.347 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -123.33 149.4 57.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 123.912 0.885 . . . . 64.11 110.371 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.38 74.9 4.04 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.605 2.203 . . . . 73.24 112.031 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.619 HG22 ' HB2' ' A' ' 113' ' ' CYS . 31.4 pt -133.78 165.11 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 124.338 1.055 . . . . 74.3 110.991 -174.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 112' ' ' ASP . 5.8 m -136.02 159.89 40.31 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.663 0.785 . . . . 62.11 109.649 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.8 p30 37.73 71.67 0.14 Allowed 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 125.9 1.68 . . . . 62.14 114.547 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.457 ' HD2' ' HD2' ' A' ' 111' ' ' PHE . 41.8 t-80 -79.39 131.0 35.97 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 116.076 -0.511 . . . . 73.25 111.881 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -129.82 118.84 22.4 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.231 1.012 . . . . 62.53 109.787 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.23 125.44 40.99 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.372 0.669 . . . . 61.43 111.312 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.4 t -124.09 117.63 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.489 0.715 . . . . 72.03 110.62 -177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.7 tp -108.35 117.32 33.85 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.642 1.177 . . . . 72.32 109.116 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -133.08 150.1 52.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.345 0.658 . . . . 74.44 110.937 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.86 113.87 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.185 0.594 . . . . 74.21 109.508 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -92.55 115.52 64.94 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 124.161 0.985 . . . . 63.24 109.902 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 77.11 0.37 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.764 2.309 . . . . 73.01 112.938 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -69.53 -33.75 73.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.217 1.007 . . . . 54.13 111.944 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 24.9 t70 -154.92 165.17 37.52 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.098 1.359 . . . . 74.22 108.944 -175.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.35 -48.88 79.97 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.853 0.861 . . . . 62.32 111.963 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.45 -6.4 27.72 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.858 0.863 . . . . 72.51 110.987 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 57.6 m80 -131.3 128.54 39.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.956 -1.09 . . . . 75.14 111.592 -175.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.423 ' SG ' HG21 ' A' ' 17' ' ' VAL . 31.5 p -130.2 133.76 46.8 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.063 0.545 . . . . 73.23 110.129 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 27.9 m -92.14 110.37 21.75 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.344 0.258 . . . . 72.42 110.383 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.11 116.68 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 70.35 109.717 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 51.8 t -107.77 109.85 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.454 1.102 . . . . 63.42 109.995 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -103.35 125.31 49.9 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.102 -0.703 . . . . 75.53 109.102 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 52.3 m -131.55 147.46 52.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.051 0.94 . . . . 74.44 110.344 -172.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.96 156.26 42.47 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.195 1.398 . . . . 70.14 108.859 169.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -162.81 146.03 11.0 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.294 0.638 . . . . 53.14 110.753 175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.457 ' HD2' ' HD2' ' A' ' 89' ' ' HIS . 2.5 p90 -158.84 155.5 27.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.717 0.807 . . . . 73.2 111.669 -168.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 87' ' ' THR . 30.2 t70 -82.99 85.44 7.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.022 0.929 . . . . 61.21 109.205 175.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.619 ' HB2' HG22 ' A' ' 86' ' ' ILE . 43.0 t -113.41 152.65 29.77 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.768 -1.105 . . . . 75.22 111.254 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 80.1 p -61.43 132.33 92.78 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.482 0.713 . . . . 73.55 110.633 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -46.95 -44.21 23.12 Favored 'Trans proline' 0 C--N 1.385 2.484 0 C-N-CA 124.293 3.329 . . . . 73.33 116.02 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -71.03 -38.62 72.57 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 122.799 0.44 . . . . 74.3 112.001 -178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 45.0 m -75.41 -26.8 58.68 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.166 0.587 . . . . 62.31 110.931 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 2' ' ' ALA . . . -68.67 -51.29 43.5 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.235 1.014 . . . . 24.23 111.125 -175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -64.01 -30.57 71.64 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.687 -0.688 . . . . 73.0 111.442 176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -66.98 -44.36 80.62 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.839 -0.619 . . . . 73.03 110.691 174.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.61 -25.51 62.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.126 0.57 . . . . 73.43 111.233 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.575 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . 52.1 mt-10 -66.09 -34.51 78.23 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.892 0.477 . . . . 74.43 111.511 173.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.6 t -76.6 -53.27 8.27 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 112.679 0.622 . . . . 51.53 112.679 171.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 84.0 t -59.81 -55.03 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.647 0.779 . . . . 74.14 112.147 -175.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.03 -46.76 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.173 0 C-N-CA 123.061 0.545 . . . . 73.31 110.653 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.94 -16.18 68.04 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 115.488 0.955 . . . . 64.14 115.488 -175.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -119.35 -57.47 1.99 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.983 0.892 . . . . 74.44 110.464 175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.52 -18.27 58.46 Favored Glycine 0 CA--C 1.541 1.692 0 N-CA-C 115.144 0.818 . . . . 74.03 115.144 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.0 t -111.77 -52.09 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.312 0.645 . . . . 60.43 110.372 173.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -75.05 -61.39 1.91 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 112.797 0.666 . . . . 74.24 112.797 -171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.59 71.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.879 0.371 . . . . 74.33 111.503 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.5 t -57.11 -56.28 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.339 0 C-N-CA 124.109 0.964 . . . . 73.43 112.579 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -65.77 -43.08 94.74 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.36 -0.382 . . . . 54.34 113.346 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -67.98 -39.39 83.29 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.952 0.901 . . . . 53.21 112.626 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -67.39 -45.46 76.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.388 0.275 . . . . 72.35 110.782 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.29 -35.14 73.22 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.493 0.717 . . . . 64.15 111.567 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.444 HD21 HG13 ' A' ' 17' ' ' VAL . 6.8 tt -66.19 -43.65 86.19 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 123.788 0.835 . . . . 72.04 110.301 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.49 -23.77 62.73 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.887 0.475 . . . . 71.23 112.193 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -72.25 -44.39 62.93 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.551 0.74 . . . . 64.03 111.768 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -73.99 -20.96 60.17 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 112.522 0.564 . . . . 73.31 112.522 -175.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -100.56 -14.86 18.03 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.05 0.54 . . . . 72.52 111.219 168.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.91 51.81 4.5 Favored Glycine 0 N--CA 1.474 1.203 0 CA-C-O 121.13 0.294 . . . . 53.11 112.503 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -72.87 -29.92 63.56 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.606 1.162 . . . . 74.34 109.921 175.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.42 -39.18 82.66 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.163 . . . . 74.15 110.805 174.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -82.5 -67.03 0.82 Allowed 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.456 0.703 . . . . 65.32 109.68 175.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.2 t60 70.78 -11.11 0.67 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.634 1.574 . . . . 64.4 113.428 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -87.75 49.91 1.89 Allowed 'General case' 0 CA--C 1.566 1.582 0 C-N-CA 123.471 0.709 . . . . 64.23 111.747 -170.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -168.72 114.61 0.62 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.114 0.965 . . . . 73.2 109.536 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -131.42 129.07 40.79 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.068 0.547 . . . . 70.53 111.487 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -98.22 168.16 10.41 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.733 0.813 . . . . 75.45 110.945 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.9 m80 . . . . . 0 N--CA 1.484 1.249 0 C-N-CA 123.444 0.697 . . . . 54.13 110.967 175.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.681 0.277 . . . . 73.24 110.829 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.03 10.81 20.23 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.327 0.584 . . . . 75.33 110.771 170.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.8 m -115.13 117.87 31.77 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.652 1.181 . . . . 71.34 109.315 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.8 mp -96.33 143.78 27.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.549 1.139 . . . . 63.13 109.931 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -143.72 135.2 26.05 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.248 0.547 . . . . 73.21 111.803 172.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -131.42 156.15 46.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.989 1.316 . . . . 73.12 109.008 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 94.6 p -145.02 157.02 44.25 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.617 0.767 . . . . 75.23 110.488 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 104' ' ' THR . 7.6 p -150.65 146.49 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 122.709 0.404 . . . . 73.02 111.149 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -93.01 123.64 36.41 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 109.855 -0.424 . . . . 72.35 109.855 171.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 87.1 t -108.36 132.57 55.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.604 1.162 . . . . 75.52 110.638 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.69 64.23 8.5 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.24 0.616 . . . . 61.51 111.585 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.59 148.58 7.88 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.333 0.653 . . . . 73.15 111.037 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.07 128.76 31.15 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.29 2.66 . . . . 44.12 113.036 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.84 -37.27 13.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.981 1.475 . . . . 75.14 114.981 -175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.34 -46.36 86.97 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.044 0.538 . . . . 71.43 112.227 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -63.52 -35.53 80.77 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.222 0.609 . . . . 54.15 112.332 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' SG ' ' A' ' 103' ' ' CYS . 58.8 t -71.25 -34.97 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 C-N-CA 123.428 0.691 . . . . 52.11 110.345 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.524 ' HE1' ' HG3' ' A' ' 70' ' ' GLU . 63.2 t-105 -72.67 -27.66 62.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.548 0.739 . . . . 73.13 111.775 176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.4 m -69.31 -29.56 67.44 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.423 0.63 . . . . 53.44 110.077 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.547 HD21 ' HB3' ' A' ' 30' ' ' TRP . 58.4 tp -75.16 -49.15 20.42 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 124.365 1.066 . . . . 75.04 111.68 -177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.44 -36.45 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 112.631 0.604 . . . . 64.43 112.631 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' HA3' HH21 ' A' ' 68' ' ' ARG . . . -65.36 -25.65 71.36 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 123.542 0.592 . . . . 55.34 114.352 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.07 108.21 11.2 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.123 -0.695 . . . . 54.33 109.123 161.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.404 ' HZ ' ' HG2' ' A' ' 63' ' ' GLU . 22.2 t80 -58.55 -27.66 64.77 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.093 0.957 . . . . 73.13 110.624 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 87.7 p -77.71 -24.46 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.981 0.912 . . . . 73.21 113.263 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.19 10.34 39.41 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 122.805 0.442 . . . . 73.11 111.799 -168.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.743 HG23 HG11 ' A' ' 34' ' ' VAL . 18.5 tt -59.49 -25.51 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 C-N-CA 123.067 0.547 . . . . 72.43 112.114 175.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -63.78 -19.25 64.85 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 113.216 0.821 . . . . 51.34 113.216 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -78.25 -25.14 46.72 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.629 0.603 . . . . 74.22 112.629 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' HB3' HD21 ' A' ' 20' ' ' LEU . 56.8 p-90 -117.07 -33.18 4.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.948 0.499 . . . . 64.24 111.791 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.457 ' ND1' HG23 ' A' ' 34' ' ' VAL . 43.5 t-80 -89.34 109.79 33.96 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 123.247 0.619 . . . . 74.02 109.567 -174.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.87 -15.65 36.75 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.928 2.419 . . . . 74.31 114.011 -172.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.425 HE21 ' CE1' ' A' ' 31' ' ' HIS . 2.4 mt-30 -90.49 -26.3 19.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.45 0.7 . . . . 74.35 111.558 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.743 HG11 HG23 ' A' ' 27' ' ' ILE . 99.3 t -74.41 103.55 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.327 0 CA-C-O 121.134 0.492 . . . . 73.14 110.434 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 m -93.45 40.98 1.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.093 0.957 . . . . 72.12 112.56 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 61.1 75.12 0.47 Allowed Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 124.801 1.241 . . . . 71.21 112.926 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.73 ' HB3' ' HA ' ' A' ' 53' ' ' PHE . 94.4 Cg_endo -82.44 -168.15 0.56 Allowed 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 123.563 2.842 . . . . 71.1 115.278 176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 86.7 m -113.77 139.58 49.0 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.596 1.158 . . . . 72.02 111.511 -167.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -92.08 143.5 26.39 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.272 0.629 . . . . 51.45 111.375 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 35.3 mmt180 -115.1 138.35 50.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.854 0.862 . . . . 71.42 110.009 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 46.85 -123.9 7.94 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 115.548 0.979 . . . . 53.13 115.548 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -37.74 139.11 0.32 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 126.153 1.781 . . . . 71.33 114.746 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.0 m -50.55 158.25 1.1 Allowed Pre-proline 0 N--CA 1.498 1.973 0 C-N-CA 125.403 1.481 . . . . 62.43 113.755 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.95 -7.03 13.99 Favored 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 123.05 2.5 . . . . 62.25 114.494 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -109.55 -13.74 14.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.707 0.803 . . . . 71.11 111.445 175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.7 m -88.57 118.43 69.39 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 123.627 0.771 . . . . 51.22 111.009 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.54 121.8 10.14 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.509 2.806 . . . . 72.25 113.319 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.83 -14.56 8.5 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 116.348 -0.387 . . . . 71.33 113.073 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.68 141.42 52.64 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.862 0.865 . . . . 64.42 112.425 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 34.7 mt-10 -116.5 163.53 15.94 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 122.751 0.421 . . . . 64.22 110.249 177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 38' ' ' THR . 48.4 ttt85 -156.17 105.68 2.34 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.93 0.492 . . . . 74.23 110.87 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 55' ' ' ALA . 22.0 t -106.84 113.82 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.289 0.636 . . . . 74.23 111.358 -170.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.73 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.4 m-85 -76.3 70.75 2.95 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 125.042 1.337 . . . . 72.53 111.658 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.49 -50.85 0.53 Allowed Glycine 0 N--CA 1.469 0.887 0 N-CA-C 111.814 -0.514 . . . . 71.11 111.814 -176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 52' ' ' VAL . . . 60.04 24.19 13.39 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.52 1.128 . . . . 53.44 113.876 172.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 139.06 53.62 0.05 OUTLIER Glycine 0 N--CA 1.474 1.23 0 C-N-CA 122.75 0.214 . . . . 42.05 112.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.9 p -121.05 -135.37 0.32 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.22 1.008 . . . . 75.53 108.86 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -130.15 -1.9 4.56 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 119.307 0.958 . . . . 65.01 111.978 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.33 46.77 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.69 0.757 . . . . 61.32 111.946 -168.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -87.15 152.35 22.41 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.384 -0.825 . . . . 60.34 112.004 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.89 132.54 43.39 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.838 0.855 . . . . 73.12 108.865 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 81' ' ' ASP . 53.5 t -102.86 116.67 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.883 -0.511 . . . . 75.43 109.902 175.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HG2' ' HZ ' ' A' ' 24' ' ' PHE . 43.5 tt0 -109.55 154.5 22.63 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.37 1.468 . . . . 75.02 109.605 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -151.94 125.66 8.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.924 0.49 . . . . 74.11 112.163 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.1 tp -66.97 120.76 14.16 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.016 1.326 . . . . 53.54 111.31 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.5 t -88.1 -50.8 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.444 0.698 . . . . 55.14 110.826 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 76' ' ' VAL . 37.5 tt0 -151.98 142.45 22.6 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.549 1.14 . . . . 74.01 109.953 -174.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.483 HH21 ' HA3' ' A' ' 22' ' ' GLY . 3.6 tmt_? -134.23 111.46 10.28 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.884 -0.784 . . . . 73.11 108.884 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -117.33 125.73 51.53 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.727 0.811 . . . . 71.45 110.709 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HG3' ' HE1' ' A' ' 18' ' ' TRP . 33.6 tt0 -90.63 -40.38 11.94 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.251 0.834 . . . . 73.33 113.251 -172.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 80.9 p -67.26 -43.53 81.62 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.878 0.471 . . . . 62.31 111.951 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.35 0.93 54.72 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.063 0.545 . . . . 65.23 112.031 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 94' ' ' GLU . 25.4 mmt85 60.1 38.31 20.51 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.355 1.062 . . . . 60.01 112.293 175.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -114.84 122.87 47.67 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.052 0.941 . . . . 71.12 111.729 -170.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 92' ' ' VAL . 50.1 tp -115.04 108.41 16.65 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.061 0.944 . . . . 71.04 110.213 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 54.1 t -106.35 123.21 60.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.464 0.706 . . . . 62.23 110.132 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.43 ' HE1' HD23 ' A' ' 93' ' ' LEU . 46.5 p90 -151.95 -178.71 6.92 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.928 0.491 . . . . 65.25 111.727 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.433 HG23 ' HD3' ' A' ' 80' ' ' PRO . 9.8 t -153.82 164.63 38.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.142 0.977 . . . . 61.21 111.184 -173.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -106.99 100.28 31.2 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 108.964 -0.754 . . . . 71.3 108.964 160.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.433 ' HD3' HG23 ' A' ' 78' ' ' THR . 36.1 Cg_endo -63.0 -23.03 74.07 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.944 2.429 . . . . 61.43 113.471 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.9 t70 -124.61 82.31 59.51 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.445 0.698 . . . . 72.43 110.028 175.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 45.7 Cg_endo -101.56 144.67 0.26 Allowed 'Trans proline' 0 CA--C 1.573 2.466 0 C-N-CA 123.759 2.973 . . . . 72.34 114.291 175.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 20.0 Cg_exo -69.81 -17.26 37.45 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.768 2.312 . . . . 71.21 113.596 172.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -80.78 155.67 73.1 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 123.942 0.897 . . . . 64.45 111.394 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -79.0 46.84 2.3 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.253 2.635 . . . . 42.31 112.949 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.53 116.8 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 124.197 0.999 . . . . 35.13 109.774 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.4 p -74.96 -79.38 0.09 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.088 0.555 . . . . 70.21 112.39 -172.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -103.38 72.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.929 0.871 . . . . 74.03 109.752 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 110' ' ' MET . 57.5 t-80 -76.03 118.95 19.32 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.622 -0.717 . . . . 72.44 111.818 -175.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.96 150.05 23.6 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.978 0.911 . . . . 74.41 108.914 170.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -147.59 119.49 8.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.6 0.76 . . . . 71.03 109.137 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 48.4 t -126.09 130.12 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.38 0.672 . . . . 54.34 111.869 -169.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.43 HD23 ' HE1' ' A' ' 77' ' ' TYR . 4.3 mm? -107.93 111.57 23.74 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.382 1.073 . . . . 62.12 109.359 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 73' ' ' ARG . 51.0 mt-10 -116.58 111.23 19.6 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.952 0.501 . . . . 74.12 110.413 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.43 105.61 17.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 108.298 -1.001 . . . . 75.43 108.298 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.448 ' HA ' ' HD3' ' A' ' 97' ' ' PRO . 15.5 m -100.57 123.7 45.12 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 122.894 0.478 . . . . 64.24 110.405 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 96' ' ' VAL . 16.4 Cg_exo -68.47 85.81 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.159 2.573 . . . . 74.32 112.614 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -32.93 74.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.143 0.977 . . . . 71.34 109.744 175.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 19.7 t70 -157.31 167.12 31.23 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 126.239 1.816 . . . . 62.44 108.259 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.7 -40.54 95.39 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.208 0.603 . . . . 53.42 112.434 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -108.98 -1.29 19.08 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.614 0.766 . . . . 75.43 111.888 -177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 65.0 m80 -132.5 124.5 28.64 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.243 -0.911 . . . . 71.13 110.153 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.508 ' SG ' HG21 ' A' ' 17' ' ' VAL . 29.1 p -133.1 142.88 48.96 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.003 0.521 . . . . 71.23 110.8 -175.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 44.9 m -97.12 114.33 26.0 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.757 0.423 . . . . 60.14 110.156 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 t -95.3 112.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 109.428 -0.582 . . . . 74.02 109.428 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.77 117.69 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 41.34 109.655 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -108.73 112.73 25.18 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.123 -0.695 . . . . 75.25 109.123 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.3 m -125.22 128.09 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.506 0.722 . . . . 72.02 110.338 -172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -118.65 148.9 42.25 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.611 0.764 . . . . 75.05 111.053 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.432 ' O ' ' HA ' ' A' ' 89' ' ' HIS . 1.8 mpt? -126.17 150.36 48.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.707 0.803 . . . . 71.23 109.139 172.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -162.77 153.14 16.52 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.323 0.649 . . . . 73.02 110.455 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -102.57 78.58 1.73 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.748 0.785 . . . . 63.42 109.456 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t -125.15 168.14 13.83 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 114.779 -1.101 . . . . 71.33 110.984 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -65.05 147.47 98.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 C-N-CA 123.399 0.68 . . . . 74.14 112.174 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -58.7 -31.57 95.16 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.955 2.436 . . . . 55.45 113.411 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -57.94 -55.96 28.12 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.007 0.923 . . . . 72.41 111.604 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.43 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 41.7 m -74.48 -32.02 62.41 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.756 -0.657 . . . . 64.24 111.157 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 122' ' ' GLU . . . -65.6 -41.53 92.69 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.085 0.554 . . . . 61.14 112.029 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -67.31 -31.35 71.58 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 122.648 0.379 . . . . 75.21 111.657 177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -64.96 -42.62 94.44 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.652 -0.499 . . . . 72.23 109.652 170.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 117' ' ' THR . 92.8 mt -72.62 -25.33 61.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.374 0.67 . . . . 75.42 111.717 -176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 118' ' ' ALA . 46.8 mt-10 -61.35 -38.18 86.01 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 118.14 0.427 . . . . 75.31 110.763 173.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 t -76.25 -51.43 12.06 Favored 'General case' 0 CA--C 1.561 1.393 0 N-CA-C 112.694 0.627 . . . . 72.4 112.694 172.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.5 t -72.26 -55.02 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 112.863 0.69 . . . . 63.31 112.863 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 64.4 mt -77.5 -45.58 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 122.75 0.42 . . . . 72.33 110.522 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 130' ' ' PHE . . . -63.45 -47.9 83.19 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 114.855 0.702 . . . . 71.42 114.855 -177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -100.99 -46.55 5.06 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.451 -1.029 . . . . 73.22 112.094 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -68.01 -19.58 71.96 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 114.94 0.736 . . . . 71.25 114.94 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.11 -53.67 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 117.88 0.84 . . . . 73.2 111.443 176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.6 m-30 -73.84 -54.62 7.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 112.333 0.494 . . . . 75.21 112.333 -172.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.05 -32.36 72.0 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.061 0.144 . . . . 74.01 110.968 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.75 -52.22 63.57 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.08 0.552 . . . . 75.51 111.754 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -64.26 -50.25 61.12 Favored Glycine 0 CA--C 1.539 1.541 0 CA-C-N 116.572 -0.285 . . . . 55.21 113.18 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 58.5 mt -62.89 -41.65 99.5 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 74.33 112.716 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.79 -41.5 78.64 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 119.2 -0.429 . . . . 74.43 110.438 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.86 -33.35 75.5 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.85 0.46 . . . . 73.53 111.876 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.504 HD21 HG13 ' A' ' 17' ' ' VAL . 7.8 tt -67.86 -41.33 83.05 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.217 0.607 . . . . 60.12 109.898 173.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.47 -27.73 62.48 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 112.353 0.501 . . . . 75.02 112.353 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -78.77 -37.89 39.97 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.184 0.994 . . . . 63.24 112.118 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 137' ' ' LEU . 8.7 ptm180 -67.71 -34.07 76.14 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.348 0.259 . . . . 65.53 110.971 178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -88.94 -16.94 30.57 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.95 0.5 . . . . 71.2 110.539 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.83 -2.04 75.06 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.878 -0.601 . . . . 35.23 113.252 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -50.07 -33.53 18.72 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.966 1.307 . . . . 74.53 110.413 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.43 151.72 29.52 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.543 1.137 . . . . 60.33 109.607 167.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 73.38 -64.05 0.41 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 125.618 1.567 . . . . 52.3 113.962 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -64.31 126.84 29.08 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.607 0.763 . . . . 73.05 112.905 -171.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -79.83 -23.2 42.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.973 0.509 . . . . 62.44 110.809 167.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 60.39 45.31 11.17 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.782 1.233 . . . . 74.11 109.763 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -146.7 101.97 3.51 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.806 -0.634 . . . . 74.13 111.334 -170.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -112.3 -16.58 12.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.955 0.902 . . . . 75.35 110.892 169.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.949 . . . . 72.11 109.651 171.629 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.971 -0.381 . . . . 71.05 109.971 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.99 79.29 1.25 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.838 0.828 . . . . 73.34 110.876 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.8 m -128.62 116.67 19.96 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.184 0.994 . . . . 62.31 109.581 174.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 126' ' ' GLY . 8.3 mp -108.76 109.49 20.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.931 1.292 . . . . 55.32 109.539 -169.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.8 ttp180 -129.48 135.2 48.34 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.441 0.639 . . . . 70.12 112.214 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -135.56 156.08 49.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.736 1.214 . . . . 74.52 110.648 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.5 p -143.84 154.2 43.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.205 1.002 . . . . 74.32 109.321 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 104' ' ' THR . 9.8 p -150.09 147.54 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 111.591 0.219 . . . . 75.15 111.591 -176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -87.27 118.5 26.74 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.196 0.598 . . . . 72.03 110.546 176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.5 t -111.0 121.05 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.671 1.188 . . . . 61.23 110.131 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.25 72.94 3.83 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.147 0.579 . . . . 52.5 111.044 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -174.02 155.76 2.42 Favored Pre-proline 0 N--CA 1.485 1.293 0 C-N-CA 123.646 0.778 . . . . 71.22 111.134 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -63.0 138.29 67.03 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.704 2.269 . . . . 54.23 111.86 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.01 -25.13 11.16 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.165 0.802 . . . . 72.05 113.165 175.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.42 47.96 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.711 0.634 . . . . 65.44 112.711 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.54 -40.07 71.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.246 0.618 . . . . 71.44 111.636 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.429 HG13 HD21 ' A' ' 137' ' ' LEU . 21.6 t -74.5 -34.86 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.524 0.73 . . . . 55.44 111.125 179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 44.7 t-105 -70.1 -27.76 64.85 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.345 0.658 . . . . 63.14 111.419 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.5 m -63.76 -29.14 70.38 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.389 0.614 . . . . 72.35 111.147 170.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 30' ' ' TRP . 57.5 tp -86.07 -56.72 3.33 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.505 1.122 . . . . 55.24 111.924 -174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -84.56 -25.69 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 C-N-CA 123.099 0.56 . . . . 72.44 112.501 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.13 0.61 62.53 Favored Glycine 0 N--CA 1.481 1.645 0 N-CA-C 114.408 0.523 . . . . 71.2 114.408 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -104.09 163.59 12.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.125 0.97 . . . . 73.44 109.206 165.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.09 -44.26 7.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.794 -0.566 . . . . 74.31 110.551 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.7 p -77.61 -20.26 54.2 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.192 0.441 . . . . 71.12 112.192 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.12 5.79 9.37 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.181 0.592 . . . . 62.51 112.549 -170.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 34' ' ' VAL . 19.1 tt -68.15 -27.31 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 123.305 0.642 . . . . 71.31 112.565 -178.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -66.31 -15.89 63.6 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 112.365 0.505 . . . . 73.13 112.365 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -80.79 -38.33 28.67 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.757 0.823 . . . . 74.21 112.595 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.63 ' HB3' HD21 ' A' ' 20' ' ' LEU . 54.5 p-90 -108.81 -36.37 6.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 122.084 -0.385 . . . . 61.12 111.679 -173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -89.89 110.56 40.71 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.107 0.563 . . . . 71.44 109.619 -176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.06 -21.57 42.75 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 123.134 2.556 . . . . 75.44 114.318 -170.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.501 HE22 ' HA ' ' A' ' 129' ' ' VAL . 35.3 mt-30 -87.45 -16.76 33.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 74.24 112.838 -173.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 27' ' ' ILE . 76.4 t -61.62 127.28 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 122.967 0.507 . . . . 61.34 111.768 176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.8 m -90.23 27.41 1.65 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.34 1.056 . . . . 74.33 112.384 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 34' ' ' VAL . . . 62.46 101.61 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.454 0 C-N-CA 124.437 1.095 . . . . 74.23 111.381 -172.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -86.46 177.51 4.33 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 122.863 2.375 . . . . 73.22 114.707 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 70.5 m -123.84 141.85 51.65 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.098 0.959 . . . . 70.43 110.731 175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.58 126.25 40.74 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.299 0.64 . . . . 65.42 111.298 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.651 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 34.0 mmt180 -103.97 123.78 47.81 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.346 0.659 . . . . 74.42 110.1 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 45.55 -177.77 0.01 OUTLIER Glycine 0 CA--C 1.549 2.177 0 N-CA-C 118.199 2.039 . . . . 63.13 118.199 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.86 -106.23 0.26 Allowed 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.428 1.491 . . . . 50.24 113.687 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.523 ' H ' ' HB2' ' A' ' 49' ' ' ALA . 40.4 t 179.01 147.34 0.39 Allowed Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.454 1.102 . . . . 71.21 109.384 -174.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -54.37 -20.9 21.55 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 123.301 2.667 . . . . 72.03 114.894 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -110.6 3.06 19.05 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.182 0.593 . . . . 73.25 112.547 178.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.4 m -102.38 118.92 57.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 123.729 0.812 . . . . 71.02 110.765 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 66' ' ' VAL . 80.1 Cg_exo -50.38 102.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.52 2.813 . . . . 74.23 113.261 173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 149.42 -31.66 1.14 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.039 -0.528 . . . . 63.31 113.704 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -65.48 144.44 57.03 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.563 0.579 . . . . 54.15 112.563 -177.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 40' ' ' ARG . 46.7 mt-10 -110.92 146.67 36.14 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.33 0.652 . . . . 75.32 111.767 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -118.68 106.59 12.74 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.564 0.746 . . . . 71.23 110.786 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 25.1 t -109.34 102.97 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 123.905 0.882 . . . . 75.44 110.84 -173.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.71 93.79 2.14 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.658 0.783 . . . . 74.03 112.505 -174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 60.43 1.87 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 112.296 -0.321 . . . . 41.41 112.296 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.52 107.63 1.44 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.645 0.778 . . . . 61.53 112.905 -173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.98 24.83 7.44 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 114.159 0.423 . . . . 61.25 114.159 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.2 p -96.52 -77.03 0.49 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.291 0.636 . . . . 75.34 110.669 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 163.11 -35.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.821 1.649 . . . . 62.31 108.491 -171.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -103.7 17.31 24.37 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.189 -0.914 . . . . 74.44 112.581 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.73 136.58 47.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.414 0.626 . . . . 54.33 112.38 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 79' ' ' MET . 44.0 tp -101.69 118.93 37.94 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.606 0.762 . . . . 72.42 109.196 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 81' ' ' ASP . 53.7 t -97.2 113.24 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.476 -0.564 . . . . 75.11 109.476 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.641 ' HA ' ' HA ' ' A' ' 79' ' ' MET . 59.3 mt-10 -108.29 169.62 8.52 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.322 1.049 . . . . 74.42 110.059 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -150.43 121.43 7.68 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.114 0.566 . . . . 74.42 110.373 -173.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.5 tp -72.04 121.59 19.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.128 0.971 . . . . 72.05 111.887 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 82.9 t -90.99 -48.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.53 0.732 . . . . 65.52 111.594 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -166.72 152.75 8.33 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.556 0.343 . . . . 64.22 111.781 -169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.511 HH12 HD22 ' A' ' 75' ' ' LEU . 93.2 mtt-85 -134.9 119.7 18.37 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.719 0.808 . . . . 75.23 111.141 173.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 74' ' ' ARG . 4.0 m-20 -95.91 99.74 11.5 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.453 1.101 . . . . 71.42 109.62 172.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -65.81 -57.87 6.96 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.126 0.57 . . . . 74.21 111.821 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.8 t -70.44 -36.69 74.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.15 0.58 . . . . 75.23 111.784 -175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . . . -79.53 -7.6 58.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.267 0.627 . . . . 33.11 112.147 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 58.21 43.64 20.12 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.761 1.224 . . . . 71.54 112.297 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' ASP . 19.2 ttp180 -124.66 143.72 50.58 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.227 1.011 . . . . 63.45 110.209 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.511 HD22 HH12 ' A' ' 68' ' ' ARG . 10.0 tp -130.39 125.87 35.63 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.905 1.282 . . . . 72.34 109.233 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.14 130.28 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.685 0.794 . . . . 71.04 110.873 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -152.28 177.29 10.71 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.696 0.798 . . . . 74.41 110.706 173.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.7 t -154.97 150.66 27.6 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.684 0.794 . . . . 53.45 110.33 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.641 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 15.4 ptt? -98.65 106.2 35.31 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 122.579 0.351 . . . . 62.25 111.57 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -66.89 -25.8 44.91 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.356 2.704 . . . . 72.14 112.673 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.53 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 10.0 m-20 -123.71 80.1 55.69 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.412 0.685 . . . . 53.45 110.819 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.88 137.49 3.97 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.788 2.325 . . . . 73.53 112.511 172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.37 -14.29 37.07 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.143 1.896 . . . . 73.23 112.118 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 85' ' ' PRO . 62.9 m-85 -76.53 147.51 78.77 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.575 1.15 . . . . 74.34 110.787 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 84' ' ' PHE . 5.5 Cg_exo -77.04 39.37 0.72 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.341 2.694 . . . . 71.25 114.094 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 113' ' ' CYS . 25.2 pt -103.28 152.06 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 124.063 0.945 . . . . 70.2 111.133 -175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 35.4 m -89.14 -86.24 0.19 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 122.522 0.329 . . . . 71.13 111.353 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -98.01 108.66 21.41 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.196 0.522 . . . . 74.32 110.881 -176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.512 ' HE1' ' HB2' ' A' ' 91' ' ' ALA . 39.1 t-80 -95.08 155.57 16.68 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.295 0.569 . . . . 65.14 111.963 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.581 ' HB3' ' HB2' ' A' ' 110' ' ' MET . 16.1 tpt180 -145.83 122.69 11.29 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.564 1.146 . . . . 72.33 108.705 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.512 ' HB2' ' HE1' ' A' ' 89' ' ' HIS . . . -126.24 126.6 44.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 118.654 0.661 . . . . 64.12 111.432 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 75.1 t -130.24 129.58 65.2 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.375 0 C-N-CA 123.377 0.671 . . . . 75.54 112.595 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.24 132.09 46.92 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.364 1.066 . . . . 62.15 108.586 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -143.94 112.57 6.55 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 119.28 0.945 . . . . 75.25 111.658 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.631 ' HB ' ' SG ' ' A' ' 103' ' ' CYS . 26.9 m -95.74 111.25 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 CA-C-O 121.966 0.889 . . . . 64.41 110.533 179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.497 HG23 ' HB ' ' A' ' 104' ' ' THR . 6.6 m -103.58 116.7 61.51 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.834 0.853 . . . . 53.22 110.322 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.01 109.49 2.83 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.652 2.235 . . . . 75.21 113.269 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -66.3 -30.89 71.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.794 0.838 . . . . 62.23 110.719 171.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 102' ' ' HIS . 31.0 t70 -158.54 174.04 15.69 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 125.199 1.399 . . . . 64.52 108.517 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.76 -37.65 66.24 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.555 0.742 . . . . 64.13 112.365 174.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -123.75 28.45 6.9 Favored 'General case' 0 CA--C 1.568 1.642 0 CA-C-O 122.037 0.923 . . . . 74.22 111.564 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 62.1 m80 -138.03 130.44 29.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 72.41 109.488 171.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 95' ' ' VAL . 46.9 t -130.89 162.83 28.8 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.858 0.863 . . . . 44.31 111.125 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.497 ' HB ' HG23 ' A' ' 96' ' ' VAL . 86.8 m -133.96 115.35 14.28 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.405 0.682 . . . . 71.43 110.042 174.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.547 HG22 HG12 ' A' ' 95' ' ' VAL . 15.2 t -90.35 114.61 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.625 -0.509 . . . . 71.12 109.625 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.4 t -106.81 110.91 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.899 0.88 . . . . 65.33 109.285 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -109.54 122.97 48.6 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.247 -0.649 . . . . 74.33 109.247 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.53 HG22 ' SD ' ' A' ' 110' ' ' MET . 21.4 m -129.86 135.98 49.01 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.41 0.684 . . . . 51.14 110.964 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.408 ' HB2' ' HZ ' ' A' ' 130' ' ' PHE . . . -131.7 116.01 16.76 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.657 0.783 . . . . 73.21 112.041 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.581 ' HB2' ' HB3' ' A' ' 90' ' ' ARG . 3.1 mpp? -103.06 134.03 47.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.441 1.097 . . . . 70.22 109.121 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -157.62 143.56 17.47 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 120.731 0.3 . . . . 75.52 111.526 173.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -92.11 82.63 5.06 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.849 0.833 . . . . 75.31 109.434 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.593 ' HB2' HG22 ' A' ' 86' ' ' ILE . 41.1 t -110.97 160.54 16.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.414 -1.266 . . . . 73.11 111.444 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -64.84 134.88 96.18 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 123.655 0.782 . . . . 71.44 110.152 175.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.66 -42.82 64.84 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.544 2.829 . . . . 73.54 115.109 -167.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.57 -37.94 89.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 120.969 0.414 . . . . 63.3 111.903 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.41 ' HB ' ' SG ' ' A' ' 113' ' ' CYS . 33.6 m -74.41 -33.25 62.95 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 122.971 0.508 . . . . 73.42 110.773 175.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.74 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.873 0.869 . . . . 42.24 111.89 -173.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -28.14 67.28 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.081 0.952 . . . . 75.23 112.149 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -69.98 -46.35 65.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.944 -0.391 . . . . 61.22 109.944 171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 76.2 mt -71.45 -22.68 61.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.334 0.654 . . . . 74.45 110.922 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -56.5 -46.47 80.48 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.27 1.028 . . . . 75.42 110.501 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 43.1 m -71.36 -50.01 36.5 Favored 'General case' 0 CA--C 1.557 1.221 0 CA-C-N 115.481 -0.781 . . . . 73.42 112.683 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.93 -56.5 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 123.383 0.673 . . . . 73.04 112.404 -174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.27 -54.29 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 123.878 0.871 . . . . 74.55 110.624 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.423 ' N ' HD23 ' A' ' 4' ' ' LEU . . . -63.94 -33.8 88.23 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 115.655 1.022 . . . . 62.42 115.655 -172.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -117.07 -43.08 2.88 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 118.39 1.095 . . . . 53.52 111.744 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -69.72 -33.84 71.74 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 116.179 -0.464 . . . . 33.0 113.927 -178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.501 ' HA ' HE22 ' A' ' 33' ' ' GLN . 96.6 t -95.93 -56.28 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.069 0.548 . . . . 75.21 110.869 174.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 5.0 m-30 -70.63 -64.16 0.95 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.132 0.573 . . . . 73.22 112.483 -171.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.17 -36.73 71.14 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 123.287 0.367 . . . . 50.11 111.601 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 t -59.78 -54.32 36.18 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 C-N-CA 123.902 0.881 . . . . 64.43 112.277 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.45 -37.74 95.28 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 116.403 -0.362 . . . . 72.44 113.505 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.7 mt -70.93 -36.68 72.74 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.856 0.862 . . . . 63.05 111.972 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -68.77 -40.07 79.92 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 122.639 0.375 . . . . 51.33 110.694 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.21 -38.65 91.81 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.076 0.55 . . . . 60.42 111.625 175.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.429 HD21 HG13 ' A' ' 17' ' ' VAL . 9.0 tt -63.91 -43.0 97.24 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 123.475 0.71 . . . . 74.2 110.335 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.41 73.94 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.057 -0.52 . . . . 61.43 111.799 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.03 -40.08 54.25 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.439 0.696 . . . . 52.51 112.819 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -67.34 -29.58 69.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 112.21 0.448 . . . . 75.14 112.21 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -89.87 -29.18 18.75 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 122.203 -0.311 . . . . 71.32 111.366 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.24 63.49 4.47 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.24 -0.436 . . . . 50.11 112.669 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -70.88 -4.57 25.02 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.137 0.975 . . . . 74.55 112.907 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.7 mt 68.25 121.16 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.725 1.21 . . . . 65.44 112.234 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.64 -16.37 62.27 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.82 0.848 . . . . 70.33 112.576 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -126.87 123.23 36.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.571 0.749 . . . . 72.02 110.069 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -67.66 115.99 7.87 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.277 0.631 . . . . 63.12 110.787 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -146.63 168.04 22.28 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.729 0.812 . . . . 60.11 110.286 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -156.62 142.14 17.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.37 0.668 . . . . 64.44 111.143 -175.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -154.29 114.99 3.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.646 0.778 . . . . 74.45 110.073 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.399 0.618 . . . . 75.41 111.382 177.257 . . . . . . . . 0 0 . 1 stop_ save_